Citrus Sinensis ID: 048205

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------103
Protein Sequence
LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG
Secondary Structure (PSIPRED)
cccccEEEcccccccccccccccccccccEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHHHcccccccEEEccccccEEcccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHHcccccccEEEcccccccccccccccccccccEEEcccccccccccccHHHHHccccccccccccccccccEEEccccccEEEcccccccccccccccccccccEEccccccccccccHHHHccccccccccccccccccccHHHHccccccEEEccccccEEcccHHHHcccccccEEEccccEEEEcccHHccccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccccccEEEcccccccccccHHHHcccccccEEEccccEEEEcccHHHHcccccccEEcccccccccccHHHHccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccEEccccccccccccHHHHccccccEEccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccHHHcccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEccccccccccccccccEEEEccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHccccccccccccccccccHHHcHHHHHHHHHHHHHHcccccccccccHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccEEEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHHccccccccHHHHccccccEEEEEccccccccccHHHccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHHcccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHHHHccccccEEEEEccccccccccHHHHcHHHHccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccccccHcccccccEEEEcccccccccccHHHHcccccEEEEccEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccccccHHHccHHHcccccEEEccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHccccHccEEEcccccEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEcccccHHHHHHcHHHEEccccccccccEEcccccccccHHcEEEEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccHHHHccHHHccccccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
LSNLEYLFLksnmfhgkipstlsnckRLRNISLslndfsgtipkeigNVTTLIGLHLrgnklqgeipeelgNLAELEELWLQnnfltgtipssifnlsslsnldlsvnNLTGELLANICsnlpllqtlfldennfdgkipstllRCKHLQTLSLSindfsgdipkeigNLTKLKYLHLDQnrlqgeipeelgNLAELEKLQLQnnfltgtippsifnlsslsdLELSFNsltgnfpkdmhIVNRLSaelpakfcnnipfLEEIYLsknmfygeipsdlgnctipkeignlAKLEKLDLQFNRlqcvipheidnlhNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYlgsnsffgrlpssadvrlpnleelslsgnnfsgtipsfifntsklstLELQRNsfsgfipntfgnlrnlkwldlgdnyltsstselsflsssnckyleyfsisnnplggilPRVIGNlsqsmedfhmpnsnisgsipkEINNLTNLIAIYLGVNKLNGSILIALGKLKklqllslkdnqlegsipdnlsfsctltsipstlwnLKDILClnlslnfftgplpleigNLKVLVQIDLSinnfsdvipttigglkDLQYLFLKYNrlqgsipdsigdminlkslnlsnnnlfgiipisLEKLLDLKDINVSFNklegeipregpfrnfslesfkgnellcgmpnlqvrscrtrihhtsskndLLIGIVlplsttfmmggksqlndanmplvanQRRFTYLELFQatngfsennligrggfGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEympygslekclyssnyILDIFQRLNIMIDVASALEYLhfgysvpiihcdlkpnnvllddnmvahlsdfgmakpflkedqslTQTQTLATIgymapeygregrvstngdvYSFGIMLMETftrkkptdesftgemTLKRWVNDLLLISIMEVVDanllshedkhfvAKEQCMSFVFNLAMkctiespeerINAKEIVTKLAG
Flexible Loop (DISEMBL)
LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLndfsgtipKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKlegeipregpfRNFSLESFKGNELLCGMPNLQVRSCRTRIhhtsskndlliGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYmapeygregrvsTNGDVYSFGIMLMETFtrkkptdesftgemTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCtiespeerinakeivtklag
Low Complexity Region (SEG)
LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPeelgnlaeleelwlQNNFLTGTIPssifnlsslsnldlsvnnlTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYltsstselsflsssNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNgsilialgklkklqllslkDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMInlkslnlsnnnlFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG
Disordered region (IsUnstruct)
****EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLS****************IPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIE*****************
Disordered Region (DISOPRED)
LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP********************LIGIVLPLSTTFMMG*****************RFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED**LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG
Disordered Region (DISEMBL)
LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG
Disordered Region (DISPRO)
LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN*KEIV**LA*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1027	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.830	0.844	0.367	1e-147
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.966	0.795	0.329	1e-140
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.948	0.777	0.338	1e-137
C0LGT6	1031	LRR receptor-like serine/	no	no	0.820	0.817	0.353	1e-136
Q9FL28	1173	LRR receptor-like serine/	no	no	0.962	0.842	0.327	1e-132
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.923	0.861	0.332	1e-129
Q9LP24	1120	Probable leucine-rich rep	no	no	0.935	0.858	0.327	1e-129
Q9SD62	1025	Putative receptor-like pr	no	no	0.834	0.836	0.355	1e-128
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.959	0.826	0.312	1e-125
O49318	1124	Probable leucine-rich rep	no	no	0.922	0.842	0.332	1e-123

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  523 bits (1347), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 351/956 (36%), Positives = 517/956 (54%), Gaps = 103/956 (10%)

Query: 145  RCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN 204
            R  HL+   L +    G I   IGNL+ L  L L +N   G IP+E+G L+ LE L +  
Sbjct: 67   RVTHLELGRLQL---GGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGI 123

Query: 205  NFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY 264
            N+L G IP  ++N S L +L L  N L G+ P ++                ++  L ++ 
Sbjct: 124  NYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSEL---------------GSLTNLVQLN 168

Query: 265  LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSF 324
            L  N   G++P+ LGN T+         LE+L L  N L+  IP ++  L  +  +    
Sbjct: 169  LYGNNMRGKLPTSLGNLTL---------LEQLALSHNNLEGEIPSDVAQLTQIWSLQLVA 219

Query: 325  NKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFI 384
            N   GV P  ++N+S+LK L +G N F GRL     + LPNL   ++ GN F+G+IP+ +
Sbjct: 220  NNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTL 279

Query: 385  FNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTS-ELSFLSS-SNCKYL 442
             N S L  L +  N+ +G IP TFGN+ NLK L L  N L S +S +L FL+S +NC  L
Sbjct: 280  SNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQL 338

Query: 443  EYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLN 502
            E   I  N LGG LP  I NLS  +    +  + ISGSIP +I NL NL  + L  N L+
Sbjct: 339  ETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLS 398

Query: 503  GSILIALGKLKKLQLLSLKDNQLEGSIP---DNLSFSCTLT--------SIPSTLWNLKD 551
            G +  +LGKL  L+ LSL  N+L G IP    N++   TL          +P++L N   
Sbjct: 399  GPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSH 458

Query: 552  ILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQ 611
            +L L +  N   G +PLEI  ++ L+++D+S N+    +P  IG L++L  L L  N+L 
Sbjct: 459  LLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLS 518

Query: 612  GSIPDSIGD-----------------------MINLKSLNLSNNNLFGIIPISLEKLLDL 648
            G +P ++G+                       ++ +K ++LSNN+L G IP        L
Sbjct: 519  GKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKL 578

Query: 649  KDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCG-MPNLQVRSCRTRI-----HHTSS 702
            + +N+SFN LEG++P +G F N +  S  GN  LCG +   Q++ C ++       H+S 
Sbjct: 579  EYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSR 638

Query: 703  KNDLLIGIVLPLS----------TTFMMGGKSQLNDANMP----LVANQRRFTYLELFQA 748
               ++IG+ + ++          T   +  + +  + N P    L     + +Y +L  A
Sbjct: 639  LKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNA 698

Query: 749  TNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN 807
            TNGFS +N++G G FG VYKA +  +   VAVKV ++Q   A+KSF  EC  +K IRHRN
Sbjct: 699  TNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRN 758

Query: 808  IIKFISSCSSDDF-----KALVLEYMPYGSLEKCLYSS--------NYILDIFQRLNIMI 854
            ++K +++CSS DF     +AL+ E+MP GSL+  L+          +  L + +RLNI I
Sbjct: 759  LVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAI 818

Query: 855  DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ-----SLTQ 909
            DVAS L+YLH     PI HCDLKP+NVLLDD++ AH+SDFG+A+  LK D+      L+ 
Sbjct: 819  DVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSS 878

Query: 910  TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL 969
                 TIGY APEYG  G+ S NGDVYSFGI+L+E FT K+PT+E F G  TL  +    
Sbjct: 879  AGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSA 938

Query: 970  LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            L   I+++VD ++L    +      +C++ VF + ++C  ESP  R+    +V +L
Sbjct: 939  LPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKEL 994

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  500 bits (1288), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 386/1170 (32%), Positives = 564/1170 (48%), Gaps = 177/1170 (15%)

Query: 3    NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKL 62
            NL +L L SN   G IP+ LSN   L ++ L  N  +G IP ++G++  +  L +  N+L
Sbjct: 96   NLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNEL 155

Query: 63   QGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANI--CS 120
             G+IPE LGNL  L+ L L +  LTG IPS +  L  + +L L  N L G + A +  CS
Sbjct: 156  VGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCS 215

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            +L +       EN  +G IP+ L R ++L+ L+L+ N  +G+IP ++G +++L+YL L  
Sbjct: 216  DLTVFTAA---ENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMA 272

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
            N+LQG IP+ L +L  L+ L L  N LTG IP   +N+S L DL L+ N L+G+ PK + 
Sbjct: 273  NQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSI- 331

Query: 241  IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIPK 285
                         C+N   LE++ LS     GEIP +L  C               +IP+
Sbjct: 332  -------------CSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPE 378

Query: 286  EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY 345
             +  L +L  L L  N L+  +   I NL NL+W++   N L G +P  I  +  L+ L+
Sbjct: 379  ALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLF 438

Query: 346  LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
            L  N F G +P        +L+ + + GN+F G IP  I    +L+ L L++N   G +P
Sbjct: 439  LYENRFSGEIPQEIG-NCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLP 497

Query: 406  NTFGNLRNLKWLDLGDNYLTSST-SELSFLSSSNCKYLEYFSISNNPLGGILP------- 457
             + GN   L  LDL DN L+ S  S   FL     K LE   + NN L G LP       
Sbjct: 498  ASLGNCHQLNILDLADNQLSGSIPSSFGFL-----KGLEQLMLYNNSLQGNLPDSLISLR 552

Query: 458  ----------RVIGNL-----SQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLN 502
                      R+ G +     S S   F + N+     IP E+ N  NL  + LG N+L 
Sbjct: 553  NLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLT 612

Query: 503  GSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLT---------------------- 540
            G I   LGK+++L LL +  N L G+IP  L     LT                      
Sbjct: 613  GKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQ 672

Query: 541  -------------SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFS 587
                         S+P+ L+N   +L L+L  N   G +P EIGNL  L  ++L  N FS
Sbjct: 673  LGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFS 732

Query: 588  DV------------------------IPTTIGGLKDLQ-YLFLKYNRLQGSIPDSIGDMI 622
                                      IP  IG L+DLQ  L L YN   G IP +IG + 
Sbjct: 733  GSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLS 792

Query: 623  NLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELL 682
             L++L+LS+N L G +P S+  +  L  +NVSFN L G++ ++  F  +  +SF GN  L
Sbjct: 793  KLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGL 850

Query: 683  CGMPNLQVRSCRT--RIHHTSSKNDLLIGIVLPLSTTFMM------------------GG 722
            CG P  +    R+  +    S+++ ++I  +  L+   +M                  G 
Sbjct: 851  CGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGH 910

Query: 723  KSQ--------LNDANMPLV---ANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARI 771
             S             + PL    A++    + ++ +AT+  SE  +IG GG G VYKA +
Sbjct: 911  GSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAEL 970

Query: 772  QDGMEVAVKVF----DLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS--SDDFKALVL 825
            ++G  VAVK      DL    + KSF  E   + RIRHR+++K +  CS  S+    L+ 
Sbjct: 971  ENGETVAVKKILWKDDLM---SNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIY 1027

Query: 826  EYMPYGSLEKCLYSSNYI-------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 878
            EYM  GS+   L+    +       LD   RL I + +A  +EYLH     PI+H D+K 
Sbjct: 1028 EYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKS 1087

Query: 879  NNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL--ATIGYMAPEYGREGRVSTNGDVY 936
            +NVLLD NM AHL DFG+AK   +   + T + T    + GY+APEY    + +   DVY
Sbjct: 1088 SNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVY 1147

Query: 937  SFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVA-KEQ 995
            S GI+LME  T K PTD  F  EM + RWV   L   +       L+  + K  +  +E 
Sbjct: 1148 SMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHL--EVAGSARDKLIDPKLKPLLPFEED 1205

Query: 996  CMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                V  +A++CT  SP+ER ++++    L
Sbjct: 1206 AACQVLEIALQCTKTSPQERPSSRQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  489 bits (1259), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 375/1107 (33%), Positives = 548/1107 (49%), Gaps = 133/1107 (12%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            L NL+ L L S    G IPS      +L+ + L  N+  G IP EIGN T+L       N
Sbjct: 167  LVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFN 226

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +L G +P EL  L  L+ L L +N  +G IPS + +L S+  L+L  N L G L+    +
Sbjct: 227  RLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQG-LIPKRLT 285

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLD 179
             L  LQTL L  NN  G I     R   L+ L L+ N  SG +PK I  N T LK L L 
Sbjct: 286  ELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLS 345

Query: 180  QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
            + +L GEIP E+ N   L+ L L NN LTG IP S+F L  L++L L+ NSL G     +
Sbjct: 346  ETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSI 405

Query: 240  HIVNRLSA------ELPAKFCNNIPF---LEEIYLSKNMFYGEIPSDLGNCT-------- 282
              +  L         L  K    I F   LE +YL +N F GE+P ++GNCT        
Sbjct: 406  SNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWY 465

Query: 283  -------IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTI 335
                   IP  IG L  L +L L+ N L   IP  + N H +  +  + N+L G +P++ 
Sbjct: 466  GNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSF 525

Query: 336  FNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
              ++ L+   + +NS  G LP S  + L NL  ++ S N F+G+I     ++S LS  ++
Sbjct: 526  GFLTALELFMIYNNSLQGNLPDSL-INLKNLTRINFSSNKFNGSISPLCGSSSYLS-FDV 583

Query: 396  QRNSFSGFIPNTFGNLRNLKWLDLGDNYLT-------SSTSELSFLSSSN---------- 438
              N F G IP   G   NL  L LG N  T          SELS L  S           
Sbjct: 584  TENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVE 643

Query: 439  ---CKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIY 495
               CK L +  ++NN L G++P  +G L   + +  + ++   GS+P EI +LTN++ ++
Sbjct: 644  LGLCKKLTHIDLNNNYLSGVIPTWLGKLPL-LGELKLSSNKFVGSLPTEIFSLTNILTLF 702

Query: 496  LGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCL 555
            L  N LNGSI   +G L+ L  L+L++NQL G              +PST+  L  +  L
Sbjct: 703  LDGNSLNGSIPQEIGNLQALNALNLEENQLSG-------------PLPSTIGKLSKLFEL 749

Query: 556  NLSLNFFTGPLPLEIGNLKVL-VQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSI 614
             LS N  TG +P+EIG L+ L   +DLS NNF+  IP+TI  L  L+ L L +N+L G +
Sbjct: 750  RLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEV 809

Query: 615  PDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLE 674
            P  IGDM +L  LNL                        S+N LEG++ ++  F  +  +
Sbjct: 810  PGQIGDMKSLGYLNL------------------------SYNNLEGKLKKQ--FSRWQAD 843

Query: 675  SFKGNELLCGMPNLQVRSCRTRIHHT-SSKNDLLIGIVLPLSTTFMM------------- 720
            +F GN  LCG P        ++   + S K  ++I  +  L+   +M             
Sbjct: 844  AFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHD 903

Query: 721  ------GG----KSQLNDANMPLVAN---QRRFTYLELFQATNGFSENNLIGRGGFGFVY 767
                  GG     S  + +  PL +N   +    + ++ +AT+  +E  +IG GG G VY
Sbjct: 904  LFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVY 963

Query: 768  KARIQDGMEVAVKVF----DLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFK 821
            KA +++G  +AVK      DL    + KSF+ E   +  IRHR+++K +  CSS  D   
Sbjct: 964  KAELKNGETIAVKKILWKDDLM---SNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLN 1020

Query: 822  ALVLEYMPYGSLEKCLYSS-----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             L+ EYM  GS+   L+++       +L    RL I + +A  +EYLH+    PI+H D+
Sbjct: 1021 LLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDI 1080

Query: 877  KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL--ATIGYMAPEYGREGRVSTNGD 934
            K +NVLLD N+ AHL DFG+AK       + T++ T+   + GY+APEY    + +   D
Sbjct: 1081 KSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSD 1140

Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKE 994
            VYS GI+LME  T K PT+  F  E  + RWV  +L           L+  E K  +  E
Sbjct: 1141 VYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCE 1200

Query: 995  QCMSF-VFNLAMKCTIESPEERINAKE 1020
            +  ++ V  +A++CT   P+ER ++++
Sbjct: 1201 EEAAYQVLEIALQCTKSYPQERPSSRQ 1227

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  485 bits (1248), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 339/959 (35%), Positives = 493/959 (51%), Gaps = 116/959 (12%)

Query: 147  KHLQTLSLSINDF--SGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN 204
            +  + +SL++  F  +G I   IGNL+ L+ L+L  N     IP+++G L  L+ L +  
Sbjct: 71   RRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSY 130

Query: 205  NFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY 264
            N L G IP S+ N S LS ++LS N L    P ++  +++L+                + 
Sbjct: 131  NLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAI---------------LD 175

Query: 265  LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSF 324
            LSKN   G  P+ L         GNL  L+KLD  +N+++  IP E+  L  + +   + 
Sbjct: 176  LSKNNLTGNFPASL---------GNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIAL 226

Query: 325  NKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFI 384
            N   G  P  ++N+S+L+ L L  NSF G L +     LPNL  L L  N F+G IP  +
Sbjct: 227  NSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTL 286

Query: 385  FNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL-GDNYLTSSTSELSFLSS-SNCKYL 442
             N S L   ++  N  SG IP +FG LRNL WL +  ++   +S+S L F+ + +NC  L
Sbjct: 287  ANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQL 346

Query: 443  EYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLN 502
            EY  +  N LGG LP  I NLS ++    +  + ISG+IP +I NL +L  + L  N L+
Sbjct: 347  EYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLS 406

Query: 503  GSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLT---------------------- 540
            G + ++ GKL  LQ++ L  N + G IP        L                       
Sbjct: 407  GELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRY 466

Query: 541  -------------SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFS 587
                         +IP  +  +  +  ++LS NF TG  P E+G L++LV +  S N  S
Sbjct: 467  LLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLS 526

Query: 588  DVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLD 647
              +P  IGG   +++LF++ N   G+IPD I  +++LK+++ SNNNL G IP  L  L  
Sbjct: 527  GKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPS 585

Query: 648  LKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLC-GMPNLQVRSCRTRIHHTSSK--- 703
            L+++N+S NK EG +P  G FRN +  S  GN  +C G+  +Q++ C  +      K   
Sbjct: 586  LRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLS 645

Query: 704  --------------NDLLIGIVLPLSTTFMMGGKSQLNDAN----MPLVANQRRFTYLEL 745
                          + LLI IV  L        K+  +D N      L     + +Y EL
Sbjct: 646  VRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEEL 705

Query: 746  FQATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR 804
              AT+ FS  NLIG G FG V+K  +  +   VAVKV +L    A KSF  EC   K IR
Sbjct: 706  HSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIR 765

Query: 805  HRNIIKFISSCSS-----DDFKALVLEYMPYGSLEKCLY--------SSNYILDIFQRLN 851
            HRN++K I+ CSS     +DF+ALV E+MP GSL+  L           +  L   ++LN
Sbjct: 766  HRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLN 825

Query: 852  IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ-----S 906
            I IDVASALEYLH     P+ HCD+KP+N+LLDD++ AH+SDFG+A+   K D+      
Sbjct: 826  IAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQ 885

Query: 907  LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV 966
             +      TIGY APEYG  G+ S  GDVYSFGI+L+E F+ KKPTDESF G+  L  + 
Sbjct: 886  FSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYT 945

Query: 967  NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                  SI+    ++  S+      A ++ +  V  + +KC+ E P +R+   E V +L
Sbjct: 946  K-----SILSGCTSSGGSN------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVREL 993

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  472 bits (1214), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 358/1094 (32%), Positives = 546/1094 (49%), Gaps = 106/1094 (9%)

Query: 14   FHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNL 73
              G +   ++N   L+ + L+ N F+G IP EIG +T L  L L  N   G IP  +  L
Sbjct: 84   LEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWEL 143

Query: 74   AELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN 133
              +  L L+NN L+G +P  I   SSL  +    NNLTG++      +L  LQ      N
Sbjct: 144  KNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKI-PECLGDLVHLQMFVAAGN 202

Query: 134  NFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGN 193
            +  G IP ++    +L  L LS N  +G IP++ GNL  L+ L L +N L+G+IP E+GN
Sbjct: 203  HLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGN 262

Query: 194  LAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSA------ 247
             + L +L+L +N LTG IP  + NL  L  L +  N LT + P  +  + +L+       
Sbjct: 263  CSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSEN 322

Query: 248  ELPAKFCNNIPFLEEI---YLSKNMFYGEIP---SDLGNCTI------------PKEIGN 289
             L       I FLE +    L  N F GE P   ++L N T+            P ++G 
Sbjct: 323  HLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL 382

Query: 290  LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSN 349
            L  L  L    N L   IP  I N   L+ +  S N++ G +P   F    L F+ +G N
Sbjct: 383  LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRG-FGRMNLTFISIGRN 441

Query: 350  SFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFG 409
             F G +P        NLE LS++ NN +GT+   I    KL  L++  NS +G IP   G
Sbjct: 442  HFTGEIPDDI-FNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIG 500

Query: 410  NLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMED 469
            NL++L  L L  N  T           SN   L+   + +N L G +P  + ++ + +  
Sbjct: 501  NLKDLNILYLHSNGFTGRIPR----EMSNLTLLQGLRMYSNDLEGPIPEEMFDM-KLLSV 555

Query: 470  FHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSI 529
              + N+  SG IP   + L +L  + L  NK NGSI  +L  L  L    + DN L G+I
Sbjct: 556  LDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTI 615

Query: 530  PDNLSFSCTLTSIPSTLWNLKDI-LCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSD 588
            P  L            L +LK++ L LN S N  TG +P E+G L+++ +IDLS N FS 
Sbjct: 616  PGEL------------LASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSG 663

Query: 589  VIPTTIGGLKDLQYLFLKYNRLQGSIPD-------------------------SIGDMIN 623
             IP ++   K++  L    N L G IPD                         S G+M +
Sbjct: 664  SIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTH 723

Query: 624  LKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLC 683
            L SL+LS+NNL G IP SL  L  LK + ++ N L+G +P  G F+N +     GN  LC
Sbjct: 724  LVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLC 783

Query: 684  GMPN-LQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMM-------------------GGK 723
            G    L+  + + +  H S +  +++ I+   +   ++                     +
Sbjct: 784  GSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSE 843

Query: 724  SQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFD 783
            S L D +  L    +RF   EL QAT+ F+  N+IG      VYK +++DG  +AVKV +
Sbjct: 844  SSLPDLDSAL--KLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLN 901

Query: 784  LQ--YGRAIKSFDIECGMIKRIRHRNIIKFIS-SCSSDDFKALVLEYMPYGSLEKCLYSS 840
            L+     + K F  E   + +++HRN++K +  +  S   KALVL +M  G+LE  ++ S
Sbjct: 902  LKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGS 961

Query: 841  NY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
               I  + +++++ + +AS ++YLH GY  PI+HCDLKP N+LLD + VAH+SDFG A+ 
Sbjct: 962  AAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARI 1021

Query: 900  F-LKEDQSLTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPT--DE 954
               +ED S T + +    TIGY+APE+    +V+T  DV+SFGI++ME  T+++PT  ++
Sbjct: 1022 LGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLND 1081

Query: 955  SFTGEMTLKRWVNDLL---LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIES 1011
              + +MTL++ V   +      ++ V+D  L   +    + +E+ +     L + CT   
Sbjct: 1082 EDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSR 1139

Query: 1012 PEERINAKEIVTKL 1025
            PE+R +  EI+T L
Sbjct: 1140 PEDRPDMNEILTHL 1153

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  463 bits (1192), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 353/1062 (33%), Positives = 523/1062 (49%), Gaps = 114/1062 (10%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            L  L  L + +N   G IP  LS C+ L  + L  N F G IP ++  + TL  L+L  N
Sbjct: 90   LHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCEN 149

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
             L G IP ++GNL+ L+EL + +N LTG IP S+  L  L  +    N  +G + + I S
Sbjct: 150  YLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEI-S 208

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
                L+ L L EN  +G +P  L + ++L  L L  N  SG+IP  +GN+++L+ L L +
Sbjct: 209  GCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHE 268

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM- 239
            N   G IP E+G L ++++L L  N LTG IP  I NL   ++++ S N LTG  PK+  
Sbjct: 269  NYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFG 328

Query: 240  HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQ 299
            HI+N                L+ ++L +N+  G          IP+E+G L  LEKLDL 
Sbjct: 329  HILN----------------LKLLHLFENILLG---------PIPRELGELTLLEKLDLS 363

Query: 300  FNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSA 359
             NRL   IP E+  L  L  +    N+L G +P  I   S    L + +NS  G +P+  
Sbjct: 364  INRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHF 423

Query: 360  DVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL 419
              R   L  LSL  N  SG IP  +     L+ L L  N  +G +P    NL+NL  L+L
Sbjct: 424  -CRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALEL 482

Query: 420  GDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISG 479
              N+L+ + S          K LE   ++NN   G +P  IGNL++ +  F++ ++ ++G
Sbjct: 483  HQNWLSGNISA----DLGKLKNLERLRLANNNFTGEIPPEIGNLTK-IVGFNISSNQLTG 537

Query: 480  SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
             IPKE+ +   +  + L  NK +G I   LG+L  L++L L DN+L G IP +       
Sbjct: 538  HIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFG----- 592

Query: 540  TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVL-VQIDLSINNFSDVIPTTIGGLK 598
                    +L  ++ L L  N  +  +P+E+G L  L + +++S NN S  IP ++G L+
Sbjct: 593  --------DLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQ 644

Query: 599  DLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
             L+ L+L  N+L G IP SIG++++L   N+SNNNL G +P          D  V     
Sbjct: 645  MLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVP----------DTAV----- 689

Query: 659  EGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIG--------- 709
                     F+     +F GN  LC   N Q   C+  + H+ SK + LI          
Sbjct: 690  ---------FQRMDSSNFAGNHGLC---NSQRSHCQPLVPHSDSKLNWLINGSQRQKILT 737

Query: 710  -IVLPLSTTFMMG-------------GKSQLNDANMPLVAN-----QRRFTYLELFQATN 750
               + + + F++                  L D   P V +     ++ FTY  L  AT 
Sbjct: 738  ITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATR 797

Query: 751  GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIK--SFDIECGMIKRIRHRNI 808
             FSE+ ++GRG  G VYKA +  G  +AVK  + +   A    SF  E   + +IRHRNI
Sbjct: 798  NFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNI 857

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFG 866
            +K    C   +   L+ EYM  GSL + L     N +LD   R  I +  A  L YLH  
Sbjct: 858  VKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHD 917

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
                I+H D+K NN+LLD+   AH+ DFG+AK  +    S + +    + GY+APEY   
Sbjct: 918  CRPQIVHRDIKSNNILLDERFQAHVGDFGLAK-LIDLSYSKSMSAVAGSYGYIAPEYAYT 976

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL--LISIMEVVDANLLS 984
             +V+   D+YSFG++L+E  T K P      G   L  WV   +  +I  +E+ DA L +
Sbjct: 977  MKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMIPTIEMFDARLDT 1035

Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
            + DK  V +   MS V  +A+ CT  SP  R   +E+V  + 
Sbjct: 1036 N-DKRTVHE---MSLVLKIALFCTSNSPASRPTMREVVAMIT 1073

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  462 bits (1188), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 355/1085 (32%), Positives = 527/1085 (48%), Gaps = 124/1085 (11%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            LSNL Y+ L  N+  G IP    N  +L    LS N  +G I   +GN+  L  L+L  N
Sbjct: 101  LSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQN 160

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
             L   IP ELGN+  + +L L  N LTG+IPSS+ NL +L  L L  N LTG +   +  
Sbjct: 161  YLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPEL-G 219

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            N+  +  L L +N   G IPSTL   K+L  L L  N  +G IP EIGN+  +  L L Q
Sbjct: 220  NMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQ 279

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP---- 236
            N+L G IP  LGNL  L  L L  N+LTG IPP + N+ S+ DLELS N LTG+ P    
Sbjct: 280  NKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLG 339

Query: 237  --KDMHIV----NRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC--------- 281
              K++ I+    N L+  +P +   N+  + ++ L+ N   G IPS  GN          
Sbjct: 340  NLKNLTILYLYENYLTGVIPPEL-GNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLY 398

Query: 282  ------TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTI 335
                   IP+E+GN+  +  LDL  N+L   +P    N   LE +    N L G +P  +
Sbjct: 399  LNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGV 458

Query: 336  FNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
             N S L  L L +N+F G  P +   +   L+ +SL  N+  G IP  + +   L     
Sbjct: 459  ANSSHLTTLILDTNNFTGFFPETV-CKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARF 517

Query: 396  QRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGI 455
              N F+G I   FG   +L ++D   N             SSN +        +  LG +
Sbjct: 518  LGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEI-------SSNWE-------KSPKLGAL 563

Query: 456  LPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKL 515
            +               M N+NI+G+IP EI N+T L+ + L  N L G +  A+G L  L
Sbjct: 564  I---------------MSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNL 608

Query: 516  QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKV 575
              L L  NQL G +P  LSF             L ++  L+LS N F+  +P    +   
Sbjct: 609  SRLRLNGNQLSGRVPAGLSF-------------LTNLESLDLSSNNFSSEIPQTFDSFLK 655

Query: 576  LVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLF 635
            L  ++LS N F   IP  +  L  L  L L +N+L G IP  +  + +L  L+LS+NNL 
Sbjct: 656  LHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLS 714

Query: 636  GIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCG-MPNLQVRSCR 694
            G+IP + E ++ L ++++S NKLEG +P    FR  + ++ + N  LC  +P  +++ CR
Sbjct: 715  GLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCR 774

Query: 695  TRIHHTSSKNDLLIGIVLPL----------STTFMMG-GKSQLNDA---------NMPLV 734
              +       +L++ I++P+          + TF     K +L +          NM + 
Sbjct: 775  -ELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIF 833

Query: 735  ANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVK----VFDLQYGRAI 790
            +   +F Y ++ ++TN F   +LIG GG+  VY+A +QD + +AVK      D +  + +
Sbjct: 834  SVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPV 892

Query: 791  --KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI--LDI 846
              + F  E   +  IRHRN++K    CS      L+ EYM  GSL K L +      L  
Sbjct: 893  VKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTW 952

Query: 847  FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
             +R+N++  VA AL Y+H     PI+H D+   N+LLD++  A +SDFG AK  LK D S
Sbjct: 953  TKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAK-LLKTDSS 1011

Query: 907  LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTD-----ESFTGEMT 961
               +    T GY+APE+    +V+   DVYSFG++++E    K P D      S  GE  
Sbjct: 1012 -NWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEA- 1069

Query: 962  LKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                      +S+  + D  +L    ++   +E+ +  V  +A+ C   +PE R     I
Sbjct: 1070 ----------LSLRSISDERVLEPRGQN---REKLLKMV-EMALLCLQANPESRPTMLSI 1115

Query: 1022 VTKLA 1026
             T  +
Sbjct: 1116 STTFS 1120

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  459 bits (1182), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 342/962 (35%), Positives = 499/962 (51%), Gaps = 105/962 (10%)

Query: 144  LRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQ 203
            L+ + +  + L     +G +   +GNL+ L+ L+L  N   G IP E+GNL  L+ L + 
Sbjct: 78   LKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMS 137

Query: 204  NNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEI 263
            NN   G IP  + N SSLS L+LS N L    P +   +++L      +           
Sbjct: 138  NNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGR----------- 186

Query: 264  YLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFS 323
                N   G+ P+ LGN         L  L+ LD  +N+++  IP +I  L  + +   +
Sbjct: 187  ----NNLTGKFPASLGN---------LTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIA 233

Query: 324  FNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSF 383
             NK  GV P  I+N+S+L FL +  NSF G L       LPNL+ L +  N+F+GTIP  
Sbjct: 234  LNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPET 293

Query: 384  IFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS-STSELSFLSS-SNCKY 441
            + N S L  L++  N  +G IP +FG L+NL  L L +N L + S+ +L FL + +NC  
Sbjct: 294  LSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQ 353

Query: 442  LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKL 501
            L+Y ++  N LGG LP  I NLS  + +  +  + ISGSIP  I NL +L  + LG N L
Sbjct: 354  LQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLL 413

Query: 502  NGSILIALGKLKKLQ------------------------LLSLKDNQLEGSIPDNLSFSC 537
             G +  +LG+L +L+                         L L +N  EGSIP +L  SC
Sbjct: 414  TGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLG-SC 472

Query: 538  TL------------TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINN 585
            +              SIP  L  L  ++ LN+S N   GPL  +IG LK L+ +D+S N 
Sbjct: 473  SYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNK 532

Query: 586  FSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKL 645
             S  IP T+     L++L L+ N   G IPD I  +  L+ L+LS NNL G IP  +   
Sbjct: 533  LSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANF 591

Query: 646  LDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLC-GMPNLQVRSCRTRI--HHTSS 702
              L+++N+S N  +G +P EG FRN S  S  GN  LC G+P+LQ++ C   +   H+S 
Sbjct: 592  SKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSV 651

Query: 703  KNDLLIGIV------------------LPLSTTFMMGGKSQLNDANMPLVANQRRFTYLE 744
            +  + I +                     L    +    ++ + +  P+ +   + +Y E
Sbjct: 652  RKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDE 711

Query: 745  LFQATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI 803
            L++ T GFS +NLIG G FG V+K  +      VA+KV +L    A KSF  EC  +  I
Sbjct: 712  LYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGI 771

Query: 804  RHRNIIKFISSCSS-----DDFKALVLEYMPYGSLEKCLY--------SSNYILDIFQRL 850
            RHRN++K ++ CSS     +DF+ALV E+MP G+L+  L+        + +  L +F RL
Sbjct: 772  RHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARL 831

Query: 851  NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
            NI IDVASAL YLH     PI HCD+KP+N+LLD ++ AH+SDFG+A+  LK D+     
Sbjct: 832  NIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHI 891

Query: 911  Q-----TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW 965
            Q        TIGY APEYG  G  S  GDVYSFGI+L+E FT K+PT++ F   +TL  +
Sbjct: 892  QFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSF 951

Query: 966  VNDLLLI-SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024
                L     +++ D  +L           +C++ VF + + C+ ESP  RI+  E ++K
Sbjct: 952  TKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISK 1011

Query: 1025 LA 1026
            L 
Sbjct: 1012 LV 1013

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  450 bits (1158), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 356/1138 (31%), Positives = 542/1138 (47%), Gaps = 153/1138 (13%)

Query: 15   HGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLA 74
             G+IP  +S+ K LR + L+ N FSG IP EI N+  L  L L GN L G +P  L  L 
Sbjct: 78   RGQIPKEISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELP 137

Query: 75   ELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN 133
            +L  L L +N  +G++P S F +L +LS+LD+S N+L+GE+   I   L  L  L++  N
Sbjct: 138  QLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEI-GKLSNLSNLYMGLN 196

Query: 134  NFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGN 193
            +F G+IPS +     L+  +     F+G +PKEI  L  L  L L  N L+  IP+  G 
Sbjct: 197  SFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGE 256

Query: 194  LAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIV---------NR 244
            L  L  L L +  L G IPP + N  SL  L LSFNSL+G  P ++  +         N+
Sbjct: 257  LHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQ 316

Query: 245  LSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIPKEIGN 289
            LS  LP+ +      L+ + L+ N F GEIP ++ +C               +IP+E+  
Sbjct: 317  LSGSLPS-WMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCG 375

Query: 290  LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSN 349
               LE +DL  N L   I    D   +L  ++ + N++ G +P  ++ +  L  L L SN
Sbjct: 376  SGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKL-PLMALDLDSN 434

Query: 350  SFFGRLPSS----------------ADVRLP-------NLEELSLSGNNFSGTIPSFIFN 386
            +F G +P S                 +  LP       +L+ L LS N  +G IP  I  
Sbjct: 435  NFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGK 494

Query: 387  TSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSE-LSFLSSSNCKYLEY- 444
             + LS L L  N F G IP   G+  +L  LDLG N L     + ++ L+   C  L Y 
Sbjct: 495  LTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYN 554

Query: 445  ------------------------------FSISNNPLGGILPRVIGNLSQSMEDFHMPN 474
                                          F +S N L G +P  +G     +E   + N
Sbjct: 555  NLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVE-ISLSN 613

Query: 475  SNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLS 534
            +++SG IP  ++ LTNL  + L  N L GSI   +G   KLQ L+L +NQL G IP++  
Sbjct: 614  NHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFG 673

Query: 535  FSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI 594
                          L  ++ LNL+ N   GP+P  +GNLK L  +DLS NN S  + + +
Sbjct: 674  L-------------LGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSEL 720

Query: 595  GGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVS 654
              ++ L  L+++ N+  G IP  +G++  L+ L++S N L G IP  +  L +L+ +N++
Sbjct: 721  STMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLA 780

Query: 655  FNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCR---TRIHHTSSKNDLLIG-- 709
             N L GE+P +G  ++ S     GN+ LCG   +    C+   T++        L++G  
Sbjct: 781  KNNLRGEVPSDGVCQDPSKALLSGNKELCG--RVVGSDCKIEGTKLRSAWGIAGLMLGFT 838

Query: 710  -----IVLPLSTTFMMGGKSQLND------------------------ANMPLVANQRRF 740
                  V  L    M     Q +D                        +  PL  N   F
Sbjct: 839  IIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMF 898

Query: 741  TYL-------ELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSF 793
                      ++ +AT+ FS+ N+IG GGFG VYKA +     VAVK       +  + F
Sbjct: 899  EQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREF 958

Query: 794  DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF---QRL 850
              E   + +++H N++  +  CS  + K LV EYM  GSL+  L +   +L++    +RL
Sbjct: 959  MAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRL 1018

Query: 851  NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
             I +  A  L +LH G+   IIH D+K +N+LLD +    ++DFG+A+  +   +S   T
Sbjct: 1019 KIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLAR-LISACESHVST 1077

Query: 911  QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFT---GEMTLKRWVN 967
                T GY+ PEYG+  R +T GDVYSFG++L+E  T K+PT   F    G   +   + 
Sbjct: 1078 VIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQ 1137

Query: 968  DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +     ++V+D  L+S      VA +     +  +AM C  E+P +R N  +++  L
Sbjct: 1138 KINQGKAVDVIDPLLVS------VALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKAL 1189

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  442 bits (1138), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 352/1060 (33%), Positives = 509/1060 (48%), Gaps = 113/1060 (10%)

Query: 30   NISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGT 89
            ++ LS  + SG +   IG +  L+ L+L  N L G+IP E+GN ++LE ++L NN   G+
Sbjct: 89   SLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGS 148

Query: 90   IPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHL 149
            IP  I  LS L + ++  N L+G L   I  +L  L+ L    NN  G +P +L     L
Sbjct: 149  IPVEINKLSQLRSFNICNNKLSGPLPEEI-GDLYNLEELVAYTNNLTGPLPRSLGNLNKL 207

Query: 150  QTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG 209
             T     NDFSG+IP EIG    LK L L QN + GE+P+E+G L +L+++ L  N  +G
Sbjct: 208  TTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSG 267

Query: 210  TIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNM 269
             IP  I NL+SL  L L  NSL G  P ++                N+  L+++YL +N 
Sbjct: 268  FIPKDIGNLTSLETLALYGNSLVGPIPSEI---------------GNMKSLKKLYLYQNQ 312

Query: 270  FYGEIPSDLGNCT---------------IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL 314
              G IP +LG  +               IP E+  +++L  L L  N+L  +IP+E+  L
Sbjct: 313  LNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKL 372

Query: 315  HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGN 374
             NL  +  S N L G +P    N+++++ L L  NS  G +P    +  P L  +  S N
Sbjct: 373  RNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSP-LWVVDFSEN 431

Query: 375  NFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS-TSELSF 433
              SG IP FI   S L  L L  N   G IP      ++L  L +  N LT    +EL  
Sbjct: 432  QLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTEL-- 489

Query: 434  LSSSNCKY--LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNL 491
                 CK   L    +  N   G LP  IG   Q ++  H+  +  S ++P EI+ L+NL
Sbjct: 490  -----CKLVNLSAIELDQNRFSGPLPPEIGT-CQKLQRLHLAANQFSSNLPNEISKLSNL 543

Query: 492  IAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKD 551
            +   +  N L G I   +   K LQ L L  N   GS+P  L              +L  
Sbjct: 544  VTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELG-------------SLHQ 590

Query: 552  ILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLF-LKYNRL 610
            +  L LS N F+G +P  IGNL  L ++ +  N FS  IP  +G L  LQ    L YN  
Sbjct: 591  LEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDF 650

Query: 611  QGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 670
             G IP  IG++  L  L+L+NN+L G IP + E L  L   N S+N L G++P    F+N
Sbjct: 651  SGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQN 710

Query: 671  FSLESFKGNELLCGMPNLQVRSC---RTRIHHTSSKND---------------------L 706
             +L SF GN+ LCG     +RSC    +   H SS                        L
Sbjct: 711  MTLTSFLGNKGLCGG---HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLL 767

Query: 707  LIGIVL-----PLSTT--FMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIG 759
            LI IV+     P+  T  ++   +    ++++  V  + RFT  ++ +AT GF ++ ++G
Sbjct: 768  LIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE-RFTVKDILEATKGFHDSYIVG 826

Query: 760  RGGFGFVYKARIQDGMEVAVKVFD-------LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            RG  G VYKA +  G  +AVK  +               SF  E   + +IRHRNI++  
Sbjct: 827  RGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLY 886

Query: 813  SSC--SSDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSV 869
            S C     +   L+ EYM  GSL + L+   ++ +D   R  I +  A  L YLH     
Sbjct: 887  SFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKP 946

Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
             IIH D+K NN+L+D+N  AH+ DFG+AK  +    S + +    + GY+APEY    +V
Sbjct: 947  RIIHRDIKSNNILIDENFEAHVGDFGLAK-VIDMPLSKSVSAVAGSYGYIAPEYAYTMKV 1005

Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW----VNDLLLISIMEVVDANLLSH 985
            +   D+YSFG++L+E  T K P      G   L  W    + D  L S  E++D  L   
Sbjct: 1006 TEKCDIYSFGVVLLELLTGKAPVQPLEQGG-DLATWTRNHIRDHSLTS--EILDPYLTKV 1062

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            ED   +     M  V  +A+ CT  SP +R   +E+V  L
Sbjct: 1063 EDDVILNH---MITVTKIAVLCTKSSPSDRPTMREVVLML 1099

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1027
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.982	0.693	0.471	0.0
359485176	1160	PREDICTED: probable LRR receptor-like se	0.981	0.868	0.471	0.0
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.996	0.832	0.445	0.0
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.996	0.848	0.448	0.0
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.979	0.708	0.460	0.0
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.996	0.833	0.445	0.0
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.956	0.791	0.451	0.0
359485453	1202	PREDICTED: probable LRR receptor-like se	0.972	0.831	0.463	0.0
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.994	0.816	0.442	0.0
359485449	1583	PREDICTED: LRR receptor-like serine/thre	0.967	0.627	0.465	0.0

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  891 bits (2303), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 516/1094 (47%), Positives = 683/1094 (62%), Gaps = 85/1094 (7%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            L NL+ L+L  N   G++PSTLS C +L+++SL  N F+G IP   GN+T L  L L  N
Sbjct: 368  LPNLQGLYLSWNKLSGQLPSTLSLCGQLQSLSLWGNRFTGNIPPSFGNLTALQVLELAEN 427

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
             + G IP ELGNL  L+ L L  N LTG IP +IFN+SSL  +D S N+L+G L  +IC 
Sbjct: 428  NIPGNIPSELGNLINLQYLKLSANNLTGIIPEAIFNISSLQEIDFSNNSLSGCLPMDICK 487

Query: 121  NLPLLQTL-FLD--ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLH 177
            +LP L  L F+D   N   G+IPS+L  C HL+ LSLS+N F+G IP+ IG+L+ L+ L+
Sbjct: 488  HLPDLPKLEFIDLSSNQLKGEIPSSLSHCPHLRGLSLSLNQFTGGIPQAIGSLSNLEELY 547

Query: 178  LDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPK 237
            L  N L G IP E+GNL+ L  L   ++ ++G IPP IFN+SSL   +L+ NSL G+ P 
Sbjct: 548  LAYNNLVGGIPREIGNLSNLNILDFGSSGISGPIPPEIFNISSLQIFDLTDNSLLGSLPM 607

Query: 238  DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------T 282
            D++               ++P L+E+YLS N   G++PS L  C                
Sbjct: 608  DIY--------------KHLPNLQELYLSWNKLSGQLPSTLSLCGQLQSLSLWGNRFTGN 653

Query: 283  IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLK 342
            IP   GNL  L+ L+L  N +Q  IP+E+ NL NL+ +  S N L G++P  IFN+S L+
Sbjct: 654  IPPSFGNLTALQDLELGDNNIQGNIPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQ 713

Query: 343  FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSG 402
             L L  N F G LPSS   +LP+LE L++  N FSG IP  I N S+L+ L++  N F+G
Sbjct: 714  SLSLAQNHFSGSLPSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTG 773

Query: 403  FIPNTFGNLRNLKWLDLGDNYLTS--STSELSFLSS-SNCKYLEYFSISNNPLGGILPRV 459
             +P   GNLR L++L+LG N LT   S SE+ FL+S +NC +L    I +NPL GILP  
Sbjct: 774  DVPKDLGNLRRLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNS 833

Query: 460  IGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLS 519
            +GNLS S+E F        G+IP  I NLT+LI++ LG N L G I   LG+LKKLQ L 
Sbjct: 834  LGNLSISLESFDASACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELG 893

Query: 520  LKDNQLEGSIPDNLSF-------------------SCT----------------LTSIPS 544
            +  N+L GSIP++L                     SC                  ++IP 
Sbjct: 894  IAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPP 953

Query: 545  TLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLF 604
            +LW L+ +L LNLS NF TG LP E+GN+K +  +DLS N  S  IP T+G L++L+ L 
Sbjct: 954  SLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLS 1013

Query: 605  LKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPR 664
            L  NRLQG IP   GD+++LK L+LS NNL G+IP SL+ L  LK +NVSFNKL+GEIP 
Sbjct: 1014 LSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPD 1073

Query: 665  EGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLI-GIVLP------LSTT 717
             GPF NF+ ESF  NE LCG P+ QV +C       S +  L I   +LP          
Sbjct: 1074 GGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVV 1133

Query: 718  FMMGGKSQLNDANMP------LVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARI 771
            F++    +  +  +P      L  +  + ++ +L  ATN F E+NLIG+G    VYK  +
Sbjct: 1134 FLVLWIRRRKNLEVPTPIDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVL 1193

Query: 772  QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG 831
             +G+ VAVKVF+L++  A +SFD EC +++ IRHRN++K I+ CS+ DFKALVLEYMP G
Sbjct: 1194 SNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKG 1253

Query: 832  SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL 891
            SL+K LYS NY LD+ QRLNIMIDVASALEYLH      ++HCDLKPNN+LLDD+MVAH+
Sbjct: 1254 SLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHV 1313

Query: 892  SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
             DFG+A+  L E +S+ QT+TL TIGYMAPEYG +G VST GDV+S+GIMLME F RKKP
Sbjct: 1314 GDFGIAR-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKP 1372

Query: 952  TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIES 1011
             DE F G++TLK WV   L  S++EVVDANLL  ED+ F  K  C+S +  LA+ CT +S
Sbjct: 1373 MDEMFNGDLTLKSWVES-LADSMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDS 1431

Query: 1012 PEERINAKEIVTKL 1025
            PEERI+ K++V  L
Sbjct: 1432 PEERIDMKDVVVGL 1445

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  882 bits (2278), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 504/1069 (47%), Positives = 679/1069 (63%), Gaps = 61/1069 (5%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            LS L  L L +N FH  IP+ ++ C+ LR + L  N  +G+IP+ IGN++ L  L+L GN
Sbjct: 99   LSFLVTLDLSNNSFHASIPNEIAKCRELRQLYLFNNRLTGSIPQAIGNLSKLEQLYLGGN 158

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +L GEIP E+ +L  L+ L  ++N LT +IPS+IFN+SSL  + L+ N+L+G L  ++C 
Sbjct: 159  QLTGEIPREISHLLSLKILSFRSNNLTASIPSAIFNISSLQYIGLTYNSLSGTLPMDMCY 218

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            +LP L+ L+L  N   GKIP++L +C  L+ +SLS N+F G IP+ IG+L+ L+ L+L  
Sbjct: 219  SLPKLRGLYLSGNQLSGKIPTSLGKCGRLEEISLSFNEFMGSIPRGIGSLSVLEVLYLGS 278

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSI-FNLSSLSDLELSFNSLTGNFPKDM 239
            N L+GEIP+ L NL+ L   +L +N L G +P  + ++L  L  + LS N L G  P  +
Sbjct: 279  NNLEGEIPQTLFNLSSLRNFELGSNNLGGILPADMCYSLPRLQVINLSQNQLKGEIPPSL 338

Query: 240  HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIP 284
                           +N   L+ + LS N F G IPS +GN                TIP
Sbjct: 339  ---------------SNCGELQVLGLSINEFIGRIPSGIGNLSGIEKIYLGGNNLMGTIP 383

Query: 285  KEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFL 344
               GNL+ L+ L L+ N++Q  IP E+ +L  L+++  + N L G VP  IFN+S L+F+
Sbjct: 384  SSFGNLSALKTLYLEKNKIQGNIPKELGHLSELQYLSLASNILTGSVPEAIFNISNLQFI 443

Query: 345  YLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFI 404
             L  N   G LPSS    LP LEEL + GN  SG IP+ I N +KL+ L+L  N  +GF+
Sbjct: 444  VLADNHLSGNLPSSIGTSLPQLEELLIGGNYLSGIIPASISNITKLTRLDLSYNLLTGFV 503

Query: 405  PNTFGNLRNLKWLDLGDNYLTS--STSELSFLSS-SNCKYLEYFSISNNPLGGILPRVIG 461
            P   GNLR+L+ L  G+N L+   STSEL FL+S SNCK+L    I +NPL G LP  +G
Sbjct: 504  PKDLGNLRSLQHLGFGNNQLSGEYSTSELGFLTSLSNCKFLRNLWIQDNPLKGTLPNSLG 563

Query: 462  NLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLK 521
            NLS S++  +       G IP  I NLTNLI + LG N L G I   LG+LKKLQ L + 
Sbjct: 564  NLSLSLQSINASACQFKGVIPAGIGNLTNLIELGLGDNDLTGMIPTTLGQLKKLQRLYIA 623

Query: 522  DNQLEGSIPDNLSFSCTLTS-----------IPSTLWNLKDILCLNLSLNFFTGPLPLEI 570
             N++ GS+P+ +     L             +PS+LW+L  +L +NLS NF TG LP+E+
Sbjct: 624  GNRIHGSVPNGIGHLANLVYLFLSSNQLSGLVPSSLWSLNRLLVVNLSSNFLTGDLPVEV 683

Query: 571  GNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLS 630
            G++K + ++DLS N FS  IP+T+G L  L  L L  NRLQG IP   G++++L+SL+LS
Sbjct: 684  GSMKTITKLDLSQNQFSGHIPSTMGQLGGLVELSLSKNRLQGPIPREFGNLLSLESLDLS 743

Query: 631  NNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQV 690
             NNL G IP SLE L+ LK +NVSFNKLEGEIP +GPF NF+ ESF  N  LCG P  Q+
Sbjct: 744  WNNLSGAIPRSLEALVSLKYLNVSFNKLEGEIPDKGPFANFTTESFISNAGLCGAPRFQI 803

Query: 691  RSCRTRIHHTS--SKNDLLIGIVLPLST-----TFMMGGKSQLNDANMPLVANQ------ 737
              C       S  + + LL  I++P+        F++  + + + +  P   N       
Sbjct: 804  IECEKDASGQSRNATSFLLKCILIPVVAAMVFVAFVVLIRRRRSKSKAPAQVNSFHLGKL 863

Query: 738  RRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIEC 797
            RR ++ EL  ATN F E+N+IG G  G V++  + DG  VAVKVF+L++  A KSFD EC
Sbjct: 864  RRISHQELIYATNYFGEDNMIGTGSLGMVHRGVLSDGSIVAVKVFNLEFQGAFKSFDAEC 923

Query: 798  GMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA 857
             +++ I+HRN++K ISSCS  +FKALVLEYMP GSLEK LYS NY L++ QRLNIMIDVA
Sbjct: 924  EIMRNIQHRNLVKIISSCSILNFKALVLEYMPNGSLEKWLYSHNYCLNLVQRLNIMIDVA 983

Query: 858  SALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
            SALEYLH  +SV P++HCDLKPNNVLLD+ MVA L DFG++K  L E +S+ QT+TL TI
Sbjct: 984  SALEYLHHDFSVNPVVHCDLKPNNVLLDEEMVARLGDFGISK-LLTETESMEQTRTLGTI 1042

Query: 917  GYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
            GYMAPEYG EG VST GDVYS+GIM+METF RKKPTDE F GE+TL+ WV   L   +ME
Sbjct: 1043 GYMAPEYGSEGIVSTRGDVYSYGIMMMETFARKKPTDEMFGGEVTLRSWVES-LAGRVME 1101

Query: 977  VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            VVD NL+  ED+HF  KE C+  +  LA++CT ESP +RI+ KE+V +L
Sbjct: 1102 VVDGNLVRREDQHFGIKESCLRSIMALALECTTESPRDRIDMKEVVVRL 1150

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  863 bits (2230), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 512/1149 (44%), Positives = 686/1149 (59%), Gaps = 126/1149 (10%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            LS L  L L +N FHG +P  +  CK L+ ++L  N   G IP+ I N++ L  L+L  N
Sbjct: 74   LSFLVSLDLSNNHFHGSLPKDIGKCKELQQLNLFNNKLVGGIPEAICNLSKLEELYLGNN 133

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +L GEIP+++ +L  L+ L    N LTG+IP++IFN+SSL N+ LS NNL+G L  ++C 
Sbjct: 134  QLIGEIPKKMNHLQNLKVLSFPMNNLTGSIPATIFNISSLLNISLSNNNLSGSLPMDMCY 193

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
              P L+ L L  N+  GKIP+ L +C  LQ +SL+ NDF+G IP  IGNL +L+ L L  
Sbjct: 194  ANPKLKKLNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIGNLVELQRLSLQN 253

Query: 181  NRLQGEIPE------------------------------------------------ELG 192
            N   GEIP+                                                 +G
Sbjct: 254  NSFTGEIPQLLFNISSLRFLNLAVNNLEGEIPSNLSHCRELRVLSLSFNQFTGGIPQAIG 313

Query: 193  NLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIV---------- 242
            +L+ LE+L L +N LTG IP  I NLS+L+ L+LS N ++G  P ++  V          
Sbjct: 314  SLSNLEELYLSHNKLTGGIPREIGNLSNLNILQLSSNGISGPIPAEIFNVSSLQVIAFTD 373

Query: 243  NRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIPKEI 287
            N LS  LP   C ++P L+ + LS+N   G++P+ L  C               +IPKEI
Sbjct: 374  NSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEI 433

Query: 288  GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG 347
            GNL+KLEK+ L  N L   IP    NL  L+++    N L G VP  IFN+S L+ L + 
Sbjct: 434  GNLSKLEKIYLGTNSLIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMV 493

Query: 348  SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNT 407
             N   G LPSS    L +LE L ++GN FSG IP  I N SKL+ L L  NSF+G +P  
Sbjct: 494  KNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKD 553

Query: 408  FGNLRNLKWLDLGDNYLTSS--TSELSFLSS-SNCKYLEYFSISNNPLGGILPRVIGNLS 464
             GNL  LK LDL  N LT     SE+ FL+S +NCK+L+   I NNP  G LP  +GNL 
Sbjct: 554  LGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLP 613

Query: 465  QSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQ 524
             ++E F        G+IP  I NLTNLI + LG N L GSI   LG+LKKLQ L +  N+
Sbjct: 614  IALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNR 673

Query: 525  LEGSIPDNL--------------SFSCTLTS---------------------IPSTLWNL 549
            L GSIP++L                S ++ S                     IP++LW+L
Sbjct: 674  LRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSL 733

Query: 550  KDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNR 609
            +D+L LNLS NF TG LP E+GN+K +  +DLS N  S  IP  +G  ++L  L L  N+
Sbjct: 734  RDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNK 793

Query: 610  LQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFR 669
            LQG IP   GD+++L+SL+LS NNL G IP SLE L+ LK +NVS NKL+GEIP  GPF 
Sbjct: 794  LQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFI 853

Query: 670  NFSLESFKGNELLCGMPNLQVRSC--RTRIHHTSSKNDLLIGIVLPLST-----TFMMGG 722
            NF+ ESF  NE LCG P+ QV +C    R     +K+ +L  I+LP+ +      F++  
Sbjct: 854  NFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLW 913

Query: 723  KSQLNDANMP------LVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGME 776
              + ++  +P      L     + ++ +L  ATN F E+NLIG+G  G VYK  + +G+ 
Sbjct: 914  IRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLT 973

Query: 777  VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKC 836
            VA+KVF+L++  A++SFD EC +++ IRHRN+++ I+ CS+ DFKALVLEYMP GSLEK 
Sbjct: 974  VAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKW 1033

Query: 837  LYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
            LYS NY LD+ QRLNIMIDVASALEYLH   S  ++HCDLKPNNVLLDD+MVAH++DFG+
Sbjct: 1034 LYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGI 1093

Query: 897  AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESF 956
             K  L + +S+ QT+TL TIGYMAPE+G +G VST  DVYS+GI+LME F+RKKP DE F
Sbjct: 1094 TK-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMF 1152

Query: 957  TGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI 1016
            TG++TLK WV   L  S+++VVDANLL  ED+    K  C+S +  LA+ CT +SPEER+
Sbjct: 1153 TGDLTLKTWVES-LSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEERL 1211

Query: 1017 NAKEIVTKL 1025
            N K+ V +L
Sbjct: 1212 NMKDAVVEL 1220

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  860 bits (2223), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 504/1125 (44%), Positives = 679/1125 (60%), Gaps = 102/1125 (9%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            LS L  L L +N FH  +P  +  CK L+ ++L  N   G IP+ I N++ L  L+L  N
Sbjct: 74   LSFLVSLDLSNNYFHDSLPKDIGKCKELQQLNLFNNKLVGGIPEAICNLSKLEELYLGNN 133

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +L GEIP+++  L  L+ L    N LT +IP++IF++SSL N+ LS NNL+G L  ++C 
Sbjct: 134  QLIGEIPKKMNXLQNLKVLSFPMNNLTSSIPATIFSISSLLNISLSNNNLSGSLPMDMCY 193

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
              P L+ L L  N+  GKIP+ L +C  LQ +SL+ NDF+G IP  IGNL +L+ L L  
Sbjct: 194  ANPKLKELNLSSNHLSGKIPTGLGQCIKLQVISLAYNDFTGSIPNGIGNLVELQRLSLRN 253

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKD-- 238
            N L GEIP  L +  EL  L    N  TG IP +I +L +L +L L+FN LTG  P++  
Sbjct: 254  NSLTGEIPSNLSHCRELRVLSSSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIG 313

Query: 239  ----------------------------MHIV----NRLSAELPAKFCNNIPFLEEIYLS 266
                                        + ++    N LS  LP   C ++P L+ +YL+
Sbjct: 314  NLSNLNILQLGSNGISGPIPAEIFNISSLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLA 373

Query: 267  KNMFYGEIPSDLGNC---------------TIPKEIGNLAKLEKLDLQFNRLQCVIPHEI 311
            +N   G++P+ L  C               +IP+EIGNL+KLE +DL+ N L   IP   
Sbjct: 374  QNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSF 433

Query: 312  DNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSL 371
             NL  L+++    N L G VP  IFN+S L+ L L  N   G LPSS    LP+LE L +
Sbjct: 434  GNLKALKFLNLGINFLTGTVPEAIFNISELQNLALVQNHLSGSLPSSIGTWLPDLEGLYI 493

Query: 372  SGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS--TS 429
              N FSGTIP  I N SKL+ L L  NSF+G +P    NL  LK+L+L  N LT     S
Sbjct: 494  GANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLAS 553

Query: 430  ELSFLSS-SNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNL 488
             + FL+S +NCK+L Y  I  NPL G LP  +GNL  ++E F        G+IP  I NL
Sbjct: 554  GVGFLTSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGIGNL 613

Query: 489  TNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSF------------- 535
            TNLI + LG N L GSI   LG+L+KLQ L +  N++ GSIP++L               
Sbjct: 614  TNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNK 673

Query: 536  ------SC----------------TLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNL 573
                  SC                   +IP++LW+L+D+L LNLS NF TG LP E+GN+
Sbjct: 674  LSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNM 733

Query: 574  KVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNN 633
            K +  +DLS N  S  IP+ +G L+ L  L L  NRLQG I    GD+++L+SL+LS+NN
Sbjct: 734  KSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNN 793

Query: 634  LFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSC 693
            L G IP SLE L+ LK +NVSFNKL+GEIP  GPF  F+ ESF  NE LCG P+ QV +C
Sbjct: 794  LSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMAC 853

Query: 694  --RTRIHHTSSKNDLLIGIVLPLSTT-----FMMGGKSQLNDANMP------LVANQRRF 740
                R     +K+ +L  I+LP+ +T     F++    + ++  +P      L+    + 
Sbjct: 854  DKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLLGTHEKI 913

Query: 741  TYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMI 800
            ++ +L  ATN F E+NLIG+G  G VYK  + +G+ VA+KVF+L++  A++SFD EC ++
Sbjct: 914  SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVM 973

Query: 801  KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
            + IRHRN+++ I+ CS+ DFKALVLEYMP GSLEK LYS NY LD+ QRLNIMIDVASAL
Sbjct: 974  QGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASAL 1033

Query: 861  EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
            EYLH   S  ++HCDLKP+NVLLDD+MVAH++DFG+AK  L E +S+ QT+TL TIGYMA
Sbjct: 1034 EYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAK-LLTETESMQQTKTLGTIGYMA 1092

Query: 921  PEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
            PE+G  G VST  DVYS+GI+LME F RKKP DE FTG++TLK WV   L  S+++VVD 
Sbjct: 1093 PEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDV 1151

Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            NLL  ED+    K  C+S +  LA+ CT +SP+ERI+ K+ V +L
Sbjct: 1152 NLLRREDEDLATKLSCLSSIMALALACTTDSPKERIDMKDAVVEL 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  860 bits (2222), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 504/1094 (46%), Positives = 671/1094 (61%), Gaps = 88/1094 (8%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCK-RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRG 59
            +S+L  + L  N   G +P  + N   +L+ ++L+ N  SG  P  +G  T L G+ L  
Sbjct: 116  ISSLLKISLSYNSLSGSLPMDMCNTNPKLKELNLTSNHLSGKXPTGLGQCTKLQGISLSY 175

Query: 60   NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANIC 119
            N+  G IP  +GNL EL+ L L NN LTG IP S+F +SSL  L L  NNL G L   + 
Sbjct: 176  NEFTGSIPRAIGNLVELQSLSLXNNSLTGEIPQSLFKISSLRFLRLGENNLVGILPTGMG 235

Query: 120  SNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLD 179
             +LP L+ + L  N F G+IPS+L  C+ L+ LSLS+N F+G IP+ IG+L+ L+ ++L 
Sbjct: 236  YDLPKLEMIDLSINQFKGEIPSSLSHCRQLRGLSLSLNQFTGGIPQAIGSLSNLEEVYLA 295

Query: 180  QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
             N L G IP E+GNL+ L  LQL +  ++G IPP IFN+SSL  ++L+ NSL G+ P D+
Sbjct: 296  YNNLAGGIPREIGNLSNLNSLQLGSCGISGPIPPEIFNISSLQMIDLTDNSLHGSLPMDI 355

Query: 240  HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIP 284
                          C ++  L+ +YLS N   G++P+ L  C                IP
Sbjct: 356  --------------CKHLHNLQGLYLSFNQLSGQLPTTLSLCGQLLSLSLWGNRFTGNIP 401

Query: 285  KEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFL 344
               GNL  L+ L+L  N +Q  IP+E+ NL NL+ +  S N L G++P  IFN+S L+ L
Sbjct: 402  PSFGNLTVLQDLELXENNIQGNIPNELGNLINLQNLKLSVNNLTGIIPEAIFNISKLQTL 461

Query: 345  YLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFI 404
             L  N F G LPSS   +LP+LE L++  N FSG IP  I N S+L+ L++  N F+G +
Sbjct: 462  XLAQNHFSGSLPSSIGTQLPDLEGLAIGXNEFSGIIPMSISNMSELTVLDIWANFFTGDV 521

Query: 405  PNTFGNLRNLKWLDLGDNYLTS--STSELSFLSS-SNCKYLEYFSISNNPLGGILPRVIG 461
            P   GNLR L++L+LG N LT   STSE+ FL+S +NCK+L    I +NPL GILP  +G
Sbjct: 522  PKDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTSLTNCKFLRRLWIEDNPLKGILPNSLG 581

Query: 462  NLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLK 521
            NLS S+E F        G+IP  I NL NLI + L  N L G I I+ G L+KLQ  ++ 
Sbjct: 582  NLSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQWFAIS 641

Query: 522  DNQLEGSIPD------NLSF--------SCTL---------------------TSIPSTL 546
             N++ GSIP       NL +        S T+                     + IPS+L
Sbjct: 642  GNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTALRNISLHSNGLASEIPSSL 701

Query: 547  WNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLK 606
            W L+D+L LNLS NF    LPLE+GN+K L+ +DLS N FS  IP+TI  L++L  L+L 
Sbjct: 702  WTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLS 761

Query: 607  YNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREG 666
            +N+LQG +P + G +++L+ L+LS NN  G IP SLE L  LK +NVSFNKL+GEIP  G
Sbjct: 762  HNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRG 821

Query: 667  PFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTT--------- 717
            PF NF+ ESF  N  LCG P  QV +C       +    LL+  ++PLS +         
Sbjct: 822  PFANFTAESFISNLALCGAPRFQVMACEKDARRNTKS--LLLKCIVPLSVSLSTMILVVL 879

Query: 718  FMMGGKSQLNDANMPLVAN------QRRFTYLELFQATNGFSENNLIGRGGFGFVYKARI 771
            F +  + Q  ++  P+  +       R  ++ EL  AT+ F E NLIG+G  G VYK  +
Sbjct: 880  FTLWKRRQ-TESESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVYKGVL 938

Query: 772  QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG 831
             DG+ VAVKVF+L+   A KSF++EC +++ IRHRN+ K ISSCS+ DFKALVLEYMP  
Sbjct: 939  SDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNE 998

Query: 832  SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL 891
            SLEK LYS NY LD  QRL IMIDVAS LEYLH  YS P++HCDLKP+NVLLDD+MVAH+
Sbjct: 999  SLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAHI 1058

Query: 892  SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            SDFG+AK  L   + + +T+TL TIGYMAPEYG EG VST  D YS+GI+LME F RKKP
Sbjct: 1059 SDFGIAK-LLMGSEFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVRKKP 1117

Query: 952  TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIES 1011
            TDE F  E+TLK WV      +IMEV+DANLL+ ED+ F  K+ C S +  LA+ CTIE 
Sbjct: 1118 TDEMFVEELTLKSWVES-SANNIMEVIDANLLTEEDESFALKQACFSSIMTLALDCTIEP 1176

Query: 1012 PEERINAKEIVTKL 1025
            PE+RIN K++V +L
Sbjct: 1177 PEKRINMKDVVARL 1190

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  859 bits (2220), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/1148 (44%), Positives = 689/1148 (60%), Gaps = 125/1148 (10%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            LS L  L L +N F G +P  +  CK L+ ++L  N   G+IP+ I N++ L  L+L  N
Sbjct: 74   LSFLVSLDLSNNYFDGSLPKDIGKCKELQQLNLFNNKLVGSIPEAICNLSKLEELYLGNN 133

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +L GEIP+++ NL  L+ L    N LTG+IP++IFN+SSL N+ LS N+L+G L  +IC 
Sbjct: 134  QLIGEIPKKMSNLLNLKVLSFPMNNLTGSIPTTIFNMSSLLNISLSYNSLSGSLPMDICY 193

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
                L+ L L  N+  GK+P+ L +C  LQ +SLS NDF+G IP  IGNL +L+ L L  
Sbjct: 194  ANLKLKELNLSSNHLSGKVPTGLGQCIKLQGISLSCNDFTGSIPSGIGNLVELQSLSLQN 253

Query: 181  NRLQGEIPEELGNLA-----------------------ELEKLQLQNNFLTGTIPPSIFN 217
            N L GEIP+ L N++                       EL  L+L  N  TG IP ++ +
Sbjct: 254  NSLTGEIPQSLFNISSLRFLNLEINNLEGEISSFSHCRELRVLKLSINQFTGGIPKALGS 313

Query: 218  LSSLSDLELSFNSLTGNFPKD---------MHIV-------------------------N 243
            LS L +L L +N LTG  P++         +H+                          N
Sbjct: 314  LSDLEELYLGYNKLTGGIPREIGNLSNLNILHLASSGINGPIPAEIFNISSLHRIDFTNN 373

Query: 244  RLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLG---------------NCTIPKEIG 288
             LS  LP   C ++P L+ +YLS+N   G++P+ L                  +IP++IG
Sbjct: 374  SLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTLFLCGELLLLSLSINKFTGSIPRDIG 433

Query: 289  NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
            NL+KLEK+ L  N L   IP    NL  L+++    N L G +P  IFN+S L+ L L  
Sbjct: 434  NLSKLEKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLTGTIPEDIFNISKLQTLALAQ 493

Query: 349  NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTF 408
            N   G LPSS    LP+LE L + GN FSGTIP  I N SKL  L +  N F+G +P   
Sbjct: 494  NHLSGGLPSSIGTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFTGNVPKDL 553

Query: 409  GNLRNLKWLDLGDNYLTSS--TSELSFLSS-SNCKYLEYFSISNNPLGGILPRVIGNLSQ 465
             NLR L+ L+L  N LT    TSE+ FL+S +NCK+L    I  NPL G LP  +GNLS 
Sbjct: 554  SNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPNSLGNLSV 613

Query: 466  SMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQL 525
            ++E F     +  G+IP  I NLTNLI + LG N L GSI   LG L+KLQ L +  N++
Sbjct: 614  ALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRI 673

Query: 526  EGSIPDNLSF-------------------SC----------TLTS------IPSTLWNLK 550
            +GSIP++L                     SC          +L S      IP + W+L+
Sbjct: 674  QGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLR 733

Query: 551  DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRL 610
            D++ L+LS NF TG LP E+GN+K +  +DLS N  S  IP  +G L++L  L L  N+L
Sbjct: 734  DLMVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKL 793

Query: 611  QGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 670
            QGSIP   GD+++L+S++LS NNLFG IP SLE L+ LK +NVSFNKL+GEIP  GPF N
Sbjct: 794  QGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVN 853

Query: 671  FSLESFKGNELLCGMPNLQVRSC--RTRIHHTSSKNDLLIGIVLPLSTT-----FMMGGK 723
            F+ ESF  NE LCG P+ QV +C    R     +K+ +L  I+LP+ +      F++   
Sbjct: 854  FTAESFIFNEALCGAPHFQVIACDKNNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWI 913

Query: 724  SQLNDANMP------LVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEV 777
             + ++  +P      L     + +  +L  ATNGF E+NLIG+G  G VYK  + +G+ V
Sbjct: 914  RRRDNTEIPAPIDSWLPGAHEKISQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTV 973

Query: 778  AVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL 837
            A+KVF+L++  A++SFD EC +++ I HRN+I+ I+ CS+ DFKALVLEYMP GSL+K L
Sbjct: 974  AIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWL 1033

Query: 838  YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 897
            YS NY LD+FQRLNIMIDVASALEYLH   S  ++HCDLKP+NVLLD+NMVAH++DFG+A
Sbjct: 1034 YSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIA 1093

Query: 898  KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFT 957
            +  L E +S+ QT+TL TIGYMAPEYG +G VST GDVYS+GI+LME F RKKP DE FT
Sbjct: 1094 R-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFT 1152

Query: 958  GEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN 1017
            G++TLK WV   L  S++EVVDANLL  +D+    K   +S +  LA+ CT +SPEERIN
Sbjct: 1153 GDVTLKTWVES-LSSSVIEVVDANLLRRDDEDLATKLSYLSSLMALALACTADSPEERIN 1211

Query: 1018 AKEIVTKL 1025
             K++V +L
Sbjct: 1212 MKDVVVEL 1219

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  857 bits (2214), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 494/1093 (45%), Positives = 672/1093 (61%), Gaps = 111/1093 (10%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            L  L+ L L++N   G+IPS  S+C+ LR +SLS N F+G IP+ IG++  L  L+L  N
Sbjct: 183  LVELQRLSLRNNSLTGEIPSNFSHCRELRGLSLSFNQFTGGIPQAIGSLCNLEELYLAFN 242

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            KL G IP E+GNL++L  L L +N ++G IP+ IFN+SSL  +D S N+LTGE       
Sbjct: 243  KLTGGIPREIGNLSKLNILQLSSNGISGPIPTEIFNISSLQEIDFSNNSLTGE------- 295

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
                              IPS L  C+ L+ LSLS N F+G IP+ IG+L+ L+ L+L  
Sbjct: 296  ------------------IPSNLSHCRELRVLSLSFNQFTGGIPQAIGSLSNLEGLYLSY 337

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
            N+L G IP E+GNL+ L  LQL +N ++G IP  IFN+SSL  ++ S NSL+G+ P D+ 
Sbjct: 338  NKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNISSLQIIDFSNNSLSGSLPMDI- 396

Query: 241  IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIPK 285
                         C ++P L+ +YL +N   G++P+ L  C               +IP+
Sbjct: 397  -------------CKHLPNLQGLYLLQNHLSGQLPTTLSLCGELLYLSLAVNKFRGSIPR 443

Query: 286  EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY 345
            EIGNL+KLE + L+ N L   IP    NL  L+++    N L G VP  IFN+S L+ L 
Sbjct: 444  EIGNLSKLEDISLRSNSLVGSIPTSFGNLMALKYLDLGMNFLTGTVPEAIFNISELQILV 503

Query: 346  LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
            L  N   G LP S    LP+LE L +  N FSGTIP  I N SKL  L++  NSF+G +P
Sbjct: 504  LVQNHLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSISNMSKLIQLQVWDNSFTGNVP 563

Query: 406  NTFGNLRNLKWLDLGDNYLTSS--TSELSFLSS-SNCKYLEYFSISNNPLGGILPRVIGN 462
               GNL  L+ L+L  N LT+    S + FL+S +NCK+L +  I +NP  G LP  +GN
Sbjct: 564  KDLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKFLRHLWIDDNPFKGTLPNSLGN 623

Query: 463  LSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD 522
            L  ++E F        G+IP  I NLTNLI + LG N L  SI   LG+L+KLQ L +  
Sbjct: 624  LPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDLTRSIPTTLGRLQKLQRLHIAG 683

Query: 523  NQLEGSIPDNL--------------SFSCTLTS---------------------IPSTLW 547
            N++ GSIP++L                S ++ S                     IP++LW
Sbjct: 684  NRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLW 743

Query: 548  NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKY 607
            +L+D+L LNLS NF TG LP E+GN+K +  +DLS N  S  IP  +G  ++L  L L  
Sbjct: 744  SLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQ 803

Query: 608  NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGP 667
            NRLQG IP   GD+++L+SL+LS NNL G IP SLE L+ LK +NVS NKL+GEIP  GP
Sbjct: 804  NRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGP 863

Query: 668  FRNFSLESFKGNELLCGMPNLQVRSC--RTRIHHTSSKNDLLIGIVLPLSTTF------M 719
            F NF+ ESF  NE LCG P+ QV +C    R     +K+ +L  I+LP+ +T       +
Sbjct: 864  FXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIV 923

Query: 720  MGGKSQLN-------DANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ 772
            +  + + N       D+ +P      + ++ +L  ATN F E+NLIG+G  G VYK  + 
Sbjct: 924  LWIRRRDNMEIXTPIDSWLP--GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLS 981

Query: 773  DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS 832
            +G+ VA+KVF+L++  A++SFD EC +++ IRHRN+++ I+ CS+ DFKALVL+YMP GS
Sbjct: 982  NGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGS 1041

Query: 833  LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
            LEK LYS NY LD+ QRLNIMIDVASALEYLH   S  ++HCDLKP+NVLLDDBMVAH++
Sbjct: 1042 LEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDBMVAHVT 1101

Query: 893  DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPT 952
            DFG+AK  L + +S+ QT+TL TIGYMAPE+G +G VST  DVYS+GI+LME F RKKP 
Sbjct: 1102 DFGIAK-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFARKKPM 1160

Query: 953  DESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESP 1012
            DE FTG++TLK WV   L  S+++VVD NLL  ED+    K  C+S +  LA+ CT +SP
Sbjct: 1161 DEMFTGDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTNDSP 1219

Query: 1013 EERINAKEIVTKL 1025
            EER++ K+ V +L
Sbjct: 1220 EERLDMKDAVVEL 1232

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  854 bits (2207), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 507/1094 (46%), Positives = 685/1094 (62%), Gaps = 95/1094 (8%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            LS LE L+L +N   G+IP  +S+   L+ +SL +N+  G+IP  I N+++L+ + L  N
Sbjct: 122  LSKLEELYLGNNQLTGEIPKAVSHLHNLKILSLQMNNLIGSIPATIFNISSLLNISLSYN 181

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
             L G +P ++     L+ ++L  N  TG+IP +I NL  L  L L  N+LTGE+  ++  
Sbjct: 182  SLSGSLPMDM-----LQVIYLSFNEFTGSIPRAIGNLVELERLSLRNNSLTGEIPQSLF- 235

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            N+  L+ L L  NN  G+IPS+LL C+ L+ L LSIN F+G IP+ IG+L+ L+ L+L  
Sbjct: 236  NISRLKFLSLAANNLKGEIPSSLLHCRELRLLDLSINQFTGFIPQAIGSLSNLETLYLGF 295

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
            N+L G IP E+GNL+ L  L   ++ L+G IP  IFN+SSL ++  + NSL+G+ P D+ 
Sbjct: 296  NQLAGGIPGEIGNLSNLNLLNSASSGLSGPIPAEIFNISSLQEIGFANNSLSGSLPMDI- 354

Query: 241  IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIPK 285
                         C ++P L+ + LS N   G++P+ L  C               +IP+
Sbjct: 355  -------------CKHLPNLQWLLLSLNQLSGQLPTTLSLCGELLTLTLAYNNFTGSIPR 401

Query: 286  EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY 345
            EIGNL+KLE++  + +     IP E+ NL NL+++  + N L G+VP  IFN+S L+ L 
Sbjct: 402  EIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSLNVNNLTGIVPEAIFNISKLQVLS 461

Query: 346  LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
            L  N   G LPSS    LPNLE+L + GN FSG IP  I N S L +L++  N F G +P
Sbjct: 462  LAGNHLSGSLPSSIGSWLPNLEQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVP 521

Query: 406  NTFGNLRNLKWLDLGDNYLTS--STSELSFLSS-SNCKYLEYFSISNNPLGGILPRVIGN 462
               GNLR L+ L L  N LT+  S SEL+FL+S +NC +L   SIS+NPL G++P  +GN
Sbjct: 522  KDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFLRTLSISDNPLKGMIPNSLGN 581

Query: 463  LSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD 522
            LS S+E  +  +  + G+IP  I+NLTNLI + L  N L G I    G+L+KLQ+LS+  
Sbjct: 582  LSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQ 641

Query: 523  NQLEGSIPD------NLSF-------------SCT----------------LTSIPSTLW 547
            N++ GSIP       NL+F             SC+                 + IPS+L 
Sbjct: 642  NRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLC 701

Query: 548  NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKY 607
            NL+ +L LNLS NF    LPL++GN+K LV +DLS N FS  IP+TI  L++L  L+L +
Sbjct: 702  NLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSH 761

Query: 608  NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGP 667
            N+LQG IP + GD+++L+SL+LS NNL G IP SLE L  L+ +NVSFNKL+GEIP  GP
Sbjct: 762  NKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGP 821

Query: 668  FRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKN--DLLIGIVLPLSTT-------- 717
            F NF+ ESF  N  LCG P  QV +C       S KN   LL+  ++PLS +        
Sbjct: 822  FANFTAESFISNLALCGAPRFQVMACE----KDSRKNTKSLLLKCIVPLSVSLSTIILVV 877

Query: 718  -FMMGGKSQLN-----DANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARI 771
             F+   + Q         ++ L    R   + EL  ATN F E+NLIG+G  G VYK  +
Sbjct: 878  LFVQWKRRQTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVL 937

Query: 772  QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG 831
             DG+ VAVKVF+L+   A KSF++EC +++ IRHRN+ K ISSCS+ DFKALVLEYMP G
Sbjct: 938  SDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNG 997

Query: 832  SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL 891
            SLEK LYS NY LD  QRL IMIDVAS LEYLH  YS P++HCDLKP+NVLLDD+MVAH+
Sbjct: 998  SLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHI 1057

Query: 892  SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            SDFG+AK  L   + + +T+TL T+GYMAPEYG EG VST GD+YS+GI+LMETF RKKP
Sbjct: 1058 SDFGIAK-LLMGSEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKP 1116

Query: 952  TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIES 1011
            TDE F  E+TLK WV      +IMEV+DANLL+ ED+ F  K  C S +  LA+ CT+E 
Sbjct: 1117 TDEMFVEELTLKSWVES-STNNIMEVIDANLLTEEDESFALKRACFSSIMTLALDCTVEP 1175

Query: 1012 PEERINAKEIVTKL 1025
            PE+RIN K++V +L
Sbjct: 1176 PEKRINTKDVVVRL 1189

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  848 bits (2192), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 507/1146 (44%), Positives = 686/1146 (59%), Gaps = 125/1146 (10%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            LS L  L L +N FHG +P  +  CK L+ ++L  N   G+IP+ I N++ L  L+L  N
Sbjct: 74   LSFLVSLDLSNNYFHGSLPKDIGKCKELQQLNLFNNKLVGSIPEAICNLSKLEELYLGNN 133

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +L GEIP+++ NL  L+ L    N LTG+IP++IFN+SSL N+ LS N+L+G L  +IC 
Sbjct: 134  QLIGEIPKKMSNLLNLKILSFPMNNLTGSIPTTIFNMSSLLNISLSYNSLSGSLPMDICY 193

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
                L+ L L  N+  GK+P+ L +C  LQ +SLS NDF+G IP  IGNL +L+ L L  
Sbjct: 194  TNLKLKELNLSSNHLSGKVPTGLGQCIKLQGISLSYNDFTGSIPSGIGNLVELQSLSLQN 253

Query: 181  NRLQGEIPEELGNL-----------------------AELEKLQLQNNFLTGTIPPSIFN 217
            N L GEIP+ L N+                        EL  L+L  N  TG IP ++ +
Sbjct: 254  NSLTGEIPQSLFNIYSLRFLNLEINNLEGEISSFSHCRELRVLKLSINQFTGGIPKALGS 313

Query: 218  LSSLSDLELSFNSLTGNFPKDMHIV----------------------------------N 243
            LS L +L L +N LTG  P+++ I+                                  N
Sbjct: 314  LSDLEELYLGYNKLTGGIPREIGILSNLNILHLASSGINGPIPAEIFNISSLHRIDFTNN 373

Query: 244  RLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIPKEIG 288
             LS  LP   C ++P L+ +YLS+N   G++P+ L  C               +IP++IG
Sbjct: 374  SLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTLFLCGELLLLSLSINKFTRSIPRDIG 433

Query: 289  NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
            NL+KL+K+ L  N L   IP    NL  L+++    N L+G +P  IFN+S L+ L L  
Sbjct: 434  NLSKLKKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLIGTIPEDIFNISKLQTLALAQ 493

Query: 349  NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTF 408
            N   G LPSS    LP+LE L + GN FSGTIP  I N SKL  L +  N F G +P   
Sbjct: 494  NHLSGGLPSSISTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFIGNVPKDL 553

Query: 409  GNLRNLKWLDLGDNYLTSS--TSELSFLSS-SNCKYLEYFSISNNPLGGILPRVIGNLSQ 465
             NLR L+ L+L  N LT    TSE+ FL+S +NCK+L    I  NPL G LP  +GNLS 
Sbjct: 554  SNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPNSLGNLSV 613

Query: 466  SMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQL 525
            ++E F     +  G+IP  I NLTNLI + LG N L GSI   LG+L+KLQ L +  N++
Sbjct: 614  ALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQRLYIAGNRI 673

Query: 526  EGSIPDNL--------------SFSCTLTS---------------------IPSTLWNLK 550
            +GSIP++L                S ++ S                     IP + W+L+
Sbjct: 674  QGSIPNDLFHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLR 733

Query: 551  DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRL 610
            D+L L+LS NF TG LP E+GN+K +  +DLS N  S  IP  +G L++L  L L  N+L
Sbjct: 734  DLLVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKL 793

Query: 611  QGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 670
            QGSIP   GD+++L+S++LS NNL G IP SLE L+ LK +NVSFNKL+GEIP  GPF N
Sbjct: 794  QGSIPVEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGPFVN 853

Query: 671  FSLESFKGNELLCGMPNLQVRSCRTRIHHTS--SKNDLLIGIVLPLST-----TFMMGGK 723
            F+ ESF  NE LCG P+ QV +C    H  S  +K+ +L  I+LP+ +      F++   
Sbjct: 854  FTAESFIFNEALCGAPHFQVIACDKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIVLWI 913

Query: 724  SQLNDANMP------LVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEV 777
             + ++  +P      L     + +  +L  ATN F E+NLIG+G  G VYK  + +G+ V
Sbjct: 914  RRQDNTEIPAPIDSWLPGAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTV 973

Query: 778  AVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL 837
            A+KVF+L++  A++SFD EC +++ I HRN+I+ I+ CS+ DFKALVLEYMP GSL+K L
Sbjct: 974  AIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWL 1033

Query: 838  YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 897
            YS NY LD+FQRLNIMIDVA ALEYLH   S  ++HCDLKP+NVLLD+NMVAH++DFG+A
Sbjct: 1034 YSHNYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIA 1093

Query: 898  KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFT 957
            +  L E +S+ QT+TL TIGYMAPEYG +G VST GDVYS+GI+LME F RKKP DE FT
Sbjct: 1094 R-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFT 1152

Query: 958  GEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN 1017
            G++TLK WV   L  S++EVVDANLL  +++    K   +S +  LA+ CT +SPEERIN
Sbjct: 1153 GDVTLKTWVES-LSSSVIEVVDANLLRRDNEDLATKLSYLSSLMALALACTADSPEERIN 1211

Query: 1018 AKEIVT 1023
             K++V 
Sbjct: 1212 MKDVVV 1217

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485449|ref|XP_002276919.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  848 bits (2191), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 515/1106 (46%), Positives = 676/1106 (61%), Gaps = 112/1106 (10%)

Query: 1    LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            L +LE + L  N   GKIPS+LS+C+ LR +SLS N F+G+IP  IG             
Sbjct: 500  LPSLEVISLSWNQLKGKIPSSLSHCQELRTLSLSFNQFTGSIPLGIG------------- 546

Query: 61   KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
                       NL++LEEL+L  N LTG +P +++N+SSL  +DL  N  +  L  +IC 
Sbjct: 547  -----------NLSKLEELYLGINNLTGELPQALYNISSLRAIDLQSNIFSDFLHTDICH 595

Query: 121  NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
             LP L+ + L  N   GKIPS+L  C+ LQ +SLS N F G IP+ IG+L+KL+ L+L  
Sbjct: 596  KLPALKVINLSRNQIKGKIPSSLSHCQELQIISLSFNQFVGGIPQAIGSLSKLEELYLGV 655

Query: 181  NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP---- 236
            N L G IP  +GNL  L+ L L +N L G IP  IFN+SSL  ++ + NSL+GN P    
Sbjct: 656  NNLAGGIPRGMGNLLNLKMLSLVSNRLQGPIPEEIFNISSLQMIDFTNNSLSGNLPIAIC 715

Query: 237  ----KDMHIV---NRLSAELPA--KFCNNIPFLEEIYLSKNMFYGEIPSDLGNC------ 281
                K   ++   N+LSA+LP     C  +  L    LSKN F G IP ++GN       
Sbjct: 716  NHLPKLQQLILSSNQLSAQLPPNLSLCGQLQVLSS--LSKNKFTGSIPIEIGNLPMLEEI 773

Query: 282  ---------TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVP 332
                     TIP   GNL+ L+ LDLQ N +Q  IP E+  L +L+ +    N L G+VP
Sbjct: 774  YLGRNSLTGTIPPSFGNLSALKVLDLQENNIQGNIPKELGCLLSLQNLSLISNDLRGIVP 833

Query: 333  TTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLST 392
              IFN+S L+ + L  N   G LPSS    LPNL +L + GN FSG IP  I N SKL +
Sbjct: 834  EAIFNISKLQSISLADNHLSGNLPSSIGAWLPNLLQLHIGGNEFSGVIPRSISNISKLIS 893

Query: 393  LELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLT--SSTSELSFLSS-SNCKYLEYFSISN 449
            L+L  N F+ ++P   GNLR+L+ L  G NYLT   STSELSFL+S + CK L    I +
Sbjct: 894  LDLSYNFFTSYVPKDLGNLRSLQHLGFGSNYLTYEHSTSELSFLTSLTKCKSLRRLWIQD 953

Query: 450  NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIAL 509
            NPL G  P   GNLS S+E     +  I G IP EI NL+NL+A+ LG N+L G I   L
Sbjct: 954  NPLKGHFPNSFGNLSVSLESIDASSCQIKGVIPTEIGNLSNLMALNLGDNELTGMIPTTL 1013

Query: 510  GKLKKLQLLSLKDNQLEGSIPDNLSF-------------------SC------------- 537
            G+L+KLQ L +  N++ GSIP++L                     SC             
Sbjct: 1014 GQLQKLQQLIISGNRIHGSIPNDLCHSENLGSLLLSSNELSGPVPSCFGNLTALQQLFLD 1073

Query: 538  ---TLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI 594
                 + I S+LW+L  IL LNLS NF  G LPLEIGN+K ++++DLS N FS  IP+++
Sbjct: 1074 SNALASQITSSLWSLGGILYLNLSSNFLNGNLPLEIGNMKTIIKLDLSKNQFSGYIPSSV 1133

Query: 595  GGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVS 654
            G L++L  L L  N LQG IP   GD+++L+SL+LS NNL G IP SLE L+ LK +NVS
Sbjct: 1134 GQLQNLVELSLSKNNLQGPIPLKFGDVVSLESLDLSWNNLSGTIPQSLEALIYLKHLNVS 1193

Query: 655  FNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSK-NDLLIGIVLP 713
            FNK +GEI   GPF NF+ +SF  NE LCG P  QV +C+      S+K   LL+  VLP
Sbjct: 1194 FNKRQGEIRNGGPFVNFTAKSFISNEALCGAPRFQVMACKKVTTRKSTKAKSLLLKCVLP 1253

Query: 714  -LSTTFMMGG--------KSQLN-----DANMPLVANQRRFTYLELFQATNGFSENNLIG 759
             +++T ++          + +L+     D+++P     R+ ++ EL  ATN FSE NLIG
Sbjct: 1254 TIASTIIILALIILLIRRQKRLDIPIQVDSSLP--TTYRKISHQELLHATNYFSEGNLIG 1311

Query: 760  RGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD 819
            +G  G VYK  + DG+  A+KVF+L++  + K F+ EC +++ IRHRN+IK ISSCS+  
Sbjct: 1312 KGSMGTVYKGVLFDGLTAAIKVFNLEFLGSFKGFEAECEVMRNIRHRNLIKIISSCSNLG 1371

Query: 820  FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN 879
            FKALVLE+MP  SLE+ LYS NY LD+ QRLNIMIDVASALEYLH  YS P++HCDLKPN
Sbjct: 1372 FKALVLEFMPNRSLERWLYSHNYCLDLIQRLNIMIDVASALEYLHHDYSNPVVHCDLKPN 1431

Query: 880  NVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFG 939
            NVLLD++ VAH+ DFG+AK  L   +S  QT+TL  IGYMAPEYG EG VST+ DVYS G
Sbjct: 1432 NVLLDEDRVAHVGDFGIAK-LLPGSESRQQTKTLGPIGYMAPEYGSEGIVSTS-DVYSNG 1489

Query: 940  IMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSF 999
            IML+E F RKKPTDE F G+ TLK WV   L  ++ME VD NLL  ED+HF  KE C+  
Sbjct: 1490 IMLLEVFARKKPTDEMFVGDPTLKSWVES-LASTVMEFVDTNLLDKEDEHFAIKENCVLC 1548

Query: 1000 VFNLAMKCTIESPEERINAKEIVTKL 1025
            +  LA++CT ESPE+RIN +++V +L
Sbjct: 1549 IMALALECTAESPEDRINMRDVVARL 1574

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1027
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.730	0.742	0.316	3.5e-124
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.682	0.597	0.310	5.1e-123
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.679	0.558	0.309	1.4e-113
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.680	0.558	0.306	4.2e-112
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.570	0.597	0.311	1.3e-107
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.290	0.290	0.420	2.7e-107
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.472	0.470	0.324	4.9e-106
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.833	0.835	0.332	9.5e-105
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.949	0.870	0.307	3.7e-103
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.939	0.875	0.302	1.1e-101

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 793 (284.2 bits), Expect = 3.5e-124, Sum P(2) = 3.5e-124
 Identities = 264/835 (31%), Positives = 394/835 (47%)

Query:   112 GELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLT 171
             G +++    NL  L +L L EN F G IP  + +   L+ L + IN   G IP  + N +
Sbjct:    79 GGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCS 138

Query:   172 KLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSL 231
             +L  L LD NRL G +P ELG+L  L +L L  N + G +P S+ NL+ L  L LS N+L
Sbjct:   139 RLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNL 198

Query:   232 TGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLA 291
              G  P D+       A+L          +  + L  N F G           P  + NL+
Sbjct:   199 EGEIPSDV-------AQLTQ--------IWSLQLVANNFSG---------VFPPALYNLS 234

Query:   292 KLEKLDLQFNRLQCVIPHEIDNL-HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNS 350
              L+ L + +N     +  ++  L  NL       N   G +PTT+ N+STL+ L +  N+
Sbjct:   235 SLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENN 294

Query:   351 FFGRLPSSADVRLPNLEELSLSGNNF-SGTIPSFIFNTS-----KLSTLELQRNSFSGFI 404
               G +P+  +V  PNL+ L L  N+  S +     F TS     +L TL + RN   G +
Sbjct:   295 LTGSIPTFGNV--PNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDL 352

Query:   405 PNTFGNLR-NLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILPRVIGNL 463
             P +  NL   L  LDLG                 N   L+   +  N L G LP  +G L
Sbjct:   353 PISIANLSAKLVTLDLGGTLISGSIPYDIG----NLINLQKLILDQNMLSGPLPTSLGKL 408

Query:   464 SQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDN 523
               ++    + ++ +SG IP  I N+T L  + L  N                      DN
Sbjct:   409 L-NLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDN 467

Query:   524 QLEGSIPD-----------NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGN 572
             +L G+IP            ++S +  + S+P  +  L+++  L+L  N  +G LP  +GN
Sbjct:   468 KLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGN 527

Query:   573 LKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIXXXXXXXXXX 632
                +  + L  N F   IP  + GL  ++ + L  N L GSIP+                
Sbjct:   528 CLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFN 586

Query:   633 XXFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRS 692
                G +P+  + + +    N +   + G     G    F L+       L   P++ V+ 
Sbjct:   587 NLEGKVPV--KGIFE----NATTVSIVGNNDLCGGIMGFQLKP-----CLSQAPSV-VKK 634

Query:   693 CRTRIHHTSSKNDLLIGIVLPL---STTFMMGGKSQLN-DANMP----LVANQRRFTYLE 744
               +R+        + I ++L L   S T +   K + N + N P    L     + +Y +
Sbjct:   635 HSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGD 694

Query:   745 LFQATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI 803
             L  ATNGFS +N++G G FG VYKA +  +   VAVKV ++Q   A+KSF  EC  +K I
Sbjct:   695 LRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDI 754

Query:   804 RHRNIIKFISSCSSDDF-----KALVLEYMPYGSLEKCLYSSNY--------ILDIFQRL 850
             RHRN++K +++CSS DF     +AL+ E+MP GSL+  L+             L + +RL
Sbjct:   755 RHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERL 814

Query:   851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ 905
             NI IDVAS L+YLH     PI HCDLKP+NVLLDD++ AH+SDFG+A+  LK D+
Sbjct:   815 NIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 758 (271.9 bits), Expect = 5.1e-123, Sum P(2) = 5.1e-123
 Identities = 231/745 (31%), Positives = 333/745 (44%)

Query:     1 LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             L+ L+ L L SN F GKIP+ +     L  + L LN FSG+IP  I  +  +  L LR N
Sbjct:    95 LTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFYLDLRNN 154

Query:    61 KLQGEIPXXXXXXXXXXXXXXQNNFLTGTIPXXXXXXXXXXXXXXXXXXXTGELLANICS 120
              L G++P                N LTG IP                   TG +  +I  
Sbjct:   155 LLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSI-G 213

Query:   121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
              L  L  L L  N   GKIP       +LQ+L L+ N   GDIP EIGN + L  L L  
Sbjct:   214 TLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYD 273

Query:   181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTG------N 234
             N+L G+IP ELGNL +L+ L++  N LT +IP S+F L+ L+ L LS N L G       
Sbjct:   274 NQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIG 333

Query:   235 FPKDMHIV----NRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNL 290
             F + + ++    N  + E P     N+  L  + +  N   GE+P+DLG  T      NL
Sbjct:   334 FLESLEVLTLHSNNFTGEFPQSI-TNLRNLTVLTVGFNNISGELPADLGLLT------NL 386

Query:   291 AKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNS 350
               L   D   N L   IP  I N   L+ +  S N++ G +P   F    L F+ +G N 
Sbjct:   387 RNLSAHD---NLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRG-FGRMNLTFISIGRNH 442

Query:   351 FFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGN 410
             F G +P        NLE LS++ NN +GT+   I    KL  L++  NS +G IP   GN
Sbjct:   443 FTGEIPDDI-FNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGN 501

Query:   411 LRNLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF 470
             L++L  L L  N               N   L+   + +N L G +P  + ++ + +   
Sbjct:   502 LKDLNILYLHSN----GFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDM-KLLSVL 556

Query:   471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDNQLEGSIP 530
              + N+  SG IP   + L +L  + L  NK N                   DN L G+IP
Sbjct:   557 DLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIP 616

Query:   531 DNL-----------SFSCTLTS--IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLV 577
               L           +FS  L +  IP  L  L+ +  ++LS N F+G +P  +   K + 
Sbjct:   617 GELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVF 676

Query:   578 QIDLSINNFSDVIPTTI-GGLKDLQYLFLKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFG 636
              +D S NN S  IP  +  G+  +  L L  N   G IP S G+M              G
Sbjct:   677 TLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTG 736

Query:   637 IIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPN-LQVRSCRT 695
              IP SL  L  LK + ++ N L+G +P  G F+N +     GN  LCG    L+  + + 
Sbjct:   737 EIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQ 796

Query:   696 RIHHTSSKNDLLIGIVLPLSTTFMM 720
             +  H S +  +++ I+L  +   ++
Sbjct:   797 KSSHFSKRTRVIL-IILGSAAALLL 820

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 717 (257.5 bits), Expect = 1.4e-113, Sum P(2) = 1.4e-113
 Identities = 231/747 (30%), Positives = 336/747 (44%)

Query:     1 LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             L NL+ L L S    G IPS L    R++++ L  N   G IP E+GN + L       N
Sbjct:   166 LVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAEN 225

Query:    61 KLQGEIPXXXXXXXXXXXXXXQNNFLTGTIPXXXXXXXXXXXXXXXXXXXTGELLANICS 120
              L G IP               NN LTG IP                    G L+    +
Sbjct:   226 MLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQG-LIPKSLA 284

Query:   121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLD 179
             +L  LQTL L  NN  G+IP        L  L L+ N  SG +PK I  N T L+ L L 
Sbjct:   285 DLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLS 344

Query:   180 QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNF-PKD 238
               +L GEIP EL     L++L L NN L G+IP ++F L  L+DL L  N+L G   P  
Sbjct:   345 GTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSI 404

Query:   239 MHIVN---------RLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGN 289
              ++ N          L  +LP K  + +  LE ++L +N F GEIP ++GNCT       
Sbjct:   405 SNLTNLQWLVLYHNNLEGKLP-KEISALRKLEVLFLYENRFSGEIPQEIGNCT------- 456

Query:   290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSN 349
                L+ +D+  N  +  IP  I  L  L  +    N+LVG +P ++ N   L  L L  N
Sbjct:   457 --SLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADN 514

Query:   350 SFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFG 409
                G +PSS    L  LE+L L  N+  G +P  + +   L+ + L  N  +G I    G
Sbjct:   515 QLSGSIPSSFGF-LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG 573

Query:   410 NLRNLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILPRVIGNLSQ-SME 468
             +   L + D+ +N               N + L+   +  N L G +P  +G + + S+ 
Sbjct:   574 SSSYLSF-DVTNN----GFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLL 628

Query:   469 DFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDNQLEGS 528
             D  M ++ ++G+IP ++     L  I L  N L+                    NQ   S
Sbjct:   629 D--MSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVES 686

Query:   529 IPDNLSFSCT----LT--------SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVL 576
             +P  L F+CT    L+        SIP  + NL  +  LNL  N F+G LP  +G L  L
Sbjct:   687 LPTEL-FNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKL 745

Query:   577 VQIDLSINNFSDVIPTTIGGLKDLQY-LFLKYNRLQGSIPDSIGDMIXXXXXXXXXXXXF 635
              ++ LS N+ +  IP  IG L+DLQ  L L YN   G IP +IG +              
Sbjct:   746 YELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLT 805

Query:   636 GIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRT 695
             G +P S+  +  L  +NVSFN L G++ ++  F  +  +SF GN  LCG P  +    R+
Sbjct:   806 GEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVRS 863

Query:   696 --RIHHTSSKNDLLIGIVLPLSTTFMM 720
               +    S+++ ++I  +  L+   +M
Sbjct:   864 NNKQQGLSARSVVIISAISALTAIGLM 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 718 (257.8 bits), Expect = 4.2e-112, Sum P(2) = 4.2e-112
 Identities = 228/745 (30%), Positives = 328/745 (44%)

Query:     1 LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             L NL+ L L S    G IPS      +L+ + L  N+  G IP EIGN T+L       N
Sbjct:   167 LVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFN 226

Query:    61 KLQGEIPXXXXXXXXXXXXXXQNNFLTGTIPXXXXXXXXXXXXXXXXXXXTGELLANICS 120
             +L G +P               +N  +G IP                    G L+    +
Sbjct:   227 RLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQG-LIPKRLT 285

Query:   121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLD 179
              L  LQTL L  NN  G I     R   L+ L L+ N  SG +PK I  N T LK L L 
Sbjct:   286 ELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLS 345

Query:   180 QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
             + +L GEIP E+ N   L+ L L NN LTG IP S+F L  L++L L+ NSL G     +
Sbjct:   346 ETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSI 405

Query:   240 HIVNRLSA------ELPAKFCNNIPFL---EEIYLSKNMFYGEIPSDLGNCTIPKEIGNL 290
               +  L         L  K    I FL   E +YL +N F GE+P ++GNCT        
Sbjct:   406 SNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCT-------- 457

Query:   291 AKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNS 350
              +L+++D   NRL   IP  I  L +L  +    N+LVG +P ++ N   +  + L  N 
Sbjct:   458 -RLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQ 516

Query:   351 FFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGN 410
               G +PSS    L  LE   +  N+  G +P  + N   L+ +    N F+G I    G+
Sbjct:   517 LSGSIPSSFGF-LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGS 575

Query:   411 LRNLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILPRVIGNLSQ-SMED 469
                L + D+ +N               N   L+   +  N   G +PR  G +S+ S+ D
Sbjct:   576 SSYLSF-DVTEN-GFEGDIPLELGKSTN---LDRLRLGKNQFTGRIPRTFGKISELSLLD 630

Query:   470 FHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDNQLEGSI 529
               +  +++SG IP E+     L  I L  N L+                    N+  GS+
Sbjct:   631 --ISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSL 688

Query:   530 PDNLSFSCT--LT----------SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLV 577
             P  + FS T  LT          SIP  + NL+ +  LNL  N  +GPLP  IG L  L 
Sbjct:   689 PTEI-FSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLF 747

Query:   578 QIDLSINNFSDVIPTTIGGLKDLQY-LFLKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFG 636
             ++ LS N  +  IP  IG L+DLQ  L L YN   G IP +I  +              G
Sbjct:   748 ELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVG 807

Query:   637 IIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTR 696
              +P  +  +  L  +N+S+N LEG++ ++  F  +  ++F GN  LCG P        ++
Sbjct:   808 EVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSPLSHCNRAGSK 865

Query:   697 IHHT-SSKNDLLIGIVLPLSTTFMM 720
                + S K  ++I  +  L+   +M
Sbjct:   866 NQRSLSPKTVVIISAISSLAAIALM 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 641 (230.7 bits), Expect = 1.3e-107, Sum P(2) = 1.3e-107
 Identities = 204/654 (31%), Positives = 305/654 (46%)

Query:   171 TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNL-SSLSDLELSFN 229
             T++  L +    L GEI   + NL  L  L L  NF  G IPP I +L  +L  L LS N
Sbjct:    66 TQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSEN 125

Query:   230 SLTGNFPKDMHIVNRL----------SAELPAK-FCN-NIPFLEEIYLSKNMFYGEIPSD 277
              L GN P+++ ++NRL          +  +P + FCN +   L+ I LS N   GEIP +
Sbjct:   126 LLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLN 185

Query:   278 LGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFN 337
               +C       +L +L  L L  N+L   +P  + N  NL+WM    N L G +P+ + +
Sbjct:   186 Y-HC-------HLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVIS 237

Query:   338 -VSTLKFLYLGSNSFFGRL------PSSADV-RLPNLEELSLSGNNFSGTIPSFIFNTS- 388
              +  L+FLYL  N F          P  A +    +L+EL L+GN+  G I S + + S 
Sbjct:   238 KMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSV 297

Query:   389 KLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYXXXXXXXXXXXXXXNCKY--LEYFS 446
              L  + L +N   G IP    NL NL  L+L  N                CK   LE   
Sbjct:   298 NLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPREL------CKLSKLERVY 351

Query:   447 ISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXX 506
             +SNN L G +P  +G++ + +    +  +N+SGSIP    NL+ L  + L  N L+    
Sbjct:   352 LSNNHLTGEIPMELGDIPR-LGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVP 410

Query:   507 XXXXXXXXXXXXXXXDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPL 566
                             N L G+IP           + S L NLK  L LNLS N  +GP+
Sbjct:   411 QSLGKCINLEILDLSHNNLTGTIP---------VEVVSNLRNLK--LYLNLSSNHLSGPI 459

Query:   567 PLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIXXXX 626
             PLE+  + +++ +DLS N  S  IP  +G    L++L L  N    ++P S+G +     
Sbjct:   460 PLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKE 519

Query:   627 XXXXXXXXFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP 686
                      G IP S ++   LK +N SFN L G +  +G F   ++ESF G+ LLCG  
Sbjct:   520 LDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSI 579

Query:   687 NLQVRSCRTRIHHTSSKNDLLIGIVL---------PLSTTFMMG------GKSQLNDANM 731
                +++C+ +  + S    +L+ ++          PL      G       K ++ D   
Sbjct:   580 K-GMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEK 638

Query:   732 PLVANQR--RFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFD 783
                 + +  R +Y +L  AT GF+ ++LIG G FG VYK  +++  +VAVKV D
Sbjct:   639 QNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLD 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 579 (208.9 bits), Expect = 2.7e-107, Sum P(2) = 2.7e-107
 Identities = 135/321 (42%), Positives = 190/321 (59%)

Query:   727 NDANM-PLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDL 784
             ND +  P+ +   + +Y EL++ T GFS +NLIG G FG V+K  +      VA+KV +L
Sbjct:   693 NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752

Query:   785 QYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS-----DDFKALVLEYMPYGSLEKCLY- 838
                 A KSF  EC  +  IRHRN++K ++ CSS     +DF+ALV E+MP G+L+  L+ 
Sbjct:   753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812

Query:   839 -------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL 891
                    + +  L +F RLNI IDVASAL YLH     PI HCD+KP+N+LLD ++ AH+
Sbjct:   813 DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHV 872

Query:   892 SDFGMAKPFLKEDQSLTQTQ-----TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 946
             SDFG+A+  LK D+     Q        TIGY APEYG  G  S  GDVYSFGI+L+E F
Sbjct:   873 SDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIF 932

Query:   947 TRKKPTDESFTGEMTLKRWVNDLLLI-SIMEVVDANLLSHE-DKHFVAKEQCMSFVFNLA 1004
             T K+PT++ F   +TL  +    L     +++ D  +L     +HF   E C++ VF + 
Sbjct:   933 TGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE-CLTLVFRVG 991

Query:  1005 MKCTIESPEERINAKEIVTKL 1025
             + C+ ESP  RI+  E ++KL
Sbjct:   992 VSCSEESPVNRISMAEAISKL 1012

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 4.9e-106, Sum P(2) = 4.9e-106
 Identities = 164/505 (32%), Positives = 235/505 (46%)

Query:   176 LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNF 235
             L+L   +L G I   +GNL+ L  L L +N    TIP  +  L  L  L +S+N L G  
Sbjct:    78 LNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRI 137

Query:   236 PKDMHIVNRLSA-ELPAKFCNN-IPFLEEIYLSKNMFYGEIPSDL-GNCTIPKEIGNLAK 292
             P  +   +RLS  +L +    + +P  E   LSK        ++L GN   P  +GNL  
Sbjct:   138 PSSLSNCSRLSTVDLSSNHLGHGVPS-ELGSLSKLAILDLSKNNLTGN--FPASLGNLTS 194

Query:   293 LEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFF 352
             L+KLD  +N+++  IP E+  L  + +   + N   G  P  ++N+S+L+ L L  NSF 
Sbjct:   195 LQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFS 254

Query:   353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLR 412
             G L +     LPNL  L L  N F+G IP  + N S L   ++  N  SG IP +FG LR
Sbjct:   255 GNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLR 314

Query:   413 NLKWLDLGDNYXXXXXXXXXXX--XXXNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF 470
             NL WL + +N                 NC  LEY  +  N LGG LP  I NLS ++   
Sbjct:   315 NLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSL 374

Query:   471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDNQLEGSIP 530
              +  + ISG+IP +I NL +L  + L  N L+                    N + G IP
Sbjct:   375 FLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIP 434

Query:   531 D---NLSF--SCTLTS------IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQI 579
                 N++      L S      IP +L   + +L L +  N   G +P EI  +  L  I
Sbjct:   435 SYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYI 494

Query:   580 DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFGIIP 639
             DLS N  +   P  +G L+ L  L   YN+L G +P +IG  +             G IP
Sbjct:   495 DLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP 554

Query:   640 ISLEKLLDLKDINVSFNKLEGEIPR 664
               + +L+ LK+++ S N L G IPR
Sbjct:   555 -DISRLVSLKNVDFSNNNLSGRIPR 578

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
 Identities = 317/953 (33%), Positives = 470/953 (49%)

Query:   121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
             NL  L+ L L +N   G+IP  L R   LQ L LS N   G IP  IG  TKL  L L  
Sbjct:   101 NLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSH 160

Query:   181 NRLQGEIPEELG-NLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
             N+L+G IP E+G +L  L  L L  N L+G IP ++ NL+SL + +LSFN L+G  P  +
Sbjct:   161 NQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSL 220

Query:   240 HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQ 299
                 +LS+ L               L +N   G IP+          I NL+ L    ++
Sbjct:   221 ---GQLSSLLTMN------------LGQNNLSGMIPNS---------IWNLSSLRAFSVR 256

Query:   300 FNRLQCVIP-HEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSS 358
              N+L  +IP +    LH LE +    N+  G +P ++ N S L  + +  N F G + S 
Sbjct:   257 ENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSG 316

Query:   359 ADVRLPNLEELSLSGNNFS-------GTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL 411
                RL NL EL L  N F        G I S + N SKL TL L  N+  G +PN+F NL
Sbjct:   317 FG-RLRNLTELYLWRNLFQTREQDDWGFI-SDLTNCSKLQTLNLGENNLGGVLPNSFSNL 374

Query:   412 R-NLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF 470
               +L +L L  N               N   L++  + NN   G LP  +G L +++   
Sbjct:   375 STSLSFLALELN----KITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRL-KNLGIL 429

Query:   471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDNQLEGSIP 530
                 +N+SGSIP  I NLT L  + LG NK +                    N L G IP
Sbjct:   430 LAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIP 489

Query:   531 DNLSFSCTLT------------SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQ 578
               L    TL+            SIP  + +LK+++  +   N  +G +P  +G+ ++L  
Sbjct:   490 SELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRY 549

Query:   579 IDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFGII 638
             + L  N  S  IP+ +G LK L+ L L  N L G IP S+ D+              G +
Sbjct:   550 LYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEV 609

Query:   639 PISLEKLLDLKDINVSFN-KLEGEIPR-EGPFRNFSLESFKGNELLCGMPNLQVRSCRTR 696
             P ++        I++  N KL G IP    P     LE+ K   +L   P + V S    
Sbjct:   610 P-TIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVL---P-ISV-SLAAA 663

Query:   697 IHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENN 756
             +   SS     + +++        G  S+ +    PLV+      Y +L +AT+GF+  N
Sbjct:   664 LAILSS-----LYLLITWHKRTKKGAPSRTSMKGHPLVS------YSQLVKATDGFAPTN 712

Query:   757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
             L+G G FG VYK ++     VAVKV  L+  +A+KSF  EC  ++ +RHRN++K ++ CS
Sbjct:   713 LLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICS 772

Query:   817 S-----DDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYLHF 865
             S     +DFKA+V ++MP GSLE  ++      +    L++ +R+ I++DVA AL+YLH 
Sbjct:   773 SIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR 832

Query:   866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-----LATIGYMA 920
                 P++HCD+K +NVLLD +MVAH+ DFG+A+  L +  SL Q  T     + TIGY A
Sbjct:   833 HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR-ILVDGTSLIQQSTSSMGFIGTIGYAA 891

Query:   921 PEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
             PEYG     ST+GD+YS+GI+++E  T K+PTD +F  ++ L+++V   L   + +VVD 
Sbjct:   892 PEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDT 951

Query:   981 NLLSHEDKHFVAKE--------QCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
              L+   +    +          +C+ ++  L + C+ E P  R    +I+ +L
Sbjct:   952 KLILDSENWLNSTNNSPCRRITECIVWLLRLGLSCSQELPSSRTPTGDIIDEL 1004

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 1022 (364.8 bits), Expect = 3.7e-103, P = 3.7e-103
 Identities = 328/1065 (30%), Positives = 475/1065 (44%)

Query:     1 LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             LSNL Y+ L  N+  G IP    N  +L    LS N  +G I   +GN+  L  L+L  N
Sbjct:   101 LSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQN 160

Query:    61 KLQGEIPXXXXXXXXXXXXXXQNNFLTGTIPXXXXXXXXXXXXXXXXXXXTGELLANICS 120
              L   IP                N LTG+IP                   TG +   +  
Sbjct:   161 YLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPEL-G 219

Query:   121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
             N+  +  L L +N   G IPSTL   K+L  L L  N  +G IP EIGN+  +  L L Q
Sbjct:   220 NMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQ 279

Query:   181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP---- 236
             N+L G IP  LGNL  L  L L  N+LTG IPP + N+ S+ DLELS N LTG+ P    
Sbjct:   280 NKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLG 339

Query:   237 --KDMHIV----NRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNL 290
               K++ I+    N L+  +P +   N+  + ++ L+ N   G IPS  GN         L
Sbjct:   340 NLKNLTILYLYENYLTGVIPPEL-GNMESMIDLQLNNNKLTGSIPSSFGN---------L 389

Query:   291 AKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNS 350
               L  L L  N L  VIP E+ N+ ++  +  S NKL G VP +  N + L+ LYL  N 
Sbjct:   390 KNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNH 449

Query:   351 FFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGN 410
               G +P        +L  L L  NNF+G  P  +    KL  + L  N   G IP +  +
Sbjct:   450 LSGAIPPGV-ANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRD 508

Query:   411 LRNL-KWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILPRVIGNLSQS--M 467
              ++L +   LG+ +              N  ++++   S+N   G    +  N  +S  +
Sbjct:   509 CKSLIRARFLGNKFTGDIFEAFGIYPDLN--FIDF---SHNKFHG---EISSNWEKSPKL 560

Query:   468 EDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDNQLEG 527
                 M N+NI+G+IP EI N+T L+ + L  N L                     NQL G
Sbjct:   561 GALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSG 620

Query:   528 SIPDNLSFSCTLTS-----------IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVL 576
              +P  LSF   L S           IP T  +   +  +NLS N F G +P  +  L  L
Sbjct:   621 RVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQL 679

Query:   577 VQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFG 636
              Q+DLS N     IP+ +  L+ L  L L +N L G IP +   MI             G
Sbjct:   680 TQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEG 739

Query:   637 IIPIS---LEKLLDLKDINVSFNKLEGEIPREG--PFRNFSLESFKGNELLCGM-PNLQV 690
              +P +    +   D  + N+    L   IP++   P R        GN ++  + P L V
Sbjct:   740 PLPDTPTFRKATADALEENIG---LCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGV 796

Query:   691 ----RSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELF 746
                   C     +   K  L  G       T    G+      NM + +   +F Y ++ 
Sbjct:   797 LVILSICANTFTYCIRKRKLQNG-----RNTDPETGE------NMSIFSVDGKFKYQDII 845

Query:   747 QATNGFSENNLIGRGGFGFVYKARIQDGMEVAVK----VFDLQYGRAI--KSFDIECGMI 800
             ++TN F   +LIG GG+  VY+A +QD + +AVK      D +  + +  + F  E   +
Sbjct:   846 ESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPVVKQEFLNEVKAL 904

Query:   801 KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI--LDIFQRLNIMIDVAS 858
               IRHRN++K    CS      L+ EYM  GSL K L +      L   +R+N++  VA 
Sbjct:   905 TEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAH 964

Query:   859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
             AL Y+H     PI+H D+   N+LLD++  A +SDFG AK  LK D S   +    T GY
Sbjct:   965 ALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAK-LLKTDSS-NWSAVAGTYGY 1022

Query:   919 MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
             +APE+    +V+   DVYSFG++++E    K P D       +L     + L  S+  + 
Sbjct:  1023 VAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLV----SSLSSSPGEAL--SLRSIS 1076

Query:   979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023
             D  +L    ++   +E+ +  V  +A+ C   +PE R     I T
Sbjct:  1077 DERVLEPRGQN---REKLLKMV-EMALLCLQANPESRPTMLSIST 1117

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1008 (359.9 bits), Expect = 1.1e-101, P = 1.1e-101
 Identities = 319/1055 (30%), Positives = 474/1055 (44%)

Query:     7 LFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEI 66
             L L S +  GK+  ++     L+ + LS N  SG IPKEIGN ++L  L L  N+  GEI
Sbjct:    78 LNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEI 137

Query:    67 PXXXXXXXXXXXXXXQNNFLTGTIPXXXXXXXXXXXXXXXXXXXTGELLANICSNLPLLQ 126
             P               NN ++G++P                   +G+L  +I  NL  L 
Sbjct:   138 PVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSI-GNLKRLT 196

Query:   127 TLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGE 186
             +    +N   G +PS +  C+ L  L L+ N  SG++PKEIG L KL  + L +N   G 
Sbjct:   197 SFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGF 256

Query:   187 IPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLS 246
             IP E+ N   LE L L  N L G IP  + +L SL  L L  N L G  P+++       
Sbjct:   257 IPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREI------- 309

Query:   247 AELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC---------------TIPKEIGNLA 291
                      N+ +  EI  S+N   GEIP +LGN                TIP E+  L 
Sbjct:   310 --------GNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLK 361

Query:   292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSF-NKLVGVVPTTIFNVSTLKFLYLGSNS 350
              L KLDL  N L   IP     L  L +M+  F N L G +P  +   S L  L +  N 
Sbjct:   362 NLSKLDLSINALTGPIPLGFQYLRGL-FMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNH 420

Query:   351 FFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGN 410
               GR+PS   +   N+  L+L  NN SG IP+ I     L  L L RN+  G  P+    
Sbjct:   421 LSGRIPSYLCLH-SNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCK 479

Query:   411 LRNLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF 470
               N+  ++LG N               NC  L+   +++N   G LPR IG LSQ +   
Sbjct:   480 QVNVTAIELGQN----RFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQ-LGTL 534

Query:   471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXXXXXXDNQLEGSIP 530
             ++ ++ ++G +P EI N   L  + +  N  +                   +N L G+IP
Sbjct:   535 NISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIP 594

Query:   531 DNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVL-VQIDLSINNFSDV 589
                            L NL  +  L +  N F G +P E+G+L  L + ++LS N  +  
Sbjct:   595 -------------VALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGE 641

Query:   590 IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFGIIPISLEKLLDLK 649
             IP  +  L  L++L L  N L G IP S  ++              G IP+       L+
Sbjct:   642 IPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL-------LR 694

Query:   650 DINVSFNKLEGEIPREGPFRNFSLES--FKGNELLCGMPNLQVRSCRTRIHHTSSK---- 703
               N+S +   G     GP  N  +++  F  ++   G P   +RS +  I  T++     
Sbjct:   695 --NISMSSFIGNEGLCGPPLNQCIQTQPFAPSQST-GKPG-GMRSSKI-IAITAAVIGGV 749

Query:   704 NDLLIGIVL-----PLSTTFMMGGKSQLNDANMPLVANQRR-FTYLELFQATNGFSENNL 757
             + +LI +++     P+ T        Q ++ ++ +    +  FT+ +L  AT+ F E+ +
Sbjct:   750 SLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFV 809

Query:   758 IGRGGFGFVYKARIQDGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNIIKFI 812
             +GRG  G VYKA +  G  +AVK     +          SF  E   +  IRHRNI+K  
Sbjct:   810 VGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLH 869

Query:   813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
               C+      L+ EYMP GSL + L+  +  LD  +R  I +  A  L YLH      I 
Sbjct:   870 GFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIF 929

Query:   873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
             H D+K NN+LLDD   AH+ DFG+AK  +    S + +    + GY+APEY    +V+  
Sbjct:   930 HRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEK 988

Query:   933 GDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME--VVDANLLSHEDKHF 990
              D+YS+G++L+E  T K P      G   +  WV   +    +   V+DA L + ED+  
Sbjct:   989 SDIYSYGVVLLELLTGKAPVQPIDQGGDVVN-WVRSYIRRDALSSGVLDARL-TLEDERI 1046

Query:   991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             V+    M  V  +A+ CT  SP  R + +++V  L
Sbjct:  1047 VSH---MLTVLKIALLCTSVSPVARPSMRQVVLML 1078

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.3671	0.8305	0.8445	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1027
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-109
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-74
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-68
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-63
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	2e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.001
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  361 bits (929), Expect = e-109
 Identities = 292/953 (30%), Positives = 444/953 (46%), Gaps = 94/953 (9%)

Query: 96   NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLR-CKHLQTLSL 154
            N S + ++DLS  N++G++ + I   LP +QT+ L  N   G IP  +      L+ L+L
Sbjct: 67   NSSRVVSIDLSGKNISGKISSAI-FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 155  SINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPS 214
            S N+F+G IP+  G++  L+ L L  N L GEIP ++G+ + L+ L L  N L G IP S
Sbjct: 126  SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 215  IFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEI 274
            + NL+SL  L L+ N L G  P+++                 +  L+ IYL  N   GEI
Sbjct: 184  LTNLTSLEFLTLASNQLVGQIPREL---------------GQMKSLKWIYLGYNNLSGEI 228

Query: 275  PSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTT 334
            P          EIG L  L  LDL +N L   IP  + NL NL+++    NKL G +P +
Sbjct: 229  P---------YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279

Query: 335  IFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE 394
            IF++  L  L L  NS  G +P    ++L NLE L L  NNF+G IP  + +  +L  L+
Sbjct: 280  IFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338

Query: 395  LQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGG 454
            L  N FSG IP   G   NL  LDL  N LT    E    SS N   L  FS   N L G
Sbjct: 339  LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE-GLCSSGNLFKLILFS---NSLEG 394

Query: 455  ILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKK 514
             +P+ +G   +S+    + +++ SG +P E   L  +  + +  N L G I      +  
Sbjct: 395  EIPKSLGA-CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453

Query: 515  LQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLK 574
            LQ+LSL  N+  G +PD+                L++   L+LS N F+G +P ++G+L 
Sbjct: 454  LQMLSLARNKFFGGLPDSFGSK-----------RLEN---LDLSRNQFSGAVPRKLGSLS 499

Query: 575  VLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL 634
             L+Q+ LS N  S  IP  +   K L  L L +N+L G IP S  +M  L  L+LS N L
Sbjct: 500  ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559

Query: 635  FGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQ-VRSC 693
             G IP +L  +  L  +N+S N L G +P  G F   +  +  GN  LCG      +  C
Sbjct: 560  SGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC 619

Query: 694  RTRIHHTSSK----NDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQAT 749
            + R+  T S        L   ++     F        N+  +  V N+     L+ F + 
Sbjct: 620  K-RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK 678

Query: 750  -----------NGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIEC 797
                       +   E N+I RG  G  YK + I++GM+  VK  +        S   + 
Sbjct: 679  VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIADM 737

Query: 798  GMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA 857
            G   +++H NI+K I  C S+    L+ EY+   +L + L +    L   +R  I I +A
Sbjct: 738  G---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIA 790

Query: 858  SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
             AL +LH   S  ++  +L P  +++D     HL    +           T T+   +  
Sbjct: 791  KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSA 843

Query: 918  YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV-----NDLLLI 972
            Y+APE      ++   D+Y FG++L+E  T K P D  F    ++  W      +  L +
Sbjct: 844  YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903

Query: 973  SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             I   +  ++  ++++        +  V NLA+ CT   P  R  A +++  L
Sbjct: 904  WIDPSIRGDVSVNQNE--------IVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  265 bits (679), Expect = 1e-74
 Identities = 198/566 (34%), Positives = 286/566 (50%), Gaps = 74/566 (13%)

Query: 16  GKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVT-TLIGLHLRGNKLQGEIPEELGNLA 74
           GKI S +     ++ I+LS N  SG IP +I   + +L  L+L  N   G IP   G++ 
Sbjct: 83  GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIP 140

Query: 75  ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN 134
            LE L L NN L+G IP+ I + SSL  LDL  N L G++  ++ +NL  L+ L L  N 
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL-TNLTSLEFLTLASNQ 199

Query: 135 FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNL 194
             G+IP  L + K L+ + L  N+ SG+IP EIG LT L +L L  N L G IP  LGNL
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259

Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP------KDMHIV----NR 244
             L+ L L  N L+G IPPSIF+L  L  L+LS NSL+G  P      +++ I+    N 
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNN 319

Query: 245 LSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLG---NCTIPKEIGNLAKLEKLDLQFN 301
            + ++P     ++P L+ + L  N F GEIP +LG   N T+            LDL  N
Sbjct: 320 FTGKIPVALT-SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV------------LDLSTN 366

Query: 302 RLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADV 361
            L   IP  + +  NL  +I   N L G +P ++    +L+ + L  NSF G LPS    
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF-T 425

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
           +LP +  L +S NN  G I S  ++   L  L L RN F G +P++FG+ + L+ LDL  
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDL-- 482

Query: 422 NYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSI 481
                                     S N   G +PR +G+LS+ M    +  + +SG I
Sbjct: 483 --------------------------SRNQFSGAVPRKLGSLSELM-QLKLSENKLSGEI 515

Query: 482 PKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTS 541
           P E+++   L+++ L  N+L+G I  +  ++  L  L L  NQL G IP NL        
Sbjct: 516 PDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG------- 568

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLP 567
                 N++ ++ +N+S N   G LP
Sbjct: 569 ------NVESLVQVNISHNHLHGSLP 588

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  247 bits (633), Expect = 2e-68
 Identities = 170/486 (34%), Positives = 258/486 (53%), Gaps = 40/486 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           + NLE L L +NM  G+IP+ + +   L+ + L  N   G IP  + N+T+L  L L  N
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           +L G+IP ELG +  L+ ++L  N L+G IP  I  L+SL++LDL  NNLTG + +++  
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL-G 257

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
           NL  LQ LFL +N   G IP ++   + L +L LS N  SG+IP+ +  L  L+ LHL  
Sbjct: 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
           N   G+IP  L +L  L+ LQL +N  +G IP ++   ++L+ L+LS N+LTG       
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG------- 370

Query: 241 IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQF 300
                  E+P   C++    + I  S N   GEIP  LG C           L ++ LQ 
Sbjct: 371 -------EIPEGLCSSGNLFKLILFS-NSLEGEIPKSLGACR---------SLRRVRLQD 413

Query: 301 NRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSAD 360
           N     +P E   L  + ++  S N L G + +  +++ +L+ L L  N FFG LP S  
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF- 472

Query: 361 VRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG 420
                LE L LS N FSG +P  + + S+L  L+L  N  SG IP+   + + L  LDL 
Sbjct: 473 -GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531

Query: 421 DNYLT----SSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSN 476
            N L+    +S SE+  LS           +S N L G +P+ +GN+ +S+   ++ +++
Sbjct: 532 HNQLSGQIPASFSEMPVLSQ--------LDLSQNQLSGEIPKNLGNV-ESLVQVNISHNH 582

Query: 477 ISGSIP 482
           + GS+P
Sbjct: 583 LHGSLP 588

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  233 bits (596), Expect = 1e-63
 Identities = 158/417 (37%), Positives = 218/417 (52%), Gaps = 23/417 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L++LE+L L SN   G+IP  L   K L+ I L  N+ SG IP EIG +T+L  L L  N
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            L G IP  LGNL  L+ L+L  N L+G IP SIF+L  L +LDLS N+L+GE +  +  
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE-IPELVI 305

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            L  L+ L L  NNF GKIP  L     LQ L L  N FSG+IPK +G    L  L L  
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKD-- 238
           N L GEIPE L +   L KL L +N L G IP S+    SL  + L  NS +G  P +  
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425

Query: 239 -MHIV-------NRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNL 290
            + +V       N L   + ++   ++P L+ + L++N F+G +P   G+          
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKW-DMPSLQMLSLARNKFFGGLPDSFGS---------- 474

Query: 291 AKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNS 350
            +LE LDL  N+    +P ++ +L  L  +  S NKL G +P  + +   L  L L  N 
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534

Query: 351 FFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNT 407
             G++P+S    +P L +L LS N  SG IP  + N   L  + +  N   G +P+T
Sbjct: 535 LSGQIPASFS-EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (413), Expect = 5e-45
 Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 26/268 (9%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFIS 813
              +G G FG VY AR  + G  VA+KV   +  +   +    E  ++K+++H NI++   
Sbjct: 5    EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 814  SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
                +D   LV+EY   G L   L      L   +    +  + SALEYLH   S  I+H
Sbjct: 65   VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
             DLKP N+LLD++    L+DFG+A+  L   + L  T  + T  YMAPE           
Sbjct: 121  RDLKPENILLDEDGHVKLADFGLAR-QLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAV 177

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            D++S G++L E  T K P    F G+  L      +             +S E K  +  
Sbjct: 178  DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI-- 231

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEI 1021
             +    V +         PE+R+ A+E 
Sbjct: 232  RKL--LVKD---------PEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  159 bits (404), Expect = 3e-44
 Identities = 67/191 (35%), Positives = 99/191 (51%), Gaps = 9/191 (4%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           +G GGFG VY AR  + G +VA+K+   +     ++    E  ++K++ H NI+K     
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             ++   LV+EY   GSL+  L  +   L   + L I++ +   LEYLH   S  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 876 LKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR-EGRVSTNG 933
           LKP N+LLD DN    L+DFG++K              + T  YMAPE    +G  S   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 934 DVYSFGIMLME 944
           D++S G++L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (408), Expect = 3e-44
 Identities = 93/271 (34%), Positives = 126/271 (46%), Gaps = 28/271 (10%)

Query: 758  IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
            +G G FG VYKA+    G  VAVK+   +        D     E  +++R+ H NI++ I
Sbjct: 7    LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
             +    D   LV+EY   G L     S    L   +   I + +   LEYLH   S  II
Sbjct: 65   DAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 873  HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR-VST 931
            H DLKP N+LLD+N V  ++DFG+AK  LK   SLT T    T  YMAPE    G     
Sbjct: 121  HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGP 178

Query: 932  NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV 991
              DV+S G++L E  T K P    F+GE        D L + I  ++   L   E K   
Sbjct: 179  KVDVWSLGVILYELLTGKPP----FSGENI-----LDQLQL-IRRILGPPLEFDEPKWSS 228

Query: 992  AKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
              E+    +     KC  + P +R  A+EI+
Sbjct: 229  GSEEAKDLIK----KCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (391), Expect = 6e-42
 Identities = 77/279 (27%), Positives = 133/279 (47%), Gaps = 33/279 (11%)

Query: 755  NNLIGRGGFGFVYKARIQD-----GMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNI 808
               +G G FG VYK +++       +EVAVK          I+ F  E  +++++ H N+
Sbjct: 4    GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            +K +  C+ ++   +V+EYM  G L   L  +   L +   L+  + +A  +EYL    S
Sbjct: 64   VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
               IH DL   N L+ +N+V  +SDFG+++  L +D    +      I +MAPE  +EG+
Sbjct: 121  KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 929  VSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDA-NLLSHE 986
             ++  DV+SFG++L E FT  ++P        M+ +          ++E +     L   
Sbjct: 180  FTSKSDVWSFGVLLWEIFTLGEQPYP-----GMSNEE---------VLEYLKNGYRLPQP 225

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                     C   +++L ++C  E PE+R    E+V  L
Sbjct: 226  -------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  153 bits (390), Expect = 7e-42
 Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 30/275 (10%)

Query: 758  IGRGGFGFVYKARI-----QDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG VYK  +         +VAVK           + F  E  ++K++ H NI++ 
Sbjct: 7    LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
            +  C+  +   +V EYMP G L   L      L +   L + + +A  +EYL    S   
Sbjct: 67   LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
            +H DL   N L+ +N+V  +SDFG+++   ++D    +      I +MAPE  ++G+ ++
Sbjct: 124  VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 932  NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV 991
              DV+SFG++L E FT          GE       N        EV++      ED + +
Sbjct: 184  KSDVWSFGVLLWEIFTL---------GEQPYPGMSN-------EEVLEL----LEDGYRL 223

Query: 992  AK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             + E C   ++ L ++C    PE+R    E+V  L
Sbjct: 224  PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  149 bits (379), Expect = 2e-40
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)

Query: 755  NNLIGRGGFGFVYKARIQDG-----MEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNI 808
               +G G FG VYK  ++       +EVAVK        + I+ F  E  +++++ H NI
Sbjct: 4    GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGY 867
            +K +  C+ ++   +V+EYMP G L   L  +    L +   L+  + +A  +EYL    
Sbjct: 64   VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
            S   IH DL   N L+ +N+V  +SDFG+++  L +D           I +MAPE  +EG
Sbjct: 121  SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 928  RVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDA-NLLSH 985
            + ++  DV+SFG++L E FT  ++P        M+            ++E +     L  
Sbjct: 180  KFTSKSDVWSFGVLLWEIFTLGEEPYP-----GMSNAE---------VLEYLKKGYRLPK 225

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                      C   ++ L ++C  E PE+R    E+V  L
Sbjct: 226  P-------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  137 bits (348), Expect = 3e-36
 Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 41/287 (14%)

Query: 756  NLIGRGGFGFVYKARIQDG----MEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIK 810
              +G G FG VYK +++       EVAVK           K F  E  ++K++ H N+++
Sbjct: 1    KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--------YSSNYILDIFQRLNIMIDVASALEY 862
             +  C+ ++   LVLEYM  G L   L              L +   L+  I +A  +EY
Sbjct: 61   LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 863  LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
            L    S   +H DL   N L+ +++V  +SDFG+++    +D    +T     I +MAPE
Sbjct: 121  LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 923  YGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
              ++G  ++  DV+SFG++L E FT    P    + G                  + +  
Sbjct: 178  SLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPG------------------LSNEE 215

Query: 982  LLSH-EDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
            +L +    + + K E C   ++ L + C    PE+R    E+V +L 
Sbjct: 216  VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 2e-35
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 45/279 (16%)

Query: 756  NLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRA--IKSFDIECGMIKRIRHRNIIKFI 812
             L+GRG FG VY A  +D G  +AVK  +L       +++ + E  ++  ++H NI+++ 
Sbjct: 6    ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 813  SSCSSDDFKAL--VLEYMPYGSLEKCLYSSNYILDIFQRLNI------MIDVASALEYLH 864
             S   ++   L   LEY+  GSL         +L  F +L           +   L YLH
Sbjct: 66   GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 865  FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEY 923
               S  I+H D+K  N+L+D + V  L+DFG AK  L + ++   T ++  T  +MAPE 
Sbjct: 119  ---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 924  GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA--N 981
             R        D++S G  ++E  T K P  E       L   +  L  I           
Sbjct: 175  IRGEEYGRAADIWSLGCTVIEMATGKPPWSE-------LGNPMAALYKIGSSGEPPEIPE 227

Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020
             LS E K F+              KC    P++R  A E
Sbjct: 228  HLSEEAKDFL-------------RKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (312), Expect = 2e-31
 Identities = 67/196 (34%), Positives = 96/196 (48%), Gaps = 9/196 (4%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+GGFG VYKAR  + G EVA+KV  L+     +    E  ++K+ +H NI+K+  S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E+   GSL+  L S+N  L   Q   +  ++   LEYLH   S  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           K  N+LL  +    L DFG++              T+  T  +MAPE           D+
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 936 YSFGIMLMETFTRKKP 951
           +S GI  +E    K P
Sbjct: 181 WSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 1e-30
 Identities = 83/273 (30%), Positives = 128/273 (46%), Gaps = 34/273 (12%)

Query: 757  LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
             IG+G FG V     + G +VAVK        A ++F  E  ++  +RH N+++ +    
Sbjct: 13   TIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 817  SDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
              +   +V EYM  GSL   L S    ++ + Q+L   +DV   +EYL        +H D
Sbjct: 71   QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L   NVL+ +++VA +SDFG+AK     + S  Q      + + APE  RE + ST  DV
Sbjct: 128  LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV--AK 993
            +SFGI+L E +        SF G +   R       I + +VV      H +K +   A 
Sbjct: 183  WSFGILLWEIY--------SF-GRVPYPR-------IPLKDVVP-----HVEKGYRMEAP 221

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
            E C   V+ +   C    P +R   K++  +LA
Sbjct: 222  EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  120 bits (302), Expect = 6e-30
 Identities = 82/292 (28%), Positives = 123/292 (42%), Gaps = 50/292 (17%)

Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V+           D   VAVK   +     A K F+ E  ++   +H NI+K
Sbjct: 13   LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSN-------------YILDIFQRLNIMIDVA 857
            F   C+  D   +V EYM +G L K L S                 L + Q L I + +A
Sbjct: 73   FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 858  SALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            S + YL   HF      +H DL   N L+  ++V  + DFGM++     D       T+ 
Sbjct: 133  SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 915  TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLIS 973
             I +M PE     + +T  DV+SFG++L E FT  K+P       E              
Sbjct: 187  PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------------- 232

Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            ++E +    L            C S V+++ + C    P++RIN K+I  +L
Sbjct: 233  VIECITQGRL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 70/195 (35%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 757 LIGRGGFGFVYKARIQDGMEVAVKV--FDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
            IG+G FG VYK  ++   EVAVK     L      K F  E  ++K+  H NI+K I  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
           C       +V+E +P GSL   L      L + + L + +D A+ +EYL    S   IH 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI--GYMAPEYGREGRVSTN 932
           DL   N L+ +N V  +SDFGM++   +E    T +  L  I   + APE    GR ++ 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 933 GDVYSFGIMLMETFT 947
            DV+S+GI+L ETF+
Sbjct: 176 SDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (279), Expect = 4e-27
 Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 25/275 (9%)

Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            F+    +G G FG V++   ++ + VA+K+         + F  E   +KR+RH+++I  
Sbjct: 8    FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVP 870
             + CS  +   ++ E M  GSL   L S    +L +   +++   VA  + YL       
Sbjct: 68   FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
             IH DL   N+L+ +++V  ++DFG+A+  +KED  L+  + +    + APE    G  S
Sbjct: 125  SIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIP-YKWTAPEAASHGTFS 182

Query: 931  TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF 990
            T  DV+SFGI+L E FT  +             +             + A          
Sbjct: 183  TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-------------ITAGY------RM 223

Query: 991  VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                +C   ++ + ++C    PE+R + K +  +L
Sbjct: 224  PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (278), Expect = 8e-27
 Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 25/284 (8%)

Query: 756  NLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNII 809
              +G G FG V   R        G +VAVK  +       +S F+ E  +++ + H NI+
Sbjct: 10   KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 810  KFISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
            K+   C     ++  L++EY+P GSL   L      +++ + L     +   ++YL    
Sbjct: 70   KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL--ATIGYMAPEYGR 925
            S   IH DL   N+L++   +  +SDFG+AK  L ED+     +    + I + APE  R
Sbjct: 127  SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDE---SFTGEMTLKRWVNDLLLISIMEVVDANL 982
              + S+  DV+SFG+ L E FT   P+      F   + + +    +  +         L
Sbjct: 186  TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL-------LEL 238

Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
            L  E +       C   V++L   C    P++R +  +++  + 
Sbjct: 239  LK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (280), Expect = 2e-26
 Identities = 85/280 (30%), Positives = 121/280 (43%), Gaps = 27/280 (9%)

Query: 757  LIGRGGFGFVYKARIQDGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRH-RNIIKFI 812
             +G G FG VY AR  D   VA+KV   +     + ++ F  E  ++  + H  NI+K  
Sbjct: 7    KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 813  SSCSSDDFKALVLEYMPYGSLEK--CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +    LV+EY+  GSLE           L   + L I+  + SALEYLH   S  
Sbjct: 65   DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 871  IIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLA----TIGYMAPEY-- 923
            IIH D+KP N+LLD D  V  L DFG+AK       + +     +    T GYMAPE   
Sbjct: 122  IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 924  -GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
                   S++ D++S GI L E  T   P    F GE           L  I+E+   +L
Sbjct: 182  GLSLAYASSSSDIWSLGITLYELLTGLPP----FEGEKNSSA--TSQTLKIILELPTPSL 235

Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
             S         E       +L  K   + P+ R+++   +
Sbjct: 236  ASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  109 bits (274), Expect = 2e-26
 Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFDL------QYGRAIKSFDIECGMIKRIRHRNI 808
             IG+G FG VY  R   DG    +K  DL      +   A+     E  ++K++ H NI
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLHF 865
           IK+  S        +V+EY   G L + +         F   Q L+  + +  AL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  I+H D+KP N+ L  N +  L DFG++K  L     L +T  + T  Y++PE  +
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTV-VGTPYYLSPELCQ 176

Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
               +   D++S G +L E  T K P    F GE
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  107 bits (270), Expect = 1e-25
 Identities = 77/270 (28%), Positives = 122/270 (45%), Gaps = 31/270 (11%)

Query: 758  IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
            IG G  G VYKA     G EVA+K   L+  +  +    E  ++K  +H NI+ +  S  
Sbjct: 27   IGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
              D   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  +IH D+
Sbjct: 86   VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 877  KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
            K +N+LL  +    L+DFG A   L +++S   +  + T  +MAPE  +        D++
Sbjct: 143  KSDNILLSKDGSVKLADFGFAAQ-LTKEKSKRNSV-VGTPYWMAPEVIKRKDYGPKVDIW 200

Query: 937  SFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---IMEVVDANLLSHEDKHFVAK 993
            S GIM +E     +P          L        LI+   I  + +    S E K F+  
Sbjct: 201  SLGIMCIE-MAEGEPPYLREPPLRALF-------LITTKGIPPLKNPEKWSPEFKDFLN- 251

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEIVT 1023
                        KC ++ PE+R +A+E++ 
Sbjct: 252  ------------KCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 71/209 (33%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGM-----IKRIRHRNIIKF 811
           +G+G FG V   R +D G   A+KV  L+  + IK  ++E  +     + RI H  I+K 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
             +  +++   LVLEY P G L   L       +   R     ++  ALEYLH   S+ I
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGI 114

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVS 930
           I+ DLKP N+LLD +    L+DFG+AK    E     +T T   T  Y+APE        
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYG 171

Query: 931 TNGDVYSFGIMLMETFTRKKPTDESFTGE 959
              D +S G++L E  T K P    F  E
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPP----FYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (257), Expect = 2e-24
 Identities = 69/195 (35%), Positives = 100/195 (51%), Gaps = 11/195 (5%)

Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVF--DLQYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           L+G+G FG V+K  ++D   VAVK    DL     IK F  E  ++K+  H NI+K I  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
           C+      +V+E +P G     L      L   Q +   +D A+ + YL    S   IH 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI--GYMAPEYGREGRVSTN 932
           DL   N L+ +N V  +SDFGM++   +ED  +  +  L  I   + APE    GR S+ 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 933 GDVYSFGIMLMETFT 947
            DV+S+GI+L ETF+
Sbjct: 175 SDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 3e-24
 Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 756 NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFI 812
           +LIGRG FG VYK   ++ G  VA+K   L+     A+KS   E  ++K ++H NI+K+I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFG 866
            S  + D   ++LEY   GSL +       I+  F           +  V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLAYLH-- 116

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
               +IH D+K  N+L   + V  L+DFG+A      D S      + T  +MAPE    
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEM 173

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKP 951
              ST  D++S G  ++E  T   P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  101 bits (253), Expect = 2e-23
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 49/288 (17%)

Query: 758  IGRGGFGFVYKAR------IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        +D M VAVK        A K F  E  ++  ++H +I+KF
Sbjct: 13   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYS---------------SNYILDIFQRLNIMIDV 856
               C   D   +V EYM +G L K L +               +   L + Q L+I   +
Sbjct: 73   YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 857  ASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            AS + YL   HF      +H DL   N L+  N++  + DFGM++     D       T+
Sbjct: 133  ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 914  ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS 973
              I +M PE     + +T  DV+SFG++L E FT  K            + W      +S
Sbjct: 187  LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ----LS 230

Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
              EV++      + +       C   V+++ + C    P++R+N KEI
Sbjct: 231  NTEVIEC---ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  100 bits (250), Expect = 4e-23
 Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 42/288 (14%)

Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        QD M VAVK        A + F  E  ++  ++H++I++F
Sbjct: 13   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSN---YILD-----------IFQRLNIMIDVA 857
               C+      +V EYM +G L + L S      IL            + Q L I   +A
Sbjct: 73   YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 858  SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            S + YL    S+  +H DL   N L+   +V  + DFGM++     D      +T+  I 
Sbjct: 133  SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 918  YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            +M PE     + +T  D++SFG++L E FT  K            + W      +S  E 
Sbjct: 190  WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQ----LSNTEA 233

Query: 978  VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            ++      E +       C   V+ +   C    P++R+  K+I ++L
Sbjct: 234  IECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 47/277 (16%)

Query: 758  IGRGGFGFVYKAR-IQDGMEVAVKVF----DLQYGRAIKSFDIECGMIKRIRHRNIIK-- 810
            +G+G  G VYK R    G   A+K      D ++ + +     E   ++      ++K  
Sbjct: 9    LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCESPYVVKCY 65

Query: 811  --FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              F          ++VLEYM  GSL   L     I +      I   +   L+YLH    
Sbjct: 66   GAFYKEGEI----SIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH--TK 118

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEYGREG 927
              IIH D+KP+N+L++      ++DFG++K     + +L Q  T + T+ YM+PE  +  
Sbjct: 119  RHIIHRDIKPSNLLINSKGEVKIADFGISK---VLENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV----VDANLL 983
              S   D++S G+ L+E    K P      G+ +   +    L+ +I +     + A   
Sbjct: 176  SYSYAADIWSLGLTLLECALGKFPF--LPPGQPS---FFE--LMQAICDGPPPSLPAEEF 228

Query: 984  SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020
            S E + F++              C  + P++R +A E
Sbjct: 229  SPEFRDFIS-------------ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 64/192 (33%), Positives = 99/192 (51%), Gaps = 8/192 (4%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V++    +   VAVK   L+ G    K F  E  ++K++RH  +I+  + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKT--LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            ++   +V E M YGSL + L       L + Q +++   VAS + YL    +   IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   NVL+ +N +  ++DFG+A+  +KED    +      I + APE     R S   DV
Sbjct: 129 LAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 936 YSFGIMLMETFT 947
           +SFGI+L E  T
Sbjct: 188 WSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 14/195 (7%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+        +VAVK   L+ G  + ++F  E  ++K++RH  +++  + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID----VASALEYLHFGYSVPII 872
            ++   +V EYM  GSL   L S         RL  ++D    +A  + YL    S   I
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H DL   N+L+ +N+V  ++DFG+A+  +++D+   +      I + APE    GR +  
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 933 GDVYSFGIMLMETFT 947
            DV+SFGI+L E  T
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.5 bits (241), Expect = 7e-22
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 33/221 (14%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKF 811
           +IG G F  V  A+  +   E A+K+ D +     + +K   IE  ++ R+  H  IIK 
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 812 ISSCSSDDFKALVLEYMPYGSLEK--CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
             +   ++    VLEY P G L +    Y S   LD         ++  ALEYLH   S 
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG------------ 917
            IIH DLKP N+LLD +M   ++DFG AK  L  + S    +  AT              
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 918 -------YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
                  Y++PE   E     + D+++ G ++ +  T K P
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (252), Expect = 1e-21
 Identities = 65/180 (36%), Positives = 99/180 (55%), Gaps = 14/180 (7%)

Query: 486 NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPST 545
           NN + +++I L    ++G I  A+ +L  +Q ++L +NQL G IPD++  + +       
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS------- 118

Query: 546 LWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFL 605
                 +  LNLS N FTG +P   G++  L  +DLS N  S  IP  IG    L+ L L
Sbjct: 119 -----SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171

Query: 606 KYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPRE 665
             N L G IP+S+ ++ +L+ L L++N L G IP  L ++  LK I + +N L GEIP E
Sbjct: 172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231

Length = 968

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 75/271 (27%), Positives = 119/271 (43%), Gaps = 42/271 (15%)

Query: 758  IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSC 815
            IGRG FG V+  R++ D   VAVK         +K+ F  E  ++K+  H NI++ I  C
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +      +V+E +  G     L +    L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63   TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI--GYMAPEYGREGRVSTNG 933
            L   N L+ +  V  +SDFGM++   +ED     T  +  I   + APE    GR S+  
Sbjct: 120  LAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            DV+SFGI+L E F                          S+  V  ANL + + +  + +
Sbjct: 178  DVWSFGILLWEAF--------------------------SLGAVPYANLSNQQTREAIEQ 211

Query: 994  -------EQCMSFVFNLAMKCTIESPEERIN 1017
                   E C   V+ L  +C    P +R +
Sbjct: 212  GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 71/270 (26%), Positives = 127/270 (47%), Gaps = 26/270 (9%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G G FG V+  + +  ++VA+K+  ++ G  +   F  E  ++ ++ H N+++    C+
Sbjct: 12   LGSGQFGVVHLGKWRGKIDVAIKM--IREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
                  +V EYM  G L   L      L     L++  DV  A+EYL    S   IH DL
Sbjct: 70   KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDL 126

Query: 877  KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
               N L+ ++ V  +SDFG+A+ ++ +DQ  +   T   + +  PE     R S+  DV+
Sbjct: 127  AARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 937  SFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQC 996
            SFG+++ E F+          G+M  +R+ N        EVV++             +  
Sbjct: 186  SFGVLMWEVFS---------EGKMPYERFSN-------SEVVES---VSAGYRLYRPKLA 226

Query: 997  MSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
             + V+ +   C  E PE+R   K+++++L 
Sbjct: 227  PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.1 bits (231), Expect = 7e-21
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 6/204 (2%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V+     +  +VA+K    +   + + F  E  ++ ++ H  +++    C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                LV E+M +G L   L +          L + +DV   + YL    S  +IH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127

Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 938 FGIMLMETFTR-KKPTDESFTGEM 960
           FG+++ E F+  K P +     E+
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.7 bits (230), Expect = 8e-21
 Identities = 64/192 (33%), Positives = 99/192 (51%), Gaps = 13/192 (6%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++ +     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 818 DDFKA-LVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL    +   +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 936 YSFGIMLMETFT 947
           +SFGI+L E ++
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)

Query: 756 NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFI 812
           N IG G FG VY A  +  G  +AVK   +Q      IK    E  +++ ++H N++K+ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 813 SSCSSDDFKALVLEYMPYGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                 +   + +EY   G+LE+   +       + +   + +     L YLH   S  I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL-TQTQTLA-TIGYMAPEYGREGRV 929
           +H D+KP N+ LD N V  L DFG A        ++  + Q+LA T  YMAPE    G+ 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 930 STNG---DVYSFGIMLMETFTRKKP 951
             +G   D++S G +++E  T K+P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 39/275 (14%)

Query: 757  LIGRGGFGFVYKA-RIQDGMEVAVKVFDL----QYGR-AIKSFDIECGMIKRIRHRNIIK 810
            L+G G FG VY+   + DG   AVK   L    Q G+ A+K  + E  ++ +++H NI++
Sbjct: 7    LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            ++ +   +D   + LE +P GSL K L                  +   LEYLH      
Sbjct: 67   YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEY-GRE 926
             +H D+K  N+L+D N V  L+DFGMAK      Q +  +   +  G   +MAPE   ++
Sbjct: 123  TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
            G      D++S G  ++E  T K P  +   G   + +      L  I +      LS E
Sbjct: 177  GGYGLAADIWSLGCTVLEMATGKPPWSQ-LEGVAAVFKIGRSKELPPIPDH-----LSDE 230

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
             K F+             +KC    P  R  A E+
Sbjct: 231  AKDFI-------------LKCLQRDPSLRPTAAEL 252

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.0 bits (227), Expect = 5e-20
 Identities = 55/175 (31%), Positives = 82/175 (46%), Gaps = 23/175 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG---------RAIKSFDIECGMIKRIRHRN 807
           +G G +G VYKAR  + G  VA+K   L            R I        ++K ++H N
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS-------LLKELKHPN 59

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           I+K +    ++    LV EY     L+K L      L      +IM  +   L Y H   
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           S  I+H DLKP N+L++ + V  L+DFG+A+ F    ++   T  + T+ Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.3 bits (226), Expect = 6e-20
 Identities = 80/289 (27%), Positives = 122/289 (42%), Gaps = 46/289 (15%)

Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        QD + VAVK        A K F  E  ++  ++H +I+KF
Sbjct: 13   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSN------------YILDIFQRLNIMIDVASA 859
               C   D   +V EYM +G L K L +                L   Q L+I   +A+ 
Sbjct: 73   YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 860  LEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
            + YL   HF      +H DL   N L+ +N++  + DFGM++     D       T+  I
Sbjct: 133  MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 917  GYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
             +M PE     + +T  DV+S G++L E FT  K            + W      +S  E
Sbjct: 187  RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQ----LSNNE 230

Query: 977  VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            V++      + +       C   V++L + C    P  R+N KEI + L
Sbjct: 231  VIEC---ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)

Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFISSC 815
           +G G  G V K   +  G  +AVK   L+   AI K    E  ++ +     I+ F  + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            ++   ++ +EYM  GSL+K L      +       I + V   L YLH  +   IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEYGREGRVSTN 932
           +KP+N+L++      L DFG++         L  +     +G   YMAPE  +    S  
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSG-------QLVNSLAKTFVGTSSYMAPERIQGNDYSVK 179

Query: 933 GDVYSFGIMLMETFTRKKP 951
            D++S G+ L+E  T + P
Sbjct: 180 SDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 8e-20
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
           IG G +G VYKAR  + G  VA+K   ++  +  + F I    E  +++++RH NI++  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 813 SSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              +S    +  +V EYM +  L   L S        Q    M  +   L+YLH   S  
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-------Y 923
           I+H D+K +N+L++++ V  L+DFG+A+P+ K   S   T  + T+ Y  PE       Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGATRY 179

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRK 949
           G E  V    D++S G +L E F  K
Sbjct: 180 GPE--V----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 22/216 (10%)

Query: 752 FSENN---LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN 807
           + EN    ++G+G +G VY AR +   + +A+K    +  R ++    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYILDIFQRLNIMIDVASALE 861
           I++++ S S + F  + +E +P GSL   L S       N    IF    I+      L+
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           YLH      I+H D+K +NVL++  + V  +SDFG +K  L      T+T T  T+ YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGINPCTETFT-GTLQYMA 177

Query: 921 PEYGREGR--VSTNGDVYSFGIMLMETFTRKKPTDE 954
           PE   +G        D++S G  ++E  T K P  E
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 90.7 bits (226), Expect = 9e-20
 Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 41/215 (19%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGM----------IK--- 801
             +G G +  VYKAR  + G  VA+K         IK  + +             IK   
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIK--------KIKLGERKEAKDGINFTALREIKLLQ 57

Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
            ++H NII  +          LV E+M    LEK +   + +L      + M+     LE
Sbjct: 58  ELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           YLH  +   I+H DLKPNN+L+  + V  L+DFG+A+ F   ++ +T  Q + T  Y AP
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAP 171

Query: 922 E-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
           E       YG         D++S G +  E   R 
Sbjct: 172 ELLFGARHYG------VGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.3 bits (219), Expect = 5e-19
 Identities = 70/290 (24%), Positives = 128/290 (44%), Gaps = 44/290 (15%)

Query: 758  IGRGGFGFVYKARI--QDGME----VAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIK 810
            +G G FG VYK  +   +       VA+K         ++  F  E  ++  ++H NI+ 
Sbjct: 13   LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMID 855
             +  C+ +    ++ EY+ +G L + L  ++                 LD    L+I I 
Sbjct: 73   LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
            +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++     D    Q+++L  
Sbjct: 133  IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM 975
            + +M PE    G+ +T  D++SFG++L E F+        F+ +              ++
Sbjct: 190  VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------------EVI 236

Query: 976  EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            E++ +  L          E C + V+ L ++C  E P  R   K+I T+L
Sbjct: 237  EMIRSRQL------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 13/197 (6%)

Query: 756 NLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           + +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYL---HFGYSVP 870
           C+ +    ++ E+M YG+L   L   N   ++    L +   ++SA+EYL   +F     
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----- 125

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 126 -IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 48/292 (16%)

Query: 758  IGRGGFGFVYKARIQ-DGME----VAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G   FG +YK  +   GM+    VA+K   D+   +    F  E  ++  + H NI+  
Sbjct: 13   LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLY----------SSN------YILDIFQRLNIMID 855
            +   + +    ++ EY+  G L + L           SS+        LD    L+I I 
Sbjct: 73   LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 856  VASALEYL--HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+++     D    Q ++L
Sbjct: 133  IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 914  ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS 973
              I +M PE    G+ S++ D++SFG++L E F+        F+ +              
Sbjct: 188  LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------------E 234

Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            ++E+V    L          E C   +++L  +C  E P  R   K+I T+L
Sbjct: 235  VIEMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 757 LIGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRA--IKSFDIECGMIKRIRHRNII 809
            +G+G FG V   R   +QD  G  VAVK   LQ+  A  ++ F+ E  ++K ++H NI+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 810 KFISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           K+   C S   +   LV+EY+PYGSL   L      LD  + L     +   +EYL    
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--- 125

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK--PFLKEDQSLTQTQTLATIGYMAPEYGR 925
           S   +H DL   N+L++      + DFG+ K  P  KE   + +    + I + APE   
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE-SPIFWYAPESLT 184

Query: 926 EGRVSTNGDVYSFGIMLMETFT 947
           E + S   DV+SFG++L E FT
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 756 NLIGRGGFGFVYKARIQDGM-----EVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRN 807
           N +G G FG VY+    D +      + V V  L+ G      K F  E  ++    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNY------ILDIFQRLNIMIDVASALE 861
           I+K +  C  ++ + +++E M  G L   L  +        +L + + L+I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 862 YL---HFGYSVPIIHCDLKPNNVLL-----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
           YL   HF      IH DL   N L+     D + V  + DFG+A+   K D    + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
             + +MAPE   +G+ +T  DV+SFG+++ E  T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 20/208 (9%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYG---RAIKSFDI-ECGMIKRIRHRNIIKFI 812
           IG+G FG V K  R  DG  +  K  ++ YG      K   + E  +++ ++H NI+++ 
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 813 SSCSSDDFKALVLEYMPY------GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
                D     +   M Y        L +        ++      I+  +  AL   H  
Sbjct: 66  DR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 867 YSVP---IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
            S P   ++H DLKP N+ LD N    L DFG+AK  L  D S  +T  + T  YM+PE 
Sbjct: 125 -SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKT-YVGTPYYMSPEQ 181

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKP 951
                     D++S G ++ E      P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 817 SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 186 VWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 37/281 (13%)

Query: 757  LIGRGGFGFVYKA--------RIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRN 807
             +G G FG V +          I     VAVK     +    +  F  E  ++  + H N
Sbjct: 2    KLGDGSFGVVRRGEWSTSGGKVIP----VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFG 866
            +I+      +     +V E  P GSL   L         I    +  + +A+ + YL   
Sbjct: 58   LIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE-- 114

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT-IGYMAPEYGR 925
             S   IH DL   N+LL  +    + DFG+ +   + +      + L     + APE  R
Sbjct: 115  -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
                S   DV+ FG+ L E FT          GE     W   L    I++ +D      
Sbjct: 174  TRTFSHASDVWMFGVTLWEMFT---------YGEEP---WAG-LSGSQILKKIDKEG--- 217

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
              +     E C   ++N+ ++C   +P +R     +   L 
Sbjct: 218  --ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 757 LIGRGGFGFVYKARI--QDG--MEVAVKVF--DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           ++G G FG V + ++   DG  ++VAVK    D+     I+ F  E   +K   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 811 FISSC--SSDDFK----ALVLEYMPYGSLEKCLYSSN-----YILDIFQRLNIMIDVASA 859
            I  C  +S   K     ++L +M +G L   L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           +EYL    +   IH DL   N +L ++M   ++DFG++K     D           + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 920 APEYGREGRVSTNGDVYSFGIMLMETFTR 948
           A E   +   ++  DV++FG+ + E  TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 38/216 (17%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           F     +G G +G VYKA   + G  VA+KV  +     ++    E  ++K+     I+K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN----------IMIDVASAL 860
           +  S   +    +V+EY   GS          + DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IG- 917
           EYLH   S   IH D+K  N+LL++   A L+DFG++         LT T       IG 
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGT 162

Query: 918 --YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
             +MAPE  +E   +   D++S GI  +E    K P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 54/191 (28%), Positives = 101/191 (52%), Gaps = 13/191 (6%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V +     G +VAVK  +++     ++F  E  ++ ++ H+N+++ +     
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 818 DDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    +V+E M  G+L   L +    ++ + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
              N+L+ ++ VA +SDFG+A+       S+    +   + + APE  +  + S+  DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 937 SFGIMLMETFT 947
           S+G++L E F+
Sbjct: 182 SYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 76/300 (25%), Positives = 117/300 (39%), Gaps = 66/300 (22%)

Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVF------DLQYGRAIKSFDIECGMIKRIRH 805
            IG+G FG V++AR       +    VAVK+       D+Q       F  E  ++    H
Sbjct: 13   IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-----ADFQREAALMAEFDH 67

Query: 806  RNIIKFISSCSSDDFKALVLEYMPYGSLEKCL--------------------YSSNYI-L 844
             NI+K +  C+      L+ EYM YG L + L                       N + L
Sbjct: 68   PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 845  DIFQRLNIMIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
               ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++   
Sbjct: 128  SCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 902  KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT 961
              D           I +M PE     R +T  DV+++G++L E F+           E  
Sbjct: 182  SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241

Query: 962  LKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                        I  V D N+LS         + C   ++NL   C  + P +R +   I
Sbjct: 242  ------------IYYVRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 35/204 (17%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G +G VYKAR I  G  VA+KV  L+ G   +    E  M+K  RH NI+ +  S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN----------IMIDVASALEYLHFG 866
             D   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEY 923
                IH D+K  N+LL ++    L+DFG++    +   ++ + ++   IG   +MAPE 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTATIAKRKSF--IGTPYWMAPEV 172

Query: 924 G---REGRVSTNGDVYSFGIMLME 944
               R+G      D+++ GI  +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--------GRAIKSFDIECGMIKR 802
            F    +IG+G FG V   + +D      K+F ++Y          ++++   E  +++ 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTK----KMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDV 856
           + H  ++    S   ++   LV++ +  G L        Y L    + +       + ++
Sbjct: 57  LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEI 109

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
             ALEYLH   S  IIH D+KP+N+LLD+    H++DF +A     +  +   T T  T 
Sbjct: 110 VLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163

Query: 917 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           GYMAPE       S   D +S G+   E    K+P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 38/285 (13%)

Query: 758  IGRGGFGFVYK---ARIQDG---MEVAVK-VFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+     +  G     VA+K V +    R    F  E  ++K     ++++
Sbjct: 14   LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS--------SNY-ILDIFQRLNIMIDVASALE 861
             +   S+     +V+E M  G L+  L S               + + + +  ++A  + 
Sbjct: 74   LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL    +   +H DL   N ++ +++   + DFGM +   + D      + L  + +MAP
Sbjct: 134  YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T           E   +   N+     +++ V   
Sbjct: 191  ESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQPYQGLSNE----EVLKFVIDG 237

Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                   H    E C   +  L   C   +P+ R    EIV+ L 
Sbjct: 238  ------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 10/201 (4%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDL-QYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G    VY A  + +  +VA+K  DL +   ++     E   + +  H N++K+ +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
              D   LV+ Y+  GSL   + SS     LD      ++ +V   LEYLH   S   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLK--EDQSLTQTQTLATIGYMAPEYGREGRVST 931
            D+K  N+LL ++    ++DFG++       +     +   + T  +MAPE   +     
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 932 NG-DVYSFGIMLMETFTRKKP 951
              D++SFGI  +E  T   P
Sbjct: 186 FKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 14/200 (7%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           I +G +G V+ A+    G   A+KV    D+     +     E  ++ + +   ++K   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           S        LV+EY+P G L   L +    LD       + ++  ALEYLH   S  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ------TQTLATIGYMAPEYGREG 927
            DLKP+N+L+D N    L+DFG++K  L   Q           + + T  Y+APE     
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 928 RVSTNGDVYSFGIMLMETFT 947
             S   D +S G +L E   
Sbjct: 177 GHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 75/276 (27%), Positives = 127/276 (46%), Gaps = 42/276 (15%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH---RN 807
            LIGRG +G VY+ + +  G  VA+K+ +L         D+     E  ++ ++R     N
Sbjct: 8    LIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
            I K+  S        +++EY   GS+ + L  +  I + +  + I+ +V  AL+Y+H   
Sbjct: 64   ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY-MAPEYGRE 926
             V +IH D+K  N+L+ +     L DFG+A      +Q+ ++  T     Y MAPE   E
Sbjct: 119  KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 927  GRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
            G+   T  D++S GI + E  T   P    ++     +     L+  S    ++ N  S 
Sbjct: 176  GKYYDTKADIWSLGITIYEMATGNPP----YSDVDAFR--AMMLIPKSKPPRLEDNGYSK 229

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
              + FVA              C  E P+ER++A+E+
Sbjct: 230  LLREFVA-------------ACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)

Query: 749 TNGFSENNLIGRGGFGFVYKAR-IQDGMEVA---VKVFDLQYGRAIKSFDIECGMIKRIR 804
              F     IG+G F  VYKA  + DG  VA   V++F++   +A +    E  ++K++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLE---KCLYSSNYILDIFQRLNIMIDVASALE 861
           H N+IK+++S   ++   +VLE    G L    K       ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           ++H   S  I+H D+KP NV +    V  L D G+ + F    ++      + T  YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Query: 922 EYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           E   E   +   D++S G +L E    + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 16/211 (7%)

Query: 752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRIRH 805
           +++  ++G+G +G VY      G  +AVK  +L         +  +    E  ++K ++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDI-FQRLNIMIDVASALEYLH 864
            NI++++ +C  D+  ++ +E++P GS+   L     + +  F +    I     + YLH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG----YMA 920
              +  ++H D+K NNV+L  N +  L DFG A+         T +  L ++     +MA
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 921 PEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           PE   E       D++S G  + E  T K P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 65/277 (23%), Positives = 117/277 (42%), Gaps = 31/277 (11%)

Query: 755  NNLIGRGGFGFVYKA----RIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNII 809
               IG G FG VY+        + + VAVK        +++  F  E  ++++  H +I+
Sbjct: 11   GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            K I   + ++   +V+E  P G L   L  + Y LD+   +     +++AL YL    S 
Sbjct: 71   KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
              +H D+   NVL+       L DFG+++ +L+++     ++    I +MAPE     R 
Sbjct: 127  RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 930  STNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK 988
            ++  DV+ FG+ + E      KP            + V +  +I  +E           +
Sbjct: 186  TSASDVWMFGVCMWEILMLGVKPF-----------QGVKNNDVIGRIE---------NGE 225

Query: 989  HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                   C   +++L  KC    P +R    E+  +L
Sbjct: 226  RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 84.1 bits (209), Expect = 2e-17
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 43/218 (19%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVK----VF-DLQYG----RAIKSFDIECGMIKRIRH 805
             IG G +G V  A   + G +VA+K    VF DL       R IK       +++ +RH
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-------LLRHLRH 58

Query: 806 RNIIK---FISSCSSDDFKAL--VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
            NII     +   S +DF  +  V E M    L K + S   + D   +   +  +   L
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQY-FLYQILRGL 116

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIGY 918
           +YLH   S  +IH DLKP+N+L++ N    + DFG+A+  +  D+      T  + T  Y
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVDPDEDEKGFLTEYVVTRWY 172

Query: 919 MAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
            APE       Y      +   D++S G +  E  TRK
Sbjct: 173 RAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 30/283 (10%)

Query: 750  NGFSENNLIGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIR 804
            +  ++  +IG G FG V++   ++    EVAV +  L+ G   K    F  E  ++ +  
Sbjct: 5    SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 805  HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
            H NII+     +      ++ EYM  G+L+K L   +     +Q + ++  +A+ ++YL 
Sbjct: 65   HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 865  FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG--YMAPE 922
                +  +H DL   N+L++ N+   +SDFG+++  L++D   T T +   I   + APE
Sbjct: 125  ---DMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 923  YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
                 + ++  DV+SFGI++ E  +          GE       N  ++ +I        
Sbjct: 181  AIAYRKFTSASDVWSFGIVMWEVMS---------FGERPYWDMSNHEVMKAI-------- 223

Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
              ++     A   C S V+ L ++C  +    R    +IV  L
Sbjct: 224  --NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 82.7 bits (204), Expect = 4e-17
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 37/284 (13%)

Query: 758  IGRGGFGFVYKARI-----QDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V   R        G +VAVK    +  G  I     E  +++ + H NI+K+
Sbjct: 12   LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 812  ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               C+ D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72   KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGR 928
              +H DL   NVL++      + DFG+ K    + +  T    L + + + APE   + +
Sbjct: 129  QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 929  VSTNGDVYSFGIMLMETFTRKKPTDESFT----------GEMTLKRWVNDLLLISIMEVV 978
                 DV+SFG+ L E  T         T          G+MT+ R V  L         
Sbjct: 189  FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL--------- 239

Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
                   E K       C   V+ L  KC    P +R   + ++
Sbjct: 240  ------EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 67/291 (23%), Positives = 124/291 (42%), Gaps = 37/291 (12%)

Query: 751  GFSENNLIGRGGFGFVYKARIQDGME------VAVKVFDLQYGRAIKS-FDIECGMIKRI 803
               E   +GRG FG V+ A+ +   E      V VK         ++S F  E  M +++
Sbjct: 6    NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 804  RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI--------LDIFQRLNIMID 855
             H+N+++ +  C   +   ++LEY   G L++ L ++           L   Q++ +   
Sbjct: 66   SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
            +A  +++L    +   +H DL   N L+       +S   ++K     +    +   L  
Sbjct: 126  IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIP 181

Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM 975
            + ++APE  +E   ST  DV+SFG+++ E FT          GE+      ++       
Sbjct: 182  LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSDE------- 225

Query: 976  EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
            EV+  N L          E C S ++ L  +C   +P++R +  E+V+ L 
Sbjct: 226  EVL--NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 5/204 (2%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++ ++ H  +++    C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                +V EYM  G L   L          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+DD     +SDFG+++ ++ +D+  +   +   + +  PE     + S+  DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 938 FGIMLMETFTRKKPTDESFTGEMT 961
           FG+++ E ++  K   E F    T
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSET 210

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 11/196 (5%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+        +VAVK   L+ G  + +SF  E  ++K++RH  +++  +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKT--LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L +   +++   VA+ + Y+     +  IH D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ D +V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 13/207 (6%)

Query: 751 GFSENNLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRN 807
            F     +G+G +G VYK  R+ D    A+K  DL      +  D   E  ++  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR---LNIMIDVASALEYLH 864
           II +  +    +   +V+EY P+G L K +        +        I I +   L+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
                 I+H DLK  N+LL  N +  + D G++K  LK  +++ +TQ   T  YMAPE  
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISK-VLK--KNMAKTQI-GTPHYMAPEVW 173

Query: 925 REGRVSTNGDVYSFGIMLMETFTRKKP 951
           +    S   D++S G +L E  T   P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.1 bits (200), Expect = 8e-17
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 24/268 (8%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
            +G G FG V+  + +  ++VA+K  + +   + + F  E  ++ ++ H  +++    C+ 
Sbjct: 12   LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 818  DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                 +V E+M  G L   L      L     L++  DV   +EYL        IH DL 
Sbjct: 71   QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 878  PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
              N L+    V  +SDFGM + ++ +D+  + +     + +  PE     + S+  DV+S
Sbjct: 128  ARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 938  FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCM 997
            FG+++ E FT          G+M  ++  N        EVV+   +S   + +  K   M
Sbjct: 187  FGVLMWEVFTE---------GKMPFEKKSN-------YEVVEM--ISRGFRLYRPKLASM 228

Query: 998  SFVFNLAMKCTIESPEERINAKEIVTKL 1025
            + V+ +   C  E PE R    E++  +
Sbjct: 229  T-VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 8e-17
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 42/221 (19%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRA---------IKSFDIECGMIKRIRHR 806
           LIG G FG VY       G  +AVK  +L    A         + +   E  ++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 807 NIIKFISSCSSDDFKALVLEYMP----------YGSLEKCLYSSNYILDIFQRLNIMIDV 856
           NI++++ S    D   + LEY+P          YG+ E+ L   N++  I +        
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV-RNFVRQILK-------- 117

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-- 914
              L YLH   +  IIH D+K  N+L+D+     +SDFG++K    E  SL+     A  
Sbjct: 118 --GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARP 170

Query: 915 ----TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
               ++ +MAPE  ++   +   D++S G +++E  T K P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 756 NLIGRGGFGFVYKARIQ-DG--MEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRNIIK 810
           ++IG G FG V +A I+ DG  M  A+K+  +       + F  E  ++ ++  H NII 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------LDIFQRLNIMID 855
            + +C +  +  + +EY PYG+L   L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA+ ++YL        IH DL   NVL+ +N+ + ++DFG+++    E+  + +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           + +MA E       +T  DV+SFG++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 50/285 (17%)

Query: 758  IGRGGFGFVYKA--RIQDG--MEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V K    ++ G  +EVAVK      +  G+  K F  E  ++ ++ H  I++
Sbjct: 3    LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD--IFQRLNI---MIDVASALEYLHF 865
             I  C  +    LV+E  P G L K      Y+         ++      VA  + YL  
Sbjct: 61   LIGVCKGEPL-MLVMELAPLGPLLK------YLKKRREIPVSDLKELAHQVAMGMAYLE- 112

Query: 866  GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEY 923
              S   +H DL   NVLL +   A +SDFGM++  L       +  T     + + APE 
Sbjct: 113  --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRA-LGAGSDYYRATTAGRWPLKWYAPEC 169

Query: 924  GREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
               G+ S+  DV+S+G+ L E F+   KP      GEM             ++ ++++  
Sbjct: 170  INYGKFSSKSDVWSYGVTLWEAFSYGAKP-----YGEMKGA---------EVIAMLESGE 215

Query: 983  -LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
             L   ++       C   ++++ + C    PE+R    E+ +   
Sbjct: 216  RLPRPEE-------CPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 33/222 (14%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRA----------IKSFDIECGMIKRIRH 805
           LIG+G +G VY A  +  G  +AVK  +L    A          +K+   E   +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            NI++++   +++++ ++ LEY+P GS+  CL +     +   R      V   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA---TIGYMAPE 922
             S  I+H DLK +N+L+D + +  +SDFG++K   K D      Q ++   ++ +MAPE
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 923 ------YGREGRVSTNGDVYSFGIMLMETFTRKKP--TDESF 956
                  G   +V    D++S G +++E F  ++P   +E+ 
Sbjct: 181 VIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 11/203 (5%)

Query: 758 IGRGGFGFVYKAR-IQDG----MEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKF 811
           +G G FG VYK   I +G    + VA+KV   +    A K    E  ++  + H ++++ 
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
           +  C S     L+ + MP G L   + +    +     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           +H DL   NVL+       ++DFG+AK    +++          I +MA E       + 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 932 NGDVYSFGIMLMETFT-RKKPTD 953
             DV+S+G+ + E  T   KP +
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+        +VA+K   L+ G  + ++F  E  ++K++RH  ++   +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V E+M  GSL   L   +   L + Q +++   +A  + Y+     +  IH D
Sbjct: 72  EEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ DN+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIKFIS 813
           ++G G +G V K R +  G  VA+K F          K+   E  +++++RH NI+    
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           +        LV EY+    LE  L +S   L      + +  +  A+ Y H   S  IIH
Sbjct: 68  AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-------YGRE 926
            D+KP N+L+ ++ V  L DFG A+  L+   +   T  +AT  Y APE       YG+ 
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 927 GRVSTNGDVYSFGIMLMETFT 947
                  DV++ G ++ E   
Sbjct: 183 ------VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 758 IGRGGFGFV----YKARIQD-GMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKF 811
           +G G FG V    Y       G  VAVK    + G+   S +  E  ++K + H NI+K+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 812 ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
              CS    K   L++EY+P GSL   L      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--------LKEDQSLTQTQTLATIGYMAP 921
             IH DL   NVLLD++ +  + DFG+AK          ++ED         + + + A 
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD-------SPVFWYAV 179

Query: 922 EYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           E  +E + S   DV+SFG+ L E  T    
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 62/197 (31%), Positives = 89/197 (45%), Gaps = 12/197 (6%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDL-QYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G VYKAR    G  VA+K   L      I    + E  ++K + H NIIK +  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
                   LV E+M    L K +      L      + +  +   L + H   S  I+H 
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGRVSTN 932
           DLKP N+L++   V  L+DFG+A+ F         T  + T  Y APE   G +G  ST 
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKG-YSTP 179

Query: 933 GDVYSFGIMLMETFTRK 949
            D++S G +  E  +R+
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVK---VFDLQYGRAIKSFDIECGMIKRIRHRN 807
           F     IGRG F  VY+A  + DG+ VA+K   +FDL   +A      E  ++K++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNI---MIDVASALEYLH 864
           +IK+ +S   D+   +VLE    G L + +        +     +    + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
              S  ++H D+KP NV +    V  L D G+ + F    ++      + T  YM+PE  
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERI 178

Query: 925 REGRVSTNGDVYSFGIMLMETFTRKKP 951
            E   +   D++S G +L E    + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.0 bits (197), Expect = 4e-16
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 756 NLIGRGGFGFVYKARI-QDG--MEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRNIIK 810
           ++IG G FG V KARI +DG  M+ A+K + +       + F  E  ++ ++  H NII 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------LDIFQRLNIMID 855
            + +C    +  L +EY P+G+L   L  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T     
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           + +MA E       +TN DV+S+G++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 41/218 (18%)

Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           F+    IG+G FG VYKA  +     VA+KV DL+        +IE  + +       I+
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQE------IQ 51

Query: 811 FISSCSS-----------DDFK-ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS 858
           F+S C S              K  +++EY   GS    L      LD      I+ +V  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-----L 913
            LEYLH       IH D+K  N+LL +     L+DFG++         LT T +     +
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSG-------QLTSTMSKRNTFV 159

Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            T  +MAPE  ++       D++S GI  +E    + P
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           L+G+G FG VY     D G E+AVK         +  + + + + E  ++K ++H  I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           +      D+  ++ +EYMP GS++  L +   + +   R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-----LATIGYMAPE--- 922
           I+H D+K  N+L D      L DFG +K      Q++  + T       T  +M+PE   
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 923 ---YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
              YGR+       DV+S G  ++E  T K P
Sbjct: 181 GEGYGRK------ADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.4 bits (196), Expect = 6e-16
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 35/216 (16%)

Query: 756 NLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIK 810
             IG G +G VYKAR +D G  VA+K   L   +  + F I    E  +++++ HRNI+ 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70

Query: 811 F----ISSCSSDDFKA------LVLEYMP---YGSLEKCL--YSSNYILDIFQRLNIMID 855
                     + DFK       LV EYM     G LE  L  +S ++I    ++L     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
               LE L++ +    +H D+K +N+LL++     L+DFG+A+ +  E+     T  + T
Sbjct: 126 ----LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVIT 180

Query: 916 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTRK 949
           + Y  PE   G E R     DV+S G +L E FT+K
Sbjct: 181 LWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 56/185 (30%), Positives = 86/185 (46%), Gaps = 36/185 (19%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK------VFD---LQYGRAIKSFDIECGMIKRIRHRN 807
           IG G  G V+KA+  + G  VA+K      +      Q  R IK+       ++  +H  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA-------LQACQHPY 60

Query: 808 IIKFI------SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
           ++K +      S         LV+EYMP   L + L      L   Q  + M  +   + 
Sbjct: 61  VVKLLDVFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           Y+H   +  I+H DLKP N+L+  + V  ++DFG+A+ F +E+  L   Q +AT  Y AP
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAP 169

Query: 922 E--YG 924
           E  YG
Sbjct: 170 ELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 756 NLIGRGGFGFVYKA--RIQDG----MEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNI 808
             +G G FG VY+   R +DG    ++VAVK          +S F +E  ++ +  H+NI
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN------YILDIFQRLNIMIDVASALEY 862
           ++ I        + ++LE M  G L+  L  +         L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 863 L---HFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
           L   HF      IH D+   N LL       VA ++DFGMA+   +        + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 917 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +M PE   +G  ++  DV+SFG++L E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.5 bits (196), Expect = 7e-16
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 27/206 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF-DI--ECGMIKRIRHRNIIKFIS 813
           IG G FG VY AR ++    VA+K       ++ + + DI  E   ++++RH N I++  
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY-K 81

Query: 814 SCSSDDFKA-LVLEYMPYGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYLHFGYS 868
            C   +  A LV+EY        CL S++ IL++     Q + I      AL+ L + +S
Sbjct: 82  GCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY---GR 925
              IH D+K  N+LL +     L+DFG A   +    S      + T  +MAPE      
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSAS-LVSPANSF-----VGTPYWMAPEVILAMD 187

Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           EG+     DV+S GI  +E   RK P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 81.8 bits (202), Expect = 7e-16
 Identities = 35/88 (39%), Positives = 51/88 (57%)

Query: 128 LFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI 187
           L LD     G IP+ + + +HLQ+++LS N   G+IP  +G++T L+ L L  N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 188 PEELGNLAELEKLQLQNNFLTGTIPPSI 215
           PE LG L  L  L L  N L+G +P ++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 11/203 (5%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+  + G+  A K+  ++    ++ F +E  ++   +H NI+    +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            ++   +++E+   G+L+  +      L   Q   +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-----GREGRVST 931
           K  N+LL  +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 932 NGDVYSFGIMLMETFTRKKPTDE 954
             D++S GI L+E    + P  E
Sbjct: 188 KADIWSLGITLIELAQMEPPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 21/222 (9%)

Query: 752 FSENNLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQ-YGRAIKSFDI-ECGMIKRIRHRNI 808
           F   N IG+G FG V+K  R  D    A+K  DL    R  +   I E  ++ ++    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYS-------SNYILDIFQRLNIMIDVASALE 861
           I++  S        +V+EY   G L K L          + +   F      I +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           +LH   S  I+H D+K  N+ LD      + D G+AK  L  D +      + T  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSP 170

Query: 922 EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
           E   +   +   DV++ G++L E  T K P D +  G + LK
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 756 NLIGRGGFGFVYKARI--QDGMEV--AVK----VFDLQYGRAIKSFDIECGMIKRIRHRN 807
            +IG+G FG VY   +   DG ++  AVK    + DL+    ++ F  E  ++K   H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE---EVEQFLKEGIIMKDFSHPN 57

Query: 808 IIKFISSCSSDDFKALV-LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           ++  +  C   +   LV L YM +G L   + S  +   +   +   + VA  +EYL   
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-- 115

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL-KEDQSLTQ-TQTLATIGYMAPEYG 924
            S   +H DL   N +LD++    ++DFG+A+    KE  S+   T     + +MA E  
Sbjct: 116 -SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 925 REGRVSTNGDVYSFGIMLMETFTRKKP 951
           +  + +T  DV+SFG++L E  TR  P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 752 FSENNLIGRGGFGFVYKARIQ----DGMEVAVKVF--DLQYGRAIKSFDIECGMIKRIRH 805
           F+   ++G+G FG V +A+++       +VAVK+   D+     I+ F  E   +K   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 806 RNIIKFISSCSSDDFKA------LVLEYMPYGSLEKCLYSSN-----YILDIFQRLNIMI 854
            N+IK I        K       ++L +M +G L   L  S      + L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
           D+AS +EYL    S   IH DL   N +L++NM   ++DFG++K     D       +  
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR 948
            + ++A E   +   +T+ DV++FG+ + E  TR
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 75/292 (25%), Positives = 118/292 (40%), Gaps = 45/292 (15%)

Query: 757  LIGRGGFGFVYKARIQD------GMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRNI 808
             +G G FG V KA             VAVK+  D    + +     E  M+K I +H+NI
Sbjct: 19   PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILDIFQRL------NIM 853
            I  +  C+ +    +V+EY  +G+L   L          S +      + L      +  
Sbjct: 79   INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 854  IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
              VA  +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+     D     T   
Sbjct: 139  YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 914  ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS 973
              + +MAPE   +   +   DV+SFG++L E FT        + G             I 
Sbjct: 196  LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LGGSPYPG-------------IP 239

Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            + E+     L  E       + C   +++L   C  E P +R   K++V  L
Sbjct: 240  VEELFK---LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)

Query: 777 VAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEK 835
           VAVK+      + A   F  E  ++ R+++ NII+ +  C SDD   ++ EYM  G L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 836 CL-----YS----SNYI--LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD 884
            L      S    +N I  + I   L + + +AS ++YL    S+  +H DL   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163

Query: 885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           ++    ++DFGM++     D    Q + +  I +MA E    G+ +T  DV++FG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 945 TFT--RKKP----TDESF---TGE 959
            FT  +++P    +DE     TGE
Sbjct: 224 MFTLCKEQPYSLLSDEQVIENTGE 247

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.5 bits (188), Expect = 4e-15
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)

Query: 757 LIGRGGFGFVYKARI--QDGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G FG V   R+      E+ V +  L+ G   +  + F  E  ++ +  H NII  
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVP 870
               +      +V EYM  GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG--YMAPEYGREGR 928
            +H DL   N+L++ N+V  +SDFG+++  L++D     T     I   + APE     +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 929 VSTNGDVYSFGIMLMETFT 947
            ++  DV+S+GI++ E  +
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK---VFDLQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           IGRG F  VY+A  + D   VA+K   +F++   +A +    E  ++K++ H N+IK++ 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 814 SCSSDDFKALVLEYMPYGSLEKCL-YSSNYILDIFQRL--NIMIDVASALEYLHFGYSVP 870
           S   D+   +VLE    G L + + Y       I +R      + + SA+E++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           ++H D+KP NV +    V  L D G+ + F    ++      + T  YM+PE   E   +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 931 TNGDVYSFGIMLMETFTRKKP 951
              D++S G +L E    + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 66/277 (23%), Positives = 121/277 (43%), Gaps = 29/277 (10%)

Query: 755  NNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNII 809
              +IG G FG V + R++      ++VA+K        +    F  E  ++ +  H NII
Sbjct: 9    EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 868
            +     +      ++ EYM  GSL+K L  ++    + Q + ++  +AS ++YL    Y 
Sbjct: 69   RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
               +H DL   N+L++ N+V  +SDFG+++     + + T       I + APE     +
Sbjct: 128  ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 929  VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK 988
             ++  DV+SFGI++ E          S+ GE       N  ++ ++           +  
Sbjct: 185  FTSASDVWSFGIVMWEVM--------SY-GERPYWDMSNQDVIKAVE----------DGY 225

Query: 989  HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                   C S ++ L + C  +   ER    +IV+ L
Sbjct: 226  RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.5 bits (188), Expect = 5e-15
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 33/220 (15%)

Query: 758 IGRGGFGFVYKA---RIQDG---MEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIK 810
           +G G FG V KA   R++       VAVK+       + ++    E  ++K++ H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDIFQRLNIMID---------- 855
              +CS D    L++EY  YGSL   L  S     +Y+     R +  +D          
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 856 --------VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL 907
                   ++  ++YL     + ++H DL   NVL+ +     +SDFG+++   +ED  +
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +++    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 76.2 bits (188), Expect = 6e-15
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 20/193 (10%)

Query: 777 VAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL 833
           VAVKV  L+      A + F  E  ++ R+   NI + +  C+ D    +++EYM  G L
Sbjct: 49  VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 834 EKCLY--------SSNYILDIFQR--LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL 883
            + L          +     +     L +   +AS + YL    S+  +H DL   N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163

Query: 884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM 943
             N    ++DFGM++     D    Q +    I +MA E    G+ +T  DV++FG+ L 
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223

Query: 944 ETFT--RKKPTDE 954
           E  T  R++P + 
Sbjct: 224 EILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.3 bits (188), Expect = 8e-15
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 34/213 (15%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
           IG+G FG V+KAR  +    VA+K   +      + F I    E  +++ ++H N++  I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 813 SSCSS-----DDFKA---LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
             C +     + +K    LV E+  +  L   L + N    + +   +M  + + L Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL--KEDQSLTQTQTLATIGYMAPE 922
                 I+H D+K  N+L+  + +  L+DFG+A+ F   K  +    T  + T+ Y  PE
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 923 -------YGREGRVSTNGDVYSFGIMLMETFTR 948
                  YG         D++  G ++ E +TR
Sbjct: 194 LLLGERDYG------PPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.7 bits (186), Expect = 9e-15
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  +  G EVA+K  +LQ     +    E  +++  +H NI+ ++ S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 56/297 (18%)

Query: 752  FSENNL-----IGRGGFGFVYKARIQD-GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIR 804
            F+  +L     IGRG FG V K   +  G  +AVK        +  K   ++  ++ R  
Sbjct: 1    FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 805  H-RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---NIMIDVA--- 857
                I+KF  +   +    + +E M   SL+K      Y+ ++ + +    I+  +A   
Sbjct: 61   DCPYIVKFYGALFREGDCWICMELMDI-SLDKF---YKYVYEVLKSVIPEEILGKIAVAT 116

Query: 858  -SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
              AL YL     + IIH D+KP+N+LLD N    L DFG++   +    S+ +T+     
Sbjct: 117  VKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCR 171

Query: 917  GYMAPEYGREGRVSTNG--------DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVND 968
             YMAPE     R+  +         DV+S GI L E  T K P  +          W  +
Sbjct: 172  PYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK----------W--N 214

Query: 969  LLLISIMEVV--DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023
             +   + +VV  D  +LS+ ++    +E   SFV N    C I+   +R   KE++ 
Sbjct: 215  SVFDQLTQVVKGDPPILSNSEE----REFSPSFV-NFINLCLIKDESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)

Query: 756 NLIGRGGFGFVYKARIQ-DG--MEVAVKVFDLQYGRAI--KSFDIECGMIKRI-RHRNII 809
           ++IG G FG V KARI+ DG  M+ A+K    +Y      + F  E  ++ ++  H NII
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------LDIFQRLNIMI 854
             + +C    +  L +EY P+G+L   L  S  +               L   Q L+   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
           DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T    
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 173

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
            + +MA E       +TN DV+S+G++L E
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 13/200 (6%)

Query: 757 LIGRGGFGFVYKARI-QDGME---VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G FG V + R+   G     VA+K     Y  +  + F  E  ++ +  H NII  
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               +      ++ E+M  G+L+  L  ++    + Q + ++  +A+ ++YL     +  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQTQTLA---TIGYMAPEYGREG 927
           +H DL   N+L++ N+V  +SDFG+++ FL++D S  T T +L     I + APE     
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 928 RVSTNGDVYSFGIMLMETFT 947
           + ++  DV+S+GI++ E  +
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 11/212 (5%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           ++GRG FG V+   R  D   V +K   ++        +   EC ++K + H NII++  
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
           +   D    +V+EY P G+L + +    N +LD    L+  + +  AL ++H   +  I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 873 HCDLKPNNVLLDDN-MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           H DLK  N+LLD + MV  + DFG++K    + ++ T    + T  Y++PE       + 
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQ 180

Query: 932 NGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
             D+++ G +L E  + K+  + +    + LK
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLK 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 752 FSENNL-----IGRGGFGFVYKA------RIQDGMEVAVKVF----DLQYGRAIKSFDIE 796
           F  NNL     +G G FG V +A      +    M+VAVK+           A+ S   E
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88

Query: 797 CGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMI 854
             ++  +  H NI+  + +C+      ++ EY  YG L   L       L +   L+   
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            VA  + +L    S   IH DL   NVLL    +  + DFG+A+  + +   + +     
Sbjct: 149 QVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            + +MAPE       +   DV+S+GI+L E F+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              VA  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 11/199 (5%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           +G+GGFG V   +++  G   A K  D   L+  +  +    E  +++++  R I+    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPII 872
           +  + D   LV+  M  G L+  +Y+         + +     +   LE+LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           + DLKP NVLLDD+    +SD G+A                 T GYMAPE  +      +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 933 GDVYSFGIMLMETFTRKKP 951
            D ++ G  L E    + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 38/217 (17%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI------ECGMIKRIRHRNII 809
            +G G F   Y+AR ++ G  +AVK        + +  ++      E  ++ R+ H +II
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLY---------SSNYILDIFQRLNIMIDVASAL 860
           + + +   D    L +E+M  GS+   L            NY   + +           L
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPFLKEDQSLT-----QTQTLA 914
            YLH      IIH D+K  N+L+D       ++DFG A    +     T     Q Q L 
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAA---ARLAAKGTGAGEFQGQLLG 170

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           TI +MAPE  R  +   + DV+S G +++E  T K P
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 14/191 (7%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG G  G V  A     G +VAVK  DL  Q  R +  F+ E  +++  +H NI++  SS
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL-LFN-EVVIMRDYQHPNIVEMYSS 84

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
               D   +V+E++  G+L   +  +   ++  Q   + + V  AL +LH   +  +IH 
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHR 139

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY-MAPEYGREGRVSTNG 933
           D+K +++LL  +    LSDFG      KE   + + ++L    Y MAPE        T  
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTEV 196

Query: 934 DVYSFGIMLME 944
           D++S GIM++E
Sbjct: 197 DIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 52/294 (17%)

Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G   FG VYK  +      +    VA+K   D   G   + F  E  M  R++H NI+ 
Sbjct: 13   LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY---------------SSNYILDIFQRLNIMID 855
             +   + +   +++  Y  +  L + L                +    L+    ++I+  
Sbjct: 73   LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
            +A+ +E+L    S  ++H DL   NVL+ D +   +SD G+ +     D       +L  
Sbjct: 133  IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG----EMTLKRWVNDLLL 971
            I +M+PE    G+ S + D++S+G++L E F+        ++     EM   R V     
Sbjct: 190  IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV----- 244

Query: 972  ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                      L   +D        C ++V+ L ++C  E P  R   K+I ++L
Sbjct: 245  ----------LPCPDD--------CPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.0 bits (179), Expect = 8e-14
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)

Query: 765 FVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL 823
           F         + VAVK+      + A   F  E  ++ R++  NII+ ++ C + D   +
Sbjct: 37  FSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCM 96

Query: 824 VLEYMPYGSLEKCL---------YSSNYILDIFQRLNIM-IDVASALEYLHFGYSVPIIH 873
           + EYM  G L + L           ++ +   +  L  M   +AS ++YL    S+  +H
Sbjct: 97  ITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVH 153

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            DL   N L+  N    ++DFGM++     D    Q + +  I +M+ E    G+ +T  
Sbjct: 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213

Query: 934 DVYSFGIMLMETFT--RKKP----TDESF---TGE 959
           DV++FG+ L E  T  +++P    +DE     TGE
Sbjct: 214 DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 52/195 (26%), Positives = 100/195 (51%), Gaps = 8/195 (4%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+     +  +VAVK   L+ G  ++++F  E  ++K ++H  +++  +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCD 875
            ++   ++ EYM  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L+  NVL+ ++++  ++DFG+A+  +++++   +      I + APE    G  +   DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  K
Sbjct: 188 WSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VYKAR +  G   AVK+  L+ G        E  M+K  +H NI+ +  S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           S +   + +EY   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEYGREGRVSTNG-- 933
           K  N+LL DN    L+DFG+A    K   ++ + ++ + T  +MAPE      V  NG  
Sbjct: 133 KGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYWMAPEV---AAVEKNGGY 186

Query: 934 ----DVYSFGIMLMETFTRKKP 951
               D+++ GI  +E    + P
Sbjct: 187 NQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 62/260 (23%), Positives = 116/260 (44%), Gaps = 28/260 (10%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G G FG V+        +VA+K   L+ G  + ++F  E  ++K+++H  +++  +  +
Sbjct: 14   LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             +    ++ EYM  GSL   L +   I L I + +++   +A  + ++        IH D
Sbjct: 72   QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127

Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L+  N+L+ + +   ++DFG+A+  +++++   +      I + APE    G  +   DV
Sbjct: 128  LRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQ 995
            +SFGI+L E  T  +      T                  EV+  NL           + 
Sbjct: 187  WSFGILLTEIVTYGRIPYPGMTNP----------------EVI-QNL--ERGYRMPRPDN 227

Query: 996  CMSFVFNLAMKCTIESPEER 1015
            C   ++ L   C  E PEER
Sbjct: 228  CPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 73.8 bits (181), Expect = 1e-13
 Identities = 79/247 (31%), Positives = 121/247 (48%), Gaps = 11/247 (4%)

Query: 17  KIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLA-E 75
                L N   L ++ L+LN     I  E+  +T L  L L  N +  +IP  +G L   
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNI-TDIPPLIGLLKSN 141

Query: 76  LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
           L+EL L +N +  ++PS + NL +L NLDLS N+L+   L  + SNL  L  L L  N  
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD--LPKLLSNLSNLNNLDLSGNKI 198

Query: 136 DGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLA 195
              +P  +     L+ L LS N    ++   + NL  L  L L  N+L+ ++PE +GNL+
Sbjct: 199 -SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255

Query: 196 ELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
            LE L L NN +  +   S+ +L++L +L+LS NSL+   P    ++  L   L      
Sbjct: 256 NLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313

Query: 256 NIPFLEE 262
               L+ 
Sbjct: 314 KALELKL 320

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 32/79 (40%), Positives = 47/79 (59%)

Query: 16  GKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAE 75
           G IP+ +S  + L++I+LS N   G IP  +G++T+L  L L  N   G IPE LG L  
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 76  LEELWLQNNFLTGTIPSSI 94
           L  L L  N L+G +P+++
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 11/203 (5%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+ ++ G   A KV + +    ++ + +E  ++    H  I+K + +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            D    +++E+ P G+++  +   +  L       I +     LE L + +S+ IIH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-----GREGRVST 931
           K  NVLL  +    L+DFG++   +K  Q   +   + T  +MAPE       ++     
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 932 NGDVYSFGIMLMETFTRKKPTDE 954
             D++S GI L+E    + P  E
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHE 217

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 757 LIGRGGFGFVYKARIQDGME--VAVK---VFDLQYGRAIKSFD-------IECGMIK-RI 803
            +G G FG VYK R ++  +  +A+K   V +  +G+  +  D        E  +IK ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF--QRL-NIMIDVASAL 860
           RH NI+++  +   +D   +V++ +    L +   S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
            YLH      I+H DL PNN++L ++    ++DFG+AK   ++      T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181

Query: 921 PEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           PE  +        DV++FG +L +  T + P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 38/284 (13%)

Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 14   LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS-----SNYILDIFQRLNIMI----DVASALE 861
             +   S      +++E M  G L+  L S      N  +     L  MI    ++A  + 
Sbjct: 74   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 134  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 191  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------VMEGG 238

Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 239  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKV--FD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
           L+GRG FG VY     D G E+AVK   FD    +  + + + + E  ++K +RH  I++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 811 FISSCSSDDFKALVL--EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +       + K L +  EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY-MAPE----- 922
             I+H D+K  N+L D      L DFG +K       S T  +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184

Query: 923 -YGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
            YGR+       DV+S    ++E  T K P  E
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 3e-13
 Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 27/168 (16%)

Query: 555 LNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSI 614
           L L      G +P +I  L+ L  I+LS N+    IP ++G +  L+ L L YN   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 615 PDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLE 674
           P+S+G + +L+ LNL+ N+L G +P +L                 G         NF+  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFNFT-- 523

Query: 675 SFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGG 722
               N  LCG+P L  R+C     H S    + I   + ++  F++  
Sbjct: 524 ---DNAGLCGIPGL--RACGP---HLSVGAKIGIAFGVSVAFLFLVIC 563

Length = 623

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)

Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG G FG +Y A+ + D     +K  DL     +  ++   E  ++ +++H NI+ F +S
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 815 CSSDDFKALVLEYMPYGSLEK-------CLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
              +    +V+EY   G L K        L+S + IL  F      + ++  L+++H   
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
              I+H D+K  N+ L  N MVA L DFG+A+  L +   L  T  + T  Y++PE  + 
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYT-CVGTPYYLSPEICQN 176

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
              +   D++S G +L E  T K P + +   ++ LK
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.0 bits (176), Expect = 3e-13
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K +    + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILD---------IFQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +      +Y  D          F+ L + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+     D     T  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G VYKAR    G  VA+K   L      + S  I E  ++K + H NI+K +  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA-----LEYLHFGYSV 869
             +++   LV E++ +  L+K        +D      I + +  +     L+ L F +S 
Sbjct: 68  IHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     + 
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKY 177

Query: 930 -STNGDVYSFGIMLMETFTRK 949
            ST  D++S G +  E  TR+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 60/202 (29%), Positives = 85/202 (42%), Gaps = 14/202 (6%)

Query: 750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAI-KSFDIECGMIKRIRHRN 807
               E + +G G  G V K R+   GM  A+K         + K    E  + K  +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 808 IIKFISSC--SSDDFKALVLEYMPYGSLE---KCLYSSNYILDIFQRLNIMIDVASALEY 862
           I+K+  +    S     + +EY   GSL+   K +      +       I   V   L Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           LH   S  IIH D+KP+N+LL       L DFG++   +    SL  T T  T  YMAPE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTSFYMAPE 173

Query: 923 YGREGRVSTNGDVYSFGIMLME 944
             +    S   DV+S G+ L+E
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G +G VYKAR +  G   A+KV  L+ G        E  M+K  +H NI+ +  S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   + +E+   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEYG---REGRVS 930
           K  N+LL DN    L+DFG++        + T  +  + IG   +MAPE     R+G  +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 931 TNGDVYSFGIMLMETFTRKKP 951
              D+++ GI  +E    + P
Sbjct: 188 QLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKV--FDL---QYGRAIKSFDIECGMIKRIRHRNIIK 810
           L+G+G FG VY    +  G E+A K   FD    +  + + + + E  ++K ++H  I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 811 FISSCSSDDFKALV--LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +         K L   +EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY-MAPE----- 922
             I+H D+K  N+L D      L DFG +K       S T  +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 923 -YGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
            YGR+       DV+S G  ++E  T K P  E
Sbjct: 185 GYGRK------ADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)

Query: 758 IGRGGFGFVYKARIQDGMEVA-VKVFDLQYGRAIK---SFDIECGMIKRIRHRNIIKFIS 813
           IG G FG V       GM  A V V +L+          F  E    + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYIL------DIFQRLNIMIDVASALEYLHFGY 867
            C       LVLE+ P G L+  L S+  ++      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE- 926
               IH DL   N  L  ++   + D+G+A     ED  +T+      + ++APE     
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 927 ------GRVSTNGDVYSFGIMLMETFT 947
                    +   +++S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.5 bits (172), Expect = 5e-13
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G V+ A  +  G EVA+K  +LQ     +    E  ++K +++ NI+ F+ S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   +  +IH D+
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +NVLL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 70.5 bits (172), Expect = 6e-13
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ ++ S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 6e-13
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 55/212 (25%)

Query: 758 IGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDI-----ECGMIKRIRHRNIIKF 811
           +G G FG V   R +   +  A+K+      + +K   +     E  +++ IRH  ++  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIM----IDVA--------SA 859
             S   D    LV+EY+P G             ++F  L         VA         A
Sbjct: 67  YGSFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYAAQVVLA 113

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGY 918
           LEYLH   S+ I++ DLKP N+LLD +    ++DFG AK  +K       T TL  T  Y
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGR-----TYTLCGTPEY 164

Query: 919 MAPE------YGREGRVSTNGDVYSFGIMLME 944
           +APE      YG+        D ++ GI++ E
Sbjct: 165 LAPEIILSKGYGKA------VDWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 13/207 (6%)

Query: 752 FSENNLIGRGGFGFVYKA---RIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRN 807
           F++   IG+G FG V+K    R Q    VA+K+ DL+     I+    E  ++ +     
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           + K+  S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S   IH D+K  NVLL ++    L+DFG+A      D  + +   + T  +MAPE  ++ 
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDE 954
              +  D++S GI  +E    + P  E
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSE 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 13/207 (6%)

Query: 752 FSENNLIGRGGFGFVYKA---RIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRN 807
           F++   IG+G FG V+K    R Q    VA+K+ DL+     I+    E  ++ +     
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           + K+  S        +++EY+  GS    L +  +  D FQ   ++ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S   IH D+K  NVLL +     L+DFG+A      D  + +   + T  +MAPE  ++ 
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDE 954
              +  D++S GI  +E    + P  +
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (172), Expect = 9e-13
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 17/215 (7%)

Query: 758 IGRGGFGFVYKARIQDGME-VAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           +G+GG+G V+ A+ +D  E VA+K      L     ++    E  ++   +   ++K + 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPII 872
           +   D++  L +EY+P G   + L ++  +L        M ++  A++ LH  GY    I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H DLKP N L+D +    L+DFG++K  +    S+     + +  YMAPE  R       
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDFT 178

Query: 933 GDVYSFGIMLMETFTRKKPTDESFTGEM--TLKRW 965
            D +S G ML E      P   S   E    LK W
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 70.6 bits (173), Expect = 1e-12
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 52/267 (19%)

Query: 705 DLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFG 764
           D  + + LPL         S  + A+    +  +  + LE           N IG G  G
Sbjct: 38  DPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELE---------RVNRIGSGAGG 88

Query: 765 FVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFISSCSSDD 819
            VYK   +  G   A+KV    YG    +       E  +++ + H N++K       + 
Sbjct: 89  TVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145

Query: 820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN 879
              ++LE+M  GSLE       +I D     ++   + S + YLH      I+H D+KP+
Sbjct: 146 EIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPS 197

Query: 880 NVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-----QTLATIGYMAPEYGREGRVSTN-- 932
           N+L++      ++DFG+++        L QT      ++ TI YM+PE     R++T+  
Sbjct: 198 NLLINSAKNVKIADFGVSR-------ILAQTMDPCNSSVGTIAYMSPE-----RINTDLN 245

Query: 933 --------GDVYSFGIMLMETFTRKKP 951
                   GD++S G+ ++E +  + P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDL-QYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G VYKAR    G  VA+K   L      + S  I E  ++K + H NI++ +  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
             S++   LV E++    L+K + S     LD     + +  +   + Y H   S  ++H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPF---LKEDQSLTQTQTLATIGYMAPEYGREGR-V 929
            DLKP N+L+D      L+DFG+A+ F   ++     T T  + T+ Y APE     R  
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVR-----TYTHEVVTLWYRAPEILLGSRQY 177

Query: 930 STNGDVYSFGIMLMETFTRK 949
           ST  D++S G +  E   R+
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKVF-DLQYGRAIKSFDI-ECGMIKRIRHRNIIKFIS 813
           L+G G +G V K + ++ G  VA+K F + +  + +K   + E  M+K++RH N++  I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
                    LV E++ +  L+      N  LD  +    +  +   +E+ H   S  IIH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-------YGRE 926
            D+KP N+L+  + V  L DFG A+      +    T  +AT  Y APE       YGR 
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGRA 181

Query: 927 GRVSTNGDVYSFGIMLMETFT 947
                  D+++ G ++ E  T
Sbjct: 182 ------VDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 2e-12
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  I  G EVA+K  +LQ     +    E  +++  ++ NI+ ++ S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   AL++LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.8 bits (176), Expect = 2e-12
 Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 16/188 (8%)

Query: 772 QDGMEVAVKVF--DLQYG-RAIKSFDIECGMIKRIRHRNIIKFISS-CSSDDFKALVLEY 827
             G EVA+K+   D          F  E  +  R+ H NI+  + S  +       V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---D 884
           +P  +L + L +++  L   +   +M+ V  AL   H   +  I+H DLKP N+++    
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 885 DNMVAHLSDFGMAK--PFLKEDQSLTQTQT---LATIGYMAPEYGREGRVSTNGDVYSFG 939
               A + DFG+    P +++    T T+T   L T  Y APE  R   V+ N D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 940 IMLMETFT 947
           ++ +E  T
Sbjct: 177 LIFLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.7 bits (171), Expect = 2e-12
 Identities = 76/313 (24%), Positives = 128/313 (40%), Gaps = 79/313 (25%)

Query: 758  IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDI---------ECGMIKRIRHRN 807
            IG G +G V  A   + G +VA+K       +   +FD+         E  +++  +H N
Sbjct: 13   IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 808  I--IKFISSCSSDDFKA--LVLEYMPYGSLEKCLYSS--------NYILDIFQRLNIMID 855
            I  I+ I      DFK   +V++ M    L   ++S          Y L  +Q L     
Sbjct: 66   IIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFL--YQLLR---- 118

Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK--EDQSLTQTQTL 913
                L+Y+H   S  +IH DLKP+N+L++++    + DFGMA+       +     T+ +
Sbjct: 119  ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 914  ATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI 972
            AT  Y APE        +T  D++S G +  E   R+    + F G    K +V+ L LI
Sbjct: 173  ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG----KNYVHQLKLI 224

Query: 973  SIM------EVVDA-----------NLLSHEDKHFV-----AKEQCMSFVFNLAMKCTIE 1010
              +      EV++            NL   +   +      A  + +  +  +       
Sbjct: 225  LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML----QF 280

Query: 1011 SPEERINAKEIVT 1023
             PEERI  ++ + 
Sbjct: 281  DPEERITVEQALQ 293

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRA-IKSFDI-ECGMIKRIR---H 805
           + E   IG G +G VYKAR +  G  VA+K   +      I    + E  ++K++    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 806 RNIIKFISSCSSDDFK-----ALVLEYMPY---GSLEKCLYSSNYILDIFQRLNIMIDVA 857
            NI++ +  C            LV E++       L KC       L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLL 117

Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
             +++LH   S  I+H DLKP N+L+  +    ++DFG+A+ +   + +L  T  + T+ 
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMAL--TSVVVTLW 171

Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           Y APE   +   +T  D++S G +  E F R+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 757 LIGRGGFGFVYKA-RIQDG----MEVAVKVFDLQYGRAIKSF-DIECGM--IKRIRHRNI 808
           L+G G FG V+K   I +G    + VA+K    + GR  ++F +I   M  +  + H  I
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYI 71

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           ++ +  C     + LV +  P GSL   +      LD  + LN  + +A  + YL     
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H +L   N+LL  + +  ++DFG+A     +D+    ++    I +MA E    GR
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 929 VSTNGDVYSFGIMLMETFT 947
            +   DV+S+G+ + E  +
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 758 IGRGGFGFVYKARIQDGME-VAVKVFDL-QYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G VYKAR +   E +A+K   L Q    + S  I E  ++K ++H NI++    
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
             S+    LV EY+    L+K + SS ++  +       +  +   + Y H   S  ++H
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125

Query: 874 CDLKPNNVLLDDNMVA-HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR-VST 931
            DLKP N+L+D    A  L+DFG+A+ F    +  T T  + T+ Y APE     R  ST
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYST 183

Query: 932 NGDVYSFGIMLMETFTRK 949
             D++S G +  E   +K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 19/168 (11%)

Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSN---- 841
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         Y  N    
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 842 --YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 43/216 (19%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIR---HRNIIKF 811
           IG G +G VYKAR    G  VA+K   +Q            E  ++KR+    H NI++ 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 812 ISSCSS-----------------DDFKALVLEYMPYG-SLEKCLYSSNYILDIFQRLNIM 853
           +  C++                  D +  + +  P G   E        I D+ ++    
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-------IKDLMRQF--- 117

Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
                 L++LH      I+H DLKP N+L+       L+DFG+A+ +      +  T  +
Sbjct: 118 ---LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVV 168

Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
            T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 3e-12
 Identities = 67/242 (27%), Positives = 103/242 (42%), Gaps = 61/242 (25%)

Query: 757 LIGRGGFGFVYKARIQDGME----VAVKVF----------DLQYGRAIKSFDIECGMIKR 802
           ++G+GG+G V++ R   G +     A+KV           D  + +A      E  +++ 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA------ERNILEA 56

Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSL----EK---------CLYSSNYILDIFQR 849
           ++H  I+  I +  +     L+LEY+  G L    E+         C Y S   L     
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL----- 111

Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
                    ALE+LH      II+ DLKP N+LLD      L+DFG+ K  + E  ++T 
Sbjct: 112 ---------ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTH 158

Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT---------RKKPTDESFTGEM 960
           T    TI YMAPE           D +S G ++ +  T         RKK  D+   G++
Sbjct: 159 T-FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL 217

Query: 961 TL 962
            L
Sbjct: 218 NL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 34/268 (12%)

Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFI 812
            +G G FG V    YK R +  ++VA+KV   +  ++++   + E  ++ ++ +  I++ I
Sbjct: 3    LGSGNFGCVKKGVYKMRKKQ-IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              C ++    LV+E    G L K L      + +   + +M  V+  ++YL        +
Sbjct: 62   GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 873  HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGREGRVS 930
            H DL   NVLL +   A +SDFG++K  L  D S  + ++     + + APE     + S
Sbjct: 118  HRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 931  TNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
            +  DV+S+GI + E F+  +KP  +    E           ++S +E         + K 
Sbjct: 177  SRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----------VMSFIE---------QGKR 216

Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERIN 1017
                 +C   ++ L   C I   E+R N
Sbjct: 217  LDCPAECPPEMYALMKDCWIYKWEDRPN 244

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.5 bits (167), Expect = 4e-12
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)

Query: 758 IGRGGFGFVYKA--------RIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V +A        R    + VAVK+  D    + +     E  ++K I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  +  C+ +    +++EY   G+L + L +      +Y  DI         F+ L + 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+     D     +  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFGI++ E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)

Query: 765 FVYKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCSSDDFKAL 823
           F +  R    + VAVK+      +  ++ F  E  ++ R++  NII+ +  C  +D   +
Sbjct: 37  FPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCM 96

Query: 824 VLEYMPYGSLEKCLYSSNYILDIFQR-------------------LNIMIDVASALEYLH 864
           + EYM  G L + L SS+++ D  +                    L++ + +AS ++YL 
Sbjct: 97  ITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
              S+  +H DL   N L+ +N+   ++DFGM++     D    Q + +  I +MA E  
Sbjct: 156 ---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212

Query: 925 REGRVSTNGDVYSFGIMLMETFT--RKKP----TDE 954
             G+ +T  DV++FG+ L E     +++P    TDE
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 14/205 (6%)

Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQY---GRAIKSFDIECGMIKRIRHRN 807
           F + N IG G +G VY+AR     E VA+K   +     G  I S   E  ++  +RH N
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPN 67

Query: 808 II--KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
           I+  K +      D   LV+EY     L   L +        Q   +M+ +   L+YLH 
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE 126

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
            +   IIH DLK +N+LL D     ++DFG+A+ +    + +  T  + T+ Y APE   
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLL 181

Query: 926 EGRVSTNG-DVYSFGIMLMETFTRK 949
                T   D+++ G +L E    K
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F +  ++G+GGFG V   +++  G   A K  + +  +  K   +   E  +++++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFG 866
           ++    +  + D   LVL  M  G L+  +Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
               I++ DLKP N+LLDD+    +SD G+A   + E Q++     + T+GYMAPE  + 
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTI--KGRVGTVGYMAPEVVKN 175

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKP 951
            R + + D ++ G +L E    + P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 758 IGRGGFGFVYKARIQDGMEV-AVK------VFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G GGFG V   +++      A+K      + +      I S   E  +++   H  I+K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              +     +  +++EY   G L   L       D +     +  V  A EYLH   +  
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRG 113

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE------Y 923
           II+ DLKP N+LLD N    L DFG A    K+ +S  +T T   T  Y+APE      Y
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFA----KKLKSGQKTWTFCGTPEYVAPEIILNKGY 169

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
                   + D +S GI+L E  T + P    F  +
Sbjct: 170 DF------SVDYWSLGILLYELLTGRPP----FGED 195

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           +G+GGFG V   ++++ G   A K  D   L+     K   +E  +++++    I+    
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPII 872
           +  S     LV+  M  G L+  +Y+     L++ + ++    +   + +LH   S+ I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           + D+KP NVLLDD     LSD G+A   LK+ +++TQ     T GYMAPE  +E   S  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVE-LKDGKTITQRA--GTNGYMAPEILKEEPYSYP 174

Query: 933 GDVYSFGIMLMETFTRKKP 951
            D ++ G  + E    + P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 24/204 (11%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G VYK R  + G  VA+K   L+     + S  I E  ++K ++H NI+     
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-------FGY 867
              +    L+ E++    L+K L S              +D      YL+       F +
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGR 925
           S  ++H DLKP N+L+D+  V  L+DFG+A+ F    +    T  + T+ Y APE   G 
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGS 176

Query: 926 EGRVSTNGDVYSFGIMLMETFTRK 949
             R ST  D++S G +  E  T+K
Sbjct: 177 P-RYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.0 bits (163), Expect = 7e-12
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 758 IGRGGFGFVYKARI-QDG--MEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFI 812
           +G G FG V + ++ QD   ++VAVK   +       ++ F  E   +K   H N+++ I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 813 SSC----SSDDFKA--LVLEYMPYGSLEKCLYSSNY-----ILDIFQRLNIMIDVASALE 861
             C     S+ + +  ++L +M +G L   L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           YL    S   IH DL   N +L++NM   ++DFG++K     D           + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 922 EYGREGRVSTNGDVYSFGIMLMETFTR 948
           E   +   +T  DV+SFG+ + E  TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 9e-12
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 51/221 (23%)

Query: 756 NLIGRGGFGFVYKA-RIQDGMEVAVK--------VFDLQYGRAIKSFDIECGMIKRIRHR 806
           + IG G +G V  A     G++VA+K         F  +  R IK       +++R +H 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK-------ILRRFKHE 63

Query: 807 NIIKF---ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILD-----IFQRLNIMIDV 856
           NII     I   S + F    +V E M    L K + + +   D     ++Q L      
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR----- 117

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-DQSLTQTQTLAT 915
              L+Y+H   S  ++H DLKP+N+LL+ N    + DFG+A+    E D +   T+ +AT
Sbjct: 118 --GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 916 IGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
             Y APE       Y      +   D++S G +L E  + +
Sbjct: 173 RWYRAPEIMLNSKGY------TKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 66.5 bits (162), Expect = 9e-12
 Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 38/284 (13%)

Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 14   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS-----SNYILDIFQRLNIMI----DVASALE 861
             +   S      +V+E M +G L+  L S      N        L  MI    ++A  + 
Sbjct: 74   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 134  YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 191  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238

Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L          + C   V +L   C   +P+ R    EIV  L
Sbjct: 239  YLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 34/85 (40%), Positives = 47/85 (55%)

Query: 152 LSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTI 211
           L L      G IP +I  L  L+ ++L  N ++G IP  LG++  LE L L  N   G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 212 PPSIFNLSSLSDLELSFNSLTGNFP 236
           P S+  L+SL  L L+ NSL+G  P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF-DI--ECGMIKRIRHRN 807
           F++   IG G FG VY AR ++    VA+K       ++ + + DI  E   ++RI+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYL 863
            I++      +    LV+EY        CL S++ +L++ ++    +++A+    AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG---MAKPFLKEDQSLTQTQTLATIGYMA 920
            + +S  +IH D+K  N+LL +     L+DFG   +A P             + T  +MA
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---------ANSFVGTPYWMA 189

Query: 921 PEY---GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           PE      EG+     DV+S GI  +E   RK P
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 10/196 (5%)

Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  AR +  G +VAVK+ DL+  +  +    E  +++  +H+N+++   S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY-MAPEYGREGRVSTNGDV 935
           K +++LL  +    LSDFG      K+   + + ++L    Y MAPE        T  D+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 936 YSFGIMLMETFTRKKP 951
           +S GIM++E    + P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 34/226 (15%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS- 814
           +IGRGGFG VY  R  D G   A+K  D       K   ++ G    +  R ++  +S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 815 ------CSSDDFKA-----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
                 C +  F        +L+ M  G L   L       +   R     ++   LE++
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H  +   +++ DLKP N+LLD++    +SD G+A  F K+        ++ T GYMAPE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEV 166

Query: 924 GREGRV-STNGDVYSFGIMLME------TFTRKKPTDESFTGEMTL 962
            ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.9 bits (166), Expect = 2e-11
 Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 1/93 (1%)

Query: 100 LSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDF 159
           +  L L    L G +  +I S L  LQ++ L  N+  G IP +L     L+ L LS N F
Sbjct: 420 IDGLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 160 SGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELG 192
           +G IP+ +G LT L+ L+L+ N L G +P  LG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 2/98 (2%)

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
           IP+ +  L+ +  +NLS N   G +P  +G++  L  +DLS N+F+  IP ++G L  L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 602 YLFLKYNRLQGSIPDSIGD-MINLKSLNLSNN-NLFGI 637
            L L  N L G +P ++G  +++  S N ++N  L GI
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531

Length = 623

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 33/217 (15%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKVFDL-----QYGRAIKSFDIECGMIKRIRHRNIIK 810
           L+G+G FG VY     D G E+AVK         +  + + + + E  ++K + H  I++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 811 FISSCSSDDFK---ALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
           +   C  D  +   ++ +E+MP GS++  L S   + + + ++    I     LE + + 
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYL 122

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPE- 922
           +S  I+H D+K  N+L D      L DFG +K    +   L+ T   +  G   +M+PE 
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPYWMSPEV 180

Query: 923 -----YGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
                YGR+       D++S G  ++E  T K P  E
Sbjct: 181 ISGEGYGRK------ADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)

Query: 757 LIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYGRAIK---SFDIECGMIKRIRHRNIIKF 811
           ++G G FG + +  ++     E+ V +  L+ G + K    F  E   + +  H NI++ 
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVP 870
               +  +   +V EYM  G+L+  L      L   Q + ++  +AS ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL---ATIGYMAPEYGREG 927
            +H  L  + VL++ ++V  +S F      L+ED+S     T+   + + + APE  +  
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRR----LQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 928 RVSTNGDVYSFGIMLME 944
             S+  DV+SFGI++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 11/203 (5%)

Query: 758 IGRGGFG--FVYKARIQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFIS 813
           +G+G FG   +Y+ R +D   V  K  +L      +  D   E  ++  ++H NII + +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 814 SCSSDDFKALVLEYMPYGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
               D+   + +EY   G+L +K +     + +    L  +  + SA+ Y+H      I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+K  N+ L    +  L DFG++K  L  + S+ +T  + T  YM+PE  +  + +  
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181

Query: 933 GDVYSFGIMLMETFTRKKPTDES 955
            D+++ G +L E  T K+  D +
Sbjct: 182 SDIWALGCVLYELLTLKRTFDAT 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 29/215 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK---VFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI- 812
           +G G FG VYKAR I+ G  VA+K   + + + G  I +   E  ++K+++H N++  I 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74

Query: 813 -----SSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
                   S     +  +V  YM +  L   L + +  L   Q    M+ +   + YLH 
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH- 132

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ---------TQTLATI 916
                I+H D+K  N+L+D+  +  ++DFG+A+P+     +            T  + T 
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190

Query: 917 GYMAPEY--GREGRVSTNGDVYSFGIMLMETFTRK 949
            Y  PE   G E R +T  D++  G +  E FTR+
Sbjct: 191 WYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 757 LIGRGGFGFVYKARIQDG--------MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI 808
           ++G G +G V+  R   G        M+V  K   +Q  + ++    E  +++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 809 IKFISSCSSDDFKA-LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           +  +      + K  L+L+Y+  G +   LY  +   +   R     ++  ALE+LH   
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR-E 926
            + I++ D+K  N+LLD      L+DFG++K FL E++  T +    TI YMAPE  R +
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGK 181

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKP 951
           G      D +S GI++ E  T   P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 7/146 (4%)

Query: 758 IGRGGFGFVYKARIQDGME-VAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G V+KA+ ++  E VA+K   L      + S  + E  ++K ++H+NI++    
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             SD    LV EY     L+K   S N  +D     + M  +   L + H   S  ++H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPF 900
           DLKP N+L++ N    L+DFG+A+ F
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 66/274 (24%)

Query: 758  IGRGGFGFVYKARIQD-GMEVAVK----VFD-----LQYGRAIKSFDIECGMIKRIRHRN 807
            IGRG +G V  A+  +   +VA+K     FD      +  R IK       +++ + H N
Sbjct: 13   IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK-------LLRHLDHEN 65

Query: 808  IIKF---ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILD------IFQRLNIMIDV 856
            +I     +     + F    +V E M    L + + SS  + D      ++Q L      
Sbjct: 66   VIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLR----- 119

Query: 857  ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
               L+Y+H   S  ++H DLKP+N+LL+ N    + DFG+A+   ++   +  T+ + T 
Sbjct: 120  --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTR 172

Query: 917  GYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL 969
             Y APE       Y       T  DV+S G +  E   R KP    F G    K +V+ L
Sbjct: 173  WYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGR-KPL---FPG----KDYVHQL 218

Query: 970  LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNL 1003
             L  I E++ +   S ED  F+  E+   ++ +L
Sbjct: 219  KL--ITELLGSP--SEEDLGFIRNEKARRYIRSL 248

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF-DI--ECGMIKRIRHRN 807
           FS+   IG G FG VY AR +++   VA+K       ++ + + DI  E   ++++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYL 863
            I++      +    LV+EY        CL S++ +L++     Q + I      AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
            + +S  +IH D+K  N+LL +  +  L DFG A   +        T       +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFVGTPY-----WMAPEV 182

Query: 924 ---GREGRVSTNGDVYSFGIMLMETFTRKKP 951
                EG+     DV+S GI  +E   RK P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 15/210 (7%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGM------IKRIRHRNIIK 810
           IG+G FG V  A+   DG   AVKV  LQ    +K  + +  M      +K ++H  ++ 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              S  + D    VL+Y+  G L   L       +   R     ++ASAL YLH   S+ 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           II+ DLKP N+LLD      L+DFG+ K  +  + S T +    T  Y+APE  R+    
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 931 TNGDVYSFGIMLMETFTRKKPTDESFTGEM 960
              D +  G +L E      P     T EM
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 757 LIGRGGFGFVYKARIQDGME-VAVKVF---DLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G G FG V+  R +      A+KV    ++   +  +    E  ++K + H  II+  
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
            +     F  +++EY+P G L   L +S    +         ++  ALEYLH   S  I+
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE-YGREGRVS 930
           + DLKP N+LLD      L+DFG AK      +   +T TL  T  Y+APE    +G  +
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPEVIQSKGH-N 176

Query: 931 TNGDVYSFGIMLMETFTRKKP 951
              D ++ GI++ E      P
Sbjct: 177 KAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 35/224 (15%)

Query: 755 NNLIGRGGFGFVYKAR-IQDGMEVA---VKVFDLQYGRAIKSFDI-ECGM---------- 799
              +G G +G V KA     G  VA   VK+ ++          +  CG+          
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 800 IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
           +  I+H NI+  +      DF  LV++ M    L+K +      L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKCILLQILNG 131

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF-----------LKEDQS-L 907
           L  LH  Y    +H DL P N+ ++   +  ++DFG+A+ +            +  Q   
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 908 TQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTRK 949
             T  + T+ Y APE   G E +     D++S G +  E  T K
Sbjct: 189 EMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  A ++   E+ AVKV  L+    ++  D+EC M  KR+     +H  + 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
           +  S   + D    V+EY+  G L   +  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGR 928
            II+ DLK +NVLLD      ++DFGM K  +    +   T T   T  Y+APE      
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172

Query: 929 VSTNGDVYSFGIMLMETFTRKKPTD 953
                D ++ G++L E    + P +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 55/192 (28%), Positives = 100/192 (52%), Gaps = 9/192 (4%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+ A      +VAVK   ++ G  ++++F  E  ++K ++H  ++K  +  +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCD 875
            +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH D
Sbjct: 72  KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L+  N+L+  ++V  ++DFG+A+  +++++   +      I + APE    G  +   DV
Sbjct: 128 LRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 936 YSFGIMLMETFT 947
           +SFGI+LME  T
Sbjct: 187 WSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 5e-11
 Identities = 79/249 (31%), Positives = 121/249 (48%), Gaps = 46/249 (18%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK-VFDLQYGR--AIKSFDIECGMIKRIR-HRNIIKFI 812
           +G+G +G V+KA   +    VA+K +FD       A ++F  E   ++ +  H NI+K +
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73

Query: 813 SSCSSDDFKA-------LVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEY 862
                +  KA       LV EYM     E  L++   +N + D+ +R  IM  +  AL+Y
Sbjct: 74  -----NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKY 122

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ---TQTLATIGYM 919
           +H   S  +IH DLKP+N+LL+ +    L+DFG+A+   + +++      T  +AT  Y 
Sbjct: 123 IH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 920 APEYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
           APE        T G D++S G +L E     KP    F G  TL    N L    I+EV+
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEML-LGKPL---FPGTSTL----NQLEK--IIEVI 229

Query: 979 DANLLSHED 987
                S ED
Sbjct: 230 GP--PSAED 236

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 8/195 (4%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A     G +VAVK  DL+  +  +    E  +++   H N++   +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE        T  D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 203 SLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)

Query: 758 IGRGGFGFVYKARIQDGMEVA-VKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIKFIS 813
           IG G FG V    +  G   A V V +L+   +++    F  E    + ++H N+++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 814 SCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            C+      LV+E+ P G     L  C  +     D      +  ++A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE--G 927
             IH DL   N LL  ++   + D+G++    KED  +T  Q    + ++APE   E  G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 928 RV-----STNGDVYSFGIMLMETF 946
            +     +   +V+S G+ + E F
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 6e-11
 Identities = 66/232 (28%), Positives = 96/232 (41%), Gaps = 61/232 (26%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR--IRH----RNII 809
           +IGRG FG V+  R    G   A+KV        ++  D    MIKR  I H    R+I+
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKV--------LRKSD----MIKRNQIAHVRAERDIL 55

Query: 810 KFISS-------CS--SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
               S        S   ++   LV+EYMP G L   L   +   +   R  I  ++  AL
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLAL 114

Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS------------- 906
           + +H  G+    IH D+KP+N+L+D +    L+DFG+ K   K                 
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 907 ---------LTQTQTLA--TIG---YMAPEYGREGRVSTNGDVYSFGIMLME 944
                      Q +  A  T+G   Y+APE  R        D +S G++L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 7e-11
 Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 39/198 (19%)

Query: 751 GFSENNLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYGR-------AIKSFDIECGMI 800
            +     IGRG +G VYKA+ +   DG E A+K F     +       A +    E  ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALL 56

Query: 801 KRIRHRNIIKFISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRL---NIMID 855
           + ++H N++  +        K+  L+ +Y  +   +   +               +++  
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMA-------KPFLKED 904
           + + + YLH   S  ++H DLKP N+L+     +  V  + D G+A       KP    D
Sbjct: 117 ILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 905 QSLTQTQTLATIGYMAPE 922
                   + TI Y APE
Sbjct: 174 ------PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 34/226 (15%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS- 814
           +IGRGGFG VY  R  D G   A+K  D       K   ++ G    +  R ++  +S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 815 ------CSSDDFK-----ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
                 C S  F      + +L+ M  G L   L S + +    +      ++   LE++
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H  +   +++ DLKP N+LLD++    +SD G+A  F K+        ++ T GYMAPE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEV 166

Query: 924 GREGRV-STNGDVYSFGIMLME------TFTRKKPTDESFTGEMTL 962
            ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFISSC 815
           +G G  G V K   I  G  +A KV  +    ++ K    E  ++   R   I+ F  + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            +++   + +E+M  GSL++       I ++I  +  I + V   L YL+      I+H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
           D+KP+N+L++      L DFG++   +    S+  T  + T  YM+PE  + G+ +   D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184

Query: 935 VYSFGIMLMETFTRKKPTDES 955
           V+S GI ++E    K P   S
Sbjct: 185 VWSLGISIIELALGKFPFAFS 205

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 23/203 (11%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHR-----NI 808
           I +G FG VY A+    G   A+KV    D+     + +   E    + I         +
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESPYV 59

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            K   S  S D+  LV+EY+  G     + +   + + + +   + +V   +E LH    
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---Q 115

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH D+KP N+L+D      L+DFG+++        L   + + T  Y+APE      
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILGVG 169

Query: 929 VSTNGDVYSFGIMLMETFTRKKP 951
                D +S G ++ E      P
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 17/209 (8%)

Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGR-AIKSFDIECGMIKRIRHRNII 809
           F++   IG+G FG VYK       EV A+K+ DL+     I+    E  ++ +     I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 810 KFISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
           ++  S        +++EY+  GS    L+       YI  I +      ++   L+YLH 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 118

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S   IH D+K  NVLL +     L+DFG+A      D  + +   + T  +MAPE  +
Sbjct: 119 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIK 174

Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
           +       D++S GI  +E    + P  +
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 44/131 (33%), Positives = 68/131 (51%), Gaps = 7/131 (5%)

Query: 823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL 882
           L+L+Y+  G L   LY   +  +   R+ I  ++  AL++LH    + II+ D+K  N+L
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137

Query: 883 LDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG--DVYSFGI 940
           LD      L+DFG++K FL E++    +    TI YMAPE  R G    +   D +S G+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196

Query: 941 MLMETFTRKKP 951
           +  E  T   P
Sbjct: 197 LTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 48/225 (21%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI--------- 795
           F+ TN + +   +G G FG V  AR Q  G  VA+K       + +K F           
Sbjct: 6   FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYR 58

Query: 796 ECGMIKRIRHRNIIK----FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN 851
           E  ++K +RH NII     FIS    D +   V E +  G+    L +S  +   F +  
Sbjct: 59  ELKLLKHLRHENIISLSDIFISP-LEDIY--FVTELL--GTDLHRLLTSRPLEKQFIQY- 112

Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
            +  +   L+Y+H   S  ++H DLKP+N+L+++N    + DFG+A+      Q    T 
Sbjct: 113 FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTG 164

Query: 912 TLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
            ++T  Y APE       Y  E       D++S G +  E    K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 24/225 (10%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK-----VFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
           +GRG +G V K R +  G  +AVK     V   +  R +   DI    ++ +     + F
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS---MRSVDCPYTVTF 65

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIM----IDVASALEYLHFGY 867
             +   +    + +E M   SL+K  Y   Y   +    +I+    + +  ALEYLH   
Sbjct: 66  YGALFREGDVWICMEVMD-TSLDK-FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY---- 923
           SV  IH D+KP+NVL++ N    L DFG++   +    S+ +T       YMAPE     
Sbjct: 124 SV--IHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPE 178

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVND 968
             +       DV+S GI ++E  T + P D   T    LK+ V +
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 41/255 (16%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDL----QYGRAIKSFDIECGMIKRIRHRNIIKFI 812
           +G G  G VYKA  +     +AVKV  L    +  + I S   E  ++ +     II F 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS---ELEILYKCDSPYIIGFY 65

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------NIMIDVASALEYLHFG 866
            +   ++  ++  E+M  GSL           D+++++       I + V   L YL   
Sbjct: 66  GAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL--- 111

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +S+ I+H D+KP+N+L++      L DFG++   +    S+ +T  + T  YMAPE    
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERISG 167

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME----VVDANL 982
            +   + DV+S GI  ME    + P  +    + +L   +   LL  I++    V+    
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---MPLQLLQCIVDEDPPVLPVGQ 224

Query: 983 LSHEDKHFVAKEQCM 997
            S +  HF+   QCM
Sbjct: 225 FSEKFVHFIT--QCM 237

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 12/201 (5%)

Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRHRNIIKFIS 813
           +G+GGFG V   +++  G   A K  + +  +  K ++   +E  ++ ++  R I+    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           +  +     LV+  M  G L   +Y+    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           II+ DLKP NVLLD++    +SD G+A   LK+ QS T+     T G+MAPE  +     
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVE-LKDGQSKTKGYA-GTPGFMAPELLQGEEYD 175

Query: 931 TNGDVYSFGIMLMETFTRKKP 951
            + D ++ G+ L E    + P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+ ++ G+  A KV D +    ++ + +E  ++    H NI+K + +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEY-----GREGRVS 930
           K  N+L   +    L+DFG++    K  +++ +  + + T  +MAPE       ++    
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 931 TNGDVYSFGIMLMETFTRKKPTDE 954
              DV+S GI L+E    + P  E
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNI-- 808
           N I  G +G VY+AR  + G  VA+K   L+  +  + F I    E  ++ +++H NI  
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +   S+ D   +V+EY+ +  L+  + +        +   +M+ + S + +LH  + 
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGRE 926
             I+H DLK +N+LL++  +  + DFG+A+ +         TQ + T+ Y APE   G  
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLG-A 181

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKP 951
              ST  D++S G +  E    KKP
Sbjct: 182 KEYSTAIDMWSVGCIFAE-LLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 70/235 (29%), Positives = 100/235 (42%), Gaps = 53/235 (22%)

Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRI------R 804
           F    +IGRG FG V   R +   +V A+K+        +  F+    MIKR        
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL--------LSKFE----MIKRSDSAFFWE 92

Query: 805 HRNIIKFISS-------CSSDDFKAL--VLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMI 854
            R+I+   +S        +  D K L  V+EYMP G L   +  SNY I + + R     
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA- 149

Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
           +V  AL+ +H   S+  IH D+KP+N+LLD +    L+DFG              T  + 
Sbjct: 150 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVG 205

Query: 915 TIGYMAPE----------YGREGRVSTNGDVYSFGIMLMETFTRKKP-TDESFTG 958
           T  Y++PE          YGRE       D +S G+ L E      P   +S  G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTPFYADSLVG 254

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 47/135 (34%), Positives = 68/135 (50%), Gaps = 22/135 (16%)

Query: 845 DIFQRLN--IMI----------DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           D+F RL+  +M           ++A AL++LH   S+ II+ DLKP N+LLD+     L+
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140

Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           DFG++K     D          T+ YMAPE   R G  + + D +SFG+++ E  T   P
Sbjct: 141 DFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Query: 952 ---TDESFTGEMTLK 963
               D   T  M LK
Sbjct: 198 FQGKDRKETMTMILK 212

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 29/217 (13%)

Query: 757 LIGRGGFGFV-YKARIQDGMEVAVKVFDLQ-YGRAIK---SFDIECGMIKRIRHRNIIKF 811
           ++G G  G V    R+ DG   AVKV D++    A K     ++ C +       +I+K 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL--NCDFFSIVK- 95

Query: 812 ISSCSSDDFK------------ALVLEYMPYGSLEKCLYSSNYILDIFQRLN---IMIDV 856
              C  D  K            ALVL+Y   G L + + S       F+      + I V
Sbjct: 96  ---CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
             A+ ++H   S  +IH D+K  N+LL  N +  L DFG +K +              T 
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 917 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTD 953
            Y+APE  R    S   D++S G++L E  T K+P D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 11/205 (5%)

Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F +  ++G+GGFG V   +++  G   A K  + +  +  K   +   E  +++++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFG 866
           ++    +  + D   LVL  M  G L+  +Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
                ++ DLKP N+LLDD     +SD G+A   +K  +  +    + T+GYMAPE    
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA---VKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKP 951
            R + + D +  G ++ E    + P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  A ++   EV A+KV  L+    ++  D++C M  KRI     +H  + 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
                  + D    V+EY+  G L   +  S    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            +I+ DLK +N+LLD      L+DFGM K  +     +T T    T  Y+APE  +E   
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173

Query: 930 STNGDVYSFGIMLMETFTRKKP 951
             + D ++ G+++ E    + P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N+++  +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 201 SLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 27/206 (13%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQY-GRAI--KSFDI--ECGMIKRIRHRNIIKFI 812
           IG G FG VY A      EV V V  + Y G+    K  DI  E   +++++H N I++ 
Sbjct: 29  IGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYLHFGYS 868
                +    LV+EY        CL S++ +L++     Q + I      AL+ L + +S
Sbjct: 88  GCYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY---GR 925
             +IH D+K  N+LL +     L+DFG A       +S      + T  +MAPE      
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMD 193

Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           EG+     DV+S GI  +E   RK P
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 63/288 (21%), Positives = 121/288 (42%), Gaps = 52/288 (18%)

Query: 758  IGRGGFGFVYKARIQD---------GMEVAVKVFDL-QYGRAIKSFDIECGMIKRIRHRN 807
            +G+G F  +YK  ++          G EV+V +  L    R   +F     ++ ++ H++
Sbjct: 3    LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
            ++K    C  D+   +V EY+ +G L+  L+     + +  +L++   +ASAL YL    
Sbjct: 63   LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 868  SVPIIHCDLKPNNVLL---DDNM----VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
               ++H ++   N+L+     N        LSD G+    L  ++ + +      I ++A
Sbjct: 119  DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWIA 172

Query: 921  PEYGREGRVSTN--GDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            PE  R G+ S     D +SFG  L+E  +  ++P     + E                  
Sbjct: 173  PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-------------- 218

Query: 978  VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                   ++D+H +    C   + NL  +C    P +R + + I+  L
Sbjct: 219  -------YQDQHRLPMPDCAE-LANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 4e-10
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 1/90 (1%)

Query: 54  GLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGE 113
           GL L    L+G IP ++  L  L+ + L  N + G IP S+ +++SL  LDLS N+  G 
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 114 LLANICSNLPLLQTLFLDENNFDGKIPSTL 143
           +  ++   L  L+ L L+ N+  G++P+ L
Sbjct: 482 IPESL-GQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.3 bits (151), Expect = 4e-10
 Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 15/195 (7%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGM------IKRIRHRNII 809
           +IG+G FG V  A R  DG   AVKV  LQ    +K  +    M      +K ++H  ++
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               S  + +    VL+Y+  G L   L      L+   R     +VASA+ YLH   S+
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            II+ DLKP N+LLD      L+DFG+ K  ++ ++  T +    T  Y+APE  R+   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPY 173

Query: 930 STNGDVYSFGIMLME 944
               D +  G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 10/197 (5%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G +G V   R   DG +  +K  +L+    R  K+ + E  ++ +++H NI+ +  S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 815 CSSDD-FKALVLEYMPYGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D    +V+ +   G L  K       +L   Q +   + +A AL+YLH  +   I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H DLK  NV L    +  + D G+A+  + E+Q    +  + T  YM+PE       +  
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 933 GDVYSFGIMLMETFTRK 949
            DV++ G  + E  T K
Sbjct: 183 SDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.8 bits (151), Expect = 4e-10
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 50/214 (23%)

Query: 758 IGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGM----IKRIR----HRNI 808
           +G G FG VY AR ++  E VA+K    ++     S++ EC M    +K +R    H NI
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWE-EC-MNLREVKSLRKLNEHPNI 60

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL-------NIMIDVASALE 861
           +K       +D    V EYM     E  LY    + D   +        +I+  +   L 
Sbjct: 61  VKLKEVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 862 YLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK------PFLKEDQSLTQTQTLA 914
           ++H  G+     H DLKP N+L+    V  ++DFG+A+      P+         T  ++
Sbjct: 114 HIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---------TDYVS 160

Query: 915 TIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFT 947
           T  Y APE   R    S+  D+++ G ++ E +T
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 28/207 (13%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFI-- 812
           +IG G +G VYKAR  + G  VA+K+ D+      +    E  ++++   H NI  F   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 813 ----SSCSSDDFKALVLEYMPYGS---LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
               +   +DD   LV+E    GS   L K L      L       I+ +    L YLH 
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH- 130

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPE 922
                +IH D+K  N+LL  N    L DFG++      D +L +  T   IG   +MAPE
Sbjct: 131 --ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT--FIGTPYWMAPE 183

Query: 923 -----YGREGRVSTNGDVYSFGIMLME 944
                   +       DV+S GI  +E
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.9 bits (153), Expect = 6e-10
 Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 3/104 (2%)

Query: 33  LSLND--FSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTI 90
           L L++    G IP +I  +  L  ++L GN ++G IP  LG++  LE L L  N   G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 91  PSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN 134
           P S+  L+SL  L+L+ N+L+G + A +     L +  F   +N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-GGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 757 LIGRGGFGFVYKARIQDG--------MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI 808
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 809 IKFISSCSSDDFKA-LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI-DVASALEYLHFG 866
           +  +      D K  L+L+Y+  G L   L       +  Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
             + II+ D+K  N+LLD N    L+DFG++K F  ED+         TI YMAP+  R 
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180

Query: 927 GRVSTNG--DVYSFGIMLMETFTRKKP 951
           G    +   D +S G+++ E  T   P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.5 bits (150), Expect = 8e-10
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)

Query: 756 NLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK-- 810
           + +G G +G V  A     G +VA+K     +  AI  K    E  ++K + H N+I   
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 811 --FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASAL 860
             F  + S +DF+   LV   M  G+        N I+   Q+L+      ++  +   L
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM--GA------DLNNIVK-CQKLSDDHIQFLVYQILRGL 131

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           +Y+H   S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y A
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 183

Query: 921 PE--YGREGRVSTNGDVYSFGIMLMETFTRK 949
           PE         +   D++S G ++ E  T K
Sbjct: 184 PEIMLNW-MHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.2 bits (148), Expect = 9e-10
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 11/209 (5%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKVFDLQY---GRAIKSFDIECG-MIKRIRHRNIIKF 811
           +IG+G FG V  A R  DG   AVKV   +     +  K    E   ++K ++H  ++  
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
             S  + +    VL+++  G L   L       +   R     ++ASAL YLH   S+ I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           ++ DLKP N+LLD      L+DFG+ K  +   QS T T    T  Y+APE  R+     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 932 NGDVYSFGIMLMETFTRKKPTDESFTGEM 960
             D +  G +L E      P       EM
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 11/211 (5%)

Query: 757 LIGRGGFGFVYKA-RIQDG----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
           ++G G FG VYK   + +G    + VA+K+ +   G +A   F  E  ++  + H ++++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +  C S   + LV + MP+G L   ++     +     LN  + +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           ++H DL   NVL+       ++DFG+A+    +++          I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 931 TNGDVYSFGIMLMETFT-RKKPTDESFTGEM 960
              DV+S+G+ + E  T   KP D   T E+
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 61/265 (23%), Positives = 116/265 (43%), Gaps = 32/265 (12%)

Query: 758  IGRGGFGFVYKARIQ---DGMEVAVKVF-DLQYGRAIKSFDI-ECGMIKRIRHRNIIKFI 812
            +G G FG V K   +       VAVK+  +     A+K   + E  +++++ +  I++ I
Sbjct: 3    LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              C ++ +  LV+E    G L K L  + ++ +      ++  V+  ++YL        +
Sbjct: 63   GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117

Query: 873  HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGREGRVS 930
            H DL   NVLL     A +SDFG++K  L  D++  + +T     + + APE     + S
Sbjct: 118  HRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 931  TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF 990
            +  DV+SFG+++ E F+          G+   K           M+  +   +    +  
Sbjct: 177  SKSDVWSFGVLMWEAFS---------YGQKPYKG----------MKGNEVTQMIESGERM 217

Query: 991  VAKEQCMSFVFNLAMKCTIESPEER 1015
               ++C   +++L   C     +ER
Sbjct: 218  ECPQRCPPEMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 44/218 (20%)

Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI------RHRNIIK 810
           +IGRG FG V   R     + + KV+ +   + +  F+    MIKR         R+I+ 
Sbjct: 50  VIGRGAFGEVQLVR----HKSSQKVYAM---KLLSKFE----MIKRSDSAFFWEERDIMA 98

Query: 811 FISS-------CSSDDFKAL--VLEYMPYGSLEKCLYSSNYILDIFQRLN--IMIDVASA 859
           F +S       C+  D K L  V+EYMP G L   +  SNY  D+ ++       +V  A
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLA 154

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQTQT-LATIG 917
           L+ +H   S+ +IH D+KP+N+LLD +    L+DFG     +K D++ + +  T + T  
Sbjct: 155 LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGTPD 208

Query: 918 YMAPEY----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           Y++PE     G +G      D +S G+ L E      P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 15/202 (7%)

Query: 757 LIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  AR+ + G   AVKV  L+    ++  D+EC M  KRI      H  + 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
           +      + D    V+E++  G L   +  S    +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            II+ DLK +NVLLD      L+DFGM K  +      T +    T  Y+APE  +E   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQEMLY 173

Query: 930 STNGDVYSFGIMLMETFTRKKP 951
             + D ++ G++L E      P
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 19/126 (15%)

Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           + + +  AL YL   + V  IH D+KP+N+LLD +    L DFG++   L + ++ T++ 
Sbjct: 119 MTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAKTRSA 175

Query: 912 TLATIGYMAPEYGREGRVSTN---------GDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
             A   YMAPE     R+             DV+S GI L+E  T + P     T    L
Sbjct: 176 GCAA--YMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228

Query: 963 KRWVND 968
            + + +
Sbjct: 229 TKILQE 234

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 30/190 (15%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRI 803
           F   + + +   +G G +  VYK + + +G  VA+KV  LQ         I E  ++K +
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 804 RHRNIIKFISSCSSDDFKALVLEYM-----------PYGSLEKCLYSSNYILDIFQRLNI 852
           +H NI+       + +   LV EY+           P G     L+  N  L +FQ L  
Sbjct: 61  KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLLR- 114

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
                  L Y+H  Y   I+H DLKP N+L+ D     L+DFG+A+   K   S T +  
Sbjct: 115 ------GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNE 163

Query: 913 LATIGYMAPE 922
           + T+ Y  P+
Sbjct: 164 VVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           +G G  G V K + +  G+ +A K+  L+   AI++  I E  ++       I+ F  + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            SD   ++ +E+M  GSL++ L  +  I  +I  +++I   V   L YL   +   I+H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHR 128

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
           D+KP+N+L++      L DFG++   +           + T  YM+PE  +    S   D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 935 VYSFGIMLMETFTRKKP 951
           ++S G+ L+E    + P
Sbjct: 185 IWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 3e-09
 Identities = 32/107 (29%), Positives = 59/107 (55%), Gaps = 1/107 (0%)

Query: 427 STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEIN 486
           S ++  F S+    +++   + N  L G +P  I  L + ++  ++  ++I G+IP  + 
Sbjct: 405 SGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLG 463

Query: 487 NLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNL 533
           ++T+L  + L  N  NGSI  +LG+L  L++L+L  N L G +P  L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIEC------GMIKRIR 804
           F    ++G+GGFG V   +++  G   A K   L+  R IK    E        +++++ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKR-IKKRKGEAMALNEKQILEKVN 58

Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYL 863
            R ++    +  + D   LVL  M  G L+  +Y+  N   D  + +    ++   LE L
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H      I++ DLKP N+LLDD     +SD G+A   + E +++     + T+GYMAPE 
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVE-IPEGETI--RGRVGTVGYMAPEV 172

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKP 951
            +  R + + D +  G ++ E    K P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 3e-09
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK----VFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
           IG G FG V+     +DG  VA+K    VF  Q   + K    E  M+   +H N++  +
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 813 SSCSS---DDFKAL-VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                   D F+ + V+  +    L K + S   +     ++  +  +   L+YLH   S
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH---S 121

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-DQSLTQTQTLATIGYMAPEYGREG 927
             I+H D+KP N+L++ N V  + DFG+A+  ++E D+S   TQ + T  Y APE     
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 928 RVSTNG-DVYSFGIMLMETFTRK 949
           R  T+  D++S G +  E   R+
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 15/211 (7%)

Query: 757 LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGM------IKRIRHRNII 809
           +IG+G FG V  AR + +    AVKV  LQ    +K  + +  M      +K ++H  ++
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               S  + D    VL+Y+  G L   L      L+   R     ++ASAL YLH   S+
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            I++ DLKP N+LLD      L+DFG+ K  ++ +   T +    T  Y+APE   +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPY 173

Query: 930 STNGDVYSFGIMLMETFTRKKPTDESFTGEM 960
               D +  G +L E      P     T EM
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 11/203 (5%)

Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNII 809
           F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       I+
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYS 868
            F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 124

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  +   
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH 178

Query: 929 VSTNGDVYSFGIMLMETFTRKKP 951
            S   D++S G+ L+E    + P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 29/276 (10%)

Query: 757  LIGRGGFGFVYKA-RIQDG----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            ++G G FG VYK   I DG    + VA+KV       +A K    E  ++  +    + +
Sbjct: 14   VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
             +  C +   + LV + MPYG L   +  +   +     LN  + +A  + YL     V 
Sbjct: 74   LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            ++H DL   NVL+       ++DFG+A+    ++           I +MA E     R +
Sbjct: 130  LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 931  TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF 990
               DV+S+G+ + E  T      +         R + DLL               + +  
Sbjct: 190  HQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLL--------------EKGERL 230

Query: 991  VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                 C   V+ + +KC +   E R   +E+V + +
Sbjct: 231  PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR------IRHRNII 809
           ++G+G FG V  A ++   E  A+K   L+    ++  D+EC M++R        H  + 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               +  + +    V+EY+  G L   + SS    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGR 928
            II+ DLK +NVLLD +    ++DFGM K  +  +    +  T   T  Y+APE  +  +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQK 172

Query: 929 VSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
            + + D +SFG++L E    + P    F GE
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP----FHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+   K+   + +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +MAPE   +   +T  DV+SFG++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 11/195 (5%)

Query: 758 IGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           +G G +  VYK R +   E VA+K   L       S  I E  ++K ++H NI++     
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 816 SSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
            +++   LV EYM    L+K +  +     LD     +    +   + + H      ++H
Sbjct: 68  HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STN 932
            DLKP N+L++      L+DFG+A+ F       T +  + T+ Y AP+     R  ST+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 933 GDVYSFGIMLMETFT 947
            D++S G ++ E  T
Sbjct: 182 IDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFI-- 812
           ++G G +G VYK R ++ G   A+KV D+      +   +E  M+K+   HRNI  +   
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 813 ----SSCSSDDFKALVLEYMPYGSLEKCL-------YSSNYILDIFQRLNIMIDVASALE 861
               S    DD   LV+E+   GS+   +          ++I  I +      ++   L 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR------EILRGLA 135

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMA 920
           +LH      +IH D+K  NVLL +N    L DFG++      D+++ +  T + T  +MA
Sbjct: 136 HLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMA 189

Query: 921 PEY-----GREGRVSTNGDVYSFGIMLME 944
           PE        +       D++S GI  +E
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 6e-09
 Identities = 28/71 (39%), Positives = 42/71 (59%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L +L+ + L  N   G IP +L +   L  + LS N F+G+IP+ +G +T+L  L+L GN
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500

Query: 61  KLQGEIPEELG 71
            L G +P  LG
Sbjct: 501 SLSGRVPAALG 511

Length = 623

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 8e-09
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 38/215 (17%)

Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI------RHRNIIK 810
           +IGRG FG V   R     +   KV+ +   + +  F+    MIKR         R+I+ 
Sbjct: 50  VIGRGAFGEVQLVR----HKSTRKVYAM---KLLSKFE----MIKRSDSAFFWEERDIMA 98

Query: 811 FISSC---------SSDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASAL 860
           F +S            D +  +V+EYMP G L   +  SNY + + + R     +V  AL
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLAL 155

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           + +H   S+  IH D+KP+N+LLD +    L+DFG      KE      T  + T  Y++
Sbjct: 156 DAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYIS 211

Query: 921 PEY----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           PE     G +G      D +S G+ L E      P
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.4 bits (141), Expect = 9e-09
 Identities = 75/258 (29%), Positives = 115/258 (44%), Gaps = 19/258 (7%)

Query: 337 NVSTLKFLYLGSNSFFGRLP-SSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
           ++S L  L L S S    L  S   + L  L  L L+ N     I S +   + L++L+L
Sbjct: 65  SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDL 123

Query: 396 QRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGI 455
             N+ +   P       NLK LDL DN + S  S L      N   L+   +S N L   
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPL-----RNLPNLKNLDLSFNDL-SD 177

Query: 456 LPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKL 515
           LP+++ NLS ++ +  +  + IS  +P EI  L+ L  + L  N +   +L +L  LK L
Sbjct: 178 LPKLLSNLS-NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234

Query: 516 QLLSLKDNQLEGSI--------PDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLP 567
             L L +N+LE            + L  S    S  S+L +L ++  L+LS N  +  LP
Sbjct: 235 SGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALP 294

Query: 568 LEIGNLKVLVQIDLSINN 585
           L    L +L  +   +  
Sbjct: 295 LIALLLLLLELLLNLLLT 312

Length = 394

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.1 bits (140), Expect = 9e-09
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDG----MEVAVKVF-DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G    + VA+K   +    +A K    E  ++  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    +++          I +MA E   
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISS 814
           L+G G +G VYK R ++ G   A+KV D+  G   +    E  M+K+   HRNI  +  +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 815 C------SSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGY 867
                    DD   LV+E+   GS+   + ++    L       I  ++   L +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEY--- 923
              +IH D+K  NVLL +N    L DFG++      D+++ +  T + T  +MAPE    
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 924 --GREGRVSTNGDVYSFGIMLME 944
               +       D++S GI  +E
Sbjct: 186 DENPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 9e-09
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+   K+   + +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 14/222 (6%)

Query: 750 NGFSENNLIGRGGFGFVYKARIQDGME-VAVKVF-DLQYGRAIKSFDI-ECGMIKRIRHR 806
           N F    ++G G +G V K R ++  E VA+K F D +    +K   + E  M++ ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 807 NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           NI++   +        LV EY+    LE      N +     R  I       ++ +H+ 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +   I+H D+KP N+L+  N V  L DFG A+  L E  +   T+ +AT  Y +PE    
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSPELLLG 175

Query: 927 GRVSTNGDVYSFGIMLME------TFTRKKPTDESFTGEMTL 962
                  D++S G +L E       F  +   D+ FT +  L
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.7 bits (142), Expect = 1e-08
 Identities = 27/73 (36%), Positives = 45/73 (61%), Gaps = 1/73 (1%)

Query: 353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLR 412
           G +P+    +L +L+ ++LSGN+  G IP  + + + L  L+L  NSF+G IP + G L 
Sbjct: 432 GFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 413 NLKWLDLGDNYLT 425
           +L+ L+L  N L+
Sbjct: 491 SLRILNLNGNSLS 503

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 93/355 (26%), Positives = 144/355 (40%), Gaps = 37/355 (10%)

Query: 75  ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN 134
               L L +N L   +PSS+  L SL  L  S  +           NL  L +L L+ N 
Sbjct: 48  NRLALNLSSNTLL-LLPSSLSRLLSLDLLSPSGISSLDGSENL--LNLLPLPSLDLNLNR 104

Query: 135 FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLT-KLKYLHLDQNRLQGEIPEELGN 193
                 S LL   +L +L L  N+ + DIP  IG L   LK L L  N+++  +P  L N
Sbjct: 105 L-RSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN 161

Query: 194 LAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF 253
           L  L+ L L  N L+  +P  + NLS+L++L+LS N ++ + P ++     LSA      
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI---ELLSA------ 210

Query: 254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDN 313
                 LEE+ LS N              +   + NL  L  L+L  N+L+  +P  I N
Sbjct: 211 ------LEELDLSNN----------SIIELLSSLSNLKNLSGLELSNNKLED-LPESIGN 253

Query: 314 LHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSG 373
           L NLE      +       +++ +++ L+ L L  NS    LP  A + L     L+L  
Sbjct: 254 LSNLET--LDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLL 311

Query: 374 NNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSST 428
              +  +       +       + +S          N        L ++ L    
Sbjct: 312 TLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYI 366

Length = 394

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+   K+   + +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +MAPE   +   +T  DV+SFG++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 1e-08
 Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 18/185 (9%)

Query: 795 IECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS-LEKCLYSSNYILDIFQRLNIM 853
           IE  +++ + H ++I+   +  S     +VL +  Y S L   L   +  L I Q L I 
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH--YSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
             +   L YLH   +  IIH D+K  N+ ++D     + D G A+  +     L    T+
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220

Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKK---------PTDESFTGEMTLKR 964
            T    APE     + ++  D++S GI+L E               P +   +    L +
Sbjct: 221 ET---NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277

Query: 965 WVNDL 969
            ++ L
Sbjct: 278 IISTL 282

Length = 357

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 32/205 (15%)

Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA-----IKSFDIECGMIKRIRHRNIIKF 811
           +G+G +G VYK   +  G+ +A+K   L+   +     I   DI    + +     I+ F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDI----LHKAVSPYIVDF 64

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYS 868
             +   +    + +EYM  GSL+K LY    +   +       I   V   L++L   ++
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEYGR 925
             IIH D+KP NVL++ N    L DFG++   +    SL +T     IG   YMAPE  +
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---SLAKTN----IGCQSYMAPERIK 174

Query: 926 EGRVSTNG------DVYSFGIMLME 944
            G  + N       DV+S G+ ++E
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 757 LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V+ A ++      A+K   L+    +   D+EC M+ KR+      H  + 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               +  + +    V+EY+  G L   + S  +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGR 928
            I++ DLK +N+LLD +    ++DFGM K  +  D    +T T   T  Y+APE     +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQK 172

Query: 929 VSTNGDVYSFGIMLMETFTRKKP 951
            +T+ D +SFG++L E    + P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 25/197 (12%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           +G G  G V K      G+ +A K+  L+   AI++  I E  ++       I+ F  + 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            SD   ++ +E+M  GSL++ L  +  I +      I I V   L YL   +   I+H D
Sbjct: 69  YSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRD 125

Query: 876 LKPNNVLLDDNMVAHLSDFG--------MAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           +KP+N+L++      L DFG        MA  F            + T  YM+PE  +  
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPERLQGT 173

Query: 928 RVSTNGDVYSFGIMLME 944
             +   D++S G+ L+E
Sbjct: 174 HYTVQSDIWSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 9/168 (5%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVF-DLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G V+K R ++ G  VA+K F + +    IK   + E  M+K+++H N++  I  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
                   LV EY  +  L + L  +   +       I+     A+ + H       IH 
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHR 124

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           D+KP N+L+       L DFG A+           T  +AT  Y APE
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 18/136 (13%)

Query: 830 YGSLEKCLYSSNYILDIFQ-----RLNIMIDVASALEY---LHFGYSVP----------I 871
           Y  +E   Y S Y   +       R + +I+ + AL Y   + F Y V            
Sbjct: 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC 260

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           +H DL   NVL+ +  +  + DFG+A+  +++   +++  T   + +MAPE       +T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 932 NGDVYSFGIMLMETFT 947
             DV+SFGI+L E FT
Sbjct: 321 LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 22/200 (11%)

Query: 757 LIGR----GGFGFVYKARIQDGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIRHRNIIK 810
           LIG+         + K +  + + VAVK  +L       +K    E    ++++H NI+ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---NIMIDVASALEYLHFGY 867
           +++S   D    +V   M YGS E  L    +  +    L    I+ DV +AL+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ-----TQTLATIGYMAPE 922
           S   IH  +K +++LL  +    LS    +   +K  +           ++  + +++PE
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 923 YGREGRVSTN--GDVYSFGI 940
             ++     N   D+YS GI
Sbjct: 179 VLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 32/211 (15%)

Query: 758 IGRGGFGFVYKAR--IQDGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIR---HRNII 809
           IG G +G V+KAR     G  VA+K   +Q    G  + +   E  +++ +    H N++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67

Query: 810 KFISSC--SSDDFKA---LVLEYMPYG---SLEKCL---YSSNYILDIFQRLNIMIDVAS 858
           +    C  S  D +    LV E++       L+K       +  I D+      M  +  
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM------MFQLLR 121

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            L++LH   S  ++H DLKP N+L+  +    L+DFG+A+ +    Q    T  + T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL-TSVVVTLWY 175

Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
            APE   +   +T  D++S G +  E F RK
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.7 bits (139), Expect = 2e-08
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 3/104 (2%)

Query: 844 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE 903
           L     L+    VA  +E+L    S   +H DL   NVLL    +  + DFG+A+  + +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              +++  T   + +MAPE   +   +T  DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 32/234 (13%)

Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRHRN 807
           F     +G G FG V  A+ +  G   A+K    +    +K       E  ++  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS----NYILDIFQRLNIMIDVASALEYL 863
           I+  + S   ++    +LE++  G L   L  +    N +   +       ++  A EYL
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE 922
           H   S  II+ DLKP N+LLD+     ++DFG AK      +   +T TL  T  Y+APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAPE 185

Query: 923 YGREGRVSTNGDVYSFGIMLMETFTRKKP-TDES--------FTGEMTLKRWVN 967
             +        D ++ G++L E      P  D++          G +    W +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239

Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 25/227 (11%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRIRHRN----IIK 810
           ++G+G FG V  A  +   E+ A+K+  L+    I+  D+EC M+ KR+   +     + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 811 FISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            + SC  + D    V+EY+  G L   +Y    +   F+  + +   A     L F +S 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            II+ DLK +NV+LD      ++DFGM K  + +   +T      T  Y+APE       
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPY 178

Query: 930 STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
             + D ++FG++L E    + P    F GE        D L  SIME
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAP----FEGED------EDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 45/222 (20%)

Query: 746 FQATNGFSENNLIGRGGFGFVYK--ARIQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKR 802
           F A   +     +G G +  VYK  +RI +G  VA+KV  ++    +    I E  ++K 
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKG 59

Query: 803 IRHRNIIKFISSCSSDDFKALVLEYM-----------PYGSLEKCLYSSNYILDIFQRLN 851
           ++H NI+       + +    V EYM           P G     L+  N  L +FQ L 
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR 114

Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
                   L Y+H  +   I+H DLKP N+L+       L+DFG+A+   K   S T + 
Sbjct: 115 -------GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSS 162

Query: 912 TLATIGYMAP-------EYGREGRVSTNGDVYSFGIMLMETF 946
            + T+ Y  P       +Y      S+  D++  G + +E  
Sbjct: 163 EVVTLWYRPPDVLLGATDY------SSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 11/205 (5%)

Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F    ++G+GGFG V   +++  G   A K  + +  +  K   +   E  +++++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFG 866
           ++    +  + D   LVL  M  G L+  +Y+  N   D  + +    ++   LE L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
               I++ DLKP N+LLDD     +SD G+A   ++  +  T    + T+GYMAPE    
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLA---VQIPEGETVRGRVGTVGYMAPEVINN 175

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKP 951
            + + + D +  G ++ E    + P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF---IS 813
           +G G  G V+ A   D    VAVK   L   +++K    E  +I+R+ H NI+K    + 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 814 SCSSDDFKAL-----------VLEYMPYG---SLEKCLYSSNYI-LDIFQRLNIMIDVAS 858
              SD  + +           V EYM       LE+   S  +  L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAK---PFLKEDQSLTQTQTLA 914
            L+Y+H   S  ++H DLKP NV ++ +++V  + DFG+A+   P       L  ++ L 
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL--SEGLV 180

Query: 915 TIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           T  Y +P         T   D+++ G +  E  T K
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 34/205 (16%)

Query: 758 IGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRIRHRNII------- 809
           IG+G FG VY+ R +D   + A+KV   +   A K       +   I  RNI+       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE------VAHTIGERNILVRTLLDE 54

Query: 810 -------KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI-DVASALE 861
                  KF     SD +  LV +YM  G L   L       +   R    I ++  ALE
Sbjct: 55  SPFIVGLKFSFQTDSDLY--LVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALE 110

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMA 920
           +LH      I++ DLKP N+LLD      L DFG++K  L ++++   T T   T  Y+A
Sbjct: 111 HLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLA 164

Query: 921 PEYGREGRVSTNG-DVYSFGIMLME 944
           PE   + +  T   D +S G+++ E
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.5 bits (134), Expect = 6e-08
 Identities = 72/270 (26%), Positives = 117/270 (43%), Gaps = 52/270 (19%)

Query: 758  IGRGGFGFVYKAR---IQDGMEVAVK----VFD--LQYGRAIKSFDIECGMIKRIR-HRN 807
            +G+G +G V  AR     +   VA+K    VF   +   RA++    E  +++  R H+N
Sbjct: 8    LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 808  IIKFISS--CSSDDFKALVL--EYMPYGSLEKCLYSSNYILD------IFQRLNIMIDVA 857
            I            +F  L L  E M    L + + S   + D      I+Q L       
Sbjct: 64   ITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQIL------- 115

Query: 858  SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--LKEDQSLTQTQTLAT 915
              L+Y+H   S  ++H DLKP N+L++ +    + DFG+A+ F     + +   T+ +AT
Sbjct: 116  CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 916  IGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI-S 973
              Y APE     +  T   DV+S G +L E   R KP    F G    K +V+ L  I  
Sbjct: 173  RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR-KPV---FKG----KDYVDQLNQILQ 224

Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNL 1003
            ++   D   LS      +   +  +++ +L
Sbjct: 225  VLGTPDEETLSR-----IGSPKAQNYIRSL 249

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.2 bits (135), Expect = 6e-08
 Identities = 45/160 (28%), Positives = 65/160 (40%), Gaps = 24/160 (15%)

Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------------ 851
            H  I+K      SDD   L++EY   G L K          I QRL             
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGL 173

Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           +   +  AL+ +H   S  ++H DLK  N+ L    +  L DFG +K +         + 
Sbjct: 174 LFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
              T  Y+APE     R S   D++S G++L E  T  +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 11/160 (6%)

Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLE-YMPYGSLEKCLYSSNYI-------LDIF 847
           E  ++  + H+NI+  +  C  D     VL  YM +G+L+  L             L   
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL 907
           Q +++ I +A  + YLH      +IH D+   N ++D+ +   ++D  +++     D   
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174

Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                   + +MA E       S+  DV+SFG++L E  T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)

Query: 758 IGRGGFGFVY-----KARIQDGMEV--AVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G+G FG VY     KA  ++ ++V   + V +L     +++ + E  ++ ++ H  I+K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F +S    D   ++ EY     L+  L    +         +       L  +H+ +   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           I+H DLK  N+ L +N++  + DFG+++  L     L  T T  T  YM+PE  +     
Sbjct: 127 ILHRDLKAKNIFLKNNLL-KIGDFGVSR-LLMGSCDLATTFT-GTPYYMSPEALKHQGYD 183

Query: 931 TNGDVYSFGIMLME 944
           +  D++S G +L E
Sbjct: 184 SKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.0 bits (132), Expect = 8e-08
 Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 41/235 (17%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR--IRHRNIIKFIS 813
           ++G+G FG V  A  +   E+ A+K+  L+    I+  D+EC M+++  +  ++   F++
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 814 ---SC-SSDDFKALVLEYMPYGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGY 867
              SC  + D    V+EY+  G L   +Y    +      Q +    +++  L +LH   
Sbjct: 65  QLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE----- 922
              II+ DLK +NV+LD      ++DFGM K  + +   +T      T  Y+APE     
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQ 176

Query: 923 -YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
            YG+      + D +++G++L E    + P    F GE        D L  SIME
Sbjct: 177 PYGK------SVDWWAYGVLLYEMLAGQPP----FDGED------EDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 1e-07
 Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 39/228 (17%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVF--DL-QYGRAIKSFDIECGMIKRIRHRNIIKFI 812
           LIG+GG G VY A        VA+K    DL +     K F  E  +   + H  I+   
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 813 SSCSSDDFKALVLEYMPY--GSLEKCLYSSNYILDIFQR-----------LNIMIDVASA 859
           S CS  D    V   MPY  G   K L  S +  +   +           L+I   + + 
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA--KPFLKEDQ------------ 905
           +EY+H   S  ++H DLKP+N+LL       + D+G A  K   +ED             
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 906 -SLTQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            S+T   + + T  YMAPE       S + D+Y+ G++L +  T   P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 51/240 (21%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  A  +   E+ A+K+  L+    I+  D+EC M+ KR+     +   + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYL 863
           +  S   + D    V+EY+  G L        Y +    +           ++A  L +L
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE 922
           H   S  II+ DLK +NV+LD      ++DFGM K  +   ++   T+T   T  Y+APE
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPE 171

Query: 923 ------YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
                 YG+      + D ++FG++L E    + P    F GE        D L  SIME
Sbjct: 172 IIAYQPYGK------SVDWWAFGVLLYEMLAGQPP----FDGED------EDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 15/144 (10%)

Query: 812 ISSCSSDDFKALVLEYMP--------YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
            SS  SD +    +E  P          S ++     ++ LD+   L     VA  +++L
Sbjct: 173 FSSQGSDTY----VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL 228

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
               S   IH D+   NVLL D  VA + DFG+A+  + +   + +      + +MAPE 
Sbjct: 229 A---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 285

Query: 924 GREGRVSTNGDVYSFGIMLMETFT 947
             +   +   DV+S+GI+L E F+
Sbjct: 286 IFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 2e-07
 Identities = 32/103 (31%), Positives = 58/103 (56%), Gaps = 2/103 (1%)

Query: 280 NCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS 339
           +C      G    ++ L L    L+  IP++I  L +L+ +  S N + G +P ++ +++
Sbjct: 408 DCQFDSTKGKWF-IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT 466

Query: 340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPS 382
           +L+ L L  NSF G +P S   +L +L  L+L+GN+ SG +P+
Sbjct: 467 SLEVLDLSYNSFNGSIPESLG-QLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 15/202 (7%)

Query: 757 LIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  A ++   E  AVK   L+    +   D+EC M+ KR+      +  + 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               +  + +    V+E++  G L   +       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            II+ DLK +NV+LD +    ++DFGM K  +  D     +    T  Y+APE  +  + 
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKY 173

Query: 930 STNGDVYSFGIMLMETFTRKKP 951
           + + D +SFG++L E    + P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 3e-07
 Identities = 25/81 (30%), Positives = 47/81 (58%)

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLK 342
           IP +I  L  L+ ++L  N ++  IP  + ++ +LE +  S+N   G +P ++  +++L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 343 FLYLGSNSFFGRLPSSADVRL 363
            L L  NS  GR+P++   RL
Sbjct: 494 ILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.5 bits (131), Expect = 3e-07
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 27/191 (14%)

Query: 758 IGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRIR-HRN-------- 807
           I RG FG VY  R ++  ++ AVKV         K+  I   M+ +++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERDALALSKSP 64

Query: 808 -IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
            I+    S  S +   LV+EY+  G ++  L+   Y  D    +  + +VA AL+YLH  
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-- 121

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
               IIH DLKP+N+L+ +     L+DFG++K  L  + ++    T  ++     +Y R 
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSR- 179

Query: 927 GRVSTNGDVYS 937
               T G V S
Sbjct: 180 ----TPGQVLS 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 47/228 (20%)

Query: 757 LIGRGGFGFVYKARIQDGM----EVAVKVFDLQ----------YGRAIKSFDIECGM-IK 801
           LIG GGFG VY+ +         +   K+ +L+          Y        I     I 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---------NI 852
            I H  I K+   C S  FK   + Y  +  LEK + ++    +IF+R+         NI
Sbjct: 79  NIDHLGIPKYYG-CGS--FKRCRM-YYRFILLEKLVENTK---EIFKRIKCKNKKLIKNI 131

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL---------KE 903
           M D+ + LEY+H      I H D+KP N+++D N   ++ D+G+A  F+         KE
Sbjct: 132 MKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            + L +     T+ Y   +      V+  GD+ S G  +++    K P
Sbjct: 189 QKDLHR----GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 21/199 (10%)

Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           +G G +  V+K R +     VA+K   L++        I E  ++K ++H NI+      
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            ++    LV EY+    L++ L +   ++ +      M  +   L Y H      I+H D
Sbjct: 73  HTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRD 128

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP-------EYGREGR 928
           LKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P       EY     
Sbjct: 129 LKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEY----- 181

Query: 929 VSTNGDVYSFGIMLMETFT 947
            ST  D++  G +L E  T
Sbjct: 182 -STPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.1 bits (127), Expect = 4e-07
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)

Query: 756 NLIGRGGFGFVYKARIQDGME-VAVK--VFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
           N+IG G FG VY+A   D  E VA+K  + D QY       + E  ++K + H NII   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINIIFLK 125

Query: 813 SSCSSDDFKA--------LVLEYMPYGSLEKCLYSS--NYILDIFQRLNIMIDVASALEY 862
               ++ FK         +V+E++P    +   + +  N+ L +F        +  AL Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           +H  +   I H DLKP N+L+D N     L DFG AK  L   +S++    + +  Y AP
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAP 239

Query: 922 EYGR-EGRVSTNGDVYSFGIMLME 944
           E        +T+ D++S G ++ E
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAE 263

Length = 440

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 11/191 (5%)

Query: 758 IGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           +G G +  V+K R  + + + VA+K   L++        I E  ++K ++H NI+     
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             +D    LV EY+    L++ +     I+ +    N+ I +   L  L + +   ++H 
Sbjct: 73  VHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGREGRVSTNG 933
           DLKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P+        ST  
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186

Query: 934 DVYSFGIMLME 944
           D++  G +  E
Sbjct: 187 DMWGVGCIFFE 197

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 17/203 (8%)

Query: 758 IGRGGFGFVYKARIQDGMEVA-VKVFDLQYGRAIKSFD--IECGMIKRI-RHRNIIKFIS 813
           IG G FG V  + I     VA V V +L+   + K  +  ++ G   RI +H NI++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYIL---DIFQRLNIMIDVASALEYLHFGYSVP 870
            C       LV EY   G L+  L    +      +     +  ++A+ + ++H      
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY--GREGR 928
            +H DL   N  L  ++   + D+G+     KED   T+      + ++APE      G 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 929 VSTN-----GDVYSFGIMLMETF 946
           + T       +V++ G+ L E F
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 6e-07
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 36/162 (22%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
           L+G+G  G V+  R++   ++ A+KV D   +     +K    E  ++  + H  +    
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 813 SSCSSDDFKALVLEYMPYGSL--------EKCL-------YSSNYILDIFQRLNIMIDVA 857
           +S  ++ +  LV++Y P G L         KCL       Y++              +V 
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA--------------EVL 113

Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
            ALEYLH    + I++ DLKP N+LL ++    LSDF ++K 
Sbjct: 114 LALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.8 bits (112), Expect = 9e-07
 Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 3/63 (4%)

Query: 572 NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
           NLK L   DLS N  + +      GL +L+ L L  N L    P++   + +L+SL+LS 
Sbjct: 1   NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 632 NNL 634
           NNL
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 18/203 (8%)

Query: 757 LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRHRNIIKFI 812
           L+G+G FG V   R +  G   A+K+   +   A   +     E  ++K  RH  +    
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
            S  + D    V+EY+  G L   L       +   R     ++ SAL+YLH G    I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---KIV 117

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI----GYMAPEYGREGR 928
           + DLK  N++LD +    ++DFG+ K      + +T   T+ T      Y+APE   +  
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAPEVLEDND 171

Query: 929 VSTNGDVYSFGIMLMETFTRKKP 951
                D +  G+++ E    + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 45/211 (21%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR-----AIKSFDIECGMIKRIRHRNIIKF 811
           +G G +  VYK R    G  VA+K   L++       AI+    E  ++K ++H NI+  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTL 68

Query: 812 ISSCSSDDFKALVLEYM-----PYGSLEKC---LYSSNYILDIFQRLNIMIDVASALEYL 863
                +     LV EY+      Y  ++ C   L   N  L +FQ L         L Y 
Sbjct: 69  HDIIHTKKTLTLVFEYLDTDLKQY--MDDCGGGLSMHNVRLFLFQLLR-------GLAYC 119

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP-- 921
           H      ++H DLKP N+L+ +     L+DFG+A+   K   S T +  + T+ Y  P  
Sbjct: 120 HQRR---VLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDV 174

Query: 922 -----EYGREGRVSTNGDVYSFGIMLMETFT 947
                EY      ST+ D++  G +  E  T
Sbjct: 175 LLGSTEY------STSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 758 IGRGGFG--FVYKARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           IG G FG   + K++ +DG +  +K  ++     +  +    E  ++  ++H NI+++  
Sbjct: 8   IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 814 SCSSDDFKALVLEYMPYGSLEK-------CLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           S   +    +V++Y   G L K        L+  + ILD F      + +  AL+++H  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKHVH-- 118

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
               I+H D+K  N+ L  +    L DFG+A+  L     L +T  + T  Y++PE    
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELART-CIGTPYYLSPEICEN 175

Query: 927 GRVSTNGDVYSFGIMLMETFTRK 949
              +   D+++ G +L E  T K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 43/213 (20%)

Query: 758 IGRGGFGFVYK-ARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-----RHRNIIKF 811
           IG+G +G VYK    +DG   AVK+ D      I   D E      I      H N++KF
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSLPNHPNVVKF 84

Query: 812 ISSCSSDDFKA-----LVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASAL 860
                  D        LVLE    GS+ + +     +L   QRL+      I+      L
Sbjct: 85  YGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGL 141

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           ++LH   +  IIH D+K NN+LL       L DFG++         L +  ++ T  +MA
Sbjct: 142 QHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMA 196

Query: 921 PE---------YGREGRVSTNGDVYSFGIMLME 944
           PE         Y  + R     DV+S GI  +E
Sbjct: 197 PEVIACEQQYDYSYDARC----DVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 11/194 (5%)

Query: 758 IGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           +G G +  VYK R  + D + VA+K   L++        I E  ++K ++H NI+     
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV EY+    L++ L      +++    N+ + +   L  L++ +   ++H 
Sbjct: 73  IHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGREGRVSTNG 933
           DLKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P+        ST  
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186

Query: 934 DVYSFGIMLMETFT 947
           D++  G +  E  T
Sbjct: 187 DMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 2e-06
 Identities = 19/60 (31%), Positives = 26/60 (43%)

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
           NL+ L LS N  +            L  L+L  N+ +   P  F  L +L+ LDL  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 75/297 (25%), Positives = 118/297 (39%), Gaps = 59/297 (19%)

Query: 758  IGRGGFGFV-YKARIQDGMEVAVKVF------DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G +G V      + G +VA+K        +L   RA +    E  ++K ++H N+I 
Sbjct: 23   VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 811  ----FISSCSSDDFKALVLEYMPY--GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
                F    S D F    L  MP+    L K +       D  Q L  +  +   L+Y+H
Sbjct: 79   LLDVFTPDLSLDRFHDFYL-VMPFMGTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYIH 135

Query: 865  FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
               +  IIH DLKP N+ ++++    + DFG+A+   + D  +  T  + T  Y APE  
Sbjct: 136  ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGYVVTRWYRAPEVI 187

Query: 925  REG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD---- 979
                  +   D++S G ++ E  T K      F G   L +      L+ IM+V      
Sbjct: 188  LNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHLDQ------LMEIMKVTGTPSK 237

Query: 980  ---ANLLSHEDKHFVAK-------------EQCMSFVFNLAMKCTIESPEERINAKE 1020
                 L S + K++V K                     N+  K  +   E RI A E
Sbjct: 238  EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 43/182 (23%)

Query: 788 RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-- 845
           RA    + E   + R+ H NI+K      S+    ++ +   +      LYS  Y     
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD-----LYSFMYDEAFD 259

Query: 846 ------IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
                 + Q   IM  +  A+EY+H      +IH D+K  N+ L+ +    L DFG A P
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG-------------DVYSFGIMLMETF 946
           F KE +              A +YG  G V+TN              D++S G++L++  
Sbjct: 317 FEKERE--------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Query: 947 TR 948
           + 
Sbjct: 363 SH 364

Length = 501

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 3e-06
 Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 3/104 (2%)

Query: 844 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE 903
           LD    L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+    +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +      + +MAPE       +   DV+S+GI+L E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 3e-06
 Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 30/161 (18%)

Query: 757 LIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNI------ 808
           +IGRG FG V   + +D G   A+K          KS  +E   +  +R  R+I      
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60

Query: 809 ---IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF---QRLNIMIDVASALEY 862
              +K   S   +++  L++EY+P G +   L       D F   +    + +   A++ 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDS 116

Query: 863 LH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK 902
           +H  GY    IH D+KP+N+LLD      LSDFG+     K
Sbjct: 117 IHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 14/215 (6%)

Query: 750 NGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRH 805
             F   +L+GRG FG V   R    G   A+KV     L     +  F+ E  ++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             I +   +    D   LV+EY P G L   L   N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-- 923
            + +  +H D+KP NVL+D      L+DFG A   L  ++ +     + T  Y+APE   
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR-LTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 924 ----GREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
                 +G      D +S G++  E    + P  E
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 4e-06
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 42/213 (19%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK--- 810
            +G G +G V  A   + G +VA+K     +   I  K    E  ++K ++H N+I    
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 811 -FISSCSSDDFKA--LVLEYMPYGSLEKCL---YSSNYI-LDIFQRLNIMIDVASALEYL 863
            F S+ S D+F+   LV+ YM    L+K +    S + +   ++Q L         L+Y+
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQML-------CGLKYI 133

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  IIH DLKP N+ ++++    + DFG+A+     D  +T        GY+   +
Sbjct: 134 H---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT--------GYVVTRW 179

Query: 924 GREGRVSTNG-------DVYSFGIMLMETFTRK 949
            R   V  N        D++S G ++ E  T K
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.2 bits (120), Expect = 5e-06
 Identities = 36/133 (27%), Positives = 50/133 (37%), Gaps = 48/133 (36%)

Query: 176 LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNF 235
           L LD   L+G IP ++  L  L+ + L  N + G IPPS+ +++SL  L+LS+NS     
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS----- 477

Query: 236 PKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEK 295
                                             F G IP  L         G L  L  
Sbjct: 478 ----------------------------------FNGSIPESL---------GQLTSLRI 494

Query: 296 LDLQFNRLQCVIP 308
           L+L  N L   +P
Sbjct: 495 LNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)

Query: 758 IGRGGFGFVYKA---RIQDG-----MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
           +G+G F  ++K     + D       EV +KV D  +    +SF     M+ ++ H++++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
                C   D   +V EY+ +GSL+  L  +  +++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 870 PIIHCDLKPNNVLL---DDNMVAH-----LSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            + H ++   NVLL   +D    +     LSD G++   L ++  L +      I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER------IPWVPP 173

Query: 922 EYGREGR-VSTNGDVYSFGIMLMETFT 947
           E     + +S   D +SFG  L E F+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 5e-06
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 32/180 (17%)

Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIK-- 810
           +G G +G V   Y  R++   +VAVK     +   I +     E  ++K ++H N+I   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 811 --FISSCSSDDFKALVLEYMPYGS----LEKC--LYSSNYILDIFQRLNIMIDVASALEY 862
             F  + S ++F  + L     G+    + KC  L   +    I+Q L         L+Y
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR-------GLKY 133

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           +H   S  IIH DLKP+NV ++++    + DFG+A+   + D  +  T  +AT  Y APE
Sbjct: 134 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 42/217 (19%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVK----VFD-----LQYGRAIKSFDIECGMIKRIRHR 806
           +IG+G +G V  A     G +VA+K    VF+      +  R IK       +++ +RH 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK-------LLRLLRHP 59

Query: 807 NI--IKFISSCSS-DDFKAL--VLEYMPYGSLEKC------LYSSNYILDIFQRLNIMID 855
           +I  IK I    S  +FK +  V E M    L +       L   ++   ++Q L     
Sbjct: 60  DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLR---- 114

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP-FLKEDQSLTQTQTLA 914
              AL+Y+H   +  + H DLKP N+L + +    + DFG+A+  F     ++  T  +A
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168

Query: 915 TIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRK 949
           T  Y APE       + +   D++S G +  E  T K
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.3 bits (117), Expect = 6e-06
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 5/99 (5%)

Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
           +++ AL YLH      II+ DLK +NVLLD      L+D+GM K  L+     T +    
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCG 158

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTD 953
           T  Y+APE  R      + D ++ G+++ E    + P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 58/251 (23%), Positives = 94/251 (37%), Gaps = 57/251 (22%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC- 815
           IG G +G VYKAR    G  VA+K       +     D E      +R  ++++ +S   
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 816 -----------SSDDFKA---LVLEYMPYGSLEKCLYSSNY-----ILDIFQRLNIMIDV 856
                         + K    LV EY+   S  K    SN       L      + M  +
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYL--DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
              + + H      ++H DLKP N+L+D    +  ++D G+ + F    +S   T  + T
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174

Query: 916 IGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRK--------------------KPTDE 954
           + Y APE        ST  D++S G +  E   ++                     PT++
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234

Query: 955 SFTGEMTLKRW 965
            + G   L+ W
Sbjct: 235 VWPGVSKLRDW 245

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 758 IGRGGFGFVYKARIQDG---MEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIK--- 810
           +GRG +G VYKA+ +DG    E A+K  +   G  I  S   E  +++ ++H N+I    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE---GTGISMSACREIALLRELKHPNVIALQK 65

Query: 811 -FISSCSSDDFKALVLEYMPYG-----SLEKCLYSSNYILDIFQRL--NIMIDVASALEY 862
            F+S   SD    L+ +Y  +         +   ++   + + + +  +++  +   + Y
Sbjct: 66  VFLS--HSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 863 LHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQ-TLATIG 917
           LH  +   ++H DLKP N+L+     +     ++D G A+ F    + L      + T  
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 918 YMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           Y APE     R  T   D+++ G +  E  T +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 57/270 (21%), Positives = 102/270 (37%), Gaps = 37/270 (13%)

Query: 765  FVYKARIQDGMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSS 817
             +YK  I +  EV ++ F      +   I   + E   ++RI   NI+K     I     
Sbjct: 35   SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 818  DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                +L+LEY   G L + L      L    +L++ ID    L  L+   + P  + +L 
Sbjct: 94   LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 878  PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDV 935
              + L+ +N    +   G+ K       S    + +  + Y + +   +     +   D+
Sbjct: 151  SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQ 995
            YS G++L E FT K P +   T E+                    +L+ +++        
Sbjct: 206  YSLGVVLWEIFTGKIPFENLTTKEIY-------------------DLIINKNNSLKLPLD 246

Query: 996  CMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            C   +  +   CT     +R N KEI+  L
Sbjct: 247  CPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 19/199 (9%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 811 FISSCSSDDFKALVLEYMPYGS-LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
           F  + S ++F  + L     G+ L   +       D  Q L  +  +   L+Y+H   S 
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 139

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-R 928
            IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 194

Query: 929 VSTNGDVYSFGIMLMETFT 947
            +   D++S G ++ E  T
Sbjct: 195 YNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 20/204 (9%)

Query: 757 LIGRGGFG--FVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           ++G G FG   + +    D      ++   +   A++    E  ++ +++H NI+ F  S
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 815 CSSDDFKALVLEYMPYGSLEKC-------LYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
             +D    +V+EY   G L +        L+  + IL  F      + +   ++++H   
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQHIH--- 117

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
              ++H D+K  N+ L  N    L DFG A+  L    +   T  + T  Y+ PE     
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYACTY-VGTPYYVPPEIWENM 175

Query: 928 RVSTNGDVYSFGIMLMETFTRKKP 951
             +   D++S G +L E  T K P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 2/91 (2%)

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           L+F +   II+ DLK +NVLLD      L+D+GM K  ++     T +    T  Y+APE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPE 166

Query: 923 YGREGRVSTNGDVYSFGIMLMETFTRKKPTD 953
             R      + D ++ G+++ E    + P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 45/196 (22%), Positives = 88/196 (44%), Gaps = 24/196 (12%)

Query: 775 MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE 834
           ++V +KV D  +     +F     M++++ H++I+     C  D    +V E++ +G L+
Sbjct: 33  IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 835 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF 894
             ++  + +L    +  +   +ASAL YL       ++H ++   N+LL    +    + 
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGID--GEC 147

Query: 895 GMAKPFLKEDQS------LTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFT 947
           G   PF+K          L++ + +  I ++APE   + +  S   D +SFG  L E   
Sbjct: 148 G---PFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI-- 202

Query: 948 RKKPTDESFTGEMTLK 963
                   + GE+ LK
Sbjct: 203 -------CYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 11/202 (5%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFD---IECGMIKRIRHRNIIKFI 812
           +IGRG +  V   R++   ++ A+KV   +     +  D    E  + ++      +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 813 SSCSSDDFKA-LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
            SC     +  LV+EY+  G L   +     + +   R     ++  AL +LH      I
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           I+ DLK +NVLLD +    L+D+GM K  L      T +    T  Y+APE  R      
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGF 175

Query: 932 NGDVYSFGIMLMETFTRKKPTD 953
           + D ++ G+++ E    + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRIRHRN-----IIK 810
           +IGRG FG V   ++++  +V A+K+  L     +K  +  C   +R    N     I  
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDNQWITT 65

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGY 867
              +   ++   LV++Y   G L   L    + + +   R  +  M+    ++  LH+  
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR-- 925
               +H D+KP+N+L+D N    L+DFG     L ED ++  +  + T  Y++PE  +  
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 926 ---EGRVSTNGDVYSFGIMLMETFTRKKP 951
              +G+     D +S G+ + E    + P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 2e-05
 Identities = 47/176 (26%), Positives = 69/176 (39%), Gaps = 15/176 (8%)

Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           + N IK   S ++     L+++Y+  G L   L      L   +   I+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMV-AHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
                 IIH D+K  NVL D      +L D+G+ K             TL    Y +PE 
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYDGTLD---YFSPEK 177

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKP----TDESFTGEMTLKRWVNDLLLISIM 975
            +      + D ++ G++  E  T K P     DE    E  LKR    L  I  +
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233

Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 25/214 (11%)

Query: 740 FTYLELFQATNGFSENNLIGRGGFGFVYKA-RIQDGMEVAVKVFD--LQYGRAIKSFDIE 796
           FT L+ +Q          IG G  G V  A     G+ VAVK      Q     K    E
Sbjct: 17  FTVLKRYQQLKP------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRE 70

Query: 797 CGMIKRIRHRNIIK----FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRL 850
             ++K + H+NII     F    S ++F+   LV+E M   +L + ++     LD  +  
Sbjct: 71  LVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME---LDHERMS 126

Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
            ++  +   +++LH   S  IIH DLKP+N+++  +    + DFG+A+       +   T
Sbjct: 127 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMT 180

Query: 911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
             + T  Y APE         N D++S G ++ E
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.9 bits (114), Expect = 3e-05
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 1/83 (1%)

Query: 327 LVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFN 386
           L G +P  I  +  L+ + L  NS  G +P S    + +LE L LS N+F+G+IP  +  
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGSIPESLGQ 488

Query: 387 TSKLSTLELQRNSFSGFIPNTFG 409
            + L  L L  NS SG +P   G
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.3 bits (112), Expect = 3e-05
 Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 42/213 (19%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRHRNIIKFI 812
           +G G FG V  A  ++     V +   +  + IK   +     E  ++  I H   +   
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 813 SSCSSDDFKALVLEYMPYGSLEK-------------CLYSSNYILDIFQRLNIMIDVASA 859
            S   + +  LVLE++  G                 C Y++  +L IF            
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF------------ 144

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGY 918
            EYL    S+ I++ DLKP N+LLD +    ++DFG AK         T+T TL  T  Y
Sbjct: 145 -EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEY 194

Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           +APE           D ++ GI + E      P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 12/211 (5%)

Query: 758 IGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFD---IECGMIKRIRHRNIIKFIS 813
           IG+G FG V + R +D   + A+K     +  +         E  ++ ++    I+    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           S  S +   LVL ++  G L   L       D+ +      ++  ALE LH      +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIY 116

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGRVSTN 932
            DLKP N+LLD      L DFG+ K  +K+D    +T T   T  Y+APE       +  
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 933 GDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
            D ++ G++L E  T   P  +    EM  K
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRK 204

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 10/199 (5%)

Query: 757 LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRHRNIIKFI 812
           L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH  +    
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
            +  + D    V+EY   G L   L       +   R     ++ SALEYLH   S  ++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           + D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   +      
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 933 GDVYSFGIMLMETFTRKKP 951
            D +  G+++ E    + P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 28/105 (26%)

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL-------------KEDQ 905
           ALEYLH   +  I+H DLKP+N+L+       L+DFG++K  L             K+ +
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 906 SLTQTQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 944
                Q   T  Y+APE      YG+        D ++ GI+L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 5e-05
 Identities = 25/60 (41%), Positives = 31/60 (51%), Gaps = 1/60 (1%)

Query: 76  LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
           L+ L L NN LT     +   L +L  LDLS NNLT  +     S LP L++L L  NN 
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 6e-05
 Identities = 22/59 (37%), Positives = 31/59 (52%)

Query: 600 LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
           L+ L L  NRL      +   + NLK L+LS NNL  I P +   L  L+ +++S N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 6e-05
 Identities = 49/165 (29%), Positives = 70/165 (42%), Gaps = 23/165 (13%)

Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKC-LYSSNYI-----LDIFQR 849
           E  ++K I HR II  I +     +K+ V   MP     KC L++  Y+     L + Q 
Sbjct: 136 EIDILKTISHRAIINLIHAYR---WKSTVCMVMPK---YKCDLFT--YVDRSGPLPLEQA 187

Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
           + I   +  AL YLH      IIH D+K  N+ LD+   A L DFG A    K D     
Sbjct: 188 ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDT 241

Query: 910 TQTLATIGYM---APEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            Q     G +   +PE           D++S G++L E   +   
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSC 815
           IG+G +G V+K    ++G + AVK+ D  +    +  + E  ++K +  H N++KF    
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 816 SSDDFKA-----LVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLH 864
              D K      LVLE    GS+   +      L   +R+       I+ +    L++LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY- 923
              +   IH D+K NN+LL       L DFG++         L +  ++ T  +MAPE  
Sbjct: 142 VNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVI 196

Query: 924 GREGRVSTN----GDVYSFGIMLME 944
             E ++ +      DV+S GI  +E
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.9 bits (109), Expect = 7e-05
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 18/153 (11%)

Query: 799 MIKRIRHRNIIK----FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNI 852
           ++K + H+NII     F    S ++F+   LV+E M   +L + +      LD  +R++ 
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI---QMDLD-HERMSY 122

Query: 853 MI-DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           ++  +   +++LH   S  IIH DLKP+N+++  +    + DFG+A+       S   T 
Sbjct: 123 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 176

Query: 912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
            + T  Y APE         N D++S G ++ E
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 55/226 (24%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIK----FI 812
           +GRG +G VYKA+ +DG +          G  I  S   E  +++ ++H N+I     F+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 813 SSCSSDDFKALVLEY-----------------------MPYGSLEKCLYSSNYILDIFQR 849
           S   +D    L+ +Y                       +P G ++  LY    ILD    
Sbjct: 69  SH--ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ---ILD---- 119

Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQ 905
                     + YLH  +   ++H DLKP N+L+     +     ++D G A+ F    +
Sbjct: 120 ---------GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 906 SLTQTQ-TLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
            L      + T  Y APE     R  T   D+++ G +  E  T +
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNV 881
           L++E++P G L   L   +   +   R   M +   A+E +H  G+    IH D+KP+N+
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVHKLGF----IHRDIKPDNI 132

Query: 882 LLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
           L+D      LSDFG++  F K+  S    + L
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 6/94 (6%)

Query: 369 LSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSST 428
           L L      G IP+ I     L ++ L  NS  G IP + G++ +L+ LDL  N    S 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 429 SE-LSFLSSSNCKYLEYFSISNNPLGGILPRVIG 461
            E L  L+S     L   +++ N L G +P  +G
Sbjct: 483 PESLGQLTS-----LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 45.3 bits (107), Expect = 2e-04
 Identities = 88/311 (28%), Positives = 127/311 (40%), Gaps = 75/311 (24%)

Query: 49  VTTLIGL---HLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDL 105
           V +L GL    LRG+K   EIP+ L     LE L L +      +PSSI  L+ L +LD+
Sbjct: 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688

Query: 106 S-----------VN-------NLTG----ELLANICSNLPLLQTLFLDENNFDGKIPSTL 143
           S           +N       NL+G    +   +I +N   +  L LDE   + + PS L
Sbjct: 689 SRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTN---ISWLDLDETAIE-EFPSNL 744

Query: 144 LRCKHLQTL-SLSINDF-SGDIPKEIGNLT--------KLKYLHLDQNRLQGEIPEELGN 193
                L+ L  L + +  S  + + +  LT         L  L L       E+P  + N
Sbjct: 745 ----RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQN 800

Query: 194 LAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF 253
           L +LE L+++N     T+P  I NL SL  L+LS  S    FP                 
Sbjct: 801 LHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP---------------DI 844

Query: 254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQ-FNRLQCVIPHEID 312
             NI    ++ LS+           G   +P  I   + L  LD+   N LQ V  + I 
Sbjct: 845 STNI---SDLNLSRT----------GIEEVPWWIEKFSNLSFLDMNGCNNLQRVSLN-IS 890

Query: 313 NLHNLEWMIFS 323
            L +LE + FS
Sbjct: 891 KLKHLETVDFS 901

syringae 6; Provisional. Length = 1153

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.2 bits (105), Expect = 2e-04
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 29/178 (16%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF-DIEC-------GMIKRIR-HRN 807
           IG G F  V KA+  + G   A+K          K F  +E          ++R+  H N
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK-------CMKKHFKSLEQVNNLREIQALRRLSPHPN 59

Query: 808 IIKFISSCSSDDFK---ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           I++ I     D      ALV E M   +L + +      L   +  + M  +  +L+++H
Sbjct: 60  ILRLIE-VLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
                 I H D+KP N+L+ D+++  L+DFG  +           T+ ++T  Y APE
Sbjct: 118 ---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGI---YSKPPYTEYISTRWYRAPE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 43.9 bits (104), Expect = 3e-04
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 32/216 (14%)

Query: 758 IGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-------RHRNI 808
           +GRG FG V  A  +   E+ A+K   L+ G  I   ++E  M  KRI       RH  +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS---ALEYLHF 865
           +   +   ++D    V+EY   G L   +++     D+F     +   A     L+YLH 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ-TQTL-ATIGYMAPEY 923
                I++ DLK +N+LLD      ++DFG+     KE       T T   T  ++APE 
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLC----KEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
             E   +   D +  G+++ E    + P    F G+
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 27/133 (20%), Positives = 59/133 (44%), Gaps = 15/133 (11%)

Query: 766 VYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII--KFISSCSSDDFKAL 823
           VY    +D  +  +K+            + E  +++ +  + +   K ++S  SD +  L
Sbjct: 14  VYLLGTKDE-DYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70

Query: 824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVL 882
           ++E++   +L++        +   ++ +I   +A  L  LH     V + H DL P N+L
Sbjct: 71  LMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLV-LCHGDLHPGNIL 121

Query: 883 LDDNMVAHLSDFG 895
           +DD  +  + D+ 
Sbjct: 122 VDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 4/97 (4%)

Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
           ++ SAL+YLH   +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      
Sbjct: 103 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCG 158

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 16/160 (10%)

Query: 796 ECGMIKRIRHRNIIK----FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQR 849
           E  ++K + H+NII     F    S ++F+   LV+E M   +L + +      LD  + 
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQME---LDHERM 121

Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
             ++  +   +++LH   S  IIH DLKP+N+++  +    + DFG+A+       S   
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175

Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           T  + T  Y APE         N D++S G ++ E    K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 23/209 (11%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRIRHRN-----IIK 810
           +IGRG FG V   +++    + A+K+  L     +K  +  C   +R    N     I  
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETACFREERNVLVNGDCQWITT 65

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGY 867
              +   +++  LV++Y   G L   L    + + +   R  I  M+    ++  LH+  
Sbjct: 66  LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY-- 123

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE- 926
               +H D+KP+NVLLD N    L+DFG     + +D ++  +  + T  Y++PE  +  
Sbjct: 124 ----VHRDIKPDNVLLDMNGHIRLADFGSCLK-MNQDGTVQSSVAVGTPDYISPEILQAM 178

Query: 927 ----GRVSTNGDVYSFGIMLMETFTRKKP 951
               G+     D +S G+ + E    + P
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.6 bits (103), Expect = 4e-04
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 12/97 (12%)

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQ----RLNIMIDVASALEYL 863
           ++K   S    D    V++Y+P G +   L      L IF+    R  I  ++  A+E +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCAIESV 117

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF 900
           H    +  IH D+KP+N+L+D +    L+DFG+   F
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 4e-04
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 11/99 (11%)

Query: 859 ALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
           A++ +H  GY    +H D+KP+NVLLD N    L+DFG     L  D ++     + T  
Sbjct: 114 AIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLR-LLADGTVQSNVAVGTPD 168

Query: 918 YMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKP 951
           Y++PE  +     +GR     D +S G+ + E    + P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 8/149 (5%)

Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRN 807
           F    +IGRG FG V   + +D G   A+K+    D+     +     E  ++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S        L++E++P G +   L   + + +   +  I  +   A++ +H   
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
            +  IH D+KP+N+LLD      LSDFG+
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 8e-04
 Identities = 18/60 (30%), Positives = 27/60 (45%)

Query: 292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
            L+ LDL  NRL  +       L NL+ +  S N L  + P     + +L+ L L  N+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 8e-04
 Identities = 25/61 (40%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 172 KLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNS 230
            LK L L  NRL          L  L+ L L  N LT +I P  F  L SL  L+LS N+
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 231 L 231
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 8e-04
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 16/155 (10%)

Query: 796 ECGMIKRIRHRNIIK----FISSCSSDDFKAL--VLEYMPYGSLEKCLYSSNYILDIFQR 849
           E  ++K + H+NII     F    S ++F+ +  V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME---LDHERM 128

Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
             ++  +   +++LH   S  IIH DLKP+N+++  +    + DFG+A+       S   
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182

Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 22/64 (34%), Positives = 28/64 (43%), Gaps = 4/64 (6%)

Query: 389 KLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSIS 448
            L +L+L  N  +      F  L NLK LDL  N LTS + E    + S    L    +S
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE----AFSGLPSLRSLDLS 56

Query: 449 NNPL 452
            N L
Sbjct: 57  GNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 16/59 (27%), Positives = 24/59 (40%)

Query: 125 LQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRL 183
           L++L L  N              +L+ L LS N+ +   P+    L  L+ L L  N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 24/183 (13%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDI-----ECGMIKRIRHRNIIK 810
           L+G+G FG V   R +   +  A+K+  L+    I   ++     E  +++  RH  +  
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKI--LKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              S  + D    V+EY   G L   L       +   R     ++ SAL YLH   S  
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---SCD 115

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL--ATIGYMAPE------ 922
           +++ DLK  N++LD +    ++DFG+     KE  S   T      T  Y+APE      
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLC----KEGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 923 YGR 925
           YGR
Sbjct: 172 YGR 174

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 24/196 (12%)

Query: 775 MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE 834
           + V +KV D  +     +F     ++ ++ H ++      C       +V E++ +G L+
Sbjct: 45  LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 835 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF 894
            CL      + +  ++ +   +ASAL YL       ++H ++   N+LL     A L   
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILL-----ARLGLA 156

Query: 895 GMAKPFLKEDQ------SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFT 947
               PF+K         +L++ + +  I ++APE    G  +ST  D +SFG  L+E   
Sbjct: 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-- 214

Query: 948 RKKPTDESFTGEMTLK 963
                   F GE+ LK
Sbjct: 215 -------CFDGEVPLK 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 42/156 (26%), Positives = 66/156 (42%), Gaps = 14/156 (8%)

Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++ I H +II+   + + + F  L+L    Y +   C  ++   + I   L I   
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPR--YKTDLYCYLAAKRNIAICDILAIERS 190

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA-KPFLKEDQSLTQTQTL- 913
           V  A++YLH      IIH D+K  N+ ++      L DFG A  P       +   +   
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV-----DINANKYYG 242

Query: 914 --ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              TI   APE           D++S GI+L E  T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 8/149 (5%)

Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRN 807
           F    +IGRG FG V   + +D G   A+K+    D+     +     E  ++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S        L++E++P G +   L   + + +   +  I  +   A++ +H   
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
            +  IH D+KP+N+LLD      LSDFG+
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 38/153 (24%), Positives = 66/153 (43%), Gaps = 8/153 (5%)

Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRN 807
           F +   +G G FG V  AR  D     A+K     D+     +     E  ++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           +++   S    D    V++Y+P G +   L       +   R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF 900
            +  IH D+KP+N+L+D +    L+DFG+   F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 4/93 (4%)

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S    D    V++Y+P G +   L       ++  R  I  ++  A+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF 900
            +  IH D+KP+N+L+D +    L+DFG+   F
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1027
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
smart00090	237	RIO RIO-like kinase.	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.55
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
PLN03150	623	hypothetical protein; Provisional	99.42
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.3
PLN03150	623	hypothetical protein; Provisional	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.24
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.24
KOG1243	690	consensus Protein kinase [General function predict	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.16
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.13
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.12
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.12
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.09
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.06
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.05
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.97
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.86
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.77
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.76
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.75
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.7
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.67
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.51
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.5
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.5
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.46
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.46

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.5e-105  Score=1022.79  Aligned_cols=860  Identities=32%  Similarity=0.487  Sum_probs=636.4

Q ss_pred             CCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCccccc-CCCCCCEEEccCcccCCccCccccCCCCCCeE
Q 048205           25 CKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELG-NLAELEELWLQNNFLTGTIPSSIFNLSSLSNL  103 (1027)
Q Consensus        25 ~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  103 (1027)
                      ..+++.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+. .+++|++|+|++|.+++.+|.  ..+++|++|
T Consensus        68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L  145 (968)
T PLN00113         68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL  145 (968)
T ss_pred             CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence            35799999999999999999999999999999999999888887754 999999999999999987775  457889999


Q ss_pred             eCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccC
Q 048205          104 DLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRL  183 (1027)
Q Consensus       104 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  183 (1027)
                      +|++|.+++.++. .+..+++|++|+|++|.+.+..|..|.++++|++|+|++|.+.+.+|..++++++|++|+|++|++
T Consensus       146 ~Ls~n~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  224 (968)
T PLN00113        146 DLSNNMLSGEIPN-DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL  224 (968)
T ss_pred             ECcCCcccccCCh-HHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence            9999888754443 345667777777777777666677777777777777777777666666777777777777777777


Q ss_pred             CCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEE
Q 048205          184 QGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEI  263 (1027)
Q Consensus       184 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L  263 (1027)
                      ++.+|..++.+++|++|++++|.+++.+|..+.++++|+.|++++|++++.+                            
T Consensus       225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~----------------------------  276 (968)
T PLN00113        225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI----------------------------  276 (968)
T ss_pred             CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccC----------------------------
Confidence            6666666666777777777777666666666666666666666666665322                            


Q ss_pred             EeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcce
Q 048205          264 YLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKF  343 (1027)
Q Consensus       264 ~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  343 (1027)
                                          |..+.++++|++|++++|++.+..|..+..+++|+.|++++|.+.+..|..+..+++|+.
T Consensus       277 --------------------p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~  336 (968)
T PLN00113        277 --------------------PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV  336 (968)
T ss_pred             --------------------chhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCE
Confidence                                233344455555555555555555555555555555555555555555555555555555


Q ss_pred             EEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCC
Q 048205          344 LYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY  423 (1027)
Q Consensus       344 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  423 (1027)
                      |++++|.+.+.+|... ..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..++.+++|+.|++++|+
T Consensus       337 L~L~~n~l~~~~p~~l-~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~  415 (968)
T PLN00113        337 LQLWSNKFSGEIPKNL-GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS  415 (968)
T ss_pred             EECcCCCCcCcCChHH-hCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCE
Confidence            5555555554444432 234556666666666655566666666666666666666666666655555555555555554


Q ss_pred             CCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccC
Q 048205          424 LTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNG  503 (1027)
Q Consensus       424 l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~  503 (1027)
                      +                                                     ++.+|..+.++++|+.|++++|++++
T Consensus       416 l-----------------------------------------------------~~~~p~~~~~l~~L~~L~Ls~N~l~~  442 (968)
T PLN00113        416 F-----------------------------------------------------SGELPSEFTKLPLVYFLDISNNNLQG  442 (968)
T ss_pred             e-----------------------------------------------------eeECChhHhcCCCCCEEECcCCcccC
Confidence            3                                                     23456666777778888888888888


Q ss_pred             chhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccc
Q 048205          504 SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSI  583 (1027)
Q Consensus       504 ~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  583 (1027)
                      .+|..+..+++|++|+|++|++.|.+|..              ...++|+.|++++|.+++.+|..++++++|+.|+|++
T Consensus       443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~--------------~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~  508 (968)
T PLN00113        443 RINSRKWDMPSLQMLSLARNKFFGGLPDS--------------FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE  508 (968)
T ss_pred             ccChhhccCCCCcEEECcCceeeeecCcc--------------cccccceEEECcCCccCCccChhhhhhhccCEEECcC
Confidence            88888888889999999999988766542              2347899999999999999999999999999999999


Q ss_pred             cccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCC
Q 048205          584 NNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIP  663 (1027)
Q Consensus       584 n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p  663 (1027)
                      |++.+.+|..++++++|++|+|++|.++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.+++++|+++|.+|
T Consensus       509 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             CcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccCCccccCCCc-cccccccccccccccccceeeeeecc------ce--eeeeecccCCC-----cCC
Q 048205          664 REGPFRNFSLESFKGNELLCGMPN-LQVRSCRTRIHHTSSKNDLLIGIVLP------LS--TTFMMGGKSQL-----NDA  729 (1027)
Q Consensus       664 ~~~~~~~~~~~~~~~n~~l~g~~~-~~~~~c~~~~~~~~~~~~~~~~~~~~------~~--~~~~~~~~~~~-----~~~  729 (1027)
                      ..++|.++.+.+|.||+++||.+. ...++|..... .. ....++++++.      +.  .++...+++..     ...
T Consensus       589 ~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  666 (968)
T PLN00113        589 STGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-TP-SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE  666 (968)
T ss_pred             CcchhcccChhhhcCCccccCCccccCCCCCccccc-cc-eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccc
Confidence            999999999999999999999542 23567854311 11 11111111100      00  11111111110     000


Q ss_pred             CCccc------cccccccHHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhh
Q 048205          730 NMPLV------ANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKR  802 (1027)
Q Consensus       730 ~~~~~------~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~  802 (1027)
                      ...+.      ...+.+++.+   ....|+..+.||+|+||+||+|++. +++.||||+++....    ....|++.+++
T Consensus       667 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~  739 (968)
T PLN00113        667 DGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGK  739 (968)
T ss_pred             cccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhh
Confidence            00000      0011223333   3356788899999999999999874 789999998864322    12346888999


Q ss_pred             ccCCccceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 048205          803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL  882 (1027)
Q Consensus       803 l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  882 (1027)
                      ++|||||+++++|.+.+..++||||+++|+|.++++.    ++|.++.+++.|+|+|++|||+.++.+|+|||+||+||+
T Consensus       740 l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil  815 (968)
T PLN00113        740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII  815 (968)
T ss_pred             CCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence            9999999999999999999999999999999999964    799999999999999999999777789999999999999


Q ss_pred             EcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhH
Q 048205          883 LDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL  962 (1027)
Q Consensus       883 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~  962 (1027)
                      ++.++.+++. ||.+.....      .....+|+.|+|||++.+..++.++|||||||++|||+||+.||+.........
T Consensus       816 ~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~  888 (968)
T PLN00113        816 IDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI  888 (968)
T ss_pred             ECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcH
Confidence            9999988875 666543211      122367899999999999999999999999999999999999997665555667


Q ss_pred             HHHHHHHHhh-hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          963 KRWVNDLLLI-SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       963 ~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .+|+...... ...+++|+......    ........++.+++.+||+.||++||+|+||+++|++
T Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  950 (968)
T PLN00113        889 VEWARYCYSDCHLDMWIDPSIRGDV----SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES  950 (968)
T ss_pred             HHHHHHhcCccchhheeCccccCCC----CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence            7777654322 23344454442211    1123345678899999999999999999999999873

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-59  Score=601.12  Aligned_cols=518  Identities=36%  Similarity=0.545  Sum_probs=372.4

Q ss_pred             CCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEc
Q 048205           75 ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSL  154 (1027)
Q Consensus        75 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  154 (1027)
                      +++.|+|++|.+++.++..|..+++|++|+|++|++++.++...+..+++|++|+|++|.+++.+|.  ..+++|++|+|
T Consensus        70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L  147 (968)
T PLN00113         70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL  147 (968)
T ss_pred             cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence            4555555555555555555555666666666666655555555555566666666666666555543  34566777777


Q ss_pred             cCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCC
Q 048205          155 SINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN  234 (1027)
Q Consensus       155 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  234 (1027)
                      ++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..+.++++|++|+|++|++++.
T Consensus       148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  227 (968)
T PLN00113        148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE  227 (968)
T ss_pred             cCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCc
Confidence            77777666666677777777777777777666666777777777777777777666677777777777777777766643


Q ss_pred             CCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCc
Q 048205          235 FPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL  314 (1027)
Q Consensus       235 ~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  314 (1027)
                      +|..+               ..+++|++|++++|.+++         .+|..++++++|+.|++++|++.+..|..+.++
T Consensus       228 ~p~~l---------------~~l~~L~~L~L~~n~l~~---------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l  283 (968)
T PLN00113        228 IPYEI---------------GGLTSLNHLDLVYNNLTG---------PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL  283 (968)
T ss_pred             CChhH---------------hcCCCCCEEECcCceecc---------ccChhHhCCCCCCEEECcCCeeeccCchhHhhc
Confidence            33221               234445555555555443         234445566677777777777766666666666


Q ss_pred             CcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeee
Q 048205          315 HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE  394 (1027)
Q Consensus       315 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  394 (1027)
                      ++|+.|++++|.+.+..|..+.++++|++|++++|.+.+.+|..+ ..+++|+.|+|++|.+++.+|..+..+++|+.|+
T Consensus       284 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~-~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~  362 (968)
T PLN00113        284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL-TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD  362 (968)
T ss_pred             cCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH-hcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEE
Confidence            677777777666666666666666666666666666655554432 3455666666666666555555555556666666


Q ss_pred             cCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCC
Q 048205          395 LQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPN  474 (1027)
Q Consensus       395 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~  474 (1027)
                      +++|++++.+|..+..+++|+.|++++|+                                                   
T Consensus       363 Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~---------------------------------------------------  391 (968)
T PLN00113        363 LSTNNLTGEIPEGLCSSGNLFKLILFSNS---------------------------------------------------  391 (968)
T ss_pred             CCCCeeEeeCChhHhCcCCCCEEECcCCE---------------------------------------------------
Confidence            66666655555555555555555555444                                                   


Q ss_pred             CccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccE
Q 048205          475 SNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILC  554 (1027)
Q Consensus       475 n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~  554 (1027)
                        +.+.+|..++.+++|+.|++++|++++.+|..|.++++|+.|+|++|+++|.+             |..++.+++|+.
T Consensus       392 --l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-------------~~~~~~l~~L~~  456 (968)
T PLN00113        392 --LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI-------------NSRKWDMPSLQM  456 (968)
T ss_pred             --ecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCcc-------------ChhhccCCCCcE
Confidence              34567778888999999999999999999999999999999999999998654             455677899999


Q ss_pred             EecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccc
Q 048205          555 LNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL  634 (1027)
Q Consensus       555 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l  634 (1027)
                      |++++|.+.+.+|..++ ..+|+.||+++|++++.+|..++++++|+.|+|++|+++|.+|.+++.+++|++|+|++|++
T Consensus       457 L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  535 (968)
T PLN00113        457 LSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL  535 (968)
T ss_pred             EECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence            99999999999998764 58999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCchhhhhcccCCcceeccCCCCCCCCCCC-CCCCCcccccccCCccccCCC
Q 048205          635 FGIIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNFSLESFKGNELLCGMP  686 (1027)
Q Consensus       635 ~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~g~~  686 (1027)
                      +|.+|..+..+++|+.|++++|+++|.+|.. ..+..+......+|+..+..|
T Consensus       536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            9999999999999999999999999999973 344555556677787655555

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=425.92  Aligned_cols=285  Identities=42%  Similarity=0.677  Sum_probs=244.7

Q ss_pred             ccccccHHHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEE
Q 048205          736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC  815 (1027)
Q Consensus       736 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  815 (1027)
                      ..+.|++.++..+|++|...+.||+|+||.||+|...+|+.||||++........++|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999987654332145699999999999999999999999


Q ss_pred             ecCC-eeEEEEEecCCCCHHHHHhcCCc-cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          816 SSDD-FKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       816 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                      .+.+ ++++|||||++|+|+++++.... .++|.+|++||.++|+||+|||+.+...|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998776 889999999999999999999988888899999999999999999999999


Q ss_pred             ecCCcccccCCCcceeccc-ccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCc-ccchhHHHHHHHHHh
Q 048205          894 FGMAKPFLKEDQSLTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESF-TGEMTLKRWVNDLLL  971 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~  971 (1027)
                      ||+|+........  .... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... .++..+..|+.....
T Consensus       221 FGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999754321111  1112 79999999999999999999999999999999999999888653 445568999876665


Q ss_pred             h-hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          972 I-SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       972 ~-~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      . .+.+++|+.+.......    ......+..++.+|++.+|++||+|.||+++|+
T Consensus       299 ~~~~~eiiD~~l~~~~~~~----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPD----EKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             CcchhheeCCCccCCCCCh----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            5 58899999876321110    034455889999999999999999999999874

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-46  Score=383.89  Aligned_cols=250  Identities=25%  Similarity=0.325  Sum_probs=209.2

Q ss_pred             CccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCC-eeEEEEEecC
Q 048205          753 SENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-FKALVLEYMP  829 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~  829 (1027)
                      +..+.||+|+.|+||+|+++ +++.+|+|++..... ...+++.+|++++++.+||+||.+||.|..+. ...|+||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            44678999999999999987 688999999965533 44678899999999999999999999999998 5999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +|+|++.+... +.+++....+|+.+|++||.|||+  +++||||||||+|||+...|+|||||||.++.+...    ..
T Consensus       162 gGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a  234 (364)
T KOG0581|consen  162 GGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA  234 (364)
T ss_pred             CCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence            99999988765 448999999999999999999993  389999999999999999999999999999976543    45


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ...+||..|||||.+.+..|+.++||||||+.++|+++|+.||....+...   .|+..     +..+++    ..+. .
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~---~~~~L-----l~~Iv~----~ppP-~  301 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL---DIFEL-----LCAIVD----EPPP-R  301 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC---CHHHH-----HHHHhc----CCCC-C
Confidence            667899999999999999999999999999999999999999987522211   22211     112222    1111 1


Q ss_pred             hhHHh-hhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          990 FVAKE-QCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       990 ~~~~~-~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        .+. .+++++..++..|+++||.+||+++|++++
T Consensus       302 --lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  302 --LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             --CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              122 488899999999999999999999999863

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-45  Score=397.44  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=214.4

Q ss_pred             CCCCccceeeccccceEEEEEe-cCCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .+|...++||+|+|+.||.++. .+|+.||+|++.+.   .....+.+.+|+++.++++|||||+++++|++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999997 68999999999763   3455678889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+|+.++|.++++ +++.+++.+++.++.||+.|+.|||   +.+|+|||||-.|+|++++.+|||+|||+|..+..++.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999888 4556999999999999999999999   99999999999999999999999999999998765432


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        .....||||.|.|||++....++..+||||+|||+|.|+.|++||+...                 +.+.+++.... 
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------------vkety~~Ik~~-  233 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------------VKETYNKIKLN-  233 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------HHHHHHHHHhc-
Confidence              4456799999999999999999999999999999999999999998642                 11222222111 


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         +...|...+.+..+||.++|+++|.+|||+.+|+.
T Consensus       234 ---~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ---EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               22233456677899999999999999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-45  Score=378.82  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=206.6

Q ss_pred             CCCCccceeeccccceEEEEEe-cCCceEEEEEEecccch-------hHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGR-------AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      +.|.+.+.+|+|+||.|-+|.. ++|+.||||++++....       ....+.+|+++|++++|||||+++++|..++..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            4577889999999999999985 48999999999765321       123456899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeecCCc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAK  898 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~  898 (1027)
                      |+||||++||+|.+.+-..+. +.+..-..+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+|+
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            999999999999998876654 677777889999999999999   9999999999999999765   789999999999


Q ss_pred             ccccCCCcceecccccCccccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      ...   ....+...||||.|.|||++.++.   +..++|+||+|||+|-+++|.+||.+...+. .+.+.+         
T Consensus       328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI---------  394 (475)
T KOG0615|consen  328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQI---------  394 (475)
T ss_pred             ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHH---------
Confidence            654   233556789999999999998765   3457899999999999999999998753332 122211         


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         -+   .........+...+.+..++|.+||..||++|||+.|+++
T Consensus       395 ---~~---G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  395 ---LK---GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ---hc---CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence               11   1222233456677888999999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=375.20  Aligned_cols=200  Identities=32%  Similarity=0.496  Sum_probs=181.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.+.  ..+..+....|+++++.++|||||++++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356888888999999999999976 6899999999866  4455677888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC------CcEEEeeecCCcc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN------MVAHLSDFGMAKP  899 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfgla~~  899 (1027)
                      |||+||||.+|+++.+ .+++.++..++.|+|.|+++||   +++||||||||.|||++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999876 4899999999999999999999   9999999999999999764      4689999999997


Q ss_pred             cccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDES  955 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  955 (1027)
                      +..   .......+|+|.|||||++...+|+.|+|+||+|+|+|+|++|++||+..
T Consensus       165 L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  165 LQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             CCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            753   34556679999999999999999999999999999999999999999865

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=7.7e-49  Score=404.39  Aligned_cols=490  Identities=28%  Similarity=0.404  Sum_probs=336.7

Q ss_pred             CCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeC
Q 048205           26 KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDL  105 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  105 (1027)
                      ..++.|++++|.+. .+-..+.++..|++|++++|+++ ..|.+++.+..++.|+.++|++. .+|..++.+.+|+.|+.
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            45667777777776 45555667777777777777776 66666777777777777777776 66777777777777777


Q ss_pred             CcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCC
Q 048205          106 SVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       106 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      ++|.+. +.+.++ ..+..++.|+..+|++. ..|+++..+.+|..|++.+|+++...|..+ +++.|++||+..|-++ 
T Consensus       122 s~n~~~-el~~~i-~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-  196 (565)
T KOG0472|consen  122 SSNELK-ELPDSI-GRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-  196 (565)
T ss_pred             ccccee-ecCchH-HHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-
Confidence            777766 344433 34556777777777777 677888889999999999999985545444 4999999999999998 


Q ss_pred             CCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEe
Q 048205          186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYL  265 (1027)
Q Consensus       186 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~L  265 (1027)
                      .+|+.++.+.+|+.|+|.+|+|. ..| .|.+++.|++|+++.|+|.               .+|+..+++++++..|||
T Consensus       197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~---------------~lpae~~~~L~~l~vLDL  259 (565)
T KOG0472|consen  197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE---------------MLPAEHLKHLNSLLVLDL  259 (565)
T ss_pred             cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH---------------hhHHHHhcccccceeeec
Confidence            78999999999999999999998 677 8999999999999999996               889999999999999999


Q ss_pred             ccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccC--Ccce
Q 048205          266 SKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS--TLKF  343 (1027)
Q Consensus       266 s~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~  343 (1027)
                      .+|+++          ++|+++.-+++|.+||+|+|.|++ .|.+++++ .|+.|-+.+|.+.++-.+.+.+-+  -|++
T Consensus       260 RdNklk----------e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy  327 (565)
T KOG0472|consen  260 RDNKLK----------EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY  327 (565)
T ss_pred             cccccc----------cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence            999998          789999999999999999999995 67789999 999999999999865444333222  1343


Q ss_pred             EEc--cCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcc--cccEEec
Q 048205          344 LYL--GSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLR--NLKWLDL  419 (1027)
Q Consensus       344 L~L--~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L  419 (1027)
                      |.=  ..-.++..  .+.     .-..-++    .. ..-.....+.+.+.|+++.-+++.++.+.|..-.  -....++
T Consensus       328 Lrs~~~~dglS~s--e~~-----~e~~~t~----~~-~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~Vnf  395 (565)
T KOG0472|consen  328 LRSKIKDDGLSQS--EGG-----TETAMTL----PS-ESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNF  395 (565)
T ss_pred             HHHhhccCCCCCC--ccc-----ccccCCC----CC-CcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEec
Confidence            321  11111100  000     0000000    00 1111223344556666666666643333332221  1455566


Q ss_pred             CCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccce-EEecC
Q 048205          420 GDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIA-IYLGV  498 (1027)
Q Consensus       420 ~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~-L~L~~  498 (1027)
                      +.|++..+|..+                                                      ..+..+.+ +.+++
T Consensus       396 skNqL~elPk~L------------------------------------------------------~~lkelvT~l~lsn  421 (565)
T KOG0472|consen  396 SKNQLCELPKRL------------------------------------------------------VELKELVTDLVLSN  421 (565)
T ss_pred             ccchHhhhhhhh------------------------------------------------------HHHHHHHHHHHhhc
Confidence            666554444333                                                      22333332 23333


Q ss_pred             ccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccE
Q 048205          499 NKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQ  578 (1027)
Q Consensus       499 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  578 (1027)
                      |++ +.+|..++.+++|+.|+|++|-+              -.+|.+++.+..|+.||+|.|.|. .+|..+-.+..++.
T Consensus       422 n~i-sfv~~~l~~l~kLt~L~L~NN~L--------------n~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEt  485 (565)
T KOG0472|consen  422 NKI-SFVPLELSQLQKLTFLDLSNNLL--------------NDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLET  485 (565)
T ss_pred             Ccc-ccchHHHHhhhcceeeecccchh--------------hhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHH
Confidence            333 36777777777888888887776              245666666666777777777666 46766666666666


Q ss_pred             EcccccccccccchhhccCccccEEEccCCccccCcccccccccccccccccccccc
Q 048205          579 IDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLF  635 (1027)
Q Consensus       579 L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~  635 (1027)
                      +-.++|++....|..+++|.+|..|||.+|.+. .||+.+|+|++|++|+|++|++.
T Consensus       486 llas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  486 LLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            666667776444444777777777777777777 67777777777777777777776

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-44  Score=390.96  Aligned_cols=249  Identities=33%  Similarity=0.506  Sum_probs=208.5

Q ss_pred             ccceeeccccceEEEEEecCCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCC-eeEEEEEecCC
Q 048205          754 ENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-FKALVLEYMPY  830 (1027)
Q Consensus       754 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~  830 (1027)
                      ..+.+|+|+||+||+|.|+....||||++.....  ...+.|.+|+.++.+++|||||+++|+|.++. ..++||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3455999999999999998555599999975432  22568999999999999999999999999987 79999999999


Q ss_pred             CCHHHHHhc-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeccCCCCcEEEcCCC-cEEEeeecCCcccccCCCcc
Q 048205          831 GSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVP-IIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       831 gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      |+|.++++. .+..+++..++.+|.|||+|++|||   +.+ ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            999999988 4677999999999999999999999   888 99999999999999998 99999999998654321  3


Q ss_pred             eecccccCccccCccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          908 TQTQTLATIGYMAPEYGR--EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      ..+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....  ......+           +..     
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v-----------~~~-----  261 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAV-----------VVG-----  261 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHH-----------Hhc-----
Confidence            334468999999999999  66999999999999999999999999987643  1111111           001     


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ..+...+..++..+..++.+||..||++||++.+++..|+
T Consensus       262 -~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  262 -GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             -CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence             1122223348888999999999999999999999999886

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-44  Score=358.65  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=209.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      +.|+...++|+|+||+||+++++ +|+.||||++....  ....+-..+|++++++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778889999999999999987 69999999985332  2334556789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      ||+- ++.+-+.......+...+.+++.|+++|+.|||   .++++||||||+||+++.+|.+|+||||+|+.+..+  .
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--g  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--G  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--c
Confidence            9987 554556666666899999999999999999999   999999999999999999999999999999987643  3


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--hhHHHhhhcccc
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--ISIMEVVDANLL  983 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~~~  983 (1027)
                      ...+.++.|.||+|||.+.+ .+|+.++||||+||++.||++|.+.|.+..+-+ .+.........  .....++...-.
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHHHHHcccCHHHHHHhccCCc
Confidence            45677889999999999887 789999999999999999999999988753322 22222222221  122333322211


Q ss_pred             Ccc-----chhh----hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHE-----DKHF----VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~-----~~~~----~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...     ....    ..-...+.-+.+++.+|++.||++|++.+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111     0000    011233446889999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-45  Score=359.30  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=203.5

Q ss_pred             CCCccceeeccccceEEEEEe-cCCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEe-EEecCC-eeEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFIS-SCSSDD-FKALVL  825 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~-~~~lV~  825 (1027)
                      +|++.+.||+|+||+||+|+. .+|+.||.|.++-.  ..+..+....|+.++++++|||||++++ .+.++. ..+|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            477788999999999999984 58999999988633  3445677888999999999999999998 454444 489999


Q ss_pred             EecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          826 EYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       826 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |||+.|+|...++.   .++.+++.++++++.|++.||++||..+.+ -|+||||||.||+++.+|.||++|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999998753   446799999999999999999999943223 38899999999999999999999999999775


Q ss_pred             cCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ..  ...+...+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.     ++....         ..+...
T Consensus       180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~---------~KI~qg  243 (375)
T KOG0591|consen  180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLC---------KKIEQG  243 (375)
T ss_pred             ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHH---------HHHHcC
Confidence            43  33456689999999999999999999999999999999999999999874     222211         111111


Q ss_pred             ccCccchhhhHH-hhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 LLSHEDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ~~~~~~~~~~~~-~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .      ..+.| +.++.++.+++..|+.+||+.||+...++.
T Consensus       244 d------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  244 D------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             C------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence            0      11122 568889999999999999999998444433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=369.57  Aligned_cols=243  Identities=29%  Similarity=0.372  Sum_probs=204.1

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..++|++.++||+|+||+||.++.+ +++.||+|++++..   ....+...+|..++.+++||.||+++..|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3467999999999999999999866 68999999997653   2346778889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+||+.||.|...+++++. +++..+.-++.+|+.||.|||   +.||||||+||+|||+|.+|+++|+|||+++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999987654 888888999999999999999   999999999999999999999999999999854332


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                        ...+...+||+.|||||++.+.+|+.++|+||+|+++|||++|.+||.....     .++...            ...
T Consensus       179 --~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~------------I~~  239 (357)
T KOG0598|consen  179 --GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDK------------ILK  239 (357)
T ss_pred             --CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHH------------Hhc
Confidence              2234557999999999999999999999999999999999999999987532     222221            111


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCC
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI 1016 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp 1016 (1027)
                      ..   ....+.-.+.+..+++.+.+..||++|.
T Consensus       240 ~k---~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  240 GK---LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             Cc---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            11   0111122556688999999999999995

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=9.3e-48  Score=396.41  Aligned_cols=512  Identities=29%  Similarity=0.458  Sum_probs=347.2

Q ss_pred             EEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCC
Q 048205           54 GLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN  133 (1027)
Q Consensus        54 ~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N  133 (1027)
                      .|+++++.+. .+|..+..+.           .+.-....++.-..|+.|++++|.+.  .......++..|..|++++|
T Consensus        13 ~lnlsnr~l~-~vp~~vyq~~-----------~t~~e~e~wW~qv~l~~lils~N~l~--~l~~dl~nL~~l~vl~~~~n   78 (565)
T KOG0472|consen   13 SLNLSNRSLK-DVPTEVYQIN-----------LTTGEGENWWEQVDLQKLILSHNDLE--VLREDLKNLACLTVLNVHDN   78 (565)
T ss_pred             ccccccchhh-hccHHHHHHH-----------hhccchhhhhhhcchhhhhhccCchh--hccHhhhcccceeEEEeccc
Confidence            4556666655 4555443332           22122234445566777777777775  23334456777777777777


Q ss_pred             cCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCc
Q 048205          134 NFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPP  213 (1027)
Q Consensus       134 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  213 (1027)
                      ++. ..|.+++.+..++.|+.++|.++ .+|+.++.+.+|+.|++++|.+. +.|+.++.+..|+.|+..+|+++ ..|+
T Consensus        79 ~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~  154 (565)
T KOG0472|consen   79 KLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPE  154 (565)
T ss_pred             hhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCch
Confidence            777 67778888888888888888887 78888888888888888888888 67778888888888888888888 6788


Q ss_pred             cccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCc
Q 048205          214 SIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL  293 (1027)
Q Consensus       214 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L  293 (1027)
                      .++.+.+|..|++.+|+++               .+|+.... +..|++||..+|.++          ++|..++.+.+|
T Consensus       155 ~~~~~~~l~~l~~~~n~l~---------------~l~~~~i~-m~~L~~ld~~~N~L~----------tlP~~lg~l~~L  208 (565)
T KOG0472|consen  155 DMVNLSKLSKLDLEGNKLK---------------ALPENHIA-MKRLKHLDCNSNLLE----------TLPPELGGLESL  208 (565)
T ss_pred             HHHHHHHHHHhhccccchh---------------hCCHHHHH-HHHHHhcccchhhhh----------cCChhhcchhhh
Confidence            8888888888888888886               33433333 555666666666655          555555555555


Q ss_pred             cceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccc
Q 048205          294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSG  373 (1027)
Q Consensus       294 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~  373 (1027)
                      ..|+|..|+|..                         .| .|.+++.|+.|+++.|++ ..+|......+++|.+|||.+
T Consensus       209 ~~LyL~~Nki~~-------------------------lP-ef~gcs~L~Elh~g~N~i-~~lpae~~~~L~~l~vLDLRd  261 (565)
T KOG0472|consen  209 ELLYLRRNKIRF-------------------------LP-EFPGCSLLKELHVGENQI-EMLPAEHLKHLNSLLVLDLRD  261 (565)
T ss_pred             HHHHhhhccccc-------------------------CC-CCCccHHHHHHHhcccHH-HhhHHHHhcccccceeeeccc
Confidence            555555555552                         22 455555555555555555 355555555666666777777


Q ss_pred             cccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccc-cccccccccEe----ecc
Q 048205          374 NNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFL-SSSNCKYLEYF----SIS  448 (1027)
Q Consensus       374 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~-~~~~l~~L~~L----~Ls  448 (1027)
                      |+++ ..|+.+.-+.+|++||+|+|.|++ .|.+++++ .|+.|-+.||++..+..++..- .-.-+++|+.=    -+|
T Consensus       262 Nklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS  338 (565)
T KOG0472|consen  262 NKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLS  338 (565)
T ss_pred             cccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCC
Confidence            7765 566677777777777777777763 56667777 6777777777766554433211 00112222220    000


Q ss_pred             CCCCC----C-CCCccccC--cccccceeecCCCccccccCcccccccc---cceEEecCccccCchhHhhhcccccce-
Q 048205          449 NNPLG----G-ILPRVIGN--LSQSMEDFHMPNSNISGSIPKEINNLTN---LIAIYLGVNKLNGSILIALGKLKKLQL-  517 (1027)
Q Consensus       449 ~N~l~----~-~~~~~~~~--l~~~l~~l~l~~n~~~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~-  517 (1027)
                      .-+=+    . .++..|.+  ...+.+.|+.+.-+++ .+|+++..-..   .+..+++.|++. .+|..+..++.+.+ 
T Consensus       339 ~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~  416 (565)
T KOG0472|consen  339 QSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTD  416 (565)
T ss_pred             CCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHH
Confidence            00000    0 00011110  0122344444444444 45555544433   567788888887 67777777766544 


Q ss_pred             eeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccC
Q 048205          518 LSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGL  597 (1027)
Q Consensus       518 L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l  597 (1027)
                      +.+++|+++              .+|..++.+++|..|+|++|.+. .+|.+++.+..|++||+|.|+|. .+|..+..+
T Consensus       417 l~lsnn~is--------------fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~l  480 (565)
T KOG0472|consen  417 LVLSNNKIS--------------FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYEL  480 (565)
T ss_pred             HHhhcCccc--------------cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhH
Confidence            567777762              46778889999999999999998 49999999999999999999998 799999999


Q ss_pred             ccccEEEccCCccccCccc-cccccccccccccccccccCCchhhhhcccCCcceeccCCCCC
Q 048205          598 KDLQYLFLKYNRLQGSIPD-SIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE  659 (1027)
Q Consensus       598 ~~L~~L~L~~N~l~g~ip~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  659 (1027)
                      ..|+.+--++|++. .+|+ .+++|.+|..|||.+|.+. .||+.++++++|+.|++++|++.
T Consensus       481 q~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  481 QTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            88988888889998 5554 4999999999999999998 89999999999999999999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=381.81  Aligned_cols=249  Identities=29%  Similarity=0.489  Sum_probs=213.5

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      +..+.||+|.||+||.|++.....||+|.++.. .-..+.|.+|+++|++++|++||+++++|..++.++||||||+.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            446789999999999999998889999998754 2234678899999999999999999999999889999999999999


Q ss_pred             HHHHHhc-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecc
Q 048205          833 LEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ  911 (1027)
Q Consensus       833 L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  911 (1027)
                      |.+++.. .+..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..+||+|||+|+.. .++.......
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~~  363 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASEG  363 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceeecCC
Confidence            9999987 5567899999999999999999999   999999999999999999999999999999943 3333333444


Q ss_pred             cccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       912 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ..-+..|+|||.+..+.++.|+|||||||+|||++| |+.|+......     +         +.+.++      ...++
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----e---------v~~~le------~GyRl  423 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----E---------VLELLE------RGYRL  423 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----H---------HHHHHh------ccCcC
Confidence            445678999999999999999999999999999999 77887664221     1         112222      34577


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +.|..||.++.++|..||+.+|++|||++.+...++
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            888999999999999999999999999998887765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=376.02  Aligned_cols=268  Identities=22%  Similarity=0.278  Sum_probs=213.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHH-HHHHHHHHHhhcc-CCccceEEeEEecCC-eeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIR-HRNIIKFISSCSSDD-FKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lV  824 (1027)
                      .++|...+.||.|+||.||+|+.+ +|..||||.+++....+.+ .-.+|++.++++. |||||++.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            467888899999999999999855 7999999998765433322 2347999999998 999999999999988 99999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||||+. +|.++++.+++.+++..++.|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+||.+..  
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--  162 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc--
Confidence            999987 999999999999999999999999999999999   99999999999999999999999999999997643  


Q ss_pred             CcceecccccCccccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---------H
Q 048205          905 QSLTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---------I  974 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~  974 (1027)
                       ....+.++.|.||+|||++. .+.|+.++||||+|||++|+.+-++.|.+..+-+ .+.+.....+...         +
T Consensus       163 -kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  163 -KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             -CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCCccccchhHHHH
Confidence             34567889999999999876 5678999999999999999999999998754322 2222222222111         1


Q ss_pred             HHhhhccccCccchh-hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          975 MEVVDANLLSHEDKH-FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...+.-......... ...-..++.+..+++.+|+.+||++||||.|++++
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111111111111 11123478889999999999999999999999874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=371.36  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=214.1

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCe
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  820 (1027)
                      ....++|..++.||+|+|++|++|+.. +++.||||++.+..   ....+-+.+|-.+|.+| .||.|++++..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            445678999999999999999999855 79999999987653   23345677888899999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      +|+|+||+++|+|.++|++.+ .+++..++.++.+|+.|++|||   ++|||||||||+|||+|+||++||+|||-|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999998775 4899999999999999999999   999999999999999999999999999999987


Q ss_pred             ccCCCc---------c--eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH
Q 048205          901 LKEDQS---------L--TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL  969 (1027)
Q Consensus       901 ~~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  969 (1027)
                      ......         .  .....+||..|++||++..+..++.+|+|+||||+|+|+.|++||.+..+ ...+.+     
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqk-----  298 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQK-----  298 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHH-----
Confidence            533211         1  11447899999999999999999999999999999999999999987521 111111     


Q ss_pred             HhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          970 LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       970 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             +++-        .+..++++++.+.+|+.+.+..||.+|++++||.++
T Consensus       299 -------I~~l--------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 -------IQAL--------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -------HHHh--------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                   1111        223345677889999999999999999999998764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-41  Score=335.17  Aligned_cols=267  Identities=26%  Similarity=0.346  Sum_probs=212.3

Q ss_pred             CCCCccceeeccccceEEEEEe-cCCceEEEEEEecccch--hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .+|...+++|+|.||.||+|+. ++|+.||||.++.....  ......+|++.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677788999999999999985 47999999999755322  23456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      ||+- +|+..++.....+....+..++.++++|++|||   ++.|+|||+||.|++++.+|.+||+|||+|+.+...+..
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9976 999999999989999999999999999999999   999999999999999999999999999999988765544


Q ss_pred             ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------HHHhhh
Q 048205          907 LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------IMEVVD  979 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d  979 (1027)
                      ...  .+.|.||+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+. .+-..+....+......      ..+.-|
T Consensus       158 ~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 QTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             ccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHHcCCCCcccCcccccccc
Confidence            332  3789999999988875 5899999999999999999887766553 33333333333332111      111111


Q ss_pred             ccc---cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          980 ANL---LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       980 ~~~---~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      -..   ...+..+. .-..++.+..+|+.+|+..+|.+|++++|++++
T Consensus       235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111   11111111 223567778999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-42  Score=364.44  Aligned_cols=267  Identities=26%  Similarity=0.280  Sum_probs=212.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV  824 (1027)
                      +.|..+++||+|+||.||+|+.. +|+.||+|.++.+.  ........+|+.++++++||||+++.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            34666788999999999999854 79999999987654  44456678899999999999999999999876  689999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +|||+. ||.-++......+++.++..+++|++.||+|||   .+||+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999987 999998887778999999999999999999999   9999999999999999999999999999999775443


Q ss_pred             CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---HH-----
Q 048205          905 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---IM-----  975 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~-----  975 (1027)
                       ....+.++-|.||+|||.+.+. .|+.++|+||.|||+.||++|++.|.+..+- ..+....+......   +.     
T Consensus       273 -~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  273 -SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             -CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhccccccCC
Confidence             3346778899999999998875 6999999999999999999999999875332 22222222221111   00     


Q ss_pred             --HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          976 --EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       976 --~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ..+.+.... ...-.+.....+....+|+..+|..||++|.||.++++
T Consensus       351 ~~~~~kp~~~y-~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPY-KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcc-cchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              000000000 00111123456777899999999999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=337.08  Aligned_cols=237  Identities=26%  Similarity=0.314  Sum_probs=202.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .+|+..+.+|.|+||.|.+++.+ +|..+|+|+++++.   .+..+....|..+++.+.||.++++++.|.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45888999999999999999976 68899999998653   334566778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||++||.|..++++.++ +++..++-+|.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.+..   
T Consensus       124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            99999999999987654 899999999999999999999   99999999999999999999999999999996532   


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        .+...||||.|+|||++..+++..++|+|||||++|||+.|.+||......                 .++++.+.  
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-----------------~iY~KI~~--  255 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-----------------QIYEKILE--  255 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-----------------HHHHHHHh--
Confidence              245678999999999999999999999999999999999999999875431                 11111111  


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCC
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERI 1016 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp 1016 (1027)
                        .....|.-++.++.+|+.+.++.|-.+|.
T Consensus       256 --~~v~fP~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  256 --GKVKFPSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             --CcccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence              11223345667789999999999988883

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=366.04  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=215.9

Q ss_pred             CCCCccceeeccccceEEEEEe-cCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ..|.....||+|+.|.||.|+. .+++.||||+++.......+-+..|+.+|+..+|+|||.+++.|-..+..++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4477778999999999999974 478999999999887777788889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +||+|.|.+....  +++.++..|+.++++||+|||   .+||+|||||.+||+++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999887644  899999999999999999999   99999999999999999999999999999998765443  4


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....+|||.|||||+.....|++++||||||++++||+.|++||.....-. .+..                 .......
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-AlyL-----------------Ia~ng~P  487 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYL-----------------IATNGTP  487 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-HHHH-----------------HhhcCCC
Confidence            456789999999999999999999999999999999999999997632111 0110                 0112233


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ....++..+..+.+++.+||..||++||+|+|+|++
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            445566788899999999999999999999999863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=354.74  Aligned_cols=254  Identities=30%  Similarity=0.424  Sum_probs=205.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC--eeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD--FKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e  826 (1027)
                      .+|...+.||+|+||.||++... +|+..|||.+........+.+.+|++++++++|||||+.+|......  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            44667889999999999999876 49999999987664444677899999999999999999999855544  6899999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecCCccccc-CC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLK-ED  904 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~-~~  904 (1027)
                      |+++|+|.+++.+.+..+++..+..+..||++||+|||   ++|||||||||+|||++. ++.+||+|||.++.... ..
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999887656899999999999999999999   999999999999999999 79999999999987653 11


Q ss_pred             CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .........||+.|||||++..+ ...+++||||+||++.||+||++||... .+   ...++-...       ...   
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~---~~~~~~~ig-------~~~---  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE---EAEALLLIG-------RED---  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc---hHHHHHHHh-------ccC---
Confidence            22234457899999999999964 3445999999999999999999998763 11   111111000       000   


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        .  ....+...+.+..+++.+|+..+|++||||.+++..
T Consensus       240 --~--~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  240 --S--LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             --C--CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence              0  112234567788999999999999999999999874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=368.83  Aligned_cols=394  Identities=25%  Similarity=0.263  Sum_probs=302.1

Q ss_pred             CcEEEccCCcccccCCccccc-c-CCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeC
Q 048205           28 LRNISLSLNDFSGTIPKEIGN-V-TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDL  105 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~-l-~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  105 (1027)
                      -+.||++++.+....-..+.. + ..-+.||+++|++...-+..|.++++|+++++.+|.++ .+|.......+|+.|+|
T Consensus        54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L  132 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL  132 (873)
T ss_pred             ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence            467899999887321111111 1 34567999999999888999999999999999999998 88887777788999999


Q ss_pred             CcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCC
Q 048205          106 SVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       106 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      .+|.|+ .+..+..+.++.|++|||+.|.|+.+.-.+|..-.++++|+|++|.|+....+.|.++.+|..|.|+.|+++.
T Consensus       133 ~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt  211 (873)
T KOG4194|consen  133 RHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT  211 (873)
T ss_pred             eccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence            999998 7788888899999999999999998888889888999999999999998888999999999999999999997


Q ss_pred             CCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEe
Q 048205          186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYL  265 (1027)
Q Consensus       186 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~L  265 (1027)
                      ..+..|.++++|+.|+|..|+|.-...-.|.++.+|+.|.|..|.|+               .+..+.|..+..+++|+|
T Consensus       212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~---------------kL~DG~Fy~l~kme~l~L  276 (873)
T KOG4194|consen  212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS---------------KLDDGAFYGLEKMEHLNL  276 (873)
T ss_pred             cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc---------------cccCcceeeecccceeec
Confidence            77789999999999999999998444668999999999999999997               677788888888888888


Q ss_pred             ccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEE
Q 048205          266 SKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY  345 (1027)
Q Consensus       266 s~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  345 (1027)
                      +.|+++..-         -.++.++++|+.|+||+|.|..+.++.+.-.++|++|+|++|+|+...+..|..+..|+.|.
T Consensus       277 ~~N~l~~vn---------~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln  347 (873)
T KOG4194|consen  277 ETNRLQAVN---------EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN  347 (873)
T ss_pred             ccchhhhhh---------cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence            888887321         12466778888888888888888888888888888888888888877777777777777777


Q ss_pred             ccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCC
Q 048205          346 LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLT  425 (1027)
Q Consensus       346 L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  425 (1027)
                      |++|++. .+.+.+|..+.+|++|||++|.++..+.+.                     ...|.+|++|+.|+|.+|+|.
T Consensus       348 Ls~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDa---------------------a~~f~gl~~LrkL~l~gNqlk  405 (873)
T KOG4194|consen  348 LSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDA---------------------AVAFNGLPSLRKLRLTGNQLK  405 (873)
T ss_pred             ccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecc---------------------hhhhccchhhhheeecCceee
Confidence            7777773 555566666666666666666666544431                     123445555555555555555


Q ss_pred             CCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCC
Q 048205          426 SSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNS  475 (1027)
Q Consensus       426 ~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n  475 (1027)
                      +++...    ++.+..|+.|||.+|.|..+.|++|..+  .|++|.|...
T Consensus       406 ~I~krA----fsgl~~LE~LdL~~NaiaSIq~nAFe~m--~Lk~Lv~nSs  449 (873)
T KOG4194|consen  406 SIPKRA----FSGLEALEHLDLGDNAIASIQPNAFEPM--ELKELVMNSS  449 (873)
T ss_pred             ecchhh----hccCcccceecCCCCcceeecccccccc--hhhhhhhccc
Confidence            554432    2455555566666666666666666654  4555554443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.7e-40  Score=357.94  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=205.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..++|+.++.||+|+||+||+|+.+ +|..+|+|++++..   ...++.+..|-.+|...++|.||+++..|++.+.+|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            5688999999999999999999865 79999999998653   3456778889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||++||++..++...+. +++..+..++.+++.|++-+|   +.|+|||||||+|+|||..|++||+|||++.-+...
T Consensus       219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999987664 888888889999999999999   999999999999999999999999999998543210


Q ss_pred             ---------------------CCcc------------------------eecccccCccccCcccccCCCCCcchhHHHH
Q 048205          904 ---------------------DQSL------------------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSF  938 (1027)
Q Consensus       904 ---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  938 (1027)
                                           ....                        .....+|||.|+|||++.+..|+..+|+||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0000                        0113469999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCcccch--hHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC
Q 048205          939 GIMLMETFTRKKPTDESFTGEM--TLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI 1016 (1027)
Q Consensus       939 Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp 1016 (1027)
                      |||+|||+.|.+||.+..+.+.  .+..|...+                   .++....++.+..+||.+|+. ||+.|.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-------------------~fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-------------------KFPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-------------------cCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            9999999999999987643321  222222111                   111122345778999999999 999998


Q ss_pred             C---HHHHH
Q 048205         1017 N---AKEIV 1022 (1027)
Q Consensus      1017 s---~~evl 1022 (1027)
                      -   +.||.
T Consensus       435 G~~G~~EIK  443 (550)
T KOG0605|consen  435 GSKGAEEIK  443 (550)
T ss_pred             CcccHHHHh
Confidence            4   55554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-40  Score=365.23  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=209.0

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc----cc-hhHHHHHHHHHHHhhcc-CCccceEEeEEecCC
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ----YG-RAIKSFDIECGMIKRIR-HRNIIKFISSCSSDD  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  819 (1027)
                      ....+|...+.||+|+||.|+.|++. +++.||+|++++.    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34567999999999999999999865 7899999987754    12 23456778999999999 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCCc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAK  898 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~  898 (1027)
                      ..++||||+.||+|.+++.. ..++.+..+..++.|++.|++|||   ++||+||||||+||+++.+ +.+||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 556888999999999999999999   9999999999999999999 999999999999


Q ss_pred             ccccCCCcceecccccCccccCcccccCCC-CC-cchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGR-VS-TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+....... +..            
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~~k------------  234 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-YRK------------  234 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-HHH------------
Confidence            763  2223445678999999999999877 74 789999999999999999999987321111 000            


Q ss_pred             hhhccccCccchhhhHHhhh-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VVDANLLSHEDKHFVAKEQC-MSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~-~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       +.       ...+..+..+ +.++..++.+|+..+|.+|+++.+++.
T Consensus       235 -i~-------~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  235 -IR-------KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -Hh-------cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             11       1122233344 777899999999999999999999984

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=368.26  Aligned_cols=393  Identities=24%  Similarity=0.251  Sum_probs=339.8

Q ss_pred             cEEecCCCcCcccCCccCcCC--CCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc
Q 048205            5 EYLFLKSNMFHGKIPSTLSNC--KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ   82 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~--~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~   82 (1027)
                      +.||.+++++...--..+.++  ..-+.||+++|.++...+..|.++++|+.++|.+|.++ .+|.......+|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence            567888888774322233332  45677999999999888888999999999999999998 888877777889999999


Q ss_pred             CcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccc
Q 048205           83 NNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD  162 (1027)
Q Consensus        83 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  162 (1027)
                      +|.|+.+-...+..++.|+.||||.|.|+ +++...|..-.++++|+|++|+|+.+-.+.|..+.+|.+|.|++|+|+..
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL  212 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL  212 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence            99999887888999999999999999998 77777777778899999999999988889999999999999999999988


Q ss_pred             cCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhh
Q 048205          163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIV  242 (1027)
Q Consensus       163 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  242 (1027)
                      .+..|+++++|+.|+|..|+|.-..--.|.++.+|+.|.|..|.|.......|..+.++++|+|+.|+++          
T Consensus       213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~----------  282 (873)
T KOG4194|consen  213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ----------  282 (873)
T ss_pred             CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh----------
Confidence            8888999999999999999998444568899999999999999999777788999999999999999987          


Q ss_pred             hhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceec
Q 048205          243 NRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIF  322 (1027)
Q Consensus       243 ~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  322 (1027)
                           .+..+..-++..|+.|+||+|.|...         -++.+.-.++|+.|+|++|+|+...+.+|..+..|+.|+|
T Consensus       283 -----~vn~g~lfgLt~L~~L~lS~NaI~ri---------h~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL  348 (873)
T KOG4194|consen  283 -----AVNEGWLFGLTSLEQLDLSYNAIQRI---------HIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL  348 (873)
T ss_pred             -----hhhcccccccchhhhhccchhhhhee---------ecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence                 55666677889999999999998742         2344555689999999999999999999999999999999


Q ss_pred             cCcccccccCccccccCCcceEEccCccccccCCC--CccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcc
Q 048205          323 SFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS--SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSF  400 (1027)
Q Consensus       323 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  400 (1027)
                      ++|.+..+...+|..+++|+.|||++|.++..+..  .+|..++.|+.|+|.+|++..+.-..|.++..|++|||.+|.|
T Consensus       349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai  428 (873)
T KOG4194|consen  349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI  428 (873)
T ss_pred             cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence            99999999999999999999999999999877754  4567899999999999999866667899999999999999999


Q ss_pred             cCCCCcccCCcccccEEecCCCCC
Q 048205          401 SGFIPNTFGNLRNLKWLDLGDNYL  424 (1027)
Q Consensus       401 ~~~~p~~~~~l~~L~~L~L~~N~l  424 (1027)
                      ..+.|++|..+ .|++|-+..-.+
T Consensus       429 aSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  429 ASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             eeecccccccc-hhhhhhhcccce
Confidence            99999999999 899888765443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=361.37  Aligned_cols=264  Identities=27%  Similarity=0.407  Sum_probs=214.8

Q ss_pred             cHHHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC
Q 048205          741 TYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD  818 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  818 (1027)
                      +..+.+...+.+.....||+|.||+||+|+|.  -.||||++....  .+..+.|+.|+.++++-||.||+-+.|||..+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            33444455566777889999999999999986  479999987653  44678899999999999999999999999998


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      .. .||+.||+|.+|+.+++..+..++..+...||+|||+|+.|||   .++|||||+|..||++.++++|||+|||++.
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence            87 9999999999999999998888999999999999999999999   9999999999999999999999999999997


Q ss_pred             ccccCCCcceecccccCccccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      ...............|..-|||||++...   +|++.+||||||+|+|||+||..||.....+.+  . |          
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--i-f----------  603 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--I-F----------  603 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--E-E----------
Confidence            54333222333344577889999998753   689999999999999999999999983321111  0 0          


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ++-+.  ............|+.++.+|+..||..++++||.+.+|+.+|+
T Consensus       604 -mVGrG--~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  604 -MVGRG--YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             -Eeccc--ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence             00011  0011122234578889999999999999999999999999775

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-40  Score=355.39  Aligned_cols=246  Identities=28%  Similarity=0.415  Sum_probs=209.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|...+.||+|+||.||||+.+ +.+.||+|.+.+..  .+..+.+.+|+++++.++|||||.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56777889999999999999866 68999999997653  3456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+.| +|..++...+ .++++.+..++.+++.||.|||   +.+|.|||+||.||+++..|.+|+||||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9987 9999887654 4899999999999999999999   99999999999999999999999999999997643  34


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ...+...|||.|||||+..+.+|+..+|+||+|||+||+++|++||...     .+.+.++...       -|+..    
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~-------~d~v~----  218 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSIL-------KDPVK----  218 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHh-------cCCCC----
Confidence            4556678999999999999999999999999999999999999999763     2222222111       01111    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           -+...+..+.+++...+.+||.+|.+..+++.
T Consensus       219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -----CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                 12256778999999999999999999998874

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=338.75  Aligned_cols=273  Identities=25%  Similarity=0.279  Sum_probs=211.8

Q ss_pred             HHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEec--ccchhHHHHHHHHHHHhhccCCccceEEeEEec----
Q 048205          745 LFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS----  817 (1027)
Q Consensus       745 ~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----  817 (1027)
                      .+.....|...+.||+|+||.|+.|..+ +|+.||||.+..  +.....++..+|+++++.++|+||+.+.+.+..    
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            3445566777889999999999999865 799999999873  344456788899999999999999999999865    


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          818 -DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       818 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                       -..+|+|+|+|+ .+|...++..+. ++...+..+++|+++|++|+|   +.+|+|||+||+|++++.+..+||+|||+
T Consensus        97 ~f~DvYiV~elMe-tDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   97 KFNDVYLVFELME-TDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ccceeEEehhHHh-hHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence             346899999994 599998877553 888899999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh--h
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI--S  973 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~  973 (1027)
                      |+...........+.++.|.||+|||++.. ..|+.++||||+|||+.||++|++-|.+...- ..+.......+..  .
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILELLGTPSEE  250 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHhcCCCCHH
Confidence            997754433445678889999999998764 57999999999999999999999999875321 1111111111110  0


Q ss_pred             ---------HHHhhhccccCcc-chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 ---------IMEVVDANLLSHE-DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 ---------~~~~~d~~~~~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                               ....+ +.....+ ......-....+...+|+.+|+..||.+|+|++|+++.
T Consensus       251 ~l~~i~s~~ar~yi-~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  251 DLQKIRSEKARPYI-KSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHhccHHHHHHH-HhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                     11111 1111111 11122223667778999999999999999999999863

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=337.99  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=212.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .+.|.....||.|..++||+|+.. .++.||||++..+.. ...+.+.+|++.++.++||||++++..|..+...++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            356888899999999999999855 689999999987643 345888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||.+|++.+.+... ...+++..+..|.+++++||.|||   .+|.||||||+.||||+.+|.|||+|||.+..+...+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999988754 345899999999999999999999   99999999999999999999999999999876654332


Q ss_pred             c-cee-cccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          906 S-LTQ-TQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       906 ~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      . ... ...+||+.|||||++..  ..|+.|+||||||+...|+.+|..||....+-...+...-...+          .
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp----------~  251 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP----------T  251 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC----------C
Confidence            1 112 45689999999999543  46999999999999999999999999876443332222211100          0


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .. ...........+...+.+++..|+.+||++||||+++++
T Consensus       252 ~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00 011122334456668999999999999999999999886

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=326.19  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=207.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++.|++.+.||+|+|+.||++.+. +|+.+|+|++...  .....+.+++|+++-+.++||||+++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            355777889999999999998755 7999999988643  3446788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~  902 (1027)
                      |+|+|++|..-+-.+ ..+++..+-.++.||++|+.|||   .++|||||+||+|+++.   ...-+|++|||+|..+. 
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999996544333 45788899999999999999999   99999999999999994   45679999999999775 


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                        .......++|||+|||||++...+|+.++|||+.|||+|-++.|++||.+....+                 ++....
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-----------------lye~I~  225 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----------------LYEQIK  225 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-----------------HHHHHh
Confidence              2334567889999999999999999999999999999999999999997642211                 111111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..........+....++..+|+++|+..||.+|.|+.|+++
T Consensus       226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            11112222234566778899999999999999999999885

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6e-40  Score=332.14  Aligned_cols=266  Identities=25%  Similarity=0.275  Sum_probs=207.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccch--hHHHHHHHHHHHhhccCCccceEEeEEec--CCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV  824 (1027)
                      +.|+.++.|++|+||.||+|+++ +++.||+|+++.+...  .--...+|+.++.+.+|||||.+-.+...  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45778899999999999999976 7889999998755422  12345689999999999999999888755  4579999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||||+. +|..++......+...++..++.|+++|++|||   ...|+|||+||+|++++..|.+||+|||+|+.+..+ 
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            999987 999999988888999999999999999999999   888999999999999999999999999999988654 


Q ss_pred             CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------HHHh
Q 048205          905 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------IMEV  977 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~  977 (1027)
                       ....+..+.|.||+|||.+.+. .|+.++|+||+|||+.||+++++-|.+..+. ..+...+......+      +.+.
T Consensus       231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCCCcccc
Confidence             3445667889999999998875 5899999999999999999999998775322 22333333222111      1111


Q ss_pred             hhc---cccCcc----chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDA---NLLSHE----DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~---~~~~~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      -..   .....+    ...+... ..+..-++|+..++..||++|.||.|.++
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             chhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhc
Confidence            000   000000    0111111 13467789999999999999999999885

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-40  Score=375.02  Aligned_cols=252  Identities=31%  Similarity=0.513  Sum_probs=214.7

Q ss_pred             CCccceeeccccceEEEEEec------CCceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ....+.||+|+||+||+|+..      +...||||.++..... ..++|++|++++..++|||||+++|+|.+++..++|
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            445678999999999999743      3567999999866554 788999999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------c----cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          825 LEYMPYGSLEKCLYSSN---------Y----ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~---------~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                      +|||..|||.+++....         .    .++..+.++||.|||.|++||-   ++.+|||||..+|+||.++..|||
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEe
Confidence            99999999999986432         1    2788999999999999999999   999999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +|||+++.....+.........-..+|||||.+..++++.++||||+||+|||+++ |+.||.+....+  +        
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--V--------  714 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--V--------  714 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--H--------
Confidence            99999998766665554444556788999999999999999999999999999999 889987653221  1        


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                          .+.+.      .+...+.++.||.++++||..||+..|++||+++||-..|+
T Consensus       715 ----Ie~i~------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  715 ----IECIR------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             ----HHHHH------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence                11111      12235678899999999999999999999999999988876

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-40  Score=358.33  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=209.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      -|..++.||.|+.|.|..|++. +|+.+|||++.+..   ......+++|+-+|+-+.||||+++|+++++..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3677889999999999999965 89999999997552   2234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |++||.|.+++-+++. +++.++.+++.||+.|+.|||   ..+|+|||+||+|+++|..+.+||+|||+|..-. .+  
T Consensus        93 yv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~g--  165 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PG--  165 (786)
T ss_pred             ecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc-CC--
Confidence            9999999999987664 788888999999999999999   8999999999999999999999999999998432 22  


Q ss_pred             ceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      ..-...||+|.|.|||++.+.+| +.++||||+|||+|.++||+.||++.     ++.....         .+       
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLl---------KV-------  224 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLL---------KV-------  224 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHH---------HH-------
Confidence            23345689999999999999887 67899999999999999999999853     2222111         11       


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..+.++.|...+.+..+|+++|+..||++|.|++||+++
T Consensus       225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            223455567788899999999999999999999999874

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=315.78  Aligned_cols=249  Identities=25%  Similarity=0.331  Sum_probs=210.5

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      +.++|.+++.||+|.||.||.|+.+ ++-.||+|++.+..   ....+++.+|+++-+.++||||.++|++|.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3467999999999999999999965 67789999986542   3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          824 VLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ++||.++|++...+..+. ..+++.....++.|+|.|+.|||   ..+|+||||||+|+|++.++.+|++|||.+..-. 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999988544 45889999999999999999999   9999999999999999999999999999997432 


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                         .......+||..|.|||...+..++..+|+|++|++.||++.|.+||.... ....+.+..+       .++.+   
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k-------~~~~~---  241 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK-------VDLKF---  241 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH-------ccccC---
Confidence               334456789999999999999999999999999999999999999998754 2222222211       11122   


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                                +...+.+..++|.+|+.++|.+|.+..|+++.
T Consensus       242 ----------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 ----------PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                      23456668899999999999999999999864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=357.49  Aligned_cols=243  Identities=22%  Similarity=0.300  Sum_probs=205.1

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  822 (1027)
                      ..++|...++||+|+||+|++|..+ +++.||||++++..   ...++..+.|.+++.... ||.++.++..|+++++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3467999999999999999999976 68899999998763   345677888888888774 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      .||||+.||++..+.+  ...+++..+.-+|..|+.||+|||   ++||||||||-+|||+|.+|.+||+|||+++.-..
T Consensus       446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            9999999999544433  345899999999999999999999   99999999999999999999999999999996432


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                        ....++..+|||.|||||++.+..|+.++|+|||||++|||+.|+.||.+..++                 |++|..+
T Consensus       521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~FdsI~  581 (694)
T KOG0694|consen  521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDSIV  581 (694)
T ss_pred             --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHh
Confidence              233667889999999999999999999999999999999999999999875332                 2222222


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                      ...    ...|..++.+..+++++++.++|++|.-+
T Consensus       582 ~d~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 NDE----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cCC----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            211    12344677888999999999999999865

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-38  Score=359.29  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=202.7

Q ss_pred             hCCCCccceeeccccceEEEEEe------cCCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecC-C
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI------QDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD-D  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  819 (1027)
                      .++|++.+.||+|+||.||+|++      .+++.||||++.... ....+.+..|++++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46789999999999999999974      235689999986433 23346788899999999 899999999988764 4


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN----------------------------------------------------------  841 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  841 (1027)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6889999999999999886432                                                          


Q ss_pred             ---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccc
Q 048205          842 ---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY  918 (1027)
Q Consensus       842 ---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  918 (1027)
                         ..+++.++..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               23677888999999999999999   999999999999999999999999999999865432222222233466789


Q ss_pred             cCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhH
Q 048205          919 MAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCM  997 (1027)
Q Consensus       919 ~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  997 (1027)
                      +|||++.+..++.++|||||||++|||++ |..||......+. +..           .+.+...       ...+..++
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~-----------~~~~~~~-------~~~~~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQ-----------RLKDGTR-------MRAPENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHH-----------HHhcCCC-------CCCCCCCC
Confidence            99999998899999999999999999997 9999876432211 111           0011100       01123456


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          998 SFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       998 ~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .++.+++.+||+.||++||++.|+++.|+
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~  332 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILG  332 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            77899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-39  Score=330.42  Aligned_cols=246  Identities=22%  Similarity=0.308  Sum_probs=205.7

Q ss_pred             CCCCccceeeccccceEEEEEe-cCCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .+|.+.+.||+|.||.|-+|+. ..|+.||||.+++..-   +..-.+.+|+++|+.++||||+++|.+|+..+..+|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4566778899999999999984 6899999999976543   33446788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||..+|.|.||+..++. +++.++.+++.||..|+.|||   .+++||||+|.+||++|.++.+||+|||++..+..   
T Consensus       133 EYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---  205 (668)
T ss_pred             EecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc---
Confidence            99999999999987654 899999999999999999999   99999999999999999999999999999987643   


Q ss_pred             cceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      ......+||+|-|.+||++.+.+| ++.+|.||+||++|.++.|..||++..     ....++..-         .....
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs---------~GaYr  271 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQIS---------RGAYR  271 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhh---------ccccc
Confidence            234466899999999999999887 678999999999999999999998752     222222211         11111


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .        ..-+.+..-||+.|+..+|++|.|..+|...
T Consensus       272 E--------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  272 E--------PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             C--------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            1        1223445679999999999999999998753

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=340.76  Aligned_cols=249  Identities=28%  Similarity=0.380  Sum_probs=210.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ..|+..+.||+|+||.||+|... +++.||+|+++.+.. ..+.++..|+.++.+++++||.++|+.|..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777789999999999999855 789999999987654 3467888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +.||++.+.+..... +++..+.-|+.+++.|+.|+|   .++.+|||||+.||++..+|.+|++|||.+..+....  .
T Consensus        93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--K  166 (467)
T ss_pred             hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh--h
Confidence            999999998877653 478888889999999999999   9999999999999999999999999999998775433  2


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....+|||.|||||++....|+.|+||||||++.+||++|.+|+....+..-              .-.+.+    ...
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--------------lflIpk----~~P  228 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--------------LFLIPK----SAP  228 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------------EEeccC----CCC
Confidence            33678999999999999988999999999999999999999999876533110              000111    111


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      +..+  ..+++.+++++..|+.++|+.||+|.++++.
T Consensus       229 P~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 PRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             Cccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1222  2677789999999999999999999999864

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-38  Score=328.54  Aligned_cols=268  Identities=28%  Similarity=0.315  Sum_probs=206.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccch--hHHHHHHHHHHHhhccCCc-cceEEeEEecCC------
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRN-IIKFISSCSSDD------  819 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  819 (1027)
                      ..|...++||+|+||+||+|+.+ +|+.||+|+++.+..+  .-....+|+.+++.++|+| |+.+++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34566678999999999999965 7899999999866442  3456678999999999999 999999998877      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                      ..++||||++. +|.+++....   ...+...+..++.|+++|++|||   +++|+||||||.||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            88999999976 9999998765   35777889999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--  973 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  973 (1027)
                      |+.+.-+  ....+..++|.+|+|||++.+. .|+..+||||+|||++||+++++-|.+..+ ...+...........  
T Consensus       167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCcc
Confidence            9965422  2235667899999999998876 689999999999999999999998877533 222222222221110  


Q ss_pred             ----HHHhhhccccC-ccc-hh--hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 ----IMEVVDANLLS-HED-KH--FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 ----~~~~~d~~~~~-~~~-~~--~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          .....+..... ... ..  .........+..+++.+|++.+|.+|.|++.++.+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                11111111100 000 00  00111122478899999999999999999999874

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-39  Score=347.45  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=214.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCe-eEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF-KALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lV~  825 (1027)
                      ++|..++.+|+|+||.++.++++ +++.||+|.+....  .........|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888899999999999999876 68899999987543  3334467789999999999999999999999988 99999


Q ss_pred             EecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          826 EYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +|++||++.+.+.+.+ ..+++..+..++.|++.|+.|||   +..|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998776 67899999999999999999999   9999999999999999999999999999999876543


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                        ......+||+.||.||++.+.+|..|+||||+||++|||++-+++|.+....     ..+..        +....   
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~k--------i~~~~---  222 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELILK--------INRGL---  222 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHHH--------Hhhcc---
Confidence              2455678999999999999999999999999999999999999999875322     11111        11111   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          ..+.+..++.++..+|..|+..+|+.||++.+++.+
T Consensus       223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                123445678889999999999999999999999874

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-38  Score=326.70  Aligned_cols=252  Identities=27%  Similarity=0.358  Sum_probs=206.9

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ..|+..+.||+|.-|+||+|+.+ ++..+|+|+++++.-   +...+...|-+||+.++||.++.+|+.++.+...|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34667789999999999999977 468999999987643   33456667999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC-
Q 048205          826 EYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-  903 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~-  903 (1027)
                      |||+||+|..+.+++. ..+++..++-++.+|+.||+|||   -.|||+|||||+|||+.++|++-++||.++...... 
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999887764 66899999999999999999999   999999999999999999999999999998543210 


Q ss_pred             --------------------------------CC---------------------cceecccccCccccCcccccCCCCC
Q 048205          904 --------------------------------DQ---------------------SLTQTQTLATIGYMAPEYGREGRVS  930 (1027)
Q Consensus       904 --------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~  930 (1027)
                                                      ..                     .......+||-+|.|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                            00                     0112245689999999999999999


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhccc
Q 048205          931 TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIE 1010 (1027)
Q Consensus       931 ~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~ 1010 (1027)
                      .++|+|+|||++|||+.|..||.+.... ..+..            ++-+.+      .++.....+.++.+||++.|.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~N------------Iv~~~l------~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRN------------IVGQPL------KFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHH------------HhcCCC------cCCCCCcchhHHHHHHHHHhcc
Confidence            9999999999999999999999986433 22222            222222      2222235667889999999999


Q ss_pred             CCCCCCC----HHHHHH
Q 048205         1011 SPEERIN----AKEIVT 1023 (1027)
Q Consensus      1011 dP~~Rps----~~evl~ 1023 (1027)
                      ||.+|..    |+||-+
T Consensus       375 dP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ChhhhhccccchHHhhc
Confidence            9999997    777654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-37  Score=344.06  Aligned_cols=262  Identities=24%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             CCCCccceeeccccceEEEEEecC-----------------CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD-----------------GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKF  811 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  811 (1027)
                      .+|++.+.||+|+||.||+|++.+                 +..||+|++.... ....+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            468889999999999999997532                 3469999987543 3345678899999999999999999


Q ss_pred             EeEEecCCeeEEEEEecCCCCHHHHHhcCC------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 048205          812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSN------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIH  873 (1027)
Q Consensus       812 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  873 (1027)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++.++..++.||+.|++|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999885432                  23677889999999999999999   999999


Q ss_pred             ccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCC
Q 048205          874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--RKKP  951 (1027)
Q Consensus       874 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p  951 (1027)
                      |||||+||+++.++.+||+|||+++.+.............++..|+|||++..+.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543332222233445788999999988899999999999999999987  4566


Q ss_pred             CCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          952 TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      |.....  .....++...        ......   ......+..++..+.+++.+||..||++|||+.||.+.|+.
T Consensus       242 ~~~~~~--~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTD--EQVIENAGEF--------FRDQGR---QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCH--HHHHHHHHHH--------hhhccc---cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            654321  1111111111        000000   00011123467789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-38  Score=329.89  Aligned_cols=261  Identities=26%  Similarity=0.350  Sum_probs=205.4

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC-----eeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-----FKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lV  824 (1027)
                      .|...+++|.|+||.||+|... +++.||||.+-.+..    --.+|+++|+.++|||||++..+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666789999999999999966 578999998753321    2236999999999999999998885532     34589


Q ss_pred             EEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCCccc
Q 048205          825 LEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPF  900 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~  900 (1027)
                      ||||+. +|.+.++.   .+..++...+.-++.||++|++|||   +.+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 99998874   2455778888889999999999999   8999999999999999976 99999999999987


Q ss_pred             ccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ......   ..+..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+ .++...+...++.....+..++-.
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhh
Confidence            655443   345678899999988875 689999999999999999999999987 455666777777766544333321


Q ss_pred             ccc----------cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          980 ANL----------LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       980 ~~~----------~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      -..          ....-.+ ......+++..+++.+++.++|.+|.++.|++.+
T Consensus       253 mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            111          1111101 1234567889999999999999999999998753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-38  Score=330.62  Aligned_cols=255  Identities=28%  Similarity=0.383  Sum_probs=200.3

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------------hhHHHHHHHHHHHhhccCCccceE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------------RAIKSFDIECGMIKRIRHRNIIKF  811 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l  811 (1027)
                      ...++|.+.+.||+|.||.|.+|+.. +++.||||++.+...              ...+.+.+|+.++++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999966 799999999975421              123578899999999999999999


Q ss_pred             EeEEecC--CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          812 ISSCSSD--DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       812 ~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      +++..++  +.+|+|+|||..|.+...= ..+..+.+.+++.++.+++.||+|||   .+||+||||||+|+|++++|+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence            9999764  6899999999998875531 11222889999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCC---CcceecccccCccccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhH
Q 048205          890 HLSDFGMAKPFLKED---QSLTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL  962 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~  962 (1027)
                      ||+|||.+.......   ........+|||.|+|||...++.    .+.+.||||+||.||.|+.|+.||.+...-+   
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---  326 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---  326 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH---
Confidence            999999998653221   111223368999999999988743    3678899999999999999999998642211   


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                                ....++...+....      .++....+.+|+.+||.+||+.|.+..+|..+
T Consensus       327 ----------l~~KIvn~pL~fP~------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  327 ----------LFDKIVNDPLEFPE------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ----------HHHHHhcCcccCCC------cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence                      11222222222221      12456678999999999999999999988643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=341.16  Aligned_cols=240  Identities=27%  Similarity=0.435  Sum_probs=203.0

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      ..++-+|.|+.|.||+|+.+ ++.||||+++       +.-+.+++-+++++||||+.+.|+|.....++||||||..|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34567999999999999986 6889999865       222347788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceeccc
Q 048205          833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT  912 (1027)
Q Consensus       833 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  912 (1027)
                      |...++..+. +.....+.+..+||.|+.|||   .+.|||||||.-||||+.+..|||+|||-++.....   .....+
T Consensus       199 L~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  199 LYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            9999987654 677778899999999999999   999999999999999999999999999999865332   344567


Q ss_pred             ccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhH
Q 048205          913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVA  992 (1027)
Q Consensus       913 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  992 (1027)
                      +||..|||||++...+.+.|+||||||||||||+||..||.......+   -|               .+. .-.-..+.
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---Iw---------------GVG-sNsL~Lpv  332 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IW---------------GVG-SNSLHLPV  332 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---EE---------------ecc-CCcccccC
Confidence            899999999999999999999999999999999999999986532211   00               110 11123456


Q ss_pred             HhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          993 KEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       993 ~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +..|+..++-|+.+||..-|..||++++++.+|+
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            7789999999999999999999999999998774

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=375.62  Aligned_cols=463  Identities=29%  Similarity=0.383  Sum_probs=327.6

Q ss_pred             CCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeecc
Q 048205          124 LLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQ  203 (1027)
Q Consensus       124 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  203 (1027)
                      +|+.|++++|++. ..|..+..+.+|+.|.++.|.|. ..|.+..++.+|++|.|..|++. ..|..+..+.+|++|+++
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS  122 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence            3555555555554 45556666666666666666665 45566666666666666666666 566666666666666666


Q ss_pred             ccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCC
Q 048205          204 NNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTI  283 (1027)
Q Consensus       204 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  283 (1027)
                      .|++. .+|..+..++.+..++.++|....              .++.      ..++.+++..|.+.+.++        
T Consensus       123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~--------------~lg~------~~ik~~~l~~n~l~~~~~--------  173 (1081)
T KOG0618|consen  123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQ--------------RLGQ------TSIKKLDLRLNVLGGSFL--------  173 (1081)
T ss_pred             hhccC-CCchhHHhhhHHHHHhhhcchhhh--------------hhcc------ccchhhhhhhhhcccchh--------
Confidence            66665 566666666666666666662110              1111      114555666666655333        


Q ss_pred             CccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCC
Q 048205          284 PKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRL  363 (1027)
Q Consensus       284 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l  363 (1027)
                       .++..++.  .|+|++|++.   -..+..+.+|+.|....|++....    ..-++|+.|+.++|.++...+..   .-
T Consensus       174 -~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p---~p  240 (1081)
T KOG0618|consen  174 -IDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP---VP  240 (1081)
T ss_pred             -cchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecccc---cc
Confidence             23333333  5777777765   234566677777777777776432    23457778888888776322221   12


Q ss_pred             CCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCcccccccccccccc
Q 048205          364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLE  443 (1027)
Q Consensus       364 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~  443 (1027)
                      .+|+++++++|+++ .+|+++..+.+|+.|+..+|+++ .+|..+...++|+.|+...|.+..+|..+.     .++.|+
T Consensus       241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le-----~~~sL~  313 (1081)
T KOG0618|consen  241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLE-----GLKSLR  313 (1081)
T ss_pred             ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCccc-----ccceee
Confidence            46888888888887 56688888888888888888885 567777778888888888888887777654     457788


Q ss_pred             EeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCc
Q 048205          444 YFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDN  523 (1027)
Q Consensus       444 ~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  523 (1027)
                      +|+|..|+|...++..+..+..++..++-+.|.+...---.=.....|+.|++.+|.++...-+.+.+.++|++|+|++|
T Consensus       314 tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyN  393 (1081)
T KOG0618|consen  314 TLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYN  393 (1081)
T ss_pred             eeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccc
Confidence            88888888888777777777676777777777776432222235578999999999999988889999999999999999


Q ss_pred             eeecccCCCCCccccccccCc-cccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccE
Q 048205          524 QLEGSIPDNLSFSCTLTSIPS-TLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY  602 (1027)
Q Consensus       524 ~l~g~~p~~~~~~~~~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~  602 (1027)
                      +|              .++|+ .+.++..|+.|+||+|+++ .+|+++.++..|++|...+|++. ..| ++..++.|+.
T Consensus       394 rL--------------~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~  456 (1081)
T KOG0618|consen  394 RL--------------NSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKV  456 (1081)
T ss_pred             cc--------------ccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceE
Confidence            98              35563 4668999999999999999 59999999999999999999998 678 8999999999


Q ss_pred             EEccCCcccc-CccccccccccccccccccccccCCchhhhhcccCCcceeccCC
Q 048205          603 LFLKYNRLQG-SIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN  656 (1027)
Q Consensus       603 L~L~~N~l~g-~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N  656 (1027)
                      +|+|.|+|+- .+|.... -++|++|||++|.-.-.--..|..+..++.+++.-|
T Consensus       457 lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  457 LDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             EecccchhhhhhhhhhCC-CcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            9999999984 3444332 289999999999843344456777778888887766

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-37  Score=353.15  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=203.2

Q ss_pred             CCCCccceeeccccceEEEEEe------cCCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARI------QDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      ++|+..+.||+|+||.||+|++      .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688889999999999999974      235689999986432 33456788899999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC------------------------------------------------------------
Q 048205          822 ALVLEYMPYGSLEKCLYSSN------------------------------------------------------------  841 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------  841 (1027)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999886422                                                            


Q ss_pred             --------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          842 --------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       842 --------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                                    ..+++..+..++.||++|++|||   +.+|+||||||+||+++.++.+||+|||+++.+.......
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                          14678889999999999999999   9999999999999999999999999999998654332211


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....++            .....   
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~------------~~~~~---  335 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMI------------KEGYR---  335 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHH------------HhCcc---
Confidence            2222335677999999999999999999999999999998 888886542221 111111            11100   


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                         ...+...+.++.+++.+||..||++||++.|+++.|++
T Consensus       336 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 ---MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               01112345678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.8e-37  Score=338.31  Aligned_cols=243  Identities=22%  Similarity=0.281  Sum_probs=198.2

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccch---hHHHHHHHHHHHhhccCCccceEEeEEec----CCeeEEEEEe
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR---AIKSFDIECGMIKRIRHRNIIKFISSCSS----DDFKALVLEY  827 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~  827 (1027)
                      ...||+|++|.||+|++ +|+.||||+++.....   ..+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999987 6899999998754322   25678899999999999999999999876    3578999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++|+|.+++.... .+++..+..++.+++.|++|||   + .+++||||||+||+++.++.+||+|||+++.+...   
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---  176 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---  176 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence            99999999997654 5889999999999999999999   6 48899999999999999999999999999854321   


Q ss_pred             ceecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          907 LTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                        .....+++.|+|||++.+  ..++.++|||||||++|||++|+.||......     .+...        +....   
T Consensus       177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~~--------i~~~~---  238 (283)
T PHA02988        177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYDL--------IINKN---  238 (283)
T ss_pred             --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHHH--------HHhcC---
Confidence              123457899999999876  67899999999999999999999999764221     11110        00000   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         .....+..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       239 ---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        239 ---NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             ---CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence               011122346778999999999999999999999999886

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-37  Score=339.32  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=201.8

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .|+..+.||+|+||+||+|... +|+.||+|++....   ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999865 79999999987542   1223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999998876533 45899999999999999999999   9999999999999999999999999999998643221 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....             +..... 
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~-------------~~~~~~-  219 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEV-------------DRRVKE-  219 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHH-------------HHHhhc-
Confidence              22345689999999999999999999999999999999999999986432211 0010             000000 


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                        .....+..++.++.+|+.+||..||++||+     ++++++
T Consensus       220 --~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 --DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              001112345667899999999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.1e-37  Score=338.08  Aligned_cols=268  Identities=20%  Similarity=0.214  Sum_probs=204.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|++.+.||+|+||+||+|+++ +++.||||++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999976 68899999987542  2334667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |++++.+..+. .....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            99987766544 33445889999999999999999999   9999999999999999999999999999998653222 1


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh---hhHHHhh-hcc-
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL---ISIMEVV-DAN-  981 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~-d~~-  981 (1027)
                      .......|++.|+|||++.+..++.++||||+||++|||++|++||......+ ...........   ....... ++. 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchh
Confidence            22234568999999999998889999999999999999999999997642211 11111110000   0000000 000 


Q ss_pred             -------ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 -------LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 -------~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                             ..............++.++.+++.+|+++||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                   000000011112235678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5e-37  Score=337.89  Aligned_cols=269  Identities=22%  Similarity=0.278  Sum_probs=204.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            356899999999999999999866 689999999875432 234467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++ +|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9985 999988776666889999999999999999999   9999999999999999999999999999997543221  


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---hHHHhhh---
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---SIMEVVD---  979 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d---  979 (1027)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|++||......+ .+..........   ...++.+   
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchh
Confidence            12233468899999998865 568999999999999999999999997643221 111111111000   0000000   


Q ss_pred             --ccccCc--cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          980 --ANLLSH--EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       980 --~~~~~~--~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        ......  ...........+.+..+++.+|+.+||.+|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000  001111122456678999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-37  Score=346.31  Aligned_cols=241  Identities=23%  Similarity=0.307  Sum_probs=197.8

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999997542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecc
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ  911 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  911 (1027)
                      +|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999887644 5789999999999999999999   9999999999999999999999999999987532221  12334


Q ss_pred             cccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhh
Q 048205          912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV  991 (1027)
Q Consensus       912 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  991 (1027)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....           +....        ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~-----------~~~~~--------~~  213 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL-----------ILMEE--------IR  213 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHH-----------HHcCC--------CC
Confidence            569999999999999999999999999999999999999997542111  1110           00000        01


Q ss_pred             HHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          992 AKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       992 ~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      .+...+.++.+++.+|++.||++||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1234567789999999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=341.89  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   .+..+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999976 68999999987532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999987654 4788999999999999999999   999999999999999999999999999999865321  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+....    
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~--------~i~~~~----  214 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYE--------KILAGK----  214 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--------HHHhCC----
Confidence               12346899999999999988999999999999999999999999764211     1111        011110    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~~ 1024 (1027)
                          ...+...+..+.+++.+|+..||.+||+     +.|+++.
T Consensus       215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                0111234566889999999999999995     8888753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=306.15  Aligned_cols=258  Identities=22%  Similarity=0.300  Sum_probs=207.4

Q ss_pred             hCCCCccceeeccccceEEEEE-ecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecC-----CeeE
Q 048205          749 TNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----DFKA  822 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  822 (1027)
                      .++|++.+.+|+|+|+.||.++ ..+++.||+|++.-...+..+...+|++..++++|||+++++++...+     .+.|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4678899999999999999998 557899999999877777788899999999999999999999887443     3589


Q ss_pred             EEEEecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          823 LVLEYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                      ++++|...|+|.+.+...   +..+++.+.++|+.+|++||++||   +..  ++||||||.||++++++.+++.|||.+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            999999999999988654   356899999999999999999999   665  999999999999999999999999999


Q ss_pred             cccccCCCc-------ceecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHH
Q 048205          898 KPFLKEDQS-------LTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVN  967 (1027)
Q Consensus       898 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  967 (1027)
                      +...-.-..       ........|..|+|||.+.   +...+.++|||||||++|+|+.|..||+.....+.++.-   
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---  253 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---  253 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE---
Confidence            865311100       0111223688999999876   345789999999999999999999999876443322211   


Q ss_pred             HHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          968 DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       968 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                              .+....      ..++....++..+.+++.+|++.||.+||++.+++..+.
T Consensus       254 --------Av~n~q------~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  254 --------AVQNAQ------ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             --------eeeccc------cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence                    111111      122222347788999999999999999999999998875

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.2e-37  Score=339.91  Aligned_cols=269  Identities=22%  Similarity=0.264  Sum_probs=202.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 689999999875432 223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |++ +++.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            996 5888888766666889999999999999999999   9999999999999999999999999999987543221  


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH------HH--h
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI------ME--V  977 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~--~  977 (1027)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+....+............      ..  .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22234568999999998865 457889999999999999999999998643322222111111100000      00  0


Q ss_pred             hhccccCc-cch---hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSH-EDK---HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~-~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .++..... ...   ........+.++.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000 000   00011123456889999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.3e-38  Score=308.01  Aligned_cols=251  Identities=28%  Similarity=0.392  Sum_probs=205.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------hhHHHHHHHHHHHhhc-cCCccceEEeEEecCC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD  819 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  819 (1027)
                      +.|...+.+|+|..++|.++.++ +|+++|+|++.....        +..+....|+.+++++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45778889999999999998765 789999999864311        1234556799999998 5999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++|+|.|+.|.|.|++.+.- .++++...+|+.|+.+|++|||   .+.|||||+||+||++|++.++||+|||+|+.
T Consensus        97 F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeec
Confidence            9999999999999999997654 4899999999999999999999   99999999999999999999999999999998


Q ss_pred             cccCCCcceecccccCccccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      +.+..   .....||||+|.|||.+.      ...|+..+|+||+|||+|.++.|.+||--.  ..+.+..         
T Consensus       173 l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR---------  238 (411)
T KOG0599|consen  173 LEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLR---------  238 (411)
T ss_pred             cCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHH---------
Confidence            75543   345678999999999876      246889999999999999999999998532  1111111         


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        -+..    ....-..+.+.+.+....+||.+|++.||.+|.|++|+++.
T Consensus       239 --~Ime----GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  239 --MIME----GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             --HHHh----cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence              0111    11122334566778889999999999999999999999863

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.2e-37  Score=351.04  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=202.5

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      ++|++.+.||+|+||.||+|++.      +++.||||+++... ......+.+|+++++.+ +||||++++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46888999999999999999743      24579999987543 33346688899999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC------------------------------------------------------------
Q 048205          822 ALVLEYMPYGSLEKCLYSSN------------------------------------------------------------  841 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------  841 (1027)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885421                                                            


Q ss_pred             ---------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceeccc
Q 048205          842 ---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT  912 (1027)
Q Consensus       842 ---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  912 (1027)
                               ..+++.++.+++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++.+............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     23678889999999999999999   999999999999999999999999999999865433222122223


Q ss_pred             ccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhh
Q 048205          913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV  991 (1027)
Q Consensus       913 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  991 (1027)
                      .+++.|+|||++....++.++||||+||++|||++ |+.||........ ...            ......      ...
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~------------~~~~~~------~~~  335 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYK------------MVKRGY------QMS  335 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHH------------HHHccc------Ccc
Confidence            35678999999998899999999999999999997 9999876432211 111            011100      001


Q ss_pred             HHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          992 AKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       992 ~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .+...+.++.+++.+||+.||++||++.++++.|+
T Consensus       336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ  370 (374)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11224567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=346.08  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||.||+|++. +++.||||++....   ....+.+..|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999976 58999999997542   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999987654 4788999999999999999999   99999999999999999999999999999985432   


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. .... .   .  ..........  
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i-~---~--~~~~~~~~~~--  222 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENL-K---Y--WKETLQRPVY--  222 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHH-H---h--ccccccCCCC--
Confidence              23345799999999999998999999999999999999999999976422111 0000 0   0  0000000000  


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          ......++.++.+++.+|+..+|++||++.++++.
T Consensus       223 ----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 ----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                00012356778999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-37  Score=346.34  Aligned_cols=244  Identities=21%  Similarity=0.284  Sum_probs=201.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999976 68999999987542   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            9999999999987654 4788889999999999999999   999999999999999999999999999999865322  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||......    ..+ .        .+....    
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~-~--------~i~~~~----  231 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY-E--------KILAGR----  231 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHH-H--------HHhcCC----
Confidence               12346899999999999999999999999999999999999999753211    100 0        011111    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                          ...+..++..+.+++.+||+.||++||+     +++++.
T Consensus       232 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        232 ----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                0111234566889999999999999996     677764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=367.10  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=213.3

Q ss_pred             CCCCccceeeccccceEEEEEecC--Cc----eEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD--GM----EVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ..-+..+.||+|+||+||.|...+  |.    .||||.+.+. ..+...+|.+|..+|++++|||||+++|+|-+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345567889999999999998653  43    4899988754 3455788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcC------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          823 LVLEYMPYGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                      |++|||.+|+|..+++..      ...+.....+.++.|||+|+.||+   ++++|||||..+|+|++....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999887      567899999999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      |+.+...+.........-...|||||.+..+.++.|+|||||||++||++| |..||...... ..+..|.         
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~---------  918 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVL---------  918 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHH---------
Confidence            996654444333333234578999999999999999999999999999999 77787654221 1111111         


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                ...+.+.+..|+..++++|..||+.+|++||++..+++.++
T Consensus       919 ----------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  919 ----------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             ----------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence                      12266777899999999999999999999999999998765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.2e-37  Score=332.64  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=205.2

Q ss_pred             CCCCccceeeccccceEEEEEec----CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++.... .....+.+|++++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999754    356899999875432 3345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++......+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999876666899999999999999999999   9999999999999999999999999999876432111


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                       ........++..|+|||.+.+..++.++||||+||++||+++ |+.||......  .....           +.+ .. 
T Consensus       162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~-----------~~~-~~-  225 (266)
T cd05064         162 -IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA-----------VED-GF-  225 (266)
T ss_pred             -hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH-----------HHC-CC-
Confidence             111112235678999999999999999999999999999775 99998754211  11111           001 00 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                           ....+..++..+.+++.+||+.+|++||++.++.+.|++
T Consensus       226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                 111234567789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=344.70  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=207.9

Q ss_pred             CCCCccceeeccccceEEEEEecC--C--ce-EEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD--G--ME-VAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      ++....+.||+|+||+||+|+++.  +  .. ||||..+..   .....+++..|++++++++|||||++||++......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            344455899999999999998653  2  23 899988742   355678899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++|||+|+||+|.+++...+..++..++..++.++|+||+|||   +.+++||||-++|+|++.++.+||+|||+++.-.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            9999999999999999988777999999999999999999999   9999999999999999999999999999988432


Q ss_pred             cCCCcceec-ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          902 KEDQSLTQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       902 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                         ...... ...-...|+|||.+..+.++.++|||||||++||+++ |..||.+....  ....|+.            
T Consensus       314 ---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~------------  376 (474)
T KOG0194|consen  314 ---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV------------  376 (474)
T ss_pred             ---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH------------
Confidence               111111 2235678999999999999999999999999999999 78898775322  2233221            


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           ....+...+...+.++..++.+||..+|++||+|.++.+.++
T Consensus       377 -----~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  377 -----KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             -----hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence                 011122333467788999999999999999999999999876

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.1e-36  Score=339.67  Aligned_cols=264  Identities=23%  Similarity=0.339  Sum_probs=205.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||.||+|++. +|..||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999976 688999999876532 345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999987654 4789999999999999999999   65 6999999999999999999999999999755321  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--------------
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--------------  971 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------  971 (1027)
                        ......|++.|+|||++.+..++.++||||+||++|||++|+.||......+  +.........              
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccc
Confidence              2234568999999999999899999999999999999999999997542211  1111100000              


Q ss_pred             -----------------hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          972 -----------------ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       972 -----------------~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                                       ....+..+..... ..... ....++.++.+++.+||++||++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPKL-PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhC-CCcCC-CCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                             0000000000000 00000 011356779999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=325.57  Aligned_cols=245  Identities=24%  Similarity=0.351  Sum_probs=209.5

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccch--hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      |...+.||+|.|.+|-+|++- +|+.||||++++..-.  ....+..|++.|+-++|||||++|++......+|+|.|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            666788999999999999865 8999999999866433  3456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|+||+.++...+.+.-+.+++.||+.|+.|||   +..|||||+||+||++. .-|-||++|||++..+.+..   
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---  173 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---  173 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence            999999999998888999999999999999999999   88899999999998875 56899999999999876543   


Q ss_pred             eecccccCccccCcccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      .....||+..|-|||++.+..|+ +++||||+|||+|-+++|++||....+.+.             +.-+.|=      
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDC------  234 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDC------  234 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcc------
Confidence            34567899999999999998875 578999999999999999999987655432             1112221      


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .+..|...+.++.+||..|+..||++|.+.+||..
T Consensus       235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence              12334567788999999999999999999999864

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-36  Score=328.14  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=204.5

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      ++|+..+.||+|+||.||+|+++++..+|+|.+.... ...+.+..|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4578889999999999999999888899999876432 234678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|++|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eecc
Confidence            99999998765556899999999999999999999   9999999999999999999999999999998653221 1112


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....++..|+|||+.....++.++||||+|+++|||++ |+.||......  ....++           .....      
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i-----------~~~~~------  219 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMI-----------SRGFR------  219 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH-----------HCCCC------
Confidence            22335668999999988889999999999999999999 89998653211  111111           00000      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ...+...+.++.+++.+||.++|++||++.++++.|.
T Consensus       220 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 -LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             0111234567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-37  Score=331.30  Aligned_cols=248  Identities=34%  Similarity=0.564  Sum_probs=196.7

Q ss_pred             cceeeccccceEEEEEec-----CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          755 NNLIGRGGFGFVYKARIQ-----DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+.||.|+||.||+|++.     .+..|+||++..... +..+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            568999999999999977     256799999965333 34688999999999999999999999999888899999999


Q ss_pred             CCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+++... ...+++.++..|+.||++||+|||   +.+++|+||+++||+++.++.+||+|||+++.........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999887 566899999999999999999999   8999999999999999999999999999998763333333


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ..........|+|||.+....++.++||||||+++||+++ |+.||......     ++...         +...     
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----~~~~~---------~~~~-----  221 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----EIIEK---------LKQG-----  221 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----HHHHH---------HHTT-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccc---------cccc-----
Confidence            3344456788999999999999999999999999999999 67887654211     11111         1010     


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L 1025 (1027)
                       .....+..++..+.+++.+||..+|++||+++++++.|
T Consensus       222 -~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 -QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             11222345677899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-36  Score=341.62  Aligned_cols=266  Identities=21%  Similarity=0.284  Sum_probs=198.6

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC-----CeeE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----DFKA  822 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  822 (1027)
                      +|+..+.||+|+||.||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999865 68999999986432  23345678899999999999999999988543     2479


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+. ++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 58999887554 4899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCC-cceecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH---------
Q 048205          903 EDQ-SLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL---------  970 (1027)
Q Consensus       903 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------  970 (1027)
                      ... ........||+.|+|||++.+  ..++.++||||+||++|||++|++||......  ....++....         
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence            221 112234578999999999875  67899999999999999999999999764221  1111111100         


Q ss_pred             ---hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 ---LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ---~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         .....+....................+..+.+++.+|++.||++||+++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               00000111100000011111111235567899999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=356.06  Aligned_cols=250  Identities=22%  Similarity=0.262  Sum_probs=204.4

Q ss_pred             CCCccceeeccccceEEEEEec-C-CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-D-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888899999999999999754 4 6789999876555555567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          829 PYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       829 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ++|+|.+++...   ...+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999987642   345889999999999999999999   99999999999999999999999999999986643322


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......     .....        +......  
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~--------~~~~~~~--  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQ--------VLYGKYD--  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH--------HHhCCCC--
Confidence            22234456999999999999999999999999999999999999999753211     11110        0000000  


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ..+..++.++.+++.+||..||++||++.+++.
T Consensus       290 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 -----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                 112245667899999999999999999999875

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-36  Score=340.59  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=197.1

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecc
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ  911 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  911 (1027)
                      +|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9998886654 5889999999999999999999   9999999999999999999999999999987532221  12234


Q ss_pred             cccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhh
Q 048205          912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV  991 (1027)
Q Consensus       912 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  991 (1027)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...            +....        ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~------------~~~~~--------~~  213 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FEL------------ILMEE--------IR  213 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHH------------HhcCC--------CC
Confidence            5689999999999999999999999999999999999999975422110 000            00000        01


Q ss_pred             HHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          992 AKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       992 ~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      .+..++.++.+++.+|+.+||++||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            1234567789999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-36  Score=338.20  Aligned_cols=253  Identities=23%  Similarity=0.376  Sum_probs=204.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCc----eEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGM----EVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..+.||+|+||.||+|++. +++    .||+|+++... ....+.+.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56899999999999999999864 343    48999986443 33456788899999999999999999999765 5689


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+||+++|+|.+++......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999876543


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..........++..|+|||++.+..++.++|||||||++||+++ |+.||......+  ...+            .....
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~------------~~~~~  228 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI------------LEKGE  228 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH------------HhCCC
Confidence            33222223335678999999999999999999999999999998 999987532111  1111            11110


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++.++.+++.+||..+|++||++.+++..+.
T Consensus       229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                  11112345667899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-36  Score=340.45  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=198.0

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542   234567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecc
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ  911 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  911 (1027)
                      +|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            9998886643 5889999999999999999999   999999999999999999999999999998753221  112234


Q ss_pred             cccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhh
Q 048205          912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV  991 (1027)
Q Consensus       912 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  991 (1027)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||......     ......         ..       ....
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~---------~~-------~~~~  213 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI---------LM-------EDIK  213 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHh---------cc-------CCcc
Confidence            56999999999999889999999999999999999999999753211     111100         00       0011


Q ss_pred             HHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048205          992 AKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVTK 1024 (1027)
Q Consensus       992 ~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~~ 1024 (1027)
                      .+..++.++.+++.+|+.+||++||     ++.|+++.
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1234566789999999999999997     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-37  Score=342.81  Aligned_cols=246  Identities=22%  Similarity=0.252  Sum_probs=201.6

Q ss_pred             hCCCCccceeeccccceEEEEEecC--CceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD--GMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|+..+.||+|+||.||+|+++.  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568899999999999999998653  3689999987432   2345667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999987654 4889999999999999999999   999999999999999999999999999999865321


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                           .....||+.|+|||++.+..++.++||||+||++|||++|+.||......    ..+         ..+..... 
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~---------~~i~~~~~-  245 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LIY---------QKILEGII-  245 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HHH---------HHHhcCCC-
Confidence                 23356999999999999888999999999999999999999999764211    000         01111110 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~~ 1024 (1027)
                             ..+...+..+.+++.+|++.||++|+     +++++++.
T Consensus       246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   11223455678999999999999995     89988763

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-36  Score=345.11  Aligned_cols=257  Identities=24%  Similarity=0.416  Sum_probs=204.8

Q ss_pred             hCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  820 (1027)
                      .++|++.+.||+|+||.||+|++.      .+..||||++.... ....+.+.+|+++++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            457888999999999999999853      23479999986443 233467889999999996 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-----------------------------------------------------------  841 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  841 (1027)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999876421                                                           


Q ss_pred             ------------------------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC
Q 048205          842 ------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD  885 (1027)
Q Consensus       842 ------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  885 (1027)
                                                          ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                23677888999999999999999   999999999999999999


Q ss_pred             CCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHH
Q 048205          886 NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKR  964 (1027)
Q Consensus       886 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  964 (1027)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ ...
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYN  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHH
Confidence            99999999999986543322222233456788999999998899999999999999999997 8899875422111 110


Q ss_pred             HHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          965 WVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       965 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .            +....      ....+..++.++.+++.+||..+|++||++.++.+.|++
T Consensus       352 ~------------~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         352 K------------IKSGY------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             H------------HhcCC------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence            0            00000      111223567789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-36  Score=342.76  Aligned_cols=263  Identities=21%  Similarity=0.203  Sum_probs=201.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ..+|+..+.||+|+||.||+|+.. +++.||+|...      .+.+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999865 68899999753      23567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +. ++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+...... ..
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            96 58888876543 4789999999999999999999   9999999999999999999999999999997532211 12


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcc------cchhHHHHHHHHHhh---------
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFT------GEMTLKRWVNDLLLI---------  972 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~------~~~~~~~~~~~~~~~---------  972 (1027)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ....+...+......         
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            23345799999999999999999999999999999999999988754321      111111111111100         


Q ss_pred             -hHHHhh---hccc--cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 -SIMEVV---DANL--LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 -~~~~~~---d~~~--~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ...+.+   ....  .......+......+.++.+++.+|++.||++|||++|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             001111   0000  00011112222345678899999999999999999999986

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=338.28  Aligned_cols=244  Identities=27%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             eeeccccceEEEEEecC-CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHHH
Q 048205          757 LIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEK  835 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  835 (1027)
                      ++|+|.||+||.|++.+ ...+|||.+.....+..+.+.+|+...++++|.|||+++|.|.+.+..-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999764 56799999987777778889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCccC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeecCCcccccCCCcceeccc
Q 048205          836 CLYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQT  912 (1027)
Q Consensus       836 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~  912 (1027)
                      ++...=.++  .+.+.-.+.+||++||.|||   +..|||||||-+||++. -.|.+||+|||-++++..-  ...+...
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence            998654445  67778889999999999999   99999999999999994 6899999999999876432  3455667


Q ss_pred             ccCccccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          913 LATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       913 ~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      .||..|||||++..+  .|++++|||||||.+.||.||++||.........+-               .-   ...+...
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF---------------kV---GmyKvHP  798 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF---------------KV---GMYKVHP  798 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh---------------hh---cceecCC
Confidence            899999999999876  489999999999999999999999987543322111               11   1223334


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +.|+..+.+..+++.+|+.+||.+||+|++++.
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            456678888999999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.5e-36  Score=331.85  Aligned_cols=255  Identities=27%  Similarity=0.486  Sum_probs=207.3

Q ss_pred             CCCCccceeeccccceEEEEEecC------CceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ++|+..+.||+|+||.||+|+...      .+.||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357888999999999999998643      25799998864432 33467889999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 048205          823 LVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  887 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  887 (1027)
                      ++|||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999986532               34788899999999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHH
Q 048205          888 VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWV  966 (1027)
Q Consensus       888 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  966 (1027)
                      .+||+|||+++...............+++.|+|||.+....++.++||||+||++|||++ |..||......+  ...+ 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~-  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEM-  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH-
Confidence            999999999986543332223334456888999999988899999999999999999998 999987642211  1111 


Q ss_pred             HHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          967 NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       967 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                                 +....      ....+..++.++.+++.+||..||++||+++||++.|++
T Consensus       239 -----------i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 -----------IRSRQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -----------HHcCC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                       11110      011234677889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-37  Score=339.58  Aligned_cols=239  Identities=24%  Similarity=0.288  Sum_probs=195.1

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999876 58899999987532   23345677899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL  913 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  913 (1027)
                      .+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99987654 4899999999999999999999   9999999999999999999999999999998532221  2233457


Q ss_pred             cCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       914 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||......     .+...        +...        ....+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~--------~~~~--------~~~~~  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRK--------ILQE--------PLRFP  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHH--------HHcC--------CCCCC
Confidence            999999999999999999999999999999999999999753211     11111        0100        01112


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048205          994 EQCMSFVFNLAMKCTIESPEERIN---AKEIVT 1023 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps---~~evl~ 1023 (1027)
                      ..++.++.+++.+||..||++||+   +.|++.
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            345667899999999999999985   666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-36  Score=343.76  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=197.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||+||+|+.. +++.||||++++..   ......+.+|++++.+++||+|+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999865 68999999997542   223456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999987654 4899999999999999999999   99999999999999999999999999999975432110


Q ss_pred             c---------------------------------ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 048205          906 S---------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPT  952 (1027)
Q Consensus       906 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~  952 (1027)
                      .                                 ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012357999999999999999999999999999999999999999


Q ss_pred             CCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 048205          953 DESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTI--ESPEERINAKEIVTK 1024 (1027)
Q Consensus       953 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~--~dP~~Rps~~evl~~ 1024 (1027)
                      ......+    .+..         +....    ....++.....+.++.+++.+++.  ..+..||++.|+++.
T Consensus       237 ~~~~~~~----~~~~---------i~~~~----~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQE----TYKK---------VMNWK----ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHHH----HHHH---------HHcCc----CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            7642211    1100         00000    000011111244567778887554  233356899999763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-37  Score=328.71  Aligned_cols=261  Identities=25%  Similarity=0.423  Sum_probs=216.3

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ....+.++||+|-||+|..+....+..||||.++..... ..++|..|+++|.+++||||++++|+|..++..++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            345667899999999999999888899999999866443 4588999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCcc-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+++..+... .+-....+|+.|||.|++||.   +.++||||+.+.|+|+|.++++||+|||.++-+...+...
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            999999999877532 355667789999999999999   9999999999999999999999999999999766555555


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .....+-...|||+|.+..++++.++|||+|||.+||+++  .+.||....++ .         ......++.+..   .
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-~---------vven~~~~~~~~---~  761 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-Q---------VVENAGEFFRDQ---G  761 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-H---------HHHhhhhhcCCC---C
Confidence            5555667789999999999999999999999999999876  66777654221 1         111222333221   1


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .......|..|+..+.++|.+||..|-++||+++++...|+
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence            12234456789999999999999999999999999988775

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=335.69  Aligned_cols=251  Identities=25%  Similarity=0.324  Sum_probs=211.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  823 (1027)
                      ...|+..+.||+|.||.||+|+.+ +|+.+|+|++.+...   .....+.+|+++++++. |||||.++++|++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456888899999999999999976 599999999976543   24568899999999998 9999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC----CCcEEEeeecCCcc
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD----NMVAHLSDFGMAKP  899 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~  899 (1027)
                      |||++.||.|.+.+... . +++..+..++.|++.|++|||   +.||+|||+||+|+++..    ++.+|++|||+|..
T Consensus       114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999998876 3 899999999999999999999   999999999999999963    35899999999997


Q ss_pred             cccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ...   .......+||++|+|||++....|+.++||||+||++|.|++|.+||..........             .+..
T Consensus       189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------~i~~  252 (382)
T KOG0032|consen  189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------AILR  252 (382)
T ss_pred             ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------HHHc
Confidence            654   345567789999999999999999999999999999999999999998753322211             1111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...    .-..+.+...+..+.+++.+|+..||.+|+++.++++.
T Consensus       253 ~~~----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  253 GDF----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCC----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            111    11223345667789999999999999999999999863

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=346.80  Aligned_cols=252  Identities=22%  Similarity=0.346  Sum_probs=201.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999976 68999999997532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987654 4899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c------------------------------------ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCC
Q 048205          906 S------------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK  949 (1027)
Q Consensus       906 ~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~  949 (1027)
                      .                                    ......+||+.|+|||++....++.++||||+||++|||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                    0111246899999999999999999999999999999999999


Q ss_pred             CCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048205          950 KPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN---AKEIVT 1023 (1027)
Q Consensus       950 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps---~~evl~ 1023 (1027)
                      .||......+. ..            .+....    ...........+.++.+++.+|+. +|.+|++   +.|++.
T Consensus       237 ~Pf~~~~~~~~-~~------------~i~~~~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQET-YR------------KIINWK----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHH-HH------------HHHcCC----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99976422110 00            011000    000011111345678899999997 9999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.1e-36  Score=330.60  Aligned_cols=255  Identities=31%  Similarity=0.476  Sum_probs=206.5

Q ss_pred             CCCCccceeeccccceEEEEEecC------CceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      .+|.+.+.||+|+||.||+|++.+      ++.||||++...... ..+.+.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457788999999999999998643      478999998755433 4578899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCC-------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          823 LVLEYMPYGSLEKCLYSSN-------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      +||||+++++|.+++....             ..+++.++..++.|++.|++|+|   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999986542             34788899999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |+.||......+  ....   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~---  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIEC---  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH---
Confidence            9999999975433222222223346788999999999999999999999999999998 999986542211  1111   


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                               +......      ..+..++..+.+++.+||..+|++||++.|+++.|++
T Consensus       237 ---------~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 ---------ITQGRLL------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ---------HHcCCcC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                     0011000      1112456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.4e-36  Score=323.85  Aligned_cols=249  Identities=28%  Similarity=0.425  Sum_probs=199.9

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      +.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999875 78999999876443 33456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL  913 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  913 (1027)
                      .+++......+++.++..++.|+++||+|||   +.+++||||||+||+++.++.+|++|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999776666899999999999999999999   9999999999999999999999999999987543211111111112


Q ss_pred             cCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhH
Q 048205          914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVA  992 (1027)
Q Consensus       914 gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  992 (1027)
                      .+..|+|||.+.++.++.++||||+||++|||++ |..||.......  .            ........      ....
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~------------~~~~~~~~------~~~~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--T------------REAIEQGV------RLPC  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--H------------HHHHHcCC------CCCC
Confidence            3457999999998889999999999999999998 888886432110  0            01111110      0112


Q ss_pred             HhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          993 KEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       993 ~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      +..++..+.+++.+|+..+|++||++.+++++|++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            23456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-36  Score=326.25  Aligned_cols=256  Identities=25%  Similarity=0.422  Sum_probs=207.7

Q ss_pred             hCCCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|+..+.||+|+||.||+|++..    ...||||+++... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568899999999999999998752    4579999887543 3345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++++|.+++......+++.++..++.|++.|++|||   +++|+||||||+||+++.++.++++|||+++.+...
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876422


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..........+++.|+|||......++.++||||+|+++|||++ |..||......  ....++           .+.. 
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~-----------~~~~-  225 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAV-----------EDGY-  225 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHH-----------HcCC-
Confidence            22222222335678999999998899999999999999999998 99998653211  111110           0000 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                            ..+.+..++..+.+++.+|++.+|++||++.|+++.|++
T Consensus       226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                  001123456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3e-36  Score=331.87  Aligned_cols=254  Identities=30%  Similarity=0.471  Sum_probs=205.6

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|.+.+.||+|+||.||+|...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46888899999999999999742      345699999876555566788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          824 VLEYMPYGSLEKCLYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                      ||||+++++|.+++....            ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432            24899999999999999999999   999999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+  ....     
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~-----  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC-----  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-----
Confidence            99999986543322222233345778999999998889999999999999999998 898886542211  1110     


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            +.....       ...+..++.++.+++.+||+.+|.+||++.++.+.|+
T Consensus       235 ------i~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~  277 (288)
T cd05093         235 ------ITQGRV-------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ  277 (288)
T ss_pred             ------HHcCCc-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence                  000000       0111235567899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-36  Score=346.08  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=198.7

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .|...+.||+|+||+||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788999999999999999865 68899999997542   2345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC-
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ-  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  905 (1027)
                      |+++|+|.+++.+.. .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 4788889999999999999999   99999999999999999999999999999864311000 


Q ss_pred             --------------------------------------------cceecccccCccccCcccccCCCCCcchhHHHHHHH
Q 048205          906 --------------------------------------------SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM  941 (1027)
Q Consensus       906 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvi  941 (1027)
                                                                  .......+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        001123469999999999998889999999999999


Q ss_pred             HHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHh--cccCCCCCCCHH
Q 048205          942 LMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKC--TIESPEERINAK 1019 (1027)
Q Consensus       942 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~c--l~~dP~~Rps~~ 1019 (1027)
                      +|||++|+.||......+.. .            .+.+...    ....+....++.++.+++.+|  +..+|..||++.
T Consensus       238 l~elltG~~Pf~~~~~~~~~-~------------~i~~~~~----~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ-L------------KVINWEN----TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH-H------------HHHcccc----ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999764321110 0            0111000    001111123456788899884  455666699999


Q ss_pred             HHHHH
Q 048205         1020 EIVTK 1024 (1027)
Q Consensus      1020 evl~~ 1024 (1027)
                      |+++.
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.9e-37  Score=342.96  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=203.9

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999866 68999999997542   234566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999877667899999999999999999999   99999999999999999999999999999986543222


Q ss_pred             cceecccccCccccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          906 SLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                       .......||+.|+|||++.      ...++.++||||+||++|||++|+.||......     ....        .+..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~--------~i~~  223 (330)
T cd05601         158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYN--------NIMN  223 (330)
T ss_pred             -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHH--------HHHc
Confidence             2223346899999999986      456788999999999999999999999754221     1111        1111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..    ....++.....+.++.+++.+|++ +|++||++.+++.
T Consensus       224 ~~----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         224 FQ----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CC----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00    000111122356678899999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=314.67  Aligned_cols=248  Identities=25%  Similarity=0.371  Sum_probs=216.1

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      |.++.++|+|+||.||+|.++ +|+.+|||.+..+  ...+++..|+.++.+.+.|+||++||.|.....+++|||||.-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            556778999999999999876 6999999987543  4567888999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+..+.+..+++.+.+.++..+....++||+|||   ...-+|||||+.||++.-+|.+|++|||.|..+.  +.-....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhhC
Confidence            9999999988889999999999999999999999   8889999999999999999999999999998663  2334456


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      .++|||.|||||++..-.|+.++||||+|+...||..|++||.+..+....+                  .....+.+.+
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------------MIPT~PPPTF  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------------MIPTKPPPTF  249 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------------eccCCCCCCC
Confidence            6789999999999999999999999999999999999999998754332110                  0112344566


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..++.++.++.+++++|+.+.|++|.+|.++++.
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            6788899999999999999999999999998764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.9e-36  Score=327.12  Aligned_cols=255  Identities=26%  Similarity=0.459  Sum_probs=210.9

Q ss_pred             HhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ...+|+..+.||.|+||.||+|+..+++.+|+|++..........+..|+++++.++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568889999999999999999888999999999866555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+..+....  
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--  158 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--  158 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence            99999999997643 45899999999999999999999   9999999999999999999999999999998653221  


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......++..|+|||......++.++||||+|+++|+|++ |+.||......+  ...+            +....   
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~------------~~~~~---  221 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQ------------ITAGY---  221 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHH------------HHhCC---
Confidence            11223346678999999988889999999999999999998 899986542111  1111            00000   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                         ....+..++.++.+++.+|+..+|++||+++++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 ---RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               111223566778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.9e-36  Score=337.50  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecC-Ce
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD-DF  820 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~  820 (1027)
                      ++|++.+.||+|+||.||+|+..      +++.||+|+++... ....+.+..|++++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            46889999999999999999632      35789999987432 23345677899999999 899999999988654 56


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-----------------------------------------------------------  841 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  841 (1027)
                      .++||||+++++|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999885421                                                           


Q ss_pred             -ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccC
Q 048205          842 -YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA  920 (1027)
Q Consensus       842 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  920 (1027)
                       ..+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.+||+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             25789999999999999999999   99999999999999999999999999999987643322222333446678999


Q ss_pred             cccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHH
Q 048205          921 PEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSF  999 (1027)
Q Consensus       921 PE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  999 (1027)
                      ||++.+..++.++||||+||++|||++ |..||......+. +...            ......      ...+..++.+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~------------~~~~~~------~~~~~~~~~~  304 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRR------------LKEGTR------MRAPEYATPE  304 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHH------------HhccCC------CCCCccCCHH
Confidence            999999999999999999999999998 9999875322211 1111            001000      0112245567


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205         1000 VFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus      1000 l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      +.+++.+||+.+|++||++.|++++|++
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            8999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.3e-36  Score=328.57  Aligned_cols=255  Identities=25%  Similarity=0.430  Sum_probs=205.2

Q ss_pred             CCCCccceeeccccceEEEEEe-----cCCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..+.||+|+||.||+|++     .+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     246789999986433 3344678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC----------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 048205          824 VLEYMPYGSLEKCLYSS----------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  887 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  887 (1027)
                      ||||+++++|.+++...                ...+++.++..++.|++.|++|||   +.+++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            99999999999998532                124788889999999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHH
Q 048205          888 VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWV  966 (1027)
Q Consensus       888 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  966 (1027)
                      .+|++|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.....  ....+  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~--  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE--  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH--
Confidence            999999999986543332222333446778999999988889999999999999999999 8888865321  11111  


Q ss_pred             HHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          967 NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       967 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                                .++...      ....+..++.++.+++.+|++.||++||++.++.++|.+
T Consensus       238 ----------~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 ----------MVRKRQ------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------HHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                      111111      011223466778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-36  Score=323.88  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=204.2

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .+|++.+.||+|+||.||+|+++++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35778899999999999999988778999999864322 23567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-cccc
Confidence            99999999876667899999999999999999999   9999999999999999999999999999998653221 1111


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....++..|+|||...+..++.++||||+|+++||+++ |+.||......+.  ...            +....      
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~------------~~~~~------  218 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VES------------VSAGY------  218 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HHH------------HHcCC------
Confidence            12223457999999998899999999999999999999 7888865322111  110            00000      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....+..++.++.+++.+||..+|++||++.|+++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            01112346778999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.1e-36  Score=323.96  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=204.5

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .+|+..+.||+|+||.||+|++.++..||+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999998877789999886432 234678899999999999999999999999889999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +|+|.+++......+++.++..++.||+.|++|||   +.+++|+||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            99999998775556899999999999999999999   9999999999999999999999999999988653321 1122


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....++..|+|||......++.++|||||||++|||++ |+.||.......  ....           +.....      
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~-----------~~~~~~------  219 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEK-----------VSQGLR------  219 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH-----------HhcCCC------
Confidence            22335677999999988889999999999999999999 999986532211  1110           000000      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ...+...+..+.+++.+||+++|++||++.++++.|+
T Consensus       220 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 -LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             0111234567899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.2e-36  Score=328.15  Aligned_cols=257  Identities=23%  Similarity=0.421  Sum_probs=204.1

Q ss_pred             HhCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCe
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  820 (1027)
                      ..++|+..+.||+|+||.||+|.+.      +++.||||++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999753      35679999886432 2334568889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          821 KALVLEYMPYGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                      .++||||+++|+|.+++....         ...++..+..++.|++.|++|||   +.+++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         23577888999999999999999   899999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......  ....+     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~-----  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRF-----  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-----
Confidence            99999986543222222222345788999999998889999999999999999999 68888654211  11111     


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                            +......       ..+..++..+.+++.+|++.+|++||++.|+++.|++
T Consensus       234 ------~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 ------VMEGGLL-------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ------HHcCCcC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                  0111100       1123456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=345.98  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=198.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999865 78999999986532   233466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999987654 4788899999999999999999   99999999999999999999999999999964321100


Q ss_pred             c---------------------------------------------ceecccccCccccCcccccCCCCCcchhHHHHHH
Q 048205          906 S---------------------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI  940 (1027)
Q Consensus       906 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  940 (1027)
                      .                                             ......+||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                             0001246999999999999889999999999999


Q ss_pred             HHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCC---CC
Q 048205          941 MLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER---IN 1017 (1027)
Q Consensus       941 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R---ps 1017 (1027)
                      ++|||++|++||......+ .+..            +....    ....++....++.++.+++.+|+. +|.+|   ++
T Consensus       237 il~elltG~~Pf~~~~~~~-~~~~------------i~~~~----~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         237 IMFECLIGWPPFCSENSHE-TYRK------------IINWR----ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHH-HHHH------------HHccC----CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999997542211 1111            00000    000011112345678899999998 66665   59


Q ss_pred             HHHHHHH
Q 048205         1018 AKEIVTK 1024 (1027)
Q Consensus      1018 ~~evl~~ 1024 (1027)
                      +.|++..
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-36  Score=352.00  Aligned_cols=255  Identities=24%  Similarity=0.303  Sum_probs=205.2

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC----
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD----  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  819 (1027)
                      ...++|++.+.||+|+||+||+|+.. +|+.||||+++...  ......+.+|+..+..++|+|++++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34568999999999999999999865 78999999987542  334566788999999999999999988775432    


Q ss_pred             ----eeEEEEEecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 048205          820 ----FKALVLEYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  892 (1027)
Q Consensus       820 ----~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  892 (1027)
                          ..++||||+++|+|.+++...   ...+++..+..++.|++.||+|+|   +.+|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                368999999999999988653   245889999999999999999999   9999999999999999999999999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      |||+++.+.............||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ..++...   
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~---  257 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKT---  257 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH---
Confidence            99999865433222233445799999999999999999999999999999999999999975321     1111111   


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           .....       ...+..++.++.+++.+||+.||++||++.++++.
T Consensus       258 -----~~~~~-------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 -----LAGRY-------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -----hcCCC-------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                 00000       01223466779999999999999999999999863

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=344.40  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ....+.+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999976 78999999997542   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC-
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED-  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-  904 (1027)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998776 45899999999999999999999   9999999999999999999999999999998654322 


Q ss_pred             --------------------------CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc
Q 048205          905 --------------------------QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG  958 (1027)
Q Consensus       905 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~  958 (1027)
                                                .........||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      011223456899999999999999999999999999999999999999764311


Q ss_pred             chhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 048205          959 EMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-AKEIVTK 1024 (1027)
Q Consensus       959 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~evl~~ 1024 (1027)
                      .    .+.         .+....    .....+....++.++.+++.+|+. ||++||+ +.|+++.
T Consensus       237 ~----~~~---------~i~~~~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 E----TYN---------KIINWK----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H----HHH---------HHhccC----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1    110         011100    000011111256778999999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-36  Score=335.65  Aligned_cols=241  Identities=25%  Similarity=0.362  Sum_probs=195.7

Q ss_pred             ceeeccccceEEEEEec----CCceEEEEEEeccc----chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          756 NLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY----GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +.||+|+||.||+|+..    +++.||||+++...    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999853    57899999987532    22345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++|+|.+++.... .+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            99999999987654 4778888899999999999999   9999999999999999999999999999987543222  1


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+....      
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~--------~~~~~~------  216 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTID--------KILKGK------  216 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHH--------HHHcCC------
Confidence            223456899999999999888999999999999999999999999764211     1111        111111      


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                        ...+..++.++.+++.+|+++||++||     ++.++++
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              111233566789999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.1e-36  Score=335.21  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=203.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||.||+|++. +++.+|+|++..... ...+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467999999999999999999976 688999998875432 345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++|+|.+++.... .+++..+..++.+++.|++|||   +. +|+||||||+||+++.++.+||+|||++..+...  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999987654 4788899999999999999999   64 7999999999999999999999999998754321  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------------
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------------  973 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  973 (1027)
                        ......|++.|+|||++.+..++.++||||+||++|||++|+.||.......  ............            
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCcccCC
Confidence              1233468999999999998889999999999999999999999997542211  111100000000            


Q ss_pred             -----------------HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 -----------------IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 -----------------~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                                       .....+..... ...... ...++.++.+++.+||++||++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcC-CCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                             00000000000 000000 0124567899999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-36  Score=338.59  Aligned_cols=242  Identities=23%  Similarity=0.303  Sum_probs=196.7

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999997542   233456678999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      +|.+++.... .+++..+..++.||+.||+|||   + .+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            9999886544 4899999999999999999999   7 799999999999999999999999999987533221  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.......     ...         .+...       ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~~~---------~i~~~-------~~  213 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFE---------LILME-------EI  213 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----HHH---------HHhcC-------CC
Confidence            3569999999999999999999999999999999999999997542211     110         00000       00


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVTK 1024 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~~ 1024 (1027)
                      ..+...+.++.+++.+|++.||++|+     ++.++++.
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11233566789999999999999997     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.5e-36  Score=335.28  Aligned_cols=244  Identities=21%  Similarity=0.312  Sum_probs=195.5

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHH---hhccCCccceEEeEEecCCeeEEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMI---KRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      |++.+.||+|+||.||+|++. +++.||||+++...   ....+.+.+|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999865 68999999997542   22334556665554   567899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|..++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999887653  4899999999999999999999   9999999999999999999999999999987532221


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                        ......+|++.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+.....  
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~--------~i~~~~~--  218 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFD--------SIVNDEV--  218 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHH--------HHHhCCC--
Confidence              2233457999999999999989999999999999999999999999764221     1111        0111100  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                            ..+..++..+.+++.+|+..||++||     ++.++++
T Consensus       219 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                  11234566788999999999999999     5777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=322.50  Aligned_cols=253  Identities=27%  Similarity=0.422  Sum_probs=205.8

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999998888899999986543 23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.+.... ..
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YE  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cc
Confidence            9999999987644 45899999999999999999999   9999999999999999999999999999998664221 11


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      .......+..|+|||+..+..++.++||||+|+++|||++ |+.||...... . ...            .++....   
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~-~~~------------~~~~~~~---  222 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-E-VLQ------------QVDQGYR---  222 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-H-HHH------------HHHcCCC---
Confidence            1112223457999999998899999999999999999999 99998653211 1 011            0111100   


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         ...+..++..+.+++.+|++.+|++||++.+++..|+
T Consensus       223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence               0112245677899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.3e-36  Score=323.95  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=206.7

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35688899999999999999998888899999876432 23567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++... ...+++.++..++.|+++|++|||   +.+++||||||+||+++.++.++++|||+++....... .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999998754 345788899999999999999999   89999999999999999999999999999986533211 1


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......++..|+|||+.....++.++||||+||++|+|++ |+.||......  ....++.            ...    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~------------~~~----  221 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQ------------RGY----  221 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHH------------cCC----
Confidence            1222345678999999988889999999999999999998 99998653211  1111110            000    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        ..+....++.++.+++.+|+..+|++||++.++.+.|+.
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              011112456678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.3e-36  Score=328.90  Aligned_cols=254  Identities=31%  Similarity=0.476  Sum_probs=205.8

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|...+.||+|+||.||+|++.      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777889999999999999743      355699999876555556788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 048205          824 VLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV  888 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  888 (1027)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   +++|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999986532               34789999999999999999999   999999999999999999999


Q ss_pred             EEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHH
Q 048205          889 AHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVN  967 (1027)
Q Consensus       889 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  967 (1027)
                      ++|+|||+++...............++..|+|||++....++.++||||+||++|||+| |+.||.......  ..+.  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~--  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIEC--  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--
Confidence            99999999986543322222333456788999999998899999999999999999999 999986542211  1111  


Q ss_pred             HHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          968 DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       968 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                               +......       ..+..++..+.+++.+||..+|++||++.+++++|+
T Consensus       238 ---------~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         238 ---------ITQGRVL-------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             ---------HhCCCCC-------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                     0000000       011235667899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=346.22  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             CCCccceeeccccceEEEEEecCC-ceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEE-ec------CCee
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDG-MEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSC-SS------DDFK  821 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~-~~------~~~~  821 (1027)
                      ++++.+.|.+|+|+.||.|+...+ ..||+|++-.......+.+++|+++|++|+ |+|||.+++.. ..      .-++
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            456778999999999999997755 999999887667778889999999999997 99999999932 11      1367


Q ss_pred             EEEEEecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          822 ALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ++.||||.||.|.|++..+ ...+++.++++|+.++++|+++||. +..+|+|||||-+|||++.+|..||||||.|...
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            8999999999999998754 2459999999999999999999993 3667999999999999999999999999999743


Q ss_pred             ccCCCcc-------eecccccCccccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          901 LKEDQSL-------TQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       901 ~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      .......       ..-....|+.|+|||++   .+.+.++|+|||||||+||.++....||+....-.           
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----------  265 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----------  265 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------
Confidence            3221110       01123468999999975   46789999999999999999999999998752211           


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            +++      ....++....++..+.+||+.||++||++||++-||+..+.
T Consensus       266 ------Iln------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  266 ------ILN------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             ------EEe------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                  111      12223333578889999999999999999999999998764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.3e-36  Score=336.35  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=199.1

Q ss_pred             CCCccceeeccccceEEEEEec----CCceEEEEEEeccc----chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY----GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      +|++.+.||+|+||.||+|+..    +++.||+|++.+..    ....+.+..|+++++++ +||+|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999753    57899999987432    22345677899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 4789999999999999999999   9999999999999999999999999999998653


Q ss_pred             cCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||........ .......        +...
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~--------~~~~  226 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRR--------ILKC  226 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHH--------HhcC
Confidence            3222 122345799999999998765 478899999999999999999999975322111 1111110        0000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                              ....+...+..+.+++.+|+..||++||     +++++++
T Consensus       227 --------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 --------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                    0011223566788999999999999999     7778765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-35  Score=321.68  Aligned_cols=256  Identities=24%  Similarity=0.344  Sum_probs=206.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+...   .....+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999965 7899999987642   2334457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++|+|.+++..   ....+++..+..++.|+++|++|||   +.+++|+||||+||+++.++.++++|||.+..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2345788999999999999999999   99999999999999999999999999999886532


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..  .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||......   ...+...         +....
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~---------~~~~~  224 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQK---------IEQCD  224 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHH---------HhcCC
Confidence            21  1122345888999999998888999999999999999999999998653221   1111111         11100


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .   .  ......++.++.+++.+||..+|++||++.+|++.+++
T Consensus       225 ~---~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         225 Y---P--PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             C---C--CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            0   0  01122456778999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.3e-36  Score=334.46  Aligned_cols=236  Identities=24%  Similarity=0.318  Sum_probs=191.6

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|+.+ +++.||||++.+..   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 68899999987542   23345667788888776 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99999887654 4889999999999999999999   9999999999999999999999999999987532221  2233


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......     .....        +....        .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~--------i~~~~--------~  213 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEA--------ILNDE--------V  213 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHH--------HhcCC--------C
Confidence            457999999999999889999999999999999999999999764221     11110        00000        0


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                      ..+...+.++.+++.+|++.||++||++
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1112355678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.9e-36  Score=338.63  Aligned_cols=247  Identities=23%  Similarity=0.353  Sum_probs=194.4

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +|+..+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4566789999999999999866 689999999865432 33567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++|+|.+..     ..++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+....  ..
T Consensus       155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  224 (353)
T PLN00034        155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP  224 (353)
T ss_pred             CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence            999986532     2567778899999999999999   9999999999999999999999999999998653221  11


Q ss_pred             ecccccCccccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          909 QTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .....||..|+|||++..     ...+.++|||||||++|||++|+.||......     .|......     +...   
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~-----~~~~---  291 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCA-----ICMS---  291 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHH-----Hhcc---
Confidence            234568999999998743     23456899999999999999999999743221     12111100     0000   


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          .....+..++.++.+++.+||..||++||++.|+++.
T Consensus       292 ----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0011123456778999999999999999999999864

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.6e-36  Score=326.45  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=205.8

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..+.||+|+||.||+|...      ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45777889999999999999632      456899998876655566789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC--------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          824 VLEYMPYGSLEKCLYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      ||||+++++|.+++....              ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              24788999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |++||......+  ...    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~----  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIE----  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHH----
Confidence            9999999975543222111222345678999999998899999999999999999998 899986532211  110    


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                              ......      ....+..++..+.+++.+||+.||++||++.|+.+.|++
T Consensus       236 --------~~~~~~------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 --------CITQGR------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             --------HHHcCc------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                    000100      011123456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.1e-36  Score=344.39  Aligned_cols=251  Identities=23%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .|+..+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999865 68899999987542   2345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC-
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ-  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  905 (1027)
                      |+++|+|.+++.+.. .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999987654 4788889999999999999999   99999999999999999999999999999853321000 


Q ss_pred             --------------------------------------------cceecccccCccccCcccccCCCCCcchhHHHHHHH
Q 048205          906 --------------------------------------------SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM  941 (1027)
Q Consensus       906 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvi  941 (1027)
                                                                  .......+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000123468999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC---H
Q 048205          942 LMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN---A 1018 (1027)
Q Consensus       942 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps---~ 1018 (1027)
                      +|||++|++||......+. ..            .+....    .....+.....++++.+++.+|+ .+|++|++   +
T Consensus       238 l~elltG~~Pf~~~~~~~~-~~------------~i~~~~----~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLET-QM------------KVINWQ----TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHH-HH------------HHHccC----CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999976422111 00            011000    00011111234566788888875 59999997   8


Q ss_pred             HHHHH
Q 048205         1019 KEIVT 1023 (1027)
Q Consensus      1019 ~evl~ 1023 (1027)
                      .|+++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            88764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-35  Score=325.24  Aligned_cols=253  Identities=22%  Similarity=0.360  Sum_probs=201.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCc----eEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGM----EVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..+.||+|+||+||+|++. +++    .||+|.+.... ......+..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999875 454    47777765332 2334667788889999999999999998864 45789


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+||+++|+|.+++......+++..+..++.||+.|++|||   +.+++||||||+||+++.++.+||+|||.++.+...
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999865443


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..........++..|+|||....+.++.++|||||||++||+++ |+.||.+....  ...++            +....
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~------------~~~~~  228 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDL------------LEKGE  228 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH------------HHCCC
Confidence            33233334457788999999998899999999999999999998 99998754221  11111            11111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++.++.+++.+||..+|++||++.|+++.|.
T Consensus       229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                  01112235567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.2e-36  Score=333.90  Aligned_cols=241  Identities=22%  Similarity=0.276  Sum_probs=194.8

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCC-ccceEEeEEecCCeeEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHR-NIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~  825 (1027)
                      +|++.+.||+|+||.||+|+.. +++.||||++.+..   ....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999866 57899999997542   23445677889999999765 5888999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999999887654 4788999999999999999999   9999999999999999999999999999987432211 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ...           .+....    
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~-----------~i~~~~----  217 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQ-----------SIMEHN----  217 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH-----------HHHcCC----
Confidence             12234568999999999999999999999999999999999999997642211  110           011110    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                          ...+...+.++.+++.+|+.+||++|+++
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                01122356678899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.1e-36  Score=340.84  Aligned_cols=254  Identities=22%  Similarity=0.275  Sum_probs=202.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999876 68899999997432   2234557789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999988754  3788888899999999999999   999999999999999999999999999999865332


Q ss_pred             CCcceecccccCccccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      . ........||+.|+|||++...    .++.++||||+||++|||++|+.||......    ..+         ..+.+
T Consensus       196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~---------~~i~~  261 (370)
T cd05596         196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTY---------SKIMD  261 (370)
T ss_pred             C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHH---------HHHHc
Confidence            2 1122345799999999988653    4788999999999999999999999764211    111         11111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVTK 1024 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~~ 1024 (1027)
                      ...    ...++....++.++.+++.+|+..+|++  ||++.|+++.
T Consensus       262 ~~~----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         262 HKN----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCC----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            100    0011112235677899999999999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-35  Score=322.05  Aligned_cols=253  Identities=24%  Similarity=0.402  Sum_probs=205.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+|+..+.||+|+||.||+|.++ +++.||+|++... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999866 5889999998744 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++.... ..+++..+..++.|+++|++|||   +.+++||||||+||++++++.+||+|||++........ .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            9999999987543 45899999999999999999999   99999999999999999999999999999986543211 1


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......++..|+|||+..+..++.++|||||||++|||++ |..||.....     .++...         .....    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~---------~~~~~----  222 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL---------LEKGY----  222 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH---------HHCCC----
Confidence            1112234568999999998899999999999999999998 8889865321     111111         11110    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        ....+..++.++.+++.+|+..+|++||++.+++++|+.
T Consensus       223 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         223 --RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence              011223466789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-35  Score=327.15  Aligned_cols=266  Identities=25%  Similarity=0.337  Sum_probs=196.5

Q ss_pred             CCCCccceeeccccceEEEEEec--CCceEEEEEEecccc--hhHHHHHHHHHHHhhc---cCCccceEEeEEec-----
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRI---RHRNIIKFISSCSS-----  817 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  817 (1027)
                      .+|++.+.||+|+||+||+|+..  +++.||+|+++....  .....+.+|+++++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  468899999875432  2233455677666655   69999999999852     


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          818 DDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       818 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                      ....++||||++ ++|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999997 58999886543 45889999999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---h
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---S  973 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~  973 (1027)
                      ++.....   .......||+.|+|||.+....++.++||||+||++|||++|++||...... ..+...+......   .
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence            9865322   2233456899999999998889999999999999999999999999865322 1111111111000   0


Q ss_pred             H-HHh-hh-ccccCccch-hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 I-MEV-VD-ANLLSHEDK-HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ~-~~~-~d-~~~~~~~~~-~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      . .+. .. ......... .......++..+.+++.+|++.||++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0 000 00 000000000 00111235667889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-35  Score=322.95  Aligned_cols=254  Identities=27%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46899999999999999999964 68899999997655555667888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++.... .+++..+..++.|++.|++|||   +.+|+|||+||+||+++.++.+||+|||++..+....  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cc
Confidence            9999999886543 4789999999999999999999   9999999999999999999999999999998653221  11


Q ss_pred             ecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          909 QTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .....+++.|+|||.+.   ...++.++||||+||++|||++|+.||......+. ...+            .....   
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~------------~~~~~---  226 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM------------SKSNF---  226 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heee------------ecCCC---
Confidence            23346888999999874   34578899999999999999999999864321111 0000            00000   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L 1025 (1027)
                      ..........++..+.+++.+||..+|++||+++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0001111223556789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8e-36  Score=332.36  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=191.0

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhh-ccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKR-IRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|+.. +++.||||+++...   ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 58899999997542   2233445556666654 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999887654 4889999999999999999999   9999999999999999999999999999997543222  2334


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ..+||+.|+|||++.+..++.++||||+||++|||++|+.||......     +....        +...        ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~--------i~~~--------~~  213 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDS--------ILND--------RP  213 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHH--------HHcC--------CC
Confidence            457999999999999889999999999999999999999999764221     11110        0000        00


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAK-EIV 1022 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-evl 1022 (1027)
                      ..+..++.++.+++.+||+.+|++||++. +++
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11223556788999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-36  Score=344.78  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      +|++.+.||+|+||.||+|+.. +++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999865 68999999986432   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC--
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED--  904 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~--  904 (1027)
                      |+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|..+....  
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999987654 4788888999999999999999   9999999999999999999999999999985331100  


Q ss_pred             ---------------------------------------CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHH
Q 048205          905 ---------------------------------------QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET  945 (1027)
Q Consensus       905 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el  945 (1027)
                                                             ........+||+.|+|||++.+..++.++||||+||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                   00011234699999999999999999999999999999999


Q ss_pred             HcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC---CHHHHH
Q 048205          946 FTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI---NAKEIV 1022 (1027)
Q Consensus       946 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp---s~~evl 1022 (1027)
                      ++|+.||......+.     ...        +....    ..........++.++.+++.+|+ .+|++|+   ++.|++
T Consensus       238 l~G~~Pf~~~~~~~~-----~~~--------i~~~~----~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         238 LVGQPPFLADTPAET-----QLK--------VINWE----TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             hhCCCCCCCCCHHHH-----HHH--------HhccC----ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999976432111     000        00000    00001111234566788888876 5999999   899987


Q ss_pred             HH
Q 048205         1023 TK 1024 (1027)
Q Consensus      1023 ~~ 1024 (1027)
                      +.
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.5e-36  Score=333.74  Aligned_cols=241  Identities=22%  Similarity=0.307  Sum_probs=194.6

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|+.. +++.||||++....   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999876 57899999987542   23345567788888766 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            99999887654 4788999999999999999999   9999999999999999999999999999987543222  2233


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ...           .+....        .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~-----------~i~~~~--------~  213 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFE-----------SILHDD--------V  213 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHH-----------HHHcCC--------C
Confidence            4568999999999998899999999999999999999999997643211  111           011000        0


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERI-------NAKEIVT 1023 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rp-------s~~evl~ 1023 (1027)
                      ..+..++.++.+++.+|+..||++||       ++.++++
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            11123456788999999999999999       7888764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-35  Score=333.05  Aligned_cols=247  Identities=21%  Similarity=0.284  Sum_probs=196.7

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|++. +++.||||++++..   ....+.+..|..+++++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999876 68899999997542   23345677899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++...+ .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99999886543 5899999999999999999999   9999999999999999999999999999987432211  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc---chhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG---EMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ..+||+.|+|||++.+..++.++||||+||++|||++|+.||+.....   ......+...       .+....      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~~~------  221 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ-------VILEKQ------  221 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH-------HHHcCC------
Confidence            457899999999999999999999999999999999999999743211   1111122111       011111      


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERIN------AKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps------~~evl~ 1023 (1027)
                        ...+..++.++.+++.+|+..||++||+      ++++++
T Consensus       222 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         222 --IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              1112345667899999999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.1e-36  Score=339.66  Aligned_cols=255  Identities=22%  Similarity=0.273  Sum_probs=201.2

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999976 68899999987432   223455778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|..+..
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999998654  3788899999999999999999   99999999999999999999999999999986532


Q ss_pred             CCCcceecccccCccccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      .. .......+||+.|+|||++...    .++.++||||+||++|||++|+.||...... ..+            ..+.
T Consensus       195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~------------~~i~  260 (370)
T cd05621         195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTY------------SKIM  260 (370)
T ss_pred             CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHH------------HHHH
Confidence            22 1122345799999999998754    3788999999999999999999999754211 111            1111


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVTK 1024 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~~ 1024 (1027)
                      +....    ..++.....+..+.+++.+|+..+|.+  |+++.|+++.
T Consensus       261 ~~~~~----~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         261 DHKNS----LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             hCCcc----cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11100    011111234566788999999865544  8999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-35  Score=332.59  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=195.0

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|+.+ +++.||+|++++..   ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 68899999997542   23345677888888776 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99998876543 4899999999999999999999   9999999999999999999999999999987532221  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc---chhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG---EMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......   ......++...       +....      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------i~~~~------  221 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------ILEKQ------  221 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-------HhcCC------
Confidence            457899999999999999999999999999999999999999642111   11111111110       01110      


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERIN------AKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps------~~evl~ 1023 (1027)
                        ...+...+..+.+++.+|+..||++||+      +.++++
T Consensus       222 --~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         222 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence              1112345667889999999999999998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-35  Score=324.01  Aligned_cols=244  Identities=23%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ||+|+||+||+|++. +|+.||+|++.....   ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 789999999875422   2335667899999999999999999999999999999999999999


Q ss_pred             HHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          834 EKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       834 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      .+++..   ....+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988753   2345899999999999999999999   99999999999999999999999999999976543221  223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......        .+...        ..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~--------~~~~~--------~~  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQ--------RILND--------SV  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHH--------hhccc--------CC
Confidence            45689999999999999999999999999999999999999975422111 111100        00000        01


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      ..+..++.++.+++.+|++.||++||     +++++++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11234667789999999999999999     6777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-36  Score=322.54  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=205.6

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEec--ccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ...|++.+.||+|+.+.||++...+.+.||+|.+..  ........|..|+..|.+++ |.+||++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            345888899999999999999988888888886542  23456788999999999995 999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||-+. +|..++.......+...++.+.+|++.|+.++|   +.||||.||||.|+++ -+|.+||+|||+|..+..+..
T Consensus       440 E~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence            98865 999999887765554578889999999999999   9999999999999998 467999999999998887777


Q ss_pred             cceecccccCccccCcccccCC-----------CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          906 SLTQTQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      ......-+||+.||+||.+...           +.++++||||+|||+|+|+.|++||....      -.|.      .+
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~a------Kl  582 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIA------KL  582 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHH------HH
Confidence            7777777899999999987532           25788999999999999999999987531      1222      23


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+.|+...-..+.-.     ...++.++|..||..||++||+..++++
T Consensus       583 ~aI~~P~~~Iefp~~~-----~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHEIEFPDIP-----ENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCccccccCCC-----CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            3455553321111111     1122889999999999999999999986

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-35  Score=328.37  Aligned_cols=268  Identities=21%  Similarity=0.272  Sum_probs=203.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|...+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            367889999999999999999876 678899999875432 233457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++ ++.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            9975 898888776666899999999999999999999   9999999999999999999999999999997543222  


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---hHH------H
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---SIM------E  976 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~------~  976 (1027)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|++||......+ ............   ...      +
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhh
Confidence            12233467899999998865 468899999999999999999999997643221 111111111000   000      0


Q ss_pred             hhhcccc-CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VVDANLL-SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~d~~~~-~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+.... .............+.++.+++.+|+..||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000 0000111122345677899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-35  Score=326.21  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             CCCccceeeccccceEEEEEec------CCceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      +|+..+.||+|+||.||+|++.      +++.||+|+++..... ..+.+.+|+++++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667789999999999999854      2578999998754332 34668889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC---------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 048205          824 VLEYMPYGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV  888 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  888 (1027)
                      ++||+++++|.+++...               ...+++..+..++.|++.|++|+|   +++|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532               134788889999999999999999   999999999999999999999


Q ss_pred             EEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHH
Q 048205          889 AHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVN  967 (1027)
Q Consensus       889 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  967 (1027)
                      +||+|||+++...............+++.|+|||.+..+.++.++||||+||++|||++ |..||......     ++..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence            99999999886543322222233346788999999988889999999999999999998 78887653211     1111


Q ss_pred             HHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          968 DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       968 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .        +.+...       ...+..++..+.+++.+||+.+|++||++++++..|+
T Consensus       238 ~--------i~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         238 M--------IRNRQV-------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             H--------HHcCCc-------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            1        111111       0112457778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.2e-35  Score=352.83  Aligned_cols=255  Identities=25%  Similarity=0.323  Sum_probs=200.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .+|++.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999876 68999999987532   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcC----------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          826 EYMPYGSLEKCLYSS----------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                      ||++||+|.+++...          ....++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          123566788899999999999999   9999999999999999999999999999


Q ss_pred             CCcccccCCC----------------cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc
Q 048205          896 MAKPFLKEDQ----------------SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE  959 (1027)
Q Consensus       896 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  959 (1027)
                      +++.......                .......+||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                001123468999999999999999999999999999999999999997632211


Q ss_pred             hhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 048205          960 MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-AKEIVTKL 1025 (1027)
Q Consensus       960 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~evl~~L 1025 (1027)
                      .....           ...++.       ........+..+.+++.+|+..||++||+ ++++.+.|
T Consensus       239 i~~~~-----------~i~~P~-------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        239 ISYRD-----------VILSPI-------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             hhhhh-----------hccChh-------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            10000           000000       01111245667889999999999999975 55555544

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-35  Score=330.59  Aligned_cols=240  Identities=21%  Similarity=0.303  Sum_probs=192.0

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhh-ccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKR-IRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|+++ +|+.||+|+++...   ....+....|.+++.. .+||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999997542   2234456667777765 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            99999887643 4789999999999999999999   9999999999999999999999999999987432211  2234


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......     .....         +....       .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~~~~~---------~~~~~-------~  213 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----ELFES---------IRVDT-------P  213 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHH---------HHhCC-------C
Confidence            457899999999999999999999999999999999999999754211     11110         00000       0


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAK-EIV 1022 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-evl 1022 (1027)
                      ..+..++.++.+++.+|++.||++||++. +++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            01123456788999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-35  Score=329.81  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=192.0

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhh-ccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKR-IRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|++. +++.||||+++...   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 57899999997542   2234456667777775 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++... ..+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            9999988764 34788999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.         ...+          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~---------~~~~----------  213 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIR---------MDNP----------  213 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---------hCCC----------
Confidence            456899999999999889999999999999999999999999764211  1111100         0000          


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAK-EIV 1022 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-evl 1022 (1027)
                      ..+..++.++.+++.+|++.||++||++. ++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            01123455688999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=326.37  Aligned_cols=262  Identities=27%  Similarity=0.395  Sum_probs=202.0

Q ss_pred             CCCCccceeeccccceEEEEEecC---------------CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD---------------GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFIS  813 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~  813 (1027)
                      ++|++.+.||+|+||.||+|+..+               ...||+|.++... ......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468889999999999999987542               2358999987543 233457889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhcCC-----------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 048205          814 SCSSDDFKALVLEYMPYGSLEKCLYSSN-----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL  882 (1027)
Q Consensus       814 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  882 (1027)
                      ++......++||||+++++|.+++....           ..+++..+..++.|++.|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986432           23688899999999999999999   999999999999999


Q ss_pred             EcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCcccch
Q 048205          883 LDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--RKKPTDESFTGEM  960 (1027)
Q Consensus       883 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~~  960 (1027)
                      ++.++.+|++|||++................++..|+|||+...+.++.++|||||||++|||++  |..||...... .
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-Q  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-H
Confidence            99999999999999986533222222222345678999999988889999999999999999998  55676643211 1


Q ss_pred             hHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          961 TLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       961 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ......         +..+......   ....+..++..+.+++.+|+..+|++||++.+|++.|++
T Consensus       241 ~~~~~~---------~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 VIENTG---------EFFRNQGRQI---YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHH---------Hhhhhccccc---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            111110         0001000000   001122356679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-35  Score=323.19  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=202.7

Q ss_pred             hCCCCccceeeccccceEEEEEecC------CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|++.+.||+|+||.||+|.+.+      +..||+|.+.... ......+..|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999998753      5678999876443 23345688899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEe
Q 048205          822 ALVLEYMPYGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLS  892 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  892 (1027)
                      ++||||+++++|.+++....      ..+++..+.+++.||+.|++|||   +.+++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987653      25889999999999999999999   99999999999999998765   69999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.......     ...    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~~~----  232 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----VME----  232 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH----
Confidence            9999986532221111122234567999999998899999999999999999997 999987542211     111    


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           .+....      ....+..++..+.+++.+|++.+|++||++.+|++.|.
T Consensus       233 -----~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 -----FVTGGG------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----HHHcCC------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                 111110      01112345677899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.7e-35  Score=326.27  Aligned_cols=256  Identities=24%  Similarity=0.394  Sum_probs=205.0

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      ++|...+.||+|+||.||+|++.      ++..||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            46888999999999999999742      34579999887543 33456788999999999 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ++||||+++|+|.+++.... ..+++.++..++.|++.|++|||   +.+|+|+||||+||+++.++.++++|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999987643 34799999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      .............+++.|+|||.+.+..++.++||||+||++|||++ |+.||......+ ....+            .+
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~------------~~  258 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKL------------IK  258 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHH------------HH
Confidence            43322212222345778999999998899999999999999999998 999987543221 11111            11


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ....      ...+...+.++.+++.+|+.++|++||++.|+++.|++
T Consensus       259 ~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         259 EGYR------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             cCCc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            1110      01112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=318.22  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=203.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-----chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ++|+..+.||+|++|.||+|... +++.||+|++....     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999865 68999999986432     1234568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999887654 4788889999999999999999   999999999999999999999999999999765322


Q ss_pred             CCcc-eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .... ......++..|+|||++.+..++.++||||+|+++||+++|+.||........ ...            ..... 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~------------~~~~~-  223 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFK------------IATQP-  223 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHH------------HhccC-
Confidence            1111 11234578899999999998899999999999999999999999865321110 000            00000 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           .....+..++..+.+++.+||..+|++||++.|+++.
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 0111223466678999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-35  Score=330.40  Aligned_cols=241  Identities=22%  Similarity=0.300  Sum_probs=195.4

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|++. +++.||||++++..   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999997542   23345667788888877 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            99999887654 4899999999999999999999   9999999999999999999999999999987432211  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ..+|++.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+.....        
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~--------~i~~~~~--------  213 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQ--------SILEDEV--------  213 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHH--------HHHcCCC--------
Confidence            346899999999999999999999999999999999999999754211     1111        0111110        


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINA-----KEIVT 1023 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~-----~evl~ 1023 (1027)
                      ..+..++..+.+++.+||+.||++||++     .++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1122356678999999999999999999     87765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3e-35  Score=335.93  Aligned_cols=266  Identities=23%  Similarity=0.275  Sum_probs=200.0

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC-----eeE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-----FKA  822 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  822 (1027)
                      +|+..+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999865 78999999886432  234467888999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+. ++|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999997 4888877654 35899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---------
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---------  972 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------  972 (1027)
                      .. ........+++.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..........         
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhh
Confidence            22 2223344678999999998764 4789999999999999999999999764321 1111111100000         


Q ss_pred             -hHHHhhhccccCcc--chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 -SIMEVVDANLLSHE--DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 -~~~~~~d~~~~~~~--~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       .....+........  ..........+.++.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence             00000100000000  0001112234667899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-35  Score=336.48  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=203.0

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  821 (1027)
                      ++|.+.+.||+|+||.||+|++.      .++.||+|+++... ....+.+..|++++.++. ||||++++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45777899999999999999854      34689999997543 233456888999999997 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC------------------------------------------------------------
Q 048205          822 ALVLEYMPYGSLEKCLYSSN------------------------------------------------------------  841 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------  841 (1027)
                      ++||||+++|+|.++++...                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999986432                                                            


Q ss_pred             -------------------------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 048205          842 -------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  884 (1027)
Q Consensus       842 -------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  884 (1027)
                                                           ..+++..+..++.|++.|++|||   +.+++||||||+||+++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                 13567788899999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHH
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLK  963 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  963 (1027)
                      .++.+|++|||+++.+.............+++.|+|||.+....++.++||||+||++|||++ |+.||......+. . 
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~-  351 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F-  351 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H-
Confidence            999999999999986533222112223356788999999998889999999999999999998 8889865422111 0 


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                                 .+.+....      +...+..++.++.+++.+||..+|++||+++|+++.|++
T Consensus       352 -----------~~~~~~~~------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         352 -----------YNAIKRGY------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             -----------HHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                       01111111      011123456779999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-35  Score=331.48  Aligned_cols=241  Identities=22%  Similarity=0.285  Sum_probs=194.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      +|+..+.||+|+||.||+|+.. +++.||||++.+..   ....+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999876 57899999987542   22334556677777777 5889999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            9999999999887654 4789999999999999999999   9999999999999999999999999999997543221 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ....           .+.....   
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~-----------~i~~~~~---  218 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQ-----------SIMEHNV---  218 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHH-----------HHHhCCC---
Confidence             1233457899999999999999999999999999999999999999764221  1111           0111110   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                           ..+...+.++.+++.+|++.||++|+++
T Consensus       219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 1122355678899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-35  Score=323.84  Aligned_cols=264  Identities=25%  Similarity=0.404  Sum_probs=202.9

Q ss_pred             CCccceeeccccceEEEEEe-----cCCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEE
Q 048205          752 FSENNLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKAL  823 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  823 (1027)
                      |+..+.||+|+||+||+++.     .+++.||+|+++.... ...+.+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988652     3578899999875432 3456788899999999999999999988653  46789


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999998764  3899999999999999999999   999999999999999999999999999999865432


Q ss_pred             CCcce-ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH-HhhhHHHhhhcc
Q 048205          904 DQSLT-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL-LLISIMEVVDAN  981 (1027)
Q Consensus       904 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~  981 (1027)
                      ..... .....++..|+|||......++.++||||||+++|||++|+.|+............+.... ......+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            22111 1223356679999999888899999999999999999999999865432211111111100 000111122221


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .      ....+..++.++.+++.+||.++|++||+++++++.|+
T Consensus       241 ~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~  279 (283)
T cd05080         241 M------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK  279 (283)
T ss_pred             C------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            1      11123456778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-35  Score=324.02  Aligned_cols=266  Identities=26%  Similarity=0.428  Sum_probs=205.3

Q ss_pred             CCCCccceeeccccceEEEEEec-----CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec--CCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-----DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  822 (1027)
                      .+|++.+.||+|+||.||+|+..     +++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     578999999876655566788999999999999999999998754  34688


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999876666899999999999999999999   99999999999999999999999999999986543


Q ss_pred             CCCccee-cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh-----hhHHH
Q 048205          903 EDQSLTQ-TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL-----ISIME  976 (1027)
Q Consensus       903 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~  976 (1027)
                      ....... ....++..|+|||+..+..++.++||||+||++|||++|..|+......   ..........     ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence            2221111 1122345699999999888999999999999999999988775432110   0000000000     00111


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .....      .....+..++.++.+++.+||.++|++|||+.|+++.|++
T Consensus       238 ~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         238 LLKNN------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHhcC------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            11111      1112234566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-37  Score=328.50  Aligned_cols=244  Identities=27%  Similarity=0.347  Sum_probs=204.4

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      |+..+-||.|+||.||-|++. +.+.||||.+...   ..+...++..|++++++++|||+|.+-|+|-.+.+.++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            666788999999999999855 7889999998633   344567888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      |-| +-.|++.-.++++-+-++..|..+.+.||+|||   +.+.||||||+.||++++.|.||++|||.|..+.+     
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence            965 888888877788999999999999999999999   99999999999999999999999999999986543     


Q ss_pred             eecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          908 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       ...++|||.|||||++.   .+.|+-++||||+|+...|+...++|...+...    ....+..      .--.|.+  
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM----SALYHIA------QNesPtL--  245 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIA------QNESPTL--  245 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH----HHHHHHH------hcCCCCC--
Confidence             34578999999999876   568999999999999999999999998765321    1111100      0001111  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             ....++..+.+++..|+++-|.+|||..++++.
T Consensus       246 -------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 -------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                   124577789999999999999999999999864

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-35  Score=320.52  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=200.8

Q ss_pred             CCccceeeccccceEEEEEecC----CceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCe-----
Q 048205          752 FSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF-----  820 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  820 (1027)
                      |++.+.||+|+||.||+|++..    +..||+|+++...  ......+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998652    3679999987542  2345678899999999999999999998866554     


Q ss_pred             -eEEEEEecCCCCHHHHHhcC-----CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 048205          821 -KALVLEYMPYGSLEKCLYSS-----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       821 -~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                       .++||||+++|+|.+++...     ...+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999987543     235889999999999999999999   999999999999999999999999999


Q ss_pred             cCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      |+++.+.............++..|+|||++....++.++||||+||++|||++ |..||......  ...+++       
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~-------  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL-------  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-------
Confidence            99986643332222222335678999999988889999999999999999999 88888653221  111111       


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                          .+...       ...+..++.++.+++.+|+..||++||++.|+++.|++
T Consensus       229 ----~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         229 ----RHGNR-------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             ----HcCCC-------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                11110       11123567789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.8e-35  Score=315.38  Aligned_cols=248  Identities=29%  Similarity=0.435  Sum_probs=200.9

Q ss_pred             ceeeccccceEEEEEecCCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHH
Q 048205          756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE  834 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  834 (1027)
                      ++||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999875433 33456888999999999999999999999999999999999999999


Q ss_pred             HHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceeccccc
Q 048205          835 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA  914 (1027)
Q Consensus       835 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  914 (1027)
                      +++......+++.++..++.|++.|+.|+|   +.+++||||||+||+++.++.+|++|||++....... ........+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            998776666899999999999999999999   9999999999999999999999999999987532211 111112234


Q ss_pred             CccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       915 t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      ++.|+|||+.....++.++||||+|+++||+++ |..||.......  ....            +....      ....+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~------------~~~~~------~~~~~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQ------------VEKGY------RMSCP  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHH------------HHcCC------CCCCC
Confidence            567999999998889999999999999999998 999986542111  1110            00100      00112


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ..++..+.+++.+|+..+|++||++.|+++.|++
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  250 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA  250 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence            2356778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=324.99  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=201.2

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      +|+..+.||+|+||+||+|... +++.||+|++.....   .....+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999865 689999999874321   223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 45899999999999999999999   9999999999999999999999999999998643221 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.         ..+....   
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~---------~~~~~~~---  221 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVE---------RRVKEDQ---  221 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHH---------HHhhhcc---
Confidence              122346899999999999888999999999999999999999999764221 1111110         1111100   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                          ...+..++..+.+++.+|+..||++||     ++.++++
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 ----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                011223566789999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-35  Score=336.79  Aligned_cols=258  Identities=22%  Similarity=0.276  Sum_probs=202.4

Q ss_pred             HHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       744 ~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      ++....++|+..+.||+|+||.||+|+++ +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.+.+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445688999999999999999999976 68899999986432   223455778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++||||+++|+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            999999999999999988654  3788888999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      +.... .......+||+.|+|||++...    .++.++||||+||++|||++|+.||...... ....            
T Consensus       192 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~------------  257 (371)
T cd05622         192 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYS------------  257 (371)
T ss_pred             cCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHH------------
Confidence            54322 1222345799999999998754    3788999999999999999999999764211 1111            


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVTK 1024 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~~ 1024 (1027)
                      .+....    ....++.....+..+.+++.+|+..++.+  |+++.|+++.
T Consensus       258 ~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         258 KIMNHK----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHcCC----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            111100    00111122345667889999999844443  7899998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=341.26  Aligned_cols=264  Identities=26%  Similarity=0.313  Sum_probs=195.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecC--------
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--------  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  818 (1027)
                      ...+|+..+.||+|+||.||+|+.. +++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999875 68899999885432    2345699999999999999998876432        


Q ss_pred             CeeEEEEEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeee
Q 048205          819 DFKALVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDF  894 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  894 (1027)
                      ...++||||+++ ++.+++..   ....+++..+..++.||+.||+|||   +.+|+||||||+||+++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999986 77776643   3456899999999999999999999   99999999999999998665 7999999


Q ss_pred             cCCcccccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      |+|+.+....   ......||+.|+|||++.+. .++.++||||+||++|||++|++||.+.... ..+...+.......
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence            9998654322   22345689999999988654 6899999999999999999999999764322 22222222111111


Q ss_pred             HH--Hhhhcccc-------CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 IM--EVVDANLL-------SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ~~--~~~d~~~~-------~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..  ....+...       .........+...+.++.+|+.+||.+||++|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00  00011000       0001111223345678999999999999999999999985

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.1e-35  Score=324.24  Aligned_cols=254  Identities=26%  Similarity=0.437  Sum_probs=202.9

Q ss_pred             CCCccceeeccccceEEEEEec------CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      +|+..+.||+|+||.||+|+..      ....+|+|.+..... .....+..|+++++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999753      235789998865432 345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 048205          824 VLEYMPYGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN  880 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  880 (1027)
                      |+||+.+|+|.+++....                       ..+++.++..++.|++.|++|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999876421                       24788999999999999999999   9999999999999


Q ss_pred             EEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccc
Q 048205          881 VLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGE  959 (1027)
Q Consensus       881 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~  959 (1027)
                      |++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |+.||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543332222233345678999999988889999999999999999998 99998653211 


Q ss_pred             hhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          960 MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       960 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                       .+.+            ......      ....+..++.++.+++.+|++.+|++||++.|+++.|++
T Consensus       237 -~~~~------------~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         237 -RLFN------------LLKTGY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             -HHHH------------HHhCCC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence             1111            111111      011123456678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.5e-35  Score=319.88  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=197.0

Q ss_pred             CCccceeeccccceEEEEEecC-Cc--eEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC------Ce
Q 048205          752 FSENNLIGRGGFGFVYKARIQD-GM--EVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD------DF  820 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  820 (1027)
                      |.+.+.||+|+||.||+|++.+ ++  .||+|.++...  ....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999998764 33  68999886542  33456788899999999999999999987432      24


Q ss_pred             eEEEEEecCCCCHHHHHhc-----CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          821 KALVLEYMPYGSLEKCLYS-----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                      .++||||+++|+|.+++..     ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988742     2244789999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      +++.+.............+++.|+|||+..+..++.++||||+||++|||++ |+.||......  ....   ..     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~---~~-----  227 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYD---YL-----  227 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH---HH-----
Confidence            9986543322111222346678999999999899999999999999999999 78888653211  1111   00     


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                         ....       ....+..++..+.+++.+||.++|++|||+.++++.|+.
T Consensus       228 ---~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         228 ---RQGN-------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             ---HcCC-------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence               0000       001123456678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.4e-35  Score=321.18  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=202.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCc----eEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGM----EVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      .++|+..+.||+|+||+||+|++. +|+    .||+|++.... ....+.+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            356888999999999999999864 454    48999886443 33456788899999999999999999999764 468


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +++||+++|+|.+++......+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876666899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ...........+++.|+|||...+..++.++|||||||++|||++ |..||.....  .....++.            ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~------------~~  227 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLE------------KG  227 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH------------CC
Confidence            322222222345678999999998889999999999999999998 8898865321  11112111            11


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .      ....+..++.++.+++.+||..||++||++.++++.++
T Consensus       228 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         228 E------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             C------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            0      00112345677899999999999999999999998775

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=303.79  Aligned_cols=249  Identities=24%  Similarity=0.297  Sum_probs=205.4

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..++|...+++|+|.||.|-+++-+ +|+.||+|+++++.-   ..++....|-++++..+||.+..+...|+..++.+.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467888999999999999999855 799999999987642   334556678999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+.||.|.-++.+.+ .+++.....+-.+|+.||.|||   +++||+||+|.+|.|+|.||++||+|||+++.-.. 
T Consensus       246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-  320 (516)
T ss_pred             EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence            999999999998887654 4788888889999999999999   99999999999999999999999999999984322 


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                       ....+...||||.|.|||++....|+.++|+|.+|||+|||++|+.||.....+..              .+.+--   
T Consensus       321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------------FeLIl~---  382 (516)
T KOG0690|consen  321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------------FELILM---  382 (516)
T ss_pred             -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------------HHHHHh---
Confidence             23456678999999999999999999999999999999999999999987533211              111000   


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                          .....|...+++...|+...+.+||.+|.     .++||.+
T Consensus       383 ----ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  383 ----EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ----hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                01112334566778899999999999997     5666654

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.6e-35  Score=324.11  Aligned_cols=263  Identities=25%  Similarity=0.372  Sum_probs=205.9

Q ss_pred             hCCCCccceeeccccceEEEEEecC-----------------CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccce
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD-----------------GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIK  810 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  810 (1027)
                      ..+|++.+.||+|+||.||+|+...                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3568899999999999999997542                 2458999987543 234567889999999999999999


Q ss_pred             EEeEEecCCeeEEEEEecCCCCHHHHHhcCC----------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 048205          811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN  880 (1027)
Q Consensus       811 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  880 (1027)
                      +++++...+..++||||+++++|.+++....          ..+++..+..++.|++.|++|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987644          25899999999999999999999   9999999999999


Q ss_pred             EEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCccc
Q 048205          881 VLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--RKKPTDESFTG  958 (1027)
Q Consensus       881 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~  958 (1027)
                      |+++.++.++++|||+++...............+++.|+|||+.....++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986543322222333456788999999988889999999999999999998  66777543211


Q ss_pred             chhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          959 EMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       959 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        .....+        .+......   .......+..++.++.+++.+|++.||++||++.|+++.|++
T Consensus       241 --~~~~~~--------~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 --QVIENA--------GHFFRDDG---RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHH--------Hhcccccc---ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              111111        01100000   000111123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.7e-35  Score=323.44  Aligned_cols=250  Identities=25%  Similarity=0.342  Sum_probs=204.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|||++++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999864 68999999988665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998653  3788999999999999999999   99999999999999999999999999999875432221  1


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......    .+..        ......      .
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~--------~~~~~~------~  234 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL--------IATNGT------P  234 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHH--------HhcCCC------C
Confidence            233468899999999998889999999999999999999999997543211    1100        000000      0


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ....+...+..+.+++.+|+.++|++||++.++++.
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            011122355668899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-35  Score=326.45  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=204.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec--------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEec
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSS  817 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  817 (1027)
                      ...+|.+.+.||+|+||.||+|++.        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3456888999999999999999742        34579999886442 34456788999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 048205          818 DDFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL  882 (1027)
Q Consensus       818 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  882 (1027)
                      ....++||||+++|+|.+++....               ..+++.++..++.||++|++|||   +.+++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            999999999999999999987532               24778889999999999999999   999999999999999


Q ss_pred             EcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchh
Q 048205          883 LDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMT  961 (1027)
Q Consensus       883 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  961 (1027)
                      ++.++.+||+|||.++.+.............+++.|+|||++.+..++.++||||+|+++||+++ |..||....     
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----  244 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----  244 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence            99999999999999986643332222233345678999999988889999999999999999998 778875432     


Q ss_pred             HHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          962 LKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       962 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..++....         ....      ....+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus       245 ~~~~~~~~---------~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~  294 (304)
T cd05101         245 VEELFKLL---------KEGH------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD  294 (304)
T ss_pred             HHHHHHHH---------HcCC------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            11111111         0000      01112346678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.4e-35  Score=317.58  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=203.3

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      ++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++.. ...++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            46888999999999999999988888999999875433 34578899999999999999999998854 56789999999


Q ss_pred             CCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          830 YGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       830 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +++|.+++.... ..+++.++..++.+++.|++|||   +.+++||||||+||++++++.++++|||.+..+..... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence            999999987643 45899999999999999999999   99999999999999999999999999999986533221 11


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....++..|+|||+.....++.++||||||+++|||++ |+.||......  ....+            +....     
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~------------~~~~~-----  220 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQ------------VERGY-----  220 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HHcCC-----
Confidence            122335668999999988889999999999999999999 88888653211  11111            11100     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                       ..+.+..++..+.+++.+|+.++|++|||+.++.+.|+.
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             011123456779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.6e-35  Score=317.63  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=202.2

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .+|++.+.||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            46889999999999999999987777899999875332 34578899999999999999999998754 55799999999


Q ss_pred             CCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          830 YGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       830 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +|+|.+++.... ..+++..+..++.|+++|++|+|   +.+++||||||+||+++.++.++|+|||.++.+..... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence            999999997643 45789999999999999999999   99999999999999999999999999999986543221 11


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....++..|+|||+..+..++.++||||+||++||+++ |+.||........    + .         ......     
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----~-~---------~~~~~~-----  220 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----L-D---------QVERGY-----  220 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----H-H---------HHhcCC-----
Confidence            223346678999999988889999999999999999999 7888865422110    0 0         000000     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       .......++..+.+++.+|++.+|++||++.+++++|+
T Consensus       221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence             01112345677899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=339.73  Aligned_cols=265  Identities=25%  Similarity=0.441  Sum_probs=220.5

Q ss_pred             ccccHHHHHHHh---------CCCCccceeeccccceEEEEEec-CC---ceEEEEEEeccc-chhHHHHHHHHHHHhhc
Q 048205          738 RRFTYLELFQAT---------NGFSENNLIGRGGFGFVYKARIQ-DG---MEVAVKVFDLQY-GRAIKSFDIECGMIKRI  803 (1027)
Q Consensus       738 ~~~~~~~~~~~~---------~~f~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l  803 (1027)
                      .+++|++.-++.         ....+.++||.|.||+||+|+++ .|   ..||||.++... .+...+|..|+.+|.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            355666654443         33456789999999999999976 23   469999998654 44567899999999999


Q ss_pred             cCCccceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       804 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      +||||+++.|+......+.||.|||++|+|+.+++..+..+.+.+...+..+||.|+.||-   ++++|||||.++|||+
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV  764 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV  764 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence            9999999999999999999999999999999999999888999999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceeccccc--CccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccch
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA--TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEM  960 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  960 (1027)
                      +.+-.+|++|||+++.+..+ ....++...|  ...|.|||.+...+++.++||||+|+|+||.++ |.+||-++...  
T Consensus       765 NsnLvCKVsDFGLSRvledd-~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--  841 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDD-PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--  841 (996)
T ss_pred             ccceEEEeccccceeecccC-CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--
Confidence            99999999999999966433 2222333333  467999999999999999999999999999887 88887543221  


Q ss_pred             hHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          961 TLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       961 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                     +++...   +...+.+.|.+||..+.+||..||++|-.+||.+.||+..|.
T Consensus       842 ---------------dVIkaI---e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  842 ---------------DVIKAI---EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD  889 (996)
T ss_pred             ---------------HHHHHH---HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence                           111110   134466778899999999999999999999999999998875

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6e-35  Score=315.67  Aligned_cols=246  Identities=24%  Similarity=0.410  Sum_probs=197.1

Q ss_pred             eeeccccceEEEEEec---CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          757 LIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      .||+|+||.||+|++.   ++..||+|++..... ...+.+.+|++++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999764   355799999875533 334678899999999999999999998864 56899999999999


Q ss_pred             HHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce-ecc
Q 048205          833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT-QTQ  911 (1027)
Q Consensus       833 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  911 (1027)
                      |.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||++..+........ ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999866667899999999999999999999   89999999999999999999999999999986543322111 111


Q ss_pred             cccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       912 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ..+++.|+|||.+....++.++|||||||++||+++ |+.||......+  ...            .+....      ..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~------------~~~~~~------~~  217 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMS------------FIEQGK------RL  217 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH------------HHHCCC------CC
Confidence            223578999999988889999999999999999996 999987642211  111            111110      11


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..+..++.++.+++.+||..+|++||++.+|.+.|+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            223456778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=358.72  Aligned_cols=462  Identities=29%  Similarity=0.380  Sum_probs=295.3

Q ss_pred             CCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEcc
Q 048205           76 LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLS  155 (1027)
Q Consensus        76 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  155 (1027)
                      |+.||+++|++. ..|..+..+.+|+.|+++.|-|. .++ ..+..+.+|++|.|.+|++. ..|..+..+++|++|+++
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp-~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVP-SSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS  122 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCc-hhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence            444444444444 44444444444444444444443 122 22233334444444444443 567777777888888888


Q ss_pred             CCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCC
Q 048205          156 INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNF  235 (1027)
Q Consensus       156 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  235 (1027)
                      .|++. .+|..+..++.+..+..++|.....    ++... ++.+++..|.+.+.++..+..+..  .|||++|.+. . 
T Consensus       123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~-  192 (1081)
T KOG0618|consen  123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V-  192 (1081)
T ss_pred             hhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h-
Confidence            88776 6777777777777777777722212    22222 677777777777777666666655  6777777764 0 


Q ss_pred             CcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcC
Q 048205          236 PKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH  315 (1027)
Q Consensus       236 p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  315 (1027)
                                      .                                 .+.++.+|+.|....|++...    --..+
T Consensus       193 ----------------~---------------------------------dls~~~~l~~l~c~rn~ls~l----~~~g~  219 (1081)
T KOG0618|consen  193 ----------------L---------------------------------DLSNLANLEVLHCERNQLSEL----EISGP  219 (1081)
T ss_pred             ----------------h---------------------------------hhhhccchhhhhhhhcccceE----EecCc
Confidence                            0                                 112233444444444444321    11234


Q ss_pred             cccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeec
Q 048205          316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL  395 (1027)
Q Consensus       316 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  395 (1027)
                      +|+.|+.++|.++...+.  .--.+|+++++++|+++ .+|++ ...+.+|+.++..+|+++ .+|..+...++|+.|.+
T Consensus       220 ~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~w-i~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~  294 (1081)
T KOG0618|consen  220 SLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEW-IGACANLEALNANHNRLV-ALPLRISRITSLVSLSA  294 (1081)
T ss_pred             chheeeeccCcceeeccc--cccccceeeecchhhhh-cchHH-HHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence            455555555555432221  12235666666666663 45533 335666666666666664 56666666667777777


Q ss_pred             CCCcccCCCCcccCCcccccEEecCCCCCCCCCCcccccccccc-ccccEeeccCCCCCCCCCccccCcccccceeecCC
Q 048205          396 QRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNC-KYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPN  474 (1027)
Q Consensus       396 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~  474 (1027)
                      .+|.+. -+|....+++.|++|+|..|+|.++|....    .-. ..|+.|+.+.|++...+ ..=......++.|++.+
T Consensus       295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l----~v~~~~l~~ln~s~n~l~~lp-~~~e~~~~~Lq~Lylan  368 (1081)
T KOG0618|consen  295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFL----AVLNASLNTLNVSSNKLSTLP-SYEENNHAALQELYLAN  368 (1081)
T ss_pred             hhhhhh-hCCCcccccceeeeeeehhccccccchHHH----hhhhHHHHHHhhhhccccccc-cccchhhHHHHHHHHhc
Confidence            777776 345566667777777777777766665221    112 23666666777766554 22222335577788888


Q ss_pred             CccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccE
Q 048205          475 SNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILC  554 (1027)
Q Consensus       475 n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~  554 (1027)
                      |.++...=..+.+...|+.|+|++|++.......+.++..|++|+||+|+|              +.+|.++.++..|+.
T Consensus       369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL--------------~~Lp~tva~~~~L~t  434 (1081)
T KOG0618|consen  369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKL--------------TTLPDTVANLGRLHT  434 (1081)
T ss_pred             CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchh--------------hhhhHHHHhhhhhHH
Confidence            888877777888899999999999999976667799999999999999998              688999999999999


Q ss_pred             EecCCCccccCccccccCcccccEEcccccccccc-cchhhccCccccEEEccCCccccCccccccccccccccccccc
Q 048205          555 LNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDV-IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNN  632 (1027)
Q Consensus       555 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N  632 (1027)
                      |...+|++. ..| ++..+++|+.+|+|.|+++.. +|..... ++|++|||++|.=.-.=-..+..++.+..++++-|
T Consensus       435 L~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  435 LRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             HhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            999999999 578 899999999999999999843 4444333 89999999999832122345666777777777776

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-35  Score=336.84  Aligned_cols=266  Identities=19%  Similarity=0.181  Sum_probs=200.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ..+|.+.+.||+|+||.||+|++. +++.||||...      ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999876 57889999642      23456799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +. ++|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6899888766567899999999999999999999   9999999999999999999999999999998654322222


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc------chhHHHHHHHHHhh--h------
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG------EMTLKRWVNDLLLI--S------  973 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~------~~~~~~~~~~~~~~--~------  973 (1027)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..|+......      ...+.+.+......  .      
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            223456999999999999999999999999999999999988765432111      01111111111000  0      


Q ss_pred             --HHHhhhcc-----ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 --IMEVVDAN-----LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 --~~~~~d~~-----~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        ....+...     ........+........++.+|+.+||+.||++|||+.|+++.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence              00000000     0000000111111234568899999999999999999999974

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-35  Score=314.20  Aligned_cols=249  Identities=31%  Similarity=0.464  Sum_probs=201.7

Q ss_pred             ceeeccccceEEEEEecCCceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHH
Q 048205          756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE  834 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  834 (1027)
                      ++||+|+||.||+|...+++.||+|.+...... ..+.+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998755433 4567889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceeccccc
Q 048205          835 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA  914 (1027)
Q Consensus       835 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  914 (1027)
                      +++......+++..+..++.+++.|++|||   +.+++||||||+||+++.++.+||+|||.+.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776556889999999999999999999   99999999999999999999999999999975432111111112234


Q ss_pred             CccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       915 t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      +..|+|||.+.++.++.++||||+||++|||+| |..||.......  ....            +....      ....+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~------------~~~~~------~~~~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRER------------IESGY------RMPAP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHH------------HhcCC------CCCCC
Confidence            567999999988889999999999999999999 788886542211  1111            11100      01112


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ..++.++.+++.+|+..+|++||++.|+++.|.+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            3456679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.4e-35  Score=319.74  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ||+|+||.||+|+.+ +|+.||+|++....   ....+.+..|++++++++||||+++++++......++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 68999999986432   12234456699999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceeccc
Q 048205          834 EKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT  912 (1027)
Q Consensus       834 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  912 (1027)
                      .+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            98876543 45889999999999999999999   999999999999999999999999999998765322   122335


Q ss_pred             ccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhH
Q 048205          913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVA  992 (1027)
Q Consensus       913 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  992 (1027)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+..        .......    .  . .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~--------~~~~~~~----~--~-~  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKR--------RTLEDEV----K--F-E  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHH--------Hhhcccc----c--c-c
Confidence            68999999999998889999999999999999999999987532211 1111111        0111110    0  0 0


Q ss_pred             HhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          993 KEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       993 ~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...++.++.+++.+|+.+||++||+++|+++.
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            12356678999999999999999999766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.9e-35  Score=318.66  Aligned_cols=256  Identities=24%  Similarity=0.349  Sum_probs=205.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+...   .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999964 7899999987643   2234467888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++++|.+++..   ....+++..+..++.|+++|++|||   +.+++|+||||+||+++.++.++++|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998764   2345899999999999999999999   99999999999999999999999999999876532


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ...  ......++..|+|||+..+..++.++||||+|+++|+|++|+.||.....+.   ..+....     .+...+. 
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~-----~~~~~~~-  227 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKI-----EQCDYPP-  227 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HHHhhhh-----hcCCCCC-
Confidence            221  1223468889999999988889999999999999999999999986532211   1111110     0000000 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                              ..+..++..+.+++.+||..+|++|||+.+|++.+++
T Consensus       228 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         228 --------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             --------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence                    0112356678999999999999999999988887763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-35  Score=326.11  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=204.1

Q ss_pred             HhCCCCccceeeccccceEEEEEecC------CceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCC
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  819 (1027)
                      ..++|+..+.||+|+||.||+|++..      ...+|+|.+.... .+....+.+|+++++++ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34568888999999999999998642      3679999987542 23446688899999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcC---------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 048205          820 FKALVLEYMPYGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  884 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  884 (1027)
                      ..++||||+++|+|.+++...               ...+++..+..++.|++.|++|||   +.+|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999998642               245889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHH
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLK  963 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  963 (1027)
                      .++.+|++|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||......+  ..
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~  244 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF  244 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence            999999999999986543322222222234677999999988899999999999999999998 888886532111  01


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .            ......      ....+..++..+.+++.+|+..+|++|||+.|+++.|+
T Consensus       245 ~------------~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         245 K------------LLKEGY------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             H------------HHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence            1            011110      01112345667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.2e-35  Score=315.70  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=204.7

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|++|.||+|+.+ +++.||+|.+...  .....+.+..|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999876 6899999998743  234456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++... ...+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998765 456889999999999999999999   99999999999999999999999999999886543221 


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                       ......+++.|+|||+..+..++.++|+|||||++|||++|+.||......  .....+           .. ....  
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~-----------~~-~~~~--  219 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKI-----------IR-GVFP--  219 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-----------Hc-CCCC--
Confidence             223346889999999999999999999999999999999999999754311  111110           00 0000  


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          ..+..++..+.+++.+||+.+|++||++.++++.
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                0112456678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-35  Score=331.36  Aligned_cols=237  Identities=29%  Similarity=0.341  Sum_probs=189.3

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHH-HHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECG-MIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|+.. +|+.||||++....   ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999976 68999999987542   122234444444 56789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence            99999887644 5788999999999999999999   999999999999999999999999999998753221  12233


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......     +...        .+.....        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~--------~i~~~~~--------  213 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYD--------NILNKPL--------  213 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHH--------HHHcCCC--------
Confidence            456899999999999999999999999999999999999999764211     1111        1111111        


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAK 1019 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~ 1019 (1027)
                      ..+...+..+.+++.+|++.||++||+++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11123466788999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.1e-35  Score=323.49  Aligned_cols=262  Identities=24%  Similarity=0.384  Sum_probs=202.9

Q ss_pred             CCCCccceeeccccceEEEEEec-----------------CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-----------------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKF  811 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  811 (1027)
                      ++|++.+.||+|+||.||+|++.                 ++..||+|++.... ....+.+.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999998643                 23468999987543 3345678899999999999999999


Q ss_pred             EeEEecCCeeEEEEEecCCCCHHHHHhcCC----------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 048205          812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNV  881 (1027)
Q Consensus       812 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  881 (1027)
                      ++++...+..++||||+++|+|.+++....          ..+++.++..++.|++.|++|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999987542          23677889999999999999999   99999999999999


Q ss_pred             EEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCcccc
Q 048205          882 LLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--RKKPTDESFTGE  959 (1027)
Q Consensus       882 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~  959 (1027)
                      +++.++.++++|||+++.+.............+++.|+|||....+.++.++||||+||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999986543322112222334678999999888889999999999999999998  67787643221 


Q ss_pred             hhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          960 MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       960 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                          +++...     .+.......   ......+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       241 ----~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 ----QVIENT-----GEFFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ----HHHHHH-----HHHHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                111110     011110000   00011123456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-35  Score=337.95  Aligned_cols=266  Identities=21%  Similarity=0.187  Sum_probs=201.9

Q ss_pred             hCCCCccceeeccccceEEEEEec---CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ..+|.+.+.||+|+||.||+|...   .++.||+|.+...     +...+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   4678999987532     23467999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |++. +++.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.+.....
T Consensus       166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9996 588888843 345899999999999999999999   99999999999999999999999999999986544333


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc--hhHHHHHHHHHhhh----------
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE--MTLKRWVNDLLLIS----------  973 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~----------  973 (1027)
                      ........||+.|+|||++....++.++||||+||++|||++|+.||.......  ..+...++......          
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            333345679999999999999999999999999999999999999997643221  11111111110000          


Q ss_pred             HHHhhhccccC-c---cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 IMEVVDANLLS-H---EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 ~~~~~d~~~~~-~---~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ....+...... .   ..........++.++.+++.+|+..||++||++.|++..
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000000 0   000111112345678899999999999999999999863

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.2e-35  Score=326.86  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=202.4

Q ss_pred             CCCCccceeeccccceEEEEEec--------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD  819 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  819 (1027)
                      ++|.+.+.||+|+||.||+|++.        ++..+|+|.++... ......+..|+++++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46889999999999999999753        23569999987542 33456788899999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  884 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  884 (1027)
                      ..++||||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999997542               24788999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHH
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLK  963 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  963 (1027)
                      .++.+||+|||.++...............+++.|+|||++.+..++.++||||+||++|||++ |+.||.....     .
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----~  249 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----E  249 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----H
Confidence            999999999999976533221111222234568999999998889999999999999999998 8888764321     1


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....         .+....      ....+..++.++.+++.+|++.+|++||++.++++.|.
T Consensus       250 ~~~~---------~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         250 ELFK---------LLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             HHHH---------HHHcCC------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            1111         111110      11122345678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-35  Score=321.13  Aligned_cols=256  Identities=24%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             hCCCCccceeeccccceEEEEEecC------CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|++.+.||+|+||.||+|...+      ++.||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3568889999999999999998642      4689999986443 23345788899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 048205          822 ALVLEYMPYGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  892 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  892 (1027)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986532         23678899999999999999999   9999999999999999999999999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |||+++.+.............++..|+|||....+.++.++|||||||++||+++ |+.||......  ....+..    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~----  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVI----  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHh----
Confidence            9999986543332222233456788999999988889999999999999999998 88888653211  1111110    


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                             +..       ....+..++.++.+++.+||+.+|++|||+.++++.|++
T Consensus       236 -------~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 -------DGG-------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -------cCC-------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                   000       111223456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-35  Score=337.19  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=198.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999876 68999999997432   234566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987654 4889999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 048205          906 S---------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPT  952 (1027)
Q Consensus       906 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~  952 (1027)
                      .                                 ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0112346999999999999999999999999999999999999999


Q ss_pred             CCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048205          953 DESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN---AKEIVT 1023 (1027)
Q Consensus       953 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps---~~evl~ 1023 (1027)
                      ........    + .        .+....    ....++.....+.++.+++.+|+ .||++|++   +.|++.
T Consensus       237 ~~~~~~~~----~-~--------~i~~~~----~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         237 CSETPQET----Y-R--------KVMNWK----ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCHHHH----H-H--------HHHcCC----CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            76432111    0 0        001000    00001111124556788888876 49999985   677664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.3e-35  Score=333.09  Aligned_cols=266  Identities=23%  Similarity=0.258  Sum_probs=198.8

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC-----
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-----  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  819 (1027)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999865 68999999986432  234566778999999999999999999986543     


Q ss_pred             -eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          820 -FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       820 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                       ..++||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             57999999976 66666543   3788889999999999999999   9999999999999999999999999999997


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------  972 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  972 (1027)
                      ....   ........+|+.|+|||++.+..++.++||||+||++|||++|+.||......+ ............      
T Consensus       172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHH
Confidence            5422   122334568999999999999999999999999999999999999997643211 111111110000      


Q ss_pred             ----hHHHhhhccccCcc------------chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 ----SIMEVVDANLLSHE------------DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ----~~~~~~d~~~~~~~------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          ..............            ..........+.++.+++.+|+..||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                00000000000000            00000111235668999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-35  Score=315.95  Aligned_cols=249  Identities=20%  Similarity=0.292  Sum_probs=203.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +|++.+.||+|+||.||+|++. +++.||+|.++.. .....+.+..|+++++.++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999876 6899999998643 2344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|++.+++... ...+++..+..++.|++.|++|||   +.+|+|+||||+||++++++.++++|||.++......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            999999988653 345789999999999999999999   9999999999999999999999999999997653322  1


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||......     ......        .....     
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~--------~~~~~-----  217 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKV--------CQGSY-----  217 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHH--------hcCCC-----
Confidence            223356888999999999888999999999999999999999999753211     111000        00000     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        ...+..++..+.+++.+||..||++||++.+++..
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 --KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              00112345668899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.6e-35  Score=322.64  Aligned_cols=256  Identities=28%  Similarity=0.441  Sum_probs=205.0

Q ss_pred             hCCCCccceeeccccceEEEEEec------CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|+..+.||+|+||.||+|+..      +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457889999999999999999853      467899999875432 3346788899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC---------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 048205          822 ALVLEYMPYGSLEKCLYSSN---------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN  880 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  880 (1027)
                      ++||||+++|+|.+++....                     ..+++.+++.++.|++.|++|||   +.+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999986432                     24678889999999999999999   9999999999999


Q ss_pred             EEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccc
Q 048205          881 VLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGE  959 (1027)
Q Consensus       881 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~  959 (1027)
                      |+++.++.++++|||++..+..............++.|+|||...+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999875533222112222345677999999988899999999999999999998 88888653211 


Q ss_pred             hhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          960 MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       960 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                          ++...        +.+...       ...+..++.++.+++.+|++.+|++||++.|+++.|++
T Consensus       240 ----~~~~~--------~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVIYY--------VRDGNV-------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHH--------HhcCCC-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                11111        111111       01123456779999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-35  Score=322.99  Aligned_cols=256  Identities=23%  Similarity=0.388  Sum_probs=202.2

Q ss_pred             HhCCCCccceeeccccceEEEEEec------CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCe
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  820 (1027)
                      ..++|++.+.||+|+||.||+|+.+      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999754      245799998764432 233467789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          821 KALVLEYMPYGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                      .++||||+++|+|.+++....         ...++..+..++.|++.|++|||   +++|+||||||+||+++.++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986532         23466788899999999999999   999999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +|||+++...............++..|+|||...++.++.++||||+||++|||++ |+.||......     ++...  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~--  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKF--  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH--
Confidence            99999986543322222222345678999999998899999999999999999999 78888653211     11111  


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            +.+...       ...+..++..+.+++.+|++.||++||++.++++.++
T Consensus       234 ------~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  276 (288)
T cd05061         234 ------VMDGGY-------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK  276 (288)
T ss_pred             ------HHcCCC-------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                  111111       0112244567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.3e-38  Score=340.68  Aligned_cols=364  Identities=27%  Similarity=0.399  Sum_probs=215.4

Q ss_pred             CCcEEEccCCccc-cccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEc
Q 048205          148 HLQTLSLSINDFS-GDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLEL  226 (1027)
Q Consensus       148 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  226 (1027)
                      -.+-.|+++|.++ +..|.....+++++.|-|...++. .+|++++.+.+|+.|.+++|++. .+-..+..++.|+.+++
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~   85 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV   85 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence            3444555666665 345555666666666666666665 45666666666666666666665 34445555666666666


Q ss_pred             cCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCcccccc
Q 048205          227 SFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCV  306 (1027)
Q Consensus       227 s~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~  306 (1027)
                      ..|++..             +.+|..+| .+..|+.||||+|+++          ++|..+..-+++-.|+||+|+|..+
T Consensus        86 R~N~LKn-------------sGiP~diF-~l~dLt~lDLShNqL~----------EvP~~LE~AKn~iVLNLS~N~IetI  141 (1255)
T KOG0444|consen   86 RDNNLKN-------------SGIPTDIF-RLKDLTILDLSHNQLR----------EVPTNLEYAKNSIVLNLSYNNIETI  141 (1255)
T ss_pred             hcccccc-------------CCCCchhc-ccccceeeecchhhhh----------hcchhhhhhcCcEEEEcccCccccC
Confidence            6666541             13333333 2444555555555555          5666666777788888888888876


Q ss_pred             CCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEcccccc-CCcCccccc
Q 048205          307 IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNF-SGTIPSFIF  385 (1027)
Q Consensus       307 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~  385 (1027)
                      +...|.+++.|-.||||+|++...+| .+..+..|++|.|++|.+... .-.....+++|++|.+|+.+= ...+|..+.
T Consensus       142 Pn~lfinLtDLLfLDLS~NrLe~LPP-Q~RRL~~LqtL~Ls~NPL~hf-QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld  219 (1255)
T KOG0444|consen  142 PNSLFINLTDLLFLDLSNNRLEMLPP-QIRRLSMLQTLKLSNNPLNHF-QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLD  219 (1255)
T ss_pred             CchHHHhhHhHhhhccccchhhhcCH-HHHHHhhhhhhhcCCChhhHH-HHhcCccchhhhhhhcccccchhhcCCCchh
Confidence            66677788888888888888775444 466677777777777765311 000011244555555555332 224555555


Q ss_pred             CCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCccc
Q 048205          386 NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQ  465 (1027)
Q Consensus       386 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  465 (1027)
                      .+.+|..+|||.|.+. .+|+++-++++|+.|+||+|+|+.+                                      
T Consensus       220 ~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL--------------------------------------  260 (1255)
T KOG0444|consen  220 DLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL--------------------------------------  260 (1255)
T ss_pred             hhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee--------------------------------------
Confidence            5555555555555555 4555555555555555555554422                                      


Q ss_pred             ccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCcc
Q 048205          466 SMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPST  545 (1027)
Q Consensus       466 ~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~  545 (1027)
                                      ..+++.+.+|++|+|+.|+++ .+|.++++|++|+.|.+.+|+|.            +..||+.
T Consensus       261 ----------------~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~------------FeGiPSG  311 (1255)
T KOG0444|consen  261 ----------------NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT------------FEGIPSG  311 (1255)
T ss_pred             ----------------eccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc------------ccCCccc
Confidence                            234566778888888888887 78888899999999999998883            3344444


Q ss_pred             ccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccc
Q 048205          546 LWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLK  625 (1027)
Q Consensus       546 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~  625 (1027)
                      |                        |++.+|+.+..++|.+. ..|+.+..+..|+.|.|+.|++- ++|+.|.-|+.|+
T Consensus       312 I------------------------GKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~  365 (1255)
T KOG0444|consen  312 I------------------------GKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLK  365 (1255)
T ss_pred             h------------------------hhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcc
Confidence            4                        44555555555555543 44555555555555555555554 4555555555555


Q ss_pred             cccccccc
Q 048205          626 SLNLSNNN  633 (1027)
Q Consensus       626 ~L~l~~N~  633 (1027)
                      .|||.+|.
T Consensus       366 vLDlreNp  373 (1255)
T KOG0444|consen  366 VLDLRENP  373 (1255)
T ss_pred             eeeccCCc
Confidence            55555554

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-35  Score=316.18  Aligned_cols=248  Identities=30%  Similarity=0.520  Sum_probs=205.5

Q ss_pred             ceeeccccceEEEEEecC----CceEEEEEEecccchh-HHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQD----GMEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|+...    +..||+|++....... .+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998763    7889999987654433 67888999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcC--------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          831 GSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       831 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ++|.+++...        ...+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        466899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ...........+++.|+|||......++.++||||+||++|||++ |..||.....  ....+.           ..+. 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~-----------~~~~-  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEY-----------LRKG-  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH-----------HHcC-
Confidence            332223344557889999999988889999999999999999999 6999876421  111111           1110 


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            .....+..++.++.+++.+|+..+|++||++.|+++.|+
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  111223455778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.3e-35  Score=317.97  Aligned_cols=256  Identities=23%  Similarity=0.440  Sum_probs=205.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CC---ceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DG---MEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|+..+.||+|+||.||+|+.+ ++   ..+|+|.++... ....+.+..|++++++++|||++++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346788899999999999999875 33   379999886543 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999776666899999999999999999999   999999999999999999999999999999865432


Q ss_pred             CCcce-ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          904 DQSLT-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       904 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ..... ......++.|+|||++....++.++||||+||++||+++ |+.||......     .+....         ...
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i---------~~~  226 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAI---------NDG  226 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHH---------hcC
Confidence            21111 111223457999999988889999999999999999997 99998653211     111111         000


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .      ..+....++.++.+++.+|+..+|++||++.+|++.|++
T Consensus       227 ~------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         227 F------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             C------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            0      111123456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.3e-35  Score=321.05  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=202.0

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      |++.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++|||++++++++......++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999876 5788999998765555667788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      ++|.+++......+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+|++|||++......  .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence            9999988765666899999999999999999999   999999999999999999999999999998754322  11223


Q ss_pred             ccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          911 QTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      ...+++.|+|||++.     ...++.++||||+||++|||++|++||......+ .......            .     
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~------------~-----  223 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK------------S-----  223 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhh------------c-----
Confidence            356889999999874     3457789999999999999999999987532111 1111100            0     


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .......+..++.++.+++.+||..+|++||++.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         224 EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111122356678999999999999999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.3e-35  Score=318.71  Aligned_cols=255  Identities=23%  Similarity=0.426  Sum_probs=204.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CC---ceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DG---MEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .+|+..+.||+|+||.||+|++. ++   ..||||++.... ....+.+..|++++++++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34778899999999999999865 33   369999987543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||++..+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999987554322


Q ss_pred             Ccceecccc---cCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          905 QSLTQTQTL---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       905 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .........   .+..|+|||+.....++.++||||+||++||+++ |..||.....  .....++.            .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~------------~  226 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIE------------Q  226 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHH------------c
Confidence            211111111   2457999999998899999999999999999886 9999865321  11122111            0


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .      .....+..++..+.+++.+||..+|++||++.+++..|++
T Consensus       227 ~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         227 D------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             C------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            0      0111123466778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.2e-35  Score=315.18  Aligned_cols=250  Identities=26%  Similarity=0.371  Sum_probs=207.5

Q ss_pred             hCCCCccceeeccccceEEEEEecC-CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|+..+.||+|+||.||+|++.+ ++.||+|.+.....  .+.+.+|++++++++||||+++++++.+....++|+||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3578899999999999999999874 88999999875433  67889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++++|.+++......+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.+||+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            9999999999876677899999999999999999999   99999999999999999999999999999986543221  


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......++..|+|||++.+..++.++||||+||++|+|++|+.||........ ...             ...    ...
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~-------------~~~----~~~  216 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFM-------------IPN----KPP  216 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhh-------------hcc----CCC
Confidence            22334578899999999988999999999999999999999999875422111 000             000    001


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....+..++.++.+++.+|++.+|++||++.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111223345667899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-35  Score=331.89  Aligned_cols=238  Identities=25%  Similarity=0.341  Sum_probs=193.2

Q ss_pred             ceeeccccceEEEEEe----cCCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          756 NLIGRGGFGFVYKARI----QDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999975    3578999999975432  233456779999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999986543 4899999999999999999999   9999999999999999999999999999998543221  123


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+....        
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~--------~i~~~~--------  214 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMT--------MILKAK--------  214 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHH--------HHHcCC--------
Confidence            3457899999999999888999999999999999999999999754211     1100        011000        


Q ss_pred             hhHHhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 048205          990 FVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020 (1027)
Q Consensus       990 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~e 1020 (1027)
                      ...+..++.++.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0112235667889999999999999999543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.6e-35  Score=315.74  Aligned_cols=240  Identities=22%  Similarity=0.368  Sum_probs=191.2

Q ss_pred             ceeeccccceEEEEEecC-------------CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          756 NLIGRGGFGFVYKARIQD-------------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      +.||+|+||.||+|++.+             ...||+|+++.......+.+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2358899877655555567888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-------EEEeeec
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-------AHLSDFG  895 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~Dfg  895 (1027)
                      +||||+++|+|..++......+++..+..++.||++|++|||   +.+|+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999988776666899999999999999999999   999999999999999987664       8999999


Q ss_pred             CCcccccCCCcceecccccCccccCccccc-CCCCCcchhHHHHHHHHHHHH-cCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETF-TRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      ++..+..      .....++..|+|||.+. ...++.++||||+||++|||+ +|+.||......+  ...         
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~---------  220 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KER---------  220 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHH---------
Confidence            9875422      12345788899999887 466889999999999999998 5787775432111  000         


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         ......        ........++.+++.+||+.||++||++.++++.|.
T Consensus       221 ---~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 ---FYEGQC--------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ---HHhcCc--------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence               000000        001123456889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-35  Score=317.76  Aligned_cols=252  Identities=31%  Similarity=0.462  Sum_probs=200.3

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccchhH--HHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      |+..+.||+|+||+||+|+.. +++.||+|++........  ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567889999999999999976 567899999986643322  23345999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++... ..+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||.+..+  ......
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred             cccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence            999999999833 34799999999999999999999   899999999999999999999999999999754  122234


Q ss_pred             ecccccCccccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....++..|+|||+.. +..++.++||||+|+++|+|++|..||......  .............   ...        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~---~~~--------  221 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKRP---LPS--------  221 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHTH---HHH--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhccccc---ccc--------
Confidence            45567899999999998 788999999999999999999999999865111  1111111000000   000        


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ...........+.+++.+|++.||++||++.++++
T Consensus       222 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 -SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00011112367899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.9e-35  Score=320.37  Aligned_cols=256  Identities=22%  Similarity=0.368  Sum_probs=206.2

Q ss_pred             HhCCCCccceeeccccceEEEEEecC-----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEec-CCe
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQD-----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSS-DDF  820 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  820 (1027)
                      ..++|+..+.||+|+||.||+|.+.+     +..||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678889999999999999999765     6889999886432 3345678889999999999999999998766 567


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                      .++++||+++++|.+++....       ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999986542       35889999999999999999999   99999999999999999999999999


Q ss_pred             ecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhh
Q 048205          894 FGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      ||+++.+.............++..|+|||++....++.++||||+||++||+++ |+.||.....  .....++.     
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~-----  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLK-----  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHH-----
Confidence            999986644332222223346678999999988889999999999999999999 9999875321  11122111     


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                             ...      ....+..++.++.+++.+||..||++||++.++++.|+
T Consensus       234 -------~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         234 -------DGY------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             -------cCC------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence                   000      01112235677899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.6e-35  Score=317.52  Aligned_cols=255  Identities=24%  Similarity=0.421  Sum_probs=204.9

Q ss_pred             CCCCccceeeccccceEEEEEec-C---CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-D---GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .+|++.+.||+|+||.||+|++. +   +..+|+|.++... ....+.+..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999864 2   3479999886543 33456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876666899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             Ccce-ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          905 QSLT-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       905 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .... .....++..|+|||++.+..++.++|+||+||++||+++ |+.||......  ....++           .+.. 
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~-----------~~~~-  226 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAI-----------EEGY-  226 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHH-----------hCCC-
Confidence            2111 111223567999999998889999999999999999887 99998653211  111111           0000 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                            ..+.+..++..+.+++.+|++.+|++||++.++++.|++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                  011123456778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=328.28  Aligned_cols=255  Identities=20%  Similarity=0.256  Sum_probs=199.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999965 68999999987421   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.+....+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999776666899999999999999999999   99999999999999999999999999999876533221


Q ss_pred             cceecccccCccccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          906 SLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                       .......||+.|+|||++..     ..++.++||||+||++|||++|+.||......     +....        +...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~--------i~~~  223 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGK--------IMNH  223 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHH--------HHcC
Confidence             12233468999999999863     45788999999999999999999999753211     11110        1100


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~~ 1024 (1027)
                      ......   ......++.++.+++.+|+..++++  ||++.++++.
T Consensus       224 ~~~~~~---~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         224 KEHFQF---PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCcccC---CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000000   0011235667889999988654443  8899998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.6e-35  Score=315.76  Aligned_cols=253  Identities=23%  Similarity=0.389  Sum_probs=204.5

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|++.+.||+|+||.||+|..++++.||+|.+..... ....+.+|++++++++|+|++++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            356888999999999999999988899999999875433 3467889999999999999999999874 45689999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YT  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cc
Confidence            9999999886543 45889999999999999999999   9999999999999999999999999999997654221 11


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......++..|+|||+.....++.++||||+|+++||+++ |+.||......+  ....            .....    
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~------------~~~~~----  220 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQN------------LERGY----  220 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHH------------HHcCC----
Confidence            1223345678999999998889999999999999999999 999987542211  1111            11110    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        ....+..++.++.+++.+|+..+|++||+++++...|+.
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              011123356679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.2e-35  Score=314.48  Aligned_cols=246  Identities=23%  Similarity=0.385  Sum_probs=196.9

Q ss_pred             eeeccccceEEEEEec---CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          757 LIGRGGFGFVYKARIQ---DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      .||+|+||.||+|.++   +++.||+|+++...  ....+.+..|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   57889999986443  2345678899999999999999999998864 4678999999999


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce-ec
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT-QT  910 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~  910 (1027)
                      +|.+++.... .+++..+..++.|++.|++|+|   +++|+||||||+||+++.++.+||+|||+++.+........ ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999987543 4889999999999999999999   99999999999999999999999999999986543322111 12


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ...+++.|+|||......++.++|||||||++|||++ |+.||......  ....            .+....      .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~------------~i~~~~------~  216 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ------------MIESGE------R  216 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH------------HHHCCC------C
Confidence            2234578999999988889999999999999999998 99998754221  1111            111111      1


Q ss_pred             hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          990 FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       990 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ...+..++.++.+++.+||+.||++||++.+|...|+.
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            11223567789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=6.9e-38  Score=338.26  Aligned_cols=373  Identities=27%  Similarity=0.426  Sum_probs=323.2

Q ss_pred             CCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccc
Q 048205          256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTI  335 (1027)
Q Consensus       256 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  335 (1027)
                      -+|..+-+|+++|-|+|.        .+|.....+++++.|.|...++. .+|+.++.+.+|+.|.+++|++..+ -+.+
T Consensus         5 VLpFVrGvDfsgNDFsg~--------~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~v-hGEL   74 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGD--------RFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISV-HGEL   74 (1255)
T ss_pred             ccceeecccccCCcCCCC--------cCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhh-hhhh
Confidence            356778889999988863        66777888899999999998887 6788999999999999999999864 3457


Q ss_pred             cccCCcceEEccCcccc-ccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccc
Q 048205          336 FNVSTLKFLYLGSNSFF-GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNL  414 (1027)
Q Consensus       336 ~~l~~L~~L~L~~N~l~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  414 (1027)
                      ..++.|+.+.+.+|++- .-+|..+| ++..|..||||+|++. ..|..+...+++-.|+||+|+|..++-..|.+|+-|
T Consensus        75 s~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDL  152 (1255)
T KOG0444|consen   75 SDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDL  152 (1255)
T ss_pred             ccchhhHHHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhH
Confidence            78889999999999883 34777776 6889999999999997 789999999999999999999997666778899999


Q ss_pred             cEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCcccc-ccCcccccccccce
Q 048205          415 KWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISG-SIPKEINNLTNLIA  493 (1027)
Q Consensus       415 ~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~-~~p~~~~~l~~L~~  493 (1027)
                      -.||||+|++..+|..+.     .+..|++|+||+|++.-..-..+..+ .+++.|+|++.+-+- .+|.++..+.||..
T Consensus       153 LfLDLS~NrLe~LPPQ~R-----RL~~LqtL~Ls~NPL~hfQLrQLPsm-tsL~vLhms~TqRTl~N~Ptsld~l~NL~d  226 (1255)
T KOG0444|consen  153 LFLDLSNNRLEMLPPQIR-----RLSMLQTLKLSNNPLNHFQLRQLPSM-TSLSVLHMSNTQRTLDNIPTSLDDLHNLRD  226 (1255)
T ss_pred             hhhccccchhhhcCHHHH-----HHhhhhhhhcCCChhhHHHHhcCccc-hhhhhhhcccccchhhcCCCchhhhhhhhh
Confidence            999999999999998775     56789999999999754322222222 468889998876553 59999999999999


Q ss_pred             EEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCc
Q 048205          494 IYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNL  573 (1027)
Q Consensus       494 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l  573 (1027)
                      ++|+.|.+. .+|+.+.++.+|+.|+||+|+|              +++-...+...+|+.|+||.|+++ .+|+.++++
T Consensus       227 vDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i--------------teL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL  290 (1255)
T KOG0444|consen  227 VDLSENNLP-IVPECLYKLRNLRRLNLSGNKI--------------TELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL  290 (1255)
T ss_pred             ccccccCCC-cchHHHhhhhhhheeccCcCce--------------eeeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence            999999998 8999999999999999999999              466667788899999999999999 699999999


Q ss_pred             ccccEEcccccccc-cccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCccee
Q 048205          574 KVLVQIDLSINNFS-DVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDIN  652 (1027)
Q Consensus       574 ~~L~~L~ls~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~  652 (1027)
                      +.|+.|++.+|++. .-||..||.|.+|+.+..++|.+. -.|..++.+..|+.|.|++|+|. .+|..+.-|+.|..||
T Consensus       291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLD  368 (1255)
T KOG0444|consen  291 TKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLD  368 (1255)
T ss_pred             HHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceee
Confidence            99999999999986 239999999999999999999999 89999999999999999999998 8999999999999999


Q ss_pred             ccCCCCCCCCCC
Q 048205          653 VSFNKLEGEIPR  664 (1027)
Q Consensus       653 l~~N~l~g~~p~  664 (1027)
                      +..|.---.+|.
T Consensus       369 lreNpnLVMPPK  380 (1255)
T KOG0444|consen  369 LRENPNLVMPPK  380 (1255)
T ss_pred             ccCCcCccCCCC
Confidence            999986666665

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-35  Score=330.44  Aligned_cols=240  Identities=27%  Similarity=0.313  Sum_probs=189.6

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHH-HHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIEC-GMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|++. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 57889999987532   11223333343 456888999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+.+..+..++.||++||+|||   +.||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999887654 4678888889999999999999   9999999999999999999999999999997543221  1233


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ..+||+.|+|||++.+..++.++||||+||++|||++|++||......     ....        .+.....        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~--------~i~~~~~--------  213 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYD--------NILNKPL--------  213 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHH--------HHHhCCc--------
Confidence            457999999999999999999999999999999999999999754221     1111        0111100        


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                      ..+...+..+.+++.+|++.||.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            11124566788999999999999999887443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7e-35  Score=322.45  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=199.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCc--eEEEEEEecc-cchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGM--EVAVKVFDLQ-YGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|++.+.||+|+||.||+|+.+ ++.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57889999999999999999875 343  4788887642 233456788899999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          825 LEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      +||+++++|.+++....               ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               24788999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||++.....   .........+..|+|||+.....++.++|||||||++|||++ |+.||......     .+.. 
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~-  229 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYE-  229 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH-
Confidence            9999999863211   111111223457999999988889999999999999999997 99998754221     1111 


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                              ......      ....+..++..+.+++.+|+..+|.+||++.++++.|+
T Consensus       230 --------~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         230 --------KLPQGY------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             --------HHhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                    111111      01112346677899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-35  Score=326.95  Aligned_cols=241  Identities=21%  Similarity=0.287  Sum_probs=193.9

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      +|+..+.||+|+||+||+|+.. +|+.||+|++.+..   ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999865 68999999987542   233456677888888886 567888999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999887654 4889999999999999999999   9999999999999999999999999999987542221 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ....           .+.....   
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~-----------~i~~~~~---  218 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQ-----------SIMEHNV---  218 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH-----------HHHhCCC---
Confidence             1223456899999999999889999999999999999999999999764221  1111           1111110   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                           ..+..++.++.+++.+|++.+|++|+++
T Consensus       219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 1122345678899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-34  Score=320.07  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=203.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45888999999999999999876 58999999998666666778889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +++++..++.+....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......  ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence            999999888766666899999999999999999999   999999999999999999999999999998753221  112


Q ss_pred             ecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          909 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .....+++.|+|||++.     ...++.++||||+||++|||++|+.||..... ......+            ...   
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~------------~~~---  230 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKI------------AKS---  230 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHH------------hcC---
Confidence            23345788999999885     34568899999999999999999999865321 1111111            000   


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .......+..++.++.+++.+||..+|++||++.|+++
T Consensus       231 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 --EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             --CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              00011112345567889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.3e-35  Score=319.82  Aligned_cols=268  Identities=23%  Similarity=0.408  Sum_probs=204.3

Q ss_pred             CCCccceeeccccceEEEEEe-----cCCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeE
Q 048205          751 GFSENNLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKA  822 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  822 (1027)
                      -|++.+.||+|+||.||+|+.     .+++.||+|.++... ......+.+|++++++++|||++++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999974     257889999987543 33456788999999999999999999998775  5689


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++++|.+++.+....+++.++..++.|++.|++|+|   +.+++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999998766556899999999999999999999   99999999999999999999999999999986543


Q ss_pred             CCCcc-eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHH-HHHHHHhhhHHHhhhc
Q 048205          903 EDQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKR-WVNDLLLISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~  980 (1027)
                      ..... ......++..|+|||+..+..++.++||||+||++||+++++.|+............ +..........+....
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            22211 122345677899999998888999999999999999999988765432110000000 0000000000111111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ..      ....+..++.++.+++.+|++.+|++||++.++++.+++
T Consensus       242 ~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         242 GK------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             Cc------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            10      111223467789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=313.86  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=207.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ++|+..+.||.|+||.||+|+.. +++.+|+|++........+.+.+|++++++++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999875 57889999998665556778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++......+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+.......  ..
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence            999999998776566899999999999999999999   9999999999999999999999999999987653321  12


Q ss_pred             ecccccCccccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          909 QTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .....++..|+|||.....   .++.++||||+||++|||++|+.||......... ...       . .....      
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~-------~-~~~~~------  222 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLI-------S-KSNFP------  222 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH-------H-hccCC------
Confidence            2334678899999998776   7889999999999999999999998754221110 000       0 00000      


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ..........+.++.+++.+||..+|++||++.+++.
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 -PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0011122345667899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=320.82  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=206.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ++|++.+.||.|+||.||+|++. +++.||+|++........+.+..|++++++++||||+++++++......++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46888899999999999999875 68999999998666566678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++......+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||++.......  ..
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~  159 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QK  159 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cc
Confidence            999999998876667899999999999999999999   9999999999999999999999999999987543221  12


Q ss_pred             ecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          909 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .....+++.|+|||.+.     ...++.++||||+||++|||++|+.||...... .....+            ..    
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~------------~~----  222 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKI------------LK----  222 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHH------------hc----
Confidence            23346889999999875     345678999999999999999999998754211 111111            00    


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       ........+..++.++.+++.+||+.+|++||++.++++.
T Consensus       223 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 -SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             0001112223456778999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-35  Score=330.79  Aligned_cols=238  Identities=28%  Similarity=0.352  Sum_probs=189.4

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHH-HHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECG-MIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|+.. +|+.||+|++....   ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 68999999987542   122334445544 57789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.||+.||+|||   +.||+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence            99998886543 5889999999999999999999   999999999999999999999999999998753221  12233


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ...        .+.....        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~--------~~~~~~~--------  213 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYD--------NILHKPL--------  213 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHH--------HHHcCCc--------
Confidence            4579999999999999999999999999999999999999997642111     100        1111111        


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKE 1020 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~e 1020 (1027)
                      ..+...+..+.+++.+|+..+|++||++++
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            111234566789999999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.8e-35  Score=327.28  Aligned_cols=263  Identities=24%  Similarity=0.313  Sum_probs=202.2

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CC-----ccceEEeEEecCCeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HR-----NIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~l  823 (1027)
                      +|.+.++||+|+||.|.+|.+. +++.||||+++.. .....+...|+.+|..++ |.     |+|+++++|.-.++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7888999999999999999854 7999999999754 334556677999999997 43     89999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--CCcEEEeeecCCccc
Q 048205          824 VLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKPF  900 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~  900 (1027)
                      |+|.++- +|.++++..+ ..++...++.|+.||+.||.+||   +.+|||+||||+|||+.+  ...+||+|||.|+..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999965 9999998765 55889999999999999999999   999999999999999964  448999999999854


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh--hHHH--
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI--SIME--  976 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~--  976 (1027)
                      ..     ....++-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.. +.+.+...+......  ...+  
T Consensus       342 ~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n-e~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  342 SQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN-EYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             CC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC-HHHHHHHHHHHhCCCCHHHHHhc
Confidence            22     1225677889999999999999999999999999999999987776642 223333333322211  0100  


Q ss_pred             -----hhhc-----c------------------------c---cC-cc-chhhhHHhhhHHHHHHHHHHhcccCCCCCCC
Q 048205          977 -----VVDA-----N------------------------L---LS-HE-DKHFVAKEQCMSFVFNLAMKCTIESPEERIN 1017 (1027)
Q Consensus       977 -----~~d~-----~------------------------~---~~-~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps 1017 (1027)
                           .++.     .                        .   .. .. .............+.+++.+|+.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                 1111     0                        0   00 00 0000011133455899999999999999999


Q ss_pred             HHHHHHH
Q 048205         1018 AKEIVTK 1024 (1027)
Q Consensus      1018 ~~evl~~ 1024 (1027)
                      +.|+++.
T Consensus       496 p~qal~H  502 (586)
T KOG0667|consen  496 PAQALNH  502 (586)
T ss_pred             HHHHhcC
Confidence            9999863

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-34  Score=313.74  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=206.9

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|++++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999977 7999999988642   2233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++|+|.+++..   .+..+++.++..++.++++|++|||   +.+++||||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998864   2345789999999999999999999   99999999999999999999999999999875432


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..  .......+++.|+|||...+..++.++||||+||++|+|++|+.||.....   ...++...         .....
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~---------~~~~~  224 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKK---------IEKCD  224 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhh---------hhcCC
Confidence            21  112234588899999999888899999999999999999999999865321   11111111         00100


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..    . .....++..+.+++.+||..+|++||++.+++++++
T Consensus       225 ~~----~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~  263 (267)
T cd08224         225 YP----P-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK  263 (267)
T ss_pred             CC----C-CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence            00    0 011245667899999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.8e-35  Score=318.05  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=202.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777889999999999999865 68999999988665555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++.... .+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||++......  ...
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence            9999999886554 4889999999999999999999   999999999999999999999999999998755322  122


Q ss_pred             ecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          909 QTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .....|++.|+|||++.   ...++.++||||+||++|||++|+.||.......... ..            ......  
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~------------~~~~~~--  227 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LM------------TKSNFQ--  227 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hh------------hccCCC--
Confidence            23456899999999874   4568889999999999999999999986542211100 00            000000  


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       .........++..+.+++.+|+..+|++||++.++++.
T Consensus       228 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         228 -PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence             00011111345568899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-34  Score=316.07  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .+++.+.....||+|+||.||+|++. +++.||+|.+........+.+.+|++++++++|+||+++++++...+..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            44556666789999999999999865 67889999987666566678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++++|.+++......+  ++..+..++.|++.|++|||   +.+|+||||||+||+++. ++.++|+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999987654434  78888999999999999999   999999999999999976 67999999999875532


Q ss_pred             CCCcceecccccCccccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ...  ......+++.|+|||++....  ++.++||||+|+++|+|++|++||........  ..|..             
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~-------------  224 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKV-------------  224 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhh-------------
Confidence            221  222345789999999986543  78899999999999999999999865322111  11100             


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...   ......+..++.++.+++.+||+.+|++||++.|++..
T Consensus       225 ~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 GMF---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhh---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            000   00011123456678999999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.6e-35  Score=328.84  Aligned_cols=242  Identities=23%  Similarity=0.297  Sum_probs=192.8

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|+.. +++.||+|++++..   ....+.+..|+.++.++ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 67899999998542   23345677899998888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99998886544 4899999999999999999999   9999999999999999999999999999987532221  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc-chhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG-EMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ..+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+....       +....        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~--------  219 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-------ILEKP--------  219 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-------HHhCC--------
Confidence            457999999999999999999999999999999999999999653221 11111111111       00110        


Q ss_pred             hhHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          990 FVAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       990 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                      ...+...+..+.+++.+|+..||++|+++
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            01122345667899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-34  Score=320.66  Aligned_cols=249  Identities=27%  Similarity=0.360  Sum_probs=205.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+|+..+.||.|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            45889999999999999999864 78999999987665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++...  .+++.++..++.+++.|++|||   +.+++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988653  4799999999999999999999   99999999999999999999999999999886533221  1


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      .....+++.|+|||.+.+..++.++||||+||++|++++|+.||........ ...+             ...    ...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~-------------~~~----~~~  233 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI-------------ATN----GTP  233 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-------------Hhc----CCc
Confidence            2234688899999999988899999999999999999999999976432111 0000             000    000


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....+..++..+.+++.+||..||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11122345667889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-34  Score=313.94  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=201.7

Q ss_pred             ceeeccccceEEEEEecC--C--ceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQD--G--MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+..|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998653  3  3699999876655 566788999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc-e
Q 048205          831 GSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL-T  908 (1027)
Q Consensus       831 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~  908 (1027)
                      ++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997765 56899999999999999999999   9999999999999999999999999999998764432221 1


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....++..|+|||+.....++.++||||+||++|||++ |+.||......+  ...   ..         +...     
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~---~~---------~~~~-----  217 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILK---KI---------DKEG-----  217 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---HH---------HhcC-----
Confidence            122446788999999998889999999999999999999 999986532111  111   00         0000     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .....+..++..+.+++.+|+..+|++||++.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence            0011123456778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.4e-35  Score=328.17  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             CCCCccceeeccccceEEEEEe------cCCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecC-Ce
Q 048205          750 NGFSENNLIGRGGFGFVYKARI------QDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD-DF  820 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~  820 (1027)
                      ++|++.+.||+|+||+||+|++      .+++.||||+++... ......+.+|++++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5689999999999999999973      247889999987543 23456688899999999 689999999988654 46


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-----------------------------------------------------------  841 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  841 (1027)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999886421                                                           


Q ss_pred             -------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceeccccc
Q 048205          842 -------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA  914 (1027)
Q Consensus       842 -------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  914 (1027)
                             ..+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++..+.............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                   23678888999999999999999   99999999999999999999999999999986533222222222345


Q ss_pred             CccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       915 t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      ++.|+|||...+..++.++||||+|+++|||++ |..||........    ...         .+.....      ...+
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~---------~~~~~~~------~~~~  304 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCR---------RLKEGTR------MRAP  304 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHH---------HHhccCC------CCCC
Confidence            677999999988889999999999999999997 8889865322111    000         0000000      0011


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...+.++.+++.+||+.+|++||++.|+++.|+
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~  337 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  337 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            224456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6e-35  Score=323.76  Aligned_cols=251  Identities=29%  Similarity=0.456  Sum_probs=198.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCc--eEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGM--EVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|++.+.||+|+||.||+|+++ ++.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56888899999999999999875 454  45777765332 23446788899999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          825 LEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      |||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999987542               24789999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||++.....   ........++..|+|||+.....++.++|||||||++|||+| |..||......     +....
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~  235 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK  235 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHHH
Confidence            9999999863211   111111234567999999988889999999999999999998 99998653221     11110


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .         ....      ....+..++.++.+++.+|++.+|++||++.+++..++
T Consensus       236 ~---------~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         236 L---------PQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             H---------hcCC------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            0         0000      00112235567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-34  Score=321.67  Aligned_cols=268  Identities=22%  Similarity=0.264  Sum_probs=202.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            356889999999999999999876 68899999987443 2233467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |++ ++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            997 4999988776666899999999999999999999   99999999999999999999999999999975432221 


Q ss_pred             ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh---hhHHHhhhccc
Q 048205          907 LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL---ISIMEVVDANL  982 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~~  982 (1027)
                       ......+++.|+|||++.+. .++.++||||+||++|||++|++||......+ ...........   .......+...
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhchhhhcccc
Confidence             22234578899999987654 57889999999999999999999997643211 11111100000   00001111000


Q ss_pred             cCc---c----chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSH---E----DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~---~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...   +    .........++..+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000   0    0001112345677899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.2e-35  Score=331.40  Aligned_cols=267  Identities=22%  Similarity=0.235  Sum_probs=199.2

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC-----
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----  818 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  818 (1027)
                      ...++|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999865 68899999987542  23446677899999999999999999988643     


Q ss_pred             -CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          819 -DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       819 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                       ...++||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357999999976 67666643   3788899999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh------
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL------  971 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------  971 (1027)
                      +....   ........+|+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+.....      
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            85432   122334578999999999998899999999999999999999999997642211 11111110000      


Q ss_pred             ----hhHHHhhhccccCc------------cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          972 ----ISIMEVVDANLLSH------------EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       972 ----~~~~~~~d~~~~~~------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          .......+......            ...........+.++.+++.+|+..||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                00011111000000            000000112234568899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=314.25  Aligned_cols=254  Identities=27%  Similarity=0.441  Sum_probs=206.4

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|++.+.||+|+||.||+|..++++.||||.+..... ..+.+.+|++++++++|+|++++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            467889999999999999999988888999999875432 3467889999999999999999999999988999999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++.... ..+++.++..++.+++.|++|||   +.+++|+||||+||+++.++.+|++|||.+..+.... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999997654 46899999999999999999999   9999999999999999999999999999988654221 11


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......++..|+|||...+..++.++||||+||++||+++ |+.||...... ......             ....    
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~-------------~~~~----  221 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQV-------------ERGY----  221 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH-------------HcCC----
Confidence            1112234568999999998889999999999999999999 99998653211 111110             0000    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        ....+..++.++.+++.+|+..+|++||+++++...|+.
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              011122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=313.73  Aligned_cols=246  Identities=25%  Similarity=0.340  Sum_probs=204.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .+.|+.-++||+|+||+||-++.+ +|+.||.|.+++..-   ........|-+++.++..+.||.+-.+|++++..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            456888999999999999999866 799999998765422   2233456789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          825 LEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      +..|.||+|.-+|+..+ ..+++..+.-++.+|+.||++||   ..+||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999888765 45899999999999999999999   999999999999999999999999999999977543


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .   ....++||.+|||||++..+.|+..+|+||+||++|||+.|+.||......    ..|          |-+|++..
T Consensus       341 ~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk~----------eEvdrr~~  403 (591)
T KOG0986|consen  341 K---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VKR----------EEVDRRTL  403 (591)
T ss_pred             C---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hhH----------HHHHHHHh
Confidence            2   334568999999999999999999999999999999999999999764221    111          22333332


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN 1017 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps 1017 (1027)
                      ....   ..++.++.+..++.+..+++||++|.-
T Consensus       404 ~~~~---ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  404 EDPE---EYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cchh---hcccccCHHHHHHHHHHHccCHHHhcc
Confidence            2221   223567788899999999999999974

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-34  Score=314.52  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=191.8

Q ss_pred             ceeeccccceEEEEEecC---CceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          756 NLIGRGGFGFVYKARIQD---GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      +.||+|+||.||+|++.+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45799998865432 33457888999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC----ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          832 SLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       832 sL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +|.+++....    ...++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987532    24577788899999999999999   9999999999999999999999999999997543322222


Q ss_pred             eecccccCccccCcccccCC-------CCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          908 TQTQTLATIGYMAPEYGREG-------RVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ......++..|+|||++...       .++.++||||+||++|||++ |+.||......+.  ..+.           +.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~-----------~~  224 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT-----------VR  224 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH-----------hh
Confidence            22334567889999987642       35789999999999999996 9999965422211  1100           00


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ........  .......+..+.+++.+|+ .+|++||++.||++.|+
T Consensus       225 ~~~~~~~~--~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         225 EQQLKLPK--PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cccCCCCC--CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000000  0111234556788999999 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.7e-34  Score=312.99  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      ++|...+.||+|++|.||+|++..+..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            4588889999999999999998877789999876432 234678889999999999999999998754 56789999999


Q ss_pred             CCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          830 YGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       830 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||.++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999997643 44789999999999999999999   99999999999999999999999999999976532221 11


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....++..|+|||...+..++.++||||+||++|||++ |+.||......+  ...+..            ...     
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~------------~~~-----  220 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVE------------RGY-----  220 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH------------cCC-----
Confidence            222345678999999988889999999999999999999 899987542211  111110            000     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                       ....+...+..+.+++.+|+.++|++||+++++++.|+.
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             001122456778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-34  Score=321.13  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=203.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|++.+.||+|+||.||+|++. ++..||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999866 688899998875432 3345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++... ..+++..+..++.|+++|++|||   + .+++||||||+||+++.++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999998765 34788999999999999999999   6 58999999999999999999999999998754321   


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh--------------
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI--------------  972 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------------  972 (1027)
                       ......+++.|+|||...+..++.++||||+||++|||++|+.||.....  .....+.......              
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCC
Confidence             12345688999999999888899999999999999999999999865321  1111111100000              


Q ss_pred             -------hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 -------SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 -------~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             ...+..+...... .... ....++.++.+++.+|+..+|++||++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEP-PPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCC-CccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0000111000000 0000 011256678999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-34  Score=311.51  Aligned_cols=249  Identities=30%  Similarity=0.460  Sum_probs=205.1

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            456888999999999999999875 78999999875543 4577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999999987654 35899999999999999999999   9999999999999999999999999999998652211   


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                        .....+..|+|||++..+.++.++||||+|+++||+++ |+.||......  .....            +....    
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~------------~~~~~----  216 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPH------------VEKGY----  216 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HhcCC----
Confidence              12234567999999988889999999999999999997 99998653211  11110            00000    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        ....+..++.++.+++.+|+..+|++||++.|++++|+.
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              011123456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.8e-35  Score=327.40  Aligned_cols=237  Identities=26%  Similarity=0.316  Sum_probs=188.3

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHH-HHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIEC-GMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|+.. +++.||+|++.+..   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 68899999987542   12233444444 467889999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99998886543 4788888999999999999999   9999999999999999999999999999987532221  2233


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .....        .+....        .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~--------~i~~~~--------~  213 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYD--------NILHKP--------L  213 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHH--------HHhcCC--------C
Confidence            45689999999999988999999999999999999999999976421     11111        111111        1


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAK 1019 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~ 1019 (1027)
                      ..+...+.++.+++.+|++.||++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11223456688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-34  Score=316.06  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             hCCCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|+..+.||+|+||.||+|.+.+    ...||||...... ....+.+.+|++++++++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3458888999999999999998643    3468999887554 3455678899999999999999999999876 45789


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++.++..++.+++.|++|+|   +.+++||||||+||+++.++.+|++|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999876666899999999999999999999   999999999999999999999999999998865432


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      . ........++..|+|||.+....++.++||||+||++||+++ |+.||......+  ...+..            .. 
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~------------~~-  224 (270)
T cd05056         161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIE------------NG-  224 (270)
T ss_pred             c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH------------cC-
Confidence            1 112222334568999999988889999999999999999986 999987543221  111110            00 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           .....+..++..+.+++.+|+.++|++||++.+++..|+
T Consensus       225 -----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         225 -----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                 011122356678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-34  Score=313.12  Aligned_cols=252  Identities=26%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999987788999998864322 24578889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +++|.+++......+++..+..++.+++.|++|||   +.+++||||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            99999999876666889999999999999999999   9999999999999999999999999999987543221 1111


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....++.+|+|||...++.++.++||||+|+++|||++ |+.||......     ......         ....      
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~---------~~~~------  218 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI---------NAGF------  218 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH---------hCCC------
Confidence            22335678999999998889999999999999999998 89998754221     111110         0000      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....+...+.++.+++.+||..+|++||++.|+++.|+
T Consensus       219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            00011224567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=319.91  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=211.4

Q ss_pred             CCCCccceeeccccceEEEEEecC-CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+....++||.|-||.||.|.|+. .-.||||.++.+ .-..++|..|..+|+.++|||+|+++|+|..+..+|||+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            445667899999999999999985 567999998744 345688999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCc-cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ..|+|.+|+.+.++ -.+.-..+.+|.||..|++||.   .+++||||+.+.|.|+.++..||++|||+++.+..+. ..
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YT  421 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YT  421 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-ee
Confidence            99999999987763 3566677889999999999999   9999999999999999999999999999999875433 32


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      .+........|.|||-+....++-|+|||+|||+|||+.| |-.||.+..     +.+         +-+.++      .
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSq---------VY~LLE------k  481 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ---------VYGLLE------K  481 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHH---------HHHHHh------c
Confidence            3333445678999999999999999999999999999999 666766532     111         112222      2


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..++..+++|++.+++||++||.++|.+||+++|+-+.++
T Consensus       482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            3467778999999999999999999999999999987664

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-34  Score=320.10  Aligned_cols=249  Identities=25%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67899999999999999999864 78999999987655555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~  171 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--C
Confidence            999999988653  3788899999999999999999   99999999999999999999999999999876533221  1


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      .....+++.|+|||...+..++.++||||+||++|++++|+.||............+                  .....
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~------------------~~~~~  233 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------------TNGTP  233 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec------------------cCCCC
Confidence            233468889999999998889999999999999999999999997542211100000                  00000


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....+...+..+.+++.+||..+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11112345566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-34  Score=326.98  Aligned_cols=265  Identities=21%  Similarity=0.213  Sum_probs=197.2

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ....+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34567999999999999999999876 5788999975422      2345899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+. ++|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||.++.....  
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            9996 5898888776667899999999999999999999   999999999999999999999999999998743211  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc--hh-------HHHHHHHHHhhh---
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE--MT-------LKRWVNDLLLIS---  973 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--~~-------~~~~~~~~~~~~---  973 (1027)
                       .......||+.|+|||++.+..++.++||||+||++|||+++..|+.......  ..       +...+.......   
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence             12234568999999999999999999999999999999998665543321111  10       111111000000   


Q ss_pred             --------HHHhhhcc-ccCccch--hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 --------IMEVVDAN-LLSHEDK--HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 --------~~~~~d~~-~~~~~~~--~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                              ..+..+.. .......  .......++.++.+++.+||..||++||||.|+++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                    00000000 0000000  001112345567789999999999999999999863

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-34  Score=323.35  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=201.0

Q ss_pred             CCCCccceeeccccceEEEEEec--------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD  819 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  819 (1027)
                      ++|.+.+.||+|+||.||+|+..        .+..||+|.++... ......+..|+++++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46888999999999999999742        24579999887442 33456788899999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  884 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  884 (1027)
                      ..++||||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.|++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999986532               34788999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHH
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLK  963 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  963 (1027)
                      .++.+||+|||.++...............+++.|+|||++.+..++.++||||+||++|||++ |..||......  ...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~  246 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--ELF  246 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence            999999999999986543221111122234567999999998889999999999999999999 88888653211  111


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..            .....      ....+..++.++.+++.+|+..+|++||++.|+++.|+
T Consensus       247 ~~------------~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~  291 (314)
T cd05099         247 KL------------LREGH------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD  291 (314)
T ss_pred             HH------------HHcCC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            10            00000      01112345667889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=339.40  Aligned_cols=266  Identities=20%  Similarity=0.229  Sum_probs=193.8

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCC------ccceEEeEEecC
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR------NIIKFISSCSSD  818 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~  818 (1027)
                      ...+.+|++.+.||+|+||+||+|++. +++.||||+++... ........|+++++.++|.      +++.+++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345678999999999999999999865 57899999986432 2234456677777777654      588888888764


Q ss_pred             -CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCC---------
Q 048205          819 -DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNM---------  887 (1027)
Q Consensus       819 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~---------  887 (1027)
                       ...++|||++ +++|.+++.... .+++..+..|+.||+.||+|||   . .+||||||||+||+++.++         
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccccc
Confidence             5788999998 668988887653 4899999999999999999999   7 5999999999999998765         


Q ss_pred             -------cEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccch
Q 048205          888 -------VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEM  960 (1027)
Q Consensus       888 -------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  960 (1027)
                             .+||+|||.+....     ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ 
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-  352 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE-  352 (467)
T ss_pred             ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                   49999999886321     12334679999999999999999999999999999999999999997643211 


Q ss_pred             hHHHHHHHHH-----------hhhHHHhhhccccCcc--ch---------hhhHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          961 TLKRWVNDLL-----------LISIMEVVDANLLSHE--DK---------HFVAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       961 ~~~~~~~~~~-----------~~~~~~~~d~~~~~~~--~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                      .+........           .....+.++.......  ..         ...........+.+|+.+||++||++|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            1111111100           0000111111000000  00         000001123557899999999999999999


Q ss_pred             HHHHH
Q 048205         1019 KEIVT 1023 (1027)
Q Consensus      1019 ~evl~ 1023 (1027)
                      +|+++
T Consensus       433 ~e~L~  437 (467)
T PTZ00284        433 RQMTT  437 (467)
T ss_pred             HHHhc
Confidence            99986

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-34  Score=316.53  Aligned_cols=239  Identities=23%  Similarity=0.359  Sum_probs=189.7

Q ss_pred             eeeccccceEEEEEecC-------------------------CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceE
Q 048205          757 LIGRGGFGFVYKARIQD-------------------------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF  811 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  811 (1027)
                      .||+|+||.||+|++..                         ...||+|+++.........+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999997421                         13588998875544455678889999999999999999


Q ss_pred             EeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----
Q 048205          812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----  887 (1027)
Q Consensus       812 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----  887 (1027)
                      +++|.+....++||||+++|+|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999998776667899999999999999999999   99999999999999997644    


Q ss_pred             ---cEEEeeecCCcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHH-cCCCCCCCCcccchhH
Q 048205          888 ---VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETF-TRKKPTDESFTGEMTL  962 (1027)
Q Consensus       888 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~  962 (1027)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+  .
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence               4899999988643211      22357788999998865 56899999999999999985 7899886542211  1


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..+            ......        .+......+.+++.+||..+|++||++.++++.|+
T Consensus       231 ~~~------------~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERF------------YEKKHR--------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH------------HHhccC--------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111            111000        01112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-34  Score=317.55  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=199.9

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .|+..+.||+|+||+||+|++. +++.||+|.+....   ......+.+|++++++++|++++.+++++...+..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3677889999999999999875 68999999987542   2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++++|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            999999998886543 45899999999999999999999   9999999999999999999999999999987543211 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......|++.|+|||++.+..++.++|+||+||++|||++|+.||........ ...+....        ....    
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~--------~~~~----  221 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRV--------LETE----  221 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhh--------hccc----
Confidence              12334689999999999988999999999999999999999999976422111 11111100        0000    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                          ...+..++.++.+++.+|++.||++||+     +.++++
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 ----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                0111235566889999999999999999     667664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-34  Score=317.85  Aligned_cols=265  Identities=25%  Similarity=0.298  Sum_probs=196.1

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhc---cCCccceEEeEEec-----CC
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRI---RHRNIIKFISSCSS-----DD  819 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~  819 (1027)
                      +|++.+.||+|+||+||+|+.. +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999876 689999999875422  1223455677766655   79999999998864     34


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ..++||||+++ ++.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999985 8988886543 34899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh-
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV-  977 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  977 (1027)
                      ......   ......+++.|+|||++.+..++.++||||+||++|||++|++||...... ..+.............+. 
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence            653221   223356889999999999889999999999999999999999998754322 122222111110000000 


Q ss_pred             --h---hccccC-ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 --V---DANLLS-HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 --~---d~~~~~-~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .   ...... ...........++.++.+++.+|+++||++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              0   000000 000011112345677899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=316.87  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=212.7

Q ss_pred             CCCccceeeccccceEEEEEec---CCc--eEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ---DGM--EVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .....++||+|-||.||+|...   .|+  .||||.-+.+ .....+.|..|.-++++++|||||+++|+|.+.. .+||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEE
Confidence            3445678999999999999743   233  5889987764 3345678999999999999999999999998764 6899


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||.++-|.|..|++..+..++..+...++.||+.|++|||   +..+|||||..+||++.....||++|||+++.+..+.
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            9999999999999999988999999999999999999999   9999999999999999999999999999999765433


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                       ....+...-...|||||-+...+++.++|||-|||.+||+++ |..||.+....+                    -...
T Consensus       546 -yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------------------VI~~  604 (974)
T KOG4257|consen  546 -YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------------------VIGH  604 (974)
T ss_pred             -hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------------------eEEE
Confidence             334444445678999999999999999999999999999887 889998753321                    1111


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      -..+.+.+.|+.|++.++.|+.+||.++|.+||.+.|+...|+
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            2334577888999999999999999999999999999988775

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-34  Score=317.41  Aligned_cols=266  Identities=24%  Similarity=0.419  Sum_probs=208.2

Q ss_pred             CCCCccceeeccccceEEEEEec-----CCceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEec--CCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-----DGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  821 (1027)
                      +.|+..+.||+|+||.||+|++.     +++.||||++...... ..+.+..|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777899999999999999854     3688999998755443 46788999999999999999999999877  5578


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999877666899999999999999999999   9999999999999999999999999999998664


Q ss_pred             cCCCcce-ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH----HhhhHHH
Q 048205          902 KEDQSLT-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL----LLISIME  976 (1027)
Q Consensus       902 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~  976 (1027)
                      ....... .....++..|+|||......++.++||||+|+++|||++|+.|+.........   ++...    ......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  237 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence            2222111 11223456799999998889999999999999999999999998654222110   00000    0001111


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ......      ....+..++.++.+++.+|++.+|++||++.|++++|++
T Consensus       238 ~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         238 LLKEGE------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHHcCC------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            111111      111223466789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-34  Score=326.82  Aligned_cols=267  Identities=22%  Similarity=0.263  Sum_probs=199.3

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecC----
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSD----  818 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  818 (1027)
                      ....++|+..+.||+|+||.||+|+.. +++.||||++.....  ...+.+.+|++++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999865 688999999865422  2345677899999999999999999887543    


Q ss_pred             --CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          819 --DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       819 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                        ...++++|++ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence              3578999998 67998887643  4899999999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--  973 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  973 (1027)
                      ++....     ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ...+..+........  
T Consensus       165 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         165 ARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             ceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHH
Confidence            986432     1234568999999999876 5688999999999999999999999975421 112222221111000  


Q ss_pred             H-HHh-------hhccccCccchh-hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 I-MEV-------VDANLLSHEDKH-FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 ~-~~~-------~d~~~~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      . ..+       ............ ........+.+.+++.+|+..||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0 000       000000000000 00112344567899999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.1e-34  Score=320.71  Aligned_cols=195  Identities=23%  Similarity=0.320  Sum_probs=160.5

Q ss_pred             cceeeccccceEEEEEec---CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec--CCeeEEEEEecC
Q 048205          755 NNLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFKALVLEYMP  829 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~  829 (1027)
                      .+.||+|+||+||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   46789999986432  23456789999999999999999998854  456889999996


Q ss_pred             CCCHHHHHhcC--------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeecCC
Q 048205          830 YGSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMA  897 (1027)
Q Consensus       830 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla  897 (1027)
                      + ++.+++...        ...+++..+..++.||+.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 888876532        134788999999999999999999   9999999999999999    46689999999999


Q ss_pred             cccccCCCc-ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 048205          898 KPFLKEDQS-LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDES  955 (1027)
Q Consensus       898 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~  955 (1027)
                      +.+...... .......+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            865432211 223345789999999998764 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.9e-34  Score=310.52  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=205.6

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||.|+||.||.++.. +++.+|+|.+....  ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4888999999999999999855 68899999887542  34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++... ...+++.++..++.|+++|++|||   +.+++||||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998765 356899999999999999999999   89999999999999999999999999999986533221 


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                       ......+++.|+|||...+..++.++||||+|+++|||++|+.||......     +...        ++......   
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~--------~~~~~~~~---  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVV--------KIVQGNYT---  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHH--------HHHcCCCC---
Confidence             223456889999999998888899999999999999999999998753211     1111        11111000   


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L 1025 (1027)
                          ..+..++.++.+++.+|+..+|++||++.++++..
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                01134566789999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-34  Score=315.67  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=199.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999864 78999999987542 33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++++..+.     .+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997642     3678888999999999999999   999999999999999999999999999999755322    


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......++..|+|||++.+..++.++||||+||++|+|++|+.||.......... .+...     ...+.+.....   
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~-----~~~~~~~~~~~---  219 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQL-----LQCIVDEDPPV---  219 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHH-----HHHHhccCCCC---
Confidence            2233568999999999998899999999999999999999999997543221110 00000     00011110000   


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                         ......+.++.+++.+|++.+|++||+++|+++.
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 ---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               0012245568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-34  Score=317.27  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=200.5

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .|+..+.||+|+||.||+|.+. +++.||||.+....   ....+.+..|+.++++++|++++.+++++.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999866 68999999986432   1223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++++|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999999886533 45889999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+         ....+...   
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~---------~~~~~~~~---  221 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV---------ERLVKEVQ---  221 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH---------Hhhhhhhh---
Confidence              1233468999999999999899999999999999999999999997643211 00010         00000000   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                          ...+..++.++.+++.+|++.||++||+     +.|+++
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                0112235567889999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=315.01  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=203.9

Q ss_pred             CCCCccceeeccccceEEEEEec-CCc----eEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGM----EVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..+.||+|+||.||+|+++ +|+    .||+|+...... .....+.+|++++++++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46788899999999999999865 333    589998765533 345678889999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999877666899999999999999999999   899999999999999999999999999999866533


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..........++..|+|||......++.++|+||+||++||+++ |+.||......  .+...+            ... 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~------------~~~-  227 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLL------------EKG-  227 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHH------------hCC-
Confidence            32222222234567999999988889999999999999999999 99998764211  111111            110 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           .....+..++..+.+++.+||..+|++||++.++++.|+
T Consensus       228 -----~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         228 -----ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence                 011112235567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-34  Score=310.76  Aligned_cols=247  Identities=27%  Similarity=0.419  Sum_probs=197.2

Q ss_pred             ceeeccccceEEEEEecC----CceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQD----GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|++..    +..||+|.+..... ...+.+.+|+++++.++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999997542    26899999875443 345678889999999999999999998764 457999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce-e
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT-Q  909 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~  909 (1027)
                      |+|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++.......... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997655 5899999999999999999999   99999999999999999999999999999986643322211 1


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....++..|+|||......++.++|||||||++||+++ |+.||.....  .....++..            .      .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~------------~------~  215 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLES------------G------E  215 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHc------------C------C
Confidence            11123467999999998899999999999999999998 9999875422  112222110            0      0


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ....+..++..+.+++.+|+..+|++||++.++++.|++
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111223466778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-34  Score=316.05  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=198.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecC------C
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD------D  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~  819 (1027)
                      +...|+..+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +|||++++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4566888899999999999999865 68899999987543 2345678899999998 699999999998653      4


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.|++|||   +.+|+|||+||+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6899999999999999987643 45889999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccCCCcceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      ......  .......|++.|+|||++.     ...++.++||||+||++|||++|+.||......    ..+...     
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~-----  228 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLI-----  228 (272)
T ss_pred             eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHH-----
Confidence            543221  1223456889999999886     345788999999999999999999998653211    111000     


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ..  ...       .......++.++.+++.+||..+|.+||++.|+++
T Consensus       229 -~~--~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 -PR--NPA-------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -hc--CCC-------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             00  000       00011234567899999999999999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-34  Score=312.52  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=202.2

Q ss_pred             CCCccceeeccccceEEEEEecCCceEEEEEEeccc------chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY------GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      +|+..+.||+|+||+||+|...+++.+|+|.+....      .+..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999998889999999886432      12345688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999987654 4788999999999999999999   9999999999999999999999999999987543211


Q ss_pred             C----cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          905 Q----SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       905 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .    ........++..|+|||+..+..++.++||||+||++|+|++|+.||........ ....            ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~------------~~~  223 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYI------------GAH  223 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHh------------hhc
Confidence            1    1112234588999999999988899999999999999999999999975321110 0000            000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..     .....+..++.++.+++.+|++.+|++||++.|++.
T Consensus       224 ~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 RG-----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             cC-----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00     000112345677899999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-34  Score=325.43  Aligned_cols=255  Identities=18%  Similarity=0.243  Sum_probs=199.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||+||+|+.+ +++.||+|++.+..   ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999976 57889999986432   223345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.+....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence            999999999999876566899999999999999999999   9999999999999999999999999999987553322 


Q ss_pred             cceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          906 SLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .......+||+.|+|||++.     ...++.++||||+||++|||++|+.||......     +....        +...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----~~~~~--------i~~~  223 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGK--------IMNH  223 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----HHHHH--------HhCC
Confidence            22233457999999999986     346788999999999999999999999754211     11110        1110


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~~ 1024 (1027)
                      ....   ........++.++.+++.+|+..+|++  |+++.|+++.
T Consensus       224 ~~~~---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         224 KERF---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             Cccc---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0000   000111245677889999988665444  7899998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-34  Score=312.19  Aligned_cols=248  Identities=25%  Similarity=0.461  Sum_probs=192.3

Q ss_pred             ceeeccccceEEEEEec----CCceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEe-cCCeeEEEEEecC
Q 048205          756 NLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCS-SDDFKALVLEYMP  829 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~  829 (1027)
                      +.||+|+||.||+|++.    ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999854    2457999987533 2334567888999999999999999999875 4556899999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc--c
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS--L  907 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--~  907 (1027)
                      +|+|.+++.......++..+..++.|+++|++|||   +.+++||||||+||+++.++.+||+|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876555788888999999999999999   999999999999999999999999999999754322111  1


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK-KPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......+++.|+|||+.....++.++|||||||++|||++|+ +||.....  .....++           ....     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~-----------~~~~-----  219 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL-----------LQGR-----  219 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH-----------hcCC-----
Confidence            111234567899999998888999999999999999999964 55543211  1111110           0000     


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        ....+..++..+.+++.+||..+|++||++.|+++.|+
T Consensus       220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence              01111234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-34  Score=310.71  Aligned_cols=247  Identities=29%  Similarity=0.426  Sum_probs=199.8

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEe-cCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS-SDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~  828 (1027)
                      .+|+..+.||+|+||.||+|... |+.||+|.+....  ..+.+.+|++++++++|++++++++++. .....++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999765 7889999986432  3467889999999999999999999764 456789999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999987654 34789999999999999999999   9999999999999999999999999999987543211   


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                        ....++..|+|||+.....++.++||||+||++|||++ |+.||....     ...+....         ....    
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~---------~~~~----  216 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRV---------EKGY----  216 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH---------hcCC----
Confidence              22234568999999998889999999999999999997 999886431     11111110         0100    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      .  ...+..++..+.+++.+|++.+|++||++.++++.|+.
T Consensus       217 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         217 K--MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            0  01123466788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=313.99  Aligned_cols=248  Identities=27%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++|+|++++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999876 68999999987553 34456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++++|.+++...  .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++++|||+++.+....  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998765  5899999999999999999999   9999999999999999999999999999998764321  1


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......+++.|+|||++.+..++.++||||+||++|+|++|+.||.......     .....         ....    .
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~---------~~~~----~  215 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLI---------PKNN----P  215 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHHh---------hhcC----C
Confidence            2233468889999999998889999999999999999999999997542111     00000         0000    0


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..... ..++.++.+++.+|+..+|++||+++++++
T Consensus       216 ~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         216 PSLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCcc-cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            00000 115667899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-34  Score=325.34  Aligned_cols=255  Identities=18%  Similarity=0.236  Sum_probs=199.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999876 68899999987431   223445778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||++||+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999876566899999999999999999999   99999999999999999999999999999986543221


Q ss_pred             cceecccccCccccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          906 SLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                       .......||+.|+|||++.+     +.++.++||||+||++|||++|+.||......     ....        .+...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~--------~i~~~  223 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYG--------KIMNH  223 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHH--------HHHcC
Confidence             22233569999999998875     46788999999999999999999999754211     1100        11110


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~~ 1024 (1027)
                      .......   ......+.++.+++.+|+..++++  |++++++++.
T Consensus       224 ~~~~~~p---~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         224 EERFQFP---SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCcccCC---CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0000000   011234567889999999876554  5688887653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-34  Score=328.17  Aligned_cols=266  Identities=21%  Similarity=0.215  Sum_probs=198.8

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC------
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD------  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  818 (1027)
                      ..++|+..+.||+|+||.||+|+.. .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999865 68899999987532  33456677899999999999999999987543      


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ...++||||+++ ++.+++..   .+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999976 77776643   3788899999999999999999   9999999999999999999999999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--hh---
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--IS---  973 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~---  973 (1027)
                      ....   ........+|+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...+.....  ..   
T Consensus       175 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         175 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            5432   12223456899999999999999999999999999999999999999764321 111111111000  00   


Q ss_pred             -----HHHhhhccccCcc------------chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 -----IMEVVDANLLSHE------------DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 -----~~~~~d~~~~~~~------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           .............            ............++.+++.+|++.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 0000000000000            00000111234568899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-34  Score=319.64  Aligned_cols=254  Identities=24%  Similarity=0.390  Sum_probs=201.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCc----eEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGM----EVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      .++|+..+.||+|+||.||+|++. +|+    .||+|.+..... .....+.+|+.+++.++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999864 444    478888764432 2334678899999999999999999998764 467


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +|+||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999876666899999999999999999999   99999999999999999999999999999986543


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ...........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....  .....++            ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~------------~~~  227 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLL------------EKG  227 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH------------HCC
Confidence            322222223345778999999998889999999999999999997 8899865321  1112211            111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .      ....+..++.++.+++.+||..+|++||+++++++.++
T Consensus       228 ~------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         228 E------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             C------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            0      01112235567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=347.19  Aligned_cols=254  Identities=20%  Similarity=0.302  Sum_probs=197.8

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEec--CCee
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFK  821 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  821 (1027)
                      ...++|.+.+.||+|+||+||+|++. +++.||+|++...  .......+..|+.++++++||||++++++|..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            44578999999999999999999976 5788999998743  22345678889999999999999999998854  4578


Q ss_pred             EEEEEecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCC----CCCeEeccCCCCcEEEcC---------
Q 048205          822 ALVLEYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGY----SVPIIHCDLKPNNVLLDD---------  885 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlkp~NIll~~---------  885 (1027)
                      ++||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    ..+||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998653   245899999999999999999999321    145999999999999964         


Q ss_pred             --------CCcEEEeeecCCcccccCCCcceecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 048205          886 --------NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDES  955 (1027)
Q Consensus       886 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~  955 (1027)
                              .+.+||+|||++..+...   .......||+.|+|||++.+  ..++.++||||||||+|||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    345899999999865322   12234579999999999864  45889999999999999999999999753


Q ss_pred             cccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          956 FTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       956 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..    ...++...         ....      .. ....++.++.+||.+||..+|++||++.|++.
T Consensus       247 ~~----~~qli~~l---------k~~p------~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NN----FSQLISEL---------KRGP------DL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             Cc----HHHHHHHH---------hcCC------CC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            21    11111111         0000      00 01234567899999999999999999999984

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.7e-34  Score=311.76  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=200.7

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc---------hhHHHHHHHHHHHhhccCCccceEEeEEecCCe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  820 (1027)
                      +|...+.||+|++|.||+|... +++.||+|.+.....         +..+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999865 688999998864321         123567889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997653 4788899999999999999999   999999999999999999999999999999866


Q ss_pred             ccCCCc----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          901 LKEDQS----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       901 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      ......    .......++..|+|||...+..++.++||||+||++|+|++|+.||....... ...            .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~------------~  223 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIF------------K  223 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHH------------H
Confidence            421111    11122357889999999998889999999999999999999999997532111 000            0


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +... .      ....+..++..+.+++.+||+.||++||++.|+++
T Consensus       224 ~~~~-~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 IGEN-A------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             Hhcc-C------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0000 0      00112345667899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-34  Score=312.05  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=189.3

Q ss_pred             eeeccccceEEEEEecC---CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          757 LIGRGGFGFVYKARIQD---GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      .||+|+||+||+|+..+   ...+|+|.+.... ......+.+|++.++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3468888765432 2334567889999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC----ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          833 LEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       833 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      |.+++....    ...++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999987643    23467788899999999999999   99999999999999999999999999999875432221112


Q ss_pred             ecccccCccccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          909 QTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .....+++.|+|||+...       ..++.++||||+||++|||++ |..||......+ .....            ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~------------~~~  225 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQV------------VRE  225 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHH------------hhc
Confidence            233345678999998643       356889999999999999999 777876532211 11110            000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .......  ...+..++..+.+++..|+ .||++||++++|++.|.
T Consensus       226 ~~~~~~~--~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         226 QDIKLPK--PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCccCCC--CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0000000  1112345667788999999 59999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.3e-34  Score=313.73  Aligned_cols=266  Identities=26%  Similarity=0.320  Sum_probs=200.0

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|++++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999875 68999999986432  22346678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ++ +++.+++....  ..+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58988876533  56899999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh------hhHHHh-
Q 048205          906 SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL------ISIMEV-  977 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~-  977 (1027)
                       .......+++.|+|||++.+. .++.++||||+||++|||+||++||....... ...........      ...... 
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence             122233578899999987654 57889999999999999999999997642211 11111110000      000000 


Q ss_pred             -hhccccCc-cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 -VDANLLSH-EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 -~d~~~~~~-~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       +....... ..........++.++.+++.+|+..||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00000000 00001112235677899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.1e-34  Score=314.00  Aligned_cols=249  Identities=29%  Similarity=0.485  Sum_probs=198.5

Q ss_pred             ceeeccccceEEEEEecC-------CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          756 NLIGRGGFGFVYKARIQD-------GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +.||+|+||.||+|++.+       ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998642       2579999876433 23456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-----cEEEeeecC
Q 048205          828 MPYGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-----VAHLSDFGM  896 (1027)
Q Consensus       828 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgl  896 (1027)
                      +++++|.+++...      ...+++.++..++.|++.|++|||   +.+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998653      234788999999999999999999   99999999999999999887     899999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      ++...............++..|+|||++.++.++.++|||||||++|||++ |+.||......  ....++         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~---------  226 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHV---------  226 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHH---------
Confidence            986543322222223345678999999999999999999999999999998 99998653211  111111         


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                         +..      .....+..++..+.+++.+||..+|++||++.++++.|++
T Consensus       227 ---~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 ---TAG------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---hcC------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               000      0111223456778999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-34  Score=323.64  Aligned_cols=254  Identities=27%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             CCCCccceeeccccceEEEEEec--------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD  819 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  819 (1027)
                      .+|++.+.||+|+||.||+|++.        ++..||+|+++... ....+.+.+|+++++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999886432 33456788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  884 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  884 (1027)
                      ..++||||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999986532               34788899999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHH
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLK  963 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  963 (1027)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||+||++|||++ |..||.....     .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence            999999999999986543222222222334567999999999899999999999999999998 8888865321     1


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .+.....        ...       ....+..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus       244 ~~~~~~~--------~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         244 ELFKLLK--------EGH-------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             HHHHHHH--------cCC-------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            1111110        000       01112345667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-34  Score=316.39  Aligned_cols=268  Identities=25%  Similarity=0.287  Sum_probs=202.0

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999976 68999999986432  22235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++ ++.+++......+++..+..++.||++|++|||   +.+++||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            975 888888765566899999999999999999999   99999999999999999999999999999985532221  


Q ss_pred             eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------hHHHhhhc
Q 048205          908 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------SIMEVVDA  980 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~d~  980 (1027)
                      ......+++.|+|||++.+. .++.++||||+||++|||++|+.|+....+....+..........      ...+..+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            12234578899999988764 468999999999999999999999754433222211111111000      00111111


Q ss_pred             cccCccc---hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          981 NLLSHED---KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .......   ...+.....+.++.+++.+|+..||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000000   0011123456788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.2e-34  Score=316.88  Aligned_cols=260  Identities=23%  Similarity=0.296  Sum_probs=202.0

Q ss_pred             cHHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEe--
Q 048205          741 TYLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCS--  816 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--  816 (1027)
                      .+..+..+.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            33445567788999999999999999999865 68899999876432 2235677899999999 6999999999884  


Q ss_pred             ---cCCeeEEEEEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 048205          817 ---SDDFKALVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  890 (1027)
Q Consensus       817 ---~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  890 (1027)
                         .....++||||+++++|.+++..   ....+++..+..++.|+++|+.|||   +.+++||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence               34578999999999999998753   2345788999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW  965 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  965 (1027)
                      ++|||+++.+....  .......|++.|+|||++..     ..++.++||||+||++|||++|+.||.......    .+
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~  238 (286)
T cd06638         165 LVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----AL  238 (286)
T ss_pred             EccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HH
Confidence            99999988653221  12233468899999998753     447889999999999999999999987542111    11


Q ss_pred             HHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          966 VNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       966 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..          ....    .......+..++.++.+++.+|++.||++||++.|+++.
T Consensus       239 ~~----------~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FK----------IPRN----PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hh----------cccc----CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00          0000    000111122345568999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-34  Score=313.81  Aligned_cols=240  Identities=25%  Similarity=0.356  Sum_probs=191.4

Q ss_pred             ceeeccccceEEEEEecC--------CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          756 NLIGRGGFGFVYKARIQD--------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +.||+|+||.||+|.+..        ...||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998642        234888887655555566788899999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--------EEEeeecCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--------AHLSDFGMAKP  899 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgla~~  899 (1027)
                      +++|+|.+++......+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876667899999999999999999999   999999999999999987765        69999999875


Q ss_pred             cccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCC-CCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRK-KPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      ...      .....+++.|+|||++.+. .++.++||||+||++|||++|. .|+.......  ...            .
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~------------~  217 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQ------------F  217 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHH------------H
Confidence            432      1234578889999998864 5789999999999999999995 4544321110  000            0


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .....        ..+.....++.+++.+||+.+|++||+++++++.|+
T Consensus       218 ~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YEDRH--------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHccc--------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            01000        111223456889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-36  Score=321.82  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=209.9

Q ss_pred             CCccceeeccccceEEEEEecC-CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      |.++.-||-|+||.||+|..++ +-..|.|++.....+..++|.-|++++...+||+||++++.|.-.+.++|..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4556779999999999999775 455678999888888889999999999999999999999999888999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |-++..+-.-+..+++.++..+++|++.||.|||   +..|+|||+|+.||+++-+|.++++|||.+.....  ......
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence            9999988888888999999999999999999999   99999999999999999999999999999874322  223445


Q ss_pred             ccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          911 QTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .++|||+|||||+..     ..+|++++||||||+.+.||..+.+|.......    .-.+             +. ...
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVll-------------Ki-aKS  250 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLL-------------KI-AKS  250 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHH-------------HH-hhc
Confidence            678999999999754     568999999999999999999999997653211    1110             11 111


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .++....|..++..+.+++.+|+.++|+.||+++++++.
T Consensus       251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            223344556678889999999999999999999999863

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4e-34  Score=310.02  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=204.4

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46788999999999999999998888889999886432 335678889999999999999999999887 7789999999


Q ss_pred             CCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++... ....++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-cc
Confidence            999999998764 345788899999999999999999   8999999999999999999999999999997553221 11


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......++..|+|||++....++.++|+||+||++|++++ |+.||......  ....+..            ...    
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~------------~~~----  220 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALE------------RGY----  220 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHh------------CCC----
Confidence            2222345677999999998889999999999999999999 89998753211  1111111            100    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        ..+.+...+.++.+++.+|++++|++||++.++.+.|+.
T Consensus       221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              001113455678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.8e-34  Score=308.31  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=201.0

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec-CCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS-DDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e  826 (1027)
                      +|+..+.||+|++|.||+|+.+ +++.||+|.+....  ....+.+..|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5888999999999999999865 57899999987542  2345678889999999999999999998764 446789999


Q ss_pred             ecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++++|.+++... ...+++.++..++.+++.|++|||   +.+++||||||+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999998764 345899999999999999999999   9999999999999999999999999999998653222 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       .......+++.|+|||+..+..++.++||||+|++++++++|+.||.....     ..+.....        .....  
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~--------~~~~~--  220 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRII--------EGKLP--  220 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH--------hcCCC--
Confidence             122334688999999999999999999999999999999999999875321     11111110        00000  


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           ..+...+.++.+++.+|+..+|++||++.++++.
T Consensus       221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 1112355678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-34  Score=311.75  Aligned_cols=245  Identities=29%  Similarity=0.453  Sum_probs=193.2

Q ss_pred             ceeeccccceEEEEEecC-Cc--eEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQD-GM--EVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|++++ +.  .+|+|.+.... ....+.+..|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999763 44  46888876432 33456788899999999 799999999999999999999999999


Q ss_pred             CCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          831 GSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       831 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                      |+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               24788999999999999999999   9999999999999999999999999999


Q ss_pred             CCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      ++.....   .........+..|+|||+.....++.++|||||||++|||++ |+.||......     ....       
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~-------  222 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE-------  222 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHH-------
Confidence            9863211   111111224567999999988889999999999999999997 99998653211     1111       


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        .+....      ....+..++.++.+++.+|++.+|.+||++.+++..|+
T Consensus       223 --~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         223 --KLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             --HHhCCC------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence              011100      00112235567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.6e-34  Score=320.34  Aligned_cols=267  Identities=20%  Similarity=0.298  Sum_probs=195.8

Q ss_pred             ccceeecc--ccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          754 ENNLIGRG--GFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       754 ~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ..++||+|  +|++||+++.+ +|+.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35689999  67899999865 78999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998654 234889999999999999999999   9999999999999999999999999998765432111110


Q ss_pred             -----eecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh------hhH
Q 048205          908 -----TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL------ISI  974 (1027)
Q Consensus       908 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~  974 (1027)
                           ......++..|+|||++.+  ..++.++||||+||++|||++|+.||...................      ...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 1122346778999999876  458899999999999999999999997543221111111000000      000


Q ss_pred             HHh--------hhcccc-----------CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 MEV--------VDANLL-----------SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ~~~--------~d~~~~-----------~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .+.        .+....           ............+++++.+++.+||++||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000        000000           0000001112245667899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.8e-34  Score=311.32  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=203.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ..|+..+.||.|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34777889999999999999876 58899999987543 34457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++|+|.+++...  .+++.++..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++.......  .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            9999999988653  4788899999999999999999   9999999999999999999999999999997654322  1


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......++..|+|||++.+..++.++|+|||||++|||++|+.||........     .         .......     
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~---------~~~~~~~-----  217 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L---------FLIPKNN-----  217 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h---------hhhhcCC-----
Confidence            22334578899999999888899999999999999999999999875422110     0         0000000     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       .......++..+.+++.+||+.+|++||++.+++..
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             011223466778999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.4e-34  Score=313.29  Aligned_cols=268  Identities=22%  Similarity=0.261  Sum_probs=203.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++....  ....+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999976 68999999886432  2233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |++++.+..+.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99998888776543 34899999999999999999999   89999999999999999999999999999986543321 


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--hhHHHhhhccc-
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--ISIMEVVDANL-  982 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~~-  982 (1027)
                       ......++..|+|||++.+ ..++.++||||+||++|||++|++||......+ ....+......  ....+..+... 
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcccccc
Confidence             1223457889999999875 457889999999999999999999997643221 11111111100  00111111100 


Q ss_pred             -----cCccc---hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          983 -----LSHED---KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       983 -----~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           .....   .........+..+.+++.+|+..+|++||++.|++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                 00000   0001112346778999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=321.48  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=207.2

Q ss_pred             ccceeeccccceEEEEEec--CCc--eEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          754 ENNLIGRGGFGFVYKARIQ--DGM--EVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       754 ~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ..+.||+|+||+|++|.|.  .|+  .||||.++..... ...+|.+|+.+|.+++|||++++||++.+ ....+|||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3568999999999999987  354  5899998765443 67899999999999999999999999987 5678999999


Q ss_pred             CCCCHHHHHhc-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+.+++ ....+-......++.|||.|+.||.   .+++||||+...|+++.....|||+|||+.+.+...+..+
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99999999988 4456788888999999999999999   9999999999999999999999999999999876554433


Q ss_pred             e-ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          908 T-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       908 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      . .....-...|+|||.+....++.++|||+|||.+|||+| |+.||.+...  .            .+.+.+|      
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~------------qIL~~iD------  329 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--I------------QILKNID------  329 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--H------------HHHHhcc------
Confidence            3 333445677999999999999999999999999999999 7788776421  1            1222233      


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .+.+...++.|+.++++++..||...|++||++..+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            23456677899999999999999999999999999864

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.4e-34  Score=311.88  Aligned_cols=254  Identities=24%  Similarity=0.426  Sum_probs=204.2

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ++|+..+.||+|+||+||+|+.+      +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999864      2467999988754443 4577899999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHHhcCC--------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 048205          823 LVLEYMPYGSLEKCLYSSN--------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                      +||||+++|+|.+++....        ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544        15899999999999999999999   999999999999999999999999999


Q ss_pred             cCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      |++....... ........++..|+|||.+.+..++.++||||+|+++|++++ |..||......  ......       
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~-------  231 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRL-------  231 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHH-------
Confidence            9987543221 122233456778999999988888999999999999999999 77888643211  111110       


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                          .....      .+..+..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus       232 ----~~~~~------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 ----QAGKL------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ----HcCCc------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                00000      01112346678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.1e-34  Score=307.29  Aligned_cols=250  Identities=30%  Similarity=0.544  Sum_probs=202.3

Q ss_pred             CCccceeeccccceEEEEEecC-----CceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQD-----GMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      |++.+.||+|+||.||+|++.+     +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..++||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999998763     378999998755433 5678889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCcc-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          826 EYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||+++++|.+++...... +++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998765544 899999999999999999999   9999999999999999999999999999998654332


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      ... .....+++.|+|||......++.++||||+|+++|+|++ |++||.....  ....+.+            .... 
T Consensus       158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~------------~~~~-  221 (258)
T smart00219      158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYL------------KKGY-  221 (258)
T ss_pred             ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH------------hcCC-
Confidence            211 112236788999999988889999999999999999998 7888765211  1111111            0000 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L 1025 (1027)
                           ....+..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus       222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 0111223667799999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.8e-34  Score=312.92  Aligned_cols=270  Identities=21%  Similarity=0.253  Sum_probs=200.3

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 689999999865432 22346678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+. +++.+++......+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 6887777655555788889999999999999999   89999999999999999999999999999975432221


Q ss_pred             cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------------
Q 048205          906 SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------------  972 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------  972 (1027)
                        ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.........+..........            
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              12334578899999998754 578899999999999999999999976433211111111100000            


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...+....................+..+.+++.+|+..||++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000000000000001122456889999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.4e-34  Score=310.07  Aligned_cols=253  Identities=25%  Similarity=0.328  Sum_probs=205.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999876 68999999987653 23456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++......+++..+..++.|+++|++|+|   + .+++|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999876566899999999999999999999   8 9999999999999999999999999999875532211 


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                         ....++..|+|||+..+..++.++||||+|+++|+|++|+.||.............+...        ....    .
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~----~  221 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--------VNEP----P  221 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH--------hcCC----C
Confidence               115688899999999988999999999999999999999999976532222222221111        1110    0


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ..... ..++.++.+++.+|+..+|++||++.+++.
T Consensus       222 -~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 -PRLPS-GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -CCCCh-hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             00001 115667899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1e-33  Score=307.99  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=196.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-----chhHHHHHHHHHHHhhccCCccceEEeEEec--CCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  821 (1027)
                      .+|+..+.||+|+||.||+|... +++.||+|++....     .+....+.+|++++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999865 68999999886432     2234568889999999999999999998865  3578


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++|+||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999987654 3788899999999999999999   9999999999999999999999999999997653


Q ss_pred             cCCC-cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          902 KEDQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       902 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .... ........++..|+|||++.+..++.++||||+||++||+++|+.||......    ... .        .....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~-~--------~~~~~  224 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAI-F--------KIATQ  224 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHH-H--------HHhcC
Confidence            2211 11112345788999999999888999999999999999999999998753211    110 0        00000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .    .  ....+......+.+++ +|+..+|++||+++|+++
T Consensus       225 ~----~--~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         225 P----T--NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C----C--CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0    0  0111223445567777 688899999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.7e-34  Score=313.51  Aligned_cols=246  Identities=25%  Similarity=0.344  Sum_probs=200.2

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      |+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            566778999999999999865 67899999987443 3445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +++|.+++...  .+++..+..++.|+++|++|||   +.+++|+||+|+||+++.++.++++|||++..+....  ...
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~  158 (277)
T cd06642          86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR  158 (277)
T ss_pred             CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence            99999988653  4789999999999999999999   9999999999999999999999999999997654221  122


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ....++..|+|||.+.+..++.++||||+||++|||++|+.||.......  ...+            ......      
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~------------~~~~~~------  218 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFL------------IPKNSP------  218 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhh------------hhcCCC------
Confidence            23457889999999998889999999999999999999999986532211  0100            000000      


Q ss_pred             hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          990 FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       990 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ......++..+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            01112355678899999999999999999999873

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.6e-34  Score=307.20  Aligned_cols=249  Identities=20%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|+||.||+++.. +|+.||+|.+....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4888999999999999999865 68999999987432  23446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++.... ..+++.++..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999887643 35789999999999999999999   99999999999999999999999999999976533221 


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                       ......+++.|+|||+..+..++.++|+||+||+++++++|+.||......     ..+.        ++.....    
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~--------~~~~~~~----  218 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVL--------KIIRGSY----  218 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHH--------HHhcCCC----
Confidence             122345788999999999888999999999999999999999998753211     1111        1111100    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                         ...+..++.++.+++.+|++.+|++||++.+|++.
T Consensus       219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               01123456778999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.2e-34  Score=312.37  Aligned_cols=259  Identities=21%  Similarity=0.327  Sum_probs=203.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46778899999999999999865 68899999886543 33457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++...+ .+++..+..++.+++.|+.|||   + .+++||||||+||+++.++.++|+|||++......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            99999999887643 4789999999999999999999   5 58999999999999999999999999998754221   


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                       ......|+..|+|||++.+..++.++||||+||++|++++|+.||......+.....      .....+........ .
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~-~  229 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD------PMGILDLLQQIVQE-P  229 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh------hhHHHHHHHHHhhc-c
Confidence             122346889999999998888999999999999999999999999864332110000      00000111110000 0


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..... ...++.++.+++.+|+.+||++||++.|++++
T Consensus       230 ~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         230 PPRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00111 11256678999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-33  Score=309.54  Aligned_cols=268  Identities=23%  Similarity=0.278  Sum_probs=204.6

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|++.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|++++++++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 68999999987543  33356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      + +++|.+++......+++.++..++.||++|++|||   +.+++|+||||+||+++.++.++++|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999998776667899999999999999999999   99999999999999999999999999999986543321 1


Q ss_pred             eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------hHHHhhhc
Q 048205          908 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------SIMEVVDA  980 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~d~  980 (1027)
                      ......++..|+|||++.+. .++.++||||+||++|||++|++||....+. ..+..........      ...+..+.
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence            22345688999999988654 4689999999999999999998877653221 1111111110000      00000000


Q ss_pred             cccCcc---c-hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          981 NLLSHE---D-KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~---~-~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ......   . .........+..+.+++.+|+.++|++||+++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000   0 0001112345788999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.4e-35  Score=292.75  Aligned_cols=271  Identities=24%  Similarity=0.270  Sum_probs=201.9

Q ss_pred             CCCCccceeeccccceEEEEEec---C--CceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEec-CCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ---D--GMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSS-DDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  821 (1027)
                      ..|.....||+|.||.||+|.-+   +  .+.+|+|.++.+..  .......+|+..++.++|||++.+..++-+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            45888999999999999999533   2  34799999875422  223456789999999999999999999877 7789


Q ss_pred             EEEEEecCCCCHHHHHhcCC----ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC----CcEEEee
Q 048205          822 ALVLEYMPYGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHLSD  893 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D  893 (1027)
                      ++++||++. +|.+.++-+.    +.++...+..|+.||+.|+.|||   +.=|+|||+||.|||+..+    |+|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 8988876332    56888999999999999999999   6779999999999999877    9999999


Q ss_pred             ecCCcccccCCCcc-eecccccCccccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCcccc--------hhHH
Q 048205          894 FGMAKPFLKEDQSL-TQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGE--------MTLK  963 (1027)
Q Consensus       894 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~--------~~~~  963 (1027)
                      +|+|+.+..+-... ....++.|.||+|||.+.+.. |++++||||.|||+.||+|-++.|......-        ..+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999886554332 445677899999999988764 8999999999999999999999887642211        1122


Q ss_pred             HHHHHHHhhhHHHh-------------hhcc--ccCc--cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          964 RWVNDLLLISIMEV-------------VDAN--LLSH--EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~-------------~d~~--~~~~--~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      +..+......-.++             -|-.  ....  ....+.....-++...+|+.+++.+||.+|.|++++++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            22222111100000             0000  0000  011222233334447899999999999999999999864

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-33  Score=305.73  Aligned_cols=247  Identities=27%  Similarity=0.357  Sum_probs=201.6

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc-----chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      +|+..+.||+|+||.||+|... +++.||+|.+....     .+..+.+.+|+++++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999976 78999999886533     23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987654 4789999999999999999999   9999999999999999999999999999987653322


Q ss_pred             CcceecccccCccccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         ......+++.|+|||...... ++.++|+||+||++|++++|+.||....... ....+    .     ..  ... 
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~----~-----~~--~~~-  220 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKI----G-----RS--KEL-  220 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHH----H-----hc--ccC-
Confidence               223456889999999987766 8999999999999999999999987642110 00000    0     00  000 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            ...+..++.++.+++.+|+..+|++||++.+++.
T Consensus       221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  0112235667889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-33  Score=314.42  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=199.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999876 57899999987543   233456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC-
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED-  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-  904 (1027)
                      ||++|++|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++...... 
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999987654 4788999999999999999999   9999999999999999999999999999986421100 


Q ss_pred             ------------CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          905 ------------QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       905 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                                  .........++..|+|||.+....++.++|+|||||++||+++|+.||.+....     ++....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~---  228 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQV---  228 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH---
Confidence                        001112235788899999998888999999999999999999999998753211     111110   


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L 1025 (1027)
                           .......     ......++.++.+++.+|++.+|++||++.++.+.+
T Consensus       229 -----~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         229 -----ISDDIEW-----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             -----HhcccCC-----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence                 0000000     001113566789999999999999999865554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-34  Score=313.10  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35788899999999999999976 78999999887542 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC--CccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          828 MPYGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       828 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +++++|.+++...  ...+++..+..++.+++.|++|||   + .+|+||||||+||+++.++.+||+|||.+..+... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999988764  235899999999999999999999   5 59999999999999999999999999998754322 


Q ss_pred             CcceecccccCccccCcccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                         ......+++.|+|||.+.+..      ++.++||||+||++|||++|+.||......     .+...     ...+.
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~-----~~~~~  223 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQ-----LSAIV  223 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHH-----HHHHh
Confidence               122345788999999886543      478999999999999999999999653211     11000     01111


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +...       ...+..++.++.+++.+|+..+|++||++.+++.
T Consensus       224 ~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DGDP-------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hcCC-------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1110       0112236677899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-33  Score=314.57  Aligned_cols=195  Identities=24%  Similarity=0.325  Sum_probs=159.7

Q ss_pred             cceeeccccceEEEEEec---CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec--CCeeEEEEEecC
Q 048205          755 NNLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFKALVLEYMP  829 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~  829 (1027)
                      ...||+|+||+||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            358999999999999865   45789999886432  23457789999999999999999998854  567899999997


Q ss_pred             CCCHHHHHhcC--------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeecCC
Q 048205          830 YGSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMA  897 (1027)
Q Consensus       830 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla  897 (1027)
                      + ++.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 787776421        134788899999999999999999   9999999999999999    56789999999999


Q ss_pred             cccccCCCc-ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 048205          898 KPFLKEDQS-LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDES  955 (1027)
Q Consensus       898 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~  955 (1027)
                      +........ .......+|+.|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            865432211 122345689999999998764 5789999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-33  Score=308.20  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=200.0

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc----------hhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG----------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      +|...+.||+|+||.||+|... +|+.||+|.++....          ...+.+..|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999865 689999998863211          12346778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++||||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987764 5888999999999999999999   89999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      ..............++..|+|||......  ++.++||||+|+++||+++|..||......    ..+.         +.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~---------~~  224 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMF---------KL  224 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHH---------Hh
Confidence            43222222223345788999999987654  789999999999999999999998643211    1111         00


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...........  .....++..+.+++.+|+.++|++||++.++++.
T Consensus       225 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         225 GNKRSAPPIPP--DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hccccCCcCCc--cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00000000000  1112356778999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=311.74  Aligned_cols=269  Identities=23%  Similarity=0.280  Sum_probs=200.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|++|.||+|+.+ +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367889999999999999999876 689999999875432 223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++ +|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            9985 999988876667899999999999999999999   99999999999999999999999999999875422111 


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh--h-HHHhhh---
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI--S-IMEVVD---  979 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~-~~~~~d---  979 (1027)
                       ......++..|+|||+..+ ..++.++||||+||++|||++|+.||.........+..........  . .....+   
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1122346788999998865 4578999999999999999999999975432211111111110000  0 000000   


Q ss_pred             ---ccccCc-cchhhhHHhhh--HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ---ANLLSH-EDKHFVAKEQC--MSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ---~~~~~~-~~~~~~~~~~~--~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         ...... ...........  ..++.+++.+|++++|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               000000 00000000111  256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-33  Score=306.47  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+......++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999865 68899999986443 33567888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.++++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987642  45899999999999999999999   99999999999999999999999999999986654332


Q ss_pred             cc--eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          906 SL--TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       906 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..  ......++..|+|||++... .++.++|+||+||++|||++|+.||....... ....+...          .+..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~----------~~~~  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN----------DPPS  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC----------CCCC
Confidence            21  22334688999999998877 78999999999999999999999997542211 11111100          0000


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .    ........++.++.+++.+|+..||++||++.++++
T Consensus       227 ~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 L----ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             c----CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0    000011345677899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=324.03  Aligned_cols=240  Identities=25%  Similarity=0.295  Sum_probs=186.9

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhc---cCCccceEEeEEecCCeeEEEEEecCC
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRI---RHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      ||+|+||+||+|+.. +++.||||++.+...   ........|..++...   +||+|+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999876 689999999874321   2233444566666655   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++.... .+++..+..++.||++|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            99999887644 4889999999999999999999   9999999999999999999999999999987533222  1233


Q ss_pred             ccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          911 QTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ..+||+.|+|||++.+. .++.++||||+||++|||++|+.||......     +....        +.....      .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~--------i~~~~~------~  215 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRN--------IAFGKV------R  215 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHH--------HHcCCC------C
Confidence            45799999999998754 4789999999999999999999999764211     11110        000000      0


Q ss_pred             hhHHhhhHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 048205          990 FVAKEQCMSFVFNLAMKCTIESPEERI----NAKEIVT 1023 (1027)
Q Consensus       990 ~~~~~~~~~~l~~Li~~cl~~dP~~Rp----s~~evl~ 1023 (1027)
                      +. ....+.++.+++.+|+.+||++||    ++.++++
T Consensus       216 ~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         216 FP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            00 112456678999999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.6e-33  Score=306.66  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=187.5

Q ss_pred             eeeccccceEEEEEecCC---ceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          757 LIGRGGFGFVYKARIQDG---MEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      .||+|+||+||+|+..++   ..+++|.+.... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999976543   345666665432 2345678889999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          833 LEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       833 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      |.+++....   ...++..+..++.||++|++|||   +.+++||||||+||+++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999987642   33567778899999999999999   999999999999999999999999999998643222211222


Q ss_pred             cccccCccccCcccccC-------CCCCcchhHHHHHHHHHHHHcC-CCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          910 TQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ....++..|+|||+...       ..++.++|||||||++|||+++ ..||......     ++.............++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  233 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-----EVLNHVIKDQQVKLFKPQ  233 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhhcccccCCCc
Confidence            34567889999998753       2457889999999999999974 6676543211     111111000001111111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                ....++..+.+++..|| .+|++||+++++++.|.
T Consensus       234 ----------~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 ----------LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ----------cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                      11235567888999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-33  Score=312.07  Aligned_cols=259  Identities=25%  Similarity=0.296  Sum_probs=202.0

Q ss_pred             cHHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecC
Q 048205          741 TYLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD  818 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  818 (1027)
                      +..++..+.++|+..+.||+|+||.||+|+.. +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            33445556788999999999999999999875 68899999986432 2345677899999998 799999999998654


Q ss_pred             -----CeeEEEEEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 048205          819 -----DFKALVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  890 (1027)
Q Consensus       819 -----~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  890 (1027)
                           +..++||||+++++|.++++.   ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                 358999999999999998763   2345899999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccCCC-----CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR-----VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW  965 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  965 (1027)
                      |+|||++........  ......++..|+|||.+....     ++.++||||+||++|||++|+.||....... ....+
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~  245 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKI  245 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHH
Confidence            999999886543221  122346788999999876433     6789999999999999999999987542211 11111


Q ss_pred             HHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          966 VNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       966 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .            ...     ......+......+.+++.+|+..+|++||++.|+++
T Consensus       246 ~------------~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 P------------RNP-----PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             h------------cCC-----CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0            000     0011112234556899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.6e-34  Score=313.82  Aligned_cols=247  Identities=25%  Similarity=0.345  Sum_probs=199.7

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      |.....||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++.++|||++++++++...+..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999865 6899999998765444556788899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      ++|.+++..  ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++.......  ....
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            999997755  34789999999999999999999   9999999999999999999999999999987543221  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...+++.|+|||++.+..++.++||||+||++|||++|+.||......+ .+..+ .            ..    .....
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~-~------------~~----~~~~~  237 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMKRL-R------------DS----PPPKL  237 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-h------------cc----CCCCc
Confidence            3568899999999998889999999999999999999999987532111 11110 0            00    00001


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ......+..+.+++.+|+..+|++||++.++++
T Consensus       238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         238 KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            112234566889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-33  Score=304.71  Aligned_cols=248  Identities=24%  Similarity=0.389  Sum_probs=201.9

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|+||.||+|... +++.+|+|++....  ....+.+..|++++++++|||++++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4888999999999999999865 68899999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~  905 (1027)
                      +++++|.+++.... ..+++..+..++.++++|++|||   +.+++||||||+||+++.+ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997653 45899999999999999999999   9999999999999999855 468999999998654322 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||......     ..+..        ......   
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~--------~~~~~~---  218 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLK--------IMSGTF---  218 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHH--------HHhcCC---
Confidence              122346788999999999888899999999999999999999998754221     11110        000000   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          ...+..++.++.+++.+||.++|++||++.|++..
T Consensus       219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                01122356678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-33  Score=312.29  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=204.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            56888899999999999999865 68899999987555555677888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++.+.  .+++.++..++.|++.|++|||   +.+++|||+||+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            999999998754  3788899999999999999999   99999999999999999999999999999875543222  2


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      .....+++.|+|||......++.++||||+||++|++++|+.||........ ...+                 ......
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~-----------------~~~~~~  233 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI-----------------ATNGTP  233 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh-----------------hcCCCC
Confidence            2334688899999999888899999999999999999999999976422111 0000                 000011


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .+..+...+..+.+++.+||..+|++||++.+++.+
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111223345668899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-33  Score=305.74  Aligned_cols=238  Identities=24%  Similarity=0.411  Sum_probs=190.1

Q ss_pred             ceeeccccceEEEEEecCCc-----------eEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          756 NLIGRGGFGFVYKARIQDGM-----------EVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      +.||+|+||.||+|++.+..           .|++|++...... ...+.+|++++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36899999999999976432           5788876544332 5788899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-------cEEEeeecCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-------VAHLSDFGMA  897 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfgla  897 (1027)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876656899999999999999999999   99999999999999999888       7999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCC--CCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      .....      .....++..|+|||++...  .++.++||||+||++||+++ |..||......  ....+..       
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~-------  220 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ-------  220 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh-------
Confidence            86432      2233466789999998876  78999999999999999999 46666543211  1111100       


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                          ......         .....++.+++.+||..+|++||++.++++.|+
T Consensus       221 ----~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ----DQHRLP---------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----cCCCCC---------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                010000         011156889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=290.36  Aligned_cols=252  Identities=22%  Similarity=0.239  Sum_probs=197.8

Q ss_pred             HhCCCCcc-ceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEec----CCe
Q 048205          748 ATNGFSEN-NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSS----DDF  820 (1027)
Q Consensus       748 ~~~~f~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~  820 (1027)
                      .+++|++. ++||-|-.|.|..+.++ +++.+|+|++.     +.....+|++..-.. .|||||.++++|..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45556654 47999999999998765 79999999875     223455677764433 69999999999854    457


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecC
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGM  896 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl  896 (1027)
                      +.+|||.|+||.|...+..++ ..+++.++..|+.||+.|+.|||   +.+|.|||+||+|+|.+   .+..+|++|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999999998765 56999999999999999999999   99999999999999996   466899999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      |+.-..   .......+.||.|+|||++...+|+...|+||+||++|-|++|.+||+.......  ..-+++.       
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgMk~r-------  278 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKRR-------  278 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhHHhH-------
Confidence            985322   2334456789999999999999999999999999999999999999987533111  1100100       


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       +...-...+   .+.|...+.+.+++|+++++.+|.+|.+..++++
T Consensus       279 -I~~gqy~FP---~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  279 -IRTGQYEFP---EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -hhccCccCC---ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence             001111111   1334567888999999999999999999999875

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.3e-34  Score=311.99  Aligned_cols=267  Identities=24%  Similarity=0.325  Sum_probs=201.9

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|+||.||+|.++ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999976 589999998764322  234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |++++++.++.... ..+++.++..++.|+++|++|||   +.+++|||++|+||++++++.++++|||++.......  
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            99999888876543 34899999999999999999999   8999999999999999999999999999988654322  


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH--hhhHHHhhhcc--
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL--LISIMEVVDAN--  981 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~--  981 (1027)
                      .......++..|+|||+..+ ..++.++||||+||++|||++|++||......+ ..........  .....+..+..  
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccchH
Confidence            12233457889999998875 447889999999999999999999986532111 1111000000  00000111100  


Q ss_pred             ----ccC---ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 ----LLS---HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ----~~~---~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          ...   ...........++..+.+++.+||..+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                000   001111122356778999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.1e-34  Score=313.77  Aligned_cols=245  Identities=25%  Similarity=0.345  Sum_probs=198.8

Q ss_pred             cceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          755 NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ...||+|+||.||+|... +++.||||.+........+.+.+|+.++++++|||++++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            457999999999999865 6889999998765555567788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL  913 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  913 (1027)
                      .+++...  .+++.++..++.||+.|++|||   +.+|+||||||+||+++.++.++|+|||++.......  .......
T Consensus       107 ~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~  179 (292)
T cd06658         107 TDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV  179 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence            9988543  4788999999999999999999   9999999999999999999999999999987543222  1223346


Q ss_pred             cCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       914 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      +++.|+|||...+..++.++||||+||++|||++|+.||....... .+..         ......+..        ...
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~---------~~~~~~~~~--------~~~  241 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR---------IRDNLPPRV--------KDS  241 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH---------HHhcCCCcc--------ccc
Confidence            8899999999988889999999999999999999999987532111 0100         000111110        111


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...+..+.+++.+|+..||++||+++|+++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2345568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-33  Score=306.50  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=200.7

Q ss_pred             CCCccceeeccccceEEEEEecC--CceEEEEEEecc----------cchhHHHHHHHHHHHhh-ccCCccceEEeEEec
Q 048205          751 GFSENNLIGRGGFGFVYKARIQD--GMEVAVKVFDLQ----------YGRAIKSFDIECGMIKR-IRHRNIIKFISSCSS  817 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  817 (1027)
                      +|++.+.||+|+||.||+|++..  ++.+|+|.+...          .......+..|++++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999764  688999987532          12234556778888765 799999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEee
Q 048205          818 DDFKALVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       818 ~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                      .+..++||||+++++|.+++..   ....+++..++.++.|++.|++|||   + .+++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3456899999999999999999999   6 6899999999999999999999999


Q ss_pred             ecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          894 FGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      ||.+.......   ......++..|+|||+..+..++.++||||+|+++|||++|+.||......     ....      
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~~------  223 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLAT------  223 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHHH------
Confidence            99998653322   234456889999999999888999999999999999999999998653211     1111      


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        .+.+.....      .....++..+.+++.+||+.||++||++.|+.++++
T Consensus       224 --~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 --KIVEAVYEP------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --HHhhccCCc------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              111111100      001234567899999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-33  Score=304.63  Aligned_cols=250  Identities=23%  Similarity=0.309  Sum_probs=197.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-----chhHHHHHHHHHHHhhccCCccceEEeEEecC--Cee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  821 (1027)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999875 68999999886332     22356788899999999999999999998763  467


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 3788889999999999999999   9999999999999999999999999999998553


Q ss_pred             cCCCc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          902 KEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       902 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..... .......++..|+|||...+..++.++|||||||++|||++|+.||......    ....         +....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~---------~~~~~  224 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIF---------KIATQ  224 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHH---------HHhcC
Confidence            22111 1123345888999999998888999999999999999999999998653111    1100         00000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .      .....+...+..+.+++.+|+. +|++||+++|+++
T Consensus       225 ~------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 P------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             C------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0      0111223445668889999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-33  Score=310.24  Aligned_cols=244  Identities=25%  Similarity=0.301  Sum_probs=201.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999876 68999999987432   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987654 5889999999999999999999   999999999999999999999999999999865332  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                         .....+++.|+|||.+.+...+.++||||+|+++|+|++|+.||...... . ...           .+....    
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~-~~~-----------~~~~~~----  214 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-Q-IYE-----------KILEGK----  214 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-H-HHH-----------HHhcCC----
Confidence               23446889999999998888899999999999999999999998754211 0 000           111100    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                          ...+...+..+.+++.+||..+|++||     +++|+++
T Consensus       215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                111223456788999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-33  Score=304.91  Aligned_cols=246  Identities=26%  Similarity=0.448  Sum_probs=198.7

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999874 57889999986432  345788899999999999999999998765 4799999999


Q ss_pred             CCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          830 YGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       830 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999987653 35789999999999999999999   999999999999999999999999999998753221     


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......+..|+|||++.+..++.++||||+||++|||++ |+.||......     .+..         .+....     
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~---------~~~~~~-----  214 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKE---------CVEKGY-----  214 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHH---------HHhCCC-----
Confidence            112234567999999988899999999999999999998 89998653211     1111         111111     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                       ....+..++..+.+++.+|+..+|++||++++++..|+.
T Consensus       215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             011123456778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.2e-33  Score=309.60  Aligned_cols=267  Identities=25%  Similarity=0.305  Sum_probs=201.5

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccch-----hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR-----AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      +|+..+.||+|+||.||+|... +|+.||||.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999865 6899999998754322     334567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+ +|+|.+++......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999776546899999999999999999999   9999999999999999999999999999998654332


Q ss_pred             CcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---hHH---Hh
Q 048205          905 QSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---SIM---EV  977 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~  977 (1027)
                      .  ......+++.|+|||.+.+ ..++.++||||+||++|||++|.+||....+. ..+..........   ...   ..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence            1  2223356788999998754 45788999999999999999998877653221 1111111111000   000   00


Q ss_pred             hhccccC--ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          978 VDANLLS--HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       978 ~d~~~~~--~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .+.....  ............+..+.+++.+|+.++|++||+++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000  0000011122346678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-33  Score=306.93  Aligned_cols=253  Identities=26%  Similarity=0.442  Sum_probs=197.7

Q ss_pred             CCccceeeccccceEEEEEec----CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC------
Q 048205          752 FSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------  819 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  819 (1027)
                      |.+.+.||+|+||.||+|.+.    +++.||||++....  ....+.+.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999754    36889999986542  334567888999999999999999999886532      


Q ss_pred             eeEEEEEecCCCCHHHHHhcC-----CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 048205          820 FKALVLEYMPYGSLEKCLYSS-----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                      ..++++||+.+|+|.+++...     ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999999887532     134788899999999999999999   999999999999999999999999999


Q ss_pred             cCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      |+++...............+++.|++||......++.++||||+||++|||++ |++||.....  .....+..      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~------  229 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI------  229 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH------
Confidence            99986543222222223345678999999998889999999999999999999 8888865322  11111110      


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                           ....       ...+..++..+.+++.+|+..+|++||++.+++..|++
T Consensus       230 -----~~~~-------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         230 -----KGNR-------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             -----cCCc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                 0000       00112355678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-33  Score=309.56  Aligned_cols=258  Identities=23%  Similarity=0.323  Sum_probs=202.3

Q ss_pred             cHHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEec-
Q 048205          741 TYLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSS-  817 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  817 (1027)
                      +..++......|+..+.||+|+||.||+|++. +++.||+|++..... ....+..|+.+++++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44455566678999999999999999999875 688999999875432 345678899999998 69999999999853 


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          818 -----DDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       818 -----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                           ....++||||+++|+|.+++.... ..+++..+..++.|+++|++|||   +.+|+|||+||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999887543 45788889999999999999999   999999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV  966 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  966 (1027)
                      +|||++.......  .......|++.|+|||.+.     ...++.++||||+||++|||++|+.||.........     
T Consensus       163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----  235 (282)
T cd06636         163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----  235 (282)
T ss_pred             eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence            9999987543211  1223356889999999875     345788999999999999999999998653211100     


Q ss_pred             HHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          967 NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       967 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                              ........     .. .....++.++.+++.+||+.||++||++.|+++
T Consensus       236 --------~~~~~~~~-----~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 --------FLIPRNPP-----PK-LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------hhHhhCCC-----CC-CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    00000000     00 111245677999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=285.79  Aligned_cols=267  Identities=22%  Similarity=0.340  Sum_probs=208.2

Q ss_pred             HHHHHHHhCCCCccceeeccccceEEEEE-ecCCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCC
Q 048205          742 YLELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDD  819 (1027)
Q Consensus       742 ~~~~~~~~~~f~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  819 (1027)
                      +.+.+..+.     +.||+|+|+.|--+. ..+|.+||||+++++.....+++-+|++++.+.+ |+||++++++|++++
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            556655553     589999999999887 6689999999999988888899999999999995 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeeecC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFGM  896 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgl  896 (1027)
                      ..|+|||-|.||.|...++.+.. +.+.++.++.++|+.||.|||   .+||.|||+||+||+.....   -||||||.+
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999999987765 889999999999999999999   99999999999999996543   589999998


Q ss_pred             CcccccCC-----CcceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHH
Q 048205          897 AKPFLKED-----QSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV  966 (1027)
Q Consensus       897 a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  966 (1027)
                      ..-+....     ........+|+..|||||+..     ...|+.+.|.||+|||+|-|++|.+||.+.-..+-   -|-
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWd  302 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWD  302 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---Ccc
Confidence            86432111     112223457889999999753     24589999999999999999999999976422111   121


Q ss_pred             HHHH----hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          967 NDLL----LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       967 ~~~~----~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +-..    ...+.+-+.......+.   ..|...+.+..+++...+..||.+|.++.+++.
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkYeFPd---kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKYEFPD---KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCCcCCh---hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1100    11122222222222222   134566778899999999999999999998875

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=307.43  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=200.8

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCC------
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD------  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------  819 (1027)
                      .+++|+..+.||+|++|.||+|+.+ +++.||+|++..... ..+.+.+|+++++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999975 678999999875433 346788999999999 6999999999997644      


Q ss_pred             eeEEEEEecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          820 FKALVLEYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                      ..++||||+++++|.+++...   +..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+|++|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999987653   356899999999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      +.......  .......+++.|+|||++..     ..++.++||||+||++|+|++|+.||....... ....       
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-------  229 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFK-------  229 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHH-------
Confidence            87543221  22233468899999998753     346788999999999999999999996532111 1111       


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           +...     .......+..++.++.+++.+|+..||++|||+.|+++
T Consensus       230 -----~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 -----IPRN-----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----hhcc-----CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 0000     01111222346677899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=336.38  Aligned_cols=257  Identities=23%  Similarity=0.302  Sum_probs=207.2

Q ss_pred             HHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       744 ~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      ++.-..++|.++++||+|+||.|..++++ +++.||+|++.+-   .....+.|..|-.+|..-+.+-|++++.+|+++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34445678999999999999999999976 6899999998752   2334567889999999889999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      +.|+|||||+||+|-.++.+.+ .+++.-+..++.+|+-||.-+|   +.|+|||||||+|||+|..|++|++|||-+-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998877 6888888889999999999999   99999999999999999999999999999987


Q ss_pred             cccCCCcceecccccCccccCccccc----C-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGR----E-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      +..++ .......+|||-|.+||++.    + +.|++.+|+||+||++|||+.|..||+...     ++.-        +
T Consensus       225 m~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveT--------Y  290 (1317)
T KOG0612|consen  225 MDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVET--------Y  290 (1317)
T ss_pred             cCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHH--------H
Confidence            76544 45556678999999999886    2 568999999999999999999999998631     1111        1


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN---AKEIVT 1023 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps---~~evl~ 1023 (1027)
                      ..+.+.    ...-.|+.....+.+..+||.+.+. +|+.|..   +.++-.
T Consensus       291 ~KIm~h----k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  291 GKIMNH----KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HHHhch----hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            111111    0111112123366777888888777 7777776   776643

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.1e-33  Score=307.24  Aligned_cols=247  Identities=24%  Similarity=0.318  Sum_probs=200.8

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      |...+.||+|++|.||+|... +++.||+|+++.......+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            555679999999999999864 6889999998765555556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      ++|.+++..  ..+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||.+.......  ....
T Consensus       101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~  173 (285)
T cd06648         101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK  173 (285)
T ss_pred             CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence            999999876  34789999999999999999999   9999999999999999999999999999887543221  1223


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...|++.|+|||...+..++.++||||+||++|||++|+.||.....     ..+.....     ...        ....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~-----~~~--------~~~~  235 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIR-----DNL--------PPKL  235 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHH-----hcC--------CCCC
Confidence            34688999999999888899999999999999999999999865321     11111110     000        0011


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....++..+.+++.+||.++|++||++.++++
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            111235567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.8e-33  Score=307.64  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=193.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHH-HhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGM-IKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|++.+.||+|+||.||+|++. +|+.||+|+++.... .....+..|+.. ++..+||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999976 699999999875432 223444455554 667789999999999999999999999


Q ss_pred             ecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          827 YMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       827 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      |++ |+|.+++..   ....+++..+..++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||.++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 588777654   2346899999999999999999999   76 999999999999999999999999999986532


Q ss_pred             CCCcceecccccCccccCcccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      .   .......++..|+|||.+.+    ..++.++|+||+||++|||++|+.||.............            .
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------~  221 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV------------V  221 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH------------H
Confidence            1   12233457889999998764    456889999999999999999999986532221111111            1


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....     ... ...++.++.+++.+|+..+|++||++.++++
T Consensus       222 ~~~~~-----~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         222 EEPSP-----QLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             hcCCC-----CCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000     000 1135667899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.5e-33  Score=302.66  Aligned_cols=252  Identities=28%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|+||.||+|... +++.||+|++.....  ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888899999999999999865 689999999876544  3567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++++|.+++.... .+++..+..++.++++|++|||   +.+++|+||+|+||+++.++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987653 4788899999999999999999   9999999999999999999999999999998654332211


Q ss_pred             e--ecccccCccccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          908 T--QTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       908 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .  .....+++.|+|||++....   ++.++||||+|+++||+++|+.||....... .....+.        .      
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~--------~------  221 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVG--------A------  221 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHh--------c------
Confidence            1  11345788999999988766   8899999999999999999999997542111 0110000        0      


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ......+....++..+.+++.+|++.+|++||++.|++.
T Consensus       222 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 --GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              001111111234667889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-33  Score=304.26  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             CCCccceeeccccceEEEEEe-cCCceEEEEEEeccc------chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQY------GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      +|+..+.||+|+||.||+|+. .+++.||+|++....      ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999986 478999999987433      1235678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCccccc
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLK  902 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~  902 (1027)
                      ||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987644 4788999999999999999999   99999999999999998776 699999999986643


Q ss_pred             CCCc--ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          903 EDQS--LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ....  .......++..|+|||.+.+..++.++||||+|+++|++++|+.||........ ...+ .        +....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~-~--------~~~~~  226 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALI-F--------KIASA  226 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHH-H--------HHhcc
Confidence            3111  111234578899999999888899999999999999999999999864322111 1111 0        00000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          .  .....+...+.++.+++.+|+..+|++||++.|+++
T Consensus       227 ----~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 ----T--TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ----C--CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                0  001122345677899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-33  Score=312.31  Aligned_cols=252  Identities=27%  Similarity=0.370  Sum_probs=203.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+.....   ...+.+..|+++++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999876 589999999875432   24567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          826 EYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||+.+++|.+++.... ..+++..+..++.|+++|++|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987542 56899999999999999999999   9999999999999999999999999999987543211


Q ss_pred             Cc---------------------------ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcc
Q 048205          905 QS---------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFT  957 (1027)
Q Consensus       905 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~  957 (1027)
                      ..                           .......|+..|+|||+..+..++.++||||+|+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011123578899999999988899999999999999999999999975432


Q ss_pred             cchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 048205          958 GEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN----AKEIVT 1023 (1027)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps----~~evl~ 1023 (1027)
                      ..    .+         .++.+....      +......+.++.+++.+|+..||++||+    +.|++.
T Consensus       238 ~~----~~---------~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DE----TF---------SNILKKEVT------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH----HH---------HHHhcCCcc------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11    11         111111111      1111125677999999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.7e-33  Score=303.80  Aligned_cols=255  Identities=24%  Similarity=0.288  Sum_probs=200.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  825 (1027)
                      ++|...+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||++++++|.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999975 688999999875433 3456788999999999999999999998653  4789999


Q ss_pred             EecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887653   3345788899999999999999999   99999999999999999999999999999875432


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc---chhHHHHHHHHHhhhHHHhhh
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG---EMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ..    .....++..|+|||...+..++.++||||+||++|+|++|+.||......   ......|....   ..     
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~-----  225 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PN-----  225 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cc-----
Confidence            21    12345788899999999889999999999999999999999999865321   11122221110   00     


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +..    ..........+.++.+++.+||+.+|++||++.|+++
T Consensus       226 ~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 PEL----KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhh----ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            000    0000101124567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.3e-33  Score=309.73  Aligned_cols=247  Identities=26%  Similarity=0.348  Sum_probs=198.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ...|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++|||+++++++|...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            355888899999999999999875 68999999986432   23346788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+. |++.+++......+++..+..++.|++.|++|||   +.+|+||||+|+||+++.++.++|+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99997 4787777655556899999999999999999999   999999999999999999999999999998754321 


Q ss_pred             CcceecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          905 QSLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                           ....+++.|+|||++.   ...++.++||||||+++|||++|+.||........  ..           ......
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~-----------~~~~~~  230 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY-----------HIAQND  230 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HH-----------HHhcCC
Confidence                 2345788999999874   45688899999999999999999999865421110  00           000000


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           ... .....++.++.+++.+||..+|++||++.+++..
T Consensus       231 -----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 -----SPT-LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -----CCC-CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 000 0112356678999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.5e-33  Score=301.96  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=206.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++..... ...+.+..|++++.+++|+|++++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999977 599999999876543 4467888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++... ..+++..+..++.|+++|++|+|   + .+++||||+|+||+++.++.++++|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999998765 45899999999999999999999   8 99999999999999999999999999999865432221


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                        .....++..|+|||......++.++|+||||+++|+|++|+.||......  ...+...        .+.....    
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~--------~~~~~~~----  220 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQ--------AICDGPP----  220 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHH--------HHhcCCC----
Confidence              12345788999999999988999999999999999999999998765321  1111100        1111100    


Q ss_pred             chhhhHHhh-hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          987 DKHFVAKEQ-CMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       987 ~~~~~~~~~-~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                         ...+.. ++..+.+++.+|+..+|++||++.|+++.
T Consensus       221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               011122 56779999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6e-33  Score=301.71  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=202.4

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec--CCeeEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFKALVL  825 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  825 (1027)
                      +|++.+.||.|+||.||+|... +++.||+|++....  ....+.+..|++++++++||||+++++++..  ....++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999865 68899999986432  3345678889999999999999999998754  45679999


Q ss_pred             EecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          826 EYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGY--SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|+|..+  +.+++|+||||+||+++.++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998654   456899999999999999999999544  678999999999999999999999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .....  ......+++.|+|||.+....++.++|+||+|+++|+|++|+.||.....  ..+.+.            +..
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~------------~~~  224 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASK------------IKE  224 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHH------------Hhc
Confidence            43221  12334688999999999988899999999999999999999999876421  111111            111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ....      ..+..++.++.+++.+|+..+|++||++.+|++.
T Consensus       225 ~~~~------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 GKFR------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCC------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1100      1123456778999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=305.26  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhcc---CCccceEEeEEecCCeeEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIR---HRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .|+..+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999964 78999999987542 344567888999999997   999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++++|.+++...  .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++++|||.+..+.... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999988654  5889999999999999999999   9999999999999999999999999999998664332 


Q ss_pred             cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          906 SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       .......|+..|+|||...++ .++.++||||+||++|+|++|+.||......     .+...         ....   
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~---------~~~~---  217 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML---------IPKS---  217 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc---------cccC---
Confidence             122334688899999988754 4688999999999999999999999754211     11100         0000   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ..... ....++.++.+++.+|+..||++||++.|+++
T Consensus       218 -~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 -KPPRL-EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -CCCCC-CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence             00000 01125667899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.8e-34  Score=332.92  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=189.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEE-----------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSC-----------  815 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-----------  815 (1027)
                      .++|...++||+|+||.||+|+.+ ||+.||||++... .......+.+|++.+.+++|||||+++..+           
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            456888899999999999999988 9999999998755 334456788899999999999999985211           


Q ss_pred             -------------------------------------------------e------------------------------
Q 048205          816 -------------------------------------------------S------------------------------  816 (1027)
Q Consensus       816 -------------------------------------------------~------------------------------  816 (1027)
                                                                       .                              
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                             0                              


Q ss_pred             ----------------------c-------CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 048205          817 ----------------------S-------DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY  867 (1027)
Q Consensus       817 ----------------------~-------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~  867 (1027)
                                            +       ....||-||||+..++.+++.+....-.....++++.+|++||+|+|   
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---
Confidence                                  0       01368899999997777777665432256788999999999999999   


Q ss_pred             CCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc----------------cCCCcceecccccCccccCcccccCCC---
Q 048205          868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL----------------KEDQSLTQTQTLATIGYMAPEYGREGR---  928 (1027)
Q Consensus       868 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~---  928 (1027)
                      ++|+|||||||.||++|+++.|||+|||+|+...                ........+..+||.-|+|||++.+..   
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999998721                011122456678999999999988654   


Q ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhc
Q 048205          929 VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCT 1008 (1027)
Q Consensus       929 ~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl 1008 (1027)
                      |+.|+|+||+|||++||+.   ||....+....+..             +.......+ ..+  +....+.=..+|++|+
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~-------------LR~g~iP~~-~~f--~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN-------------LRKGSIPEP-ADF--FDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh-------------cccCCCCCC-ccc--ccccchHHHHHHHHHh
Confidence            9999999999999999995   56543211111111             111111111 111  1122233467999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 048205         1009 IESPEERINAKEIVT 1023 (1027)
Q Consensus      1009 ~~dP~~Rps~~evl~ 1023 (1027)
                      +.||.+||||.|++.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999985

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6e-33  Score=299.21  Aligned_cols=249  Identities=31%  Similarity=0.407  Sum_probs=205.7

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .|+..+.||+|++|.||+|+.. +++.|++|++........+.+.+|++++++++|++++++++++......++|+||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777899999999999999976 689999999976655566788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +++|.+++......+++..+..++.++++|++|||   +.+++||||+|+||+++.++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999998876566899999999999999999999   89999999999999999999999999999986543321   2


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ....++..|+|||......++.++||||+|+++|+|++|+.||.......     .....         ...    ....
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~---------~~~----~~~~  216 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----ALFKI---------ATN----GPPG  216 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHH---------Hhc----CCCC
Confidence            34568889999999988888999999999999999999999987542111     00000         000    0001


Q ss_pred             hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          990 FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       990 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ......++..+.+++.+|+..||++||++.|+++
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111223567899999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-33  Score=310.43  Aligned_cols=269  Identities=23%  Similarity=0.276  Sum_probs=199.4

Q ss_pred             CCCccceeeccccceEEEEEec---CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKA  822 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  822 (1027)
                      +|++.+.||+|+||.||+|+..   +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999865   47899999987632   33346677899999999999999999999988  8899


Q ss_pred             EEEEecCCCCHHHHHhcC----CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC----CCcEEEeee
Q 048205          823 LVLEYMPYGSLEKCLYSS----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD----NMVAHLSDF  894 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  894 (1027)
                      +||||+++ ++.+++...    ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 677665432    135789999999999999999999   999999999999999999    999999999


Q ss_pred             cCCcccccCCC-cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccc--------hhHHH
Q 048205          895 GMAKPFLKEDQ-SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE--------MTLKR  964 (1027)
Q Consensus       895 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~--------~~~~~  964 (1027)
                      |+++.+..... ........+++.|+|||++.+. .++.++||||+||++|+|++|++||.......        ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543222 1222345678999999987664 57899999999999999999999997653322        01111


Q ss_pred             HHHHHHhh------------hHHH---hhhccccC--ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          965 WVNDLLLI------------SIME---VVDANLLS--HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       965 ~~~~~~~~------------~~~~---~~d~~~~~--~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ++......            ....   ........  ............+.++.+++.+|+++||++|||+.|++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111000            0000   00000000  000011111145567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-34  Score=312.02  Aligned_cols=249  Identities=27%  Similarity=0.333  Sum_probs=207.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch--hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ....|.+.+.||+|.|++|..|++. ++..||||.+++..-.  ....+.+|+++++.++|||||+++.+...+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3456888999999999999999866 7999999999865432  334578899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+.+|.+++++...+.. .+..+..++.|+.+|++|||   ++.|||||||++||+++.+..+||+|||++..+..  
T Consensus       134 ~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             EEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc--
Confidence            9999999999999887764 44888899999999999999   99999999999999999999999999999998753  


Q ss_pred             CcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                       .......+|++.|.|||+..+.+| ++.+|+||+|+++|.++.|..||++..-.+                 .-++.+.
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------Lr~rvl~  269 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------LRPRVLR  269 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------ccchhee
Confidence             234456789999999999998776 678999999999999999999998742111                 1111111


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..    +-.+.-.+.++.+++++++..+|.+|++..++++.
T Consensus       270 gk----~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  270 GK----YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ee----ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            11    11122345567899999999999999999998763

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.1e-33  Score=306.51  Aligned_cols=263  Identities=25%  Similarity=0.307  Sum_probs=199.6

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||.|++|.||+|+.. +|+.||||++....  ....+.+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999875 68999999886443  22345788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +. ++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+|++|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 58988886543 45899999999999999999999   99999999999999999999999999999875532221 


Q ss_pred             ceecccccCccccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------------h
Q 048205          907 LTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------------S  973 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~  973 (1027)
                       ......+++.|+|||+..+.. ++.++||||+||++|||+||+.||...... ....+........            .
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             122335688999999887644 588999999999999999999999754221 1222222111100            0


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....+....   ...........+.++.+++.+|++.||++||++++++.
T Consensus       234 ~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWA---RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhccccc---ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000000000   00000111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.3e-33  Score=303.67  Aligned_cols=247  Identities=26%  Similarity=0.352  Sum_probs=200.9

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      -|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3677889999999999999865 68899999986433 334567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++...  .+++..+..++.+++.|++|||   +.+++|+||||+||+++.++.++++|||++..+....  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            999999988653  4789999999999999999999   9999999999999999999999999999987653221  11


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      .....++..|+|||...+..++.++|+||+||++|+|++|..||......     .+...         +....      
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~---------~~~~~------  217 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL---------IPKNN------  217 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH---------HhcCC------
Confidence            22345788999999998888899999999999999999999998653211     11110         00000      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .......++.++.+++.+|++.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            001122356678899999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5e-33  Score=306.08  Aligned_cols=252  Identities=28%  Similarity=0.356  Sum_probs=206.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..+.|+..+.+|+|++|.||+|.++ +++.||+|++..... ..+.+.+|+++++.++|+|++++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4566888899999999999999977 689999999976544 45678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++++|.+++......+++..+..++.+++.|++|||   +.+++|+|++|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            99999999999876556899999999999999999999   99999999999999999999999999999875432221 


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                       ......+++.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+            ....     
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~------------~~~~-----  232 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLI------------TTKG-----  232 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH------------HhcC-----
Confidence             122335788999999998888999999999999999999999998653211 111110            0000     


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .........++..+.+++.+|++.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0111122235677899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-33  Score=307.82  Aligned_cols=268  Identities=24%  Similarity=0.285  Sum_probs=202.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|+||.||+|+++ +++.||+|+++...  ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999976 58899999886432  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |++++.+..+... ...+++.++..++.||+.|++|||   +.+++|||++|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            9998766665543 345899999999999999999999   99999999999999999999999999999986644332 


Q ss_pred             ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--hhHHHhh--hcc
Q 048205          907 LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--ISIMEVV--DAN  981 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~--d~~  981 (1027)
                      .......++..|+|||+..+. .++.++||||+|+++|+|++|++||......+ ...........  .......  ++.
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCcc
Confidence            122335678899999999888 78999999999999999999999987542211 11110000000  0000000  000


Q ss_pred             ccC----ccc-h---hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 LLS----HED-K---HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ~~~----~~~-~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...    ... .   ....+..++.++.+++.+||..+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000    000 0   00111234778999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.6e-33  Score=309.92  Aligned_cols=268  Identities=26%  Similarity=0.279  Sum_probs=199.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch--hHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  823 (1027)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++.....  ....+.+|++++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999975 6899999998744321  223456799999999999999999998765  56899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+.+ +|.+++......+++.++..++.|+++|++|||   +.+++||||||+||+++.++.+||+|||.+......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999975 898888766566899999999999999999999   999999999999999999999999999999865432


Q ss_pred             CCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh----
Q 048205          904 DQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV----  978 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  978 (1027)
                      ..  ......+++.|+|||++.+ ..++.++||||+||++|||++|++||...... ..+........ .......    
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~  237 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLG-TPNESIWPGFS  237 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcC-CCChhhchhhh
Confidence            21  1223345788999998865 45789999999999999999999999754221 11111111000 0000000    


Q ss_pred             h-----ccccC-cc-chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          979 D-----ANLLS-HE-DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       979 d-----~~~~~-~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      +     ..... .. ..........+.++.+++.+|+++||++||++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0     00000 00 00000112246678899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-33  Score=304.34  Aligned_cols=248  Identities=24%  Similarity=0.317  Sum_probs=204.0

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      +|+..+.||.|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999976 68999999987542   2346788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+.+++|.+++... ..+++.++..++.|+++|++|||   +.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998765 45889999999999999999999   9999999999999999999999999999988654322  


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                       ......++..|+|||+.....++.++|+||+|+++|+|++|+.||......  .....+.         ....      
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~---------~~~~------  216 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRA---------KQET------  216 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHH---------Hhcc------
Confidence             223345788999999999888999999999999999999999998764321  1111111         1110      


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINA--KEIVT 1023 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~--~evl~ 1023 (1027)
                       .....+...+..+.+++.+||..||++||++  +|+++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0111223456778999999999999999999  77764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-33  Score=304.55  Aligned_cols=265  Identities=26%  Similarity=0.310  Sum_probs=199.8

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      |+..+.||.|++|.||+|++. +|+.||+|++....  ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            667889999999999999865 79999999987543  223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      + ++|.+++.... ..+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++|+|||.+..+.....  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 58999887654 45899999999999999999999   89999999999999999999999999999975532211  


Q ss_pred             eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---------HHHh
Q 048205          908 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---------IMEV  977 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~  977 (1027)
                      ......+++.|+|||++.+. .++.++||||+|+++|+|++|++||...... ..............         ..+.
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            12223568899999987664 5688999999999999999999999764321 11111111110000         0000


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...................+..+.+++.+|++.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000011112345577899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.1e-33  Score=307.12  Aligned_cols=267  Identities=23%  Similarity=0.269  Sum_probs=200.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV  824 (1027)
                      ++|+..+.||+|+||.||+|++. +++.||+|.++....  .....+.+|++++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999976 688999999874432  2234567899999999999999999998877  889999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++ +|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..+....
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 999988776667899999999999999999999   9999999999999999999999999999998654332


Q ss_pred             CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------hHHHh
Q 048205          905 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------SIMEV  977 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~  977 (1027)
                      .  ......+++.|+|||.+.+. .++.++|+||+|+++|||++|++||...... .............      ...+.
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhcc
Confidence            1  22334578899999988754 4688999999999999999999999764321 1111111110000      00000


Q ss_pred             hhcc---ccCccch--hhhHHhh-hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDAN---LLSHEDK--HFVAKEQ-CMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~---~~~~~~~--~~~~~~~-~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....   .......  ....+.. .+..+.+++.+|++.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000   0000000  0001111 3667899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=299.33  Aligned_cols=270  Identities=27%  Similarity=0.331  Sum_probs=200.6

Q ss_pred             CCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhh--ccCCccceEEeEEecCC----eeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR--IRHRNIIKFISSCSSDD----FKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lV  824 (1027)
                      ..+...+||+|.||.||+|+.. ++.||||++..   +..+.|..|-++.+.  ++|+||++++++-...+    ...+|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3455678999999999999986 49999999973   345677777777664  58999999998876554    78999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC------CCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG------YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      +||.+.|+|.+|+...  ..+|....+|+.-+++||+|||+.      +..+|+|||||++|||+..|+++.|+|||+|.
T Consensus       287 t~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            9999999999999875  489999999999999999999943      35679999999999999999999999999999


Q ss_pred             ccccCCCcceecccccCccccCcccccCCC-C-----CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGR-V-----STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      .+...........-+||.+|||||++.+.- +     -.+.||||+|.|+||++++..-++....++-.+..-.....+.
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            887655555555578999999999988653 1     2357999999999999998765542211111111111111122


Q ss_pred             hHHHhhhccccCccc---hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          973 SIMEVVDANLLSHED---KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ++.++.+-.+....+   +..-.....+.-+.+.+..||..||+.|.|+.=|.+.++
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence            222222222211111   122223356777999999999999999999987766553

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-32  Score=298.82  Aligned_cols=249  Identities=22%  Similarity=0.233  Sum_probs=195.3

Q ss_pred             HHHHHHhCCCCcccee--eccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecC
Q 048205          743 LELFQATNGFSENNLI--GRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD  818 (1027)
Q Consensus       743 ~~~~~~~~~f~~~~~l--G~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  818 (1027)
                      .+.....++|++.+.+  |+|+||.||+++.+ +++.+|+|++........     |+.....+ +|||++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444445677777776  99999999999865 688999999874322111     22222222 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCC
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMA  897 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla  897 (1027)
                      +..++||||+++++|.+++.... .+++.++..++.|+++|++|||   +.+++||||||+||+++.++ .++++|||.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999987664 6899999999999999999999   99999999999999999988 9999999998


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      +.....      ....++..|+|||++.+..++.++||||+||++|||++|+.||............|....        
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  223 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--------  223 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------
Confidence            754321      223578899999999988999999999999999999999999985543332222222111        


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-AKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~evl~ 1023 (1027)
                       ..        ....+..++..+.+++.+|++.+|++||+ ++|+++
T Consensus       224 -~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 -QK--------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -cc--------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             00        11112246677899999999999999996 698875

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=279.74  Aligned_cols=250  Identities=22%  Similarity=0.272  Sum_probs=199.7

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEec
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+.+..||.|+.|.|++++.+ +|...|||.+.+.. .+..+++...+.++.+-+ .|+||+.+|||..+..+.+.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344567999999999999976 68999999987543 445567777777766554 899999999999999899999998


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      .- -.+.++.+-...+++..+-++...+..||.||.+  .++|+|||+||+||++|+.|.+|+||||++.++...   ..
T Consensus       174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kA  247 (391)
T KOG0983|consen  174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KA  247 (391)
T ss_pred             HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc---cc
Confidence            53 5566677767778998888999999999999984  569999999999999999999999999999876532   33


Q ss_pred             ecccccCccccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          909 QTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .+...|.+.|||||.+...   .|+-.+||||||+.++|+.||+.||.....+-..+..                .+.. 
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk----------------vln~-  310 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK----------------VLNE-  310 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH----------------HHhc-
Confidence            4556789999999988643   5888999999999999999999999875433222221                1111 


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..+.......+++++.+++..|+.+|+.+||...+++++
T Consensus       311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            112333344578889999999999999999999998863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=259.43  Aligned_cols=268  Identities=26%  Similarity=0.279  Sum_probs=206.0

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .|...++||+|.||+||+|+.+ +++.||+|.++.+..  ..-....+|+-+++.++|+|||+++++...+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666788999999999999965 688999999876532  2345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      |+. +|..+..+....++.+.+..++.|+++|+.++|   ++.+.|||+||.|.+|..+|++|++|||+|+.+.-+.  .
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            976 999999888888999999999999999999999   9999999999999999999999999999999765332  2


Q ss_pred             eecccccCccccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------HHHhhhc
Q 048205          908 TQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------IMEVVDA  980 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~  980 (1027)
                      ..+..+.|.+|++|.++.+.+ |+...|+||.|||+.|+....+|.....+-+..+++..+......      ....-|-
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            344557899999999998765 788999999999999999865554433333334444443332111      1111121


Q ss_pred             cccCccc---hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          981 NLLSHED---KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .......   ...+.-+.....-.+++.+.+.-+|.+|.+++++++.
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1111111   0111122333445788999999999999999998763

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-32  Score=297.57  Aligned_cols=251  Identities=27%  Similarity=0.364  Sum_probs=206.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKALVL  825 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  825 (1027)
                      +|+..+.||+|++|.||+|+.. +++.|++|++.....  ...+.+.+|++++++++||||+++++++...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999976 789999999875542  4567888999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++++|.+++.... .+++..+..++.++++|++|||   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999987765 6899999999999999999999   89999999999999999999999999999986654332


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      ........++..|+|||.......+.++||||+|+++|+|++|+.||........  ..|          .....     
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----------~~~~~-----  219 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALY----------KIGSS-----  219 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHH----------hcccc-----
Confidence            1123345688899999999988899999999999999999999999976531110  000          00000     


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ......+...+..+.+++.+|+..+|++||++.|++.
T Consensus       220 -~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         220 -GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             0011122334677999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-33  Score=311.75  Aligned_cols=269  Identities=22%  Similarity=0.247  Sum_probs=199.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCC-----ee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-----FK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  821 (1027)
                      .++|++.+.||+|+||.||+|++. +|+.||||++... .......+.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 6899999998643 2234466788999999999999999998876543     57


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++|+||+++ ++.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999999975 888877543  4899999999999999999999   9999999999999999999999999999998653


Q ss_pred             cCCCc-ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh---hhHHH
Q 048205          902 KEDQS-LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL---ISIME  976 (1027)
Q Consensus       902 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  976 (1027)
                      ..... .......+++.|+|||.+.+ ..++.++||||+||++|+|++|++||..... ......+......   .....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHH
Confidence            32211 11233568899999998654 5688999999999999999999999965321 1111111111100   00111


Q ss_pred             hhhccc-------cCccc-hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          977 VVDANL-------LSHED-KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       977 ~~d~~~-------~~~~~-~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      +.+...       ..... .........+.++.+++.+||+.+|++||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111000       00000 0001112346678999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-32  Score=301.21  Aligned_cols=262  Identities=22%  Similarity=0.259  Sum_probs=195.7

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhcc-CCccceEEeEEecC--CeeEEEEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIR-HRNIIKFISSCSSD--DFKALVLE  826 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e  826 (1027)
                      |+..+.||+|+||.||+|+.. +++.||+|+++.... ........|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 689999999875422 22233456888888885 99999999999887  88999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++ ++.+.+......+++.++..++.|++.||+|||   +.+++||||||+||+++. +.+||+|||+++....... 
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            9975 888888765566899999999999999999999   999999999999999999 9999999999986533221 


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---hHHHhhhccc
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---SIMEVVDANL  982 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~~  982 (1027)
                        .....+++.|+|||+... ..++.++||||+||++|||++|++||......  ....+.......   ..........
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcccc
Confidence              123457889999997654 55788999999999999999999999764321  111111111100   0000110000


Q ss_pred             cCc-------cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSH-------EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~-------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...       ...-.......+.++.+++.+|+.++|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000       00001112345788999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.1e-33  Score=313.67  Aligned_cols=266  Identities=23%  Similarity=0.238  Sum_probs=199.5

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC-----
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----  818 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  818 (1027)
                      ...++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34578999999999999999999865 78999999986432  23345677899999999999999999988644     


Q ss_pred             -CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          819 -DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       819 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                       ...++||||+.+ ++.+.+...   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             357999999965 888877643   788899999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--hhHH
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--ISIM  975 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~  975 (1027)
                      +......   ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||...... ............  ....
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence            8653221   123345788999999999999999999999999999999999999754221 111111110000  0000


Q ss_pred             --------HhhhccccCccc-------------hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          976 --------EVVDANLLSHED-------------KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       976 --------~~~d~~~~~~~~-------------~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                              ...+........             .........+.++.+++.+|++.||++||++.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    011100000000             000001234667889999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-32  Score=306.24  Aligned_cols=244  Identities=27%  Similarity=0.334  Sum_probs=197.1

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      |+..+.||+|+||.||+|+.. +++.||+|++....   .+..+.+..|++++++++|||++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            677889999999999999865 68899999986432   23446788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +.+ ++.+.+......+++.++..++.+++.|+.|||   +.+|+||||+|+||+++.++.+||+|||++.....     
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            975 888877666666899999999999999999999   99999999999999999999999999999874322     


Q ss_pred             eecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          908 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       .....+++.|+|||++.   .+.++.++||||+||++|||++|+.||...... .....+.            ..... 
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~------------~~~~~-  242 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA------------QNESP-  242 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH------------hccCC-
Confidence             12345888999999874   456889999999999999999999998753211 1111111            00000 


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           ......++..+.+++.+|++.+|++||++.++++.
T Consensus       243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence                 01112355678999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.3e-32  Score=301.25  Aligned_cols=242  Identities=24%  Similarity=0.308  Sum_probs=187.8

Q ss_pred             eeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHH---HhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          757 LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGM---IKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .||+|+||.||+|+.. +++.||+|.+.....   .....+.+|..+   +...+||+++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 689999998865321   112233344433   334479999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +|+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++|||++......    ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            999999887554 4899999999999999999999   999999999999999999999999999998754321    12


Q ss_pred             cccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....|++.|+|||.... ..++.++||||+||++|||++|+.||........  .. ...        ....       .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~-~~~--------~~~~-------~  214 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDR--------MTLT-------V  214 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HH-HHH--------Hhhc-------C
Confidence            23468999999998864 5688999999999999999999999975432211  11 000        0000       0


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVTK 1024 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~~ 1024 (1027)
                      ....+..++.++.+++.+|+..||++||     +++|++++
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1112234667789999999999999999     69998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.3e-33  Score=299.66  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=201.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|+||.||+|... +|+.||+|.+....  ....+.+.+|++++++++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999976 68899999987532  12345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~  905 (1027)
                      +++++|.+++.... ..+++..+..++.|+++|++|||   +.+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987643 35799999999999999999999   99999999999999999886 469999999986543221


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......|++.|+|||+.....++.++||||+|+++|||++|+.||....     ..+++...        ......  
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~--------~~~~~~--  220 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKI--------CQGYFA--  220 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHH--------hcccCC--
Confidence              2223458889999999988889999999999999999999999986532     12222111        111100  


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           ......+.++.+++.+|+..+|++||++.|+++.
T Consensus       221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 0112345678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-32  Score=303.03  Aligned_cols=260  Identities=21%  Similarity=0.272  Sum_probs=187.8

Q ss_pred             hCCCCccceeeccccceEEEEEecC----CceEEEEEEecccchhH-----------HHHHHHHHHHhhccCCccceEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQYGRAI-----------KSFDIECGMIKRIRHRNIIKFIS  813 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~  813 (1027)
                      .++|++.+.||+|+||.||+|++.+    +..+|+|+.........           .....+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999998764    45677776443221110           11122334556678999999998


Q ss_pred             EEecCC----eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          814 SCSSDD----FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       814 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      ++....    ..++++|++.. ++.+.+... ...++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            776543    44778888754 666665543 23578888999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHH
Q 048205          890 HLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKR  964 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~  964 (1027)
                      +|+|||+|+.+......     .......||+.|+|||+..+..++.++||||+||++|||++|+.||........ ...
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHH
Confidence            99999999876432211     112234699999999999999999999999999999999999999976522211 111


Q ss_pred             HHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          965 WVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       965 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      -..       .+.+.+...    .. .....++.++.+++..|+..+|++||++.++.+.+.
T Consensus       245 ~~~-------~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AAK-------CDFIKRLHE----GK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HhH-------HHHHHHhhh----hh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            000       000000000    00 011245677999999999999999999999998763

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=340.34  Aligned_cols=254  Identities=26%  Similarity=0.349  Sum_probs=205.8

Q ss_pred             HhCCCCccceeeccccceEEEEEe-cCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .+-+++...+||.|.||.||-|.. .+|...|+|.+..+.  ....+.+.+|+.++..++|||+|++||+-...+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            456688889999999999999985 479999999876443  34567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||||++|+|++.+...+ ..++.....+..|++.|++|||   +.|||||||||+||+++.+|.+|++|||.|..+....
T Consensus      1313 MEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999999876543 4677777778899999999999   9999999999999999999999999999998775432


Q ss_pred             C--cceecccccCccccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          905 Q--SLTQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       905 ~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      .  ........||+.|||||++.+.   ....+.||||+|||+.||+||++||......      |.         -++.
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~a---------IMy~ 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WA---------IMYH 1453 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hH---------HHhH
Confidence            1  1223456799999999998764   4677899999999999999999999764322      11         0111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      -..    ....+.|+..+.+-.+++.+|+..||++|.++.|+++.
T Consensus      1454 V~~----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAA----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             Hhc----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            111    11123344477788999999999999999999988764

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.2e-33  Score=311.22  Aligned_cols=269  Identities=22%  Similarity=0.256  Sum_probs=201.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec----CCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS----DDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  821 (1027)
                      ..+|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            467899999999999999999865 68999999987542  2335667789999999999999999988753    3468


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+. ++|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999996 58999887654 3899999999999999999999   9999999999999999999999999999997654


Q ss_pred             cCCCc--ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------
Q 048205          902 KEDQS--LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------  972 (1027)
Q Consensus       902 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  972 (1027)
                      .....  .......++..|+|||++.. ..++.++||||+||++|||++|+.||...... ..+..........      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHhhh
Confidence            32211  11233468899999998765 45889999999999999999999999764221 1111111111100      


Q ss_pred             -----hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 -----SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 -----~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ...+..+.................+.++.+++.+|++.+|++||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 000111100000000011112345778999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-32  Score=324.08  Aligned_cols=272  Identities=19%  Similarity=0.217  Sum_probs=191.9

Q ss_pred             HhCCCCccceeeccccceEEEEEecC--CceEEEEEE--------------ec---ccchhHHHHHHHHHHHhhccCCcc
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQD--GMEVAVKVF--------------DL---QYGRAIKSFDIECGMIKRIRHRNI  808 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~ni  808 (1027)
                      ...+|++.+.||+|+||+||+|+++.  +..+++|.+              .+   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35689999999999999999987542  222332211              00   112234567889999999999999


Q ss_pred             ceEEeEEecCCeeEEEEEecCCCCHHHHHhcCC----ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 048205          809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  884 (1027)
Q Consensus       809 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  884 (1027)
                      +++++++...+..++|+|++.+ ++.+++....    ......++..++.|++.||+|||   +.+||||||||+||+++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            9999999999999999999964 7777765432    22345667789999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcc--cchhH
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFT--GEMTL  962 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~--~~~~~  962 (1027)
                      .++.+||+|||+++.+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.++.....  ....+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999986643221 222345799999999999999999999999999999999998865432211  11122


Q ss_pred             HHHHHHHHh--h-------hHHHhhhccccC---ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          963 KRWVNDLLL--I-------SIMEVVDANLLS---HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       963 ~~~~~~~~~--~-------~~~~~~d~~~~~---~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .+.+.....  .       ...+.++.....   ............+.++.+++.+|+++||++||++.|++..
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            221111100  0       011111110000   0001111122345667889999999999999999999863

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-32  Score=309.49  Aligned_cols=270  Identities=24%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhc-cCCccceEEeEEecC--Cee
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD--DFK  821 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  821 (1027)
                      ..++|+..+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+++++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999876 6889999988543  223345677899999999 999999999998654  368


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++ +|.+++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            999999975 999988765  5789999999999999999999   9999999999999999999999999999998654


Q ss_pred             cCCCc---ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh------
Q 048205          902 KEDQS---LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL------  971 (1027)
Q Consensus       902 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------  971 (1027)
                      .....   .......+++.|+|||.+.. ..++.++||||+|+++|+|++|+.||....... ...........      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence            33221   22233568899999998764 457889999999999999999999997543221 11111111000      


Q ss_pred             -----hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          972 -----ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       972 -----~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           ....+..+................++.++.+++.+|++.||++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 00111111110001111111112357789999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=302.24  Aligned_cols=267  Identities=26%  Similarity=0.324  Sum_probs=201.4

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEEEEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKALVLE  826 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  826 (1027)
                      |++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999976 58999999998653  33346688899999999999999999999888  88999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++ +|.+++......+++..+..++.|+++|++|||   +.+++|+||||+||++++++.+|++|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899988776566899999999999999999999   89999999999999999999999999999986644321 


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------HHHh--
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------IMEV--  977 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~--  977 (1027)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..............      ....  
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence            12233456788999997764 45789999999999999999999998764321 11111111100000      0000  


Q ss_pred             ---hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          978 ---VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       978 ---~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                         ..+...............++.++.+++.+|+..+|++||+++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               00000000000000111136788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.2e-32  Score=306.97  Aligned_cols=269  Identities=22%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCC------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  819 (1027)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+.....  .....+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            456999999999999999999876 689999998864322  22345567999999999999999999987654      


Q ss_pred             --eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          820 --FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       820 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                        ..++||||+.+ ++.+++......+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              45999999975 888888766556899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccCCCc--ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh--
Q 048205          898 KPFLKEDQS--LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI--  972 (1027)
Q Consensus       898 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  972 (1027)
                      ..+......  .......++..|+|||.+.+. .++.++||||+|+++|||++|+.||......  .....+......  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~~  244 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSIT  244 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence            865432211  112234578889999987664 3688999999999999999999998754221  111111110000  


Q ss_pred             -h------HHHhhhccccCcc-chhhh---HHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 -S------IMEVVDANLLSHE-DKHFV---AKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 -~------~~~~~d~~~~~~~-~~~~~---~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       .      ..+..+....... .....   .+......+.+++.+|+..||++||+++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             0      0000000000000 00000   01112355789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-32  Score=303.13  Aligned_cols=244  Identities=23%  Similarity=0.312  Sum_probs=197.6

Q ss_pred             cceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          755 NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ...||+|+||.||+|..+ +++.||||++........+.+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999875 7899999998655445566788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL  913 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  913 (1027)
                      .+++...  .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||++.......  .......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            9987543  4788999999999999999999   9999999999999999999999999999987553222  1223346


Q ss_pred             cCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       914 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      +++.|+|||...+..++.++|+||+||++|+|++|+.||......  .......        +...+        .....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~--------~~~~~--------~~~~~  239 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIR--------DNLPP--------KLKNL  239 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH--------hhCCc--------ccCCc
Confidence            889999999998888899999999999999999999998753211  1111100        00000        11111


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..++..+.+++.+||..+|.+||++.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            234566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.1e-32  Score=299.50  Aligned_cols=266  Identities=22%  Similarity=0.293  Sum_probs=200.7

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +|+..+.||+|++|.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999976 689999999875432 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          829 PYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       829 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      ++ ++.+++....  ..+++..+..++.|+++|++|||   +.+++||||||+||++++++.++++|||.++......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            85 8888876543  45899999999999999999999   9999999999999999999999999999997543221  


Q ss_pred             ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---hHHHhhh---
Q 048205          907 LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---SIMEVVD---  979 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d---  979 (1027)
                      .......+++.|+|||++.+. .++.++||||+||++|++++|+.||......+ ............   ......+   
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCch
Confidence            122234578899999987654 56889999999999999999999997643221 111111110000   0000000   


Q ss_pred             --ccccCcc-chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 --ANLLSHE-DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 --~~~~~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ....... ..........+..+.+++.+|++.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0000000 0001112245677899999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-32  Score=296.40  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=199.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecc-----cchhHHHHHHHHHHHhhccCCccceEEeEEecC--Cee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ-----YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  821 (1027)
                      .+|+..+.||+|+||.||+|+.. +++.||+|++...     .....+.+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57889999999999999999865 6899999987532     123456788999999999999999999998764  467


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++|+||+++++|.+++..... +++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            899999999999999876543 788899999999999999999   9999999999999999999999999999998653


Q ss_pred             cCCC-cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          902 KEDQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       902 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      .... ........++..|+|||+..+..++.++|+||+||++|++++|+.||........ ..+            ....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~------------~~~~  224 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFK------------IATQ  224 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHH------------HHcC
Confidence            2111 1112234688999999999988899999999999999999999999875321110 000            0000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                            ......+...+.++.+++.+|+. +|..||++.+++..
T Consensus       225 ------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         225 ------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                  00111234466778999999999 57999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-32  Score=294.39  Aligned_cols=247  Identities=29%  Similarity=0.418  Sum_probs=203.3

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|++|.||+|+.. +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999866 688999999875543  4567888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++++|.+++... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+........  
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            9999999998765 45899999999999999999999   99999999999999999999999999999986543322  


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......++..|+|||...+..++.++||||+|+++|+|++|+.||.....    ......         .....      
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~---------~~~~~------  215 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFR---------IVQDD------  215 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHH---------HhccC------
Confidence            12334678899999998888889999999999999999999999875321    111100         00000      


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ....+...+..+.+++.+|+..+|++||++.+++.
T Consensus       216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             00112244667889999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.8e-32  Score=301.66  Aligned_cols=267  Identities=23%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhcc-CCccceEEeEEecCCe-----
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDF-----  820 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  820 (1027)
                      ++|+..+.||+|+||.||+|++. +++.||+|+++....  .....+.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999976 689999998865432  23456788999999995 6999999999987665     


Q ss_pred             eEEEEEecCCCCHHHHHhcCC----ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeec
Q 048205          821 KALVLEYMPYGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFG  895 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  895 (1027)
                      .++||||+++ ++.+++....    ..+++..+..++.||++||+|||   +.+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 8988876432    34799999999999999999999   999999999999999998 8999999999


Q ss_pred             CCcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh-
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS-  973 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  973 (1027)
                      +++.+.....  ......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||........ ............ 
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence            9986533211  1222356888999998765 4578999999999999999999999976422111 111111000000 


Q ss_pred             -----HHHhhhccccCc-cchh-hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 -----IMEVVDANLLSH-EDKH-FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 -----~~~~~d~~~~~~-~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ..+..+...... .... ....+..+.++.+++.+|+.++|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                 000000000000 0000 0111245677899999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.7e-32  Score=295.24  Aligned_cols=249  Identities=27%  Similarity=0.377  Sum_probs=205.5

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|+..+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999976 689999999875432  4566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          828 MPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       828 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +++++|.+++...   ...+++.++..++.+++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998765   366899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                        .......+++.|+|||......++.++||||+|+++++|++|+.||.....     ......        ....... 
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~--------~~~~~~~-  221 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALK--------ILKGQYP-  221 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHH--------HhcCCCC-
Confidence              123334688899999999888899999999999999999999999865421     111111        0111100 


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                            ..+..++.++.+++.+|+..+|++||++.|+++.
T Consensus       222 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         222 ------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  1112456778999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-32  Score=304.61  Aligned_cols=271  Identities=24%  Similarity=0.265  Sum_probs=202.1

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC----
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD----  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  819 (1027)
                      ...++|++.+.||+|+||.||+|+++ +|+.||+|+++...  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999976 68999999987543  223356778999999999999999999987654    


Q ss_pred             ------eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          820 ------FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       820 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999986 777777765556899999999999999999999   99999999999999999999999999


Q ss_pred             ecCCcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          894 FGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      ||.+..+..... .......++..|+|||...+ ..++.++||||+||++|||++|++||..... ...+..........
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence            999986543322 11222346778999998764 3578899999999999999999999975321 11121111111000


Q ss_pred             ---hHHHhhhccccC-------ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 ---SIMEVVDANLLS-------HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 ---~~~~~~d~~~~~-------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         ...++.......       ............+..+.+++.+|+..+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               000000000000       000001112235678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.1e-32  Score=295.69  Aligned_cols=242  Identities=26%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ||.|++|.||+|+.. +++.||+|++....   ....+.+..|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 58999999987543   23456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL  913 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  913 (1027)
                      .+++.+.. .+++..+..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||.+.......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99987654 4789999999999999999999   9999999999999999999999999999998654322   223346


Q ss_pred             cCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       914 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      +++.|+|||.+....++.++|+||+|+++|+|++|+.||.....+.   ..+..        .+.+..      .....+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~--------~~~~~~------~~~~~~  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYN--------DILKGN------GKLEFP  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHH--------HHhccC------CCCCCC
Confidence            7889999999988889999999999999999999999997653211   11111        111100      011112


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          994 EQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                      ...+.++.+++.+||..+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            233667899999999999999999     788765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-32  Score=301.30  Aligned_cols=266  Identities=25%  Similarity=0.305  Sum_probs=197.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|++|+||+|+.+ +|+.||+|.+.....  ...+.+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999876 689999998864322  234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecCCcccccCC
Q 048205          827 YMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |+++ ++.+++.... ...++..+..++.||+.|++|||   +.+++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9964 8887775443 33678888899999999999999   999999999999999985 5679999999997543221


Q ss_pred             CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh----
Q 048205          905 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD----  979 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d----  979 (1027)
                        .......+++.|+|||++.+. .++.++||||+||++|+|+||++||......+ .......... ....+..+    
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~  233 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILG-TPNEETWPGVTS  233 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC-CCChhhcccccc
Confidence              112234578899999988664 57889999999999999999999997642211 1111110000 00000000    


Q ss_pred             ---c-cccC--ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ---A-NLLS--HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ---~-~~~~--~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         . ....  ............+.++.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0 0000  000011112345667899999999999999999999986

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-32  Score=299.75  Aligned_cols=243  Identities=24%  Similarity=0.299  Sum_probs=193.8

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ||+|+||+||+|... +|+.||+|++....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 68999999987532   22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceeccc
Q 048205          834 EKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT  912 (1027)
Q Consensus       834 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  912 (1027)
                      .+++.... ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99987654 35899999999999999999999   999999999999999999999999999998754321   122334


Q ss_pred             ccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhH
Q 048205          913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVA  992 (1027)
Q Consensus       913 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  992 (1027)
                      .++..|+|||+..+..++.++||||+||++|+|++|+.||........ .....         +   . ...   .....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~---------~---~-~~~---~~~~~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELK---------R---R-TLE---MAVEY  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHH---------h---c-ccc---ccccC
Confidence            578899999999888899999999999999999999999976432110 00000         0   0 000   01112


Q ss_pred             HhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          993 KEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       993 ~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      +..++..+.+++.+||+.+|++||     ++.+++.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            234567789999999999999999     6766764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.4e-32  Score=302.11  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=195.4

Q ss_pred             CCCCccceeeccccceEEEEEecC-CceEEEEEEeccc-chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|+||.||+|++.+ ++.||||++.... ......+..|+.++.+.. ||||+++++++.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568888999999999999999874 8999999987543 223445666777666664 9999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+.+ ++.++.......+++..+..++.|+++|++|||   + .+|+||||+|+||+++.++.+||+|||++..+.....
T Consensus        95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            9854 788877665557899999999999999999999   6 5999999999999999999999999999876532221


Q ss_pred             cceecccccCccccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                         .....+++.|+|||.+.+..    ++.++||||||+++|||++|+.||.........+..            +.+..
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------------~~~~~  235 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK------------ILQEE  235 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH------------HhcCC
Confidence               12235778899999987553    788999999999999999999998653221111111            11111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..     .......++.++.+++.+|+..||++||++.++++.
T Consensus       236 ~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 PP-----SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10     011111356678999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-32  Score=298.78  Aligned_cols=265  Identities=26%  Similarity=0.299  Sum_probs=203.2

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      |+..+.||+|++|.||+|+.. +++.+|+|.+.....  .....+..|++++++++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999875 689999999875432  24567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++ ++.+++......+++.++..++.|+++|++|||   +.+|+|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            76 888888776567899999999999999999999   9999999999999999999999999999998664432  12


Q ss_pred             ecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------hHHHhhhcc
Q 048205          909 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------SIMEVVDAN  981 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~d~~  981 (1027)
                      .....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ ............      ...+.....
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence            2234578889999998776 78999999999999999999999986543211 111111100000      000000000


Q ss_pred             ccCc----cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 LLSH----EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ~~~~----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....    ..........++.++.+++.+||.+||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000    00011123456788999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-32  Score=295.32  Aligned_cols=247  Identities=26%  Similarity=0.357  Sum_probs=202.5

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|++.+.||+|+||.||+|+.. +++.+|+|.+....  ......+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 68899999987542  23345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          828 MPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       828 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +++++|.+++...   ...+++..+..++.|+++|++|||   +.+++|+||+|+||+++.++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   245899999999999999999999   999999999999999999999999999999865432 


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                         ......+++.|+|||...+..++.++|+||+|+++||+++|+.||......+  ....            +..... 
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~------------~~~~~~-  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYK------------VQRGKY-  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH------------HhcCCC-
Confidence               2223457889999999998889999999999999999999999997642211  1110            001100 


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           ...+..++.++.+++.+|+..+|++||++.|+++.
T Consensus       219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                 01122456778999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=296.56  Aligned_cols=241  Identities=24%  Similarity=0.303  Sum_probs=187.3

Q ss_pred             ceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHH-HhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGM-IKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||.||+|+.. +|+.||+|++.+...   .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999875 689999999865321   122333444444 4455899999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      ++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999987654 4788999999999999999999   99999999999999999999999999999875322      22


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...+++.|+|||...+..++.++||||+|+++|||++|..||......     ......        ......    ...
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~--------~~~~~~----~~~  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNI--------LSRRIN----WPE  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHH--------HhcccC----CCC
Confidence            345788999999998888899999999999999999999999754221     111100        000000    000


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....++..+.+++.+|+..+|++||++.++.+
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            111246677899999999999999997754443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-32  Score=306.00  Aligned_cols=267  Identities=22%  Similarity=0.269  Sum_probs=199.7

Q ss_pred             HHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC--
Q 048205          745 LFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD--  819 (1027)
Q Consensus       745 ~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  819 (1027)
                      +....++|+..+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3445678999999999999999999855 78999999986432  223456778999999999999999999987653  


Q ss_pred             ----eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          820 ----FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       820 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                          ..++||||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 67998887643  4899999999999999999999   9999999999999999999999999999


Q ss_pred             CCcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHH-------
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVN-------  967 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-------  967 (1027)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||...... ........       
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCH
Confidence            99854321     123457889999998876 45788999999999999999999999754221 11111111       


Q ss_pred             ----HHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          968 ----DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       968 ----~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          ............................++.++.+++.+|++.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                00000000000000000000011112346677899999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-32  Score=303.32  Aligned_cols=252  Identities=27%  Similarity=0.339  Sum_probs=193.7

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +|...+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..+...++||||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999865 68999999987543 234567888999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHH---hc-CCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          828 MPYGSLEKCL---YS-SNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       828 ~~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +.. ++.++.   .. ....+++..+..++.+++.|++|||   + .+++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            865 655532   22 2355899999999999999999999   5 4999999999999999999999999999976533


Q ss_pred             CCCcceecccccCccccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ..   ......+++.|+|||.+...   .++.++||||+||++|||++|+.||.....    ...-        ..+...
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~--------~~~~~~  225 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQ--------LTQVVK  225 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHH--------HhhhcC
Confidence            22   11233578899999998776   688999999999999999999999875321    0000        011110


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...   +......+..++.++.+++.+|+.++|++||++.++++.
T Consensus       226 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         226 GDP---PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCC---CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000   000011113466779999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.9e-32  Score=304.41  Aligned_cols=260  Identities=21%  Similarity=0.284  Sum_probs=190.1

Q ss_pred             ccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHHHHHh
Q 048205          762 GFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLY  838 (1027)
Q Consensus       762 ~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~  838 (1027)
                      ++|.||.++.. +++.||||++...  .....+.+..|+++++.++||||+++++++.+.+..+++|||+++|++.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            33445555433 6899999998754  34456788999999999999999999999999999999999999999999987


Q ss_pred             cC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc-----ceeccc
Q 048205          839 SS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-----LTQTQT  912 (1027)
Q Consensus       839 ~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~  912 (1027)
                      .. ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||.+..+......     ......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            54 345788999999999999999999   999999999999999999999999999998755322211     112233


Q ss_pred             ccCccccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh---hhHHHhhhcccc----
Q 048205          913 LATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL---ISIMEVVDANLL----  983 (1027)
Q Consensus       913 ~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~~~----  983 (1027)
                      .++..|+|||++...  .++.++||||+||++|||++|+.||...................   ............    
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            467889999998763  57889999999999999999999997643222111111000000   000000000000    


Q ss_pred             ------CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 ------SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ------~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                            ............+..++.+++.+||.+||++||++.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                  00011122233456678999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-32  Score=308.96  Aligned_cols=269  Identities=23%  Similarity=0.259  Sum_probs=200.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecC-----C
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----D  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  819 (1027)
                      ..++|.+.+.||+|+||+||+|+.. +++.||||.++..  .....+.+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3467999999999999999999865 6899999998643  223345677899999999999999999988654     3


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++|+||+. ++|.+++... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            4799999996 5898888654 35899999999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------  972 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  972 (1027)
                      .....  .......++..|+|||.+.. ..++.++||||+||++|+|++|++||...... .............      
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhh
Confidence            53322  12233457889999998765 46889999999999999999999999754211 1111111110000      


Q ss_pred             -----hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 -----SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 -----~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           .......................++.++.+++.+|+..+|++||+++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                 0000000000000000111223567788999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-33  Score=307.74  Aligned_cols=242  Identities=28%  Similarity=0.393  Sum_probs=191.6

Q ss_pred             ceeeccccceEEEEEec-CCceEE---EEEEe-cccchhHHHHHHHHHHHhhccCCccceEEeEEecCCe--eEEEEEec
Q 048205          756 NLIGRGGFGFVYKARIQ-DGMEVA---VKVFD-LQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF--KALVLEYM  828 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~-~~~~va---vK~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~~  828 (1027)
                      .+||+|+|-+||+|.+. +|.+||   ||.-+ .+..+..+.|..|+.+++.|+||||+++|+++.+...  ..+|+|.+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            57999999999999875 577776   33211 1223445789999999999999999999999987654  77899999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ..|+|..|.++.+. .+...++.|+.||++||.|||.+ ..+|+|||||-+||||+. .|.|||+|.|+|+.+...    
T Consensus       126 TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----  199 (632)
T KOG0584|consen  126 TSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----  199 (632)
T ss_pred             cCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc----
Confidence            99999999988765 78889999999999999999954 689999999999999975 689999999999976432    


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ....++|||.|||||+.. ..|+..+||||||+.++||+|+..||..-.....                ++.+......+
T Consensus       200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ----------------IYKKV~SGiKP  262 (632)
T KOG0584|consen  200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ----------------IYKKVTSGIKP  262 (632)
T ss_pred             ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH----------------HHHHHHcCCCH
Confidence            223378999999999887 7899999999999999999999999875432211                11111111111


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+..  --.++++++|.+|+.. ..+|||+.|++.
T Consensus       263 ~sl~k--V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  263 AALSK--VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHhhc--cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            11111  1134588999999999 999999999986

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.3e-32  Score=303.91  Aligned_cols=268  Identities=25%  Similarity=0.282  Sum_probs=201.2

Q ss_pred             HHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec-CCe
Q 048205          745 LFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS-DDF  820 (1027)
Q Consensus       745 ~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  820 (1027)
                      +...+++|+..+.||+|+||.||+|+.. +++.||||++.+..  ....+.+..|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999865 78999999886432  2234677789999999999999999999865 567


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++|+||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||+|+||+++.++.++++|||.+...
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999999 45898887643  3688888899999999999999   999999999999999999999999999998754


Q ss_pred             ccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH---------
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL---------  970 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------  970 (1027)
                      ...     .....+++.|+|||++.+ ..++.++||||+||++|+|++|++||..... ......+.....         
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence            221     123457888999998765 5689999999999999999999999975422 111111111111         


Q ss_pred             --hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          971 --LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       971 --~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        .....+.+.................++.++.+++.+|+..+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              000011111000000001111112456789999999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-32  Score=305.91  Aligned_cols=262  Identities=22%  Similarity=0.258  Sum_probs=194.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  819 (1027)
                      ..+|...+.||+|+||.||+|++. +|+.||||++....  ......+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999865 68999999986532  223456788999999999999999999986542      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++|+||+.. ++.++..   ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999965 7777652   24789999999999999999999   99999999999999999999999999999875


Q ss_pred             cccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH--hhhHHH
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL--LISIME  976 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  976 (1027)
                      ...     ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+........  .....+
T Consensus       167 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         167 ADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            422     1123457889999999876 468899999999999999999999997642211 1111111000  000001


Q ss_pred             hhhcc--------ccC-ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VVDAN--------LLS-HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~d~~--------~~~-~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+..        ... ............+..+.+++.+|++.||++||+++|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00000        000 000011111235567899999999999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.1e-32  Score=303.93  Aligned_cols=263  Identities=22%  Similarity=0.321  Sum_probs=193.6

Q ss_pred             eeecc--ccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          757 LIGRG--GFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       757 ~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      .||+|  +||+||+|++. +|+.||+|++....  ....+.+.+|+.+++.++||||++++++|...+..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            45666  99999999875 79999999987532  234577889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce--
Q 048205          832 SLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT--  908 (1027)
Q Consensus       832 sL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--  908 (1027)
                      ++.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+...........  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999887643 34889999999999999999999   99999999999999999999999999986543321111100  


Q ss_pred             ---ecccccCccccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH---------HhhhH
Q 048205          909 ---QTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL---------LLISI  974 (1027)
Q Consensus       909 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~~  974 (1027)
                         .....++..|+|||++.+.  .++.++||||+||++|||++|+.||........ ........         .....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchhh
Confidence               1112345679999998764  478999999999999999999999976432211 11110000         00000


Q ss_pred             HHhhhc-----------c-------ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 MEVVDA-----------N-------LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ~~~~d~-----------~-------~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+.+.           .       ..............++.++.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            000000           0       000001112223457788999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-32  Score=297.76  Aligned_cols=244  Identities=27%  Similarity=0.374  Sum_probs=195.1

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999977 599999999875433   3456788899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC------cc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ------SL  907 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------~~  907 (1027)
                      .+++.+.. .+++..+..++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987755 5899999999999999999999   99999999999999999999999999999875432211      11


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......++..|+|||.......+.++||||+|+++|++++|+.||......     .+...        ......     
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~--------~~~~~~-----  218 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQN--------ILNGKI-----  218 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH--------HhcCCc-----
Confidence            223445788999999998888999999999999999999999999754311     11100        000000     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       .+......+..+.+++.+|++.+|++||++.++.+.
T Consensus       219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence             000111136778999999999999999999444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=312.69  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=214.7

Q ss_pred             CCccceeeccccceEEEEEec-CC----ceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DG----MEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ....++||+|+||+||+|.|- +|    -+||+|++... ..+..+++.+|+-.|.+++|||+++++++|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            445689999999999999864 44    36899988644 3445678899999999999999999999998776 78999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      +|++.|.|.++++.++..+.....+.|..|||+|+.|||   ++++|||||-.+|||+..-..+||+|||+|+....++.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999998888899999999999999999999   99999999999999999999999999999998877766


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      ......-.-.+.|||-|.+....|+.++|||||||.+||++| |..|+++...++.  .            +.+.     
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--~------------dlle-----  914 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--P------------DLLE-----  914 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--h------------HHHh-----
Confidence            666555556778999999999999999999999999999999 8899887533221  1            1111     


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ...+...++.|+.+++.++.+||..|++.||+++++...+.
T Consensus       915 -~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs  955 (1177)
T KOG1025|consen  915 -KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS  955 (1177)
T ss_pred             -ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence             12346778899999999999999999999999999988764

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-32  Score=305.12  Aligned_cols=271  Identities=21%  Similarity=0.267  Sum_probs=201.4

Q ss_pred             cHHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec
Q 048205          741 TYLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS  817 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  817 (1027)
                      ...++...+++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34566778899999999999999999999854 78999999987532  2234567789999999999999999998854


Q ss_pred             C------CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          818 D------DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       818 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                      .      ...++|++++ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence            3      3467888887 67998887653  4899999999999999999999   999999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +|||+++....     ......++..|+|||...+ ..++.++||||+||++|||++|+.||...... ...........
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~  235 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVG  235 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            99999875422     1233467889999998766 46788999999999999999999998653221 11111111110


Q ss_pred             h--hhHH-Hh-------hhccccCccchhh-hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 L--ISIM-EV-------VDANLLSHEDKHF-VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ~--~~~~-~~-------~d~~~~~~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .  .... .+       +...........+ ......+.++.+++.+|++.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0  0000 00       0000000000001 011134667899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-32  Score=306.70  Aligned_cols=268  Identities=25%  Similarity=0.272  Sum_probs=203.8

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC-----eeE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-----FKA  822 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  822 (1027)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999976 58999999987543  334567889999999999999999999998775     789


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++ +|.+++.+.. .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999985 8998887654 6899999999999999999999   99999999999999999999999999999986543


Q ss_pred             CCCc-ceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh--------
Q 048205          903 EDQS-LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI--------  972 (1027)
Q Consensus       903 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  972 (1027)
                      .... .......+++.|+|||++.+. .++.++|+||+|+++|+|++|++||......+. ...........        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhc
Confidence            3210 122334678899999999887 789999999999999999999999976532111 11100000000        


Q ss_pred             ---hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 ---SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ---~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                         ...+.+..................+..+.+++.+||+++|++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               0000000000000000111122356778999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.8e-32  Score=295.39  Aligned_cols=241  Identities=24%  Similarity=0.298  Sum_probs=187.6

Q ss_pred             eeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHH---HHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          757 LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIEC---GMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .||+|+||.||+|+.. +++.||+|.+.....   .....+..|.   +.++...||+|+.+++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 688999999875421   1112233333   34555679999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      ||+|.+++... ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++..+...    ..
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~  152 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence            99999988654 35899999999999999999999   999999999999999999999999999998755322    12


Q ss_pred             cccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....|+..|+|||++.++ .++.++||||+||++|||++|+.||.............           ....       .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~-------~  214 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------MTLT-------M  214 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-----------Hhhc-------c
Confidence            234689999999998754 68899999999999999999999997642211100000           0000       0


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      ....+..++.++.+++.+|+..+|.+||     ++.++++
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1111223567789999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.5e-32  Score=299.47  Aligned_cols=243  Identities=26%  Similarity=0.321  Sum_probs=194.4

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      |...+.||+|+||+||+|+.. +++.||+|++....   ....+.+..|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999865 68899999987432   23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +. |++.+++......+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||++....      
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------  172 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------  172 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence            96 5888887766666899999999999999999999   9999999999999999999999999999986432      


Q ss_pred             eecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          908 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      ......++..|+|||++.   ...++.++||||+||++|||++|++||.......  ...+..           ....  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~~~-----------~~~~--  237 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA-----------QNDS--  237 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-----------hcCC--
Confidence            122346888999999974   4568889999999999999999999987642111  111100           0000  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       .  . .....++..+.+++.+|++++|++||++.++++
T Consensus       238 -~--~-~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 -P--T-LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -C--C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0  0 001224456889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-33  Score=309.21  Aligned_cols=199  Identities=32%  Similarity=0.469  Sum_probs=170.1

Q ss_pred             CccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCC------eeEEE
Q 048205          753 SENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------FKALV  824 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV  824 (1027)
                      ...+.||+|+||.||+++++ +|+.||||.++... ....+...+|++++++++|+|||+++++-.+..      ...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            34568999999999999965 79999999987542 344567788999999999999999998765533      56899


Q ss_pred             EEecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--CCC--cEEEeeecCCc
Q 048205          825 LEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNM--VAHLSDFGMAK  898 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfgla~  898 (1027)
                      ||||.||||...+.+-.  ..+++.+.+.+..+++.|+.|||   +.+||||||||.||++-  .+|  .-||+|||.|+
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999999997643  56999999999999999999999   99999999999999994  333  57999999999


Q ss_pred             ccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcc
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFT  957 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~  957 (1027)
                      .+....   .....+||..|.+||.... +.|+..+|.|||||++|+++||..||.....
T Consensus       173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            764332   4556789999999999995 8899999999999999999999999986543

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.7e-32  Score=301.31  Aligned_cols=245  Identities=27%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+...   .....+.+.+|+++++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999976 6788999988642   22334567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+. |++.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            997 5888877665566899999999999999999999   999999999999999999999999999998754321   


Q ss_pred             ceecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          907 LTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         ....+++.|+|||.+.   ...++.++||||+||++|||++|+.||....... ....+.             ....
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~-------------~~~~  231 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA-------------QNES  231 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHh-------------hcCC
Confidence               2345788999999874   3467889999999999999999999986532111 011110             0000


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          .. .....++..+.+++.+||.++|++||++.++++.
T Consensus       232 ----~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 ----PA-LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ----CC-cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                00 0112456678999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=294.09  Aligned_cols=264  Identities=26%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhc---cCCccceEEeEEecCCe-----
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRI---RHRNIIKFISSCSSDDF-----  820 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  820 (1027)
                      |++.+.||+|+||.||+|+++ +++.||+|+++....  .....+..|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677889999999999999987 489999999874322  2234455677776665   59999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      .+++|||+++ ++.+++.... ..+++..+..++.|+++|++|||   +.+++|+|++|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8988887643 35899999999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      +.....   .....++..|+|||++.+..++.++||||+||++|||++|++||..... ......+..............
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence            533221   1233478889999999988999999999999999999999999875322 222222222111000000000


Q ss_pred             -----ccccCc-c-chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 -----ANLLSH-E-DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 -----~~~~~~-~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           +..... . ..........+..+.+++.+||..||++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 000000 0 0001111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.8e-32  Score=285.14  Aligned_cols=265  Identities=27%  Similarity=0.403  Sum_probs=199.8

Q ss_pred             HHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhh--ccCCccceEEeEEecC----Ce
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR--IRHRNIIKFISSCSSD----DF  820 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~  820 (1027)
                      ....+.+..+.||+|.||+||+|+|+ |+.||||++...   ..+.+.+|.++.+.  ++|+||..++++-..+    .+
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34466778899999999999999998 899999999743   33455667777665  5999999999876443    36


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhh-----cCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                      +++|++|.+.|+|.||+.+  ..++.....+++..+|.||++||     .+-...|.|||||+.||++..+|.+.|+|+|
T Consensus       284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            8999999999999999987  45888999999999999999999     2335679999999999999999999999999


Q ss_pred             CCcccccCCC--cceecccccCccccCcccccCCC------CCcchhHHHHHHHHHHHHcC----------CCCCCCCcc
Q 048205          896 MAKPFLKEDQ--SLTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTR----------KKPTDESFT  957 (1027)
Q Consensus       896 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg----------~~p~~~~~~  957 (1027)
                      +|........  .......+||..|||||++...-      .-..+||||||.|+||+..+          +.||++.-+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            9987754422  23455678999999999987542      12358999999999998863          356665433


Q ss_pred             cchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          958 GEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .+-.+.+..+.        +-.+......+.++ ....+...+.++|+.||..+|.-|.||--+-+.|+
T Consensus       442 ~DPs~eeMrkV--------VCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  442 SDPSFEEMRKV--------VCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             CCCCHHHHhcc--------eeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence            33322222111        11112222222222 23456778999999999999999999887776654

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.8e-32  Score=306.69  Aligned_cols=265  Identities=24%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCe---
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF---  820 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  820 (1027)
                      ...++|+..+.||+|++|.||+|++. +++.||||++....  ....+.+.+|+.++++++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            44678999999999999999999976 68899999986432  2234567789999999999999999988866554   


Q ss_pred             ---eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          821 ---KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       821 ---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                         .++|+||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 56999988753  4899999999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH-------
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL-------  969 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------  969 (1027)
                      ......     .....++..|+|||...+ ..++.++||||+||++||+++|+.||...... ..+.......       
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHH
Confidence            865322     233457889999998765 36788999999999999999999999754221 1111111100       


Q ss_pred             ----HhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          970 ----LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       970 ----~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          ..........................++.++.+++.+|+..+|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                000000011100000000011112235678999999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=7.5e-32  Score=297.03  Aligned_cols=254  Identities=23%  Similarity=0.309  Sum_probs=198.8

Q ss_pred             CCCccceeeccccceEEEEEec----CCceEEEEEEeccc----chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY----GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      +|++.+.||+|+||.||+|+..    +++.||||++....    ....+.+..|++++.++ +||+|+++++++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999743    57889999987432    22345677899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++|+|.+++.... .+++..+..++.|+++|++|||   +.+++||||||+||+++.++.++++|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999887543 4788899999999999999999   9999999999999999999999999999988654


Q ss_pred             cCCCcceecccccCccccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      .... .......++..|+|||...+..  .+.++||||+|+++|||++|+.||...... .....+..        .+..
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~--------~~~~  226 (288)
T cd05583         157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISR--------RILK  226 (288)
T ss_pred             cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHH--------HHHc
Confidence            3321 1222345889999999987655  788999999999999999999998643211 11111111        1111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..        ...+..++..+.+++.+|+..+|++|||++++...++
T Consensus       227 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         227 SK--------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             cC--------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            00        1112335567899999999999999999887766553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=7.5e-32  Score=304.18  Aligned_cols=268  Identities=21%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecC---------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD---------  818 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  818 (1027)
                      ..+|+..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            357899999999999999999865 6899999998766556667788999999999999999999776543         


Q ss_pred             -----CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEe
Q 048205          819 -----DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLS  892 (1027)
Q Consensus       819 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~  892 (1027)
                           ...++||||++ ++|.+++...  .+++..+..++.||++|++|||   +.+|+||||||+||+++. ++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999997 4898887643  4789999999999999999999   999999999999999974 5678999


Q ss_pred             eecCCcccccCCCcc-eecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          893 DFGMAKPFLKEDQSL-TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      |||.++......... ......++..|+|||.+.. ..++.++||||+||++|||++|+.||....... .........+
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence            999997653221111 1122357889999997654 567889999999999999999999997643211 1111111100


Q ss_pred             h------hhH----HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 L------ISI----MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ~------~~~----~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .      ...    ......................+.++.+++.+|+.+||++||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0      000    0000000000000011112245667889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.7e-33  Score=286.30  Aligned_cols=241  Identities=22%  Similarity=0.282  Sum_probs=194.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..+|..+.+||+|+||.|-+|..+ +.+.||||+++++.-   ...+-...|-+++.-- +-|.+++++.+|+.-+.+|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            356888999999999999999765 567899999876532   2233344566666655 46789999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+.||+|-..++.-++ +.+..+.-+|.+||-||-+||   ++||++||+|..|||+|.+|++||+|||+++.-..+
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999888876554 788888899999999999999   999999999999999999999999999999853322


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                        ...+...+|||.|+|||++...+|+.++|+||+||++|||+.|++||++..+++ .+            ..+.+..+ 
T Consensus       504 --~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF------------~aI~ehnv-  567 (683)
T KOG0696|consen  504 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LF------------QAIMEHNV-  567 (683)
T ss_pred             --CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HH------------HHHHHccC-
Confidence              234556799999999999999999999999999999999999999999854322 11            12222222 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCC
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI 1016 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp 1016 (1027)
                             ..+...+.+..++....+.+.|.+|.
T Consensus       568 -------syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 -------SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -------cCcccccHHHHHHHHHHhhcCCcccc
Confidence                   22345566778888888999999986

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=7.3e-34  Score=276.42  Aligned_cols=268  Identities=21%  Similarity=0.316  Sum_probs=198.5

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEec--ccchhHHHHHHHHHHHhhccCCccceEEeEEecC--------C
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--------D  819 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~  819 (1027)
                      .|....+||+|.||+||+|+.+ +|+.||+|++-.  +....-....+|++++..++|+|++.+++.|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3555678999999999999866 688899986432  2222234567899999999999999998887442        3


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..|+||++|+- +|...+......++..++.++++++..||.|+|   ...|+|||+||+|++|+.+|.+||+|||+|+.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            58999999976 999999887778999999999999999999999   99999999999999999999999999999987


Q ss_pred             cccCC--CcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH----h-
Q 048205          900 FLKED--QSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL----L-  971 (1027)
Q Consensus       900 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~-  971 (1027)
                      +....  .....+.++.|.+|++||.+.+ ..|+++.|||+.|||+.||+||.+.+.+..+.  .....+....    . 
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSITKE  251 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHhccCCcc
Confidence            65332  2234566788999999998776 46899999999999999999999888764221  1111111110    0 


Q ss_pred             --h-----hHHHhhh-ccccCccch---hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          972 --I-----SIMEVVD-ANLLSHEDK---HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       972 --~-----~~~~~~d-~~~~~~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        .     ++.+.+. +.+.....+   +...+-...++..+|+.+++..||.+|+.+.+++..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence              0     0111110 001000000   011111223467899999999999999999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.5e-32  Score=297.88  Aligned_cols=220  Identities=24%  Similarity=0.351  Sum_probs=183.8

Q ss_pred             cccccHHHHHHHhC---CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccc
Q 048205          737 QRRFTYLELFQATN---GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNII  809 (1027)
Q Consensus       737 ~~~~~~~~~~~~~~---~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv  809 (1027)
                      +++-.|..+.++.-   -|..++.||-|+||+|++++.- +...||+|.+++..   ...+..++.|-.||..-+.+-||
T Consensus       613 QKESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVV  692 (1034)
T KOG0608|consen  613 QKESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVV  692 (1034)
T ss_pred             hhhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceE
Confidence            34455556655543   3778889999999999999744 56789999887542   34567788899999999999999


Q ss_pred             eEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       810 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      ++|..|++++.+|+||||++||++-.++.+.+ .+++.-+..++.++.+|+++.|   ..|+|||||||+|||||.+|++
T Consensus       693 rLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHI  768 (1034)
T KOG0608|consen  693 RLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHI  768 (1034)
T ss_pred             EEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCce
Confidence            99999999999999999999999999887765 4788888888899999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCC----------------------------------------CcceecccccCccccCcccccCCCC
Q 048205          890 HLSDFGMAKPFLKED----------------------------------------QSLTQTQTLATIGYMAPEYGREGRV  929 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~  929 (1027)
                      ||+|||+++-+.+..                                        ........+||+.|+|||++....+
T Consensus       769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~  848 (1034)
T KOG0608|consen  769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY  848 (1034)
T ss_pred             eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence            999999986543211                                        0011224468999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHcCCCCCCCCcccch
Q 048205          930 STNGDVYSFGIMLMETFTRKKPTDESFTGEM  960 (1027)
Q Consensus       930 ~~~~DvwslGvil~elltg~~p~~~~~~~~~  960 (1027)
                      +..+|+||.|||||||+.|++||......+.
T Consensus       849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  849 TQLCDWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             cccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            9999999999999999999999987655543

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=7.7e-32  Score=300.63  Aligned_cols=270  Identities=22%  Similarity=0.264  Sum_probs=197.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch--hHHHHHHHHHHHhhccCCccceEEeEEecC-------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISSCSSD-------  818 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  818 (1027)
                      .++|++.+.||+|+||.||+|++. +++.||||++......  ....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999966 6899999988644322  234567899999999999999999887543       


Q ss_pred             -CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          819 -DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       819 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                       ...++|+||+.+ ++...+......+++.++..++.|+++||+|||   +.+|+||||||+||++++++.+|++|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346999999975 787777765667999999999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcc---------eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHH
Q 048205          898 KPFLKEDQSL---------TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVN  967 (1027)
Q Consensus       898 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  967 (1027)
                      +.........         ......+++.|+|||...+. .++.++||||+||++|||++|++||...... ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            8654322111         11233568889999987654 5789999999999999999999998754321 11111111


Q ss_pred             HHHhhh---------HHHhhhccccCc-cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          968 DLLLIS---------IMEVVDANLLSH-EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       968 ~~~~~~---------~~~~~d~~~~~~-~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ......         .....+...... ..............+.+++.+|+..||++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            100000         000000000000 00001111233467889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=1.4e-31  Score=301.61  Aligned_cols=268  Identities=22%  Similarity=0.254  Sum_probs=196.7

Q ss_pred             CCCCc-cceeeccccceEEEEEec-CCceEEEEEEecccchh--------------HHHHHHHHHHHhhccCCccceEEe
Q 048205          750 NGFSE-NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA--------------IKSFDIECGMIKRIRHRNIIKFIS  813 (1027)
Q Consensus       750 ~~f~~-~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~  813 (1027)
                      ++|.. .+.||+|+||+||+|+.. +++.||||++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            44543 467999999999999865 68999999986432211              124678999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       814 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                      ++...+..++||||++ |+|.+++... ..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999997 5999988654 34889999999999999999999   99999999999999999999999999


Q ss_pred             ecCCcccccCC------------CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccch
Q 048205          894 FGMAKPFLKED------------QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEM  960 (1027)
Q Consensus       894 fgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  960 (1027)
                      ||.+.......            .........+++.|+|||.+.+. .++.++||||+||++|||++|++||......+ 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-  241 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-  241 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            99997654111            01111223467889999988764 46889999999999999999999997653221 


Q ss_pred             hHHHHHHHHHhhh---HHHhh-----hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          961 TLKRWVNDLLLIS---IMEVV-----DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       961 ~~~~~~~~~~~~~---~~~~~-----d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .+...........   +.+..     .+...............++.++.+++.+|++.+|++||++.|++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1111111110000   00000     000000001111112244677899999999999999999999985

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=5.1e-32  Score=297.11  Aligned_cols=249  Identities=28%  Similarity=0.423  Sum_probs=202.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999876 78999999987532   233467788999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999987654 5899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             Cc------------------ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHH
Q 048205          905 QS------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV  966 (1027)
Q Consensus       905 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  966 (1027)
                      ..                  .......++..|+|||......++.++||||+|++++++++|+.||..... .....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~---  232 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQ---  232 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHH---
Confidence            11                  122334578899999999888899999999999999999999999876421 00000   


Q ss_pred             HHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 048205          967 NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA----KEIVT 1023 (1027)
Q Consensus       967 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~----~evl~ 1023 (1027)
                               ...+.        ....+...+..+.+++.+|+..+|++||++    +++++
T Consensus       233 ---------~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 ---------KILKL--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---------HHHhc--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                     01100        001112335668899999999999999999    88775

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=295.07  Aligned_cols=265  Identities=22%  Similarity=0.260  Sum_probs=197.3

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccch-hHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEec
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      |++.+.||+|++|+||+|+.. +++.||||++...... ......+|+..+++++ |||++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            667889999999999999976 5789999998654322 2234456889999999 999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                       +|++.+++.... ..+++.++..++.|+++|++|||   +.+++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             779998887654 46899999999999999999999   9999999999999999999999999999998653321   


Q ss_pred             eecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---------hHHHh
Q 048205          908 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---------SIMEV  977 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~  977 (1027)
                      ......++..|+|||+... ..++.++|+||||++++||++|++||......+. ...........         .....
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcc
Confidence            2233567889999998754 4578999999999999999999999865422111 11100000000         00000


Q ss_pred             hhccccCccchh-hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          978 VDANLLSHEDKH-FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       978 ~d~~~~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .+.......... .......+.++.+++.+|++.+|++||+++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000000 00111225678999999999999999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=2.1e-31  Score=299.52  Aligned_cols=267  Identities=23%  Similarity=0.261  Sum_probs=194.1

Q ss_pred             CCCccceeeccccceEEEEEec-C--CceEEEEEEeccc--chhHHHHHHHHHHHhhc-cCCccceEEeEEec----CCe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-D--GMEVAVKVFDLQY--GRAIKSFDIECGMIKRI-RHRNIIKFISSCSS----DDF  820 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~  820 (1027)
                      +|+..+.||+|+||.||+|+.. +  ++.||+|++....  ....+.+.+|+++++++ +||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999865 4  7889999986432  22345677899999999 59999999987543    245


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++++||+. ++|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999986 5899988654 35899999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCCCc--ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh---hhH
Q 048205          901 LKEDQS--LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL---ISI  974 (1027)
Q Consensus       901 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~  974 (1027)
                      ......  .......|++.|+|||+..+ ..++.++||||+||++|++++|++||...... ..+...+.....   ...
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            432211  11233468999999998765 46889999999999999999999998764211 111111111000   000


Q ss_pred             HHhhh-------ccccCccchhh-hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 MEVVD-------ANLLSHEDKHF-VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ~~~~d-------~~~~~~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+.+       ..........+ ......+..+.+++.+|++.+|++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000       00000010011 111234567899999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=1.9e-31  Score=294.13  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             CCCccceeeccccceEEEEEe----cCCceEEEEEEeccc----chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          751 GFSENNLIGRGGFGFVYKARI----QDGMEVAVKVFDLQY----GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      +|++.+.||+|+||.||+|+.    .+|+.||+|++....    ....+.+.+|+++++++ +|++|+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    368899999987432    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 4788899999999999999999   9999999999999999999999999999998653


Q ss_pred             cCCCcceecccccCccccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ... ........|+..|+|||.....  .++.++||||+|+++|+|++|+.||..... ......+.....         
T Consensus       157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~---------  225 (290)
T cd05613         157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRIL---------  225 (290)
T ss_pred             ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhh---------
Confidence            322 1122234688999999998753  467899999999999999999999864321 111122111110         


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      ..   ..    ..+..++..+.+++.+|+..||++||     ++.+++.
T Consensus       226 ~~---~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         226 KS---EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             cc---CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            00   00    01223566788999999999999997     7777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=292.67  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=197.4

Q ss_pred             cceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          755 NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      .+.+|.|-||+||-|+++ +|+.||||++++..  .+....+.+|++++.+++||.||.+-.-|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            368999999999999865 79999999998642  334577889999999999999999999999999999999999875


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeecCCcccccCCCcce
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      -|+-.+...+.++++.....++.||+.||.|||   ..+|||+|+||+||++...   -.+||||||+|+.+....   .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            555566666778999999999999999999999   8999999999999999643   379999999999875432   3


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....+|||.|.|||++..+.|...-|+||+|||+|--++|..||....+-...+.               ........  
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ---------------NAaFMyPp--  785 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ---------------NAAFMYPP--  785 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh---------------ccccccCC--
Confidence            3457899999999999999999999999999999999999999976422111111               11111111  


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ..|.+.+....++|...++..=++|.|+.+.+.
T Consensus       786 --~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  786 --NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             --CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence              123455666788888888888888888876553

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.8e-33  Score=288.86  Aligned_cols=257  Identities=27%  Similarity=0.371  Sum_probs=200.3

Q ss_pred             hCCCCccceeeccccceEEEEEe-cCCceEEEEEEeccc-------chhHHHHHHHHHHHhhccCCccceEEeEEec-CC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQY-------GRAIKSFDIECGMIKRIRHRNIIKFISSCSS-DD  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  819 (1027)
                      .++|-.+++||+|+|++||+|.+ ...+.||||+-....       ....+...+|.++.+.++||-||++|+|+.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            45677788999999999999974 467889999865332       1234556789999999999999999999975 46


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGM  896 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl  896 (1027)
                      .++-|+|||+|.+|+-|++..+ .+++.++..|+.||+.||.||.+- ..+|+|-|+||.||++.   .-|.+||+|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7899999999999999998765 488999999999999999999944 67899999999999994   468999999999


Q ss_pred             CcccccCCCc-----ceecccccCccccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHH
Q 048205          897 AKPFLKEDQS-----LTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVN  967 (1027)
Q Consensus       897 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  967 (1027)
                      ++.+..+...     ..++...||.||.+||.+.-+    +.+.|+||||+|||+|+++.|+.||.-.... ..+.+.  
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdILqe--  696 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDILQE--  696 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHHhh--
Confidence            9988654322     234556799999999987643    4688999999999999999999999754221 111111  


Q ss_pred             HHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          968 DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       968 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                       .      -++..     ..-.|+..+..+.+..++|++|+.+.-++|..+.++.
T Consensus       697 -N------TIlkA-----tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 -N------TILKA-----TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -h------chhcc-----eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             0      01111     1112333345667788999999999999999888765

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=291.95  Aligned_cols=265  Identities=29%  Similarity=0.323  Sum_probs=200.8

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      |+..+.||+|.+|.||+|+.. +++.||+|++....  ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999976 58999999987653  233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++ +|.+++......+++..+..++.+++.|++|||   +.+|+||||+|+||+++.++.+||+|||.++.......  .
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            84 999999876556899999999999999999999   89999999999999999999999999999986543221  2


Q ss_pred             ecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH---hhhHHHhh-----h
Q 048205          909 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL---LISIMEVV-----D  979 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~-----d  979 (1027)
                      .....++..|+|||.+.+. .++.++||||+||++||+++|++||...... ..+........   .....+..     +
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            2233467789999998766 7899999999999999999999998664211 11111111000   00000110     0


Q ss_pred             ccccCccchhh-hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHF-VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ........... ......+..+.+++.+|+..+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000000 111223667999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=3.8e-31  Score=320.98  Aligned_cols=146  Identities=31%  Similarity=0.410  Sum_probs=131.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||.||+|++. +++.||||+++...   ......+..|+.+++.++||||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367899999999999999999976 68999999987532   23346788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      |||+.+++|.+++.... .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999987654 4788899999999999999999   8999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-32  Score=298.40  Aligned_cols=239  Identities=23%  Similarity=0.284  Sum_probs=191.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++.|.....+|.|+|+.|..+... +++.++||++.+..    .+..+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            455666777999999999988755 78999999997652    2233456554444 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE-cCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL-DDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ++.|+-+.+.+..... +. .++..|+.+|+.|+.|||   ++||||||+||+|||+ +..+.++|+|||.++.....  
T Consensus       397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988887765443 22 677789999999999999   9999999999999999 58999999999999865433  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                         ....+-|..|.|||+.....|++++|+||+|++||+|++|+.||.....+ ..+..-                +...
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~----------------i~~~  529 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR----------------IQMP  529 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh----------------hcCC
Confidence               22335688999999999999999999999999999999999999876444 111110                0000


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         .+  ....+...++|+.+|++.||.+||+|.++..
T Consensus       530 ---~~--s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 ---KF--SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ---cc--ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence               01  1456777899999999999999999999864

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.2e-31  Score=287.33  Aligned_cols=247  Identities=22%  Similarity=0.291  Sum_probs=193.9

Q ss_pred             CCCccceeeccccceEEEEEecC-CceEEEEEEecc-----cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQ-----YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      +|.+.+.||+|+||.||+|++.. +..+++|+.+..     .......+.+|++++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998653 455666665421     112234566789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          825 LEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |||+++++|.+++..   ....+++..+..++.|+++|++|||   +.+++|+|+||+||+++. +.++++|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   2356899999999999999999999   999999999999999975 579999999987654


Q ss_pred             cCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ....  ......+++.|+|||......++.++|+||+|+++|+|++|..||.....     ......        .....
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~--------~~~~~  221 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLR--------IVEGP  221 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH--------HHcCC
Confidence            3221  22234578899999998888889999999999999999999999864311     111110        00000


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                             ....+..++.++.+++.+|+..+|++||++.|+++
T Consensus       222 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 -------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   00112345677899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-31  Score=315.25  Aligned_cols=252  Identities=29%  Similarity=0.461  Sum_probs=206.8

Q ss_pred             CCccceeeccccceEEEEEec----C----CceEEEEEEecc-cchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          752 FSENNLIGRGGFGFVYKARIQ----D----GMEVAVKVFDLQ-YGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      ..+.+.+|+|+||.|++|...    .    ...||||..+.. .....+.+..|+++++.+ +|+||+.++|+|..++..
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            345569999999999999743    1    356999988643 234567889999999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN  886 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  886 (1027)
                      ++|+||+..|+|.++++..+               ..+.....+.++.|||.|++||+   +.++||||+.++||+++++
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCC
Confidence            99999999999999998766               34888899999999999999999   9999999999999999999


Q ss_pred             CcEEEeeecCCcccccCCCcceecccc--cCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHH
Q 048205          887 MVAHLSDFGMAKPFLKEDQSLTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLK  963 (1027)
Q Consensus       887 ~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  963 (1027)
                      ..+||+|||+|+.....+..... ...  -...|||||.+....|+.++|||||||++||++| |..||.+.... ..+.
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~l~  532 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EELL  532 (609)
T ss_pred             CEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HHHH
Confidence            99999999999965544333212 112  2456999999999999999999999999999999 77887653211 1112


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +++                  ....+...|..|+.+++++|..||+.+|++||++.++.+.++
T Consensus       533 ~~l------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  533 EFL------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             HHH------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            221                  123455667889999999999999999999999999998875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=280.46  Aligned_cols=264  Identities=22%  Similarity=0.250  Sum_probs=199.5

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccC--C----ccceEEeEEecCCe
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH--R----NIIKFISSCSSDDF  820 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~  820 (1027)
                      .+++|.+...+|+|+||.|..+-+. .+..||||+++. .....+....|++++.++.+  |    -+|++.++|.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3688999999999999999998754 478999999863 23344556679999999942  2    37788889999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--------------
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--------------  885 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------------  885 (1027)
                      .+||+|.+ |-++.+++.... ..++...+..|+.|++++++|||   +.+++|.|+||+||++.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999999 459999998754 66899999999999999999999   999999999999999931              


Q ss_pred             ------CCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc
Q 048205          886 ------NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE  959 (1027)
Q Consensus       886 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  959 (1027)
                            ...+|++|||.|+.-..     ..+..+.|..|+|||++.+-+++.++||||+||||+|++||...|..-.+.+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  33589999999985322     2355678999999999999999999999999999999999999987653222


Q ss_pred             hhHHHHHHHH-Hhhh--------HHHhhhcc-----ccCcc-------------chhhhHHhhhHHHHHHHHHHhcccCC
Q 048205          960 MTLKRWVNDL-LLIS--------IMEVVDAN-----LLSHE-------------DKHFVAKEQCMSFVFNLAMKCTIESP 1012 (1027)
Q Consensus       960 ~~~~~~~~~~-~~~~--------~~~~~d~~-----~~~~~-------------~~~~~~~~~~~~~l~~Li~~cl~~dP 1012 (1027)
                       .+ ..+... ++.+        ....+...     .....             ...+........++.+|+.+|+..||
T Consensus       317 -HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  317 -HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             -HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence             11 111111 1110        01111110     00000             01111223445569999999999999


Q ss_pred             CCCCCHHHHHH
Q 048205         1013 EERINAKEIVT 1023 (1027)
Q Consensus      1013 ~~Rps~~evl~ 1023 (1027)
                      .+|+|++|++.
T Consensus       395 ~~RiTl~EAL~  405 (415)
T KOG0671|consen  395 ARRITLREALS  405 (415)
T ss_pred             cccccHHHHhc
Confidence            99999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.3e-31  Score=257.31  Aligned_cols=264  Identities=21%  Similarity=0.301  Sum_probs=207.3

Q ss_pred             HhCCCCccceeeccccceEEEEEe-cCCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecC--CeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSD--DFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l  823 (1027)
                      ..++|++.+.+|+|.|++||.|.. .+.+.++||+++..   ..+.+.+|+.++..++ ||||+.+++...++  ....+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            457799999999999999999984 46889999998743   3467889999999997 99999999999765  46789


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCCccccc
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~  902 (1027)
                      |+||+.+.+...+-.    .++...+..++.+++.||.|||   ++||+|||+||.|+|||.. -.++++|+|+|..+.+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999988766433    3677788889999999999999   9999999999999999864 5799999999998754


Q ss_pred             CCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh--
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD--  979 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  979 (1027)
                      ..   ...-++.+..|.-||.+..- .|+.+-|+|||||++.+|+..+.||.-..+....+...++......+...++  
T Consensus       186 ~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Cc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            33   33445677889999988764 5789999999999999999999999876666666777666655443322222  


Q ss_pred             -----ccccC----ccchhh------hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          980 -----ANLLS----HEDKHF------VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       980 -----~~~~~----~~~~~~------~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           +....    .....+      .......++..+++.+.+.+|-.+|+||+|+++.
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                 21111    011111      1122345778999999999999999999999863

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.8e-31  Score=282.51  Aligned_cols=239  Identities=28%  Similarity=0.350  Sum_probs=194.9

Q ss_pred             eeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      ||+|+||.||+|+.. +++.||+|++.....   ...+.+..|++++++++|||++++++++......++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 589999999875432   2455788899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL  913 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  913 (1027)
                      .+++.... .+++..+..++.|+++|+.|+|   +.+++|+||+|+||+++.++.++++|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99987654 4799999999999999999999   8999999999999999999999999999998654321  1233456


Q ss_pred             cCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       914 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      ++..|+|||...+...+.++|+||+|+++|++++|+.||.....  ......           +...        ....+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~-----------~~~~--------~~~~~  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEK-----------ILKD--------PLRFP  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH-----------HhcC--------CCCCC
Confidence            78899999999888889999999999999999999999975422  111110           0000        11122


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINA---KEIVT 1023 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~---~evl~ 1023 (1027)
                      ...+..+.+++.+|+..||++||++   .+++.
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            2335678899999999999999999   56554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=270.22  Aligned_cols=249  Identities=26%  Similarity=0.313  Sum_probs=190.4

Q ss_pred             cceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHh-hccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          755 NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIK-RIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      ...||.|+||+|++..++ .|+..|||.++.... ...+++..|.+... .-+.||||++||++..++..++.||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            467999999999999876 699999999986543 44567777777644 44799999999999999999999999964 


Q ss_pred             CHHHHH---hc-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          832 SLEKCL---YS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       832 sL~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++.+-   +. .+..+++...-+|....+.||.||-+  +..|+|||+||+||+++..|.+|+||||++..+..   +.
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence            765532   22 23457888888899999999999984  56899999999999999999999999999976532   33


Q ss_pred             eecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          908 TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      ..+..+|...|||||.+..  ..|+-++||||+|+.+||+.||..|+..+.          ..+.+....-.-|+.....
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----------svfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----------SVFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----------HHHHHHHHHHcCCCCeecC
Confidence            4455678899999998874  358899999999999999999999987642          2221111111112211111


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..    ....++..+..++.-|+.+|-.+||+..++.+
T Consensus       293 ~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 DK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11    01235667899999999999999999998865

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=269.36  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=197.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  823 (1027)
                      -++|+..++||+|+|+.|..++++ +.+.||+|+++++   ..+.+..+..|-.+..+- +||.+|.++.+|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467999999999999999999865 6788999999765   234455666676666655 69999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |.||++||+|--.+++.++ ++++.+..+..+|.-||.|||   ++||++||+|..||++|..|.+|++|+|.++.-..+
T Consensus       329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            9999999999877776554 788888889999999999999   999999999999999999999999999999854332


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCC--cccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDES--FTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                        ...++..+|||.|.|||++.+..|...+|+|++||+++||+.|+.||+-.  ...+.+..++.-..       ++++.
T Consensus       405 --gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-------ilekq  475 (593)
T KOG0695|consen  405 --GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-------ILEKQ  475 (593)
T ss_pred             --CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-------Hhhhc
Confidence              23456789999999999999999999999999999999999999999753  23333333332211       11221


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI 1016 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp 1016 (1027)
                      ..        .+...+.....++..-+.+||.+|.
T Consensus       476 ir--------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 IR--------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cc--------ccceeehhhHHHHHHhhcCCcHHhc
Confidence            11        1122334455678888899999986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=8.4e-31  Score=279.50  Aligned_cols=219  Identities=22%  Similarity=0.145  Sum_probs=176.8

Q ss_pred             cccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHHHHHhc
Q 048205          761 GGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYS  839 (1027)
Q Consensus       761 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  839 (1027)
                      |.+|.||+|++. +++.||+|++....     .+..|...+....|||++++++++.+.+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 68999999987532     233455555566799999999999999999999999999999998876


Q ss_pred             CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCcccc
Q 048205          840 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM  919 (1027)
Q Consensus       840 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  919 (1027)
                      .. .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++++|||.+..+...     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            54 4899999999999999999999   999999999999999999999999999988654321     12234567799


Q ss_pred             CcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHH
Q 048205          920 APEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSF  999 (1027)
Q Consensus       920 aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  999 (1027)
                      |||......++.++||||+|+++|||++|+.|+........                   .      ......+..++..
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------------~------~~~~~~~~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------------T------HTTLNIPEWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------------c------ccccCCcccCCHH
Confidence            99999888899999999999999999999988654211000                   0      0000112235567


Q ss_pred             HHHHHHHhcccCCCCCCCH
Q 048205         1000 VFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus      1000 l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                      +.+++.+|++.||++||++
T Consensus       205 ~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHccCCHHHhcCC
Confidence            8999999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=287.73  Aligned_cols=243  Identities=23%  Similarity=0.279  Sum_probs=197.2

Q ss_pred             hCCCCccceeeccccceEEEEEecC-CceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..+++.+..||-|+||.|-+++... ...+|+|++++.   ..+..+.+..|-++|...+.|.||++|..|.+...+|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            3456667789999999999998664 335899887654   334456677799999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||-|-||.+...+..++. ++..++..++..+++|++|||   .++||+||+||+|.++|.+|.+|+.|||+|+.+....
T Consensus       499 mEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999999998876654 888888889999999999999   9999999999999999999999999999999875443


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                         .+-..+|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+..+.    +.|-..+      .-+|..   
T Consensus       575 ---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktYn~IL------kGid~i---  638 (732)
T KOG0614|consen  575 ---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTYNLIL------KGIDKI---  638 (732)
T ss_pred             ---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHH------hhhhhh---
Confidence               344578999999999999999999999999999999999999999875322    2221111      111111   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN 1017 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps 1017 (1027)
                            ..|........++|.+..+..|.+|.-
T Consensus       639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 ------EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence                  112233445678999999999999974

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-30  Score=292.08  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=207.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEec-----CCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSS-----DDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~  821 (1027)
                      +..|.+...||.|.+|.||+++.. +|+.+|||+.+..... .++++.|.++++.. .|||++.++|+|..     ++.+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            455888899999999999999855 7889999988755433 35677788888887 69999999999854     5689


Q ss_pred             EEEEEecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          822 ALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ++|||||.||+.-|+++.- +..++|..+..|..+++.|+.+||   ...++|||||-.||+++.+|.||++|||.+..+
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            9999999999999988754 356899999999999999999999   899999999999999999999999999999876


Q ss_pred             ccCCCcceecccccCccccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      ..  ........+|||.|||||++...     .|+..+|+||+|++..||.-|.+|+.+..+....+.            
T Consensus       174 ds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------------  239 (953)
T KOG0587|consen  174 DS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------  239 (953)
T ss_pred             ec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------------
Confidence            43  33445667899999999998743     467789999999999999999999877543221000            


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            ....+++....+..+..++.++|..|+.+|.+.||++.++++
T Consensus       240 ------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 ------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                  011233444556778889999999999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=269.52  Aligned_cols=261  Identities=22%  Similarity=0.294  Sum_probs=215.7

Q ss_pred             HHHHHHhCCCCccceeeccccceEEEEEecC------CceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEE
Q 048205          743 LELFQATNGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSC  815 (1027)
Q Consensus       743 ~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  815 (1027)
                      .++.....+++...++.+|.||.||.|.|.+      .+.|.+|.++.. .+-....+..|.-.+..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4555556678888899999999999997653      345667765432 223456677888889999999999999998


Q ss_pred             ec-CCeeEEEEEecCCCCHHHHHhcC-------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 048205          816 SS-DDFKALVLEYMPYGSLEKCLYSS-------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  887 (1027)
Q Consensus       816 ~~-~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  887 (1027)
                      .+ .+..++++.++.-|+|..++...       .+..+-.+...++.|++.|++|||   .++|||.||..+|.+||+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            65 45778999999999999998722       144667788899999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHH
Q 048205          888 VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWV  966 (1027)
Q Consensus       888 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  966 (1027)
                      ++|++|-.+++.+.+.+...-......+..||+||.+....|+.++|||||||++|||+| |+.|+...++.++  ..+.
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~yl  511 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYL  511 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHH
Confidence            999999999999988887777777778889999999999999999999999999999999 8899876533222  1111


Q ss_pred             HHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          967 NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       967 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                        ..+.+..+|-+||++++.+|.-||..+|++||+++|++.-|+
T Consensus       512 ------------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  512 ------------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             ------------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence                              123456677899999999999999999999999999987654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=9.7e-30  Score=300.52  Aligned_cols=263  Identities=21%  Similarity=0.236  Sum_probs=170.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-C----CceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeE------Ee
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-D----GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS------CS  816 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  816 (1027)
                      ..++|+..+.||+|+||.||+|++. +    ++.||||++......  +....|  .++...+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999975 4    689999987532211  111111  1111122222222111      24


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhcCCcc-------------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 048205          817 SDDFKALVLEYMPYGSLEKCLYSSNYI-------------------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  877 (1027)
Q Consensus       817 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  877 (1027)
                      .....++||||+++++|.+++......                   .....+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            566789999999999999988754311                   112345679999999999999   9999999999


Q ss_pred             CCcEEEcC-CCcEEEeeecCCcccccCCCcceecccccCccccCcccccCC----------------------CCCcchh
Q 048205          878 PNNVLLDD-NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG----------------------RVSTNGD  934 (1027)
Q Consensus       878 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  934 (1027)
                      |+|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 6899999999998653322 2233456789999999965322                      2344669


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh-----hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcc
Q 048205          935 VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI-----SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTI 1009 (1027)
Q Consensus       935 vwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~ 1009 (1027)
                      |||+||++|||+++..|++..      ...+.......     .+.....+.........+...........+|+.+|++
T Consensus       362 VwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            999999999999976664321      11111111100     0111111110000001111111223345689999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 048205         1010 ESPEERINAKEIVTK 1024 (1027)
Q Consensus      1010 ~dP~~Rps~~evl~~ 1024 (1027)
                      .||++|||++|++++
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999863

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.1e-29  Score=289.25  Aligned_cols=265  Identities=20%  Similarity=0.265  Sum_probs=183.0

Q ss_pred             HhCCCCccceeeccccceEEEEEe-----------------cCCceEEEEEEecccchhHH--------------HHHHH
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARI-----------------QDGMEVAVKVFDLQYGRAIK--------------SFDIE  796 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~e  796 (1027)
                      ..++|++.++||+|+||+||+|..                 ..++.||||++........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999963                 23567999998654322222              23346


Q ss_pred             HHHHhhccCCcc-----ceEEeEEec--------CCeeEEEEEecCCCCHHHHHhcCC----------------------
Q 048205          797 CGMIKRIRHRNI-----IKFISSCSS--------DDFKALVLEYMPYGSLEKCLYSSN----------------------  841 (1027)
Q Consensus       797 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------  841 (1027)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777776654     667777643        356899999999999999887421                      


Q ss_pred             -ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccC
Q 048205          842 -YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA  920 (1027)
Q Consensus       842 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  920 (1027)
                       ...++..+..++.|+++|++|+|   +.+|+||||||+||+++.++.+||+|||+++.+.... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence             12467788899999999999999   8999999999999999999999999999997543221 111122235789999


Q ss_pred             cccccCCC--------------------C--CcchhHHHHHHHHHHHHcCCC-CCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          921 PEYGREGR--------------------V--STNGDVYSFGIMLMETFTRKK-PTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       921 PE~~~~~~--------------------~--~~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      ||.+....                    +  ..+.||||+||++|+|++|.. |+.....-......+-.....  + ..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~-r~  455 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--W-RM  455 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--H-Hh
Confidence            99875432                    1  134699999999999999875 654321111111111000000  0 00


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESP---EERINAKEIVTK 1024 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP---~~Rps~~evl~~ 1024 (1027)
                           .......+......+...++++.+|+..+|   .+|+|++|++++
T Consensus       456 -----~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 -----YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -----hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                 011111223334456778999999999866   689999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=6.1e-29  Score=266.10  Aligned_cols=238  Identities=31%  Similarity=0.361  Sum_probs=193.9

Q ss_pred             ccceEEEEEec-CCceEEEEEEecccchh-HHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHHHHHhc
Q 048205          762 GFGFVYKARIQ-DGMEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYS  839 (1027)
Q Consensus       762 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  839 (1027)
                      +||.||+|++. +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 58999999987654433 67899999999999999999999999999999999999999999999876


Q ss_pred             CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCcccc
Q 048205          840 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM  919 (1027)
Q Consensus       840 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  919 (1027)
                      ... +++..+..++.+++++++|||   +.+++|+||+|+||+++.++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            544 789999999999999999999   8999999999999999999999999999998654332   233456788999


Q ss_pred             CcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHH
Q 048205          920 APEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSF  999 (1027)
Q Consensus       920 aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  999 (1027)
                      |||......++.++||||+|++++++++|..||....... ...++..            .....    .......++.+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~------------~~~~~----~~~~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIG------------KPKPP----FPPPEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHh------------ccCCC----CccccccCCHH
Confidence            9999988888999999999999999999999987632111 1111110            00000    00000115667


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 048205         1000 VFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus      1000 l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-31  Score=259.56  Aligned_cols=265  Identities=24%  Similarity=0.347  Sum_probs=194.1

Q ss_pred             CCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCC-----eeEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-----FKAL  823 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  823 (1027)
                      .+..+.||.|+||+||.+++. +|+.||.|++.....  ...+.+-+|++++..++|.|+...++..+...     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            455689999999999999865 899999998753322  34678889999999999999998887765542     5688


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+|.|.. +|...+-+- ..++...+.-+.+||++||+|||   +.+|.||||||.|.++..+..+||||||+|+.-. .
T Consensus       135 ~TELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q  208 (449)
T ss_pred             HHHHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-h
Confidence            8998865 888766543 34777788889999999999999   9999999999999999999999999999999543 3


Q ss_pred             CCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh-HH------
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS-IM------  975 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~------  975 (1027)
                      +....++..+.|..|+|||++.+. .|+.++||||+|||+.|++-++..|....+  ....+.+....... .+      
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHh
Confidence            334455666789999999999876 589999999999999999988887765322  11222222221111 11      


Q ss_pred             -----HhhhccccCccch---hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          976 -----EVVDANLLSHEDK---HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       976 -----~~~d~~~~~~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           .++..........   ....+.....+...+..+++..||++|.+..+.+..
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence                 1111111100000   011112233446778889999999999999988754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=289.26  Aligned_cols=244  Identities=27%  Similarity=0.425  Sum_probs=188.0

Q ss_pred             CCccceeeccccc-eEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecC
Q 048205          752 FSENNLIGRGGFG-FVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       752 f~~~~~lG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      |...+++|.|+.| .||+|... |+.||||++-.   +..+...+|++.++.- +|||||++++.-.+++..||+.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            3445678999998 56888765 78999998753   3345567899999888 59999999999899999999999997


Q ss_pred             CCCHHHHHhcC--Cc-cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---C--CcEEEeeecCCcccc
Q 048205          830 YGSLEKCLYSS--NY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---N--MVAHLSDFGMAKPFL  901 (1027)
Q Consensus       830 ~gsL~~~l~~~--~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfgla~~~~  901 (1027)
                      . +|.+++...  +. .........+..|+++||++||   +.+|||||+||.||||+.   +  .+++|+|||+++++.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            7 999999874  11 1111344678899999999999   999999999999999975   3  478999999999886


Q ss_pred             cCCCcc-eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          902 KEDQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       902 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ...... ......||-+|+|||.+....-+.++||||+|||+|+.++| .+||......+.++..-.             
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~-------------  729 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN-------------  729 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc-------------
Confidence            554332 34566799999999999999888999999999999999996 899987533222111100             


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+.     .......+  +..+||.+|++++|..||+|.+|+.
T Consensus       730 ~~L~-----~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 YTLV-----HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ccee-----eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0000     00001112  5789999999999999999999985

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=236.81  Aligned_cols=204  Identities=26%  Similarity=0.348  Sum_probs=165.6

Q ss_pred             cceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHh-hccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          755 NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIK-RIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      ...||+|+||.|-+.++. +|+..|+|.++... .+..++..+|+.+.. ....|.+|.+||.+......++.||.|+- 
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence            456999999999998865 79999999987543 334456667777644 45799999999999999999999999964 


Q ss_pred             CHHHHH---hcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          832 SLEKCL---YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       832 sL~~~l---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +|..+-   ...+...++...-+||..+.+|+.|||+  ...++|||+||+|||++.+|+||+||||++..+..   +..
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiA  204 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIA  204 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh---hhH
Confidence            776542   2345668999999999999999999994  46899999999999999999999999999986542   223


Q ss_pred             ecccccCccccCcccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHH
Q 048205          909 QTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKR  964 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~  964 (1027)
                      .+...|...|||||.+..    ..|+-++||||+|+.+.||.+++.||+.+...-..+++
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq  264 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ  264 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence            344568888999998763    46899999999999999999999999987655444443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=255.14  Aligned_cols=263  Identities=24%  Similarity=0.277  Sum_probs=200.3

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC-----
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----  818 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  818 (1027)
                      ....+|...+.+|.|+- .|..|.+. .++.||+|....+.  ....+...+|...+..+.|+||++++.+|...     
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34567888889999998 67777655 68999999875442  33456778899999999999999999998554     


Q ss_pred             -CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          819 -DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       819 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                       ...|+|||||+. +|...++-   .++-.++..+..|+++|+.|+|   +.||+|||+||+||++..++.+||.|||+|
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence             367999999976 99888773   3688899999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh-----
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI-----  972 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  972 (1027)
                      +...   .....+.++.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+    +..+.+|.+....-     
T Consensus       166 r~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  166 RTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             cccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHHHhcCCCH
Confidence            8532   23566778899999999999998999999999999999999999988764    34455554432111     


Q ss_pred             hHHH--------hhh---ccccCcc---------chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 SIME--------VVD---ANLLSHE---------DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ~~~~--------~~d---~~~~~~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...+        .+.   +-.....         ....+...-....+.+++.+|+..+|++|.|+++++++
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0000        000   0000000         00011111233457889999999999999999999863

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=266.23  Aligned_cols=200  Identities=24%  Similarity=0.315  Sum_probs=170.1

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------hhHHHHHHHHHHHhhcc---CCccceEEeE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRIR---HRNIIKFISS  814 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~  814 (1027)
                      ....+|+..+.+|+|+||.|+.|.++ +...|+||.+.++.-        +..-.+-.|+++|..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34456899999999999999999977 467799998865421        11123456999999997   9999999999


Q ss_pred             EecCCeeEEEEEec-CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          815 CSSDDFKALVLEYM-PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       815 ~~~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                      |++++..|++||-- +|.+|.+++..+. .+++.++..|++||+.|+++||   +.||||||||-+||.++.+|-+|++|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence            99999999999975 5569999987654 4899999999999999999999   99999999999999999999999999


Q ss_pred             ecCCcccccCCCcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCC
Q 048205          894 FGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDE  954 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~  954 (1027)
                      ||.|....    ...-...+||..|.|||++.+.+| +..-|||++|+++|.++...-||+.
T Consensus       714 fgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  714 FGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99987432    223355789999999999998876 5668999999999999999999863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-27  Score=252.85  Aligned_cols=130  Identities=27%  Similarity=0.336  Sum_probs=109.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-----CC---ccceEEeEEec---
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-----HR---NIIKFISSCSS---  817 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~---niv~l~~~~~~---  817 (1027)
                      .+|...++||.|.|++||+|.+. ..+.||+|+.+.. ....+....|++++++++     |+   +||+++++|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67889999999999999999755 5788999998743 233455677999999984     33   69999999965   


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          818 -DDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       818 -~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                       ..++++|+|++ |-+|..+|.... +.++...+.+|++||+.||.|||..  .||+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence             45899999999 558989887665 5589999999999999999999964  499999999999999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=8.3e-29  Score=271.96  Aligned_cols=252  Identities=26%  Similarity=0.359  Sum_probs=206.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ++|.....+|.|+||.||||++. +++..|+|+++.+....++....|+-+++..+|||||.+++.+-..+..+++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            56888899999999999999965 78999999999988888888999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      .||+|++.-+. -..+++.++..+.++.++|++|||   +.|-+|||||-.||++++.|.+|++|||.+..+...  -..
T Consensus        95 gggslQdiy~~-TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K  168 (829)
T KOG0576|consen   95 GGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK  168 (829)
T ss_pred             CCCcccceeee-cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence            99999995443 345888899999999999999999   999999999999999999999999999999866432  223


Q ss_pred             ecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          909 QTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      ....+||+.|||||+..   .+.|...+|||++|+...|+-.-++|.....+....              -...+.... 
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l--------------~LmTkS~~q-  233 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL--------------FLMTKSGFQ-  233 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH--------------HHhhccCCC-
Confidence            44578999999999764   567899999999999999999988885543221110              111111111 


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ......+......+.+++..|+.++|++||+++.++.
T Consensus       234 -pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 -PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             1112223445667899999999999999999987764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.6e-26  Score=239.80  Aligned_cols=211  Identities=36%  Similarity=0.533  Sum_probs=183.7

Q ss_pred             eeccccceEEEEEecC-CceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHHH
Q 048205          758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEK  835 (1027)
Q Consensus       758 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  835 (1027)
                      ||+|++|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++|+||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 899999998755432 35678899999999999999999999999999999999999999999


Q ss_pred             HHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecCCcccccCCCcceeccccc
Q 048205          836 CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLKEDQSLTQTQTLA  914 (1027)
Q Consensus       836 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  914 (1027)
                      ++......+++..+..++.+++++++|||   +.+++|+||+|.||+++. ++.++++|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            98876445899999999999999999999   899999999999999999 89999999999986543221  1233457


Q ss_pred             CccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHH
Q 048205          915 TIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       915 t~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  993 (1027)
                      ...|++||..... .++.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            7889999998877 788999999999999999                                                


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L 1025 (1027)
                          ..+.+++.+|+..+|++||++.++++.+
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                2367899999999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=233.15  Aligned_cols=251  Identities=21%  Similarity=0.263  Sum_probs=189.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeE-EecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISS-CSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~  825 (1027)
                      .+.|.+.+.+|+|.||.+-+|+++ +.+.+++|-+..+.. ..++|.+|...--.+ .|.||+.-|++ |+..+..+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            345888899999999999999987 578899998875533 357788887654444 58999987764 57778888999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--CCCcEEEeeecCCcccccC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||++.|+|..-+...+  +.+....+++.|+++|+.|||   +..+||||||.+||||-  +..++|+||||..+.....
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999999887654  678888999999999999999   99999999999999993  3458999999998854321


Q ss_pred             CCcceecccccCccccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                           ......+..|.|||.....     ...+.+|+|.||+++|.++||+.||......+..+.+|..-..+..     
T Consensus       177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-----  246 (378)
T KOG1345|consen  177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-----  246 (378)
T ss_pred             -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-----
Confidence                 1122345669999976532     2567889999999999999999999876666666666654332111     


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ..-+.   .-..+++.+.++..+-+.++|++|-...++.+
T Consensus       247 -----~~~P~---~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  247 -----PALPK---KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             -----ccCch---hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence                 11111   11235566788899999999999955554433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.1e-26  Score=244.94  Aligned_cols=270  Identities=24%  Similarity=0.302  Sum_probs=204.9

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec----CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCCe
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDF  820 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  820 (1027)
                      ....+.|..+++||+|+|++||+|.+.    ..+.||+|.+.....  -..+..|++++..+. +.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            345567899999999999999999754    367899998864432  356788999999995 8999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeecCCcc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKP  899 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~  899 (1027)
                      +.+|+||++..+..++...    ++..++..++..+..||+++|   ..|||||||||+|++.+ ..++-.|+|||+|..
T Consensus       110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999888887655    667889999999999999999   99999999999999997 457889999999973


Q ss_pred             cccCC------------------------------------------CcceecccccCccccCcccccCC-CCCcchhHH
Q 048205          900 FLKED------------------------------------------QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVY  936 (1027)
Q Consensus       900 ~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  936 (1027)
                      +....                                          .......+.||+||+|||++... ..++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            21100                                          00111234689999999998765 468899999


Q ss_pred             HHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH---hhhccccCc----------------------cc----
Q 048205          937 SFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME---VVDANLLSH----------------------ED----  987 (1027)
Q Consensus       937 slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~~~~~~----------------------~~----  987 (1027)
                      |.|||+..+++++.||....++...+.+.+....+.....   ..+......                      ..    
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            9999999999999999887777666666655444332111   111100000                      00    


Q ss_pred             -hhh-hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          988 -KHF-VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       988 -~~~-~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       ... ...+..+..+.+++.+|+..+|.+|.+|+++++.
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence             000 1112234468999999999999999999999864

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-28  Score=255.82  Aligned_cols=296  Identities=23%  Similarity=0.232  Sum_probs=191.4

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc-
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV-  107 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-  107 (1027)
                      ..++.++-.++ ++|..+.  +.-+.++|..|+|+...|++|+.+++|++||||+|.|+.+.|++|.++.+|..|.+.+ 
T Consensus        49 ~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~  125 (498)
T KOG4237|consen   49 GIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN  125 (498)
T ss_pred             ceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence            46777777887 7888876  5668889999999988888899999999999999999988999999999888777666 


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCC--
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG--  185 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--  185 (1027)
                      |+|+ .++...|.++.+|+.|.+.-|++.-+...+|..+++|..|.+..|.+..+--..|..+.+++.+++..|.+..  
T Consensus       126 NkI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC  204 (498)
T KOG4237|consen  126 NKIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC  204 (498)
T ss_pred             Cchh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence            8898 7899999999999999999999998888999999999999999999985444589999999999999888431  


Q ss_pred             ----------CCChhccCCCCCCeeeccccccCCCCCccccCC-CCCCEEEccCccCCCCCCcchhhhhhccccCCcccc
Q 048205          186 ----------EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNL-SSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFC  254 (1027)
Q Consensus       186 ----------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~  254 (1027)
                                ..|-.+++.....-..+.++++..+.+..|... .++..=-.+.+...              ...|+..|
T Consensus       205 nL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d--------------~~cP~~cf  270 (498)
T KOG4237|consen  205 NLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPD--------------SICPAKCF  270 (498)
T ss_pred             ccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcC--------------CcChHHHH
Confidence                      223334444444444444444443333322211 11110000111110              13344445


Q ss_pred             CCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCcc
Q 048205          255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTT  334 (1027)
Q Consensus       255 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  334 (1027)
                      ..+++|+.|+|++|++++.         -+.+|..+.+++.|.|..|+|..+....|.++..|+.|+|.+|+|+.+.|.+
T Consensus       271 ~~L~~L~~lnlsnN~i~~i---------~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~a  341 (498)
T KOG4237|consen  271 KKLPNLRKLNLSNNKITRI---------EDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGA  341 (498)
T ss_pred             hhcccceEeccCCCccchh---------hhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccc
Confidence            5555555555555555431         1233444445555555555554444444555555555555555555555555


Q ss_pred             ccccCCcceEEccCccc
Q 048205          335 IFNVSTLKFLYLGSNSF  351 (1027)
Q Consensus       335 ~~~l~~L~~L~L~~N~l  351 (1027)
                      |..+.+|.+|+|-.|.+
T Consensus       342 F~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  342 FQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             ccccceeeeeehccCcc
Confidence            55555555555444433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.6e-25  Score=236.63  Aligned_cols=199  Identities=31%  Similarity=0.415  Sum_probs=173.4

Q ss_pred             CCccceeeccccceEEEEEecC-CceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      |...+.||.|++|.||+|+..+ ++.+|+|.+...... ..+.+..|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999999774 899999999865544 56788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCccee
Q 048205          830 YGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +++|.+++......+++..+..++.+++.++.|+|   +.+++|+|++|+||+++.++.++++|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            99999998765543789999999999999999999   88999999999999999999999999999986643321 122


Q ss_pred             cccccCccccCcccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 048205          910 TQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTRKKPTDE  954 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltg~~p~~~  954 (1027)
                      ....++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999998 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=7e-27  Score=249.28  Aligned_cols=211  Identities=23%  Similarity=0.248  Sum_probs=176.3

Q ss_pred             cccccHHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc------CCccc
Q 048205          737 QRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR------HRNII  809 (1027)
Q Consensus       737 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv  809 (1027)
                      ..+|.+..-+....+|.+....|+|-|++|.+|... .|..||||+|.... .-.+.-..|+++|++|.      .-|++
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            345555555667788999999999999999999866 48899999997442 23455667999999995      23899


Q ss_pred             eEEeEEecCCeeEEEEEecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-
Q 048205          810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-  886 (1027)
Q Consensus       810 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-  886 (1027)
                      +++..|.-..++|+|||-+.- +|.++++..+  ..+....+..+++|+.-||..|-   ..+|+|.||||.|||+.+. 
T Consensus       498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCc
Confidence            999999999999999999865 9999987654  44677889999999999999999   8999999999999999864 


Q ss_pred             CcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCc
Q 048205          887 MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESF  956 (1027)
Q Consensus       887 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  956 (1027)
                      ..+||||||.|......    ..+.+..+..|.|||++.+.+|+...|+||+||.|||++||+..|.+..
T Consensus       574 ~iLKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  574 NILKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ceeeeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            57899999999865322    2234456678999999999999999999999999999999999987753

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-28  Score=253.72  Aligned_cols=428  Identities=23%  Similarity=0.284  Sum_probs=259.5

Q ss_pred             CCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccC-ccCCCCCChhccCCCCCCeeec
Q 048205          124 LLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ-NRLQGEIPEELGNLAELEKLQL  202 (1027)
Q Consensus       124 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L  202 (1027)
                      .-..++|..|+|+.+++.+|..+++|+.||||+|+|+.+-|++|.++.+|..|-+-+ |+|+....+.|+++.+|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            477889999999988889999999999999999999988899999998888776665 8898766678899999999999


Q ss_pred             cccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCC
Q 048205          203 QNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT  282 (1027)
Q Consensus       203 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  282 (1027)
                      .-|++..+..+.|..+++|..|.+..|.+.               .++...|..+..++.+.+..|.+-.       .|.
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q---------------~i~~~tf~~l~~i~tlhlA~np~ic-------dCn  205 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ---------------SICKGTFQGLAAIKTLHLAQNPFIC-------DCN  205 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhh---------------hhccccccchhccchHhhhcCcccc-------ccc
Confidence            999998777788888999988888888875               5666677777777777777776531       111


Q ss_pred             CCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCcccccc-CCcceEEccCccccccCCCCccC
Q 048205          283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNV-STLKFLYLGSNSFFGRLPSSADV  361 (1027)
Q Consensus       283 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~  361 (1027)
                             ++.+.. ++.      ..|..+++..-..-..+.++++..+.+..|..- ..+..=..+.+...+.-|..+|.
T Consensus       206 -------L~wla~-~~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~  271 (498)
T KOG4237|consen  206 -------LPWLAD-DLA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFK  271 (498)
T ss_pred             -------cchhhh-HHh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHh
Confidence                   111111 111      123334444444444555555555554444221 12221122233333455666666


Q ss_pred             CCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCcccccccccccc
Q 048205          362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKY  441 (1027)
Q Consensus       362 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~  441 (1027)
                      .+++|+.|+|++|+++++-+.+|.++..+++|+|..|+|..+....|.++..|+.|+|.+|+||.+...    .|..+..
T Consensus       272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~----aF~~~~~  347 (498)
T KOG4237|consen  272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG----AFQTLFS  347 (498)
T ss_pred             hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc----cccccce
Confidence            777777777777777766677777777777777777777766666677777777777777776643322    2234445


Q ss_pred             ccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeecc
Q 048205          442 LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLK  521 (1027)
Q Consensus       442 L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  521 (1027)
                      |.+|+|-.|++..                   +|.+.     +++.+       |..+.-.|..|  -.+-..++.++++
T Consensus       348 l~~l~l~~Np~~C-------------------nC~l~-----wl~~W-------lr~~~~~~~~~--Cq~p~~~~~~~~~  394 (498)
T KOG4237|consen  348 LSTLNLLSNPFNC-------------------NCRLA-----WLGEW-------LRKKSVVGNPR--CQSPGFVRQIPIS  394 (498)
T ss_pred             eeeeehccCcccC-------------------ccchH-----HHHHH-------HhhCCCCCCCC--CCCCchhccccch
Confidence            5555555555421                   11110     01000       00000000000  0111234455555


Q ss_pred             CceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccE-EcccccccccccchhhccCccc
Q 048205          522 DNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQ-IDLSINNFSDVIPTTIGGLKDL  600 (1027)
Q Consensus       522 ~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~ls~n~l~~~~p~~~~~l~~L  600 (1027)
                      ++.+.       .|.|.   -|++.+-.            -++.-|.   .++.+.+ ...|++.+. .+|..+.  ..-
T Consensus       395 dv~~~-------~~~c~---~~ee~~~~------------~s~~cP~---~c~c~~tVvRcSnk~lk-~lp~~iP--~d~  446 (498)
T KOG4237|consen  395 DVAFG-------DFRCG---GPEELGCL------------TSSPCPP---PCTCLDTVVRCSNKLLK-LLPRGIP--VDV  446 (498)
T ss_pred             hcccc-------ccccC---CccccCCC------------CCCCCCC---CcchhhhhHhhcccchh-hcCCCCC--chh
Confidence            55442       12222   22221111            0111222   2333332 234444443 5555442  234


Q ss_pred             cEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCC
Q 048205          601 QYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN  656 (1027)
Q Consensus       601 ~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N  656 (1027)
                      ..|.+.+|.++ .+|.+  .+.+| .+|+|+|+++..--..|.+++.|.+|-+|+|
T Consensus       447 telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  447 TELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             HHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            66788888888 78877  67778 8888888888666677888888888888886

>PLN03210 Resistant to P

Probab=99.92  E-value=8.3e-24  Score=271.45  Aligned_cols=353  Identities=21%  Similarity=0.237  Sum_probs=226.6

Q ss_pred             CccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcC
Q 048205          212 PPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLA  291 (1027)
Q Consensus       212 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~  291 (1027)
                      +.+|.++.+|+.|.+..+.....        +.....+|.++..-.+.|+.|++.+|.++          .+|..+ ...
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~--------~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~----------~lP~~f-~~~  611 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQK--------KEVRWHLPEGFDYLPPKLRLLRWDKYPLR----------CMPSNF-RPE  611 (1153)
T ss_pred             HHHHhcCccccEEEEeccccccc--------ccceeecCcchhhcCcccEEEEecCCCCC----------CCCCcC-Ccc
Confidence            34566666777776655543210        00011233332222234677777777665          444444 346


Q ss_pred             CccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEc
Q 048205          292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSL  371 (1027)
Q Consensus       292 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  371 (1027)
                      +|+.|+|++|++.. .+..+..+++|+.|+|++|.....+|. +..+++|++|+|++|.....+|... ..+++|+.|++
T Consensus       612 ~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si-~~L~~L~~L~L  688 (1153)
T PLN03210        612 NLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSI-QYLNKLEDLDM  688 (1153)
T ss_pred             CCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhh-hccCCCCEEeC
Confidence            77777777777763 455666777777777777654444453 6667777777777776656666653 36777778888


Q ss_pred             cccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCC
Q 048205          372 SGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNP  451 (1027)
Q Consensus       372 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~  451 (1027)
                      ++|...+.+|..+ ++++|+.|++++|...+..|..   .++|++|+|++|.++.+|..+      .+++|++|+++++.
T Consensus       689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~------~l~~L~~L~l~~~~  758 (1153)
T PLN03210        689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNL------RLENLDELILCEMK  758 (1153)
T ss_pred             CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccc------cccccccccccccc
Confidence            7765555666655 6777888888877655555543   456778888888887777653      35667777776654


Q ss_pred             CCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCC
Q 048205          452 LGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPD  531 (1027)
Q Consensus       452 l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~  531 (1027)
                      ...+...                  +....|.......+|+.|+|++|...+.+|..++++++|+.|+|++|..-     
T Consensus       759 ~~~l~~~------------------~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L-----  815 (1153)
T PLN03210        759 SEKLWER------------------VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL-----  815 (1153)
T ss_pred             hhhcccc------------------ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc-----
Confidence            3222111                  00111112223457778888888777778888888888888888876432     


Q ss_pred             CCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCC-cc
Q 048205          532 NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYN-RL  610 (1027)
Q Consensus       532 ~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N-~l  610 (1027)
                              +.+|..+ ++++|+.|++++|..-..+|..   ..+|+.|+|++|.++ .+|.+++.+++|++|+|++| ++
T Consensus       816 --------~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L  882 (1153)
T PLN03210        816 --------ETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNL  882 (1153)
T ss_pred             --------CeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCc
Confidence                    3445444 5778888888887655556543   356788888888887 57888888888888888884 44


Q ss_pred             ccCcccccccccccccccccccc
Q 048205          611 QGSIPDSIGDMINLKSLNLSNNN  633 (1027)
Q Consensus       611 ~g~ip~~~~~l~~L~~L~l~~N~  633 (1027)
                      + .+|..+..++.|+.+++++|.
T Consensus       883 ~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        883 Q-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             C-ccCcccccccCCCeeecCCCc
Confidence            4 688888888888888888874

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=1.7e-23  Score=268.55  Aligned_cols=344  Identities=23%  Similarity=0.277  Sum_probs=158.8

Q ss_pred             cCcCCCCCcEEEccCCc------ccccCCccccccC-CCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCcc
Q 048205           21 TLSNCKRLRNISLSLND------FSGTIPKEIGNVT-TLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSS   93 (1027)
Q Consensus        21 ~~~~~~~L~~L~L~~n~------l~~~~p~~i~~l~-~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~   93 (1027)
                      +|.++++|+.|.+..+.      +...+|..+..++ +|+.|++.++.++ .+|..| ...+|++|+|++|++. .++..
T Consensus       553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~  629 (1153)
T PLN03210        553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG  629 (1153)
T ss_pred             HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence            45555555555554332      1223344444332 3555555555554 444444 2345555555555554 34444


Q ss_pred             ccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCC
Q 048205           94 IFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKL  173 (1027)
Q Consensus        94 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  173 (1027)
                      +..+++|+.|+|++|..                         ...+| .+..+++|++|+|++|.....+|..++++++|
T Consensus       630 ~~~l~~Lk~L~Ls~~~~-------------------------l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L  683 (1153)
T PLN03210        630 VHSLTGLRNIDLRGSKN-------------------------LKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKL  683 (1153)
T ss_pred             cccCCCCCEEECCCCCC-------------------------cCcCC-ccccCCcccEEEecCCCCccccchhhhccCCC
Confidence            44555555555554432                         22232 24444555555555444333444555555555


Q ss_pred             cEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccc
Q 048205          174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF  253 (1027)
Q Consensus       174 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~  253 (1027)
                      +.|++++|..-..+|..+ ++++|+.|++++|.....+|..   ..+|+.|++++|.++               .+|...
T Consensus       684 ~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~---------------~lP~~~  744 (1153)
T PLN03210        684 EDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE---------------EFPSNL  744 (1153)
T ss_pred             CEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc---------------cccccc
Confidence            555555443222334332 4455555555554433333321   234555555555543               122211


Q ss_pred             cCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCc
Q 048205          254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPT  333 (1027)
Q Consensus       254 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  333 (1027)
                        .+++|+.|++.++... .++..+.. ..|......++|+.|+|++|.....+|..++++++|+.|++++|...+.+|.
T Consensus       745 --~l~~L~~L~l~~~~~~-~l~~~~~~-l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~  820 (1153)
T PLN03210        745 --RLENLDELILCEMKSE-KLWERVQP-LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT  820 (1153)
T ss_pred             --cccccccccccccchh-hccccccc-cchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence              2344444444432211 00000000 0011112234566666666655555566666666666666665543333444


Q ss_pred             cccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCccc
Q 048205          334 TIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRN  413 (1027)
Q Consensus       334 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  413 (1027)
                      .+ ++++|+.|++++|.....+|..    .++|++|+|++|.++ .+|.++..+++|+.|+|++|+--..+|..+..+++
T Consensus       821 ~~-~L~sL~~L~Ls~c~~L~~~p~~----~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~  894 (1153)
T PLN03210        821 GI-NLESLESLDLSGCSRLRTFPDI----STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKH  894 (1153)
T ss_pred             CC-CccccCEEECCCCCcccccccc----ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccC
Confidence            33 4556666666665444344332    245666666666665 45555566666666666553222234445555555


Q ss_pred             ccEEecCCC
Q 048205          414 LKWLDLGDN  422 (1027)
Q Consensus       414 L~~L~L~~N  422 (1027)
                      |+.+++++|
T Consensus       895 L~~L~l~~C  903 (1153)
T PLN03210        895 LETVDFSDC  903 (1153)
T ss_pred             CCeeecCCC
Confidence            555555544

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=4.6e-24  Score=253.01  Aligned_cols=101  Identities=28%  Similarity=0.269  Sum_probs=59.8

Q ss_pred             cccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccc
Q 048205          551 DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLS  630 (1027)
Q Consensus       551 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~  630 (1027)
                      +|+.|++++|++++ +|..   ..+|+.|++++|+|++ +|...   ++|+.|++++|+|+ .+|..   ..+|+.|+|+
T Consensus       363 ~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls  430 (788)
T PRK15387        363 ELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPML---PSGLLSLSVY  430 (788)
T ss_pred             ccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcc---hhhhhhhhhc
Confidence            34445555555553 4432   2345666666666653 55432   45666677777666 36643   2356666777


Q ss_pred             cccccCCchhhhhcccCCcceeccCCCCCCCCCC
Q 048205          631 NNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       631 ~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~  664 (1027)
                      +|+|+ .+|.++.+++.|+.|+|++|+|+|.+|.
T Consensus       431 ~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        431 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             cCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            77766 5666666677777777777777766654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1e-23  Score=213.65  Aligned_cols=165  Identities=22%  Similarity=0.222  Sum_probs=126.5

Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |+|.+++...+..+++.++..++.|+++||+|||   +.+      ||+||+++.++.+|+  ||.++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999876667999999999999999999999   666      999999999999999  9998854321       


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||............+.....         +.   ... ..
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~---~~~-~~  129 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP---------AD---DPR-DR  129 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---------cC---Ccc-cc
Confidence            125889999999999999999999999999999999999998754332222222221110         00   000 00


Q ss_pred             hHHhhhHH--HHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          991 VAKEQCMS--FVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       991 ~~~~~~~~--~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ........  ++.+++.+|+..+|++||++.|+++.+.
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            11122232  6899999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.4e-24  Score=270.92  Aligned_cols=196  Identities=17%  Similarity=0.236  Sum_probs=139.5

Q ss_pred             hccC-CccceEEeEE-------ecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 048205          802 RIRH-RNIIKFISSC-------SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH  873 (1027)
Q Consensus       802 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  873 (1027)
                      .++| +||+.++++|       ...+.++.++||+ +++|.+++......+++.+++.++.||++||+|||   ++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            3455 5777888877       2234577889988 55999999866666899999999999999999999   999999


Q ss_pred             ccCCCCcEEEcCC-------------------CcEEEeeecCCcccccCCC--------------cceecccccCccccC
Q 048205          874 CDLKPNNVLLDDN-------------------MVAHLSDFGMAKPFLKEDQ--------------SLTQTQTLATIGYMA  920 (1027)
Q Consensus       874 ~Dlkp~NIll~~~-------------------~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y~a  920 (1027)
                      |||||+|||++..                   +.+|++|||+++.......              ........||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4556666666653211000              000112357899999


Q ss_pred             cccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHH
Q 048205          921 PEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFV 1000 (1027)
Q Consensus       921 PE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l 1000 (1027)
                      ||++.+..++.++|||||||++|||++|.+|+....   ..+..+..        ....+.        .   .......
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~--------~~~~~~--------~---~~~~~~~  241 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRH--------RVLPPQ--------I---LLNWPKE  241 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHH--------hhcChh--------h---hhcCHHH
Confidence            999999999999999999999999999888754311   01111100        000000        0   0112334


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 048205         1001 FNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus      1001 ~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..++.+||+++|.+||++.|+++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhh
Confidence            67888999999999999999986

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=6.8e-23  Score=243.10  Aligned_cols=183  Identities=27%  Similarity=0.300  Sum_probs=92.8

Q ss_pred             CccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEc
Q 048205          292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSL  371 (1027)
Q Consensus       292 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  371 (1027)
                      +|+.|++++|+|+.+ |.   .+++|+.|++++|+++++ |..   ..+|+.|++++|++. .+|..    ..+|++|+|
T Consensus       283 ~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~-~LP~l----p~~Lq~LdL  349 (788)
T PRK15387        283 GLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLT-SLPTL----PSGLQELSV  349 (788)
T ss_pred             hcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCC---cccccccccccCccc-ccccc----ccccceEec
Confidence            444555555555532 21   124455555555555543 221   124555666666663 34431    135666777


Q ss_pred             cccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCC
Q 048205          372 SGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNP  451 (1027)
Q Consensus       372 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~  451 (1027)
                      ++|+|+ .+|..   ..+|+.|++++|+|+. +|..   ..+|+.|+|++|+|+.+|..        .+.|+.|++++|+
T Consensus       350 S~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~l--------~s~L~~LdLS~N~  413 (788)
T PRK15387        350 SDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPVL--------PSELKELMVSGNR  413 (788)
T ss_pred             CCCccC-CCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCCCc--------ccCCCEEEccCCc
Confidence            777666 34432   2455666677776664 3432   24566677777776665532        1356666777776


Q ss_pred             CCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhh
Q 048205          452 LGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIAL  509 (1027)
Q Consensus       452 l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  509 (1027)
                      |++++.     ++..++.|++++|+++ .+|..++++.+|+.|+|++|++++..+..+
T Consensus       414 LssIP~-----l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        414 LTSLPM-----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCCCCc-----chhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            665332     1223344444444443 344444444444444444444444444433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=8.2e-23  Score=225.09  Aligned_cols=167  Identities=21%  Similarity=0.174  Sum_probs=130.2

Q ss_pred             HHhCCCCccceeeccccceEEEEEec--CCceEEEEEEecc-----cchhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ--DGMEVAVKVFDLQ-----YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      ....+|+..+.||+|+||+||+|++.  +++.||||++...     .....+.+.+|++++++++|+|++..+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            34567999999999999999999865  5778899987533     122356789999999999999998533222   4


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCcEEEcCCCcEEEeeecCCc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL-KPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ..++||||++|++|.. ....    .   ...++.++++||+|||   ++||+|||| ||+||+++.++.+||+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            5799999999999973 2111    1   1457889999999999   999999999 9999999999999999999999


Q ss_pred             ccccCCCcce------ecccccCccccCcccccCC
Q 048205          899 PFLKEDQSLT------QTQTLATIGYMAPEYGREG  927 (1027)
Q Consensus       899 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  927 (1027)
                      .+........      .....+++.|+|||++...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            7654332111      1345688889999987644

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.2e-23  Score=203.51  Aligned_cols=242  Identities=23%  Similarity=0.353  Sum_probs=186.5

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      ..+|.+...|+.|+|+|+ |..+++|++....  .....+|..|.-.++-+.||||..+++.|..+....++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            456888999999999998 4556667765332  2334678889999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe--eecCCcccccCCCccee
Q 048205          833 LEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS--DFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       833 L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~  909 (1027)
                      |+..++... ...+..++++++.++|+|++|||.. +.-|..--+.+..|++|++.+.+|+  |--++         ...
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs---------fqe  343 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS---------FQE  343 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee---------eec
Confidence            999998764 4578889999999999999999932 2334444688999999999887765  32221         122


Q ss_pred             cccccCccccCcccccCCCC---CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          910 TQTLATIGYMAPEYGREGRV---STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ..+.-.|.||+||.+..++.   -.++|+|||++++||+.|...||....+.+..++--                   .+
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------------------le  404 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------------------LE  404 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------------------hc
Confidence            23345688999999987764   357899999999999999999998765444322221                   11


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .-+...+++.+..+.+++.-|+..||.+||.+..|+-.|+
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence            1122334566777889999999999999999998887765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.9e-21  Score=214.77  Aligned_cols=256  Identities=21%  Similarity=0.244  Sum_probs=191.9

Q ss_pred             CCCccceeeccccceEEEEEecCC--ceEEEEEEecccchhHHHHHHHHHHHhhccC----CccceEEeEE-ecCCeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDG--MEVAVKVFDLQYGRAIKSFDIECGMIKRIRH----RNIIKFISSC-SSDDFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  823 (1027)
                      +|.+.+.||+|+||.||.|...+.  +.+|+|+...........+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999986643  5799998765433322367788888888873    5899999999 57788999


Q ss_pred             EEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-----CcEEEeeecCC
Q 048205          824 VLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-----MVAHLSDFGMA  897 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgla  897 (1027)
                      ||+.+ |.+|.++..... ..++..++.+|+.|++.+|+++|   +.|++||||||+|+++...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99998 569999875554 67999999999999999999999   9999999999999999765     46999999999


Q ss_pred             c--ccccCCCc----ce--ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH
Q 048205          898 K--PFLKEDQS----LT--QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL  969 (1027)
Q Consensus       898 ~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  969 (1027)
                      +  .+......    ..  .....||..|+++++..+...+++.|+||++.++.|+..|..||........ ...... .
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~-~  252 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEK-D  252 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHH-H
Confidence            9  43322211    11  2334599999999999999999999999999999999999999865432211 111100 0


Q ss_pred             HhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          970 LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       970 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         ........           .....+..+.++...+-..+..++|....+...++
T Consensus       253 ---~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~  295 (322)
T KOG1164|consen  253 ---PRKLLTDR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLK  295 (322)
T ss_pred             ---hhhhcccc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence               00000000           11223445666666666688999998888877653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.4e-22  Score=238.33  Aligned_cols=253  Identities=21%  Similarity=0.237  Sum_probs=192.0

Q ss_pred             ccceeeccccceEEEEEec-CCceEEEEEEec----c-cch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          754 ENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDL----Q-YGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       754 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~----~-~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..+++|.|++|.|+.+... ..+.++.|.++.    . ... ....+..|+-+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            3568999999988887643 445555554431    1 111 12226668888888999999888887777666666699


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      ||++ +|...+.+. ..+...++..+++|++.|++|+|   +.||.|||+|++|++++.+|.+||+|||.+..+..+...
T Consensus       402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 999988765 34788889999999999999999   999999999999999999999999999999876544443


Q ss_pred             --ceecccccCccccCcccccCCCCCc-chhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          907 --LTQTQTLATIGYMAPEYGREGRVST-NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       907 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                        ......+|+..|+|||++.+..|.+ .+||||.|++++.|++|+.||......+..+..          ....+... 
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----------~~~~~~~~-  545 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----------NNYSDQRN-  545 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----------hccccccc-
Confidence              5667788999999999999988865 579999999999999999999876443322100          00011111 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ...+........+.....++.+|+++||.+|.++.+|++
T Consensus       546 -~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 -IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             111222333456777889999999999999999999985

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=7.1e-21  Score=193.73  Aligned_cols=200  Identities=21%  Similarity=0.279  Sum_probs=172.3

Q ss_pred             CCCccceeeccccceEEEEE-ecCCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEec
Q 048205          751 GFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .|.++++||+|+||+++.|+ .-+++.||||.-..  .....++..|.+..+.+. .++|..++.+..+..+-.+|+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            48889999999999999998 45899999997432  233467788999888885 689999999999988899999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-----CcEEEeeecCCcccccC
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-----MVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgla~~~~~~  903 (1027)
                       |-+|+|+..=+++.++.+++..+|.|++.-++|+|   ++..|.|||||+|.||..-     ..+.++|||+|+.+..+
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence             56999988878888999999999999999999999   9999999999999999643     36899999999988655


Q ss_pred             CCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCc
Q 048205          904 DQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESF  956 (1027)
Q Consensus       904 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  956 (1027)
                      ...     .......||..||+-....+...+...|+=|+|-|+++++-|..||.+-.
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            432     22334569999999999999999999999999999999999999998753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.9e-21  Score=187.96  Aligned_cols=256  Identities=20%  Similarity=0.182  Sum_probs=193.1

Q ss_pred             HHhCCCCccceeeccccceEEEEE-ecCCceEEEEEEecccchhHHHHHHHHHHHhhccC-CccceEEeEEecCCeeEEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH-RNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV  824 (1027)
                      .....|..++.||.|+||.+|.|. ..+|..||||+-.....  ..++..|.++.+.+++ ..|..+..|..+...-++|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            345679999999999999999997 55799999998653322  2456778899999976 4788888888899999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCCcccc
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~  901 (1027)
                      ||.. |.+|+++..-..+.++..+++-.|-|++.-++|+|   .++++||||||+|.+..-   ...+.++|||+|+.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999 56999998877778999999999999999999999   999999999999999963   4578999999999875


Q ss_pred             cCCCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          902 KEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       902 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      .....     .......||..|.+-....+...+...|+-|+|.++.++--|..||.+.....  ..+-        .+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t--k~QK--------yEk  235 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT--KKQK--------YEK  235 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh--HHHH--------HHH
Confidence            43321     12234569999999888888888899999999999999999999998753221  1110        111


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~ev 1021 (1027)
                      +.+.....   .-.+.-.++|.++.-.+.-|-..--++-|...-+
T Consensus       236 I~EkK~s~---~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl  277 (341)
T KOG1163|consen  236 ISEKKMST---PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL  277 (341)
T ss_pred             HHHhhcCC---CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence            11111111   1112234566666667777776666776765433

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=3.4e-21  Score=230.68  Aligned_cols=246  Identities=23%  Similarity=0.335  Sum_probs=156.7

Q ss_pred             CcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEec
Q 048205          340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL  419 (1027)
Q Consensus       340 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  419 (1027)
                      +...|+++++.++ .+|....   ++|+.|+|++|+++ .+|..+.  ++|++|++++|+++. +|..+.  .+|+.|+|
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip---~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L  248 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP---EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL  248 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc---cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence            4566777777764 4555432   45777777777776 4555443  467777777777764 344432  35677777


Q ss_pred             CCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCc
Q 048205          420 GDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVN  499 (1027)
Q Consensus       420 ~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N  499 (1027)
                      ++|+++.+|..+.       ..|+.|++++|+|+.+                          |..+.  .+|+.|++++|
T Consensus       249 s~N~L~~LP~~l~-------s~L~~L~Ls~N~L~~L--------------------------P~~l~--~sL~~L~Ls~N  293 (754)
T PRK15370        249 SINRITELPERLP-------SALQSLDLFHNKISCL--------------------------PENLP--EELRYLSVYDN  293 (754)
T ss_pred             cCCccCcCChhHh-------CCCCEEECcCCccCcc--------------------------ccccC--CCCcEEECCCC
Confidence            7777776665432       3566666666666543                          33332  35666666666


Q ss_pred             cccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEE
Q 048205          500 KLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQI  579 (1027)
Q Consensus       500 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  579 (1027)
                      ++++ +|..+.  ++|+.|++++|++++              +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|
T Consensus       294 ~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~--------------LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L  351 (754)
T PRK15370        294 SIRT-LPAHLP--SGITHLNVQSNSLTA--------------LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVL  351 (754)
T ss_pred             cccc-Ccccch--hhHHHHHhcCCcccc--------------CCcccc--ccceeccccCCcccc-CChhhc--CcccEE
Confidence            6663 333332  356777777777742              232221  467777778887775 666553  578888


Q ss_pred             cccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhh----hcccCCcceeccC
Q 048205          580 DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISL----EKLLDLKDINVSF  655 (1027)
Q Consensus       580 ~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l----~~l~~L~~l~l~~  655 (1027)
                      ++++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|+.+.  .+|+.|++++|+|+ .+|.++    ..++.+..+++.+
T Consensus       352 ~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~  424 (754)
T PRK15370        352 DVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEY  424 (754)
T ss_pred             ECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeC
Confidence            88888887 5676653  57888888888888 5777654  36888888888887 455444    3346778888888


Q ss_pred             CCCC
Q 048205          656 NKLE  659 (1027)
Q Consensus       656 N~l~  659 (1027)
                      |+++
T Consensus       425 Npls  428 (754)
T PRK15370        425 NPFS  428 (754)
T ss_pred             CCcc
Confidence            8876

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=7.3e-20  Score=206.28  Aligned_cols=257  Identities=31%  Similarity=0.400  Sum_probs=197.0

Q ss_pred             CCccceeeccccceEEEEEecCCceEEEEEEecccch---hHHHHHHHHHHHhhccCC-ccceEEeEEecCCeeEEEEEe
Q 048205          752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR---AIKSFDIECGMIKRIRHR-NIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      |...+.||.|+||.||++...  ..+|+|.+......   ....+.+|+++++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999877  88999998755332   367788999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCcccccCC
Q 048205          828 MPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~  904 (1027)
                      +.++++.+++....  ..+.......++.|++.+++|+|   +.+++|||+||+||+++..+ .++++|||.++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997766544  25888999999999999999999   99999999999999999988 79999999998554333


Q ss_pred             Ccc----eecccccCccccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCccc--chhHHHHHHHHHhhhHH
Q 048205          905 QSL----TQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTRKKPTDESFTG--EMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       905 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  975 (1027)
                      ...    ......|+..|+|||....   ..+....|+||+|++++++++|..||......  .......+...      
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~------  230 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL------  230 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc------
Confidence            221    3456679999999999987   57889999999999999999999997654321  11111111100      


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ..+...........  ......+.+++.+|+..+|..|.++.+...
T Consensus       231 --~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         231 --PTPSLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             --CCcccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence              00000000000000  223356788999999999999999887654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=3.6e-21  Score=230.39  Aligned_cols=286  Identities=28%  Similarity=0.428  Sum_probs=136.2

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      ...|+++++.++ .+|..+.  +.|+.|+|++|+|+ .+|..+.  ++|+.|++++|+++ .+|..+.  .+|+.|+|++
T Consensus       180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~  250 (754)
T PRK15370        180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI  250 (754)
T ss_pred             ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence            445555555554 3444443  34555555555554 3343332  24555555555544 2333332  2344444444


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |+++ .+                         |..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|+|++|+++. +
T Consensus       251 N~L~-~L-------------------------P~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-L  298 (754)
T PRK15370        251 NRIT-EL-------------------------PERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-L  298 (754)
T ss_pred             CccC-cC-------------------------ChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-C
Confidence            4444 23                         33222  24555555555554 2343332  345555555555552 3


Q ss_pred             ChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEecc
Q 048205          188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSK  267 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~  267 (1027)
                      |..+.  .+|+.|++++|.++ .+|..+.  ++|+.|++++|.+++               +|..++   ++|+.|++++
T Consensus       299 P~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~---------------LP~~l~---~sL~~L~Ls~  355 (754)
T PRK15370        299 PAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS---------------LPASLP---PELQVLDVSK  355 (754)
T ss_pred             cccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc---------------CChhhc---CcccEEECCC
Confidence            33222  24555555555555 2333322  455566666665542               222111   3456666666


Q ss_pred             ccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCc----cccccCCcce
Q 048205          268 NMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPT----TIFNVSTLKF  343 (1027)
Q Consensus       268 N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~  343 (1027)
                      |+|+          .+|..+.  ++|+.|+|++|+|+.+ |..+.  ..|+.|++++|++.++ |.    .+..++.+..
T Consensus       356 N~L~----------~LP~~lp--~~L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~  419 (754)
T PRK15370        356 NQIT----------VLPETLP--PTITTLDVSRNALTNL-PENLP--AALQIMQASRNNLVRL-PESLPHFRGEGPQPTR  419 (754)
T ss_pred             CCCC----------cCChhhc--CCcCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCcccC-chhHHHHhhcCCCccE
Confidence            6655          2222221  3566666666666643 33332  2566677777776643 33    2334467778


Q ss_pred             EEccCccccccCCCCccCCCCCccEEEccccccCC-cCcccccCCCCCCeeecCCCccc
Q 048205          344 LYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSG-TIPSFIFNTSKLSTLELQRNSFS  401 (1027)
Q Consensus       344 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~  401 (1027)
                      |++.+|.+..       ..+.+|+.| ++.+.+.| .++...+..++++....-++.+.
T Consensus       420 L~L~~Npls~-------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~  470 (754)
T PRK15370        420 IIVEYNPFSE-------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ  470 (754)
T ss_pred             EEeeCCCccH-------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHh
Confidence            8888887742       234556666 44455544 23333334444444333333333

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=1.4e-20  Score=192.15  Aligned_cols=171  Identities=13%  Similarity=0.120  Sum_probs=133.2

Q ss_pred             HhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhH---HH------HHHHHHHHhhccCCccceEEeEEecC
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAI---KS------FDIECGMIKRIRHRNIIKFISSCSSD  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~niv~l~~~~~~~  818 (1027)
                      ..++|+..+++|.|+||.||.+.. ++..+|||+++.......   ..      +.+|++.+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999766 577899999975433222   22      67899999999999999999886543


Q ss_pred             --------CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 048205          819 --------DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  890 (1027)
Q Consensus       819 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  890 (1027)
                              ...++||||++|.+|.++..     .+.    ....+++.++..+|   +.|++|||+||+||+++.+| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988632     222    24569999999999   99999999999999999998 99


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF  946 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  946 (1027)
                      ++|||.......... .             ..+.....+..++|+||+|+.+....
T Consensus       175 liDfg~~~~~~e~~a-~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKA-K-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhh-H-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999998875421110 0             11333445667899999999876554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=6.3e-20  Score=186.30  Aligned_cols=139  Identities=19%  Similarity=0.180  Sum_probs=109.1

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccch--h------------------------HHHHHHHHHHHhhccCCcc
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR--A------------------------IKSFDIECGMIKRIRHRNI  808 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  808 (1027)
                      ...||+|+||.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999998754211  0                        1122359999999998877


Q ss_pred             ceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccCCCCcEEEcCCC
Q 048205          809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVPIIHCDLKPNNVLLDDNM  887 (1027)
Q Consensus       809 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~NIll~~~~  887 (1027)
                      .....+...  ..++||||++|+++...... ...+++.++..++.|++.+++|+ |   +.||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            543333222  23899999999877654332 23578899999999999999999 7   88999999999999998 57


Q ss_pred             cEEEeeecCCccc
Q 048205          888 VAHLSDFGMAKPF  900 (1027)
Q Consensus       888 ~~kl~Dfgla~~~  900 (1027)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.7e-20  Score=217.72  Aligned_cols=249  Identities=23%  Similarity=0.261  Sum_probs=180.2

Q ss_pred             CCCccceeeccccceEEEEEecCCceEEEEEEecccc-h---hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG-R---AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      +|...+.+|.+.|=+|.+|++.+|. |+||++-++.. -   ..++-.+|++ ...++|||++++..+-......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999998887 99999865542 2   2333334555 566799999999888777778899999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc-ccCCC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF-LKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~-~~~~~  905 (1027)
                      |+.. +|+|.+..+. .+...+.+.|+.|++.|+..+|   ..||+|||||.+||||+.=..+.|+||.--+.. .+.+.
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9976 9999887654 4677778889999999999999   999999999999999999999999999765532 22222


Q ss_pred             cceeccccc----CccccCcccccCC----------C-CCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHH
Q 048205          906 SLTQTQTLA----TIGYMAPEYGREG----------R-VSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDL  969 (1027)
Q Consensus       906 ~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  969 (1027)
                      ....+....    -.-|.|||.+..+          . .+++-||||+||+++|+++ |++||.-+     .+..|... 
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~-  250 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG-  250 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc-
Confidence            211111112    2349999976542          1 5678899999999999988 67777542     11111110 


Q ss_pred             HhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          970 LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       970 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                    ......+....-....+.+++..|++.||.+|.+|.+.++.=+
T Consensus       251 --------------~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  251 --------------NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             --------------CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence                          0011111111112224788999999999999999999998643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=5.7e-19  Score=180.36  Aligned_cols=139  Identities=22%  Similarity=0.209  Sum_probs=110.8

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccch--------------------------hHHHHHHHHHHHhhccCCcc
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR--------------------------AIKSFDIECGMIKRIRHRNI  808 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  808 (1027)
                      .+.||+|++|.||+|+..+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754211                          01223578999999999987


Q ss_pred             ceEEeEEecCCeeEEEEEecCCCCHHHH-HhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCC
Q 048205          809 IKFISSCSSDDFKALVLEYMPYGSLEKC-LYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDN  886 (1027)
Q Consensus       809 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~  886 (1027)
                      .....+....  .++||||++|+++... +..  ..++...+..++.+++.++.++|   . .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5544443332  4899999998865443 332  34678889999999999999999   7 9999999999999999 8


Q ss_pred             CcEEEeeecCCcccc
Q 048205          887 MVAHLSDFGMAKPFL  901 (1027)
Q Consensus       887 ~~~kl~Dfgla~~~~  901 (1027)
                      +.++++|||+|+...
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            999999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6.4e-19  Score=175.54  Aligned_cols=188  Identities=16%  Similarity=0.086  Sum_probs=139.6

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccc----hhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEe
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG----RAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .....|++|+||+||.+.. .+.+++.+.+.....    -....+.+|+++++++. |+++++++++    ...++||||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999998765 678888777653322    11235788999999995 5789999886    346999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL-KPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +.|.+|.+....        ....++.|++++++++|   +.||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998764321        12347789999999999   999999999 799999999999999999999854332210


Q ss_pred             ----c-------eecccccCccccCcccccCC-CCC-cchhHHHHHHHHHHHHcCCCCCCCCc
Q 048205          907 ----L-------TQTQTLATIGYMAPEYGREG-RVS-TNGDVYSFGIMLMETFTRKKPTDESF  956 (1027)
Q Consensus       907 ----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGvil~elltg~~p~~~~~  956 (1027)
                          .       .......++.|++|+...-. ..+ ...++++.|+-+|.++|++.++....
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0       01122357778888743322 222 55699999999999999999876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.2e-20  Score=209.73  Aligned_cols=224  Identities=26%  Similarity=0.310  Sum_probs=177.3

Q ss_pred             eeccccceEEEEEe----cCCceEEEEEEecccc--hhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEecCC
Q 048205          758 IGRGGFGFVYKARI----QDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       758 lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +|+|+||.|+.++.    ..|..+|+|+..+...  ........|..++...+ ||.++++...++.+...+++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            69999999998752    3477899998765422  11224556778888887 99999999999999999999999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceec
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT  910 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  910 (1027)
                      |++...+..... +++.....+...++-|++++|   +.+|+|||+|++||+++.+|.+++.|||+++.......     
T Consensus        82 g~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----  152 (612)
T KOG0603|consen   82 GDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----  152 (612)
T ss_pred             chhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence            999988776554 566666777888999999999   99999999999999999999999999999986543222     


Q ss_pred             ccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       911 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                       .+||..|||||++.  ....++|+||+|++++||+||..||..     ..+...    .                ...+
T Consensus       153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~I----l----------------~~~~  204 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRI----L----------------KAEL  204 (612)
T ss_pred             -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHH----h----------------hhcc
Confidence             28999999999998  667889999999999999999999876     111111    0                1122


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                      ..+......+.+++.+++..+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            3344556667788888888888888744

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=7.1e-19  Score=185.13  Aligned_cols=229  Identities=22%  Similarity=0.248  Sum_probs=146.9

Q ss_pred             CccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccC----------CccceEEeEEe--
Q 048205          753 SENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRH----------RNIIKFISSCS--  816 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~--  816 (1027)
                      ...+.||.|+++.||.+++. +|+.+|||++....   ....+.+++|.-....+.+          -.++-.++...  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            44678999999999999977 58999999886432   2345667776655544322          12222222221  


Q ss_pred             -------cC---C-----eeEEEEEecCCCCHHHHHh---cCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 048205          817 -------SD---D-----FKALVLEYMPYGSLEKCLY---SSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD  875 (1027)
Q Consensus       817 -------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  875 (1027)
                             ..   .     ..+++|+-+.+ ||.+.+.   ...   .......+..+..|+++.+++||   ..|+||+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence                   11   1     23678888854 8888753   222   12344556677789999999999   99999999


Q ss_pred             CCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccC--------CCCCcchhHHHHHHHHHHHHc
Q 048205          876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMETFT  947 (1027)
Q Consensus       876 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~ellt  947 (1027)
                      |||+|++++.+|.+.++||+.......   . . .....+..|.+||....        ..++.+.|.|++|+++|.+++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~---~-~-~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGT---R-Y-RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTE---E-E-EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCc---e-e-eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999998775322   1 1 11345577999997643        247889999999999999999


Q ss_pred             CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCC
Q 048205          948 RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER 1015 (1027)
Q Consensus       948 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R 1015 (1027)
                      |+.||+..........                         .+..-...+..+..||..++.++|++|
T Consensus       246 ~~lPf~~~~~~~~~~~-------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW-------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG-------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc-------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999986533211000                         111112567778999999999999998

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=1.6e-20  Score=173.23  Aligned_cols=168  Identities=27%  Similarity=0.488  Sum_probs=147.2

Q ss_pred             ccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccc
Q 048205          484 EINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT  563 (1027)
Q Consensus       484 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~  563 (1027)
                      .+-++.+++.|.|++|+++ .+|..++.+.+|++|++++||+              +++|.+++.++.|+.|+++-|.+.
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqi--------------e~lp~~issl~klr~lnvgmnrl~   92 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQI--------------EELPTSISSLPKLRILNVGMNRLN   92 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchh--------------hhcChhhhhchhhhheecchhhhh
Confidence            3456778888999999998 7888899999999999999998              578889999999999999999988


Q ss_pred             cCccccccCcccccEEccccccccc-ccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhh
Q 048205          564 GPLPLEIGNLKVLVQIDLSINNFSD-VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISL  642 (1027)
Q Consensus       564 ~~~p~~~~~l~~L~~L~ls~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l  642 (1027)
                       .+|..||.++.|+.|||..|++.. .+|..|..|+.|+.|.|++|.|. .+|+.+|++++|+.|.+.+|.+. ++|.++
T Consensus        93 -~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkei  169 (264)
T KOG0617|consen   93 -ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEI  169 (264)
T ss_pred             -cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHH
Confidence             689999999999999999999873 58888888999999999999998 79999999999999999999987 889999


Q ss_pred             hcccCCcceeccCCCCCCCCCCCCCCC
Q 048205          643 EKLLDLKDINVSFNKLEGEIPREGPFR  669 (1027)
Q Consensus       643 ~~l~~L~~l~l~~N~l~g~~p~~~~~~  669 (1027)
                      +.++.|+.|.+.+|+|+-.+|..+++.
T Consensus       170 g~lt~lrelhiqgnrl~vlppel~~l~  196 (264)
T KOG0617|consen  170 GDLTRLRELHIQGNRLTVLPPELANLD  196 (264)
T ss_pred             HHHHHHHHHhcccceeeecChhhhhhh
Confidence            999999999999999988777755443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.3e-18  Score=181.09  Aligned_cols=196  Identities=19%  Similarity=0.241  Sum_probs=140.0

Q ss_pred             cCCccceEEeEEec---------------------------CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHH
Q 048205          804 RHRNIIKFISSCSS---------------------------DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV  856 (1027)
Q Consensus       804 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i  856 (1027)
                      +|||||++.++|.+                           ....|+||.-++. +|.+++....  .+...+.-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999877633                           2357899999876 9999987654  3555666788999


Q ss_pred             HHHHHHhhcCCCCCeEeccCCCCcEEE--cCCC--cEEEeeecCCcccccCC----CcceecccccCccccCcccccCCC
Q 048205          857 ASALEYLHFGYSVPIIHCDLKPNNVLL--DDNM--VAHLSDFGMAKPFLKED----QSLTQTQTLATIGYMAPEYGREGR  928 (1027)
Q Consensus       857 ~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~  928 (1027)
                      ++|+.|||   .+||.|||+|++||++  |+|+  .+.|+|||.+-.-...+    .........|.-.-||||+....+
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   9999999999999999  4444  46789999764211100    011112234566689999876432


Q ss_pred             ------CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHH
Q 048205          929 ------VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFN 1002 (1027)
Q Consensus       929 ------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~ 1002 (1027)
                            -..|+|.|+.|.+.||++...-||+...+...+...|                   .+.+-...+..+++.+.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y-------------------qe~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY-------------------QESQLPALPSRVPPVARQ  488 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-------------------hhhhCCCCcccCChHHHH
Confidence                  2357899999999999999999998742221111111                   112222345678888999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHH
Q 048205         1003 LAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus      1003 Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ++...++.||.+|+++.=+...
T Consensus       489 lV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhH
Confidence            9999999999999987644443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=8.6e-20  Score=204.22  Aligned_cols=285  Identities=22%  Similarity=0.234  Sum_probs=179.9

Q ss_pred             eEEccCccccccCCCCccCCCCCccEEEccccccCC----cCcccccCCCCCCeeecCCCcccC------CCCcccCCcc
Q 048205          343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSG----TIPSFIFNTSKLSTLELQRNSFSG------FIPNTFGNLR  412 (1027)
Q Consensus       343 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~  412 (1027)
                      .|+|+.+.+.+.--...+..+.+|++|+++++.++.    .++..+...+.+++|++++|.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            466766766533222333455668888888887743    245555566677777777777652      2234455666


Q ss_pred             cccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccc-ccc
Q 048205          413 NLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNL-TNL  491 (1027)
Q Consensus       413 ~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l-~~L  491 (1027)
                      +|+.|++++|.+.............. ++|++|++++|++++...                     ..+...+..+ .+|
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~-~~L~~L~ls~~~~~~~~~---------------------~~l~~~l~~~~~~L  139 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRS-SSLQELKLNNNGLGDRGL---------------------RLLAKGLKDLPPAL  139 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhcc-CcccEEEeeCCccchHHH---------------------HHHHHHHHhCCCCc
Confidence            77777777777653222111000111 446666666666553111                     1223344555 778


Q ss_pred             ceEEecCccccC----chhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccC--
Q 048205          492 IAIYLGVNKLNG----SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP--  565 (1027)
Q Consensus       492 ~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~--  565 (1027)
                      +.|++++|.+++    .++..+..+.+|++|+|++|.+++.         ....++..+..+++|+.|++++|.+++.  
T Consensus       140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~---------~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  210 (319)
T cd00116         140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA---------GIRALAEGLKANCNLEVLDLNNNGLTDEGA  210 (319)
T ss_pred             eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchH---------HHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence            888888888874    3445566777888888888887642         1223444555667888888888887643  


Q ss_pred             --ccccccCcccccEEcccccccccccchhhcc-----CccccEEEccCCccc----cCccccccccccccccccccccc
Q 048205          566 --LPLEIGNLKVLVQIDLSINNFSDVIPTTIGG-----LKDLQYLFLKYNRLQ----GSIPDSIGDMINLKSLNLSNNNL  634 (1027)
Q Consensus       566 --~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~-----l~~L~~L~L~~N~l~----g~ip~~~~~l~~L~~L~l~~N~l  634 (1027)
                        ++..+..+++|+.|++++|.+++..+..+..     .+.|+.|++++|.++    ..++..+..+++|+++++++|.+
T Consensus       211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l  290 (319)
T cd00116         211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF  290 (319)
T ss_pred             HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCC
Confidence              3445666788888888888887643333322     368889999998886    23555666678888999999988


Q ss_pred             cCC----chhhhhcc-cCCcceeccCCCC
Q 048205          635 FGI----IPISLEKL-LDLKDINVSFNKL  658 (1027)
Q Consensus       635 ~~~----~p~~l~~l-~~L~~l~l~~N~l  658 (1027)
                      +..    +...+... +.|+.+++.+|.+
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         291 GEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             cHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            855    44455555 6788888887764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=5.5e-18  Score=189.56  Aligned_cols=214  Identities=27%  Similarity=0.396  Sum_probs=161.7

Q ss_pred             HhhccCCccceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe-EeccCCC
Q 048205          800 IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI-IHCDLKP  878 (1027)
Q Consensus       800 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dlkp  878 (1027)
                      ++.+.|.|+.+++|.+.++...++|.+|+..|+|.|.+......+++.....++.+|+.|++|+|   .-.| +|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            45789999999999999999999999999999999999988888999999999999999999999   4444 9999999


Q ss_pred             CcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCC-------CCcchhHHHHHHHHHHHHcCCCC
Q 048205          879 NNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR-------VSTNGDVYSFGIMLMETFTRKKP  951 (1027)
Q Consensus       879 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~elltg~~p  951 (1027)
                      .|.++|....+|++|||+.................-..-|.|||.+....       .+.+.||||+|++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999988653211111122222345689999887641       46679999999999999999999


Q ss_pred             CCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          952 TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      |+........ .+.+...        .+ .......+......+.++++..++..||..+|++||+++++-..++
T Consensus       158 ~~~~~~~~~~-~eii~~~--------~~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  158 FDLRNLVEDP-DEIILRV--------KK-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             cccccccCCh-HHHHHHH--------Hh-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            9875433321 1111110        00 0000111112211245557899999999999999999999877654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.75  E-value=2.3e-20  Score=172.28  Aligned_cols=158  Identities=34%  Similarity=0.547  Sum_probs=112.6

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS  101 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  101 (1027)
                      +.++..++.|-||+|.++ .+|..|+++.+|+.|++++|+|+ .+|.+++.++.|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            456677889999999998 78888999999999999999998 88999999999999999999998 8899999999999


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCc
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQN  181 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  181 (1027)
                      .|||++|++.....+.-|-.+..|+.|+|++|.+. .+|+.++++++|+.|.+..|.+- .+|..++.++.|++|++.+|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            99999999875332232333444555555555554 44445555555555555555544 34455555555555555555


Q ss_pred             cCC
Q 048205          182 RLQ  184 (1027)
Q Consensus       182 ~l~  184 (1027)
                      +++
T Consensus       184 rl~  186 (264)
T KOG0617|consen  184 RLT  186 (264)
T ss_pred             eee
Confidence            554

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2.1e-17  Score=169.04  Aligned_cols=137  Identities=16%  Similarity=0.234  Sum_probs=107.4

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhc-----cCCccceEEeEEecCC---eeE-E
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-----RHRNIIKFISSCSSDD---FKA-L  823 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  823 (1027)
                      ...+.||+|+||.||.  +.+....+||++........+.+.+|+++++.+     .||||+++++++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4457899999999995  443333479998765444567789999999999     5799999999998863   433 7


Q ss_pred             EEEe--cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEeccCCCCcEEEcC----CCcEEEeeecC
Q 048205          824 VLEY--MPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDLKPNNVLLDD----NMVAHLSDFGM  896 (1027)
Q Consensus       824 V~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgl  896 (1027)
                      |+||  +.+|+|.+++.+..  +++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  55799999996642  5554  35677888777 9999   999999999999999974    34899999554


Q ss_pred             Cc
Q 048205          897 AK  898 (1027)
Q Consensus       897 a~  898 (1027)
                      ++
T Consensus       156 ~~  157 (210)
T PRK10345        156 ES  157 (210)
T ss_pred             Cc
Confidence            43

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=1.5e-19  Score=202.16  Aligned_cols=285  Identities=21%  Similarity=0.213  Sum_probs=207.9

Q ss_pred             ceeccCcccc-cccCccccccCCcceEEccCcccccc----CCCCccCCCCCccEEEccccccCC------cCcccccCC
Q 048205          319 WMIFSFNKLV-GVVPTTIFNVSTLKFLYLGSNSFFGR----LPSSADVRLPNLEELSLSGNNFSG------TIPSFIFNT  387 (1027)
Q Consensus       319 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l  387 (1027)
                      .|+|..+.++ ......|..+..|+.|+++++.+...    ++.. ....++|++|+++++.+.+      .++..+..+
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~-l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~   80 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASA-LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG   80 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHH-HhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence            5788888887 44455567788899999999988432    2222 2356789999999998862      345567788


Q ss_pred             CCCCeeecCCCcccCCCCcccCCccc---ccEEecCCCCCCCCCCcccccccccc-ccccEeeccCCCCCCCCCccccCc
Q 048205          388 SKLSTLELQRNSFSGFIPNTFGNLRN---LKWLDLGDNYLTSSTSELSFLSSSNC-KYLEYFSISNNPLGGILPRVIGNL  463 (1027)
Q Consensus       388 ~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~l~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l  463 (1027)
                      ++|+.|++++|.+.+..+..|..+.+   |++|++++|+++........-....+ ++|+.|++++|.+++....     
T Consensus        81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-----  155 (319)
T cd00116          81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE-----  155 (319)
T ss_pred             CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH-----
Confidence            99999999999998777777777766   99999999998753222211123344 7888888888887642111     


Q ss_pred             ccccceeecCCCccccccCcccccccccceEEecCccccC----chhHhhhcccccceeeccCceeecccCCCCCccccc
Q 048205          464 SQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNG----SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL  539 (1027)
Q Consensus       464 ~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~  539 (1027)
                                      .++..+..+..|++|++++|.+++    .++..+..+++|++|+|++|.+++..         .
T Consensus       156 ----------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~---------~  210 (319)
T cd00116         156 ----------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG---------A  210 (319)
T ss_pred             ----------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH---------H
Confidence                            234456667788899999998884    34455666779999999999886431         2


Q ss_pred             cccCccccccCcccEEecCCCccccCccccccC-----cccccEEcccccccc----cccchhhccCccccEEEccCCcc
Q 048205          540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGN-----LKVLVQIDLSINNFS----DVIPTTIGGLKDLQYLFLKYNRL  610 (1027)
Q Consensus       540 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~ls~n~l~----~~~p~~~~~l~~L~~L~L~~N~l  610 (1027)
                      ..++..+..+++|++|++++|.+++.-...+..     ...|+.|++++|.++    ..+...+..+++|+++++++|.+
T Consensus       211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l  290 (319)
T cd00116         211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF  290 (319)
T ss_pred             HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCC
Confidence            345556677889999999999988633333322     378999999999997    23556677789999999999999


Q ss_pred             ccC----cccccccc-ccccccccccccc
Q 048205          611 QGS----IPDSIGDM-INLKSLNLSNNNL  634 (1027)
Q Consensus       611 ~g~----ip~~~~~l-~~L~~L~l~~N~l  634 (1027)
                      +..    +...+... ..|++||+.+|++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         291 GEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             cHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            954    55555555 7899999999874

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=1.8e-18  Score=201.16  Aligned_cols=212  Identities=25%  Similarity=0.296  Sum_probs=148.3

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ...+|..++.|..|+||.||.++++ +.+.+|+|+-+ +.-     +.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCccee-----------------
Confidence            3467899999999999999999987 47789995422 211     1110  22222333333                 


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC---
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE---  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~---  903 (1027)
                          |+-.+.++..+. ++.        +++.+++|+|   ..||||||+||+|.+|+.-|++|++|||+++.....   
T Consensus       136 ----gDc~tllk~~g~-lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGP-LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcccCCC-Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                344444443322 222        2277899999   999999999999999999999999999998753211   


Q ss_pred             ----------CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          904 ----------DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       904 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                                .........+|||.|.|||++....|...+|+|++|+|+||++.|+.||++...+ ..+...+...    
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~visd~----  274 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDD----  274 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhhhhhh----
Confidence                      1112234568999999999999999999999999999999999999999875332 2222222211    


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA 1018 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~ 1018 (1027)
                                   ....+..+..+.+..+++.+.++.+|.+|--.
T Consensus       275 -------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  275 -------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             -------------ccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence                         11111234566778899999999999999733

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=2.9e-17  Score=196.18  Aligned_cols=198  Identities=25%  Similarity=0.295  Sum_probs=157.8

Q ss_pred             HHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhcc---CCccceEEeEEecCCeeEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR---HRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  823 (1027)
                      ...+.|.+.+.||+|+||.||+|...+|+.||+|+-+.....   +|..-.+++.+|+   -+.|..+..++.-.+.-++
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            345668888999999999999999888999999986654332   1222234444554   2345555555555667789


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-------CCCcEEEeeecC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-------DNMVAHLSDFGM  896 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~Dfgl  896 (1027)
                      |+||.+.|+|.+++.. .+.++|.-++.+..|+++.+++||   ..+||||||||+|.++.       ...-++|+|||-
T Consensus       772 v~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            9999999999999984 445899999999999999999999   99999999999999994       234689999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP  951 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p  951 (1027)
                      +..+.--.....-...++|-.+-.+|+..+.++++.+|-|.++-+++-|+.|+.-
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9876533333344556788899999999999999999999999999999999754

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=7.1e-17  Score=169.71  Aligned_cols=142  Identities=18%  Similarity=0.142  Sum_probs=111.5

Q ss_pred             CCCCccceeeccccceEEEEE--ecCCceEEEEEEecccch------------------------hHHHHHHHHHHHhhc
Q 048205          750 NGFSENNLIGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGR------------------------AIKSFDIECGMIKRI  803 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  803 (1027)
                      .-|++.+.||+|+||.||+|+  ..+|+.||||+++.....                        ....+..|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            348889999999999999998  568999999998743210                        112356799999999


Q ss_pred             cCCc--cceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeccCCCCc
Q 048205          804 RHRN--IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP-IIHCDLKPNN  880 (1027)
Q Consensus       804 ~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~N  880 (1027)
                      .+..  +.+++++    ...++||||++|+++....... ...+..++..++.|++.++++||   +.+ |+||||||+|
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N  179 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN  179 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence            7633  3444443    2358999999998887654332 23566667889999999999999   999 9999999999


Q ss_pred             EEEcCCCcEEEeeecCCccc
Q 048205          881 VLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       881 Ill~~~~~~kl~Dfgla~~~  900 (1027)
                      |+++ ++.++++|||.|...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 889999999998743

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=2.7e-16  Score=162.19  Aligned_cols=143  Identities=24%  Similarity=0.173  Sum_probs=112.0

Q ss_pred             HHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccch----------------------hHHHHHHHHHHHhh
Q 048205          745 LFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR----------------------AIKSFDIECGMIKR  802 (1027)
Q Consensus       745 ~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~  802 (1027)
                      +.....-|...+.||+|+||.||+|...+|+.||||+++.....                      .......|..++.+
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33333448888999999999999999888999999987643210                      11235678889999


Q ss_pred             ccCCc--cceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 048205          803 IRHRN--IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN  880 (1027)
Q Consensus       803 l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  880 (1027)
                      +.|++  +..+++.    ...++||||++|++|.+....       .....++.++++++.++|   +.+|+||||||+|
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~N  155 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFN  155 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCccc
Confidence            98874  4444432    345899999999998775431       234578899999999999   8999999999999


Q ss_pred             EEEcCCCcEEEeeecCCcccc
Q 048205          881 VLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       881 Ill~~~~~~kl~Dfgla~~~~  901 (1027)
                      |++++++.++|+|||.+....
T Consensus       156 ill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEEcCCCcEEEEECCccccCC
Confidence            999999999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=3.2e-16  Score=163.76  Aligned_cols=134  Identities=23%  Similarity=0.278  Sum_probs=113.4

Q ss_pred             ceeeccccceEEEEEecCCceEEEEEEecccc--------hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      +.||+|++|.||+|++ .|..|++|+......        .....+.+|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 678899998653221        1124577899999999999988777777777788999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ++|++|.+++....    + ++..++.+++.+++++|   +.+++|||++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886532    2 78889999999999999   99999999999999999 88999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=6e-16  Score=160.06  Aligned_cols=130  Identities=22%  Similarity=0.322  Sum_probs=106.5

Q ss_pred             eeeccccceEEEEEecCCceEEEEEEeccc--------chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQY--------GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .||+|+||.||+|.+ +|+.|++|+.....        ......+.+|+++++.++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 57889999864321        112356778999999999987665555555666779999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      +|++|.+++.....        .++.+++.+++++|   +.+++|||++|+||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988754321        78999999999999   99999999999999999 89999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=3.2e-17  Score=179.18  Aligned_cols=175  Identities=25%  Similarity=0.395  Sum_probs=131.1

Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                      .+.||.|+++...+|.+|+.+.+  ...++.....++.|++.|++|      ++.+|+|+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            35789999999999999997543  446788899999999999999      5899999999999999999999999999


Q ss_pred             CcccccCC----CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHh
Q 048205          897 AKPFLKED----QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       897 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      ........    ....++...||.+||+||.+.+..|+.++||||||+|++|+++ =..+++..                
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------  466 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------  466 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------------
Confidence            98765443    2334566789999999999999999999999999999999997 22222110                


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                       .....++.....   +.+  ..+++. =..++.+++++.|.+||++.+..
T Consensus       467 -~t~~d~r~g~ip---~~~--~~d~p~-e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  467 -ATLTDIRDGIIP---PEF--LQDYPE-EYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             -HhhhhhhcCCCC---hHH--hhcCcH-HHHHHHHhcCCCcccCchHHHHh
Confidence             011111111111   011  111221 24789999999999999666554

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=1.2e-15  Score=181.51  Aligned_cols=144  Identities=19%  Similarity=0.258  Sum_probs=115.0

Q ss_pred             HHHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEE-ecccc-------hhHHHHHHHHHHHhhccCCccceEEe
Q 048205          742 YLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVF-DLQYG-------RAIKSFDIECGMIKRIRHRNIIKFIS  813 (1027)
Q Consensus       742 ~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~  813 (1027)
                      +.........|...+.||+|+||+||+|.+.+. .+++|+. .+...       ...+.+.+|+++++.++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            333334445567789999999999999987644 3444432 21111       12356788999999999999998888


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       814 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                      ++......++||||++|++|.+++.         ....++.+++++++|||   +.+++|||+||+||++ .++.++|+|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEe
Confidence            8777777899999999999999775         35678999999999999   9999999999999999 678999999


Q ss_pred             ecCCcc
Q 048205          894 FGMAKP  899 (1027)
Q Consensus       894 fgla~~  899 (1027)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999974

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.58  E-value=1e-14  Score=149.15  Aligned_cols=135  Identities=24%  Similarity=0.234  Sum_probs=98.3

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccch--hHHH----------------------HHHHHHHHhhccCCc--c
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR--AIKS----------------------FDIECGMIKRIRHRN--I  808 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  808 (1027)
                      .+.||+|+||.||+|+..+|+.||||++......  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998753211  1111                      134666666665443  4


Q ss_pred             ceEEeEEecCCeeEEEEEecCCCCHHH-HHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCC
Q 048205          809 IKFISSCSSDDFKALVLEYMPYGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDN  886 (1027)
Q Consensus       809 v~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~  886 (1027)
                      .+.+++    ...++||||++++.+.. .+....  .. .++..++.+++.++.++|   . .+|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444433    23589999999954321 111111  11 567789999999999999   7 9999999999999999 9


Q ss_pred             CcEEEeeecCCccc
Q 048205          887 MVAHLSDFGMAKPF  900 (1027)
Q Consensus       887 ~~~kl~Dfgla~~~  900 (1027)
                      +.++++|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            99999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=1.8e-16  Score=186.81  Aligned_cols=255  Identities=23%  Similarity=0.280  Sum_probs=197.3

Q ss_pred             CCCCccceeeccccceEEEEEecC--CceEEEEEEeccc--chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD--GMEVAVKVFDLQY--GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..|...+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-+.+. |+|++.+++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456777889999999998887543  3456666654332  223344445777777776 99999999999999999999


Q ss_pred             EEecCCCCHHHHH-hcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCccccc
Q 048205          825 LEYMPYGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLK  902 (1027)
Q Consensus       825 ~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~  902 (1027)
                      .||..|+++.+-+ +......+...+..++.|+..++.|+|.  ..++.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999988 5443346666778899999999999994  56899999999999999999 999999999998876


Q ss_pred             -CCCcceeccccc-CccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          903 -EDQSLTQTQTLA-TIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       903 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                       .+........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+............|...-          
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~----------  247 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK----------  247 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc----------
Confidence             555556666778 9999999998884 557788999999999999999999987755555445553311          


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                            .......+........++..+++..+|..|.+.+++.
T Consensus       248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence                  0001122234455567888999999999999988764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=2.7e-14  Score=140.51  Aligned_cols=135  Identities=21%  Similarity=0.263  Sum_probs=114.0

Q ss_pred             ccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccC--CccceEEeEEecCCeeEEEEEecCCC
Q 048205          754 ENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH--RNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       754 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      +.+.||+|.++.||+++..+ +.+++|+......  ...+..|+++++.++|  ..++++++++...+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999764 7899999865433  4578889999999987  58999999888888899999999987


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||++++++.++++|||.++.
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        4556777899999999999944346899999999999999999999999999873

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.55  E-value=3.1e-16  Score=170.88  Aligned_cols=173  Identities=28%  Similarity=0.452  Sum_probs=147.4

Q ss_pred             eecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCcccccc
Q 048205          470 FHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNL  549 (1027)
Q Consensus       470 l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l  549 (1027)
                      .+++.|.+. .+|..++.+..|+.+.|+.|.+. .+|++++++..|+.|||+.|+++              .+|..++.|
T Consensus        80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS--------------~lp~~lC~l  143 (722)
T KOG0532|consen   80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS--------------HLPDGLCDL  143 (722)
T ss_pred             hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh--------------cCChhhhcC
Confidence            344444444 67888888899999999999998 88999999999999999999985              456666665


Q ss_pred             CcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccccccc
Q 048205          550 KDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNL  629 (1027)
Q Consensus       550 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l  629 (1027)
                       -|+.|-+++|+++ .+|++++.+..|..||.|.|.+. .+|..++++.+|+.|++..|++. .+|++++.|+ |..||+
T Consensus       144 -pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDf  218 (722)
T KOG0532|consen  144 -PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDF  218 (722)
T ss_pred             -cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeec
Confidence             4788899999998 58999998899999999999997 68999999999999999999999 7898888665 899999


Q ss_pred             ccccccCCchhhhhcccCCcceeccCCCCCCCCCC
Q 048205          630 SNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       630 ~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~  664 (1027)
                      |.|+++ .||.+|.+|..|++|-|.+|+|..++.+
T Consensus       219 ScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq  252 (722)
T KOG0532|consen  219 SCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ  252 (722)
T ss_pred             ccCcee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence            999998 8999999999999999999999876543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.52  E-value=1.1e-13  Score=145.96  Aligned_cols=135  Identities=16%  Similarity=0.206  Sum_probs=105.4

Q ss_pred             cceee-ccccceEEEEEecCCceEEEEEEeccc-------------chhHHHHHHHHHHHhhccCCcc--ceEEeEEecC
Q 048205          755 NNLIG-RGGFGFVYKARIQDGMEVAVKVFDLQY-------------GRAIKSFDIECGMIKRIRHRNI--IKFISSCSSD  818 (1027)
Q Consensus       755 ~~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  818 (1027)
                      ...|| .|+.|+||.++.. +..+|||.+....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999999875 7789999885321             1123467789999999998875  6677665432


Q ss_pred             C----eeEEEEEecCC-CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          819 D----FKALVLEYMPY-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       819 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                      .    ..++||||++| .+|.+++...  .++..    .+.+++.++.+||   +.||+||||||+||+++.++.++++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 6999887653  24433    3568999999999   99999999999999999999999999


Q ss_pred             ecCCcc
Q 048205          894 FGMAKP  899 (1027)
Q Consensus       894 fgla~~  899 (1027)
                      ||.++.
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998874

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=1.7e-15  Score=165.32  Aligned_cols=182  Identities=33%  Similarity=0.420  Sum_probs=113.9

Q ss_pred             CCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCcccccccccccc
Q 048205          362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKY  441 (1027)
Q Consensus       362 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~  441 (1027)
                      .+.--...||+.|++. .+|..+..+..|+.+.|.+|.|. .+|..++++..|++|||+.|+++.+|..++++      -
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~l------p  144 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDL------P  144 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcC------c
Confidence            3445567788888887 78888888888888888888888 67888888888888888888888777766543      1


Q ss_pred             ccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeecc
Q 048205          442 LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLK  521 (1027)
Q Consensus       442 L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  521 (1027)
                      |+.                                                 |-+++|+++ .+|+.++.+.+|..||.+
T Consensus       145 Lkv-------------------------------------------------li~sNNkl~-~lp~~ig~~~tl~~ld~s  174 (722)
T KOG0532|consen  145 LKV-------------------------------------------------LIVSNNKLT-SLPEEIGLLPTLAHLDVS  174 (722)
T ss_pred             cee-------------------------------------------------EEEecCccc-cCCcccccchhHHHhhhh
Confidence            333                                                 333333333 344445555556666666


Q ss_pred             CceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCcccc
Q 048205          522 DNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ  601 (1027)
Q Consensus       522 ~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~  601 (1027)
                      .|++              ..+|+.++++.+|+.|++..|.+. .+|++++ .-.|..||+|.|+++ .||.+|..|+.|+
T Consensus       175 ~nei--------------~slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq  237 (722)
T KOG0532|consen  175 KNEI--------------QSLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQ  237 (722)
T ss_pred             hhhh--------------hhchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhhe
Confidence            6655              344445555555555555555444 2555555 224556666666665 4566666666666


Q ss_pred             EEEccCCccccCcccccc
Q 048205          602 YLFLKYNRLQGSIPDSIG  619 (1027)
Q Consensus       602 ~L~L~~N~l~g~ip~~~~  619 (1027)
                      +|-|.+|.|+ +.|..|+
T Consensus       238 ~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  238 VLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             eeeeccCCCC-CChHHHH
Confidence            6666666665 4555443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=3.6e-13  Score=154.47  Aligned_cols=141  Identities=20%  Similarity=0.215  Sum_probs=100.3

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccchhH----------------------------------------HHHH
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAI----------------------------------------KSFD  794 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  794 (1027)
                      .+.||.|++|.||+|+.++|+.||||+.+....+..                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999864321100                                        0234


Q ss_pred             HHHHHHhhcc----CCccceEEeEEe-cCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHH-HHHHhhcCCC
Q 048205          795 IECGMIKRIR----HRNIIKFISSCS-SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS-ALEYLHFGYS  868 (1027)
Q Consensus       795 ~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~  868 (1027)
                      +|++.+.+++    |.+-+.+-.++. -.+..++||||++|+++.++........   .+..++..+++ .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence            4555555553    333333333332 2345799999999999988764322112   23456666666 467888   8


Q ss_pred             CCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       869 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      .|++|+|+||.||+++.+++++++|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.42  E-value=1.9e-13  Score=164.08  Aligned_cols=118  Identities=34%  Similarity=0.584  Sum_probs=77.0

Q ss_pred             ccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccC
Q 048205          576 LVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSF  655 (1027)
Q Consensus       576 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~  655 (1027)
                      ++.|+|++|.++|.+|..++.|++|+.|+|++|+|+|.+|+.++.+++|+.|||++|+++|.+|.+++++++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            45666666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             CCCCCCCCCC--CCCCCcccccccCCccccCCCccccccccc
Q 048205          656 NKLEGEIPRE--GPFRNFSLESFKGNELLCGMPNLQVRSCRT  695 (1027)
Q Consensus       656 N~l~g~~p~~--~~~~~~~~~~~~~n~~l~g~~~~~~~~c~~  695 (1027)
                      |+++|.+|..  +.+.+.....+.||+.+||.|.  .+.|..
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~  539 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGP  539 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcc
Confidence            6666666652  1122333456889999999874  457853

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=3.1e-13  Score=155.66  Aligned_cols=155  Identities=37%  Similarity=0.513  Sum_probs=89.0

Q ss_pred             ccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCcccc
Q 048205          490 NLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLE  569 (1027)
Q Consensus       490 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  569 (1027)
                      +|+.|++++|++. .+|..++.+++|+.|++++|++              ..+|...+.+++|+.|++++|+++ .+|..
T Consensus       141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l--------------~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~  204 (394)
T COG4886         141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL--------------SDLPKLLSNLSNLNNLDLSGNKIS-DLPPE  204 (394)
T ss_pred             hcccccccccchh-hhhhhhhccccccccccCCchh--------------hhhhhhhhhhhhhhheeccCCccc-cCchh
Confidence            4444444444444 3334455555555555555555              234444445555555555555555 35555


Q ss_pred             ccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCc
Q 048205          570 IGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLK  649 (1027)
Q Consensus       570 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~  649 (1027)
                      +..+..|++|++++|++. .++..+..+.++..|.+++|++. .+|..++.+.++++|++++|+++ .++. ++.+.+++
T Consensus       205 ~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~  280 (394)
T COG4886         205 IELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLR  280 (394)
T ss_pred             hhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccC
Confidence            555555666666666433 35666666666666666666666 44666666666666666666666 3333 66666666


Q ss_pred             ceeccCCCCCCCCCC
Q 048205          650 DINVSFNKLEGEIPR  664 (1027)
Q Consensus       650 ~l~l~~N~l~g~~p~  664 (1027)
                      .|++++|.+...+|.
T Consensus       281 ~L~~s~n~~~~~~~~  295 (394)
T COG4886         281 ELDLSGNSLSNALPL  295 (394)
T ss_pred             EEeccCccccccchh
Confidence            666666666666554

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.34  E-value=1.3e-12  Score=150.53  Aligned_cols=71  Identities=32%  Similarity=0.445  Sum_probs=40.0

Q ss_pred             CccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCC
Q 048205          284 PKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS  357 (1027)
Q Consensus       284 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  357 (1027)
                      +..+.++.++..+.+++|++... +..++.++++++|++++|+++.+.+  +..+.+++.|++++|.+....|.
T Consensus       225 ~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         225 LSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             chhhhhcccccccccCCceeeec-cchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence            34455555666666666666532 4555556666666666666665443  55556666666666655444433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.30  E-value=1.5e-11  Score=142.18  Aligned_cols=144  Identities=19%  Similarity=0.203  Sum_probs=95.3

Q ss_pred             CCCCccceeeccccceEEEEEecC-CceEEEEEEecccch------------------------------h----HH---
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGR------------------------------A----IK---  791 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~------------------------------~----~~---  791 (1027)
                      ..|+. +.||.|++|.||+|++++ |+.||||+.++...+                              .    .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999887 999999999754211                              0    01   


Q ss_pred             ---HHHHHHHHHhhcc----CCccceEEeEEec-CCeeEEEEEecCCCCHHHH--HhcCCccCCHHHHHHHHHHHHH-HH
Q 048205          792 ---SFDIECGMIKRIR----HRNIIKFISSCSS-DDFKALVLEYMPYGSLEKC--LYSSNYILDIFQRLNIMIDVAS-AL  860 (1027)
Q Consensus       792 ---~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~~i~~-~l  860 (1027)
                         ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.+.  +...+  .+..   .++...++ -+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHH
Confidence               1333444444443    4444444444433 3457899999999999774  22222  2211   12222222 12


Q ss_pred             HHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecCCccccc
Q 048205          861 EYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAKPFLK  902 (1027)
Q Consensus       861 ~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~  902 (1027)
                      ..++   ..|++|+|+||.||+++.+|    +++++|||++..+..
T Consensus       274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3334   67999999999999999988    999999999987643

>PLN03150 hypothetical protein; Provisional

Probab=99.30  E-value=2.5e-12  Score=154.50  Aligned_cols=114  Identities=35%  Similarity=0.492  Sum_probs=105.4

Q ss_pred             cccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccc
Q 048205          551 DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLS  630 (1027)
Q Consensus       551 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~  630 (1027)
                      .++.|+|++|.++|.+|.+++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCchhhhhcc-cCCcceeccCCCCCCCCCC
Q 048205          631 NNNLFGIIPISLEKL-LDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       631 ~N~l~~~~p~~l~~l-~~L~~l~l~~N~l~g~~p~  664 (1027)
                      +|+++|.+|..+..+ ..+..+++++|.....+|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            999999999999875 4678899999985444553

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=4.7e-12  Score=142.11  Aligned_cols=248  Identities=21%  Similarity=0.230  Sum_probs=183.7

Q ss_pred             CCCccceeec--cccceEEEEEe--c-CCceEEEEEEecccc--hhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeE
Q 048205          751 GFSENNLIGR--GGFGFVYKARI--Q-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       751 ~f~~~~~lG~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  822 (1027)
                      .|.+...+|.  |.+|.||.++.  + ++..+|+|.-+....  ...+.-.+|+...++++ |++.++.+..+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4666788999  99999999986  3 688999997443222  22333445666666664 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCC
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMA  897 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla  897 (1027)
                      +-+|++. .++.++.+.....++....+.+..+..+    |+.++|   ..+++|-|+||.||+...+ ...+++|||+.
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            9999996 5899988887777888889999999999    999999   9999999999999999999 88999999999


Q ss_pred             cccccCCCcc---eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          898 KPFLKEDQSL---TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       898 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      ..+....-..   ......|...|++||...+ -++.+.|+|++|.+..+..++..++....     ...|..       
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~-------  337 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQ-------  337 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccc-------
Confidence            8775443111   1112246778999998764 56788999999999999999877654321     111211       


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         .+....  .   .+.-..-..++...+..|++.+|..|++++.+.+
T Consensus       338 ---~r~~~i--p---~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 ---LRQGYI--P---LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ---cccccC--c---hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence               011110  0   0011122344555888999999999999988764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=2.1e-11  Score=122.58  Aligned_cols=127  Identities=22%  Similarity=0.203  Sum_probs=96.2

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccc-eEEeEEecCCeeEEEEEecCCCCH
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII-KFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+..|+++++.+.+.+++ +++++..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467899999999999865 77899999764432 223567899999998766554 4554433  335899999999887


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP-----IIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      .+.    .     .....++.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            653    0     112345678999999999   666     59999999999999 6789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.24  E-value=1.4e-12  Score=138.87  Aligned_cols=214  Identities=26%  Similarity=0.292  Sum_probs=163.2

Q ss_pred             cCCccCcCCCCCcEEEccCCcccccCC--ccccccCCCcEEEccccccc--eeCcccccCCCCCCEEEccCcccCCccCc
Q 048205           17 KIPSTLSNCKRLRNISLSLNDFSGTIP--KEIGNVTTLIGLHLRGNKLQ--GEIPEELGNLAELEELWLQNNFLTGTIPS   92 (1027)
Q Consensus        17 ~~~~~~~~~~~L~~L~L~~n~l~~~~p--~~i~~l~~L~~L~L~~n~i~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~   92 (1027)
                      .+.+.-.++++|++..|.+..+. ..+  .....+++++.||||.|-+.  ..+......+++|+.|+|+.|++......
T Consensus       112 ki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s  190 (505)
T KOG3207|consen  112 KIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS  190 (505)
T ss_pred             HHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc
Confidence            34444578899999999999987 344  36778999999999999876  23445567899999999999998732222


Q ss_pred             -cccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccC--ccccC
Q 048205           93 -SIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIP--KEIGN  169 (1027)
Q Consensus        93 -~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~  169 (1027)
                       .-..+++|+.|.|+.|.++..........+|+|+.|+|..|...........-++.|+.|||++|++. ..+  ...+.
T Consensus       191 ~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~  269 (505)
T KOG3207|consen  191 NTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGT  269 (505)
T ss_pred             cchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-cccccccccc
Confidence             22357899999999999997667778888999999999999654455666777889999999999987 333  45778


Q ss_pred             CCCCcEEEccCccCCCCC-Chh-----ccCCCCCCeeeccccccCCC-CCccccCCCCCCEEEccCccCC
Q 048205          170 LTKLKYLHLDQNRLQGEI-PEE-----LGNLAELEKLQLQNNFLTGT-IPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       170 l~~L~~L~L~~N~l~~~~-p~~-----~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      ++.|+.|+++.+.+..+- |+.     ...+++|++|++..|+|... .-..+..+.+|+.|....|.++
T Consensus       270 l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  270 LPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            999999999999987543 222     24568899999999988632 1134556677777777777775

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.2e-11  Score=126.79  Aligned_cols=201  Identities=21%  Similarity=0.311  Sum_probs=138.9

Q ss_pred             HhhccCCccceEEeEEecCC-----eeEEEEEecCCCCHHHHHhcCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 048205          800 IKRIRHRNIIKFISSCSSDD-----FKALVLEYMPYGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPI  871 (1027)
Q Consensus       800 l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  871 (1027)
                      +-.+-|.|+|+++.|+.+..     +..++.|||..|++..++++.+   ..+......++..||..||.||| .|+..|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCcc
Confidence            44557999999999986543     5678999999999999987543   45667777889999999999999 458899


Q ss_pred             EeccCCCCcEEEcCCCcEEEeeecCCcccc--cCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCC
Q 048205          872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFL--KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK  949 (1027)
Q Consensus       872 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~  949 (1027)
                      +|+++.-.-|++..+|-+|+.--.-.....  ............+-++|.|||.-.....+.++|||+||....||..|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999999975321111000  000011112234678999999988888888999999999999999886


Q ss_pred             CCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          950 KPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       950 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .--..+......             .+-+...........          =..++.+|+...|..||+|++++.+
T Consensus       280 iq~tnseS~~~~-------------ee~ia~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  280 IQSTNSESKVEV-------------EENIANVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eccCCCcceeeh-------------hhhhhhheeeccCcc----------ccCcCcccccCCCCCCcchhhhhcC
Confidence            542222111100             011111111111110          1246789999999999999998754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.20  E-value=1.5e-10  Score=130.97  Aligned_cols=166  Identities=18%  Similarity=0.236  Sum_probs=129.2

Q ss_pred             ecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHH
Q 048205          771 IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL  850 (1027)
Q Consensus       771 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~  850 (1027)
                      ..++.+|.|.+++...........+-++.++.+|||+|+++++.+.+++..|+|+|-+.  -|..++..    +......
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence            44788999999886665556667788889999999999999999999999999999986  46666665    3355667


Q ss_pred             HHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCC
Q 048205          851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS  930 (1027)
Q Consensus       851 ~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  930 (1027)
                      ..+.||+.||.|||+  +.+++|+++.-..|+++..|+.||++|.++........  ......--..|..|+.+....  
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence            788999999999984  67899999999999999999999999998875432221  111111223366676544333  


Q ss_pred             cchhHHHHHHHHHHHHcC
Q 048205          931 TNGDVYSFGIMLMETFTR  948 (1027)
Q Consensus       931 ~~~DvwslGvil~elltg  948 (1027)
                      -..|.|-|||+++|++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            246999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=3.8e-10  Score=113.24  Aligned_cols=135  Identities=20%  Similarity=0.184  Sum_probs=98.9

Q ss_pred             ceeeccccceEEEEEecC-------CceEEEEEEeccc----------------------chhHHHH----HHHHHHHhh
Q 048205          756 NLIGRGGFGFVYKARIQD-------GMEVAVKVFDLQY----------------------GRAIKSF----DIECGMIKR  802 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~l~~  802 (1027)
                      ..||.|.-+.||.|...+       +..+|||+++...                      ....+.+    ++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997543       4799999875321                      0112233    379999999


Q ss_pred             ccC--CccceEEeEEecCCeeEEEEEecCCCCHHH-HHhcCCccCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccCCC
Q 048205          803 IRH--RNIIKFISSCSSDDFKALVLEYMPYGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVPIIHCDLKP  878 (1027)
Q Consensus       803 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp  878 (1027)
                      +..  -++.+++++    ...++||||+.++.+.. .+..  ..++..+...+..+++.++.++ |   ..++||||+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            864  356666754    44689999997754422 2222  2244556677889999999999 8   88999999999


Q ss_pred             CcEEEcCCCcEEEeeecCCccc
Q 048205          879 NNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       879 ~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .||+++ ++.+.++|||.|...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 578999999988743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.16  E-value=5.2e-12  Score=145.52  Aligned_cols=161  Identities=27%  Similarity=0.267  Sum_probs=101.1

Q ss_pred             CcCCccceeccCccccccCC-ccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCC--C
Q 048205          289 NLAKLEKLDLQFNRLQCVIP-HEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLP--N  365 (1027)
Q Consensus       289 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~--~  365 (1027)
                      .++.|+.+++++|++..+.+ . ...+.+++.+++++|.+..+.  .+..+..+..+++..|.+...-+..   .+.  .
T Consensus       160 ~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~~~~l~---~~~~~~  233 (414)
T KOG0531|consen  160 SLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISKLEGLN---ELVMLH  233 (414)
T ss_pred             cchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc--chHHHHHHHHhhcccccceeccCcc---cchhHH
Confidence            35566666666666664433 2 456666777777777765432  2333444555577777764322211   122  3


Q ss_pred             ccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEe
Q 048205          366 LEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYF  445 (1027)
Q Consensus       366 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L  445 (1027)
                      |+.+++++|++. .++..+..+..+..|++.+|++...  ..+.....+..+.+..|.+...............++++..
T Consensus       234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (414)
T KOG0531|consen  234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL  310 (414)
T ss_pred             HHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence            788888888886 4446677788888888888888754  3456677788888888887644333332224566778888


Q ss_pred             eccCCCCCCCCCc
Q 048205          446 SISNNPLGGILPR  458 (1027)
Q Consensus       446 ~Ls~N~l~~~~~~  458 (1027)
                      ++..|++....+.
T Consensus       311 ~~~~~~~~~~~~~  323 (414)
T KOG0531|consen  311 TLELNPIRKISSL  323 (414)
T ss_pred             ccccCcccccccc
Confidence            8888887765443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=3.1e-12  Score=132.83  Aligned_cols=110  Identities=22%  Similarity=0.326  Sum_probs=54.4

Q ss_pred             CCCcEEEccCCcCCcc----CcccccCCCCCcEEEccCCcccc----ccCccccCCCCCcEEEccCccCCCC----CChh
Q 048205          123 PLLQTLFLDENNFDGK----IPSTLLRCKHLQTLSLSINDFSG----DIPKEIGNLTKLKYLHLDQNRLQGE----IPEE  190 (1027)
Q Consensus       123 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~  190 (1027)
                      +.|+.+..++|++..-    +...|...+.|+.+.++.|.|..    .+...|..++.|+.|||.+|-++..    +.+.
T Consensus       157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Laka  236 (382)
T KOG1909|consen  157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKA  236 (382)
T ss_pred             cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHH
Confidence            3455555555554421    12334444555555555555531    1223445555555555555555432    2234


Q ss_pred             ccCCCCCCeeeccccccCCCCCcccc-----CCCCCCEEEccCccCC
Q 048205          191 LGNLAELEKLQLQNNFLTGTIPPSIF-----NLSSLSDLELSFNSLT  232 (1027)
Q Consensus       191 ~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~  232 (1027)
                      ++.++.|+.|++++|.++..-..+|.     ..++|++|.+.+|.|+
T Consensus       237 L~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  237 LSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             hcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            45555666666666666543322221     2456666666666665

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.13  E-value=1.1e-11  Score=132.20  Aligned_cols=176  Identities=26%  Similarity=0.268  Sum_probs=124.8

Q ss_pred             EEccccccceeCcccc----cCCCCCCEEEccCcccCCccC--ccccCCCCCCeEeCCcccccc-cchhhhhcCCCCCcE
Q 048205           55 LHLRGNKLQGEIPEEL----GNLAELEELWLQNNFLTGTIP--SSIFNLSSLSNLDLSVNNLTG-ELLANICSNLPLLQT  127 (1027)
Q Consensus        55 L~L~~n~i~~~~p~~l----~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~L~~  127 (1027)
                      +.+++-++....-+.+    +++++|++..|.+..+. ..+  .....+++++.||||.|-+.. .....+++.+|+|+.
T Consensus        98 ~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~  176 (505)
T KOG3207|consen   98 LSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN  176 (505)
T ss_pred             hhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence            3444555543333333    56788999999998887 333  356678999999999998863 345678889999999


Q ss_pred             EEccCCcCCccCcc-cccCCCCCcEEEccCCcccc-ccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeecccc
Q 048205          128 LFLDENNFDGKIPS-TLLRCKHLQTLSLSINDFSG-DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN  205 (1027)
Q Consensus       128 L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  205 (1027)
                      |+|+.|++..-..+ .-..+++|+.|.|+.|.++. .+......+++|+.|+|..|....+.......+..|+.|||++|
T Consensus       177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N  256 (505)
T KOG3207|consen  177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNN  256 (505)
T ss_pred             cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCC
Confidence            99999998732222 22357888999999998873 23334456788888999988644344455566778888889888


Q ss_pred             ccCCCCC--ccccCCCCCCEEEccCccCC
Q 048205          206 FLTGTIP--PSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       206 ~l~~~~p--~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      ++.. .+  ...+.++.|+.|+++.+.++
T Consensus       257 ~li~-~~~~~~~~~l~~L~~Lnls~tgi~  284 (505)
T KOG3207|consen  257 NLID-FDQGYKVGTLPGLNQLNLSSTGIA  284 (505)
T ss_pred             cccc-cccccccccccchhhhhccccCcc
Confidence            8873 33  35667788888888888876

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.12  E-value=2.7e-11  Score=122.46  Aligned_cols=137  Identities=23%  Similarity=0.261  Sum_probs=67.1

Q ss_pred             cccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecC
Q 048205          479 GSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLS  558 (1027)
Q Consensus       479 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls  558 (1027)
                      |..-..+..+..|++++|++|.|+ .+.+...-+++++.|++|+|.+.              .+ ..+..+.+|+.||||
T Consensus       274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~--------------~v-~nLa~L~~L~~LDLS  337 (490)
T KOG1259|consen  274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR--------------TV-QNLAELPQLQLLDLS  337 (490)
T ss_pred             CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee--------------ee-hhhhhcccceEeecc
Confidence            344444555666677777777666 45555666666666666666662              11 113344455555555


Q ss_pred             CCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcc--cccccccccccccccccccc
Q 048205          559 LNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP--DSIGDMINLKSLNLSNNNLF  635 (1027)
Q Consensus       559 ~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip--~~~~~l~~L~~L~l~~N~l~  635 (1027)
                      +|.++. +-..=.++.+.++|.|+.|.+..  -..++.|-+|.+||+++|+|. .+-  ..||+|+.|+++.|.+|.+.
T Consensus       338 ~N~Ls~-~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  338 GNLLAE-CVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             cchhHh-hhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCcc
Confidence            555442 22122233444445555554431  123444444555555555544 221  23444444444444444444

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.12  E-value=5.3e-12  Score=145.42  Aligned_cols=246  Identities=29%  Similarity=0.286  Sum_probs=130.2

Q ss_pred             ccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcE
Q 048205           48 NVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQT  127 (1027)
Q Consensus        48 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~  127 (1027)
                      .+..++.+++..|.|. .+-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|+|+.   ...+..++.|+.
T Consensus        70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~---i~~l~~l~~L~~  144 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITK---LEGLSTLTLLKE  144 (414)
T ss_pred             HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccc---ccchhhccchhh
Confidence            3455555556666665 233335555666666666666652 22225556666666666666652   122333444666


Q ss_pred             EEccCCcCCccCcccccCCCCCcEEEccCCccccccC-ccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccc
Q 048205          128 LFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIP-KEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNF  206 (1027)
Q Consensus       128 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  206 (1027)
                      |++++|.|+..  ..+..++.|+.+++++|.+....+ . ...+.+++.+++.+|.+..+  ..+..+..+..+++..|.
T Consensus       145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~  219 (414)
T KOG0531|consen  145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK  219 (414)
T ss_pred             heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence            66666666532  334446666666666666663322 1 45566666666666666522  333444445555666666


Q ss_pred             cCCCCCccccCCC--CCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCC
Q 048205          207 LTGTIPPSIFNLS--SLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIP  284 (1027)
Q Consensus       207 l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p  284 (1027)
                      ++...  .+..+.  +|+.+++++|++..               ++ .....+..+..+++++|++...           
T Consensus       220 i~~~~--~l~~~~~~~L~~l~l~~n~i~~---------------~~-~~~~~~~~l~~l~~~~n~~~~~-----------  270 (414)
T KOG0531|consen  220 ISKLE--GLNELVMLHLRELYLSGNRISR---------------SP-EGLENLKNLPVLDLSSNRISNL-----------  270 (414)
T ss_pred             ceecc--CcccchhHHHHHHhcccCcccc---------------cc-ccccccccccccchhhcccccc-----------
Confidence            65322  122222  26666666666641               10 1223445566666666666521           


Q ss_pred             ccccCcCCccceeccCcccccc---CCcc-ccCcCcccceeccCcccccccC
Q 048205          285 KEIGNLAKLEKLDLQFNRLQCV---IPHE-IDNLHNLEWMIFSFNKLVGVVP  332 (1027)
Q Consensus       285 ~~l~~l~~L~~L~L~~N~l~~~---~~~~-~~~l~~L~~L~Ls~N~l~~~~~  332 (1027)
                      ..+.....+..+.+..|.+...   .... ......++...+..|.+....+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  271 EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            1233345556666666665422   1111 4556677777777777765544

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=4.6e-11  Score=117.40  Aligned_cols=103  Identities=33%  Similarity=0.329  Sum_probs=33.6

Q ss_pred             CCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccC-cccccCCCCCcE
Q 048205           73 LAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKI-PSTLLRCKHLQT  151 (1027)
Q Consensus        73 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~  151 (1027)
                      +.+|+.|+|++|.|+..  ..+..++.|++|++++|+|+ .+...+...+|+|++|+|++|+|.... -..+..+++|+.
T Consensus        41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~  117 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV  117 (175)
T ss_dssp             -TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred             hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence            34444444444444421  12444444445555555444 222222233455555555555554321 134566777777


Q ss_pred             EEccCCcccccc---CccccCCCCCcEEEc
Q 048205          152 LSLSINDFSGDI---PKEIGNLTKLKYLHL  178 (1027)
Q Consensus       152 L~Ls~N~l~~~~---p~~~~~l~~L~~L~L  178 (1027)
                      |+|.+|++....   ...+..+++|+.||-
T Consensus       118 L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen  118 LSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             eeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            777777776321   123556777777764

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.09  E-value=5.6e-12  Score=130.94  Aligned_cols=144  Identities=22%  Similarity=0.277  Sum_probs=99.5

Q ss_pred             CCCCCcEEEccCCcccc----ccCccccCCCCCcEEEccCccCCCC----CChhccCCCCCCeeeccccccCCC----CC
Q 048205          145 RCKHLQTLSLSINDFSG----DIPKEIGNLTKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQNNFLTGT----IP  212 (1027)
Q Consensus       145 ~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p  212 (1027)
                      .-+.|+++...+|++..    .+...|...+.|+.+.+++|.|...    +...|..+++|++|||++|.++..    +.
T Consensus       155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La  234 (382)
T KOG1909|consen  155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA  234 (382)
T ss_pred             CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence            45688999999998863    2344577778899999999988632    223577888999999999988743    33


Q ss_pred             ccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCC
Q 048205          213 PSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAK  292 (1027)
Q Consensus       213 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~  292 (1027)
                      ..+..+++|+.|++++|.+...          ....+-..+-...|.|+.|.+.+|.++..--.     .+-..+...+.
T Consensus       235 kaL~s~~~L~El~l~dcll~~~----------Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~-----~la~~~~ek~d  299 (382)
T KOG1909|consen  235 KALSSWPHLRELNLGDCLLENE----------GAIAFVDALKESAPSLEVLELAGNEITRDAAL-----ALAACMAEKPD  299 (382)
T ss_pred             HHhcccchheeecccccccccc----------cHHHHHHHHhccCCCCceeccCcchhHHHHHH-----HHHHHHhcchh
Confidence            4566778899999999988621          11122223334567889999999988843111     12223455788


Q ss_pred             ccceeccCccc
Q 048205          293 LEKLDLQFNRL  303 (1027)
Q Consensus       293 L~~L~L~~N~l  303 (1027)
                      |..|+|++|++
T Consensus       300 L~kLnLngN~l  310 (382)
T KOG1909|consen  300 LEKLNLNGNRL  310 (382)
T ss_pred             hHHhcCCcccc
Confidence            99999999998

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.08  E-value=7.7e-11  Score=115.81  Aligned_cols=108  Identities=31%  Similarity=0.387  Sum_probs=24.2

Q ss_pred             CCCCCcEEEccCCcccccCCcccc-ccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccc-cCCCCCC
Q 048205           24 NCKRLRNISLSLNDFSGTIPKEIG-NVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSI-FNLSSLS  101 (1027)
Q Consensus        24 ~~~~L~~L~L~~n~l~~~~p~~i~-~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~  101 (1027)
                      +..++++|+|++|.|+ .+ +.++ .+.+|+.|+|++|+|+ .+. .+..+++|++|++++|+|+.. ...+ ..+++|+
T Consensus        17 n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~   91 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQ   91 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred             cccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCcc-ccchHHhCCcCC
Confidence            3334455555555554 22 2233 3445555555555554 222 244455555555555555422 2222 2345555


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCcCC
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD  136 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~  136 (1027)
                      +|++++|+|...-.-...+.+++|+.|+|.+|.+.
T Consensus        92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             EEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            55555555543222233444555555555555544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.4e-09  Score=104.60  Aligned_cols=130  Identities=23%  Similarity=0.359  Sum_probs=101.6

Q ss_pred             ceeeccccceEEEEEecCCceEEEEE-Eecccc-------hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          756 NLIGRGGFGFVYKARIQDGMEVAVKV-FDLQYG-------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ..+++|+-+.+|.+.+. |..+++|. +.+...       -......+|++++.+++--.|...+-+..+++...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 34466664 322221       1234566799999999877777666677777888999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ++|..|.+.+...        +..++..+=.-+.-||   ..||||+|+.++||.+..++ +.++|||++.
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            9998888888764        2456677778889999   99999999999999997765 9999999987

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=8.3e-11  Score=132.21  Aligned_cols=243  Identities=19%  Similarity=0.140  Sum_probs=171.1

Q ss_pred             hCCCCccceeeccccceEEEEEec--CCceEEEEEEecccchhHHHH--HHHHHHHhhc-cCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYGRAIKSF--DIECGMIKRI-RHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..+|..+..||.|.|+.|+.+..+  ++..|++|...........++  ..|+.+...+ .|.+++..+..+...+..|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            456888999999999999998744  678899997653322222221  2344444444 48889988888888888889


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCCccccc
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~  902 (1027)
                      --||+++++...... -...+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.+..+..
T Consensus       344 p~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             chhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccce
Confidence            999999998877652 2234778888999999999999999   9999999999999999886 8889999999874321


Q ss_pred             CCCcceecccccCcccc--CcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          903 EDQSLTQTQTLATIGYM--APEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..     ....+.-++.  +++......+..++|++|||.-+.|.++|..--...       ..|..             
T Consensus       420 ~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~~~-------------  474 (524)
T KOG0601|consen  420 SS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQSLT-------------  474 (524)
T ss_pred             ec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc-------cccee-------------
Confidence            11     1112333344  555666677889999999999999999986542211       11111             


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          ......+.......++..+...+..+++..||.+.+...+
T Consensus       475 ----i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  475 ----IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             ----eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence                0001111112223456677788889999999998876543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.06  E-value=3.2e-11  Score=121.93  Aligned_cols=133  Identities=30%  Similarity=0.310  Sum_probs=98.8

Q ss_pred             CCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcE
Q 048205           96 NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKY  175 (1027)
Q Consensus        96 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  175 (1027)
                      ....|+++|||+|.|+ .+..+ ..-+|.++.|++++|.|..+  +.+..+++|+.||||+|.++ .+.++-..+-+++.
T Consensus       282 TWq~LtelDLS~N~I~-~iDES-vKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDES-VKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             hHhhhhhccccccchh-hhhhh-hhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            3457888888888887 34333 35578888888888888743  23778888888888888887 45556667788888


Q ss_pred             EEccCccCCCCCChhccCCCCCCeeeccccccCCCC-CccccCCCCCCEEEccCccCCCCC
Q 048205          176 LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTI-PPSIFNLSSLSDLELSFNSLTGNF  235 (1027)
Q Consensus       176 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~  235 (1027)
                      |.|++|.|...  ..++.+.+|+.||+++|+|.... -..+++++-|+++.|.+|.+.+..
T Consensus       357 L~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  357 LKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             eehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            88888888632  45677888888888888887432 246788888888888888887544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.06  E-value=3.8e-11  Score=141.07  Aligned_cols=251  Identities=23%  Similarity=0.265  Sum_probs=173.0

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ...++|.+.+.+-+|+++.++.++-. .|...++|+.....   ....+....+-.+.-..+||-++.....+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34567777888999999999988743 45555555543221   112222223333333345566666655555566789


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +|++|+.++++...++.... .+...+......+..+.+|||   ...+.|+|++|.|+++..+|..+++|||.......
T Consensus       881 L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccc
Confidence            99999999999999887653 344445556778889999999   88899999999999999999999999984432210


Q ss_pred             C-----------------------------CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 048205          903 E-----------------------------DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTD  953 (1027)
Q Consensus       903 ~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~  953 (1027)
                      .                             +.........+|+.|.|||...+.....++|+|+.|++++|.++|.+||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                             00011234468999999999999999999999999999999999999998


Q ss_pred             CCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHH
Q 048205          954 ESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAK 1019 (1027)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~ 1019 (1027)
                      ....... +                 ..+..........+...+....+++.+.+..+|.+|-.|.
T Consensus      1037 a~tpq~~-f-----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-F-----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhh-h-----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            7533211 1                 1111111122223344555677888888888998887664

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.05  E-value=1.4e-09  Score=114.68  Aligned_cols=142  Identities=17%  Similarity=0.170  Sum_probs=110.0

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccc-hhHHHHHHHHHHHhhccCC--ccceEEeEEecCC---eeEEEEEec
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHR--NIIKFISSCSSDD---FKALVLEYM  828 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~  828 (1027)
                      .+.++.|.++.||+++..+|+.+++|+...... .....+..|+++++.+++.  .+.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            357899999999999887778999998764322 1345678899999999764  4577787776643   568999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG------------------------------------------  866 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  866 (1027)
                      +|.++.+.+..  ..++......++.++++++++||..                                          
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99888775432  2367777778888888888888831                                          


Q ss_pred             -----------CCCCeEeccCCCCcEEEcC--CCcEEEeeecCCc
Q 048205          867 -----------YSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAK  898 (1027)
Q Consensus       867 -----------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~  898 (1027)
                                 ....++|+|++|.||+++.  ++.+.++||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                       0245799999999999998  6678999999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=9.2e-09  Score=109.62  Aligned_cols=259  Identities=14%  Similarity=0.078  Sum_probs=162.1

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeE------Eec-CCeeEEE
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISS------CSS-DDFKALV  824 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~-~~~~~lV  824 (1027)
                      ...+.+|+|+-+.+|-.-  +-...+.|+++........+.   +.++.+. .||-+-.-+.+      ... .....+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            346789999999998642  223345688876543322222   2223333 46533221111      111 2236788


Q ss_pred             EEecCCCCHHHHHhcC------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          825 LEYMPYGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      |..++|..=-..+.+.      -.-.+|...++++..+|.+.+.||   +.|.+-+|+.++|+|+++++.|.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            8888765222222211      134789999999999999999999   9999999999999999999999999855433


Q ss_pred             ccccCCCcceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcC-CCCCCCCcccc---hhHH-HHHHH
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGE---MTLK-RWVND  968 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~---~~~~-~~~~~  968 (1027)
                      ..   ......-..+|...|.+||...     +...+...|.|.+||++++++.| ++||.+.....   .... .... 
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-  241 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-  241 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-
Confidence            22   2223344557899999999754     33456778999999999999987 99997653211   1111 0000 


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccC--CCCCCCHHHHHHHhh
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIES--PEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~d--P~~Rps~~evl~~L~ 1026 (1027)
                         ..+..--+........+........++++..+..+|+...  |.-||+++-.+..|.
T Consensus       242 ---g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~  298 (637)
T COG4248         242 ---GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD  298 (637)
T ss_pred             ---ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence               0011111222222222222334556778889999999764  678999998887764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.97  E-value=6.6e-09  Score=99.11  Aligned_cols=141  Identities=20%  Similarity=0.220  Sum_probs=105.9

Q ss_pred             ccceeeccccceEEEEEecCCceEEEEE-Eecccc-------hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          754 ENNLIGRGGFGFVYKARIQDGMEVAVKV-FDLQYG-------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       754 ~~~~lG~G~~g~V~~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ...++-+|+-+.|+++.+. |+.+.||. +.+.+.       -..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999876 67777774 333221       12356778999999988767666555666666678999


Q ss_pred             EecCC-CCHHHHHhcCCccCCHHHH-HHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeeecCCc
Q 048205          826 EYMPY-GSLEKCLYSSNYILDIFQR-LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFGMAK  898 (1027)
Q Consensus       826 e~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~  898 (1027)
                      ||++| .++.+++......-..... ..++..|-+.+.-||   ..+|+|+|+..+||++..++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 4777777654322222333 678889999999999   99999999999999997655   45899999986

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=1.9e-08  Score=100.76  Aligned_cols=124  Identities=27%  Similarity=0.287  Sum_probs=82.0

Q ss_pred             eEEEEEecCCceEEEEEEecccc--------------------------hhHHHHHHHHHHHhhccCC--ccceEEeEEe
Q 048205          765 FVYKARIQDGMEVAVKVFDLQYG--------------------------RAIKSFDIECGMIKRIRHR--NIIKFISSCS  816 (1027)
Q Consensus       765 ~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  816 (1027)
                      .||.|...+|..+|||+.+....                          .......+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988999999999853210                          0123456799999999876  456666442 


Q ss_pred             cCCeeEEEEEecC--CCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          817 SDDFKALVLEYMP--YGSLEKCLYSSNYILDIFQRLNIMIDVASALEY-LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       817 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                         ..++||||++  |..+..+... .  ++......++.+++..+.. +|   ..|++|+|+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               2479999998  6555443322 1  1123445677788885555 57   8999999999999999887 999999


Q ss_pred             ecCCcc
Q 048205          894 FGMAKP  899 (1027)
Q Consensus       894 fgla~~  899 (1027)
                      ||.+..
T Consensus       150 f~qav~  155 (188)
T PF01163_consen  150 FGQAVD  155 (188)
T ss_dssp             GTTEEE
T ss_pred             cCccee
Confidence            998874

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.78  E-value=4.1e-09  Score=129.39  Aligned_cols=84  Identities=32%  Similarity=0.288  Sum_probs=43.0

Q ss_pred             CCCcEEEccCCcccccCCccccccCCCcEEEccccc--cceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeE
Q 048205           26 KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK--LQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNL  103 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~--i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  103 (1027)
                      ...+...+.+|.+. .++....+ +.|++|-+.+|.  +.....+.|..++.|+.|||++|.=-+.+|..++.|.+||+|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            45555555555554 34433322 245555555554  332333345555555555555554444555555555555555


Q ss_pred             eCCccccc
Q 048205          104 DLSVNNLT  111 (1027)
Q Consensus       104 ~Ls~N~l~  111 (1027)
                      +|++..++
T Consensus       601 ~L~~t~I~  608 (889)
T KOG4658|consen  601 DLSDTGIS  608 (889)
T ss_pred             cccCCCcc
Confidence            55555554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=1e-07  Score=101.57  Aligned_cols=139  Identities=15%  Similarity=0.056  Sum_probs=100.1

Q ss_pred             ceeeccccceEEEEEecCCceEEEEEEecccc-----------hhHHHHHHHHHHHhhccCCcc--ceEEeEEec-----
Q 048205          756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG-----------RAIKSFDIECGMIKRIRHRNI--IKFISSCSS-----  817 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----  817 (1027)
                      +.+-+.....|+++.+ +|+.|.||.......           .....+.+|.+.+.++...+|  ++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444455667655 578899997643221           111247789999888864443  345556543     


Q ss_pred             CCeeEEEEEecCCC-CHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-------CCc
Q 048205          818 DDFKALVLEYMPYG-SLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-------NMV  888 (1027)
Q Consensus       818 ~~~~~lV~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~  888 (1027)
                      ...-++|+|++++. +|.+++... ....+...+..++.+++..+.-||   +.||+|+|++++||+++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23568999999886 798887532 233456677789999999999999   999999999999999975       468


Q ss_pred             EEEeeecCCc
Q 048205          889 AHLSDFGMAK  898 (1027)
Q Consensus       889 ~kl~Dfgla~  898 (1027)
                      +.++||+.++
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999886

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.77  E-value=4.6e-08  Score=99.94  Aligned_cols=134  Identities=24%  Similarity=0.204  Sum_probs=98.2

Q ss_pred             CCccceeeccccceEEEEEecCCceEEEEEEecccc----------------------hhHHHHHHHHHHHhhccCC--c
Q 048205          752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG----------------------RAIKSFDIECGMIKRIRHR--N  807 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--n  807 (1027)
                      +.++..||.|.-+.||.|....|.++|||.-+....                      -.....++|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345678999999999999999999999996432100                      0223456799999998755  5


Q ss_pred             cceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 048205          808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  887 (1027)
Q Consensus       808 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  887 (1027)
                      |.+.+++    +..++||||++|-.|...-      ++......++..|++-+.-.-   ..||||+|+.+-||++++||
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            6666543    4568999999997665532      123334445555666555555   67899999999999999999


Q ss_pred             cEEEeeecCCc
Q 048205          888 VAHLSDFGMAK  898 (1027)
Q Consensus       888 ~~kl~Dfgla~  898 (1027)
                      .+.++||--+.
T Consensus       240 ~~~vIDwPQ~v  250 (304)
T COG0478         240 DIVVIDWPQAV  250 (304)
T ss_pred             CEEEEeCcccc
Confidence            99999997665

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.76  E-value=2.9e-07  Score=101.19  Aligned_cols=166  Identities=19%  Similarity=0.220  Sum_probs=125.2

Q ss_pred             cceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec----CCeeEEEEEecCCC-CHHHH
Q 048205          763 FGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS----DDFKALVLEYMPYG-SLEKC  836 (1027)
Q Consensus       763 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~g-sL~~~  836 (1027)
                      ..+.|+|... ||..|++|+++............-+++++++.|+|+|++.+++..    +...++||+|.++. +|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999754 899999999964433333233446788999999999999988863    34678999998764 66665


Q ss_pred             Hhc--------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          837 LYS--------------SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       837 l~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      -..              .+...++...|.++.|+..||.++|   +.|...+-+.|.+|+++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            321              1234678899999999999999999   99999999999999999999999998887664433


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCC
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKK  950 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~  950 (1027)
                      +..                |.+.   --.+-|.-.+|.+++.+.||..
T Consensus       446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            220                1111   1235688999999999999853

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.75  E-value=5.9e-09  Score=84.22  Aligned_cols=61  Identities=43%  Similarity=0.697  Sum_probs=47.4

Q ss_pred             CCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCC
Q 048205          364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL  424 (1027)
Q Consensus       364 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  424 (1027)
                      |+|++|++++|+++...+..|.++++|++|++++|+++.+.|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4677788888888765556777788888888888888877777888888888888888764

...

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.73  E-value=1.1e-09  Score=98.50  Aligned_cols=138  Identities=23%  Similarity=0.254  Sum_probs=101.5

Q ss_pred             ccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccc-cCcccccEEcccccccccccch
Q 048205          514 KLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPT  592 (1027)
Q Consensus       514 ~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~n~l~~~~p~  592 (1027)
                      .+..+||++++|- .+          ...+..+.....|...+|++|.|.. +|+.| ...+.+++|+|++|.++ .+|+
T Consensus        28 E~h~ldLssc~lm-~i----------~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPe   94 (177)
T KOG4579|consen   28 ELHFLDLSSCQLM-YI----------ADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPE   94 (177)
T ss_pred             Hhhhcccccchhh-HH----------HHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchH
Confidence            3456677776661 11          1223334455566677888888885 55554 34558899999999998 6899


Q ss_pred             hhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCCCC
Q 048205          593 TIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREG  666 (1027)
Q Consensus       593 ~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~  666 (1027)
                      ++..++.|+.|+++.|.|. ..|..|..|.+|-.||..+|.+. +||..+---+.....++.++.+.+.-|.++
T Consensus        95 E~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl  166 (177)
T KOG4579|consen   95 ELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL  166 (177)
T ss_pred             HHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence            9999999999999999998 78888988999999999999987 777665444455666777888888777643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=6e-08  Score=111.73  Aligned_cols=141  Identities=20%  Similarity=0.204  Sum_probs=94.7

Q ss_pred             ceeeccccceEEEEEecCCceEEEEEEecccch------------------------------hHH----------HHHH
Q 048205          756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR------------------------------AIK----------SFDI  795 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------------------~~~----------~~~~  795 (1027)
                      ..|+.++-|.||+|++++|+.||||+.++...+                              ..+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            689999999999999999999999998643211                              011          2334


Q ss_pred             HHHHHhhcc----CCccceEEeEE-ecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHH-HHHhhcCCCC
Q 048205          796 ECGMIKRIR----HRNIIKFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA-LEYLHFGYSV  869 (1027)
Q Consensus       796 e~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~~~  869 (1027)
                      |...+.+++    ...-+.+-.+| +-....+++|||++|..+.+...-.....+.   ..++..++++ +..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHH---hc
Confidence            554455443    22223333333 2245578999999999888874222233453   3344444443 33333   56


Q ss_pred             CeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       870 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      |++|+|.+|.||+++.+|++.+.|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999999987643

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.70  E-value=1.1e-08  Score=82.61  Aligned_cols=60  Identities=37%  Similarity=0.550  Sum_probs=39.2

Q ss_pred             CccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccc
Q 048205          292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF  351 (1027)
Q Consensus       292 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  351 (1027)
                      +|++|++++|+|+.+.+..|.++++|++|++++|+++.+.+.+|.++++|++|++++|++
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            456666666666666666666666666666666666666666666666666666666653

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.67  E-value=1e-08  Score=125.85  Aligned_cols=130  Identities=26%  Similarity=0.332  Sum_probs=100.4

Q ss_pred             cCCccceeccCccccccCCccccCcCcccceeccCcc--cccccCccccccCCcceEEccCccccccCCCCccCCCCCcc
Q 048205          290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNK--LVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLE  367 (1027)
Q Consensus       290 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  367 (1027)
                      ....+...+-+|++..+ +....+ ++|+.|-+..|.  +..+.+..|..++.|+.|||++|.-.+.+|+... .+-+|+
T Consensus       522 ~~~~rr~s~~~~~~~~~-~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~-~Li~Lr  598 (889)
T KOG4658|consen  522 WNSVRRMSLMNNKIEHI-AGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG-ELVHLR  598 (889)
T ss_pred             hhheeEEEEeccchhhc-cCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh-hhhhhh
Confidence            35667777777777633 333322 368888888886  6666666678888999999998877677887764 678899


Q ss_pred             EEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCC
Q 048205          368 ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY  423 (1027)
Q Consensus       368 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  423 (1027)
                      +|+|++..++ .+|..+.++..|.+|++..+.-...+|.....|++|++|.+..-.
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            9999999887 789999999999999999888776777778889999999887765

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.52  E-value=2e-09  Score=121.24  Aligned_cols=126  Identities=33%  Similarity=0.358  Sum_probs=56.7

Q ss_pred             CCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEc
Q 048205           99 SLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL  178 (1027)
Q Consensus        99 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  178 (1027)
                      .|.+.+.++|.++  .......-++.|+.|+|++|+++...  .+..+++|++|||++|.+. .+|..=..-.+|..|.+
T Consensus       165 ~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeee
Confidence            3444455555543  12233344445555555555554221  4455555555555555554 22221111122555555


Q ss_pred             cCccCCCCCChhccCCCCCCeeeccccccCCCCC-ccccCCCCCCEEEccCccC
Q 048205          179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIP-PSIFNLSSLSDLELSFNSL  231 (1027)
Q Consensus       179 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l  231 (1027)
                      ++|.++..  ..+.++.+|+.||+++|-|.+--. ..+..+.+|+.|+|.+|.+
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl  291 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL  291 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence            55555421  234455555555555555543210 1233344555555555554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.51  E-value=1.6e-06  Score=88.04  Aligned_cols=152  Identities=22%  Similarity=0.208  Sum_probs=101.4

Q ss_pred             ccHHHHHHHhCCCCccceee---ccccceEEEEEecCCceEEEEEEecccch------------------------hHHH
Q 048205          740 FTYLELFQATNGFSENNLIG---RGGFGFVYKARIQDGMEVAVKVFDLQYGR------------------------AIKS  792 (1027)
Q Consensus       740 ~~~~~~~~~~~~f~~~~~lG---~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------------~~~~  792 (1027)
                      .+...+....++..+....|   .|.-+.||+|...++..+|||+++.....                        ....
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            45555666666666666555   55556899999888999999998643211                        1122


Q ss_pred             HHHHHHHHhhcc--CCccceEEeEEecCCeeEEEEEecCCCCHH-HHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 048205          793 FDIECGMIKRIR--HRNIIKFISSCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV  869 (1027)
Q Consensus       793 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL~-~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~  869 (1027)
                      ...|++-|+++.  +-.+.+.+++..    -.+||||+...... -.+.  +...+..+...+..++++.+.-|-  +..
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~--~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLY--KEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHH--Hhc
Confidence            345677777764  334445554433    37999999653110 0111  112333357778888888888887  148


Q ss_pred             CeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       870 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ++||+|++.-|||+. ++.+.|+|||-|...
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECcccccc
Confidence            999999999999999 889999999988743

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.50  E-value=8.1e-07  Score=101.88  Aligned_cols=138  Identities=20%  Similarity=0.225  Sum_probs=90.0

Q ss_pred             ceeeccccceEEEEEecCCceEEEEEEecccch-------------------------------hHH------HHHHHHH
Q 048205          756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-------------------------------AIK------SFDIECG  798 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------------------~~~------~~~~e~~  798 (1027)
                      +.||..+.|.||+|+.++|+.||||+-+.....                               ..+      +|..|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            679999999999999999999999997643211                               011      2333444


Q ss_pred             HHhh----ccCCc------cceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 048205          799 MIKR----IRHRN------IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS  868 (1027)
Q Consensus       799 ~l~~----l~h~n------iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~  868 (1027)
                      -..+    ++|-+      |.+++-.+  ...++++||||+|..+.|.-.-.+..++...+   +..+.++...+=  ..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qI--f~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQI--FK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHH--Hh
Confidence            3333    34545      33444333  34579999999999776653222223455443   334444322221  14


Q ss_pred             CCeEeccCCCCcEEEc----CCCcEEEeeecCCccc
Q 048205          869 VPIIHCDLKPNNVLLD----DNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       869 ~~ivH~Dlkp~NIll~----~~~~~kl~Dfgla~~~  900 (1027)
                      .|++|+|-+|.||+++    .++++.+.|||+....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            5899999999999998    3779999999998754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.50  E-value=5.2e-08  Score=111.26  Aligned_cols=152  Identities=16%  Similarity=0.157  Sum_probs=105.0

Q ss_pred             HHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc-------eecccccCccccCccccc
Q 048205          853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL-------TQTQTLATIGYMAPEYGR  925 (1027)
Q Consensus       853 ~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~  925 (1027)
                      +.+++.|+.|+|.  +.++||+.|.|++|.++..+..||+.|+++..........       ..........|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3456699999994  7899999999999999999999999999886543311110       011122456799999999


Q ss_pred             CCCCCcchhHHHHHHHHHHHH-cCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHH
Q 048205          926 EGRVSTNGDVYSFGIMLMETF-TRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLA 1004 (1027)
Q Consensus       926 ~~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li 1004 (1027)
                      +...+.++|+||+||++|.+. .|++-+........ ... .               ........+-.....+.++.+=+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~-~---------------~~~~~~~~~~~s~~~p~el~~~l  245 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSF-S---------------RNLLNAGAFGYSNNLPSELRESL  245 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-hhh-h---------------hcccccccccccccCcHHHHHHH
Confidence            988899999999999999999 45555544321110 000 0               00001111112245677888999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 048205         1005 MKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus      1005 ~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .+++..++..||++.++..
T Consensus       246 ~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  246 KKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHhcCCcccCcchhhhhc
Confidence            9999999999998776643

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.46  E-value=4.6e-08  Score=99.55  Aligned_cols=63  Identities=32%  Similarity=0.335  Sum_probs=32.1

Q ss_pred             CCCCcEEEccCccCCC--CCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          170 LTKLKYLHLDQNRLQG--EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       170 l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      .+.+++|||.+|+|+.  .+..-+.+++.|++|+|++|++...+...-..+.+|+.|-|.+..+.
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~  134 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLS  134 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCC
Confidence            3455566666666553  12223445666666666666665332211134456666666555553

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.46  E-value=2.1e-08  Score=90.49  Aligned_cols=137  Identities=23%  Similarity=0.169  Sum_probs=105.4

Q ss_pred             cceEEecCccccCchhHhhhc---ccccceeeccCceeecccCCCCCccccccccCcccccc-CcccEEecCCCccccCc
Q 048205          491 LIAIYLGVNKLNGSILIALGK---LKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNL-KDILCLNLSLNFFTGPL  566 (1027)
Q Consensus       491 L~~L~L~~N~l~~~~~~~~~~---l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~  566 (1027)
                      +..++|+++++. .++.+...   ...|+..+|++|.+              +.+|..+... +..+.|+|++|+++ .+
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~f--------------k~fp~kft~kf~t~t~lNl~~neis-dv   92 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGF--------------KKFPKKFTIKFPTATTLNLANNEIS-DV   92 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchh--------------hhCCHHHhhccchhhhhhcchhhhh-hc
Confidence            345566666665 34444444   45566668999988              4556665543 46788999999999 59


Q ss_pred             cccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcc
Q 048205          567 PLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKL  645 (1027)
Q Consensus       567 p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l  645 (1027)
                      |+++..++.|+.|++++|.|. ..|..|..|.+|.+|+..+|.+. .||-.+---+..-..++.++.+.+.-|..++.+
T Consensus        93 PeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~  169 (177)
T KOG4579|consen   93 PEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL  169 (177)
T ss_pred             hHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence            999999999999999999998 68999988999999999999999 788776555556667778889988877665544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1027
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-37
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-36
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-36
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-35
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-32
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-31
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-23
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-12
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
4fcg_A	328	Structure Of The Leucine-Rich Repeat Domain Of The		4e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		7e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		8e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		2e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		2e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-04
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		5e-04
3zyj_A	440	Netring1 In Complex With Ngl1 Length = 440		5e-04
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		5e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  152 bits (385), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 176/640 (27%), Positives = 249/640 (38%), Gaps = 116/640 (18%)
Query: 111 TGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNL 170
           +G++  + C NL  L    +  NNF   IP  L  C  LQ L +S N  SGD  + I   
Sbjct: 188 SGDVDVSRCVNLEFLD---VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 243
Query: 171 TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN-LSSLSDLELSFN 229
           T+LK L++  N+  G IP     L  L+ L L  N  TG IP  +     +L+ L+LS N
Sbjct: 244 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 301
Query: 230 SLTGNFPK----------DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLG 279
              G  P                N  S ELP      +  L+ + LS N F GE+P  L 
Sbjct: 302 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 361
Query: 280 NCTIPKEIGNLAKLEKLDLQFNRLQC-VIPHEIDNLHN-LEWMIFSFNKLVGVVPTTIFN 337
           N +        A L  LDL  N     ++P+   N  N L+ +    N   G +P T+ N
Sbjct: 362 NLS--------ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 413
Query: 338 VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR 397
            S L  L+L  N   G +PSS    L  L +L L  N   G IP  +     L TL L  
Sbjct: 414 CSELVSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 472
Query: 398 NSFSGFIPNTFGNLRNLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILP 457
           N  +G IP+   N  NL W+                            S+SNN L G +P
Sbjct: 473 NDLTGEIPSGLSNCTNLNWI----------------------------SLSNNRLTGEIP 504
Query: 458 RVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXX 517
           + IG L +++    + N++ SG+IP E+ +  +LI + L  N  N               
Sbjct: 505 KWIGRL-ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA 563
Query: 518 XXXXD---------------------------------NQLEGSIPDNLSFSCTLTSIPS 544
                                                 N+L    P N++          
Sbjct: 564 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 623
Query: 545 TLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLF 604
           T  N   ++ L++S N  +G +P EIG++  L  ++L  N+ S  IP  +G L+ L  L 
Sbjct: 624 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 683
Query: 605 LKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFGIIPISLEKLLDLKDINVSFNKLEGEIPR 664
           L  N+L G IP                         ++  L  L +I++S N L G IP 
Sbjct: 684 LSSNKLDGRIPQ------------------------AMSALTMLTEIDLSNNNLSGPIPE 719
Query: 665 EGPFRNFSLESFKGNELLCG--MPNLQVRSCRTRIHHTSS 702
            G F  F    F  N  LCG  +P     +     HH  S
Sbjct: 720 MGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRS 759

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  151 bits (382), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 149/459 (32%), Positives = 210/459 (45%), Gaps = 59/459 (12%)
Query: 1   LSNLEYLFLKSNMFHGKIPSTLSN-CKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRG 59
           L +L+YL L  N F G+IP  LS  C  L  + LS N F G +P   G+ + L  L L  
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 60  NKLQGEIPXXXXXXXXXXXXXXQN-NFLTGTIPXXXXXXXXXXXXXXXXXXX-TGELLAN 117
           N   GE+P               + N  +G +P                    +G +L N
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 118 ICSNLP-LLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYL 176
           +C N    LQ L+L  N F GKIP TL  C  L +L LS N  SG IP  +G+L+KL+ L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 177 HLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP 236
            L  N L+GEIP+EL  +  LE L L  N LTG IP  + N ++L+ + LS N LTG  P
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 237 K------DMHIV----NRLSAELPAKF--CNNIPFLEEIYLSKNMFYGEIPSDL------ 278
           K      ++ I+    N  S  +PA+   C ++ +L+   L+ N+F G IP+ +      
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD---LNTNLFNGTIPAAMFKQSGK 564
Query: 279 --------------GNCTIPKEI---GNLAKLEKL-DLQFNRLQCVIPHEI--------- 311
                          N  + KE    GNL + + +   Q NRL    P  I         
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 312 ----DNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSS-ADVRLPNL 366
               DN  ++ ++  S+N L G +P  I ++  L  L LG N   G +P    D+R   L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR--GL 682
Query: 367 EELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
             L LS N   G IP  +   + L+ ++L  N+ SG IP
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  151 bits (382), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 173/622 (27%), Positives = 244/622 (39%), Gaps = 114/622 (18%)
Query: 111 TGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNL 170
           +G++  + C NL  L    +  NNF   IP  L  C  LQ L +S N  SGD  + I   
Sbjct: 191 SGDVDVSRCVNLEFLD---VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246
Query: 171 TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN-LSSLSDLELSFN 229
           T+LK L++  N+  G IP     L  L+ L L  N  TG IP  +     +L+ L+LS N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 230 SLTGNFPK----------DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLG 279
              G  P                N  S ELP      +  L+ + LS N F GE+P  L 
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 280 NCTIPKEIGNLAKLEKLDLQFNRLQC-VIPHEIDNLHN-LEWMIFSFNKLVGVVPTTIFN 337
           N +        A L  LDL  N     ++P+   N  N L+ +    N   G +P T+ N
Sbjct: 365 NLS--------ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 338 VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR 397
            S L  L+L  N   G +PSS    L  L +L L  N   G IP  +     L TL L  
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 398 NSFSGFIPNTFGNLRNLKWLDLGDNYXXXXXXXXXXXXXXNCKYLEYFSISNNPLGGILP 457
           N  +G IP+   N  NL W+                            S+SNN L G +P
Sbjct: 476 NDLTGEIPSGLSNCTNLNWI----------------------------SLSNNRLTGEIP 507
Query: 458 RVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNXXXXXXXXXXXXXXX 517
           + IG L +++    + N++ SG+IP E+ +  +LI + L  N  N               
Sbjct: 508 KWIGRL-ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA 566
Query: 518 XXXXD---------------------------------NQLEGSIPDNLSFSCTLTSIPS 544
                                                 N+L    P N++          
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626
Query: 545 TLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLF 604
           T  N   ++ L++S N  +G +P EIG++  L  ++L  N+ S  IP  +G L+ L  L 
Sbjct: 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 686
Query: 605 LKYNRLQGSIPDSIGDMIXXXXXXXXXXXXFGIIPISLEKLLDLKDINVSFNKLEGEIPR 664
           L  N+L G IP                         ++  L  L +I++S N L G IP 
Sbjct: 687 LSSNKLDGRIPQ------------------------AMSALTMLTEIDLSNNNLSGPIPE 722
Query: 665 EGPFRNFSLESFKGNELLCGMP 686
            G F  F    F  N  LCG P
Sbjct: 723 MGQFETFPPAKFLNNPGLCGYP 744

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  151 bits (381), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 152/298 (51%), Gaps = 15/298 (5%)
Query: 738  RRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIK-SFDIE 796
            +RF+  EL  A++ FS  N++GRGGFG VYK R+ DG  VAVK    +  +  +  F  E
Sbjct: 26   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 797  CGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLY---SSNYILDIFQRLNIM 853
              MI    HRN+++    C +   + LV  YM  GS+  CL     S   LD  +R  I 
Sbjct: 86   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 854  IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            +  A  L YLH      IIH D+K  N+LLD+   A + DFG+AK    +D  +      
Sbjct: 146  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 914  ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG---EMTLKRWVNDLL 970
             TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D +      ++ L  WV  LL
Sbjct: 205  GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 971  LISIME-VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
                +E +VD +L  +       K++ +  +  +A+ CT  SP ER    E+V  L G
Sbjct: 265  KEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  147 bits (370), Expect = 4e-35,   Method: Composition-based stats.
 Identities = 102/298 (34%), Positives = 150/298 (50%), Gaps = 15/298 (5%)
Query: 738  RRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIK-SFDIE 796
            +RF+  EL  A++ F   N++GRGGFG VYK R+ DG  VAVK    +  +  +  F  E
Sbjct: 18   KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 797  CGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLY---SSNYILDIFQRLNIM 853
              MI    HRN+++    C +   + LV  YM  GS+  CL     S   LD  +R  I 
Sbjct: 78   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 854  IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            +  A  L YLH      IIH D+K  N+LLD+   A + DFG+AK    +D  +      
Sbjct: 138  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 914  ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG---EMTLKRWVNDLL 970
              IG++APEY   G+ S   DV+ +G+ML+E  T ++  D +      ++ L  WV  LL
Sbjct: 197  GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 971  LISIME-VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
                +E +VD +L  +       K++ +  +  +A+ CT  SP ER    E+V  L G
Sbjct: 257  KEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  136 bits (343), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 153/292 (52%), Gaps = 14/292 (4%)
Query: 739  RFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECG 798
            R   ++L +ATN F    LIG G FG VYK  ++DG +VA+K    +  + I+ F+ E  
Sbjct: 28   RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 799  MIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN---YILDIFQRLNIMID 855
             +   RH +++  I  C   +   L+ +YM  G+L++ LY S+     +   QRL I I 
Sbjct: 88   TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
             A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   + DQ+        T
Sbjct: 148  AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT-LKRW-VNDLLLIS 973
            +GY+ PEY  +GR++   DVYSFG++L E    +    +S   EM  L  W V       
Sbjct: 205  LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            + ++VD NL    DK    + + +    + A+KC   S E+R +  +++ KL
Sbjct: 265  LEQIVDPNL---ADK---IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  134 bits (336), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 97/292 (33%), Positives = 152/292 (52%), Gaps = 14/292 (4%)
Query: 739  RFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECG 798
            R   ++L +ATN F    LIG G FG VYK  ++DG +VA+K    +  + I+ F+ E  
Sbjct: 28   RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 799  MIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN---YILDIFQRLNIMID 855
             +   RH +++  I  C   +   L+ +YM  G+L++ LY S+     +   QRL I I 
Sbjct: 88   TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
             A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   +  Q+        T
Sbjct: 148  AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT-LKRW-VNDLLLIS 973
            +GY+ PEY  +GR++   DVYSFG++L E    +    +S   EM  L  W V       
Sbjct: 205  LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            + ++VD NL    DK    + + +    + A+KC   S E+R +  +++ KL
Sbjct: 265  LEQIVDPNL---ADK---IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/228 (34%), Positives = 115/228 (50%), Gaps = 19/228 (8%)
Query: 740 FTYLELFQATNGFSEN------NLIGRGGFGFVYKARIQDGMEVAVK----VFDLQYGRA 789
           F++ EL   TN F E       N +G GGFG VYK  + +   VAVK    + D+     
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 790 IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE---KCLYSSNYILDI 846
            + FD E  ++ + +H N+++ +   S  D   LV  YMP GSL     CL      L  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 132
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
           +  ++ + T  YMAPE  R G ++   D+YSFG++L+E  T     DE
Sbjct: 190 VMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/228 (34%), Positives = 114/228 (50%), Gaps = 19/228 (8%)
Query: 740 FTYLELFQATNGFSEN------NLIGRGGFGFVYKARIQDGMEVAVK----VFDLQYGRA 789
           F++ EL   TN F E       N +G GGFG VYK  + +   VAVK    + D+     
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 790 IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE---KCLYSSNYILDI 846
            + FD E  ++ + +H N+++ +   S  D   LV  YMP GSL     CL      L  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 132
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
           +   + + T  YMAPE  R G ++   D+YSFG++L+E  T     DE
Sbjct: 190 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/228 (34%), Positives = 113/228 (49%), Gaps = 19/228 (8%)
Query: 740 FTYLELFQATNGFSEN------NLIGRGGFGFVYKARIQDGMEVAVK----VFDLQYGRA 789
           F++ EL   TN F E       N +G GGFG VYK  + +   VAVK    + D+     
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 790 IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE---KCLYSSNYILDI 846
            + FD E  ++ + +H N+++ +   S  D   LV  YMP GSL     CL      L  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 126
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
           +   + + T  YMAPE  R G ++   D+YSFG++L+E  T     DE
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 3e-24,   Method: Composition-based stats.
 Identities = 71/198 (35%), Positives = 108/198 (54%), Gaps = 8/198 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG V++A    G +VAVK+   Q  +   +  F  E  ++KR+RH NI+ F+ + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            DLK  N+L+D      + DFG+++  LK    L       T  +MAPE  R+   +   
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 934 DVYSFGIMLMETFTRKKP 951
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 6e-24,   Method: Composition-based stats.
 Identities = 70/198 (35%), Positives = 109/198 (55%), Gaps = 8/198 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG V++A    G +VAVK+   Q  +   +  F  E  ++KR+RH NI+ F+ + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            +LK  N+L+D      + DFG+++  LK    L+      T  +MAPE  R+   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 934 DVYSFGIMLMETFTRKKP 951
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Composition-based stats.
 Identities = 76/228 (33%), Positives = 110/228 (48%), Gaps = 19/228 (8%)
Query: 740 FTYLELFQATNGFSEN------NLIGRGGFGFVYKARIQDGMEVAVK----VFDLQYGRA 789
           F++ EL   TN F E       N  G GGFG VYK  + +   VAVK    + D+     
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 790 IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE---KCLYSSNYILDI 846
            + FD E  +  + +H N+++ +   S  D   LV  Y P GSL     CL      L  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLSW 123
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
           +  ++ + T  Y APE  R G ++   D+YSFG++L+E  T     DE
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 49/288 (17%)
Query: 758  IGRGGFGFVYKAR------IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        +D M VAVK        A K F  E  ++  ++H +I+KF
Sbjct: 23   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYS---------------SNYILDIFQRLNIMIDV 856
               C   D   +V EYM +G L K L +               +   L + Q L+I   +
Sbjct: 83   YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 857  ASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            AS + YL   HF      +H DL   N L+  N++  + DFGM++     D       T+
Sbjct: 143  ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 914  ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS 973
              I +M PE     + +T  DV+SFG++L E FT  K            + W      +S
Sbjct: 197  LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ----LS 240
Query: 974  IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
              EV++      + +       C   V+++ + C    P++R+N KEI
Sbjct: 241  NTEVIEC---ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+  +        ++F  E  ++++ RH NI+ F+   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           + D+  A+V ++    SL K L+       +FQ ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRD 157
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           +K NN+ L + +   + DFG+A    +   S    Q   ++ +MAPE  R       S  
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVYS+GI+L E  T + P
Sbjct: 218 SDVYSYGIVLYELMTGELP 236

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVF----DLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
           +IG GGFG VY+A    G EVAVK      D    + I++   E  +   ++H NII   
Sbjct: 14  IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
             C  +    LV+E+   G L + L       DI   +N  + +A  + YLH    VPII
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPII 130
Query: 873 HCDLKPNNVLL--------DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
           H DLK +N+L+          N +  ++DFG+A    +E    T+        +MAPE  
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVI 186
Query: 925 REGRVSTNGDVYSFGIMLMETFTRKKP 951
           R    S   DV+S+G++L E  T + P
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 182
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 126 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 181
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 131 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 186
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 200
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 125 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 180
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 182
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 200
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 213
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 134 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 189
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 133 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 188
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIF 182
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 132 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 187
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L +    +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           ++GRG FG V KA+ +   +VA+K  + +  R  K+F +E   + R+ H NI+K   +C 
Sbjct: 16  VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
           +     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +IH 
Sbjct: 73  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 875 DLKPNNVLL-DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
           DLKP N+LL     V  + DFG A      D     T    +  +MAPE       S   
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 934 DVYSFGIMLMETFTRKKPTDE 954
           DV+S+GI+L E  TR+KP DE
Sbjct: 186 DVFSWGIILWEVITRRKPFDE 206

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           ++GRG FG V KA+ +   +VA+K  + +  R  K+F +E   + R+ H NI+K   +C 
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
           +     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +IH 
Sbjct: 72  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 875 DLKPNNVLL-DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
           DLKP N+LL     V  + DFG A      D     T    +  +MAPE       S   
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 934 DVYSFGIMLMETFTRKKPTDE 954
           DV+S+GI+L E  TR+KP DE
Sbjct: 185 DVFSWGIILWEVITRRKPFDE 205

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           ++    A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L ++    + DFG+A    +   S    Q   +I +MAPE  R       S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++E++PYGSL + L      +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH DL   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L ++    + DFG+A    +   S    Q   +I +MAPE  R       S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           ++    A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 80/289 (27%), Positives = 119/289 (41%), Gaps = 46/289 (15%)
Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        QD + VAVK        A K F  E  ++  ++H +I+KF
Sbjct: 21   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSN------------YILDIFQRLNIMIDVASA 859
               C   D   +V EYM +G L K L +                L   Q L+I   +A+ 
Sbjct: 81   YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 860  LEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
            + YL   HF      +H DL   N L+ +N++  + DFGM++     D       T+  I
Sbjct: 141  MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 917  GYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
             +M PE     + +T  DV+S G++L E FT  K            + W      +S  E
Sbjct: 195  RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQ----LSNNE 238
Query: 977  VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            V++      + +       C   V+ L + C    P  R N K I T L
Sbjct: 239  VIEC---ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L ++    + DFG+A    +   S    Q   +I +MAPE  R       S  
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 194 SDVYAFGIVLYELMTGQLP 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 94  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 210 SDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 218 SDVYAFGIVLYELMTGQLP 236

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 76  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 192 SDVYAFGIVLYELMTGQLP 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 195 SDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 195 SDVYAFGIVLYELMTGQLP 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 752 FSENNL-----IGRGGFGFVYKAR---IQD--GMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R   +QD  G  VAVK         ++ F+ E  ++K
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 802 RIRHRNIIKFISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            ++H NI+K+   C S   +   L++EY+PYGSL   L      +D  + L     +   
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT--LATIG 917
           +EYL    +   IH +L   N+L+++     + DFG+ K  L +D+   + +    + I 
Sbjct: 128 MEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIF 183
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + APE   E + S   DV+SFG++L E FT
Sbjct: 184 WYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 101 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 217 SDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSC 815
           IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTN 932
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 933 GDVYSFGIMLMETFTRKKP 951
            DVY+FGI+L E  T + P
Sbjct: 218 SDVYAFGIVLYELMTGQLP 236

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 118/277 (42%), Gaps = 38/277 (13%)
Query: 758  IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSC 815
            IGRG FG V+  R++ D   VAVK         +K+ F  E  ++K+  H NI++ I  C
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182  TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L   N L+ +  V  +SDFGM++       + +       + + APE    GR S+  DV
Sbjct: 239  LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK-- 993
            +SFGI+L ETF                          S+      NL + + + FV K  
Sbjct: 299  WSFGILLWETF--------------------------SLGASPYPNLSNQQTREFVEKGG 332
Query: 994  -----EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                 E C   VF L  +C    P +R +   I  +L
Sbjct: 333  RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 118/277 (42%), Gaps = 38/277 (13%)
Query: 758  IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSC 815
            IGRG FG V+  R++ D   VAVK         +K+ F  E  ++K+  H NI++ I  C
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182  TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L   N L+ +  V  +SDFGM++       + +       + + APE    GR S+  DV
Sbjct: 239  LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK-- 993
            +SFGI+L ETF                          S+      NL + + + FV K  
Sbjct: 299  WSFGILLWETF--------------------------SLGASPYPNLSNQQTREFVEKGG 332
Query: 994  -----EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                 E C   VF L  +C    P +R +   I  +L
Sbjct: 333  RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        QD M VAVK        A + F  E  ++  ++H++I++F
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 857
               C+      +V EYM +G L + L S              +   L + Q L +   VA
Sbjct: 86   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 858  SALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            + + YL   HF      +H DL   N L+   +V  + DFGM++     D      +T+ 
Sbjct: 146  AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 915  TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI 974
             I +M PE     + +T  DV+SFG++L E FT  K            + W      +S 
Sbjct: 200  PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSN 243
Query: 975  MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             E +D      + +       C   V+ +   C    P++R + K++  +L
Sbjct: 244  TEAIDC---ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        QD M VAVK        A + F  E  ++  ++H++I++F
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 857
               C+      +V EYM +G L + L S              +   L + Q L +   VA
Sbjct: 80   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 858  SALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            + + YL   HF      +H DL   N L+   +V  + DFGM++     D      +T+ 
Sbjct: 140  AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 915  TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI 974
             I +M PE     + +T  DV+SFG++L E FT  K            + W      +S 
Sbjct: 194  PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSN 237
Query: 975  MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             E +D      + +       C   V+ +   C    P++R + K++  +L
Sbjct: 238  TEAIDC---ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V+ A        QD M VAVK        A + F  E  ++  ++H++I++F
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 857
               C+      +V EYM +G L + L S              +   L + Q L +   VA
Sbjct: 109  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 858  SALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            + + YL   HF      +H DL   N L+   +V  + DFGM++     D      +T+ 
Sbjct: 169  AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 915  TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI 974
             I +M PE     + +T  DV+SFG++L E FT  K            + W      +S 
Sbjct: 223  PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSN 266
Query: 975  MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             E +D      + +       C   V+ +   C    P++R + K++  +L
Sbjct: 267  TEAIDC---ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 72/281 (25%), Positives = 128/281 (45%), Gaps = 31/281 (11%)
Query: 753  SENNLIGRGGFGFVYKARIQDG---MEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHR 806
            +   +IG G FG VYK  ++      EV V +  L+ G   K    F  E G++ +  H 
Sbjct: 47   TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 807  NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
            NII+     S      ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL   
Sbjct: 107  NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG--YMAPEYG 924
             ++  +H DL   N+L++ N+V  +SDFG+++  L++D   T T +   I   + APE  
Sbjct: 165  -NMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 925  REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
               + ++  DV+SFGI++ E  T  +      +    +K   +   L + M+        
Sbjct: 223  SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD-------- 274
Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                       C S ++ L M+C  +    R    +IV+ L
Sbjct: 275  -----------CPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 6/207 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VAVK+   +   +   F  E   + ++ H  ++KF   CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
           +    +V EY+  G L   L S    L+  Q L +  DV   + +L    S   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+D ++   +SDFGM + ++ +DQ ++   T   + + APE     + S+  DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 938 FGIMLMETFTR-KKPTDESFTGEMTLK 963
           FGI++ E F+  K P D     E+ LK
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 5/193 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V+     +  +VA+K    +   + + F  E  ++ ++ H  +++    C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                LV E+M +G L   L +   +      L + +DV   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 938 FGIMLMETFTRKK 950
           FG+++ E F+  K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 34/263 (12%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 275  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 817  SDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 333  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
            L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 389  LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV--A 992
            V+SFGI+L E  T+ +                     +    +V+  +L   ++ +    
Sbjct: 447  VWSFGILLTELTTKGR---------------------VPYPGMVNREVLDQVERGYRMPC 485
Query: 993  KEQCMSFVFNLAMKCTIESPEER 1015
              +C   + +L  +C  + PEER
Sbjct: 486  PPECPESLHDLMCQCWRKEPEER 508

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 34   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 151  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 211  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 251
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 252  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 139 IPSTLLRCKHLQTLSLS-INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAEL 197
           IPS+L    +L  L +  IN+  G IP  I  LT+L YL++    + G IP+ L  +  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 198 EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP----------KDMHIV-NRLS 246
             L    N L+GT+PPSI +L +L  +    N ++G  P            M I  NRL+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 247 AELPAKFCN-NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAK------------- 292
            ++P  F N N+ F++   LS+NM  G+     G+    ++I +LAK             
Sbjct: 188 GKIPPTFANLNLAFVD---LSRNMLEGDASVLFGSDKNTQKI-HLAKNSLAFDLGKVGLS 243
Query: 293 --LEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVP 332
             L  LDL+ NR+   +P  +  L  L  +  SFN L G +P
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 108/251 (43%), Gaps = 18/251 (7%)
Query: 438 NCKYLEYFSISN-NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYL 496
           N  YL +  I   N L G +P  I  L+Q +   ++ ++N+SG+IP  ++ +  L+ +  
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 497 GVNKLNXXXXXXXXXXXXXXXXXXXDNQLEGSIPDNL-SFSCTLTSIPSTLWNLKDILCL 555
             N L+                    N++ G+IPD+  SFS   TS             +
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS-------------M 179
Query: 556 NLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP 615
            +S N  TG +P    NL  L  +DLS N          G  K+ Q + L  N L   + 
Sbjct: 180 TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL- 237
Query: 616 DSIGDMIXXXXXXXXXXXXFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLES 675
             +G               +G +P  L +L  L  +NVSFN L GEIP+ G  + F + +
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297
Query: 676 FKGNELLCGMP 686
           +  N+ LCG P
Sbjct: 298 YANNKCLCGSP 308

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 5/193 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V+     +  +VA+K    +   + + F  E  ++ ++ H  +++    C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                LV E+M +G L   L +   +      L + +DV   + YL       +IH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 938 FGIMLMETFTRKK 950
           FG+++ E F+  K
Sbjct: 188 FGVLMWEVFSEGK 200

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 5/193 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V+     +  +VA+K    +   + + F  E  ++ ++ H  +++    C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                LV E+M +G L   L +   +      L + +DV   + YL       +IH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 938 FGIMLMETFTRKK 950
           FG+++ E F+  K
Sbjct: 193 FGVLMWEVFSEGK 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 5/193 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V+     +  +VA+K    +   + + F  E  ++ ++ H  +++    C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                LV E+M +G L   L +   +      L + +DV   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 938 FGIMLMETFTRKK 950
           FG+++ E F+  K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 34/263 (12%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 817  SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 250  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
            L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 306  LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV--A 992
            V+SFGI+L E  T+ +                     +    +V+  +L   ++ +    
Sbjct: 364  VWSFGILLTELTTKGR---------------------VPYPGMVNREVLDQVERGYRMPC 402
Query: 993  KEQCMSFVFNLAMKCTIESPEER 1015
              +C   + +L  +C  + PEER
Sbjct: 403  PPECPESLHDLMCQCWRKEPEER 425

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 54   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 114  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 171  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 231  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 271
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 272  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 312

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 34/263 (12%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 817  SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 250  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
            L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 306  LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV--A 992
            V+SFGI+L E  T+ +                     +    +V+  +L   ++ +    
Sbjct: 364  VWSFGILLTELTTKGR---------------------VPYPGMVNREVLDQVERGYRMPC 402
Query: 993  KEQCMSFVFNLAMKCTIESPEER 1015
              +C   + +L  +C  + PEER
Sbjct: 403  PPECPESLHDLMCQCWRKEPEER 425

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 53   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 113  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 170  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 230  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 270
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 271  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 311

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 27   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 87   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 144  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 204  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 244
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 245  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 285

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 5/193 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V+     +  +VA+K    +   +   F  E  ++ ++ H  +++    C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                LV E+M +G L   L +   +      L + +DV   + YL       +IH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 938 FGIMLMETFTRKK 950
           FG+++ E F+  K
Sbjct: 210 FGVLMWEVFSEGK 222

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 36   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  +++L    S
Sbjct: 96   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+  L ++      +T A   + +MA E  + 
Sbjct: 153  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 213  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 253
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 254  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 748  ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-------DLQYGRAIKSFDIECGM 799
            A N       IG+GGFG V+K R ++D   VA+K         + +     + F  E  +
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 800  IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            +  + H NI+K      +     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77   MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 860  LEYLHFGYSVPIIHCDLKPNNVL---LDDN--MVAHLSDFGMAKPFLKEDQSL-TQTQTL 913
            +EY+    + PI+H DL+  N+    LD+N  + A ++DFG+++      QS+ + +  L
Sbjct: 135  IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLL 187
Query: 914  ATIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
                +MAPE     E   +   D YSF ++L    T + P DE   G++           
Sbjct: 188  GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--------- 238
Query: 972  ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                     N++  E       E C   + N+   C    P++R +   IV +L+
Sbjct: 239  --------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 152  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 212  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 252
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 253  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 5/193 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG G FG V+     +  +VA+K    +   + + F  E  ++ ++ H  +++    C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                LV E+M +G L   L +   +      L + +DV   + YL       +IH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 938 FGIMLMETFTRKK 950
           FG+++ E F+  K
Sbjct: 191 FGVLMWEVFSEGK 203

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 30   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 90   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 147  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 207  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 247
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 248  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 33   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 93   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 150  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 210  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 250
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 251  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 291

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 34   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 151  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 211  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 251
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 252  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 32   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 92   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 149  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 209  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 249
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 250  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 152  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 212  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 252
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 253  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 34/263 (12%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 817  SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 250  EEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
            L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 306  LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV--A 992
            V+SFGI+L E  T+ +                     +    +V+  +L   ++ +    
Sbjct: 364  VWSFGILLTELTTKGR---------------------VPYPGMVNREVLDQVERGYRMPC 402
Query: 993  KEQCMSFVFNLAMKCTIESPEER 1015
              +C   + +L  +C  + PEER
Sbjct: 403  PPECPESLHDLMCQCWRKEPEER 425

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 40/294 (13%)
Query: 748  ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-------DLQYGRAIKSFDIECGM 799
            A N       IG+GGFG V+K R ++D   VA+K         + +     + F  E  +
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 800  IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            +  + H NI+K      +     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77   MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 860  LEYLHFGYSVPIIHCDLKPNNVL---LDDN--MVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            +EY+    + PI+H DL+  N+    LD+N  + A ++DFG ++  +     L     L 
Sbjct: 135  IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-----LG 188
Query: 915  TIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI 972
               +MAPE     E   +   D YSF ++L    T + P DE   G++            
Sbjct: 189  NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 973  SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                    N++  E       E C   + N+   C    P++R +   IV +L+
Sbjct: 239  -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++ +     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 818 DDFK-ALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 936 YSFGIMLMETFT 947
           +SFGI+L E ++
Sbjct: 370 WSFGILLWEIYS 381

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++ +     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 818 DDFKA-LVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 936 YSFGIMLMETFT 947
           +SFGI+L E ++
Sbjct: 183 WSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++ +     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 818 DDFKA-LVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 936 YSFGIMLMETFT 947
           +SFGI+L E ++
Sbjct: 198 WSFGILLWEIYS 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 34/263 (12%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 193  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 817  SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 251  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
            L+  N+L+ +N+V  ++DFG+ +  L ED   T  Q     I + APE    GR +   D
Sbjct: 307  LRAANILVGENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV--A 992
            V+SFGI+L E  T+ +                     +    +V+  +L   ++ +    
Sbjct: 365  VWSFGILLTELTTKGR---------------------VPYPGMVNREVLDQVERGYRMPC 403
Query: 993  KEQCMSFVFNLAMKCTIESPEER 1015
              +C   + +L  +C  + PEER
Sbjct: 404  PPECPESLHDLMCQCWRKDPEER 426

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 40   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  +++L    S
Sbjct: 100  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 157  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 217  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 257
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 258  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 298

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  +++L    S
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 152  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 212  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 252
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 253  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 817 SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 130 LRAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 188 VWSFGILLTELTTKGR 203

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 36   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  +++L    S
Sbjct: 96   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 153  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 213  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 253
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 254  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V+EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V+EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 64/192 (33%), Positives = 97/192 (50%), Gaps = 13/192 (6%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++ +     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 818 DDFKA-LVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE   ST  DV
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 936 YSFGIMLMETFT 947
           +SFGI+L E ++
Sbjct: 189 WSFGILLWEIYS 200

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 94   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  +++L    S
Sbjct: 154  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 211  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 271  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 311
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 312  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K+IRH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 758 IGRGGFGFVYKARIQD---GMEVAVKVFDL---QYGRAIKSFDIECGMIKRIRHRNIIKF 811
           +G GG   VY A  +D    ++VA+K   +   +    +K F+ E     ++ H+NI+  
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
           I     DD   LV+EY+   +L + +  S+  L +   +N    +   +++ H    + I
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLATIGYMAPEYGREGRVS 930
           +H D+KP N+L+D N    + DFG+AK     + SLTQT   L T+ Y +PE  +     
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 931 TNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
              D+YS GI+L E    + P    F GE  +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP----FNGETAV 218

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 33   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  +++L    S
Sbjct: 93   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 150  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 210  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 250
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 251  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 291

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 14/225 (6%)
Query: 731 MPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY 786
           +P  + Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y
Sbjct: 15  VPRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 73
Query: 787 G-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD 845
             +  + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    
Sbjct: 74  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 846 IFQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED 904
           + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDD 188
Query: 905 QSLTQTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 189 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 755  NNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   +   DG ++   V  L     I     F  E  ++K   H N++
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 810  KFISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C  S+    +VL YM +G L   + +  +   +   +   + VA  +++L    S
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  + 
Sbjct: 152  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P                       +   D  +   +
Sbjct: 212  QKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------------VNTFDITVYLLQ 252
Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             +  +  E C   ++ + +KC     E R +  E+V++++ 
Sbjct: 253  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 40/294 (13%)
Query: 748  ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-------DLQYGRAIKSFDIECGM 799
            A N       IG+GGFG V+K R ++D   VA+K         + +     + F  E  +
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 800  IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            +  + H NI+K      +     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77   MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 860  LEYLHFGYSVPIIHCDLKPNNVL---LDDN--MVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            +EY+    + PI+H DL+  N+    LD+N  + A ++DF +++  +     L     L 
Sbjct: 135  IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-----LG 188
Query: 915  TIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI 972
               +MAPE     E   +   D YSF ++L    T + P DE   G++            
Sbjct: 189  NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 973  SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                    N++  E       E C   + N+   C    P++R +   IV +L+
Sbjct: 239  -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 817 SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 133 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 191 VWSFGILLTELTTKGR 206

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+A+  L++D     
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLAR-VLEDDPEAAY 205
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK---VFDLQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           IGRG F  VY+A  + DG+ VA+K   +FDL   +A      E  ++K++ H N+IK+ +
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNI---MIDVASALEYLHFGYSVP 870
           S   D+   +VLE    G L + +        +     +    + + SALE++H   S  
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           ++H D+KP NV +    V  L D G+ + F    ++      + T  YM+PE   E   +
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 931 TNGDVYSFGIMLMETFTRKKP 951
              D++S G +L E    + P
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP 235

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 37/284 (13%)
Query: 758  IGRGGFGFVYKARIQ-----DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V   R        G +VAVK    + G   I     E  +++ + H NI+K+
Sbjct: 17   LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 812  ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               C+ D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 77   KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT-QTQTLATIGYMAPEYGREGR 928
              +H DL   NVL++      + DFG+ K    + +  T +    + + + APE   + +
Sbjct: 134  QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 929  VSTNGDVYSFGIMLMETFTRKKPTDESFT----------GEMTLKRWVNDLLLISIMEVV 978
                 DV+SFG+ L E  T                    G+MT+ R VN L         
Sbjct: 194  FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL--------- 244
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
                   E K       C   V+ L  KC    P  R + + ++
Sbjct: 245  ------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 282

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 37/284 (13%)
Query: 758  IGRGGFGFVYKARIQ-----DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V   R        G +VAVK    + G   I     E  +++ + H NI+K+
Sbjct: 29   LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 812  ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               C+ D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89   KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT-QTQTLATIGYMAPEYGREGR 928
              +H DL   NVL++      + DFG+ K    + +  T +    + + + APE   + +
Sbjct: 146  QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 929  VSTNGDVYSFGIMLMETFTRKKPTDESFT----------GEMTLKRWVNDLLLISIMEVV 978
                 DV+SFG+ L E  T                    G+MT+ R VN L         
Sbjct: 206  FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL--------- 256
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
                   E K       C   V+ L  KC    P  R + + ++
Sbjct: 257  ------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 294

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 129 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 187 VWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 131 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 189 VWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 817 SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 137 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 817 SDDFKALVLEYMPYGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 137 LRAANILVGENLVCKVADFGLAR--LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V+EYM  G L   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 14/221 (6%)
Query: 735 ANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RA 789
           + Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  + 
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 790 IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR 849
            + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q 
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 120
Query: 850 LNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
           + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D    
Sbjct: 121 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAA 175
Query: 909 QTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D     
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAY 205
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D     
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAY 205
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D     
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAY 205
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+ +  L++D     
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAY 205
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 757 LIGRGGFGFVYKARI----QDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G  G V   R+    Q  + VA+K     Y  R  + F  E  ++ +  H NII+ 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVP 870
               +      +V EYM  GSL+  L + +    I Q + ++  V + + YL   GY   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-DQSLTQTQTLATIGYMAPEYGREGRV 929
            +H DL   NVL+D N+V  +SDFG+++    + D + T T     I + APE       
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 930 STNGDVYSFGIMLMETF 946
           S+  DV+SFG+++ E  
Sbjct: 232 SSASDVWSFGVVMWEVL 248

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L   N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LAAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 757 LIGRGGFGFVYKARI----QDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G  G V   R+    Q  + VA+K     Y  R  + F  E  ++ +  H NII+ 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVP 870
               +      +V EYM  GSL+  L + +    I Q + ++  V + + YL   GY   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-DQSLTQTQTLATIGYMAPEYGREGRV 929
            +H DL   NVL+D N+V  +SDFG+++    + D + T T     I + APE       
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF 231
Query: 930 STNGDVYSFGIMLMETF 946
           S+  DV+SFG+++ E  
Sbjct: 232 SSASDVWSFGVVMWEVL 248

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D     
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAY 205
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 30  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 88
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 89  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 148
Query: 851 NIMIDVASALEYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D     
Sbjct: 149 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAY 203
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 204 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 747 QATNGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIR 804
           Q    +     +G GGFG+V +   QD G +VA+K    +   +  + + +E  ++K++ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 805 HRNIIKF------ISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDV 856
           H N++        +   + +D   L +EY   G L K L  + +   L       ++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
           +SAL YLH      IIH DLKP N++L      ++  + D G AK     DQ    T+ +
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 184
Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            T+ Y+APE   + + +   D +SFG +  E  T  +P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 12/219 (5%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V EYM  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
            ++  +AS ++YL     +  +H DL   N+L++ N+V  +SDFG+++  L++D     T
Sbjct: 151 GMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 206
Query: 911 QTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                  I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 747 QATNGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIR 804
           Q    +     +G GGFG+V +   QD G +VA+K    +   +  + + +E  ++K++ 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 805 HRNIIKF------ISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDV 856
           H N++        +   + +D   L +EY   G L K L  + +   L       ++ D+
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
           +SAL YLH      IIH DLKP N++L      ++  + D G AK     DQ    T+ +
Sbjct: 132 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 185
Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            T+ Y+APE   + + +   D +SFG +  E  T  +P
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  +++  +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  G L   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DG--MEVAVKVFDLQYGRAI--KSFDIECGMIKRI- 803
           N     ++IG G FG V KARI+ DG  M+ A+K    +Y      + F  E  ++ ++ 
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 73
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------LDIFQ 848
            H NII  + +C    +  L +EY P+G+L   L  S  +               L   Q
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
            L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + 
Sbjct: 134 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK 187
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           +T     + +MA E       +TN DV+S+G++L E
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 223

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DG--MEVAVKVFDLQYGRAI--KSFDIECGMIKRI- 803
           N     ++IG G FG V KARI+ DG  M+ A+K    +Y      + F  E  ++ ++ 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 83
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------LDIFQ 848
            H NII  + +C    +  L +EY P+G+L   L  S  +               L   Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
            L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + 
Sbjct: 144 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK 197
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           +T     + +MA E       +TN DV+S+G++L E
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 743 LELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFD-------I 795
           L++      + + + +G G F  VYKAR ++  ++ V +  ++ G   ++ D        
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALR 61
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++ + H NII  + +       +LV ++M    LE  +  ++ +L        M+ 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
               LEYLH  +   I+H DLKPNN+LLD+N V  L+DFG+AK F   +++      + T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVT 175
Query: 916 IGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTR 948
             Y APE     R+   G D+++ G +L E   R
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 5/214 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++  + H  +++    C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 938 FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           FG+++ E ++  K   E FT   T +     L L
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 5/214 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++  + H  +++    C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  D+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 938 FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           FG+++ E ++  K   E FT   T +     L L
Sbjct: 198 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 231

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 5/214 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++  + H  +++    C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 938 FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           FG+++ E ++  K   E FT   T +     L L
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 224

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 5/214 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++  + H  +++    C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 938 FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           FG+++ E ++  K   E FT   T +     L L
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 225

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 5/214 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++  + H  +++    C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 938 FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           FG+++ E ++  K   E FT   T +     L L
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 5/214 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++  + H  +++    C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 938 FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           FG+++ E ++  K   E FT   T +     L L
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 735 ANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RA 789
           + Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  + 
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 790 IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR 849
            + F  E  ++ +  H NII+     +      +V E M  GSL+  L   +    + Q 
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL 120
Query: 850 LNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
           + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D    
Sbjct: 121 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAA 175
Query: 909 QTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 5/214 (2%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V   + +   +VA+K+   +   +   F  E  ++  + H  +++    C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 937
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 938 FGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           FG+++ E ++  K   E FT   T +     L L
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 225

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 14/220 (6%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V E M  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D     
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAY 205
Query: 910 TQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           T       I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DG--MEVAVKVFDLQYGRAI--KSFDIECGMIKRI- 803
           N     ++IG G FG V KARI+ DG  M+ A+K    +Y      + F  E  ++ ++ 
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 80
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------LDIFQ 848
            H NII  + +C    +  L +EY P+G+L   L  S  +               L   Q
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
            L+   DVA  ++YL        IH +L   N+L+ +N VA ++DFG+++    ++  + 
Sbjct: 141 LLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVK 194
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           +T     + +MA E       +TN DV+S+G++L E
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 230

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+        +VA+K   L+ G  + +SF  E  ++K+++H  +++  +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYM  GSL   L       L +   +++   VA+ + Y+     +  IH D
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGD 934
           L+  N+L+ + ++  ++DFG+A+  L ED   T  Q     I + APE    GR +   D
Sbjct: 131 LRSANILVGNGLICKIADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 935 VYSFGIMLMETFTRKK 950
           V+SFGI+L E  T+ +
Sbjct: 189 VWSFGILLTELVTKGR 204

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 758 IGRGGFGFVYKARIQDGME------VAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIK 810
           IG G FG V++AR    +       VAVK+   +    +++ F  E  ++    + NI+K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNY-----------------------ILDIF 847
            +  C+      L+ EYM YG L + L S +                         L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL 907
           ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++     D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                   I +M PE     R +T  DV+++G++L E F+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 12/219 (5%)
Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG-RAI 790
            Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  +  
Sbjct: 32  TQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
           + F  E  ++ +  H NII+     +      +V E M  GSL+  L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
            ++  +AS ++YL     +  +H DL   N+L++ N+V  +SDFG+++  L++D     T
Sbjct: 151 GMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 206
Query: 911 QTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                  I + +PE     + ++  DV+S+GI+L E  +
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 744 ELFQATNGFSENN---LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGM 799
           +L +    + EN    ++G+G +G VY  R + + + +A+K    +  R  +    E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 800 IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMI-DVA 857
            K ++H+NI++++ S S + F  + +E +P GSL   L S    + D  Q +      + 
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
             L+YLH      I+H D+K +NVL++  + V  +SDFG +K  L      T+T T  T+
Sbjct: 133 EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFT-GTL 187
Query: 917 GYMAPEYGREG--RVSTNGDVYSFGIMLMETFTRKKP 951
            YMAPE   +G        D++S G  ++E  T K P
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           ++G+G +G VY  R + + + +A+K    +  R  +    E  + K ++H+NI++++ S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMI-DVASALEYLHFGYSVPIIH 873
           S + F  + +E +P GSL   L S    + D  Q +      +   L+YLH      I+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 874 CDLKPNNVLLDD-NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG--RVS 930
            D+K +NVL++  + V  +SDFG +K  L      T+T T  T+ YMAPE   +G     
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTETFT-GTLQYMAPEIIDKGPRGYG 189
Query: 931 TNGDVYSFGIMLMETFTRKKP 951
              D++S G  ++E  T K P
Sbjct: 190 KAADIWSLGCTIIEMATGKPP 210

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 70/317 (22%), Positives = 133/317 (41%), Gaps = 46/317 (14%)
Query: 731  MPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARI------QDGMEVAVKVF-D 783
            MPL+   ++    E+  +   F E   +G   FG VYK  +      +    VA+K   D
Sbjct: 9    MPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 784  LQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI 843
               G   + F  E  +  R++H N++  +   + D   +++  Y  +G L + L   +  
Sbjct: 67   KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 844  LDIFQR---------------LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV 888
             D+                  ++++  +A+ +EYL    S  ++H DL   NVL+ D + 
Sbjct: 127  SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183
Query: 889  AHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR 948
              +SD G+ +     D       +L  I +MAPE    G+ S + D++S+G++L E F+ 
Sbjct: 184  VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243
Query: 949  KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCT 1008
                   ++ +  ++   N  +L                      + C ++V+ L ++C 
Sbjct: 244  GLQPYCGYSNQDVVEMIRNRQVL-------------------PCPDDCPAWVYALMIECW 284
Query: 1009 IESPEERINAKEIVTKL 1025
             E P  R   K+I ++L
Sbjct: 285  NEFPSRRPRFKDIHSRL 301

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFISSC 815
           ++G+G FG   K   ++  EV V    +++     ++F  E  +++ + H N++KFI   
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             D     + EY+  G+L   + S +      QR++   D+AS + YLH   S+ IIH D
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---------------YMA 920
           L  +N L+ +N    ++DFG+A+  + E    TQ + L ++                +MA
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 921 PEYGREGRVSTNGDVYSFGIMLMETFTR 948
           PE           DV+SFGI+L E   R
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY    +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +V EYMPYG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N V  ++DFG+++  +  D           I + APE       S   DV
Sbjct: 156 LAARNCLVGENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 215 WAFGVLLWEIAT 226

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 752 FSENNL-----IGRGGFGFVYKARI-----QDG-MEVAVKVF-DLQYGRAIKSFDIECGM 799
           F  NNL     +G G FG V +A       +D  ++VAVK+     +    ++   E  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 800 IKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS 858
           +  + +H NI+  + +C+      ++ EY  YG L   L   + +L+      I    AS
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 859 ALEYLHFGYSVP----------IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
             + LHF   V            IH D+   NVLL +  VA + DFG+A+  + +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ ++ S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     +++ + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    +++E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-----YILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    +++E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 755 NNLIGRGGFGFVY--------KARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR 806
           + +IG+G FG VY        + RIQ  ++   ++ ++Q    +++F  E  +++ + H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ---QVEAFLREGLLMRGLNHP 82
Query: 807 NIIKFIS-SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
           N++  I      +    ++L YM +G L + + S      +   ++  + VA  +EYL  
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA- 141
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA--TIGYMAPEY 923
                 +H DL   N +LD++    ++DFG+A+  L  +    Q    A   + + A E 
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKP 951
            +  R +T  DV+SFG++L E  TR  P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +++E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           +G G +G VYKA+   G  VA+K   L      I S  I E  ++K + H NI+  I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            S+    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFME-KDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-GREGRVSTNGD 934
           LKP N+L++ +    L+DFG+A+ F    +S   T  + T+ Y AP+      + ST+ D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 935 VYSFGIMLMETFTRK 949
           ++S G +  E  T K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK     Y    +  F +E  +I +  H+NI++
Sbjct: 53   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 864  --HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 173  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 227  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 273
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 274  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           +G G +G VYKA+   G  VA+K   L      I S  I E  ++K + H NI+  I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            S+    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFME-KDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-GREGRVSTNGD 934
           LKP N+L++ +    L+DFG+A+ F    +S   T  + T+ Y AP+      + ST+ D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 935 VYSFGIMLMETFTRK 949
           ++S G +  E  T K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 68/259 (26%), Positives = 119/259 (45%), Gaps = 26/259 (10%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
            +G G FG V+ A      +VAVK        ++++F  E  ++K ++H  ++K  +  + 
Sbjct: 23   LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 818  DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDL 876
            +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 82   EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 877  KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
            +  N+L+  ++V  ++DFG+A+  +++++   +      I + APE    G  +   DV+
Sbjct: 138  RAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 937  SFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQC 996
            SFGI+LME  T  +     + G             +S  EV+ A             E C
Sbjct: 197  SFGILLMEIVTYGRI---PYPG-------------MSNPEVIRA---LERGYRMPRPENC 237
Query: 997  MSFVFNLAMKCTIESPEER 1015
               ++N+ M+C    PEER
Sbjct: 238  PEELYNIMMRCWKNRPEER 256

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ ++ S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 757 LIGRGGFGFVYKARIQDGME----VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G FG V + R++   +    VA+K     Y  R  + F  E  ++ +  H NII+ 
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               ++     ++ E+M  G+L+  L  ++    + Q + ++  +AS + YL     +  
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 139
Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQTQTLA---TIGYMAPEYGREG 927
           +H DL   N+L++ N+V  +SDFG+++ FL+E+ S  T+T +L     I + APE     
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 928 RVSTNGDVYSFGIMLMETFT 947
           + ++  D +S+GI++ E  +
Sbjct: 199 KFTSASDAWSYGIVMWEVMS 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ ++ S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ ++ S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 123/260 (47%), Gaps = 28/260 (10%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G G FG V+ A      +VAVK   ++ G  ++++F  E  ++K ++H  ++K  +  +
Sbjct: 196  LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCD 875
             +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH D
Sbjct: 254  KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L+  N+L+  ++V  ++DFG+A+  +++++   +      I + APE    G  +   DV
Sbjct: 310  LRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQ 995
            +SFGI+LME  T  +     + G             +S  EV+ A    +        E 
Sbjct: 369  WSFGILLMEIVTYGRI---PYPG-------------MSNPEVIRALERGY---RMPRPEN 409
Query: 996  CMSFVFNLAMKCTIESPEER 1015
            C   ++N+ M+C    PEER
Sbjct: 410  CPEELYNIMMRCWKNRPEER 429

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 131 RAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 189 WSFGILLTEIVTHGR 203

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 27   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 87   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 147  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 204  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 251
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 252  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 142 RAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 137 RAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 195 WSFGILLTEIVTHGR 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 146 RAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 204 WSFGILLTEIVTHGR 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 141 RAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 199 WSFGILLTEIVTHGR 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 145 RAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 203 WSFGILLTEIVTHGR 217

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 138 RAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 196 WSFGILLTEIVTHGR 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 142 RAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 144 RAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 202 WSFGILLTEIVTHGR 216

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +++E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    +++E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 25/206 (12%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK- 810
           +++  +IG G FG VY+A++ D  E+ V +  +  G+A K+ +++  +++++ H NI++ 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 811 ---FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
              F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 863 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           +H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 921 PE--YGREGRVSTNGDVYSFGIMLME 944
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCL-----------YSSNYILD---IFQRL-NI 852
           II  + +C+ D    +++EY   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D      +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 23   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 83   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 143  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 200  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 247
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 248  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 135
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 195 IKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 26   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 86   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 146  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 203  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 250
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 251  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 27   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 87   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 147  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 204  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 251
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 252  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 24   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 84   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 144  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 201  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 248
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 249  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 25/206 (12%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK- 810
           +++  +IG G FG VY+A++ D  E+ V +  +  G+A K+ +++  +++++ H NI++ 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 811 ---FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
              F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 863 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           +H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 921 PE--YGREGRVSTNGDVYSFGIMLME 944
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 25/206 (12%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK- 810
           +++  +IG G FG VY+A++ D  E+ V +  +  G+A K+ +++  +++++ H NI++ 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 811 ---FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
              F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 863 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           +H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 921 PE--YGREGRVSTNGDVYSFGIMLME 944
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 33   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 93   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 153  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 210  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 257
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 258  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 20   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 80   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 140  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 197  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 244
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 245  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 752 FSENNL-----IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIR- 804
           F  NNL     +G G FG V +A     G E AV    ++  ++    D +  ++  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 805 ------HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS 858
                 H NI+  + +C+      ++ EY  YG L   L   + +L+      I     S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 859 ALEYLHFGYSVP----------IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
             + LHF   V            IH D+   NVLL +  VA + DFG+A+  + +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 757 LIGRGGFGFVYKARIQDGME----VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G FG V + R++   +    VA+K     Y  R  + F  E  ++ +  H NII+ 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               ++     ++ E+M  G+L+  L  ++    + Q + ++  +AS + YL     +  
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 137
Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQTQTLA---TIGYMAPEYGREG 927
           +H DL   N+L++ N+V  +SDFG+++ FL+E+ S  T T +L     I + APE     
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 928 RVSTNGDVYSFGIMLMETFT 947
           + ++  D +S+GI++ E  +
Sbjct: 197 KFTSASDAWSYGIVMWEVMS 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIK---SFDIECGMIKRIRHRNIIKFI 812
           ++G GG   V+ AR ++D  +VAVKV      R       F  E      + H  I+   
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 813 SSCSSDD----FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            +  ++        +V+EY+   +L   +++      +  +  I + +A A + L+F + 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSHQ 134
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLATIGYMAPEYGREG 927
             IIH D+KP N+++       + DFG+A+       S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
            V    DVYS G +L E  T + P    FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIK---SFDIECGMIKRIRHRNIIKFI 812
           ++G GG   V+ AR ++D  +VAVKV      R       F  E      + H  I+   
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 813 SSCSSDD----FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            +  ++        +V+EY+   +L   +++      +  +  I + +A A + L+F + 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSHQ 134
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLATIGYMAPEYGREG 927
             IIH D+KP N+++       + DFG+A+       S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
            V    DVYS G +L E  T + P    FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 757 LIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G FG V   R++     +VAV +  L+ G   +  + F  E  ++ +  H N++  
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVP 870
               +      +V+E+M  G+L+  L   +    + Q + ++  +A+ + YL   GY   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY--- 166
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG--YMAPEYGREGR 928
            +H DL   N+L++ N+V  +SDFG+++  +++D     T T   I   + APE  +  +
Sbjct: 167 -VHRDLAARNILVNSNLVCKVSDFGLSR-VIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 929 VSTNGDVYSFGIMLMETFT 947
            ++  DV+S+GI++ E  +
Sbjct: 225 FTSASDVWSYGIVMWEVMS 243

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 26   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 86   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 146  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 203  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 250
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 251  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 33   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 93   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 153  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 210  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 257
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 258  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 758  IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 267  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             +    ++ E+M YG+L   L   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 383  LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQ 995
            ++FG++L E  T        + G             I + +V +   L  +D      E 
Sbjct: 442  WAFGVLLWEIATYGM---SPYPG-------------IDLSQVYE---LLEKDYRMERPEG 482
Query: 996  CMSFVFNLAMKCTIESPEERINAKEI 1021
            C   V+ L   C   +P +R +  EI
Sbjct: 483  CPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 756 NLIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIK 810
            +IG G FG V    ++     E+ V +  L+ G   +  + F  E  ++ +  H N+I 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                +      ++ E+M  GSL+  L  ++    + Q + ++  +A+ ++YL     + 
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 155
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQTQTLA---TIGYMAPEYGRE 926
            +H DL   N+L++ N+V  +SDFG+++ FL++D S  T T  L     I + APE  + 
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 927 GRVSTNGDVYSFGIMLMETFT 947
            + ++  DV+S+GI++ E  +
Sbjct: 215 RKFTSASDVWSYGIVMWEVMS 235

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 870
            +    ++ E+M YG+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 931 TNGDVYSFGIMLMETFT 947
              DV++FG++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 201 WAFGVLLWEIAT 212

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/284 (21%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 55   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 115  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 175  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 232  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 279
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 280  LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 22/224 (9%)
Query: 741 TYLELFQATNGFSEN---------NLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG 787
           TY +  QA + F++           +IG G FG V   R++      + VA+K   + Y 
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 788 -RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDI 846
            +  + F  E  ++ +  H NII      +      +V EYM  GSL+  L  ++    +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 847 FQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ 905
            Q + ++  +++ ++YL   GY    +H DL   N+L++ N+V  +SDFG+++  L++D 
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDP 178
Query: 906 SLTQTQTLATIG--YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               T     I   + APE     + ++  DV+S+GI++ E  +
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VY+   +   + VAVK    +    ++ F  E  ++K I+H N+++ +  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   N L+ +N +  ++DFG+++  +  D           I + APE     + S   DV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 936 YSFGIMLMETFT 947
           ++FG++L E  T
Sbjct: 403 WAFGVLLWEIAT 414

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++ Y   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 30/232 (12%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI------- 803
           F   NL+G+G F  VY+A  I  G+EVA+K+ D       K    + GM++R+       
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID-------KKAMYKAGMVQRVQNEVKIH 65
Query: 804 ---RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
              +H +I++  +     ++  LVLE    G + + L +        +  + M  + + +
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF-LKEDQSLTQTQTLATIGYM 919
            YLH   S  I+H DL  +N+LL  NM   ++DFG+A    +  ++  T      T  Y+
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYI 179
Query: 920 APEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
           +PE           DV+S G M       + P D       T+K  +N ++L
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD-----TVKNTLNKVVL 226

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISS 814
           LIG+G FG VY  R     EVA+++ D++      +K+F  E    ++ RH N++ F+ +
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
           C S    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H 
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 875 DLKPNNVLLDDNMVAHLSDFGM------AKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
           DLK  NV  D+  V  ++DFG+       +   +ED+   Q   L    ++APE  R+  
Sbjct: 155 DLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC---HLAPEIIRQLS 210
Query: 929 ---------VSTNGDVYSFGIMLMETFTRKKP 951
                     S + DV++ G +  E   R+ P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 740 FTYLELFQATNGFSEN---------NLIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYG- 787
           FT+ +  QA   F++           +IG G FG V   R++     E+ V +  L+ G 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 788 --RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD 845
             +  + F  E  ++ +  H NII      +      ++ EYM  GSL+  L  ++    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 846 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ 905
           + Q + ++  + S ++YL     +  +H DL   N+L++ N+V  +SDFGM++  L++D 
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDP 185
Query: 906 SLTQTQTLATIG--YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               T     I   + APE     + ++  DV+S+GI++ E  +
Sbjct: 186 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ ++ S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +N+LL  +    L+DFG       E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 937 SFGIMLMETFTRKKP 951
           S GIM +E    + P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 752 FSENNLI-----GRGGFGFVYKA-----RIQDG-MEVAVKVFDLQYGRA-IKSFDIECGM 799
           F   NL+     G G FG V KA     + + G   VAVK+       + ++    E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 800 IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------- 843
           +K++ H ++IK   +CS D    L++EY  YGSL   L  S  +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 844 -------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
                  L +   ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           ++   +ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF-DI--ECGMIKRIRHRN 807
           FS+   IG G FG VY AR +++   VA+K       ++ + + DI  E   ++++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYL 863
            I++      +    LV+EY        CL S++ +L++ ++    +++A+    AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
            + +S  +IH D+K  N+LL +  +  L DFG A      +        + T  +MAPE 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 221
Query: 924 ---GREGRVSTNGDVYSFGIMLMETFTRKKP 951
                EG+     DV+S GI  +E   RK P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I ++ H+NI++
Sbjct: 53   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 864  --HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 173  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 227  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 273
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 274  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 752 FSENNLI-----GRGGFGFVYKA-----RIQDG-MEVAVKVFDLQYGRA-IKSFDIECGM 799
           F   NL+     G G FG V KA     + + G   VAVK+       + ++    E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 800 IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------- 843
           +K++ H ++IK   +CS D    L++EY  YGSL   L  S  +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 844 -------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
                  L +   ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           ++   +ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G FG V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 132 RAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 190 WSFGILLTEIVTHGR 204

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 64/290 (22%), Positives = 122/290 (42%), Gaps = 44/290 (15%)
Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G   FG VYK  +      +    VA+K   D   G   + F  E  +  R++H N++ 
Sbjct: 17   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR---------------LNIMID 855
             +   + D   +++  Y  +G L + L   +   D+                  ++++  
Sbjct: 77   LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
            +A+ +EYL    S  ++H DL   NVL+ D +   +SD G+ +     D       +L  
Sbjct: 137  IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM 975
            I +MAPE    G+ S + D++S+G++L E F+        ++ +  ++   N  +L    
Sbjct: 194  IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL---- 249
Query: 976  EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                              + C ++V+ L ++C  E P  R   K+I ++L
Sbjct: 250  ---------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K + ++ + VAVK+  D    + +     E  M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----NYILDI---------FQRL-NI 852
           II  + +C+ D    +++ Y   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIK---SFDIECGMIKRIRHRNIIKFI 812
           ++G GG   V+ AR ++D  +VAVKV      R       F  E      + H  I+   
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 813 SSCSSDD----FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            +  ++        +V+EY+   +L   +++      +  +  I + +A A + L+F + 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSHQ 134
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLATIGYMAPEYGREG 927
             IIH D+KP N+L+       + DFG+A+       S+ QT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD 194
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
            V    DVYS G +L E  T + P    FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I ++ H+NI++
Sbjct: 39   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99   CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 159  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 213  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 259
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 260  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 752 FSENNLIGRGGFGFVYKARI--QDG--MEVAVKVF--DLQYGRAIKSFDIECGMIKRIRH 805
           F+   ++G+G FG V +A++  +DG  ++VAVK+   D+     I+ F  E   +K   H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 806 RNIIKFISSCSSDDFKA------LVLEYMPYGSLEKCLYSSN-----YILDIFQRLNIMI 854
            ++ K +        K       ++L +M +G L   L +S      + L +   +  M+
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
           D+A  +EYL    S   IH DL   N +L ++M   ++DFG+++     D       +  
Sbjct: 145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR 948
            + ++A E   +   + + DV++FG+ + E  TR
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI 808
           N FS + +IGRGGFG VY  R  D G   A+K  D       K   ++ G    +  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIM 241
Query: 809 IKFISS-------CSSDDFK-----ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV 856
           +  +S+       C S  F      + +L+ M  G L   L       +   R     ++
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 300
Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
              LE++H  +   +++ DLKP N+LLD++    +SD G+A  F K+        ++ T 
Sbjct: 301 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 353
Query: 917 GYMAPEYGREG-RVSTNGDVYSFGIMLME------TFTRKKPTDESFTGEMTL 962
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI 808
           N FS + +IGRGGFG VY  R  D G   A+K  D       K   ++ G    +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIM 242
Query: 809 IKFISS-------CSSDDFK-----ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV 856
           +  +S+       C S  F      + +L+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
              LE++H  +   +++ DLKP N+LLD++    +SD G+A  F K+        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 917 GYMAPEYGREG-RVSTNGDVYSFGIMLME------TFTRKKPTDESFTGEMTL 962
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 755 NNLIGRGGFGFVYKARI--QDG--MEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNI 808
             ++G G FG V +  +  +DG  ++VAVK   L     R I+ F  E   +K   H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 809 IKFISSC---SSDDFKA--LVLEYMPYGSLEKCLYSSNY-----ILDIFQRLNIMIDVAS 858
           I+ +  C   SS       ++L +M YG L   L  S        + +   L  M+D+A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            +EYL    +   +H DL   N +L D+M   ++DFG++K     D           + +
Sbjct: 159 GMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFTR 948
           +A E   +   ++  DV++FG+ + E  TR
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 61/284 (21%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 18   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 78   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 138  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 195  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 242
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +  L   C   +P+ R +  EI++ +
Sbjct: 243  LLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 757 LIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G FG V   R++     E+ V +  L+ G   +  + F  E  ++ +  H NII  
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               +      ++ EYM  GSL+  L  ++    + Q + ++  + S ++YL     +  
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 131
Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG--YMAPEYGREGRV 929
           +H DL   N+L++ N+V  +SDFGM++  L++D     T     I   + APE     + 
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 930 STNGDVYSFGIMLMETFT 947
           ++  DV+S+GI++ E  +
Sbjct: 191 TSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 757 LIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKF 811
           +IG G FG V   R++     E+ V +  L+ G   +  + F  E  ++ +  H NII  
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               +      ++ EYM  GSL+  L  ++    + Q + ++  + S ++YL     +  
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 137
Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG--YMAPEYGREGRV 929
           +H DL   N+L++ N+V  +SDFGM++  L++D     T     I   + APE     + 
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 930 STNGDVYSFGIMLMETFT 947
           ++  DV+S+GI++ E  +
Sbjct: 197 TSASDVWSYGIVMWEVMS 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 752 FSENNLI-----GRGGFGFVYKA-----RIQDG-MEVAVKVFDLQYGRA-IKSFDIECGM 799
           F   NL+     G G FG V KA     + + G   VAVK+       + ++    E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 800 IKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------- 843
           +K++ H ++IK   +CS D    L++EY  YGSL   L  S  +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 844 -------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
                  L +   ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           ++   +ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI 808
           N FS + +IGRGGFG VY  R  D G   A+K  D       K   ++ G    +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIM 242
Query: 809 IKFISS-------CSSDDFK-----ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV 856
           +  +S+       C S  F      + +L+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
              LE++H  +   +++ DLKP N+LLD++    +SD G+A  F K+        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTH 354
Query: 917 GYMAPEYGREG-RVSTNGDVYSFGIMLME------TFTRKKPTDESFTGEMTL 962
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI 808
           N FS + +IGRGGFG VY  R  D G   A+K  D       K   ++ G    +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIM 242
Query: 809 IKFISS-------CSSDDFK-----ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV 856
           +  +S+       C S  F      + +L+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
              LE++H  +   +++ DLKP N+LLD++    +SD G+A  F K+        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTH 354
Query: 917 GYMAPEYGREG-RVSTNGDVYSFGIMLME------TFTRKKPTDESFTGEMTL 962
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 30   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 90   CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 864  --HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 150  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 204  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 250
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 251  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 52/195 (26%), Positives = 100/195 (51%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+     +  +VAVK   L+ G  ++++F  E  ++K ++H  +++  +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCD 875
            ++   ++ EYM  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L+  NVL+ ++++  ++DFG+A+  +++++   +      I + APE    G  +   DV
Sbjct: 136 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  K
Sbjct: 195 WSFGILLYEIVTYGK 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 91
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E   S + D+++ G ++ +
Sbjct: 208 EKSASKSSDLWALGCIIYQ 226

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 72/223 (32%), Positives = 102/223 (45%), Gaps = 42/223 (18%)
Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI---RHRNIIKFI- 812
           LIGRG +G VYK  + D   VAVKVF      A +   I    I R+    H NI +FI 
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 813 --SSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF--- 865
                ++D      LV+EY P GSL K  Y S +  D      +   V   L YLH    
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 866 ---GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA---------KPFLKEDQSLTQTQTL 913
               Y   I H DL   NVL+ ++    +SDFG++         +P  +++ ++++   +
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE---V 189
Query: 914 ATIGYMAPEYGREGRVSTNG--------DVYSFGIMLMETFTR 948
            TI YMAPE   EG V+           D+Y+ G++  E F R
Sbjct: 190 GTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 38   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98   CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 158  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 212  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 258
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 259  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 39   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99   CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 159  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 213  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 259
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 260  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 746 FQATNGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVF-DLQYGRAIKSFDI-ECGMIKR 802
           FQ+   +    L+G G +G V K R +D G  VA+K F +    + +K   + E  ++K+
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKC-LYSSNYILDIFQRLNIMIDVASALE 861
           +RH N++  +  C       LV E++ +  L+   L+ +     + Q+    I     + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----IN 135
Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            + F +S  IIH D+KP N+L+  + V  L DFG A+      +       +AT  Y AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193
Query: 922 E-------YGREGRVSTNGDVYSFGIMLMETF 946
           E       YG+        DV++ G ++ E F
Sbjct: 194 ELLVGDVKYGKA------VDVWAIGCLVTEMF 219

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 45   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 105  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 165  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 219  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 265
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 266  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 55   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 115  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 175  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 229  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 275
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 276  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 79   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 139  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 199  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 253  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 299
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 300  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 759 GRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS---- 814
            RG FG V+KA++ +   VAVK+F +Q  ++ ++ + E   +  ++H NI++FI +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF-------GY 867
            S D    L+  +   GSL   L ++  ++   +  +I   +A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
              I H D+K  NVLL +N+ A ++DFG+A  F     +      + T  YMAPE   EG
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEG 207
Query: 928 RVSTNG------DVYSFGIMLMETFTR----KKPTDE 954
            ++         D+Y+ G++L E  +R      P DE
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 39   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99   CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 159  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 213  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 259
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 260  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 758 IGRGGFGFVY--------KARIQDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRI-RHRN 807
           +G G FG V         K +     +VAVK+       + +     E  M+K I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILDIFQRLN------I 852
           II  + +C+ D    +++EY   G+L + L         YS N   +  ++L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+     D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 56   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 116  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 864  --HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 176  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 230  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 276
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 277  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 56/185 (30%), Positives = 87/185 (47%), Gaps = 23/185 (12%)
Query: 774 GMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCSSDDFKAL--VLEYMPY 830
           G  VAVK      G   +S +  E  +++ + H +IIK+   C     K+L  V+EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
           GSL    Y   + + + Q L     +   + YLH   S   IH +L   NVLLD++ +  
Sbjct: 103 GSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVK 157
Query: 891 LSDFGMAKPF--------LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + DFG+AK          ++ED         + + + APE  +E +     DV+SFG+ L
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGD-------SPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 943 METFT 947
            E  T
Sbjct: 211 YELLT 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 742 YLELFQATNGFSENNLIGRGGFGFVYKA---RIQDGMEVAVKVFDLQYGRAIKSF-DIEC 797
           Y +       F++   IG+G FG V+K    R Q    VA+K+ DL+           E 
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEI 76
Query: 798 GMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA 857
            ++ +     + K+  S   D    +++EY+  GS    L      LD  Q   I+ ++ 
Sbjct: 77  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREIL 134
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
             L+YLH   S   IH D+K  NVLL ++    L+DFG+A      D  + +   + T  
Sbjct: 135 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPF 189
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDE 954
           +MAPE  ++    +  D++S GI  +E    + P  E
Sbjct: 190 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 226

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 53   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + +++E M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 864  --HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 173  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 227  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 273
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 274  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 65   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 125  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 185  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 239  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 285
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 286  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +G G  G V+        +VAVK    Q   +  +F  E  ++K+++H+ +++  +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
           +    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 935
           +  N+L+ D +   ++DFG+A+  L ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLAR--LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 758  IGRGGFGFVYKARIQ------DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 38   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYL- 863
             I        + +++E M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98   CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 158  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV 978
            M PE   EG  ++  D +SFG++L E F+          G M      N      ++E V
Sbjct: 212  MPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFV 258
Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +       K+      C   V+ +  +C    PE+R N   I+ ++
Sbjct: 259  TSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 764 GFVYKARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--D 819
           G ++K R Q G ++ VKV  ++    R  + F+ EC  ++   H N++  + +C S    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 820 FKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 878
              L+  +MPYGSL   L+  +N+++D  Q +   +D+A  + +LH    +   H  L  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LNS 141
Query: 879 NNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN---GDV 935
            +V++D++M A +S   MA        S      +    ++APE  ++    TN    D+
Sbjct: 142 RSVMIDEDMTARIS---MADVKF----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 936 YSFGIMLMETFTRKKPTDESFTGEMTLK 963
           +SF ++L E  TR+ P  +    E+ +K
Sbjct: 195 WSFAVLLWELVTREVPFADLSNMEIGMK 222

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 756 NLIGRGGFGFVYKA-RIQDG----MEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNII 809
            ++G G FG V+K   I +G    + V +KV + + GR + ++       I  + H +I+
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
           + +  C     + LV +Y+P GSL   +      L     LN  + +A  + YL      
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 152
Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            ++H +L   NVLL       ++DFG+A     +D+ L  ++    I +MA E    G+ 
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 930 STNGDVYSFGIMLMETFT 947
           +   DV+S+G+ + E  T
Sbjct: 213 THQSDVWSYGVTVWELMT 230

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 752 FSENNLIGRGGFGFVYKA---RIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIRHRN 807
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           + K+  S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S   IH D+K  NVLL ++    L+DFG+A      D  + +   + T  +MAPE  ++ 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDE 954
              +  D++S GI  +E    + P  E
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSE 206

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 752 FSENNLIGRGGFGFVYKA---RIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIRHRN 807
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           + K+  S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S   IH D+K  NVLL ++    L+DFG+A      D  + +   + T  +MAPE  ++ 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDE 954
              +  D++S GI  +E    + P  E
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSE 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T+   T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 752 FSENNLIGRGGFGFVYKA---RIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIRHRN 807
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           + K+  S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 136
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S   IH D+K  NVLL ++    L+DFG+A      D  + +   + T  +MAPE  ++ 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDE 954
              +  D++S GI  +E    + P  E
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSE 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 38/260 (14%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G G FG V+ A      +VAVK   ++ G  ++++F  E  ++K ++H  ++K  +  +
Sbjct: 190  LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCD 875
             +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH D
Sbjct: 248  KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 303
Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L+  N+L+  ++V  ++DFG+A+   K             I + APE    G  +   DV
Sbjct: 304  LRAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSFTIKSDV 352
Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQ 995
            +SFGI+LME  T  +     + G             +S  EV+ A    +        E 
Sbjct: 353  WSFGILLMEIVTYGRI---PYPG-------------MSNPEVIRALERGY---RMPRPEN 393
Query: 996  CMSFVFNLAMKCTIESPEER 1015
            C   ++N+ M+C    PEER
Sbjct: 394  CPEELYNIMMRCWKNRPEER 413

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 9/178 (5%)
Query: 774 GMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCSSDDFKAL--VLEYMPY 830
           G  VAVK      G   +S +  E  +++ + H +IIK+   C      +L  V+EY+P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
           GSL    Y   + + + Q L     +   + YLH  +    IH DL   NVLLD++ +  
Sbjct: 120 GSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVK 174
Query: 891 LSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + DFG+AK   +  +    +    + + + APE  +E +     DV+SFG+ L E  T
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 756 NLIGRGGFGFVYKARIQ--DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIK 810
            +IG G FG V    ++     E+ V +  L+ G   +  + F  E  ++ +  H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                +      ++ E+M  GSL+  L  ++    + Q + ++  +A+ ++YL     + 
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 129
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQTQTLA---TIGYMAPEYGRE 926
            +H  L   N+L++ N+V  +SDFG+++ FL++D S  T T  L     I + APE  + 
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 927 GRVSTNGDVYSFGIMLMETFT 947
            + ++  DV+S+GI++ E  +
Sbjct: 189 RKFTSASDVWSYGIVMWEVMS 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 23/185 (12%)
Query: 774 GMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCSSDDFKAL--VLEYMPY 830
           G  VAVK      G   +S +  E  +++ + H +IIK+   C     K+L  V+EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
           GSL    Y   + + + Q L     +   + YLH  +    IH +L   NVLLD++ +  
Sbjct: 103 GSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLVK 157
Query: 891 LSDFGMAKPF--------LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + DFG+AK          ++ED         + + + APE  +E +     DV+SFG+ L
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGD-------SPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 943 METFT 947
            E  T
Sbjct: 211 YELLT 215

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 91
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 208 EKSAXKSSDLWALGCIIYQ 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIK---SFDIECGMIKRIRHRNIIKFI 812
           ++G GG   V+ AR ++   +VAVKV      R       F  E      + H  I+   
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 813 SSCSSDD----FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           ++  ++        +V+EY+   +L   +++      +  +  I + +A A + L+F + 
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSHQ 134
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLATIGYMAPEYGREG 927
             IIH D+KP N+++       + DFG+A+       S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
            V    DVYS G +L E  T + P    FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 91
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 208 EKSACKSSDLWALGCIIYQ 226

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 61/284 (21%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVY----KARIQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIK 810
            +G+G FG VY    K  ++D  E  V +  +    +++    F  E  ++K     ++++
Sbjct: 20   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 861
             +   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 80   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N  + ++    + DFGM +   + D      + L  + +M+P
Sbjct: 140  YLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V++  
Sbjct: 197  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 244
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            LL   D        C   +  L   C   +P+ R +  EI++ +
Sbjct: 245  LLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 92
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 209 EKSACKSSDLWALGCIIYQ 227

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 89
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 206 EKSACKSSDLWALGCIIYQ 224

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 91
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 208 EKSACKSSDLWALGCIIYQ 226

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 89
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 206 EKSACKSSDLWALGCIIYQ 224

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 92
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 209 EKSACKSSDLWALGCIIYQ 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 94
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 211 EKSACKSSDLWALGCIIYQ 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 91
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 208 EKSACKSSDLWALGCIIYQ 226

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 111
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 223
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 89
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 206 EKSACKSSDLWALGCIIYQ 224

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLA 914
           +A A + L+F +   IIH D+KP N+++       + DFG+A+       S+TQT   + 
Sbjct: 139 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
           T  Y++PE  R   V    DVYS G +L E  T + P    FTG+
Sbjct: 199 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 239

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLA 914
           +A A + L+F +   IIH D+KP N+++       + DFG+A+       S+TQT   + 
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
           T  Y++PE  R   V    DVYS G +L E  T + P    FTG+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 84
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 143
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 144 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYY 196
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 197 RAPELIFGATDYTSSI-DVWSAGCVLAE 223

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 91
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 208 EKSACKSSDLWALGCIIYQ 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 95
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 154
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 155 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYY 207
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 208 RAPELIFGATDYTSSI-DVWSAGCVLAE 234

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFIS 813
           +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +RH NI++   
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
                    L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            D+KP N+LL  N    ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM-IEGRMHDEK 190
Query: 934 -DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
            D++S G++  E F    P  E+ T + T +R
Sbjct: 191 VDLWSLGVLCYE-FLVGMPPFEAHTYQETYRR 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 105
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 164
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 165 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 217
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 218 APELIFGATDYTSSI-DVWSAGCVLAE 243

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 88
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 205 EKSACKSSDLWALGCIIYQ 223

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 73
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 131
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 190 EKSACKSSDLWALGCIIYQ 208

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 89
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 201
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 23/232 (9%)
Query: 724 SQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARI-----QDGMEVA 778
           +QL     P +  +R   Y+            + +G+G FG V   R        G  VA
Sbjct: 9   AQLYACQDPTIFEERHLKYI------------SQLGKGNFGSVELCRYDPLGDNTGALVA 56
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF--ISSCSSDDFKALVLEYMPYGSLEKC 836
           VK          + F  E  ++K +    I+K+  +S         LV+EY+P G L   
Sbjct: 57  VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 116
Query: 837 LYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
           L      LD  + L     +   +EYL    S   +H DL   N+L++      ++DFG+
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL 173
Query: 897 AKPF-LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           AK   L +D  + +    + I + APE   +   S   DV+SFG++L E FT
Sbjct: 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF-DI--ECGMIKRIRHRN 807
           FS+   IG G FG VY AR +++   VA+K       ++ + + DI  E   ++++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYL 863
            I++      +    LV+EY        CL S++ +L++ ++    +++A+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
            + +S  +IH D+K  N+LL +  +  L DFG A      +        + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182
Query: 924 ---GREGRVSTNGDVYSFGIMLMETFTRKKP 951
                EG+     DV+S GI  +E   RK P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 68
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 126
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 127 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 185 EKSACKSSDLWALGCIIYQ 203

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 67
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 125
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 184 EKSACKSSDLWALGCIIYQ 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 69
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 127
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 128 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 186 EKSACKSSDLWALGCIIYQ 204

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 77
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 136
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 137 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYY 189
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 190 RAPELIFGATDYTSSI-DVWSAGCVLAE 216

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 182
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 115
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 174
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 175 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 227
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 228 APELIFGATDYTSSI-DVWSAGCVLAE 253

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 88
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 205 EKSACKSSDLWALGCIIYQ 223

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 178
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 218

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 66
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 124
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 125 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 183 EKSACKSSDLWALGCIIYQ 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXK 186
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 183
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 192 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 189 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHN 142
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 193 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 182
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 89
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 201
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 156
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 215
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 216 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 268
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 269 APELIFGATDYTSSI-DVWSAGCVLAE 294

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+ ++ G   A KV + +    ++ + +E  ++    H  I+K + +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-----GREGRVST 931
           K  NVL+       L+DFG++   LK  Q   +   + T  +MAPE       ++     
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 932 NGDVYSFGIMLMETFTRKKPTDE 954
             D++S GI L+E    + P  E
Sbjct: 194 KADIWSLGITLIEMAQIEPPHHE 216

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTXLCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 76
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYY 188
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 189 RAPELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+ ++ G   A KV + +    ++ + +E  ++    H  I+K + +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-----GREGRVST 931
           K  NVL+       L+DFG++   LK  Q   +   + T  +MAPE       ++     
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 932 NGDVYSFGIMLMETFTRKKPTDE 954
             D++S GI L+E    + P  E
Sbjct: 202 KADIWSLGITLIEMAQIEPPHHE 224

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 180
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 111
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 223
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 76
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYY 188
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 189 RAPELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 82
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 141
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 142 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 194
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 195 APELIFGATDYTSSI-DVWSAGCVLAE 220

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 39/225 (17%)
Query: 756 NLIGRGGFGFVYKA------RIQDGMEVAVKVF----DLQYGRAIKSFDIECGMIKRI-R 804
            ++G G FG V  A      +    ++VAVK+     D     A+ S   E  M+ ++  
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELKMMTQLGS 107
Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSL-------------EKCLYSSNYILDIFQRLN 851
           H NI+  + +C+      L+ EY  YG L             ++  Y +   L+  + LN
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 852 IMI---------DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK 902
           ++           VA  +E+L F      +H DL   NVL+    V  + DFG+A+  + 
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           +   + +      + +MAPE   EG  +   DV+S+GI+L E F+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 181
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 221

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 180
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 123
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 176
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 177 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 216

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 182
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 180
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 22   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 82   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 142  YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 199  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 246
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P+ R    EIV  L
Sbjct: 247  YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 113
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 172
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 173 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 225
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 226 APELIFGATDYTSSI-DVWSAGCVLAE 251

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F  V  AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 96
Query: 806 RNIIKFISSCSSDDFKALV-LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
              +K +  C  DD K    L Y   G L K +       +   R     ++ SALEYLH
Sbjct: 97  PFFVK-LYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH 154
Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
                 IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE  
Sbjct: 155 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 925 REGRVSTNGDVYSFGIMLME 944
            E     + D+++ G ++ +
Sbjct: 212 TEKSACKSSDLWALGCIIYQ 231

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 76
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYY 188
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 189 RAPELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 23/185 (12%)
Query: 774 GMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCSSDDFKA--LVLEYMPY 830
           G  VAVK      G  ++S +  E  +++ + H +I+K+   C     K+  LV+EY+P 
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
           GSL    Y   + + + Q L     +   + YLH  +    IH  L   NVLLD++ +  
Sbjct: 97  GSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVK 151
Query: 891 LSDFGMAKPF--------LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + DFG+AK          ++ED         + + + APE  +E +     DV+SFG+ L
Sbjct: 152 IGDFGLAKAVPEGHEYYRVREDGD-------SPVFWYAPECLKECKFYYASDVWSFGVTL 204
Query: 943 METFT 947
            E  T
Sbjct: 205 YELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 23/185 (12%)
Query: 774 GMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCSSDDFKA--LVLEYMPY 830
           G  VAVK      G  ++S +  E  +++ + H +I+K+   C     K+  LV+EY+P 
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
           GSL    Y   + + + Q L     +   + YLH  +    IH  L   NVLLD++ +  
Sbjct: 98  GSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVK 152
Query: 891 LSDFGMAKPF--------LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + DFG+AK          ++ED         + + + APE  +E +     DV+SFG+ L
Sbjct: 153 IGDFGLAKAVPEGHEYYRVREDGD-------SPVFWYAPECLKECKFYYASDVWSFGVTL 205
Query: 943 METFT 947
            E  T
Sbjct: 206 YELLT 210

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 81
Query: 811 ----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
               F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 140
Query: 862 YLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y 
Sbjct: 141 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 193
Query: 920 APE--YGREGRVSTNGDVYSFGIMLME 944
           APE  +G     S+  DV+S G +L E
Sbjct: 194 APELIFGATDYTSSI-DVWSAGCVLAE 219

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 145  YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P+ R    EIV  L
Sbjct: 250  YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 89
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 148
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 149 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYY 201
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 202 RAPELIFGATDYTSSI-DVWSAGCVLAE 228

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 186
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G +G VYKA   + G  VA+K   ++    ++    E  ++++    +++K+  S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            +    +V+EY   GS+   +   N  L   +   I+      LEYLHF   +  IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDI 151
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K  N+LL+    A L+DFG+A      D    +   + T  +MAPE  +E   +   D++
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 937 SFGIMLMETFTRKKP 951
           S GI  +E    K P
Sbjct: 210 SLGITAIEMAEGKPP 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKR-------IRHRN 807
           + +G G FG V     Q  G +VAVK+ + Q    I+S D+  G IKR        RH +
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDV-VGKIKREIQNLKLFRHPH 72
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           IIK     S+     +V+EY+  G L   +     + ++  R  +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM 131
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
              ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y APE    G
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNYAAPEV-ISG 184
Query: 928 RVSTNG--DVYSFGIMLMETFTRKKPTDE 954
           R+      D++S G++L        P D+
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 752 FSENNL-----IGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R        G  VAVK          + F  E  ++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 802 RIRHRNIIKF--ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            +    I+K+  +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF-LKEDQSLTQTQTLATIGY 918
           +EYL    S   +H DL   N+L++      ++DFG+AK   L +D  + +    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            APE   +   S   DV+SFG++L E FT
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 752 FSENNL-----IGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R        G  VAVK          + F  E  ++K
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 802 RIRHRNIIKF--ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            +    I+K+  +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF-LKEDQSLTQTQTLATIGY 918
           +EYL    S   +H DL   N+L++      ++DFG+AK   L +D  + +    + I +
Sbjct: 127 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            APE   +   S   DV+SFG++L E FT
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 752 FSENNL-----IGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIK 801
           F E +L     +G+G FG V   R        G  VAVK          + F  E  ++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 802 RIRHRNIIKF--ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASA 859
            +    I+K+  +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF-LKEDQSLTQTQTLATIGY 918
           +EYL    S   +H DL   N+L++      ++DFG+AK   L +D  + +    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            APE   +   S   DV+SFG++L E FT
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKA---RIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIRHRN 807
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           + K+  S        +++EY+  GS    L +  +  D FQ   ++ ++   L+YLH   
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 137
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S   IH D+K  NVLL +     L+DFG+A      D  + +   + T  +MAPE  ++ 
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 928 RVSTNGDVYSFGIMLME 944
              +  D++S GI  +E
Sbjct: 196 AYDSKADIWSLGITAIE 212

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 751 GFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R  K+ +++  +++++ H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIV 76
Query: 810 K----FISSCSSDD--FKALVLEYMP---YGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           +    F SS    D  +  LVL+Y+P   Y        +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 861 EYLH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            Y+H FG    I H D+KP N+LLD D  V  L DFG AK  ++ + +++    + +  Y
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYY 188
Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLME 944
            APE  +G     S+  DV+S G +L E
Sbjct: 189 RAPELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 121
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 174
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 175 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 65/284 (22%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 145  YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P  R    EIV  L
Sbjct: 250  YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 24   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 84   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 144  YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 201  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 248
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P+ R    EIV  L
Sbjct: 249  YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 141
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 194
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 195 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 234

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 203
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 204 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 243

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 145  YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P+ R    EIV  L
Sbjct: 250  YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 100/195 (51%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+     +  +VAVK   L+ G  ++++F  E  ++K ++H  +++  +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCD 875
            ++   ++ E+M  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L+  NVL+ ++++  ++DFG+A+  +++++   +      I + APE    G  +   +V
Sbjct: 135 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 936 YSFGIMLMETFTRKK 950
           +SFGI+L E  T  K
Sbjct: 194 WSFGILLYEIVTYGK 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEX 182
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR      D++S G++  E F   KP  E+ T + T KR
Sbjct: 183 -IEGRXHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V    + A     + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                  +   K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 86   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREG 927
               IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +  
Sbjct: 140  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D + FG+ L E FT  +       G   L +                  +  E 
Sbjct: 200  TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 241
Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEER 1015
            +     E C   ++N+ ++C    PE+R
Sbjct: 242  ERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V    + A     + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                  +   K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREG 927
               IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +  
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D + FG+ L E FT  +       G   L +                  +  E 
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 231
Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEER 1015
            +     E C   ++N+ ++C    PE+R
Sbjct: 232  ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----CHAPSSRRTTLSGTLDYLPPEM 178
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 218

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRH 805
           F    ++G G F     AR +    E A+K+ + ++   IK   +     E  ++ R+ H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDH 89
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
              +K   +   D+     L Y   G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 926 EGRVSTNGDVYSFGIMLME 944
           E     + D+++ G ++ +
Sbjct: 206 EKSACKSSDLWALGCIIYQ 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V    + A     + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                  +   K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 80   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 133
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREG 927
               IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +  
Sbjct: 134  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D + FG+ L E FT  +       G   L +                  +  E 
Sbjct: 194  TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 235
Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEER 1015
            +     E C   ++N+ ++C    PE+R
Sbjct: 236  ERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V    + A     + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                  +   K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 80   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 133
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREG 927
               IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +  
Sbjct: 134  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D + FG+ L E FT  +       G   L +                  +  E 
Sbjct: 194  TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 235
Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEER 1015
            +     E C   ++N+ ++C    PE+R
Sbjct: 236  ERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V    + A     + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                  +   K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREG 927
               IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +  
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D + FG+ L E FT  +       G   L +                  +  E 
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 231
Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEER 1015
            +     E C   ++N+ ++C    PE+R
Sbjct: 232  ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V    + A     + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                  +   K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 86   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREG 927
               IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +  
Sbjct: 140  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D + FG+ L E FT  +       G   L +                  +  E 
Sbjct: 200  TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 241
Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEER 1015
            +     E C   ++N+ ++C    PE+R
Sbjct: 242  ERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 758  IGRGGFGFV----YKARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V    + A     + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                  +   K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREG 927
               IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +  
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D + FG+ L E FT  +       G   L +                  +  E 
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 231
Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEER 1015
            +     E C   ++N+ ++C    PE+R
Sbjct: 232  ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         +S N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 200 IHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFIS 813
           +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +RH NI++   
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
                    L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 874 CDLKPNNVLLDDNMVAHLSDFGMA--KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
            D+KP N+LL  N    ++DFG +   P  + D          T+ Y+ PE   EGR+  
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRD------TLCGTLDYLPPEM-IEGRMHD 188
Query: 932 NG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
              D++S G++  E F    P  E+ T + T +R
Sbjct: 189 EKVDLWSLGVLCYE-FLVGMPPFEAHTYQETYRR 221

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA--KPFLKEDQSLTQTQTLATIGYMAP 921
           H   S  +IH D+KP N+LL       ++DFG +   P  + D          T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD------DLCGTLDYLPP 178
Query: 922 EYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
           E   EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 179 EM-IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 756 NLIGRGGFGFVYKARIQDG--------MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN 807
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           I+  I +  +     L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
              II+ DLKP N++L+      L+DFG+ K  +  D ++T T    TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAPEILMRS 196
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
             +   D +S G ++ +  T   P    FTGE
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         Y  N   +
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLXGTLDYLPPEM 182
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKARIQDGMEV-AVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR ++   + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQDTYKR 217

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA--KPFLKEDQSLTQTQTLATIGYMAP 921
           H   S  +IH D+KP N+LL       ++DFG +   P  + D          T+ Y+ P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD------TLCGTLDYLPP 176
Query: 922 EYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
           E   EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 177 EM-IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 218

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 178
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 178
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEM 180
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEM 179
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 219

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 796 ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILD 845
           E  M+K I +H+NII  + +C+ D    +++EY   G+L + L         Y  N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 846 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
               D     T     + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       +++FG +        S  +T    T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEM 179
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 219

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       +++FG +        S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEM 180
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L K    ++ +  I   L I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEM 180
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEM 177
Query: 924 GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+    L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+    L      + S  I E  ++K + H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 30/213 (14%)
Query: 747 QATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR 806
           Q    ++   +IG G FG V++A++ +  EVA+K   LQ  R       E  +++ ++H 
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKNR---ELQIMRIVKHP 92
Query: 807 NIIK----FISSCSSDD--FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNI------MI 854
           N++     F S+    D  F  LVLEY+P    E    +S +   + Q + +      M 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            +  +L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK  +  + +++    +
Sbjct: 149 QLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XI 202
Query: 914 ATIGYMAPE--YGREGRVSTNGDVYSFGIMLME 944
            +  Y APE  +G     +TN D++S G ++ E
Sbjct: 203 CSRYYRAPELIFGATN-YTTNIDIWSTGCVMAE 234

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 183
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKR-------IRHRN 807
           + +G G FG V     Q  G +VAVK+ + Q    I+S D+  G IKR        RH +
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDV-VGKIKREIQNLKLFRHPH 72
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           IIK     S+     +V+EY+  G L   +     + ++  R  +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM 131
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
              ++H DLKP NVLLD +M A ++DFG++   +  D    +  +  +  Y APE    G
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLR-DSCGSPNYAAPEV-ISG 184
Query: 928 RVSTNG--DVYSFGIMLMETFTRKKPTDE 954
           R+      D++S G++L        P D+
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 759 GRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS---C 815
            RG FG V+KA++ +   VAVK+F LQ  ++ +S + E      ++H N+++FI++    
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 816 SSDDFKA-LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF--------G 866
           S+ + +  L+  +   GSL    Y    I+   +  ++   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +   I H D K  NVLL  ++ A L+DFG+A  F            + T  YMAPE   E
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-LE 198
Query: 927 GRVSTNG------DVYSFGIMLMETFTRKKPTD 953
           G ++         D+Y+ G++L E  +R K  D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 752 FSENNLIGRGGFGFVYK-ARIQDGMEVAVKVFDL--------QYGRAIKSFDIECGMIKR 802
           +   ++IGRG    V +      G E AVK+ ++        Q     ++   E  ++++
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 803 IR-HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
           +  H +II  I S  S  F  LV + M  G L   L +    L   +  +IM  +  A+ 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           +LH      I+H DLKP N+LLDDNM   LSDFG +   L+  + L   +   T GY+AP
Sbjct: 215 FLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKL--RELCGTPGYLAP 268
Query: 922 E------------YGREGRVSTNGDVYSFGIML 942
           E            YG+E       D+++ G++L
Sbjct: 269 EILKCSMDETHPGYGKE------VDLWACGVIL 295

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-FDLQYGRAIKSFDI--ECGMIKRI 803
           A   F     +G+G FG VY AR  Q    +A+KV F  Q  +A     +  E  +   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           RH NI++            L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA--KPFLKEDQSLTQTQTLATIGYMAP 921
           H   S  +IH D+KP N+LL       ++DFG +   P  + D          T+ Y+ P
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD------DLCGTLDYLPP 201
Query: 922 EYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
           E   EGR+     D++S G++  E F   KP  E+ T + T KR
Sbjct: 202 EM-IEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 243

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 752 FSENNL-----IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIR- 804
           F  NNL     +G G FG V +A     G E AV    ++  ++    D +  ++  ++ 
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 805 ------HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------LDIFQR 849
                 H NI+  + +C+      ++ EY  YG L   L               L++   
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
           L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+  + +   + +
Sbjct: 155 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                 + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVAVK+ D       +++    E  ++K + H NI+K    
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV+EY   G +   L +  ++ +   R      + SA++Y H  +   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 933
           DLK  N+LLD +M   ++DFG +  F   ++  T      +  Y APE  +  +      
Sbjct: 131 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 187
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 188 DVWSLGVILYTLVSGSLPFD 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 757 LIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGM------IKRIRHRNIIK 810
           +IG+G FG V  AR     EV   V  LQ    +K  + +  M      +K ++H  ++ 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              S  + D    VL+Y+  G L   L      L+   R     ++ASAL YLH   S+ 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           I++ DLKP N+LLD      L+DFG+ K  ++ +   T +    T  Y+APE   +    
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYD 217
Query: 931 TNGDVYSFGIMLMETFTRKKPTDESFTGEM 960
              D +  G +L E      P     T EM
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 757 LIGRGGFGFVYKAR-IQDG----MEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIK 810
           ++G G FG V+K   I +G    + V +KV + + GR + ++       I  + H +I++
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +  C     + LV +Y+P GSL   +      L     LN  + +A  + YL       
Sbjct: 80  LLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHG 135
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           ++H +L   NVLL       ++DFG+A     +D+ L  ++    I +MA E    G+ +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 931 TNGDVYSFGIMLMETFT 947
              DV+S+G+ + E  T
Sbjct: 196 HQSDVWSYGVTVWELMT 212

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++    L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSM-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++    L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSM-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 46/285 (16%)
Query: 750  NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRN 807
            + F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       
Sbjct: 9    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
            I+ F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 69   IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 126
Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            +   I+H D+KP+N+L++      L DFG++   + E       + + T  YM+PE  + 
Sbjct: 127  HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQG 180
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
               S   D++S G+ L+E    + P                    ++I E++D       
Sbjct: 181  THYSVQSDIWSMGLSLVEMAVGRYPRPP-----------------MAIFELLD------- 216
Query: 987  DKHFVAKE---QCMSFVFNLAM-----KCTIESPEERINAKEIVT 1023
               ++  E   +  S VF+L       KC I++P ER + K+++ 
Sbjct: 217  ---YIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 752 FSENNL-----IGRGGFGFVYKARI-----QDG-MEVAVKVF-DLQYGRAIKSFDIECGM 799
           F  NNL     +G G FG V +A       +D  ++VAVK+     +    ++   E  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 800 IKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLY---------SSNYILDIFQR 849
           +  + +H NI+  + +C+      ++ EY  YG L   L               L++   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
           L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+  + +   + +
Sbjct: 163 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                 + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 26   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 86   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H +L   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 146  YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 203  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 250
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P  R    EIV  L
Sbjct: 251  YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H +L   N ++  +    + DFGM +   + D      + L  + +MAP
Sbjct: 145  YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P  R    EIV  L
Sbjct: 250  YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L K    ++ +  I   L I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           +G+G +G V++   Q G  VAVK+F     R  KS+  E  +   +  RH NI+ FI+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 868
            +    +    L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 869 --VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-----LATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 922 E----------YGREGRVSTNGDVYSFGIMLMETFTR 948
           E          +    RV    D+++FG++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARR 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           +G+G +G V++   Q G  VAVK+F     R  KS+  E  +   +  RH NI+ FI+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 868
            +    +    L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 869 --VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-----LATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 922 E----------YGREGRVSTNGDVYSFGIMLMETFTR 948
           E          +    RV    D+++FG++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARR 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           +G+G +G V++   Q G  VAVK+F     R  KS+  E  +   +  RH NI+ FI+S 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 868
            +    +    L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 869 --VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-----LATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 922 E----------YGREGRVSTNGDVYSFGIMLMETFTR 948
           E          +    RV    D+++FG++L E   R
Sbjct: 216 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARR 248

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 758  IGRGGFGFVYKARIQDGME------VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 861
             +   S      +V+E M +G L+  L S     +         + + + +  ++A  + 
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++  +    + DFGM +   +        + L  + +MAP
Sbjct: 145  YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             L   D        C   V +L   C   +P+ R    EIV  L
Sbjct: 250  YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 41/229 (17%)
Query: 757 LIGRGGFGFVYKARIQDGMEV----AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNII 809
           ++G+G FG V+  +   G +     A+KV     L+    +++  +E  ++  + H  I+
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 90
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------------IMIDVA 857
           K   +  ++    L+L+++  G             D+F RL+             + ++A
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 137
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D          T+ 
Sbjct: 138 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVE 192
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP---TDESFTGEMTLK 963
           YMAPE       + + D +SFG+++ E  T   P    D   T  M LK
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 241

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           +K +    +++   LV E++   S++ K    ++ +  I   L I   +   L+ L F +
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCH 123
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S  ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGC 181
Query: 928 R-VSTNGDVYSFGIMLMETFTRK 949
           +  ST  D++S G +  E  TR+
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A     G +VAVK  DL+  +  +    E  +++   H N++   SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE        T  D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 226 SLGIMVIEMIDGEPP 240

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           +K +    +++   LV E++   S++ K    ++ +  I   L I   +   L+ L F +
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCH 122
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S  ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGC 180
Query: 928 R-VSTNGDVYSFGIMLMETFTRK 949
           +  ST  D++S G +  E  TR+
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 756 NLIGRGGFGFVYKARIQDG--------MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN 807
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           I+  I +  +     L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
              II+ DLKP N++L+      L+DFG+ K  +  D ++T      TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAPEILMRS 196
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
             +   D +S G ++ +  T   P    FTGE
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 13   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 70   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 117  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 177  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 237  LA------------------LLHKILVENPSARITIPDI 257

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 41/229 (17%)
Query: 757 LIGRGGFGFVYKARIQDGMEV----AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNII 809
           ++G+G FG V+  +   G +     A+KV     L+    +++  +E  ++  + H  I+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------------IMIDVA 857
           K   +  ++    L+L+++  G             D+F RL+             + ++A
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D          T+ 
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVE 191
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP---TDESFTGEMTLK 963
           YMAPE       + + D +SFG+++ E  T   P    D   T  M LK
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 42/283 (14%)
Query: 752  FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNII 809
            F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       I+
Sbjct: 27   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYS 868
             F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   + 
Sbjct: 87   GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 144
Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
              I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  +   
Sbjct: 145  --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH 198
Query: 929  VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK 988
             S   D++S G+ L+E    + P   S +G M            +I E++D         
Sbjct: 199  YSVQSDIWSMGLSLVEMAVGRYPIG-SGSGSM------------AIFELLD--------- 236
Query: 989  HFVAKE---QCMSFVFNLAM-----KCTIESPEERINAKEIVT 1023
             ++  E   +  S VF+L       KC I++P ER + K+++ 
Sbjct: 237  -YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 278

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 41/229 (17%)
Query: 757 LIGRGGFGFVYKARIQDGMEV----AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNII 809
           ++G+G FG V+  +   G +     A+KV     L+    +++  +E  ++  + H  I+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------------IMIDVA 857
           K   +  ++    L+L+++  G             D+F RL+             + ++A
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D          T+ 
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVE 191
Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP---TDESFTGEMTLK 963
           YMAPE       + + D +SFG+++ E  T   P    D   T  M LK
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 14   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 118  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 178  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 238  LA------------------LLHKILVENPSARITIPDI 258

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  + K + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 9/190 (4%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           IG G +G VYKA+   G   A+K   L+     I S  I E  ++K ++H NI+K     
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +     LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-GREGRVSTNGD 934
           LKP N+L++      ++DFG+A+ F    +    T  + T+ Y AP+      + ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 935 VYSFGIMLME 944
           ++S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++    L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 11/191 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           IG G +G VYKA+   G   A+K   L+     I S  I E  ++K ++H NI+K     
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +     LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY--GREGRVSTNG 933
           LKP N+L++      ++DFG+A+ F    +    T  + T+ Y AP+   G + + ST  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 934 DVYSFGIMLME 944
           D++S G +  E
Sbjct: 183 DIWSVGCIFAE 193

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 477
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 478 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 533
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
             + + APE     + S+  DV+SFG+++ E F+
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR +  G EVAVK+ D       +++    E  ++K + H NI+K    
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV+EY   G +   L +   + +   R      + SA++Y H  Y   I+H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-TNG 933
           DLK  N+LLD +M   ++DFG +  F   ++  T      +  Y APE  +  +      
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 195
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 196 DVWSLGVILYTLVSGSLPFD 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNI 808
           F +   IG G +G VYKAR +  G  VA+K   L      + S  I E  ++K + H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +K +    +++   LV E++ +  L+  + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             ++H DLKP N+L++      L+DFG+A+ F    +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 929 -VSTNGDVYSFGIMLMETFTRK 949
             ST  D++S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           IG+G FG V++ + + G EVAVK+F     R  +S+  E  + + +  RH NI+ FI++ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 867
           + D+       LV +Y  +GSL    Y + Y + +   + + +  AS L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 868 -SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAP
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 922 EY------GREGRVSTNGDVYSFGIMLMETFTR 948
           E        +        D+Y+ G++  E   R
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           IG+G FG V++ + + G EVAVK+F     R  +S+  E  + + +  RH NI+ FI++ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 867
           + D+       LV +Y  +GSL    Y + Y + +   + + +  AS L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 868 -SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAP
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 922 EY------GREGRVSTNGDVYSFGIMLMETFTR 948
           E        +        D+Y+ G++  E   R
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           IG+G FG V++ + + G EVAVK+F     R  +S+  E  + + +  RH NI+ FI++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 867
           + D+       LV +Y  +GSL    Y + Y + +   + + +  AS L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 868 -SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 922 EY------GREGRVSTNGDVYSFGIMLMETFTR 948
           E        +        D+Y+ G++  E   R
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           IG+G FG V++ + + G EVAVK+F     R  +S+  E  + + +  RH NI+ FI++ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 867
           + D+       LV +Y  +GSL    Y + Y + +   + + +  AS L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 868 -SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAP
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 922 EY------GREGRVSTNGDVYSFGIMLMETFTR 948
           E        +        D+Y+ G++  E   R
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           IG+G FG V++ + + G EVAVK+F     R  +S+  E  + + +  RH NI+ FI++ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 867
           + D+       LV +Y  +GSL    Y + Y + +   + + +  AS L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 868 -SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAP
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 922 EY------GREGRVSTNGDVYSFGIMLMETFTR 948
           E        +        D+Y+ G++  E   R
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           IG+G FG V++ + + G EVAVK+F     R  +S+  E  + + +  RH NI+ FI++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 867
           + D+       LV +Y  +GSL    Y + Y + +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 868 -SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAP 921
               I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 922 EY------GREGRVSTNGDVYSFGIMLMETFTR 948
           E        +        D+Y+ G++  E   R
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 11/191 (5%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQY-GRAIKSFDI-ECGMIKRIRHRNIIKFISSC 815
           IG G +G VYKA+   G   A+K   L+     I S  I E  ++K ++H NI+K     
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +     LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY--GREGRVSTNG 933
           LKP N+L++      ++DFG+A+ F    +    T  + T+ Y AP+   G + + ST  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 934 DVYSFGIMLME 944
           D++S G +  E
Sbjct: 183 DIWSVGCIFAE 193

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 478
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 534
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
             + + APE     + S+  DV+SFG+++ E F+
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 36/285 (12%)
Query: 750  NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRN 807
            + F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       
Sbjct: 6    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
            I+ F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 66   IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            +   I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  + 
Sbjct: 124  HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
               S   D++S G+ L+E    + P       E       +    ++I E++D       
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-------DSRPPMAIFELLD------- 223
Query: 987  DKHFVAKE---QCMSFVFNLAM-----KCTIESPEERINAKEIVT 1023
               ++  E   +  S VF+L       KC I++P ER + K+++ 
Sbjct: 224  ---YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 265

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVAVK+ D       +++    E  ++K + H NI+K    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 933
           DLK  N+LLD +M   ++DFG +  F   ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 739 RFTYLELFQAT-NGFSENNLIGRGGFGFVYKARIQDGMEVAV------KVFDLQYGRAIK 791
           ++ +LE    T N F +  ++G+GGFG V   +++   ++        K    + G A+ 
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 792 SFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRL 850
             + +  +++++  R ++    +  + D   LVL  M  G L+  +Y          + +
Sbjct: 232 LNEKQ--ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
               ++   LE LH      I++ DLKP N+LLDD+    +SD G+A   + E Q++   
Sbjct: 290 FYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTI--K 343
Query: 911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
             + T+GYMAPE  +  R + + D ++ G +L E    + P
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVAVK+ D       +++    E  ++K + H NI+K    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 933
           DLK  N+LLD +M   ++DFG +  F   ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 29/277 (10%)
Query: 755  NNLIGRGGFGFVYKARIQD--GMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N ++G G FG VY+    +  G ++ V V   +    +   + F  E  ++K + H +I+
Sbjct: 13   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            K I     +    +++E  PYG L   L  +   L +   +   + +  A+ YL    S+
Sbjct: 73   KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
              +H D+   N+L+       L DFG+++ +++++     + T   I +M+PE     R 
Sbjct: 129  NCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
            +T  DV+ F + + E  +  K   + F        W+ +  +I ++E  D          
Sbjct: 188  TTASDVWMFAVCMWEILSFGK---QPFF-------WLENKDVIGVLEKGD---------R 228
Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                + C   ++ L  +C    P +R    E+V  L+
Sbjct: 229  LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 265

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 29/277 (10%)
Query: 755  NNLIGRGGFGFVYKARIQD--GMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N ++G G FG VY+    +  G ++ V V   +    +   + F  E  ++K + H +I+
Sbjct: 17   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            K I     +    +++E  PYG L   L  +   L +   +   + +  A+ YL    S+
Sbjct: 77   KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
              +H D+   N+L+       L DFG+++ +++++     + T   I +M+PE     R 
Sbjct: 133  NCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
            +T  DV+ F + + E  +  K   + F        W+ +  +I ++E  D          
Sbjct: 192  TTASDVWMFAVCMWEILSFGK---QPFF-------WLENKDVIGVLEKGD---------R 232
Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                + C   ++ L  +C    P +R    E+V  L+
Sbjct: 233  LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 29/277 (10%)
Query: 755  NNLIGRGGFGFVYKARIQD--GMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNII 809
            N ++G G FG VY+    +  G ++ V V   +    +   + F  E  ++K + H +I+
Sbjct: 29   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            K I     +    +++E  PYG L   L  +   L +   +   + +  A+ YL    S+
Sbjct: 89   KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
              +H D+   N+L+       L DFG+++ +++++     + T   I +M+PE     R 
Sbjct: 145  NCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
            +T  DV+ F + + E  +  K   + F        W+ +  +I ++E  D          
Sbjct: 204  TTASDVWMFAVCMWEILSFGK---QPFF-------WLENKDVIGVLEKGD---------R 244
Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                + C   ++ L  +C    P +R    E+V  L+
Sbjct: 245  LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 281

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 16/252 (6%)
Query: 748 ATNGF---SENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI 803
           A N F   S+  ++G G FG V+K      G+++A K+   +  +  +    E  ++ ++
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
            H N+I+   +  S +   LV+EY+  G L   +   +Y L     +  M  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 864 HFGYSVPIIHCDLKPNNVLL--DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           H  Y   I+H DLKP N+L    D     + DFG+A+ +   ++         T  ++AP
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAP 257
Query: 922 EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
           E      VS   D++S G++     +   P    F G+   +   N L     +E  +  
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSP----FLGDNDAETLNNILACRWDLEDEEFQ 313
Query: 982 LLSHEDKHFVAK 993
            +S E K F++K
Sbjct: 314 DISEEAKEFISK 325

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 745 LFQATNGFSEN----NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQY--GRAIKSFDIEC 797
           +  A+  FS+N      +G+G F  V +      G+E A K+ + +    R  +  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 798 GMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA 857
            + ++++H NI++   S   + F  LV + +  G L + + +  +    +   +    + 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQ 135
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
             LE + + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAG 192
Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIML 942
           T GY++PE  ++   S   D+++ G++L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 739 RFTYLELFQAT-NGFSENNLIGRGGFGFVYKARIQDGMEVAV------KVFDLQYGRAIK 791
           ++ +LE    T N F +  ++G+GGFG V   +++   ++        K    + G A+ 
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 792 SFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRL 850
             + +  +++++  R ++    +  + D   LVL  M  G L+  +Y          + +
Sbjct: 232 LNEKQ--ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
               ++   LE LH      I++ DLKP N+LLDD+    +SD G+A   + E Q++   
Sbjct: 290 FYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTI--K 343
Query: 911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
             + T+GYMAPE  +  R + + D ++ G +L E    + P
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 756 NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKR-------IRHRN 807
           + +G G FG V   + +  G +VAVK+ + Q    I+S D+  G I+R        RH +
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDV-VGKIRREIQNLKLFRHPH 77
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           IIK     S+     +V+EY+  G L   +   N  LD  +   +   + S ++Y H   
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
              ++H DLKP NVLLD +M A ++DFG++   +  D    +  +  +  Y APE    G
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRX-SCGSPNYAAPEVI-SG 189
Query: 928 RVSTNG--DVYSFGIMLMETFTRKKPTDE 954
           R+      D++S G++L        P D+
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 752 FSENNL-----IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIR- 804
           F  NNL     +G G FG V +A     G E AV    ++  ++    D +  ++  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 805 ------HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------YSSNYILDIFQR 849
                 H NI+  + +C+      ++ EY  YG L   L         YS N   +  ++
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 850 LNIMIDVASALEYLHFGYSVP----------IIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
           L       S+ + LHF   V            IH D+   NVLL +  VA + DFG+A+ 
Sbjct: 163 L-------SSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            + +   + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 216 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           F E  LIG GGFG V+KA+ + DG    +K       +A +    E   + ++ H NI+ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 811 F------------ISSCSSDDFKA----LVLEYMPYGSLEKCLYSSN-YILDIFQRLNIM 853
           +             SS +S   K     + +E+   G+LE+ +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
             +   ++Y+H   S  +I+ DLKP+N+ L D     + DFG+    LK D    +++  
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRXRSK-- 182
Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
            T+ YM+PE           D+Y+ G++L E
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 756 NLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNI 808
            ++G+G FG V  AR+++ G   AVKV  L+    ++  D+EC M  KRI      H  +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            +      + D    V+E++  G L   +  S    +   R     ++ SAL +LH    
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---D 142
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             II+ DLK +NVLLD      L+DFGM K  +     +T      T  Y+APE  +E  
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEML 200
Query: 929 VSTNGDVYSFGIMLMETFTRKKP 951
                D ++ G++L E      P
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 113
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 169
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 125
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 126 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 181
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 191
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 191
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 115
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 171
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 175
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 133
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 134 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 189
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++++ +  I++ I  C ++ +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENXYKAQTHGK 175
Query: 916 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKP 951
             + + APE     + S+  DV+SFG+++ E F+  +KP
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  AR +  G +VAVK+ DL+  +  +    E  +++  +H N+++   S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      K+     +   + T  +MAPE       +T  D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 226 SLGIMVIEMVDGEPP 240

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVAV++ D       +++    E  ++K + H NI+K    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 933
           DLK  N+LLD +M   ++DFG +  F   ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+ ++  +  A KV D +    ++ + +E  ++    H NI+K + +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-----GREGRVST 931
           K  N+L   +    L+DFG++    +  Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 932 NGDVYSFGIMLMETFTRKKPTDE 954
             DV+S GI L+E    + P  E
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHE 242

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+ ++  +  A KV D +    ++ + +E  ++    H NI+K + +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEY-----GREGRVS 930
           K  N+L   +    L+DFG++    K  +++ +  + + T  +MAPE       ++    
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 931 TNGDVYSFGIMLMETFTRKKPTDE 954
              DV+S GI L+E    + P  E
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHE 242

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVAV++ D       +++    E  ++K + H NI+K    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-TNG 933
           DLK  N+LLD +M   ++DFG +  F   ++     +   +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG VYKA+ ++  +  A KV D +    ++ + +E  ++    H NI+K + +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-----GREGRVST 931
           K  N+L   +    L+DFG++    +  Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 932 NGDVYSFGIMLMETFTRKKPTDE 954
             DV+S GI L+E    + P  E
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHE 242

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 748 ATNGFSENNLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRH 805
           +++ F +   +G G +  VYK      G+ VA+K   L       S  I E  ++K ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNY----------ILDIFQRLNIMID 855
            NI++      +++   LV E+M    L+K + S             ++  FQ       
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
               L+ L F +   I+H DLKP N+L++      L DFG+A+ F     +   +  + T
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVT 171
Query: 916 IGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRK 949
           + Y AP+     R  ST+ D++S G +L E  T K
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           F E  LIG GGFG V+KA+ + DG    ++       +A +    E   + ++ H NI+ 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 811 F--------------ISSCSSDDFKA---------------LVLEYMPYGSLEKCLYS-S 840
           +                S  S D+                 + +E+   G+LE+ +    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 841 NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF 900
              LD    L +   +   ++Y+H   S  +IH DLKP+N+ L D     + DFG+    
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS- 185
Query: 901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           LK D   T+++   T+ YM+PE           D+Y+ G++L E
Sbjct: 186 LKNDGKRTRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 46/258 (17%)
Query: 777  VAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL 833
            VAVK+ D++  RA+   ++   E  + K + H N++KF       + + L LEY   G L
Sbjct: 34   VAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 834  EKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------FGYSVPIIHCDLKPNNVLLD 884
                         F R+  +I +    A  + H       + + + I H D+KP N+LLD
Sbjct: 92   -------------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 885  DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLM 943
            +     +SDFG+A  F   ++     +   T+ Y+APE  +         DV+S GI+L 
Sbjct: 139  ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 944  ETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNL 1003
                 + P D+          W      ++  + +D+  L+                  L
Sbjct: 199  AMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------------------L 240
Query: 1004 AMKCTIESPEERINAKEI 1021
              K  +E+P  RI   +I
Sbjct: 241  LHKILVENPSARITIPDI 258

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 757 LIGRGGFGFVY----KARIQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNII 809
           ++G+G FG V+      R   G   A+KV     L+    +++  +E  ++  + H  ++
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFVV 93
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------------IMIDVA 857
           K   +  ++    L+L+++  G             D+F RL+             + ++A
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 140
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
             L++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D          T+ 
Sbjct: 141 LGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVE 195
Query: 918 YMAPE-YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           YMAPE   R+G  S + D +S+G+++ E  T   P
Sbjct: 196 YMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLP 229

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 49/279 (17%)
Query: 758  IGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAI---KSFDIECGMIKRIRHRNIIKFI 812
            +G G +G V  A  R+ +   VAVK+ D++  RA+   ++   E  +   + H N++KF 
Sbjct: 15   LGEGAYGEVQLAVNRVTE-EAVAVKIVDMK--RAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH------ 864
                  + + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 865  -FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
             + + + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE 
Sbjct: 119  VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 924  GREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
             +         DV+S GI+L      + P D+          W      ++  + +D+  
Sbjct: 179  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            L+                  L  K  +E+P  RI   +I
Sbjct: 239  LA------------------LLHKILVENPSARITIPDI 259

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR------IRHRNII 809
            +IGRG FG V   R     + + KV+ +   + +  F+    MIKR         R+I+
Sbjct: 81  KVIGRGAFGEVQLVR----HKASQKVYAM---KLLSKFE----MIKRSDSAFFWEERDIM 129
Query: 810 KFISS-------CSSDDFKAL--VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
            F +S       C+  D K L  V+EYMP G L   +  SNY +          +V  AL
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLAL 187
Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQTQT-LATIGY 918
           + +H   S+ +IH D+KP+N+LLD +    L+DFG     +K D++ +    T + T  Y
Sbjct: 188 DAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVHCDTAVGTPDY 241
Query: 919 MAPEY----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           ++PE     G +G      D +S G+ L E      P
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVAVK+ D       +++    E  ++K + H NI+K    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 933
           DLK  N+LLD +M   ++DFG +  F   ++            Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     M VA+K        +++  F  E   +++  H +I+K I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 193 SDVWMFGVCMWE 204

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 11/216 (5%)
Query: 750 NGFSENNLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRN 807
           + F + + +G G  G V+K +    G+ +A K+  L+   AI++  I E  ++       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
           I+ F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 185
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +   I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  + 
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 239
Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
              S   D++S G+ L+E    + P       E+ L
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSF-DIECGMIKRIRHRNII 809
           F++ + IG+G FG VYK       EV A+K+ DL+           E  ++ +     I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 810 KFISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
           ++  S        +++EY+  GS    L+       YI  I +      ++   L+YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 133
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S   IH D+K  NVLL +     L+DFG+A      D  + +   + T  +MAPE  +
Sbjct: 134 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIK 189
Query: 926 EGRVSTNGDVYSFGIMLME 944
           +       D++S GI  +E
Sbjct: 190 QSAYDFKADIWSLGITAIE 208

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 758 IGRGGFGFVYKARIQDGMEVA----VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           IG G +G V+KA+ ++  E+     V++ D   G    +    C ++K ++H+NI++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHD 68
Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
              SD    LV E+     L+K   S N  LD     + +  +   L + H   S  ++H
Sbjct: 69  VLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STN 932
            DLKP N+L++ N    L+DFG+A+ F    +    +  + T+ Y  P+     ++ ST+
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 933 GDVYSFGIMLMETFTRKKP 951
            D++S G +  E     +P
Sbjct: 183 IDMWSAGCIFAELANAARP 201

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 91
Query: 805 HRNIIKFISSCSSDDFKALVL-EYMPYGSLEKCL---------YSSNYILDIFQRLNIMI 854
           H N++  + +C+      +V+ E+  +G+L   L         Y    +   F  L  +I
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 855 ----DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
                VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + + 
Sbjct: 152 XYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 911 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 11/216 (5%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRN 807
           + F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
           I+ F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 150
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +   I+H D+KP+N+L++      L DFG++   +    S+  +  + T  YM+PE  + 
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 204
Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
              S   D++S G+ L+E    + P       E+ L
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 38/231 (16%)
Query: 752 FSENNL-----IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIR- 804
           F  NNL     +G G FG V +A     G E AV    ++  ++    D +  ++  ++ 
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 805 ------HRNIIKFISSCSSDDFKALVLEYMPYGSL----------------------EKC 836
                 H NI+  + +C+      ++ EY  YG L                      E  
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 837 LYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 896
                  L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           A+  + +   + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 11/216 (5%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRN 807
           + F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
           I+ F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +   I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  + 
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
              S   D++S G+ L+E    + P       E+ L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 11/216 (5%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRN 807
           + F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
           I+ F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +   I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  + 
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
              S   D++S G+ L+E    + P       E+ L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 89
Query: 805 HRNIIKFISSCSSDDFKALVL-EYMPYGSLEKCLYSSNY-----------ILDIFQRLNI 852
           H N++  + +C+      +V+ E+  +G+L   L S               L +   +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +   
Sbjct: 150 SFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 25/200 (12%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGME--VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
           F   + +GRG    VY+ + Q G +   A+KV      + I     E G++ R+ H NII
Sbjct: 55  FEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNII 111
Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           K      +    +LVLE +  G L     EK  YS     D  ++      +  A+ YLH
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAYLH 165
Query: 865 FGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
                 I+H DLKP N+L      +    ++DFG++K  + E Q L +T    T GY AP
Sbjct: 166 ---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKT-VCGTPGYCAP 219
Query: 922 EYGREGRVSTNGDVYSFGIM 941
           E  R        D++S GI+
Sbjct: 220 EILRGCAYGPEVDMWSVGII 239

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     M VA+K        +++  F  E   +++  H +I+K I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    + LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFTSA 192
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 193 SDVWMFGVCMWE 204

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR------IRHRNII 809
           +IGRG FG V   R +   +V A+K+        +  F+    MIKR         R+I+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKL--------LSKFE----MIKRSDSAFFWEERDIM 123
Query: 810 KFISS---------CSSDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASA 859
            F +S            D +  +V+EYMP G L   +  SNY + + + R     +V  A
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLA 180
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           L+ +H   S+  IH D+KP+N+LLD +    L+DFG      KE      T  + T  Y+
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYI 236
Query: 920 APEY----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           +PE     G +G      D +S G+ L E      P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR------IRHRNII 809
           +IGRG FG V   R +   +V A+K+        +  F+    MIKR         R+I+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKL--------LSKFE----MIKRSDSAFFWEERDIM 128
Query: 810 KFISS---------CSSDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASA 859
            F +S            D +  +V+EYMP G L   +  SNY + + + R     +V  A
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLA 185
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           L+ +H   S+  IH D+KP+N+LLD +    L+DFG      KE      T  + T  Y+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYI 241
Query: 920 APEY----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           +PE     G +G      D +S G+ L E      P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 37/236 (15%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G +G V  AR +  G +VA+K       +   +FD+     + +R   I+K     +
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR-LNIMIDVASALEYLHFGY-------- 867
               K ++   +PYG   K +Y    +LD+ +  L+ +I  +  L   H  Y        
Sbjct: 116 IIAIKDILRPTVPYGEF-KSVY---VVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 868 -----SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL--KEDQSLTQTQTLATIGYMA 920
                S  +IH DLKP+N+L+++N    + DFGMA+       +     T+ +AT  Y A
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 921 PEYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM 975
           PE        T   D++S G +  E   R+    + F G    K +V+ L LI ++
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPG----KNYVHQLQLIMMV 279

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 121/295 (41%), Gaps = 38/295 (12%)
Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
            IG+G +G V+  + + G +VAVKVF      A    + E      +RH NI+ FI++   
Sbjct: 45   IGKGRYGEVWMGKWR-GEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFIAA--- 99
Query: 818  DDFKA--------LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-- 867
             D K         L+ +Y   GSL   L S+   LD    L +     S L +LH     
Sbjct: 100  -DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 868  ---SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE--DQSLTQTQTLATIGYMAPE 922
                  I H DLK  N+L+  N    ++D G+A  F+ +  +  +     + T  YM PE
Sbjct: 157  TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 923  YGREG------RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL-----L 971
               E       +     D+YSFG++L E   R          E  L    +DL+      
Sbjct: 217  VLDESLNRNHFQSYIMADMYSFGLILWEVARR--CVSGGIVEEYQLP--YHDLVPSDPSY 272
Query: 972  ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
              + E+V    L     +  + ++C+  +  L  +C   +P  R+ A  +   LA
Sbjct: 273  EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 43/217 (19%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVF--------DLQYGRAIKSFDIECGMIKRIRHRNI 808
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH +I
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 75
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID---------VASA 859
           IK      S D   +V+EY           + N + D   + + M +         + SA
Sbjct: 76  IKLYDVIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISA 124
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           +EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y 
Sbjct: 125 VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYA 178
Query: 920 APEYGREGRVSTNG--DVYSFGIMLMETFTRKKPTDE 954
           APE    G++      DV+S G++L     R+ P D+
Sbjct: 179 APEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 37/236 (15%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G +G V  AR +  G +VA+K       +   +FD+     + +R   I+K     +
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR-LNIMIDVASALEYLHFGY-------- 867
               K ++   +PYG   K +Y    +LD+ +  L+ +I  +  L   H  Y        
Sbjct: 115 IIAIKDILRPTVPYGEF-KSVY---VVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 868 -----SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE--DQSLTQTQTLATIGYMA 920
                S  +IH DLKP+N+L+++N    + DFGMA+       +     T+ +AT  Y A
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 921 PEYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM 975
           PE        T   D++S G +  E   R+    + F G    K +V+ L LI ++
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPG----KNYVHQLQLIMMV 278

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDI-ECGMIKRIRHRNIIKFI 812
           IG G +G   K R + DG  +  K  +L YG    A K   + E  +++ ++H NI+++ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 813 SSC--SSDDFKALVLEYMPYGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF- 865
                 ++    +V+EY   G L     K      Y+ + F  L +M  +  AL+  H  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 866 ---GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
              G++V  +H DLKP NV LD      L DFG+A+  L  D S  +T  + T  YM+PE
Sbjct: 131 SDGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKT-FVGTPYYMSPE 186
Query: 923 YGREGRVSTNGDVYSFGIMLME 944
                  +   D++S G +L E
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR------IRHRNII 809
           +IGRG FG V   R +   +V A+K+        +  F+    MIKR         R+I+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKL--------LSKFE----MIKRSDSAFFWEERDIM 128
Query: 810 KFISS---------CSSDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASA 859
            F +S            D +  +V+EYMP G L   +  SNY + + + R     +V  A
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLA 185
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           L+ +H   S+  IH D+KP+N+LLD +    L+DFG      KE      T  + T  Y+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYI 241
Query: 920 APEY----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           +PE     G +G      D +S G+ L E      P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 43/218 (19%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVF--------DLQYGRAIKSFDIECGMIKRIRHRNI 808
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH +I
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 66
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID---------VASA 859
           IK      S D   +V+EY           + N + D   + + M +         + SA
Sbjct: 67  IKLYDVIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISA 115
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           +EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y 
Sbjct: 116 VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYA 169
Query: 920 APEYGREGRVSTNG--DVYSFGIMLMETFTRKKPTDES 955
           APE    G++      DV+S G++L     R+ P D+ 
Sbjct: 170 APEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 43/218 (19%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVF--------DLQYGRAIKSFDIECGMIKRIRHRNI 808
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH +I
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 76
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID---------VASA 859
           IK      S D   +V+EY           + N + D   + + M +         + SA
Sbjct: 77  IKLYDVIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISA 125
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           +EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y 
Sbjct: 126 VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYA 179
Query: 920 APEYGREGRVSTNG--DVYSFGIMLMETFTRKKPTDES 955
           APE    G++      DV+S G++L     R+ P D+ 
Sbjct: 180 APEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRN 807
           + F   + +G G  G V K + +  G+ +A K+  L+   AI++  I E  ++       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 866
           I+ F  +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 133
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           +   I+H D+KP+N+L++      L DFG++   +           + T  YMAPE  + 
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERLQG 187
Query: 927 GRVSTNGDVYSFGIMLMETFTRKKP 951
              S   D++S G+ L+E    + P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 43/218 (19%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVF--------DLQYGRAIKSFDIECGMIKRIRHRNI 808
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH +I
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 70
Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID---------VASA 859
           IK      S D   +V+EY           + N + D   + + M +         + SA
Sbjct: 71  IKLYDVIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISA 119
Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           +EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y 
Sbjct: 120 VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYA 173
Query: 920 APEYGREGRVSTNG--DVYSFGIMLMETFTRKKPTDES 955
           APE    G++      DV+S G++L     R+ P D+ 
Sbjct: 174 APEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 89
Query: 805 HRNIIKFISSCSSDDFKALVL-EYMPYGSLEKCLYSSNY-------ILDIFQRLNIMI-- 854
           H N++  + +C+      +V+ E+  +G+L   L S          +   F  L  +I  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 855 --DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +   
Sbjct: 150 SFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 27/241 (11%)
Query: 723 KSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDG-------- 774
           K +L  AN+   A +      EL +         ++G G +G V+  R   G        
Sbjct: 36  KHELRTANLTGHAEKVGIENFELLK---------VLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 775 MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK-ALVLEYMPYGSL 833
           M+V  K   +Q  +  +    E  +++ IR    +  +      + K  L+L+Y+  G L
Sbjct: 87  MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 146
Query: 834 EKCLYSSNYILDIFQRLNIMI-DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
              L       +    + I + ++  ALE+LH    + II+ D+K  N+LLD N    L+
Sbjct: 147 FTHLSQRERFTE--HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT 201
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG--DVYSFGIMLMETFTRKK 950
           DFG++K F+  D++        TI YMAP+  R G    +   D +S G+++ E  T   
Sbjct: 202 DFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
Query: 951 P 951
           P
Sbjct: 261 P 261

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     + VA+K        +++  F  E   +++  H +I+K I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 193 SDVWMFGVCMWE 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     + VA+K        +++  F  E   +++  H +I+K I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 220
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 221 SDVWMFGVCMWE 232

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 71/177 (40%), Gaps = 33/177 (18%)
Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
            VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+   K    + +  T   
Sbjct: 208  VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP------TDESFTGEMTLKRWVNDL 969
            + +MAPE   +   ST  DV+S+G++L E F+           DE F   +         
Sbjct: 265  LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL--------- 315
Query: 970  LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                            E     A E     ++ + + C    P+ER    E+V KL 
Sbjct: 316  ---------------REGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLG 357

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----R 804
           F  + ++G+G FG V+ A  +   +  A+K   L+    +   D+EC M+ KR+      
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           H  +     +  + +    V+EY+  G L   + S  +  D+ +      ++   L++LH
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 136
Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
              S  I++ DLK +N+LLD +    ++DFGM K  +  D      +   T  Y+APE  
Sbjct: 137 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIAPEIL 191
Query: 925 REGRVSTNGDVYSFGIMLMETFTRKKP 951
              + + + D +SFG++L E    + P
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 757 LIGRGGFGFVYKA-RIQDG----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
           ++G G FG VYK   + +G    + VA+K+ +   G +A   F  E  ++  + H ++++
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +  C S   + LV + MP+G L + ++     +     LN  + +A  + YL       
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 160
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           ++H DL   NVL+       ++DFG+A+    +++          I +MA E     + +
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 931 TNGDVYSFGIMLMETFT-RKKPTDESFTGEM 960
              DV+S+G+ + E  T   KP D   T E+
Sbjct: 221 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 757 LIGRGGFGFVYKA-RIQDG----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
           ++G G FG VYK   + +G    + VA+K+ +   G +A   F  E  ++  + H ++++
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +  C S   + LV + MP+G L + ++     +     LN  + +A  + YL       
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 137
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           ++H DL   NVL+       ++DFG+A+    +++          I +MA E     + +
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 931 TNGDVYSFGIMLMETFT-RKKPTDESFTGEM 960
              DV+S+G+ + E  T   KP D   T E+
Sbjct: 198 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRIRH 805
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I H
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 126
Query: 806 R-NIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
             N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 184
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 185 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 242 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 764 GFVYKARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--D 819
           G ++K R Q G ++ VKV  ++    R  + F+ EC  ++   H N++  + +C S    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 820 FKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 878
              L+  + PYGSL   L+  +N+++D  Q +   +D A    +LH    +   H  L  
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA-LNS 141
Query: 879 NNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN---GDV 935
            +V +D++  A +S   +   F    QS  +    A   ++APE  ++    TN    D 
Sbjct: 142 RSVXIDEDXTARISXADVKFSF----QSPGRXYAPA---WVAPEALQKKPEDTNRRSADX 194
Query: 936 YSFGIMLMETFTRKKP 951
           +SF ++L E  TR+ P
Sbjct: 195 WSFAVLLWELVTREVP 210

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     + VA+K        +++  F  E   +++  H +I+K I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 190 SDVWMFGVCMWE 201

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRNIIKFIS 813
           +G G FG V+  R + +G   A+KV   +    +K  +    E  M+  + H  II+   
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           +        ++++Y+  G L   L  S    +   +     +V  ALEYLH   S  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            DLKP N+LLD N    ++DFG AK        L       T  Y+APE       + + 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKSI 184
Query: 934 DVYSFGIMLMETFTRKKPTDESFT 957
           D +SFGI++ E      P  +S T
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNT 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     + VA+K        +++  F  E   +++  H +I+K I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 195
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 196 SDVWMFGVCMWE 207

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRH 805
           + F +  ++GRGGFG V+  +++  G   A K  + +  +  K +    +E  ++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI---DVASALEY 862
           R I+    +  +     LV+  M  G +   +Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           LH      II+ DLKP NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPE 359
Query: 923 --YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
              G E   S   D ++ G+ L E    + P
Sbjct: 360 LLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 50/228 (21%)
Query: 747 QATNGFSEN----NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDI------ 795
            +T+GF EN     ++GRG    V +        E AVK+ D+  G +  + ++      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 796 ---ECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
              E  +++++  H NII+   +  ++ F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
            + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +    + D  
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPG 177
Query: 907 LTQTQTLATIGYMAPE------------YGREGRVSTNGDVYSFGIML 942
               +   T  Y+APE            YG+E       D++S G+++
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     + VA+K        +++  F  E   +++  H +I+K I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 194
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 195 SDVWMFGVCMWE 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     + VA+K        +++  F  E   +++  H +I+K I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 198 SDVWMFGVCMWE 209

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     M VA+K        +++  F  E   +++  H +I+K I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    + LD+   +     +++AL YL    S   +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 573 SDVWMFGVCMWE 584

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRH 805
           + F +  ++GRGGFG V+  +++  G   A K  + +  +  K +    +E  ++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI---DVASALEY 862
           R I+    +  +     LV+  M  G +   +Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           LH      II+ DLKP NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPE 359
Query: 923 --YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
              G E   S   D ++ G+ L E    + P
Sbjct: 360 LLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRH 805
           + F +  ++GRGGFG V+  +++  G   A K  + +  +  K +    +E  ++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI---DVASALEY 862
           R I+    +  +     LV+  M  G +   +Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           LH      II+ DLKP NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPE 359
Query: 923 --YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
              G E   S   D ++ G+ L E    + P
Sbjct: 360 LLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 91
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD--FLTL 149
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 150 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 207 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRH 805
           + F +  ++GRGGFG V+  +++  G   A K  + +  +  K +    +E  ++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI---DVASALEY 862
           R I+    +  +     LV+  M  G +   +Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           LH      II+ DLKP NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPE 359
Query: 923 --YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
              G E   S   D ++ G+ L E    + P
Sbjct: 360 LLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 80
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 138
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 139 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 89
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 147
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 148 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 89
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 147
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 148 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 80
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 138
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 139 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 11/214 (5%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNII 809
           F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYS 868
            F  +  SD   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   + 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREKHK 125
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  +   
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH 179
Query: 929 VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
            S   D++S G+ L+E    + P       E+ L
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 11/214 (5%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNII 809
           F + + +G G  G V+K   +  G+ +A K+  L+   AI++  I E  ++       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYS 868
            F  +  SD   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   + 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREKHK 125
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             I+H D+KP+N+L++      L DFG++   +           + T  YM+PE  +   
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH 179
Query: 929 VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
            S   D++S G+ L+E    + P       E+ L
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVA---VKVFDLQYGRAIKSFDIECGMIKRI 803
           AT+ +     IG G +G VYKAR    G  VA   V+V + + G  I +   E  +++R+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 804 R---HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-------LDIFQRLNIM 853
               H N+++ +  C++      +   + +  +++ L +  Y+       L      ++M
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKDLM 118
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
                 L++LH   +  I+H DLKP N+L+       L+DFG+A+ +      +     +
Sbjct: 119 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVV 172
Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
            T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 90
Query: 805 HRNIIKFISSCSSDDFKALVL-EYMPYGSLEKCLYSSNY----------ILDIFQRLNIM 853
           H N++  + +C+      +V+ E+  +G+L   L S             +   F  L  +
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 854 I----DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
           I     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
                 + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N+++  +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE           D++
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 255 SLGIMVIEMVDGEPP 269

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 21/228 (9%)
Query: 746 FQATNGFSENNLIGRGGFG-FVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKR 802
           FQ+   +     IG G FG  +     +DG +  +K  ++     +  +    E  ++  
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEK-------CLYSSNYILDIFQRLNIMID 855
           ++H NI+++  S   +    +V++Y   G L K        L+  + ILD F      + 
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF------VQ 133
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           +  AL+++H      I+H D+K  N+ L  +    L DFG+A+  L     L +   + T
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARA-CIGT 188
Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
             Y++PE       +   D+++ G +L E  T K   +      + LK
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVA+K+ D       +++    E  ++K + H NI+K    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    L++EY   G +   L +   + +   R      + SA++Y H      I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI----GYMAPEYGREGRV- 929
           DLK  N+LLD +M   ++DFG +  F       T    L T      Y APE  +  +  
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEF-------TVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 930 STNGDVYSFGIMLMETFTRKKPTD 953
               DV+S G++L    +   P D
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 80
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 138
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 139 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 89
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 147
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 148 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 758 IGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI-R 804
           +GRG FG V +A      +      VAVK+  L+ G      RA+ S   E  ++  I  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS---ELKILIHIGH 80
Query: 805 HRNIIKFISSCSSDDFKALVL------------------EYMPYGSLEKCLYSSNYILDI 846
           H N++  + +C+      +V+                  E++PY    + LY     L +
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTL 138
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   
Sbjct: 139 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 75/298 (25%), Positives = 121/298 (40%), Gaps = 31/298 (10%)
Query: 729  ANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF---DL 784
            A MP    +R+FT        + F     +G+G FG VY AR  Q+   +A+KV     L
Sbjct: 5    AEMP----KRKFT-------IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 53
Query: 785  QYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYIL 844
            +          E  +   +RH NI++  +         L+LE+ P G L K L       
Sbjct: 54   EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-F 112
Query: 845  DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED 904
            D  +    M ++A AL Y H      +IH D+KP N+L+       ++DFG +       
Sbjct: 113  DEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHA 165
Query: 905  QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             SL +     T+ Y+ PE           D++  G++  E      P D     E T +R
Sbjct: 166  PSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRR 224
Query: 965  WVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
             VN       +++     LS   K  ++K         L +K  +E P  + N++ ++
Sbjct: 225  IVN-------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 275

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 50/228 (21%)
Query: 747 QATNGFSEN----NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDI------ 795
            +T+GF EN     ++GRG    V +        E AVK+ D+  G +  + ++      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 796 ---ECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
              E  +++++  H NII+   +  ++ F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
            + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +    + D  
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPG 177
Query: 907 LTQTQTLATIGYMAPE------------YGREGRVSTNGDVYSFGIML 942
                   T  Y+APE            YG+E       D++S G+++
Sbjct: 178 EKLRSVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N+++  +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE           D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 332 SLGIMVIEMVDGEPP 346

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 758 IGRGGFGFVYKARIQDGMEVA----VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           IG G +G V+KA+ ++  E+     V++ D   G    +    C ++K ++H+NI++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHD 68
Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
              SD    LV E+     L+K   S N  LD     + +  +   L + H   S  ++H
Sbjct: 69  VLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STN 932
            DLKP N+L++ N    L++FG+A+ F    +    +  + T+ Y  P+     ++ ST+
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 933 GDVYSFGIMLMETFTRKKP 951
            D++S G +  E     +P
Sbjct: 183 IDMWSAGCIFAELANAGRP 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVA---VKVFDLQYGRAIKSFDIECGMIKRI 803
           AT+ +     IG G +G VYKAR    G  VA   V+V + + G  I +   E  +++R+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 804 R---HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-------LDIFQRLNIM 853
               H N+++ +  C++      +   + +  +++ L +  Y+       L      ++M
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKDLM 118
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
                 L++LH   +  I+H DLKP N+L+       L+DFG+A+ +      +     +
Sbjct: 119 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVV 172
Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
            T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDI-ECGMIKRIRHRNIIKFI 812
           IG G +G   K R + DG  +  K  +L YG    A K   + E  +++ ++H NI+++ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 813 SSC--SSDDFKALVLEYMPYGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF- 865
                 ++    +V+EY   G L     K      Y+ + F  L +M  +  AL+  H  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 866 ---GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
              G++V  +H DLKP NV LD      L DFG+A+  L  D+   + + + T  YM+PE
Sbjct: 131 SDGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDEDFAK-EFVGTPYYMSPE 186
Query: 923 YGREGRVSTNGDVYSFGIMLME 944
                  +   D++S G +L E
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDI-ECGMIKRIRHRNIIKFI 812
           IG G +G   K R + DG  +  K  +L YG    A K   + E  +++ ++H NI+++ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 813 SSC--SSDDFKALVLEYMPYGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF- 865
                 ++    +V+EY   G L     K      Y+ + F  L +M  +  AL+  H  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 866 ---GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
              G++V  +H DLKP NV LD      L DFG+A+  L  D S  +   + T  YM+PE
Sbjct: 131 SDGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKA-FVGTPYYMSPE 186
Query: 923 YGREGRVSTNGDVYSFGIMLME 944
                  +   D++S G +L E
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYE 208

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 752 FSEN----NLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIR 804
           FS+N      +G+G F  V +      G+E A K+ + +    R  +  + E  + ++++
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           H NI++   S   + F  LV + +  G L + + +  +    +   +    +   LE + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIA 119
Query: 865 FGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY++P
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSP 176
Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E  ++   S   D+++ G++L
Sbjct: 177 EVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 752 FSEN----NLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIR 804
           FS+N      +G+G F  V +      G+E A K+ + +    R  +  + E  + ++++
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           H NI++   S   + F  LV + +  G L + + +  +    +   +    +   LE + 
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIA 118
Query: 865 FGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY++P
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSP 175
Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E  ++   S   D+++ G++L
Sbjct: 176 EVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 752 FSEN----NLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIR 804
           FS+N      +G+G F  V +      G+E A K+ + +    R  +  + E  + ++++
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           H NI++   S   + F  LV + +  G L + + +  +    +   +    +   LE + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIA 119
Query: 865 FGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
           + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY++P
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSP 176
Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E  ++   S   D+++ G++L
Sbjct: 177 EVLKKDPYSKPVDIWACGVIL 197

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVA---VKVFDLQYGRAIKSFDIECGMIKRI 803
           AT+ +     IG G +G VYKAR    G  VA   V+V + + G  I +   E  +++R+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 804 R---HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-------LDIFQRLNIM 853
               H N+++ +  C++      +   + +  +++ L +  Y+       L      ++M
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKDLM 118
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
                 L++LH   +  I+H DLKP N+L+       L+DFG+A+ +      +     +
Sbjct: 119 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVV 172
Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
            T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVA+K+ D       +++    E  ++K + H NI+K    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    L++EY   G +   L +   + +   R      + SA++Y H      I+H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEYGREGRV-S 930
           DLK  N+LLD +M   ++DFG +  F          +  A  G   Y APE  +  +   
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEF------TVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 931 TNGDVYSFGIMLMETFTRKKPTD 953
              DV+S G++L    +   P D
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 755 NNLIGRGGFGFVYKARIQD-GMEVAVKVFD-LQYGRAIKSFDIECGMIKRIRHRNIIKF- 811
           ++++G+G    V++ R +  G   A+KVF+ + + R +     E  ++K++ H+NI+K  
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 812 -ISSCSSDDFKALVLEYMPYGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            I   ++   K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 869 VPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-Y 923
             I+H ++KP N++     D   V  L+DFG A+    ++Q ++      T  Y+ P+ Y
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMY 187
Query: 924 GR-------EGRVSTNGDVYSFGIMLMETFTRKKP 951
            R       + +     D++S G+      T   P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 47/191 (24%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 758 IGRGGFGFVYK-ARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V +  ++  G E A K+ + +    R  +  + E  + + ++H NI++   S
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S + F  LV + +  G L + + +  Y    +   +    +   LE +   + + ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 875 DLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           DLKP N+LL          L+DFG+A     + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKEAYGK 185
Query: 932 NGDVYSFGIML 942
             D+++ G++L
Sbjct: 186 PVDIWACGVIL 196

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 75/298 (25%), Positives = 121/298 (40%), Gaps = 31/298 (10%)
Query: 729  ANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF---DL 784
            A MP    +R+FT        + F     +G+G FG VY AR  Q+   +A+KV     L
Sbjct: 4    AEMP----KRKFT-------IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 52
Query: 785  QYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYIL 844
            +          E  +   +RH NI++  +         L+LE+ P G L K L       
Sbjct: 53   EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-F 111
Query: 845  DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED 904
            D  +    M ++A AL Y H      +IH D+KP N+L+       ++DFG +       
Sbjct: 112  DEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHA 164
Query: 905  QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             SL +     T+ Y+ PE           D++  G++  E      P D     E T +R
Sbjct: 165  PSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRR 223
Query: 965  WVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
             VN       +++     LS   K  ++K         L +K  +E P  + N++ ++
Sbjct: 224  IVN-------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 755 NNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRN 807
           + ++G+G FG V+ A  +   +  A+K   L+    +   D+EC M+ KR+      H  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           +     +  + +    V+EY+  G L   + S  +  D+ +      ++   L++LH   
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH--- 135
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S  I++ DLK +N+LLD +    ++DFGM K  +  D          T  Y+APE     
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAPEILLGQ 193
Query: 928 RVSTNGDVYSFGIMLMETFTRKKP 951
           + + + D +SFG++L E    + P
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 745 LFQATNGFSENNLIGRGGFGFVYKARIQDGME-VAVK--------VFDLQYGRAIKSFDI 795
           ++  ++ F   +L+G G +G V  A  +   E VA+K        +F L+  R IK    
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK---- 61
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFK----ALVLEYMPYGSLEKCLYSSNYILDIFQRLN 851
              ++K  +H NII   +    D F+      +++ +    L + + +     D  Q   
Sbjct: 62  ---ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF- 117
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED------- 904
            +     A++ LH G +V  IH DLKP+N+L++ N    + DFG+A+  + E        
Sbjct: 118 -IYQTLRAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEP 172
Query: 905 --QSLTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTRK 949
             Q    T+ +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 173 TGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G F  V +  +I  G E A K+ + +    R  +  + E  + + ++H NI++   S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 875 DLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           DLKP N+LL          L+DFG+A     + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 932 NGDVYSFGIML 942
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G F  V +  +I  G E A K+ + +    R  +  + E  + + ++H NI++   S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 875 DLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           DLKP N+LL          L+DFG+A     + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 932 NGDVYSFGIML 942
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 758 IGRGGFGFVYKARIQDG-MEVAVKVFDLQYGRAIKSFDIECGMIKRIR------HRNIIK 810
           +G+G FG VY AR +     VA+KV    +   I+   +E  + + I       H NI++
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVL---FKSQIEKEGVEHQLRREIEIQAHLHHPNILR 87
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
             +         L+LEY P G L K L  S    D  +   IM ++A AL Y H      
Sbjct: 88  LYNYFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCH---GKK 143
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           +IH D+KP N+LL       ++DFG +        SL +     T+ Y+ PE   EGR+ 
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPPEM-IEGRMH 198
Query: 931 TNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV 966
               D++  G++  E      P  ES +   T +R V
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPF-ESASHNETYRRIV 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N+++  +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE           D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 210 SLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N+++  +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE           D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 212 SLGIMVIEMVDGEPP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N+++  +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 201 SLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N+++  +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 936
           K +++LL  +    LSDFG      KE     +   + T  +MAPE           D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 937 SFGIMLMETFTRKKP 951
           S GIM++E    + P
Sbjct: 205 SLGIMVIEMVDGEPP 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 758 IGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRI---RHRNIIK 810
           IG G +G V+KAR     G  VA+K   +Q G          E  +++ +    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR-------LNIMIDVASALEYL 863
               C+           + +  +++ L  + Y+  + +         ++M  +   L++L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  ++H DLKP N+L+  +    L+DFG+A+ +      +  T  + T+ Y APE 
Sbjct: 137 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 190
Query: 924 GREGRVSTNGDVYSFGIMLMETFTRK 949
             +   +T  D++S G +  E F RK
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 758 IGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRI---RHRNIIK 810
           IG G +G V+KAR     G  VA+K   +Q G          E  +++ +    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR-------LNIMIDVASALEYL 863
               C+           + +  +++ L  + Y+  + +         ++M  +   L++L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  ++H DLKP N+L+  +    L+DFG+A+ +      +  T  + T+ Y APE 
Sbjct: 137 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 190
Query: 924 GREGRVSTNGDVYSFGIMLMETFTRK 949
             +   +T  D++S G +  E F RK
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 758 IGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRI---RHRNIIK 810
           IG G +G V+KAR     G  VA+K   +Q G          E  +++ +    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR-------LNIMIDVASALEYL 863
               C+           + +  +++ L  + Y+  + +         ++M  +   L++L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S  ++H DLKP N+L+  +    L+DFG+A+ +      +  T  + T+ Y APE 
Sbjct: 137 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 190
Query: 924 GREGRVSTNGDVYSFGIMLMETFTRK 949
             +   +T  D++S G +  E F RK
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI-----KSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V  ++   A      K    E  ++  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 111 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 168
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 169 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 755 NNLIGRGGFGFVYKARIQD-GMEVAVKVFD-LQYGRAIKSFDIECGMIKRIRHRNIIKF- 811
           ++++G+G    V++ R +  G   A+KVF+ + + R +     E  ++K++ H+NI+K  
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 812 -ISSCSSDDFKALVLEYMPYGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            I   ++   K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 869 VPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-Y 923
             I+H ++KP N++     D   V  L+DFG A+    ++Q +       T  Y+ P+ Y
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX---LYGTEEYLHPDMY 187
Query: 924 GR-------EGRVSTNGDVYSFGIMLMETFTRKKP 951
            R       + +     D++S G+      T   P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 745 LFQATNGFSENNLIGRGGFGFVYKARIQDGME-VAVK--------VFDLQYGRAIKSFDI 795
           ++  ++ F   +L+G G +G V  A  +   E VA+K        +F L+  R IK    
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK---- 61
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFK----ALVLEYMPYGSLEKCLYSSNYILDIFQRLN 851
              ++K  +H NII   +    D F+      +++ +    L + + +     D  Q   
Sbjct: 62  ---ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF- 117
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED------- 904
            +     A++ LH G +V  IH DLKP+N+L++ N    + DFG+A+  + E        
Sbjct: 118 -IYQTLRAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEP 172
Query: 905 --QSLTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTRK 949
             Q    T+ +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 173 TGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 756 NLIGRGGFG--FVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
            ++G G F   F+ K R+  G   A+K           S + E  ++K+I+H NI+    
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 814 SCSSDDFKALVLEYMPYGS-----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              S     LV++ +  G      LE+ +Y+      + Q+      V SA++YLH    
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH---E 124
Query: 869 VPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             I+H DLKP N+L    ++N    ++DFG++K     +Q+   +    T GY+APE   
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLA 180
Query: 926 EGRVSTNGDVYSFGIM 941
           +   S   D +S G++
Sbjct: 181 QKPYSKAVDCWSIGVI 196

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 87/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIK-SFDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     M VA+K        +++  F  E   +++  H +I+K I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    + LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+       L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 193 SDVWMFGVCMWE 204

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 752 FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNI 808
           F     +GRGGFG V++A+ + D    A+K   L   R +    +  E   + ++ H  I
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGI 65
Query: 809 IKFISSC----SSDDFKALVLEYMPYGSLEKCLYSS-----NYILDIFQR-----LNIMI 854
           +++ ++     +++  +    +   Y  ++ C   +     N    I +R     L+I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT------ 908
            +A A+E+LH   S  ++H DLKP+N+    + V  + DFG+     ++++  T      
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 909 ----QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
                T  + T  YM+PE       S   D++S G++L E
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 87/192 (45%), Gaps = 10/192 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFI 812
           IG G FG V    Y +     M VA+K        +++  F  E   +++  H +I+K I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              + +    +++E    G L   L    + LD+   +     +++AL YL    S   +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+   NVL+       L DFG+++ ++++      ++    I +MAPE     R ++ 
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 933 GDVYSFGIMLME 944
            DV+ FG+ + E
Sbjct: 573 SDVWMFGVCMWE 584

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 48/293 (16%)
Query: 758  IGRGGFGFVYKA-RIQDGMEVAVK-VFDL--QYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
            +G+G +G V+K+   + G  VAVK +FD       A ++F     + +   H NI+  ++
Sbjct: 17   LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 814  SCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               +D+ +   LV +YM    L   + ++  IL+   +  ++  +   ++YLH G    +
Sbjct: 77   VLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---GL 130
Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-------------------EDQSLTQTQT 912
            +H D+KP+N+LL+      ++DFG+++ F+                    +D     T  
Sbjct: 131  LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 913  LATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL 971
            +AT  Y APE        T G D++S G +L E     KP    F G  T+ +      L
Sbjct: 191  VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPI---FPGSSTMNQ------L 240
Query: 972  ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024
              I+ V+D    S+ED   +      + + +L  K  I       N ++I TK
Sbjct: 241  ERIIGVID--FPSNEDVESIQSPFAKTMIESLKEKVEIRQS----NKRDIFTK 287

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 746 FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR 804
            +  + F E  ++G+G FG V KAR   D    A+K         + +   E  ++  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 805 H-------------RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN 851
           H             RN +K +++        + +EY   G+L   ++S N      +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK------PFLKED- 904
           +   +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK        LK D 
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 905 -----QSLTQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLME 944
                 S   T  + T  Y+A E     G  +   D+YS GI+  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 756 NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNII 809
            +IG+G F  V +    + G + AVK+ D+       G + +    E  +   ++H +I+
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCL-----YSSNYILDIFQRLNIMIDVASALEYLH 864
           + + + SSD    +V E+M    L  C        + ++       + M  +  AL Y H
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 865 FGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
                 IIH D+KP NVLL   +++    L DFG+A      +  L     + T  +MAP
Sbjct: 148 ---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAP 202
Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E  +        DV+  G++L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV--AVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
           ++  N IGRG +G V K  +Q G  +  A K     +   +  F  E  ++K + H NII
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 810 KFISSCSSDDFKALVLEYMPYGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +   +   +    LV+E    G L E+ ++   +      R  IM DV SA+ Y H    
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---K 124
Query: 869 VPIIHCDLKPNNVL-LDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
           + + H DLKP N L L D+  + L   DFG+A  F       T+   + T  Y++P+   
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQV-L 180
Query: 926 EGRVSTNGDVYSFGIML 942
           EG      D +S G+M+
Sbjct: 181 EGLYGPECDEWSAGVMM 197

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 50/224 (22%)
Query: 751 GFSEN----NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDI---------E 796
           GF EN     ++GRG    V +        E AVK+ D+  G +  + ++         E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 797 CGMIKRIR-HRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRL 850
             +++++  H NII+   +  ++ F  LV + M  G L     EK   S      I + L
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
              ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +    + D      
Sbjct: 121 ---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLR 168
Query: 911 QTLATIGYMAPE------------YGREGRVSTNGDVYSFGIML 942
           +   T  Y+APE            YG+E       D++S G+++
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV--AVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
           ++  N IGRG +G V K  +Q G  +  A K     +   +  F  E  ++K + H NII
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 810 KFISSCSSDDFKALVLEYMPYGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +   +   +    LV+E    G L E+ ++   +      R  IM DV SA+ Y H    
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---K 141
Query: 869 VPIIHCDLKPNNVL-LDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
           + + H DLKP N L L D+  + L   DFG+A  F       T+   + T  Y++P+   
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQV-L 197
Query: 926 EGRVSTNGDVYSFGIML 942
           EG      D +S G+M+
Sbjct: 198 EGLYGPECDEWSAGVMM 214

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 748 ATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIK-----SFDIECGMIK 801
           AT+ +     IG G +G VYKAR    G  VA+K   +  G         S   E  +++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 802 RIR---HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-------LDIFQRLN 851
           R+    H N+++ +  C++      +   + +  +++ L +  Y+       L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKD 124
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           +M      L++LH   +  I+H DLKP N+L+       L+DFG+A+ +      +  T 
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTP 178
Query: 912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
            + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 740 FTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQY---GRAIKSFDI 795
           F + E+ +A         IG+G FG V   +  D  ++ A+K  + Q       +++   
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
           E  +++ + H  ++    S   ++   +V++ +  G L   L  + +  +   +L I  +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CE 123
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA- 914
           +  AL+YL    +  IIH D+KP+N+LLD++   H++DF +A    +E    TQ  T+A 
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 915 TIGYMAPEY--GREGR-VSTNGDVYSFGIMLMETFTRKKP 951
           T  YMAPE    R+G   S   D +S G+   E    ++P
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDI------ECGMIKRIRHRNIIK 810
           +G G FG V  A   +   +VA+K    Q    +K  D+      E   +K +RH +IIK
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 811 FISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
                ++     +V+EY   G L     EK   + +     FQ+      +  A+EY H 
Sbjct: 74  LYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQ------IICAIEYCH- 125
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                I+H DLKP N+LLDDN+   ++DFG++   +  D +  +T +  +  Y APE   
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAPEVI- 179
Query: 926 EGRVSTNG--DVYSFGIMLMETFTRKKPTDESF 956
            G++      DV+S GI+L      + P D+ F
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKA-RIQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 160 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISS 814
           L+G G +G VYK R ++ G   A+KV D+  G   +    E  M+K+   HRNI  +  +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 815 C------SSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGY 867
                    DD   LV+E+   GS+   + ++    L       I  ++   L +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEY--- 923
              +IH D+K  NVLL +N    L DFG++      D+++ +  T + T  +MAPE    
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 924 --GREGRVSTNGDVYSFGIMLME 944
               +       D++S GI  +E
Sbjct: 204 DENPDATYDFKSDLWSLGITAIE 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 11/204 (5%)
Query: 757 LIGRGGFGFVYKA-RIQDG----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
           ++G G FG VYK   I DG    + VA+KV       +A K    E  ++  +    + +
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +  C +   + LV + MPYG L   +  +   L     LN  + +A  + YL     V 
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DVR 139
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           ++H DL   NVL+       ++DFG+A+    ++           I +MA E     R +
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 931 TNGDVYSFGIMLMETFT-RKKPTD 953
              DV+S+G+ + E  T   KP D
Sbjct: 200 HQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 792 SFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
           S + E  ++ +I+H NI+       S     L+++ +  G L     EK  Y+       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER----- 116
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPFLKE 903
                ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    E
Sbjct: 117 -DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---ME 169
Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 941
           D     +    T GY+APE   +   S   D +S G++
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 792 SFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
           S + E  ++ +I+H NI+       S     L+++ +  G L     EK  Y+       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER----- 116
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPFLKE 903
                ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    E
Sbjct: 117 -DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---ME 169
Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 941
           D     +    T GY+APE   +   S   D +S G++
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 792 SFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
           S + E  ++ +I+H NI+       S     L+++ +  G L     EK  Y+       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER----- 116
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPFLKE 903
                ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    E
Sbjct: 117 -DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---ME 169
Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 941
           D     +    T GY+APE   +   S   D +S G++
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 792 SFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
           S + E  ++ +I+H NI+       S     L+++ +  G L     EK  Y+       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER----- 116
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPFLKE 903
                ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    E
Sbjct: 117 -DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---ME 169
Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 941
           D     +    T GY+APE   +   S   D +S G++
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 11/200 (5%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           IG+G F  V  AR I  G EVAVK+ D       +++    E  + K + H NI+K    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV EY   G +   L +     +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-TNG 933
           DLK  N+LLD +    ++DFG +  F   ++            Y APE  +  +      
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 934 DVYSFGIMLMETFTRKKPTD 953
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIKFI 812
           +G G FG V    Y+ R +  ++VA+KV      +A  +    E  ++ ++ +  I++ I
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
             C ++    LV+E    G L K L      + +     ++  V+  ++YL        +
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT-QTQTLATIGYMAPEYGREGRVST 931
           H DL   NVLL +   A +SDFG++K    +D   T ++     + + APE     + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 932 NGDVYSFGIMLMETFTR-KKP 951
             DV+S+G+ + E  +  +KP
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIKFISSC 815
           +G G FG V+    +  G+E  +K  +    +  ++  + E  ++K + H NIIK     
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFG 866
                  +V+E    G L + + S+          Y+ ++ +++       +AL Y H  
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAYFH-- 141
Query: 867 YSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE- 922
            S  ++H DLKP N+L  D   +    + DFG+A+ F  ++ S   T    T  YMAPE 
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEV 197
Query: 923 YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG 958
           + R+  V+   D++S G+++    T   P    FTG
Sbjct: 198 FKRD--VTFKCDIWSAGVVMYFLLTGCLP----FTG 227

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 51/172 (29%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVF-DLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G V+K R +D G  VA+K F + +    IK   + E  M+K+++H N++  +  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR---LNIMIDVA-SALEYLHFGYSVP 870
                   LV EY        C ++  + LD +QR    +++  +    L+ ++F +   
Sbjct: 71  FRRKRRLHLVFEY--------CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
            IH D+KP N+L+  + V  L DFG A+  L    S      +AT  Y +PE
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPE 172

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 45/191 (23%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 758 IGRGGFGFVYK-ARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G F  V +  ++  G E A K+ + +    R  +  + E  + + ++H NI++   S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S +    L+ + +  G L + + +  Y    +   +    +   LE +   + + ++H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 875 DLKPNNVLLDDNM---VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           DLKP N+LL   +      L+DFG+A     E Q+        T GY++PE  R+     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 203
Query: 932 NGDVYSFGIML 942
             D+++ G++L
Sbjct: 204 PVDLWACGVIL 214

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 745 LFQATNGFSENNLIGRGGFGFVYKARIQDGME-VAVK--------VFDLQYGRAIKSFDI 795
           ++  ++ F   +L+G G +G V  A  +   E VA+K        +F L+  R IK    
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK---- 61
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFK----ALVLEYMPYGSLEKCLYSSNYILDIFQRLN 851
              ++K  +H NII   +    D F+      +++ +    L + + +     D  Q   
Sbjct: 62  ---ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF- 117
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED------- 904
            +     A++ LH G +V  IH DLKP+N+L++ N    + DFG+A+  + E        
Sbjct: 118 -IYQTLRAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEP 172
Query: 905 --QSLTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTRK 949
             Q     + +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 12/233 (5%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++    D  EV A K+     L      +   +E  + + + H++++ F 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGRVST 931
           H DLK  N+ L++++   + DFG+A    K +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 932 NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
             DV+S G ++      K P + S   E  L+   N+  +   +  V A+L+ 
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 249

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +GRG FG V++    Q G + AVK   L+  RA +   + C  +   R   I+    +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGAVR 155
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
              +  + +E +  GSL + L      L   + L  +      LEYLH   S  I+H D+
Sbjct: 156 EGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDV 211
Query: 877 KPNNVLL-DDNMVAHLSDFGMA---KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           K +NVLL  D   A L DFG A   +P       LT      T  +MAPE          
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAK 271
Query: 933 GDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
            DV+S   M++       P  + F G + LK
Sbjct: 272 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 12/233 (5%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++    D  EV A K+     L      +   +E  + + + H++++ F 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGRVST 931
           H DLK  N+ L++++   + DFG+A    K +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 932 NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
             DV+S G ++      K P + S   E  L+   N+  +   +  V A+L+ 
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 249

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 747 QATNGFSENNLIGRGGFGF----VYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR 802
           Q T+G+     IG G +      ++KA     ME AVK+ D       +  +I   +++ 
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRDPTEEIEI---LLRY 72
Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
            +H NII          +  +V E M  G L   +    +  +  +   ++  +   +EY
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEY 131
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
           LH   +  ++H DLKP+N+L  D         + DFG AK  L+ +  L  T    T  +
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLMTPCY-TANF 186
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           +APE           D++S G++L    T   P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 12/233 (5%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++    D  EV A K+     L      +   +E  + + + H++++ F 
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 143
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGREGRVST 931
           H DLK  N+ L++++   + DFG+A    K +    + +TL  T  Y+APE   +   S 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 932 NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
             DV+S G ++      K P + S   E  L+   N+  +   +  V A+L+ 
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 253

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 135
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 138
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 135
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
           ++G+G FG V  A  +   E+ A+K+  L+    I+  D+EC M+++     +     + 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 811 FISSC-SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            + SC  + D    V+EY+  G L   +Y    +   F+    +   A     L F +  
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQV-GKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            II+ DLK +NV+LD      ++DFGM K  + +   +T  +   T  Y+APE       
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD--GVTTREFCGTPDYIAPEIIAYQPY 197
Query: 930 STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
             + D +++G++L E    + P    F GE        D L  SIME
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPP----FDGE------DEDELFQSIME 234

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIK-- 810
           +G G +G V   Y AR++   +VAVK     +   I +     E  ++K ++H N+I   
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 811 --FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
             F  + S +DF  + L     G+    +  S  + D   +  ++  +   L+Y+H   S
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH---S 149
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+NV ++++    + DFG+A+   + D+ +T        GY+A  + R   
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRWYRAPE 198
Query: 929 VSTNG-------DVYSFGIMLMETFTRK 949
           +  N        D++S G ++ E    K
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +GRG FG V++    Q G + AVK   L+  RA +   + C  +   R   I+    +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGAVR 136
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
              +  + +E +  GSL + L      L   + L  +      LEYLH   S  I+H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDV 192
Query: 877 KPNNVLL-DDNMVAHLSDFGMA---KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           K +NVLL  D   A L DFG A   +P       LT      T  +MAPE          
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAK 252
Query: 933 GDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
            DV+S   M++       P  + F G + LK
Sbjct: 253 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 746 FQATNGFSENNLIGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI 803
           F     +++   IG G +G V  A   ++       K+   ++    +    E  ++ R 
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRF 98
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN-----IMIDVAS 858
           RH N+I       +   +A+   Y+    +E  LY    +L   Q  N      +  +  
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHICYFLYQILR 155
Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-DQSLTQTQTLATIG 917
            L+Y+H   S  ++H DLKP+N+L++      + DFG+A+    E D +   T+ +AT  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 918 YMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           Y APE     +  T   D++S G +L E  + +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +      
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 758 IGRGGFGFV----YKARIQDGMEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNIIKFI 812
           +G G FG V    Y+ R +  ++VA+KV      +A  +    E  ++ ++ +  I++ I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
             C ++    LV+E    G L K L      + +     ++  V+  ++YL        +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT-QTQTLATIGYMAPEYGREGRVST 931
           H +L   NVLL +   A +SDFG++K    +D   T ++     + + APE     + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 932 NGDVYSFGIMLMETFT 947
             DV+S+G+ + E  +
Sbjct: 519 RSDVWSYGVTMWEALS 534

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 796 ECGMIKRIRHRNIIKFISSCSS--DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIM 853
           E  ++K++ H N++K +       +D   +V E +  G + +         D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            D+   +EYLH+     IIH D+KP+N+L+ ++    ++DFG++  F   D  L  + T+
Sbjct: 144 QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 914 ATIGYMAPEYGREGRVSTNG---DVYSFGIML 942
            T  +MAPE   E R   +G   DV++ G+ L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  +  +   E+ AVK+  L+    I+  D+EC M+ KR+     +   + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
           +  S   + D    V+EY+  G L   +Y    +   F+  + +   A     L F  S 
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            II+ DLK +NV+LD      ++DFGM K  + +   +T      T  Y+APE       
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 930 STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
             + D ++FG++L E    + P    F GE        D L  SIME
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAP----FEGE------DEDELFQSIME 556

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +      
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 47/191 (24%), Positives = 87/191 (45%), Gaps = 12/191 (6%)
Query: 758 IGRGGFGFVYK-ARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G F  V +  +     E A K+ + +    R  +  + E  + + ++H NI++   S
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIHQILESVNHIHQHDIVHR 154
Query: 875 DLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           DLKP N+LL          L+DFG+A     E Q+        T GY++PE  R+     
Sbjct: 155 DLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 212
Query: 932 NGDVYSFGIML 942
             D+++ G++L
Sbjct: 213 PVDIWACGVIL 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +      
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +      
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 916 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 45/214 (21%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIK-- 810
           +G G +G V   Y AR++   +VAVK     +   I +     E  ++K ++H N+I   
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 811 --FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILD--IFQRLNIMIDVASALEY 862
             F  + S +DF  + L     G+    + KC   S+  +   ++Q L         L+Y
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR-------GLKY 146
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           +H   S  IIH DLKP+NV ++++    + DFG+A+   + D+ +T        GY+A  
Sbjct: 147 IH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATR 192
Query: 923 YGREGRVSTNG-------DVYSFGIMLMETFTRK 949
           + R   +  N        D++S G ++ E    K
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLE-------KCLYSSNYILDIFQRLNIMI 854
           R RH NII       +   + +   Y+    +E       KC + SN  +  F     + 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-----LY 135
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  +  +   E+ AVK+  L+    I+  D+EC M+ KR+     +   + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
           +  S   + D    V+EY+  G L   +Y    +   F+  + +   A     L F  S 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            II+ DLK +NV+LD      ++DFGM K  + +   +T      T  Y+APE       
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 930 STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
             + D ++FG++L E    + P    F GE        D L  SIME
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAP----FEGE------DEDELFQSIME 235

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 27/203 (13%)
Query: 758 IGRGGFGFVYKARIQDGM-EVAVKVFDL-QYGRAIKSFDI------------ECGMIKRI 803
           +G G +G V   + ++G  E A+KV    Q+ +   S D             E  ++K +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSL-EKCLYSSNYILDIFQRLNIMIDVASALEY 862
            H NIIK         +  LV E+   G L E+ +  + +  D     NIM  + S + Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII--NRHKFDECDAANIMKQILSGICY 161
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
           LH      I+H D+KP N+LL++    +   + DFG++  F  +D  L     L T  Y+
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDYKL--RDRLGTAYYI 215
Query: 920 APEYGREGRVSTNGDVYSFGIML 942
           APE  ++ + +   DV+S G+++
Sbjct: 216 APEVLKK-KYNEKCDVWSCGVIM 237

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 45/214 (21%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIK-- 810
           +G G +G V   Y AR++   +VAVK     +   I +     E  ++K ++H N+I   
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 811 --FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILD--IFQRLNIMIDVASALEY 862
             F  + S +DF  + L     G+    + KC   S+  +   ++Q L         L+Y
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR-------GLKY 138
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           +H   S  IIH DLKP+NV ++++    + DFG+A+   + D+ +T        GY+A  
Sbjct: 139 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYVATR 184
Query: 923 YGREGRVSTNG-------DVYSFGIMLMETFTRK 949
           + R   +  N        D++S G ++ E    K
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    L   L  ++ Y L   Q L+       + 
Sbjct: 97  RFRHENIIGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 151
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G F  V +  ++  G E A  + + +    R  +  + E  + + ++H NI++   S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S +    L+ + +  G L + + +  Y    +   +    +   LE +   + + ++H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 875 DLKPNNVLLDDNM---VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           +LKP N+LL   +      L+DFG+A     E Q+        T GY++PE  R+     
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 192
Query: 932 NGDVYSFGIML 942
             D+++ G++L
Sbjct: 193 PVDLWACGVIL 203

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 31/223 (13%)
Query: 749 TNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH-- 805
            + F E  ++G+G FG V KAR   D    A+K         + +   E  ++  + H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 806 -----------RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI 854
                      RN +K +++        + +EY    +L   ++S N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK------PFLKED---- 904
            +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK        LK D    
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 905 --QSLTQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLME 944
              S   T  + T  Y+A E     G  +   D+YS GI+  E
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 14/225 (6%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR 802
           E  +  +  +    +GRG FG V++ +  Q G + AVK   L+  R  +   + C  +  
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSS 125
Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
            R   I+    +     +  + +E +  GSL + L      L   + L  +      LEY
Sbjct: 126 PR---IVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEY 181
Query: 863 LHFGYSVPIIHCDLKPNNVLL-DDNMVAHLSDFGMA---KPFLKEDQSLTQTQTLATIGY 918
           LH   +  I+H D+K +NVLL  D   A L DFG A   +P       LT      T  +
Sbjct: 182 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
           MAPE           D++S   M++       P  + F G + LK
Sbjct: 239 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 757 LIGRGGFGFVYKARIQDGME-VAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISS 814
           +IG G    V  A      E VA+K  +L+  + ++     E   + +  H NI+ + +S
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYS-------SNYILDIFQRLNIMIDVASALEYLHFGY 867
               D   LV++ +  GS+   +          + +LD      I+ +V   LEYLH   
Sbjct: 77  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 136
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT----LATIGYMAPEY 923
               IH D+K  N+LL ++    ++DFG++  FL     +T+ +     + T  +MAPE 
Sbjct: 137 Q---IHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 924 GREGR-VSTNGDVYSFGIMLMETFTRKKP 951
             + R      D++SFGI  +E  T   P
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 757 LIGRGGFGFVYKARIQDGME-VAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISS 814
           +IG G    V  A      E VA+K  +L+  + ++     E   + +  H NI+ + +S
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYS-------SNYILDIFQRLNIMIDVASALEYLHFGY 867
               D   LV++ +  GS+   +          + +LD      I+ +V   LEYLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT----LATIGYMAPEY 923
               IH D+K  N+LL ++    ++DFG++  FL     +T+ +     + T  +MAPE 
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 924 GREGR-VSTNGDVYSFGIMLMETFTRKKP 951
             + R      D++SFGI  +E  T   P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI--RHRNIIKFISSC 815
           +G+G +G V++  +  G  VAVK+F     R  +S+  E  +   +  RH NI+ FI+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 816 SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 868
            +    +    L+  Y  +GSL   L      L+    L + +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 869 --VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT--QTQTLATIGYMAPEYG 924
               I H D K  NVL+  N+   ++D G+A    +    L       + T  YMAPE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 925 REGRVSTN-------GDVYSFGIMLMETFTR 948
            E ++ T+        D+++FG++L E   R
Sbjct: 190 DE-QIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 10/232 (4%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++    D  EV A K+     L      +   +E  + + + H++++ F 
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H DLK  N+ L++++   + DFG+A     E     +     T  Y+APE   +   S  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 933 GDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
            DV+S G ++      K P + S   E  L+   N+  +   +  V A+L+ 
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 74  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE- 131
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 132 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 140
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 141 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 144
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 145 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 128
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG AK    E++          I +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG AK    E++          I +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 138
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG AK    E++          I +MA E   
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 82  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 82
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 83  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 137
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 138 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 73
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 74  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 128
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 129 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 75  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 75  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAV-KVFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+ K+   ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILL 80
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILL 80
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 79  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 10/232 (4%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++    D  EV A K+     L      +   +E  + + + H++++ F 
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 161
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H DLK  N+ L++++   + DFG+A     E     +     T  Y+APE   +   S  
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 933 GDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
            DV+S G ++      K P + S   E  L+   N+  +   +  V A+L+ 
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 271

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 14/225 (6%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR 802
           E  +  +  +    +GRG FG V++ +  Q G + AVK   L+  R  +   + C  +  
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSS 123
Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
            R   I+    +     +  + +E +  GSL + L      L   + L  +      LEY
Sbjct: 124 PR---IVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEY 179
Query: 863 LHFGYSVPIIHCDLKPNNVLL-DDNMVAHLSDFGMA---KPFLKEDQSLTQTQTLATIGY 918
           LH   +  I+H D+K +NVLL  D   A L DFG A   +P       LT      T  +
Sbjct: 180 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
           MAPE           D++S   M++       P  + F G + LK
Sbjct: 237 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 25  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 84
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 85  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 139
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 140 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 792 SFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
           S + E  ++++I+H NI+       S +   LV++ +  G L     EK  Y+      +
Sbjct: 66  SIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL 125
Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKE 903
            ++      V  A+ YLH    + I+H DLKP N+L    D+     +SDFG++K    E
Sbjct: 126 IRQ------VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK---ME 173
Query: 904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 941
            +    +    T GY+APE   +   S   D +S G++
Sbjct: 174 GKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     IG G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EYMP G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     IG G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EYMP G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 749 TNGFSENNLIGRGGFGFVY--KARIQDGMEVAVKVFDLQYGRAIK------SFDIECGMI 800
           ++ +    ++G+G FG V   K +I  G E AVKV      R +K      S   E  ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVIS---KRQVKQKTDKESLLREVQLL 80
Query: 801 KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           K++ H NI+K         +  LV E    G L   + S     ++     I+  V S +
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGI 139
Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            Y+H      I+H DLKP N+LL+    +    + DFG++  F   + S      + T  
Sbjct: 140 TYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAY 193
Query: 918 YMAPEYGREGRVSTNGDVYSFGIML 942
           Y+APE    G      DV+S G++L
Sbjct: 194 YIAPEV-LHGTYDEKCDVWSTGVIL 217

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 97  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 151
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-DQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+    + D +   T+ +
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 758 IGRGGFGFVYK--ARIQDGMEVAVKVFDLQYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           +G G +  VYK  +++ D + VA+K   L++        I E  ++K ++H NI+     
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
             ++    LV EY+    L++ L     I+++    N+ + +   L  L + +   ++H 
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGRVSTN 932
           DLKP N+L+++     L+DFG+A+   K   + T    + T+ Y  P+   G     ST 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLGSTD-YSTQ 181
Query: 933 GDVYSFGIMLMETFT 947
            D++  G +  E  T
Sbjct: 182 IDMWGVGCIFYEMAT 196

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGRE 926
           S+ +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T  Y+APE    
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYLAPEIILS 213
Query: 927 GRVSTNGDVYSFGIMLME 944
              +   D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 755 NNLIGRGGFGFVYKAR-IQDGMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
             ++  GGF FVY+A+ +  G E A+K     + +  RAI      C M K   H NI++
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPNIVQ 90
Query: 811 FISSCS-----SDDFKA--LVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALE 861
           F S+ S     SD  +A  L+L  +  G L + L    S   L     L I      A++
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 897
           ++H     PIIH DLK  N+LL +     L DFG A
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 10/216 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRN 807
           +     +G+GGF   Y+    D  EV A KV     L      +    E  + K + + +
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++ F      DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 159
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           +  +IH DLK  N+ L+D+M   + DFG+A     E     +     T  Y+APE   + 
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKK 217
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
             S   D++S G +L      K P + S   E  ++
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIR 253

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIK------SFDIECGMIK 801
           ++ +    ++G+G FG V   + +  G E AVKV      R +K      S   E  ++K
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS---KRQVKQKTDKESLLREVQLLK 87
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
           ++ H NI+K         +  LV E    G L   + S     ++     I+  V S + 
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGIT 146
Query: 862 YLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
           Y+H      I+H DLKP N+LL+    +    + DFG++  F   + S      + T  Y
Sbjct: 147 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYY 200
Query: 919 MAPEYGREGRVSTNGDVYSFGIML 942
           +APE    G      DV+S G++L
Sbjct: 201 IAPEV-LHGTYDEKCDVWSTGVIL 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
           IG+G FG V+KAR +  G +VA+K   ++  +  + F I    E  +++ ++H N++  I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 83
Query: 813 SSCSS-----DDFKA---LVLEYMPY---GSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
             C +     +  KA   LV ++  +   G L   L    + L   +R+  M+   + L 
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML--LNGLY 139
Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--LKEDQSLTQTQTLATIGYM 919
           Y+H      I+H D+K  NVL+  + V  L+DFG+A+ F   K  Q       + T+ Y 
Sbjct: 140 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 920 APE--YGREGRVSTNGDVYSFGIMLMETFTR 948
            PE   G E       D++  G ++ E +TR
Sbjct: 197 PPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 10/232 (4%)
Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++    D  EV A K+     L      +   +E  + + + H++++ F 
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H DLK  N+ L++++   + DFG+A     E     +     T  Y+APE   +   S  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 933 GDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
            DV+S G ++      K P + S   E  L+   N+  +   +  V A+L+ 
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 10/216 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRN 807
           +     +G+GGF   Y+    D  EV A KV     L      +    E  + K + + +
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++ F      DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 159
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           +  +IH DLK  N+ L+D+M   + DFG+A     E     +     T  Y+APE   + 
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKTLCGTPNYIAPEVLCKK 217
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
             S   D++S G +L      K P + S   E  ++
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIR 253

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 749 TNGFSENNLIGRGGFGFVY--KARIQDGMEVAVKVFDLQYGRAIK------SFDIECGMI 800
           ++ +    ++G+G FG V   K +I  G E AVKV      R +K      S   E  ++
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVIS---KRQVKQKTDKESLLREVQLL 103
Query: 801 KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           K++ H NI+K         +  LV E    G L   + S     ++     I+  V S +
Sbjct: 104 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGI 162
Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            Y+H      I+H DLKP N+LL+    +    + DFG++  F   + S      + T  
Sbjct: 163 TYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAY 216
Query: 918 YMAPEYGREGRVSTNGDVYSFGIML 942
           Y+APE    G      DV+S G++L
Sbjct: 217 YIAPEV-LHGTYDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 749 TNGFSENNLIGRGGFGFVY--KARIQDGMEVAVKVFDLQYGRAIK------SFDIECGMI 800
           ++ +    ++G+G FG V   K +I  G E AVKV      R +K      S   E  ++
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVIS---KRQVKQKTDKESLLREVQLL 104
Query: 801 KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           K++ H NI+K         +  LV E    G L   + S     ++     I+  V S +
Sbjct: 105 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGI 163
Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            Y+H      I+H DLKP N+LL+    +    + DFG++  F   + S      + T  
Sbjct: 164 TYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAY 217
Query: 918 YMAPEYGREGRVSTNGDVYSFGIML 942
           Y+APE    G      DV+S G++L
Sbjct: 218 YIAPEV-LHGTYDEKCDVWSTGVIL 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 10/216 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRN 807
           +     +G+GGF   Y+    D  EV A KV     L      +    E  + K + + +
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++ F      DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 159
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           +  +IH DLK  N+ L+D+M   + DFG+A     E     +     T  Y+APE   + 
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPEVLCKK 217
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
             S   D++S G +L      K P + S   E  ++
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIR 253

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++  G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+++ MP+G L   +      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 10/216 (4%)
Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFD---LQYGRAIKSFDIECGMIKRIRHRN 807
           +     +G+GGF   Y+    D  EV A KV     L      +    E  + K + + +
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++ F      DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 88  VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 143
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           +  +IH DLK  N+ L+D+M   + DFG+A     E     +     T  Y+APE   + 
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKK 201
Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
             S   D++S G +L      K P + S   E  ++
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIR 237

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 14/192 (7%)
Query: 757 LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFIS 813
           ++G+G FG V K + +    E AVKV +    +   +  I  E  ++K++ H NI+K   
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
                    +V E    G L   +       +      I+  V S + Y+H      I+H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 874 CDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
            DLKP N+LL+    +    + DFG++  F    Q+      + T  Y+APE  R G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 931 TNGDVYSFGIML 942
              DV+S G++L
Sbjct: 201 EKCDVWSAGVIL 212

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQY------GRAIKSFDIECGMIKRIRHRNIIK 810
           +G G +G VYKA        VA+K   L++      G AI+    E  ++K ++HRNII+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
             S    +    L+ EY     L+K +  +    D+  R+ I   +   +  ++F +S  
Sbjct: 98  LKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP---DVSMRV-IKSFLYQLINGVNFCHSRR 152
Query: 871 IIHCDLKPNNVLL-----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
            +H DLKP N+LL      +  V  + DFG+A+ F    +    T  + T+ Y  PE   
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILL 210
Query: 926 EGR-VSTNGDVYS----FGIMLMET 945
             R  ST+ D++S    +  MLM+T
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKT 235

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
           IG+G FG V+KAR +  G +VA+K   ++  +  + F I    E  +++ ++H N++  I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 83
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYS-------------SNYILD--IFQRLNIMIDVA 857
             C +        +  PY   +  +Y              SN ++   + +   +M  + 
Sbjct: 84  EICRT--------KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--LKEDQSLTQTQTLAT 915
           + L Y+H      I+H D+K  NVL+  + V  L+DFG+A+ F   K  Q       + T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 916 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTR 948
           + Y  PE   G E       D++  G ++ E +TR
Sbjct: 193 LWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG AK    E++          I +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG AK    E++          I +MA E   
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++G G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG AK    E++          I +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 742 YLELFQATNGFSENNLIGRGGFG----FVYKARIQDGMEVAVKVFDLQYGRAIKSFDIEC 797
           Y +    ++G+     IG G +      V+KA     ME AVKV D       +  +I  
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI-- 73
Query: 798 GMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA 857
            +++  +H NII             LV E M  G L   +    +  +      ++  + 
Sbjct: 74  -LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIG 131
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAKPFLKEDQSLTQTQTL 913
             +EYLH   S  ++H DLKP+N+L  D         + DFG AK  L+ +  L  T   
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY 187
Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIML 942
            T  ++APE  +        D++S GI+L
Sbjct: 188 -TANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 756 NLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRI-----RHRNII 809
            +IGRG FG V   ++++  +V A+K+  L     +K  +  C   +R        + I 
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFG 866
               +   D+   LV++Y   G L   L    + + +   R  +  M+    ++  LH+ 
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY- 196
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY--- 923
                +H D+KP+N+L+D N    L+DFG     L ED ++  +  + T  Y++PE    
Sbjct: 197 -----VHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 924 --GREGRVSTNGDVYSFGIMLMETFTRKKP 951
             G +GR     D +S G+ + E    + P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 48/276 (17%)
Query: 758  IGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMI--KRIRHRNIIKFISS 814
            IG G FG     R +   E VAVK   ++ G  I + +++  +I  + +RH NI++F   
Sbjct: 27   IGSGNFGVARLMRDKQSNELVAVKY--IERGEKIAA-NVKREIINHRSLRHPNIVRFKEV 83
Query: 815  CSSDDFKALVLEYMPYGSL-EKCLYSSNYILD----IFQRLNIMIDVASALEYLHFGYSV 869
              +    A+V+EY   G L E+   +  +  D     FQ+L       S + Y H   ++
Sbjct: 84   ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH---AM 134
Query: 870  PIIHCDLKPNNVLLDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEY---- 923
             + H DLK  N LLD +    L   DFG +K  +   Q  +   T+ T  Y+APE     
Sbjct: 135  QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKK 191
Query: 924  GREGRVSTNGDVYSFG----IMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD 979
              +G+V+   DV+S G    +ML+  +  + P +E      T+ R +N    I      D
Sbjct: 192  EYDGKVA---DVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILNVQYAIP-----D 242
Query: 980  ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER 1015
               +S E +H +++     FV + A + +I  PE R
Sbjct: 243  YVHISPECRHLISR----IFVADPAKRISI--PEIR 272

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 3/80 (3%)
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT-QTLATIGYMAPEYGREGRVST 931
           H D+KP N+L+  +  A+L DFG+A      D+ LTQ   T+ T+ Y APE   E   + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 932 NGDVYSFGIMLMETFTRKKP 951
             D+Y+   +L E  T   P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 746 FQATNGFSENN----LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI--ECG 798
           FQ T  F+E      ++G+G FG V K + +    E AVKV +    +   +  I  E  
Sbjct: 16  FQGT--FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 799 MIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQR-------- 849
           ++K++ H NI+K            +V E          LY+   + D I +R        
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGE----------LYTGGELFDEIIKRKRFSEHDA 123
Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQS 906
             I+  V S + Y+H      I+H DLKP N+LL+    +    + DFG++  F    Q+
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQN 177
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
                 + T  Y+APE  R G      DV+S G++L
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
           IG+G FG V+KAR +  G +VA+K   ++  +  + F I    E  +++ ++H N++  I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 83
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYS-------------SNYILD--IFQRLNIMIDVA 857
             C +        +  PY   +  +Y              SN ++   + +   +M  + 
Sbjct: 84  EICRT--------KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--LKEDQSLTQTQTLAT 915
           + L Y+H      I+H D+K  NVL+  + V  L+DFG+A+ F   K  Q       + T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 916 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTR 948
           + Y  PE   G E       D++  G ++ E +TR
Sbjct: 193 LWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 20/202 (9%)
Query: 749 TNGFSENNLIGRGGFG----FVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR 804
           ++G+     IG G +      V+KA     ME AVKV D       +  +I   +++  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEI---LLRYGQ 79
Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           H NII             LV E M  G L   +    +  +      ++  +   +EYLH
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH 138
Query: 865 FGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
              S  ++H DLKP+N+L  D         + DFG AK  L+ +  L  T    T  ++A
Sbjct: 139 ---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY-TANFVA 193
Query: 921 PEYGREGRVSTNGDVYSFGIML 942
           PE  +        D++S GI+L
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILL 215

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
           IG+G FG V+KAR +  G +VA+K   ++  +  + F I    E  +++ ++H N++  I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 82
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYS-------------SNYILD--IFQRLNIMIDVA 857
             C +        +  PY   +  +Y              SN ++   + +   +M  + 
Sbjct: 83  EICRT--------KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--LKEDQSLTQTQTLAT 915
           + L Y+H      I+H D+K  NVL+  + V  L+DFG+A+ F   K  Q       + T
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 916 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTR 948
           + Y  PE   G E       D++  G ++ E +TR
Sbjct: 192 LWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 755 NNLIGRGGFGFVYKA-RIQDG-------MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR 806
           N  +G+G F  ++K  R + G        EV +KV D  +    +SF     M+ ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 807 NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           +++     C   D   LV E++ +GSL+  L  +   ++I  +L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 867 YSVPIIHCDLKPNNVLL---DDNMVAH-----LSDFGMAKPFLKEDQSLTQTQTLATIGY 918
               +IH ++   N+LL   +D    +     LSD G++   L +D  + Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 919 MAPEYGREGR-VSTNGDVYSFGIMLME 944
           + PE     + ++   D +SFG  L E
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +    + +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
           R RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 82  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +    + +
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 746 FQATNGFSENN----LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDI--ECG 798
           FQ T  F+E      ++G+G FG V K + +    E AVKV +    +   +  I  E  
Sbjct: 16  FQGT--FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 799 MIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQR-------- 849
           ++K++ H NI+K            +V E          LY+   + D I +R        
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGE----------LYTGGELFDEIIKRKRFSEHDA 123
Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQS 906
             I+  V S + Y+H      I+H DLKP N+LL+    +    + DFG++  F    Q+
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQN 177
Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
                 + T  Y+APE  R G      DV+S G++L
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 65/260 (25%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKS----FDIECGMIKRIRHRNIIKFIS 813
           IGRG F  VYK  +     V V   +LQ  +  KS    F  E   +K ++H NI++F  
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 814 SCSS----DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYL 863
           S  S         LV E    G+L+  L         F+   I +       +   L++L
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKR-------FKVXKIKVLRSWCRQILKGLQFL 145
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           H   + PIIH DLK +N+ +        + D G+A   LK  ++      + T  + APE
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LK--RASFAKAVIGTPEFXAPE 200
Query: 923 YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV--------NDLLLISI 974
              E +   + DVY+FG   +E  T + P  E        +R          + + +  +
Sbjct: 201 XYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 975 MEVVDANLLSHEDKHFVAKE 994
            E+++  +  ++D+ +  K+
Sbjct: 260 KEIIEGCIRQNKDERYSIKD 279

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 159
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 215 GYNKAVDWWALGVLIYE 231

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 730 NMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGR 788
           +MP++ +  R+ +++             IG G FG     R +   E VAVK   ++ G 
Sbjct: 12  DMPIMHDSDRYDFVKD------------IGSGNFGVARLMRDKLTKELVAVKY--IERGA 57
Query: 789 AIKSFDIECGMI--KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL-EKCLYSSNYILD 845
           AI   +++  +I  + +RH NI++F     +    A+++EY   G L E+   +  +  D
Sbjct: 58  AIDE-NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED 116
Query: 846 ----IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS--DFGMAKP 899
                FQ+L       S + Y H   S+ I H DLK  N LLD +    L   DFG +K 
Sbjct: 117 EARFFFQQL------LSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167
Query: 900 FLKEDQSLTQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIML 942
            +   Q  +   T+ T  Y+APE   R+       DV+S G+ L
Sbjct: 168 SVLHSQPKS---TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 754 ENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HR 806
           + +++G G       AR+Q         E AVK+ + Q G        E  M+ + + HR
Sbjct: 17  QEDVLGEGA-----HARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 807 NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           N+++ I     +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH-- 128
Query: 867 YSVPIIHCDLKPNNVLLDD-NMVA--HLSDFGMAKPF-LKEDQSLTQTQTLAT----IGY 918
            +  I H DLKP N+L +  N V+   + DFG+     L  D S   T  L T      Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 919 MAPE----YGREGRV-STNGDVYSFGIML 942
           MAPE    +  E  +     D++S G++L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     IG G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 149
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE    
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLN 203
Query: 927 G-RVSTNGDVYSFGIMLMETFT 947
               +   D++S G ++ E  T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 205 SKGYNKAVDWWALGVLIYE 223

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK-----VFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
           +GRG +G V K R +  G  +AVK     V   +  R +   DI    ++ +     + F
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------NIMIDVASALEYLHF 865
             +   +    + +E M   SL+K  Y    ++D  Q +       I + +  ALE+LH 
Sbjct: 116 YGALFREGDVWICMELMD-TSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA----- 920
             SV  IH D+KP+NVL++      + DFG++   +    S+ +T       YMA     
Sbjct: 172 KLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERIN 226
Query: 921 PEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVND 968
           PE  ++G  S   D++S GI ++E    + P D   T    LK+ V +
Sbjct: 227 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 273

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 149
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE    
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLN 203
Query: 927 G-RVSTNGDVYSFGIMLMETFT 947
               +   D++S G ++ E  T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 149
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE    
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLN 203
Query: 927 G-RVSTNGDVYSFGIMLMETFT 947
               +   D++S G ++ E  T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++  G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF-----DLQYGRAIKSFDIECGMIKRIRH 805
           F +  ++  G FG VYK   I +G +V + V      +    +A K    E  ++  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            ++ + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                ++H DL   NVL+       ++DFG+AK    E++          I +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 926 EGRVSTNGDVYSFGIMLMETFT-RKKPTD 953
               +   DV+S+G+ + E  T   KP D
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 749 TNGFSENNLIGRGGFGFVY--KARIQDGMEVAVKVFDLQYGRAIK------SFDIECGMI 800
           ++ +    ++G+G FG V   K +I  G E AVKV      R +K      S   E  ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVIS---KRQVKQKTDKESLLREVQLL 80
Query: 801 KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
           K++ H NI K         +  LV E    G L   + S     ++     I+  V S +
Sbjct: 81  KQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGI 139
Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            Y H      I+H DLKP N+LL+    +    + DFG++  F   + S      + T  
Sbjct: 140 TYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAY 193
Query: 918 YMAPEYGREGRVSTNGDVYSFGIML 942
           Y+APE    G      DV+S G++L
Sbjct: 194 YIAPEV-LHGTYDEKCDVWSTGVIL 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           IG G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 147
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE    
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 201
Query: 927 G-RVSTNGDVYSFGIMLMETFT 947
               +   D++S G ++ E  T
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLT 223

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 215 GYNKAVDWWALGVLIYE 231

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 194
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 750 NGFSENNLIGRGGFGFVYKA------RIQDGMEVAVKVFD----LQYGRAIKSFDIECGM 799
           N  S    +G G FG V +A      +    M VAVK+      L    A+ S   E  +
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 95
Query: 800 IKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEK----------CLYSSNYILDIFQ 848
           +  +  H NI+  + +C+      ++ EY  YG L            C  +S  I++  +
Sbjct: 96  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 155
Query: 849 RL-------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
                    +    VA  + +L    S   IH DL   N+LL    +  + DFG+A+   
Sbjct: 156 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 212
Query: 902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 213 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 21/201 (10%)
Query: 756 NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNII 809
            +IG+G F  V +    + G + AVK+ D+       G + +    E  +   ++H +I+
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCL-----YSSNYILDIFQRLNIMIDVASALEYLH 864
           + + + SSD    +V E+M    L  C        + ++       + M  +  AL Y H
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 149
Query: 865 FGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
                 IIH D+KP+ VLL   +++    L  FG+A      +  L     + T  +MAP
Sbjct: 150 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAP 204
Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E  +        DV+  G++L
Sbjct: 205 EVVKREPYGKPVDVWGCGVIL 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  +  ++ G+++AVK     +   I  K    E  ++K ++H N+I     
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 174
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 175 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 223
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 758  IGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFISSC 815
            IG G FG     R +   E VAVK   ++ G  I ++   E    + +RH NI++F    
Sbjct: 26   IGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 816  SSDDFKALVLEYMPYGSL-EKCLYSSNYILD----IFQRLNIMIDVASALEYLHFGYSVP 870
             +    A+V+EY   G L E+   +  +  D     FQ+L       S + Y H   ++ 
Sbjct: 84   LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH---AMQ 134
Query: 871  IIHCDLKPNNVLLDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEY----G 924
            + H DLK  N LLD +    L   DFG +K  +   Q  +   T+ T  Y+APE      
Sbjct: 135  VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 191
Query: 925  REGRVSTNGDVYSFG----IMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
             +G+V+   DV+S G    +ML+  +  + P +E      T+ R +N    I      D 
Sbjct: 192  YDGKVA---DVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILNVQYAIP-----DY 242
Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER 1015
              +S E +H +++     FV + A + +I  PE R
Sbjct: 243  VHISPECRHLISR----IFVADPAKRISI--PEIR 271

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKC--LYSSNYILDIFQRLNIMIDVASALEYLH 864
           F  + S ++F  + L     G+    + KC  L   +    I+Q       +   L+Y+H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-------ILRGLKYIH 142
Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
              S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE  
Sbjct: 143 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIM 194
Query: 925 REG-RVSTNGDVYSFGIMLMETFT 947
                 +   D++S G ++ E  T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 144
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGRE 926
           S+ +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T  Y+APE    
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYLAPEIILS 198
Query: 927 GRVSTNGDVYSFGIMLME 944
              +   D ++ G+++ E
Sbjct: 199 KGYNKAVDWWALGVLIYE 216

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 146 IIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 194
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 750 NGFSENNLIGRGGFGFVYKA------RIQDGMEVAVKVFD----LQYGRAIKSFDIECGM 799
           N  S    +G G FG V +A      +    M VAVK+      L    A+ S   E  +
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 79
Query: 800 IKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEK----------CLYSSNYILDIFQ 848
           +  +  H NI+  + +C+      ++ EY  YG L            C  +S  I++  +
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 849 RL-------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
                    +    VA  + +L    S   IH DL   N+LL    +  + DFG+A+   
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 20/130 (15%)
Query: 850 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS--- 906
           L+I I +A A+E+LH   S  ++H DLKP+N+    + V  + DFG+     ++++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 907 LTQTQTLAT----IG---YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
           LT     AT    +G   YM+PE       S   D++S G++L E          SF+ +
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-------SFSTQ 276
Query: 960 MTLKRWVNDL 969
           M   R + D+
Sbjct: 277 MERVRIITDV 286

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 205 SKGYNKAVDWWALGVLIYE 223

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 21/201 (10%)
Query: 756 NLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNII 809
            +IG+G F  V +    + G + AVK+ D+       G + +    E  +   ++H +I+
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCL-----YSSNYILDIFQRLNIMIDVASALEYLH 864
           + + + SSD    +V E+M    L  C        + ++       + M  +  AL Y H
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 865 FGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
                 IIH D+KP+ VLL   +++    L  FG+A      +  L     + T  +MAP
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAP 202
Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E  +        DV+  G++L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
           I +A+     H   ++ IIH D+KP+N+LLD +    L DFG++   +    S+ +T+  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 914 ATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
               YMAPE       R+G      DV+S GI L E  T + P
Sbjct: 187 GCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATGRFP 228

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 750 NGFSENNLIGRGGFGFVYKA------RIQDGMEVAVKVFD----LQYGRAIKSFDIECGM 799
           N  S    +G G FG V +A      +    M VAVK+      L    A+ S   E  +
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 97
Query: 800 IKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEK----------CLYSSNYILDIFQ 848
           +  +  H NI+  + +C+      ++ EY  YG L            C  +S  I++  +
Sbjct: 98  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 157
Query: 849 RL-------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
                    +    VA  + +L    S   IH DL   N+LL    +  + DFG+A+   
Sbjct: 158 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 214
Query: 902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 215 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 156
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 157 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 211
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 212 NQTVDIWSVGCIMAELLT 229

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 194
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 147
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE    
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 201
Query: 927 G-RVSTNGDVYSFGIMLMETFT 947
               +   D++S G ++ E  T
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLT 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
             RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 79  AFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 750 NGFSENNLIGRGGFGFVYKA------RIQDGMEVAVKVFD----LQYGRAIKSFDIECGM 799
           N  S    +G G FG V +A      +    M VAVK+      L    A+ S   E  +
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 102
Query: 800 IKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEK----------CLYSSNYILDIFQ 848
           +  +  H NI+  + +C+      ++ EY  YG L            C  +S  I++  +
Sbjct: 103 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 162
Query: 849 RL-------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
                    +    VA  + +L    S   IH DL   N+LL    +  + DFG+A+   
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 219
Query: 902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 147
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R 
Sbjct: 148 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRA 195
Query: 927 GRVSTNG-------DVYSFGIMLMETFT 947
             +  N        D++S G ++ E  T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 194
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 194
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 143
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 144 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 192
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +  S  + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+ +    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 179
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 234
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 235 GYNKAVDWWALGVLIYE 251

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 147
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 202
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 203 NQTVDIWSVGCIMAELLT 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 142
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 191
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 147
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 202
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 203 NQTVDIWSVGCIMAELLT 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 147
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 202
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 203 NQTVDIWSVGCIMAELLT 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 150
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 205
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 206 NQTVDIWSVGCIMAELLT 223

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+++D      ++DFG+AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 165
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 220
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 221 NQTVDIWSVGCIMAELLT 238

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 144
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 145 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 199
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 200 NQTVDIWSVGCIMAELLT 217

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 142
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R 
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRA 190
Query: 927 GRVSTNG-------DVYSFGIMLMETFT 947
             +  N        D++S G ++ E  T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 164
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 219
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 220 NQTVDIWSVGCIMAELLT 237

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 750 NGFSENNLIGRGGFGFVYKA------RIQDGMEVAVKVFD----LQYGRAIKSFDIECGM 799
           N  S    +G G FG V +A      +    M VAVK+      L    A+ S   E  +
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 102
Query: 800 IKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSLEK----------CLYSSNYILDIFQ 848
           +  +  H NI+  + +C+      ++ EY  YG L            C  +S  I++  +
Sbjct: 103 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 162
Query: 849 RL-------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
                    +    VA  + +L    S   IH DL   N+LL    +  + DFG+A+   
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIK 219
Query: 902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 157
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 212
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 213 NQTVDIWSVGCIMAELLT 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 138
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R 
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRA 186
Query: 927 GRVSTNG-------DVYSFGIMLMETFT 947
             +  N        D++S G ++ E  T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 157
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 212
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 213 NQTVDIWSVGCIMAELLT 230

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 147
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 148 IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 202
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 203 NQTVDIWSVGCIMAELLT 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 151
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 206
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 207 NQTVDIWSVGCIMAELLT 224

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 139
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R 
Sbjct: 140 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRA 187
Query: 927 GRVSTNG-------DVYSFGIMLMETFT 947
             +  N        D++S G ++ E  T
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 152
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   + 
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEIM 201
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 168
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 223
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 224 NQTVDIWSVGCIMAELLT 241

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGM-IKRIRHRN 807
           + F     +G G FG V   + ++ G   A+K+ D Q  + +K   IE  +  KRI+   
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRIQQAV 99
Query: 808 ----IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
               ++K   S   +    +VLEY P G +   L       +   R      +    EYL
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYL 158
Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
           H   S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEI 210
Query: 924 GREGRVSTNGDVYSFGIMLME 944
                 +   D ++ G+++ E
Sbjct: 211 ILSKGYNKAVDWWALGVLIYE 231

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 148
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE    
Sbjct: 149 -SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 202
Query: 927 G-RVSTNGDVYSFGIMLMETFT 947
               +   D++S G ++ E  T
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLT 224

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 156
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 157 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 211
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 212 NQTVDIWSVGCIMAELLT 229

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 11/203 (5%)
Query: 756 NLIGRGGFGFVYKARIQDGMEV-AVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKF 811
            +IGRG +  V   R++    + A+KV   +       I     E  + ++  +   +  
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 812 ISSCSSDDFKAL-VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           + SC   + +   V+EY+  G L   +     + +   R     +++ AL YLH      
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 126
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           II+ DLK +NVLLD      L+D+GM K  L+     T +    T  Y+APE  R     
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDYG 184
Query: 931 TNGDVYSFGIMLMETFTRKKPTD 953
            + D ++ G+++ E    + P D
Sbjct: 185 FSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKAL--VLEYMPYGSLEKCLYSSNYILDIFQRLNIM 853
           E  +++R+RH+N+I+ +    +++ + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK---PFLKEDQSLTQT 910
             +   LEYLH   S  I+H D+KP N+LL       +S  G+A+   PF  +D   T  
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 911 QTLATIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVN 967
            + A   +  PE    G  + +G   D++S G+ L    T   P    F G+   K + N
Sbjct: 173 GSPA---FQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLFEN 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 26/217 (11%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +GRG FG V++ +  Q G + AVK   L+  R  +   + C  +   R   I+    +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 120
Query: 817 SDDFKALVLEYMPYGSLEK------CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              +  + +E +  GSL +      CL     +  + Q L         LEYLH   +  
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-------EGLEYLH---TRR 170
Query: 871 IIHCDLKPNNVLL-DDNMVAHLSDFGMA---KPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I+H D+K +NVLL  D   A L DFG A   +P       LT      T  +MAPE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
                  D++S   M++       P  + F G + LK
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVK-VFDLQYGRAIKSFDIECGMIK 801
           ++F     ++  + IG G +G V  A    + + VA+K +   ++    +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLN------IMI 854
             RH NII       +D  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 79  AFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK-PFLKEDQSLTQTQTL 913
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 914 ATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 755 NNLIGRGGFGFVYKA-RIQDG-------MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR 806
           N  +G+G F  ++K  R + G        EV +KV D  +    +SF     M+ ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 807 NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           +++     C   D   LV E++ +GSL+  L  +   ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 867 YSVPIIHCDLKPNNVLL---DDNMVAH-----LSDFGMAKPFLKEDQSLTQTQTLATIGY 918
               +IH ++   N+LL   +D    +     LSD G++   L +D  + Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 919 MAPEYGREGR-VSTNGDVYSFGIMLME 944
           + PE     + ++   D +SFG  L E
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 11/203 (5%)
Query: 756 NLIGRGGFGFVYKARIQDGMEV-AVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKF 811
            +IGRG +  V   R++    + A+KV   +       I     E  + ++  +   +  
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 812 ISSCSSDDFKAL-VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           + SC   + +   V+EY+  G L   +     + +   R     +++ AL YLH      
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 130
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           II+ DLK +NVLLD      L+D+GM K  L+     T +    T  Y+APE  R     
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDYG 188
Query: 931 TNGDVYSFGIMLMETFTRKKPTD 953
            + D ++ G+++ E    + P D
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 11/203 (5%)
Query: 756 NLIGRGGFGFVYKARIQDGMEV-AVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKF 811
            +IGRG +  V   R++    + A+KV   +       I     E  + ++  +   +  
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 812 ISSCSSDDFKAL-VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           + SC   + +   V+EY+  G L   +     + +   R     +++ AL YLH      
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 141
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           II+ DLK +NVLLD      L+D+GM K  L+     T +    T  Y+APE  R     
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDYG 199
Query: 931 TNGDVYSFGIMLMETFTRKKPTD 953
            + D ++ G+++ E    + P D
Sbjct: 200 FSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 151
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 206
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 207 NQTVDIWSVGCIMAELLT 224

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 157
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 212
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 213 NQTVDIWSVGCIMAELLT 230

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 17/199 (8%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGM-----IKRIRH 805
           F     +G G FG V   + ++ G   A+K+ D Q  + +K  +IE  +     ++ +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKEIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+++D      ++DFG+AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 77  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 130
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE  ++   S  
Sbjct: 131 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 20/213 (9%)
Query: 747 QATNGFSENNLIGRGGFGF----VYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR 802
           Q T+G+     IG G +      ++KA      E AVK+ D       +  +I   +++ 
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNXEFAVKIIDKSKRDPTEEIEI---LLRY 72
Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
            +H NII          +  +V E    G L   +    +  +  +   ++  +   +EY
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKTVEY 131
Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
           LH   +  ++H DLKP+N+L  D         + DFG AK  L+ +  L  T    T  +
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLXTPCY-TANF 186
Query: 919 MAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           +APE           D++S G++L    T   P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 31/220 (14%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH----- 805
           F E  ++G+G FG V KAR   D    A+K         + +   E  ++  + H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 806 --------RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA 857
                   RN +K  ++        +  EY    +L   ++S N      +   +   + 
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK------PFLKED------Q 905
            AL Y+H   S  IIH +LKP N+ +D++    + DFG+AK        LK D       
Sbjct: 127 EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 906 SLTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLME 944
           S   T  + T  Y+A E     G  +   D YS GI+  E
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIK 810
            F   +++G G  G +    + D  +VAVK             D E  +++    H N+I+
Sbjct: 26   FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +  +     F+ + +E +   +L++ +   ++     + + ++    S L +LH   S+ 
Sbjct: 83   YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 871  IIHCDLKPNNVLLD-----DNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYG 924
            I+H DLKP+N+L+        + A +SDFG+ K       S ++   +  T G++APE  
Sbjct: 139  IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 925  REG---RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
             E      +   D++S G +          ++ S     +L+R  N LL    ++ +   
Sbjct: 199  SEDCKENPTYTVDIFSAGCVFYYVI-----SEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
               HED   +A+E        L  K     P++R +AK ++
Sbjct: 254  --KHED--VIARE--------LIEKMIAMDPQKRPSAKHVL 282

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVK-----VFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
           +GRG +G V K R +  G  +AVK     V   +  R +   DI    ++ +     + F
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 71
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------NIMIDVASALEYLHF 865
             +   +    + +E M   SL+K  Y    ++D  Q +       I + +  ALE+LH 
Sbjct: 72  YGALFREGDVWICMELMD-TSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA----- 920
             SV  IH D+KP+NVL++      + DFG++  +L +D  + +        YMA     
Sbjct: 128 KLSV--IHRDVKPSNVLINALGQVKMCDFGISG-YLVDD--VAKDIDAGCKPYMAPERIN 182
Query: 921 PEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVND 968
           PE  ++G  S   D++S GI ++E    + P D   T    LK+ V +
Sbjct: 183 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 11/203 (5%)
Query: 756 NLIGRGGFGFVYKARIQDGMEV-AVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKF 811
            +IGRG +  V   R++    + A++V   +       I     E  + ++  +   +  
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 812 ISSCSSDDFKAL-VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           + SC   + +   V+EY+  G L   +     + +   R     +++ AL YLH      
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 173
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           II+ DLK +NVLLD      L+D+GM K  L+     T +    T  Y+APE  R     
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG 231
Query: 931 TNGDVYSFGIMLMETFTRKKPTD 953
            + D ++ G+++ E    + P D
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 55/282 (19%)
Query: 758  IGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDIECGMI--KRIRHRNIIKFISS 814
            IG G FG     R +   E VAVK   ++ G  I   +++  +I  + +RH NI++F   
Sbjct: 27   IGAGNFGVARLMRDKQANELVAVKY--IERGEKIDE-NVKREIINHRSLRHPNIVRFKEV 83
Query: 815  CSSDDFKALVLEYMPYGSL-EKCLYSSNYILD----IFQRLNIMIDVASALEYLHFGYSV 869
              +    A+V+EY   G L E+   +  +  D     FQ+L       S + Y H   ++
Sbjct: 84   ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYAH---AM 134
Query: 870  PIIHCDLKPNNVLLDDNMVAHL--SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY---- 923
             + H DLK  N LLD +    L  +DFG +K  +   Q       + T  Y+APE     
Sbjct: 135  QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP---KSAVGTPAYIAPEVLLKK 191
Query: 924  GREGRVSTNGDVYSFG----IMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD 979
              +G+V+   DV+S G    +ML+  +  + P +E      T+ R +N    I      D
Sbjct: 192  EYDGKVA---DVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILNVQYAIP-----D 242
Query: 980  ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
               +S E +H +++      +F       +  P +RI+  EI
Sbjct: 243  YVHISPECRHLISR------IF-------VADPAKRISIPEI 271

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 177
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE  ++   S  
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 811 FISSCSSDDFKALVLEYMPYGS-LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
           F  + S ++F  + L     G+ L   +  +    D  Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R   +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEI 189
Query: 930 STNG-------DVYSFGIMLMETFT 947
             N        D++S G ++ E  T
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + D+G+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 735 ANQRRFTYLE------LFQATNGFSENNLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYG 787
           A+Q R T+        +++    +   + +G G +G V  A   + G+ VAVK     + 
Sbjct: 24  ASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 83
Query: 788 RAI--KSFDIECGMIKRIRHRNIIK----FISSCSSDDFKALVLEYMPYGSLEKCLYSSN 841
             I  K    E  ++K ++H N+I     F  + S ++F  + L     G+    +    
Sbjct: 84  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 842 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
            + D   +  ++  +   L+Y+H   S  IIH DLKP+N+ ++++    + DFG+A+   
Sbjct: 144 KLTDDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 199
Query: 902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNG-------DVYSFGIMLMETFT 947
            E             GY+A  + R   +  N        D++S G ++ E  T
Sbjct: 200 DE-----------MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVF------DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G G +G V  A   + G +VA+K        +L   RA +    E  ++K +RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 811 ----FISSCSSDDFKALVLEYMPY--GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
               F    + DDF    L  MP+    L K +       D  Q L  +  +   L Y+H
Sbjct: 89  LLDVFTPDETLDDFTDFYL-VMPFMGTDLGKLMKHEKLGEDRIQFL--VYQMLKGLRYIH 145
Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
              +  IIH DLKP N+ ++++    + DFG+A+   + D  +     + T  Y APE  
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--XGXVVTRWYRAPEVI 197
Query: 925 REG-RVSTNGDVYSFGIMLMETFTRK 949
               R +   D++S G ++ E  T K
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 164
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 219
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 220 NQTVDIWSVGCIMAELLT 237

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 155
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 156 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 210
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 211 NQTVDIWSVGCIMAELLT 228

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 165
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 220
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 221 NQTVDIWSVGCIMAELLT 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 37/208 (17%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 138
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DFG+A+     D  +T        GY+A  + R 
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRA 186
Query: 927 GRVSTNG-------DVYSFGIMLMETFT 947
             +  N        D++S G ++ E  T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFIS--- 813
           +G GG G V+ A   D    VA+K   L   +++K    E  +I+R+ H NI+K      
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 814 ---SCSSDDFKAL--------VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
              S  +DD  +L        V EYM    L   L     +L+   RL  M  +   L+Y
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL-EQGPLLEEHARL-FMYQLLRGLKY 135
Query: 863 LHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAK---PFLKEDQSLTQTQTLATIGY 918
           +H   S  ++H DLKP N+ ++ +++V  + DFG+A+   P       L  ++ L T  Y
Sbjct: 136 IH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--SEGLVTKWY 190
Query: 919 MAPEYGREGRVSTNG-DVYSFGIMLMETFTRK 949
            +P         T   D+++ G +  E  T K
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 17/199 (8%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGM-IKRIRHRNII 809
           F     +G G FG V   + ++ G   A+K+ D Q  + +K   IE  +  KRI      
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 810 KFIS----SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            F++    S   +    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 151
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y APE        
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 206
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 207 NQTVDIWSVGCIMAELLT 224

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIK------SFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G+E A K    +  RA +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L +    L   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 871 IIHCDLKPNNV-LLDDNM-VAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N+ LLD N+ + H+   DFG+A      +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 754 ENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HR 806
           + +++G G       AR+Q         E AVK+ + Q G        E  M+ + + HR
Sbjct: 17  QEDVLGEGA-----HARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 807 NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           N+++ I     +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH-- 128
Query: 867 YSVPIIHCDLKPNNVLLDD-NMVA--HLSDFGMAKPF-LKEDQSLTQTQTLAT----IGY 918
            +  I H DLKP N+L +  N V+   + DF +     L  D S   T  L T      Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 919 MAPE----YGREGRV-STNGDVYSFGIML 942
           MAPE    +  E  +     D++S G++L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 17/248 (6%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           +GRG FG V++       +  +  F    G        E  ++   RHRNI+    S  S
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 877
            +   ++ E++    + + + +S + L+  + ++ +  V  AL++LH   S  I H D++
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129
Query: 878 PNNVLLDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           P N++      + +   +FG A+  LK   +     T     Y APE  +   VST  D+
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLFTAPE--YYAPEVHQHDVVSTATDM 186
Query: 936 YSFGIMLMETF---------TRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
           +S G ++             T ++  +     E T        + I  M+ VD  L+   
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
Query: 987 DKHFVAKE 994
                A E
Sbjct: 247 KSRMTASE 254

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 31/184 (16%)
Query: 794 DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL------EKCLYSSNYILDIF 847
           + E  ++K++ H  IIK  +   ++D+  +VLE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKED 904
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  +
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGE 169
Query: 905 QSLTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTRKKPTDESFTGE 959
            SL +T    T  Y+APE      V T G     D +S G++L    +   P  E  T +
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-Q 225
Query: 960 MTLK 963
           ++LK
Sbjct: 226 VSLK 229

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 31/184 (16%)
Query: 794 DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL------EKCLYSSNYILDIF 847
           + E  ++K++ H  IIK  +   ++D+  +VLE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKED 904
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  +
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGE 169
Query: 905 QSLTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTRKKPTDESFTGE 959
            SL +T    T  Y+APE      V T G     D +S G++L    +   P  E  T +
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-Q 225
Query: 960 MTLK 963
           ++LK
Sbjct: 226 VSLK 229

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 31/184 (16%)
Query: 794 DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL------EKCLYSSNYILDIF 847
           + E  ++K++ H  IIK  +   ++D+  +VLE M  G L       K L  +   L  +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKED 904
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  +
Sbjct: 128 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGE 175
Query: 905 QSLTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTRKKPTDESFTGE 959
            SL +T    T  Y+APE      V T G     D +S G++L    +   P  E  T +
Sbjct: 176 TSLMRT-LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-Q 231
Query: 960 MTLK 963
           ++LK
Sbjct: 232 VSLK 235

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 31/184 (16%)
Query: 794 DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL------EKCLYSSNYILDIF 847
           + E  ++K++ H  IIK  +   ++D+  +VLE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKED 904
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  +
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGE 169
Query: 905 QSLTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTRKKPTDESFTGE 959
            SL +T    T  Y+APE      V T G     D +S G++L    +   P  E  T +
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-Q 225
Query: 960 MTLK 963
           ++LK
Sbjct: 226 VSLK 229

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 31/184 (16%)
Query: 794 DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSL------EKCLYSSNYILDIF 847
           + E  ++K++ H  IIK  +   ++D+  +VLE M  G L       K L  +   L  +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKED 904
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  +
Sbjct: 121 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGE 168
Query: 905 QSLTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTRKKPTDESFTGE 959
            SL +T    T  Y+APE      V T G     D +S G++L    +   P  E  T +
Sbjct: 169 TSLMRT-LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-Q 224
Query: 960 MTLK 963
           ++LK
Sbjct: 225 VSLK 228

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLE 178
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L       +   R     ++ SALEYLH 
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 127
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   
Sbjct: 128 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLE 183
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLE 178
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLE 178
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLE 178
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 215 GYNKAVDWWALGVLIYE 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L       +   R     ++ SALEYLH 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 125
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   
Sbjct: 126 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLE 181
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLE 178
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIK------SFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G+E A K    +  RA +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L +    L   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 871 IIHCDLKPNNV-LLDDNM-VAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N+ LLD N+ + H+   DFG+A      +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIK------SFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G+E A K    +  RA +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L +    L   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 871 IIHCDLKPNNV-LLDDNM-VAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N+ LLD N+ + H+   DFG+A      +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 25/239 (10%)
Query: 720 MGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGME 776
           MG KS++++    +      FT L+ +Q          IG G  G V   Y A +   + 
Sbjct: 1   MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVA 54
Query: 777 VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPY 830
           +       Q     K    E  ++K + H+NII     F    + ++F+   LV+E M  
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD- 113
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
            +L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    
Sbjct: 114 ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167
Query: 891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           + DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 168 ILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYG 924
             S+ +I+ DLKP N+L+D      ++DFG AK      +   +T  LA T  Y+APE  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLAGTPEYLAPEII 210
Query: 925 REGRVSTNGDVYSFGIMLME 944
                +   D ++ G+++ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 177
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE  ++   S  
Sbjct: 178 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 46/275 (16%)
Query: 758  IGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFISSC 815
            IG G FG     R +   E VAVK   ++ G  I ++   E    + +RH NI++F    
Sbjct: 27   IGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 816  SSDDFKALVLEYMPYGSL-EKCLYSSNYILD----IFQRLNIMIDVASALEYLHFGYSVP 870
             +    A+V+EY   G L E+   +  +  D     FQ+L       S + Y H   ++ 
Sbjct: 85   LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH---AMQ 135
Query: 871  IIHCDLKPNNVLLDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEY----G 924
            + H DLK  N LLD +    L    FG +K  +   Q  +   T+ T  Y+APE      
Sbjct: 136  VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 192
Query: 925  REGRVSTNGDVYSFG----IMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
             +G+V+   DV+S G    +ML+  +  + P +E      T+ R +N    I      D 
Sbjct: 193  YDGKVA---DVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILNVQYAIP-----DY 243
Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER 1015
              +S E +H +++     FV + A + +I  PE R
Sbjct: 244  VHISPECRHLISR----IFVADPAKRISI--PEIR 272

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 111/246 (45%), Gaps = 49/246 (19%)
Query: 757 LIGRGGFG-FVYKARIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIR----HRNIIK 810
           ++G G  G  V++   Q G  VAVK       R +  F DI    IK +     H N+I+
Sbjct: 22  ILGYGSSGTVVFQGSFQ-GRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNY------ILDIFQRLNIMIDVASALEYLH 864
           +  S ++D F  + LE     +L+  + S N       +   +  ++++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 865 FGYSVPIIHCDLKPNNVLLD-------------DNMVAHLSDFGMAKPFLKEDQSLTQT- 910
              S+ IIH DLKP N+L+              +N+   +SDFG+ K  L   QS  +T 
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQSSFRTN 188
Query: 911 --QTLATIGYMAPEYGREG-------RVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEM 960
                 T G+ APE   E        R++ + D++S G +     ++ K P  + ++ E 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 961 TLKRWV 966
            + R +
Sbjct: 249 NIIRGI 254

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 81/187 (43%), Gaps = 9/187 (4%)
Query: 758 IGRGGFGFVYK-ARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V++      G     K  +  Y     +   E  ++ ++ H  +I    +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
                 L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 877 KPNNVLLDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
           KP N++ +    + +   DFG+A   L  D+ +    T AT  + APE      V    D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATK-LNPDEIV--KVTTATAEFAAPEIVDREPVGFYTD 232
Query: 935 VYSFGIM 941
           +++ G++
Sbjct: 233 MWAIGVL 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 17/199 (8%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGM-IKRIRHRNII 809
           F     +G G FG V   + ++ G   A+K+ D Q  + +K   IE  +  KRI      
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 810 KFIS----SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            F++    S   +    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 46/275 (16%)
Query: 758  IGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFISSC 815
            IG G FG     R +   E VAVK   ++ G  I ++   E    + +RH NI++F    
Sbjct: 27   IGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 816  SSDDFKALVLEYMPYGSL-EKCLYSSNYILD----IFQRLNIMIDVASALEYLHFGYSVP 870
             +    A+V+EY   G L E+   +  +  D     FQ+L       S + Y H   ++ 
Sbjct: 85   LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH---AMQ 135
Query: 871  IIHCDLKPNNVLLDDNMVAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEY----G 924
            + H DLK  N LLD +    L    FG +K  +   Q      T+ T  Y+APE      
Sbjct: 136  VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP---KDTVGTPAYIAPEVLLKKE 192
Query: 925  REGRVSTNGDVYSFG----IMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
             +G+V+   DV+S G    +ML+  +  + P +E      T+ R +N    I      D 
Sbjct: 193  YDGKVA---DVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILNVQYAIP-----DY 243
Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER 1015
              +S E +H +++     FV + A + +I  PE R
Sbjct: 244  VHISPECRHLISR----IFVADPAKRISI--PEIR 272

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 76  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 129
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE  ++   S  
Sbjct: 130 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 188
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 189 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 17/199 (8%)
Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGM-IKRIRHRNII 809
           F     +G G FG V   + ++ G   A+K+ D Q  + +K   IE  +  KRI      
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 810 KFIS----SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
            F++    S   +    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 28/250 (11%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIK------SFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G+E A K    +  RA +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L +    L   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 871 IIHCDLKPNNV-LLDDNM-VAH--LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N+ LLD N+ + H  L DFG+A      +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             +    D++S G++     +   P    F G+   +   N   + S+    D    SH 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLAN---ITSVSYDFDEEFFSHT 245
Query: 987 D---KHFVAK 993
               K F+ K
Sbjct: 246 SELAKDFIRK 255

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 15/198 (7%)
Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 179
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPEYGRE 926
           S+ +I+ DLKP N+L+D      ++DFG AK      +    T TL  T  Y+APE    
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGATWTLCGTPEYLAPEIILS 233
Query: 927 GRVSTNGDVYSFGIMLME 944
              +   D ++ G+++ E
Sbjct: 234 KGYNKAVDWWALGVLIYE 251

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 206
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 207 SKGYNKAVDWWALGVLIYE 225

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIK------SFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G+E A K    +  RA +        + E  +++++ H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L +    L   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 871 IIHCDLKPNNV-LLDDNM-VAHLS--DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N+ LLD N+ + H+   DFG+A      +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 18/146 (12%)
Query: 749 TNGFSENNLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI---- 803
           T  F E   IG G FG V+K  +  DG   A+K    +  + +     E   ++ +    
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYAHA 65
Query: 804 ---RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---NIMIDVA 857
              +H +++++ S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLL 883
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 18/146 (12%)
Query: 749 TNGFSENNLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI---- 803
           T  F E   IG G FG V+K  +  DG   A+K    +  + +     E   ++ +    
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYAHA 61
Query: 804 ---RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---NIMIDVA 857
              +H +++++ S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLL 883
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 122 RGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 18/146 (12%)
Query: 749 TNGFSENNLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI---- 803
           T  F E   IG G FG V+K  +  DG   A+K    +  + +     E   ++ +    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYAHA 63
Query: 804 ---RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---NIMIDVA 857
              +H +++++ S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLL 883
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 18/146 (12%)
Query: 749 TNGFSENNLIGRGGFGFVYK-ARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI---- 803
           T  F E   IG G FG V+K  +  DG   A+K    +  + +     E   ++ +    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYAHA 63
Query: 804 ---RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---NIMIDVA 857
              +H +++++ S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLL 883
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 179
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE     
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 234
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 235 GYNKAVDWWALGVLIYE 251

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC- 815
           +G GGF +V     + DG   A+K       +  +    E  M +   H NI++ ++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 816 ---SSDDFKALVLEYMPYGSL----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF-GY 867
               +     L+L +   G+L    E+     N++ +  Q L +++ +   LE +H  GY
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED-QILWLLLGICRGLEAIHAKGY 155
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-------ATIGYMA 920
           +    H DLKP N+LL D     L D G         +   Q  TL        TI Y A
Sbjct: 156 A----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 921 PE-YGREGR--VSTNGDVYSFGIMLMETFTRKKPTDESF 956
           PE +  +    +    DV+S G +L      + P D  F
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 80  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 133
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE  ++   S  
Sbjct: 134 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 192
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 193 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 96  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 149
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE  ++   S  
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 177
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +  S+ +   +  + YM PE  ++   S  
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 165
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E         +AT  Y APE        
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIMLNWMHY 220
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 221 NQTVDIWSVGCIMAELLT 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    +  FG+A+     D  +T        GY+A  + R   + 
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMT--------GYVATRWYRAPEIM 194
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIK------SFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G+E A K    +  RA +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L +    L   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 871 IIHCDLKPNNV-LLDDNM-VAH--LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N+ LLD N+ + H  L DFG+A      +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 16/179 (8%)
Query: 755 NNLIGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFI 812
           + L+G G +  V  A  +Q+G E AVK+ + Q G +      E   + + + ++NI++ I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                D    LV E +  GS+   +    +  +  +   ++ DVA+AL++LH   +  I 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 873 HCDLKPNNVLLDDN---MVAHLSDFGMAKPFLKEDQSLTQTQT------LATIGYMAPE 922
           H DLKP N+L +         + DF +    +K + S T   T        +  YMAPE
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSG-MKLNNSCTPITTPELTTPCGSAEYMAPE 191

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E         +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-----VATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           IIH DLKP+N+ ++++    + D G+A+     D  +T        GY+A  + R   + 
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMT--------GYVATRWYRAPEIM 194
Query: 931 TNG-------DVYSFGIMLMETFT 947
            N        D++S G ++ E  T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E         +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-----VATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 141
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + DFG+A+    E         +AT  Y APE        
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-----VATRWYRAPEIMLNWMHY 196
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 197 NQTVDIWSVGCIMAELLT 214

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + D G+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 18/174 (10%)
Query: 138 KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGN---- 193
           ++P T  +   L+TL+L+ N     +P  I +L +L+ L +       E+PE L +    
Sbjct: 118 ELPDTXQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 194 -----LAELEKLQLQNNFLTG--TIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLS 246
                L  L+ L+L+    TG  ++P SI NL +L  L++  + L+   P  +H + +L 
Sbjct: 177 GEHQGLVNLQSLRLE---WTGIRSLPASIANLQNLKSLKIRNSPLSALGPA-IHHLPKLE 232
Query: 247 AELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC-TIPKEIGNLAKLEKLDLQ 299
            EL  + C  +     I+  +      I  D  N  T+P +I  L +LEKLDL+
Sbjct: 233 -ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G+ VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           F  + S ++F  + L     G+    +     + D   +  ++  +   L+Y+H   S  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---SAD 145
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RV 929
           IIH DLKP+N+ ++++    + D G+A+    E      T  +AT  Y APE        
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 200
Query: 930 STNGDVYSFGIMLMETFT 947
           +   D++S G ++ E  T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 17/153 (11%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN---I 852
           E  ++K++ H NI+K            LV+E    G L    +    +   F  ++   I
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVI 109
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQ 909
           M  V S   YLH      I+H DLKP N+LL+    + +  + DFG++  F   +     
Sbjct: 110 MKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKM 163
Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
            + L T  Y+APE  R+ +     DV+S G++L
Sbjct: 164 KERLGTAYYIAPEVLRK-KYDEKCDVWSCGVIL 195

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLT 908
           IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   +
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 173
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
            T+   T  Y+APE     +   + D++S G+++
Sbjct: 174 LTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 27/158 (17%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN---- 851
           E  ++K + H NI+K            LV+E         C        +I  R+     
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVME---------CYKGGELFDEIIHRMKFNEV 136
Query: 852 ----IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKED 904
               I+  V S + YLH      I+H DLKP N+LL+    + +  + DFG++  F  E+
Sbjct: 137 DAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--EN 191
Query: 905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           Q     + L T  Y+APE  R+ +     DV+S G++L
Sbjct: 192 QK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
           H NI+K            LV+E +  G L + +    +  +  +   IM  + SA+ ++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH 123
Query: 865 FGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
               V ++H DLKP N+L    +DN+   + DFG A+    ++Q L       T+ Y AP
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP 178
Query: 922 EYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           E   +     + D++S G++L    + + P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQY------GRAIKSFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G E A K    +       G + +  + E  +++ IRH NII 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  +   + YLH   S  
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 135
Query: 871 IIHCDLKPNNVLLDDNMVAH----LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V +    L DFG+A      ++         T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNY 192
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 9/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   + +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     S  + D    V+EY   G L   L       +   R     ++ SAL+YLH 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 126
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      T  Y+APE   
Sbjct: 127 EKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLE 182
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 9/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   + +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     S  + D    V+EY   G L   L       +   R     ++ SAL+YLH 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 127
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      T  Y+APE   
Sbjct: 128 EKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLE 183
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 9/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   + +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     S  + D    V+EY   G L   L       +   R     ++ SAL+YLH 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 128
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      T  Y+APE   
Sbjct: 129 EKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLE 184
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 56/237 (23%)
Query: 758 IGRGGFGFVYKARIQDGMEV--AVKVFDLQYGRAIKSFDIE-----CGMIKRIRHRNIIK 810
           IG+G +G V +  I++      A+K+ +    R I   D+E       ++K++ H NI +
Sbjct: 34  IGQGSYGVV-RVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 811 FISSCSSDDFKALVLEYMPYGSL------------EKC---------------------- 836
                  + +  LV+E    G L             KC                      
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 837 -LYSSNYILDIFQR----LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN--MVA 889
            ++     LD  QR     NIM  + SAL YLH   +  I H D+KP N L   N     
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209
Query: 890 HLSDFGMAKPFLK--EDQSLTQTQTLATIGYMAPEYGREGRVS--TNGDVYSFGIML 942
            L DFG++K F K    +    T    T  ++APE       S     D +S G++L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 17/153 (11%)
Query: 796 ECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN---I 852
           E  ++K++ H NI+K            LV+E    G L    +    +   F  ++   I
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVI 126
Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLTQ 909
           M  V S   YLH      I+H DLKP N+LL+    + +  + DFG++  F   +     
Sbjct: 127 MKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKM 180
Query: 910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
            + L T  Y+APE  R+ +     DV+S G++L
Sbjct: 181 KERLGTAYYIAPEVLRK-KYDEKCDVWSCGVIL 212

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVKVFDLQY------GRAIKSFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G E A K    +       G + +  + E  +++ IRH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  +   + YLH   S  
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 128
Query: 871 IIHCDLKPNNVLLDDNMVAH----LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V +    L DFG+A      ++         T  ++APE    
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNY 185
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 186 EPLGLEADMWSIGVI 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQ-DGMEVAVK------VFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G G F  V K R +  G E A K      +   + G + +  + E  +++ IRH NII 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  +   + YLH   S  
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 149
Query: 871 IIHCDLKPNNVLLDDNMVAH----LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V +    L DFG+A      ++         T  ++APE    
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNY 206
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 207 EPLGLEADMWSIGVI 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPAFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 25/239 (10%)
Query: 720 MGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGME 776
           M  KS++++    +      FT L+ +Q          IG G  G V   Y A +   + 
Sbjct: 1   MASKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVA 54
Query: 777 VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPY 830
           +       Q     K    E  ++K + H+NII     F    + ++F+   LV+E M  
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD- 113
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
            +L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    
Sbjct: 114 ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167
Query: 891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           + DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 168 ILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRHRN 807
           F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +    
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
           ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 145
Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
           S+ +I+ DLKP N+L+D+     ++DFG AK        L  T       Y+APE     
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEIILSK 200
Query: 928 RVSTNGDVYSFGIMLME 944
             +   D ++ G+++ E
Sbjct: 201 GYNKAVDWWALGVLIYE 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 752 FSENNLIGRGGFGFVYKARIQD-GMEVAVK------------VFDLQYGRAIKSFDIECG 798
           +S  + +G G FGFV+ A  ++   EV VK            + D + G+      +E  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT----LEIA 81
Query: 799 MIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS 858
           ++ R+ H NIIK +    +  F  LV+E    G         +  LD      I   + S
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
           A+ YL       IIH D+K  N+++ ++    L DFG A     E   L  T    TI Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEY 195
Query: 919 MAPE 922
            APE
Sbjct: 196 CAPE 199

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 133
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 191 EPLGLEADMWSIGVI 205

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 133
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 191 EPLGLEADMWSIGVI 205

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 55
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 56  KLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 114
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 115 LXQVIQME---LDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 747 QATNGFSENNLIGRGGFGFVY-KARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH 805
           +  N +     IG G FG +Y  A I  G EVA+K+  ++         IE    K ++ 
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHP--QLHIESKFYKMMQG 63
Query: 806 RNIIKFISSCSSD-DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
              I  I  C ++ D+  +V+E +   SLE      +    +   L +   + S +EY+H
Sbjct: 64  GVGIPSIKWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 865 FGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPF----------LKEDQSLTQT 910
              S   IH D+KP+N L+      N+V ++ DFG+AK +           +E+++LT T
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 911 QTLATIG-YMAPEYGREGRVSTNGDVYSFGIMLM 943
              A+I  ++  E  R        D+ S G +LM
Sbjct: 179 ARYASINTHLGIEQSRR------DDLESLGYVLM 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 9/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   + +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     S  + D    V+EY   G L   L       +   R     ++ SAL+YLH 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 269
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      T  Y+APE   
Sbjct: 270 EKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLE 325
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 326 DNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 55
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 56  KLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 114
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 115 LXQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFC 254
           A+ +KL LQ+N L+     +   L+ L  L L+ N L                 LPA   
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ---------------TLPAGIF 81
Query: 255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL 314
             +  LE ++++ N     +P  +           L  L +L L  N+L+ + P   D+L
Sbjct: 82  KELKNLETLWVTDNKLQA-LPIGV--------FDQLVNLAELRLDRNQLKSLPPRVFDSL 132
Query: 315 HNLEWMIFSFNKLVGVVPTTIFN-VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSG 373
             L ++   +N+L   +P  +F+ +++LK L L +N    R+P  A  +L  L+ L L  
Sbjct: 133 TKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLKLDN 190
Query: 374 NNFSGTIPSFIFNT-SKLSTLELQRNSF 400
           N     +P   F++  KL  L+LQ N +
Sbjct: 191 NQLK-RVPEGAFDSLEKLKMLQLQENPW 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 9/206 (4%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   + +  G   A+K+   +   A   +     E  +++  RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     S  + D    V+EY   G L   L       +   R     ++ SAL+YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 266
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      T  Y+APE   
Sbjct: 267 EKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLE 322
Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRN--IIKFIS 813
           IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+   
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 814 SCSSDDFKALVLEYMPYGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
              +D +  +V+E    G+++          +D ++R +   ++   LE +H  +   I+
Sbjct: 96  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 149
Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-T 931
           H DLKP N L+ D M+  L DFG+A     +   + +   + T+ YM PE  ++   S  
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 932 NG----------DVYSFGIMLMETFTRKKP 951
           NG          DV+S G +L      K P
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ +
Sbjct: 212 SKGYNKAVDWWALGVLIYQ 230

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 128/316 (40%), Gaps = 55/316 (17%)
Query: 652 NVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSC-RTRIHHTSSKNDLLIGI 710
            V   KLE ++  +GP+RN   ES    E L     L V  C  T   H++ + D  +  
Sbjct: 4   KVRLKKLE-QLLLDGPWRN---ESALSVETL-----LDVLVCLYTECSHSALRRDKYVAE 54
Query: 711 VLPLSTTFMMGGKS-QLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKA 769
            L  +  F    K  QL+  +  ++                      +IGRG FG V   
Sbjct: 55  FLEWAKPFTQLVKEMQLHREDFEII---------------------KVIGRGAFGEVAVV 93
Query: 770 RIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRIRHRN-----IIKFISSCSSDDFKAL 823
           ++++   + A+K+  L     +K  +  C   +R    N     I     +   ++   L
Sbjct: 94  KMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYL 151
Query: 824 VLEYMPYGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGYSVPIIHCDLKPNN 880
           V++Y   G L   L    + + +   R  I  M+    ++  LH+      +H D+KP+N
Sbjct: 152 VMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDIKPDN 205
Query: 881 VLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDV 935
           VLLD N    L+DFG     + +D ++  +  + T  Y++PE  +      G+     D 
Sbjct: 206 VLLDVNGHIRLADFGSCLK-MNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDW 264
Query: 936 YSFGIMLMETFTRKKP 951
           +S G+ + E    + P
Sbjct: 265 WSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 128/316 (40%), Gaps = 55/316 (17%)
Query: 652 NVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSC-RTRIHHTSSKNDLLIGI 710
            V   KLE ++  +GP+RN   ES    E L     L V  C  T   H++ + D  +  
Sbjct: 20  KVRLKKLE-QLLLDGPWRN---ESALSVETL-----LDVLVCLYTECSHSALRRDKYVAE 70
Query: 711 VLPLSTTFMMGGKS-QLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKA 769
            L  +  F    K  QL+  +  ++                      +IGRG FG V   
Sbjct: 71  FLEWAKPFTQLVKEMQLHREDFEII---------------------KVIGRGAFGEVAVV 109
Query: 770 RIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKRIRHRN-----IIKFISSCSSDDFKAL 823
           ++++   + A+K+  L     +K  +  C   +R    N     I     +   ++   L
Sbjct: 110 KMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYL 167
Query: 824 VLEYMPYGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGYSVPIIHCDLKPNN 880
           V++Y   G L   L    + + +   R  I  M+    ++  LH+      +H D+KP+N
Sbjct: 168 VMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDIKPDN 221
Query: 881 VLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDV 935
           VLLD N    L+DFG     + +D ++  +  + T  Y++PE  +      G+     D 
Sbjct: 222 VLLDVNGHIRLADFGSCLK-MNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDW 280
Query: 936 YSFGIMLMETFTRKKP 951
           +S G+ + E    + P
Sbjct: 281 WSLGVCMYEMLYGETP 296

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+++D      ++DFG AK        L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIII 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 45/243 (18%)
Query: 756 NLIGRGGFG-FVYKARIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIR----HRNII 809
            ++G G  G  V++   Q G  VAVK       R +  F DI    IK +     H N+I
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVI 90
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNY------ILDIFQRLNIMIDVASALEYL 863
           ++  S ++D F  + LE     +L+  + S N       +   +  ++++  +AS + +L
Sbjct: 91  RYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 864 HFGYSVPIIHCDLKPNNVLLD-------------DNMVAHLSDFGMAKPFLKEDQSLTQT 910
           H   S+ IIH DLKP N+L+              +N+   +SDFG+ K  L   Q   + 
Sbjct: 150 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQXXFRX 205
Query: 911 ---QTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLK 963
                  T G+ APE   E    R++ + D++S G +     ++ K P  + ++ E  + 
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 964 RWV 966
           R +
Sbjct: 266 RGI 268

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A ++  + +       Q     K    E  ++K + H+NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    S ++F+   +V+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQME---LDHERMSYLLYQMLVGIKHLH---S 144
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 929 VSTNGDVYSFGIMLME 944
              N D++S G+++ E
Sbjct: 202 YKENVDIWSVGVIMGE 217

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G  VAVK     +   I  K    E  ++K ++H N+I     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 811 FISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
           F  + S ++F  + L     G+    + KC   ++   D  Q L  +  +   L+Y+H  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH-- 142
Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            S  IIH DLKP+N+ ++++    + DF +A+    E      T  +AT  Y APE    
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEIMLN 196
Query: 927 G-RVSTNGDVYSFGIMLMETFT 947
               +   D++S G ++ E  T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLT 908
           IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   +
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 175
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
            T    T  Y+APE     +   + D++S G+++
Sbjct: 176 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 45/243 (18%)
Query: 756 NLIGRGGFG-FVYKARIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIR----HRNII 809
            ++G G  G  V++   Q G  VAVK       R +  F DI    IK +     H N+I
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVI 90
Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNY------ILDIFQRLNIMIDVASALEYL 863
           ++  S ++D F  + LE     +L+  + S N       +   +  ++++  +AS + +L
Sbjct: 91  RYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 864 HFGYSVPIIHCDLKPNNVLLD-------------DNMVAHLSDFGMAKPFLKEDQSLTQT 910
           H   S+ IIH DLKP N+L+              +N+   +SDFG+ K  L   Q   + 
Sbjct: 150 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQXXFRX 205
Query: 911 ---QTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLK 963
                  T G+ APE   E    R++ + D++S G +     ++ K P  + ++ E  + 
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 964 RWV 966
           R +
Sbjct: 266 RGI 268

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 756 NLIGRGGFGFVYKARI-QDGMEVAVKV---FDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +IGRG F  V   ++ Q G   A+K+   +D+     +  F  E  ++     R I + 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVP 870
             +   +++  LV+EY   G L   L      +        + ++  A++ +H  GY   
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY--- 183
Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-------Y 923
            +H D+KP+N+LLD      L+DFG     L+ D ++     + T  Y++PE        
Sbjct: 184 -VHRDIKPDNILLDRCGHIRLADFGSCLK-LRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 924 GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
              G      D ++ G+   E F  + P     T E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLT 908
           IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   +
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 173
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
            T    T  Y+APE     +   + D++S G+++
Sbjct: 174 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSLT 908
           IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   +
Sbjct: 127 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 180
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
            T    T  Y+APE     +   + D++S G+++
Sbjct: 181 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A ++  + +       Q     K    E  ++K + H+NII     
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    S ++F+   +V+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQME---LDHERMSYLLYQMLVGIKHLH---S 144
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 929 VSTNGDVYSFGIMLME 944
              N D++S G+++ E
Sbjct: 202 YKENVDIWSVGVIMGE 217

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKA-RIQDGMEVAVK 780
            KS++++    +      FT L+ +Q          IG G  G V  A     G+ VAVK
Sbjct: 2   SKSKVDNQFYSVEVADSTFTVLKRYQQLKP------IGSGAQGIVCAAFDTVLGINVAVK 55
Query: 781 VFD--LQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 56  KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 114
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + ++     LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 115 LCQVIHME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           DFG+A+       +   T  + T  Y APE       + N D++S G ++ E
Sbjct: 169 DFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 10/105 (9%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           + + +  AL YL   + V  IH D+KP+N+LLD+     L DFG++   + +     + +
Sbjct: 129 MTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDR 183
Query: 912 TLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTRKKP 951
           +     YMAPE        +       DV+S GI L+E  T + P
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLT 908
           IM D+ +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK   +  Q+  
Sbjct: 114 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNAL 167
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           QT    T  Y+APE     +   + D++S G+++
Sbjct: 168 QTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLT 908
           IM D+ +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK   +  Q+  
Sbjct: 133 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNAL 186
Query: 909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           QT    T  Y+APE     +   + D++S G+++
Sbjct: 187 QTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 794 DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIM 853
           + E  ++K++ H  IIK  +   ++D+  +VLE M  G L   +  +  + +   +L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 259
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQT 910
             +  A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  + SL +T
Sbjct: 260 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 314
Query: 911 QTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
               T  Y+APE     G  G  +   D +S G++L    +   P  E  T +++LK
Sbjct: 315 -LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLK 368

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSL 907
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 180
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 758 IGRGGFGFVYKARIQD-GMEVAVKVFDLQYG----RAIKSFDIE--CGMIKRIRHRNIIK 810
           +G G F  V K R +  G++ A K    +      R +   DIE    ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 +     L+LE +  G L   L     + +  +    +  + + + YLH   S+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 871 IIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
           I H DLKP N++L D  V      + DFG+A    K D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 927 GRVSTNGDVYSFGIM 941
             +    D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSL 907
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 218
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSL 907
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 178
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 794 DIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIM 853
           + E  ++K++ H  IIK  +   ++D+  +VLE M  G L   +  +  + +   +L   
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 245
Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQT 910
             +  A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  + SL +T
Sbjct: 246 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 300
Query: 911 QTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
               T  Y+APE     G  G  +   D +S G++L    +   P  E  T +++LK
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLK 354

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSL 907
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 173
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSL 907
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 174
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSL 907
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 224
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 225 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 33/240 (13%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQD-GMEVAVK 780
           G   +   N    A++R    ++ FQ         + G+G FG V   + +  GM VA+K
Sbjct: 1   GPGSMMSLNAAAAADERSRKEMDRFQV------ERMAGQGTFGTVQLGKEKSTGMSVAIK 54
Query: 781 VFDLQYGRAIKSFDIECGM-IKRIRHRNIIKFIS-------SCSSDDFKALVLEYMPYGS 832
              +Q  R  ++ +++    +  + H NI++  S           D +  +V+EY+P  +
Sbjct: 55  KV-IQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DT 111
Query: 833 LEKCLYSSNYILDIFQRLNIMIDV-----ASALEYLHFGYSVPIIHCDLKPNNVLLDD-N 886
           L +C    NY         I+I V       ++  LH   SV + H D+KP+NVL+++ +
Sbjct: 112 LHRC--CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEAD 168
Query: 887 MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLME 944
               L DFG AK   K   S      + +  Y APE  +G +   +T  D++S G +  E
Sbjct: 169 GTLKLCDFGSAK---KLSPSEPNVAYICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAE 224

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 851 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKEDQSL 907
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 188
Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 942
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 189 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 55
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 56  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 114
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 115 LXQVIQME---LDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 55
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 56  KLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 114
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 115 LCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 49/246 (19%)
Query: 757 LIGRGGFG-FVYKARIQDGMEVAVKVFDLQYGRAIKSF-DIECGMIKRIR----HRNIIK 810
           ++G G  G  V++   Q G  VAVK       R +  F DI    IK +     H N+I+
Sbjct: 22  ILGYGSSGTVVFQGSFQ-GRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNY------ILDIFQRLNIMIDVASALEYLH 864
           +  S ++D F  + LE     +L+  + S N       +   +  ++++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 865 FGYSVPIIHCDLKPNNVLLD-------------DNMVAHLSDFGMAKPFLKEDQSLTQT- 910
              S+ IIH DLKP N+L+              +N+   +SDFG+ K  L   Q   +  
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQXXFRXN 188
Query: 911 --QTLATIGYMAPEYGREG-------RVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEM 960
                 T G+ APE   E        R++ + D++S G +     ++ K P  + ++ E 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 961 TLKRWV 966
            + R +
Sbjct: 249 NIIRGI 254

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A +   + +       Q     K    E  ++K + H+NII     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    + ++F+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 85  FTPQKTLEEFQDVYLVMELMD-ANLXQVIQME---LDHERMSYLLYQMLXGIKHLH---S 137
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 138 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 929 VSTNGDVYSFGIMLMETFTRK 949
              N D++S G ++ E    K
Sbjct: 195 YKENVDIWSVGCIMGEMVRHK 215

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 32/242 (13%)
Query: 161 GDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN-LS 219
            ++P  I      +YL+L +N +Q    +   +L  LE LQL  N L   I    FN L 
Sbjct: 27  AEVPASIP--VNTRYLNLQENSIQVIRTDTFKHLRHLEILQLSKN-LVRKIEVGAFNGLP 83
Query: 220 SLSDLELSFNSLTGNFP----------KDMHIVNRLSAELPAKFCNNIPFLEEI------ 263
           SL+ LEL  N LT   P          +++ + N     +P+   N +P L  +      
Sbjct: 84  SLNTLELFDNRLT-TVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELK 142
Query: 264 ---YLSKNMFYGEIP---SDLGNCTIPKEIGNLA---KLEKLDLQFNRLQCVIPHEIDNL 314
              Y+S+  F G +     +LG C + K+I NL    +LE+L+L  NRL  + P     L
Sbjct: 143 RLEYISEAAFEGLVNLRYLNLGMCNL-KDIPNLTALVRLEELELSGNRLDLIRPGSFQGL 201
Query: 315 HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGN 374
            +L  +     ++  +      ++ +L+ L L  N+    LP      L  LE + L+ N
Sbjct: 202 TSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMS-LPHDLFTPLHRLERVHLNHN 260
Query: 375 NF 376
            +
Sbjct: 261 PW 262

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 32/242 (13%)
Query: 161 GDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN-LS 219
            ++P  I      +YL+L +N +Q    +   +L  LE LQL  N L   I    FN L 
Sbjct: 27  AEVPASIP--VNTRYLNLQENSIQVIRTDTFKHLRHLEILQLSKN-LVRKIEVGAFNGLP 83
Query: 220 SLSDLELSFNSLTGNFP----------KDMHIVNRLSAELPAKFCNNIPFLEEI------ 263
           SL+ LEL  N LT   P          +++ + N     +P+   N +P L  +      
Sbjct: 84  SLNTLELFDNRLT-TVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELK 142
Query: 264 ---YLSKNMFYGEIP---SDLGNCTIPKEIGNLA---KLEKLDLQFNRLQCVIPHEIDNL 314
              Y+S+  F G +     +LG C + K+I NL    +LE+L+L  NRL  + P     L
Sbjct: 143 RLEYISEAAFEGLVNLRYLNLGMCNL-KDIPNLTALVRLEELELSGNRLDLIRPGSFQGL 201
Query: 315 HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGN 374
            +L  +     ++  +      ++ +L+ L L  N+    LP      L  LE + L+ N
Sbjct: 202 TSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMS-LPHDLFTPLHRLERVHLNHN 260
Query: 375 NF 376
            +
Sbjct: 261 PW 262

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L       T  Y+AP    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G +VA+K     +   I  K    E  ++K ++H N+I     
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 811 FISSCSSDDFKALVLEYMPY--GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F  + S  +F    L  MP+    L+K +         F    I   V   L+ L + +S
Sbjct: 110 FTPASSLRNFYDFYL-VMPFMQTDLQKIMGME------FSEEKIQYLVYQMLKGLKYIHS 162
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG- 927
             ++H DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE      
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM 217
Query: 928 RVSTNGDVYSFGIMLMETFTRK 949
             +   D++S G ++ E  T K
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 756 NLIGRGGFGFVYKARIQDGME-VAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFI 812
           +LIGRG +G+VY A  ++  + VA+K  +  +   I    I  E  ++ R++   II+  
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 813 SSCSSDD---FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
                DD   F  L +      S  K L+ +   L       I+ ++     ++H     
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ES 148
Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAK 898
            IIH DLKP N LL+ +    + DFG+A+
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 746 FQATNGFSENNLIGRGGFGFVYKA-RIQDGMEVAVKVFD--LQYGRAIKSFDIECGMIKR 802
           F     + +   IG G  G V  A     G+ VAVK      Q     K    E  ++K 
Sbjct: 18  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 77
Query: 803 IRHRNIIK----FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV 856
           + H+NII     F    + ++F+   LV+E M   +L + ++     LD  +   ++  +
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHME---LDHERMSYLLYQM 133
Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
              +++LH   S  IIH DLKP+N+++  +    + DFG+A+       +   T  + T 
Sbjct: 134 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTR 187
Query: 917 GYMAPEYGREGRVSTNGDVYSFGIMLME 944
            Y APE         N D++S G ++ E
Sbjct: 188 YYRAPEVILGMGYKENVDIWSVGCIMGE 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 25/238 (10%)
Query: 721 GGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEV 777
             KS++++    +      FT L+ +Q          IG G  G V   Y A +   + +
Sbjct: 1   ASKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAI 54
Query: 778 AVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYG 831
                  Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   
Sbjct: 55  KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-A 113
Query: 832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL 891
           +L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    +
Sbjct: 114 NLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
            DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 168 LDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 22/222 (9%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVK-VFD-LQYGRAI---------KS 792
           EL    + ++    I  G +G V      +G+ VA+K VF+ +  GR +         K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 793 FDIECGMIKRIRHRNIIK----FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQ 848
              E  ++    H NI+     F+        K  ++  +    L + ++    ++    
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
               M  +   L  LH      ++H DL P N+LL DN    + DF +A+   ++     
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADAN 189
Query: 909 QTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTRK 949
           +T  +    Y APE   + +  T   D++S G ++ E F RK
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 758 IGRGGFGFVYKA-RIQDGMEVAVKVFDLQYGRAI--KSFDIECGMIKRIRHRNIIK---- 810
           +G G +G V  A   + G +VA+K     +   I  K    E  ++K ++H N+I     
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 811 FISSCSSDDFKALVLEYMPY--GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F  + S  +F    L  MP+    L+K +         F    I   V   L+ L + +S
Sbjct: 92  FTPASSLRNFYDFYL-VMPFMQTDLQKIMGLK------FSEEKIQYLVYQMLKGLKYIHS 144
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG- 927
             ++H DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE      
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM 199
Query: 928 RVSTNGDVYSFGIMLMETFTRK 949
             +   D++S G ++ E  T K
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 22/222 (9%)
Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVK-VFD-LQYGRAI---------KS 792
           EL    + ++    I  G +G V      +G+ VA+K VF+ +  GR +         K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 793 FDIECGMIKRIRHRNIIK----FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQ 848
              E  ++    H NI+     F+        K  ++  +    L + ++    ++    
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
               M  +   L  LH      ++H DL P N+LL DN    + DF +A+   ++     
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADAN 189
Query: 909 QTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTRK 949
           +T  +    Y APE   + +  T   D++S G ++ E F RK
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A ++  + +       Q     K    E  ++K + H+NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    S ++F+   +V+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 929 VSTNGDVYSFGIMLME 944
              N D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 25/234 (10%)
Query: 720 MGGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGME 776
           MG +S+ ++    +      FT L+ +Q          IG G  G V   Y A ++  + 
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAILERNVA 54
Query: 777 VAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPY 830
           +       Q     K    E  ++K + H+NII     F    S ++F+   +V+E M  
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD- 113
Query: 831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 890
            +L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    
Sbjct: 114 ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167
Query: 891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
           + DFG+A+       S   T  + T  Y APE         N D++S G ++ E
Sbjct: 168 ILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 13/199 (6%)
Query: 750 NGFSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDI---ECGMIKRIRH 805
           + F     +G G FG V   + ++ G   A+K+ D Q    +K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             ++K   S   +    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S+ +I+ DLKP N+L+D      ++DFG AK        L  T        +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEIIL 211
Query: 926 EGRVSTNGDVYSFGIMLME 944
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A ++  + +       Q     K    E  ++K + H+NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    S ++F+   +V+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQME---LDHERMSYLLYQMLVGIKHLH---S 144
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 929 VSTNGDVYSFGIMLME 944
              N D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A ++  + +       Q     K    E  ++K + H+NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    S ++F+   +V+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 929 VSTNGDVYSFGIMLME 944
              N D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 55
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 56  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 114
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 115 LCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 1   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 54
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 55  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 113
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 114 LCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 167
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK 949
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 168 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 747 QATNGFSENNLIGRGGFGFVY-KARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH 805
           +  N +     IG G FG +Y    I  G EVA+K+  ++         IE  + K ++ 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQG 63
Query: 806 RNIIKFISSCSSD-DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
              I  I  C ++ D+  +V+E +   SLE      +    +   L +   + S +EY+H
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 865 FGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPF----------LKEDQSLTQT 910
              S   IH D+KP+N L+      N+V ++ DFG+AK +           +E+++LT T
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 911 QTLATIG-YMAPEYGREGRVSTNGDVYSFGIMLM 943
              A+I  ++  E  R        D+ S G +LM
Sbjct: 179 ARYASINTHLGIEQSRR------DDLESLGYVLM 206

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 747 QATNGFSENNLIGRGGFGFVY-KARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH 805
           +  N +     IG G FG +Y    I  G EVA+K+  ++         IE  + K ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQG 61
Query: 806 RNIIKFISSCSSD-DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
              I  I  C ++ D+  +V+E +   SLE      +    +   L +   + S +EY+H
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 865 FGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPF----------LKEDQSLTQT 910
              S   IH D+KP+N L+      N+V ++ DFG+AK +           +E+++LT T
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 911 QTLATIG-YMAPEYGREGRVSTNGDVYSFGIMLM 943
              A+I  ++  E  R        D+ S G +LM
Sbjct: 177 ARYASINTHLGIEQSRR------DDLESLGYVLM 204

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 29/253 (11%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 94  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 152
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 153 LCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPT 952
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K   
Sbjct: 207 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 261
Query: 953 DESFTGEMTLKRW 965
              F G   + +W
Sbjct: 262 --LFPGRDYIDQW 272

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A +   + +       Q     K    E  ++K + H+NII     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    + ++F+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 85  FTPQKTLEEFQDVYLVMELMD-ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 137
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 929 VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW 965
              N D++S G ++ E    K      F G   + +W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           I+  V ++  Y+H      I H D+KP+N+L+D N    LSDFG ++  +  D+ +  ++
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR 211
Query: 912 TLATIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVND 968
              T  +M PE+      S NG   D++S GI L   F    P    F+ +++L    N+
Sbjct: 212 --GTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVELFNN 264
Query: 969 LLLISIMEVVDAN 981
           +   +I   +D N
Sbjct: 265 IRTKNIEYPLDRN 277

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A +   + +       Q     K    E  ++K + H+NII     
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    + ++F+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 86  FTPQKTLEEFQDVYLVMELMD-ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 138
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 139 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 929 VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW 965
              N D++S G ++ E    K      F G   + +W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A ++  + +       Q     K    E  ++K + H+NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    S ++F+   +V+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 929 VSTNGDVYSFGIMLME 944
              N D++S G ++ E
Sbjct: 202 YKENVDIWSVGCIMGE 217

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 758 IGRGGFGFV---YKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK---- 810
           IG G  G V   Y A +   + +       Q     K    E  ++K + H+NII     
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 811 FISSCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           F    + ++F+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 86  FTPQKTLEEFQDVYLVMELMD-ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 138
Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
             IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE      
Sbjct: 139 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 929 VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW 965
              N D++S G ++ E    K      F G   + +W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 29/253 (11%)
Query: 722 GKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFV---YKARIQDGMEVA 778
            KS++++    +      FT L+ +Q          IG G  G V   Y A +   + + 
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKP------IGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 779 VKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFK--ALVLEYMPYGS 832
                 Q     K    E  ++K + H+NII     F    + ++F+   LV+E M   +
Sbjct: 94  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-AN 152
Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
           L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +    + 
Sbjct: 153 LCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPT 952
           DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K   
Sbjct: 207 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 261
Query: 953 DESFTGEMTLKRW 965
              F G   + +W
Sbjct: 262 --LFPGRDYIDQW 272

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 122/314 (38%), Gaps = 78/314 (24%)
Query: 170 LTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFN 229
           L  L  ++   N+L    P  L NL +L  + + NN +    P  + NL++L+ L L  N
Sbjct: 66  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 121
Query: 230 SLTGNFP-KDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG 288
            +T   P K++  +NRL  EL +   ++I  L  +   + + +G   +DL      K + 
Sbjct: 122 QITDIDPLKNLTNLNRL--ELSSNTISDISALSGLTSLQQLSFGNQVTDL------KPLA 173
Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPT--------------- 333
           NL  LE+LD+  N++  +    +  L NLE +I + N++  + P                
Sbjct: 174 NLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQ 231
Query: 334 -----TIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP------- 381
                T+ +++ L  L L +N      P S    L  L EL L  N  S   P       
Sbjct: 232 LKDIGTLASLTNLTDLDLANNQISNLAPLSG---LTKLTELKLGANQISNISPLAGLTAL 288
Query: 382 -------------SFIFNTSKLSTLELQRNSFSGFIP--------------------NTF 408
                        S I N   L+ L L  N+ S   P                    ++ 
Sbjct: 289 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSL 348
Query: 409 GNLRNLKWLDLGDN 422
            NL N+ WL  G N
Sbjct: 349 ANLTNINWLSAGHN 362

>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 110/243 (45%), Gaps = 36/243 (14%)
Query: 162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN-LSS 220
           ++P  I   T+L  L+L +N++Q        +L  LE LQL  N +  TI    FN L++
Sbjct: 57  EVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 221 LSDLELSFNSLT----GNFP-----KDMHIVNRLSAELPAKFCNNIPFLEEI-------- 263
           L+ LEL  N LT    G F      K++ + N     +P+   N IP L  +        
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 264 -YLSKNMFYGEIP---SDLGNCTIPKEIGNLA---KLEKLDLQFNRLQCVIPHEIDNLHN 316
            Y+S+  F G       +L  C + +EI NL    KL++LDL  N L  + P     L +
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNL-REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 317 LE--WMIFSFNKLVGVVPTTIF-NVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSG 373
           L+  WMI S    + V+    F N+ +L  + L  N+    LP      L +LE + L  
Sbjct: 233 LQKLWMIQS---QIQVIERNAFDNLQSLVEINLAHNN-LTLLPHDLFTPLHHLERIHLHH 288
Query: 374 NNF 376
           N +
Sbjct: 289 NPW 291

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 122/314 (38%), Gaps = 78/314 (24%)
Query: 170 LTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFN 229
           L  L  ++   N+L    P  L NL +L  + + NN +    P  + NL++L+ L L  N
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122
Query: 230 SLTGNFP-KDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG 288
            +T   P K++  +NRL  EL +   ++I  L  +   + + +G   +DL      K + 
Sbjct: 123 QITDIDPLKNLTNLNRL--ELSSNTISDISALSGLTSLQQLSFGNQVTDL------KPLA 174
Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPT--------------- 333
           NL  LE+LD+  N++  +    +  L NLE +I + N++  + P                
Sbjct: 175 NLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQ 232
Query: 334 -----TIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP------- 381
                T+ +++ L  L L +N      P S    L  L EL L  N  S   P       
Sbjct: 233 LKDIGTLASLTNLTDLDLANNQISNLAPLSG---LTKLTELKLGANQISNISPLAGLTAL 289
Query: 382 -------------SFIFNTSKLSTLELQRNSFSGFIP--------------------NTF 408
                        S I N   L+ L L  N+ S   P                    ++ 
Sbjct: 290 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSL 349
Query: 409 GNLRNLKWLDLGDN 422
            NL N+ WL  G N
Sbjct: 350 ANLTNINWLSAGHN 363

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1027
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-179
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-130
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-108
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-86
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-96
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-81
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-64
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-58
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-84
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-83
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-68
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-83
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-79
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-60
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-82
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-80
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-77
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-74
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-73
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-74
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-65
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-73
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-72
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-67
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-36
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-70
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-63
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-50
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-55
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-51
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-49
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-15
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-44
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-43
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-47
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-44
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-33
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-33
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-37
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-33
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-33
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-31
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-30
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-08
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-30
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-29
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-29
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-29
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-29
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-29
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-28
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-28
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-13
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-06
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-09
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-21
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-21
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-06
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-06
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-16
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	6e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	5e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	4e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  540 bits (1394), Expect = e-179
 Identities = 192/696 (27%), Positives = 285/696 (40%), Gaps = 60/696 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIPS--TLSNCKRLRNISLSLNDFSGTIPKEIG-NVTTLIGLHL 57
            ++L  L L  N   G + +  +L +C  L+ +++S N          G  + +L  L L
Sbjct: 99  SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158

Query: 58  RGNKLQGEIPEEL---GNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGEL 114
             N + G             EL+ L +  N ++G +   +    +L  LD+S NN +  +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216

Query: 115 LANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLK 174
                 +   LQ L +  N   G     +  C  L+ L++S N F G IP     L  L+
Sbjct: 217 PF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQ 272

Query: 175 YLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTG 233
           YL L +N+  GEIP+ L G    L  L L  N   G +PP   + S L  L LS N+ +G
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332

Query: 234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
             P D                  +  L+ + LS N F GE+P  L N +        A L
Sbjct: 333 ELPMD--------------TLLKMRGLKVLDLSFNEFSGELPESLTNLS--------ASL 370

Query: 294 EKLDLQFNRLQCVIPHEIDN--LHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
             LDL  N     I   +     + L+ +    N   G +P T+ N S L  L+L  N  
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430

Query: 352 FGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL 411
            G +PSS    L  L +L L  N   G IP  +     L TL L  N  +G IP+   N 
Sbjct: 431 SGTIPSSL-GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489

Query: 412 RNLKWLDLGDNYLTSS-TSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF 470
            NL W+ L +N LT      +        + L    +SNN   G +P  +G+   S+   
Sbjct: 490 TNLNWISLSNNRLTGEIPKWI-----GRLENLAILKLSNNSFSGNIPAELGDCR-SLIWL 543

Query: 471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIP 530
            +  +  +G+IP  +   +      +  N + G   + +      +      N LE    
Sbjct: 544 DLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ-- 597

Query: 531 DNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVI 590
                          L  L      N++   + G       N   ++ +D+S N  S  I
Sbjct: 598 ---------GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 591 PTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKD 650
           P  IG +  L  L L +N + GSIPD +GD+  L  L+LS+N L G IP ++  L  L +
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708

Query: 651 INVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP 686
           I++S N L G IP  G F  F    F  N  LCG P
Sbjct: 709 IDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  413 bits (1063), Expect = e-130
 Identities = 160/581 (27%), Positives = 258/581 (44%), Gaps = 62/581 (10%)

Query: 96  NLSSLSNLDLSVNNLTGEL--LANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLS 153
               ++++DLS   L      +++   +L  L++LFL  ++ +G +         L +L 
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLD 106

Query: 154 LSINDFSGDIP--KEIGNLTKLKYLHLDQNRLQGEIP-EELGNLAELEKLQLQNNFLTGT 210
           LS N  SG +     +G+ + LK+L++  N L           L  LE L L  N ++G 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 211 IPPSIF---NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSK 267
                        L  L +S N ++G+                    +    LE + +S 
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD-----------------VSRCVNLEFLDVSS 209

Query: 268 NMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKL 327
           N F   IP           +G+ + L+ LD+  N+L       I     L+ +  S N+ 
Sbjct: 210 NNFSTGIPF----------LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259

Query: 328 VGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT 387
           VG +P     + +L++L L  N F G +P         L  L LSGN+F G +P F  + 
Sbjct: 260 VGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317

Query: 388 SKLSTLELQRNSFSGFIP-NTFGNLRNLKWLDLGDNYLTSS-TSELSFLSSSNCKYLEYF 445
           S L +L L  N+FSG +P +T   +R LK LDL  N  +      L+ LS+S    L   
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS----LLTL 373

Query: 446 SISNNPLGGILPRVIGNLS-QSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGS 504
            +S+N   G +   +      ++++ ++ N+  +G IP  ++N + L++++L  N L+G+
Sbjct: 374 DLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT 433

Query: 505 ILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTG 564
           I  +LG L KL+ L L  N LEG IP  L +  TL +             L L  N  TG
Sbjct: 434 IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET-------------LILDFNDLTG 480

Query: 565 PLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINL 624
            +P  + N   L  I LS N  +  IP  IG L++L  L L  N   G+IP  +GD  +L
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540

Query: 625 KSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPRE 665
             L+L+ N   G IP ++ K        ++ N + G+    
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVY 577

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  275 bits (705), Expect = 1e-79
 Identities = 112/427 (26%), Positives = 173/427 (40%), Gaps = 42/427 (9%)

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPT--TIFNVS 339
            +   + +L  LE L L  + +   +        +L  +  S N L G V T  ++ + S
Sbjct: 68  AVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126

Query: 340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF---NTSKLSTLELQ 396
            LKFL + SN+       S  ++L +LE L LS N+ SG             +L  L + 
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186

Query: 397 RNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGIL 456
            N  SG +        NL++LD+  N  ++    L      +C  L++  IS N L G  
Sbjct: 187 GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL-----GDCSALQHLDISGNKLSGDF 239

Query: 457 PRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIAL-GKLKKL 515
            R I   +  ++  ++ ++   G IP     L +L  + L  NK  G I   L G    L
Sbjct: 240 SRAISTCT-ELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL 296

Query: 516 QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLE-IGNLK 574
             L L  N   G             ++P    +   +  L LS N F+G LP++ +  ++
Sbjct: 297 TGLDLSGNHFYG-------------AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343

Query: 575 VLVQIDLSINNFSDVIPTTIGGLK-DLQYLFLKYNRLQGSIPDSIGDMI--NLKSLNLSN 631
            L  +DLS N FS  +P ++  L   L  L L  N   G I  ++       L+ L L N
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403

Query: 632 NNLFGIIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNFSLESFKGNEL-------LC 683
           N   G IP +L    +L  +++SFN L G IP   G            N L       L 
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463

Query: 684 GMPNLQV 690
            +  L+ 
Sbjct: 464 YVKTLET 470

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  351 bits (903), Expect = e-108
 Identities = 141/705 (20%), Positives = 239/705 (33%), Gaps = 93/705 (13%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            +N+  L L  N       +  +   +L ++ +  N  S   P+    +  L  L+L+ N
Sbjct: 24  PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           +L     +       L EL L +N +     +      +L  LDLS N L+         
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQV 142

Query: 121 NLPLLQTLFLDENNFDGKIPSTL--LRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
            L  LQ L L  N         L       L+ L LS N      P     + +L  L L
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202

Query: 179 DQNRLQGEIPEELG---NLAELEKLQLQNNFLTGTIPPSIFNL--SSLSDLELSFNSLTG 233
           +  +L   + E+L        +  L L N+ L+ T   +   L  ++L+ L+LS+N+L  
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262

Query: 234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
                          +       +P LE  +L  N         L              +
Sbjct: 263 ---------------VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF---------NV 298

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFG 353
             L+L+                +      S   L  +   +   +  L+ L +  N   G
Sbjct: 299 RYLNLK---------------RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343

Query: 354 RLPSSADVRLPNLEELSLSGNNFS-GTIPSFIF---NTSKLSTLELQRNSFSGFIPNTFG 409
            + S+    L NL+ LSLS +  S  T+ +  F     S L  L L +N  S    + F 
Sbjct: 344 -IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402

Query: 410 NLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMED 469
            L +L+ LDLG N +    +   +      + +    +S N    +       +  S++ 
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEW---RGLENIFEIYLSYNKYLQLTRNSFALV-PSLQR 458

Query: 470 FHMPNSNISG--SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEG 527
             +    +    S P     L NL  + L  N +       L  L+KL++L L+ N L  
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA- 517

Query: 528 SIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFS 587
                                        L  +   G     +  L  L  ++L  N F 
Sbjct: 518 ----------------------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549

Query: 588 DVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLD 647
           ++       L +L+ + L  N L         + ++LKSLNL  N +  +          
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609

Query: 648 -LKDINVSFNKLEGEIPREGPFRNFSLESFK-----GNELLCGMP 686
            L ++++ FN  +        F N+  E+        +  LC  P
Sbjct: 610 NLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  292 bits (749), Expect = 2e-86
 Identities = 115/612 (18%), Positives = 215/612 (35%), Gaps = 86/612 (14%)

Query: 75  ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN 134
             E     +  LT  +P  +   ++++ L+L+ N L   L A   +    L +L +  N 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNT 60

Query: 135 FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNL 194
                P    +   L+ L+L  N+ S    K     T L  LHL  N +Q          
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFC 254
             L  L L +N L+ T   +   L +L +L LS N +                       
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA--------------------- 159

Query: 255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL 314
                     L                    +I   + L+KL+L  N+++   P     +
Sbjct: 160 ----------LKSEEL---------------DIFANSSLKKLELSSNQIKEFSPGCFHAI 194

Query: 315 HNLEWMIFSFNKLVGVVPTTIF---NVSTLKFLYLGSNSFFGRLPSS-ADVRLPNLEELS 370
             L  +  +  +L   +   +      ++++ L L ++       ++   ++  NL  L 
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254

Query: 371 LSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTS- 429
           LS NN +           +L    L+ N+      ++   L N+++L+L  ++   S S 
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314

Query: 430 ----ELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI 485
               ++   S    K LE+ ++ +N + GI   +   L  +++   + NS  S       
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNE 373

Query: 486 N----NLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTS 541
                  + L  + L  NK++     A   L  L++L L  N++   +            
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT----------- 422

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDV--IPTTIGGLKD 599
                  L++I  + LS N +          +  L ++ L      +V   P+    L++
Sbjct: 423 -GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481

Query: 600 LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL--------FGIIPISLEKLLDLKDI 651
           L  L L  N +     D +  +  L+ L+L +NNL         G     L+ L  L  +
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541

Query: 652 NVSFNKLEGEIP 663
           N+  N  +    
Sbjct: 542 NLESNGFDEIPV 553

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  317 bits (815), Expect = 2e-96
 Identities = 97/646 (15%), Positives = 191/646 (29%), Gaps = 98/646 (15%)

Query: 30  NISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTG- 88
           N +  L+ +       + +   + GL L G    G +P+ +G L ELE L L ++     
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 89  ---TIPSSIFNLSSLSNLDLSVNNLTGELLANICS-NLPLLQTLFLDENNFDGKIPSTLL 144
                P  I    S         +     +      +   L    ++ +     I  +  
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 145 RCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN 204
                  +    N+ +  + K +  LTKL+  ++  +    E   E            + 
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEY 234

Query: 205 NFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY 264
                T      NL  L+D+E+         P  +                 +P ++ I 
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL---------------KALPEMQLIN 279

Query: 265 LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCV-IPHEIDNLHNLEWMIFS 323
           ++ N           +     +     K++ + + +N L+   +   +  +  L  +   
Sbjct: 280 VACNRGIS-GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL 338

Query: 324 FNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPS- 382
           +N+L G +P    +   L  L L  N     +P++       +E LS + N     IP+ 
Sbjct: 339 YNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNI 395

Query: 383 -FIFNTSKLSTLELQRNSFSGFIPNTF-------GNLRNLKWLDLGDNYLTSSTSELSFL 434
               + S +S ++   N         F           N+  ++L +N ++    E    
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE---- 451

Query: 435 SSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAI 494
             S    L   ++  N L  I                    N      +   N   L +I
Sbjct: 452 LFSTGSPLSSINLMGNMLTEI------------------PKNSLKDENENFKNTYLLTSI 493

Query: 495 YLGVNKLNGSIL-IALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDIL 553
            L  NKL           L  L  + L  N                +  P+   N   + 
Sbjct: 494 DLRFNKLTKLSDDFRATTLPYLVGIDLSYNS--------------FSKFPTQPLNSSTLK 539

Query: 554 CLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGS 613
              +                      D   N      P  I     L  L +  N ++  
Sbjct: 540 GFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-K 580

Query: 614 IPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
           + + I    N+  L++ +N    I    +   ++     + ++K +
Sbjct: 581 VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  276 bits (707), Expect = 4e-81
 Identities = 76/490 (15%), Positives = 151/490 (30%), Gaps = 56/490 (11%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            S+L    + S+     I  +     +   I    N+ +  + K +  +T L   ++  +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
               E   E            +      T      NL  L+++++       +L   +  
Sbjct: 217 PFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK- 270

Query: 121 NLPLLQTLFLDENNF--------DGKIPSTLLRCKHLQTLSLSINDF-SGDIPKEIGNLT 171
            LP +Q + +  N          D +  +     + +Q + +  N+  +  +   +  + 
Sbjct: 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK 330

Query: 172 KLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNS 230
           KL  L    N+L+G++P   G+  +L  L L  N +T  IP +       + +L  + N 
Sbjct: 331 KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNK 388

Query: 231 LTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNL 290
           L    P                   ++  +  I  S N        +     +       
Sbjct: 389 LKY-IPNIFDA-------------KSVSVMSAIDFSYNEIGSVDGKNFDP--LDPTPFKG 432

Query: 291 AKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGV-------VPTTIFNVSTLKF 343
             +  ++L  N++             L  +    N L  +             N   L  
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492

Query: 344 LYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQ------R 397
           + L  N             LP L  + LS N+FS   P+   N+S L    ++       
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551

Query: 398 NSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILP 457
           N      P       +L  L +G N +         ++      +    I +NP   I  
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-------VNEKITPNISVLDIKDNPNISIDL 604

Query: 458 RVIGNLSQSM 467
             +    ++ 
Sbjct: 605 SYVCPYIEAG 614

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  227 bits (581), Expect = 8e-64
 Identities = 66/422 (15%), Positives = 131/422 (31%), Gaps = 48/422 (11%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
               E    +    +        N K L ++ +        +P  +  +  +  +++  N
Sbjct: 224 CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283

Query: 61  KL--------QGEIPEELGNLAELEELWLQ-NNFLTGTIPSSIFNLSSLSNLDLSVNNLT 111
           +           +   +     +++ +++  NN  T  + +S+  +  L  L+   N L 
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343

Query: 112 GELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPK--EIGN 169
           G  L     +   L +L L  N       +     + ++ LS + N     IP   +  +
Sbjct: 344 G-KLPAFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKS 400

Query: 170 LTKLKYLHLDQNRLQG-------EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS 222
           ++ +  +    N +          +         +  + L NN ++          S LS
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460

Query: 223 DLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT 282
            + L  N LT        I      +    F  N   L  I L  N    ++  D     
Sbjct: 461 SINLMGNMLTE-------IPKNSLKDENENFK-NTYLLTSIDLRFNKL-TKLSDDFR--- 508

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWM------IFSFNKLVGVVPTTIF 336
                  L  L  +DL +N      P +  N   L+            N+ +   P  I 
Sbjct: 509 ----ATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT 563

Query: 337 NVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQ 396
              +L  L +GSN    ++        PN+  L +  N       S++    +     L 
Sbjct: 564 LCPSLTQLQIGSND-IRKVNEKI---TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLF 619

Query: 397 RN 398
            +
Sbjct: 620 YD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  212 bits (542), Expect = 1e-58
 Identities = 79/507 (15%), Positives = 143/507 (28%), Gaps = 96/507 (18%)

Query: 190 ELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAEL 249
            L +   +  L L+    +G +P +I  L+ L  L L  +    N               
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER----------LFG 125

Query: 250 PAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPH 309
           P     N+   E+    +  +                  + + L K  +  +  Q  I  
Sbjct: 126 PKGISANM-SDEQKQKMRMHYQKTFVDYDPRE-------DFSDLIKDCINSDPQQKSIKK 177

Query: 310 EIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEEL 369
                     +    N +  V    +  ++ L+  Y+G++ F               E  
Sbjct: 178 SSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICE------AWENE 230

Query: 370 SLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTS 429
           +        T      N   L+ +E+        +P     L  ++ +++  N   S   
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290

Query: 430 ELSFLSS----SNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI 485
                 +       + ++   I  N           NL              +  +   +
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYN-----------NLK-------------TFPVETSL 326

Query: 486 NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPST 545
             +  L  +    N+L G +  A G   KL  L+L  NQ+              T IP+ 
Sbjct: 327 QKMKKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQI--------------TEIPAN 371

Query: 546 LW-NLKDILCLNLSLNFFTG-PLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYL 603
                + +  L+ + N     P   +  ++ V+  ID S N    V              
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP------- 424

Query: 604 FLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIP 663
                     +  +    IN+ S+NLSNN +             L  IN+  N L   IP
Sbjct: 425 ----------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IP 473

Query: 664 REGPFRNFSLESFKGNELLCGMPNLQV 690
           +              NE       L  
Sbjct: 474 KN--------SLKDENENFKNTYLLTS 492

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  115 bits (289), Expect = 2e-26
 Identities = 35/293 (11%), Positives = 80/293 (27%), Gaps = 70/293 (23%)

Query: 370 SLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTS 429
           +   + +       + +  +++ L L+    SG +P+  G L  L+ L LG +       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV--- 119

Query: 430 ELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLT 489
                                                         N     PK I+   
Sbjct: 120 ----------------------------------------------NERLFGPKGISANM 133

Query: 490 NLIAIYLGVNKLNGSILIALGKLKKLQL--LSLKDNQLEGSIPDNLSFSCTLTSIPSTLW 547
           +             + +    +     L    +  +  + SI  +   +   T       
Sbjct: 134 SDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ------ 187

Query: 548 NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKY 607
                  +    N  T  +   +  L  L Q  +  + F           ++ +Y     
Sbjct: 188 -------IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY----- 234

Query: 608 NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEG 660
            +   +      ++ +L  + + N      +P  L+ L +++ INV+ N+   
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  284 bits (729), Expect = 2e-84
 Identities = 118/679 (17%), Positives = 205/679 (30%), Gaps = 113/679 (16%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK 61
            + + L L  N        +  +   L+ + LS  +          +++ L  L L GN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 62  LQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSN 121
           +Q         L+ L++L      L       I +L +L  L+++ N +    L    SN
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 122 LPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQN 181
           L  L+ L L  N       + L     +  L+LS                    L L  N
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS--------------------LDLSLN 187

Query: 182 RLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMH 240
            +    P     +  L KL L+NNF +  +  +    L+ L    L           +  
Sbjct: 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246

Query: 241 IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQF 300
             + L           +  L                D     I      L  +    L  
Sbjct: 247 DKSALE---------GLCNLTIEEFRLAYL------DYYLDDIIDLFNCLTNVSSFSLVS 291

Query: 301 NRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSAD 360
             ++ V           + +     K        + ++  L F      + F      ++
Sbjct: 292 VTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF------SE 343

Query: 361 VRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG 420
           V LP+LE L LS N                        SF G    +     +LK+LDL 
Sbjct: 344 VDLPSLEFLDLSRNG----------------------LSFKGCCSQSDFGTTSLKYLDLS 381

Query: 421 DNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGS 480
            N + + +S    L       LE+    ++ L  +                         
Sbjct: 382 FNGVITMSSNFLGLEQ-----LEHLDFQHSNLKQMSE----------------------- 413

Query: 481 IPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLT 540
                 +L NLI + +       +       L  L++L +  N  + +            
Sbjct: 414 -FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL---------- 462

Query: 541 SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDL 600
             P     L+++  L+LS        P    +L  L  +++S NNF  +       L  L
Sbjct: 463 --PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520

Query: 601 QYLFLKYNRLQGSIPDSIGDMI-NLKSLNLSNNNLFGIIPIS--LEKLLDLKDINVSFNK 657
           Q L    N +  S    +     +L  LNL+ N+          L+ + D + + V   +
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER 580

Query: 658 LEGEIPREGPFRNFSLESF 676
           +E   P     +   + S 
Sbjct: 581 MECATP--SDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  279 bits (717), Expect = 7e-83
 Identities = 122/633 (19%), Positives = 200/633 (31%), Gaps = 105/633 (16%)

Query: 42  IPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS 101
           IP  +    +   L L  N L+        +  EL+ L L    +      +  +LS LS
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDF-S 160
            L L+ N +   L     S L  LQ L   E N        +   K L+ L+++ N   S
Sbjct: 80  TLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 161 GDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELE----KLQLQNNFLTGTIPPSIF 216
             +P+   NLT L++L L  N++Q     +L  L ++      L L  N +   I P  F
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197

Query: 217 NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPS 276
               L  L L  N  + N  K                   +  LE   L    F  E   
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKT--------------CIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 277 DLGNCTIPKEIGNLAKLEKLDLQFNRLQC---VIPHEIDNLHNLEWMIFSFNKLVGVVPT 333
           +         +  L  L   + +   L      I    + L N+         +  V   
Sbjct: 244 EK---FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD- 299

Query: 334 TIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTL 393
                   + L L +  F G+ P+     L +L+ L+ + N           +   L  L
Sbjct: 300 -FSYNFGWQHLELVNCKF-GQFPTLK---LKSLKRLTFTSNKGGNAFS--EVDLPSLEFL 352

Query: 394 ELQRN--SFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNP 451
           +L RN  SF G    +     +LK+LDL  N + + +S    L       LE+    ++ 
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ-----LEHLDFQHSN 407

Query: 452 LGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGK 511
           L  +                               +L NLI + +       +       
Sbjct: 408 LKQMSE------------------------FSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 512 LKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG 571
           L  L++L +  N  + +                                      P    
Sbjct: 444 LSSLEVLKMAGNSFQENFL------------------------------------PDIFT 467

Query: 572 NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
            L+ L  +DLS      + PT    L  LQ L + +N            + +L+ L+ S 
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527

Query: 632 NNLFGIIPISLEKLLD-LKDINVSFNKLEGEIP 663
           N++       L+     L  +N++ N       
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  240 bits (615), Expect = 1e-68
 Identities = 90/523 (17%), Positives = 176/523 (33%), Gaps = 54/523 (10%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDF-SGTIPKEIGNVTTLIGLHLRG 59
           LS+L+ L              + + K L+ ++++ N   S  +P+   N+T L  L L  
Sbjct: 99  LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 60  NKLQGEIPEELGNLAELE----ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELL 115
           NK+Q     +L  L ++      L L  N +   I    F    L  L L  N  +  ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVM 217

Query: 116 ANICSNLPLLQTLFLDENNFDGK------IPSTLLRCKHLQTLSLSIN---DFSGDIPKE 166
                 L  L+   L    F  +        S L    +L      +     +  DI   
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 167 IGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLEL 226
              LT +    L    ++             + L+L N          + +L  L+    
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335

Query: 227 SFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKE 286
              +                         ++P LE + LS+N    +           + 
Sbjct: 336 KGGNAFSEV--------------------DLPSLEFLDLSRNGLSFKGC-------CSQS 368

Query: 287 IGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF-NVSTLKFLY 345
                 L+ LDL FN +   +      L  LE + F  + L  +   ++F ++  L +L 
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427

Query: 346 LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFI 404
           +          +     L +LE L ++GN+F       IF     L+ L+L +       
Sbjct: 428 ISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 405 PNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLS 464
           P  F +L +L+ L++  N   S    L          L+    S N +     + + +  
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFS----LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542

Query: 465 QSMEDFHMPNSNISGSIPKE--INNLTNLIAIYLGVNKLNGSI 505
            S+   ++  ++ + +   +  +  + +   + + V ++  + 
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 585

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  148 bits (376), Expect = 2e-37
 Identities = 65/369 (17%), Positives = 125/369 (33%), Gaps = 48/369 (13%)

Query: 331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKL 390
           +P  +    + K L L  N     L S +    P L+ L LS             + S L
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 391 STLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNN 450
           STL L  N         F  L +L+ L   +  L S    L      + K L+  ++++N
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS----LENFPIGHLKTLKELNVAHN 134

Query: 451 PL-GGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNL----IAIYLGVNKLNGSI 505
            +    LP    NL+ ++E   + ++ I      ++  L  +    +++ L +N +N   
Sbjct: 135 LIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193

Query: 506 LIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP 565
             A  +++ L  L+L++N    ++              + +  L  +    L L  F   
Sbjct: 194 PGAFKEIR-LHKLTLRNNFDSLNVM------------KTCIQGLAGLEVHRLVLGEFR-- 238

Query: 566 LPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGS---IPDSIGDMI 622
                           +  N      + + GL +L     +   L      I D    + 
Sbjct: 239 ----------------NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

Query: 623 NLKSLNLSNNNLFGIIPIS-LEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNEL 681
           N+ S +L +  +  +   S       L+ +N  F +      +      F+         
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342

Query: 682 LCGMPNLQV 690
              +P+L+ 
Sbjct: 343 EVDLPSLEF 351

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  112 bits (283), Expect = 8e-26
 Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 3/173 (1%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
           L NL YL +             +    L  + ++ N F      +I   +  L  L L  
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANIC 119
            +L+   P    +L+ L+ L + +N            L+SL  LD S+N++       + 
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539

Query: 120 SNLPLLQTLFLDENNFDGKIPSTLLR--CKHLQTLSLSINDFSGDIPKEIGNL 170
                L  L L +N+F             K  + L + +       P +   +
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.0 bits (242), Expect = 8e-21
 Identities = 29/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)

Query: 532 NLSFSCT---LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSD 588
           N+++ C       IP  L        L+LS N           +   L  +DLS      
Sbjct: 9   NITYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 589 VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDL 648
           +       L  L  L L  N +Q     +   + +L+ L     NL  +    +  L  L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 649 KDINVSFNKLEG 660
           K++NV+ N ++ 
Sbjct: 127 KELNVAHNLIQS 138

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  286 bits (734), Expect = 6e-83
 Identities = 91/664 (13%), Positives = 187/664 (28%), Gaps = 115/664 (17%)

Query: 30  NISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGT 89
           N +  L+ +      ++ N   + GL L G   +G +P+ +G L EL+ L    +  T +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 90  IPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK---IPSTLLRC 146
                    +    +   + +              L    L ++  +      P      
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 147 KHLQTLSLS-INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN 205
             L+   +  + +    I K I  LTKL+ ++   +    +         + E       
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYA 477

Query: 206 FLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYL 265
                   S  NL  L+D+EL         P  ++               ++P L+ + +
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY---------------DLPELQSLNI 522

Query: 266 SKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFN 325
           + N              +  +     K++   +                         +N
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYM------------------------GYN 558

Query: 326 KLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF 385
            L     +                            ++  L  L    N     + +F  
Sbjct: 559 NLEEFPASASLQ------------------------KMVKLGLLDCVHNKVR-HLEAF-G 592

Query: 386 NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYF 445
              KL+ L+L  N       +       ++ L    N L    +  +     +   +   
Sbjct: 593 TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNA---KSVYVMGSV 649

Query: 446 SISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSI 505
             S N +G     +  ++                          N   + L  N++    
Sbjct: 650 DFSYNKIGSEGRNISCSMDDY--------------------KGINASTVTLSYNEIQKFP 689

Query: 506 LIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTG- 564
                    +  + L +N +  SIP+N      L        N   +  ++L  N  T  
Sbjct: 690 TELFATGSPISTIILSNNLMT-SIPENS-----LKPKDGNYKNTYLLTTIDLRFNKLTSL 743

Query: 565 PLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYL------FLKYNRLQGSIPDSI 618
                   L  L  +D+S N FS   PT       L+          + NR+    P  I
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802

Query: 619 GDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL-EGEIPREGPFRNFSLESFK 677
               +L  L + +N++  +      +L  L   +++ N     ++    P+    +    
Sbjct: 803 TTCPSLIQLQIGSNDIRKVDEKLTPQLYIL---DIADNPNISIDVTSVCPYIEAGMYVLL 859

Query: 678 GNEL 681
            ++ 
Sbjct: 860 YDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  275 bits (704), Expect = 9e-79
 Identities = 96/660 (14%), Positives = 184/660 (27%), Gaps = 116/660 (17%)

Query: 12  NMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELG 71
           +M+  +    L N  R+  +SL+     G +P  IG +T L  L    +           
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 72  NLAELEELWLQNNFLTGTIPS------SIFNLSSLSNLDLSVNNLTGELLANICSNLPLL 125
                +    + + +               NLS L    ++ N     +  +   +L   
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 126 QTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG 185
           Q    +  N    I   + R   LQ +  + + F+ D              + D  +   
Sbjct: 429 Q--IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAKQYE 481

Query: 186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRL 245
                  NL +L  ++L N      +P  +++L  L  L ++ N       +      RL
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRL 540

Query: 246 SAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC 305
           + +      +  P ++  Y+  N    E P           +  + KL  LD   N+++ 
Sbjct: 541 ADDE-----DTGPKIQIFYMGYNNL-EEFP-------ASASLQKMVKLGLLDCVHNKVR- 586

Query: 306 VIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPN 365
                      L  +   +N++  +          ++ L    N             +  
Sbjct: 587 -HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV 645

Query: 366 LEELSLSGNNFSGTIPSF-----IFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG 420
           +  +  S N       +       +     ST+ L  N    F    F     +  + L 
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705

Query: 421 DNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGS 480
           +N +TS                             +P                  N    
Sbjct: 706 NNLMTS-----------------------------IP-----------------ENSLKP 719

Query: 481 IPKEINNLTNLIAIYLGVNKLNG-SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
                 N   L  I L  NKL   S       L  L  + +  N                
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNC--------------F 765

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD 599
           +S P+   N   +    +                      D   N      PT I     
Sbjct: 766 SSFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPS 807

Query: 600 LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
           L  L +  N ++  + + +     L  L++++N    I   S+   ++     + ++K +
Sbjct: 808 LIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  220 bits (562), Expect = 7e-60
 Identities = 79/499 (15%), Positives = 144/499 (28%), Gaps = 97/499 (19%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+ L+ ++  ++ F     +         + +               N+  L  + L   
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTG---------TIPSSIFNLSSLSNLDLSVNNLT 111
               ++P+ L +L EL+ L +  N              +         +    +  NNL 
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561

Query: 112 GELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLT 171
                      P                 ++L +   L  L    N       +  G   
Sbjct: 562 E---------FP---------------ASASLQKMVKLGLLDCVHNKVR--HLEAFGTNV 595

Query: 172 KLKYLHLDQNRLQGEIPEELGNLA-ELEKLQLQNNFLTGTIPPSIF--NLSSLSDLELSF 228
           KL  L LD N+++ EIPE+      ++E L   +N L   IP      ++  +  ++ S+
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY 653

Query: 229 NSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG 288
           N +             +S  +      N      + LS N                +   
Sbjct: 654 NKIGS-------EGRNISCSMDDYKGIN---ASTVTLSYNEIQK---------FPTELFA 694

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
             + +  + L  N +   IP                   +        N   L  + L  
Sbjct: 695 TGSPISTIILSNNLMT-SIPENS----------------LKPKDGNYKNTYLLTTIDLRF 737

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR------NSFSG 402
           N             LP L  + +S N FS + P+   N+S+L    ++       N    
Sbjct: 738 NKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796

Query: 403 FIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGI-LPRVIG 461
             P       +L  L +G N +         +       L    I++NP   I +  V  
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIRK-------VDEKLTPQLYILDIADNPNISIDVTSVCP 849

Query: 462 NLSQSMEDFHM-PNSNISG 479
            +   M         +I G
Sbjct: 850 YIEAGMYVLLYDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  106 bits (265), Expect = 2e-23
 Identities = 42/323 (13%), Positives = 89/323 (27%), Gaps = 73/323 (22%)

Query: 368 ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS 427
             +   + +       + N  +++ L L      G +P+  G L  LK L  G +  T  
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET-- 360

Query: 428 TSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINN 487
                                      +  R+ G+   + +        I     K    
Sbjct: 361 ---------------------------VSGRLFGDEELTPDMSEERKHRIRMHYKKMF-- 391

Query: 488 LTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLW 547
                                L   ++L L  L  + +        + +  +  I     
Sbjct: 392 ---------------------LDYDQRLNLSDLLQDAI--------NRNPEMKPIKKDSR 422

Query: 548 NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKY 607
                  +    N  T  +   I  L  L  I  + + F+           D +     Y
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDY 476

Query: 608 NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGP 667
            +   +   S  ++ +L  + L N      +P  L  L +L+ +N++ N+       +  
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536

Query: 668 FRNFSLESFKGNELLCGMPNLQV 690
           +   +       +     P +Q+
Sbjct: 537 WTRLA-------DDEDTGPKIQI 552

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.3 bits (146), Expect = 3e-09
 Identities = 27/247 (10%), Positives = 65/247 (26%), Gaps = 14/247 (5%)

Query: 428 TSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINN 487
               + L      Y E      NP       +   ++       +P            + 
Sbjct: 167 NRVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQ 226

Query: 488 LTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLW 547
                +     +    S  +   KL K   + ++  +    I D  +      ++    W
Sbjct: 227 SGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNW 286

Query: 548 NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKY 607
                   N   +                   +  ++ + D     +     +  L L  
Sbjct: 287 RYYSGTINNTIHSLNWN--------------FNKELDMWGDQPGVDLDNNGRVTGLSLAG 332

Query: 608 NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGP 667
              +G +PD+IG +  LK L+   ++      +  ++ L         +++     +   
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392

Query: 668 FRNFSLE 674
             +  L 
Sbjct: 393 DYDQRLN 399

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  269 bits (690), Expect = 2e-82
 Identities = 95/301 (31%), Positives = 151/301 (50%), Gaps = 14/301 (4%)

Query: 730  NMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRA 789
            +  +     R   ++L +ATN F    LIG G FG VYK  ++DG +VA+K    +  + 
Sbjct: 19   SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78

Query: 790  IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN---YILDI 846
            I+ F+ E   +   RH +++  I  C   +   L+ +YM  G+L++ LY S+     +  
Sbjct: 79   IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138

Query: 847  FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
             QRL I I  A  L YLH      IIH D+K  N+LLD+N V  ++DFG++K   + DQ+
Sbjct: 139  EQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195

Query: 907  LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESF-TGEMTLKRW 965
               T    T+GY+ PEY  +GR++   DVYSFG++L E    +    +S     + L  W
Sbjct: 196  HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255

Query: 966  VNDLLLIS-IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024
              +      + ++VD NL        + K        + A+KC   S E+R +  +++ K
Sbjct: 256  AVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAVKCLALSSEDRPSMGDVLWK 309

Query: 1025 L 1025
            L
Sbjct: 310  L 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  264 bits (676), Expect = 2e-80
 Identities = 103/300 (34%), Positives = 148/300 (49%), Gaps = 15/300 (5%)

Query: 736  NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKS-FD 794
              +RF+  EL  A++ FS  N++GRGGFG VYK R+ DG  VAVK    +  +  +  F 
Sbjct: 16   QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 795  IECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLY---SSNYILDIFQRLN 851
             E  MI    HRN+++    C +   + LV  YM  GS+  CL     S   LD  +R  
Sbjct: 76   TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 852  IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
            I +  A  L YLH      IIH D+K  N+LLD+   A + DFG+AK  +    +   T 
Sbjct: 136  IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTA 194

Query: 912  TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE---MTLKRWVND 968
               TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D +       + L  WV  
Sbjct: 195  VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 969  LLLI-SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
            LL    +  +VD +L  +     V +      +  +A+ CT  SP ER    E+V  L G
Sbjct: 255  LLKEKKLEALVDVDLQGNYKDEEVEQ------LIQVALLCTQSSPMERPKMSEVVRMLEG 308

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  265 bits (679), Expect = 2e-77
 Identities = 115/594 (19%), Positives = 203/594 (34%), Gaps = 57/594 (9%)

Query: 77  EELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
           +    +N  L   IP ++   +S   L+ S N L   +     S L  L  L L      
Sbjct: 15  KTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIY 70

Query: 137 GKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAE 196
                T      L TL L+ N         +     LK+L   Q  +       L N   
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 197 LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNN 256
           LE L L +N ++    P  F    L  L+   N++     +DM  + + +          
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT---------- 180

Query: 257 IPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDN--L 314
                 + L+ N              I     + A  + L+    +   VI   + N  +
Sbjct: 181 ---NLSLNLNGNDIA----------GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227

Query: 315 HNLEWMIFSFNKLVGVVPTTIFNVS--TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLS 372
            +L    F       + P     +   +++ + L  + FF  + S+       L+EL L+
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLT 286

Query: 373 GNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELS 432
             + S  +PS +   S L  L L  N F      +  N  +L  L +  N          
Sbjct: 287 ATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345

Query: 433 FLSSSNCKYLEYFSISNNPLGGI--LPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTN 490
                N + L    +S++ +         + NLS  ++  ++  +       +       
Sbjct: 346 L---ENLENLRELDLSHDDIETSDCCNLQLRNLS-HLQSLNLSYNEPLSLKTEAFKECPQ 401

Query: 491 LIAIYLGVNKLNGSI-LIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNL 549
           L  + L   +L           L  L++L+L  + L+ S                    L
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ-------------LFDGL 448

Query: 550 KDILCLNLSLNFFTGPLPLEIG---NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLK 606
             +  LNL  N F      +      L  L  + LS  + S +       LK + ++ L 
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508

Query: 607 YNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEG 660
           +NRL  S  +++  +  +  LNL++N++  I+P  L  L   + IN+  N L+ 
Sbjct: 509 HNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  254 bits (652), Expect = 8e-74
 Identities = 112/639 (17%), Positives = 191/639 (29%), Gaps = 116/639 (18%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            ++ E L    N+      +T S    L  + L+             +   L  L L  N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            L       L     L+ L+     ++      + N  +L +L L  N+++         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI------- 144

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
                                     + L+ L    N       +++ +L +   L L+ 
Sbjct: 145 ------------------KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186

Query: 181 NRLQ-GEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN--LSSLSDLELSFNSLTGNFPK 237
           N      I     + A  + L          I   + N  + SL                
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD------ 240

Query: 238 DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLD 297
                  +S  +    C     +E I L K+ F+    +     +          L++LD
Sbjct: 241 -----EDISPAVFEGLCEM--SVESINLQKHYFFNISSNTFHCFS---------GLQELD 284

Query: 298 LQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS 357
           L    L   +P  +  L  L+ ++ S NK   +   +  N  +L  L +  N+    L +
Sbjct: 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 358 SADVRLPNLEELSLSGNN--FSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLK 415
                L NL EL LS ++   S      + N S L +L L  N         F     L+
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403

Query: 416 WLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNS 475
            LDL    L    ++  F                                          
Sbjct: 404 LLDLAFTRLKVKDAQSPF------------------------------------------ 421

Query: 476 NISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSF 535
                      NL  L  + L  + L+ S       L  LQ L+L+ N            
Sbjct: 422 ----------QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ---- 467

Query: 536 SCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIG 595
                   ++L  L  +  L LS    +        +LK++  +DLS N  +      + 
Sbjct: 468 ------KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521

Query: 596 GLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL 634
            LK + YL L  N +   +P  +  +   +++NL  N L
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  254 bits (650), Expect = 2e-73
 Identities = 97/514 (18%), Positives = 186/514 (36%), Gaps = 41/514 (7%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
              L+ L L +N       + LS  K L+++       S      + N  TL  L+L  N
Sbjct: 80  QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +      +     +L+ L  QNN +       + +L   +NL L++N      +     
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199

Query: 121 NLPLLQTLFLDENNFDGKIP-----STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKY 175
           +  + Q+L          I      ST+          +   D S  + + +  ++ ++ 
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS-VES 258

Query: 176 LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNF 235
           ++L ++             + L++L L    L+  +P  +  LS+L  L LS N      
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN-- 315

Query: 236 PKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEK 295
                        L     +N P L  + +  N    E+ +          + NL  L +
Sbjct: 316 -------------LCQISASNFPSLTHLSIKGNTKRLELGTGC--------LENLENLRE 354

Query: 296 LDLQFNRLQCV--IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFG 353
           LDL  + ++       ++ NL +L+ +  S+N+ + +          L+ L L       
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414

Query: 354 RLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFI---PNTFGN 410
           +   S    L  L+ L+LS +    +          L  L LQ N F        N+   
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

Query: 411 LRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF 470
           L  L+ L L    L+S        + ++ K + +  +S+N L       + +L       
Sbjct: 475 LGRLEILVLSFCDLSSIDQH----AFTSLKMMNHVDLSHNRLTSSSIEALSHLKG--IYL 528

Query: 471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGS 504
           ++ +++IS  +P  +  L+    I L  N L+ +
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  254 bits (652), Expect = 8e-74
 Identities = 111/650 (17%), Positives = 199/650 (30%), Gaps = 101/650 (15%)

Query: 16  GKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAE 75
           G +   +     +          S  +P +I   ++   + L  N L+        N +E
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 76  LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
           L+ L L    +      +   L  LSNL L+ N +         S L  L+ L   E   
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKL 116

Query: 136 DGKIPSTLLRCKHLQTLSLSINDFSG-DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNL 194
                  + +   L+ L+++ N      +P    NLT L ++ L  N +Q     +L  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 195 AEL----EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELP 250
            E       L +  N +   I    F    L +L L  N  + N  K             
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKT------------ 223

Query: 251 AKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHE 310
                N+  L    L    F  E   ++   +I + + ++   E   L +         +
Sbjct: 224 --CLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE-FRLTYTNDFSDDIVK 280

Query: 311 IDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELS 370
              L N+  M  +   +  +    +      + L +       + P+     LP L+ L+
Sbjct: 281 FHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQL-KQFPTLD---LPFLKSLT 334

Query: 371 LSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL--RNLKWLDLGDNYLTSST 428
           L+ N  S      +   S LS L+L RN+ S     ++ +L   +L+ LDL  N     +
Sbjct: 335 LTMNKGS-ISFKKVALPS-LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS 392

Query: 429 SELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNL 488
           +    L       L++    ++ L  +                               +L
Sbjct: 393 ANFMGLEE-----LQHLDFQHSTLKRVTE------------------------FSAFLSL 423

Query: 489 TNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWN 548
             L+ + +               L  L  L +  N  + +   N+               
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV--------------- 468

Query: 549 LKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYN 608
                                  N   L  +DLS      +       L  LQ L + +N
Sbjct: 469 ---------------------FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507

Query: 609 RLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
            L          + +L +L+ S N +     I       L   N++ N +
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  230 bits (589), Expect = 3e-65
 Identities = 116/574 (20%), Positives = 201/574 (35%), Gaps = 63/574 (10%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            S L++L L                  L N+ L+ N      P     +T+L  L     
Sbjct: 55  FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTG---ELLA 116
           KL       +G L  L++L + +NF+      + F NL++L ++DLS N +       L 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 117 NICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE-IGNLTKLKY 175
            +  N  +  +L +  N     I     +   L  L+L  N  S +I K  + NL  L  
Sbjct: 175 FLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233

Query: 176 LHLDQNRLQGEIPEELGNLAELEKLQ--------LQNNFLTGTIPPSIFNLSSLSDLELS 227
             L     + E   E+   + +E L         L               L+++S + L+
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293

Query: 228 FNSLT----GNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTI 283
             S+              ++ +  +L      ++PFL+ + L+ N             +I
Sbjct: 294 GVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG-----------SI 342

Query: 284 PKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL--HNLEWMIFSFNKLVGVVPTTIFNVSTL 341
             +   L  L  LDL  N L         +L  ++L  +  SFN  + ++      +  L
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL 401

Query: 342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFS 401
           + L    ++       SA + L  L  L +S  N            + L+TL++  NSF 
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461

Query: 402 GFIP-NTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVI 460
                N F N  NL +LDL    L      +S+        L+  ++S+N          
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQ----ISWGVFDTLHRLQLLNMSHN---------- 507

Query: 461 GNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSL 520
                          N+        N L +L  +    N++  S  I     K L   +L
Sbjct: 508 ---------------NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552

Query: 521 KDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILC 554
            +N +   I ++  F   +      L N++ + C
Sbjct: 553 TNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTC 585

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 89.7 bits (223), Expect = 2e-18
 Identities = 32/145 (22%), Positives = 55/145 (37%), Gaps = 6/145 (4%)

Query: 531 DNLSFSCT---LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFS 587
            N+++ C    L+ +P  +        ++LS N           N   L  +DLS     
Sbjct: 12  PNITYQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69

Query: 588 DVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLD 647
            +      GL  L  L L  N +Q   P S   + +L++L      L  +    + +L+ 
Sbjct: 70  TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129

Query: 648 LKDINVSFNKLEGEIPREGPFRNFS 672
           LK +NV+ N +         F N +
Sbjct: 130 LKKLNVAHNFIHS-CKLPAYFSNLT 153

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  243 bits (623), Expect = 4e-73
 Identities = 86/313 (27%), Positives = 143/313 (45%), Gaps = 24/313 (7%)

Query: 380 IPSFIFNTSKLS----TLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
           I   + N + LS    T +    ++ G + +T      +  LDL    L       S L+
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 436 SSNCKYLEYFSISN-NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAI 494
             N  YL +  I   N L G +P  I  L+Q +   ++ ++N+SG+IP  ++ +  L+ +
Sbjct: 74  --NLPYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 495 YLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDIL- 553
               N L+G++  ++  L  L  ++   N++ G+IP              +  +   +  
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP-------------DSYGSFSKLFT 177

Query: 554 CLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGS 613
            + +S N  TG +P    NL  L  +DLS N          G  K+ Q + L  N L   
Sbjct: 178 SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 614 IPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSL 673
           +   +G   NL  L+L NN ++G +P  L +L  L  +NVSFN L GEIP+ G  + F +
Sbjct: 237 LG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDV 295

Query: 674 ESFKGNELLCGMP 686
            ++  N+ LCG P
Sbjct: 296 SAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  240 bits (615), Expect = 5e-72
 Identities = 80/318 (25%), Positives = 124/318 (38%), Gaps = 36/318 (11%)

Query: 17  KIPSTLSNCKRLRN----ISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGE--IPEEL 70
           +I   L N   L +           + G +         +  L L G  L     IP  L
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 71  GNLAELEELWLQN-NFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLF 129
            NL  L  L++   N L G IP +I  L+ L  L ++  N++G +   + S +  L TL 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL-SQIKTLVTLD 131

Query: 130 LDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKL-KYLHLDQNRLQGEIP 188
              N   G +P ++    +L  ++   N  SG IP   G+ +KL   + + +NRL G+IP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

Query: 189 EELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAE 248
               NL  L  + L  N L G       +  +   + L+ NSL  +  K           
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK----------- 239

Query: 249 LPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIP 308
                      L  + L  N  YG         T+P+ +  L  L  L++ FN L   IP
Sbjct: 240 -----VGLSKNLNGLDLRNNRIYG---------TLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 309 HEIDNLHNLEWMIFSFNK 326
            +  NL   +   ++ NK
Sbjct: 286 -QGGNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  239 bits (612), Expect = 1e-71
 Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 32/301 (10%)

Query: 12  NMFHGKIPSTLSNCKRLRNISLSLNDFSGT--IPKEIGNVTTLIGLHLRG-NKLQGEIPE 68
             + G +  T +   R+ N+ LS  +      IP  + N+  L  L++ G N L G IP 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 69  ELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTL 128
            +  L +L  L++ +  ++G IP  +  + +L  LD S N L+G L  +I S+LP L  +
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGI 154

Query: 129 FLDENNFDGKIPSTLLRCKHLQT-LSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI 187
             D N   G IP +      L T +++S N  +G IP    NL  L ++ L +N L+G+ 
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213

Query: 188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSA 247
               G+    +K+ L  N L   +   +    +L+ L+L  N + G  P+ +        
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGL-------- 264

Query: 248 ELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVI 307
                    + FL  + +S N   GEIP            GNL + +      N+  C  
Sbjct: 265 -------TQLKFLHSLNVSFNNLCGEIPQ----------GGNLQRFDVSAYANNKCLCGS 307

Query: 308 P 308
           P
Sbjct: 308 P 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  235 bits (603), Expect = 2e-70
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 5/240 (2%)

Query: 1   LSNLEYLFLKSNMFHG--KIPSTLSNCKRLRNISLS-LNDFSGTIPKEIGNVTTLIGLHL 57
              +  L L          IPS+L+N   L  + +  +N+  G IP  I  +T L  L++
Sbjct: 49  TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108

Query: 58  RGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLAN 117
               + G IP+ L  +  L  L    N L+GT+P SI +L +L  +    N ++G +  +
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168

Query: 118 ICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLH 177
             S   L  ++ +  N   GKIP T      L  + LS N   GD     G+    + +H
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIH 227

Query: 178 LDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPK 237
           L +N L  ++  ++G    L  L L+NN + GT+P  +  L  L  L +SFN+L G  P+
Sbjct: 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  227 bits (581), Expect = 3e-67
 Identities = 85/341 (24%), Positives = 125/341 (36%), Gaps = 61/341 (17%)

Query: 90  IPSSIFNLSSLSN----LDLSVNNLTGELLANICSNLPLLQTLFLDENNFDG--KIPSTL 143
           I   + N ++LS+     D       G L     +    +  L L   N      IPS+L
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 144 LRCKHLQTLSLS-INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQL 202
               +L  L +  IN+  G IP  I  LT+L YL++    + G IP+ L  +  L  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 203 QNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEE 262
             N L+GT+PPSI +L +L  +    N ++G                             
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISG----------------------------- 163

Query: 263 IYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL-EKLDLQFNRLQCVIPHEIDNLHNLEWMI 321
                               IP   G+ +KL   + +  NRL   IP    NL NL ++ 
Sbjct: 164 -------------------AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVD 203

Query: 322 FSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP 381
            S N L G       +    + ++L  NS    L         NL  L L  N   GT+P
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL--SKNLNGLDLRNNRIYGTLP 261

Query: 382 SFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
             +     L +L +  N+  G IP   GNL+        +N
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  137 bits (347), Expect = 9e-36
 Identities = 55/203 (27%), Positives = 81/203 (39%), Gaps = 19/203 (9%)

Query: 480 SIPKEINNLTNL----IAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSF 535
            I K++ N T L               G +     +  ++  L L    L    P     
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----- 67

Query: 536 SCTLTSIPSTLWNLKDILCLNLS-LNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI 594
                 IPS+L NL  +  L +  +N   GP+P  I  L  L  + ++  N S  IP  +
Sbjct: 68  ------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121

Query: 595 GGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDL-KDINV 653
             +K L  L   YN L G++P SI  + NL  +    N + G IP S      L   + +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181

Query: 654 SFNKLEGEIPREGPFRNFSLESF 676
           S N+L G+IP    F N +L   
Sbjct: 182 SRNRLTGKIPPT--FANLNLAFV 202

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 23/84 (27%), Positives = 36/84 (42%), Gaps = 2/84 (2%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             N + + L  N     +   +   K L  + L  N   GT+P+ +  +  L  L++  N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 61  KLQGEIPEELGNLAELEELWLQNN 84
            L GEIP+  GNL   +     NN
Sbjct: 279 NLCGEIPQG-GNLQRFDVSAYANN 301

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  233 bits (598), Expect = 9e-70
 Identities = 89/306 (29%), Positives = 138/306 (45%), Gaps = 31/306 (10%)

Query: 736  NQRRFTYLELFQATNGFSE------NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRA 789
                F++ EL   TN F E       N +G GGFG VYK  + +   VAVK   L     
Sbjct: 11   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK--LAAMVD 67

Query: 790  IKS------FDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNY- 842
            I +      FD E  ++ + +H N+++ +   S  D   LV  YMP GSL   L   +  
Sbjct: 68   ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127

Query: 843  -ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
              L    R  I    A+ + +LH       IH D+K  N+LLD+   A +SDFG+A+   
Sbjct: 128  PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184

Query: 902  KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT 961
            K  Q++  ++ + T  YMAPE  R G ++   D+YSFG++L+E  T     DE       
Sbjct: 185  KFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQL 242

Query: 962  LKRWVNDLLL--ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAK 1019
            L     ++     +I + +D  +    D    + E       ++A +C  E   +R + K
Sbjct: 243  LLDIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIK 295

Query: 1020 EIVTKL 1025
            ++   L
Sbjct: 296  KVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  217 bits (554), Expect = 2e-63
 Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 22/304 (7%)

Query: 740  FTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGM 799
                 L+  +       +  RG FG V+KA++     VAVK+F +Q  +     + E   
Sbjct: 14   LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYS 71

Query: 800  IKRIRHRNIIKFISSCSSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID 855
            +  ++H NI++FI +            L+  +   GSL   L     ++   +  +I   
Sbjct: 72   LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129

Query: 856  VASALEYLH-------FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
            +A  L YLH        G+   I H D+K  NVLL +N+ A ++DFG+A  F     +  
Sbjct: 130  MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 909  QTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTRKKPTDESFTGEMTLK 963
                + T  YMAPE                D+Y+ G++L E  +R    D      M   
Sbjct: 190  THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 964  RWV--NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                     L  + EVV         + +  K   M+ +     +C     E R++A  +
Sbjct: 250  EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 1022 VTKL 1025
              ++
Sbjct: 310  GERI 313

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  211 bits (538), Expect = 7e-57
 Identities = 148/697 (21%), Positives = 240/697 (34%), Gaps = 106/697 (15%)

Query: 57  LRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELL 115
            R   L  ++P+    L   E L L  N++  T+ +S F  L  L  L+L        + 
Sbjct: 11  YRFCNLT-QVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 116 ANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDI--PKEIGNLTKL 173
                NLP L+ L L  +      P       HL  L L     S  +       NL  L
Sbjct: 66  KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125

Query: 174 KYLHLDQNRLQG-EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT 232
             L L +N+++   +    G L  L+ +   +N +   +         L    LSF SL 
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHEL--EPLQGKTLSFFSLA 182

Query: 233 GNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLA- 291
            N       V+    +    F N +  LE + +S N +  +I  +  N     +  +L  
Sbjct: 183 ANSLY--SRVSVDWGKCMNPFRNMV--LEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238

Query: 292 --KLEKLDLQFNRLQCVIPHEIDNLH--NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG 347
              +      F+ ++    +    L   ++  +  S   +  +       +  LK L L 
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPN 406
            N    ++   A   L NL+ L+LS N     + S  F    K++ ++LQ+N  +     
Sbjct: 299 YNKIN-KIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356

Query: 407 TFGNLRNLKWLDLGDNYLTSSTSELS----FLSSSNCKYLEYFSISNNPLGGILPRVIGN 462
           TF  L  L+ LDL DN LT+     S    FLS +    L   +++ N +         +
Sbjct: 357 TFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLI---------H 407

Query: 463 LSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD 522
           LS+                    N L NL             IL  L ++  LQ+L L  
Sbjct: 408 LSE--------------------NRLENL------------DILYFLLRVPHLQILILNQ 435

Query: 523 NQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-----GNLKVLV 577
           N+   S   + + S               +  L L  N        E+       L  L 
Sbjct: 436 NRFS-SCSGDQTPS-----------ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483

Query: 578 QIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGI 637
            + L+ N  + + P     L  L+ L L  NRL   +  +     NL+ L++S N L   
Sbjct: 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAP 541

Query: 638 IPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKG-----NELLCGMP------ 686
            P        L  ++++ NK   E      F N+   +         ++ C  P      
Sbjct: 542 NPDVFVS---LSVLDITHNKFICECE-LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGV 597

Query: 687 ---NLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMM 720
              +L    C       S K  L I   + L+   M 
Sbjct: 598 SLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMT 634

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  191 bits (486), Expect = 2e-50
 Identities = 120/667 (17%), Positives = 221/667 (33%), Gaps = 79/667 (11%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
           L+  E L L  N       S+    ++L+ + L       TI KE   N+  L  L L  
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLT-GTIPSSIF-NLSSLSNLDLSVNNLTGELLAN 117
           +K+    P+    L  L EL L    L+   +    F NL +L+ LDLS N +    L  
Sbjct: 83  SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142

Query: 118 ICSNLPLLQTLFLDENNFDGKIPSTL--LRCKHLQTLSLSINDFSGDIPKEIGNLTK-LK 174
               L  L+++    N         L  L+ K L   SL+ N     +  + G      +
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202

Query: 175 YLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN 234
            + L+   +        GN   ++     +N ++ +   S+     +      F+++   
Sbjct: 203 NMVLEILDVS-------GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-- 253

Query: 235 FPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLE 294
                           A    +   +  + LS    +  + S +           L  L+
Sbjct: 254 ---------DPDQNTFAGLARS--SVRHLDLSHGFVF-SLNSRV--------FETLKDLK 293

Query: 295 KLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGR 354
            L+L +N++  +       L NL+ +  S+N L  +  +  + +  + ++ L  N     
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-I 352

Query: 355 LPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNL 414
           +       L  L+ L L  N       + I     +  + L  N                
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL----TA 403

Query: 415 KWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPN 474
             + L +N L +       L      +L+   ++ N           + + S+E   +  
Sbjct: 404 NLIHLSENRLENLDILYFLL---RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE 460

Query: 475 SNISGSIPKEIN-----NLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSI 529
           + +  +   E+       L++L  +YL  N LN         L  L+ LSL  N+L   +
Sbjct: 461 NMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VL 519

Query: 530 PDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDV 589
             N      L               L++S N    P P    +L     +D++ N F   
Sbjct: 520 SHN-DLPANLEI-------------LDISRNQLLAPNPDVFVSLS---VLDITHNKFICE 562

Query: 590 IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLK 649
                    +L       N    +I     D+  +   + S  +LF +     ++   LK
Sbjct: 563 C--------ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLK 614

Query: 650 DINVSFN 656
            +  S  
Sbjct: 615 SLKFSLF 621

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  115 bits (289), Expect = 2e-26
 Identities = 80/399 (20%), Positives = 136/399 (34%), Gaps = 50/399 (12%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            S++ +L L                K L+ ++L+ N  +    +    +  L  L+L  N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            L          L ++  + LQ N +      +   L  L  LDL  N LT         
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT------IH 378

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG-DIPKEIGNLTKLKYLHLD 179
            +P +  +FL  N     +P   L       + LS N     DI   +  +  L+ L L+
Sbjct: 379 FIPSIPDIFLSGNKL-VTLPKINLT---ANLIHLSENRLENLDILYFLLRVPHLQILILN 434

Query: 180 QNRLQGEIPEEL-GNLAELEKLQLQNNFLTG----TIPPSIF-NLSSLSDLELSFNSLTG 233
           QNR      ++       LE+L L  N L       +   +F  LS L  L L+ N L  
Sbjct: 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN- 493

Query: 234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
                          LP    +++  L  + L+ N       + L +  +P        L
Sbjct: 494 --------------SLPPGVFSHLTALRGLSLNSNRL-----TVLSHNDLPA------NL 528

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF----NVSTLKFLYLGSN 349
           E LD+  N+L    P   D   +L  +  + NK +     + F    N + +      ++
Sbjct: 529 EILDISRNQLLAPNP---DVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPAD 585

Query: 350 SFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTS 388
            +     S + V L +L            ++   +F   
Sbjct: 586 IYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVC 624

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  196 bits (501), Expect = 2e-56
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 27/272 (9%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSC 815
            IG G FG V++A    G +VAVK+   Q      +  F  E  ++KR+RH NI+ F+ + 
Sbjct: 45   IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
            +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104  TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
             +LK  N+L+D      + DFG+++  LK    L+      T  +MAPE  R+   +   
Sbjct: 163  RNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            DVYSFG++L E  T ++P                    ++  +VV A  +  + K     
Sbjct: 221  DVYSFGVILWELATLQQPWGN-----------------LNPAQVVAA--VGFKCKRLEIP 261

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                  V  +   C    P +R +   I+  L
Sbjct: 262  RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  191 bits (488), Expect = 7e-55
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 40/283 (14%)

Query: 758  IGRGGFGFVYKAR-IQDGMEVAVKVF-------DLQYGRAIKSFDIECGMIKRIRHRNII 809
            IG+GGFG V+K R ++D   VA+K         + +     + F  E  ++  + H NI+
Sbjct: 27   IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
            K      +     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87   KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 870  PIIHCDLKPNNVLLD-----DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-- 922
            PI+H DL+  N+ L        + A ++DFG+++         + +  L    +MAPE  
Sbjct: 144  PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198

Query: 923  YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL 982
               E   +   D YSF ++L    T + P DE                  S  ++   N+
Sbjct: 199  GAEEESYTEKADTYSFAMILYTILTGEGPFDE-----------------YSYGKIKFINM 241

Query: 983  LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +  E       E C   + N+   C    P++R +   IV +L
Sbjct: 242  IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  196 bits (501), Expect = 9e-54
 Identities = 114/602 (18%), Positives = 201/602 (33%), Gaps = 83/602 (13%)

Query: 81  LQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIP 140
                    IP ++    S  NLDLS N L   L +    + P LQ L L          
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 141 STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKL 200
                  HL TL L+ N            L+ L+ L   +  L       +G+L  L++L
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129

Query: 201 QLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPF 259
            + +N +     P  F NL++L  L+LS N +             +              
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-----------SIYCTDLRVLHQMPLL 178

Query: 260 LEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHE-IDNLHNLE 318
              + LS N              I        +L KL L+ N     +    I  L  LE
Sbjct: 179 NLSLDLSLNPMN----------FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 319 W------MIFSFNKLVGVVPTTIFNVSTLKF--LYLGSNSFFGRLPSSADVRLPNLEELS 370
                     +   L     + +  +  L      L    ++          L N+   S
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288

Query: 371 LSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSE 430
           L        +  F +N      LEL    F  F       L++LK L    N   ++ SE
Sbjct: 289 LVSVTIE-RVKDFSYNFG-WQHLELVNCKFGQF---PTLKLKSLKRLTFTSNKGGNAFSE 343

Query: 431 LSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTN 490
           +      +   LE+  +S N L                       +  G   +     T+
Sbjct: 344 V------DLPSLEFLDLSRNGL-----------------------SFKGCCSQSDFGTTS 374

Query: 491 LIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLK 550
           L  + L  N +  ++      L++L+ L  + + L+  + +   F            +L+
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL-----------SLR 421

Query: 551 DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI-GGLKDLQYLFLKYNR 609
           +++ L++S              L  L  + ++ N+F +     I   L++L +L L   +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 610 LQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFR 669
           L+   P +   + +L+ LN+++N L  +     ++L  L+ I +  N  +   PR     
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 541

Query: 670 NF 671
            +
Sbjct: 542 RW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  189 bits (482), Expect = 3e-51
 Identities = 104/519 (20%), Positives = 187/519 (36%), Gaps = 29/519 (5%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK 61
            + + L L  N        +  +   L+ + LS  +          +++ L  L L GN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 62  LQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSN 121
           +Q         L+ L++L      L       I +L +L  L+++ N +    L    SN
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 122 LPLLQTLFLDENNFDGKIPSTLLRCKHLQ----TLSLSINDFSGDIPKEIGNLTKLKYLH 177
           L  L+ L L  N       + L     +     +L LS+N  +  I        +L  L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206

Query: 178 LDQNRLQGEIPEE-LGNLAELEKLQLQNNFLTG-----TIPPSIF-NLSSLSDLELSFNS 230
           L  N     + +  +  LA LE  +L                S    L +L+  E     
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 231 LTGNFPKDMHIVNRLSAELPAKFCNN-IPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGN 289
           L       + + N L+        +  I  +++   +    + E+  +      P     
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL-VNCKFGQFPT--LK 323

Query: 290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKL--VGVVPTTIFNVSTLKFLYLG 347
           L  L++L    N+          +L +LE++  S N L   G    + F  ++LK+L L 
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPN 406
            N     + S+    L  LE L    +N        +F +   L  L++           
Sbjct: 382 FNGVI-TMSSNFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 407 TFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQS 466
            F  L +L+ L +  N    +     F   +  + L +  +S   L  + P    +LS S
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIF---TELRNLTFLDLSQCQLEQLSPTAFNSLS-S 495

Query: 467 MEDFHMPNSNISGSIPKEI-NNLTNLIAIYLGVNKLNGS 504
           ++  +M ++ +  S+P  I + LT+L  I+L  N  + S
Sbjct: 496 LQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  184 bits (469), Expect = 1e-49
 Identities = 99/473 (20%), Positives = 175/473 (36%), Gaps = 38/473 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           LS+L  L L  N          S    L+ +     + +      IG++ TL  L++  N
Sbjct: 75  LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134

Query: 61  KLQ-GEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSN----LDLSVNNLTGELL 115
            +Q  ++PE   NL  LE L L +N +     + +  L  +      LDLS+N +   + 
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193

Query: 116 ANICSNLPLLQTLFLDENNFDGKIPSTLLR-CKHLQTLSLSINDFSGD---IPKEIGNLT 171
                 +  L  L L  N     +  T ++    L+   L + +F  +      +   L 
Sbjct: 194 PGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 172 KLKYLHLDQNRLQG------EIPEELGNLAELEKLQLQNNFLTGTIPPSIF--NLSSLSD 223
            L  L +++ RL        +I +    L  +    L +  +   +    +      L  
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL 311

Query: 224 LELSFNSLTGNFPKDMHIVNRLSAELPAKFCN-NIPFLEEIYLSKNMFYGEIPSDLGNCT 282
           +   F        K +  +   S +    F   ++P LE + LS+N       S  G C 
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL-----SFKGCC- 365

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF-NVSTL 341
             +       L+ LDL FN +   +      L  LE + F  + L  +   ++F ++  L
Sbjct: 366 -SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423

Query: 342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSF 400
            +L +          +     L +LE L ++GN+F       IF     L+ L+L +   
Sbjct: 424 IYLDISHTH-TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482

Query: 401 SGFIPNTFGNLRNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPL 452
               P  F +L +L+ L++  N L S        L+S     L+   +  NP 
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS-----LQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 78.2 bits (193), Expect = 5e-15
 Identities = 31/144 (21%), Positives = 51/144 (35%), Gaps = 6/144 (4%)

Query: 532 NLSFSCT---LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSD 588
           N+++ C       IP  L        L+LS N           +   L  +DLS      
Sbjct: 9   NITYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 589 VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDL 648
           +       L  L  L L  N +Q     +   + +L+ L     NL  +    +  L  L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 649 KDINVSFNKLEGEIPREGPFRNFS 672
           K++NV+ N ++        F N +
Sbjct: 127 KELNVAHNLIQ-SFKLPEYFSNLT 149

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  188 bits (479), Expect = 2e-53
 Identities = 76/271 (28%), Positives = 114/271 (42%), Gaps = 31/271 (11%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
            +GRG FG V KA      +VA+K  + +     K+F +E   + R+ H NI+K   +C +
Sbjct: 16   VGRGAFGVVCKA-KWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 818  DDFKALVLEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
                 LV+EY   GSL   L+ +           ++  +  +  + YLH      +IH D
Sbjct: 73   P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 876  LKPNNVLLDDNM-VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
            LKP N+LL     V  + DFG A      D     T    +  +MAPE       S   D
Sbjct: 131  LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKE 994
            V+S+GI+L E  TR+KP DE                   IM  V      H        +
Sbjct: 186  VFSWGIILWEVITRRKPFDE------------IGGPAFRIMWAV------HNGTRPPLIK 227

Query: 995  QCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                 + +L  +C  + P +R + +EIV  +
Sbjct: 228  NLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  186 bits (475), Expect = 2e-53
 Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 36/276 (13%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSC 815
            +     G ++K R Q G ++ VKV  ++    R  + F+ EC  ++   H N++  + +C
Sbjct: 18   LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 816  SS--DDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
             S       L+  +MPYGSL   L+  +N+++D  Q +   +D+A  + +LH      I 
Sbjct: 77   QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 873  HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
               L   +V++D++M A +S   +         S      +    ++APE  ++    TN
Sbjct: 136  RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 933  G---DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
                D++SF ++L E  TR+ P    F               +S ME+     ++ E   
Sbjct: 189  RRSADMWSFAVLLWELVTREVP----FAD-------------LSNMEIGMK--VALEGLR 229

Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                      V  L   C  E P +R     IV  L
Sbjct: 230  PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (476), Expect = 3e-53
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 26/273 (9%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSC 815
            IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+   
Sbjct: 32   IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            ++    A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90   TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE---YGREGRVSTN 932
            LK NN+ L ++    + DFG+A    +   S    Q   +I +MAPE          S  
Sbjct: 146  LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 933  GDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVA 992
             DVY+FGI+L E  T + P    ++  +  +          I+E+V    LS +      
Sbjct: 206  SDVYAFGIVLYELMTGQLP----YSN-INNRD--------QIIEMVGRGSLSPDLS--KV 250

Query: 993  KEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +  C   +  L  +C  +  +ER +   I+ ++
Sbjct: 251  RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  188 bits (478), Expect = 5e-53
 Identities = 77/320 (24%), Positives = 113/320 (35%), Gaps = 41/320 (12%)

Query: 740  FTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGM 799
                E     +      LIGRG +G VYK  + D   VAVKVF     +   +F  E  +
Sbjct: 3    AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 800  --IKRIRHRNIIKFISSCSSDDFKA-----LVLEYMPYGSLEKCLYSSNYILDIFQRLNI 852
              +  + H NI +FI               LV+EY P GSL K  Y S +  D      +
Sbjct: 59   YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRL 116

Query: 853  MIDVASALEYLH------FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
               V   L YLH        Y   I H DL   NVL+ ++    +SDFG++         
Sbjct: 117  AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 907  LTQTQTLA------TIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTRKKPTD 953
                +  A      TI YMAPE                  D+Y+ G++  E F R   TD
Sbjct: 177  RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TD 234

Query: 954  ESFTGEMT-----LKRWVNDLLLISIME--VVDANLLSHEDKHFVAKEQCMSFVFNLAMK 1006
                  +       +  V +      M+  V          + +      +  +      
Sbjct: 235  LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 1007 CTIESPEERINAKEIVTKLA 1026
            C  +  E R+ A+    ++A
Sbjct: 295  CWDQDAEARLTAQXAEERMA 314

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  186 bits (475), Expect = 8e-53
 Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 39/284 (13%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFIS 813
             LIG+G FG VY  R     EVA+++ D++      +K+F  E    ++ RH N++ F+ 
Sbjct: 39   ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 814  SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
            +C S    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H
Sbjct: 97   ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA---TIGYMAPEYGREGRVS 930
             DLK  NV  D+  V  ++DFG+            + +       + ++APE  R+    
Sbjct: 154  KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 931  TNG---------DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
            T           DV++ G +  E   R+ P             +       +I+  +   
Sbjct: 213  TEEDKLPFSKHSDVFALGTIWYELHAREWP-------------F-KTQPAEAIIWQMGTG 258

Query: 982  LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +     K  +++      + ++ + C     EER    +++  L
Sbjct: 259  M-----KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (463), Expect = 1e-51
 Identities = 76/280 (27%), Positives = 113/280 (40%), Gaps = 38/280 (13%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVF----DLQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
            IG GGFG VY+A    G EVAVK      D    + I++   E  +   ++H NII    
Sbjct: 15   IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 814  SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
             C  +    LV+E+   G L + L      +     +N  + +A  + YLH    VPIIH
Sbjct: 74   VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 874  CDLKPNNVLLD--------DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             DLK +N+L+          N +  ++DFG+A    +E    T+        +MAPE  R
Sbjct: 132  RDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIR 187

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
                S   DV+S+G++L E  T + P    F G             I  + V     ++ 
Sbjct: 188  ASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------------IDGLAVAYG--VAM 228

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                      C      L   C    P  R +   I+ +L
Sbjct: 229  NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  175 bits (445), Expect = 5e-49
 Identities = 70/292 (23%), Positives = 113/292 (38%), Gaps = 30/292 (10%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIK--RIRHRNIIKFIS 813
              +G+G +G V++   Q G  VAVK+F  +     KS+  E  +     +RH NI+ FI+
Sbjct: 14   ECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69

Query: 814  SCSSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH----- 864
            S  +    +    L+  Y   GSL   L      LD    L I++ +AS L +LH     
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 865  FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA--TIGYMAPE 922
                  I H DLK  N+L+  N    ++D G+A    +    L         T  YMAPE
Sbjct: 128  TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 923  ------YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
                             D+++FG++L E   R          +      V +      M 
Sbjct: 188  VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 977  --VVDANL-LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
              V       +  ++     +  ++ +  L  +C  ++P  R+ A  I   L
Sbjct: 248  KVVCVDQQRPNIPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (447), Expect = 8e-49
 Identities = 71/291 (24%), Positives = 112/291 (38%), Gaps = 26/291 (8%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
              IG+G +G V+  + + G +VAVKVF      A    + E      +RH NI+ FI++ 
Sbjct: 43   KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 816  SSDDFK----ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 866
                       L+ +Y   GSL   L   +  LD    L +     S L +LH       
Sbjct: 101  IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA--TIGYMAPE-- 922
                I H DLK  N+L+  N    ++D G+A  F+ +   +         T  YM PE  
Sbjct: 159  GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 923  ----YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME-- 976
                     +     D+YSFG++L E   R          ++     V        M   
Sbjct: 219  DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278

Query: 977  VVDANL-LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
            V    L  S  ++   + ++C+  +  L  +C   +P  R+ A  +   LA
Sbjct: 279  VCIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  174 bits (443), Expect = 1e-48
 Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 34/281 (12%)

Query: 758  IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G+G FG   K    + G  + +K          ++F  E  +++ + H N++KFI    
Sbjct: 18   LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 876
             D     + EY+  G+L   + S +      QR++   D+AS + YLH   S+ IIH DL
Sbjct: 78   KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 877  KPNNVLLDDNMVAHLSDFGMAK------------PFLKEDQSLTQTQTLATIGYMAPEYG 924
              +N L+ +N    ++DFG+A+              LK+     +   +    +MAPE  
Sbjct: 135  NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 925  REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
                     DV+SFGI+L E   R          +                  +D  L  
Sbjct: 195  NGRSYDEKVDVFSFGIVLCEIIGRVNADP-----DYL-------------PRTMDFGLNV 236

Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                       C    F + ++C    PE+R +  ++   L
Sbjct: 237  RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  176 bits (449), Expect = 1e-47
 Identities = 94/483 (19%), Positives = 168/483 (34%), Gaps = 66/483 (13%)

Query: 20  STLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEEL 79
            T +         L   + + T+     ++  +  L      ++    + +  L  L ++
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73

Query: 80  WLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKI 139
              NN LT   P  + NL+ L ++ ++ N +    +  + +NL  L  L L  N      
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPL-ANLTNLTGLTLFNNQI--TD 126

Query: 140 PSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEK 199
              L    +L  L LS N  S      +  LT L+ L            + L NL  LE+
Sbjct: 127 IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLER 181

Query: 200 LQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPF 259
           L + +N ++      +  L++L  L  + N ++   P                    +  
Sbjct: 182 LDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP-----------------LGILTN 222

Query: 260 LEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEW 319
           L+E+ L+ N                  + +L  L  LDL  N++  + P  +  L  L  
Sbjct: 223 LDELSLNGNQL-----------KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269

Query: 320 MIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGT 379
           +    N++  + P  +  ++ L  L L  N      P S    L NL  L+L  NN S  
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISPISN---LKNLTYLTLYFNNISDI 324

Query: 380 IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNC 439
            P  + + +KL  L    N  S        NL N+ WL  G N ++  T        +N 
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTPL------ANL 374

Query: 440 KYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVN 499
             +    +++            N+S         N   +   P  I++  +     +  N
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPNTVK---NVTGALIAPATISDGGSYTEPDITWN 431

Query: 500 KLN 502
             +
Sbjct: 432 LPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  175 bits (445), Expect = 3e-47
 Identities = 93/511 (18%), Positives = 175/511 (34%), Gaps = 79/511 (15%)

Query: 149 LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT 208
           L + +++ +     I      L +     L +  +   +     +L ++  LQ     + 
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

Query: 209 GTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKN 268
                 +  L++L+ +  S N LT                       N+  L +I ++ N
Sbjct: 60  --SIDGVEYLNNLTQINFSNNQLTD-----------------ITPLKNLTKLVDILMNNN 100

Query: 269 MFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLV 328
                             + NL  L  L L  N++  + P  + NL NL  +  S N + 
Sbjct: 101 QI-----------ADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS 147

Query: 329 GVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTS 388
            +    +  +++L+ L  G+              L  LE L +S N  S    S +   +
Sbjct: 148 DISA--LSGLTSLQQLSFGNQ----VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLT 199

Query: 389 KLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSIS 448
            L +L    N  S   P   G L NL  L L  N L      +  L+  +   L    ++
Sbjct: 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD----IGTLA--SLTNLTDLDLA 251

Query: 449 NNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIA 508
           NN +  + P  +  L+  + +  +  + IS   P  +  LT L  + L  N+L    +  
Sbjct: 252 NNQISNLAP--LSGLT-KLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISP 304

Query: 509 LGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPL 568
           +  LK L  L+L  N +    P               + +L  +  L    N  +    L
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP---------------VSSLTKLQRLFFYNNKVSDVSSL 349

Query: 569 EIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN 628
              NL  +  +    N  SD+ P  +  L  +  L L       +  +   ++    ++ 
Sbjct: 350 --ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405

Query: 629 LSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
                L  I P ++       + ++++N   
Sbjct: 406 NVTGAL--IAPATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  170 bits (432), Expect = 1e-45
 Identities = 117/512 (22%), Positives = 207/512 (40%), Gaps = 77/512 (15%)

Query: 92  SSIFNLSSLSN---LDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKH 148
           + IF  ++L+      L   N+T  +     ++L  + TL  D      K    +    +
Sbjct: 15  NQIFTDTALAEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGI--KSIDGVEYLNN 69

Query: 149 LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT 208
           L  ++ S N  +   P  + NLTKL  + ++ N++    P  L NL  L  L L NN +T
Sbjct: 70  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 125

Query: 209 GTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKN 268
              P  + NL++L+ LELS N+++                + A   + +  L+++     
Sbjct: 126 DIDP--LKNLTNLNRLELSSNTISD---------------ISAL--SGLTSLQQLSFGNQ 166

Query: 269 MFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLV 328
           +            T  K + NL  LE+LD+  N++  +    +  L NLE +I + N++ 
Sbjct: 167 V------------TDLKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQIS 212

Query: 329 GVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTS 388
            + P  +  ++ L  L L  N     + + A   L NL +L L+ N  S   P  +   +
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKD-IGTLAS--LTNLTDLDLANNQISNLAP--LSGLT 265

Query: 389 KLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSIS 448
           KL+ L+L  N  S   P     L  L  L+L +N L   +        SN K L Y ++ 
Sbjct: 266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS------PISNLKNLTYLTLY 317

Query: 449 NNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIA 508
            N +  I P  + +L++ ++     N+ +S      + NLTN+  +  G N+++   L  
Sbjct: 318 FNNISDISP--VSSLTK-LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTP 370

Query: 509 LGKLKKLQLLSLKDNQLEG---------SIPDNLSFSCTLTSIPSTLWNLKDILCLNLSL 559
           L  L ++  L L D              SIP+ +         P+T+ +       +++ 
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITW 430

Query: 560 NFFTGPLPLEIGNLKVLVQIDLSINNFSDVIP 591
           N  +             V I      FS  + 
Sbjct: 431 NLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  165 bits (419), Expect = 8e-44
 Identities = 94/462 (20%), Positives = 171/462 (37%), Gaps = 78/462 (16%)

Query: 202 LQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLE 261
            Q+  +      +   L+      L   ++T    +                  ++  + 
Sbjct: 9   TQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT-----------------DLDQVT 49

Query: 262 EIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMI 321
            +   +                   +  L  L +++   N+L  + P  + NL  L  ++
Sbjct: 50  TLQADRL-----------GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 96

Query: 322 FSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP 381
            + N++  + P  + N++ L  L L +N             L NL  L LS N  S    
Sbjct: 97  MNNNQIADITP--LANLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTISD--I 149

Query: 382 SFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKY 441
           S +   + L  L    N  +   P    NL  L+ LD+  N ++     +S L+      
Sbjct: 150 SALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD----ISVLA--KLTN 200

Query: 442 LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKL 501
           LE    +NN +  I P  +G L+ ++++  +  + +       + +LTNL  + L  N++
Sbjct: 201 LESLIATNNQISDITP--LGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255

Query: 502 NGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNF 561
           +   L  L  L KL  L L  NQ+    P               L  L  +  L L+ N 
Sbjct: 256 SN--LAPLSGLTKLTELKLGANQISNISP---------------LAGLTALTNLELNENQ 298

Query: 562 FTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDM 621
                P  I NLK L  + L  NN SD+ P  +  L  LQ LF   N++  S   S+ ++
Sbjct: 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANL 352

Query: 622 INLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIP 663
            N+  L+  +N +  + P++   L  +  + ++         
Sbjct: 353 TNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTNAPV 392

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  162 bits (413), Expect = 5e-43
 Identities = 103/433 (23%), Positives = 182/433 (42%), Gaps = 58/433 (13%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+NL  +   +N      P  L N  +L +I ++ N  +   P  + N+T L GL L  N
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           ++    P  L NL  L  L L +N ++    S++  L+SL  L    N +T   L  + +
Sbjct: 123 QITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD--LKPL-A 174

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
           NL  L+ L +  N       S L +  +L++L  + N  S   P  +G LT L  L L+ 
Sbjct: 175 NLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG 230

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
           N+L+      L +L  L  L L NN ++   P  +  L+ L++L+L  N ++   P    
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP---- 282

Query: 241 IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQF 300
                           +  L  + L++N                  I NL  L  L L F
Sbjct: 283 -------------LAGLTALTNLELNENQL-----------EDISPISNLKNLTYLTLYF 318

Query: 301 NRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSAD 360
           N +  + P  + +L  L+ + F  NK+     +++ N++ + +L  G N      P +  
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA-- 372

Query: 361 VRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG 420
             L  + +L L+   ++    ++  N S  +T++    +     P T  +  +    D+ 
Sbjct: 373 -NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDIT 429

Query: 421 DNYLTSSTSELSF 433
            N  +  T+E+S+
Sbjct: 430 WNLPS-YTNEVSY 441

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 62.7 bits (153), Expect = 3e-10
 Identities = 21/137 (15%), Positives = 48/137 (35%), Gaps = 8/137 (5%)

Query: 527 GSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNF 586
           G +        T  +   T   L + +   L     T  +     +L  +  +       
Sbjct: 1   GPLGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58

Query: 587 SDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLL 646
             +    +  L +L  +    N+L    P  + ++  L  + ++NN +  I P++   L 
Sbjct: 59  KSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLT 112

Query: 647 DLKDINVSFNKLEGEIP 663
           +L  + +  N++    P
Sbjct: 113 NLTGLTLFNNQITDIDP 129

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  175 bits (445), Expect = 1e-46
 Identities = 79/581 (13%), Positives = 179/581 (30%), Gaps = 86/581 (14%)

Query: 57  LRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLA 116
            R       IP  L   A ++ L L  N +T      +   ++L  L L  + +   +  
Sbjct: 12  GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67

Query: 117 NICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG-DIPKEIGNLTKLKY 175
           +   +L  L+ L L +N+      S       L+ L+L  N +    +     NLT L+ 
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 176 LHLDQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTG 233
           L +       EI       L  L +L+++   L          ++  +  L L  +    
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA- 185

Query: 234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
                          L   F + +  +  + L          S L    +          
Sbjct: 186 --------------FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV---------S 222

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFG 353
             +     R   +     + L  L   I   +++         + +         +    
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSES-D 275

Query: 354 RLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRN 413
            +     V    +  L +        + +      K+  + ++ +       +   +L++
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335

Query: 414 LKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMP 473
           L++LDL +N +     + +         L+   +S N L         ++ ++ E     
Sbjct: 336 LEFLDLSENLMVEEYLK-NSACKGAWPSLQTLVLSQNHLR--------SMQKTGEILL-- 384

Query: 474 NSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNL 533
                         L NL ++ +  N  +  +  +    +K++ L+L    +        
Sbjct: 385 -------------TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-------- 422

Query: 534 SFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTT 593
                   + + +   + +  L++S N       L +  L+ L    +S N    +   +
Sbjct: 423 ------RVVKTCI--PQTLEVLDVSNNNLDS-FSLFLPRLQEL---YISRNKLKTLPDAS 470

Query: 594 IGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL 634
           +     L  + +  N+L+         + +L+ + L  N  
Sbjct: 471 L--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  170 bits (432), Expect = 5e-45
 Identities = 89/529 (16%), Positives = 190/529 (35%), Gaps = 48/529 (9%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
            + ++ L L  N         L  C  L+ + L  +  + TI  +   ++ +L  L L  
Sbjct: 25  TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           N L        G L+ L+ L L  N       +S+F NL++L  L +       E+    
Sbjct: 84  NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
            + L  L  L +   +       +L   + +  L+L +++ +  +      L+ ++YL L
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKD 238
               L       L        ++      +     S   L  L    L  + +   F   
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE--FDDC 261

Query: 239 MHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDL 298
                       +   + +  +E + + +      IP       +      L K++++ +
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRL----HIPQFYLFYDLSTVYSLLEKVKRITV 317

Query: 299 QFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSS 358
           + +++  V      +L +LE++  S N               +   YL +++  G  PS 
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENL--------------MVEEYLKNSACKGAWPS- 362

Query: 359 ADVRLPNLEELSLSGNNFS--GTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKW 416
                  L+ L LS N+          +     L++L++ RN+F   +P++      +++
Sbjct: 363 -------LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414

Query: 417 LDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSN 476
           L+L    +         + +   + LE   +SNN L       +  L    ++ ++  + 
Sbjct: 415 LNLSSTGIRV-------VKTCIPQTLEVLDVSNNNLDSF-SLFLPRL----QELYISRNK 462

Query: 477 ISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQL 525
           +  ++P + +    L+ + +  N+L         +L  LQ + L  N  
Sbjct: 463 LK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  166 bits (423), Expect = 9e-44
 Identities = 89/455 (19%), Positives = 172/455 (37%), Gaps = 51/455 (11%)

Query: 1   LSNLEYLFLKSNMFHG-KIPSTLSNCKRLRNISLSLNDFSGTIPKE-IGNVTTLIGLHLR 58
           LS+L+YL L  N +    + S   N   L+ + +   +    I +     +T+L  L ++
Sbjct: 97  LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156

Query: 59  GNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTG------ 112
              L+    + L ++ ++  L L  +     +      LSS+  L+L   NL        
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216

Query: 113 -ELLANICSNLPLLQTLFLDENNFDG--KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGN 169
                +        +   L + +F+   K+   +L    ++    ++N      P E   
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276

Query: 170 LTK--------LKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSS 220
           +++        ++ LH+ Q  L  ++      L +++++ ++N+ +   +P S   +L S
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKS 335

Query: 221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN 280
           L  L+LS N +   + K             +      P L+ + LS+N     +      
Sbjct: 336 LEFLDLSENLMVEEYLK------------NSACKGAWPSLQTLVLSQNHLR-SMQKTGEI 382

Query: 281 CTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST 340
                    L  L  LD+  N     +P        + ++  S   +  VV T I    T
Sbjct: 383 LL------TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QT 432

Query: 341 LKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSF 400
           L+ L + +N+       S  + LP L+EL +S N    T+P        L  +++ RN  
Sbjct: 433 LEVLDVSNNNL-----DSFSLFLPRLQELYISRNKLK-TLPDASLFPV-LLVMKISRNQL 485

Query: 401 SGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
                  F  L +L+ + L  N    S   + +LS
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 520

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  133 bits (337), Expect = 9e-33
 Identities = 67/404 (16%), Positives = 141/404 (34%), Gaps = 48/404 (11%)

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTL 341
           +IP  +   A ++ LDL FN++  +   ++    NL+                       
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQ----------------------- 53

Query: 342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSF 400
             L L S+     +   A   L +LE L LS N+ S ++ S  F   S L  L L  N +
Sbjct: 54  -VLILKSSR-INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPY 110

Query: 401 SGF-IPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRV 459
               + + F NL NL+ L +G+    S    + F   ++   L    I    L     + 
Sbjct: 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS---LNELEIKALSLRNYQSQS 167

Query: 460 IGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLS 519
           + ++ + +    +  S  +  +    + L+++  + L    L       L   +    + 
Sbjct: 168 LKSI-RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226

Query: 520 LKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLK----- 574
               +  GS+  + SF+  L  +   +  L ++   + +LN      P E   +      
Sbjct: 227 KLAFR--GSVLTDESFNE-LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283

Query: 575 ---VLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
               + ++ +        + T    L+ ++ + ++ +++          + +L+ L+LS 
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343

Query: 632 NNLFGII---PISLEKLLDLKDINVSFNKLEGEIPREGPFRNFS 672
           N +                L+ + +S N L              
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  130 bits (328), Expect = 1e-31
 Identities = 65/377 (17%), Positives = 139/377 (36%), Gaps = 30/377 (7%)

Query: 296 LDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRL 355
            D +       IP  +     ++ +  SFNK+  +    +   + L+ L L S+     +
Sbjct: 10  CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTI 65

Query: 356 PSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGF-IPNTFGNLRN 413
              A   L +LE L LS N+ S ++ S  F   S L  L L  N +    + + F NL N
Sbjct: 66  EGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124

Query: 414 LKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMP 473
           L+ L +G+    S    + F   ++   L    I    L     + + ++ + +    + 
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTS---LNELEIKALSLRNYQSQSLKSI-RDIHHLTLH 180

Query: 474 NSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNL 533
            S  +  +    + L+++  + L    L       L   +    +     +  GS+  + 
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR--GSVLTDE 238

Query: 534 SFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTT 593
           SF+  L  +   +  L ++   + +LN      P E   +  L +++             
Sbjct: 239 SFNE-LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV----------- 286

Query: 594 IGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINV 653
                 ++ L +    L   +      +  +K + + N+ +F +     + L  L+ +++
Sbjct: 287 -----TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL 341

Query: 654 SFNKLEGEIPREGPFRN 670
           S N +  E  +    + 
Sbjct: 342 SENLMVEEYLKNSACKG 358

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 88.2 bits (219), Expect = 4e-18
 Identities = 42/329 (12%), Positives = 99/329 (30%), Gaps = 45/329 (13%)

Query: 364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY 423
                      +F+ +IPS +   + + +L+L  N  +           NL+ L L  + 
Sbjct: 5   DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61

Query: 424 LTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPK 483
           + +    +   +  +   LE+  +S+N L  +     G L                    
Sbjct: 62  INT----IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL-------------------- 97

Query: 484 EINNLTNLIAIYLGVNKLNG-SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSI 542
                ++L  + L  N      +      L  LQ L + + +    I             
Sbjct: 98  -----SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR------------ 140

Query: 543 PSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY 602
                 L  +  L +            + +++ +  + L ++  + ++      L  ++Y
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200

Query: 603 LFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEI 662
           L L+   L       +        +         +   S  +LL L    +  +++E + 
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260

Query: 663 PREGPFRNFSLESFKGNELLCGMPNLQVR 691
                  +F+         L  +  + +R
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIR 289

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 81.3 bits (201), Expect = 5e-16
 Identities = 41/249 (16%), Positives = 81/249 (32%), Gaps = 15/249 (6%)

Query: 462 NLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLK 521
            L+ +M+   +  + I+     ++    NL  + L  +++N     A   L  L+ L L 
Sbjct: 23  GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82

Query: 522 DNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTG-PLPLEIGNLKVLVQID 580
           DN L  S+              S    L  +  LNL  N +    +     NL  L  + 
Sbjct: 83  DNHLS-SLS------------SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129

Query: 581 LSINNFSDVIP-TTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIP 639
           +        I      GL  L  L +K   L+     S+  + ++  L L  +    ++ 
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189

Query: 640 ISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHH 699
           I  + L  ++ + +    L        P    S    K       + +         + +
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249

Query: 700 TSSKNDLLI 708
               +++  
Sbjct: 250 ILELSEVEF 258

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  165 bits (421), Expect = 2e-45
 Identities = 60/367 (16%), Positives = 108/367 (29%), Gaps = 53/367 (14%)

Query: 67  PEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQ 126
                + +  E L+ Q +         +       N D +  +          +N    Q
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQ-----ANSNNPQ 59

Query: 127 TLFLDENNFDGKIPSTLLRCKH--LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQ 184
                           L          L L         P +   L+ L+++ +D   L 
Sbjct: 60  IETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117

Query: 185 GEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNR 244
            E+P+ +   A LE L L  N L   +P SI +L+ L +L +         P+ +     
Sbjct: 118 -ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL---AS 172

Query: 245 LSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQ 304
             A    +   N   L+ + L                ++P  I NL  L+ L ++ + L 
Sbjct: 173 TDASGEHQGLVN---LQSLRLEWTGI----------RSLPASIANLQNLKSLKIRNSPLS 219

Query: 305 CVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLP 364
             +   I +L  LE                         L L   +     P        
Sbjct: 220 -ALGPAIHHLPKLEE------------------------LDLRGCTALRNYPPIFG-GRA 253

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
            L+ L L   +   T+P  I   ++L  L+L+       +P+    L     + +  +  
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

Query: 425 TSSTSEL 431
                  
Sbjct: 314 AQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  154 bits (392), Expect = 2e-41
 Identities = 69/361 (19%), Positives = 126/361 (34%), Gaps = 72/361 (19%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            S  E L+ + +         LS  +R  N   +             N          G 
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 61  KLQGEIPEELGNLAE--LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANI 118
            L+    + L +  +     L L++  L    P   F LS L ++ +    L        
Sbjct: 67  ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM------- 117

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
                              ++P T+ +   L+TL+L+ N     +P  I +L +L+ L +
Sbjct: 118 -------------------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157

Query: 179 DQNRLQGEIPEELGN---------LAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFN 229
                  E+PE L +         L  L+ L+L+   +  ++P SI NL +L  L++  +
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 230 SLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGN 289
            L+                L      ++P LEE+ L          + L     P   G 
Sbjct: 217 PLS---------------ALGPAIH-HLPKLEELDLRGC-------TALR--NYPPIFGG 251

Query: 290 LAKLEKLDLQ-FNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
            A L++L L+  + L   +P +I  L  LE +       +  +P+ I  +     + +  
Sbjct: 252 RAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310

Query: 349 N 349
           +
Sbjct: 311 H 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  145 bits (367), Expect = 3e-38
 Identities = 59/384 (15%), Positives = 111/384 (28%), Gaps = 69/384 (17%)

Query: 286 EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY 345
              + +  E L  Q +         +           +             N +  +   
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62

Query: 346 LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
               +         D   P    L L         P   F  S L  + +        +P
Sbjct: 63  RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LP 120

Query: 406 NTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQ 465
           +T      L+ L L  N L +                             LP  I +L  
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-----------------------------LPASIASL-N 150

Query: 466 SMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQL 525
            + +  +        +P+ + +                        L  LQ L L+   +
Sbjct: 151 RLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGI 195

Query: 526 EGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINN 585
                          S+P+++ NL+++  L +  +  +  L   I +L  L ++DL    
Sbjct: 196 --------------RSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT 240

Query: 586 FSDVIPTTIGGLKDLQYLFLK-YNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEK 644
                P   GG   L+ L LK  + L  ++P  I  +  L+ L+L        +P  + +
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299

Query: 645 LLDLKDINVSFNKLEGEIPREGPF 668
           L     I V  + L+ ++ +  P 
Sbjct: 300 LPANCIILVPPH-LQAQLDQHRPV 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  144 bits (366), Expect = 4e-38
 Identities = 49/242 (20%), Positives = 90/242 (37%), Gaps = 17/242 (7%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
                 L L+S     + P        L+++++        +P  +     L  L L  N
Sbjct: 80  QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN 137

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFN---------LSSLSNLDLSVNNLT 111
            L+  +P  + +L  L EL ++       +P  + +         L +L +L L    + 
Sbjct: 138 PLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196

Query: 112 GELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLT 171
             L A+I  NL  L++L +  +     +   +     L+ L L       + P   G   
Sbjct: 197 -SLPASIA-NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253

Query: 172 KLKYLHL-DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNS 230
            LK L L D + L   +P ++  L +LEKL L+       +P  I  L +   + +  + 
Sbjct: 254 PLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312

Query: 231 LT 232
             
Sbjct: 313 QA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  120 bits (304), Expect = 6e-30
 Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 14/200 (7%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNV---------TT 51
            + LE L L  N     +P+++++  RLR +S+        +P+ + +            
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184

Query: 52  LIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLT 111
           L  L L    ++  +P  + NL  L+ L ++N+ L+  +  +I +L  L  LDL      
Sbjct: 185 LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242

Query: 112 GELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLT 171
                        L+ L L + +    +P  + R   L+ L L        +P  I  L 
Sbjct: 243 RNYPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301

Query: 172 KLKYLHLDQNRLQGEIPEEL 191
               + +  + LQ ++ +  
Sbjct: 302 ANCIILVPPH-LQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 24/123 (19%), Positives = 48/123 (39%), Gaps = 2/123 (1%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L NL+ L ++++     +   + +  +L  + L         P   G    L  L L+  
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
                +P ++  L +LE+L L+       +PS I  L +   + +   +L  +L  +   
Sbjct: 264 SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHRPV 322

Query: 121 NLP 123
             P
Sbjct: 323 ARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 17/129 (13%), Positives = 35/129 (27%), Gaps = 9/129 (6%)

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLK 598
           + S      +      L    +    P    +   +     D +  +             
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56

Query: 599 DLQYLFLKYNRLQGSIPDSIGD--MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
           + Q        L+ +  D + D       +L L +  L    P    +L  L+ + +   
Sbjct: 57  NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAA 114

Query: 657 KLEGEIPRE 665
            L  E+P  
Sbjct: 115 GLM-ELPDT 122

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  169 bits (430), Expect = 2e-45
 Identities = 102/570 (17%), Positives = 172/570 (30%), Gaps = 124/570 (21%)

Query: 43  PKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSN 102
           P+ + N T L       + L  E+P E  N+    E +   +      P        ++ 
Sbjct: 5   PRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 103 LDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD 162
             L                      L L+       +P       HL++L  S N  + +
Sbjct: 63  SRLRDCLDRQ------------AHELELNNLGLS-SLPELP---PHLESLVASCNSLT-E 105

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS 222
           +P+   +L  L   + +   L    P        LE L + NN L     P + N S L 
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK--LPELQNSSFLK 156

Query: 223 DLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT 282
            +++  NSL                +LP    +  P LE I    N              
Sbjct: 157 IIDVDNNSLK---------------KLP----DLPPSLEFIAAGNNQL-----------E 186

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLK 342
              E+ NL  L  +    N L+ +         +LE ++   N L       + N+  L 
Sbjct: 187 ELPELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNIL--EELPELQNLPFLT 240

Query: 343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSG 402
            +Y  +N     LP       P+LE L++  N  +  +P    + + L   E   +  S 
Sbjct: 241 TIYADNNL-LKTLPDL----PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSE 294

Query: 403 FIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGN 462
             P       NL +L+   N + S               LE  ++SNN L          
Sbjct: 295 LPP-------NLYYLNASSNEIRSLCDLPP--------SLEELNVSNNKL---------- 329

Query: 463 LSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD 522
                             +P     L  L       N L   +      LK+L +     
Sbjct: 330 ----------------IELPALPPRLERL---IASFNHLA-EVPELPQNLKQLHVEYNPL 369

Query: 523 NQLEGSIPD--NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQID 580
            +         +L  +  L  +P    NLK    L++  N      P    +++ L    
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQNLKQ---LHVETNPLRE-FPDIPESVEDL---R 422

Query: 581 LSINNFSDVIPTTIGGLKDLQYLFLKYNRL 610
           ++     D           L+    +++  
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  164 bits (416), Expect = 1e-43
 Identities = 108/538 (20%), Positives = 178/538 (33%), Gaps = 108/538 (20%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNV----------- 49
            + L+     S+    ++P    N K       + +++    P   G             
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 50  --TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV 107
                  L L    L   +PE   +   LE L    N LT  +P    +L SL   + ++
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123

Query: 108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI 167
             L+           PLL+ L +  N  + K+P  L     L+ + +  N     +P   
Sbjct: 124 KALS--------DLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP 172

Query: 168 GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELS 227
            +L    ++    N+L+ E+P EL NL  L  +   NN L   +P    +L S+      
Sbjct: 173 PSLE---FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AG 223

Query: 228 FNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEI 287
            N L                ELP     N+PFL  IY   N+            T+P   
Sbjct: 224 NNILE---------------ELPE--LQNLPFLTTIYADNNLL----------KTLPDLP 256

Query: 288 GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG 347
            +L  L   D     L    P    +L  L+     F+ L  + P        L +L   
Sbjct: 257 PSLEALNVRDNYLTDL----PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNAS 305

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNT 407
           SN     L        P+LEEL++S N     +P+      +L  L    N  +  +P  
Sbjct: 306 SNE-IRSLCDL----PPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPEL 355

Query: 408 FGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSM 467
                NLK L +  N L         +              N+ L   +P +  NL    
Sbjct: 356 PQ---NLKQLHVEYNPLREFPDIPESVEDLRM---------NSHL-AEVPELPQNL---- 398

Query: 468 EDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQL 525
           +  H+  + +    P    ++ +L    +   ++      A     KL+    + +  
Sbjct: 399 KQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  163 bits (414), Expect = 3e-43
 Identities = 94/535 (17%), Positives = 176/535 (32%), Gaps = 116/535 (21%)

Query: 147 KHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNF 206
             LQ      ++ + ++P E  N+      +   +  +   P   G   E+   +L++  
Sbjct: 11  TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69

Query: 207 LTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLS 266
                           +LEL+   L+                LP       P LE +  S
Sbjct: 70  DR-----------QAHELELNNLGLS---------------SLPE----LPPHLESLVAS 99

Query: 267 KNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNK 326
            N              +P+   +L  L   +     L  + P        LE++  S N+
Sbjct: 100 CNSL----------TELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQ 142

Query: 327 LVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFN 386
           L  +    + N S LK + + +NS   +LP       P+LE ++   N     +P    N
Sbjct: 143 LEKL--PELQNSSFLKIIDVDNNS-LKKLPDL----PPSLEFIAAGNNQLE-ELPELQ-N 193

Query: 387 TSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFS 446
              L+ +    NS             +L+ +  G+N L             N  +L    
Sbjct: 194 LPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILE------ELPELQNLPFLTTIY 243

Query: 447 ISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSIL 506
             NN L   LP +  +L    E  ++ ++ ++  +P+   +LT L       + L+    
Sbjct: 244 ADNNLL-KTLPDLPPSL----EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP- 296

Query: 507 IALGKLKKLQLLSLKDNQLEGSIPDNLS-------FSCTLTSIPSTLWNLKDILCLNLSL 559
                   L  L+   N++  S+ D           +  L  +P+    L+    L  S 
Sbjct: 297 ------PNLYYLNASSNEIR-SLCDLPPSLEELNVSNNKLIELPALPPRLER---LIASF 346

Query: 560 NFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD----------------LQYL 603
           N     +P    NLK L    +  N   +  P     ++D                L+ L
Sbjct: 347 NHLAE-VPELPQNLKQL---HVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQL 401

Query: 604 FLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
            ++ N L+   PD      +++ L +++  +      + E    L+D     +  
Sbjct: 402 HVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  145 bits (369), Expect = 2e-37
 Identities = 93/412 (22%), Positives = 167/412 (40%), Gaps = 59/412 (14%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             +LE L    N    ++P    + K L   + +L   S   P        L  L +  N
Sbjct: 90  PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNN 141

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           +L+ ++PE L N + L+ + + NN L   +P       SL  +    N L    L  +  
Sbjct: 142 QLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEE--LPEL-Q 192

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
           NLP L  ++ D N+   K+P        L+++    N        E+ NL  L  ++ D 
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLP---LSLESIVAGNNILE--ELPELQNLPFLTTIYADN 246

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
           N L+  +P+   +L   E L +++N+LT  +P    +L+ L   E  F+ L+   P +++
Sbjct: 247 NLLK-TLPDLPPSL---EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLY 300

Query: 241 IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN-----------CTIPKEIGN 289
            +N  S E+    C+  P LEE+ +S N    E+P+                 +P+   N
Sbjct: 301 YLNASSNEIR-SLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIASFNHLAEVPELPQN 358

Query: 290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSN 349
           L   ++L +++N L+   P   +++ +L       N  +  VP    N   LK L++ +N
Sbjct: 359 L---KQLHVEYNPLRE-FPDIPESVEDLR-----MNSHLAEVPELPQN---LKQLHVETN 406

Query: 350 SFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFS 401
                 P        ++E+L ++              T KL     + +   
Sbjct: 407 PL-REFPDI----PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  162 bits (412), Expect = 4e-44
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 26/290 (8%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
              IG+G FG V++ + + G EVAVK+F  +  R+    + E      +RH NI+ FI++ 
Sbjct: 48   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 816  SSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 866
            + D+       LV +Y  +GSL   L  + Y + +   + + +  AS L +LH       
Sbjct: 106  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--LKEDQSLTQTQTLATIGYMAPE-- 922
                I H DLK  N+L+  N    ++D G+A       +   +     + T  YMAPE  
Sbjct: 164  GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 923  ----YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME-- 976
                  +        D+Y+ G++  E   R          ++     V     +  M   
Sbjct: 224  DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283

Query: 977  VVDANL-LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            V +  L  +  ++      + +  +  +  +C   +   R+ A  I   L
Sbjct: 284  VCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  161 bits (410), Expect = 9e-44
 Identities = 81/385 (21%), Positives = 155/385 (40%), Gaps = 46/385 (11%)

Query: 277 DLGNCTIPK--EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTT 334
                 I +     +LA+  +  LQ   +  V+    + L ++  ++ +  K+  +    
Sbjct: 6   ATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG-- 61

Query: 335 IFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE 394
           I  ++ L++L L  N        S    L  L  L +  N    T  S + N + L  L 
Sbjct: 62  IEYLTNLEYLNLNGNQITD---ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELY 116

Query: 395 LQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGG 454
           L  ++ S   P    NL  +  L+LG N+  S  S LS ++      L Y +++ + +  
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTG-----LNYLTVTESKVKD 169

Query: 455 ILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKK 514
           + P  I NL+  +    +  + I    P  + +LT+L      VN++    +  +  + +
Sbjct: 170 VTP--IANLTD-LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTR 222

Query: 515 LQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLK 574
           L  L + +N++    P               L NL  +  L +  N  +    +   +L 
Sbjct: 223 LNSLKIGNNKITDLSP---------------LANLSQLTWLEIGTNQISDINAV--KDLT 265

Query: 575 VLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL 634
            L  +++  N  SD+    +  L  L  LFL  N+L     + IG + NL +L LS N++
Sbjct: 266 KLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323

Query: 635 FGIIPISLEKLLDLKDINVSFNKLE 659
             I P++   L  +   + +   ++
Sbjct: 324 TDIRPLA--SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  158 bits (401), Expect = 2e-42
 Identities = 81/401 (20%), Positives = 151/401 (37%), Gaps = 57/401 (14%)

Query: 52  LIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLT 111
              L      +    P    +LAE     LQ   +T  +      L S++ L ++   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 112 GELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLT 171
              +  I   L  L+ L L+ N      P  L     L  L +  N  +      + NLT
Sbjct: 58  S--IQGI-EYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLT 110

Query: 172 KLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSL 231
            L+ L+L+++ +       L NL ++  L L  N    +    + N++ L+ L ++ + +
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167

Query: 232 TGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLA 291
               P        ++         N+  L  + L+ N      P           + +L 
Sbjct: 168 KDVTP--------IA---------NLTDLYSLSLNYNQIEDISP-----------LASLT 199

Query: 292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
            L       N++  + P  + N+  L  +    NK+  + P  + N+S L +L +G+N  
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ- 254

Query: 352 FGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL 411
              + +  D  L  L+ L++  N  S    S + N S+L++L L  N          G L
Sbjct: 255 ISDINAVKD--LTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310

Query: 412 RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
            NL  L L  N++T     +  L  ++   ++    +N  +
Sbjct: 311 TNLTTLFLSQNHITD----IRPL--ASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  156 bits (398), Expect = 4e-42
 Identities = 81/430 (18%), Positives = 165/430 (38%), Gaps = 85/430 (19%)

Query: 97  LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSI 156
            ++L+ L   +N +  +      ++L       L + +       T    + +  L ++ 
Sbjct: 2   AATLATLPAPINQIFPD------ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAG 53

Query: 157 NDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF 216
              +  I   I  LT L+YL+L+ N++    P  L NL +L  L +  N +T     ++ 
Sbjct: 54  EKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQ 107

Query: 217 NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPS 276
           NL++L +L L+ ++++                                            
Sbjct: 108 NLTNLRELYLNEDNISD------------------------------------------- 124

Query: 277 DLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF 336
                     + NL K+  L+L  N     +   + N+  L ++  + +K+  V P  I 
Sbjct: 125 -------ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IA 174

Query: 337 NVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQ 396
           N++ L  L L  N        S    L +L   +   N  +   P  + N ++L++L++ 
Sbjct: 175 NLTDLYSLSLNYNQIED---ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIG 229

Query: 397 RNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGIL 456
            N  +   P    NL  L WL++G N ++     ++ +   +   L+  ++ +N +  I 
Sbjct: 230 NNKITDLSP--LANLSQLTWLEIGTNQISD----INAV--KDLTKLKMLNVGSNQISDIS 281

Query: 457 PRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQ 516
              + NLSQ +    + N+ +     + I  LTNL  ++L  N +    +  L  L K+ 
Sbjct: 282 V--LNNLSQ-LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMD 336

Query: 517 LLSLKDNQLE 526
                +  ++
Sbjct: 337 SADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  156 bits (398), Expect = 4e-42
 Identities = 78/394 (19%), Positives = 143/394 (36%), Gaps = 51/394 (12%)

Query: 32  SLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIP 91
           +L+             ++   I   L+   +   +      L  + +L +    +     
Sbjct: 4   TLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--I 59

Query: 92  SSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQT 151
             I  L++L  L+L+ N +T   ++ + SNL  L  L++  N       S L    +L+ 
Sbjct: 60  QGIEYLTNLEYLNLNGNQITD--ISPL-SNLVKLTNLYIGTNKI--TDISALQNLTNLRE 114

Query: 152 LSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTI 211
           L L+ ++ S   P  + NLTK+  L+L  N         L N+  L  L +  + +    
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVT 171

Query: 212 PPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFY 271
           P  I NL+ L  L L++N +                        ++  L       N   
Sbjct: 172 P--IANLTDLYSLSLNYNQIED-----------------ISPLASLTSLHYFTAYVNQIT 212

Query: 272 GEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVV 331
              P           + N+ +L  L +  N++  + P  + NL  L W+    N++  + 
Sbjct: 213 DITP-----------VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI- 258

Query: 332 PTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLS 391
              + +++ LK L +GSN        S    L  L  L L+ N         I   + L+
Sbjct: 259 -NAVKDLTKLKMLNVGSNQISD---ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314

Query: 392 TLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLT 425
           TL L +N  +   P    +L  +   D  +  + 
Sbjct: 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  151 bits (385), Expect = 2e-40
 Identities = 75/377 (19%), Positives = 148/377 (39%), Gaps = 51/377 (13%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+      L+          T    + +  + ++         + I  +T L  L+L GN
Sbjct: 21  LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGN 76

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           ++    P  L NL +L  L++  N +T    S++ NL++L  L L+ +N++   ++ + +
Sbjct: 77  QITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPL-A 129

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
           NL  + +L L  N+      S L     L  L+++ +    D+   I NLT L  L L+ 
Sbjct: 130 NLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVK-DVT-PIANLTDLYSLSLNY 186

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
           N+++   P  L +L  L       N +T   P  + N++ L+ L++  N +T        
Sbjct: 187 NQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD------- 235

Query: 241 IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQF 300
                          N+  L  + +  N             +    + +L KL+ L++  
Sbjct: 236 ----------LSPLANLSQLTWLEIGTNQI-----------SDINAVKDLTKLKMLNVGS 274

Query: 301 NRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSAD 360
           N++  +    ++NL  L  +  + N+L       I  ++ L  L+L  N      P +  
Sbjct: 275 NQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA-- 330

Query: 361 VRLPNLEELSLSGNNFS 377
             L  ++    +     
Sbjct: 331 -SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 77.2 bits (191), Expect = 4e-15
 Identities = 35/179 (19%), Positives = 71/179 (39%), Gaps = 24/179 (13%)

Query: 485 INNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPS 544
             +L   I   L    +    ++   +L+ +  L +   ++               SI  
Sbjct: 18  DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV--------------ASIQG 61

Query: 545 TLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLF 604
            +  L ++  LNL+ N  T   PL   NL  L  + +  N  +D+    +  L +L+ L+
Sbjct: 62  -IEYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYIGTNKITDISA--LQNLTNLRELY 116

Query: 605 LKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIP 663
           L  + +    P  + ++  + SLNL  N+    +   L  +  L  + V+ +K++   P
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP 172

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  165 bits (419), Expect = 9e-44
 Identities = 88/527 (16%), Positives = 168/527 (31%), Gaps = 57/527 (10%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELE 77
           I     N  R +   ++ +     +     +   +  L L GN L      +L    +LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 78  ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDG 137
            L L +N L       + +LS+L  LDL+ N +  EL        P ++TL    NN   
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-EL-----LVGPSIETLHAANNNI-S 112

Query: 138 KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG-EIPEELGNLAE 196
           ++  +  +    + + L+ N  +     + G  ++++YL L  N +      E   +   
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 197 LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNN 256
           LE L LQ NF+   +   +   + L  L+LS N L                 +  +F + 
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA---------------FMGPEFQSA 213

Query: 257 IPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHN 316
              +  I L  N              I K +     LE  DL+ N   C    +     N
Sbjct: 214 -AGVTWISLRNNKLV----------LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKN 261

Query: 317 LEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLS---- 372
                 +   +  +        +     + G+      LP+    RL  L+    +    
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC-CEDLPAPFADRLIALKRKEHALLSG 320

Query: 373 GNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELS 432
             + +  +     N ++   ++  +  +   I       +    L+     L        
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD-EQVSNG 379

Query: 433 FLSSSNCKYLEYFSISNNPLGGI---------LPRVIGNLSQSMEDFHMPNSNISGSIPK 483
             + +        ++    L            L  ++    +   +     +N       
Sbjct: 380 RRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDM 439

Query: 484 EINNLTNLIAIYLGVNKLNGSILIALGKLK-KLQLLSLKDNQLEGSI 529
             +  T L      + KLNG   +AL      LQ L +++  L   +
Sbjct: 440 YQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLASQL 486

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  150 bits (380), Expect = 1e-38
 Identities = 74/534 (13%), Positives = 150/534 (28%), Gaps = 66/534 (12%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS 222
           I +   N  + K   +  + L+  +     +   +++L L  N L+      +   + L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 223 DLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT 282
            L LS N L                E       ++  L  + L+ N              
Sbjct: 62  LLNLSSNVLY---------------ETLD--LESLSTLRTLDLNNNYV------------ 92

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLK 342
             +E+     +E L    N +  V           + +  + NK+  +        S ++
Sbjct: 93  --QELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ 147

Query: 343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSG 402
           +L L  N       +        LE L+L  N     +   +     L TL+L  N  + 
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK-LKTLDLSSNKLA- 204

Query: 403 FIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGN 462
           F+   F +   + W+ L +N L      L F  +     LE+F +  N       R   +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN-----LEHFDLRGNGFHCGTLRDFFS 259

Query: 463 LSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD 522
            +Q ++   +    +     +     T     + G             +L  L+      
Sbjct: 260 KNQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317

Query: 523 NQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLS 582
              +GS             +     N      ++     +   +       +  + ++  
Sbjct: 318 LSGQGS---------ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368

Query: 583 INNFSDVIPTTIGGLKDLQYLFLKYNRLQG--SIPDSIGDMINLKSL-----------NL 629
                + +        +L     +           +    +  L+++             
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQS 428

Query: 630 SNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLC 683
             NN      +   K   L + N    KL GE        N +L+     E   
Sbjct: 429 VQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNL 482

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  147 bits (373), Expect = 1e-37
 Identities = 76/492 (15%), Positives = 152/492 (30%), Gaps = 43/492 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             N++ L L  N       + L+   +L  ++LS N    T+   + +++TL  L L  N
Sbjct: 33  AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +Q     EL     +E L   NN ++  +  S        N+ L+ N +T  L      
Sbjct: 91  YVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKIT-MLRDLDEG 141

Query: 121 NLPLLQTLFLDENNFDG-KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLD 179
               +Q L L  N  D             L+ L+L  N    D+  ++    KLK L L 
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLS 199

Query: 180 QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
            N+L   +  E  + A +  + L+NN L   I  ++    +L   +L  N       +D 
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257

Query: 240 HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQ 299
              N+    +  +    +    E   +       +      C          +L  L  +
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVP----TLGHYGAYCCEDLPAPFADRLIALKRK 313

Query: 300 FNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSA 359
            + L      E + L                      N +  + +      +   +    
Sbjct: 314 EHALLSGQGSETERL-----------------ECERENQARQREIDALKEQYR-TVIDQV 355

Query: 360 DVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL 419
            +R      L          + +     ++L     Q       + +       L+ L  
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRA 414

Query: 420 GDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISG 479
                     E   + ++  +  + +          L      L +   +  +  ++ + 
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQ----LAEENARLKKLNGEADLALASANA 470

Query: 480 SIPKEINNLTNL 491
           ++ + +    NL
Sbjct: 471 TLQELVVREQNL 482

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 75.7 bits (186), Expect = 3e-14
 Identities = 28/191 (14%), Positives = 63/191 (32%), Gaps = 24/191 (12%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
           +I +   N        +  + L  ++         ++ L L  N L   I          
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS--------- 50

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD 599
               + L     +  LNLS N     L   + +L  L  +DL+ N         +     
Sbjct: 51  ---AADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPS 100

Query: 600 LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
           ++ L    N +   +  S       K++ L+NN +  +  +       ++ +++  N+++
Sbjct: 101 IETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

Query: 660 GEIPREGPFRN 670
             +       +
Sbjct: 158 -TVNFAELAAS 167

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  149 bits (377), Expect = 5e-39
 Identities = 78/407 (19%), Positives = 140/407 (34%), Gaps = 50/407 (12%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELE 77
           I S L       ++ + +         E   +     +  + + ++      L +  ++E
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 78  ELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
            L L +  +   I +  F    ++  L +  N +   L  ++  N+PLL  L L+ N+  
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 137 GKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEELGNLA 195
                       L TLS+S N+    I  +     T L+ L L  NRL   +   L  + 
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186

Query: 196 ELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
            L    +  N L+     ++    ++ +L+ S NS+                 +      
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---------------VVRGPVNV 226

Query: 256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH 315
               L  + L  N             T    + N   L ++DL +N L+ ++ H    + 
Sbjct: 227 E---LTILKLQHNNL-----------TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
            LE +  S N+LV  +      + TLK L L  N     +  +   +   LE L L  N+
Sbjct: 273 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH-LLHVERNQP-QFDRLENLYLDHNS 329

Query: 376 FSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
              T+         L  L L  N +           RN+    + D 
Sbjct: 330 IV-TLKLSTH--HTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  149 bits (377), Expect = 5e-39
 Identities = 77/390 (19%), Positives = 134/390 (34%), Gaps = 50/390 (12%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSS 99
            I   +        +H+           E   L   + +  +N+ +   +P+++  +   
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 100 LSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDF 159
           +  L+L+   +  E+     +    +Q L++  N      P        L  L L  ND 
Sbjct: 71  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129

Query: 160 SGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIFN 217
           S  +P+ I  N  KL  L +  N L+  I ++       L+ LQL +N LT  +  S+  
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI- 185

Query: 218 LSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSD 277
             SL    +S+N L+                           +EE+  S N         
Sbjct: 186 -PSLFHANVSYNLLS-TLAIP-------------------IAVEELDASHNSI------- 217

Query: 278 LGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFN 337
                +   +    +L  L LQ N L       + N   L  +  S+N+L  ++      
Sbjct: 218 ---NVVRGPV--NVELTILKLQHNNLT--DTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 270

Query: 338 VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR 397
           +  L+ LY+ +N     L       +P L+ L LS N+    +        +L  L L  
Sbjct: 271 MQRLERLYISNNR-LVALNLYGQ-PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 327

Query: 398 NSFSGFIPNTFGNLRNLKWLDLGDNYLTSS 427
           NS    +         LK L L  N    +
Sbjct: 328 NSIV-TLK--LSTHHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  145 bits (369), Expect = 5e-38
 Identities = 82/403 (20%), Positives = 153/403 (37%), Gaps = 56/403 (13%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
             ++       +++ G    TL+N    + ++   +     +P  +  +   +  L+L  
Sbjct: 23  FYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 78

Query: 60  NKLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLAN 117
            +++ EI          +++L++  N +   +P  +F N+  L+ L L  N+L+  L   
Sbjct: 79  LQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRG 135

Query: 118 ICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLH 177
           I  N P L TL +  NN +     T      LQ L LS N  +  +   +  +  L + +
Sbjct: 136 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHAN 192

Query: 178 LDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPK 237
           +  N L       L     +E+L   +N +   +   +     L+ L+L  N+LT     
Sbjct: 193 VSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT----- 239

Query: 238 DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEI-GNLAKLEKL 296
                     +       N P L E+ LS N              I       + +LE+L
Sbjct: 240 ----------DTAW--LLNYPGLVEVDLSYNELE----------KIMYHPFVKMQRLERL 277

Query: 297 DLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLP 356
            +  NRL   +      +  L+ +  S N L+  V         L+ LYL  NS    L 
Sbjct: 278 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLK 334

Query: 357 SSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRN 398
            S       L+ L+LS N++       +F N ++ +  +  ++
Sbjct: 335 LST---HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 374

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  130 bits (330), Expect = 8e-33
 Identities = 57/361 (15%), Positives = 129/361 (35%), Gaps = 28/361 (7%)

Query: 331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSK 389
           + + +        +++   +         D+ L N + ++   +     +P+ +  +  +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQ-DVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 390 LSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISN 449
           +  L L            F     ++ L +G N +      L      N   L    +  
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY----LPPHVFQNVPLLTVLVLER 126

Query: 450 NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI-NNLTNLIAIYLGVNKLNGSILIA 508
           N L  +   +  N    +    M N+N+   I  +     T+L  + L  N+L     + 
Sbjct: 127 NDLSSLPRGIFHNTP-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VD 181

Query: 509 LGKLKKLQLLSLKDNQLEGSIPDNLS------FSCTLTSIPSTLWNLKDILCLNLSLNFF 562
           L  +  L   ++  N L  ++   ++         ++  +   +    ++  L L  N  
Sbjct: 182 LSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNL 238

Query: 563 TGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMI 622
           T    L   N   LV++DLS N    ++      ++ L+ L++  NRL  ++      + 
Sbjct: 239 TDTAWLL--NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295

Query: 623 NLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELL 682
            LK L+LS+N+L   +  +  +   L+++ +  N +   +            +   N+  
Sbjct: 296 TLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWD 352

Query: 683 C 683
           C
Sbjct: 353 C 353

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 32/145 (22%), Positives = 51/145 (35%), Gaps = 8/145 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
              L  + L  N     +       +RL  + +S N     +      + TL  L L  N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            L   +         LE L+L +N +  T+  S     +L NL LS N+     L  +  
Sbjct: 306 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWDCNSLRALFR 361

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLR 145
           N+       +D+ +   KI   L  
Sbjct: 362 NVARPA---VDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 67.4 bits (165), Expect = 8e-12
 Identities = 30/181 (16%), Positives = 68/181 (37%), Gaps = 15/181 (8%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
            I   +        +++ +   +         L   ++++ K++ +   +P         
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP--------- 61

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD 599
               + L + + +  LNL+                 + ++ +  N    + P     +  
Sbjct: 62  ---AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 118

Query: 600 LQYLFLKYNRLQGSIPDSI-GDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
           L  L L+ N L  S+P  I  +   L +L++SNNNL  I   + +    L+++ +S N+L
Sbjct: 119 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177

Query: 659 E 659
            
Sbjct: 178 T 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.9 bits (156), Expect = 9e-11
 Identities = 16/141 (11%), Positives = 46/141 (32%), Gaps = 9/141 (6%)

Query: 527 GSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT--GPLPLEIGNLKVLVQIDLSIN 584
              P    + C  +++        D +  ++ ++  T       E   L     +    +
Sbjct: 2   NVKPRQPEYKCIDSNLQY------DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS 55

Query: 585 NFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEK 644
               +    +   + ++ L L   +++     +      ++ L +  N +  + P   + 
Sbjct: 56  TMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 115

Query: 645 LLDLKDINVSFNKLEGEIPRE 665
           +  L  + +  N L   +PR 
Sbjct: 116 VPLLTVLVLERNDLS-SLPRG 135

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  150 bits (381), Expect = 9e-39
 Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 33/337 (9%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELE 77
           +P  +      R + L  N        E  +   L  L L  N +    P    NL  L 
Sbjct: 26  VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83

Query: 78  ELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
            L L++N L   IP  +F  LS+L+ LD+S N +   LL  +  +L  L++L + +N+  
Sbjct: 84  TLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL- 140

Query: 137 GKIPSTLLR-CKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEELGNL 194
             I          L+ L+L   + +  IP E   +L  L  L L    +          L
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199

Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFC 254
             L+ L++ +     T+ P+     +L+ L ++  +LT                +P    
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT---------------AVPYLAV 244

Query: 255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL 314
            ++ +L  + LS N     I   +        +  L +L+++ L   +L  V P+    L
Sbjct: 245 RHLVYLRFLNLSYNPI-STIEGSM--------LHELLRLQEIQLVGGQLAVVEPYAFRGL 295

Query: 315 HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
           + L  +  S N+L  +  +   +V  L+ L L SN  
Sbjct: 296 NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  136 bits (344), Expect = 4e-34
 Identities = 65/349 (18%), Positives = 118/349 (33%), Gaps = 36/349 (10%)

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
           C      + +      F   +P  +      + L L  N        E  +   L+ L L
Sbjct: 7   CECSAQDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELEL 63

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPK 237
           ++N +    P    NL  L  L L++N L   IP  +F  LS+L+ L++S N +      
Sbjct: 64  NENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV----- 117

Query: 238 DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLD 297
                      L      ++  L+ + +  N     I               L  LE+L 
Sbjct: 118 ----------ILLDYMFQDLYNLKSLEVGDNDL-VYISHRA--------FSGLNSLEQLT 158

Query: 298 LQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS 357
           L+   L  +    + +LH L  +      +  +   +   +  LK L +    +   +  
Sbjct: 159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218

Query: 358 SADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKW 416
           +  +   NL  LS++  N +  +P     +   L  L L  N  S    +    L  L+ 
Sbjct: 219 NC-LYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQE 276

Query: 417 LDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQ 465
           + L    L      +   +     YL   ++S N L  +   V  ++  
Sbjct: 277 IQLVGGQLAV----VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  135 bits (342), Expect = 9e-34
 Identities = 69/310 (22%), Positives = 112/310 (36%), Gaps = 35/310 (11%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
             +LE L L  N+     P   +N   LR + L  N     IP  +   ++ L  L +  
Sbjct: 55  FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISE 113

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           NK+   +     +L  L+ L + +N L   I    F  L+SL  L L   NLT  +    
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEA 171

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
            S+L  L  L L   N +     +  R   L+ L +S   +   +         L  L +
Sbjct: 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231

Query: 179 DQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFP 236
               L   +P   + +L  L  L L  N ++ TI  S+   L  L +++L    L     
Sbjct: 232 THCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA---- 285

Query: 237 KDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEI-GNLAKLEK 295
                       +       + +L  + +S N             T+ + +  ++  LE 
Sbjct: 286 -----------VVEPYAFRGLNYLRVLNVSGNQLT----------TLEESVFHSVGNLET 324

Query: 296 LDLQFNRLQC 305
           L L  N L C
Sbjct: 325 LILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (312), Expect = 5e-30
 Identities = 78/358 (21%), Positives = 125/358 (34%), Gaps = 52/358 (14%)

Query: 330 VVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTS 388
            VP  I   +  + L LG N     L        P+LEEL L+ N  S  +    F N  
Sbjct: 25  AVPEGIP--TETRLLDLGKN-RIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLF 80

Query: 389 KLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSIS 448
            L TL L+ N         F  L NL  LD+ +N +      L      +   L+   + 
Sbjct: 81  NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI----LLDYMFQDLYNLKSLEVG 136

Query: 449 NNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIA 508
           +N L  I  R                           + L +L  + L    L      A
Sbjct: 137 DNDLVYISHRAF-------------------------SGLNSLEQLTLEKCNLTSIPTEA 171

Query: 509 LGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPL 568
           L  L  L +L L+   +  +I D             +   L  +  L +S   +   +  
Sbjct: 172 LSHLHGLIVLRLRHLNIN-AIRDY------------SFKRLYRLKVLEISHWPYLDTMTP 218

Query: 569 EIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN 628
                  L  + ++  N + V    +  L  L++L L YN +       + +++ L+ + 
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278

Query: 629 LSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNF-SLE--SFKGNELLC 683
           L    L  + P +   L  L+ +NVS N+L   +  E  F +  +LE      N L C
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 77.8 bits (192), Expect = 6e-15
 Identities = 43/243 (17%), Positives = 82/243 (33%), Gaps = 23/243 (9%)

Query: 456 LPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKL 515
              V   +        +  + I      E  +  +L  + L  N ++     A   L  L
Sbjct: 23  FVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 516 QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKV 575
           + L L+ N+L+  IP                  L ++  L++S N     L     +L  
Sbjct: 83  RTLGLRSNRLK-LIPLG------------VFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 576 LVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLF 635
           L  +++  N+   +      GL  L+ L L+   L     +++  +  L  L L + N+ 
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189

Query: 636 GIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLE--SFKGNEL-------LCGMP 686
            I   S ++L  LK + +S       +         +L   S     L       +  + 
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMT-PNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248

Query: 687 NLQ 689
            L+
Sbjct: 249 YLR 251

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  151 bits (382), Expect = 3e-38
 Identities = 100/556 (17%), Positives = 200/556 (35%), Gaps = 74/556 (13%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
             ++       +++ G    TL+N    + ++   +     +P  +  +   +  L+L  
Sbjct: 29  FYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 84

Query: 60  NKLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLAN 117
            +++ EI          +++L++  N +   +P  +F N+  L+ L L  N+L+  L   
Sbjct: 85  LQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRG 141

Query: 118 ICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLH 177
           I  N P L TL +  NN +     T      LQ L LS N  +  +   +  +  L + +
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHAN 198

Query: 178 LDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPK 237
           +  N L       L     +E+L   +N +   +   +     L+ L+L  N+LT     
Sbjct: 199 VSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT----- 245

Query: 238 DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLD 297
                     +       N P L E+ LS N    +I               + +LE+L 
Sbjct: 246 ----------DTAW--LLNYPGLVEVDLSYNEL-EKIMYHP--------FVKMQRLERLY 284

Query: 298 LQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS 357
           +  NRL   +      +  L+ +  S N L+  V         L+ LYL  NS    L  
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLKL 341

Query: 358 SADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFI---------PNT 407
           S       L+ L+LS N++       +F N ++ +  +  ++    +           + 
Sbjct: 342 ST---HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDK 398

Query: 408 FGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSM 467
               R L+++ L         ++    ++     ++  S      GG+  +    L   +
Sbjct: 399 PYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEV 458

Query: 468 EDFHMPNSNISG----------SIPKEIN-NLTNLIAIYLGVNKLNGSILIALGKLKKLQ 516
            +       ++            +  EI+ NL        G+ + + ++      LK+ Q
Sbjct: 459 NELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQ 518

Query: 517 LLSLKDNQLEGSIPDN 532
              L++ Q   +  D 
Sbjct: 519 AFKLRETQARRTEADA 534

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  142 bits (359), Expect = 2e-35
 Identities = 70/423 (16%), Positives = 147/423 (34%), Gaps = 40/423 (9%)

Query: 265 LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSF 324
           +     Y   P       I   +        + +           E   L+N + + F  
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 325 NKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFI 384
           + +  +    + +   ++ L L        + + A      +++L +  N     +P  +
Sbjct: 61  STMRKLPAALLDSFRQVELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118

Query: 385 F-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLE 443
           F N   L+ L L+RN  S      F N   L  L + +N L      +   +      L+
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER----IEDDTFQATTSLQ 174

Query: 444 YFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNG 503
              +S+N L  +   +I +L          ++N+S ++   +     +  +    N +N 
Sbjct: 175 NLQLSSNRLTHVDLSLIPSLF---------HANVSYNLLSTLAIPIAVEELDASHNSINV 225

Query: 504 SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT 563
              +      +L +L L+ N               LT     L N   ++ ++LS N   
Sbjct: 226 ---VRGPVNVELTILKLQHNN--------------LTDTA-WLLNYPGLVEVDLSYNELE 267

Query: 564 GPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIN 623
             +      ++ L ++ +S N     +      +  L+ L L +N L   +  +      
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325

Query: 624 LKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLC 683
           L++L L +N+   I+ + L     LK++ +S N  +        FRN +  +    +  C
Sbjct: 326 LENLYLDHNS---IVTLKLSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHC 381

Query: 684 GMP 686
            + 
Sbjct: 382 KID 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  140 bits (353), Expect = 1e-34
 Identities = 70/391 (17%), Positives = 127/391 (32%), Gaps = 54/391 (13%)

Query: 65  EIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPL 124
            I   L       ++ +               L++   +    + +  +L A +  +   
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 125 LQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRL 183
           ++ L L++   +            +Q L +  N     +P  +  N+  L  L L++N L
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135

Query: 184 QGEIPEEL-GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHI 241
              +P  +  N  +L  L + NN L   I    F   +SL +L+LS N LT         
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT--------- 184

Query: 242 VNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFN 301
                  +     + IP L    +S N+                 +     +E+LD   N
Sbjct: 185 ------HVDL---SLIPSLFHANVSYNLL--------------STLAIPIAVEELDASHN 221

Query: 302 RLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADV 361
            +  V          L  +    N L       + N   L  + L  N    ++     V
Sbjct: 222 SINVV---RGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNE-LEKIMYHPFV 275

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
           ++  LE L +S N     +  +      L  L+L  N     +         L+ L L  
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333

Query: 422 NYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
           N + +       L  S    L+  ++S+N  
Sbjct: 334 NSIVT-------LKLSTHHTLKNLTLSHNDW 357

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  119 bits (299), Expect = 7e-28
 Identities = 66/461 (14%), Positives = 139/461 (30%), Gaps = 87/461 (18%)

Query: 186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRL 245
            I   L        + +               L++   +    +++              
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR------------- 64

Query: 246 SAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC 305
             +LPA   ++   +E + L+      EI +                ++KL + FN ++ 
Sbjct: 65  --KLPAALLDSFRQVELLNLNDLQI-EEIDTYA--------FAYAHTIQKLYMGFNAIRY 113

Query: 306 VIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPN 365
           + PH   N+  L  ++   N L  +      N   L  L + +N+   R+         +
Sbjct: 114 LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN-LERIEDDTFQATTS 172

Query: 366 LEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLT 425
           L+ L LS N  +  +   +     L    +  N  S     T      ++ LD   N + 
Sbjct: 173 LQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224

Query: 426 SSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI 485
                   +       L    + +N L                      ++ +      +
Sbjct: 225 V-------VRGPVNVELTILKLQHNNL----------------------TDTAW-----L 250

Query: 486 NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPST 545
            N   L+ + L  N+L   +     K+++L+ L + +N+              L ++   
Sbjct: 251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR--------------LVALNLY 296

Query: 546 LWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFL 605
              +  +  L+LS N     +         L  + L  N+   +    +     L+ L L
Sbjct: 297 GQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTL 352

Query: 606 KYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLL 646
            +N    +         N+    + + +    I   LE  L
Sbjct: 353 SHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGL 391

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 77.7 bits (191), Expect = 1e-14
 Identities = 53/314 (16%), Positives = 96/314 (30%), Gaps = 17/314 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
              L  + L  N     +       +RL  + +S N     +      + TL  L L  N
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            L   +         LE L+L +N +  T+  S     +L NL LS N+     L  +  
Sbjct: 312 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWDCNSLRALFR 367

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCK-------HLQTLSLSINDFSGDIPKEIGNLTKL 173
           N+        D++          L CK             +++      + +  G  +  
Sbjct: 368 NVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSAT 427

Query: 174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTI----PPSIFNLSSLSDLELSFN 229
             ++  Q+       +    L   E+L+ + N L   +       I     L  L    +
Sbjct: 428 DTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487

Query: 230 SLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGN 289
           +    +      + R S  L   F +                 E  +     T   E  N
Sbjct: 488 TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKE-TEDLEQEN 546

Query: 290 LAKLEKLDLQFNRL 303
           +A  ++LD +  + 
Sbjct: 547 IALEKQLDNKRAKQ 560

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  147 bits (373), Expect = 6e-38
 Identities = 78/402 (19%), Positives = 140/402 (34%), Gaps = 27/402 (6%)

Query: 50  TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVN 108
             +  + L  N +          L +L+ L ++       I ++ F  LSSL  L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 109 NLTGELLANICSNLPLLQTLFLDENNF-DGKIPSTLLRC-KHLQTLSLSINDFSGDIPKE 166
               +L     + L  L+ L L + N     +     +    L+ L L  N+     P  
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 167 I-GNLTKLKYLHLDQNRLQGEIPEELGNLA--ELEKLQLQNNFLT--------GTIPPSI 215
              N+ +   L L  N+++    E+L N        L+L +  L              + 
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 216 FNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIP 275
           F  +S++ L+LS N    +  K     + ++         +  +          F     
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFF--DAIAGTKIQSLILSNSYNMGSSFGHTNF----- 261

Query: 276 SDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTI 335
            D  N T      +   ++  DL  +++  ++     +  +LE +  + N++  +     
Sbjct: 262 KDPDNFTFKGLEAS--GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF 319

Query: 336 FNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLE 394
           + ++ L  L L  N F G + S     L  LE L LS N+    +    F     L  L 
Sbjct: 320 WGLTHLLKLNLSQN-FLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELA 377

Query: 395 LQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSS 436
           L  N         F  L +L+ + L  N    S   + +LS 
Sbjct: 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 419

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  146 bits (371), Expect = 9e-38
 Identities = 80/392 (20%), Positives = 133/392 (33%), Gaps = 27/392 (6%)

Query: 74  AELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE 132
           A +  + L  N +   +  + F  L  L  L +        +  N    L  L  L LD 
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 133 NNFDGKIPSTLLRCKHLQTLSLSINDF-SGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEE 190
           N F            +L+ L+L+  +     +       LT L+ L L  N ++   P  
Sbjct: 89  NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 191 L-GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAEL 249
              N+     L L  N +  +I        +      +   L+    +DM+    L  E 
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLL--NFQGKHFTLLRLSSITLQDMNE-YWLGWEK 204

Query: 250 PAKFCNNIPFLEEIYLSKNMF----YGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC 305
                     +  + LS N F           +    I   I + +            + 
Sbjct: 205 CGNP-FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD 263

Query: 306 VIPHEIDNLH--NLEWMIFSFNKLVGVVPTTIF-NVSTLKFLYLGSNSFFGRLPSSADVR 362
                   L    ++    S +K+   +  ++F + + L+ L L  N    ++  +A   
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWG 321

Query: 363 LPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
           L +L +L+LS N    +I S +F N  KL  L+L  N        +F  L NLK L L  
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380

Query: 422 NYLTS-STSELSFLSSSNCKYLEYFSISNNPL 452
           N L S        L+S     L+   +  NP 
Sbjct: 381 NQLKSVPDGIFDRLTS-----LQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  124 bits (312), Expect = 5e-30
 Identities = 81/378 (21%), Positives = 140/378 (37%), Gaps = 36/378 (9%)

Query: 293 LEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF-NVSTLKFLYLGSNSF 351
           +  +DL  N +  +       L +L+++         V+    F  +S+L  L L  N F
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 352 FGRLPSSADVRLPNLEELSLSGNNF-SGTIPSFIF-NTSKLSTLELQRNSFSGFIPNT-F 408
             +L + A   L NLE L+L+  N     +    F   + L  L L+ N+     P + F
Sbjct: 92  -LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 409 GNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSME 468
            N+R    LDL  N + S   E   L +   K+     +S+  L                
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEED--LLNFQGKHFTLLRLSSITL---------------- 192

Query: 469 DFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGS---ILIALGKLKKLQLLSLKDNQL 525
              M    +           T++  + L  N    S            K+Q L L ++  
Sbjct: 193 -QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 526 EGSIPDNLSFSCTLTSIPSTLWNLK--DILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLS 582
            GS   +   +        T   L+   +   +LS +     L   +  +   L Q+ L+
Sbjct: 252 MGS---SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLA 307

Query: 583 INNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPIS 641
            N  + +      GL  L  L L  N L  SI   + + +  L+ L+LS N++  +   S
Sbjct: 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQS 366

Query: 642 LEKLLDLKDINVSFNKLE 659
              L +LK++ +  N+L+
Sbjct: 367 FLGLPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  122 bits (308), Expect = 1e-29
 Identities = 72/405 (17%), Positives = 137/405 (33%), Gaps = 82/405 (20%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRGN 60
           +++ Y+ L  N       ++ S  + L+ + +        I       +++LI L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 61  KLQGEIPEE-LGNLAELEELWLQNNFLTGT-IPSSIF-NLSSLSNLDLSVNNLTGELLAN 117
           +   ++       LA LE L L    L G  +  + F  L+SL  L L  NN+     A+
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 118 ICSNLPLLQTLFLDENNFD----------GKIPSTLLRCKHLQTLSLSINDFSGDIPKEI 167
              N+     L L  N                  TLLR   +    ++      +     
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 168 GNLTKLKYLHLDQNRLQGEIPEELGNL--------------------------------- 194
              T +  L L  N  +  + +   +                                  
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268

Query: 195 ------AELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSA 247
                 + ++   L  + +   +  S+F + + L  L L+ N +                
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN--------------- 312

Query: 248 ELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVI 307
           ++       +  L ++ LS+N   G I S +          NL KLE LDL +N ++  +
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRM--------FENLDKLEVLDLSYNHIRA-L 362

Query: 308 PHEI-DNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
             +    L NL+ +    N+L  V       +++L+ ++L +N +
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.8 bits (140), Expect = 9e-09
 Identities = 38/249 (15%), Positives = 74/249 (29%), Gaps = 30/249 (12%)

Query: 460 IGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSI-LIALGKLKKLQLL 518
           +  L   +    +  ++I+       + L +L  + +        I       L  L +L
Sbjct: 25  VPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84

Query: 519 SLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTG-PLPLEI-GNLKVL 576
            L  NQ    +                   L ++  L L+     G  L       L  L
Sbjct: 85  KLDYNQFL-QLE------------TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131

Query: 577 VQIDLSINNFSDVIPTTI-GGLKDLQYLFLKYNRLQGSIPDSIGDM---INLKSLNLSNN 632
             + L  NN   + P +    ++    L L +N+++ SI +         +   L LS+ 
Sbjct: 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSI 190

Query: 633 NLFGIIPISLE--------KLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCG 684
            L  +    L         K   +  +++S N  + E   +  F   +    +   L   
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNS 249

Query: 685 MPNLQVRSC 693
                    
Sbjct: 250 YNMGSSFGH 258

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  142 bits (361), Expect = 1e-37
 Identities = 70/356 (19%), Positives = 121/356 (33%), Gaps = 42/356 (11%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELE 77
           I     N  R +   ++ +     +     +   +  L L GN L      +L    +LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 78  ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDG 137
            L L +N L       + +LS+L  LDL+ N +  EL        P ++TL    NN   
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-EL-----LVGPSIETLHAANNNI-S 112

Query: 138 KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG-EIPEELGNLAE 196
           ++  +  +    + + L+ N  +     + G  ++++YL L  N +      E   +   
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 197 LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNN 256
           LE L LQ NF+   +   +   + L  L+LS N L                 +  +F  +
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA---------------FMGPEFQ-S 212

Query: 257 IPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHN 316
              +  I L  N              I K +     LE  DL+ N   C    +  + + 
Sbjct: 213 AAGVTWISLRNNKLV----------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 317 LEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLS 372
               +    + V  +        T+  L          LP+    RL  L      
Sbjct: 263 RVQTV--AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  133 bits (338), Expect = 1e-34
 Identities = 57/365 (15%), Positives = 110/365 (30%), Gaps = 51/365 (13%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS 222
           I +   N  + K   +  + L+  +     +   +++L L  N L+      +   + L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 223 DLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT 282
            L LS N L                E       ++  L  + L+ N              
Sbjct: 62  LLNLSSNVLY---------------ETLD--LESLSTLRTLDLNNNYV------------ 92

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLK 342
             +E+     +E L    N +  V           + +  + NK+  +        S ++
Sbjct: 93  --QELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ 147

Query: 343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSG 402
           +L L  N       +        LE L+L  N     +   +     L TL+L  N  + 
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK-LKTLDLSSNKLA- 204

Query: 403 FIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL-GGILPRVIG 461
           F+   F +   + W+ L +N L      L F  +     LE+F +  N    G L     
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN-----LEHFDLRGNGFHCGTLRDFFS 259

Query: 462 NLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLK 521
              +           ++    K++            +          L      +L++L 
Sbjct: 260 KNQR--------VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311

Query: 522 DNQLE 526
            +   
Sbjct: 312 HHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  132 bits (333), Expect = 6e-34
 Identities = 55/355 (15%), Positives = 110/355 (30%), Gaps = 42/355 (11%)

Query: 42  IPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS 101
           I +   N        +  + L+  +     +   ++EL L  N L+    + +   + L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG 161
            L+LS N L      ++  +L  L+TL L+ N         LL    ++TL  + N+ S 
Sbjct: 62  LLNLSSNVLYE--TLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSS 220
            +          K ++L  N++      + G  + ++ L L+ N +       +  +  +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN 280
           L  L L +N +  +    +                    L+ + LS N            
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAK----------------LKTLDLSSNKL---------- 203

Query: 281 CTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST 340
             +  E  + A +  + L+ N+L  +I   +    NLE      N          F    
Sbjct: 204 AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKN 261

Query: 341 LKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
            +   +   +   +L    +                      F      L     
Sbjct: 262 QRVQTVAKQT-VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  130 bits (330), Expect = 2e-33
 Identities = 57/267 (21%), Positives = 99/267 (37%), Gaps = 16/267 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             N++ L L  N       + L+   +L  ++LS N        ++ +++TL  L L  N
Sbjct: 33  AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNN 90

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
            +Q     EL     +E L   NN ++  +  S        N+ L+ N +T  L      
Sbjct: 91  YVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKIT-MLRDLDEG 141

Query: 121 NLPLLQTLFLDENNFDG-KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLD 179
               +Q L L  N  D             L+ L+L  N    D+  ++    KLK L L 
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLS 199

Query: 180 QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
            N+L   +  E  + A +  + L+NN L   I  ++    +L   +L  N       +D 
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257

Query: 240 HIVNRLSAELPAKFCNNIPFLEEIYLS 266
              N+    +  +    +    E   +
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECT 284

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  120 bits (302), Expect = 8e-30
 Identities = 45/320 (14%), Positives = 103/320 (32%), Gaps = 57/320 (17%)

Query: 363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
               +   ++ ++    + S   +   +  L+L  N  S            L+ L+L  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 423 YLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIP 482
            L  +  +L  LS+     L    ++NN +                              
Sbjct: 69  VLYET-LDLESLST-----LRTLDLNNNYV------------------------------ 92

Query: 483 KEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSI 542
           +E+    ++  ++   N ++    ++  + +  + + L +N++   + D           
Sbjct: 93  QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKIT-MLRDL---------- 138

Query: 543 PSTLWNLKDILCLNLSLNFFTG-PLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
                    +  L+L LN            +   L  ++L  N   DV          L+
Sbjct: 139 --DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV--VFAKLK 194

Query: 602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGE 661
            L L  N+L   +         +  ++L NN L  +I  +L    +L+  ++  N     
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCG 252

Query: 662 IPREGPFRNFSLESFKGNEL 681
             R+   +N  +++     +
Sbjct: 253 TLRDFFSKNQRVQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 29/191 (15%), Positives = 64/191 (33%), Gaps = 24/191 (12%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
           +I +   N        +  + L  ++         ++ L L  N L   I          
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS--------- 50

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD 599
               + L     +  LNLS N     L   + +L  L  +DL+ N         +     
Sbjct: 51  ---AADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPS 100

Query: 600 LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
           ++ L    N +   +  S G     K++ L+NN +  +  +       ++ +++  N+++
Sbjct: 101 IETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

Query: 660 GEIPREGPFRN 670
             +       +
Sbjct: 158 -TVNFAELAAS 167

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (353), Expect = 8e-37
 Identities = 68/277 (24%), Positives = 107/277 (38%), Gaps = 39/277 (14%)

Query: 755  NNLIGRGGFGFVYKAR-IQDGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +  IGRG F  VYK    +  +EVA              + F  E  M+K ++H NI++F
Sbjct: 31   DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 812  ISSCSSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
              S  S         LV E M  G+L K       ++ I    +    +   L++LH   
Sbjct: 91   YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 868  SVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEY 923
            + PIIH DLK +N+ +        + D G+A            +   A IG   +MAPE 
Sbjct: 149  TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAPEM 201

Query: 924  GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL 983
              E     + DVY+FG+ ++E  T + P  E       + R V       +       + 
Sbjct: 202  YEEK-YDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTS----GVKPASFDKVA 255

Query: 984  SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020
              E K  +               C  ++ +ER + K+
Sbjct: 256  IPEVKEII-------------EGCIRQNKDERYSIKD 279

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (354), Expect = 4e-36
 Identities = 76/277 (27%), Positives = 113/277 (40%), Gaps = 38/277 (13%)

Query: 758  IGRGGFGFVYKARIQ-DGMEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
            IGRG FG V+  R++ D   VAVK   +         F  E  ++K+  H NI++ I  C
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182  TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 876  LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
            L   N L+ +  V  +SDFGM++       + +       + + APE    GR S+  DV
Sbjct: 239  LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 936  YSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK-- 993
            +SFGI+L ETF+          G        N        +             FV K  
Sbjct: 299  WSFGILLWETFSL---------GASPYPNLSN-------QQTR----------EFVEKGG 332

Query: 994  -----EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                 E C   VF L  +C    P +R +   I  +L
Sbjct: 333  RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (343), Expect = 2e-35
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR---AIKSFDIECGMIKRIRHRNIIKFI 812
            +G GG   VY A      ++VA+K   +        +K F+ E     ++ H+NI+  I
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                DD   LV+EY+   +L      S+  L +   +N    +   +++ H    + I+
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEYGREGRVST 931
           H D+KP N+L+D N    + DFG+AK     + SLTQT   L T+ Y +PE  +      
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 932 NGDVYSFGIMLMETFTRKKPTDESFTGE 959
             D+YS GI+L E    + P    F GE
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FNGE 215

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  142 bits (359), Expect = 3e-35
 Identities = 82/416 (19%), Positives = 137/416 (32%), Gaps = 95/416 (22%)

Query: 76  LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
              L +  + LT T+P  +     ++ L +  NNLT     ++ +  P L+TL +  N  
Sbjct: 42  NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-----SLPALPPELRTLEVSGNQL 93

Query: 136 DGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLA 195
              +P        L   S  +      +P     L KL    +  N+L   +P     L 
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGNQLT-SLPVLPPGL- 143

Query: 196 ELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
             ++L + +N L  ++P     L  L       N LT                LP     
Sbjct: 144 --QELSVSDNQLA-SLPALPSELCKL---WAYNNQLT---------------SLPMLPSG 182

Query: 256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH 315
               L+E+ +S N             ++P     L KL   + +   L    P     L 
Sbjct: 183 ----LQELSVSDNQL----------ASLPTLPSELYKLWAYNNRLTSL----PALPSGLK 224

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
            L   I S N+L                           LP         L+EL +SGN 
Sbjct: 225 EL---IVSGNRL-------------------------TSLPVL----PSELKELMVSGNR 252

Query: 376 FSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
            + ++P      S L +L + RN  +  +P +  +L +   ++L  N L+  T +     
Sbjct: 253 LT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307

Query: 436 SSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNL 491
           +S   Y     I  +  G   PR    L  +  D+ +P      +     +     
Sbjct: 308 TSAPGYSGPI-IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  135 bits (341), Expect = 4e-33
 Identities = 65/373 (17%), Positives = 116/373 (31%), Gaps = 72/373 (19%)

Query: 25  CKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN 84
                 +++  +  + T+P  +     +  L +  N L   +P     L     L +  N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGN 91

Query: 85  FLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS-------------NLPLLQTLFLD 131
            LT ++P     L  LS     + +L   L + +C                P LQ L + 
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVS 149

Query: 132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
           +N     +P+       L  L    N  +  +P     L +L    +  N+L   +P   
Sbjct: 150 DNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLP 200

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPA 251
             L    KL   NN LT ++P      S L +L +S N LT                LP 
Sbjct: 201 SEL---YKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT---------------SLPV 238

Query: 252 KFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT-----------IPKEIGNLAKLEKLDLQF 300
                   L+E+ +S N     +P                  +P+ + +L+    ++L+ 
Sbjct: 239 LPSE----LKELMVSGNRL-TSLPMLPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEG 293

Query: 301 NRLQCVIPHEIDNLHNLEWM---IFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS 357
           N L       +  + +       I  F+      P     +      +L         P+
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

Query: 358 SADVRLPNLEELS 370
                    +   
Sbjct: 354 DRWHMFGQEDNAD 366

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (320), Expect = 2e-30
 Identities = 73/332 (21%), Positives = 132/332 (39%), Gaps = 53/332 (15%)

Query: 339 STLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRN 398
           +    L +G +     LP        ++  L +  NN + ++P+      +L TLE+  N
Sbjct: 40  NGNAVLNVGESGL-TTLPDCL---PAHITTLVIPDNNLT-SLPALP---PELRTLEVSGN 91

Query: 399 SFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPR 458
             +  +P     L  L        +L +  S L  L            I  N L   LP 
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLW-----------IFGNQLTS-LPV 138

Query: 459 VIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLL 518
           +   L    ++  + ++ ++ S+P   + L  L   +   N+L  S+ +    L++L   
Sbjct: 139 LPPGL----QELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQEL--- 186

Query: 519 SLKDNQLEGSIPDNLS-------FSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG 571
           S+ DNQL  S+P   S       ++  LTS+P+    LK+   L +S N  T  LP+   
Sbjct: 187 SVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKE---LIVSGNRLTS-LPVLPS 241

Query: 572 NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
            LK L    +S N  +  +P    GL     L +  N+L   +P+S+  + +  ++NL  
Sbjct: 242 ELKEL---MVSGNRLTS-LPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 632 NNLFGIIPISLEKLLDLKDINVSFNKLEGEIP 663
           N L      +L ++      +    + +    
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (320), Expect = 2e-30
 Identities = 75/355 (21%), Positives = 122/355 (34%), Gaps = 55/355 (15%)

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
                  L++  +  + T+P  +     ++TL +  N+ +  +P     LR    L++  
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSG 90

Query: 422 NYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSI 481
           N LTS               L  FS         LP +   L        +  + ++ S+
Sbjct: 91  NQLTSLPVLP-----PGLLELSIFSNPLTH----LPALPSGL----CKLWIFGNQLT-SL 136

Query: 482 PKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLS------- 534
           P     L  L    +  N+L  S+     +L KL      +NQL  S+P   S       
Sbjct: 137 PVLPPGLQEL---SVSDNQLA-SLPALPSELCKLWAY---NNQLT-SLPMLPSGLQELSV 188

Query: 535 FSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI 594
               L S+P+    L  +   N  L      LP     LK L    +S N  +  +P   
Sbjct: 189 SDNQLASLPTLPSELYKLWAYNNRLTS----LPALPSGLKEL---IVSGNRLTS-LPVLP 240

Query: 595 GGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVS 654
               +L+ L +  NRL  S+P        L SL++  N L   +P SL  L     +N+ 
Sbjct: 241 S---ELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQL-TRLPESLIHLSSETTVNLE 292

Query: 655 FNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKNDLLIG 709
            N L  E   +      S   + G   +         + R       +  D L+ 
Sbjct: 293 GNPLS-ERTLQALREITSAPGYSGP--IIRFDMAGASAPRETRALHLAAADWLVP 344

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 98.8 bits (246), Expect = 3e-21
 Identities = 41/245 (16%), Positives = 82/245 (33%), Gaps = 33/245 (13%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            S L  L++  N     +P        L+ +S+S N  + ++P     +  L       N
Sbjct: 120 PSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLPALPSELCKL---WAYNN 171

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGEL------ 114
           +L   +P     L   +EL + +N L  ++P+    L  L   +  + +L          
Sbjct: 172 QLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKEL 226

Query: 115 ------LANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIG 168
                 L ++      L+ L +  N     +P        L +LS+  N  +  +P+ + 
Sbjct: 227 IVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLI 281

Query: 169 NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN---FLTGTIPPSIFNLSSLSDLE 225
           +L+    ++L+ N L     + L  +                  + P     L   +   
Sbjct: 282 HLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341

Query: 226 LSFNS 230
           L    
Sbjct: 342 LVPAR 346

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  135 bits (341), Expect = 5e-35
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 19/210 (9%)

Query: 757 LIGRGGFGFVYKARIQD---GMEVAVKVFDLQYGR---AIKSFDIECGMIKRIRHRNIIK 810
           L+GRGG G VY+A   D      VA+K+                 E     R++  +++ 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                  D    + +  +    L   L      L   + + I+  + SAL+  H   +  
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEYGREGRV 929
             H D+KP N+L+  +  A+L DFG+A      D+ LTQ    + T+ YMAPE   E   
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 930 STNGDVYSFGIMLMETFTRKKPTDESFTGE 959
           +   D+Y+   +L E  T   P    + G+
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGD 238

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  134 bits (339), Expect = 1e-34
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 61/296 (20%)

Query: 758  IGRGGFGFVYKARIQDG----MEVAVKVF--DLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G+G FG V +A+++      ++VAVK+   D+     I+ F  E   +K   H ++ K 
Sbjct: 31   LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 812  ISSCSSDDFKA------LVLEYMPYGSLEKCLYSS-----NYILDIFQRLNIMIDVASAL 860
            +        K       ++L +M +G L   L +S      + L +   +  M+D+A  +
Sbjct: 91   VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 861  EYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
            EYL   +F      IH DL   N +L ++M   ++DFG+++     D       +   + 
Sbjct: 151  EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 918  YMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIME 976
            ++A E   +   + + DV++FG+ + E  TR + P    + G             I   E
Sbjct: 205  WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAG-------------IENAE 247

Query: 977  VVDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +           +++          +CM  V++L  +C    P++R +   +  +L
Sbjct: 248  IY----------NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  133 bits (336), Expect = 2e-34
 Identities = 63/281 (22%), Positives = 115/281 (40%), Gaps = 25/281 (8%)

Query: 758  IGRGGFGFVYKAR-----IQDGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNII 809
            +G G FG V   R        G +VAVK   L+       I     E  +++ + H NI+
Sbjct: 29   LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 810  KFISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
            K+   C+ D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    
Sbjct: 87   KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGR 925
            S   +H DL   NVL++      + DFG+ K  ++ D+     +      + + APE   
Sbjct: 144  SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 926  EGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
            + +     DV+SFG+ L E  T     +         +      + +  ++  +      
Sbjct: 203  QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK----- 257

Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             E K       C   V+ L  KC    P  R + + ++   
Sbjct: 258  -EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  132 bits (334), Expect = 2e-34
 Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 46/279 (16%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            IG G FG V+     +  +VA+K   ++ G  + + F  E  ++ ++ H  +++    C 
Sbjct: 16   IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPIIH 873
                  LV E+M +G L   L +   +      L + +DV   + YL           IH
Sbjct: 74   EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IH 127

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
             DL   N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+  
Sbjct: 128  RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            DV+SFG+++ E F+          G++  +   N        EVV            ++ 
Sbjct: 187  DVWSFGVLMWEVFSE---------GKIPYENRSN-------SEVV----------EDIST 220

Query: 994  -------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                       + V+ +   C  E PE+R     ++ +L
Sbjct: 221  GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  133 bits (336), Expect = 2e-34
 Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 60/295 (20%)

Query: 758  IGRGGFGFVYKARIQDG----MEVAVKV--FDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V +  ++      ++VAVK    D    R I+ F  E   +K   H N+I+ 
Sbjct: 42   LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 812  ISSCSSDDFKA-----LVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALE 861
            +  C     +      ++L +M YG L        L +    + +   L  M+D+A  +E
Sbjct: 102  LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 862  YL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            YL   +F      +H DL   N +L D+M   ++DFG++K     D           + +
Sbjct: 162  YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            +A E   +   ++  DV++FG+ + E  TR   P    + G             +   E+
Sbjct: 216  IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP----YPG-------------VQNHEM 258

Query: 978  VDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                        ++         E C+  ++ +   C    P +R     +  +L
Sbjct: 259  Y----------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (335), Expect = 2e-34
 Identities = 63/289 (21%), Positives = 118/289 (40%), Gaps = 52/289 (17%)

Query: 756  NLIGRGGFGFVYKARIQDG----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
             +IGRG FG VY   + D     +  AVK  +       +  F  E  ++K   H N++ 
Sbjct: 31   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 811  FISSCSSDDFKAL-VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 866
             +  C   +   L VL YM +G L   + +  +   +   +   + VA  ++YL    F 
Sbjct: 91   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED--QSLTQTQTLATIGYMAPEYG 924
                 +H DL   N +LD+     ++DFG+A+    ++      +T     + +MA E  
Sbjct: 150  -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 925  REGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL 983
            +  + +T  DV+SFG++L E  TR   P    +               ++  ++      
Sbjct: 205  QTQKFTTKSDVWSFGVLLWELMTRGAPP----YPD-------------VNTFDIT----- 242

Query: 984  SHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                  ++ +       E C   ++ + +KC     E R +  E+V+++
Sbjct: 243  -----VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  133 bits (336), Expect = 3e-34
 Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 23/280 (8%)

Query: 758  IGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+G FG V   R        G  VAVK         ++ F+ E  ++K ++H NI+K+ 
Sbjct: 49   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 813  SSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              C S   +   L++EY+PYGSL   L      +D  + L     +   +EYL    +  
Sbjct: 109  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGREGR 928
             IH DL   N+L+++     + DFG+ K  L +D+   + +      I + APE   E +
Sbjct: 166  YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 929  VSTNGDVYSFGIMLMETFT---RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
             S   DV+SFG++L E FT   + K     F   +   +       + +  +++  LL  
Sbjct: 225  FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ----MIVFHLIE--LLK- 277

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +      + C   ++ +  +C   +  +R + +++  ++
Sbjct: 278  NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  131 bits (332), Expect = 5e-34
 Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 23/280 (8%)

Query: 758  IGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+G FG V   R        G  VAVK         ++ F+ E  ++K ++H NI+K+ 
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 813  SSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              C S   +   L++EY+PYGSL   L      +D  + L     +   +EYL    +  
Sbjct: 78   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGREGR 928
             IH DL   N+L+++     + DFG+ K  L +D+   + +      I + APE   E +
Sbjct: 135  YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 929  VSTNGDVYSFGIMLMETFT---RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
             S   DV+SFG++L E FT   + K     F   +   +       + +  +++   L  
Sbjct: 194  FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ----MIVFHLIE---LLK 246

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +      + C   ++ +  +C   +  +R + +++  ++
Sbjct: 247  NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (342), Expect = 6e-34
 Identities = 66/278 (23%), Positives = 121/278 (43%), Gaps = 40/278 (14%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
              +G+G FG V+         VA+K        + ++F  E  ++K++RH  +++  +  
Sbjct: 190  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 249  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 875  DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
            DL+  N+L+ +N+V  ++DFG+A+  +++++   +      I + APE    GR +   D
Sbjct: 305  DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK- 993
            V+SFGI+L E  T+         G +     VN                  E    V + 
Sbjct: 364  VWSFGILLTELTTK---------GRVPYPGMVN-----------------REVLDQVERG 397

Query: 994  ------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                   +C   + +L  +C  + PEER   + +   L
Sbjct: 398  YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  138 bits (349), Expect = 7e-34
 Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 32/214 (14%)

Query: 757 LIGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGR---AIKSFDIECGMIKRIRHRNIIK- 810
            I  GG G++Y A     +G  V +K   L +     A      E   +  + H +I++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 811 --FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
             F+            +V+EY+   SL++        L + + +  ++++  AL YLH  
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH-- 199

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEYGR 925
            S+ +++ DLKP N++L +  +  L D G           +        T G+ APE  R
Sbjct: 200 -SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVR 250

Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
               +   D+Y+ G  L               G 
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  131 bits (331), Expect = 1e-33
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 17/212 (8%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR---AIKSFDIECGMIKRIRHRNIIKFI 812
           ++G GG   V+ AR ++D  +VAVKV      R       F  E      + H  I+   
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 813 SSCSSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            +  ++        +V+EY+   +L + +  +   +   + + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH---Q 134

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT-LATIGYMAPEYGREG 927
             IIH D+KP N+++       + DFG+A+       S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 928 RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
            V    DVYS G +L E  T + P    FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (335), Expect = 1e-33
 Identities = 63/289 (21%), Positives = 119/289 (41%), Gaps = 52/289 (17%)

Query: 756  NLIGRGGFGFVYKARIQDG----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIK 810
             +IGRG FG VY   + D     +  AVK  +       +  F  E  ++K   H N++ 
Sbjct: 95   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 811  FISSCSSDDFKAL-VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 866
             +  C   +   L VL YM +G L   + +  +   +   +   + VA  +++L    F 
Sbjct: 155  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYG 924
                 +H DL   N +LD+     ++DFG+A+    ++      +T A   + +MA E  
Sbjct: 214  -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 925  REGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL 983
            +  + +T  DV+SFG++L E  TR   P    +               ++  ++      
Sbjct: 269  QTQKFTTKSDVWSFGVLLWELMTRGAPP----YPD-------------VNTFDIT----- 306

Query: 984  SHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                  ++ +       E C   ++ + +KC     E R +  E+V+++
Sbjct: 307  -----VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (343), Expect = 1e-33
 Identities = 67/278 (24%), Positives = 123/278 (44%), Gaps = 40/278 (14%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
              +G+G FG V+         VA+K        + ++F  E  ++K++RH  +++  +  
Sbjct: 273  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 332  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 875  DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
            DL+  N+L+ +N+V  ++DFG+A+  +++++   +      I + APE    GR +   D
Sbjct: 388  DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK- 993
            V+SFGI+L E  T+         G +     VN        EV+            V + 
Sbjct: 447  VWSFGILLTELTTK---------GRVPYPGMVN-------REVL----------DQVERG 480

Query: 994  ------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                   +C   + +L  +C  + PEER   + +   L
Sbjct: 481  YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  130 bits (328), Expect = 2e-33
 Identities = 59/279 (21%), Positives = 117/279 (41%), Gaps = 46/279 (16%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCS 816
            +G G FG V   + +   +VA+K+  ++ G  +   F  E  ++  + H  +++    C+
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPIIH 873
                  ++ EYM  G L   L    +     Q L +  DV  A+EYL    F      +H
Sbjct: 90   KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LH 143

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
             DL   N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+  
Sbjct: 144  RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            D+++FG+++ E ++          G+M  +R+ N        E              +A+
Sbjct: 203  DIWAFGVLMWEIYSL---------GKMPYERFTNS-------ETA----------EHIAQ 236

Query: 994  -------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                         V+ +   C  E  +ER   K +++ +
Sbjct: 237  GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  130 bits (330), Expect = 2e-33
 Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 20/278 (7%)

Query: 758  IGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+G FG V   R        G  VAVK          + F  E  ++K +    I+K+ 
Sbjct: 31   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 813  SSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                    ++  LV+EY+P G L   L      LD  + L     +   +EYL    S  
Sbjct: 91   GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGREGR 928
             +H DL   N+L++      ++DFG+AK  L  D+     +      I + APE   +  
Sbjct: 148  CVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206

Query: 929  VSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
             S   DV+SFG++L E FT   K    S      +    +   L  ++E+++      E 
Sbjct: 207  FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE------EG 260

Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +   A   C + V  L   C   SP++R +   +  +L
Sbjct: 261  QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  129 bits (327), Expect = 2e-33
 Identities = 62/291 (21%), Positives = 119/291 (40%), Gaps = 52/291 (17%)

Query: 754  ENNLIGRGGFGFVYKARIQDG----MEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNI 808
             + +IG+G FG VY     D     ++ A+K    +   + +++F  E  +++ + H N+
Sbjct: 25   SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 809  IKFISSCSSDD-FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---H 864
            +  I      +    ++L YM +G L + + S      +   ++  + VA  +EYL    
Sbjct: 85   LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 865  FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED--QSLTQTQTLATIGYMAPE 922
            F      +H DL   N +LD++    ++DFG+A+  L  +             + + A E
Sbjct: 145  F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 923  YGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
              +  R +T  DV+SFG++L E  TR   P    +               I   ++    
Sbjct: 199  SLQTYRFTTKSDVWSFGVLLWELLTRGAPP----YRH-------------IDPFDLT--- 238

Query: 982  LLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                   HF+A+       E C   ++ +  +C    P  R   + +V ++
Sbjct: 239  -------HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  129 bits (326), Expect = 3e-33
 Identities = 61/279 (21%), Positives = 116/279 (41%), Gaps = 40/279 (14%)

Query: 758  IGRGGFGFVYKARIQDG---MEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIKF 811
            +G G FG V +   +     ++VA+KV  L+ G           E  ++ ++ +  I++ 
Sbjct: 18   LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 868
            I  C ++    LV+E    G L K L      + +     ++  V+  ++YL   +F   
Sbjct: 76   IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H DL   NVLL +   A +SDFG++K  L  D S    ++     + + APE    
Sbjct: 132  ---VHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + S+  DV+S+G+ + E  +          G+   K+         +M  ++      +
Sbjct: 188  RKFSSRSDVWSYGVTMWEALSY---------GQKPYKKMKGP----EVMAFIE------Q 228

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             K      +C   ++ L   C I   E+R +   +  ++
Sbjct: 229  GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (323), Expect = 5e-33
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 46/279 (16%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCS 816
            +G G FG V   + +   +VAVK+  ++ G   +  F  E   + ++ H  ++KF   CS
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKM--IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 817  SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPIIH 873
             +    +V EY+  G L   L S    L+  Q L +  DV   + +L    F      IH
Sbjct: 74   KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IH 127

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
             DL   N L+D ++   +SDFGM + ++ +DQ ++   T   + + APE     + S+  
Sbjct: 128  RDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            DV++FGI++ E F+          G+M    + N        EVV            V++
Sbjct: 187  DVWAFGILMWEVFSL---------GKMPYDLYTN-------SEVV----------LKVSQ 220

Query: 994  -------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                         ++ +   C  E PE+R   +++++ +
Sbjct: 221  GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  129 bits (327), Expect = 5e-33
 Identities = 77/358 (21%), Positives = 131/358 (36%), Gaps = 70/358 (19%)

Query: 75  ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN 134
            L  +   +  L   +P  +      + LDL  N +T E+      NL  L TL L  N 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87

Query: 135 FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNL 194
                              +S   F+         L KL+ L+L +N+L+ E+PE++   
Sbjct: 88  IS----------------KISPGAFAP--------LVKLERLYLSKNQLK-ELPEKM--P 120

Query: 195 AELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF 253
             L++L++  N +T  +  S+F  L+ +  +EL  N L              S+ +    
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK-------------SSGIENGA 166

Query: 254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDN 313
              +  L  I ++       IP  L              L +L L  N++  V    +  
Sbjct: 167 FQGMKKLSYIRIADTNI-TTIPQGL-----------PPSLTELHLDGNKITKVDAASLKG 214

Query: 314 LHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSG 373
           L+NL  +  SFN +  V   ++ N   L+ L+L +N                ++ + L  
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGGLADHKYIQVVYLHN 272

Query: 374 NNFSGTIPSFIF-------NTSKLSTLELQRN--SFSGFIPNTFGNLRNLKWLDLGDN 422
           NN S  I S  F         +  S + L  N   +    P+TF  +     + LG+ 
Sbjct: 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  124 bits (313), Expect = 4e-31
 Identities = 62/305 (20%), Positives = 105/305 (34%), Gaps = 30/305 (9%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK 61
            +   L L++N           N K L  + L  N  S   P     +  L  L+L  N+
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111

Query: 62  LQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELL-ANIC 119
           L+ E+PE++     L+EL +  N +T  +  S+F  L+ +  ++L  N L    +     
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167

Query: 120 SNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHL 178
             +  L  + + + N    IP  L     L  L L  N  +  +       L  L  L L
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKIT-KVDAASLKGLNNLAKLGL 223

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKD 238
             N +       L N   L +L L NN L   +P  + +   +  + L  N+++     +
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSN 281

Query: 239 MHIVNRLSAELPAKFCNNIPFLEEIYLSKNMF-YGEIPSDLGNCTIPKEIGNLAKLEKLD 297
                      P  +         + L  N   Y EI      C        +     + 
Sbjct: 282 --------DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC--------VYVRAAVQ 325

Query: 298 LQFNR 302
           L   +
Sbjct: 326 LGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  112 bits (283), Expect = 3e-27
 Identities = 67/362 (18%), Positives = 118/362 (32%), Gaps = 76/362 (20%)

Query: 276 SDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTI 335
           SDLG   +PK++        LDLQ N++  +   +  NL NL  +I   NK+  + P   
Sbjct: 39  SDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 96

Query: 336 FNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLE 394
             +  L+ LYL  N     LP         L+EL +  N  +  +   +F   +++  +E
Sbjct: 97  APLVKLERLYLSKNQL-KELPEKM---PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVE 151

Query: 395 LQRNSF--SGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
           L  N    SG     F  ++ L ++ + D  +T+       +       L    +  N +
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-------IPQGLPPSLTELHLDGNKI 204

Query: 453 GGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKL 512
             +                                L NL  + L  N ++     +L   
Sbjct: 205 TKV----------DAASL---------------KGLNNLAKLGLSFNSISAVDNGSLANT 239

Query: 513 KKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGN 572
             L+ L L +N+L                +P  L + K I  + L  N  +         
Sbjct: 240 PHLRELHLNNNKL--------------VKVPGGLADHKYIQVVYLHNNNIS--------- 276

Query: 573 LKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSI--PDSIGDMINLKSLNLS 630
                    +I +     P           + L  N +Q     P +   +    ++ L 
Sbjct: 277 ---------AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327

Query: 631 NN 632
           N 
Sbjct: 328 NY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  107 bits (270), Expect = 2e-25
 Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 22/241 (9%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
           L  LE L+L  N    ++P  +   K L+ + +  N+ +  + K +   +  +I + L  
Sbjct: 99  LVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGT 154

Query: 60  NKLQ-GEIPEE-LGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLAN 117
           N L+   I       + +L  + + +  +T TIP  +    SL+ L L  N +T ++ A 
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAA 210

Query: 118 ICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLH 177
               L  L  L L  N+       +L    HL+ L L+ N     +P  + +   ++ ++
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269

Query: 178 LDQNRLQGEIPEE-------LGNLAELEKLQLQNNFLTGT-IPPSIF-NLSSLSDLELSF 228
           L  N +   I              A    + L +N +    I PS F  +   + ++L  
Sbjct: 270 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328

Query: 229 N 229
            
Sbjct: 329 Y 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 63/314 (20%), Positives = 126/314 (40%), Gaps = 36/314 (11%)

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
           +L  +  S       +P  +      + L+LQ N  +      F NL+NL  L L +N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 425 TSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKE 484
           +  +   +F        LE   +S N L  +       + +++++  +  + I+  + K 
Sbjct: 89  SKISPG-AFAPLVK---LERLYLSKNQLKELPE----KMPKTLQELRVHENEIT-KVRKS 139

Query: 485 I-NNLTNLIAIYLGVNKLNGSILI--ALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT--- 538
           + N L  +I + LG N L  S +   A   +KKL  + + D  +  +IP  L  S T   
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELH 198

Query: 539 -----LTSIPS-TLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPT 592
                +T + + +L  L ++  L LS N  +      + N   L ++ L+ N     +P 
Sbjct: 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257

Query: 593 TIGGLKDLQYLFLKYNRLQGSIPDS-------IGDMINLKSLNLSNNNL--FGIIPISLE 643
            +   K +Q ++L  N +  +I  +            +   ++L +N +  + I P +  
Sbjct: 258 GLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316

Query: 644 KLLDLKDINVSFNK 657
            +     + +   K
Sbjct: 317 CVYVRAAVQLGNYK 330

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  129 bits (326), Expect = 5e-33
 Identities = 68/282 (24%), Positives = 120/282 (42%), Gaps = 29/282 (10%)

Query: 758  IGRGGFGFVYKARIQD-----GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V            G  VAVK      G +    +  E  +++ + H +IIK+
Sbjct: 39   LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 812  ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
               C      +  LV+EY+P GSL   L   +  + + Q L     +   + YLH   + 
Sbjct: 99   KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGREG 927
              IH DL   NVLLD++ +  + DFG+AK  + E     + +      + + APE  +E 
Sbjct: 154  HYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 928  RVSTNGDVYSFGIMLMETFT---RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
            +     DV+SFG+ L E  T     +     F   + + +       ++++ + +  LL 
Sbjct: 213  KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ-----MTVLRLTE--LL- 264

Query: 985  HEDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             E    + + ++C + V++L   C       R   + ++  L
Sbjct: 265  -ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (326), Expect = 8e-33
 Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 14/234 (5%)

Query: 723 KSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV 781
             +  D    L+  + +    E  +  +  +    +GRG FG V++ +  Q G + AVK 
Sbjct: 31  GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK 90

Query: 782 FDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN 841
             L+          E      +    I+    +     +  + +E +  GSL + +    
Sbjct: 91  VRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145

Query: 842 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPF 900
             L   + L  +      LEYLH   +  I+H D+K +NVLL  +   A L DFG A   
Sbjct: 146 -CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 901 LKEDQSLTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
             +    +        G   +MAPE           D++S   M++       P
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (321), Expect = 1e-32
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           ++G+G +G VY  R + + + +A+K    +  R  +    E  + K ++H+NI++++ S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLHFGYSVPIIH 873
           S + F  + +E +P GSL   L S    L   ++        +   L+YLH      I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 874 CDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPE---YGREGR 928
            D+K +NVL++  + V  +SDFG +K   +       T+T   T+ YMAPE    G  G 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 929 VSTNGDVYSFGIMLMETFTRKKP 951
                D++S G  ++E  T K P
Sbjct: 203 -GKAADIWSLGCTIIEMATGKPP 224

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  128 bits (323), Expect = 1e-32
 Identities = 56/263 (21%), Positives = 95/263 (36%), Gaps = 35/263 (13%)

Query: 721 GGKSQLNDANMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAV 779
            G+  L      ++ + + + +++             +G GGF +V     + DG   A+
Sbjct: 12  SGRENLYFQGHMVIIDNKHYLFIQK------------LGEGGFSYVDLVEGLHDGHFYAL 59

Query: 780 KVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA----LVLEYMPYGSLEK 835
           K       +  +    E  M +   H NI++ ++ C  +        L+L +   G+L  
Sbjct: 60  KRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119

Query: 836 CLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 892
            +         L   Q L +++ +   LE +H   +    H DLKP N+LL D     L 
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLM 176

Query: 893 DFGMAKPFLKEDQSLTQTQTLA-------TIGYMAPE----YGREGRVSTNGDVYSFGIM 941
           D G         +   Q  TL        TI Y APE          +    DV+S G +
Sbjct: 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCV 235

Query: 942 LMETFTRKKPTDESFTGEMTLKR 964
           L      + P D  F    ++  
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVAL 258

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  131 bits (331), Expect = 1e-32
 Identities = 65/278 (23%), Positives = 121/278 (43%), Gaps = 40/278 (14%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
              +G G FG V+ A      +VAVK        ++++F  E  ++K ++H  ++K  +  
Sbjct: 194  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            + +    ++ E+M  GSL   L S       + + ++    +A  + ++        IH 
Sbjct: 253  TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 875  DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
            DL+  N+L+  ++V  ++DFG+A+  +++++   +      I + APE    G  +   D
Sbjct: 309  DLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK- 993
            V+SFGI+LME  T          G +      N        EV+ A          + + 
Sbjct: 368  VWSFGILLMEIVTY---------GRIPYPGMSN-------PEVIRA----------LERG 401

Query: 994  ------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                  E C   ++N+ M+C    PEER   + I + L
Sbjct: 402  YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  128 bits (324), Expect = 1e-32
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 21/206 (10%)

Query: 758 IGRGGFGFVYKARIQDGME-----VAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNII 809
           +G G FG VYK       E     VA+K   L+     +A K    E  ++  + + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 866
           + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL      
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
                +H DL   NVL+       ++DFG+AK    E++          I +MA E    
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 927 GRVSTNGDVYSFGIMLMETFTR-KKP 951
              +   DV+S+G+ + E  T   KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  132 bits (333), Expect = 2e-32
 Identities = 88/489 (17%), Positives = 165/489 (33%), Gaps = 28/489 (5%)

Query: 42  IPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSL 100
           +PK++   TT   L++  N +      ++ +L++L  L + +N +   +  S+F     L
Sbjct: 15  VPKDLSQKTT--ILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71

Query: 101 SNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDG-KIPSTLLRCKHLQTLSLSINDF 159
             LDLS N L        C     L+ L L  N FD   I         L+ L LS    
Sbjct: 72  EYLDLSHNKLV----KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127

Query: 160 SGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLS 219
                  I +L     + L      GE  E+   L +     L   F T      I ++S
Sbjct: 128 EKSSVLPIAHLNIS-KVLLVLGETYGE-KEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185

Query: 220 SLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLG 279
             +   L  +++      +                     L  + L+           + 
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP----KLSNLTLNNIETTWNSFIRIL 241

Query: 280 NCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNV- 338
                  +     +  + LQ         +   +L  L       +   G   + I+ + 
Sbjct: 242 QLVWHTTVWYF-SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIF 299

Query: 339 STLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRN 398
           S +       +     +      ++     L  S N  + T+     + ++L TL LQ N
Sbjct: 300 SNMNIKNFTVSG-TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 399 SFS--GFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGIL 456
                  I      +++L+ LD+  N ++    +     + +   L   ++S+N L   +
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS---LLSLNMSSNILTDTI 415

Query: 457 PRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQ 516
            R    L   ++   + ++ I  SIPK++  L  L  + +  N+L         +L  LQ
Sbjct: 416 FR---CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQ 471

Query: 517 LLSLKDNQL 525
            + L  N  
Sbjct: 472 KIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  130 bits (329), Expect = 5e-32
 Identities = 96/508 (18%), Positives = 191/508 (37%), Gaps = 58/508 (11%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSL 221
           +PK++    K   L++ QN +      ++ +L++L  L + +N +   +  S+F     L
Sbjct: 15  VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71

Query: 222 SDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC 281
             L+LS N L                ++    C+    L+ + LS N F   +P      
Sbjct: 72  EYLDLSHNKLV---------------KIS---CHPTVNLKHLDLSFNAF-DALP------ 106

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTL 341
            I KE GN+++L+ L L    L+      I +L+  + ++                    
Sbjct: 107 -ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNT 165

Query: 342 KFLYLG--SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRN- 398
           + L++   +N  F  +   +   + NLE  ++           F+   +KL T     N 
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225

Query: 399 --SFSGFIPNTFGNLRNLKW------LDLGDNYLTSS-TSELSFLSSSNCKYLEYFSISN 449
             +      N+F  +  L W        + +  L           S ++ K L    + +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 450 NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIAL 509
           +  G     +    S  M   +   S          + ++  + +    N L  ++    
Sbjct: 286 DVFGFPQSYIYEIFSN-MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344

Query: 510 GKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLE 569
           G L +L+ L L+ NQL+            L+ I      +K +  L++S N  +      
Sbjct: 345 GHLTELETLILQMNQLK-----------ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393

Query: 570 I-GNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN 628
                K L+ +++S N  +D I   +     ++ L L  N+++ SIP  +  +  L+ LN
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450

Query: 629 LSNNNLFGIIPISLEKLLDLKDINVSFN 656
           +++N L  +     ++L  L+ I +  N
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  128 bits (324), Expect = 3e-31
 Identities = 95/564 (16%), Positives = 179/564 (31%), Gaps = 94/564 (16%)

Query: 55  LHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGEL 114
           +    N L   +P++L    +   L +  N+++    S I +LS L  L +S N +   L
Sbjct: 5   VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YL 60

Query: 115 LANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDF-SGDIPKEIGNLTKL 173
             ++      L+ L L  N    KI        +L+ L LS N F +  I KE GN+++L
Sbjct: 61  DISVFKFNQELEYLDLSHNKL-VKISCHPT--VNLKHLDLSFNAFDALPICKEFGNMSQL 117

Query: 174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTG 233
           K+L L    L+      + +L   + L +          P      +   L + F +   
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT--- 174

Query: 234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
                    N+    +       +  LE   +   +   +    L      +    L+ L
Sbjct: 175 ---------NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS-----TLKFLYLGS 348
              +++      +   ++     + +   S  KL G +    F+ S      L    + S
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTF 408
           + F     S       N+   + + +             S    L+   N  +  +    
Sbjct: 286 DVFGF-PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344

Query: 409 GNLRNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSM 467
           G+L  L+ L L  N L   S          +   L+   IS N +               
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKS---LQQLDISQNSVSYDEK---------- 391

Query: 468 EDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEG 527
                           + +   +L+++ +  N L  +I   L    ++++L L  N++  
Sbjct: 392 --------------KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-- 433

Query: 528 SIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFS 587
                        SIP  +  L+                      L+ L   +++ N   
Sbjct: 434 ------------KSIPKQVVKLE---------------------ALQEL---NVASNQLK 457

Query: 588 DVIPTTIGGLKDLQYLFLKYNRLQ 611
            V       L  LQ ++L  N   
Sbjct: 458 SVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  124 bits (312), Expect = 7e-30
 Identities = 81/456 (17%), Positives = 157/456 (34%), Gaps = 53/456 (11%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDF-SGTIPKEIGNVTTLIGLHLRG 59
              LEYL L  N           N   L+++ LS N F +  I KE GN++ L  L L  
Sbjct: 68  NQELEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTI-PSSIFNLSSLSNLDLSVNNLTGELLANI 118
             L+      + +L   + L +          P  + + ++ S   +   N     + ++
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184

Query: 119 CSNLP-------LLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNL- 170
                       +   L  ++ ++   I + L     L  L+L+  + + +    I  L 
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244

Query: 171 --TKLKYLHLDQNRLQGEIPEELGNLA-----ELEKLQLQNNFLTGTIPPSIFN-LSSLS 222
             T + Y  +   +LQG++     + +      L   Q+ ++         I+   S+++
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMN 303

Query: 223 DLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT 282
               + +                   +     + I     +  S N+      +D     
Sbjct: 304 IKNFTVSGTR---------------MVHMLCPSKISPFLHLDFSNNLL-----TDT---- 339

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCV--IPHEIDNLHNLEWMIFSFNKLVGVVPTTIF-NVS 339
           + +  G+L +LE L LQ N+L+ +  I      + +L+ +  S N +             
Sbjct: 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399

Query: 340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNS 399
           +L  L + SN       +      P ++ L L  N    +IP  +     L  L +  N 
Sbjct: 400 SLLSLNMSSNIL---TDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455

Query: 400 FSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
                   F  L +L+ + L  N    S   + +LS
Sbjct: 456 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 491

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 94.9 bits (236), Expect = 2e-20
 Identities = 67/373 (17%), Positives = 118/373 (31%), Gaps = 25/373 (6%)

Query: 296 LDLQFNRLQCV---IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFF 352
           +D   N L  V   +  +   L+       S N +  +  + I ++S L+ L +  N   
Sbjct: 5   VDRSKNGLIHVPKDLSQKTTILN------ISQNYISELWTSDILSLSKLRILIISHNRI- 57

Query: 353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGF-IPNTFGNL 411
             L  S       LE L LS N     I      T  L  L+L  N+F    I   FGN+
Sbjct: 58  QYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNM 114

Query: 412 RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFH 471
             LK+L L   +L  S   +  ++  N   +    +         P  + + +       
Sbjct: 115 SQLKFLGLSTTHLEKS--SVLPIAHLNISKVLL-VLGETYGEKEDPEGLQDFNTESLHIV 171

Query: 472 MPNSNISGSIPKEINNLT-----NLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLE 526
            P +     I             + I   L  NK +  + I        +L +L  N + 
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI- 230

Query: 527 GSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNF 586
                N           +T+W    I  + L              +LK L    +  + F
Sbjct: 231 -ETTWNSFIRILQLVWHTTVWYF-SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288

Query: 587 SDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLL 646
                       ++       +  +         +     L+ SNN L   +  +   L 
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT 348

Query: 647 DLKDINVSFNKLE 659
           +L+ + +  N+L+
Sbjct: 349 ELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.3 bits (133), Expect = 6e-08
 Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 4/91 (4%)

Query: 580 DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIP 639
           ++S N  S++  + I  L  L+ L + +NR+Q            L+ L+LS+N L     
Sbjct: 27  NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK--- 83

Query: 640 ISLEKLLDLKDINVSFNKLEGEIPREGPFRN 670
           IS    ++LK +++SFN  +  +P    F N
Sbjct: 84  ISCHPTVNLKHLDLSFNAFD-ALPICKEFGN 113

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  126 bits (320), Expect = 2e-32
 Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 52/285 (18%)

Query: 758  IGRGGFGFVYKARIQDG---MEVAVKVF--DLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G G FG V K   Q       VAVK+   +            E  +++++ +  I++ I
Sbjct: 25   LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 869
              C ++ +  LV+E    G L K L  + + +     + ++  V+  ++YL   +F    
Sbjct: 85   GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGREG 927
              +H DL   NVLL     A +SDFG++K  L+ D++  + QT     + + APE     
Sbjct: 139  --VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 195

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
            + S+  DV+SFG+++ E F+          G+   +            EV          
Sbjct: 196  KFSSKSDVWSFGVLMWEAFSY---------GQKPYRGMKG-------SEVT--------- 230

Query: 988  KHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
               + K         C   +++L   C     E R     +  +L
Sbjct: 231  -AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  131 bits (330), Expect = 3e-32
 Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 9/195 (4%)

Query: 756 NLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFIS 813
           + +G G +G VY+   +   + VAVK   L+     ++ F  E  ++K I+H N+++ + 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPII 872
            C+ +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H +L   N L+ +N +  ++DFG+++  +  D           I + APE     + S  
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 933 GDVYSFGIMLMETFT 947
            DV++FG++L E  T
Sbjct: 400 SDVWAFGVLLWEIAT 414

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (333), Expect = 4e-32
 Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 40/279 (14%)

Query: 758  IGRGGFGFVYKARIQDG---MEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKF 811
            +G G FG V +   +     ++VA+KV  L+ G      +    E  ++ ++ +  I++ 
Sbjct: 344  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 868
            I  C ++    LV+E    G L K L      + +     ++  V+  ++YL   +F   
Sbjct: 402  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGRE 926
               +H +L   NVLL +   A +SDFG++K  L  D S    ++     + + APE    
Sbjct: 458  ---VHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + S+  DV+S+G+ + E  +          G+   K+         +M  ++      +
Sbjct: 514  RKFSSRSDVWSYGVTMWEALSY---------GQKPYKKMKGP----EVMAFIE------Q 554

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             K      +C   ++ L   C I   E+R +   +  ++
Sbjct: 555  GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  127 bits (320), Expect = 4e-32
 Identities = 58/292 (19%), Positives = 116/292 (39%), Gaps = 54/292 (18%)

Query: 758  IGRGGFGFVYKARIQDG------MEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G+G FG VY+   +          VA+K   +    R    F  E  ++K     ++++
Sbjct: 33   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 811  FISSCSSDDFKALVLEYMPYGSL---------EKCLYSSNYILDIFQRLNIMIDVASALE 861
             +   S      +++E M  G L                     + + + +  ++A  + 
Sbjct: 93   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  + +M+P
Sbjct: 153  YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
            E  ++G  +T  DV+SFG++L E  T  ++P    + G             +S  +V+  
Sbjct: 210  ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQG-------------LSNEQVLR- 251

Query: 981  NLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                     FV +       + C   +F L   C   +P+ R +  EI++ +
Sbjct: 252  ---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  126 bits (318), Expect = 4e-32
 Identities = 60/283 (21%), Positives = 106/283 (37%), Gaps = 36/283 (12%)

Query: 174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLT 232
             +  +   L   +P  +   +   +L+L++N L  ++P  +F  L+ L+ L LS N L+
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 233 GNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAK 292
                             ++       L+ + LS N             T+      L +
Sbjct: 66  -------------FKGCCSQSDFGTTSLKYLDLSFNGVI----------TMSSNFLGLEQ 102

Query: 293 LEKLDLQFNRLQCVIPHEI-DNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
           LE LD Q + L+ +    +  +L NL ++  S              +S+L+ L +  NSF
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162

Query: 352 FGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGN 410
                      L NL  L LS       +    F + S L  L +  N+F       +  
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221

Query: 411 LRNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPL 452
           L +L+ LD   N++ +    EL    SS    L + +++ N  
Sbjct: 222 LNSLQVLDYSLNHIMTSKKQELQHFPSS----LAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  126 bits (318), Expect = 5e-32
 Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 11/237 (4%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLND--FSGTIPKEIGNVTTLIGLHLRG 59
           S+   L L+SN              +L  +SLS N   F G   +     T+L  L L  
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           N +   +      L +LE L  Q++ L      S+F +L +L  LD+S  +        I
Sbjct: 88  NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLR-CKHLQTLSLSINDFSGDIPKEI-GNLTKLKYL 176
            + L  L+ L +  N+F       +    ++L  L LS       +      +L+ L+ L
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVL 204

Query: 177 HLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN--LSSLSDLELSFNSL 231
           ++  N            L  L+ L    N +  T          SSL+ L L+ N  
Sbjct: 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  120 bits (303), Expect = 5e-30
 Identities = 64/303 (21%), Positives = 105/303 (34%), Gaps = 53/303 (17%)

Query: 77  EELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
            E+   +  LT ++P+ I   SS + L+L  N L   L   +   L  L  L L  N   
Sbjct: 10  TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSN--- 62

Query: 137 GKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAE 196
                       L           G         T LKYL L  N +   +      L +
Sbjct: 63  -----------GLSFKGCCSQSDFG--------TTSLKYLDLSFNGVI-TMSSNFLGLEQ 102

Query: 197 LEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
           LE L  Q++ L      S+F +L +L  L++S                           N
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR---------------VAFNGIFN 147

Query: 256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH 315
            +  LE + ++ N F      D+           L  L  LDL   +L+ + P   ++L 
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDI--------FTELRNLTFLDLSQCQLEQLSPTAFNSLS 199

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLP-NLEELSLSGN 374
           +L+ +  S N    +       +++L+ L    N              P +L  L+L+ N
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQN 258

Query: 375 NFS 377
           +F+
Sbjct: 259 DFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  111 bits (280), Expect = 5e-27
 Identities = 62/273 (22%), Positives = 95/273 (34%), Gaps = 39/273 (14%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLT-GTIPSSIF-NLS 98
           ++P  I   ++   L L  NKLQ         L +L +L L +N L+     S      +
Sbjct: 21  SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 99  SLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIP-STLLRCKHLQTLSLSIN 157
           SL  LDLS N +    +++    L  L+ L    +N       S  L  ++L  L +S  
Sbjct: 79  SLKYLDLSFNGVIT--MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136

Query: 158 DFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSI 215
                    I   L+ L+ L +  N  Q     +    L  L  L L    L   + P+ 
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194

Query: 216 F-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEI 274
           F +LSSL  L +S N+                  L       +  L+ +  S N      
Sbjct: 195 FNSLSSLQVLNMSHNNFF---------------SLDTFPYKCLNSLQVLDYSLNHIM--- 236

Query: 275 PSDLGNCTIPKEI--GNLAKLEKLDLQFNRLQC 305
                  T  K+      + L  L+L  N   C
Sbjct: 237 -------TSKKQELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 50/299 (16%), Positives = 92/299 (30%), Gaps = 51/299 (17%)

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
           +  E+  +    + ++P+ I ++   + LEL+ N         F  L  L  L L  N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPSS--ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 425 TSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKE 484
           +         S      L+Y  +S N +                           ++   
Sbjct: 65  S--FKGCCSQSDFGTTSLKYLDLSFNGVI--------------------------TMSSN 96

Query: 485 INNLTNLIAIYLGVNKLNGSILIALG---KLKKLQLLSLKDNQLEGSIPDNLSFSCTLTS 541
              L  L  +    + L    +        L+ L  L +          +          
Sbjct: 97  FLGLEQLEHLDFQHSNL--KQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG--------- 144

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIGGLKDL 600
                  L  +  L ++ N F      +I   L+ L  +DLS      + PT    L  L
Sbjct: 145 ---IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 201

Query: 601 QYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLD-LKDINVSFNKL 658
           Q L + +N            + +L+ L+ S N++       L+     L  +N++ N  
Sbjct: 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 40/166 (24%), Positives = 62/166 (37%), Gaps = 10/166 (6%)

Query: 1   LSNLEYLFLKSNMFHGKIP-STLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLR 58
           L  LE+L  + +        S   + + L  + +S           I   +++L  L + 
Sbjct: 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMA 158

Query: 59  GNKLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLA 116
           GN  Q     +    L  L  L L    L   +  + F +LSSL  L++S NN    L  
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDT 216

Query: 117 NICSNLPLLQTLFLDENNFDGKIPSTLLR--CKHLQTLSLSINDFS 160
                L  LQ L    N+         L+     L  L+L+ NDF+
Sbjct: 217 FPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 4e-32
 Identities = 53/281 (18%), Positives = 111/281 (39%), Gaps = 36/281 (12%)

Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIK 810
            F   +++G G  G +    + D  +VAVK    +        D E  +++    H N+I+
Sbjct: 26   FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +  +     F+ + +E     +L++ +   ++     + + ++    S L +LH   S+ 
Sbjct: 83   YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 871  IIHCDLKPNNVLL-----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEY- 923
            I+H DLKP+N+L+        + A +SDFG+ K       S ++   +  T G++APE  
Sbjct: 139  IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 924  --GREGRVSTNGDVYSFGIMLMETFTRKK-PTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
                +   +   D++S G +     +    P  +S   +  +      L  +   +    
Sbjct: 199  SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE-- 256

Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                   +  +              K     P++R +AK +
Sbjct: 257  ---DVIARELI-------------EKMIAMDPQKRPSAKHV 281

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (317), Expect = 5e-32
 Identities = 62/279 (22%), Positives = 99/279 (35%), Gaps = 36/279 (12%)

Query: 758  IGRGGFGFVYKAR----IQDGMEVAVKVF---DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V +          + VAVK      L    A+  F  E   +  + HRN+I+
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 867
                  +   K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ-TLATIGYMAPEYGRE 926
                IH DL   N+LL    +  + DFG+ +   + D      +       + APE  + 
Sbjct: 143  ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
               S   D + FG+ L E FT          G+                +++    +  E
Sbjct: 199  RTFSHASDTWMFGVTLWEMFTY---------GQEPWIGLNG-------SQILHK--IDKE 240

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +     E C   ++N+ ++C    PE+R     +   L
Sbjct: 241  GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  126 bits (319), Expect = 5e-32
 Identities = 69/295 (23%), Positives = 118/295 (40%), Gaps = 60/295 (20%)

Query: 758  IGRGGFGFVYKARIQDG------MEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 38   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYL- 863
             I        + +++E M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 98   CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 158  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            M PE   EG  ++  D +SFG++L E F+    P    +                S  EV
Sbjct: 212  MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPS-------------KSNQEV 254

Query: 978  VDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +           FV         + C   V+ +  +C    PE+R N   I+ ++
Sbjct: 255  L----------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  126 bits (319), Expect = 6e-32
 Identities = 71/287 (24%), Positives = 117/287 (40%), Gaps = 54/287 (18%)

Query: 758  IGRGGFGFVYKARIQDG----MEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIK 810
            IG G  G V   R++      + VA+K   L+ G   R  + F  E  ++ +  H NII+
Sbjct: 57   IGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 867
                 +      +V EYM  GSL+  L + +    I Q + ++  V + + YL    +  
Sbjct: 115  LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGR 925
                +H DL   NVL+D N+V  +SDFG+++  L++D     T T     I + APE   
Sbjct: 173  ----VHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
                S+  DV+SFG+++ E             GE       N        +V+ +     
Sbjct: 228  FRTFSSASDVWSFGVVMWEVLAY---------GERPYWNMTN-------RDVISS----- 266

Query: 986  EDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                 V +         C   +  L + C  +   +R    +IV+ L
Sbjct: 267  -----VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (317), Expect = 9e-32
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 11/201 (5%)

Query: 758 IGRGGFGFVYKARIQDGME-----VAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKF 811
           +G G FG V+K       E     V +KV + + G ++ ++       I  + H +I++ 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
           +  C     + LV +Y+P GSL   +      L     LN  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           +H +L   NVLL       ++DFG+A     +D+ L  ++    I +MA E    G+ + 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196

Query: 932 NGDVYSFGIMLMETFTR-KKP 951
             DV+S+G+ + E  T   +P
Sbjct: 197 QSDVWSYGVTVWELMTFGAEP 217

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (324), Expect = 1e-31
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 13/192 (6%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++ +     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 818 DDFKA-LVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 936 YSFGIMLMETFT 947
           +SFGI+L E ++
Sbjct: 370 WSFGILLWEIYS 381

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  124 bits (313), Expect = 1e-31
 Identities = 59/285 (20%), Positives = 108/285 (37%), Gaps = 53/285 (18%)

Query: 758  IGRGGFGFVYKARIQDG----MEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIK 810
            IG G FG V++          + VA+K    +        + F  E   +++  H +I+K
Sbjct: 23   IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 867
             I   + +    +++E    G L   L    Y LD+   +     +++AL YL    F  
Sbjct: 81   LIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF-- 137

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
                +H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     
Sbjct: 138  ----VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
            R ++  DV+ FG+ + E             G    +   N+       +V+         
Sbjct: 193  RFTSASDVWMFGVCMWEILMH---------GVKPFQGVKNN-------DVI--------- 227

Query: 988  KHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
               +           C   +++L  KC    P  R    E+  +L
Sbjct: 228  -GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  125 bits (316), Expect = 2e-31
 Identities = 70/356 (19%), Positives = 128/356 (35%), Gaps = 67/356 (18%)

Query: 75  ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN 134
            L  +   +  L   +P  I      + LDL  N+++ EL  +    L  L  L L  N 
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89

Query: 135 FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE-LGN 193
                       + LQ L +S N    +IP  +   + L  L +  NR++ ++P+     
Sbjct: 90  ISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSG 145

Query: 194 LAELEKLQLQNNFLTGT-IPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAK 252
           L  +  +++  N L  +   P  F+   L+ L +S   LT            +  +LP  
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-----------GIPKDLPET 194

Query: 253 FCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEID 312
                  L E++L  N     I  +         +   +KL +L L  N+++ +    + 
Sbjct: 195 -------LNELHLDHNKI-QAIELED--------LLRYSKLYRLGLGHNQIRMIENGSLS 238

Query: 313 NLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSA------DVRLPNL 366
            L  L  +    NKL   VP  + ++  L+ +YL +N    ++  +        V+    
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN-NITKVGVNDFCPVGFGVKRAYY 296

Query: 367 EELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
             +SL  N               +   E+Q        P TF  + +   +  G+ 
Sbjct: 297 NGISLFNN--------------PVPYWEVQ--------PATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  115 bits (290), Expect = 5e-28
 Identities = 65/305 (21%), Positives = 106/305 (34%), Gaps = 31/305 (10%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK 61
            +   L L++N             + L  + L  N  S    K    +  L  L++  N 
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113

Query: 62  LQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICS 120
           L  EIP  L   + L EL + +N +   +P  +F  L +++ +++  N L          
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLD 179
           +   L  L + E      IP  L     L  L L  N     I  E     +KL  L L 
Sbjct: 170 DGLKLNYLRISEAKLT-GIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225

Query: 180 QNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKD 238
            N+++  I    L  L  L +L L NN L+  +P  + +L  L  + L  N++T     +
Sbjct: 226 HNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

Query: 239 MHIVNRLSAELPAKFCNNIPFLEEIYLSKN-MFYGEIPSDLGNCTIPKEIGNLAKLEKLD 297
                      P  F     +   I L  N + Y E+      C        +     + 
Sbjct: 283 --------DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC--------VTDRLAIQ 326

Query: 298 LQFNR 302
               +
Sbjct: 327 FGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (286), Expect = 2e-27
 Identities = 65/338 (19%), Positives = 117/338 (34%), Gaps = 51/338 (15%)

Query: 173 LKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSL 231
           L+ +      L+  +P+E+    +   L LQNN ++  +    F  L  L  L L  N +
Sbjct: 35  LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90

Query: 232 TGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLA 291
           +               ++  K  + +  L+++Y+SKN    EIP +L            +
Sbjct: 91  S---------------KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL-----------PS 123

Query: 292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGV-VPTTIFNVSTLKFLYLGSNS 350
            L +L +  NR++ V       L N+  +    N L         F+   L +L +    
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183

Query: 351 FFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFG 409
               +P         L EL L  N     I        SKL  L L  N        +  
Sbjct: 184 L-TGIPKDL---PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238

Query: 410 NLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMED 469
            L  L+ L L +N L+   + L      + K L+   +  N +  +       +   ++ 
Sbjct: 239 FLPTLRELHLDNNKLSRVPAGLP-----DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR 293

Query: 470 FHMPNSNISG------SIPKEI-NNLTNLIAIYLGVNK 500
            +    ++         +       +T+ +AI  G  K
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (265), Expect = 7e-25
 Identities = 71/354 (20%), Positives = 123/354 (34%), Gaps = 73/354 (20%)

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTL 341
            +PKEI        LDLQ N +  +   +   L +L  ++   NK+              
Sbjct: 47  AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS------------- 91

Query: 342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFS 401
               +   +F           L  L++L +S N+    IP  +   S L  L +  N   
Sbjct: 92  ---KIHEKAFSP---------LRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR 136

Query: 402 GFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIG 461
                 F  LRN+  +++G N L +S  E           L Y  IS   L GI   +  
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK---LNYLRISEAKLTGIPKDLPE 193

Query: 462 NLSQSMEDFHMPNSNISGSIPKEI-NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSL 520
            L++     H+ ++ I  +I  E     + L  + LG N++      +L  L  L+ L L
Sbjct: 194 TLNE----LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248

Query: 521 KDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQID 580
            +N+L              + +P+ L +LK +  + L  N  T                 
Sbjct: 249 DNNKL--------------SRVPAGLPDLKLLQVVYLHTNNIT----------------K 278

Query: 581 LSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSI--PDSIGDMINLKSLNLSNN 632
           + +N+F  V             + L  N +      P +   + +  ++   N 
Sbjct: 279 VGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  104 bits (261), Expect = 2e-24
 Identities = 54/287 (18%), Positives = 100/287 (34%), Gaps = 29/287 (10%)

Query: 258 PFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNL 317
           P    + L  N    E+  D        +   L  L  L L  N++  +       L  L
Sbjct: 54  PDTTLLDLQNNDI-SELRKD--------DFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 318 EWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNF- 376
           + +  S N LV  +P  +   S+L  L +  N    ++P      L N+  + + GN   
Sbjct: 105 QKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160

Query: 377 SGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSS 436
           +       F+  KL+ L +     +G   +       L  L L  N + +    +     
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQA----IELEDL 213

Query: 437 SNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYL 496
                L    + +N +  I    +  L  ++ + H+ N+ +S  +P  + +L  L  +YL
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLP-TLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271

Query: 497 GVNKLNG------SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSC 537
             N +          +    K      +SL +N +        +F C
Sbjct: 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  100 bits (251), Expect = 5e-23
 Identities = 58/280 (20%), Positives = 93/280 (33%), Gaps = 62/280 (22%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L  L+ L++  N               L  I  +L   S            L+ L +  N
Sbjct: 101 LRKLQKLYISKN--------------HLVEIPPNL--PSS-----------LVELRIHDN 133

Query: 61  KLQGEIPEE-LGNLAELEELWLQNNFLTGT-IPSSIFNLSSLSNLDLSVNNLTGELLANI 118
           +++ ++P+     L  +  + +  N L  +      F+   L+ L +S   LT      I
Sbjct: 134 RIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-----GI 187

Query: 119 CSNLPL-LQTLFLDENNFDGKIPS-TLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKY 175
             +LP  L  L LD N     I    LLR   L  L L  N     I       L  L+ 
Sbjct: 188 PKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRE 245

Query: 176 LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-------NLSSLSDLELSF 228
           LHLD N+L   +P  L +L  L+ + L  N +T  +  + F         +  + + L  
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303

Query: 229 NSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKN 268
           N +                E+       +     I     
Sbjct: 304 NPVP-------------YWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 90.5 bits (225), Expect = 1e-19
 Identities = 69/328 (21%), Positives = 112/328 (34%), Gaps = 67/328 (20%)

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
           +L  +  S       +P  I      + L+LQ N  S    + F  L++L  L L +N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISPD--TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 425 TSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKE 484
           +    E +F        L+   IS N L  I P    NL  S+ +  + ++ I   +PK 
Sbjct: 91  SK-IHEKAFSPLRK---LQKLYISKNHLVEIPP----NLPSSLVELRIHDNRIR-KVPKG 141

Query: 485 I-NNLTNLIAIYLGVNKLNGSIL--IALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTS 541
           + + L N+  I +G N L  S     A   LK L  L + + +L   IP +L        
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDL-------- 191

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
            P TL  L                               L  N    +    +     L 
Sbjct: 192 -PETLNEL------------------------------HLDHNKIQAIELEDLLRYSKLY 220

Query: 602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGE 661
            L L +N+++     S+  +  L+ L+L NN L   +P  L  L  L+ + +  N +   
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNI--- 276

Query: 662 IPREGPFRNFSLESFKGNELLCGMPNLQ 689
                      +  F             
Sbjct: 277 -------TKVGVNDFCPVGFGVKRAYYN 297

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  126 bits (319), Expect = 2e-31
 Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 54/287 (18%)

Query: 758  IGRGGFGFVYKARIQ----DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V   R++      + VA+K   L+ G   +  + F  E  ++ +  H NII+
Sbjct: 53   VGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 867
                 +      +V EYM  GSL+  L   +    + Q + ++  +AS ++YL    +  
Sbjct: 111  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYGR 925
                +H DL   N+L++ N+V  +SDFG+ +  L++D     T       I + +PE   
Sbjct: 169  ----VHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
              + ++  DV+S+GI+L E  +          GE       N        +V+       
Sbjct: 224  YRKFTSASDVWSYGIVLWEVMSY---------GERPYWEMSN-------QDVI------- 260

Query: 986  EDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                 V +         C + ++ L + C  +    R   ++IV+ L
Sbjct: 261  ---KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  126 bits (318), Expect = 2e-31
 Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 60/295 (20%)

Query: 758  IGRGGFGFVYKARIQDG------MEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 79   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYL- 863
             I        + ++LE M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 139  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 864  --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
              HF      IH D+   N LL       VA + DFGMA+   +          +  + +
Sbjct: 199  ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 919  MAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            M PE   EG  ++  D +SFG++L E F+    P    +                S  EV
Sbjct: 253  MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPS-------------KSNQEV 295

Query: 978  VDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +           FV         + C   V+ +  +C    PE+R N   I+ ++
Sbjct: 296  L----------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  124 bits (314), Expect = 2e-31
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVK---VFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            IGRG F  VY+A  + DG+ VA+K   +FDL   +A      E  ++K++ H N+IK+ 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLHFGYSV 869
           +S   D+   +VLE    G L + +        +          + + SALE++H   S 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 870 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
            ++H D+KP NV +    V  L D G+ + F     +   +    T  YM+PE   E   
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-GTPYYMSPERIHENGY 213

Query: 930 STNGDVYSFGIMLMETFTRKKP 951
           +   D++S G +L E    + P
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP 235

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (312), Expect = 2e-31
 Identities = 51/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V+        +VAVK   L+ G      F  E  ++K+++H+ +++  +  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
            +    ++ EYM  GSL   L + +   L I + L++   +A  + ++        IH D
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134

Query: 876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 935
           L+  N+L+ D +   ++DFG+A+  +++++   +      I + APE    G  +   DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 936 YSFGIMLMETFT 947
           +SFGI+L E  T
Sbjct: 194 WSFGILLTEIVT 205

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  124 bits (314), Expect = 2e-31
 Identities = 57/281 (20%), Positives = 110/281 (39%), Gaps = 39/281 (13%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRN--IIKF 811
              IG GG   V++   +     A+K  +L+    + + S+  E   + +++  +  II+ 
Sbjct: 34   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                 +D +  +V+E      L   L      +D ++R +   ++  A+  +H      I
Sbjct: 94   YDYEITDQYIYMVMECGN-IDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--------- 922
            +H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE         
Sbjct: 149  VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 923  --YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
                 + ++S   DV+S G +L      K P  +       L   ++    I   ++   
Sbjct: 208  ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 265

Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                 + +  +               C    P++RI+  E+
Sbjct: 266  ---EKDLQDVL-------------KCCLKRDPKQRISIPEL 290

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  123 bits (312), Expect = 2e-31
 Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 42/278 (15%)

Query: 758  IGRGGFGFVYKARIQDG-MEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSC 815
            +G G +G VY+   +   + VAVK   L+     ++ F  E  ++K I+H N+++ +  C
Sbjct: 21   LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
            + +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL        IH 
Sbjct: 79   TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135

Query: 875  DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
            DL   N L+ +N +  ++DFG+++  +  D           I + APE     + S   D
Sbjct: 136  DLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK- 993
            V++FG++L E  T          G                 +V +           + K 
Sbjct: 195  VWAFGVLLWEIATY---------GMSPYPGIDL-------SQVYE----------LLEKD 228

Query: 994  ------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                  E C   V+ L   C   +P +R +  EI    
Sbjct: 229  YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (311), Expect = 2e-31
 Identities = 64/194 (32%), Positives = 98/194 (50%), Gaps = 13/194 (6%)

Query: 756 NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
             IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++ +   
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 816 SSDDFKA-LVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
             +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 934 DVYSFGIMLMETFT 947
           DV+SFGI+L E ++
Sbjct: 196 DVWSFGILLWEIYS 209

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  125 bits (315), Expect = 3e-31
 Identities = 57/281 (20%), Positives = 109/281 (38%), Gaps = 39/281 (13%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRH--RNIIKF 811
              IG GG   V++   +     A+K  +L+    + + S+  E   + +++     II+ 
Sbjct: 15   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                 +D +  +V+E      L   L      +D ++R +   ++  A+  +H      I
Sbjct: 75   YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--------- 922
            +H DLKP N L+ D M+  L DFG+A     +  S+ +   + T+ YM PE         
Sbjct: 130  VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 923  --YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
                 + ++S   DV+S G +L      K P  +       L   ++    I   ++   
Sbjct: 189  ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 246

Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                 + +  +               C    P++RI+  E+
Sbjct: 247  ---EKDLQDVL-------------KCCLKRDPKQRISIPEL 271

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  123 bits (311), Expect = 3e-31
 Identities = 80/302 (26%), Positives = 125/302 (41%), Gaps = 69/302 (22%)

Query: 758  IGRGGFGFVYKARI------QDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNII 809
            +G G FG V+ A        +D M VAVK   L+     A K F  E  ++  ++H +I+
Sbjct: 23   LGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 810  KFISSCSSDDFKALVLEYMPYGSL---------------EKCLYSSNYILDIFQRLNIMI 854
            KF   C   D   +V EYM +G L               +     +   L + Q L+I  
Sbjct: 81   KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 855  DVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
             +AS + YL   HF      +H DL   N L+  N++  + DFGM++     D       
Sbjct: 141  QIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 912  TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLL 970
            T+  I +M PE     + +T  DV+SFG++L E FT  K+P    +              
Sbjct: 195  TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQ------------ 238

Query: 971  LISIMEVVDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVT 1023
             +S  EV+            + +         C   V+++ + C    P++R+N KEI  
Sbjct: 239  -LSNTEVI----------ECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

Query: 1024 KL 1025
             L
Sbjct: 288  IL 289

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (310), Expect = 3e-31
 Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 53/285 (18%)

Query: 758  IGRGGFGFVYKARIQDG----MEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG VY+    +     + VAVK    +        + F  E  ++K + H +I+K
Sbjct: 20   LGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 867
             I     +    +++E  PYG L   L  +   L +   +   + +  A+ YL   +   
Sbjct: 78   LIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-- 134

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
                +H D+   N+L+       L DFG+++ +++++     + T   I +M+PE     
Sbjct: 135  ----VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
            R +T  DV+ F + + E  +          G+       N        +V+         
Sbjct: 190  RFTTASDVWMFAVCMWEILSF---------GKQPFFWLENK-------DVI--------- 224

Query: 988  KHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
               + K       + C   ++ L  +C    P +R    E+V  L
Sbjct: 225  -GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (310), Expect = 3e-31
 Identities = 63/292 (21%), Positives = 111/292 (38%), Gaps = 61/292 (20%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            F E  LIG GGFG V+KA+   DG    +K       +A +    E   + ++ H NI+ 
Sbjct: 13   FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68

Query: 811  FISSCSSDDFKA----------------LVLEYMPYGSLEKCL-YSSNYILDIFQRLNIM 853
            +       D+                  + +E+   G+LE+ +       LD    L + 
Sbjct: 69   YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 854  IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
              +   ++Y+H   S  +I+ DLKP+N+ L D     + DFG+         SL      
Sbjct: 129  EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT-------SLKNDGKR 178

Query: 914  AT-IG---YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL 969
                G   YM+PE           D+Y+ G++L E         E+              
Sbjct: 179  TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------------SK 226

Query: 970  LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                + + + +++   ++K  +  ++ +S           + PE+R N  EI
Sbjct: 227  FFTDLRDGIISDIFDKKEKTLL--QKLLS-----------KKPEDRPNTSEI 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  124 bits (313), Expect = 4e-31
 Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 55/288 (19%)

Query: 758  IGRGGFGFVYKARIQDG-----MEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNII 809
            IG G FG VYK  ++       + VA+K   L+ G   +    F  E G++ +  H NII
Sbjct: 52   IGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 866
            +     S      ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL   ++ 
Sbjct: 110  RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY- 168

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IGYMAPEYG 924
                 +H DL   N+L++ N+V  +SDFG+++  L++D   T T +     I + APE  
Sbjct: 169  -----VHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 925  REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
               + ++  DV+SFGI++ E  T          GE       N        EV+      
Sbjct: 223  SYRKFTSASDVWSFGIVMWEVMTY---------GERPYWELSN-------HEVM------ 260

Query: 985  HEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                  +           C S ++ L M+C  +    R    +IV+ L
Sbjct: 261  ----KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  125 bits (316), Expect = 4e-31
 Identities = 57/281 (20%), Positives = 110/281 (39%), Gaps = 39/281 (13%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRH--RNIIKF 811
              IG GG   V++   +     A+K  +L+    + + S+  E   + +++     II+ 
Sbjct: 62   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                 +D +  +V+E      L   L      +D ++R +   ++  A+  +H      I
Sbjct: 122  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--------- 922
            +H DLKP N L+ D M+  L DFG+A     +  S+ +   +  + YM PE         
Sbjct: 177  VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 923  --YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
                 + ++S   DV+S G +L      K P  +       L   ++    I   ++ + 
Sbjct: 236  ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295

Query: 981  NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            +L                   ++   C    P++RI+  E+
Sbjct: 296  DLQ------------------DVLKCCLKRDPKQRISIPEL 318

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  124 bits (312), Expect = 7e-31
 Identities = 45/199 (22%), Positives = 87/199 (43%), Gaps = 9/199 (4%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFIS 813
            IG G FG     +  +DG +  +K  ++     +  +    E  ++  ++H NI+++  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 814 SCSSDDFKALVLEYMPYGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
           S   +    +V++Y   G L ++       +    Q L+  + +  AL+++H      I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTN 932
           H D+K  N+ L  +    L DFG+A+  L     L +     T  Y++PE       +  
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSPEICENKPYNNK 205

Query: 933 GDVYSFGIMLMETFTRKKP 951
            D+++ G +L E  T K  
Sbjct: 206 SDIWALGCVLYELCTLKHA 224

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  123 bits (310), Expect = 1e-30
 Identities = 71/301 (23%), Positives = 120/301 (39%), Gaps = 68/301 (22%)

Query: 758  IGRGGFGFVYKARIQDG------MEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNII 809
            +G G FG V+ A   +       M VAVK   L+     A + F  E  ++  ++H++I+
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQHIV 106

Query: 810  KFISSCSSDDFKALVLEYMPYGSL--------------EKCLYSSNYILDIFQRLNIMID 855
            +F   C+      +V EYM +G L                    +   L + Q L +   
Sbjct: 107  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 856  VASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
            VA+ + YL   HF      +H DL   N L+   +V  + DFGM++     D      +T
Sbjct: 167  VAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 913  LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLL 971
            +  I +M PE     + +T  DV+SFG++L E FT  K+P    +               
Sbjct: 221  MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP----WYQ------------- 263

Query: 972  ISIMEVVDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024
            +S  E +            + +         C   V+ +   C    P++R + K++  +
Sbjct: 264  LSNTEAI----------DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

Query: 1025 L 1025
            L
Sbjct: 314  L 314

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  122 bits (309), Expect = 1e-30
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 21/206 (10%)

Query: 758 IGRGGFGFVYKARIQDGME-----VAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNII 809
           +G G FG VYK       E     VA+K   L+     +A K    E  ++  + + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 866
           + +  C +   + L+ + MP+G L   +      +     LN  + +A  + YL      
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
                +H DL   NVL+       ++DFG+AK    E++          I +MA E    
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 927 GRVSTNGDVYSFGIMLMETFTR-KKP 951
              +   DV+S+G+ + E  T   KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (310), Expect = 1e-30
 Identities = 71/309 (22%), Positives = 115/309 (37%), Gaps = 74/309 (23%)

Query: 758  IGRGGFGFVYKARIQDG------MEVAVKVF-DLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            IG G FG V++AR            VAVK+  +         F  E  ++    + NI+K
Sbjct: 55   IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 811  FISSCSSDDFKALVLEYMPYGSL-----------------------EKCLYSSNYILDIF 847
             +  C+      L+ EYM YG L                        +        L   
Sbjct: 115  LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 848  QRLNIMIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED 904
            ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++     D
Sbjct: 175  EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 905  QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLK 963
                       I +M PE     R +T  DV+++G++L E F+   +P    + G     
Sbjct: 229  YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP----YYG----- 279

Query: 964  RWVNDLLLISIMEVVDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERI 1016
                    ++  EV+          ++V         E C   ++NL   C  + P +R 
Sbjct: 280  --------MAHEEVI----------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 321

Query: 1017 NAKEIVTKL 1025
            +   I   L
Sbjct: 322  SFCSIHRIL 330

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (304), Expect = 3e-30
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 33/215 (15%)

Query: 758 IGRGGFGFVYKARIQD--------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII 809
           +G+G F  ++K   ++          EV +KV D  +    +SF     M+ ++ H++++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 866
                C   D   LV E++ +GSL+  L  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 867 YSVPIIHCDLKPNNVLLD--------DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
                IH ++   N+LL         +     LSD G++   L +D           I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPW 183

Query: 919 MAPEYGREGRV-STNGDVYSFGIMLMETFTR-KKP 951
           + PE     +  +   D +SFG  L E  +   KP
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (305), Expect = 3e-30
 Identities = 66/300 (22%), Positives = 124/300 (41%), Gaps = 56/300 (18%)

Query: 758  IGRGGFGFVYKARIQDG------MEVAVK-VFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V KA             VAVK + +      ++    E  ++K++ H ++IK
Sbjct: 31   LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 811  FISSCSSDDFKALVLEYMPYGSL-----------------------EKCLYSSNYILDIF 847
               +CS D    L++EY  YGSL                           +     L + 
Sbjct: 91   LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 848  QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL 907
              ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+++   +ED  +
Sbjct: 151  DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 908  TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWV 966
             ++Q    + +MA E   +   +T  DV+SFG++L E  T    P    + G        
Sbjct: 208  KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPG-------- 255

Query: 967  NDLLLISIMEVVDANLLSHEDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                 I    + +  LL  +  H + + + C   ++ L ++C  + P++R    +I   L
Sbjct: 256  -----IPPERLFN--LL--KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  119 bits (300), Expect = 7e-30
 Identities = 56/213 (26%), Positives = 83/213 (38%), Gaps = 16/213 (7%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFIS 813
            IG G +G   K R   DG  +  K  D         +    E  +++ ++H NI+++  
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 814 SCSSDDFKAL--VLEYMPYGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLH--FG 866
                    L  V+EY   G L   +               L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
               ++H DLKP NV LD      L DFG+A+  L  D S  +T  + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTF-VGTPYYMSPEQMNR 190

Query: 927 GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
              +   D++S G +L E      P    FT  
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP----FTAF 219

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  121 bits (306), Expect = 7e-30
 Identities = 71/298 (23%), Positives = 118/298 (39%), Gaps = 57/298 (19%)

Query: 758  IGRGGFGFVYKARIQD--------GMEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRN 807
            +G G FG V  A             + VAVK + D    + +     E  M+K I +H+N
Sbjct: 89   LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSL---------------EKCLYSSNYILDIFQRLNI 852
            II  + +C+ D    +++EY   G+L                         +     ++ 
Sbjct: 149  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 853  MIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
               +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+     D     
Sbjct: 209  TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 910  TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVND 968
            T     + +MAPE   +   +   DV+SFG+++ E FT    P    + G          
Sbjct: 263  TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----YPG---------- 308

Query: 969  LLLISIMEVVDANLLSHEDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
               I + E+    LL  ++ H + K   C + ++ +   C    P +R   K++V  L
Sbjct: 309  ---IPVEELFK--LL--KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  122 bits (308), Expect = 1e-29
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 29/258 (11%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEE-LGNLAEL 76
           +P  +      R ++L  N+          ++  L  L L  N ++ +I       LA L
Sbjct: 69  VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125

Query: 77  EELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
             L L +N+LT  IPS  F  LS L  L L  N +   + +   + +P L  L L E   
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183

Query: 136 DGKIPSTLLR-CKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE-LGN 193
              I         +L+ L+L + +   D+P  +  L  L+ L +  N    EI       
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHG 240

Query: 194 LAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAK 252
           L+ L+KL + N+ ++  I  + F  L+SL +L L+ N+L+                LP  
Sbjct: 241 LSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS---------------SLPHD 284

Query: 253 FCNNIPFLEEIYLSKNMF 270
               + +L E++L  N +
Sbjct: 285 LFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  121 bits (305), Expect = 3e-29
 Identities = 72/312 (23%), Positives = 116/312 (37%), Gaps = 64/312 (20%)

Query: 145 RCKH-LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQ 203
            C +    +  +    S ++P+ I   +  +YL+L +N +Q    +   +L  LE LQL 
Sbjct: 51  SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 204 NNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEE 262
            N +   I    F  L+SL+ LEL  N LT                              
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLT------------------------------ 136

Query: 263 IYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEW-MI 321
             +    F                   L+KL +L L+ N ++ +  +  + + +L    +
Sbjct: 137 -VIPSGAFEY-----------------LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178

Query: 322 FSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP 381
               KL  +       +  LK+L LG  +    +P      L  LEEL +SGN+F   I 
Sbjct: 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP--NLTPLVGLEELEMSGNHFP-EIR 234

Query: 382 SFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCK 440
              F   S L  L +  +  S    N F  L +L  L+L  N L+S    L     +  +
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS----LPHDLFTPLR 290

Query: 441 YLEYFSISNNPL 452
           YL    + +NP 
Sbjct: 291 YLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  117 bits (296), Expect = 5e-28
 Identities = 70/283 (24%), Positives = 108/283 (38%), Gaps = 37/283 (13%)

Query: 27  RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFL 86
           +   +  +    S  +P+ I + T    L+L  N +Q    +   +L  LE L L  N +
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPSNTRY--LNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 87  TGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLR 145
              I    F  L+SL+ L+L  N LT  + +     L  L+ L+L  N     IPS    
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFN 168

Query: 146 -CKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQ 203
               L  L L        I +     L  LKYL+L    ++ ++P  L  L  LE+L++ 
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMS 226

Query: 204 NNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEE 262
            N     I P  F  LSSL  L +  + ++                +     + +  L E
Sbjct: 227 GNHFP-EIRPGSFHGLSSLKKLWVMNSQVS---------------LIERNAFDGLASLVE 270

Query: 263 IYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC 305
           + L+ N     +P DL           L  L +L L  N   C
Sbjct: 271 LNLAHNNL-SSLPHDL--------FTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (280), Expect = 4e-26
 Identities = 66/235 (28%), Positives = 95/235 (40%), Gaps = 34/235 (14%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L +LE L L  N               +R I   +  F+G        + +L  L L  N
Sbjct: 98  LHHLEVLQLGRN--------------SIRQI--EVGAFNG--------LASLNTLELFDN 133

Query: 61  KLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
            L   IP      L++L ELWL+NN +  +IPS  F  + SL  LDL        +    
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGA 191

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
              L  L+ L L   N    +P  L     L+ L +S N F    P     L+ LK L +
Sbjct: 192 FEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249

Query: 179 DQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSL 231
             +++   I       LA L +L L +N L+ ++P  +F  L  L +L L  N  
Sbjct: 250 MNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  100 bits (251), Expect = 2e-22
 Identities = 58/274 (21%), Positives = 88/274 (32%), Gaps = 49/274 (17%)

Query: 364 PNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
            N   L+L  NN    I +  F +   L  L+L RNS        F  L +L  L+L DN
Sbjct: 75  SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133

Query: 423 YLTS-STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSI 481
           +LT   +    +LS      L    + NNP+  I       +   +    +        I
Sbjct: 134 WLTVIPSGAFEYLSK-----LRELWLRNNPIESIPSYAFNRVPS-LMRLDLGELKKLEYI 187

Query: 482 PKEI-NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLT 540
            +     L NL  + LG+  +    +  L  L  L+ L +  N     I    SF     
Sbjct: 188 SEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFP-EIRPG-SFH---- 239

Query: 541 SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDL 600
                                           L  L ++ +  +  S +      GL  L
Sbjct: 240 -------------------------------GLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 601 QYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL 634
             L L +N L     D    +  L  L+L +N  
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.4 bits (240), Expect = 5e-21
 Identities = 58/295 (19%), Positives = 113/295 (38%), Gaps = 50/295 (16%)

Query: 364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY 423
               ++  +    S  +P  I   S    L L  N+      +TF +L +L+ L LG N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 424 LTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPK 483
           +      +   + +    L    + +N L  I       LS  + +  + N+ I  SIP 
Sbjct: 111 IRQ----IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIE-SIPS 164

Query: 484 EI-NNLTNLIAIYLG-VNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTS 541
              N + +L+ + LG + KL      A   L  L+ L+L    +                
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--------------KD 210

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
           +P+                         +  L  L ++++S N+F ++ P +  GL  L+
Sbjct: 211 MPN-------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK 245

Query: 602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
            L++  +++     ++   + +L  LNL++NNL  +       L  L ++++  N
Sbjct: 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 74.4 bits (183), Expect = 5e-14
 Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 8/139 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPS-TLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRG 59
           + +L  L L        I          L+ ++L + +    +P  +  +  L  L + G
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227

Query: 60  NKLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLAN 117
           N    EI       L+ L++LW+ N+ ++  I  + F  L+SL  L+L+ NNL+  L  +
Sbjct: 228 NHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHD 284

Query: 118 ICSNLPLLQTLFLDENNFD 136
           + + L  L  L L  N ++
Sbjct: 285 LFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 31/154 (20%), Positives = 57/154 (37%), Gaps = 19/154 (12%)

Query: 547 WNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLK 606
                ++C    L+     +P           ++L  NN   +   T   L  L+ L L 
Sbjct: 54  NQFSKVVCTRRGLSEVPQGIPSN------TRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 607 YNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREG 666
            N ++     +   + +L +L L +N L  I   + E L  L+++ +  N +E  IP   
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP-SY 165

Query: 667 PFRNF----SLESFKGNEL-------LCGMPNLQ 689
            F        L+  +  +L         G+ NL+
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK 199

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  124 bits (314), Expect = 1e-29
 Identities = 55/281 (19%), Positives = 104/281 (37%), Gaps = 25/281 (8%)

Query: 682 LCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFT 741
            C + N   +S   R      +    I  +       +      +++ +          T
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDT 376

Query: 742 YLELFQATNGFSENNL-----IGRGGFGFVYKARIQDG----MEVAVKVFDLQYG---RA 789
           Y              +     IG G FG V++          M VA+K    +       
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSV 434

Query: 790 IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR 849
            + F  E   +++  H +I+K I   + +    +++E    G L   L    + LD+   
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASL 493

Query: 850 LNIMIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
           +     +++AL YL    F      +H D+   NVL+  N    L DFG+++ ++++   
Sbjct: 494 ILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 546

Query: 907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              ++    I +MAPE     R ++  DV+ FG+ + E   
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (297), Expect = 2e-29
 Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 70/303 (23%)

Query: 758  IGRGGFGFVYKARIQDG------MEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNI 808
            +G   FG VYK  +           VA+K   L+        + F  E  +  R++H N+
Sbjct: 17   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 809  IKFISSCSSDDFKALVLEYMPYGSL---------------EKCLYSSNYILDIFQRLNIM 853
            +  +   + D   +++  Y  +G L                    +    L+    ++++
Sbjct: 75   VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 854  IDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
              +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ +     D      
Sbjct: 135  AQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 911  QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDL 969
             +L  I +MAPE    G+ S + D++S+G++L E F+   +P    + G           
Sbjct: 189  NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCG----------- 233

Query: 970  LLISIMEVVDANLLSHEDKHFVAK-------EQCMSFVFNLAMKCTIESPEERINAKEIV 1022
               S  +VV            +         + C ++V+ L ++C  E P  R   K+I 
Sbjct: 234  --YSNQDVV----------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 281

Query: 1023 TKL 1025
            ++L
Sbjct: 282  SRL 284

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  118 bits (297), Expect = 4e-29
 Identities = 60/294 (20%), Positives = 110/294 (37%), Gaps = 49/294 (16%)

Query: 758  IGRGGFGFVYKARIQD------GMEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRNII 809
            +GRG FG V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 810  KFISSCSSDDFKALV-LEYMPYGSL---------------EKCLYSSNYILDIFQRLNIM 853
              + +C+      +V +E+  +G+L                         L +   +   
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 854  IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
              VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   + +    
Sbjct: 155  FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 914  ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLLI 972
              + +MAPE   +   +   DV+SFG++L E F+    P    + G + +       L  
Sbjct: 212  LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPG-VKIDEEFCRRL-- 264

Query: 973  SIMEVVDANLLSHEDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                         ++   +   +     ++   + C    P +R    E+V  L
Sbjct: 265  -------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  118 bits (298), Expect = 4e-29
 Identities = 72/295 (24%), Positives = 119/295 (40%), Gaps = 51/295 (17%)

Query: 758  IGRGGFGFVYKARIQD--------GMEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRN 807
            +G G FG V  A             + VAVK + D    + +     E  M+K I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSL---------------EKCLYSSNYILDIFQRLNI 852
            II  + +C+ D    +++EY   G+L                         +     ++ 
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 853  MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
               +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+     D     T  
Sbjct: 163  TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 913  LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLL 971
               + +MAPE   +   +   DV+SFG+++ E FT    P    + G             
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----YPG------------- 262

Query: 972  ISIMEVVDANLLSHEDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            I + E+    LL  ++ H + K   C + ++ +   C    P +R   K++V  L
Sbjct: 263  IPVEELFK--LL--KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  117 bits (295), Expect = 7e-29
 Identities = 58/274 (21%), Positives = 96/274 (35%), Gaps = 34/274 (12%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRI-RHRN 807
            F   + +G G +G V+K R  +DG   AVK     +   +       E G  +++ +H  
Sbjct: 59   FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
             ++   +        L  E     SL++   +    L   Q    + D   AL +LH   
Sbjct: 119  CVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
            S  ++H D+KP N+ L       L DFG+            Q        YMAPE  +  
Sbjct: 175  SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQGS 231

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
               T  DV+S G+ ++E     +       GE   +      L    +       LS E 
Sbjct: 232  Y-GTAADVFSLGLTILEVACNMELP---HGGEGWQQ------LRQGYLPPEFTAGLSSEL 281

Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            +  +             +      P+ R  A+ +
Sbjct: 282  RSVL-------------VMMLEPDPKLRATAEAL 302

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  121 bits (306), Expect = 7e-29
 Identities = 86/466 (18%), Positives = 165/466 (35%), Gaps = 35/466 (7%)

Query: 74  AELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE 132
              + L L  N ++  +       LS L  L LS N +   L  ++      L+ L +  
Sbjct: 52  PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109

Query: 133 NNFDGKIPSTLLRCKHLQTLSLSINDF-SGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
           N     I    +    L+ L LS NDF    + KE GNLTKL +L L   + +     +L
Sbjct: 110 NRL-QNISCCPM--ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDL 163

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPA 251
             +A L    +  + ++  I        SL     +   L  +      +   +S     
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETE--SLQIPNTTVLHLVFHPNSLFSVQVNMSV---- 217

Query: 252 KFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEI 311
              N +  L+   +  N    +      +         L  +    ++      V   + 
Sbjct: 218 ---NALGHLQLSNIKLNDENCQRLMTFLSELTRG--PTLLNVTLQHIETTWKCSVKLFQF 272

Query: 312 DNLHNLEWMIFSFNKLVGVVPTTIFN-----VSTLKFLYLGSNSFFGRLPSSADVRLPNL 366
                +E++      +   +    F      + +L   ++ +  F      +       +
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEM 331

Query: 367 EELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS 426
               LS ++          + S  + L   +N F+  +      L+ L+ L L  N L +
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN 391

Query: 427 STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI- 485
                  L + N   LE   +S N L           ++S+   ++ ++ ++GS+ + + 
Sbjct: 392 --FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449

Query: 486 NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPD 531
             +  L    L  N++  SI   +  L+ LQ L++  NQL+ S+PD
Sbjct: 450 PKVKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD 490

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  121 bits (305), Expect = 1e-28
 Identities = 98/524 (18%), Positives = 175/524 (33%), Gaps = 86/524 (16%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSL 221
           +PK++    + K L L QN +      ++  L+EL  L+L +N +  ++   +F     L
Sbjct: 46  VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102

Query: 222 SDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC 281
             L++S N L                        NI                        
Sbjct: 103 EYLDVSHNRLQ-----------------------NISC---------------------- 117

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCVIPH-EIDNLHNLEWMIFSFNKLVGVVPTTIFNVST 340
                   +A L  LDL FN    +    E  NL  L ++  S  K   +    + ++  
Sbjct: 118 ------CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171

Query: 341 LK-FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSK---LSTLELQ 396
               L L S    G    S  +    +  L    N+      +   N      LS ++L 
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231

Query: 397 RNSFSGFIPNTFGNLRNLKWLDLGDNYL-TSSTSELSFLSSSNCKYLEYFSISNNPLGGI 455
             +    +       R    L++   ++ T+    +        + +EY +I N  +   
Sbjct: 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITER 291

Query: 456 LPRVIGNLSQSMEDF----HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGK 511
           + R     S++        H+ N     S     +    +    L ++      ++    
Sbjct: 292 IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS 351

Query: 512 LKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT--GPLPLE 569
                 L+   N    S+              STL  L+    L L  N       + L 
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQG----------CSTLKRLQT---LILQRNGLKNFFKVALM 398

Query: 570 IGNLKVLVQIDLSINNF-SDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN 628
             N+  L  +D+S+N+  S     T    + +  L L  N L GS+   +     +K L+
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLD 456

Query: 629 LSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFS 672
           L NN +   IP  +  L  L+++NV+ N+L+  +P  G F   +
Sbjct: 457 LHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  113 bits (284), Expect = 4e-26
 Identities = 88/517 (17%), Positives = 159/517 (30%), Gaps = 70/517 (13%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEEL-GNLAEL 76
           +P         + +SLS N  S     +I  ++ L  L L  N+++  +   +     +L
Sbjct: 50  LPPRT------KALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102

Query: 77  EELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
           E L + +N L   I      ++SL +LDLS N+     +     NL  L  L L    F 
Sbjct: 103 EYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159

Query: 137 GKIPSTLLRCKHLQTLSLSINDFSG-DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLA 195
            ++    +   HL  + L +  +       E   +     LHL  +       +   ++ 
Sbjct: 160 -QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218

Query: 196 ELEKLQLQNNFLTGTIPPSIFNLS-----SLSDLELSFNSLTGNFPKDMHIVNRLSAELP 250
            L  LQL N  L       +           + L ++   +   +   + +         
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF----- 273

Query: 251 AKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHE 310
                    +E + +        I  +            L  L    ++           
Sbjct: 274 -----WPRPVEYLNIYNLTITERIDREEFT----YSETALKSLMIEHVKNQVFLFSKEAL 324

Query: 311 IDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELS 370
                 +   + S +    +      + S+  FL    N  F          L  L+ L 
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV-FTDSVFQGCSTLKRLQTLI 383

Query: 371 LSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL----RNLKWLDLGDNYLTS 426
           L  N            T  +S+LE    S +    + +        ++  L+L  N LT 
Sbjct: 384 LQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442

Query: 427 STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEIN 486
           S                               V   L   ++   + N+ I  SIPK++ 
Sbjct: 443 S-------------------------------VFRCLPPKVKVLDLHNNRIM-SIPKDVT 470

Query: 487 NLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDN 523
           +L  L  + +  N+L         +L  LQ + L DN
Sbjct: 471 HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  108 bits (272), Expect = 1e-24
 Identities = 89/461 (19%), Positives = 162/461 (35%), Gaps = 65/461 (14%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDF-SGTIPKEIGNVTTLIGLHLRG 59
             +LEYL +  N     I         LR++ LS NDF    + KE GN+T L  L L  
Sbjct: 99  NQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSN-----LDLSVNNLTGEL 114
            K +     +L  +A L    +  + ++  I         + N     L    N+L    
Sbjct: 156 AKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212

Query: 115 LANICSNLPLLQTLFLDENNFDGKIPSTLLRCK----HLQTLSLSINDFSGDIPKEIGNL 170
           +    + L  LQ   +  N+ + +   T L        L  ++L   + +     ++   
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272

Query: 171 ---TKLKYLHLDQNRLQGEIPEELGN-----LAELEKLQLQNNFLTGTIPPSIFN-LSSL 221
                ++YL++    +   I  E        L  L    ++N         ++++  + +
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEM 331

Query: 222 SDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC 281
           +   LS +                   +      +      +  ++N+F     +D    
Sbjct: 332 NIKMLSISDTP---------------FIHMVCPPSPSSFTFLNFTQNVF-----TDS--- 368

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCV--IPHEIDNLHNLEWMIFSFNKL-VGVVPTTIFNV 338
            + +    L +L+ L LQ N L+    +     N+ +LE +  S N L       T    
Sbjct: 369 -VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427

Query: 339 STLKFLYLGSN----SFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE 394
            ++  L L SN    S F  LP       P ++ L L  N    +IP  + +   L  L 
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP-------PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479

Query: 395 LQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
           +  N         F  L +L+++ L DN    +   + +LS
Sbjct: 480 VASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLS 520

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  105 bits (264), Expect = 1e-23
 Identities = 89/467 (19%), Positives = 151/467 (32%), Gaps = 49/467 (10%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           LS L  L L  N             + L  + +S N     I      + +L  L L  N
Sbjct: 75  LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFN 131

Query: 61  KLQGEIPE--ELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLT---GELL 115
                +P   E GNL +L  L L        +         LS + L + +     GE  
Sbjct: 132 DFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETE 189

Query: 116 ANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG----DIPKEIGNLT 171
           +    N  +L  +F   + F  ++  ++    HLQ  ++ +ND +         E+    
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249

Query: 172 KLKYLHLDQNRLQGEIPEELGNLAE---LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSF 228
            L  + L       +   +L        +E L + N  +T  I    F  S  +   L  
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309

Query: 229 NSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG 288
                      H+ N++         +    +    LS +    + P     C       
Sbjct: 310 E----------HVKNQVFLFSKEALYSVFAEMNIKMLSIS----DTPFIHMVCP-----P 350

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
           + +    L+   N     +      L  L+ +I   N L             +  L    
Sbjct: 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLD 409

Query: 349 NSFFGRLPSSADVRL----PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFI 404
            S    L S A  R      ++  L+LS N  +G++   +    K+  L+L  N     I
Sbjct: 410 VS-LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-I 465

Query: 405 PNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNP 451
           P    +L+ L+ L++  N L S      F        L+Y  + +NP
Sbjct: 466 PKDVTHLQALQELNVASNQLKSVPDG-VF---DRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 89.2 bits (221), Expect = 2e-18
 Identities = 71/458 (15%), Positives = 124/458 (27%), Gaps = 85/458 (18%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGT-IPKEIGNVTTLIGLHLRG 59
           L+ L +L L +  F  ++         L  I L L  +       E   +     LHL  
Sbjct: 145 LTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTG-------TIPSSIFNLSSLSNLDLSVNNLTG 112
           +       +   ++  L  L L N  L         T  S +    +L N+ L     T 
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263

Query: 113 ELLANICSNLPL--LQTLFLDENNFDGKIP-----STLLRCKHLQTLSLSINDFSGDIPK 165
           +    +        ++ L +       +I       +    K L    +    F      
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323

Query: 166 EIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLE 225
                 ++    L  +           + +    L    N  T ++      L  L  L 
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383

Query: 226 LSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPK 285
           L  N L                                                     K
Sbjct: 384 LQRNGLK-------------------------------------------------NFFK 394

Query: 286 EIGNLAKLEKLDLQFNRLQCVIPHEIDNL----HNLEWMIFSFNKLVGVVPTTIFNVSTL 341
                  +  L+     L  +  H  D       ++  +  S N L G V   +     +
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKV 452

Query: 342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSF 400
           K L L +N     +P      L  L+EL+++ N    ++P  +F   + L  + L  N +
Sbjct: 453 KVLDLHNNR-IMSIPKDVT-HLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

Query: 401 ----------SGFIPNTFGNLRNLKWLDLGDNYLTSST 428
                     S +I    G +RN       D+   S +
Sbjct: 510 DCTCPGIRYLSEWINKHSGVVRNSAGSVAPDSAKCSGS 547

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  117 bits (295), Expect = 9e-29
 Identities = 59/297 (19%), Positives = 115/297 (38%), Gaps = 54/297 (18%)

Query: 756  NLIGRGGFGFVYKARIQD------GMEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRN 807
              +G G FG V +A           ++VAVK +    +    ++   E  ++  + +H N
Sbjct: 52   KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSL-------------EKCLYSSNYILDIFQRLNIMI 854
            I+  + +C+      ++ EY  YG L             +     +N        L+   
Sbjct: 112  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 855  DVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
             VA  + +L   +       IH D+   NVLL +  VA + DFG+A+  + +   + +  
Sbjct: 172  QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 912  TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLL 970
                + +MAPE   +   +   DV+S+GI+L E F+    P    + G +          
Sbjct: 226  ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----YPGILV--------- 272

Query: 971  LISIMEVVDANLLSH-EDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                    ++      +D + +A+       ++++   C    P  R   ++I + L
Sbjct: 273  --------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  119 bits (300), Expect = 1e-28
 Identities = 68/257 (26%), Positives = 104/257 (40%), Gaps = 27/257 (10%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEE-LGNLAEL 76
           +P  +S     R ++L  N           ++  L  L L  N ++  I       LA L
Sbjct: 58  VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114

Query: 77  EELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
             L L +N LT TIP+  F  LS L  L L  N +   + +   + +P L+ L L E   
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172

Query: 136 DGKIPSTLLR-CKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNL 194
              I         +L+ L+L++ +   +IP  +  L KL  L L  N L    P     L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGL 230

Query: 195 AELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF 253
             L+KL +  + +   I  + F NL SL ++ L+ N+LT                LP   
Sbjct: 231 MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT---------------LLPHDL 274

Query: 254 CNNIPFLEEIYLSKNMF 270
              +  LE I+L  N +
Sbjct: 275 FTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  117 bits (296), Expect = 3e-28
 Identities = 61/264 (23%), Positives = 102/264 (38%), Gaps = 34/264 (12%)

Query: 162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSS 220
           ++P  I   T  + L+L +N++Q        +L  LE LQL  N +  TI    F  L++
Sbjct: 57  EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113

Query: 221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN 280
           L+ LEL  N LT                +P      +  L+E++L  N     IPS    
Sbjct: 114 LNTLELFDNRLT---------------TIPNGAFVYLSKLKELWLRNNPI-ESIPSYA-- 155

Query: 281 CTIPKEIGNLAKLEKLDLQ-FNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS 339
                    +  L +LDL    RL  +     + L NL ++  +   L  +    +  + 
Sbjct: 156 ------FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLI 207

Query: 340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRN 398
            L  L L  N     +   +   L +L++L +  +     I    F N   L  + L  N
Sbjct: 208 KLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHN 265

Query: 399 SFSGFIPNTFGNLRNLKWLDLGDN 422
           + +    + F  L +L+ + L  N
Sbjct: 266 NLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  115 bits (290), Expect = 3e-27
 Identities = 71/270 (26%), Positives = 107/270 (39%), Gaps = 38/270 (14%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSS 99
            +P  I   T L  L+L  N++Q        +L  LE L L  N +  TI    F  L++
Sbjct: 57  EVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113

Query: 100 LSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLR-CKHLQTLSLSIND 158
           L+ L+L  N LT  +       L  L+ L+L  N  +  IPS        L+ L L    
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171

Query: 159 FSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF- 216
               I +     L+ L+YL+L    L+ EIP  L  L +L++L L  N L+  I P  F 
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQ 228

Query: 217 NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPS 276
            L  L  L +  + +                 +     +N+  L EI L+ N        
Sbjct: 229 GLMHLQKLWMIQSQIQ---------------VIERNAFDNLQSLVEINLAHNNLT----- 268

Query: 277 DLGNCTIPKEI-GNLAKLEKLDLQFNRLQC 305
                 +P ++   L  LE++ L  N   C
Sbjct: 269 -----LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  115 bits (289), Expect = 3e-27
 Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 37/281 (13%)

Query: 75  ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN 134
           +  ++      L   +P  I   ++   L+L  N +   +  N   +L  L+ L L  N+
Sbjct: 44  QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99

Query: 135 FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEEL-G 192
                        +L TL L  N  +  IP      L+KLK L L  N ++  IP     
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157

Query: 193 NLAELEKLQLQ-NNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELP 250
            +  L +L L     L+  I    F  LS+L  L L+  +L                E+P
Sbjct: 158 RIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR---------------EIP 201

Query: 251 AKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHE 310
                 +  L+E+ LS N     I               L  L+KL +  +++Q +  + 
Sbjct: 202 N-L-TPLIKLDELDLSGNHL-SAIRPGS--------FQGLMHLQKLWMIQSQIQVIERNA 250

Query: 311 IDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
            DNL +L  +  + N L  +       +  L+ ++L  N +
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  112 bits (281), Expect = 3e-26
 Identities = 63/285 (22%), Positives = 108/285 (37%), Gaps = 35/285 (12%)

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
           CS       +     N   ++P  +    + + L+L  N           +L  L+ L L
Sbjct: 39  CSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95

Query: 179 DQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFP 236
            +N ++  I       LA L  L+L +N LT TIP   F  LS L +L L  N +     
Sbjct: 96  SRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE---- 149

Query: 237 KDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKL 296
                       +P+   N IP L  + L +      I               L+ L  L
Sbjct: 150 -----------SIPSYAFNRIPSLRRLDLGELKRLSYISEGA--------FEGLSNLRYL 190

Query: 297 DLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLP 356
           +L    L+ +    +  L  L+ +  S N L  + P +   +  L+ L++  +     + 
Sbjct: 191 NLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIE 247

Query: 357 SSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSF 400
            +A   L +L E++L+ NN +  +P  +F     L  + L  N +
Sbjct: 248 RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (274), Expect = 2e-25
 Identities = 64/235 (27%), Positives = 88/235 (37%), Gaps = 34/235 (14%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L +LE L L  N          +    L                          L L  N
Sbjct: 87  LRHLEILQLSRNHIRTIEIGAFNGLANLNT------------------------LELFDN 122

Query: 61  KLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           +L   IP      L++L+ELWL+NN +  +IPS  F  + SL  LDL        +    
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
              L  L+ L L   N   +IP  L     L  L LS N  S   P     L  L+ L +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238

Query: 179 DQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSL 231
            Q+++Q  I      NL  L ++ L +N LT  +P  +F  L  L  + L  N  
Sbjct: 239 IQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (261), Expect = 1e-23
 Identities = 54/270 (20%), Positives = 93/270 (34%), Gaps = 33/270 (12%)

Query: 196 ELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
           +  K+      L   +P  I   ++   L L  N +                 +      
Sbjct: 44  QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ---------------IIKVNSFK 85

Query: 256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH 315
           ++  LE + LS+N     I               LA L  L+L  NRL  +       L 
Sbjct: 86  HLRHLEILQLSRNHI-RTIEIGA--------FNGLANLNTLELFDNRLTTIPNGAFVYLS 136

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
            L+ +    N +  +       + +L+ L LG       +   A   L NL  L+L+  N
Sbjct: 137 KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN 196

Query: 376 FSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
               IP+      KL  L+L  N  S   P +F  L +L+ L +  + +       +F  
Sbjct: 197 LR-EIPNLT-PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAF-- 251

Query: 436 SSNCKYLEYFSISNNPLGGILPRVIGNLSQ 465
             N + L   ++++N L  +   +   L  
Sbjct: 252 -DNLQSLVEINLAHNNLTLLPHDLFTPLHH 280

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.8 bits (236), Expect = 2e-20
 Identities = 62/295 (21%), Positives = 115/295 (38%), Gaps = 50/295 (16%)

Query: 364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY 423
               ++     N    +P  I   +    L L  N       N+F +LR+L+ L L  N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 424 LTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPK 483
           + +    +   + +    L    + +N L  I       LS  +++  + N+ I  SIP 
Sbjct: 100 IRT----IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLS-KLKELWLRNNPIE-SIPS 153

Query: 484 EI-NNLTNLIAIYLG-VNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTS 541
              N + +L  + LG + +L+     A   L  L+ L+L    L                
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--------------RE 199

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
           IP+                         +  L  L ++DLS N+ S + P +  GL  LQ
Sbjct: 200 IPN-------------------------LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234

Query: 602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
            L++  +++Q    ++  ++ +L  +NL++NNL  +       L  L+ I++  N
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 6/138 (4%)

Query: 1   LSNLEYLFLKSNMFHGKIPS-TLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRG 59
           + +L  L L        I          LR ++L++ +    IP  +  +  L  L L G
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           N L    P     L  L++LW+  + +   I  + F NL SL  ++L+ NNLT  L  ++
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274

Query: 119 CSNLPLLQTLFLDENNFD 136
            + L  L+ + L  N ++
Sbjct: 275 FTPLHHLERIHLHHNPWN 292

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  116 bits (292), Expect = 2e-28
 Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 28/215 (13%)

Query: 758 IGRGGFGFVYKARI------QDGMEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRNII 809
           +G G FG V +A           M VAVK +    +    ++   E  ++  +  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----------------EKCLYSSNYILDIFQRLNI 852
             + +C+      ++ EY  YG L                    +      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+    +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 913 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
              + +MAPE       +   DV+S+GI L E F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  116 bits (292), Expect = 3e-28
 Identities = 54/296 (18%), Positives = 109/296 (36%), Gaps = 34/296 (11%)

Query: 149 LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFL 207
           +++L LS N  +     ++     L+ L L  N +   I E+   +L  LE L L  N+L
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112

Query: 208 TGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLS 266
           +  +  S F  LSSL+ L L  N                         +++  L+ + + 
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGN--------------PYKTLGETSLFSHLTKLQILRVG 157

Query: 267 KNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNK 326
               + +I               L  LE+L++  + LQ   P  + ++ N+  +I    +
Sbjct: 158 NMDTFTKIQRKD--------FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209

Query: 327 LVGVVPTTIFNVSTLKFLYLGSNSFFG-------RLPSSADVRLPNLEELSLSGNNFSGT 379
            + ++   +   S+++ L L                 +++ ++      + ++  +    
Sbjct: 210 HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-Q 268

Query: 380 IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
           +   +   S L  LE  RN         F  L +L+ + L  N    S   + +LS
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 324

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  112 bits (282), Expect = 6e-27
 Identities = 60/273 (21%), Positives = 102/273 (37%), Gaps = 24/273 (8%)

Query: 50  TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVN 108
             +  L L  N++      +L     L+ L L +N +  TI    F +L SL +LDLS N
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLR-CKHLQTLSLSINDFSGDIPKEI 167
            L+  L ++    L  L  L L  N +     ++L      LQ L +   D    I ++ 
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 168 -GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLE 225
              LT L+ L +D + LQ   P+ L ++  +  L L        +        SS+  LE
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228

Query: 226 LSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPK 285
           L    L           + LS                + ++    +           + K
Sbjct: 229 LRDTDLDTF------HFSELSTGETNSLI-KKFTFRNVKITDESLF----------QVMK 271

Query: 286 EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLE 318
            +  ++ L +L+   N+L+ V     D L +L+
Sbjct: 272 LLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQ 304

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (255), Expect = 2e-23
 Identities = 48/245 (19%), Positives = 92/245 (37%), Gaps = 18/245 (7%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
             NL+ L L SN  +     + S+   L ++ LS N  S  +       +++L  L+L G
Sbjct: 75  CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133

Query: 60  NKLQGEIPEE--LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLA 116
           N  +  + E     +L +L+ L + N      I    F  L+ L  L++  ++L      
Sbjct: 134 NPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEP 191

Query: 117 NICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI--------G 168
               ++  +  L L        +   +     ++ L L   D       E+         
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251

Query: 169 NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELS 227
                + + +    L  ++ + L  ++ L +L+   N L  ++P  IF  L+SL  + L 
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLH 309

Query: 228 FNSLT 232
            N   
Sbjct: 310 TNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  100 bits (250), Expect = 8e-23
 Identities = 45/238 (18%), Positives = 88/238 (36%), Gaps = 3/238 (1%)

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
               L+ L L  N +  +      +L +LE +  S+N L  +  +    +S+L FL L  
Sbjct: 74  RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLG 133

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNT 407
           N +     +S    L  L+ L +   +    I    F   + L  LE+  +    + P +
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193

Query: 408 FGNLRNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQS 466
             +++N+  L L            +   SS  C  L    +       +      +L + 
Sbjct: 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253

Query: 467 MEDFHMPNSNIS-GSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDN 523
               ++  ++ S   + K +N ++ L+ +    N+L         +L  LQ + L  N
Sbjct: 254 FTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.4 bits (196), Expect = 7e-16
 Identities = 50/330 (15%), Positives = 114/330 (34%), Gaps = 58/330 (17%)

Query: 346 LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
           + S S       ++ +          S  + + +IPS +     + +L+L  N  +    
Sbjct: 14  IISLSKEESSNQAS-LSCDRNGICKGSSGSLN-SIPSGLTEA--VKSLDLSNNRITYISN 69

Query: 406 NTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQ 465
           +      NL+ L L  N + +   E SF S  +   LE+  +S N L  +          
Sbjct: 70  SDLQRCVNLQALVLTSNGINT-IEEDSFSSLGS---LEHLDLSYNYLSNLSSSW------ 119

Query: 466 SMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSIL--IALGKLKKLQLLSLKDN 523
               F                 L++L  + L  N    ++        L KLQ+L + + 
Sbjct: 120 ----FK---------------PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNM 159

Query: 524 QLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSI 583
                I                   L  +  L +  +      P  + +++ +  + L +
Sbjct: 160 DTFTKIQRK------------DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207

Query: 584 NNFSDVIPTTIGGLKDLQYLFLKYNRLQG----SIP----DSIGDMINLKSLNLSNNNLF 635
                ++   +     ++ L L+   L       +     +S+      +++ +++ +LF
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267

Query: 636 GIIPISLEKLLDLKDINVSFNKLEGEIPRE 665
            ++ + L ++  L ++  S N+L+  +P  
Sbjct: 268 QVMKL-LNQISGLLELEFSRNQLKS-VPDG 295

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  114 bits (288), Expect = 3e-28
 Identities = 59/220 (26%), Positives = 81/220 (36%), Gaps = 14/220 (6%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEE-LGNLAEL 76
           +P  +      + I L  N  S            L  L L  N L   I       LA L
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82

Query: 77  EELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
           E+L L +N    ++  + F  L  L  L L    L  EL   +   L  LQ L+L +N  
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 136 DGKIPSTLLR-CKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEE-LG 192
              +P    R   +L  L L  N  S  +P+     L  L  L L QNR+   +      
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198

Query: 193 NLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSL 231
           +L  L  L L  N L+  +P      L +L  L L+ N  
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  111 bits (279), Expect = 4e-27
 Identities = 60/233 (25%), Positives = 90/233 (38%), Gaps = 27/233 (11%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSS 99
            +P  I   +    + L GN++             L  LWL +N L   I ++ F  L+ 
Sbjct: 25  AVPVGIPAASQR--IFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 100 LSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLR-CKHLQTLSLSIND 158
           L  LDLS N     +       L  L TL LD      ++   L R    LQ L L  N 
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNA 140

Query: 159 FSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIF 216
               +P +   +L  L +L L  NR+   +PE     L  L++L L  N +   + P  F
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAF 197

Query: 217 -NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKN 268
            +L  L  L L  N+L+                LP +    +  L+ + L+ N
Sbjct: 198 RDLGRLMTLYLFANNLS---------------ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  106 bits (267), Expect = 2e-25
 Identities = 58/273 (21%), Positives = 93/273 (34%), Gaps = 57/273 (20%)

Query: 82  QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPS 141
               L   +P  I   ++   + L  N ++  + A        L  L+L  N       +
Sbjct: 19  PQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 142 TLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEE-LGNLAELEK 199
                  L+ L LS N     +       L +L  LHLD+  LQ E+       LA L+ 
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133

Query: 200 LQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIP 258
           L LQ+N L   +P   F +L +L+ L L  N ++                          
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-------------------------- 166

Query: 259 FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLE 318
                 + +  F G                 L  L++L L  NR+  V PH   +L  L 
Sbjct: 167 -----SVPERAFRG-----------------LHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

Query: 319 WMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
            +    N L  +    +  +  L++L L  N +
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 11/220 (5%)

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTL 341
            +P  I   A  +++ L  NR+  V         NL  +    N L  +       ++ L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSF 400
           + L L  N+    +  +    L  L  L L        +   +F   + L  L LQ N+ 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 401 SGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVI 460
                +TF +L NL  L L  N ++ S  E +F        L+   +  N +  + P   
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRIS-SVPERAF---RGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 461 GNLSQSMEDFHMPNSNISGSIPKEI-NNLTNLIAIYLGVN 499
            +L   +   ++  +N+S ++P E    L  L  + L  N
Sbjct: 198 RDLG-RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 41/194 (21%), Positives = 68/194 (35%), Gaps = 18/194 (9%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDN------- 532
           ++P  I        I+L  N+++     +    + L +L L  N L   I          
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 533 -----LSFSCTLTSIPS-TLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINN 585
                LS +  L S+   T   L  +  L+L        L   +   L  L  + L  N 
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNA 140

Query: 586 FSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKL 645
              +   T   L +L +LFL  NR+      +   + +L  L L  N +  + P +   L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 646 LDLKDINVSFNKLE 659
             L  + +  N L 
Sbjct: 201 GRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 23/112 (20%), Positives = 34/112 (30%), Gaps = 28/112 (25%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L NL +LFL  N               L                          L L  N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDR------------------------LLLHQN 187

Query: 61  KLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNL 110
           ++   +      +L  L  L+L  N L+  +P+     L +L  L L+ N  
Sbjct: 188 RVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 3e-28
 Identities = 37/249 (14%), Positives = 73/249 (29%), Gaps = 59/249 (23%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIR-------- 804
           ++G+       +A   + G    V V          AIK    E   ++ +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 805 --------------HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLY----------SS 840
                              K I     +    ++  +  Y  ++  L           S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 841 NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF 900
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260

Query: 901 LKEDQSLTQTQTLATIGYMAPEY----------GREGRVSTNGDVYSFGIMLMETFTRKK 950
              D +   +      G+  PE                ++   D ++ G+ +   +    
Sbjct: 261 ---DGASAVSPI--GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 951 PTDESFTGE 959
           P     T +
Sbjct: 316 P----NTDD 320

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  114 bits (288), Expect = 4e-28
 Identities = 62/303 (20%), Positives = 110/303 (36%), Gaps = 62/303 (20%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            F E  ++G+G FG V KAR   D    A+K         + +   E  ++  + H+ +++
Sbjct: 8    FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVR 66

Query: 811  FISSCSSDDFKA-------------LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA 857
            + ++                     + +EY   G+L   ++S N      +   +   + 
Sbjct: 67   YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 858  SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--------LKEDQSLTQ 909
             AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK          L        
Sbjct: 127  EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 910  TQTLAT-IG---YMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG 958
            +  L + IG   Y+A E       Y  +       D+YS GI+  E            TG
Sbjct: 184  SDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIY--PF----STG 231

Query: 959  EMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA 1018
                      + ++  +  V        D + +  E+       +        P +R  A
Sbjct: 232  M-------ERVNILKKLRSVSIEFPPDFDDNKMKVEK------KIIRLLIDHDPNKRPGA 278

Query: 1019 KEI 1021
            + +
Sbjct: 279  RTL 281

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (290), Expect = 4e-28
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 30/214 (14%)

Query: 756 NLIGRGGFGFVYKARIQDG---MEVAVKVFDLQYG---RAIKSFDIECGMIKRI-RHRNI 808
           ++IG G FG V KARI+     M+ A+K   ++        + F  E  ++ ++  H NI
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 809 IKFISSCSSDDFKALVLEYMPYGSL---------------EKCLYSSNYILDIFQRLNIM 853
           I  + +C    +  L +EY P+G+L                    S+   L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T   
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202

Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
             + +MA E       +TN DV+S+G++L E  +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  116 bits (291), Expect = 5e-28
 Identities = 33/303 (10%), Positives = 74/303 (24%), Gaps = 57/303 (18%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
             +  G    V+  R ++   + A+KVF          ++          R+   +  +  
Sbjct: 69   PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 813  SSC----------------------SSDDFKA----LVLEYM-----PYGSLEKCLYSSN 841
                                       DD+      L++           S    +Y   
Sbjct: 129  DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 842  YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL 901
                I     +   +      L    S  ++H    P+N+ +  +    L D        
Sbjct: 189  GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 902  KEDQSLTQTQTLATIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
            K       +     + Y   E+        +   + +  G+ +   +    P    F   
Sbjct: 243  KVGTRGPASSV--PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----F--- 293

Query: 960  MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAK 1019
                  +    +    +     +   +   F +      FV  L  +        R+   
Sbjct: 294  -----GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348

Query: 1020 EIV 1022
            E +
Sbjct: 349  EAM 351

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  116 bits (292), Expect = 6e-28
 Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 51/295 (17%)

Query: 758  IGRGGFGFVYKARIQD--------GMEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRN 807
            +G G FG V  A              +VAVK +      + +     E  M+K I +H+N
Sbjct: 77   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSL---------------EKCLYSSNYILDIFQRLNI 852
            II  + +C+ D    +++EY   G+L                   ++    L     ++ 
Sbjct: 137  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 853  MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
               VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+     D     T  
Sbjct: 197  AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 913  LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR-KKPTDESFTGEMTLKRWVNDLLL 971
               + +MAPE   +   +   DV+SFG++L E FT    P    + G             
Sbjct: 254  RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP----YPG------------- 296

Query: 972  ISIMEVVDANLLSHEDKHFVAK-EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            + + E+    LL  ++ H + K   C + ++ +   C    P +R   K++V  L
Sbjct: 297  VPVEELFK--LL--KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (285), Expect = 8e-28
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 18/199 (9%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           ++    IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           ++ S    D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IG---YMAPEYGR 925
           +IH D+K +N+LL  +    L+DFG           +T  Q+  +  +G   +MAPE   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA-------QITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 926 EGRVSTNGDVYSFGIMLME 944
                   D++S GIM +E
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (284), Expect = 2e-27
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 18/199 (9%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           F     +G G +G VYKA   + G  VA+K   ++    ++    E  ++++    +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
           +  S   +    +V+EY   GS+   +   N  L   +   I+      LEYLH    + 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IG---YMAPEYGR 925
            IH D+K  N+LL+    A L+DFG+A         LT T       IG   +MAPE  +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 926 EGRVSTNGDVYSFGIMLME 944
           E   +   D++S GI  +E
Sbjct: 199 EIGYNCVADIWSLGITAIE 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  112 bits (283), Expect = 2e-27
 Identities = 57/292 (19%), Positives = 107/292 (36%), Gaps = 53/292 (18%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISS 814
             +GRGGFG V++A+   D    A+K   L     A +    E   + ++ H  I+++ ++
Sbjct: 12   CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 815  CSSDDFKA------------LVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASAL 860
                +               + ++     +L+  +    +    +    L+I + +A A+
Sbjct: 72   WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 861  EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG--- 917
            E+LH   S  ++H DLKP+N+    + V  + DFG+    + +D+      T        
Sbjct: 132  EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTPMPAYARH 187

Query: 918  --------YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL 969
                    YM+PE       S   D++S G++L E           F+ +M         
Sbjct: 188  TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------FSTQMERV-----R 235

Query: 970  LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
             L  +  +    L + +                +       SP ER  A  I
Sbjct: 236  TLTDVRNLKFPPLFTQKYPCEY----------VMVQDMLSPSPMERPEAINI 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  117 bits (295), Expect = 2e-27
 Identities = 80/457 (17%), Positives = 142/457 (31%), Gaps = 66/457 (14%)

Query: 41  TIPKEIGNVTTLIGL--HLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLS 98
           +I   I N  +L     +   +    +         +        N     +   +  ++
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59

Query: 99  SLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIND 158
             S L L+  NL+  L  N+      +  L + +N     +P        L+ L    N 
Sbjct: 60  QFSELQLNRLNLS-SLPDNLPPQ---ITVLEITQNALI-SLPELP---ASLEYLDACDNR 111

Query: 159 FSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNL 218
            S  +P+   +   LK+L +D N+L   +PE       LE +   NN LT  +P    +L
Sbjct: 112 LS-TLPELPAS---LKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTSL 162

Query: 219 SSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDL 278
             LS   +  N LT                LP    +    LE + +S N+         
Sbjct: 163 EVLS---VRNNQLT---------------FLPELPES----LEALDVSTNLL-------- 192

Query: 279 GNCTIPKEIGNLAKLEK----LDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTT 334
              ++P         E+       + NR+   IP  I +L     +I   N L       
Sbjct: 193 --ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRE 248

Query: 335 IFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE 394
             +  T +  Y G   +F       +     L +       F     S +         E
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT--AWFPENKQSDVSQIWHAFEHE 306

Query: 395 LQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGG 454
              N+FS         L +         +     + L  LS+S     + F+++ +    
Sbjct: 307 EHANTFS----AFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATES 362

Query: 455 ILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNL 491
              RV    +  +    + +    G    +   L +L
Sbjct: 363 CEDRVALTWNN-LRKTLLVHQASEGLFDNDTGALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  106 bits (265), Expect = 9e-24
 Identities = 60/335 (17%), Positives = 105/335 (31%), Gaps = 40/335 (11%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
              +  L +  N     +P   ++   L  +    N  S T+P+   +   L  L +  N
Sbjct: 79  PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPAS---LKHLDVDNN 130

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTG--ELLANI 118
           +L   +PE    L   E +   NN LT  +P      +SL  L +  N LT   EL  + 
Sbjct: 131 QLT-MLPELPALL---EYINADNNQLT-MLPELP---TSLEVLSVRNNQLTFLPELPES- 181

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQT----LSLSINDFSGDIPKEIGNLTKLK 174
                 L+ L +  N  +  +P+  +R  H +          N  +  IP+ I +L    
Sbjct: 182 ------LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTC 233

Query: 175 YLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN 234
            + L+ N L   I E L              +   ++     N       +        N
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPEN 291

Query: 235 FPKDM-HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
              D+  I +    E      +   F   +    +       S      +   +  L+  
Sbjct: 292 KQSDVSQIWHAFEHEE-----HANTFSAFLDRLSDTVSARNTSGFRE-QVAAWLEKLSAS 345

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLV 328
            +L  Q   +        ++   L W       LV
Sbjct: 346 AELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  101 bits (253), Expect = 3e-22
 Identities = 62/318 (19%), Positives = 113/318 (35%), Gaps = 56/318 (17%)

Query: 363 LPNLEELSLSGNNFSGTIPSFIFNT-------SKLSTLELQRNSFSGFIPNTFGNLRNLK 415
           LP     SLS N+F  TI     +         K +     RN     +      +    
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62

Query: 416 WLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNS 475
            L L    L+S       L  +    +    I+ N L   LP +  +L    E     ++
Sbjct: 63  ELQLNRLNLSS-------LPDNLPPQITVLEITQNALI-SLPELPASL----EYLDACDN 110

Query: 476 NISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSF 535
            +S ++P+   +L +L    +  N+L  ++L  L     L+ ++  +NQL          
Sbjct: 111 RLS-TLPELPASLKHL---DVDNNQL--TMLPEL--PALLEYINADNNQL---------- 152

Query: 536 SCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIG 595
               T +P    +L+    L++  N  T  LP    +L+ L   D+S  N  + +P    
Sbjct: 153 ----TMLPELPTSLEV---LSVRNNQLTF-LPELPESLEAL---DVS-TNLLESLPAVPV 200

Query: 596 GLKDLQ----YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDI 651
                +    +   + NR+   IP++I  +    ++ L +N L   I  SL +     D 
Sbjct: 201 RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 652 NVSFNKLEGEIPREGPFR 669
           +           ++    
Sbjct: 260 HGPRIYFSMSDGQQNTLH 277

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  113 bits (284), Expect = 2e-27
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 18/199 (9%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
                 IG G  G V  AR    G +VAVK+ DL+  +  +    E  +++  +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              S    +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IG---YMAPEYGR 925
           +IH D+K +++LL  +    LSDFG           +++        +G   +MAPE   
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA-------QISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 926 EGRVSTNGDVYSFGIMLME 944
               +T  D++S GIM++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (290), Expect = 2e-27
 Identities = 60/300 (20%), Positives = 110/300 (36%), Gaps = 53/300 (17%)

Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIK 810
                 ++G G  G V       G  VAVK   +     A+    +   + +   H N+I+
Sbjct: 17   VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL---LTESDDHPNVIR 73

Query: 811  FISSCSSDDFKALVLEYMPYGSLE------KCLYSSNYILDIFQRLNIMIDVASALEYLH 864
            +  S ++D F  + LE     +L+           +  +   +  ++++  +AS + +LH
Sbjct: 74   YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 865  FGYSVPIIHCDLKPNNVLLD-------------DNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
               S+ IIH DLKP N+L+              +N+   +SDFG+ K       S     
Sbjct: 133  ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 912  TLA--TIGYMAPEYGREGRVSTNG-------DVYSFGIMLMETFTRKK-PTDESFTGEMT 961
                 T G+ APE   E              D++S G +     ++ K P  + ++ E  
Sbjct: 190  NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249

Query: 962  LKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            + R +  L     M+ +    L  E    +              +     P +R  A ++
Sbjct: 250  IIRGIFSL---DEMKCLHDRSLIAEATDLI-------------SQMIDHDPLKRPTAMKV 293

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (285), Expect = 3e-27
 Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 33/220 (15%)

Query: 758 IGRGGFGFVYKARIQDG------MEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRNII 809
           +G G FG V  A           ++VAVK + +       ++   E  M+ ++  H NI+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 810 KFISSCSSDDFKALVLEYMPYGSL----------------------EKCLYSSNYILDIF 847
             + +C+      L+ EY  YG L                               +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL 907
             L     VA  +E+L        +H DL   NVL+    V  + DFG+A+  + +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            +      + +MAPE   EG  +   DV+S+GI+L E F+
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  115 bits (290), Expect = 3e-27
 Identities = 75/452 (16%), Positives = 136/452 (30%), Gaps = 68/452 (15%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK 61
            N       +         +      L ++    +  +      I  +T L  L    N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75

Query: 62  LQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSN 121
           +   +   L     L  L   +N LT  +   +  L+ L+ L+   N LT        S 
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT----KLDVSQ 125

Query: 122 LPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQN 181
            PLL  L    N    +I   +     L  L   +N     +   +   T+L  L    N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180

Query: 182 RLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHI 241
           ++      ++     L +L    N +T  +  +      L+ L+ S N LT         
Sbjct: 181 KITE---LDVSQNKLLNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLT--------- 225

Query: 242 VNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFN 301
                 E+       +  L     S N    E+            +  L+KL  L     
Sbjct: 226 ------EIDV---TPLTQLTYFDCSVNPL-TELD-----------VSTLSKLTTLHCIQT 264

Query: 302 RLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADV 361
            L      EID  HN + + F       +    + + + L  L   +      +      
Sbjct: 265 DLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAA----GITELDLS 315

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
           + P L  L L+    +  +   + + +KL +L         F  ++ G +  L      +
Sbjct: 316 QNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAE 370

Query: 422 NYLTS-STSELSFLSSSNCKYLEYFSISNNPL 452
               +     L+  S +     +      NP+
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  107 bits (270), Expect = 1e-24
 Identities = 78/514 (15%), Positives = 148/514 (28%), Gaps = 99/514 (19%)

Query: 48  NVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV 107
           N  + +                   LA L  L   N+ +T    + I  L+ L+ L  + 
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73

Query: 108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI 167
           NN+T   L    S    L  L  D N     +   +     L  L+   N  +     ++
Sbjct: 74  NNITTLDL----SQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLTKL---DV 123

Query: 168 GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELS 227
                L YL+  +N L  EI   + +  +L +L    N         +   + L+ L+ S
Sbjct: 124 SQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCS 178

Query: 228 FNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEI 287
           FN +T               EL          L  +    N       + L       ++
Sbjct: 179 FNKIT---------------ELDVSQNKL---LNRLNCDTNNI-----TKL-------DL 208

Query: 288 GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG 347
               +L  LD   N+L  +   ++  L  L +   S N L  +    +  +S L  L+  
Sbjct: 209 NQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCI 262

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNT 407
                  +  +       L      G      +   + + ++L  L+ Q    +      
Sbjct: 263 QTDL-LEIDLT---HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---D 313

Query: 408 FGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSM 467
                 L +L L +  LT        L  S+   L+  S  N  +               
Sbjct: 314 LSQNPKLVYLYLNNTELTE-------LDVSHNTKLKSLSCVNAHI--------------- 351

Query: 468 EDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEG 527
                   + S      +  +  L   +    +        L        +S       G
Sbjct: 352 -------QDFS-----SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399

Query: 528 SIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNF 561
           +  +       +    +     +++   N ++ +
Sbjct: 400 NPMNIEPGDGGVYDQATNTITWENLSTDNPAVTY 433

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  104 bits (262), Expect = 9e-24
 Identities = 74/496 (14%), Positives = 141/496 (28%), Gaps = 91/496 (18%)

Query: 149 LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT 208
             +   +  +           L  L  L    + +       +  L  L KL   +N +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77

Query: 209 GTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKN 268
            T+  S    ++L+ L    N LT                L          L  +    N
Sbjct: 78  -TLDLS--QNTNLTYLACDSNKLT---------------NLDVTPLTK---LTYLNCDTN 116

Query: 269 MFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLV 328
                            ++     L  L+   N L  +   ++ +   L  +    NK +
Sbjct: 117 KL------------TKLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI 161

Query: 329 GVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADV-RLPNLEELSLSGNNFSGTIPSFIFNT 387
             +   +   + L  L    N       +  DV +   L  L+   NN +  +   +   
Sbjct: 162 TKLD--VTPQTQLTTLDCSFNKI-----TELDVSQNKLLNRLNCDTNNIT-KLD--LNQN 211

Query: 388 SKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSI 447
            +L+ L+   N  +         L  L + D   N LT        L  S    L     
Sbjct: 212 IQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTE-------LDVSTLSKLTTLHC 261

Query: 448 SNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILI 507
               L  I      +L+ + +  +            ++ + T L  +      +     +
Sbjct: 262 IQTDLLEI------DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITE---L 312

Query: 508 ALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIP-STLWNLKDILCLNLSLNFFTGPL 566
            L +  KL  L L + +L              T +  S    LK + C+N  +  F+   
Sbjct: 313 DLSQNPKLVYLYLNNTEL--------------TELDVSHNTKLKSLSCVNAHIQDFS--- 355

Query: 567 PLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQG---SIPDSIGDMIN 623
              +G +  L     +      +   T+        +        G   +I    G + +
Sbjct: 356 --SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYD 413

Query: 624 LKSLNLSNNNLFGIIP 639
             +  ++  NL    P
Sbjct: 414 QATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  104 bits (262), Expect = 1e-23
 Identities = 74/466 (15%), Positives = 139/466 (29%), Gaps = 89/466 (19%)

Query: 169 NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSF 228
           N         +              LA L  L   N+ +T      I  L+ L+ L  + 
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73

Query: 229 NSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG 288
           N++T                L      N   L  +    N     +            + 
Sbjct: 74  NNIT---------------TLDLSQNTN---LTYLACDSNKLT-NLD-----------VT 103

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
            L KL  L+   N+L  +   ++     L ++  + N L  +    + + + L  L    
Sbjct: 104 PLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHL 157

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTF 408
           N    ++          L  L  S N  +  +   +     L+ L    N+ +       
Sbjct: 158 NK---KITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DL 208

Query: 409 GNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSME 468
                L +LD   N LT        +  +    L YF  S NPL  +    +  L     
Sbjct: 209 NQNIQLTFLDCSSNKLTE-------IDVTPLTQLTYFDCSVNPLTELDVSTLSKL----T 257

Query: 469 DFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGS 528
             H   +++      EI+   N   IY           + +    +L LL  +       
Sbjct: 258 TLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAG---- 308

Query: 529 IPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSD 588
                     +T +   L     ++ L L+    T    L++ +   L  +     +  D
Sbjct: 309 ----------ITELD--LSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQD 353

Query: 589 VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL 634
              +++G +  L   F    +   ++P       N  ++ +S + L
Sbjct: 354 F--SSVGKIPALNNNFEAEGQTI-TMPKETLTN-NSLTIAVSPDLL 395

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  102 bits (255), Expect = 8e-23
 Identities = 81/454 (17%), Positives = 144/454 (31%), Gaps = 72/454 (15%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+ L  L   SN     +   LS    L  ++   N  +  +   +  +T L  L+   N
Sbjct: 63  LTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTN 116

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           KL  ++   +     L  L    N LT  I  S  + + L+ LD  +N    +L     +
Sbjct: 117 KLT-KLD--VSQNPLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKL---DVT 167

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
               L TL    N         + + K L  L+   N+ +  +   +    +L +L    
Sbjct: 168 PQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSS 221

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
           N+L  EI   +  L +L       N LT  +  S   LS L+ L      L         
Sbjct: 222 NKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-------- 267

Query: 241 IVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQF 300
                  E+          L                         ++ +  +L  LD Q 
Sbjct: 268 -------EIDLTHNTQ---LIYFQAEGC-----------RKIKELDVTHNTQLYLLDCQA 306

Query: 301 NRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSAD 360
             +  +   ++     L ++  +  +L  +    + + + LK L   +        S   
Sbjct: 307 AGITEL---DLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAH-IQDFSSVGK 359

Query: 361 VRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG 420
             +P L     +           + N S    +          + + FGN  N++  D G
Sbjct: 360 --IPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD-------LLDQFGNPMNIEPGDGG 410

Query: 421 DNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGG 454
                ++T     LS+ N      F+  N  + G
Sbjct: 411 VYDQATNTITWENLSTDNPAVTYTFTSENGAIVG 444

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (281), Expect = 4e-27
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +     +G G FG VYKA+  + G   A KV + +    ++ + +E  ++    H  I+K
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            + +   D    +++E+ P G+++  +   +  L   Q   +   +  AL +LH   S  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IG---YMAPE--- 922
           IIH DLK  NVL+       L+DFG++           +T       IG   +MAPE   
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 923 --YGREGRVSTNGDVYSFGIMLME 944
               ++       D++S GI L+E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  111 bits (280), Expect = 6e-27
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 26/205 (12%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD-LQYGRAIKSFDIECGMIKRIRHRNIIKF--I 812
           ++G+G    V++ R  + G   A+KVF+ + + R +     E  ++K++ H+NI+K   I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              ++   K L++E+ P GSL   L    + Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 871 IIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPE-YG 924
           I+H ++KP N++     D   V  L+DFG A+  L++D+      +L  T  Y+ P+ Y 
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFV---SLYGTEEYLHPDMYE 188

Query: 925 REGRVSTNG-------DVYSFGIML 942
           R      +        D++S G+  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  110 bits (276), Expect = 2e-26
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 27/224 (12%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISS 814
           ++  GGF FVY+A+ +  G E A+K          ++   E   +K++  H NI++F S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 815 CS-------SDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHF 865
            S       +   + L+L  +  G L + L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA----------T 915
               PIIH DLK  N+LL +     L DFG A             Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 916 IGYMAPE----YGREGRVSTNGDVYSFGIMLMETFTRKKPTDES 955
             Y  PE    Y     +    D+++ G +L     R+ P ++ 
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFEDG 256

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (278), Expect = 4e-26
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 24/204 (11%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD-LQYGRAIKSFDIECGMIKRIRHRNIIKF--I 812
           ++G+G    V++ R  + G   A+KVF+ + + R +     E  ++K++ H+NI+K   I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              ++   K L++E+ P GSL   L    + Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 871 IIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGR 925
           I+H ++KP N++     D   V  L+DFG A+    ED     +    T  Y+ P+ Y R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189

Query: 926 EGRVSTNG-------DVYSFGIML 942
                 +        D++S G+  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTF 213

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (275), Expect = 6e-26
 Identities = 41/238 (17%), Positives = 81/238 (34%), Gaps = 32/238 (13%)

Query: 752 FSENNLIGRGGFGFVYKAR------IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR- 804
              ++L+G G F  VY+A        ++  +  +KV           F I   +++R++ 
Sbjct: 67  VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIGTQLMERLKP 123

Query: 805 --HRNIIKFISSCSSDDFKALVLEYMPYGSL----EKCLYSSNYILDIFQRLNIMIDVAS 858
                 +KF S+    +   LV E   YG+L         +   ++     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH-----------LSDFGMAKPFLKEDQSL 907
            +E +H      IIH D+KP+N +L +  +             L D G +       +  
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 908 TQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
             T    T G+   E     +      D +     +           ++  GE   + 
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (282), Expect = 1e-25
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 19/198 (9%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFI--- 812
           +G GGFG+V +      G +VA+K    +   +  + + +E  ++K++ H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 813 ---SSCSSDDFKALVLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGY 867
                 + +D   L +EY   G L K L  + +   L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 868 SVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
              IIH DLKP N++L      ++  + D G AK    +   L     + T+ Y+APE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195

Query: 925 REGRVSTNGDVYSFGIML 942
            + + +   D +SFG + 
Sbjct: 196 EQKKYTVTVDYWSFGTLA 213

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (273), Expect = 1e-25
 Identities = 44/313 (14%), Positives = 90/313 (28%), Gaps = 81/313 (25%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIR-------- 804
            ++G+       +A   + G    V V          AIK    E   ++ +R        
Sbjct: 80   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 805  -----------------HRNIIKFISSCSSDDFKALVLEYM-PYGSLEKCL------YSS 840
                              + +I+           +    Y     +L+          S+
Sbjct: 140  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 841  NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF 900
            +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 200  HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE----H 252

Query: 901  LKEDQSLTQTQTLATIGYMAPEY-----------GREGRVSTNGDVYSFGIMLMETFTRK 949
            L  D +   +    + G+  PE             R   ++ + D ++ G+++   +   
Sbjct: 253  LVRDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 950  KPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTI 1009
             P     T +                       L   +  F + +     V  L      
Sbjct: 311  LP----ITKD---------------------AALGGSEWIFRSCKNIPQPVRALLEGFLR 345

Query: 1010 ESPEERINAKEIV 1022
               E+R+   + +
Sbjct: 346  YPKEDRLLPLQAM 358

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (268), Expect = 2e-25
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 29/212 (13%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNI 808
           F++   IG+G FG V+K    +    VA+K+ DL+        DI  E  ++ +     +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 82

Query: 809 IKFISSCSSDDFKALVLEYMPYGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
            K+  S   D    +++EY+  GS    LE        I        I+ ++   L+YLH
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA------TILREILKGLDYLH 136

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT--IG---YM 919
              S   IH D+K  NVLL ++    L+DFG+A         LT TQ      +G   +M
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG-------QLTDTQIKRNTFVGTPFWM 186

Query: 920 APEYGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           APE  ++    +  D++S GI  +E    + P
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  108 bits (270), Expect = 3e-25
 Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 40/298 (13%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNI 808
            F + + +G G  G V+K      G+ +A K+  L+   AI++  I  E  ++       I
Sbjct: 35   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYI 93

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            + F  +  SD   ++ +E+M  GSL++ +      +       + I V   L YL   + 
Sbjct: 94   VGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPEYGR 925
              I+H D+KP+N+L++      L DFG++         L  +   + +G   YM+PE  +
Sbjct: 153  --IMHRDVKPSNILVNSRGEIKLCDFGVSG-------QLIDSMANSFVGTRSYMSPERLQ 203

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
                S   D++S G+ L+E    + P       E+ L          +            
Sbjct: 204  GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 986  EDKHFVAKEQCMSFVFNLAM-----------------------KCTIESPEERINAKE 1020
             +K  +     M+    L                         KC I++P ER + K+
Sbjct: 264  LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (265), Expect = 3e-25
 Identities = 43/232 (18%), Positives = 88/232 (37%), Gaps = 46/232 (19%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI- 803
           F E   IG G FG V+K     DG   A+K              A++    E      + 
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR----EVYAHAVLG 68

Query: 804 RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF---QRLNIMIDVASAL 860
           +H +++++ S+ + DD   +  EY   GSL   +  +  I+  F   +  ++++ V   L
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDN-------------------MVAHLSDFGMAKPFL 901
            Y+H   S+ ++H D+KP+N+ +                      ++  + D G      
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182

Query: 902 KEDQSLTQTQTLA-TIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTRKKP 951
                ++  Q       ++A E  +E        D+++  + ++     +  
Sbjct: 183 ----RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (265), Expect = 5e-25
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 50/228 (21%)

Query: 747 QATNGFSEN----NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI------ 795
            +T+GF EN     ++GRG    V +        E AVK+ D+  G +  + ++      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 796 ---ECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDI 846
              E  +++++  H NII+   +  ++ F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129

Query: 847 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
            +       +   +  LH    + I+H DLKP N+LLDD+M   L+DFG +   L   + 
Sbjct: 130 MR------ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEK 179

Query: 907 LTQTQTLATIGYMAPE------------YGREGRVSTNGDVYSFGIML 942
           L   +   T  Y+APE            YG+E       D++S G+++
Sbjct: 180 L--REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (262), Expect = 7e-25
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 23/197 (11%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
           L+G+G F  VY+A  I  G+EVA+K+ D   +     ++    E  +  +++H +I++  
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
           +     ++  LVLE    G + + L +        +  + M  + + + YLH   S  I+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE------YGR 925
           H DL  +N+LL  NM   ++DFG+A       +      TL  T  Y++PE      +G 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191

Query: 926 EGRVSTNGDVYSFGIML 942
           E       DV+S G M 
Sbjct: 192 E------SDVWSLGCMF 202

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (265), Expect = 9e-25
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 23/203 (11%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRHRN 807
           FS+   IG G FG VY AR +++   VA+K       ++    +    E   ++++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
            I++      +    LV+EY   GS    L      L   +   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG---YMAPE-- 922
           S  +IH D+K  N+LL +  +  L DFG A         +    +   +G   +MAPE  
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAPEVI 222

Query: 923 -YGREGRVSTNGDVYSFGIMLME 944
               EG+     DV+S GI  +E
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIE 245

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (265), Expect = 1e-24
 Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 49/213 (23%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRHRNIIKF 811
           IG+G F  V +    + G + AVK+ D+    +           E  +   ++H +I++ 
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 812 ISSCSSDDFKALVLEYMPYGSL---------EKCLYS----SNYILDIFQRLNIMIDVAS 858
           + + SSD    +V E+M    L            +YS    S+Y+  I            
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           AL Y H      IIH D+KP+ VLL   +++    L  FG+A    +          + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 916 IGYMAPE------YGREGRVSTNGDVYSFGIML 942
             +MAPE      YG+        DV+  G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (266), Expect = 1e-24
 Identities = 41/200 (20%), Positives = 82/200 (41%), Gaps = 16/200 (8%)

Query: 758 IGRG--GFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFI 812
           IG+G      V  AR    G  V V+  +L+         +  E  + K   H NI+ + 
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
           ++  +D+   +V  +M YGS +  +       ++      I+  V  AL+Y+H    +  
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED--QSLTQTQTLATIG---YMAPEYGRE 926
           +H  +K +++L+  +   +LS        +     Q +       ++    +++PE  ++
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 927 GRVSTNG--DVYSFGIMLME 944
                +   D+YS GI   E
Sbjct: 210 NLQGYDAKSDIYSVGITACE 229

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (263), Expect = 2e-24
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 43/206 (20%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD--LQYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G F  V +      G+E A K+ +      R  +  + E  + ++++H NI++   S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 815 CSSDDFKALVLEYMPYGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEYLHF 865
              + F  LV + +  G L      +  YS    S+ I  I            ++ Y H 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 145

Query: 866 GYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
             S  I+H +LKP N+LL          L+DFG+A   + + ++        T GY++PE
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSPE 200

Query: 923 ------YGREGRVSTNGDVYSFGIML 942
                 Y +        D+++ G++L
Sbjct: 201 VLKKDPYSKP------VDIWACGVIL 220

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  103 bits (259), Expect = 3e-24
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 50/209 (23%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           ++G G F  V+  +    G   A+K           S + E  ++K+I+H NI+      
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYL 863
            S     LV++ +  G L             F R+             ++  V SA++YL
Sbjct: 76  ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 864 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYM 919
           H      I+H DLKP N+L    ++N    ++DFG++K    ++  ++   T   T GY+
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMS---TACGTPGYV 174

Query: 920 APE------YGREGRVSTNGDVYSFGIML 942
           APE      Y +        D +S G++ 
Sbjct: 175 APEVLAQKPYSKA------VDCWSIGVIT 197

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  103 bits (258), Expect = 6e-24
 Identities = 51/201 (25%), Positives = 79/201 (39%), Gaps = 23/201 (11%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF---DIECGMIKRIRHRNIIKFIS 813
           IGRG +G V K      G  +AVK          +     D++  M +      I++F  
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-RSSDCPYIVQFYG 88

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFGY 867
           +   +    + +E M   S +K          +   +       I +    AL +L    
Sbjct: 89  ALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE----Y 923
              IIH D+KP+N+LLD +    L DFG++    +   S+ +T+      YMAPE     
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPS 200

Query: 924 GREGRVSTNGDVYSFGIMLME 944
                     DV+S GI L E
Sbjct: 201 ASRQGYDVRSDVWSLGITLYE 221

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (255), Expect = 6e-24
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 43/206 (20%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G F  V +      G+E A K+ + +    R  +  + E  + ++++H NI++   S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 815 CSSDDFKALVLEYMPYGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEYLHF 865
              + F  LV + +  G L      +  YS    S+ I  I            ++ Y H 
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 122

Query: 866 GYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
             S  I+H +LKP N+LL          L+DFG+A   + + ++        T GY++PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSPE 177

Query: 923 ------YGREGRVSTNGDVYSFGIML 942
                 Y +        D+++ G++L
Sbjct: 178 VLKKDPYSKP------VDIWACGVIL 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (255), Expect = 6e-24
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 34/201 (16%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G FG V K +      E AVKV +      +   +   E  ++K++ H NI+K    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 815 CSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
                   +V E    G L     ++  +S +    I +       V S + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH---KH 140

Query: 870 PIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE---- 922
            I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+APE    
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRG 197

Query: 923 -YGREGRVSTNGDVYSFGIML 942
            Y  +       DV+S G++L
Sbjct: 198 TYDEK------CDVWSAGVIL 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  101 bits (254), Expect = 8e-24
 Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 32/199 (16%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IGRG +G V  A      +  A K     +   +  F  E  ++K + H NII+   +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 817 SDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
            +    LV+E    G L      K ++  +    I +      DV SA+ Y H    + +
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127

Query: 872 IHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-----Y 923
            H DLKP N L      +    L DFG+A    K  + +     + T  Y++P+     Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSPQVLEGLY 184

Query: 924 GREGRVSTNGDVYSFGIML 942
           G E       D +S G+M+
Sbjct: 185 GPE------CDEWSAGVMM 197

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 8e-24
 Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 44/207 (21%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFISS 814
           +G+G F  V +   +  G E A  + + +   A     +  E  + + ++H NI++   S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 815 CSSDDFKALVLEYMPYGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEYLHF 865
            S +    L+ + +  G L      +  YS    S+ I  I            A+ + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH- 127

Query: 866 GYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAP 921
              + ++H +LKP N+LL          L+DFG+A     E Q+       A T GY++P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSP 182

Query: 922 E------YGREGRVSTNGDVYSFGIML 942
           E      YG+        D+++ G++L
Sbjct: 183 EVLRKDPYGKP------VDLWACGVIL 203

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (254), Expect = 8e-24
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 24/199 (12%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKF 811
             +G+G FG VY AR  Q    +A+KV     L+          E  +   +RH NI++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                      L+LEY P G++ + L   +   +       + ++A+AL Y H   S  +
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE------YGR 925
           IH D+KP N+LL       ++DFG +        S        T+ Y+ PE      +  
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTD-LCGTLDYLPPEMIEGRMHDE 186

Query: 926 EGRVSTNGDVYSFGIMLME 944
           +       D++S G++  E
Sbjct: 187 K------VDLWSLGVLCYE 199

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (255), Expect = 9e-24
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 20/202 (9%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFISS 814
           IG G    V  A       +VA+K  +L+  +     ++  E   + +  H NI+ + +S
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTS 81

Query: 815 CSSDDFKALVLEYMPYGSL-------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
               D   LV++ +  GS+              + +LD      I+ +V   LEYLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT-IG---YMAPEY 923
               IH D+K  N+LL ++    ++DFG++  FL     +T+ +   T +G   +MAPE 
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWMAPEV 197

Query: 924 GREGRV-STNGDVYSFGIMLME 944
             + R      D++SFGI  +E
Sbjct: 198 MEQVRGYDFKADIWSFGITAIE 219

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  101 bits (254), Expect = 1e-23
 Identities = 43/197 (21%), Positives = 80/197 (40%), Gaps = 24/197 (12%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++          A K+     L      +   +E  + + + H++++ F 
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE------YGR 925
           H DLK  N+ L++++   + DFG+A     + +       L  T  Y+APE      +  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPEVLSKKGHSF 194

Query: 926 EGRVSTNGDVYSFGIML 942
           E       DV+S G ++
Sbjct: 195 E------VDVWSIGCIM 205

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (252), Expect = 2e-23
 Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 52/282 (18%)

Query: 758  IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIKFIS 813
            +GRG +G V K R +  G  +AVK          +     D++  M + +     + F  
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM-RTVDCPFTVTFYG 73

Query: 814  SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFGY 867
            +   +    + +E M   SL+K       ++D  Q +       I + +  ALE+LH   
Sbjct: 74   ALFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE----Y 923
            S  +IH D+KP+NVL++      + DFG++         + +        YMAPE     
Sbjct: 130  S--VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPE 184

Query: 924  GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL-LLISIME----VV 978
              +   S   D++S GI ++E    + P D           W      L  ++E     +
Sbjct: 185  LNQKGYSVKSDIWSLGITMIELAILRFPYDS----------WGTPFQQLKQVVEEPSPQL 234

Query: 979  DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020
             A+  S E   F +             +C  ++ +ER    E
Sbjct: 235  PADKFSAEFVDFTS-------------QCLKKNSKERPTYPE 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  101 bits (255), Expect = 2e-23
 Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 24/197 (12%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+GGF   ++          A K+     L      +   +E  + + + H++++ F 
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                +DF  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE------YGR 925
           H DLK  N+ L++++   + DFG+A     + +     + L  T  Y+APE      +  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSF 220

Query: 926 EGRVSTNGDVYSFGIML 942
           E       DV+S G ++
Sbjct: 221 E------VDVWSIGCIM 231

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (255), Expect = 2e-23
 Identities = 58/303 (19%), Positives = 101/303 (33%), Gaps = 60/303 (19%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFD---LQYGRAIKSFDI--------------ECGMI 800
            + +G F  +     +D    A+K ++   L+  R     +               E  +I
Sbjct: 39   LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 801  KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL-------NIM 853
              I++   +      ++ D   ++ EYM   S+ K       +   +           I+
Sbjct: 98   TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 854  IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
              V ++  Y+H      I H D+KP+N+L+D N    LSDFG ++     D+ +   +  
Sbjct: 158  KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKI---KGS 210

Query: 914  A-TIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKR------ 964
              T  +M PE             D++S GI L   F    P     +             
Sbjct: 211  RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270

Query: 965  ------WVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA 1018
                        L +       N LS+ED  F+          N         P ERI +
Sbjct: 271  EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL---F-LRKN---------PAERITS 317

Query: 1019 KEI 1021
            ++ 
Sbjct: 318  EDA 320

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (255), Expect = 2e-23
 Identities = 68/254 (26%), Positives = 104/254 (40%), Gaps = 51/254 (20%)

Query: 721 GGKSQLNDANMPLVANQRRFTYLELFQATNGFSEN----NLIGRGGFGFVYKAR-IQDGM 775
              +Q          +      L  + A   F +     ++IGRG    V +      G 
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 776 EVAVKVFDL--------QYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLE 826
           E AVK+ ++        Q     ++   E  +++++  H +II  I S  S  F  LV +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 827 YMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNV 881
            M  G L     EK   S      I +       +  A+ +LH   +  I+H DLKP N+
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMR------SLLEAVSFLH---ANNIVHRDLKPENI 231

Query: 882 LLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPE------------YGREGR 928
           LLDDNM   LSDFG +   L+  + L     L  T GY+APE            YG+E  
Sbjct: 232 LLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKE-- 285

Query: 929 VSTNGDVYSFGIML 942
                D+++ G++L
Sbjct: 286 ----VDLWACGVIL 295

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 99.8 bits (249), Expect = 4e-23
 Identities = 58/213 (27%), Positives = 78/213 (36%), Gaps = 37/213 (17%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELE 77
           +P           + LS N         +   T L  L+L   +L  ++  + G L  L 
Sbjct: 29  LPKDT------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLG 80

Query: 78  ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDG 137
            L L +N L  ++P     L +L+ LD+S N LT  L       L  LQ L+L  N    
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGN---- 134

Query: 138 KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL-GNLAE 196
                      L+TL   +               KL+ L L  N L  E+P  L   L  
Sbjct: 135 ----------ELKTLPPGLLT----------PTPKLEKLSLANNNLT-ELPAGLLNGLEN 173

Query: 197 LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFN 229
           L+ L LQ N L  TIP   F    L    L  N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 52/189 (27%), Positives = 78/189 (41%), Gaps = 15/189 (7%)

Query: 48  NVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLS 106
            V + + ++     L   +P +L    +   L L  N L  T   +     + L+ L+L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLD 63

Query: 107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE 166
              LT      +   LP+L TL L  N     +P        L  L +S N  +  +P  
Sbjct: 64  RAELTK---LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118

Query: 167 I-GNLTKLKYLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSD 223
               L +L+ L+L  N L+  +P  L     +LEKL L NN LT  +P  +   L +L  
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176

Query: 224 LELSFNSLT 232
           L L  NSL 
Sbjct: 177 LLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 45/159 (28%), Positives = 62/159 (38%), Gaps = 9/159 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            + L  L L                  L  + LS N    ++P     +  L  L +  N
Sbjct: 54  YTRLTQLNLDRA--ELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN 110

Query: 61  KLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           +L   +P      L EL+EL+L+ N L  T+P  +      L  L L+ NNLT EL A +
Sbjct: 111 RLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL 167

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN 157
            + L  L TL L EN+    IP        L    L  N
Sbjct: 168 LNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 54/270 (20%), Positives = 84/270 (31%), Gaps = 73/270 (27%)

Query: 363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
           + +  E++    N +  +P  +      + L L  N    F   T      L  L+L   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 423 YLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIP 482
            LT        L       L    +S+N L                           S+P
Sbjct: 66  ELTK-LQVDGTLPV-----LGTLDLSHNQLQ--------------------------SLP 93

Query: 483 KEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSI 542
                L  L  + +  N+L    L AL  L +LQ L LK N+L               ++
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL--------------KTL 139

Query: 543 PSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY 602
           P  L                T            L ++ L+ NN +++    + GL++L  
Sbjct: 140 PPGL---------------LTP--------TPKLEKLSLANNNLTELPAGLLNGLENLDT 176

Query: 603 LFLKYNRLQGSIPDSIGDMINLKSLNLSNN 632
           L L+ N L  +IP        L    L  N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 45/215 (20%), Positives = 77/215 (35%), Gaps = 21/215 (9%)

Query: 289 NLAKLEKLDLQFNRLQCV---IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY 345
            +A   +++     L  +   +P +   LH       S N L      T+   + L  L 
Sbjct: 8   KVASHLEVNCDKRNLTALPPDLPKDTTILH------LSENLLYTFSLATLMPYTRLTQLN 61

Query: 346 LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
           L       +L    D  LP L  L LS N    ++P        L+ L++  N  +    
Sbjct: 62  LDRAEL-TKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 406 NTFGNLRNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLS 464
                L  L+ L L  N L +     L+         LE  S++NN L  +   ++  L 
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPK-----LEKLSLANNNLTELPAGLLNGLE 172

Query: 465 QSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVN 499
             ++   +  +++  +IPK       L   +L  N
Sbjct: 173 N-LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 22/196 (11%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
           ++P ++    +   ++L  N L    L  L    +L  L+L   +L              
Sbjct: 24  ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-------------- 67

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD 599
           T +      L  +  L+LS N     LPL    L  L  +D+S N  + +    + GL +
Sbjct: 68  TKLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125

Query: 600 LQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
           LQ L+LK N L+ ++P  +      L+ L+L+NNNL  +    L  L +L  + +  N L
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 659 EGEIPREGPFRNFSLE 674
              IP+ G F +  L 
Sbjct: 185 YT-IPK-GFFGSHLLP 198

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (251), Expect = 5e-23
 Identities = 60/222 (27%), Positives = 89/222 (40%), Gaps = 50/222 (22%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNII 809
           F    L+G G +G VYK R ++ G   A+KV D+  G   +    E  M+K+   HRNI 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 84

Query: 810 KFISS------CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN-----------I 852
            +  +         DD   LV+E+   GS+           D+ +              I
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------TDLIKNTKGNTLKEEWIAYI 134

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
             ++   L +LH      +IH D+K  NVLL +N    L DFG++         L +T  
Sbjct: 135 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-------QLDRTVG 184

Query: 913 LAT--IG---YMAPEYGREGRVSTNG-----DVYSFGIMLME 944
                IG   +MAPE                D++S GI  +E
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (252), Expect = 5e-23
 Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 51/209 (24%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
            +GRG    VY+ +        A+KV         K    E G++ R+ H NIIK     
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYL 863
            +    +LVLE +  G L             F R+            + +  +  A+ YL
Sbjct: 118 ETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILEAVAYL 164

Query: 864 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYM 919
           H      I+H DLKP N+L      +    ++DFG++K  ++    +    T+  T GY 
Sbjct: 165 H---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCGTPGYC 217

Query: 920 APE------YGREGRVSTNGDVYSFGIML 942
           APE      YG E  V    D++S GI+ 
Sbjct: 218 APEILRGCAYGPE--V----DMWSVGIIT 240

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 47/212 (22%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDI-----ECGMIKRIRHRNI 808
           +G G  G V  A   +   +VA+K+        G A ++        E  ++K++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 809 IKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           IK  +   ++D+  +VLE M  G L                  F        +  A++YL
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 864 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYM 919
           H      IIH DLKP NVLL   +++ +  ++DFG +K  L E   +    TL  T  Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 183

Query: 920 APE---------YGREGRVSTNGDVYSFGIML 942
           APE         Y R   V    D +S G++L
Sbjct: 184 APEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (253), Expect = 2e-22
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 34/201 (16%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFISS 814
           +G G +G V   R     +E A+K+          +  +  E  ++K + H NI+K    
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 815 CSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
                   LV+E    G L      +  ++      I +       V S + YLH     
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH---KH 155

Query: 870 PIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE---- 922
            I+H DLKP N+LL   + + +  + DFG++    +  + +   + L T  Y+APE    
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAPEVLRK 212

Query: 923 -YGREGRVSTNGDVYSFGIML 942
            Y  +       DV+S G++L
Sbjct: 213 KYDEK------CDVWSIGVIL 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 43/194 (22%), Positives = 78/194 (40%), Gaps = 21/194 (10%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V++      G     K  +  Y     +   E  ++ ++ H  +I    +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 817 SDDFKALVLEYMPYGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 L+LE++  G L      E    S   +      +N M      L+++H      
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV------INYMRQACEGLKHMH---EHS 169

Query: 871 IIHCDLKPNNVLLDDNMVAHL--SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
           I+H D+KP N++ +    + +   DFG+A   L  D+ +    T AT  + APE      
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAPEIVDREP 226

Query: 929 VSTNGDVYSFGIML 942
           V    D+++ G++ 
Sbjct: 227 VGFYTDMWAIGVLG 240

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 55/213 (25%), Positives = 83/213 (38%), Gaps = 43/213 (20%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISS 814
           ++G G    V     +    E AVK+ + Q G        E  M+ + + HRN+++ I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEY 862
              +D   LV E M  GS+                +             ++ DVASAL++
Sbjct: 80  FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126

Query: 863 LHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPF-LKEDQSLTQTQTLATI-- 916
           LH   +  I H DLKP N+L    +      + DF +     L  D S   T  L T   
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 917 --GYMAPEYGREGRVSTNG-----DVYSFGIML 942
              YMAPE         +      D++S G++L
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (252), Expect = 2e-22
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 35/202 (17%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
           +G+G FG V   +    G E AVKV     ++     +S   E  ++K++ H NI+K   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 814 SCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
                 +  LV E    G L      +  +S      I ++      V S + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144

Query: 869 VPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--- 922
             I+H DLKP N+LL     +    + DFG++    +  + +     + T  Y+APE   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAPEVLH 201

Query: 923 --YGREGRVSTNGDVYSFGIML 942
             Y  +       DV+S G++L
Sbjct: 202 GTYDEK------CDVWSTGVIL 217

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 36/204 (17%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKFI 812
            +G+G FG VY AR  Q+   +A+KV     L+          E  +   +RH NI++  
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFG 866
           +         L+LE+ P G L K L           R +       M ++A AL Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE---- 922
               +IH D+KP N+L+       ++DFG +           +T    T+ Y+ PE    
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRT-MCGTLDYLPPEMIEG 186

Query: 923 --YGREGRVSTNGDVYSFGIMLME 944
             +  +       D++  G++  E
Sbjct: 187 KTHDEK------VDLWCAGVLCYE 204

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 16/196 (8%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKS---FDIECGMIKRIRHRNIIKFIS 813
           +G G  G V+K R  + G  +AVK       +        D++  + K      I++   
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL-KSHDCPYIVQCFG 91

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           +  ++    + +E M     EK        +       + + +  AL YL   +   +IH
Sbjct: 92  TFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIH 148

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-----YGREGR 928
            D+KP+N+LLD+     L DFG++    +      + ++     YMAPE        +  
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 929 VSTNGDVYSFGIMLME 944
                DV+S GI L+E
Sbjct: 206 YDIRADVWSLGISLVE 221

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (250), Expect = 4e-22
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 34/201 (16%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISS 814
           +G+G FG V K +      E AVKV +      +   +   E  ++K++ H NI+K    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 815 CSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
                   +V E    G L     ++  +S +          I+  V S + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMH---KH 140

Query: 870 PIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE---- 922
            I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+APE    
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRG 197

Query: 923 -YGREGRVSTNGDVYSFGIML 942
            Y  +       DV+S G++L
Sbjct: 198 TYDEK------CDVWSAGVIL 212

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 99.0 bits (247), Expect = 5e-22
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 47/212 (22%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDI-----ECGMIKRIRHRNI 808
           +G G  G V  A   +   +VA+++        G A ++        E  ++K++ H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 809 IKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYL 863
           IK  +   ++D+  +VLE M  G L                  F        +  A++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255

Query: 864 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYM 919
           H      IIH DLKP NVLL   +++ +  ++DFG +K  L E   +    TL  T  Y+
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 308

Query: 920 APE---------YGREGRVSTNGDVYSFGIML 942
           APE         Y R   V    D +S G++L
Sbjct: 309 APEVLVSVGTAGYNRA--V----DCWSLGVIL 334

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 96.4 bits (240), Expect = 6e-22
 Identities = 31/212 (14%), Positives = 61/212 (28%), Gaps = 44/212 (20%)

Query: 757 LIGRGGFGFVYKARIQD---GMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRHRNIIK 810
             G       ++A   D     +VA+   D Q       ++        + RI    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            +    +     +V E++  GSL++   +S         +  M  +A+A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
           +      P+ V +  +        G                 LA    M     ++    
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV--------------LAYPATMPDANPQD---- 183

Query: 931 TNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
              D+   G  L      + P  E+      L
Sbjct: 184 ---DIRGIGASLYALLVNRWPLPEA-GVRSGL 211

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (250), Expect = 7e-22
 Identities = 44/194 (22%), Positives = 73/194 (37%), Gaps = 21/194 (10%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           +G G FG V++      G   A K     +    ++   E   +  +RH  ++    +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 817 SDDFKALVLEYMPYGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
            D+   ++ E+M  G L      E    S +        +  M  V   L ++H      
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA------VEYMRQVCKGLCHMH---ENN 275

Query: 871 IIHCDLKPNNVLLDDNMVAHL--SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR 928
            +H DLKP N++        L   DFG+    L   QS+    T  T  + APE      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAPEVAEGKP 332

Query: 929 VSTNGDVYSFGIML 942
           V    D++S G++ 
Sbjct: 333 VGYYTDMWSVGVLS 346

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.8 bits (244), Expect = 7e-22
 Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 21/200 (10%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            S+  ++G G FG V+K      G+++A K+   +  +  +    E  ++ ++ H N+I+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 811 FISSCSSDDFKALVLEYMPYGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
              +  S +   LV+EY+  G L      E    +    +        M  +   + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIRHMH 204

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHL--SDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
             Y   I+H DLKP N+L  +     +   DFG+A+   K  + L       T  ++APE
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKL--KVNFGTPEFLAPE 258

Query: 923 YGREGRVSTNGDVYSFGIML 942
                 VS   D++S G++ 
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.0 bits (242), Expect = 9e-22
 Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 52/209 (24%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS 816
           IG G +    +       ME AVK+ D       +  +I   +++  +H NII       
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVYD 86

Query: 817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYLH 864
              +  +V E M  G L               ++             ++  +   +EYLH
Sbjct: 87  DGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEYLH 133

Query: 865 FGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYM 919
              +  ++H DLKP+N+L      +     + DFG AK    E+  L    T   T  ++
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANFV 187

Query: 920 APE------YGREGRVSTNGDVYSFGIML 942
           APE      Y          D++S G++L
Sbjct: 188 APEVLERQGYDAA--C----DIWSLGVLL 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 52/208 (25%), Positives = 80/208 (38%), Gaps = 50/208 (24%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSC 815
           +G G F    K    +     AVK+      R   +   E   +K    H NI+K     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYL 863
                  LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 864 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           H    V ++H DLKP N+L    +DN+   + DFG A+    ++Q L       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 921 PE------YGREGRVSTNGDVYSFGIML 942
           PE      Y          D++S G++L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 55/236 (23%), Positives = 83/236 (35%), Gaps = 54/236 (22%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRHRNIIKF 811
           IG+G +G V  A   Q     A+K+ +    R I   D+     E  ++K++ H NI + 
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 812 ISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRL---------------- 850
                 + +  LV+E    G L          S+        +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 851 ------------------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL- 891
                             NIM  + SAL YLH   +  I H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 892 -SDFGMAKPFLKEDQSLTQ--TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIML 942
             DFG++K F K +       T    T  ++APE             D +S G++L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 95.7 bits (238), Expect = 2e-21
 Identities = 56/305 (18%), Positives = 84/305 (27%), Gaps = 22/305 (7%)

Query: 101 SNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS 160
           S+    +     EL     S   LL+ +  + +          L  K L   +  I    
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 161 GDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLA--ELEKLQLQNNFLTGTIPPSIFNL 218
                 +  ++ L+ L L+   + G  P  L      +L  L L+N          +  L
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAEL 143

Query: 219 SSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDL 278
                  L   S+              S     +     P L  + LS N   GE    L
Sbjct: 144 QQWLKPGLKVLSIAQA----------HSLNFSCEQVRVFPALSTLDLSDNPELGERG--L 191

Query: 279 GNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF-N 337
            +   P +   L  L   +        V          L+ +  S N L           
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251

Query: 338 VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR 397
            S L  L L       ++P         L  L LS N      PS       +  L L+ 
Sbjct: 252 PSQLNSLNLSFTG-LKQVPKGL---PAKLSVLDLSYNRLD-RNPSPDELPQ-VGNLSLKG 305

Query: 398 NSFSG 402
           N F  
Sbjct: 306 NPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 54/241 (22%), Positives = 81/241 (33%), Gaps = 32/241 (13%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFS-GTIPKEIGNVTTLIGLHLRG 59
           +S L+ L L++    G  P  L          L+L + S  T    +  +   +   L+ 
Sbjct: 94  ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK- 152

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGE--LLAN 117
                              L +            +    +LS LDLS N   GE  L++ 
Sbjct: 153 ------------------VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194

Query: 118 ICSN-LPLLQTLFLDENNF---DGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTK 172
           +C    P LQ L L         G   +       LQ L LS N              ++
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 173 LKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT 232
           L  L+L    L+ ++P+ L   A+L  L L  N L     PS   L  + +L L  N   
Sbjct: 255 LNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFL 309

Query: 233 G 233
            
Sbjct: 310 D 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.9 bits (210), Expect = 7e-18
 Identities = 43/281 (15%), Positives = 81/281 (28%), Gaps = 18/281 (6%)

Query: 386 NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYF 445
             S    L+                  +LK L +    + S       L       L+  
Sbjct: 42  GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSR-ILFGALRVLGISGLQEL 100

Query: 446 SISNNPLGGILPRVIGNLS-QSMEDFHMPNSNISG--SIPKEINNL--TNLIAIYLGVNK 500
           ++ N  + G  P  +   +   +   ++ N + +   +   E+       L  + +    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 501 LNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLN 560
                   +     L  L L DN   G      +        P     L+ +   N  + 
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL------CPLKFPTLQVLALRNAGME 214

Query: 561 FFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI-GGLKDLQYLFLKYNRLQGSIPDSIG 619
             +G           L  +DLS N+  D            L  L L +  L+  +P  + 
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273

Query: 620 DMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEG 660
               L  L+LS N L         +L  + ++++  N    
Sbjct: 274 A--KLSVLDLSYNRLDRNPSPD--ELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.6 bits (209), Expect = 9e-18
 Identities = 57/275 (20%), Positives = 94/275 (34%), Gaps = 45/275 (16%)

Query: 45  EIGNVTTLIGLHLRGNKLQGEIPE---ELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS 101
           +I    +L  L +R  ++   I      +  ++ L+EL L+N  +TGT P  +   +   
Sbjct: 63  DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122

Query: 102 NLDLSVNNLTGELLANICSNL-----PLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSI 156
              L++ N++        + L     P L+ L + + +        +     L TL LS 
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182

Query: 157 NDFSGDIPKEI----GNLTKLKYLHLDQNRLQ---GEIPEELGNLAELEKLQLQNNFLTG 209
           N   G+              L+ L L    ++   G          +L+ L L +N L  
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 210 TIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKN 268
                     S L+ L LSF  L            ++   LPAK       L  + LS N
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-----------QVPKGLPAK-------LSVLDLSYN 284

Query: 269 MFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRL 303
                 PS             L ++  L L+ N  
Sbjct: 285 RL-DRNPS----------PDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 81.5 bits (201), Expect = 9e-17
 Identities = 54/298 (18%), Positives = 87/298 (29%), Gaps = 43/298 (14%)

Query: 47  GNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSS---IFNLSSLSNL 103
           G  +    L     +       ++     L+ L ++   +   I      +  +S L  L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 104 DLSVNNLTGELLANICSNLPL-LQTLFLDENNFDGKIPSTL----LRCKHLQTLSLSIND 158
            L    +TG     +       L  L L   ++  +              L+ LS++   
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 159 FSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE----LGNLAELEKLQLQNNFLT---GTI 211
                 +++     L  L L  N   GE              L+ L L+N  +    G  
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 212 PPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFY 271
                    L  L+LS NSL                   A  C+    L  + LS     
Sbjct: 221 SALAAARVQLQGLDLSHNSLRD--------------AAGAPSCDWPSQLNSLNLSFTGLK 266

Query: 272 GEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVG 329
                      +PK +   AKL  LDL +NRL        D L  +  +    N  + 
Sbjct: 267 ----------QVPKGL--PAKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 48/289 (16%), Positives = 86/289 (29%), Gaps = 38/289 (13%)

Query: 341 LKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPS---FIFNTSKLSTLELQR 397
           L++L    ++       +  ++  +L+ L++        I      +   S L  L L+ 
Sbjct: 45  LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104

Query: 398 NSFSGFIPNTFGNL--RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGI 455
              +G  P         +L  L+L +    +  + L+ L       L+  SI+       
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164

Query: 456 LPRVIGNLS----------QSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSI 505
               +                + +  + ++      P     L  L     G+   +G  
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP----TLQVLALRNAGMETPSGVC 220

Query: 506 LIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP 565
                   +LQ L L  N L  +                +      +  LNLS       
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAG------------APSCDWPSQLNSLNLSFTGLKQ- 267

Query: 566 LPLEIG-NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGS 613
           +P  +   L VL   DLS N        +   L  +  L LK N    S
Sbjct: 268 VPKGLPAKLSVL---DLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.7 bits (186), Expect = 7e-15
 Identities = 53/310 (17%), Positives = 91/310 (29%), Gaps = 43/310 (13%)

Query: 276 SDLGNCTIPKEI---GNLAKLEKLDLQFN-RLQCVIPHEIDNLHNLEWMIFSFNKLVGVV 331
           S   NC    ++   G    LE L  + +         +I    +L+ +     ++   +
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 332 PTT---IFNVSTLKFLYLGSNSFFGRLPSS-ADVRLPNLEELSLSGNNFSGTIPS----F 383
                 +  +S L+ L L +    G  P    +   P+L  L+L   +++          
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144

Query: 384 IFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLE 443
            +    L  L + +     F          L  LDL DN        +S L       L+
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 444 YFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNG 503
             ++ N  +                         SG           L  + L  N L  
Sbjct: 205 VLALRNAGM----------------------ETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 504 SI-LIALGKLKKLQLLSLKDNQLE---GSIPDNLSF----SCTLTSIPSTLWNLKDILCL 555
           +    +     +L  L+L    L+     +P  LS        L   PS    L  +  L
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPS-PDELPQVGNL 301

Query: 556 NLSLNFFTGP 565
           +L  N F   
Sbjct: 302 SLKGNPFLDS 311

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 55/223 (24%), Positives = 86/223 (38%), Gaps = 49/223 (21%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD----------------LQYGRAIKSFDIECGM 799
            IG+G +G V  A    D    A+KV                       A        G 
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 800 I----------KRIRHRNIIKFIS--SCSSDDFKALVLEYMPYGSL----EKCLYSSNYI 843
           I          K++ H N++K +      ++D   +V E +  G +         S +  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 844 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE 903
              FQ      D+   +EYLH      IIH D+KP+N+L+ ++    ++DFG++  F   
Sbjct: 140 RFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 904 DQSLTQTQTLA-TIGYMAPEYGREGRVSTNG---DVYSFGIML 942
           D  L        T  +MAPE   E R   +G   DV++ G+ L
Sbjct: 191 DALL---SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 51/236 (21%), Positives = 87/236 (36%), Gaps = 37/236 (15%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRGN 60
            + + L L  N        +  +   L+ + LS  +   TI      +++ L  L L GN
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 61  KLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
            +Q  +       L+ L++L      L  ++ +    +L +L  L+++ N +    L   
Sbjct: 87  PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKY--- 175
            SNL  L+ L L  N               +Q  S+   D           L ++     
Sbjct: 145 FSNLTNLEHLDLSSNK--------------IQ--SIYCTDLR--------VLHQMPLLNL 180

Query: 176 -LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
            L L  N +   I         L++L L  N L  ++P  IF  L+SL  + L  N
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 56/271 (20%), Positives = 89/271 (32%), Gaps = 57/271 (21%)

Query: 171 TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
              K L L  N L+        +  EL+ L L    +  TI    + +LS LS L L+ N
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 230 SLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGN 289
            +                 L     + +  L+++   +      + +          IG+
Sbjct: 87  PIQ---------------SLALGAFSGLSSLQKLVAVETNLA-SLENFP--------IGH 122

Query: 290 LAKLEKLDLQFNRLQCVIPHEI-DNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
           L  L++L++  N +Q     E   NL NLE +  S NK+   +  T              
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR----------- 170

Query: 349 NSFFGRLPSSADVRLPNLE----ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFI 404
                         L  +      L LS N  +  I    F   +L  L L  N      
Sbjct: 171 -------------VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVP 216

Query: 405 PNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
              F  L +L+ + L  N    S   + +LS
Sbjct: 217 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 247

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 48/221 (21%), Positives = 80/221 (36%), Gaps = 16/221 (7%)

Query: 307 IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNL 366
           +P    NL        SFN L  +   + F+   L+ L L        +   A   L +L
Sbjct: 26  LPFSTKNLD------LSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHL 78

Query: 367 EELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLT 425
             L L+GN    ++    F   S L  L     + +       G+L+ LK L++  N + 
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 426 SSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQ---SMEDFHMPNSNISGSIP 482
           S      F + +N   LE+  +S+N +  I    +  L Q         +  + ++  I 
Sbjct: 138 SFKLPEYFSNLTN---LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193

Query: 483 KEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDN 523
                   L  + L  N+L         +L  LQ + L  N
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 46/188 (24%), Positives = 72/188 (38%), Gaps = 35/188 (18%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           LS+L  L L  N               ++  SL+L  FSG         ++L  L     
Sbjct: 75  LSHLSTLILTGN--------------PIQ--SLALGAFSGL--------SSLQKLVAVET 110

Query: 61  KLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
            L   +     G+L  L+EL + +N +        F NL++L +LDLS N +   +    
Sbjct: 111 NLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD 168

Query: 119 CSNLPLLQ----TLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKL 173
              L  +     +L L  N  +  I     +   L+ L+L  N     +P  I   LT L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSL 226

Query: 174 KYLHLDQN 181
           + + L  N
Sbjct: 227 QKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 55/282 (19%), Positives = 93/282 (32%), Gaps = 74/282 (26%)

Query: 380 IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNC 439
           IP  +  ++K   L+L  N        +F +   L+ LDL    + +   + ++ S S+ 
Sbjct: 22  IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSH- 77

Query: 440 KYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI-NNLTNLIAIYLGV 498
             L    ++ NP+                           S+     + L++L  +    
Sbjct: 78  --LSTLILTGNPIQ--------------------------SLALGAFSGLSSLQKLVAVE 109

Query: 499 NKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLS 558
             L       +G LK L+ L++  N ++ S      FS                   NL+
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS-------------------NLT 149

Query: 559 LNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY----LFLKYNRLQGSI 614
                        NL+ L   DLS N    +  T +  L  +      L L  N +   I
Sbjct: 150 -------------NLEHL---DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 615 PDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
                  I LK L L  N L  +     ++L  L+ I +  N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 28/204 (13%)

Query: 480 SIPKEI-NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT 538
            IP  +  +  NL    L  N L      +     +LQ+L L   +++ +I D       
Sbjct: 21  KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG------ 70

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIGGL 597
                 +L +L     L L+ N     L L     L  L ++     N + +    IG L
Sbjct: 71  ---AYQSLSHLST---LILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 598 KDLQYLFLKYNRLQGSIP--DSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINV-- 653
           K L+ L + +N +Q S    +   ++ NL+ L+LS+N +  I    L  L  +  +N+  
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 654 --SFNKLEGEIPREGPFRNFSLES 675
             S N +   I   G F+   L+ 
Sbjct: 183 DLSLNPMN-FIQP-GAFKEIRLKE 204

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.2 bits (235), Expect = 6e-21
 Identities = 41/200 (20%), Positives = 75/200 (37%), Gaps = 34/200 (17%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFISS 814
           +GRG FG V++            K       +      +  E  ++   RHRNI+    S
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 815 CSSDDFKALVLEYMPYGSL------EKCLYS----SNYILDIFQRLNIMIDVASALEYLH 864
             S +   ++ E++    +           +     +Y+  +            AL++LH
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC----------EALQFLH 119

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHL--SDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
                 I H D++P N++      + +   +FG A+  LK   +           Y APE
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAPEYYAPE 173

Query: 923 YGREGRVSTNGDVYSFGIML 942
             +   VST  D++S G ++
Sbjct: 174 VHQHDVVSTATDMWSLGTLV 193

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 11/185 (5%)

Query: 50  TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFN-LSSLSNLDLSVN 108
                L L+ NKL     +    L +L  L+L +N L  T+P+ IF  L +L  L ++ N
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLL-RCKHLQTLSLSINDFSGDIPKEI 167
            L   L   +   L  L  L LD N     +P  +      L  LSL  N+    +PK +
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152

Query: 168 -GNLTKLKYLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDL 224
              LT LK L L  N+L+  +PE     L EL+ L+L NN L   +P   F +L  L  L
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210

Query: 225 ELSFN 229
           +L  N
Sbjct: 211 QLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 26/200 (13%)

Query: 74  AELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE 132
           A+ ++L LQ+N L+ ++PS  F  L+ L  L L+ N L   L A I   L  L+TL++ +
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94

Query: 133 NNFDGKIPSTLLRC-KHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEE 190
           N     +P  +     +L  L L  N     +P  +  +LTKL YL L  N LQ  +P+ 
Sbjct: 95  NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKG 151

Query: 191 L-GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAE 248
           +   L  L++L+L NN L   +P   F  L+ L  L+L  N L                 
Sbjct: 152 VFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK---------------R 195

Query: 249 LPAKFCNNIPFLEEIYLSKN 268
           +P    +++  L+ + L +N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 66/270 (24%), Positives = 99/270 (36%), Gaps = 80/270 (29%)

Query: 82  QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPS 141
            +  LT  IPS+I   +    LDL  N L+  L +     L  L+ L+L++N        
Sbjct: 24  SSKKLT-AIPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDN-------- 71

Query: 142 TLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL-GNLAELEKL 200
                  LQTL   I  F          L  L+ L +  N+LQ  +P  +   L  L +L
Sbjct: 72  ------KLQTLPAGI--FKE--------LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAEL 114

Query: 201 QLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPF 259
           +L  N L  ++PP +F +L+ L+ L L +N L                 LP         
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ---------------SLPK-------- 150

Query: 260 LEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEW 319
                    +F                   L  L++L L  N+L+ V     D L  L+ 
Sbjct: 151 --------GVFDK-----------------LTSLKELRLYNNQLKRVPEGAFDKLTELKT 185

Query: 320 MIFSFNKLVGVVPTTIFNVSTLKFLYLGSN 349
           +    N+L  V      ++  LK L L  N
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 54/207 (26%), Positives = 78/207 (37%), Gaps = 53/207 (25%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+ L  L+L  N              +L+  +L    F             L  L +  N
Sbjct: 60  LTKLRLLYLNDN--------------KLQ--TLPAGIFKEL--------KNLETLWVTDN 95

Query: 61  KLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           KLQ  +P  +   L  L EL L  N L  ++P  +F +L+ L+ L L  N L   L   +
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
              L  L+ L L  N               L+ +     D           LT+LK L L
Sbjct: 153 FDKLTSLKELRLYNNQ--------------LKRVPEGAFD----------KLTELKTLKL 188

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNN 205
           D N+L+        +L +L+ LQLQ N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 42/136 (30%), Positives = 62/136 (45%), Gaps = 5/136 (3%)

Query: 293 LEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFN-VSTLKFLYLGSNSF 351
            +KLDLQ N+L  +       L  L  +  + NKL   +P  IF  +  L+ L++  N  
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK- 96

Query: 352 FGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSFSGFIPNTFGN 410
              LP     +L NL EL L  N    ++P  +F++ +KL+ L L  N         F  
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155

Query: 411 LRNLKWLDLGDNYLTS 426
           L +LK L L +N L  
Sbjct: 156 LTSLKELRLYNNQLKR 171

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 62/274 (22%), Positives = 88/274 (32%), Gaps = 81/274 (29%)

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
           N   +  S    +  IPS I   +K   L+LQ N  S      F  L  L+ L L DN L
Sbjct: 17  NKNSVDCSSKKLT-AIPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73

Query: 425 TSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKE 484
             +     F    N   LE   +++N L                           ++P  
Sbjct: 74  Q-TLPAGIFKELKN---LETLWVTDNKL--------------------------QALPIG 103

Query: 485 I-NNLTNLIAIYLGVNKL----NGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
           + + L NL  + L  N+L              L KL  LSL  N+              L
Sbjct: 104 VFDQLVNLAELRLDRNQLKSLPPR----VFDSLTKLTYLSLGYNE--------------L 145

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD 599
            S+P                  F          L  L ++ L  N    V       L +
Sbjct: 146 QSLPK---------------GVFDK--------LTSLKELRLYNNQLKRVPEGAFDKLTE 182

Query: 600 LQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNN 632
           L+ L L  N+L+  +P+   D +  LK L L  N
Sbjct: 183 LKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 22/199 (11%)

Query: 480 SIPKEI-NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT 538
           +IP  I  +   L    L  NKL+     A  +L KL+LL L DN+L+ ++P        
Sbjct: 30  AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG------ 79

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIGGL 597
              I   L NL+    L ++ N     LP+ +   L  L ++ L  N    + P     L
Sbjct: 80  ---IFKELKNLET---LWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL 132

Query: 598 KDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
             L YL L YN LQ S+P  + D + +LK L L NN L  +   + +KL +LK + +  N
Sbjct: 133 TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191

Query: 657 KLEGEIPREGPFRNFSLES 675
           +L+  +P         L+ 
Sbjct: 192 QLK-RVPEGAFDSLEKLKM 209

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.1 bits (232), Expect = 8e-21
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 37/204 (18%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD-LQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
           +G G FG V+       G+E  +K  +  +    ++  + E  ++K + H NIIK     
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL---------NIMIDVASALEYLHFG 866
                  +V+E    G L         I+    R           +M  + +AL Y H  
Sbjct: 90  EDYHNMYIVMETCEGGEL------LERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141

Query: 867 YSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE- 922
            S  ++H DLKP N+L      +    + DFG+A+   K D+    T    T  YMAPE 
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAPEV 197

Query: 923 ----YGREGRVSTNGDVYSFGIML 942
                  +       D++S G+++
Sbjct: 198 FKRDVTFK------CDIWSAGVVM 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.9 bits (239), Expect = 1e-20
 Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 45/214 (21%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-------------ECGMIK 801
             +G G +G V   +      E A+KV         +  D              E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 802 RIRHRNIIKFISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDV 856
            + H NIIK         +  LV E+   G L      +  +      +I ++      +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------I 155

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTL 913
            S + YLH      I+H D+KP N+LL   +  +   + DFG++  F  +D  L     L
Sbjct: 156 LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRL 209

Query: 914 ATIGYMAPE-----YGREGRVSTNGDVYSFGIML 942
            T  Y+APE     Y  +       DV+S G+++
Sbjct: 210 GTAYYIAPEVLKKKYNEK------CDVWSCGVIM 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.0 bits (239), Expect = 1e-20
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 18/203 (8%)

Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRH 805
           F +  ++GRGGFG V+  +++   ++ A K   L   R  K    +  M+++     +  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF--QRLNIMI-DVASALEY 862
           R I+    +  +     LV+  M  G +   +Y+ +     F   R       + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAP 921
           LH      II+ DLKP NVLLDD+    +SD G+A          T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMAP 358

Query: 922 EYGREGRVSTNGDVYSFGIMLME 944
           E         + D ++ G+ L E
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYE 381

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 51/208 (24%), Positives = 78/208 (37%), Gaps = 42/208 (20%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD------LQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G G F  V K R    G E A K          + G + +  + E  +++ IRH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 858
                 +     L+LE +  G L             F  L              +  +  
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEATQFLKQILD 119

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH----LSDFGMAKPFLKEDQSLTQTQTLA 914
            + YLH   S  I H DLKP N++L D  V +    L DFG+A   ++            
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFG 173

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIML 942
           T  ++APE      +    D++S G++ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.4 bits (228), Expect = 3e-20
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIRHRNIIK 810
           IG G +G V+KA+  +    VA+K   L          A++    E  ++K ++H+NI++
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                 SD    LV E+     L+K   S N  LD     + +  +   L + H   S  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGR 928
           ++H DLKP N+L++ N    L++FG+A+ F    +    +  + T+ Y  P+  +G +  
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAK-L 178

Query: 929 VSTNGDVYSFGIMLMETFTRKKP 951
            ST+ D++S G +  E     +P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRP 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 91.9 bits (229), Expect = 3e-20
 Identities = 45/201 (22%), Positives = 78/201 (38%), Gaps = 28/201 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD------LQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G G F  V K R    G+E A K          + G + +  + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 811 FISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
                 +     L+LE +  G L     +K   S             +  +   + YLH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLH- 132

Query: 866 GYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
             +  I H DLKP N++L           L DFG+A   +++           T  ++AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVAP 187

Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E      +    D++S G++ 
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 92.8 bits (231), Expect = 3e-20
 Identities = 46/208 (22%), Positives = 77/208 (37%), Gaps = 42/208 (20%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD------LQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G G F  V K R    G+E A K          + G   +  + E  +++++ H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 858
                 +     L+LE +  G L             F  L            + +  +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA 914
            + YLH   +  I H DLKP N++L           L DFG+A   +++           
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFG 180

Query: 915 TIGYMAPEYGREGRVSTNGDVYSFGIML 942
           T  ++APE      +    D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 50/212 (23%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDI-----ECGMIKRIRHRNI 808
           +G G FGFV+ A   +   EV VK      +     I+   +     E  ++ R+ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVA 857
           IK +    +  F  LV+E    G L+  L+   +I             IF++L       
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LD--LF--AFIDRHPRLDEPLASYIFRQL------V 140

Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
           SA+ YL       IIH D+K  N+++ ++    L DFG A     E   L  T    TI 
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194

Query: 918 YMAPE------Y-GREGRVSTNGDVYSFGIML 942
           Y APE      Y G E       +++S G+ L
Sbjct: 195 YCAPEVLMGNPYRGPE------LEMWSLGVTL 220

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 46/201 (22%), Positives = 79/201 (39%), Gaps = 28/201 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFD------LQYGRAIKSFDIECGMIKRIRHRNIIK 810
           +G G F  V K R    G++ A K          + G + +  + E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 811 FISSCSSDDFKALVLEYMPYGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
                 +     L+LE +  G L     EK   +     +       +  + + + YLH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLH- 131

Query: 866 GYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
             S+ I H DLKP N++L           + DFG+A   +             T  ++AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPEFVAP 186

Query: 922 EYGREGRVSTNGDVYSFGIML 942
           E      +    D++S G++ 
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 90.7 bits (226), Expect = 8e-20
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIRHRNIIKF 811
           +G G +G VYKA+   G  VA+K   L          AI+    E  ++K + H NI+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
           I    S+    LV E+M    L+K L  +   L   Q    +  +   + + H      I
Sbjct: 85  IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGRV 929
           +H DLKP N+L++ +    L+DFG+A+ F    +S   T  + T+ Y AP+   G + + 
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK-KY 197

Query: 930 STNGDVYSFGIMLMETFTRK 949
           ST+ D++S G +  E  T K
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.6 bits (228), Expect = 9e-20
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVK--VFDLQY-GRAIKSFDIECGMIKR 802
            Q    ++   +IG G FG V++A++ +  EVA+K  + D ++  R ++       +++ 
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ-------IMRI 88

Query: 803 IRHRNIIK----FISSCSSDDFKA--LVLEYMPYGSLEKCLYS---SNYILDIFQRLNIM 853
           ++H N++     F S+    D     LVLEY+P  ++ +           + +      M
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM 147

Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQT 912
             +  +L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK  +  + +      
Sbjct: 148 YQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSY 201

Query: 913 LATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
           + +  Y APE       Y      +TN D++S G ++ E    +
Sbjct: 202 ICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 91.2 bits (227), Expect = 1e-19
 Identities = 49/229 (21%), Positives = 81/229 (35%), Gaps = 36/229 (15%)

Query: 744 ELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVK--VFDLQYGRAIKSFDI------ 795
           EL    + ++    I  G +G V      +G+ VA+K     +  GR +           
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75

Query: 796 ---ECGMIKRIRHRNIIK---FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIF 847
              E  ++    H NI+                  LV E M    L + ++    ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQ 134

Query: 848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL 907
                M  +   L  LH      ++H DL P N+LL DN    + DF +A+    +    
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK- 190

Query: 908 TQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
             T  +    Y APE       +      +   D++S G ++ E F RK
Sbjct: 191 --THYVTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 53/258 (20%), Positives = 91/258 (35%), Gaps = 53/258 (20%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD----LQYGRAIKSFDIECGMIKRIRHRNIIKF 811
           L+G G +G V +    +     AVK+       +      +   E  +++R+RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 812 ---ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD----------IFQRLNIMIDVAS 858
              + +        +V+EY   G  E  +   + + +           F +L        
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQE--ML--DSVPEKRFPVCQAHGYFCQL------ID 120

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI-- 916
            LEYLH   S  I+H D+KP N+LL       +S  G+A+             T  T   
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQG 173

Query: 917 --GYMAPE--YGREGRVSTNGDVYSFGIMLMETFTRKKPTDES---------FTGEMTLK 963
              +  PE   G +       D++S G+ L    T   P +             G   + 
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP 233

Query: 964 RWVNDLL--LISIMEVVD 979
                 L  L+  M   +
Sbjct: 234 GDCGPPLSDLLKGMLEYE 251

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 44/199 (22%), Positives = 80/199 (40%), Gaps = 26/199 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHR-NIIKFIS 813
           +GRG F  V +      G E A K    +        +I  E  +++  +    +I    
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 814 SCSSDDFKALVLEYMPYGSL-EKCLYSSNYILDIFQRL------NIMIDVASALEYLHFG 866
              +     L+LEY   G +   C      + ++ + +       ++  +   + YLH  
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 867 YSVPIIHCDLKPNNVLLDDNMVAH---LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
               I+H DLKP N+LL          + DFGM++  +     L   + + T  Y+APE 
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLAPEI 204

Query: 924 GREGRVSTNGDVYSFGIML 942
                ++T  D+++ GI+ 
Sbjct: 205 LNYDPITTATDMWNIGIIA 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 40/208 (19%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
           ++G G F  V  AR +    E A+K+ + ++   IK   +     +R     + H   +K
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVK 94

Query: 811 FISSCSSDDFKALVLEYMPYGSL------EKCL-------YSSNYILDIFQRLNIMIDVA 857
              +   D+     L Y   G L                 Y++              ++ 
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA--------------EIV 140

Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATI 916
           SALEYLH      IIH DLKP N+LL+++M   ++DFG AK  L  +    +  +   T 
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTA 196

Query: 917 GYMAPEYGREGRVSTNGDVYSFGIMLME 944
            Y++PE   E     + D+++ G ++ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 90.7 bits (225), Expect = 2e-19
 Identities = 61/283 (21%), Positives = 98/283 (34%), Gaps = 57/283 (20%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEE--LGNLAELEELWLQNNFLTGTIPSSIF-NL 97
            +P+ + + T L  L L  N L   +  E     L  L  L L +N L   I S  F  +
Sbjct: 32  NVPQSLPSYTAL--LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 98  SSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN 157
            +L  LDLS N+L   L   + S+L  L+ L L  N              H+  +  +  
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN--------------HIVVVDRNA- 131

Query: 158 DFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE----LGNLAELEKLQLQNNFLTGTIPP 213
            F          + +L+ L+L QN++    P E       L +L  L L +N L   +P 
Sbjct: 132 -FED--------MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL 180

Query: 214 SIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYG 272
           +    L +     L  ++            N L  +     C            +     
Sbjct: 181 TDLQKLPAWVKNGLYLHN------------NPLECD-----CKLYQLFSHWQYRQLSSVM 223

Query: 273 EIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH 315
           +   DL  C   K++ N+  L+  +    +      H  D L 
Sbjct: 224 DFQEDL-YCMHSKKLHNIFSLDFFNCSEYKESAWEAHLGDTLT 265

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 18/207 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIPS-TLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLR 58
           L+NL  L L  N  +  I S        LR + LS N    T+ + +  ++  L  L L 
Sbjct: 63  LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120

Query: 59  GNKLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSSIF----NLSSLSNLDLSVNNLTGE 113
            N +   +      ++A+L++L+L  N ++   P  +      L  L  LDLS N L  +
Sbjct: 121 NNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-K 177

Query: 114 LLANICSNLPLL--QTLFLDENNFD----GKIPSTLLRCKHLQTLSLSINDFSGDIPKEI 167
           L       LP      L+L  N  +         +  + + L ++     D      K++
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKL 237

Query: 168 GNLTKLKYLHLDQNRLQGEIPEELGNL 194
            N+  L + +  + +           L
Sbjct: 238 HNIFSLDFFNCSEYKESAWEAHLGDTL 264

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 56/294 (19%), Positives = 88/294 (29%), Gaps = 61/294 (20%)

Query: 203 QNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEE 262
               L   +P S+   S  + L+LS N+L+           RL AE        +  L  
Sbjct: 26  SKQQLP-NVPQSLP--SYTALLDLSHNNLS-----------RLRAEW---TPTRLTNLHS 68

Query: 263 IYLSKNMFYGEIPSDLGNCTIPKEI-GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMI 321
           + LS N     +        I  E    +  L  LDL  N L  +      +L  LE ++
Sbjct: 69  LLLSHN----HLN------FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118

Query: 322 FSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP 381
              N +V                          +  +A   +  L++L LS N  S   P
Sbjct: 119 LYNNHIV-------------------------VVDRNAFEDMAQLQKLYLSQNQIS-RFP 152

Query: 382 SFIFNT----SKLSTLELQRNSFSGFIPNTFGNLRNLKW--LDLGDNYLTSSTSELSFLS 435
             +        KL  L+L  N            L       L L +N L          S
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFS 212

Query: 436 SSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLT 489
               + L         L  +  + + N+   ++ F+      S       + LT
Sbjct: 213 HWQYRQLSSVMDFQEDLYCMHSKKLHNIFS-LDFFNCSEYKESAWEAHLGDTLT 265

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 31/137 (22%), Positives = 62/137 (45%), Gaps = 9/137 (6%)

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI--GNLKVLVQIDLSINNFSDVIPTTIGG 596
           L ++P +L        L+LS N  +  L  E     L  L  + LS N+ + +       
Sbjct: 30  LPNVPQSL--PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP 86

Query: 597 LKDLQYLFLKYNRLQGSIPDSI-GDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSF 655
           + +L+YL L  N L  ++ + +  D+  L+ L L NN++  +   + E +  L+ + +S 
Sbjct: 87  VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145

Query: 656 NKLEGEIPREGPFRNFS 672
           N++    P     ++ +
Sbjct: 146 NQIS-RFP-VELIKDGN 160

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 37/185 (20%), Positives = 64/185 (34%), Gaps = 27/185 (14%)

Query: 480 SIPKEI-NNLTNLIAIYLGVNKLNGSIL--IALGKLKKLQLLSLKDNQLEGSIPDNLSFS 536
           ++P+ + +    L    L  N L   +       +L  L  L L  N L   I       
Sbjct: 32  NVPQSLPSYTALL---DLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FIS------ 80

Query: 537 CTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIG 595
                       + ++  L+LS N     L   +  +L+ L  + L  N+   V      
Sbjct: 81  ------SEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFE 133

Query: 596 GLKDLQYLFLKYNRLQGSIP----DSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDI 651
            +  LQ L+L  N++    P         +  L  L+LS+N L  +    L+KL      
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192

Query: 652 NVSFN 656
            +  +
Sbjct: 193 GLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 42/228 (18%), Positives = 66/228 (28%), Gaps = 70/228 (30%)

Query: 412 RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFH 471
                LDL  N L+   +E +    +N   L    +S+N L  I              F 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTN---LHSLLLSHNHLNFISSEA----------F- 84

Query: 472 MPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPD 531
                           + NL  + L  N L+         L+ L++L L +N +   +  
Sbjct: 85  --------------VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDR 129

Query: 532 NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIP 591
           N +F                                    ++  L ++ LS N  S    
Sbjct: 130 N-AFE-----------------------------------DMAQLQKLYLSQNQISRFPV 153

Query: 592 TTIGG---LKDLQYLFLKYNRLQGSIPDSIGDMINLK--SLNLSNNNL 634
             I     L  L  L L  N+L+      +  +       L L NN L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 29/119 (24%), Positives = 44/119 (36%), Gaps = 11/119 (9%)

Query: 554 CLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI-GGLKDLQYLFLKYNRLQG 612
           C    L      LP     L      DLS NN S +        L +L  L L +N L  
Sbjct: 25  CSKQQLPNVPQSLPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN- 77

Query: 613 SIPDSI-GDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 670
            I       + NL+ L+LS+N+L  +       L  L+ + +  N +   +     F +
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVD-RNAFED 134

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 26/224 (11%)

Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGM--------IKR 802
           FS + +IGRGGFG VY  R  D  ++ A+K   L   R          +        +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
                I+    +  + D  + +L+ M  G L   L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAP 921
           +H   +  +++ DLKP N+LLD++    +SD G+A  F K+     +      T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

Query: 922 E-YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKR 964
           E   +     ++ D +S G ML +      P    F    T  +
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDK 399

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 48/259 (18%), Positives = 87/259 (33%), Gaps = 37/259 (14%)

Query: 198 EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNI 257
                Q + +T  IP  +    +  +L      L                 +     +  
Sbjct: 12  RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR---------------VIQKGAFSGF 53

Query: 258 PFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQ-FNRLQCVIPHEIDNLHN 316
             LE+I +S+N     I +D+          NL KL ++ ++  N L  + P    NL N
Sbjct: 54  GDLEKIEISQNDVLEVIEADV--------FSNLPKLHEIRIEKANNLLYINPEAFQNLPN 105

Query: 317 LEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLP-NLEELSLSGNN 375
           L++++ S   +  +      +      L +  N     +  ++ V L      L L+ N 
Sbjct: 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165

Query: 376 FSGTIPSFIFNTSKLSTLEL-QRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS-------S 427
               I +  FN ++L  L L   N+      + F        LD+    + S       +
Sbjct: 166 IQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224

Query: 428 TSELSFLSSSNCKYLEYFS 446
             +L   S+ N K L    
Sbjct: 225 LKKLRARSTYNLKKLPTLE 243

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.1 bits (221), Expect = 5e-19
 Identities = 48/289 (16%), Positives = 93/289 (32%), Gaps = 39/289 (13%)

Query: 140 PSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE-LGNLAELE 198
              +  C   +      +  + +IP ++        L     +L+  I +       +LE
Sbjct: 3   HHRICHC-SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLE 57

Query: 199 KLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNI 257
           K+++  N +   I   +F NL  L ++ +                N L   +  +   N+
Sbjct: 58  KIEISQNDVLEVIEADVFSNLPKLHEIRIEKA-------------NNLL-YINPEAFQNL 103

Query: 258 PFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFN-RLQCVIPHEIDNL-H 315
           P L+ + +S       +P             +  +   LD+Q N  +  +  +    L  
Sbjct: 104 PNLQYLLISNTGI-KHLPDVHKI--------HSLQKVLLDIQDNINIHTIERNSFVGLSF 154

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
               +  + N +   +  + FN + L  L L  N+    LP+           L +S   
Sbjct: 155 ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR 213

Query: 376 FSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY 423
              ++PS+   N  KL             +P T   L  L    L    
Sbjct: 214 IH-SLPSYGLENLKKLRARSTYNLKK---LP-TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 88.3 bits (219), Expect = 7e-19
 Identities = 49/235 (20%), Positives = 87/235 (37%), Gaps = 13/235 (5%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHL-RG 59
            N   L               S    L  I +S ND    I  ++  N+  L  + + + 
Sbjct: 30  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           N L    PE   NL  L+ L + N  +   +P     +      LD+  N     +  N 
Sbjct: 90  NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 119 CSNLP-LLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYL 176
              L      L+L++N    +I ++      L  L+LS N+   ++P ++    +    L
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207

Query: 177 HLDQNRLQGEIPEE-LGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNS 230
            + + R+   +P   L NL +L      N        P++  L +L +  L++ S
Sbjct: 208 DISRTRIH-SLPSYGLENLKKLRARSTYNL----KKLPTLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 56/276 (20%), Positives = 93/276 (33%), Gaps = 38/276 (13%)

Query: 55  LHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGE 113
              + +K+  EIP +L       EL      L   I    F     L  +++S N++   
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 114 LLANICSNLPLLQTLFLDENNFDGKIPSTLLR-CKHLQTLSLSINDFSGDIPKEIGNLTK 172
           + A++ SNLP L  + +++ N    I     +   +LQ L +S             +  +
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129

Query: 173 LKYLHLDQNRLQGEIPEEL--GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNS 230
              L +  N     I      G   E   L L  N +   I  S FN + L +L LS N 
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN- 187

Query: 231 LTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEI-GN 289
                       N L  ELP    +       + +S+              ++P     N
Sbjct: 188 ------------NNLE-ELPNDVFHGASGPVILDISRTRI----------HSLPSYGLEN 224

Query: 290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFN 325
           L KL         L+ +    ++ L  L     ++ 
Sbjct: 225 LKKLRARST--YNLKKLPT--LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 50/279 (17%), Positives = 90/279 (32%), Gaps = 40/279 (14%)

Query: 176 LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGN 234
               ++++  EIP +L       +L+     L   I    F     L  +E+S N +   
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 235 FPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLE 294
              D+             F +N+P L EI + K      I  +           NL  L+
Sbjct: 70  IEADV-------------F-SNLPKLHEIRIEKANNLLYINPEA--------FQNLPNLQ 107

Query: 295 KLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFN--VSTLKFLYLGSNSFF 352
            L +    ++ +      +      +    N  +  +    F         L+L  N   
Sbjct: 108 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI- 166

Query: 353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSFSGFIPNTFGNL 411
             + +SA      L+EL+LS NN    +P+ +F+  S    L++ R            NL
Sbjct: 167 QEIHNSA-FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 225

Query: 412 RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNN 450
           + L+        L          +      L   S++  
Sbjct: 226 KKLRARST--YNLK------KLPTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 80.6 bits (199), Expect = 3e-16
 Identities = 46/304 (15%), Positives = 92/304 (30%), Gaps = 73/304 (24%)

Query: 331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSK 389
           +P+ +        L          +   A     +LE++ +S N+    I + +F N  K
Sbjct: 24  IPSDLP--RNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 390 LSTLELQR-NSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSIS 448
           L  + +++ N+     P  F NL NL++L + +  +     ++  + S     L+     
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSLQKVLLDIQD-- 137

Query: 449 NNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIA 508
           N  +  I       LS       +  + I   I     N T L                 
Sbjct: 138 NINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQL----------------- 179

Query: 509 LGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPL 568
                  +L    +N LE  +P++  F                                 
Sbjct: 180 ------DELNLSDNNNLE-ELPND-VFH-------------------------------- 199

Query: 569 EIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN 628
                   V +D+S      +    +  LK L+       +    +P ++  ++ L   +
Sbjct: 200 ---GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEAS 252

Query: 629 LSNN 632
           L+  
Sbjct: 253 LTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 39/295 (13%), Positives = 74/295 (25%), Gaps = 69/295 (23%)

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
           +        +  +  IPS +        L              F    +L+ +++  N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 425 TSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKE 484
                   F   SN   L    I                                     
Sbjct: 67  LEVIEADVF---SNLPKLHEIRIEKA---------------------------------- 89

Query: 485 INNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPS 544
            NNL  +                A   L  LQ L + +  ++  +PD             
Sbjct: 90  -NNLLYINPE-------------AFQNLPNLQYLLISNTGIK-HLPDV------------ 122

Query: 545 TLWNLKDILCLNLSLNFFTGPLPLEI--GNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY 602
              +    + L++  N     +      G     V + L+ N   ++  +   G +  + 
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDEL 182

Query: 603 LFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNK 657
                N L+    D          L++S   +  +    LE L  L+  +    K
Sbjct: 183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 39/162 (24%), Positives = 63/162 (38%), Gaps = 13/162 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIPS-TLSNCKRLRNISLSLNDFSGTIPKEI--GNVTTLIGLHL 57
           L NL+YL + +      +P     +  +   + +  N    TI +    G     + L L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161

Query: 58  RGNKLQGEIPEELGNLAELEEL-WLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELL 115
             N +Q EI     N  +L+EL    NN L   +P+ +F   S    LD+S   +   L 
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLP 218

Query: 116 ANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN 157
           +    NL  L+           K+P+ L +   L   SL+  
Sbjct: 219 SYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.0 bits (223), Expect = 3e-19
 Identities = 52/261 (19%), Positives = 95/261 (36%), Gaps = 71/261 (27%)

Query: 758 IGRGGFGFVYKARI------QDGMEVAVK-VFDLQYGRAIKSFDIECGMIKRI-RHRNII 809
           +GRG FG V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 810 KFISSCSSDDFKALV-LEYMPYGSLEKCL----------------------YSSNYILDI 846
             + +C+      +V +E+  +G+L   L                      Y     +D+
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 847 FQRLNIMI------------------------------DVASALEYLHFGYSV------- 869
            +RL+ +                               D  +    + + + V       
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 870 ---PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
                IH DL   N+LL +  V  + DFG+A+   K+   + +      + +MAPE   +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 927 GRVSTNGDVYSFGIMLMETFT 947
              +   DV+SFG++L E F+
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 91.8 bits (228), Expect = 4e-19
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 752 FSENNLIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRH 805
           F +  ++G+GGFG V   +++   ++ A K   L+  R  K       + ++     +  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI---DVASALEY 862
           R ++    +  + D   LVL  M  G L+  +Y  +     F     +    ++   LE 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAP 921
           LH      I++ DLKP N+LLDD+    +SD G+A    +        +    T+GYMAP
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP 354

Query: 922 EYGREGRVSTNGDVYSFGIMLME 944
           E  +  R + + D ++ G +L E
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYE 377

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.2 bits (222), Expect = 4e-19
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIK-SFDI----ECGMIKRIRHRNIIKF 811
           +G G F  VYKAR       VA+K   L +    K   +     E  +++ + H NII  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
           + +       +LV ++M    LE  +  ++ +L        M+     LEYLH      I
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGRV 929
           +H DLKPNN+LLD+N V  L+DFG+AK F   +++   T  + T  Y APE  +G     
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR-MY 190

Query: 930 STNGDVYSFGIMLMETFTRK 949
               D+++ G +L E   R 
Sbjct: 191 GVGVDMWAVGCILAELLLRV 210

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 19/200 (9%)

Query: 758 IGRGGFGFVYKARIQDGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIRHRNIIKF 811
           IG G +G VYKA+   G   A+K   L+          I+    E  ++K ++H NI+K 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                +     LV E++    L+K L      L+     + ++ + + + Y H      +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGRV 929
           +H DLKP N+L++      ++DFG+A+ F    +    T  + T+ Y AP+   G + + 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSK-KY 178

Query: 930 STNGDVYSFGIMLMETFTRK 949
           ST  D++S G +  E     
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 52/211 (24%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFI--- 812
           ++G G  G V +    + G + A+K+      +A +  D      +     +I+  +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEVDH---HWQASGGPHIVCILDVY 91

Query: 813 -SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLN----------IMIDVASAL 860
            +         +++E M  G L             I +R +          IM D+ +A+
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIGTAI 141

Query: 861 EYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
           ++LH   S  I H D+KP N+L    + + V  L+DFG AK       +L       T  
Sbjct: 142 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCYTPY 194

Query: 918 YMAPE------YGREGRVSTNGDVYSFGIML 942
           Y+APE      Y +        D++S G+++
Sbjct: 195 YVAPEVLGPEKYDKS------CDMWSLGVIM 219

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 68/284 (23%), Positives = 105/284 (36%), Gaps = 57/284 (20%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRHRNIIKFI 812
             +G G +G V  A        VAVK+ D++  RA+   +    E  + K + H N++KF 
Sbjct: 14   TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALE 861
                  + + L LEY   G L       + I              F +L       + + 
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MAGVV 119

Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YLH    + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+AP
Sbjct: 120  YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 922  E--YGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            E    RE         DV+S GI+L      + P D+          W           +
Sbjct: 177  ELLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKTYL 228

Query: 978  VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                 +       + K   +  V N         P  RI   +I
Sbjct: 229  NPWKKIDSAPLALLHK---I-LVEN---------PSARITIPDI 259

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 88.2 bits (219), Expect = 9e-19
 Identities = 58/210 (27%), Positives = 84/210 (40%), Gaps = 52/210 (24%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI------ECGMIKRIRHRNII 809
            IG G FG     R       VAVK  +       +   I      E    + +RH NI+
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVAS 858
           +F     +    A+++EY   G L         I +            FQ+L       S
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGEL------YERICNAGRFSEDEARFFFQQL------LS 127

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL--SDFGMAKPFLKEDQSLTQTQTLATI 916
            + Y H   S+ I H DLK  N LLD +    L   DFG +K       S  ++ T+ T 
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKS-TVGTP 181

Query: 917 GYMAPE--YGRE--GRVSTNGDVYSFGIML 942
            Y+APE    +E  G+++   DV+S G+ L
Sbjct: 182 AYIAPEVLLRQEYDGKIA---DVWSCGVTL 208

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 89.0 bits (221), Expect = 1e-18
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 41/225 (18%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKARIQD-GMEVAVK-VF-DLQY-GRAIKSFDIECGMIK 801
                 +++  +IG G FG VY+A++ D G  VA+K V  D ++  R ++       +++
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ-------IMR 102

Query: 802 RIRHRNIIK----FISSCSSDDFKAL--VLEYMP---YGSLEKCLYSSNYILDIFQRLNI 852
           ++ H NI++    F SS    D   L  VL+Y+P   Y        +   +  I+ +L  
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 161

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           M  +  +L Y+H   S  I H D+KP N+LLD D  V  L DFG AK  ++ + +     
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VS 215

Query: 912 TLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
            + +  Y APE       Y      +++ DV+S G +L E    +
Sbjct: 216 YICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 49/229 (21%), Positives = 93/229 (40%), Gaps = 43/229 (18%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKARIQD-GMEVAVK-VF-DLQYG----RAIKSFDIECG 798
            +  + F    + G+G FG V   + +  GM VA+K V  D ++     + ++       
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ------- 71

Query: 799 MIKRIRHRNIIK---FISSCSSDDFK----ALVLEYMP---YGSLEKCLYSSNYILDIFQ 848
            +  + H NI++   +  +    D +     +V+EY+P   +               I  
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSL 907
           ++  +  +  ++  LH   SV + H D+KP+NVL++  +    L DFG AK     + + 
Sbjct: 132 KV-FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN- 188

Query: 908 TQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
                + +  Y APE       Y      +T  D++S G +  E    +
Sbjct: 189 --VAYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.2 bits (223), Expect = 1e-18
 Identities = 65/285 (22%), Positives = 107/285 (37%), Gaps = 49/285 (17%)

Query: 68  EELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQT 127
                 AE  +  L+   +T  +  +   L+S+  +  + +++    +  I   LP +  
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGI-QYLPNVTK 69

Query: 128 LFLDENNFDGKIPSTLLRCKHLQTLSLS---INDFSGDIPKEIGNLTKLKYLHLDQNRLQ 184
           LFL+ N     I   L   K+L  L L    I D S      + +L KLK L L+ N + 
Sbjct: 70  LFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS-----LKDLKKLKSLSLEHNGIS 122

Query: 185 GEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNR 244
            +I   L +L +LE L L NN +T  I   +  L+ L  L L  N ++        I   
Sbjct: 123 -DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-------DI--- 168

Query: 245 LSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQ 304
                       +  L+ +YLSKN       SDL      + +  L  L+ L+L      
Sbjct: 169 -------VPLAGLTKLQNLYLSKNHI-----SDL------RALAGLKNLDVLELFSQECL 210

Query: 305 CVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSN 349
               +   NL     +  +   L  V P  I +    +   +  +
Sbjct: 211 NKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.5 bits (211), Expect = 3e-17
 Identities = 44/234 (18%), Positives = 87/234 (37%), Gaps = 33/234 (14%)

Query: 20  STLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEEL 79
                       +L     +  +      + ++  +    + ++  + + +  L  + +L
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70

Query: 80  WLQNNFLTGTIPSSIFNLSSLSNL---DLSVNNLTGELLANIC--SNLPLLQTLFLDENN 134
           +L  N LT      I  L++L NL    L  N +      ++    +L  L++L L+ N 
Sbjct: 71  FLNGNKLT-----DIKPLTNLKNLGWLFLDENKIK-----DLSSLKDLKKLKSLSLEHNG 120

Query: 135 FDGKIPSTLLRCKHLQTLSLS---INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
                 + L+    L++L L    I D +      +  LTKL  L L+ N++  +I   L
Sbjct: 121 I--SDINGLVHLPQLESLYLGNNKITDITV-----LSRLTKLDTLSLEDNQIS-DI-VPL 171

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRL 245
             L +L+ L L  N ++  +   +  L +L  LEL               +   
Sbjct: 172 AGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 223

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 83.2 bits (205), Expect = 1e-16
 Identities = 49/232 (21%), Positives = 95/232 (40%), Gaps = 17/232 (7%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L++++ +   ++     +   +     +  + L+ N  +   P  + N+  L  L L  N
Sbjct: 42  LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           K++ ++   L +L +L+ L L++N ++  I + + +L  L +L L  N +T   +  + S
Sbjct: 98  KIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVL-S 150

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            L  L TL L++N     I   L     LQ L LS N  S D+ + +  L  L  L L  
Sbjct: 151 RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFS 206

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT 232
                +      NL     ++  +  L    P  I +        + ++   
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.8 bits (196), Expect = 2e-15
 Identities = 70/396 (17%), Positives = 137/396 (34%), Gaps = 111/396 (28%)

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
             A+  K +L+   +   +    + L++++ +I + + +      ++  +  L       
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-----KSVQGIQYL------- 64

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTF 408
                          PN+ +L L+GN              KL+ ++              
Sbjct: 65  ---------------PNVTKLFLNGN--------------KLTDIK------------PL 83

Query: 409 GNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSME 468
            NL+NL WL L +N +      LS L   + K L+  S+ +N +                
Sbjct: 84  TNLKNLGWLFLDENKIKD----LSSLK--DLKKLKSLSLEHNGI---------------- 121

Query: 469 DFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGS 528
                 S+I+G     + +L  L ++YLG NK+  + +  L +L KL  LSL+DNQ+   
Sbjct: 122 ------SDING-----LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI--- 165

Query: 529 IPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSD 588
                      + I   L  L  +  L LS N  +    L    LK L  ++L      +
Sbjct: 166 -----------SDIVP-LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLN 211

Query: 589 VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLE--KLL 646
                   L     +      L    P+ I D  + +  N+  +       +S    + +
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPV 269

Query: 647 DLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELL 682
            +      F+    +  +E    ++ ++       +
Sbjct: 270 TIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKV 305

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.8 bits (183), Expect = 7e-14
 Identities = 52/247 (21%), Positives = 90/247 (36%), Gaps = 21/247 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIP--STLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLR 58
           L N+  LFL  N    K+     L+N K L  + L  N         + ++  L  L L 
Sbjct: 64  LPNVTKLFLNGN----KLTDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLE 117

Query: 59  GNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANI 118
            N +  +I   L +L +LE L+L NN +T    + +  L+ L  L L  N ++     +I
Sbjct: 118 HNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DI 168

Query: 119 --CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYL 176
              + L  LQ L+L +N+        L   K+L  L L   +          NL     +
Sbjct: 169 VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226

Query: 177 HLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP 236
                 L            E   ++      T  +    +   ++   +  F+       
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPL 286

Query: 237 KDMHIVN 243
           K+++ V+
Sbjct: 287 KEVYTVS 293

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.9 bits (218), Expect = 2e-18
 Identities = 48/213 (22%), Positives = 81/213 (38%), Gaps = 57/213 (26%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRI-RHRNIIKFI- 812
           +G G  G V +    +   + A+K+                E  +  R  +  +I++ + 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 813 ---SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-IFQRLN----------IMIDVAS 858
              +  +      +V+E +  G L             I  R +          IM  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
           A++YLH   S+ I H D+KP N+L      N +  L+DFG AK       SL  T    T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSL--TTPCYT 226

Query: 916 IGYMAPE------YGREGRVSTNGDVYSFGIML 942
             Y+APE      Y +        D++S G+++
Sbjct: 227 PYYVAPEVLGPEKYDKS------CDMWSLGVIM 253

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 22/202 (10%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDL-QYGRAIKSFDI-ECGMIKRIRHRNIIKFISS 814
           IG G +G V+K R    G  VA+K F   +    IK   + E  M+K+++H N++  +  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
                   LV EY  + ++   L      +      +I      A+ + H       IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 875 DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-------YGREG 927
           D+KP N+L+  + V  L DFG A+              +AT  Y +PE       Y    
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQY---- 180

Query: 928 RVSTNGDVYSFGIMLMETFTRK 949
                 DV++ G +  E  +  
Sbjct: 181 --GPPVDVWAIGCVFAELLSGV 200

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 38/213 (17%), Positives = 76/213 (35%), Gaps = 12/213 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
             + + L L             SN   +  I +S++     +      N++ +  + +R 
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 60  NKLQGEIPEE-LGNLAELEELWLQNNFLTGTIP--SSIFNLSSLSNLDLSVNNLTGELLA 116
            +    I  + L  L  L+ L + N  L    P  + +++      L+++ N     +  
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 117 NICSNLP-LLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI--GNLTKL 173
           N    L     TL L  N F   +         L  + L+ N +   I K+   G  +  
Sbjct: 149 NAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207

Query: 174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNF 206
             L + Q  +   +P +   L  L++L  +N +
Sbjct: 208 SLLDVSQTSVT-ALPSKG--LEHLKELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 41/233 (17%), Positives = 78/233 (33%), Gaps = 33/233 (14%)

Query: 194 LAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAK 252
               + L+L    L  TIP   F NL ++S + +S +               L  +L + 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID-------------VTLQ-QLESH 74

Query: 253 FCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHE-- 310
              N+  +  I +        I  D         +  L  L+ L +    L+ + P    
Sbjct: 75  SFYNLSKVTHIEIRNTRNLTYIDPDA--------LKELPLLKFLGIFNTGLK-MFPDLTK 125

Query: 311 IDNLHNLEWMIFSFNKLVGVVPTTIFN--VSTLKFLYLGSNSFFGRLPSSADVRLPNLEE 368
           + +      +  + N  +  +P   F    +    L L +N F   +   A      L+ 
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYA-FNGTKLDA 183

Query: 369 LSLSGNNFSGTIPSFIFN--TSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL 419
           + L+ N +   I    F    S  S L++ + S +        +L+ L   + 
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 9/163 (5%)

Query: 73  LAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLD 131
               + L L    L  TIPS  F NL ++S + +S++    +L ++   NL  +  + + 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 132 ENNFDGKIPS-TLLRCKHLQTLSLSINDFSGDIPKE--IGNLTKLKYLHLDQNRLQGEIP 188
                  I    L     L+ L +         P    + +      L +  N     IP
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 189 EEL--GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFN 229
                G   E   L+L NN  T ++    FN + L  + L+ N
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 34/220 (15%), Positives = 71/220 (32%), Gaps = 29/220 (13%)

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
           + + +      L  +      N+  +  +Y+  +    +L S +   L  +  + +    
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 376 FSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
               I                        P+    L  LK+L + +  L     +L+ + 
Sbjct: 92  NLTYID-----------------------PDALKELPLLKFLGIFNTGLKMF-PDLTKVY 127

Query: 436 SSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIY 495
           S++  ++   +  N  +  I       L        + N+  + S+     N T L A+Y
Sbjct: 128 STDIFFILEIT-DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185

Query: 496 LGVNKLNGSI-LIALGKLK-KLQLLSLKDNQLEGSIPDNL 533
           L  NK    I   A G +     LL +    +  ++P   
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 51/292 (17%), Positives = 84/292 (28%), Gaps = 72/292 (24%)

Query: 365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL 424
             E+  ++  +    IPS   +T    TL+L          + F NL N+  + +  +  
Sbjct: 12  QEEDFRVTCKDIQ-RIPSLPPSTQ---TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67

Query: 425 TSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKE 484
                  SF + S    + +  I N            NL+                I  +
Sbjct: 68  LQQLESHSFYNLSK---VTHIEIRNTR----------NLT---------------YIDPD 99

Query: 485 I-NNLTNLIAIYLGVNKLNG-SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSI 542
               L  L  + +    L     L  +       +L + DN    SIP N          
Sbjct: 100 ALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA--------- 150

Query: 543 PSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY 602
                              F G            + + L  N F+ V      G K L  
Sbjct: 151 -------------------FQGLCNE-------TLTLKLYNNGFTSVQGYAFNGTK-LDA 183

Query: 603 LFLKYNRLQGSIPDSI--GDMINLKSLNLSNNNLFGIIPISLEKLLDLKDIN 652
           ++L  N+    I      G       L++S  ++  +    LE L +L   N
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 68/284 (23%), Positives = 105/284 (36%), Gaps = 57/284 (20%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFD---IECGMIKRIRHRNIIKFI 812
             +G G +G V  A        VAVK+ D++  RA+   +    E  + K + H N++KF 
Sbjct: 14   TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALE 861
                  + + L LEY   G L       + I              F +L       + + 
Sbjct: 72   GHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MAGVV 119

Query: 862  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            YLH    + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+AP
Sbjct: 120  YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 922  E--YGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            E    RE         DV+S GI+L      + P D+          W           +
Sbjct: 177  ELLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKTYL 228

Query: 978  VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                 +       + K   +  V N         P  RI   +I
Sbjct: 229  NPWKKIDSAPLALLHK---I-LVEN---------PSARITIPDI 259

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 85.7 bits (212), Expect = 5e-18
 Identities = 37/186 (19%), Positives = 74/186 (39%), Gaps = 17/186 (9%)

Query: 782 FDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN 841
           + L     + +  ++   +     +N +  +   S   +  + ++     +L+  +    
Sbjct: 97  WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 842 YI--LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
            +   +    L+I I +A A+E+LH   S  ++H DLKP+N+    + V  + DFG+   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT- 212

Query: 900 FLKEDQSLTQTQTLA-----------TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR 948
            + +D+      T             T  YM+PE       S   D++S G++L E    
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

Query: 949 KKPTDE 954
                E
Sbjct: 273 FSTQME 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 18/91 (19%), Positives = 35/91 (38%), Gaps = 2/91 (2%)

Query: 752 FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNII 809
           F     +GRGGFG V++A+   D    A+K   L     A +    E   + ++ H  I+
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSS 840
           ++ ++      +    E       ++     
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.4 bits (212), Expect = 5e-18
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 39/203 (19%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRHRNIIKF 811
           IG+G F  V  AR I  G EVA+K+ D      +    +     E  ++K + H NI+K 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVASAL 860
                ++    L++EY   G +       +Y++             F+++       SA+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV------FDYLVAHGRMKEKEARSKFRQI------VSAV 127

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           +Y H      I+H DLK  N+LLD +M   ++DFG +  F    +            Y A
Sbjct: 128 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP---YAA 181

Query: 921 PE-YGREGRVSTNGDVYSFGIML 942
           PE +  +       DV+S G++L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVIL 204

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 85.1 bits (211), Expect = 7e-18
 Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 50/213 (23%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD----LQYGRAIKSFDI--ECGMIKRIRHR--N 807
           L+G GGFG VY    + D + VA+K  +      +G       +  E  ++K++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLN------IMIDVASALE 861
           +I+ +      D   L+LE  P    +  L+  ++I +    L           V  A+ 
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LF--DFITE-RGALQEELARSFFWQVLEAVR 163

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPFLKEDQSLTQTQTLAT----I 916
           + H   +  ++H D+K  N+L+D N     L DFG          +L +           
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--------ALLKDTVYTDFDGTR 212

Query: 917 GYMAPEY-------GREGRVSTNGDVYSFGIML 942
            Y  PE+       GR         V+S GI+L
Sbjct: 213 VYSPPEWIRYHRYHGRS------AAVWSLGILL 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.5 bits (212), Expect = 9e-18
 Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 51/241 (21%)

Query: 736 NQRRFTYLEL----FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK----VFDLQ- 785
               F  +E+    F     +     IG G  G V  A        VA+K     F  Q 
Sbjct: 7   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66

Query: 786 -----YGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFKA--LVLEYMPYGSLE 834
                Y R +        ++K + H+NII     F    S ++F+   +V+E M   +L 
Sbjct: 67  HAKRAY-RELV-------LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC 117

Query: 835 KCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV 888
           + +         +Y+L  +Q L         +++LH   S  IIH DLKP+N+++  +  
Sbjct: 118 QVIQMELDHERMSYLL--YQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCT 165

Query: 889 AHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR 948
             + DFG+A+       S   T  + T  Y APE         N D++S G ++ E    
Sbjct: 166 LKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

Query: 949 K 949
            
Sbjct: 223 G 223

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 63/303 (20%), Positives = 116/303 (38%), Gaps = 40/303 (13%)

Query: 358 SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWL 417
             D  L N  +++   +N + T+     +   ++TL       +         L NL  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGL 68

Query: 418 DLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNI 477
           +L DN +T     L+ L   N   +    +S NPL  +    I  L   ++   + ++ I
Sbjct: 69  ELKDNQITD----LAPLK--NLTKITELELSGNPLKNVSA--IAGLQS-IKTLDLTSTQI 119

Query: 478 SGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSC 537
           +   P  +  L+NL  +YL +N++  + +  L  L  LQ LS+ + Q+            
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQV------------ 163

Query: 538 TLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGL 597
             + + + L NL  +  L    N  +   PL   +L  L+++ L  N  SDV P  +   
Sbjct: 164 --SDL-TPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANT 216

Query: 598 KDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGII-PISLEKLLDLKDINVSFN 656
            +L  + L    +       +    NL   N+        I P ++         N+++N
Sbjct: 217 SNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273

Query: 657 KLE 659
              
Sbjct: 274 LTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 57/283 (20%), Positives = 113/283 (39%), Gaps = 23/283 (8%)

Query: 20  STLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEEL 79
                      I+   ++ + T+     ++  +  L   G  +     E +  L  L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGL 68

Query: 80  WLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKI 139
            L++N +T    + + NL+ ++ L+LS N L    ++ I + L  ++TL L         
Sbjct: 69  ELKDNQITD--LAPLKNLTKITELELSGNPLKN--VSAI-AGLQSIKTLDLTSTQITDVT 123

Query: 140 PSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEK 199
           P  L    +LQ L L +N  + +I   +  LT L+YL +   ++    P  L NL++L  
Sbjct: 124 P--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177

Query: 200 LQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP-KDMHIVNRLSAELPAKFCNNIP 258
           L+  +N ++  I P + +L +L ++ L  N ++   P  +   +  ++          I 
Sbjct: 178 LKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT-----NQTIT 230

Query: 259 FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFN 301
                Y +  +    +    G    P  I +       +L +N
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 21/234 (8%)

Query: 1   LSNLEYLFLKSNMFHGKI--PSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLR 58
           L+NL  L LK N    +I   + L N  ++  + LS N         I  + ++  L L 
Sbjct: 62  LNNLIGLELKDN----QITDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLT 115

Query: 59  GNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANI 118
             ++    P  L  L+ L+ L+L  N +T    S +  L++L  L +    ++   L  +
Sbjct: 116 STQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD--LTPL 169

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
            +NL  L TL  D+N     I   L    +L  + L  N  S D+   + N + L  + L
Sbjct: 170 -ANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVTL 224

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT 232
               +  +      NL       ++        P +I +  + +   L++N  +
Sbjct: 225 TNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 55/304 (18%), Positives = 106/304 (34%), Gaps = 57/304 (18%)

Query: 155 SINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPS 214
           +IN    D       L     +   ++ +   +     +L  +  L      +T TI   
Sbjct: 8   AINVIFPD-----PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG- 58

Query: 215 IFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEI 274
           +  L++L  LEL  N +T        +              N+  + E+ LS N      
Sbjct: 59  VQYLNNLIGLELKDNQIT-------DLAP----------LKNLTKITELELSGN------ 95

Query: 275 PSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTT 334
                       I  L  ++ LDL   ++  V P  +  L NL+ +    N++  + P  
Sbjct: 96  -----PLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP-- 146

Query: 335 IFNVSTLKFLYLGSNSFFGRLPS-SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTL 393
           +  ++ L++L +G+     ++   +    L  L  L    N  S    S + +   L  +
Sbjct: 147 LAGLTNLQYLSIGNA----QVSDLTPLANLSKLTTLKADDNKISDI--SPLASLPNLIEV 200

Query: 394 ELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSE-------LSFLSSSNCKYLEYFS 446
            L+ N  S   P    N  NL  + L +  +T+            + +   +   +   +
Sbjct: 201 HLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPAT 258

Query: 447 ISNN 450
           IS+N
Sbjct: 259 ISDN 262

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 33/164 (20%), Positives = 72/164 (43%), Gaps = 17/164 (10%)

Query: 504 SILIALGKLKKLQLLSLKDNQLEGSIP----DNLSF----SCTLTSIPSTLWNLKDILCL 555
           +++     L     ++   + +  ++     D ++        +T+I   +  L +++ L
Sbjct: 10  NVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-VQYLNNLIGL 68

Query: 556 NLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP 615
            L  N  T   PL+  NL  + +++LS N   +V    I GL+ ++ L L   ++    P
Sbjct: 69  ELKDNQITDLAPLK--NLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124

Query: 616 DSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
             +  + NL+ L L  N +  I P  L  L +L+ +++   ++ 
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 25/203 (12%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--G------RAIKSFDIECGMIKRIRHRNI 808
           +G G +  VYK +       VA+K   L++  G      R +        ++K ++H NI
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS-------LLKDLKHANI 62

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
           +       ++    LV EY+    L++ L     I+++      +  +   L Y H    
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---R 118

Query: 869 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGRE 926
             ++H DLKP N+L+++     L+DFG+A+      ++      + T+ Y  P+   G  
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDILLGST 176

Query: 927 GRVSTNGDVYSFGIMLMETFTRK 949
              ST  D++  G +  E  T +
Sbjct: 177 -DYSTQIDMWGVGCIFYEMATGR 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 46/212 (21%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFD----LQYGRAIKSFDI--ECGMIKRIR----H 805
           L+G+GGFG V+    + D ++VA+KV      L +     S     E  ++ ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 806 RNIIKFISSCSSDDFKALVLEY-MPYGSLEKCLYSSNYILDIFQRL------NIMIDVAS 858
             +I+ +    + +   LVLE  +P   L       +YI +    L           V +
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDL------FDYITE-KGPLGEGPSRCFFGQVVA 150

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIG 917
           A+++ H   S  ++H D+K  N+L+D     A L DFG     L  D+  T      T  
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFD--GTRV 203

Query: 918 YMAPEY-------GREGRVSTNGDVYSFGIML 942
           Y  PE+                  V+S GI+L
Sbjct: 204 YSPPEWISRHQYHALP------ATVWSLGILL 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 12/199 (6%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFDL-QYGRAIKSFDI-ECGMIKRIRHRNIIKFI 812
            L+G G +G V K R    G  VA+K F      + +K   + E  ++K++RH N++  +
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 813 SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
             C       LV E++ + ++   L      LD       +  + + + + H   S  II
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146

Query: 873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--YGREGRVS 930
           H D+KP N+L+  + V  L DFG A+      +       +AT  Y APE   G + +  
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPELLVG-DVKYG 203

Query: 931 TNGDVYSFGIMLMETFTRK 949
              DV++ G ++ E F  +
Sbjct: 204 KAVDVWAIGCLVTEMFMGE 222

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.1 bits (206), Expect = 4e-17
 Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 53/247 (21%)

Query: 730 NMPLVANQRRFTYLEL----FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK---- 780
           ++ L+  ++ F   ++    ++    +     +G G +G V  A   + G +VA+K    
Sbjct: 1   SLSLI-RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR 59

Query: 781 VFDLQYG-----RAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFKA--LVLEYMP 829
            F  +       R +        ++K ++H N+I     F  + S  +F    LV+ +M 
Sbjct: 60  PFQSEIFAKRAYRELL-------LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ 112

Query: 830 YGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL 883
              L+K +          Y+  ++Q L         L+Y+H   S  ++H DLKP N+ +
Sbjct: 113 T-DLQKIMGLKFSEEKIQYL--VYQMLK-------GLKYIH---SAGVVHRDLKPGNLAV 159

Query: 884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIML 942
           +++    + DFG+A+           T  + T  Y APE        +   D++S G ++
Sbjct: 160 NEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214

Query: 943 METFTRK 949
            E  T K
Sbjct: 215 AEMLTGK 221

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 4e-17
 Identities = 45/211 (21%), Positives = 86/211 (40%), Gaps = 41/211 (19%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
           +IGRG FG V   ++++  +V A+K+  L     +K  +  C   +R        + I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID----------VASAL 860
              +   D+   LV++Y   G L          L +  +    +           +  A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQTLATIGY 918
           + +H    +  +H D+KP+N+L+D N   H  L+DFG     +++    +    + T  Y
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242

Query: 919 MAPEYGREGRVSTNG-----DVYSFGIMLME 944
           ++PE  +             D +S G+ + E
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.5 bits (207), Expect = 4e-17
 Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 56/223 (25%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIEC-----GMIKRIRHRNIIK 810
            IG+G FG V   +  D  ++ A+K   +   + ++  ++        +++ + H  ++ 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKY--MNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMI------------DVAS 858
              S   ++   +V++ +  G             D+   L   +            ++  
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGG-------------DLRYHLQQNVHFKEETVKLFICELVM 126

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIG 917
           AL+YL    +  IIH D+KP+N+LLD++   H++DF +A    +E    TQ  T+A T  
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKP 179

Query: 918 YMAPE---------YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
           YMAPE         Y     V    D +S G+   E    ++P
Sbjct: 180 YMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYELLRGRRP 216

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 40/205 (19%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI------ECGMIKRIRHRNII 809
            +G G FG V        G +VAVK+ + Q    I+S D+      E   +K  RH +II
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVAS 858
           K     S+     +V+EY+  G L       +YI             +FQ++       S
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQI------LS 122

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
           A++Y H      ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNY 176

Query: 919 MAPE-YGREGRVSTNGDVYSFGIML 942
            APE            D++S G++L
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVIL 201

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI----ECGMIKRIRHRNIIKFI 812
           IG+G FG V+KAR  + G +VA+K   +      + F I    E  +++ ++H N++  I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 813 SSCSSDDFKA--------LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
             C +             LV ++  +  L   L +      + +   +M  + + L Y+H
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 865 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ--TQTLATIGYMAPE 922
                 I+H D+K  NVL+  + V  L+DFG+A+ F     S     T  + T+ Y  PE
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198

Query: 923 --YGREGRVSTNGDVYSFGIMLMETFTRK 949
              G E       D++  G ++ E +TR 
Sbjct: 199 LLLG-ERDYGPPIDLWGAGCIMAEMWTRS 226

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 83.9 bits (208), Expect = 6e-17
 Identities = 74/399 (18%), Positives = 134/399 (33%), Gaps = 61/399 (15%)

Query: 98  SSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK----IPSTLLRCKHLQTLS 153
             + +LD+    L+    A +   L   Q + LD+          I S L     L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 154 LSINDFSGDIPKEIGNL-----TKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQN 204
           L  N+        +         K++ L L    L G     +   L  L  L++L L +
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 205 NFLTGTIPPSIF-----NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPF 259
           N L       +          L  L+L + SL+             S E  A      P 
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA-----------SCEPLASVLRAKPD 171

Query: 260 LEEIYLSKNMFYGEIPSDLGNCTIPKEIG-NLAKLEKLDLQFNRLQ----CVIPHEIDNL 314
            +E+ +S N       ++ G   + + +  +  +LE L L+   +       +   + + 
Sbjct: 172 FKELTVSNNDI-----NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226

Query: 315 HNLEWMIFSFNKL--VGVV---PTTIFNVSTLKFLYLGSNSF----FGRLPSSADVRLPN 365
            +L  +    NKL  VG+    P  +   S L+ L++          G L         +
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL-CRVLRAKES 285

Query: 366 LEELSLSGNNFSGT-----IPSFIFNTSKLSTLELQRNSFSG----FIPNTFGNLRNLKW 416
           L+ELSL+GN            + +    +L +L ++  SF+        +     R L  
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345

Query: 417 LDLGDNYLTSSTSEL--SFLSSSNCKYLEYFSISNNPLG 453
           L + +N L  +        L       L    +++  + 
Sbjct: 346 LQISNNRLEDAGVRELCQGLGQPGSV-LRVLWLADCDVS 383

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.1 bits (193), Expect = 4e-15
 Identities = 84/471 (17%), Positives = 143/471 (30%), Gaps = 80/471 (16%)

Query: 28  LRNISLSLNDFSGTIPKEIG-NVTTLIGLHLRGNKLQGE----IPEELGNLAELEELWLQ 82
           ++++ +   + S     E+   +     + L    L       I   L     L EL L+
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 83  NNFLTGTIPSSIFNL-----SSLSNLDLSVNNLTGELLANICSNL---PLLQTLFLDENN 134
           +N L       +          +  L L    LTG     + S L   P LQ L L +N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 135 FDGK----IPSTLLR-CKHLQTLSLSINDFSGDIPKEIG----NLTKLKYLHLDQNRLQG 185
                   +   LL     L+ L L     S    + +          K L +  N +  
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184

Query: 186 EIPEELG-----NLAELEKLQLQNNFLT----GTIPPSIFNLSSLSDLELSFNSLTGNFP 236
                L      +  +LE L+L++  +T      +   + + +SL +L L  N L     
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG- 243

Query: 237 KDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKL 296
                +  L   L          L  +++ +        +  G   + + +     L++L
Sbjct: 244 -----MAELCPGLLHPSSR----LRTLWIWECGI-----TAKGCGDLCRVLRAKESLKEL 289

Query: 297 DLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF---FG 353
            L  N L        +    L   +                   L+ L++ S SF     
Sbjct: 290 SLAGNELGD------EGARLLCETLLEPG-------------CQLESLWVKSCSFTAACC 330

Query: 354 RLPSSADVRLPNLEELSLSGNNF--SGTIP---SFIFNTSKLSTLELQRNSFS----GFI 404
              SS   +   L EL +S N    +G            S L  L L     S      +
Sbjct: 331 SHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 390

Query: 405 PNTFGNLRNLKWLDLGDNYLTSSTSEL--SFLSSSNCKYLEYFSISNNPLG 453
             T     +L+ LDL +N L  +        +    C  LE   + +    
Sbjct: 391 AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL-LEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 67.7 bits (166), Expect = 8e-12
 Identities = 56/323 (17%), Positives = 101/323 (31%), Gaps = 75/323 (23%)

Query: 2   SNLEYLFLKSNMFHGK----IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHL 57
             LE L L+           + S L      + +++S ND +            ++   L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA-------GVRVLCQGL 194

Query: 58  RGNKLQGEIPEELGNLAELEELWLQNNFLT----GTIPSSIFNLSSLSNLDLSVNNLTGE 113
           + +  Q            LE L L++  +T      +   + + +SL  L L  N L   
Sbjct: 195 KDSPCQ------------LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 114 ----LLANICSNLPLLQTLFLDENNFDGK----IPSTLLRCKHLQTLSLSINDFSGDIPK 165
               L   +      L+TL++ E     K    +   L   + L+ LSL+ N+   +  +
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302

Query: 166 EIGNL-----TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSS 220
            +         +L+ L +              ++       L  N               
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV-------LAQN-------------RF 342

Query: 221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN 280
           L +L++S N L          V  L   L          L  ++L+         SD   
Sbjct: 343 LLELQISNNRLEDA------GVRELCQGLGQPGSV----LRVLWLADCDV-----SDSSC 387

Query: 281 CTIPKEIGNLAKLEKLDLQFNRL 303
            ++   +     L +LDL  N L
Sbjct: 388 SSLAATLLANHSLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.0 bits (159), Expect = 7e-11
 Identities = 60/341 (17%), Positives = 113/341 (33%), Gaps = 58/341 (17%)

Query: 338 VSTLKFLYLGSNSF---FGRLPSSADVRLPNLEELSLSGNNFSGT-----IPSFIFNTSK 389
           +   + + L          +  SSA    P L EL+L  N          +      + K
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 390 LSTLELQRNSFS----GFIPNTFGNLRNLKWLDLGDNYLTSSTSEL--SFLSSSNCKYLE 443
           +  L LQ    +    G + +T   L  L+ L L DN L  +  +L    L    C+ LE
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR-LE 145

Query: 444 YFSISNNPLGGILPRVIGNL---SQSMEDFHMPNSNISGSIPKEI-----NNLTNLIAIY 495
              +    L       + ++       ++  + N++I+ +  + +     ++   L A+ 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 496 LGVNKLN----GSILIALGKLKKLQLLSLKDNQLEGS-----IPDNLSFSCTLTSIPSTL 546
           L    +       +   +     L+ L+L  N+L         P  L  S  L +     
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT----- 260

Query: 547 WNLKDILCLNLSLNFFTGP----LPLEIGNLKVLVQIDLSINNFSDVIPTTIG-GLKD-- 599
                   L +     T      L   +   + L ++ L+ N   D     +   L +  
Sbjct: 261 --------LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312

Query: 600 --LQYLFLKYNRLQGSIPDSIGDMI----NLKSLNLSNNNL 634
             L+ L++K      +       ++     L  L +SNN L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 62.3 bits (152), Expect = 4e-10
 Identities = 82/493 (16%), Positives = 148/493 (30%), Gaps = 114/493 (23%)

Query: 171 TKLKYLHLDQNRLQGE-IPEELGNLAELEKLQLQNNFLTGT----IPPSIFNLSSLSDLE 225
             ++ L +    L      E L  L + + ++L +  LT      I  ++    +L++L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 226 LSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPK 285
           L  N L          V+ +   L    C     ++++ L          +  G   +  
Sbjct: 63  LRSNELGDVG------VHCVLQGLQTPSCK----IQKLSLQNCCL-----TGAGCGVLSS 107

Query: 286 EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY 345
            +  L  L++L L  N L          L  L   +                   L+ L 
Sbjct: 108 TLRTLPTLQELHLSDNLLGD------AGLQLLCEGLLDPQ-------------CRLEKLQ 148

Query: 346 LGSNSF---FGRLPSSADVRLPNLEELSLSGNNFSGT-----IPSFIFNTSKLSTLELQR 397
           L   S         +S     P+ +EL++S N+ +             +  +L  L+L+ 
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLES 208

Query: 398 NSFS----GFIPNTFGNLRNLKWLDLGDNYLTSSTSEL--SFLSSSNCKYLEYFSISNNP 451
              +      +     +  +L+ L LG N L           L   + + L    I    
Sbjct: 209 CGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR-LRTLWIWECG 267

Query: 452 LGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGK 511
           +       +  +                     +    +L  + L  N+L       L +
Sbjct: 268 ITAKGCGDLCRV---------------------LRAKESLKELSLAGNELGDEGARLLCE 306

Query: 512 L-----KKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT--G 564
                  +L+ L +K            +  C+     S L   + +L L +S N     G
Sbjct: 307 TLLEPGCQLESLWVKSCSFT-------AACCS--HFSSVLAQNRFLLELQISNNRLEDAG 357

Query: 565 PLPLEIG---NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDM 621
              L  G      VL  + L+  + SD           L    L  N             
Sbjct: 358 VRELCQGLGQPGSVLRVLWLADCDVSDS------SCSSLAAT-LLANH------------ 398

Query: 622 INLKSLNLSNNNL 634
            +L+ L+LSNN L
Sbjct: 399 -SLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.4 bits (116), Expect = 8e-06
 Identities = 29/153 (18%), Positives = 59/153 (38%), Gaps = 21/153 (13%)

Query: 22  LSNCKRLRNISLSLNDFSGTIPKEIGNV----TTLIGLHLRGNKLQGEIPEELG-----N 72
           L    +L ++ +    F+        +V      L+ L +  N+L+     EL       
Sbjct: 309 LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP 368

Query: 73  LAELEELWLQNNFLT----GTIPSSIFNLSSLSNLDLSVNNLTGE----LLANICSNLPL 124
            + L  LWL +  ++     ++ +++    SL  LDLS N L       L+ ++     L
Sbjct: 369 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 428

Query: 125 LQTLFLDENNFDGK----IPSTLLRCKHLQTLS 153
           L+ L L +  +  +    + +       L+ +S
Sbjct: 429 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 83.2 bits (206), Expect = 7e-17
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 46/212 (21%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
           +IGRG FG V   R +   +V A+K+  L     IK  D      +R          +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVA--------SALEY 862
              +   D +  +V+EYMP G L          +++    ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           +H   S+  IH D+KP+N+LLD +    L+DFG      KE      T  + T  Y++PE
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPE 239

Query: 923 ----------YGREGRVSTNGDVYSFGIMLME 944
                     YGRE       D +S G+ L E
Sbjct: 240 VLKSQGGDGYYGRE--C----DWWSVGVFLYE 265

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 30/208 (14%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--G------RAIKSFDIECGMIKRIRHRNI 808
           +G G +  VYK      G+ VA+K   L    G      R I        ++K ++H NI
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS-------LMKELKHENI 65

Query: 809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-----LDIFQRLNIMIDVASALEYL 863
           ++      +++   LV E+M    L+K + S         L++         +   L + 
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 864 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE- 922
           H      I+H DLKP N+L++      L DFG+A+ F     +   +  + T+ Y AP+ 
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDV 179

Query: 923 -YGREGRVSTNGDVYSFGIMLMETFTRK 949
             G     ST+ D++S G +L E  T K
Sbjct: 180 LMGSR-TYSTSIDIWSCGCILAEMITGK 206

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 34/186 (18%), Positives = 65/186 (34%), Gaps = 11/186 (5%)

Query: 48  NVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV 107
                +   L  +        ++ +L     + L N  +T    + I    ++ +L ++ 
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSL---TYITLANINVTDL--TGIEYAHNIKDLTINN 75

Query: 108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI 167
            + T      I S L  L+ L +   +        L     L  L +S +     I  +I
Sbjct: 76  IHATN--YNPI-SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 168 GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELS 227
             L K+  + L  N    +I   L  L EL+ L +Q + +       I +   L+ L   
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189

Query: 228 FNSLTG 233
             ++ G
Sbjct: 190 SQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 30/188 (15%), Positives = 73/188 (38%), Gaps = 36/188 (19%)

Query: 1   LSNLEYLFLKSNMFHGKIPST--LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLR 58
           +++L Y+ L +      +     +     +++++++    +   P  I  ++ L  L + 
Sbjct: 43  MNSLTYITLANI----NVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96

Query: 59  GNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANI 118
           G  +  +    L  L  L  L + ++    +I + I  L  ++++DLS N    +++   
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL- 155

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
              LP L++L +  +                      ++D+ G     I +  KL  L+ 
Sbjct: 156 -KTLPELKSLNIQFDG---------------------VHDYRG-----IEDFPKLNQLYA 188

Query: 179 DQNRLQGE 186
               + G+
Sbjct: 189 FSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 33/188 (17%), Positives = 67/188 (35%), Gaps = 23/188 (12%)

Query: 474 NSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNL 533
            S+ +     ++N+LT +    + V  L G     +     ++ L++ +           
Sbjct: 32  QSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHA-------- 78

Query: 534 SFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTT 593
                 T+  + +  L ++  L +     T      +  L  L  +D+S +   D I T 
Sbjct: 79  ------TNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 594 IGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINV 653
           I  L  +  + L YN     I   +  +  LKSLN+  + +       +E    L  +  
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188

Query: 654 SFNKLEGE 661
               + G+
Sbjct: 189 FSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 34/172 (19%), Positives = 65/172 (37%), Gaps = 21/172 (12%)

Query: 487 NLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTL 546
                +   LG +       I   ++  L  ++L +  +             LT I    
Sbjct: 21  TFKAYLNGLLGQSSTAN---ITEAQMNSLTYITLANINVT-----------DLTGI-EYA 65

Query: 547 WNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLK 606
            N+KD   L ++    T   P+    L  L ++ +   + +      + GL  L  L + 
Sbjct: 66  HNIKD---LTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120

Query: 607 YNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
           ++    SI   I  +  + S++LS N     I   L+ L +LK +N+ F+ +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 33/206 (16%), Positives = 68/206 (33%), Gaps = 25/206 (12%)

Query: 384 IFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLE 443
               S            S     T   + +L ++ L +  +T     L+ +       ++
Sbjct: 16  NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD----LTGI--EYAHNIK 69

Query: 444 YFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNG 503
             +I+N       P  I  LS  +E   +   +++      ++ LT+L  + +  +  + 
Sbjct: 70  DLTINNIHATNYNP--ISGLSN-LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126

Query: 504 SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT 563
           SIL  +  L K+  + L  N               +T I   L  L ++  LN+  +   
Sbjct: 127 SILTKINTLPKVNSIDLSYNGA-------------ITDI-MPLKTLPELKSLNIQFDGVH 172

Query: 564 GPLPLEIGNLKVLVQIDLSINNFSDV 589
               +E  +   L Q+          
Sbjct: 173 DYRGIE--DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 31/232 (13%), Positives = 71/232 (30%), Gaps = 59/232 (25%)

Query: 72  NLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLD 131
                    L  +    T   +   ++SL+ + L+  N+T   L  I      ++ L ++
Sbjct: 21  TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTD--LTGI-EYAHNIKDLTIN 74

Query: 132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
             +                       +++      I  L+ L+ L +    +  +    L
Sbjct: 75  NIH---------------------ATNYNP-----ISGLSNLERLRIMGKDVTSDKIPNL 108

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPA 251
             L  L  L + ++    +I   I  L  ++ ++LS+N    +                 
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI---------------- 152

Query: 252 KFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRL 303
                +P L+ + +  +        D       + I +  KL +L      +
Sbjct: 153 MPLKTLPELKSLNIQFDGV-----HDY------RGIEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 28/200 (14%), Positives = 61/200 (30%), Gaps = 37/200 (18%)

Query: 280 NCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS 339
           + T       +  L  + L    +  +    I+  HN++ +  +         T    +S
Sbjct: 33  SSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA-----TNYNPIS 85

Query: 340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNS 399
            L                       NLE L + G + +      +   + L+ L++  ++
Sbjct: 86  GLS----------------------NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123

Query: 400 FSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRV 459
               I      L  +  +DL  N   +    L  L       L+  +I  + +       
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPE-----LKSLNIQFDGVHDYRG-- 176

Query: 460 IGNLSQSMEDFHMPNSNISG 479
           I +  + +   +  +  I G
Sbjct: 177 IEDFPK-LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 20/116 (17%), Positives = 41/116 (35%), Gaps = 7/116 (6%)

Query: 548 NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKY 607
             K  L   L  +       +    +  L  I L+  N +D+    I    +++ L +  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 608 NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIP 663
                  P  I  + NL+ L +   ++      +L  L  L  +++S +  +  I 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 83.7 bits (206), Expect = 2e-16
 Identities = 96/530 (18%), Positives = 157/530 (29%), Gaps = 138/530 (26%)

Query: 5   EYLFLKSNMFHGKIPSTLSNCKR------LRNISLSLNDFSGTI---PKEIGNVTTLIGL 55
            Y+  +  +++        N  R      LR   L L      +       G  T +   
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-TWVALD 169

Query: 56  HLRGNKLQGEIPEE-----LGNLAELEE-LWLQNNFLTGTIPSSIFNLSSLSNLDLSVNN 109
                K+Q ++  +     L N    E  L +    L    P+        SN+ L +++
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 110 LTGELLANICSNLPLLQTLF-LDE-------NNFDGKIPSTLLRCKHL-QTLSLSINDF- 159
           +  EL   +  + P    L  L         N F+       L CK L  T    + DF 
Sbjct: 230 IQAELR-RLLKSKPYENCLLVLLNVQNAKAWNAFN-------LSCKILLTTRFKQVTDFL 281

Query: 160 SGDIPKEI------GNLTK-------LKYLHLDQNRLQGEI----PEELGNLAELEK--- 199
           S      I        LT        LKYL      L  E+    P  L  +AE  +   
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341

Query: 200 ------LQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF 253
                   +  + LT  I  S+  L   ++    F+ L   FP   HI        P   
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEP-AEYRKMFDRL-SVFPPSAHI--------PTI- 390

Query: 254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEK---LDLQFNRLQCVIPH- 309
                 L        + + ++            +  + KL K   ++ Q       IP  
Sbjct: 391 -----LLS-------LIWFDVIKS-----DVMVV--VNKLHKYSLVEKQPKESTISIPSI 431

Query: 310 ------EIDN---LHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSAD 360
                 +++N   LH    ++  +N         +      ++ Y    S  G    + +
Sbjct: 432 YLELKVKLENEYALHRS--IVDHYNIPKTFDSDDLIPPYLDQYFY----SHIGHHLKNIE 485

Query: 361 VRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG 420
               + E ++L    F      F F   K+       N+ SG I NT   L+  K     
Sbjct: 486 ----HPERMTL----FRMVFLDFRFLEQKIRHDSTAWNA-SGSILNTLQQLKFYK----- 531

Query: 421 DNYLTSSTSE--------LSFLSSSN-----CKYLEYFSIS-NNPLGGIL 456
             Y+  +  +        L FL          KY +   I+       I 
Sbjct: 532 -PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIF 580

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.8 bits (162), Expect = 3e-11
 Identities = 92/710 (12%), Positives = 177/710 (24%), Gaps = 235/710 (33%)

Query: 381  PSFIFNTSKLSTLELQRNSFSG----FI---PNTFGNLRNLKWL---------------D 418
             +F+ N       ++ ++  S      I    +       L W                 
Sbjct: 27   DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86

Query: 419  LGDNY--LTSSTSELSFLSSSNCK-YLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNS 475
            L  NY  L S         S   + Y+E      + L         N +Q    +++   
Sbjct: 87   LRINYKFLMSPIKTEQRQPSMMTRMYIEQ----RDRLY--------NDNQVFAKYNVS-- 132

Query: 476  NISGSIPKEINNLTNLI-----AIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIP 530
                   +    L   +     A  + ++ + GS     GK   + L      +++  + 
Sbjct: 133  -----RLQPYLKLRQALLELRPAKNVLIDGVLGS-----GK-TWVALDVCLSYKVQCKMD 181

Query: 531  DN---LSFS--CTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINN 585
                 L+     +  ++   L  L       +  N+ +                D S N 
Sbjct: 182  FKIFWLNLKNCNSPETVLEMLQKL----LYQIDPNWTSRS--------------DHSSN- 222

Query: 586  FSDVIPTTIGGLKDLQYLFLKYNRLQGS--IPDSIGDMINLKSLNLS--------NNNLF 635
                I   I  ++      LK    +    +  ++ +     + NLS           + 
Sbjct: 223  ----IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 636  GIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNF------SL--ESFKGNELLCGMPN 687
              +  +    + L   +++    E +         +       L  E    N     +  
Sbjct: 279  DFLSAATTTHISLDHHSMTLTPDEVK----SLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334

Query: 688  LQVRSCRTRI----HHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRRFTYL 743
              +R          H    K   +I   L           + L  A       ++ F  L
Sbjct: 335  ESIRDGLATWDNWKHVNCDKLTTIIESSL-----------NVLEPAEY-----RKMFDRL 378

Query: 744  ELFQATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVK-----------------VFDLQ 785
             +F        +  I       ++   I  D M V  K                 +  + 
Sbjct: 379  SVFP------PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 786  YGRAIKSFDIECGMIKRIR-HRNII---KFISSCSSDDFKALVLEYMPYGSLEKCLYSSN 841
                    +++  +      HR+I+       +  SDD     L+               
Sbjct: 433  -------LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD--------------Q 471

Query: 842  YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL-SDFGMAKPF 900
            Y                   Y H G+     H  LK         +   +  DF     F
Sbjct: 472  YF------------------YSHIGH-----H--LKNIEHPERMTLFRMVFLDFR----F 502

Query: 901  LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV--YSFGIMLMETFTRKKPTDESFTG 958
            L+        Q +               ++T   +  Y              P  E    
Sbjct: 503  LE--------QKIRHDST--AWNASGSILNTLQQLKFYK------PYICDNDPKYE---- 542

Query: 959  EMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV--AKEQCMSFVFNLAMK 1006
                 R VN +L    +  ++ NL+  +    +  A       +F  A K
Sbjct: 543  -----RLVNAIL--DFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHK 585

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 2e-08
 Identities = 84/646 (13%), Positives = 172/646 (26%), Gaps = 189/646 (29%)

Query: 308 PHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLE 367
              +     L W + S  + +       F    L+  Y     F    P   + R P++ 
Sbjct: 58  KDAVSGTLRLFWTLLSKQEEM----VQKFVEEVLRINY----KFLMS-PIKTEQRQPSMM 108

Query: 368 ELSLSG--NNFSGTIPSFI-FNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL----- 419
                   +        F  +N S+L      R +           LR  K + +     
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL--------ELRPAKNVLIDGVLG 160

Query: 420 -GDNYLTSST-SELSFLSSSNCK-YLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSN 476
            G  ++              + K +  + ++ N      +  ++  L   ++      S+
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 477 ISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFS 536
            S +I   I+++   +   L        +L+ L             N       +  + S
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLV-L------------LNVQNAKAWNAFNLS 265

Query: 537 C-TL----------------TSIPS--------TLWNLKDILCLNLSLNFFTGPLPLEI- 570
           C  L                T+  S        T   +K +L   L        LP E+ 
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD--LPREVL 323

Query: 571 -GNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNL 629
             N + L  I  SI +       T        +  +  ++L   I  S+     L+    
Sbjct: 324 TTNPRRLSIIAESIRDG----LATWD-----NWKHVNCDKLTTIIESSLN---VLEPAEY 371

Query: 630 SNN-NLFGIIPISLEKLLDLKDINVSFNKLE---GEIPREGP------FRNFSLESFKGN 679
               +   + P            ++    L     ++ +            +SL   +  
Sbjct: 372 RKMFDRLSVFP---------PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422

Query: 680 ELLCGMPNLQVRSCRTRIHHTSSKNDLLIGIVLPLSTTFMMGGKSQLNDANMPLVANQRR 739
           E    +P++ +                                    N+  +      R 
Sbjct: 423 ESTISIPSIYLELKVKL-----------------------------ENEYAL-----HRS 448

Query: 740 FTYLELFQATNGFSENNLIGRGGFGFVY--------KARIQDGMEVAVKVF-DLQYGRAI 790
              ++ +     F  ++LI      + Y             + M +   VF D       
Sbjct: 449 I--VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF------ 500

Query: 791 KSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL 850
             F +E    ++IRH +     S    +      L++  Y           YI D   + 
Sbjct: 501 -RF-LE----QKIRHDSTAWNASGSILNTL--QQLKF--Y---------KPYICDNDPKY 541

Query: 851 NIMIDVASALEYLHF--GYSVPII---HCDL------KPNNVLLDD 885
             +++       L F       +I   + DL        +  + ++
Sbjct: 542 ERLVN-----AILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 1e-07
 Identities = 57/482 (11%), Positives = 147/482 (30%), Gaps = 123/482 (25%)

Query: 574  KVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNN 633
              L      ++   +++   +  +  + Y FL  + ++    +     +  +      + 
Sbjct: 63   GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL-MSPIK---TEQRQPSMMTRMYIEQRDR 118

Query: 634  LFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNF--SLESFKGNE--LLCGMPN-- 687
            L+                N  F K    + R  P+     +L   +  +  L+ G+    
Sbjct: 119  LYND--------------NQVFAKYN--VSRLQPYLKLRQALLELRPAKNVLIDGVLGSG 162

Query: 688  ---LQVRSCRT---------RIH-----HTSSKNDLLIGIVLPLSTTFMMGGKSQLN-DA 729
               + +  C +         +I      + +S   +L  ++  L         S+ +  +
Sbjct: 163  KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE-MLQKLLYQIDPNWTSRSDHSS 221

Query: 730  NMPLVANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRA 789
            N+ L  +  +     L ++     EN L+            +           ++Q  +A
Sbjct: 222  NIKLRIHSIQAELRRLLKSKPY--ENCLL------------VLL---------NVQNAKA 258

Query: 790  IKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQR 849
              +F++ C ++   R + +  F+   S+     + L++           + + +  +  +
Sbjct: 259  WNAFNLSCKILLTTRFKQVTDFL---SAATTTHISLDHHSMT------LTPDEVKSLLLK 309

Query: 850  -LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-AHLSDFGMAKPFLKEDQSL 907
             L+                 +P       P       +++   + D        K     
Sbjct: 310  YLDCRPQ------------DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCD 353

Query: 908  TQTQTL-ATIGYMAPEYGREGRVSTNGDVY-SFGIMLMETFTRKKPTDESFTGEMTLKR- 964
              T  + +++  + P   R+        ++    +     F    P        + L   
Sbjct: 354  KLTTIIESSLNVLEPAEYRK--------MFDRLSV-----F----PPSAHIP-TILLSLI 395

Query: 965  WVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMS--FVFNLAMKCTIESPEERINAKEIV 1022
            W  D++   +M VV  N L       V K+   S   + ++ ++  ++   E    + IV
Sbjct: 396  W-FDVIKSDVMVVV--NKL--HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV 450

Query: 1023 TK 1024
              
Sbjct: 451  DH 452

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 1e-05
 Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 14/117 (11%)

Query: 53  IGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTG 112
           IG HL+ N    E       +     ++L   FL   I       S+  N   S+ N   
Sbjct: 477 IGHHLK-NIEHPE------RMTLFRMVFLDFRFLEQKIRHD----STAWNASGSILNTLQ 525

Query: 113 EL---LANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE 166
           +L      IC N P  + L     +F  KI   L+  K+   L +++      I +E
Sbjct: 526 QLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 44/213 (20%), Positives = 82/213 (38%), Gaps = 43/213 (20%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
           +IGRG F  V   +++   +V A+K+  +     +K  ++ C   +R        R I +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMID----------VASAL 860
              +   +++  LV+EY   G L          L +  +    I           +  A+
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQTLATIGY 918
           + +H    +  +H D+KP+N+LLD     H  L+DFG       +    +    + T  Y
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229

Query: 919 MAPEYGREGRVSTNGDVY-------SFGIMLME 944
           ++PE  +          Y       + G+   E
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 35/222 (15%)

Query: 745 LFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK----VFDLQYG-----RAIKSFD 794
           +++    +   + +G G +G V  A   + G+ VAVK     F          R ++   
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--- 80

Query: 795 IECGMIKRIRHRNIIK----FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQ 848
               ++K ++H N+I     F  + S ++F    LV   M    L   +       D  Q
Sbjct: 81  ----LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ 135

Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
              ++  +   L+Y+H   S  IIH DLKP+N+ ++++    + DFG+A+       +  
Sbjct: 136 --FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TADE 185

Query: 909 QTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTRK 949
            T  +AT  Y APE        +   D++S G ++ E  T +
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 60/326 (18%), Positives = 113/326 (34%), Gaps = 79/326 (24%)

Query: 754  ENNLIGRGGFGFVYKAR---IQDGMEVAVKVFDLQYGRAIKSFDI------ECGMIKRIR 804
            E   +GRG +G VYKA+    +D  + A+K         I+   I      E  +++ ++
Sbjct: 25   EGCKVGRGTYGHVYKAKRKDGKDDKDYALK--------QIEGTGISMSACREIALLRELK 76

Query: 805  HRNIIKFISSCSSDDFKA--LVLEYMPY-------GSLEKCLYSSNYILDIFQRLNIMID 855
            H N+I       S   +   L+ +Y  +                    L      +++  
Sbjct: 77   HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH----LSDFGMAKPFLKEDQSLTQ-T 910
            +   + YLH   +  ++H DLKP N+L+           ++D G A+ F    + L    
Sbjct: 137  ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 911  QTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK-------------- 949
              + T  Y APE       Y      +   D+++ G +  E  T +              
Sbjct: 194  PVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247

Query: 950  ---------------KPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKE 994
                            P D+ +     +      +         + +L+ + +KH V  +
Sbjct: 248  PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307

Query: 995  QCMSFVFNLAMKCTIESPEERINAKE 1020
               S  F+L  K     P +RI +++
Sbjct: 308  ---SKAFHLLQKLLTMDPIKRITSEQ 330

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.4 bits (199), Expect = 4e-16
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 41/237 (17%)

Query: 735 ANQRRFTYLELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK---VFD-LQYG-- 787
           A        ++F     ++  + IG G +G V  A    + + VA+K    F+   Y   
Sbjct: 12  AAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR 71

Query: 788 --RAIKSFDIECGMIKRIRHRNIIK---FISSCSSDDFKA--LVLEYMPYGSLEKCLYSS 840
             R IK       ++ R RH NII     I + + +  K   +V + M    L K L + 
Sbjct: 72  TLREIK-------ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT- 122

Query: 841 NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF 900
            ++ +       +  +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+  
Sbjct: 123 QHLSNDHICY-FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178

Query: 901 LKEDQSLTQ-TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
             +       T+ +AT  Y APE       Y      + + D++S G +L E  + +
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.0 bits (200), Expect = 4e-16
 Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 39/241 (16%)

Query: 730 NMPLVANQRRFTYLEL----FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK---- 780
           NM       +F  +E+    F     +     IG G  G V  A        VA+K    
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97

Query: 781 VFDLQ------YGRAIKSFDIECGMIKRIRHRNIIK----FISSCSSDDFKA--LVLEYM 828
            F  Q      Y R +        ++K + H+NII     F    + ++F+   LV+E M
Sbjct: 98  PFQNQTHAKRAY-RELV-------LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149

Query: 829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV 888
              +L + +      LD  +   ++  +   +++LH   S  IIH DLKP+N+++  +  
Sbjct: 150 DA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202

Query: 889 AHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTR 948
             + DFG+A+       S   T  + T  Y APE         N D++S G ++ E    
Sbjct: 203 LKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

Query: 949 K 949
           K
Sbjct: 260 K 260

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.6 bits (197), Expect = 5e-16
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIRHRNIIK 810
           +G G +G VYKA        VA+K   L++        AI+    E  ++K ++HRNII+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
             S    +    L+ EY     L+K +   N  + +    + +  + + + + H   S  
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRR 152

Query: 871 IIHCDLKPNNVLLDDNMVAH-----LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE--Y 923
            +H DLKP N+LL  +  +      + DFG+A+ F    +    T  + T+ Y  PE   
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILL 210

Query: 924 GREGRVSTNGDVYSFGIMLMETFTRK 949
           G     ST+ D++S   +  E   + 
Sbjct: 211 GSR-HYSTSVDIWSIACIWAEMLMKT 235

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 81.0 bits (200), Expect = 5e-16
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 40/205 (19%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI------ECGMIKRIRHRNII 809
            +G G FG V   +    G +VAVK+ + Q    I+S D+      E   +K  RH +II
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVAS 858
           K     S+     +V+EY+  G L       +YI             +FQ++       S
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGEL------FDYICKNGRLDEKESRRLFQQI------LS 127

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            ++Y H      ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNY 181

Query: 919 MAPE-YGREGRVSTNGDVYSFGIML 942
            APE            D++S G++L
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVIL 206

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.1 bits (196), Expect = 7e-16
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 61/216 (28%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
            +G G FG V+  R +      A+KV  L+    ++   +E    +R     + H  II+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 811 FISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 857
              +        ++++Y+  G L                 Y++              +V 
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--------------EVC 116

Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQTL-A 914
            ALEYLH   S  II+ DLKP N+LLD N   H  ++DFG AK           T TL  
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVTYTLCG 165

Query: 915 TIGYMAPE------YGREGRVSTNGDVYSFGIMLME 944
           T  Y+APE      Y +   +    D +SFGI++ E
Sbjct: 166 TPDYIAPEVVSTKPYNKS--I----DWWSFGILIYE 195

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 39/159 (24%), Positives = 58/159 (36%), Gaps = 30/159 (18%)

Query: 74  AELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE 132
               EL L NN  T    + IF  L  L  ++ S N +T ++          +  + L  
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 133 NNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL- 191
           N                +  ++    F G        L  LK L L  NR+   +  +  
Sbjct: 91  N----------------RLENVQHKMFKG--------LESLKTLMLRSNRIT-CVGNDSF 125

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
             L+ +  L L +N +T T+ P  F  L SLS L L  N
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 33/162 (20%), Positives = 60/162 (37%), Gaps = 19/162 (11%)

Query: 297 DLQFNRLQCV---IPHEIDNLHNLEWMIFSFNKLVGVVPTTIF-NVSTLKFLYLGSNSFF 352
           D    +L  +   IP     L        + N+   +  T IF  +  L+ +   +N   
Sbjct: 17  DCSNQKLNKIPEHIPQYTAELR------LNNNEFTVLEATGIFKKLPQLRKINFSNNKI- 69

Query: 353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNL 411
             +   A      + E+ L+ N     +   +F     L TL L+ N  +    ++F  L
Sbjct: 70  TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL 128

Query: 412 RNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPL 452
            +++ L L DN +T+ +      L S     L   ++  NP 
Sbjct: 129 SSVRLLSLYDNQITTVAPGAFDTLHS-----LSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 35/178 (19%), Positives = 56/178 (31%), Gaps = 51/178 (28%)

Query: 176 LHLDQNRLQGEIPE-ELGNLAELEKLQLQNNFLTGTIPPSIFN-LSSLSDLELSFNSLTG 233
           L L+ N             L +L K+   NN +T  I    F   S ++++ L+ N L  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94

Query: 234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
                          +                   MF G                 L  L
Sbjct: 95  --------------NVQH----------------KMFKG-----------------LESL 107

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
           + L L+ NR+ CV       L ++  +    N++  V P     + +L  L L +N F
Sbjct: 108 KTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 34/139 (24%), Positives = 58/139 (41%), Gaps = 8/139 (5%)

Query: 2   SNLEYLFLKSNMFHGKIPST--LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRG 59
                L L +N F   + +T       +LR I+ S N  +          + +  + L  
Sbjct: 32  QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90

Query: 60  NKLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLAN 117
           N+L+  +  ++   L  L+ L L++N +T  + +  F  LSS+  L L  N +T  +   
Sbjct: 91  NRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147

Query: 118 ICSNLPLLQTLFLDENNFD 136
               L  L TL L  N F+
Sbjct: 148 AFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 6/111 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
           L  L  +   +N               +  I L+ N     +  ++   + +L  L LR 
Sbjct: 56  LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRS 114

Query: 60  NKLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVN 108
           N++   +  +    L+ +  L L +N +T T+    F  L SLS L+L  N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 28/122 (22%), Positives = 54/122 (44%), Gaps = 5/122 (4%)

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIGGL 597
           L  IP  +   +    L L+ N FT      I   L  L +I+ S N  +D+      G 
Sbjct: 23  LNKIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA 80

Query: 598 KDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
             +  + L  NRL+ ++   +   + +LK+L L +N +  +   S   L  ++ +++  N
Sbjct: 81  SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139

Query: 657 KL 658
           ++
Sbjct: 140 QI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 44/174 (25%)

Query: 379 TIPSFIFNTSKLSTLELQRNSFSGFIPN-TFGNLRNLKWLDLGDNYLTSSTSELSFLSSS 437
            IP  I   +    L L  N F+       F  L  L+ ++  +N +T    E +F  +S
Sbjct: 25  KIPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGAS 81

Query: 438 NCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLG 497
               +    +++N L  +  ++          F                 L +L  + L 
Sbjct: 82  G---VNEILLTSNRLENVQHKM----------FK---------------GLESLKTLMLR 113

Query: 498 VNKL----NGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLW 547
            N++    N     +   L  ++LLSL DNQ+  ++    +F  TL S+ STL 
Sbjct: 114 SNRITCVGND----SFIGLSSVRLLSLYDNQIT-TVAPG-AFD-TLHSL-STLN 159

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 30/145 (20%), Positives = 58/145 (40%), Gaps = 20/145 (13%)

Query: 516 QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG---N 572
             L L +N+    +     F             L  +  +N S N  T    +E G    
Sbjct: 35  AELRLNNNEFT-VLEATGIFK-----------KLPQLRKINFSNNKITD---IEEGAFEG 79

Query: 573 LKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSN 631
              + +I L+ N   +V      GL+ L+ L L+ NR+   + +     + +++ L+L +
Sbjct: 80  ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138

Query: 632 NNLFGIIPISLEKLLDLKDINVSFN 656
           N +  + P + + L  L  +N+  N
Sbjct: 139 NQITTVAPGAFDTLHSLSTLNLLAN 163

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 42/201 (20%), Positives = 85/201 (42%), Gaps = 25/201 (12%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK----VF----DLQYGRAIKSFDIE 796
           +Q  + +   +LIG G +G V +A    +   VA+K    VF    D +  R ++    E
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK--RILR----E 102

Query: 797 CGMIKRIRHRNIIKF---ISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLN 851
             ++ R+ H +++K    +     + F    +VLE       +K   +  Y+ ++  +  
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT- 160

Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ 911
           ++ ++   ++Y+H   S  I+H DLKP N L++ +    + DFG+A+     +   +Q  
Sbjct: 161 LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 912 TLATIGYMAPEYGREGRVSTN 932
                  M        +    
Sbjct: 218 ISPREDDMNLVTFPHTKNLKR 238

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR-AIKSFDI----ECGMIKRIR---HR 806
             IG G +G VYKAR    G  VA+K   +  G        I    E  +++R+    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 807 NIIKFISSCSSDDFKA-----LVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASAL 860
           N+++ +  C++          LV E++    L   L  +    L      ++M      L
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133

Query: 861 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
           ++LH   +  I+H DLKP N+L+       L+DFG+A+ +      +  T  + T+ Y A
Sbjct: 134 DFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRA 187

Query: 921 PE--YGREGRVSTNGDVYSFGIMLMETFTRK 949
           PE         +T  D++S G +  E F RK
Sbjct: 188 PEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.0 bits (193), Expect = 2e-15
 Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 54/214 (25%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
           L+G+G FG V   R +      A+K+  L+    I   ++   + +       RH  +  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 811 FISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 857
              +  + D    V+EY   G L           E+    Y +              ++ 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115

Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATI 916
           SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +  +    +T   T 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTP 169

Query: 917 GYMAPE------YGREGRVSTNGDVYSFGIMLME 944
            Y+APE      YGR   V    D +  G+++ E
Sbjct: 170 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYE 197

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 48/233 (20%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK---VF-DLQYG----RAIKSFDIE 796
           +  ++ F   +L+G G +G V  A     G  VA+K    F    +     R IK     
Sbjct: 7   YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----- 61

Query: 797 CGMIKRIRHRNIIK---FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLN 851
             ++K  +H NII         S ++F    ++ E M    L + + S+  + D   +  
Sbjct: 62  --ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHIQY- 116

Query: 852 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ-- 909
            +     A++ LH      +IH DLKP+N+L++ N    + DFG+A+   +     ++  
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 910 ------TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
                  + +AT  Y APE       Y      S   DV+S G +L E F R+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 55/215 (25%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  AR+++  ++ AVKV  L+    ++  D+EC M  KRI      H  + 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 856
           +      + D    V+E++  G L           E     Y++              ++
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EI 133

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-AT 915
            SAL +LH      II+ DLK +NVLLD      L+DFGM K  +    +   T T   T
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGT 187

Query: 916 IGYMAPE------YGREGRVSTNGDVYSFGIMLME 944
             Y+APE      YG    V    D ++ G++L E
Sbjct: 188 PDYIAPEILQEMLYGPA--V----DWWAMGVLLYE 216

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 78.6 bits (194), Expect = 3e-15
 Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 53/214 (24%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR-----IRHRNIIK 810
           L+G+G FG V   + +      A+K+  L+    +   ++   + +       RH  +  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 811 FISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 857
              S  + D    V+EY   G L           E     Y +              ++ 
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--------------EIV 258

Query: 858 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATI 916
           SAL+YLH   +  +++ DLK  N++LD +    ++DFG+ K  +K+  +    +T   T 
Sbjct: 259 SALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTP 313

Query: 917 GYMAPE------YGREGRVSTNGDVYSFGIMLME 944
            Y+APE      YGR   V    D +  G+++ E
Sbjct: 314 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYE 341

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 50/305 (16%), Positives = 105/305 (34%), Gaps = 58/305 (19%)

Query: 358 SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWL 417
            +D       + +L   + +  +       + +  +    +            L N+  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73

Query: 418 DLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNI 477
            L  N LT     +  L  +N K L +  +  N +                       ++
Sbjct: 74  FLNGNKLTD----IKPL--ANLKNLGWLFLDENKV----------------------KDL 105

Query: 478 SGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSC 537
           S      + +L  L ++ L  N +  S +  L  L +L+ L L +N++            
Sbjct: 106 SS-----LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI------------ 146

Query: 538 TLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGL 597
              +  + L  L  +  L+L  N  +  +PL    L  L  + LS N+ SD+    + GL
Sbjct: 147 ---TDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISDLRA--LAGL 199

Query: 598 KDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNK 657
           K+L  L L          +   +++   ++  ++ +L     IS +   +  ++     +
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259

Query: 658 LEGEI 662
              E+
Sbjct: 260 FTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 67/313 (21%), Positives = 114/313 (36%), Gaps = 45/313 (14%)

Query: 68  EELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQT 127
                 AE  +  L+   +T  +  +   L+S+  +  + +++    +  I   LP +  
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGI-QYLPNVTK 72

Query: 128 LFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI 187
           LFL+ N     I   L   K+L  L L  N    D+   + +L KLK L L+ N +  +I
Sbjct: 73  LFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DI 127

Query: 188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSA 247
              L +L +LE L L NN +T  I   +  L+ L  L L  N ++        IV     
Sbjct: 128 -NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-------DIVP---- 173

Query: 248 ELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVI 307
                    +  L+ +YLSKN       SDL      + +  L  L+ L+L         
Sbjct: 174 ------LAGLTKLQNLYLSKNHI-----SDL------RALAGLKNLDVLELFSQECLNKP 216

Query: 308 PHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLE 367
            +   NL     +  +   L  V P  I +    +   +  +       +          
Sbjct: 217 INHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH--LPEFTNEVSFIFYQPV 272

Query: 368 ELSLSGNNFSGTI 380
            +  +   F G +
Sbjct: 273 TIGKAKARFHGRV 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 43/218 (19%), Positives = 86/218 (39%), Gaps = 27/218 (12%)

Query: 20  STLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEEL 79
            +          +L     +  +      + ++  +    + ++  + + +  L  + +L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73

Query: 80  WLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANIC--SNLPLLQTLFLDENNFDG 137
           +L  N LT      + NL +L  L L  N +      ++    +L  L++L L+ N    
Sbjct: 74  FLNGNKLTDI--KPLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGI-- 124

Query: 138 KIPSTLLRCKHLQTLSLS---INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNL 194
              + L+    L++L L    I D +      +  LTKL  L L+ N++  +I   L  L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITV-----LSRLTKLDTLSLEDNQIS-DI-VPLAGL 177

Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT 232
            +L+ L L  N ++  +   +  L +L  LEL      
Sbjct: 178 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECL 213

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 49/234 (20%), Positives = 95/234 (40%), Gaps = 17/234 (7%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L++++ +   ++     +   +     +  + L+ N  +   P  + N+  L  L L  N
Sbjct: 45  LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           K++ ++   L +L +L+ L L++N ++  I + + +L  L +L L  N +T   +  + S
Sbjct: 101 KVK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVL-S 153

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            L  L TL L++N     I   L     LQ L LS N  S D+ + +  L  L  L L  
Sbjct: 154 RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFS 209

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN 234
                +      NL     ++  +  L    P  I +        + ++     
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 53/262 (20%), Positives = 106/262 (40%), Gaps = 27/262 (10%)

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
             A+  K +L+   +   +    + L++++ +I + + +  V    I  +  +  L+L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 349 NSFFGRLPS-SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNT 407
           N    +L        L NL  L L  N       S + +  KL +L L+ N  S      
Sbjct: 78  N----KLTDIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDING-- 129

Query: 408 FGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSM 467
             +L  L+ L LG+N +T     ++ L  S    L+  S+ +N +  I+P  +  L+  +
Sbjct: 130 LVHLPQLESLYLGNNKITD----ITVL--SRLTKLDTLSLEDNQISDIVP--LAGLT-KL 180

Query: 468 EDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEG 527
           ++ ++  ++IS  + + +  L NL  + L   +     +     L     +   D  L  
Sbjct: 181 QNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL-- 236

Query: 528 SIPDNLSFSCTLTSIPSTLWNL 549
             P+ +S        P+  W+L
Sbjct: 237 VTPEIISDDGDYEK-PNVKWHL 257

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 35/162 (21%), Positives = 70/162 (43%), Gaps = 17/162 (10%)

Query: 506 LIALGKLKKLQLLSLKDNQLEGSIP----DNLS----FSCTLTSIPSTLWNLKDILCLNL 557
           + +     +    +LK   +  ++     +++      +  + S+   +  L ++  L L
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFL 75

Query: 558 SLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDS 617
           + N  T   PL   NLK L  + L  N   D+    +  LK L+ L L++N +  S  + 
Sbjct: 76  NGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI--SDING 129

Query: 618 IGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
           +  +  L+SL L NN +  I    L +L  L  +++  N++ 
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 169

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 36/167 (21%), Positives = 59/167 (35%), Gaps = 31/167 (18%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFN-LSS 99
            IP  +    T   + L  N ++   P       +L  + L NN ++  +    F  L S
Sbjct: 25  EIPTNLPETITE--IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 100 LSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDF 159
           L++L L  N +T EL  ++   L  LQ L L+ N               +          
Sbjct: 82  LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN--------------KINC-------- 118

Query: 160 SGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN 205
              +  +   +L  L  L L  N+LQ         L  ++ + L  N
Sbjct: 119 ---LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 38/159 (23%), Positives = 61/159 (38%), Gaps = 31/159 (19%)

Query: 74  AELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE 132
             + E+ L+ N +   IP   F     L  +DLS N ++ EL  +    L  L +L L  
Sbjct: 32  ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89

Query: 133 NNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL- 191
           N               +    L  + F G        L  L+ L L+ N++   +  +  
Sbjct: 90  NK--------------IT--ELPKSLFEG--------LFSLQLLLLNANKIN-CLRVDAF 124

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
            +L  L  L L +N L  TI    F  L ++  + L+ N
Sbjct: 125 QDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 7/138 (5%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRGN 60
             +  + L+ N      P   S  K+LR I LS N  S  +  +    + +L  L L GN
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 61  KLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANI 118
           K+  E+P+ L   L  L+ L L  N +   +    F +L +L+ L L  N L   +    
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147

Query: 119 CSNLPLLQTLFLDENNFD 136
            S L  +QT+ L +N F 
Sbjct: 148 FSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 39/179 (21%), Positives = 65/179 (36%), Gaps = 50/179 (27%)

Query: 174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN-LSSLSDLELSFNSLT 232
             + L+QN ++   P       +L ++ L NN ++  + P  F  L SL+ L L  N +T
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 233 GNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAK 292
                          ELP                 ++F G                 L  
Sbjct: 94  ---------------ELPK----------------SLFEG-----------------LFS 105

Query: 293 LEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
           L+ L L  N++ C+      +LHNL  +    NKL  +   T   +  ++ ++L  N F
Sbjct: 106 LQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 27/146 (18%), Positives = 57/146 (39%), Gaps = 9/146 (6%)

Query: 379 TIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSN 438
            IP+ +  T     + L++N+     P  F   + L+ +DL +N ++    +  F    +
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA-FQGLRS 81

Query: 439 CKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI-NNLTNLIAIYLG 497
              L    +  N +  +   +   L   ++   +  + I+  +  +   +L NL  + L 
Sbjct: 82  ---LNSLVLYGNKITELPKSLFEGLFS-LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 498 VNKLNGSILIALGKLKKLQLLSLKDN 523
            NKL          L+ +Q + L  N
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 5/114 (4%)

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF-NVSTLKFLYLG 347
              KL ++DL  N++  + P     L +L  ++   NK+   +P ++F  + +L+ L L 
Sbjct: 54  PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSF 400
           +N     L   A   L NL  LSL  N    TI    F+    + T+ L +N F
Sbjct: 113 ANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 34/179 (18%), Positives = 63/179 (35%), Gaps = 43/179 (24%)

Query: 480 SIPKEI-NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT 538
            IP  +   +T +    L  N +      A    KKL+ + L +NQ+   +  +      
Sbjct: 25  EIPTNLPETITEI---RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA----- 75

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLK 598
                                  F G        L+ L  + L  N  +++  +   GL 
Sbjct: 76  -----------------------FQG--------LRSLNSLVLYGNKITELPKSLFEGLF 104

Query: 599 DLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
            LQ L L  N++   +       + NL  L+L +N L  I   +   L  ++ ++++ N
Sbjct: 105 SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 4/121 (3%)

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLK 598
           LT IP+ L   + I  + L  N      P      K L +IDLS N  S++ P    GL+
Sbjct: 23  LTEIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR 80

Query: 599 DLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNK 657
            L  L L  N++   +P S+ + + +L+ L L+ N +  +   + + L +L  +++  NK
Sbjct: 81  SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139

Query: 658 L 658
           L
Sbjct: 140 L 140

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 25/110 (22%), Positives = 38/110 (34%), Gaps = 28/110 (25%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L +L  L L  N                    L  + F G        + +L  L L  N
Sbjct: 79  LRSLNSLVLYGNKIT----------------ELPKSLFEG--------LFSLQLLLLNAN 114

Query: 61  KLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVN 108
           K+   +  +   +L  L  L L +N L  TI    F  L ++  + L+ N
Sbjct: 115 KIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 37/171 (21%), Positives = 63/171 (36%), Gaps = 48/171 (28%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRI-RHRNIIKFI- 812
           +G G  G V +    +   + A+K+                E  +  R  +  +I++ + 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 813 ---SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRL--------------NIMID 855
              +  +      +V+E +  G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKE 903
           +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK    E
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 77.3 bits (191), Expect = 4e-15
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 59/217 (27%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMIKR------IRHRNII 809
           +IG+G FG V  AR +      AVKV  LQ    +K  + +  M +R      ++H  ++
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 856
               S  + D    VL+Y+  G L           E     Y++              ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQTL- 913
           ASAL YLH   S+ I++ DLKP N+LLD     H  L+DFG+ K  ++ + +   T T  
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFC 200

Query: 914 ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 944
            T  Y+APE      Y R   V    D +  G +L E
Sbjct: 201 GTPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYE 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.9 bits (194), Expect = 5e-15
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 59/230 (25%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  +  +   E+ AVK+  L+    I+  D+EC M+ KR+     +   + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-------------EKCLYSSNYILDIFQRLNIMIDV 856
           +  S   + D    V+EY+  G L                 Y++              ++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 451

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-T 915
           A  L +L    S  II+ DLK +NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 505

Query: 916 IGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
             Y+APE      YG+   V    D ++FG++L E    + P    F GE
Sbjct: 506 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAP----FEGE 545

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 49/209 (23%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI------ECGMIKRIRHRNII 809
            +G G FG V  A   +   +VA+K    Q    +K  D+      E   +K +RH +II
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 810 KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD-----------IFQRLNIMIDVAS 858
           K     ++     +V+EY   G L       +YI++            FQ++        
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GEL------FDYIVEKKRMTEDEGRRFFQQI------IC 119

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI-- 916
           A+EY H      I+H DLKP N+LLDDN+   ++DFG++          T    L T   
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-------TDGNFLKTSCG 169

Query: 917 --GYMAPE-YGREGRVSTNGDVYSFGIML 942
              Y APE    +       DV+S GI+L
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVL 198

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.5 bits (189), Expect = 7e-15
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 47/211 (22%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V+ A  +   +  A+K   L+    +   D+EC M+ KR+      H  + 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 856
               +  + +    V+EY+  G L                 Y++              ++
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--------------EI 127

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQTL- 913
              L++LH   S  I++ DLK +N+LLD +   H  ++DFGM K  +  D     T T  
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFC 179

Query: 914 ATIGYMAPEYGREGRVSTNGDVYSFGIMLME 944
            T  Y+APE     + + + D +SFG++L E
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 53/235 (22%), Positives = 91/235 (38%), Gaps = 50/235 (21%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK--VFDLQYG-----RAIKSFDIEC 797
           F   + + +   +G GG G V+ A        VA+K  V           R IK      
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK------ 60

Query: 798 GMIKRIRHRNIIK------------FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYI 843
            +I+R+ H NI+K                 S  +  +  +V EYM    L   L     +
Sbjct: 61  -IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLL 118

Query: 844 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLK 902
            +  +    M  +   L+Y+H   S  ++H DLKP N+ ++ +++V  + DFG+A+    
Sbjct: 119 EEHAR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 903 EDQSLTQ-TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRK 949
                   ++ L T  Y +P        Y      +   D+++ G +  E  T K
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 31/201 (15%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIEC-----GMIKRIRHRNIIK 810
            +G G FG V   + ++     A+K+  L   + +K   IE       +++ +    ++K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 811 FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
              S   +    +V+EY+  G +   L       +   R      +    EYLH   S+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161

Query: 871 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-ATIGYMAPE------Y 923
           +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T   +APE      Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKGY 215

Query: 924 GREGRVSTNGDVYSFGIMLME 944
            +   V    D ++ G+++ E
Sbjct: 216 NKA--V----DWWALGVLIYE 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 49/228 (21%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK----VFDLQYG-----RAIKSFDI 795
           ++    + +   +G G +G V  A   + G +VA+K     F  +       R ++    
Sbjct: 21  WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR---- 76

Query: 796 ECGMIKRIRHRNIIK----FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSN-------Y 842
              ++K +RH N+I     F    + DDF    LV+ +M    L K +           +
Sbjct: 77  ---LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF 132

Query: 843 ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK 902
           +  ++Q L         L Y+H   +  IIH DLKP N+ ++++    + DFG+A+    
Sbjct: 133 L--VYQMLK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-- 178

Query: 903 EDQSLTQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLMETFTRK 949
            D  +  T  + T  Y APE      R +   D++S G ++ E  T K
Sbjct: 179 -DSEM--TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 45/203 (22%), Positives = 78/203 (38%), Gaps = 27/203 (13%)

Query: 740 FTYLELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK----VF-DLQYG----RA 789
           F  ++     + +   +LIGRG +G+VY A        VA+K    +F DL       R 
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75

Query: 790 IKSFDIECGMIKRIRHRNIIK---FISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYIL 844
           I        ++ R++   II+    I       F    +VLE      L+K   +  ++ 
Sbjct: 76  IT-------ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLT 127

Query: 845 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED 904
           +   +  I+ ++     ++H      IIH DLKP N LL+ +    + DFG+A+    E 
Sbjct: 128 EEHIKT-ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

Query: 905 QSLTQTQTLATIGYMAPEYGREG 927
            +                   + 
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 32/213 (15%)

Query: 756 NLIGRGGFGFVYKAR--IQDGMEVAVKVFDLQYG---------RAIKSFDIECGMIKRIR 804
             IG G +G V+KAR     G  VA+K   +Q G         R +         ++   
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR----HLETFE 72

Query: 805 HRNIIKFISSCSSDDFKA-----LVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVAS 858
           H N+++    C+           LV E++    L   L       +      ++M  +  
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGY 918
            L++LH   S  ++H DLKP N+L+  +    L+DFG+A+ +      +  T  + T+ Y
Sbjct: 132 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWY 185

Query: 919 MAPE--YGREGRVSTNGDVYSFGIMLMETFTRK 949
            APE         +T  D++S G +  E F RK
Sbjct: 186 RAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 55/215 (25%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           +IGRG +  V   R++    + A+KV  ++        DI+     K +      H  ++
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 856
              S   ++     V+EY+  G L           E+    YS+              ++
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 119

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-AT 915
           + AL YLH      II+ DLK +NVLLD      L+D+GM K  L+       T T   T
Sbjct: 120 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 173

Query: 916 IGYMAPE------YGREGRVSTNGDVYSFGIMLME 944
             Y+APE      YG    V    D ++ G+++ E
Sbjct: 174 PNYIAPEILRGEDYGFS--V----DWWALGVLMFE 202

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 59/230 (25%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           ++G+G FG V  +  +   E+ AVK+  L+    I+  D+EC M+ KR+     +   + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 856
           +  S   + D    V+EY+  G L           E     Y++              ++
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-AT 915
           A  L +L    S  II+ DLK +NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184

Query: 916 IGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
             Y+APE      YG+   V    D ++FG++L E    + P    F GE
Sbjct: 185 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAP----FEGE 224

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 60/218 (27%)

Query: 757 LIGRGGFGFVYKARIQDGMEV----AVKVFDLQYGRAIKSFDIECGMIKRI----RHRNI 808
           ++G+G FG V+  +   G +     A+KV  L+         +   M + I     H  I
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 809 IKFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMID 855
           +K   +  ++    L+L+++  G L           E+    Y +              +
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA--------------E 134

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQTL 913
           +A AL++LH   S+ II+ DLKP N+LLD+    H  L+DFG++K  +  ++      + 
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSF 186

Query: 914 -ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 944
             T+ YMAPE      + +        D +SFG+++ E
Sbjct: 187 CGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFE 218

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 55/203 (27%), Positives = 83/203 (40%), Gaps = 39/203 (19%)

Query: 33  LSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELG---NLAELEELWLQNNFLTGT 89
           +  N+      + I  +  +  L L GNKL      ++     L  L  L L  N L  +
Sbjct: 46  IIANNSDIKSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-S 99

Query: 90  IPSSIFN-LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKH 148
           +P+ +F+ L++L  L L  N L   L   +   L  L  L L  N               
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHN--------------Q 144

Query: 149 LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFL 207
           LQ+L   + D           LT L  L L  N+LQ  +PE +   L +L+ L+L  N L
Sbjct: 145 LQSLPKGVFD----------KLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

Query: 208 TGTIPPSIF-NLSSLSDLELSFN 229
             ++P  +F  L+SL  + L  N
Sbjct: 194 K-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 43/234 (18%)

Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFC 254
           AE  K  L+   +T         L+S+  +  + + +        ++ N           
Sbjct: 19  AETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQGIQ-YLPN----------- 64

Query: 255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG---NLAKLEKLDLQFNRLQCVIPHEI 311
                +  + L  N                 +I     L  L  L L  N+LQ +     
Sbjct: 65  -----VRYLALGGNKL--------------HDISALKELTNLTYLILTGNQLQSLPNGVF 105

Query: 312 DNLHNLEWMIFSFNKLVGVVPTTIFN-VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELS 370
           D L NL+ ++   N+L   +P  +F+ ++ L +L L  N     LP     +L NL EL 
Sbjct: 106 DKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ-LQSLPKGVFDKLTNLTELD 163

Query: 371 LSGNNFSGTIPSFIFNT-SKLSTLELQRNSFSGFIPN-TFGNLRNLKWLDLGDN 422
           LS N    ++P  +F+  ++L  L L +N     +P+  F  L +L+++ L DN
Sbjct: 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 58/260 (22%), Positives = 93/260 (35%), Gaps = 76/260 (29%)

Query: 291 AKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNS 350
           A+  K +L+   +   +    + L++++ +I + + +  V                    
Sbjct: 19  AETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG---IQ------------- 60

Query: 351 FFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGN 410
                       LPN+  L+L GN     I +     + L+ L L  N         F  
Sbjct: 61  -----------YLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQLQSLPNGVFDK 107

Query: 411 LRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF 470
           L NLK L L +N L S    + F   +N  YL   ++++N L  +   V          F
Sbjct: 108 LTNLKELVLVENQLQSLPDGV-FDKLTNLTYL---NLAHNQLQSLPKGV----------F 153

Query: 471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKL----NGSILIALGKLKKLQLLSLKDNQLE 526
                            LTNL  + L  N+L     G       KL +L+ L L  NQL+
Sbjct: 154 D---------------KLTNLTELDLSYNQLQSLPEG----VFDKLTQLKDLRLYQNQLK 194

Query: 527 GSIP----DNLSFSCTLTSI 542
            S+P    D L+   +L  I
Sbjct: 195 -SVPDGVFDRLT---SLQYI 210

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 22/164 (13%)

Query: 474 NSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNL 533
           N++   S+   I  L N+  + LG NKL    + AL +L  L  L L  NQL        
Sbjct: 49  NNSDIKSVQG-IQYLPNVRYLALGGNKL--HDISALKELTNLTYLILTGNQL-------- 97

Query: 534 SFSCTLTSIPSTLWN-LKDILCLNLSLNFFTGPLPLEIGN-LKVLVQIDLSINNFSDVIP 591
                  S+P+ +++ L ++  L L  N     LP  + + L  L  ++L+ N    +  
Sbjct: 98  ------QSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPK 150

Query: 592 TTIGGLKDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNL 634
                L +L  L L YN+LQ S+P+ + D +  LK L L  N L
Sbjct: 151 GVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 58/260 (22%), Positives = 89/260 (34%), Gaps = 62/260 (23%)

Query: 379 TIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSN 438
             P   F  +      L++ S +  +      L ++  +   ++ + S           N
Sbjct: 12  IFPDDAFAETI--KANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG---IQYLPN 64

Query: 439 CKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGV 498
            +YL    +  N L              +                    LTNL  + L  
Sbjct: 65  VRYLA---LGGNKL------------HDISALK---------------ELTNLTYLILTG 94

Query: 499 NKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLS 558
           N+L         KL  L+ L L +NQL+ S+P           +   L NL     LNL+
Sbjct: 95  NQLQSLPNGVFDKLTNLKELVLVENQLQ-SLP---------DGVFDKLTNLTY---LNLA 141

Query: 559 LNFFTGPLPLEIG---NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP 615
            N       L  G    L  L ++DLS N    +       L  L+ L L  N+L+ S+P
Sbjct: 142 HNQLQS---LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVP 197

Query: 616 DSIGDMINLKSLN---LSNN 632
           D + D   L SL    L +N
Sbjct: 198 DGVFD--RLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 38/183 (20%), Positives = 74/183 (40%), Gaps = 29/183 (15%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
             P +       I   L    +  +  +   +L  +  +   ++ ++           ++
Sbjct: 12  IFPDDA--FAETIKANLKKKSV--TDAVTQNELNSIDQIIANNSDIK-----------SV 56

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG---NLKVLVQIDLSINNFSDVIPTTIGG 596
             I      L ++  L L  N        +I     L  L  + L+ N    +       
Sbjct: 57  QGIQY----LPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDK 107

Query: 597 LKDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSF 655
           L +L+ L L  N+LQ S+PD + D + NL  LNL++N L  +     +KL +L ++++S+
Sbjct: 108 LTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166

Query: 656 NKL 658
           N+L
Sbjct: 167 NQL 169

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 55/215 (25%)

Query: 757 LIGRGGFGFVYKARIQDGMEV-AVKVFDLQYGRAIKSFDIECGMI-KRI-----RHRNII 809
           +IGRG +  V   R++    + A++V  ++        DI+     K +      H  ++
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 810 KFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 856
              S   ++     V+EY+  G L           E+    YS+              ++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 162

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL-AT 915
           + AL YLH      II+ DLK +NVLLD      L+D+GM K  L+       T T   T
Sbjct: 163 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 216

Query: 916 IGYMAPE------YGREGRVSTNGDVYSFGIMLME 944
             Y+APE      YG    V    D ++ G+++ E
Sbjct: 217 PNYIAPEILRGEDYGFS--V----DWWALGVLMFE 245

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 52/245 (21%), Positives = 90/245 (36%), Gaps = 73/245 (29%)

Query: 758 IGRGGFGFVYKARIQD-GMEVAVK-VF-DLQYG-RAIKSFDIECGMIKRIRHRNIIK--- 810
           +G G FG V +    + G   A+K V  D +Y  R +        ++K + H NIIK   
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD-------IMKVLDHVNIIKLVD 67

Query: 811 ---------------------------------FISSCSSDDFKA--LVLEYMP---YGS 832
                                                 +    K   +++EY+P   +  
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127

Query: 833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHL 891
           L+  + S   I      +  +  +  A+ ++H   S+ I H D+KP N+L++  +    L
Sbjct: 128 LKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLME 944
            DFG AK  +  + S      + +  Y APE       Y      + + D++S G +  E
Sbjct: 184 CDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGE 234

Query: 945 TFTRK 949
               K
Sbjct: 235 LILGK 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.0 bits (180), Expect = 8e-14
 Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 66/235 (28%)

Query: 757 LIGRGGFGFVYKARIQDGMEV----AVKVFDLQYGRAI-KSFDIECGMIKR-----IRHR 806
           ++G+GG+G V++ R   G       A+KV  L+    +  + D      +R     ++H 
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHP 81

Query: 807 NIIKFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNIM 853
            I+  I +  +     L+LEY+  G L           E   C Y +             
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA------------- 128

Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQ 911
            +++ AL +LH      II+ DLKP N++L+     H  L+DFG+ K  + +      T 
Sbjct: 129 -EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---TH 179

Query: 912 TLA-TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
           T   TI YMAPE      + R   V    D +S G ++ +  T   P    FTGE
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPP----FTGE 224

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 50/160 (31%), Positives = 70/160 (43%), Gaps = 9/160 (5%)

Query: 74  AELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN 133
           A+ E+L LQ+  L     ++   L+ L+ L+L  N L   L A +  +L  L TL L  N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN 93

Query: 134 NFDGKIPSTLL-RCKHLQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEEL 191
                +P  +      L  L L  N     +P  +   LTKLK L L+ N+LQ  IP   
Sbjct: 94  QLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150

Query: 192 -GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
              L  L+ L L  N L  ++P   F  L  L  + L  N
Sbjct: 151 FDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 47/168 (27%), Positives = 69/168 (41%), Gaps = 9/168 (5%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFN-LSS 99
           ++P  I   T    L L+   L          L +L  L L  N L  T+ + +F+ L+ 
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 100 LSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLL-RCKHLQTLSLSIND 158
           L  L L+ N L   L   +  +L  L  L+L  N     +PS +  R   L+ L L+ N 
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142

Query: 159 FSGDIPKEI-GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN 205
               IP      LT L+ L L  N+LQ         L +L+ + L  N
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 9/160 (5%)

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFN-VSTLKFLYLGSNSFF 352
           EKLDLQ   L  +       L  L W+   +N+L   +   +F+ ++ L  L L +N   
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ-L 95

Query: 353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSFSGFIPNTFGNL 411
             LP      L  L++L L GN    ++PS +F+  +KL  L L  N         F  L
Sbjct: 96  ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154

Query: 412 RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNP 451
            NL+ L L  N L  S    +F        L+  ++  N 
Sbjct: 155 TNLQTLSLSTNQLQ-SVPHGAF---DRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 49/154 (31%), Positives = 70/154 (45%), Gaps = 5/154 (3%)

Query: 284 PKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST-LK 342
                 L KL  L+L +N+LQ +     D+L  L  +  + N+L   +P  +F+  T L 
Sbjct: 52  DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLD 110

Query: 343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSFS 401
            LYLG N     LPS    RL  L+EL L+ N    +IP+  F+  + L TL L  N   
Sbjct: 111 KLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168

Query: 402 GFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLS 435
                 F  L  L+ + L  N    S  E+ +LS
Sbjct: 169 SVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLS 202

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 7/139 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEI-GNVTTLIGLHLRG 59
           L+ L +L L  N           +   L  + L+ N  + ++P  +  ++T L  L+L G
Sbjct: 58  LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGG 116

Query: 60  NKLQGEIPEEL-GNLAELEELWLQNNFLTGTIPSSIFN-LSSLSNLDLSVNNLTGELLAN 117
           N+L+  +P  +   L +L+EL L  N L  +IP+  F+ L++L  L LS N L   +   
Sbjct: 117 NQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHG 173

Query: 118 ICSNLPLLQTLFLDENNFD 136
               L  LQT+ L  N FD
Sbjct: 174 AFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 42/170 (24%), Positives = 56/170 (32%), Gaps = 38/170 (22%)

Query: 367 EELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS 426
           E+L L     +    +     +KL+ L L  N         F +L  L  L L +N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 427 STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEIN 486
           S     F   +    L    +  N L  +   V          F                
Sbjct: 97  SLPLGVFDHLTQLDKL---YLGGNQLKSLPSGV----------FD--------------- 128

Query: 487 NLTNLIAIYLGVNKL----NGSILIALGKLKKLQLLSLKDNQLEGSIPDN 532
            LT L  + L  N+L     G    A  KL  LQ LSL  NQL+ S+P  
Sbjct: 129 RLTKLKELRLNTNQLQSIPAG----AFDKLTNLQTLSLSTNQLQ-SVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 4/121 (3%)

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLK 598
           L S+PS +    D   L+L               L  L  ++L  N    +       L 
Sbjct: 26  LDSVPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT 83

Query: 599 DLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNK 657
           +L  L L  N+L  S+P  + D +  L  L L  N L  +     ++L  LK++ ++ N+
Sbjct: 84  ELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQ 142

Query: 658 L 658
           L
Sbjct: 143 L 143

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 21/175 (12%)

Query: 480 SIPKEI-NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT 538
           S+P  I  +   L    L    L          L KL  L+L  NQL+ ++         
Sbjct: 28  SVPSGIPADTEKL---DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAG------ 77

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIGGL 597
              +   L  L     L L+ N     LPL +  +L  L ++ L  N    +       L
Sbjct: 78  ---VFDDLTELGT---LGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRL 130

Query: 598 KDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDI 651
             L+ L L  N+LQ SIP    D + NL++L+LS N L  +   + ++L  L+ I
Sbjct: 131 TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 41/165 (24%), Positives = 58/165 (35%), Gaps = 25/165 (15%)

Query: 474 NSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNL 533
           ++ ++         LT L  + L  N+L          L +L  L L +NQL  S+P   
Sbjct: 44  STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLG- 101

Query: 534 SFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG---NLKVLVQIDLSINNFSDVI 590
                   +   L  L     L L  N       L  G    L  L ++ L+ N    + 
Sbjct: 102 --------VFDHLTQLDK---LYLGGNQLKS---LPSGVFDRLTKLKELRLNTNQLQSIP 147

Query: 591 PTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN---LSNN 632
                 L +LQ L L  N+LQ S+P    D   L  L    L  N
Sbjct: 148 AGAFDKLTNLQTLSLSTNQLQ-SVPHGAFD--RLGKLQTITLFGN 189

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 44/234 (18%), Positives = 81/234 (34%), Gaps = 18/234 (7%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+N     L           +      ++N +   ++        +   T L  LHL  N
Sbjct: 18  LANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHN 73

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           ++  ++   L +L +LEEL +  N L      +    + LS L L  N L      ++  
Sbjct: 74  QIS-DL-SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--TDSL-I 125

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
           +L  L+ L +  N     I   L     L+ L L  N+ + +    +  L K+ ++ L  
Sbjct: 126 HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTG 181

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN 234
            +   E  +    L     ++  +       P  I N  S  D  + +      
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 51/235 (21%), Positives = 84/235 (35%), Gaps = 20/235 (8%)

Query: 68  EELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQT 127
                LA   +  L    +T     S   LS + N +   +N+    LA +      L+ 
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQS--LAGM-QFFTNLKE 67

Query: 128 LFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI 187
           L L  N     + S L     L+ LS++ N    ++         L  L LD N L+   
Sbjct: 68  LHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD-- 120

Query: 188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP-KDMHIVNRLS 246
            + L +L  LE L ++NN L  +I   +  LS L  L+L  N +T       +  VN + 
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLTRLKKVNWID 178

Query: 247 AELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFN 301
                     + +  E+Y++       +    G    P  I N        + + 
Sbjct: 179 LTGQKCVNEPVKYQPELYITNT-----VKDPDGRWISPYYISNGGSYVDGCVLWE 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 38/182 (20%), Positives = 74/182 (40%), Gaps = 20/182 (10%)

Query: 485 INNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPD--------NLSFS 536
              L N +   LG   +  + L++  +L  +Q  +  ++ ++ S+           L  S
Sbjct: 15  DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLS 71

Query: 537 CTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGG 596
               S  S L +L  +  L+++ N       +    L  L    L  N   D     +  
Sbjct: 72  HNQISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDTDS--LIH 126

Query: 597 LKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
           LK+L+ L ++ N+L+ SI   +G +  L+ L+L  N +       L +L  +  I+++  
Sbjct: 127 LKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQ 182

Query: 657 KL 658
           K 
Sbjct: 183 KC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 43/249 (17%), Positives = 83/249 (33%), Gaps = 57/249 (22%)

Query: 410 NLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMED 469
            L N    +LG   +T    +L          ++ F+  N+ +                 
Sbjct: 17  GLANAVKQNLGKQSVT----DLVSQK--ELSGVQNFNGDNSNI----------------- 53

Query: 470 FHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSI 529
                 +++G     +   TNL  ++L  N++  S L  L  L KL+ LS+  N+L+   
Sbjct: 54  -----QSLAG-----MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK--- 98

Query: 530 PDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDV 589
             NL+   +          L     L L  N       L   +LK L  + +  N    +
Sbjct: 99  --NLNGIPSA--------CLSR---LFLDNNELRDTDSLI--HLKNLEILSIRNNKLKSI 143

Query: 590 IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLK 649
           +   +G L  L+ L L  N +  +    +  +  +  ++L+             +L    
Sbjct: 144 VM--LGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITN 199

Query: 650 DINVSFNKL 658
            +     + 
Sbjct: 200 TVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 51/272 (18%), Positives = 84/272 (30%), Gaps = 59/272 (21%)

Query: 363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
           L N  + +L   +   T        S +       ++             NLK L L  N
Sbjct: 18  LANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHN 73

Query: 423 YLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIP 482
            ++    +LS L   +   LE  S++ N L                       N++G   
Sbjct: 74  QIS----DLSPLK--DLTKLEELSVNRNRL----------------------KNLNGI-- 103

Query: 483 KEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSI 542
                   L  ++L  N+L      +L  LK L++LS+++N+              L SI
Sbjct: 104 ----PSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNK--------------LKSI 143

Query: 543 PSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY 602
              L  L  +  L+L  N  T    L    LK +  IDL+     +        L     
Sbjct: 144 VM-LGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200

Query: 603 LFLKYNRLQGSIPDSIGDMINLKSLNLSNNNL 634
           +     R     P  I +  +     +     
Sbjct: 201 VKDPDGRW--ISPYYISNGGSYVDGCVLWELP 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 48/264 (18%), Positives = 87/264 (32%), Gaps = 47/264 (17%)

Query: 189 EELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAE 248
                LA   K  L    +T  +      LS + +     +++         +       
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-------SLAG----- 58

Query: 249 LPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIP 308
                      L+E++LS N    +I SDL        + +L KLE+L +  NRL+ +  
Sbjct: 59  -----MQFFTNLKELHLSHN----QI-SDLSP------LKDLTKLEELSVNRNRLKNLNG 102

Query: 309 HEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVR-LPNLE 367
                L  L       N+L      ++ ++  L+ L + +N    +L S   +  L  LE
Sbjct: 103 IPSACLSRL---FLDNNELRDT--DSLIHLKNLEILSIRNN----KLKSIVMLGFLSKLE 153

Query: 368 ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS 427
            L L GN  +      +    K++ ++L               L     +   D    S 
Sbjct: 154 VLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISP 211

Query: 428 TSELSFLSSSNCKYLEYFSISNNP 451
                   S+   Y++   +   P
Sbjct: 212 YY-----ISNGGSYVDGCVLWELP 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 30/154 (19%), Positives = 55/154 (35%), Gaps = 24/154 (15%)

Query: 506 LIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP 565
           +     L      +L                  +T +  +   L  +   N   +     
Sbjct: 12  VFPDPGLANAVKQNLGKQS--------------VTDL-VSQKELSGVQNFNGDNSNIQSL 56

Query: 566 LPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLK 625
             ++      L ++ LS N  SD+ P  +  L  L+ L +  NRL+ ++  +      L 
Sbjct: 57  AGMQ--FFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL--NGIPSACLS 109

Query: 626 SLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE 659
            L L NN L       L  L +L+ +++  NKL+
Sbjct: 110 RLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK 141

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.0 bits (172), Expect = 8e-13
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 50/216 (23%)

Query: 757 LIGRGGFGFVYKARIQDGMEV----AVKVFDLQYGRAI-KSFDIECGMI-KRI-----RH 805
           ++G G +G V+  R   G +     A+KV  L+    + K+   E     +++     + 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKV--LKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSL-----------EK--CLYSSNYILDIFQRLNI 852
             ++    +  ++    L+L+Y+  G L           E    +Y              
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------------ 166

Query: 853 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQT 910
             ++  ALE+LH    + II+ D+K  N+LLD N   H  L+DFG++K F+ ++      
Sbjct: 167 --EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD 219

Query: 911 QTLATIGYMAPEYGREGRVSTNGDV--YSFGIMLME 944
               TI YMAP+  R G    +  V  +S G+++ E
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.1 bits (172), Expect = 1e-12
 Identities = 51/256 (19%), Positives = 94/256 (36%), Gaps = 60/256 (23%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF----DIECGMIKRIR------- 804
            +G G F  V+ A+ + +   VA+K+      R  K +    + E  +++R+        
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 805 ----HRNIIKFISSCSSDDFKA---------LVLEYMPYGSLEKCLYSSNYI---LDIFQ 848
                 +I+K +     D F           +V E +   +L   +    +    L   +
Sbjct: 81  DSMGANHILKLL-----DHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVK 134

Query: 849 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH------LSDFGMAKPFLK 902
           +  I   +   L+Y+H      IIH D+KP NVL++            ++D G A     
Sbjct: 135 Q--ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CW 187

Query: 903 EDQSLTQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT 961
            D+  T + QT     Y +PE           D++S   ++ E  T        F  +  
Sbjct: 188 YDEHYTNSIQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEG 240

Query: 962 LKRWVNDLLLISIMEV 977
                +D  +  I+E+
Sbjct: 241 HSYTKDDDHIAQIIEL 256

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 63/222 (28%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR-IR-------HRNI 808
           +GRG +  V++A  I +  +V VK+        +K    +   IKR I+         NI
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKK--KIKREIKILENLRGGPNI 93

Query: 809 IK----FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS------ 858
           I          S     ALV E++     ++          ++Q L    D+        
Sbjct: 94  ITLADIVKDPVSRTP--ALVFEHVNNTDFKQ----------LYQTLTDY-DIRFYMYEIL 140

Query: 859 -ALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
            AL+Y H   S+ I+H D+KP+NV++D ++    L D+G+A+ F    Q       +A+ 
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEY--NVRVASR 194

Query: 917 GYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTRKKP 951
            +  PE       Y        + D++S G ML     RK+P
Sbjct: 195 YFKGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP 230

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 27/172 (15%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH-RNIIKFISSC 815
           IG G FG +   + +     VA+K+             +E    K++     I +     
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 816 SSDDFKALVLEYMPYG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
               + A+VLE +  G SLE      +    +   L I I + S +EY+H   S  +I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 875 DLKPNNVLL------DDNMVAHLSDFGMAKPFL----------KEDQSLTQT 910
           D+KP N L+         ++ H+ DF +AK ++          +E +SLT T
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETKKHIPYREHKSLTGT 180

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 53/324 (16%), Positives = 102/324 (31%), Gaps = 62/324 (19%)

Query: 28  LRNISLSLNDFSG----TIPKEIGNVTTLIGLHLRGNKLQGE----IPEELGNLAELEEL 79
           +   SL L+  +     ++   +    ++  + L GN +  E    + E + +  +LE  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 80  WLQNNFL----------TGTIPSSIFNLSSLSNLDLSVNNLT---GELLANICSNLPLLQ 126
              + F              +  ++     L  + LS N       E L +  S    L+
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 127 TLFLDENNF-------------DGKIPSTLLRCKHLQTLSLSINDFSGD----IPKEIGN 169
            L+L  N               +  +         L+++    N           K   +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185

Query: 170 LTKLKYLHLDQNRLQGE-----IPEELGNLAELEKLQLQNNFLTGT----IPPSIFNLSS 220
              L  + + QN ++ E     + E L    EL+ L LQ+N  T      +  ++ +  +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245

Query: 221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN 280
           L +L L+   L+            +          N   L+ + L  N            
Sbjct: 246 LRELGLNDCLLSARG------AAAVVDAF--SKLEN-IGLQTLRLQYNEI-----ELDAV 291

Query: 281 CTIPKEIG-NLAKLEKLDLQFNRL 303
            T+   I   +  L  L+L  NR 
Sbjct: 292 RTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 62/333 (18%), Positives = 105/333 (31%), Gaps = 75/333 (22%)

Query: 99  SLSNLDLSVNNLTGELLANICSNL---PLLQTLFLDENNFDGK----IPSTLLRCKHLQT 151
           S+    L ++ +T E   ++ + L     ++ + L  N    +    +   +   K L+ 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 152 LSLS---INDFSGDIPKEIGNL-------TKLKYLHLDQNRLQGE----IPEELGNLAEL 197
              S         +IP+ +  L        KL  + L  N         + + L     L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 198 EKLQLQNNFLT-------------GTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNR 244
           E L L NN L                +     N   L  +    N L             
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG---------- 174

Query: 245 LSAELPAKFCNNIPFLEEIYLSKNMFYGE-----IPSDLGNCTIPKEIGNLAKLEKLDLQ 299
            S +  AK   +   L  + + +N    E     +   L  C          +L+ LDLQ
Sbjct: 175 -SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ---------ELKVLDLQ 224

Query: 300 FNRLQC----VIPHEIDNLHNLEWMIFSFNKL-------VGVVPTTIFNVSTLKFLYLGS 348
            N         +   + +  NL  +  +   L       V    + + N   L+ L L  
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN-IGLQTLRLQY 283

Query: 349 NSF----FGRLPSSADVRLPNLEELSLSGNNFS 377
           N         L +  D ++P+L  L L+GN FS
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.9 bits (148), Expect = 1e-09
 Identities = 49/238 (20%), Positives = 85/238 (35%), Gaps = 38/238 (15%)

Query: 22  LSNCKRLRNISLSLNDFSGTIPKEIGNV----TTLIGLHLRGNKLQGEIPEELGNLAELE 77
           L  C +L  + LS N F  T  + + +     T L  L+L  N L    P+    +A   
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARA- 145

Query: 78  ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLT---GELLANICSNLPLLQTLFLDENN 134
              LQ       +     N   L ++    N L     +  A    +  LL T+ + +N 
Sbjct: 146 ---LQEL----AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198

Query: 135 FDGK-----IPSTLLRCKHLQTLSLSINDFSGD----IPKEIGNLTKLKYLHLDQNRLQG 185
              +     +   L  C+ L+ L L  N F+      +   + +   L+ L L+   L  
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258

Query: 186 E----IPEELGNLA--ELEKLQLQNNFLTGTIPPSI-----FNLSSLSDLELSFNSLT 232
                + +    L    L+ L+LQ N +      ++       +  L  LEL+ N  +
Sbjct: 259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 42/238 (17%), Positives = 77/238 (32%), Gaps = 41/238 (17%)

Query: 2   SNLEYLFLKSNMFHGK----IPSTLSNCKRLRNISLSLNDFS-------------GTIPK 44
             L  + L  N F       +   LS    L ++ L  N                  + K
Sbjct: 94  PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153

Query: 45  EIGNVTTLIGLHLRGNKLQGE----IPEELGNLAELEELWLQNNFLT-----GTIPSSIF 95
           +  N   L  +    N+L+        +   +   L  + +  N +        +   + 
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213

Query: 96  NLSSLSNLDLSVNNLTGE---LLANICSNLPLLQTLFLDENNFDGK----IPSTLLRCKH 148
               L  LDL  N  T      LA    + P L+ L L++     +    +     + ++
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273

Query: 149 --LQTLSLSINDFSGDIPKEIG-----NLTKLKYLHLDQNRLQGEIPEELGNLAELEK 199
             LQTL L  N+   D  + +       +  L +L L+ NR   E  + +  + E+  
Sbjct: 274 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFS 330

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 58.2 bits (141), Expect = 7e-09
 Identities = 52/394 (13%), Positives = 110/394 (27%), Gaps = 75/394 (19%)

Query: 167 IGNLTKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQNNFLTGT----IPPSIFNL 218
           +   + ++   L  + +  E    +   L     ++++ L  N +       +  +I + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 219 SSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDL 278
             L   E S         +    +  L   L    C     L  + LS N F        
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQAL--LKCPK---LHTVRLSDNAF-----GPT 109

Query: 279 GNCTIPKEIGNLAKLEKLDLQFNRLQ----CVIPHEIDNLHNLEWMIFSFNKLVGVVPTT 334
               +   +     LE L L  N L       I   +  L   +                
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAK------------- 156

Query: 335 IFNVSTLKFLYLGSNSFF---GRLPSSADVRLPNLEELSLSGNNF-----SGTIPSFIFN 386
             N   L+ +  G N       +  +        L  + +  N          +   +  
Sbjct: 157 --NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214

Query: 387 TSKLSTLELQRNSFSG----FIPNTFGNLRNLKWLDLGDNYLTSSTSEL--SFLSSSNCK 440
             +L  L+LQ N+F+      +     +  NL+ L L D  L++  +       S     
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274

Query: 441 YLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNK 500
            L+   +  N +       +  L   ++                   + +L+ + L  N+
Sbjct: 275 GLQTLRLQYNEIE---LDAVRTLKTVID-----------------EKMPDLLFLELNGNR 314

Query: 501 LN--GSILIALGK-LKKLQLLSLKDNQLEGSIPD 531
            +    ++  + +         L +      + D
Sbjct: 315 FSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 58/311 (18%), Positives = 104/311 (33%), Gaps = 67/311 (21%)

Query: 364 PNLEELSLSGNNFSGT----IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLR------- 412
            +++E+ LSGN         +   I +   L   E                LR       
Sbjct: 32  DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL 91

Query: 413 ---NLKWLDLGDNYLTSSTSEL--SFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSM 467
               L  + L DN    +  E    FLS      LE+  + NN LG   P+    +++++
Sbjct: 92  KCPKLHTVRLSDNAFGPTAQEPLIDFLS--KHTPLEHLYLHNNGLG---PQAGAKIARAL 146

Query: 468 EDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKL--NGSILIA--LGKLKKLQLLSLKDN 523
           ++           + K+  N   L +I  G N+L        A      + L  + +  N
Sbjct: 147 QELA---------VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 197

Query: 524 QL-----EGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP----LPLEIGNLK 574
            +     E  + + L++   L               L+L  N FT      L + + +  
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKV-------------LDLQDNTFTHLGSSALAIALKSWP 244

Query: 575 VLVQIDLSINNFSDVIPTTIG-GLKD-----LQYLFLKYNRLQGSIPDSIGDMI-----N 623
            L ++ L+    S      +           LQ L L+YN ++     ++  +I     +
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304

Query: 624 LKSLNLSNNNL 634
           L  L L+ N  
Sbjct: 305 LLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 51/342 (14%), Positives = 103/342 (30%), Gaps = 76/342 (22%)

Query: 293 LEKLDLQFNRLQ----CVIPHEIDNLHNLEWMIFSFNKL----VGVVPTTIFNVSTLKFL 344
           +E   L+ + +       +   +    +++ ++ S N +       +   I +   L+  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 345 YLGSNSFFGRLP----------SSADVRLPNLEELSLSGNNFSGT----IPSFIFNTSKL 390
                 F GR+             A ++ P L  + LS N F  T    +  F+   + L
Sbjct: 66  EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 391 STLELQRNSFS-------------GFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSS 437
             L L  N                  +     N   L+ +  G N L + + +    +  
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184

Query: 438 NCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLG 497
           + + L    +  N +                        I   + + +     L  + L 
Sbjct: 185 SHRLLHTVKMVQNGIR--------------------PEGIEHLLLEGLAYCQELKVLDLQ 224

Query: 498 VNKL--NGSILIA--LGKLKKLQLLSLKDNQL--EGSIPDNLSFSCTLTSIPSTLWNLKD 551
            N     GS  +A  L     L+ L L D  L   G+     +     + + +       
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA----AVVDAFSKLENI-----G 275

Query: 552 ILCLNLSLNFFTGPLPLEIG-----NLKVLVQIDLSINNFSD 588
           +  L L  N         +       +  L+ ++L+ N FS+
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 40/301 (13%), Positives = 101/301 (33%), Gaps = 46/301 (15%)

Query: 390 LSTLELQRNSFSG----FIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYF 445
           +    L+ ++ +      +        ++K + L  N + +  +     + ++ K LE  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 446 SISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKL--NG 503
             S+   G +   +   L                 + + +     L  + L  N      
Sbjct: 66  EFSDIFTGRVKDEIPEALR---------------LLLQALLKCPKLHTVRLSDNAFGPTA 110

Query: 504 SILIA--LGKLKKLQLLSLKDNQL--EGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSL 559
              +   L K   L+ L L +N L  +      ++ +    ++     N   +  +    
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGA--KIARALQELAVNKKAKNAPPLRSIICGR 168

Query: 560 NFFTGP----LPLEIGNLKVLVQIDLSINNFSD-----VIPTTIGGLKDLQYLFLKYNRL 610
           N               + ++L  + +  N         ++   +   ++L+ L L+ N  
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228

Query: 611 --QG--SIPDSIGDMINLKSLNLSNNNL--FGIIPIS--LEKL--LDLKDINVSFNKLEG 660
              G  ++  ++    NL+ L L++  L   G   +     KL  + L+ + + +N++E 
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288

Query: 661 E 661
           +
Sbjct: 289 D 289

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.7 bits (171), Expect = 2e-12
 Identities = 55/242 (22%), Positives = 101/242 (41%), Gaps = 56/242 (23%)

Query: 746 FQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVK----VF----DLQYGRAIKSFDIE 796
                 +     +G+G +G V+K+   + G  VAVK     F    D Q  R  +    E
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ--RTFR----E 58

Query: 797 CGMIKRIR-HRNIIKFISSCSSDDFKA--LVLEYMPYGSLEKCLYSSNYILDIFQRLNIM 853
             ++  +  H NI+  ++   +D+ +   LV +YM    L   + ++  IL+   +  ++
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVV 115

Query: 854 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ---- 909
             +   ++YLH   S  ++H D+KP+N+LL+      ++DFG+++ F+   +        
Sbjct: 116 YQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 910 ---------------TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFT 947
                          T  +AT  Y APE       Y      +   D++S G +L E   
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILC 226

Query: 948 RK 949
            K
Sbjct: 227 GK 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 32/168 (19%), Positives = 59/168 (35%), Gaps = 31/168 (18%)

Query: 758 IGRGGFGFVYKAR---------IQDGMEVAVKV---------FDLQYGRAIKSFDIECGM 799
             R   G +Y+A               + ++K+             + RA K   +    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 800 -IKRIRHRNIIKFISS-CSSDDFKALVLEYMPYG-SLEKCL-YSSNYILDIFQRLNIMID 855
            +       I   +      D ++ LVL     G SL+  L  S  ++L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 856 VASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPF 900
           +  ALE+LH       +H ++   N+ +   D + V  L+ +G A  +
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRY 211

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 3e-12
 Identities = 47/222 (21%), Positives = 76/222 (34%), Gaps = 27/222 (12%)

Query: 32  SLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTI- 90
            + L D      ++      L    L   K    +  EL +  EL+EL  +N +   TI 
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII 389

Query: 91  ------------PSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLL-------QTLFLD 131
                         ++   S+L  +D        +L +       +L       + L L 
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449

Query: 132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
             +    +   L +   +  L LS N     +P  +  L  L+ L    N L  E  + +
Sbjct: 450 HKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--ENVDGV 504

Query: 192 GNLAELEKLQLQNNFLTG-TIPPSIFNLSSLSDLELSFNSLT 232
            NL  L++L L NN L        + +   L  L L  NSL 
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.9 bits (160), Expect = 4e-11
 Identities = 49/316 (15%), Positives = 92/316 (29%), Gaps = 70/316 (22%)

Query: 125 LQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQ 184
           L    L++                 +   L  +       ++     +L    L   +  
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST 362

Query: 185 GEIPEELGNLAELEKLQLQNNFLTGTI---PPSIFNLSSLSDLELSFNSLTGNFPKDMHI 241
             +  EL +  EL++L+ +N +   TI     ++  L    +    F++L    P     
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421

Query: 242 VNRLSAEL---PAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDL 298
           ++ L ++     +        +  ++L+               T+   +  L  +  LDL
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-----------TVLCHLEQLLLVTHLDL 470

Query: 299 QFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSS 358
             NRL+  +P  +  L  LE +  S N L       +  V+                   
Sbjct: 471 SHNRLRA-LPPALAALRCLEVLQASDNAL-----ENVDGVA------------------- 505

Query: 359 ADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLD 418
               LP L+EL L  N              +L      +            +   L  L+
Sbjct: 506 ---NLPRLQELLLCNN--------------RLQQSAAIQP---------LVSCPRLVLLN 539

Query: 419 LGDNYLTSSTSELSFL 434
           L  N L         L
Sbjct: 540 LQGNSLCQEEGIQERL 555

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.2 bits (158), Expect = 6e-11
 Identities = 45/329 (13%), Positives = 101/329 (30%), Gaps = 38/329 (11%)

Query: 364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFI-PNTFGNLRNLKWLDLGDN 422
                +S      S      +   S++ TL L  +     +   T         + L D 
Sbjct: 245 LCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL 304

Query: 423 YLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNS-NISGSI 481
              S   +L   +                L         + +   + F    S   S  +
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVL 364

Query: 482 PKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTS 541
             E+ +   L  +         +I++ +  L  L               + L +  TL +
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYE-----------KETLQYFSTLKA 413

Query: 542 IPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
           +     +      L+   + F     +       +  + L+  + + +    +  L  + 
Sbjct: 414 V-----DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVT 466

Query: 602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGE 661
           +L L +NRL+ ++P ++  +  L+ L  S+N L  +    +  L  L+++ +  N+    
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNR---- 519

Query: 662 IPREGPFRNFSLESFKGNELLCGMPNLQV 690
                      L+     + L   P L +
Sbjct: 520 -----------LQQSAAIQPLVSCPRLVL 537

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.3 bits (148), Expect = 1e-09
 Identities = 28/130 (21%), Positives = 49/130 (37%), Gaps = 8/130 (6%)

Query: 3   NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKL 62
           ++  L L        +   L     + ++ LS N     +P  +  +  L  L    N L
Sbjct: 442 DVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498

Query: 63  QGEIPEELGNLAELEELWLQNNFLTG-TIPSSIFNLSSLSNLDLSVNNLTG--ELLANIC 119
             E  + + NL  L+EL L NN L        + +   L  L+L  N+L     +   + 
Sbjct: 499 --ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 556

Query: 120 SNLPLLQTLF 129
             LP + ++ 
Sbjct: 557 EMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.9 bits (147), Expect = 1e-09
 Identities = 33/155 (21%), Positives = 52/155 (33%), Gaps = 11/155 (7%)

Query: 3   NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKL 62
              YL    + F  +          +R + L+  D   T+   +  +  +  L L  N+L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL 475

Query: 63  QGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNL 122
           +  +P  L  L  LE L   +N L   +   + NL  L  L L  N L          + 
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSC 532

Query: 123 PLLQTLFLDEN------NFDGKIPSTLLRCKHLQT 151
           P L  L L  N          ++   L     + T
Sbjct: 533 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.8 bits (144), Expect = 3e-09
 Identities = 42/238 (17%), Positives = 80/238 (33%), Gaps = 23/238 (9%)

Query: 215 IFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEI 274
             +L+            TG+  +   ++ +   E   +       L    LS       +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364

Query: 275 PSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTT 334
            S+L +C        L +LE  +        ++   +D L   +  +  F+ L  V P  
Sbjct: 365 QSELESCK------ELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418

Query: 335 IFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE 394
              +  L+       S F    S   +   ++  L L+  +   T+   +     ++ L+
Sbjct: 419 AAYLDDLR-------SKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLD 469

Query: 395 LQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
           L  N     +P     LR L+ L   DN L  +   ++ L       L+   + NN L
Sbjct: 470 LSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDGVANLPR-----LQELLLCNNRL 520

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 43/157 (27%), Positives = 59/157 (37%), Gaps = 28/157 (17%)

Query: 74  AELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN 133
              + L+L +N +T   P    +L +L  L L  N L   L   +  +L  L  L L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 134 NFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGN 193
                          L  L  ++ D           L  LK L +  N+L  E+P  +  
Sbjct: 99  Q--------------LTVLPSAVFD----------RLVHLKELFMCCNKLT-ELPRGIER 133

Query: 194 LAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
           L  L  L L  N L  +IP   F  LSSL+   L  N
Sbjct: 134 LTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 4/130 (3%)

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST-LKFLYLGSNSFF 352
           + L L  N++  + P   D+L NL+ +    N+L   +P  +F+  T L  L LG+N   
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQ-L 100

Query: 353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLR 412
             LPS+   RL +L+EL +  N  +  +P  I   + L+ L L +N         F  L 
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159

Query: 413 NLKWLDLGDN 422
           +L    L  N
Sbjct: 160 SLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 38/145 (26%), Positives = 58/145 (40%), Gaps = 8/145 (5%)

Query: 380 IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNC 439
           +P+ I   ++   L L  N  +   P  F +L NLK L LG N L +    + F S +  
Sbjct: 34  VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV-FDSLTQL 90

Query: 440 KYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVN 499
             L    +  N L  +   V   L   +++  M   N    +P+ I  LT+L  + L  N
Sbjct: 91  TVL---DLGTNQLTVLPSAVFDRLVH-LKELFM-CCNKLTELPRGIERLTHLTHLALDQN 145

Query: 500 KLNGSILIALGKLKKLQLLSLKDNQ 524
           +L      A  +L  L    L  N 
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 38/170 (22%), Positives = 56/170 (32%), Gaps = 51/170 (30%)

Query: 150 QTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG 209
           Q L L  N  +   P    +L  LK L+L  N+L         +L +L  L L  N LT 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 210 TIPPSIFN-LSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKN 268
            +P ++F+ L  L +L +  N LT                                    
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT------------------------------------ 125

Query: 269 MFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLE 318
                         +P+ I  L  L  L L  N+L+ +     D L +L 
Sbjct: 126 -------------ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 39/178 (21%), Positives = 59/178 (33%), Gaps = 52/178 (29%)

Query: 29  RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTG 88
           + + L  N  +   P    ++  L  L+L  N+L         +L +L  L L  N LT 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 89  TIPSSIFN-LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCK 147
            +PS++F+ L  L  L +  N LT                                    
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE----------------------------------- 126

Query: 148 HLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN 205
                          +P+ I  LT L +L LDQN+L+         L+ L    L  N
Sbjct: 127 ---------------LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 25/86 (29%), Positives = 44/86 (51%), Gaps = 3/86 (3%)

Query: 580 DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGII 638
            L  N  + + P     L +L+ L+L  N+L  ++P  + D +  L  L+L  N L  + 
Sbjct: 46  YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLP 104

Query: 639 PISLEKLLDLKDINVSFNKLEGEIPR 664
               ++L+ LK++ +  NKL  E+PR
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPR 129

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 8e-05
 Identities = 45/160 (28%), Positives = 63/160 (39%), Gaps = 30/160 (18%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
           S+P  I   TN   +YL  N++          L  L+ L L  NQL  ++P         
Sbjct: 33  SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVG------- 82

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEI----GNLKVLVQIDLSINNFSDVIPTTIG 595
             +  +L  L     L+L  N  T  LP  +     +LK L    +  N  +  +P  I 
Sbjct: 83  --VFDSLTQLTV---LDLGTNQLTV-LPSAVFDRLVHLKEL---FMCCNKLT-ELPRGIE 132

Query: 596 GLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN---LSNN 632
            L  L +L L  N+L+ SIP    D   L SL    L  N
Sbjct: 133 RLTHLTHLALDQNQLK-SIPHGAFD--RLSSLTHAYLFGN 169

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 33/171 (19%), Positives = 66/171 (38%), Gaps = 25/171 (14%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH-RNIIKFISSC 815
           IG G FG +++   + +  +VA+K    +          E    K +     I       
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
                  LV++ +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 876 LKPNNVLL------DDNMVAHLSDFGMAKPFL----------KEDQSLTQT 910
           +KP+N L+      + NM+ ++ DFGM K +           +E ++L+ T
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 25/170 (14%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRH-RNIIKFISS 814
           IG G FG +Y    I  G EVA+K+   +  +       IE  + K ++    I      
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 815 CSSDDFKALVLEYMPYG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
            +  D+  +V+E +  G SLE      +    +   L +   + S +EY+H   S   IH
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 128

Query: 874 CDLKPNNVLL---DDNMVAHLSDFGMAKPFL----------KEDQSLTQT 910
            D+KP+N L+       + ++ DFG+AK +           +E+++LT T
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 30/167 (17%)

Query: 757 LIGRGGFGFVYKA-RIQDGMEVAVKVFDLQ-------------YGRAIKSFDIECGM-IK 801
            IG GGFG +Y A       + A  V  ++             Y R  K   I+  +  K
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 802 RIRHRNIIKFISS----CSSDDFKALVLEYMPYG-SLEKCLYSSNYILDIFQRLNIMIDV 856
           ++ +  I  F  S         ++ +V+E    G  L+K +   N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQK-ISGQNGTFKKSTVLQLGIRM 160

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPF 900
              LEY+H       +H D+K  N+LL   + + V +L+D+G++  +
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSYRY 203

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 6/91 (6%)

Query: 363 LPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
             NL EL +        +         +L  L + ++      P+ F     L  L+L  
Sbjct: 30  AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89

Query: 422 NYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
           N L S + +      S    L+   +S NPL
Sbjct: 90  NALESLSWKT-VQGLS----LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.8 bits (144), Expect = 2e-09
 Identities = 21/96 (21%), Positives = 32/96 (33%), Gaps = 3/96 (3%)

Query: 331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSK 389
               +     L  LY+ +      L       L  L  L++  +     +    F  T +
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 390 LSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLT 425
           LS L L  N+       T   L +L+ L L  N L 
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 24/104 (23%), Positives = 34/104 (32%), Gaps = 5/104 (4%)

Query: 35  LNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEE-LGNLAELEELWLQNNFLTGTIPSS 93
             D +      +     L  L++   +    +    L  L EL  L +  + L   +   
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 94  IF-NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
            F     LS L+LS N L   L       L  LQ L L  N   
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 23/94 (24%), Positives = 34/94 (36%), Gaps = 12/94 (12%)

Query: 141 STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE-LGNLAELEK 199
           S+ LRC     L              +     L  L+++  +    +    L  L EL  
Sbjct: 10  SSGLRCTRDGALD---------SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 200 LQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLT 232
           L +  + L   + P  F     LS L LSFN+L 
Sbjct: 61  LTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE 93

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 18/116 (15%), Positives = 33/116 (28%), Gaps = 10/116 (8%)

Query: 236 PKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEK 295
              +      + +           L E+Y+        +            +  L +L  
Sbjct: 10  SSGLRCTRDGALDSLHHL-PGAENLTELYIENQQHLQHLELRD--------LRGLGELRN 60

Query: 296 LDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSF 351
           L +  + L+ V P        L  +  SFN L   +        +L+ L L  N  
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 7e-07
 Identities = 17/96 (17%), Positives = 29/96 (30%), Gaps = 1/96 (1%)

Query: 89  TIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKH 148
                +    +L+ L +        L       L  L+ L + ++      P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 149 LQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQ 184
           L  L+LS N     +  +      L+ L L  N L 
Sbjct: 82  LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.2 bits (114), Expect = 7e-06
 Identities = 21/109 (19%), Positives = 41/109 (37%), Gaps = 6/109 (5%)

Query: 551 DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPT-TIGGLKDLQYLFLKYNR 609
            + C               +   + L ++ +        +    + GL +L+ L +  + 
Sbjct: 12  GLRCTRDGALD----SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 610 LQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKL 658
           L+   PD+      L  LNLS N L   +     + L L+++ +S N L
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 19/126 (15%), Positives = 35/126 (27%), Gaps = 26/126 (20%)

Query: 181 NRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDM 239
                +    L     L +L ++N      +       L  L +L +  + L        
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------- 69

Query: 240 HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQ 299
                    +     +  P L  + LS N             ++  +      L++L L 
Sbjct: 70  --------FVAPDAFHFTPRLSRLNLSFNALE----------SLSWKTVQGLSLQELVLS 111

Query: 300 FNRLQC 305
            N L C
Sbjct: 112 GNPLHC 117

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.7 bits (158), Expect = 6e-11
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 40/211 (18%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF----DIECGMIKRIRHR----- 806
           +IG+G FG V KA   +    VA+K+      R  K F      E  +++ +R +     
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 807 -NIIKFISSCSSDDFKA---LVLEYMPYGSLEKCLYSSNYI---LDIFQRLNIMIDVASA 859
            N+I  + +     F+    +  E +   +L + +  + +    L + ++      +   
Sbjct: 159 MNVIHMLEN---FTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQC 212

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQT-QTLATI 916
           L+ LH      IIHCDLKP N+LL     +   + DFG +     E Q +    Q+    
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQSRF-- 264

Query: 917 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
            Y APE     R     D++S G +L E  T
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 38/169 (22%), Positives = 75/169 (44%), Gaps = 31/169 (18%)

Query: 757 LIGRGGFGFVYKAR------IQDGMEVAVKV--------FDLQ--YGRAIKSFDIECGM- 799
            IG+GGFG +Y A       +       VKV        F     Y RA K   I+  + 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 800 IKRIRHRNIIKFISS----CSSDDFKALVLEYMPYG-SLEKCLYSSNYILDIFQRLNIMI 854
            +++++  + K+  S     +   ++ ++++   +G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 855 DVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPF 900
            +   LEY+H       +H D+K +N+LL   + + V +L D+G+A  +
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRY 204

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 33/145 (22%), Positives = 61/145 (42%), Gaps = 16/145 (11%)

Query: 51  TLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSN---LDLSV 107
             + LH     ++ ++   L  L   + L L  N +       I +LS + N   L L  
Sbjct: 26  EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGR 79

Query: 108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS--GDIPK 165
           N +    + N+ +    L+ L++  N     + S + +  +L+ L +S N  +  G+I  
Sbjct: 80  NLIKK--IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-D 134

Query: 166 EIGNLTKLKYLHLDQNRLQGEIPEE 190
           ++  L KL+ L L  N L  +  E 
Sbjct: 135 KLAALDKLEDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 12/159 (7%)

Query: 60  NKLQGEIPEELGNLAELEELWLQNNF--LTGTIPSSIFNLSSLSNLDLSVNNLTGELLAN 117
           + ++     +     E E++ L      +   + +++  L +  +L LS NN+  E +++
Sbjct: 9   DAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI--EKISS 65

Query: 118 ICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLH 177
           + S +  L+ L L  N    KI +       L+ L +S N  +  +   I  L  L+ L+
Sbjct: 66  L-SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLY 121

Query: 178 LDQNRLQ--GEIPEELGNLAELEKLQLQNNFLTGTIPPS 214
           +  N++   GEI ++L  L +LE L L  N L      +
Sbjct: 122 MSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 7/103 (6%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L   ++L L +N    KI S+LS  + LR +SL  N     I        TL  L +  N
Sbjct: 47  LKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN 103

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNL 103
           ++       +  L  L  L++ NN +T      I  L++L  L
Sbjct: 104 QI--ASLSGIEKLVNLRVLYMSNNKITN--WGEIDKLAALDKL 142

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 41/184 (22%), Positives = 74/184 (40%), Gaps = 25/184 (13%)

Query: 511 KLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI 570
           + K +     +  +L G IP        +  + +TL  LK    L LS N        +I
Sbjct: 16  ERKSVVATEAEKVELHGMIPP-------IEKMDATLSTLKACKHLALSTNNIE-----KI 63

Query: 571 GNLKVLVQI---DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSL 627
            +L  +  +    L  N     I         L+ L++ YN++  S+   I  ++NL+ L
Sbjct: 64  SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVL 120

Query: 628 NLSNNNLFGIIPIS-LEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP 686
            +SNN +     I  L  L  L+D+ ++ N L  +         + +      E++  +P
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI------EVVKRLP 174

Query: 687 NLQV 690
           NL+ 
Sbjct: 175 NLKK 178

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 40/176 (22%), Positives = 61/176 (34%), Gaps = 59/176 (33%)

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
            L   + L+LS NN             K+S+L                 + NL+ L LG 
Sbjct: 46  TLKACKHLALSTNNIE-----------KISSLS---------------GMENLRILSLGR 79

Query: 422 NYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSI 481
           N +     ++  L  +    LE   IS N +                      +++SG  
Sbjct: 80  NLIK----KIENL-DAVADTLEELWISYNQI----------------------ASLSG-- 110

Query: 482 PKEINNLTNLIAIYLGVNKLNG-SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFS 536
              I  L NL  +Y+  NK+     +  L  L KL+ L L  N L     +N + S
Sbjct: 111 ---IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 32/159 (20%), Positives = 54/159 (33%), Gaps = 40/159 (25%)

Query: 165 KEIGNLTKLKY--LHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS 222
           ++    T+ +   LH     ++ ++   L  L   + L L  N +       I +LS + 
Sbjct: 17  RKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSLSGME 70

Query: 223 DLE---LSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLG 279
           +L    L  N +         I N                LEE+++S N       + L 
Sbjct: 71  NLRILSLGRNLIK-------KIEN---------LDAVADTLEELWISYNQI-----ASLS 109

Query: 280 NCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLE 318
                  I  L  L  L +  N++      EID L  L+
Sbjct: 110 G------IEKLVNLRVLYMSNNKITNW--GEIDKLAALD 140

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 27/143 (18%), Positives = 59/143 (41%), Gaps = 20/143 (13%)

Query: 491 LIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLK 550
            + ++  +  +   +   L  LK  + L+L  N +E  I  +LS              ++
Sbjct: 27  KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLS-------------GME 70

Query: 551 DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRL 610
           ++  L+L  N       L+      L ++ +S N  + +  + I  L +L+ L++  N++
Sbjct: 71  NLRILSLGRNLIKKIENLD-AVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKI 127

Query: 611 QG-SIPDSIGDMINLKSLNLSNN 632
                 D +  +  L+ L L+ N
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 26/144 (18%), Positives = 54/144 (37%), Gaps = 20/144 (13%)

Query: 469 DFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGS 528
           + H     I   +   ++ L     + L  N +    + +L  ++ L++LSL  N ++  
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK-- 83

Query: 529 IPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSD 588
                     + ++ +    L++   L +S N       +E   L  L  + +S N  ++
Sbjct: 84  ---------KIENLDAVADTLEE---LWISYNQIASLSGIE--KLVNLRVLYMSNNKITN 129

Query: 589 VIP-TTIGGLKDLQYLFLKYNRLQ 611
                 +  L  L+ L L  N L 
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLY 153

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.5 bits (154), Expect = 2e-10
 Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 23/169 (13%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIR-HRNIIKFISS 814
           IG G FG +Y    IQ   EVA+K+   +  +        E  + + ++    I      
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
               D+  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H 
Sbjct: 72  GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127

Query: 875 DLKPNNVLLDDNMVAH---LSDFGMAKPFL----------KEDQSLTQT 910
           D+KP+N L+     A+   + DFG+AK +           +E+++LT T
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 31/166 (18%)

Query: 42  IPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFN-LSSL 100
           +P  I   TT   L L  N L+         L  L +L+L  N L  ++P+ +FN L+SL
Sbjct: 22  VPTGIPAQTTY--LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 101 SNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS 160
           + L+LS N L   L   +   L  L+ L L+ N               LQ+L   + D  
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTN--------------QLQSLPDGVFD-- 121

Query: 161 GDIPKEIGNLTKLKYLHLDQNRLQGEIPEE-LGNLAELEKLQLQNN 205
                    LT+LK L L QN+L+  +P+     L  L+ + L +N
Sbjct: 122 --------KLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 45/158 (28%), Positives = 67/158 (42%), Gaps = 29/158 (18%)

Query: 74  AELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN 133
           A+   L L+ N L          L+SL+ L L  N L   L   + + L  L  L L  N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 134 NFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL-G 192
                          LQ+L   + D           LT+LK L L+ N+LQ  +P+ +  
Sbjct: 87  --------------QLQSLPNGVFD----------KLTQLKELALNTNQLQ-SLPDGVFD 121

Query: 193 NLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
            L +L+ L+L  N L  ++P  +F  L+SL  + L  N
Sbjct: 122 KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 25/84 (29%), Positives = 34/84 (40%), Gaps = 2/84 (2%)

Query: 150 QTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG 209
             L L  N            LT L  L+L  N+LQ         L  L  L L  N L  
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 210 TIPPSIFN-LSSLSDLELSFNSLT 232
           ++P  +F+ L+ L +L L+ N L 
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ 113

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 35/134 (26%), Positives = 52/134 (38%), Gaps = 12/134 (8%)

Query: 297 DLQFNRLQCV---IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFG 353
           +        V   IP +   L          N L  +       +++L  LYLG N    
Sbjct: 13  ECYSQGRTSVPTGIPAQTTYLD------LETNSLKSLPNGVFDELTSLTQLYLGGNK-LQ 65

Query: 354 RLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSFSGFIPNTFGNLR 412
            LP+    +L +L  L+LS N    ++P+ +F+  ++L  L L  N         F  L 
Sbjct: 66  SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT 124

Query: 413 NLKWLDLGDNYLTS 426
            LK L L  N L S
Sbjct: 125 QLKDLRLYQNQLKS 138

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 5/117 (4%)

Query: 284 PKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST-LK 342
                 L  L +L L  N+LQ +     + L +L ++  S N+L   +P  +F+  T LK
Sbjct: 45  NGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLK 103

Query: 343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRN 398
            L L +N     LP     +L  L++L L  N    ++P  +F   + L  + L  N
Sbjct: 104 ELALNTNQ-LQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 2/80 (2%)

Query: 580 DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGII 638
           DL  N+   +       L  L  L+L  N+LQ S+P+ + + + +L  LNLS N L  + 
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLP 92

Query: 639 PISLEKLLDLKDINVSFNKL 658
               +KL  LK++ ++ N+L
Sbjct: 93  NGVFDKLTQLKELALNTNQL 112

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 28/157 (17%)

Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFC 254
           A+   L L+ N L          L+SL+ L L  N L                 LP    
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ---------------SLPNGVF 72

Query: 255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEI-DN 313
           N +  L  + LS N     +P              L +L++L L  N+LQ  +P  + D 
Sbjct: 73  NKLTSLTYLNLSTNQL-QSLP--------NGVFDKLTQLKELALNTNQLQ-SLPDGVFDK 122

Query: 314 LHNLEWMIFSFNKLVGVVPTTIF-NVSTLKFLYLGSN 349
           L  L+ +    N+L   VP  +F  +++L++++L  N
Sbjct: 123 LTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 8/120 (6%)

Query: 115 LANICSNLPL-LQTLFLDENNFDGKIPSTLL--RCKHLQTLSLSINDFSGDIPKEIGNLT 171
           L  I  ++PL    L L++N    +I S  L  R  HL  L L  N  +G  P      +
Sbjct: 20  LKEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78

Query: 172 KLKYLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
            ++ L L +N+++ EI  ++   L +L+ L L +N ++  + P  F +L+SL+ L L+ N
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 26/97 (26%), Positives = 35/97 (36%), Gaps = 4/97 (4%)

Query: 331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SK 389
           +P  I        L L  N            RLP+L +L L  N  +  I    F   S 
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 390 LSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS 426
           +  L+L  N         F  L  LK L+L DN ++ 
Sbjct: 80  IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC 116

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 26/118 (22%), Positives = 46/118 (38%), Gaps = 20/118 (16%)

Query: 29  RNISLSLNDFSGTIPKEI-GNVTTLIGLHLRGNKLQGEIPEEL-GNLAELEELWLQNNFL 86
             + L+ N+        + G +  L+ L L+ N+L   I        + ++EL L  N +
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 87  TGTIPSSIFN-LSSLSNLDLSVNNLTGELLANICS-------NLPLLQTLFLDENNFD 136
              I + +F  L  L  L+L  N ++                +L  L +L L  N F+
Sbjct: 91  K-EISNKMFLGLHQLKTLNLYDNQIS--------CVMPGSFEHLNSLTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 39/159 (24%), Positives = 60/159 (37%), Gaps = 55/159 (34%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFLTGTIPPSIF-NLSS 220
           IP++I   T    L L+ N L     + L G L  L KL+L+ N LT  I P+ F   S 
Sbjct: 23  IPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN 280
           + +L+L  N +                E+  K                MF G        
Sbjct: 80  IQELQLGENKIK---------------EISNK----------------MFLG-------- 100

Query: 281 CTIPKEIGNLAKLEKLDLQFNRLQCVIPHEI-DNLHNLE 318
                    L +L+ L+L  N++ CV      ++L++L 
Sbjct: 101 ---------LHQLKTLNLYDNQISCV-MPGSFEHLNSLT 129

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 32/120 (26%), Positives = 55/120 (45%), Gaps = 5/120 (4%)

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIGGL 597
           L  IP  +        L L+ N         + G L  LV+++L  N  + + P    G 
Sbjct: 20  LKEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77

Query: 598 KDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN 656
             +Q L L  N+++  I + +   +  LK+LNL +N +  ++P S E L  L  +N++ N
Sbjct: 78  SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 23/113 (20%), Positives = 42/113 (37%), Gaps = 27/113 (23%)

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
            L  L KL+L+ N+L  + P+  +   +++ +    NK+   +   +F            
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-KEISNKMFL----------- 99

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNT-SKLSTLELQRNSF 400
                         L  L+ L+L  N  S  +    F   + L++L L  N F
Sbjct: 100 -------------GLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 51/289 (17%), Positives = 90/289 (31%), Gaps = 47/289 (16%)

Query: 50  TTLIGLHLRGNKLQGEIPEELG-----NLAELEELWLQNNFLTGTIPSSIF-----NLSS 99
             +  L L  N L      EL        A +  L L  N L       +        ++
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 100 LSNLDLSVNNLTGELLANICSNLPL----LQTLFLDENNFDGK----IPSTLLRC-KHLQ 150
           +++L+LS N L+ +    +   L      +  L L  N+F  K               + 
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141

Query: 151 TLSLSINDFSGDIPKEIGNL-----TKLKYLHLDQNRLQGEIPEELGNLAE-----LEKL 200
           +L+L  ND       E+  +       +  L+L  N L  +   EL          +  L
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL 201

Query: 201 QLQNNFLTGTIPPSI-----FNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
            L  N L       +        + +  L L  N L G            S E      +
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG-----------PSLENLKLLKD 250

Query: 256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQ 304
           ++  L+ +YL  ++    + S      +     N+ K+  +D     + 
Sbjct: 251 SLKHLQTVYLDYDIV-KNM-SKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 42/260 (16%), Positives = 77/260 (29%), Gaps = 44/260 (16%)

Query: 2   SNLEYLFLKSNMFHGK----IPSTLSNC-KRLRNISLSLNDFSGTIPKEIGNV-----TT 51
             +  L L  N F  K         SN    + +++L  ND       E+  +       
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168

Query: 52  LIGLHLRGNKLQGEIPEELGNLAE-----LEELWLQNNFLTGTIPSSI-----FNLSSLS 101
           +  L+LRGN L  +   EL          +  L L  N L     + +        + + 
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228

Query: 102 NLDLSVNNLTGE---LLANICSNLPLLQTLFLDENNFDGK-------IPSTLLRCKHLQT 151
           +L+L +N L G     L  +  +L  LQT++LD +            + +     + +  
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288

Query: 152 LSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTI 211
           +  +  +        I NL +      D   L  +            +            
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIP------- 341

Query: 212 PPSIFNLSSLSDLELSFNSL 231
                    L +   +   L
Sbjct: 342 -------DELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 50/303 (16%), Positives = 100/303 (33%), Gaps = 60/303 (19%)

Query: 364 PNLEELSLSGNNFSGT-----IPSFIFNTSKLSTLELQRNSFSGFIPNTFG-----NLRN 413
             +  L LS NN         I +F    + +++L L  NS      +           N
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 414 LKWLDLGDNYLTSSTSEL--SFLSSSNCKYLEYFSISNNPLGG----ILPRVIGNLSQSM 467
           +  L+L  N+L+  +S+     L++     +    +  N           +   NL  S+
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFT-ITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140

Query: 468 EDFHMPNSNISGSIPKEI-----NNLTNLIAIYLGVNKLNGSILIALGKL-----KKLQL 517
              ++  +++      E+         N+ ++ L  N L       L K        +  
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTS 200

Query: 518 LSLKDNQL--EGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP----LPLEIG 571
           L L  N L  +         +   +SIP+ +      + LNL LN   GP    L L   
Sbjct: 201 LDLSANLLGLKSYA----ELAYIFSSIPNHV------VSLNLCLNCLHGPSLENLKLLKD 250

Query: 572 NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
           +LK L  + L  +   ++        +  + L             +  ++  +  ++ + 
Sbjct: 251 SLKHLQTVYLDYDIVKNM------SKEQCKALG-----------AAFPNIQKIILVDKNG 293

Query: 632 NNL 634
             +
Sbjct: 294 KEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 59/389 (15%), Positives = 109/389 (28%), Gaps = 84/389 (21%)

Query: 96  NLSSLSNLDLSVNNLTGE----LLANICSNLPLLQTLFLDENNFDGK----IPSTLLRCK 147
               +++LDLS+NNL       L+    +    + +L L  N+   K    +   L    
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79

Query: 148 -HLQTLSLSINDFSGDIPKEIGNL-----TKLKYLHLDQNRLQGEIPEELGNLAELEKLQ 201
            ++ +L+LS N  S     E+          +  L L  N    +   E           
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA-----FS 134

Query: 202 LQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLE 261
                            +S++ L L  N L           + L   L A   N    + 
Sbjct: 135 NLP--------------ASITSLNLRGNDLGIKS------SDELIQILAAIPAN----VN 170

Query: 262 EIYLSKNMFYGEIPSDLGNCTIPKEIGNL-AKLEKLDLQFNRLQCVIPHEIDNLHNLEWM 320
            + L  N       +      + K + ++ A +  LDL  N L       + +   L ++
Sbjct: 171 SLNLRGNNL-----ASKNCAELAKFLASIPASVTSLDLSANLLG------LKSYAELAYI 219

Query: 321 IFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFG---RLPSSADVRLPNLEELSLSGNNFS 377
             S               + +  L L  N   G            L +L+ + L  +   
Sbjct: 220 FSSIP-------------NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266

Query: 378 GT-------IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL-----RNLKWLDLGDNYLT 425
                    + +   N  K+  ++               NL            L +  L 
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326

Query: 426 -SSTSELSFLSSSNCKYLEYFSISNNPLG 453
            +   + +    +    L     +  PL 
Sbjct: 327 FAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 47/333 (14%), Positives = 103/333 (30%), Gaps = 67/333 (20%)

Query: 365 NLEELSLSGNNFSGT-----IPSFIFNTSKLSTLELQRNSFS-----GFIPNTFGNLRNL 414
           ++  L+LSGN+         +       + +++L L  N  S       +         +
Sbjct: 52  SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111

Query: 415 KWLDLGDNYLTSSTSEL--SFLSSSNCKYLEYFSISNNPLGG----ILPRVIGNLSQSME 468
             LDLG N  +S +S       S+     +   ++  N LG      L +++  +  ++ 
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPAS-ITSLNLRGNDLGIKSSDELIQILAAIPANVN 170

Query: 469 DFHMPNSNISGSIPKEI-----NNLTNLIAIYLGVNKLNGSILIALGKL-----KKLQLL 518
             ++  +N++     E+     +   ++ ++ L  N L       L  +       +  L
Sbjct: 171 SLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSL 230

Query: 519 SLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP-------LPLEIG 571
           +L  N L G   +NL              +LK +  + L  +            L     
Sbjct: 231 NLCLNCLHGPSLENLK---------LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281

Query: 572 NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
           N++ ++ +D +                 +  L  + +                   +L N
Sbjct: 282 NIQKIILVDKNGKEIHPS------HSIPISNLIRELSG-------------KADVPSLLN 322

Query: 632 NNLFGI-----IPISLEKLLDLKDINVSFNKLE 659
             L            L    +L++   +   L 
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 2e-09
 Identities = 41/263 (15%), Positives = 72/263 (27%), Gaps = 66/263 (25%)

Query: 736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKV--------FDLQYG 787
           +Q+          T        IG G FG V++    D   VA+K+         +  + 
Sbjct: 6   SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 788 RAIKSFDIECGMIKRI---------RHRNIIKFISSC----------------------- 815
           +  +    E  + K +         R    I   S                         
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 816 -------SSDDFKALVLEYMPYG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
                    DD   +VLE+   G  LE+       +  +    +I+  + ++L       
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASL 181

Query: 868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF---------LKEDQSLTQTQTLATIGY 918
                H DL   NVLL    +  L      K              D +L++ +    + +
Sbjct: 182 R--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVF 239

Query: 919 MAPEYGRE---GRVSTNGDVYSF 938
                  +   G      D+Y  
Sbjct: 240 CDVSMDEDLFTGDGDYQFDIYRL 262

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 59.9 bits (145), Expect = 3e-09
 Identities = 78/538 (14%), Positives = 162/538 (30%), Gaps = 83/538 (15%)

Query: 19  PSTLSNCKRLRNISLS----LNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLA 74
            + +    ++R++ L       DF+       G V   I                     
Sbjct: 59  ATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYT------------- 105

Query: 75  ELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLS-VNNLTGELLANICSNLPLLQTLFLDE 132
            LEE+ L+   +T      I  +  +   L LS     + + LA I +    L+ L L E
Sbjct: 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRE 165

Query: 133 NNFDGKIPSTL----LRCKHLQTLSLS-----INDFSGDIPKEIGNLTKLKYLHLDQNRL 183
           ++ D      L         L +L++S     ++     + + +     LK L L++   
Sbjct: 166 SDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSF--SALERLVTRCPNLKSLKLNRAVP 223

Query: 184 QGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVN 243
             ++   L    +LE+L     +     P     LS           L+G          
Sbjct: 224 LEKLATLLQRAPQLEELGT-GGYTAEVRPDVYSGLSVALSGCKELRCLSGF-----WDAV 277

Query: 244 RLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRL 303
                     C+    L  + LS         + + +  + K +    KL++L +     
Sbjct: 278 PAYLPAVYSVCSR---LTTLNLSY--------ATVQSYDLVKLLCQCPKLQRLWVLDYIE 326

Query: 304 QCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRL 363
              +        +L  +    ++   + P        L  + +G                
Sbjct: 327 DAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG---------------C 371

Query: 364 PNLEELSLSGNNFSG-TIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
           P LE +       +   + +   N   ++   L        I     +   L+ LD+G  
Sbjct: 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI------IEPKAPDYLTLEPLDIGFG 425

Query: 423 YLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISG-SI 481
            +     +L  LS S         +++          IG  ++ ME   +  +  S   +
Sbjct: 426 AIVEHCKDLRRLSLSGL-------LTDKVF-----EYIGTYAKKMEMLSVAFAGDSDLGM 473

Query: 482 PKEINNLTNLIAIYL-GVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT 538
              ++   +L  + +      + ++L    KL+ ++ L +    +       L     
Sbjct: 474 HHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMP 531

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 60/454 (13%), Positives = 135/454 (29%), Gaps = 57/454 (12%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIG-NVTTLIGLHLRGNKLQGE--IPEELGNLA 74
           I +  S+   L  I L     +    + I  +      L L   +      +        
Sbjct: 97  IEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCR 156

Query: 75  ELEELWLQNNFLTGTIPSSIFNLS----SLSNLDLS--VNNLTGELLANICSNLPLLQTL 128
            L+EL L+ + +       + +      SL +L++S   + ++   L  + +  P L++L
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL 216

Query: 129 FLDENNFDGKIPSTLLRCKHLQTLSLS------INDFSGDIPKEIGNLTKLKYLHLDQNR 182
            L+      K+ + L R   L+ L           D    +   +    +L+ L    + 
Sbjct: 217 KLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDA 276

Query: 183 LQGEIPEELGNLAELEKLQLQNNFLTGT-IPPSIFNLSSLSDLELSFNSLTGNFPKDMHI 241
           +   +P      + L  L L    +    +   +     L  L +               
Sbjct: 277 VPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL-------------- 322

Query: 242 VNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIP----SDLGNCTIPKEIGNLAKLEKLD 297
            + +         +    L E+ +  +  +   P    ++ G  ++        KLE + 
Sbjct: 323 -DYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM---GCPKLESVL 378

Query: 298 LQFNRLQCV-IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLP 356
               ++    +     N  N+        +       T+     + F  +  +       
Sbjct: 379 YFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEH------- 430

Query: 357 SSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGF-IPNTFGNLRNLK 415
                   +L  LSLSG               K+  L +     S   + +      +L+
Sbjct: 431 ------CKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484

Query: 416 WLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISN 449
            L++ D             ++S  + +    +S+
Sbjct: 485 KLEIRDCPFGDKA---LLANASKLETMRSLWMSS 515

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 49.9 bits (119), Expect = 4e-06
 Identities = 46/327 (14%), Positives = 90/327 (27%), Gaps = 33/327 (10%)

Query: 337 NVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFS-GTIPSFIFNTSKLSTLEL 395
           + +    +  G   +      +       LEE+ L     +   +     +      L L
Sbjct: 78  HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137

Query: 396 QR-NSFSGF-IPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLG 453
                FS   +       RNLK LDL ++ +   +             L   +IS     
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-S 196

Query: 454 GILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLK 513
            +    +  L                          NL ++ L        +   L +  
Sbjct: 197 EVSFSALERLVT---------------------RCPNLKSLKLNRAVPLEKLATLLQRAP 235

Query: 514 KLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNL 573
           +L+ L                     + +   L   K++ CL+   +     LP      
Sbjct: 236 QLEELGT-------GGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288

Query: 574 KVLVQIDLSINNFSDV-IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNN 632
             L  ++LS        +   +     LQ L++        +        +L+ L +  +
Sbjct: 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPS 348

Query: 633 NLFGIIPISLEKLLDLKDINVSFNKLE 659
             F + P        L  +++   KLE
Sbjct: 349 EPFVMEPNVALTEQGLVSVSMGCPKLE 375

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.0 bits (114), Expect = 2e-05
 Identities = 74/518 (14%), Positives = 159/518 (30%), Gaps = 81/518 (15%)

Query: 140 PSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEK 199
            + + R   ++++ L       D            Y  ++             +   LE+
Sbjct: 59  ATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA---------MSSSYTWLEE 109

Query: 200 LQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIP 258
           ++L+   +T      I  +  +   L LS                  S +  A       
Sbjct: 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSS-------------CEGFSTDGLAAIAATCR 156

Query: 259 FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC---VIPHEIDNLH 315
            L+E+ L ++        D+    +         L  L++     +     +   +    
Sbjct: 157 NLKELDLRESDV-----DDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCP 211

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
           NL+                     +LK            L      R P LEEL   G  
Sbjct: 212 NLK---------------------SLKLNRAVPLEKLATLLQ----RAPQLEELGTGGYT 246

Query: 376 FSGT------IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTS 429
                     +   +    +L  L    ++   ++P  +     L  L+L  +Y T  + 
Sbjct: 247 AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL--SYATVQSY 304

Query: 430 ELSFLSSSNCKYLEYFS----ISNNPLGGILPRVIG----NLSQSMEDFHMPNSNISGSI 481
           +L  L    C  L+       I +  L  +           +  S      PN  ++   
Sbjct: 305 DLVKL-LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363

Query: 482 PKEI-NNLTNLIAIYLGVNKLNGSILIALGK-LKKLQLLSLKDNQLEGSIPDNLSFSCTL 539
              +      L ++     ++  + LI + +    +    L    +E   PD L+     
Sbjct: 364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI--IEPKAPDYLTLEPLD 421

Query: 540 TSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG-NLKVLVQIDLSINNFSDV-IPTTIGGL 597
               + + + KD+  L+LS    T  +   IG   K +  + ++    SD+ +   + G 
Sbjct: 422 IGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGC 480

Query: 598 KDLQYLFLKYNRL-QGSIPDSIGDMINLKSLNLSNNNL 634
             L+ L ++       ++  +   +  ++SL +S+ ++
Sbjct: 481 DSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 28/155 (18%), Positives = 54/155 (34%), Gaps = 18/155 (11%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
             NL+ L L   +   K+ + L    +L    L    ++  +  ++ +            
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLE--ELGTGGYTAEVRPDVYSG----------- 256

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
                +   L    EL  L    + +   +P+     S L+ L+LS   +    L  +  
Sbjct: 257 -----LSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLC 311

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLS 155
             P LQ L++ +   D  +      CK L+ L + 
Sbjct: 312 QCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVF 346

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 60.0 bits (145), Expect = 3e-09
 Identities = 62/533 (11%), Positives = 149/533 (27%), Gaps = 93/533 (17%)

Query: 21  TLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELW 80
            L    R    +L   ++ G +   +  +                      NL +L+ + 
Sbjct: 79  KLKGKPRAAMFNLIPENWGGYVTPWVTEI--------------------SNNLRQLKSVH 118

Query: 81  LQNNFLTGTIPSSIF--NLSSLSNLDLS-VNNLTGELLANICSNLPLLQTLFLDENNFDG 137
            +   ++      +       L  L L   +  T + L +I ++   ++TL ++E++F  
Sbjct: 119 FRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSE 178

Query: 138 KIPSTLL----RCKHLQTLSLSINDFSG----DIPKEIGNLTKLKYLHLDQNRL--QGEI 187
           K    L         L+ L+  + +F+     D+     N   L  + +    +      
Sbjct: 179 KDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF 238

Query: 188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSA 247
            +   NL E     L  +        ++     L  L LS+             +     
Sbjct: 239 FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY-------------MGPNEM 285

Query: 248 ELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCV- 306
            +   F      + ++ L   +   E    L        I     LE L+ +      + 
Sbjct: 286 PILFPFAAQ---IRKLDLLYALLETEDHCTL--------IQKCPNLEVLETR----NVIG 330

Query: 307 ---IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRL 363
              +         L+ +          +      VS    + L                 
Sbjct: 331 DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG-------------C 377

Query: 364 PNLEELSLSGNNFS-GTIPSFIFNTSKLSTLELQRNSFSGFIPNTFG---------NLRN 413
             LE +++  ++ +  ++ S       L    L        I +              + 
Sbjct: 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKK 437

Query: 414 LKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMP 473
           L+           +   LS++       + +  +                  +++   M 
Sbjct: 438 LRRFAFYLRQGGLTDLGLSYI-GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMR 496

Query: 474 NSNIS-GSIPKEINNLTNLIAIYLGVNKLN--GSILIALGK-LKKLQLLSLKD 522
               S  +I   +  L +L  +++   + +  G  L+ + +    ++L+  + 
Sbjct: 497 GCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 47/321 (14%), Positives = 93/321 (28%), Gaps = 46/321 (14%)

Query: 363 LPNLEELSLSGNNFSGTIPSFIFNT--SKLSTLELQRNSFSGFIPNTFGNL----RNLKW 416
           L  L+ +       S      +       L TL+L  +  SGF  +   ++    R +K 
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKL--DKCSGFTTDGLLSIVTHCRKIKT 168

Query: 417 LDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILP---RVIGNLSQSMEDFHMP 473
           L + ++  +    +     + +   LE  +        I P     I    +S+    + 
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228

Query: 474 NSNIS--GSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPD 531
           +  I       K   NL       L  +       + L   +KL  L L           
Sbjct: 229 DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY--------- 279

Query: 532 NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLE-IGNLKVLVQIDLSINNFSDV- 589
                     +P        I  L+L             I     L  ++   N   D  
Sbjct: 280 -----MGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRG 333

Query: 590 IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDM------------INLKSLNLSNNNL--F 635
           +       K L+ L ++    +  + D  G +              L+ + +  +++   
Sbjct: 334 LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNE 393

Query: 636 GIIPIS--LEKLLDLKDINVS 654
            +  I   L+ L D + + + 
Sbjct: 394 SLESIGTYLKNLCDFRLVLLD 414

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 37/242 (15%), Positives = 77/242 (31%), Gaps = 27/242 (11%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSG-TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAEL 76
           +P       ++R + L             I     L  L  R       +        +L
Sbjct: 285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQL 344

Query: 77  EELWLQNNFLTGTIPSSIFNLS------------SLSNLDLSVNNLTGELLANICSNLPL 124
           + L ++       +      +S             L  + + V+++T E L +I + L  
Sbjct: 345 KRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKN 404

Query: 125 LQTL---------FLDENNFDGKIPSTLLRCKHLQTLSLSIN--DFSGDIPKEIG-NLTK 172
           L             + +   D  + S L+ CK L+  +  +     +      IG     
Sbjct: 405 LCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPN 464

Query: 173 LKYLHLDQNRLQGE-IPEELGNLAELEKLQLQNNFLT-GTIPPSIFNLSSLSDLELSFNS 230
           ++++ L       E + E       L+KL+++    +   I  ++  L SL  L +    
Sbjct: 465 VRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524

Query: 231 LT 232
            +
Sbjct: 525 AS 526

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 59.2 bits (142), Expect = 3e-09
 Identities = 23/163 (14%), Positives = 63/163 (38%), Gaps = 20/163 (12%)

Query: 63  QGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANIC-SN 121
           Q ++   L  +  L  L ++       +        +L +L++    L   ++ +I  S+
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217

Query: 122 LPLLQTL--FLDENNFDGKIPSTLL-------RCKHLQTLSLSINDFSGDIPKEIGN--- 169
           LP L+ L  ++   ++       +        R  +L+ L +   +    + +       
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277

Query: 170 LTKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQNNFLT 208
           L +L+ + +    L  E    + + +  +  L+ + ++ N+L+
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 55.0 bits (131), Expect = 5e-08
 Identities = 24/136 (17%), Positives = 52/136 (38%), Gaps = 17/136 (12%)

Query: 73  LAELEELWLQNNFLTGTIPSSIF--NLSSLSNLDLSVN------NLTGELLANICSN--L 122
              L+ L + +  L  ++   I   +L +L  L L V       +    +   + S    
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 123 PLLQTLFLDENNFDGKIPSTLLRC---KHLQTLSLSINDFSGD----IPKEIGNLTKLKY 175
           P L+ L + +      +    L       L+T+ +S    + +    +   +  +  LK+
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 176 LHLDQNRLQGEIPEEL 191
           +++  N L  E+ +EL
Sbjct: 312 INMKYNYLSDEMKKEL 327

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.3 bits (124), Expect = 5e-07
 Identities = 22/146 (15%), Positives = 48/146 (32%), Gaps = 18/146 (12%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTL--SNCKRLRNISLSL---NDFSGTIPKEI------GNV 49
             NL+ L + S      +   +  S+   L  + L +   +                   
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 50  TTLIGLHLRGNKLQGEIPEELGN---LAELEELWLQNNFLTGT----IPSSIFNLSSLSN 102
             L  L +   + Q  + E       L +LE + +    LT      +   +  +  L  
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 103 LDLSVNNLTGELLANICSNLPLLQTL 128
           +++  N L+ E+   +  +LP+   +
Sbjct: 312 INMKYNYLSDEMKKELQKSLPMKIDV 337

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.3 bits (106), Expect = 7e-05
 Identities = 23/183 (12%), Positives = 53/183 (28%), Gaps = 25/183 (13%)

Query: 100 LSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDF 159
             ++D     ++     ++   L  +  L   +      +        +L++L +     
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGL 205

Query: 160 SGDIPKEIG--NLTKLKYLHLD---QNRLQGEIPEEL------GNLAELEKLQLQNNFLT 208
              + ++I   +L  L+ L L    ++                     L+ L + +    
Sbjct: 206 PDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQ 265

Query: 209 GTIPPSIFN---LSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYL 265
             +         L  L  +++S   LT              A L     + I  L+ I +
Sbjct: 266 NVVVEMFLESDILPQLETMDISAGVLTDE-----------GARLLLDHVDKIKHLKFINM 314

Query: 266 SKN 268
             N
Sbjct: 315 KYN 317

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 2e-04
 Identities = 29/211 (13%), Positives = 64/211 (30%), Gaps = 30/211 (14%)

Query: 251 AKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHE 310
            +        E ++     F  +  S +    +   +  +  L  L ++      +    
Sbjct: 132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKP 191

Query: 311 IDNLHNL--EWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRL------PSSADVR 362
             NL +L         + +  ++ + + N+  L  LY+G   +          P  +  R
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDR 250

Query: 363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
            PNL+ L +        +      +                       L  L+ +D+   
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESD---------------------ILPQLETMDISAG 289

Query: 423 YLTSSTSELSFLSSSNCKYLEYFSISNNPLG 453
            LT   + L        K+L++ ++  N L 
Sbjct: 290 VLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 755 NNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF----DIECGMIKRIRHR--- 806
           ++LIG+G FG V KA    +   VA+K+      +  K+F     IE  +++ +      
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 807 ---NIIKFISSCSSDDFKA---LVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASA 859
               I+          F+    LV E + Y +L   L ++N+  + +         + +A
Sbjct: 114 MKYYIVHLKRHF---MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 860 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPFLKEDQSLTQTQTLATIG 917
           L +L     + IIHCDLKP N+LL +   +   + DFG +    +  Q +   Q + +  
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRI--YQYIQSRF 223

Query: 918 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 947
           Y +PE           D++S G +L+E  T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 39/118 (33%), Positives = 55/118 (46%), Gaps = 6/118 (5%)

Query: 115 LANICSNLPL-LQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKL 173
           L  +   +P  +  L+LD N F   +P  L   KHL  + LS N  S    +   N+T+L
Sbjct: 22  LKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 174 KYLHLDQNRLQGEIPEEL-GNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
             L L  NRL+  IP      L  L  L L  N ++  +P   F +LS+LS L +  N
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 37/123 (30%), Positives = 54/123 (43%), Gaps = 10/123 (8%)

Query: 331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSK 389
           +P  I     +  LYL  N F   L         +L  + LS N  S T+ +  F N ++
Sbjct: 25  LPKGIP--RDVTELYLDGNQF--TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 390 LSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISN 449
           L TL L  N      P TF  L++L+ L L  N + S   E +F   ++   L + +I  
Sbjct: 80  LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAF---NDLSALSHLAIGA 135

Query: 450 NPL 452
           NPL
Sbjct: 136 NPL 138

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 41/154 (26%), Positives = 59/154 (38%), Gaps = 42/154 (27%)

Query: 247 AELPAKFCNNIPF-LEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC 305
             LP      IP  + E+YL  N F            +PKE+ N   L  +DL  NR+  
Sbjct: 23  KVLPK----GIPRDVTELYLDGNQF----------TLVPKELSNYKHLTLIDLSNNRIST 68

Query: 306 VIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPN 365
           +      N+  L  +I S+N+L   +P   F+                         L +
Sbjct: 69  LSNQSFSNMTQLLTLILSYNRL-RCIPPRTFD------------------------GLKS 103

Query: 366 LEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRN 398
           L  LSL GN+ S  +P   F + S LS L +  N
Sbjct: 104 LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 4/109 (3%)

Query: 29  RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTG 88
             + L  N F+  +PKE+ N   L  + L  N++     +   N+ +L  L L  N L  
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 89  TIPSSIFN-LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
            IP   F+ L SL  L L  N+++  +     ++L  L  L +  N   
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 24/71 (33%), Positives = 36/71 (50%), Gaps = 5/71 (7%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSL 221
           +PK I        L+LD N+    +P+EL N   L  + L NN ++ T+    F N++ L
Sbjct: 25  LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 222 SDLELSFNSLT 232
             L LS+N L 
Sbjct: 81  LTLILSYNRLR 91

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 10/121 (8%)

Query: 380 IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNC 439
           +P  I        L L  N F+  +P    N ++L  +DL +N +++    LS  S SN 
Sbjct: 25  LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST----LSNQSFSNM 77

Query: 440 KYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI-NNLTNLIAIYLGV 498
             L    +S N L  I PR    L   +    +  ++IS  +P+   N+L+ L  + +G 
Sbjct: 78  TQLLTLILSYNRLRCIPPRTFDGLKS-LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGA 135

Query: 499 N 499
           N
Sbjct: 136 N 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 24/92 (26%), Positives = 43/92 (46%), Gaps = 5/92 (5%)

Query: 580 DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGD-MINLKSLNLSNNNLFGII 638
            L  N F+ ++P  +   K L  + L  NR+  ++ +     M  L +L LS N L  I 
Sbjct: 37  YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIP 94

Query: 639 PISLEKLLDLKDINVSFNKLEGEIPREGPFRN 670
           P + + L  L+ +++  N +   +P  G F +
Sbjct: 95  PRTFDGLKSLRLLSLHGNDIS-VVPE-GAFND 124

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 30/122 (24%), Positives = 45/122 (36%), Gaps = 35/122 (28%)

Query: 417 LDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSN 476
           L L  N  T    ELS       K+L    +SNN +  +  +           F      
Sbjct: 36  LYLDGNQFTLVPKELSNY-----KHLTLIDLSNNRISTLSNQS----------F------ 74

Query: 477 ISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIP----DN 532
                    +N+T L+ + L  N+L          LK L+LLSL  N +   +P    ++
Sbjct: 75  ---------SNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFND 124

Query: 533 LS 534
           LS
Sbjct: 125 LS 126

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.1 bits (97), Expect = 7e-04
 Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 26/123 (21%)

Query: 516 QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG---N 572
             L L  NQ               T +P  L N K +  ++LS N  +    L      N
Sbjct: 34  TELYLDGNQF--------------TLVPKELSNYKHLTLIDLSNNRIS---TLSNQSFSN 76

Query: 573 LKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN---L 629
           +  L+ + LS N    + P T  GLK L+ L L  N +   +P+   +  +L +L+   +
Sbjct: 77  MTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN--DLSALSHLAI 133

Query: 630 SNN 632
             N
Sbjct: 134 GAN 136

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 62/318 (19%), Positives = 98/318 (30%), Gaps = 101/318 (31%)

Query: 758  IGRGGFGFVYKAR-IQDGMEVAVKVF--DLQYGRAIKSFDIECGMIKRIR--------HR 806
            +G G F  V+ +  IQ    VA+KV      Y         E  ++K +R          
Sbjct: 45   LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNRE 101

Query: 807  NIIKFISSCSSDDFK---------ALVLEYMPYG-SLEKCLYSSNYI---LDIFQRLNIM 853
             +++ +     DDFK          +V E    G  L K +  SNY    L   ++  I+
Sbjct: 102  MVVQLL-----DDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKK--II 152

Query: 854  IDVASALEYLHFGYSVPIIHCDLKPNNVLL------------------------------ 883
              V   L+YLH      IIH D+KP N+LL                              
Sbjct: 153  QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 884  -------------------DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG 924
                                + +   ++D G A    K      QT+      Y + E  
Sbjct: 211  STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVL 265

Query: 925  REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
                 +T  D++S   M  E  T        F      +   ++  +  I+E     LL 
Sbjct: 266  IGSGYNTPADIWSTACMAFELATGDYL----FEPHSGEEYTRDEDHIALIIE-----LLG 316

Query: 985  HEDKHFVAKEQCMSFVFN 1002
               +  +   +     F 
Sbjct: 317  KVPRKLIVAGKYSKEFFT 334

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 40/231 (17%), Positives = 78/231 (33%), Gaps = 62/231 (26%)

Query: 757 LIGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAIKSF----DIECGMIKRIRHR---- 806
            +G G FG V +     +   +VA+K+      R +  +     +E  ++K+I+ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 807 --NIIKFISSCSSDDFKA---LVLEYMPYGSLEKCLY----SSNYI-LDIFQRLNIMIDV 856
               +         +F     +  E      L K  +     +N+    +    ++   +
Sbjct: 81  KFLCVLMSDWF---NFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL--------- 907
             AL +LH      + H DLKP N+L  ++    L +   +        +          
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 908 -TQTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFT 947
               +   TI     Y  PE      +      +   DV+S G +L E + 
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.0 bits (133), Expect = 6e-08
 Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 66/235 (28%)

Query: 757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSF----DIECGMIKRIRHR----- 806
            +G G FG V   + I +    AVKV      R IK +     IE  ++K+I++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 807 NIIKFISSCSSDDFKA---LVLEYMPYGSLEKCLY----SSNYI-LDIFQRLNIMIDVAS 858
           NI+K+        +     L+ E      L   LY     +NY    I       I++  
Sbjct: 97  NIVKYHGKF---MYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148

Query: 859 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT---------- 908
           AL YL     + + H DLKP N+LLDD                K+ Q             
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 909 ------QTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFT 947
                 ++    +I     Y APE      +        + D++SFG +L E +T
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 38/134 (28%), Positives = 59/134 (44%), Gaps = 29/134 (21%)

Query: 74  AELEELWLQNNFLTGTIPSSIFN-LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE 132
           +    L L++N L  ++P  +F+ L+ L+ L LS N +   L   +   L  L  L+L E
Sbjct: 28  SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHE 85

Query: 133 NNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE-L 191
           N               LQ+L   + D           LT+LK L LD N+L+  +P+   
Sbjct: 86  N--------------KLQSLPNGVFD----------KLTQLKELALDTNQLKS-VPDGIF 120

Query: 192 GNLAELEKLQLQNN 205
             L  L+K+ L  N
Sbjct: 121 DRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 34/117 (29%), Positives = 48/117 (41%), Gaps = 5/117 (4%)

Query: 42  IPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFN-LSSL 100
           +P  I +  T   L L  NKLQ         L +L +L L  N +  ++P  +F+ L+ L
Sbjct: 22  VPTGIPSSATR--LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78

Query: 101 SNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN 157
           + L L  N L   L   +   L  L+ L LD N           R   LQ + L  N
Sbjct: 79  TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 28/94 (29%), Positives = 38/94 (40%), Gaps = 8/94 (8%)

Query: 139 IPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELE 198
           IPS+         L L  N            LT+L  L L QN++Q         L +L 
Sbjct: 26  IPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79

Query: 199 KLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSL 231
            L L  N L  ++P  +F  L+ L +L L  N L
Sbjct: 80  ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 5/107 (4%)

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST-LKFLYLGSNSFF 352
            +L+L+ N+LQ +     D L  L  +  S N++   +P  +F+  T L  LYL  N   
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENK-L 88

Query: 353 GRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF-NTSKLSTLELQRN 398
             LP+    +L  L+EL+L  N    ++P  IF   + L  + L  N
Sbjct: 89  QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 37/231 (16%), Positives = 75/231 (32%), Gaps = 62/231 (26%)

Query: 757 LIGRGGFGFVYKA--RIQDGMEVAVKVFDLQYGRAIKSF----DIECGMIKRIRHR---- 806
            +G G FG V +       G  VAVK+      + +  +      E  +++ +       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 807 --NIIKFISSCSSDDFKA---LVLEYMPYGSLEKCLY----SSNYI-LDIFQRLNIMIDV 856
               ++ +      +      +V E      L    Y     + ++   +     +   +
Sbjct: 76  TFRCVQMLEWF---EHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 857 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL--------- 907
             ++ +LH   S  + H DLKP N+L   +      +  + +                  
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 908 -TQTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFT 947
               +  +T+     Y APE      +      S   DV+S G +L+E + 
Sbjct: 185 TYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 27/116 (23%), Positives = 40/116 (34%), Gaps = 5/116 (4%)

Query: 337 NVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQ 396
             + ++ L L +                NLE LSL       ++ +      KL  LEL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLP-KLKKLELS 79

Query: 397 RNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
            N   G +      L NL  L+L  N L    S L  L     + L+   + N  +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKL-KDISTLEPL--KKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 32/115 (27%), Positives = 46/115 (40%), Gaps = 6/115 (5%)

Query: 121 NLPLLQTLFLDENNFD-GKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLD 179
               ++ L LD    + GKI        +L+ LSL        +   +  L KLK L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 180 QNRLQGEIPEELGNLAELEKLQLQNNFLT--GTIPPSIFNLSSLSDLELSFNSLT 232
           +NR+ G +      L  L  L L  N L    T+ P +  L  L  L+L    +T
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 30/126 (23%), Positives = 45/126 (35%), Gaps = 8/126 (6%)

Query: 33  LSLNDFSGTIPKEIGNVTT---LIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGT 89
           L L++      K  G       L  L L    L   +   L  L +L++L L  N + G 
Sbjct: 29  LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86

Query: 90  IPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN---NFDGKIPSTLLRC 146
           +      L +L++L+LS N L           L  L++L L      N +    S     
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLL 146

Query: 147 KHLQTL 152
             L  L
Sbjct: 147 PQLTYL 152

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 30/131 (22%), Positives = 48/131 (36%), Gaps = 15/131 (11%)

Query: 109 NLTGELLANICS--NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPK- 165
            LT EL+       N    + L L        I +          +  S N+    I K 
Sbjct: 3   KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IRKL 57

Query: 166 -EIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDL 224
                L +LK L ++ NR+          L +L +L L NN L       + +L  L+ L
Sbjct: 58  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASL 112

Query: 225 E-LSFNSLTGN 234
           + L++  +  N
Sbjct: 113 KSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 23/134 (17%), Positives = 47/134 (35%), Gaps = 6/134 (4%)

Query: 22  LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWL 81
            +N  R R + L        I      +     +    N+++ ++ +    L  L+ L +
Sbjct: 15  YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLV 71

Query: 82  QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN---NFDGK 138
            NN +          L  L+ L L+ N+L      +  ++L  L  L +  N   N    
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 131

Query: 139 IPSTLLRCKHLQTL 152
               + +   ++ L
Sbjct: 132 RLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 5/93 (5%)

Query: 360 DVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL 419
              L   + +  S N     +  F     +L TL +  N            L +L  L L
Sbjct: 38  GATLDQFDAIDFSDNEIR-KLDGFPLLR-RLKTLLVNNNRICRIGEGLDQALPDLTELIL 95

Query: 420 GDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
            +N L     +L  L  ++ K L Y  I  NP+
Sbjct: 96  TNNSL-VELGDLDPL--ASLKSLTYLCILRNPV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 26/116 (22%), Positives = 42/116 (36%), Gaps = 5/116 (4%)

Query: 337 NVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQ 396
             S +K L L ++                LE LS      + +I + +   +KL  LEL 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 397 RNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
            N  SG +        NL  L+L  N +    S +  L     + L+   + N  +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKI-KDLSTIEPL--KKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 5/105 (4%)

Query: 32  SLSLNDFSGTIPKEIGNVTTLIG---LHLRGNKLQGEIPEELGNLAELEELWLQNNFLTG 88
            L L++      K  G          L      L   I   L  L +L++L L +N ++G
Sbjct: 21  ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSG 78

Query: 89  TIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN 133
            +        +L++L+LS N +           L  L++L L   
Sbjct: 79  GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 8e-05
 Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 9/128 (7%)

Query: 108 NNLTGELLANICSNLPLLQTLFLDENNFD-GKIPSTLLRCKHLQTLSLSINDFSGDIPKE 166
             +  EL     S++   + L LD +  + GK+       + L+ LS      +  I   
Sbjct: 5   RRIHLELRNRTPSDV---KELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-AN 59

Query: 167 IGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT--GTIPPSIFNLSSLSDL 224
           +  L KLK L L  NR+ G +         L  L L  N +    TI P +  L +L  L
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSL 118

Query: 225 ELSFNSLT 232
           +L    +T
Sbjct: 119 DLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 29/136 (21%), Positives = 45/136 (33%), Gaps = 29/136 (21%)

Query: 289 NLAKLEKLDLQFNRLQCV-IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG 347
             + +++L L  +R     +    D    LE++      L     T+I N+         
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLP-------- 61

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGF-IPN 406
                         +L  L++L LS N  SG +         L+ L L  N         
Sbjct: 62  --------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107

Query: 407 TFGNLRNLKWLDLGDN 422
               L NLK LDL + 
Sbjct: 108 PLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 3/85 (3%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
              LE+L    N+    I + L    +L+ + LS N  SG +         L  L+L GN
Sbjct: 41  FEELEFLST-INVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98

Query: 61  KLQG-EIPEELGNLAELEELWLQNN 84
           K++     E L  L  L+ L L N 
Sbjct: 99  KIKDLSTIEPLKKLENLKSLDLFNC 123

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 14/95 (14%)

Query: 139 IPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELG---NLA 195
           IP+T       Q L L  N  +   P     LT+L  L LD N+L   +P   G    L 
Sbjct: 28  IPTTT------QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPA--GVFDKLT 78

Query: 196 ELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFN 229
           +L +L L +N L  +IP   F NL SL+ + L  N
Sbjct: 79  QLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 3/88 (3%)

Query: 50  TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFN-LSSLSNLDLSVN 108
           TT   L+L  N++    P     L +L  L L NN LT  +P+ +F+ L+ L+ L L+ N
Sbjct: 30  TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88

Query: 109 NLTGELLANICSNLPLLQTLFLDENNFD 136
            L   +      NL  L  ++L  N +D
Sbjct: 89  QLKS-IPRGAFDNLKSLTHIWLLNNPWD 115

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 23/235 (9%)

Query: 1   LSNLEYLFL-KSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRG 59
              ++++ L  S +    +   LS C +L+N+SL     S  I   +   + L+ L+L G
Sbjct: 92  PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151

Query: 60  -NKLQGEIPEELG-NLAELEELWLQNNF-LTGTIPSSIF--NLSSLSNLDLS--VNNLTG 112
            +       + L  + + L+EL L   F  T             +++ L+LS    NL  
Sbjct: 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 211

Query: 113 ELLANICSNLPLLQTLFLDE-NNFDGKIPSTLLRCKHLQTLSLS----INDFSGDIPKEI 167
             L+ +    P L  L L +             +  +LQ LSLS    I   +     E+
Sbjct: 212 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET---LLEL 268

Query: 168 GNLTKLKYLHLDQNRLQGEIPEE-LGNLAE-LEKLQLQNNFLTGTIPPSIFNLSS 220
           G +  LK L +      G +P+  L  L E L  LQ+  +  T    P+I N  +
Sbjct: 269 GEIPTLKTLQVF-----GIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKN 318

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 35/217 (16%), Positives = 70/217 (32%), Gaps = 35/217 (16%)

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSF--SGFIPNTFGNLRNLKWLDL 419
           +   L+ LSL G   S  I + +   S L  L L   S      +     +   L  L+L
Sbjct: 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 175

Query: 420 GDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPN----- 474
              +  +    +    +   + +   ++S         + +     S      PN     
Sbjct: 176 SWCFDFTEKH-VQVAVAHVSETITQLNLSG------YRKNLQKSDLSTLVRRCPNLVHLD 228

Query: 475 ----SNISGSIPKEINNLTNLIAIYL-GVNKLNGSILIALGKLKKLQLLSLKDNQLEGSI 529
                 +     +E   L  L  + L     +    L+ LG++  L+ L +     +G++
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 288

Query: 530 PD------NLSFSCT-LTSI---------PSTLWNLK 550
                   +L  +C+  T+I            +W +K
Sbjct: 289 QLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 325

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 22/98 (22%), Positives = 43/98 (43%), Gaps = 6/98 (6%)

Query: 85  FLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLL 144
                  +  F+   + ++DLS + +    L  I S    LQ L L+       I +TL 
Sbjct: 80  SFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 139

Query: 145 RCKHLQTLSLS----INDFSGDIPKEIGNLTKLKYLHL 178
           +  +L  L+LS     ++F+  +   + + ++L  L+L
Sbjct: 140 KNSNLVRLNLSGCSGFSEFA--LQTLLSSCSRLDELNL 175

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 17/95 (17%)

Query: 50  TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVN 108
           T    L L  N++    P    +L  L++L+  +N LT  IP+ +F  L+ L+ LDL+ N
Sbjct: 33  TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91

Query: 109 NLTGELLANICS-------NLPLLQTLFLDENNFD 136
           +L         S       NL  L  ++L  N +D
Sbjct: 92  HLK--------SIPRGAFDNLKSLTHIYLYNNPWD 118

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 4/70 (5%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSL 221
           +P  I   T  + L L+ N++    P    +L  L++L   +N LT  IP  +F  L+ L
Sbjct: 27  VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 222 SDLELSFNSL 231
           + L+L+ N L
Sbjct: 84  TQLDLNDNHL 93

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 31/154 (20%), Positives = 55/154 (35%), Gaps = 17/154 (11%)

Query: 96  NLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK----IPSTLLRCK-HLQ 150
              +L  ++L+   L    L  +       + L L  N+   +    +   LL  +  + 
Sbjct: 99  GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQIT 158

Query: 151 TLSLSINDFSGDIPKEIGNL----TKLKYLHLDQNRLQGE----IPEELGNLAELEKLQL 202
           TL LS N  +      +       T + +L L    L  E    +  +L    +L++L +
Sbjct: 159 TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV 218

Query: 203 QNNFLTGT----IPPSIFNLSSLSDLELSFNSLT 232
             N    T    +  +     SL  L L FN L+
Sbjct: 219 AYNGAGDTAALALARAAREHPSLELLHLYFNELS 252

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1027
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.77
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.7
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.69
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.66
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.62
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.61
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.6
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.59
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.59
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.58
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.58
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.58
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.52
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.49
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.44
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.41
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.39
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.28
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.28
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.21
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.14
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.01
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.01
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.87
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.83
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.8
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.78
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.51
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.48
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.41
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.4
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.33
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.32
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.89
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.8
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.62
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.51
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.32
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.31
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.28
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.25
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.18
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.99
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.99
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.96
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.79
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.73
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.7
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.57
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.45
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.33
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.79
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.0
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.15

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.2e-83  Score=803.14  Aligned_cols=656  Identities=31%  Similarity=0.452  Sum_probs=599.5

Q ss_pred             CCcEEecCCCcCccc---CCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcc--cccCCCCCC
Q 048205            3 NLEYLFLKSNMFHGK---IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPE--ELGNLAELE   77 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~---~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~--~l~~l~~L~   77 (1027)
                      .++.|+|+++.+.+.   +|.+|..++.|+.++++.|.+. .+|..++.+++|++|+|++|.+++.+|.  .++++++|+
T Consensus        51 ~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~  129 (768)
T 3rgz_A           51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK  129 (768)
T ss_dssp             EEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCC
T ss_pred             cEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCC
Confidence            478999999999987   8899999999999999999987 5788999999999999999999999999  999999999


Q ss_pred             EEEccCcccCCccCccc-cCCCCCCeEeCCcccccccchhhh--hcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEc
Q 048205           78 ELWLQNNFLTGTIPSSI-FNLSSLSNLDLSVNNLTGELLANI--CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSL  154 (1027)
Q Consensus        78 ~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  154 (1027)
                      +|+|++|.+.+..|..+ .++++|++|+|++|++++..+..+  +.++++|++|++++|++.+..+.  ..+++|++|+|
T Consensus       130 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~L  207 (768)
T 3rgz_A          130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDV  207 (768)
T ss_dssp             EEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEEC
T ss_pred             EEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEEC
Confidence            99999999998888776 899999999999999997655543  78899999999999999976654  88999999999


Q ss_pred             cCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCC
Q 048205          155 SINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN  234 (1027)
Q Consensus       155 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  234 (1027)
                      ++|.+++.+|. ++++++|++|+|++|++++.+|..++.+++|++|+|++|.+++.+|..  .+++|++|++++|+++|.
T Consensus       208 s~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~  284 (768)
T 3rgz_A          208 SSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGE  284 (768)
T ss_dssp             CSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEES
T ss_pred             cCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCc
Confidence            99999987777 999999999999999999999999999999999999999999887765  899999999999999865


Q ss_pred             CCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCcc-ccC
Q 048205          235 FPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHE-IDN  313 (1027)
Q Consensus       235 ~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~-~~~  313 (1027)
                      +|              ..++..+++|++|++++|.+++.         +|..++.+++|++|++++|++++.+|.. |..
T Consensus       285 ip--------------~~~~~~~~~L~~L~Ls~n~l~~~---------~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~  341 (768)
T 3rgz_A          285 IP--------------DFLSGACDTLTGLDLSGNHFYGA---------VPPFFGSCSLLESLALSSNNFSGELPMDTLLK  341 (768)
T ss_dssp             CC--------------CCSCTTCTTCSEEECCSSEEEEC---------CCGGGGGCTTCCEEECCSSEEEEECCHHHHTT
T ss_pred             cC--------------HHHHhhcCcCCEEECcCCcCCCc---------cchHHhcCCCccEEECCCCcccCcCCHHHHhc
Confidence            44              44455568999999999999974         5667888999999999999999777765 999


Q ss_pred             cCcccceeccCcccccccCccccccC-CcceEEccCccccccCCCCccC-CCCCccEEEccccccCCcCcccccCCCCCC
Q 048205          314 LHNLEWMIFSFNKLVGVVPTTIFNVS-TLKFLYLGSNSFFGRLPSSADV-RLPNLEELSLSGNNFSGTIPSFIFNTSKLS  391 (1027)
Q Consensus       314 l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  391 (1027)
                      +++|++|++++|++++..|..+.++. +|++|++++|++.+.+|..... .+++|++|+|++|++++.+|..+.++++|+
T Consensus       342 l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~  421 (768)
T 3rgz_A          342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV  421 (768)
T ss_dssp             CTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCC
T ss_pred             CCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCC
Confidence            99999999999999999999999998 9999999999999888876542 278999999999999999999999999999


Q ss_pred             eeecCCCcccCCCCcccCCcccccEEecCCCCCCC-CCCccccccccccccccEeeccCCCCCCCCCccccCccccccee
Q 048205          392 TLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDF  470 (1027)
Q Consensus       392 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l  470 (1027)
                      +|+|++|++++.+|..|+.+++|++|++++|+++. +|..+     ..+++|++|++++|++++.+|.++++++ .++.|
T Consensus       422 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L  495 (768)
T 3rgz_A          422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL-----MYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWI  495 (768)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGG-----GGCTTCCEEECCSSCCCSCCCGGGGGCT-TCCEE
T ss_pred             EEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHH-----cCCCCceEEEecCCcccCcCCHHHhcCC-CCCEE
Confidence            99999999999999999999999999999999984 44433     4789999999999999999999998875 69999


Q ss_pred             ecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCcccc------------
Q 048205          471 HMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT------------  538 (1027)
Q Consensus       471 ~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~------------  538 (1027)
                      ++++|.+++.+|.+++.+++|++|+|++|+++|.+|..++++++|++|+|++|+++|.+|..+.....            
T Consensus       496 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~  575 (768)
T 3rgz_A          496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRY  575 (768)
T ss_dssp             ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEE
T ss_pred             EccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999976532111            


Q ss_pred             ---------------------ccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccC
Q 048205          539 ---------------------LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGL  597 (1027)
Q Consensus       539 ---------------------~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l  597 (1027)
                                           ....|..+..+..+..++++.|.++|.+|..++.+++|+.|||++|+++|.+|.+|+++
T Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l  655 (768)
T 3rgz_A          576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM  655 (768)
T ss_dssp             EEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGC
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhcc
Confidence                                 11234556667778888999999999999999999999999999999999999999999


Q ss_pred             ccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCCCCCCCCccccccc
Q 048205          598 KDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFK  677 (1027)
Q Consensus       598 ~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~  677 (1027)
                      ++|+.|+|++|+++|.||++|+++++|+.|||++|+++|.||.+++.+++|++||+++|+++|.||.+++|.+|+..+|.
T Consensus       656 ~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~  735 (768)
T 3rgz_A          656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL  735 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGC
T ss_pred             ccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCcccccccccc
Q 048205          678 GNELLCGMPNLQVRSCRTR  696 (1027)
Q Consensus       678 ~n~~l~g~~~~~~~~c~~~  696 (1027)
                      ||+++||.|+   ++|...
T Consensus       736 gN~~Lcg~~l---~~C~~~  751 (768)
T 3rgz_A          736 NNPGLCGYPL---PRCDPS  751 (768)
T ss_dssp             SCTEEESTTS---CCCCSC
T ss_pred             CCchhcCCCC---cCCCCC
Confidence            9999999994   489754

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.7e-74  Score=720.43  Aligned_cols=610  Identities=33%  Similarity=0.450  Sum_probs=548.8

Q ss_pred             CCCCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCc--cccccCCCcEEEccccccceeCcccc-cCCCCCC
Q 048205            1 LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPK--EIGNVTTLIGLHLRGNKLQGEIPEEL-GNLAELE   77 (1027)
Q Consensus         1 l~~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~--~i~~l~~L~~L~L~~n~i~~~~p~~l-~~l~~L~   77 (1027)
                      |+.|+.++++.|.+. .+|..|..+++|++|+|++|.+++.+|.  .++.+++|++|+|++|.+++.+|..+ .++++|+
T Consensus        76 L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~  154 (768)
T 3rgz_A           76 LTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE  154 (768)
T ss_dssp             CTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCS
T ss_pred             cCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCC
Confidence            356778888888776 4668899999999999999999999999  99999999999999999998888876 8999999


Q ss_pred             EEEccCcccCCccCcc---ccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEc
Q 048205           78 ELWLQNNFLTGTIPSS---IFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSL  154 (1027)
Q Consensus        78 ~L~L~~N~l~~~~p~~---l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  154 (1027)
                      +|+|++|.+++..|..   +.++++|++|++++|++++..+.   ..+++|++|+|++|++.+.+|. +..+++|++|+|
T Consensus       155 ~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~L  230 (768)
T 3rgz_A          155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDI  230 (768)
T ss_dssp             EEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEEC
T ss_pred             EEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEEC
Confidence            9999999999888877   88999999999999999865543   6789999999999999988877 999999999999


Q ss_pred             cCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCC-CCCCEEEccCccCCC
Q 048205          155 SINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNL-SSLSDLELSFNSLTG  233 (1027)
Q Consensus       155 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~  233 (1027)
                      ++|.+++.+|..|+++++|++|+|++|++++.+|..  .+++|++|++++|++++.+|..++.. ++|++|++++|++++
T Consensus       231 s~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~  308 (768)
T 3rgz_A          231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG  308 (768)
T ss_dssp             CSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEE
T ss_pred             cCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCC
Confidence            999999999999999999999999999999877765  89999999999999999999998875 999999999999986


Q ss_pred             CCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCcc-ccCcCCccceeccCccccccCCcccc
Q 048205          234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKE-IGNLAKLEKLDLQFNRLQCVIPHEID  312 (1027)
Q Consensus       234 ~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~  312 (1027)
                      .+|..               +..+++|++|++++|.++|.+         |.. ++.+++|++|++++|++++..|..+.
T Consensus       309 ~~p~~---------------~~~l~~L~~L~L~~n~l~~~i---------p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~  364 (768)
T 3rgz_A          309 AVPPF---------------FGSCSLLESLALSSNNFSGEL---------PMDTLLKMRGLKVLDLSFNEFSGELPESLT  364 (768)
T ss_dssp             CCCGG---------------GGGCTTCCEEECCSSEEEEEC---------CHHHHTTCTTCCEEECCSSEEEECCCTTHH
T ss_pred             ccchH---------------HhcCCCccEEECCCCcccCcC---------CHHHHhcCCCCCEEeCcCCccCccccHHHH
Confidence            55543               456889999999999998754         433 78899999999999999999999999


Q ss_pred             CcC-cccceeccCcccccccCccccc--cCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCC
Q 048205          313 NLH-NLEWMIFSFNKLVGVVPTTIFN--VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSK  389 (1027)
Q Consensus       313 ~l~-~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  389 (1027)
                      .++ +|+.|++++|++++..|..+..  +++|++|++++|++.+.+|..+ ..+++|++|+|++|++++.+|..+.++++
T Consensus       365 ~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  443 (768)
T 3rgz_A          365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL-SNCSELVSLHLSFNYLSGTIPSSLGSLSK  443 (768)
T ss_dssp             HHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGG-GGCTTCCEEECCSSEEESCCCGGGGGCTT
T ss_pred             hhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHH-hcCCCCCEEECcCCcccCcccHHHhcCCC
Confidence            998 9999999999999988888877  8899999999999988888765 47899999999999999999999999999


Q ss_pred             CCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCC-CCccccccccccccccEeeccCCCCCCCCCccccCcccccc
Q 048205          390 LSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS-TSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSME  468 (1027)
Q Consensus       390 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~  468 (1027)
                      |++|++++|++++.+|..|+.+++|++|+|++|+++.. |..     +..+++|++|+|++|++++.+|.+++.++ .++
T Consensus       444 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-----l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~  517 (768)
T 3rgz_A          444 LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG-----LSNCTNLNWISLSNNRLTGEIPKWIGRLE-NLA  517 (768)
T ss_dssp             CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGG-----GGGCTTCCEEECCSSCCCSCCCGGGGGCT-TCC
T ss_pred             CCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHH-----HhcCCCCCEEEccCCccCCcCChHHhcCC-CCC
Confidence            99999999999999999999999999999999999853 433     35789999999999999999999999875 699


Q ss_pred             eeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeec----------------------------
Q 048205          469 DFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSL----------------------------  520 (1027)
Q Consensus       469 ~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L----------------------------  520 (1027)
                      .|++++|.++|.+|..++++++|++|++++|+++|.+|..+..+..+..+++                            
T Consensus       518 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  597 (768)
T 3rgz_A          518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ  597 (768)
T ss_dssp             EEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECT
T ss_pred             EEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999998877665554443                            


Q ss_pred             ------------------cCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEccc
Q 048205          521 ------------------KDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLS  582 (1027)
Q Consensus       521 ------------------s~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  582 (1027)
                                        +.|.++|             .+|..+..+++|++|||++|.++|.+|.++++++.|+.|||+
T Consensus       598 ~~~~~~~~~l~~~~~~~l~~~~~~g-------------~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls  664 (768)
T 3rgz_A          598 GIRSEQLNRLSTRNPCNITSRVYGG-------------HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG  664 (768)
T ss_dssp             TCCGGGGGGGGGTCCSCTTSCEEEE-------------ECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECC
T ss_pred             cccchhhhccccccccccccceecc-------------cCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCc
Confidence                              3344443             456678889999999999999999999999999999999999


Q ss_pred             ccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCC-CCCC
Q 048205          583 INNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNK-LEGE  661 (1027)
Q Consensus       583 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~-l~g~  661 (1027)
                      +|+++|.+|.+|+++++|+.|||++|+++|.||..++.+++|++|||++|+|+|.||.. +.+..+....+.+|+ |+|.
T Consensus       665 ~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY  743 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred             CCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence            99999999999999999999999999999999999999999999999999999999965 445566677788885 8885


Q ss_pred             C
Q 048205          662 I  662 (1027)
Q Consensus       662 ~  662 (1027)
                      +
T Consensus       744 ~  744 (768)
T 3rgz_A          744 P  744 (768)
T ss_dssp             T
T ss_pred             C
Confidence            3

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=7.4e-62  Score=601.35  Aligned_cols=591  Identities=22%  Similarity=0.254  Sum_probs=367.7

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      +.+++++++++ .+|..+.  +++++|+|++|++++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus         7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   83 (680)
T 1ziw_A            7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN   83 (680)
T ss_dssp             SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred             CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence            34555555555 4554443  45555555555555444445555555555555555555555555555555555555555


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCC
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIP  188 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  188 (1027)
                      +++ .++...+.++++|++|+|++|++++..+..|.++++|++|++++|.+++..|..|+++++|++|++++|++++..+
T Consensus        84 ~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  162 (680)
T 1ziw_A           84 ELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS  162 (680)
T ss_dssp             CCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred             ccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence            555 3444445555566666666666655555666666666666666666666666666666677777777776665555


Q ss_pred             hhcc--CCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEec
Q 048205          189 EELG--NLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLS  266 (1027)
Q Consensus       189 ~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls  266 (1027)
                      ..+.  .+++|++|++++|.+++..|..|..+.+|+.|++++|.+.+....          .++...  ..+.|+.|+++
T Consensus       163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~----------~~~~~l--~~~~L~~L~L~  230 (680)
T 1ziw_A          163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE----------KLCLEL--ANTSIRNLSLS  230 (680)
T ss_dssp             HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHH----------HHHHHH--TTSCCCEEECT
T ss_pred             HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHH----------HHHHHh--hhccccEEEcc
Confidence            5443  346677777777777666666666666777777766665411000          001000  12456777777


Q ss_pred             cccccccCCCCCCCCCCCccccCcC--CccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceE
Q 048205          267 KNMFYGEIPSDLGNCTIPKEIGNLA--KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFL  344 (1027)
Q Consensus       267 ~N~l~~~~p~~~~~~~~p~~l~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  344 (1027)
                      +|.+++..|.         ++..++  +|+.|++++|+++++.|..|+.+++|++|++++|++.+..|..|.++++|++|
T Consensus       231 ~n~l~~~~~~---------~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  301 (680)
T 1ziw_A          231 NSQLSTTSNT---------TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL  301 (680)
T ss_dssp             TSCCCEECTT---------TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred             CCcccccChh---------HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence            7766654332         333333  37777777777776666677777777777777777777777777777777777


Q ss_pred             EccCcccccc-----C---CCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccC--CCCcccCCc--c
Q 048205          345 YLGSNSFFGR-----L---PSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSG--FIPNTFGNL--R  412 (1027)
Q Consensus       345 ~L~~N~l~~~-----~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l--~  412 (1027)
                      ++++|...+.     +   +...+..+++|++|++++|++++..+..|.++++|++|++++|.+..  +.+..|..+  +
T Consensus       302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~  381 (680)
T 1ziw_A          302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS  381 (680)
T ss_dssp             ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred             eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence            7776544321     1   22234456666666666666666666666666666666666665432  222333333  3


Q ss_pred             cccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCC-ccccCcccccceeecCCCccccccCccccccccc
Q 048205          413 NLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILP-RVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNL  491 (1027)
Q Consensus       413 ~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L  491 (1027)
                      +|+.|++++|+++.++..    .+..+++|++|++++|++++.+| ..+.+++ .++++++++|.+.+..|..+..+++|
T Consensus       382 ~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~~L  456 (680)
T 1ziw_A          382 PLHILNLTKNKISKIESD----AFSWLGHLEVLDLGLNEIGQELTGQEWRGLE-NIFEIYLSYNKYLQLTRNSFALVPSL  456 (680)
T ss_dssp             CCCEEECTTSCCCEECTT----TTTTCTTCCEEECCSSCCEEECCSGGGTTCT-TCCEEECCSCSEEECCTTTTTTCTTC
T ss_pred             cCceEECCCCCCCeEChh----hhhCCCCCCEEeCCCCcCccccCcccccCcc-cccEEecCCCCcceeChhhhhcCccc
Confidence            566666666666654332    22456666666666666654333 4454443 46666666666666666666667777


Q ss_pred             ceEEecCcccc--CchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCc---
Q 048205          492 IAIYLGVNKLN--GSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPL---  566 (1027)
Q Consensus       492 ~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~---  566 (1027)
                      +.|++++|+++  +.+|..|.++++|++|+|++|++++..             |..+.++++|++|++++|.+++..   
T Consensus       457 ~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~-------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~  523 (680)
T 1ziw_A          457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN-------------DDMLEGLEKLEILDLQHNNLARLWKHA  523 (680)
T ss_dssp             CEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCC-------------TTTTTTCTTCCEEECCSSCCGGGGSTT
T ss_pred             ccchhccccccccccCCcccccCCCCCEEECCCCCCCcCC-------------hhhhccccccCEEeCCCCCccccchhh
Confidence            77777777665  456666777777777777777764321             223556667777777777766531   


Q ss_pred             -----cccccCcccccEEcccccccccccch-hhccCccccEEEccCCccccCccccccccccccccccccccccCCchh
Q 048205          567 -----PLEIGNLKVLVQIDLSINNFSDVIPT-TIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPI  640 (1027)
Q Consensus       567 -----p~~~~~l~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~  640 (1027)
                           +..++.+++|+.|+|++|+++. +|. .|+++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|.
T Consensus       524 ~~~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~  602 (680)
T 1ziw_A          524 NPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK  602 (680)
T ss_dssp             STTSCCCTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHH
T ss_pred             ccCCcchhhcCCCCCCEEECCCCCCCC-CCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChh
Confidence                 1236778888888888888874 554 588888888888888888854444567888888888888888888887


Q ss_pred             hhh-cccCCcceeccCCCCCCCCC
Q 048205          641 SLE-KLLDLKDINVSFNKLEGEIP  663 (1027)
Q Consensus       641 ~l~-~l~~L~~l~l~~N~l~g~~p  663 (1027)
                      .+. .+++|+.+++++|++....+
T Consensus       603 ~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          603 VFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             HHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             HhcccccccCEEEccCCCcccCCc
Confidence            777 78888888888888877654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=4.2e-61  Score=594.57  Aligned_cols=597  Identities=22%  Similarity=0.201  Sum_probs=507.0

Q ss_pred             CcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccC
Q 048205            4 LEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQN   83 (1027)
Q Consensus         4 l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~   83 (1027)
                      -+.++.++++++ .+|..+.  +++++|+|++|.+++..+..++.+++|++|+|++|++++..|+.|+++++|++|+|++
T Consensus         6 ~~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~   82 (680)
T 1ziw_A            6 HEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH   82 (680)
T ss_dssp             SSEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred             CCeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence            367899999998 5777665  7899999999999977777899999999999999999988899999999999999999


Q ss_pred             cccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccccc
Q 048205           84 NFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDI  163 (1027)
Q Consensus        84 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  163 (1027)
                      |.+++..+..|.++++|++|++++|+++ .++...+..+++|++|++++|.+++..+..|.++++|++|++++|.+++..
T Consensus        83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  161 (680)
T 1ziw_A           83 NELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK  161 (680)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred             CccCccChhhhccCCCCCEEECCCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence            9999666668999999999999999997 566677889999999999999999999999999999999999999999777


Q ss_pred             Ccccc--CCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCcccc---CCCCCCEEEccCccCCCCCCcc
Q 048205          164 PKEIG--NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF---NLSSLSDLELSFNSLTGNFPKD  238 (1027)
Q Consensus       164 p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~  238 (1027)
                      +..+.  .+++|++|++++|++++..|..|..+.+|+.|++++|.+.......+.   ..++|+.|++++|.+++..|. 
T Consensus       162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~-  240 (680)
T 1ziw_A          162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT-  240 (680)
T ss_dssp             HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT-
T ss_pred             HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh-
Confidence            76654  568999999999999999999999999999999999988643222221   358999999999999854443 


Q ss_pred             hhhhhhccccCCccccCCCc--cccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCc
Q 048205          239 MHIVNRLSAELPAKFCNNIP--FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHN  316 (1027)
Q Consensus       239 ~~~~~~~~~~l~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  316 (1027)
                                    .+..++  +|++|++++|++++..         |..++.+++|++|++++|++++..|..|.++++
T Consensus       241 --------------~~~~l~~~~L~~L~Ls~n~l~~~~---------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  297 (680)
T 1ziw_A          241 --------------TFLGLKWTNLTMLDLSYNNLNVVG---------NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN  297 (680)
T ss_dssp             --------------TTGGGGGSCCCEEECTTSCCCEEC---------TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTT
T ss_pred             --------------HhhccCcCCCCEEECCCCCcCccC---------cccccCcccccEeeCCCCccCccChhhhcCCCC
Confidence                          333443  4999999999998633         455778899999999999999999999999999


Q ss_pred             ccceeccCccccc---------ccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCc--Cccccc
Q 048205          317 LEWMIFSFNKLVG---------VVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGT--IPSFIF  385 (1027)
Q Consensus       317 L~~L~Ls~N~l~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~  385 (1027)
                      |+.|++++|...+         +....|..+++|++|++++|++.+ ++...+..+++|++|+|++|.+...  .+..|.
T Consensus       298 L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~  376 (680)
T 1ziw_A          298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV  376 (680)
T ss_dssp             CCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC-CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTG
T ss_pred             ccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC-CChhHhccccCCcEEECCCCchhhhhcchhhhc
Confidence            9999999876542         223378899999999999999975 5555567899999999999986432  223343


Q ss_pred             CC--CCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCC-CCCccccccccccccccEeeccCCCCCCCCCccccC
Q 048205          386 NT--SKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS-STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGN  462 (1027)
Q Consensus       386 ~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  462 (1027)
                      .+  ++|+.|++++|+++++.|..|..+++|++|+|++|+++. ++.    ..+..+++|++|++++|++.++.+.+|..
T Consensus       377 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  452 (680)
T 1ziw_A          377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG----QEWRGLENIFEIYLSYNKYLQLTRNSFAL  452 (680)
T ss_dssp             GGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS----GGGTTCTTCCEEECCSCSEEECCTTTTTT
T ss_pred             ccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc----ccccCcccccEEecCCCCcceeChhhhhc
Confidence            33  589999999999999999999999999999999999874 332    23467899999999999999999999988


Q ss_pred             cccccceeecCCCccc--cccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCcccccc
Q 048205          463 LSQSMEDFHMPNSNIS--GSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLT  540 (1027)
Q Consensus       463 l~~~l~~l~l~~n~~~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~  540 (1027)
                      ++ .++.+++++|.+.  +.+|..++++++|++|++++|++++..+..|+++++|++|+|++|++++..+..+.     .
T Consensus       453 ~~-~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~  526 (680)
T 1ziw_A          453 VP-SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP-----G  526 (680)
T ss_dssp             CT-TCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTST-----T
T ss_pred             Cc-ccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhcc-----C
Confidence            75 6999999999987  67999999999999999999999998889999999999999999999764332111     0


Q ss_pred             ccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccc-
Q 048205          541 SIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIG-  619 (1027)
Q Consensus       541 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~-  619 (1027)
                      ..+..+.++++|++|+|++|.++...+..|+.+++|+.|||++|++++..|..|.++++|+.|+|++|++++..|..++ 
T Consensus       527 ~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  606 (680)
T 1ziw_A          527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP  606 (680)
T ss_dssp             SCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHH
T ss_pred             CcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcc
Confidence            1123478899999999999999954445699999999999999999976666689999999999999999987777777 


Q ss_pred             ccccccccccccccccCCch
Q 048205          620 DMINLKSLNLSNNNLFGIIP  639 (1027)
Q Consensus       620 ~l~~L~~L~l~~N~l~~~~p  639 (1027)
                      .+++|+.|+|++|++...-+
T Consensus       607 ~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          607 AFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             HHTTCSEEECTTCCCCBCCC
T ss_pred             cccccCEEEccCCCcccCCc
Confidence            89999999999999986543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=4.7e-58  Score=559.66  Aligned_cols=544  Identities=20%  Similarity=0.209  Sum_probs=317.2

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      +.++.++..++ .+|..+.  +.+++|+|++|.|++..|..|+.+++|++|+|++|++++..|+.|+++++|++|+|++|
T Consensus        15 ~~~~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n   91 (606)
T 3t6q_A           15 KTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN   91 (606)
T ss_dssp             TEEECTTSCCS-SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             ceEECCCCCcc-cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence            45666666666 4555554  35777777777777666667777777777777777777666777777777777777777


Q ss_pred             ccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccC
Q 048205           85 FLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIP  164 (1027)
Q Consensus        85 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  164 (1027)
                      ++++..|..|.++++|++|++++|+++ .+....+..+++|++|++++|++++...+.+..+++|++|++++|.+++..|
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  170 (606)
T 3t6q_A           92 PLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK  170 (606)
T ss_dssp             CCSEECTTTTSSCTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred             cccccChhhhcccccccEeeccccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence            777666667777777777777777776 3334445666667777777776665444444556667777777766666556


Q ss_pred             ccccCCCCCc--EEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhh
Q 048205          165 KEIGNLTKLK--YLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIV  242 (1027)
Q Consensus       165 ~~~~~l~~L~--~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  242 (1027)
                      ..|+.+++|+  .|++++|++++..|..|.. .+|+.|++++|.   .++..+.++.+++...+..+.+.+...      
T Consensus       171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~------  240 (606)
T 3t6q_A          171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDD------  240 (606)
T ss_dssp             HHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCC------
T ss_pred             hhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccc------
Confidence            6666666666  6666666666555544433 456666666664   233444445554444444333321100      


Q ss_pred             hhccccCCccccCCCc--cccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccce
Q 048205          243 NRLSAELPAKFCNNIP--FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWM  320 (1027)
Q Consensus       243 ~~~~~~l~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  320 (1027)
                          ..++...+..+.  .|+.|++++|.+++.         .+..|..+++|++|++++|+++ .+|..+..+++|++|
T Consensus       241 ----~~i~~~~~~~l~~~~L~~L~l~~n~l~~~---------~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L  306 (606)
T 3t6q_A          241 ----EDISPAVFEGLCEMSVESINLQKHYFFNI---------SSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL  306 (606)
T ss_dssp             ----CCCCGGGGGGGGGSEEEEEECTTCCCSSC---------CTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEE
T ss_pred             ----cccChhHhchhhcCceeEEEeecCccCcc---------CHHHhccccCCCEEeccCCccC-CCChhhcccccCCEE
Confidence                122223333332  456666666666531         1223455556666666666665 344555566666666


Q ss_pred             eccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcC--cccccCCCCCCeeecCCC
Q 048205          321 IFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTI--PSFIFNTSKLSTLELQRN  398 (1027)
Q Consensus       321 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N  398 (1027)
                      ++++|++.+..|..+.++++|++|++++|.+.+.+|...+..+++|++|++++|++++..  +..+.++++|++|++++|
T Consensus       307 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n  386 (606)
T 3t6q_A          307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN  386 (606)
T ss_dssp             ECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSC
T ss_pred             ECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCC
Confidence            666666665555556666666666666665555555554555555666666555555433  444555555555555555


Q ss_pred             cccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccc
Q 048205          399 SFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNIS  478 (1027)
Q Consensus       399 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~  478 (1027)
                      ++.+..|..|..+++|++|++++|+++.                            ..                      
T Consensus       387 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------------~~----------------------  416 (606)
T 3t6q_A          387 EPLSLKTEAFKECPQLELLDLAFTRLKV----------------------------KD----------------------  416 (606)
T ss_dssp             SCEEECTTTTTTCTTCSEEECTTCCEEC----------------------------CT----------------------
T ss_pred             cCCcCCHHHhcCCccCCeEECCCCcCCC----------------------------cc----------------------
Confidence            5555555555555555555555554321                            11                      


Q ss_pred             cccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecC
Q 048205          479 GSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLS  558 (1027)
Q Consensus       479 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls  558 (1027)
                        .+..++.+++|++|++++|++++..|..++++++|++|+|++|++++...                            
T Consensus       417 --~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----------------------------  466 (606)
T 3t6q_A          417 --AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI----------------------------  466 (606)
T ss_dssp             --TCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEE----------------------------
T ss_pred             --cchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccc----------------------------
Confidence              11235556666667777776666666667777777777777777643110                            


Q ss_pred             CCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCc
Q 048205          559 LNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGII  638 (1027)
Q Consensus       559 ~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~  638 (1027)
                            ..+..++.+++|+.|++++|++++..|..|+++++|++|+|++|++++.+|..++.+++| .|+|++|++++.+
T Consensus       467 ------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~  539 (606)
T 3t6q_A          467 ------QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL  539 (606)
T ss_dssp             ------CSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCC
T ss_pred             ------ccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccC
Confidence                  112334455555555555555555555556666666666666666665555566666666 6666666666555


Q ss_pred             hhhhhcccCCcceeccCCCCCCCCC
Q 048205          639 PISLEKLLDLKDINVSFNKLEGEIP  663 (1027)
Q Consensus       639 p~~l~~l~~L~~l~l~~N~l~g~~p  663 (1027)
                      |..+..+++|+.+++++|++.+..+
T Consensus       540 ~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          540 PSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             GGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             HhhcccCCCCCEEeCCCCCccccCC
Confidence            5556666666666666666655443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=7.9e-57  Score=548.82  Aligned_cols=538  Identities=20%  Similarity=0.174  Sum_probs=295.6

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      +.++.++++++ .+|..+.  +++++|+|++|.+++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n   90 (606)
T 3vq2_A           14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN   90 (606)
T ss_dssp             TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence            34555555555 3444333  55666666666665555555666666666666666665555555666666666666666


Q ss_pred             ccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCc-cCcccccCCCCCcEEEccCCcccccc
Q 048205           85 FLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDG-KIPSTLLRCKHLQTLSLSINDFSGDI  163 (1027)
Q Consensus        85 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~  163 (1027)
                      .+++..|..|.++++|++|++++|++++ ++...+..+++|++|++++|++++ .+|..|.++++|++|++++|.+++..
T Consensus        91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~  169 (606)
T 3vq2_A           91 PIQSFSPGSFSGLTSLENLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT  169 (606)
T ss_dssp             CCCCCCTTSSTTCTTCCEEECTTSCCCC-SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred             cccccChhhcCCcccCCEEEccCCcccc-ccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence            6655555556666666666666665552 232334455555555555555543 23555555555555555555555444


Q ss_pred             CccccCCCCCc----EEEccCccCCCCCChhccCCCCCCeeeccccccC-CCCCccccCCCCCCEEEccCccCCCCCCcc
Q 048205          164 PKEIGNLTKLK----YLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT-GTIPPSIFNLSSLSDLELSFNSLTGNFPKD  238 (1027)
Q Consensus       164 p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  238 (1027)
                      |..|+.+++|+    +|++++|.+++..+..+... +|++|++++|.++ +..|..+.++++|+.+++..+.+.+...- 
T Consensus       170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l-  247 (606)
T 3vq2_A          170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL-  247 (606)
T ss_dssp             TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCC-
T ss_pred             hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcc-
Confidence            44444444333    45555555553333333332 4555555555544 23344444555555555444433210000 


Q ss_pred             hhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceec-cCccccccCCccccCcCcc
Q 048205          239 MHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDL-QFNRLQCVIPHEIDNLHNL  317 (1027)
Q Consensus       239 ~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L-~~N~l~~~~~~~~~~l~~L  317 (1027)
                              ..++.                              ..+..+..+ +++.+++ ..|.+.+..|. +..+++|
T Consensus       248 --------~~~~~------------------------------~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L  287 (606)
T 3vq2_A          248 --------EIFEP------------------------------SIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANV  287 (606)
T ss_dssp             --------SCCCG------------------------------GGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTC
T ss_pred             --------cccCh------------------------------HHhhhhhhc-cHhheeccccccccccccc-cccCCCC
Confidence                    00000                              011111111 3344444 44555554444 5555555


Q ss_pred             cceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCC
Q 048205          318 EWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR  397 (1027)
Q Consensus       318 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  397 (1027)
                      +.|++++|.+..+ | .+..+++|++|++++|.+ +.+|..   .+++|++|++++|+..+.+  .+..+++|++|++++
T Consensus       288 ~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l-~~lp~~---~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~  359 (606)
T 3vq2_A          288 SAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQL-KQFPTL---DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSR  359 (606)
T ss_dssp             SEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCC-SSCCCC---CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCS
T ss_pred             CEEEecCccchhh-h-hccccccCCEEEcccccC-cccccC---CCCccceeeccCCcCccch--hhccCCCCCEEECcC
Confidence            5555555555433 2 455555555555555555 455522   4555555555555433222  344555555555555


Q ss_pred             CcccCC--CCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCC
Q 048205          398 NSFSGF--IPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNS  475 (1027)
Q Consensus       398 N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n  475 (1027)
                      |++++.  .|..+..+++|++|++++|.++.+                                                
T Consensus       360 n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~------------------------------------------------  391 (606)
T 3vq2_A          360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM------------------------------------------------  391 (606)
T ss_dssp             SCEEEEEECCHHHHCCSCCCEEECCSCSEEEE------------------------------------------------
T ss_pred             CccCCCcchhhhhccCCcccEeECCCCccccc------------------------------------------------
Confidence            555543  244555555555555555554332                                                


Q ss_pred             ccccccCcccccccccceEEecCccccCchh-HhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccE
Q 048205          476 NISGSIPKEINNLTNLIAIYLGVNKLNGSIL-IALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILC  554 (1027)
Q Consensus       476 ~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~  554 (1027)
                            |..++.+++|++|++++|++.+..| ..+.++++|++|++++|++.+.             .|..+.++++|++
T Consensus       392 ------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------~~~~~~~l~~L~~  452 (606)
T 3vq2_A          392 ------SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID-------------FDGIFLGLTSLNT  452 (606)
T ss_dssp             ------CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEEC-------------CTTTTTTCTTCCE
T ss_pred             ------hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCcc-------------chhhhcCCCCCCE
Confidence                  2334445555555555555555544 4555666666666666665432             2334555566666


Q ss_pred             EecCCCcccc-CccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccccccccccc
Q 048205          555 LNLSLNFFTG-PLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNN  633 (1027)
Q Consensus       555 L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~  633 (1027)
                      |++++|.+++ .+|..++.+++|+.|++++|++++.+|..|+++++|++|+|++|++++.+|..++.+++|+.|+|++|+
T Consensus       453 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  532 (606)
T 3vq2_A          453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR  532 (606)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence            6666666665 356667777777777777777777777777777777777777777777667777777777777777777


Q ss_pred             ccCCchhhhhccc-CCcceeccCCCCCCCCCC
Q 048205          634 LFGIIPISLEKLL-DLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       634 l~~~~p~~l~~l~-~L~~l~l~~N~l~g~~p~  664 (1027)
                      ++ .+|..+..++ +|+.+++++|++.+..|.
T Consensus       533 l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          533 IE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             CC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             Cc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            77 5666677776 477777777777765553

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=6.7e-56  Score=540.59  Aligned_cols=517  Identities=19%  Similarity=0.172  Sum_probs=420.9

Q ss_pred             CCCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEc
Q 048205            2 SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWL   81 (1027)
Q Consensus         2 ~~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L   81 (1027)
                      +.+++|++++|.+++..|.+|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|++
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            46899999999999999999999999999999999999888999999999999999999999899999999999999999


Q ss_pred             cCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCc--EEEccCCcc
Q 048205           82 QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQ--TLSLSINDF  159 (1027)
Q Consensus        82 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~Ls~N~l  159 (1027)
                      ++|++++..+..+.++++|++|++++|++++..... +..+++|++|++++|.+++..+..|..+++|+  .|++++|.+
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l  191 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK-GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI  191 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCT-TCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCccc-ccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence            999999877889999999999999999998533333 34499999999999999999999999999999  999999999


Q ss_pred             ccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccC-----CCCCccccCCC--CCCEEEccCccCC
Q 048205          160 SGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT-----GTIPPSIFNLS--SLSDLELSFNSLT  232 (1027)
Q Consensus       160 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~--~L~~L~Ls~N~l~  232 (1027)
                      ++..|..|.. .+|++|++++|.   ..+..+..+..+....+.-+.+.     ...+..|.++.  +|+.|++++|.++
T Consensus       192 ~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~  267 (606)
T 3t6q_A          192 AGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF  267 (606)
T ss_dssp             CEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCS
T ss_pred             CccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccC
Confidence            9877777765 689999999997   34556666666555444433332     12233444443  7899999999997


Q ss_pred             CCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCcccc
Q 048205          233 GNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEID  312 (1027)
Q Consensus       233 ~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  312 (1027)
                                     .++...+..+++|++|++++|+++          .+|..+..+++|++|++++|++++..|..+.
T Consensus       268 ---------------~~~~~~~~~l~~L~~L~l~~n~l~----------~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~  322 (606)
T 3t6q_A          268 ---------------NISSNTFHCFSGLQELDLTATHLS----------ELPSGLVGLSTLKKLVLSANKFENLCQISAS  322 (606)
T ss_dssp             ---------------SCCTTTTTTCTTCSEEECTTSCCS----------CCCSSCCSCTTCCEEECTTCCCSBGGGGCGG
T ss_pred             ---------------ccCHHHhccccCCCEEeccCCccC----------CCChhhcccccCCEEECccCCcCcCchhhhh
Confidence                           556667788999999999999998          5677788899999999999999999899999


Q ss_pred             CcCcccceeccCccccccc-CccccccCCcceEEccCccccccCC-CCccCCCCCccEEEccccccCCcCcccccCCCCC
Q 048205          313 NLHNLEWMIFSFNKLVGVV-PTTIFNVSTLKFLYLGSNSFFGRLP-SSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKL  390 (1027)
Q Consensus       313 ~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  390 (1027)
                      .+++|+.|++++|.+.+.. +..+.++++|++|++++|.+.+... ...+..+++|++|++++|++.+..|..+.++++|
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  402 (606)
T 3t6q_A          323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL  402 (606)
T ss_dssp             GCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTC
T ss_pred             ccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccC
Confidence            9999999999999998544 4568999999999999999975541 3345678999999999999998889999999999


Q ss_pred             CeeecCCCcccCCCCcc-cCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccce
Q 048205          391 STLELQRNSFSGFIPNT-FGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMED  469 (1027)
Q Consensus       391 ~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~  469 (1027)
                      ++|++++|++++..|.. |..+++|++|++++|.++..                                          
T Consensus       403 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------------------------  440 (606)
T 3t6q_A          403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS------------------------------------------  440 (606)
T ss_dssp             SEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTT------------------------------------------
T ss_pred             CeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCc------------------------------------------
Confidence            99999999999876654 88899999999988886543                                          


Q ss_pred             eecCCCccccccCcccccccccceEEecCccccCc---hhHhhhcccccceeeccCceeecccCCCCCccccccccCccc
Q 048205          470 FHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGS---ILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTL  546 (1027)
Q Consensus       470 l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l  546 (1027)
                                 .|..++.+++|++|++++|++++.   .+..+..+++|++|+|++|+++                    
T Consensus       441 -----------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~--------------------  489 (606)
T 3t6q_A          441 -----------SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS--------------------  489 (606)
T ss_dssp             -----------CTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCC--------------------
T ss_pred             -----------CHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccC--------------------
Confidence                       233444455566666666665542   1234666666666666666653                    


Q ss_pred             cccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccc
Q 048205          547 WNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKS  626 (1027)
Q Consensus       547 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~  626 (1027)
                                       +..|..++.+++|+.||+++|++++.+|..++.++.| +|+|++|++++.+|..++.+++|+.
T Consensus       490 -----------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~  551 (606)
T 3t6q_A          490 -----------------SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRT  551 (606)
T ss_dssp             -----------------EECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSE
T ss_pred             -----------------ccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCE
Confidence                             3345556667777777777777777777778888888 8888888888767777778888888


Q ss_pred             cccccccccCCch
Q 048205          627 LNLSNNNLFGIIP  639 (1027)
Q Consensus       627 L~l~~N~l~~~~p  639 (1027)
                      |+|++|++++..+
T Consensus       552 L~l~~N~~~c~c~  564 (606)
T 3t6q_A          552 INLRQNPLDCTCS  564 (606)
T ss_dssp             EECTTCCEECSGG
T ss_pred             EeCCCCCccccCC
Confidence            8888888876554

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.4e-55  Score=537.88  Aligned_cols=522  Identities=22%  Similarity=0.187  Sum_probs=427.7

Q ss_pred             CCCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEc
Q 048205            2 SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWL   81 (1027)
Q Consensus         2 ~~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L   81 (1027)
                      +++++|++++|.+++..+.+|.++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|+.|+++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            57899999999999998889999999999999999999888999999999999999999999888999999999999999


Q ss_pred             cCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCc----EEEccCC
Q 048205           82 QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQ----TLSLSIN  157 (1027)
Q Consensus        82 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~Ls~N  157 (1027)
                      ++|.+++..+..++++++|++|++++|++++...+..+.++++|++|++++|++++..+..|..+++|+    +|++++|
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n  191 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN  191 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence            999999887789999999999999999998533356788999999999999999999898888887765    8999999


Q ss_pred             ccccccCccccCCCCCcEEEccCccCC-CCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCC
Q 048205          158 DFSGDIPKEIGNLTKLKYLHLDQNRLQ-GEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP  236 (1027)
Q Consensus       158 ~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  236 (1027)
                      .+++..+..+... +|++|++++|.++ +..|..+.++++|+.+++..+.+.+..        .+..+  ....+.    
T Consensus       192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~--------~l~~~--~~~~~~----  256 (606)
T 3vq2_A          192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER--------NLEIF--EPSIME----  256 (606)
T ss_dssp             CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC--------CCSCC--CGGGGT----
T ss_pred             CcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC--------ccccc--ChHHhh----
Confidence            9997666666655 9999999999997 466788999999999999877665321        11111  011110    


Q ss_pred             cchhhhhhccccCCccccCCCccccEEEe-ccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcC
Q 048205          237 KDMHIVNRLSAELPAKFCNNIPFLEEIYL-SKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH  315 (1027)
Q Consensus       237 ~~~~~~~~~~~~l~~~~~~~l~~L~~L~L-s~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  315 (1027)
                                 .    . ..+ .++.+++ ..|.+.+.+         |. +..+++|+.|++++|.+..+ | .+..++
T Consensus       257 -----------~----l-~~l-~l~~l~l~~~~~~~~~~---------~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~  307 (606)
T 3vq2_A          257 -----------G----L-CDV-TIDEFRLTYTNDFSDDI---------VK-FHCLANVSAMSLAGVSIKYL-E-DVPKHF  307 (606)
T ss_dssp             -----------T----G-GGS-EEEEEEECCCTTCCGGG---------GS-CGGGTTCSEEEEESCCCCCC-C-CCCTTC
T ss_pred             -----------h----h-hhc-cHhheeccccccccccc---------cc-cccCCCCCEEEecCccchhh-h-hccccc
Confidence                       0    0 011 3566666 566666533         33 66778888888888888754 4 788888


Q ss_pred             cccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCc--CcccccCCCCCCee
Q 048205          316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGT--IPSFIFNTSKLSTL  393 (1027)
Q Consensus       316 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L  393 (1027)
                      +|+.|++++|++ +.+| .+ .+++|++|++++|+..+.+   .+..+++|++|+|++|++++.  +|..+..+++|++|
T Consensus       308 ~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L  381 (606)
T 3vq2_A          308 KWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF---KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL  381 (606)
T ss_dssp             CCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC---CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEE
T ss_pred             cCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch---hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEe
Confidence            899999999998 4556 44 8899999999999665554   334789999999999999865  38889999999999


Q ss_pred             ecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecC
Q 048205          394 ELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMP  473 (1027)
Q Consensus       394 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~  473 (1027)
                      ++++|.+++ +|..|..+++|++|++++|+++..+.                                            
T Consensus       382 ~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~--------------------------------------------  416 (606)
T 3vq2_A          382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTE--------------------------------------------  416 (606)
T ss_dssp             ECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTT--------------------------------------------
T ss_pred             ECCCCcccc-chhhccCCCCCCeeECCCCccCCccC--------------------------------------------
Confidence            999999986 56889999999999999888653221                                            


Q ss_pred             CCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCccc
Q 048205          474 NSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDIL  553 (1027)
Q Consensus       474 ~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~  553 (1027)
                              ...++++++|++|++++|++++..|..++++++|++|+|++|++++.            .+|..+..+++|+
T Consensus       417 --------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------~~~~~~~~l~~L~  476 (606)
T 3vq2_A          417 --------FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN------------TLSNVFANTTNLT  476 (606)
T ss_dssp             --------TTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG------------EECSCCTTCTTCC
T ss_pred             --------hhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCc------------chHHhhccCCCCC
Confidence                    03455566777777777777777777778888888888888888542            2456677888888


Q ss_pred             EEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccc-cccccccccc
Q 048205          554 CLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMI-NLKSLNLSNN  632 (1027)
Q Consensus       554 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~-~L~~L~l~~N  632 (1027)
                      .|++++|.+++..|..++.+++|+.|++++|++++.+|..|+++++|++|+|++|+++ .+|..+..++ +|++|++++|
T Consensus       477 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N  555 (606)
T 3vq2_A          477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNN  555 (606)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSC
T ss_pred             EEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCC
Confidence            9999999889888889999999999999999999988999999999999999999999 7999899987 6999999999


Q ss_pred             cccCCch
Q 048205          633 NLFGIIP  639 (1027)
Q Consensus       633 ~l~~~~p  639 (1027)
                      ++.+..+
T Consensus       556 ~~~c~c~  562 (606)
T 3vq2_A          556 SVACICE  562 (606)
T ss_dssp             CCCCSST
T ss_pred             CcccCCc
Confidence            9987655

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-55  Score=550.95  Aligned_cols=539  Identities=22%  Similarity=0.198  Sum_probs=324.1

Q ss_pred             EEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeC-cccccCCCCCCEEEccCc
Q 048205            6 YLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEI-PEELGNLAELEELWLQNN   84 (1027)
Q Consensus         6 ~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~-p~~l~~l~~L~~L~L~~N   84 (1027)
                      ..+.++++++ .+|.   ..++|++|||++|.|++..|..++.+++|++|+|++|...+.+ |..|+++++|++|+|++|
T Consensus         8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            4555666666 3443   3356666666666666555666666666666666666433333 556666666666666666


Q ss_pred             ccCCccCccccCCCCCCeEeCCcccccccch-hhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccccc
Q 048205           85 FLTGTIPSSIFNLSSLSNLDLSVNNLTGELL-ANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDI  163 (1027)
Q Consensus        85 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  163 (1027)
                      .+++..|..|.++++|++|+|++|++++.++ ...                        |..+++|++|+|++|.+++..
T Consensus        84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~------------------------~~~L~~L~~L~Ls~N~l~~~~  139 (844)
T 3j0a_A           84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY------------------------FRNLKALTRLDLSKNQIRSLY  139 (844)
T ss_dssp             CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCC------------------------CSSCSSCCEEEEESCCCCCCC
T ss_pred             cCcccCHhHccCCcccCEeeCcCCCCCcccccCcc------------------------ccccCCCCEEECCCCcccccc
Confidence            6665556666666666666666666654222 122                        445555555555555554432


Q ss_pred             C-ccccCCCCCcEEEccCccCCCCCChhccCC--CCCCeeeccccccCCCCCccccCCCC------CCEEEccCccCCCC
Q 048205          164 P-KEIGNLTKLKYLHLDQNRLQGEIPEELGNL--AELEKLQLQNNFLTGTIPPSIFNLSS------LSDLELSFNSLTGN  234 (1027)
Q Consensus       164 p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~  234 (1027)
                      + ..|+++++|++|+|++|.+++..+..+..+  ++|+.|++++|.+.+..|..+..+.+      |+.|++++|.+++.
T Consensus       140 ~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~  219 (844)
T 3j0a_A          140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD  219 (844)
T ss_dssp             CCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTT
T ss_pred             cchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchh
Confidence            2 345555555555555555555555555544  55555555555555555544444433      66666666666544


Q ss_pred             CCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCc
Q 048205          235 FPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL  314 (1027)
Q Consensus       235 ~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  314 (1027)
                      .+..+..      .      -....++.+.++.+.+..                        .+..|++....+..|.++
T Consensus       220 ~~~~~~~------~------l~~~~l~~L~l~~~~~~~------------------------~~~~~~l~~~~~~~f~~l  263 (844)
T 3j0a_A          220 ITGNFSN------A------ISKSQAFSLILAHHIMGA------------------------GFGFHNIKDPDQNTFAGL  263 (844)
T ss_dssp             TTSGGGG------T------SCSCCBSEEECCSSCCBC------------------------SSSCSSSTTGGGTTTTTT
T ss_pred             HHHHHHh------h------cCcccccceecccccccc------------------------cccccccCCCChhhhhcc
Confidence            4332210      0      011335555555333221                        111222222223333333


Q ss_pred             --CcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCe
Q 048205          315 --HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLST  392 (1027)
Q Consensus       315 --~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  392 (1027)
                        ++|+.|++++|.+.+..+..|..+++|+.|+|++|++.+..| ..+..+++|++|+|++|++++..|..|.++++|+.
T Consensus       264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  342 (844)
T 3j0a_A          264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD-EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY  342 (844)
T ss_dssp             TTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT-TTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred             ccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh-HHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence              455555555555555555555556666666666665543333 23345666666666666666666666666777777


Q ss_pred             eecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeec
Q 048205          393 LELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHM  472 (1027)
Q Consensus       393 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l  472 (1027)
                      |++++|++.++.+..|..+++|++|+|++|.++.++.         ++.|+.|++++|+++.++..              
T Consensus       343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~---------~~~L~~L~l~~N~l~~l~~~--------------  399 (844)
T 3j0a_A          343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF---------IPSIPDIFLSGNKLVTLPKI--------------  399 (844)
T ss_dssp             EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS---------CCSCSEEEEESCCCCCCCCC--------------
T ss_pred             EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC---------CCCcchhccCCCCccccccc--------------
Confidence            7777777766666667777777777777777665432         45566677777766533211              


Q ss_pred             CCCccccccCcccccccccceEEecCccccCc-hhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCc
Q 048205          473 PNSNISGSIPKEINNLTNLIAIYLGVNKLNGS-ILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKD  551 (1027)
Q Consensus       473 ~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~  551 (1027)
                                     ..+++.|++++|++++. .+..+.++++|++|+|++|++++..+.            ..+..+++
T Consensus       400 ---------------~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~------------~~~~~~~~  452 (844)
T 3j0a_A          400 ---------------NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD------------QTPSENPS  452 (844)
T ss_dssp             ---------------CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSS------------SSSCSCTT
T ss_pred             ---------------ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccc------------cccccCCc
Confidence                           12455555666665543 223455677777777777776543221            11233566


Q ss_pred             ccEEecCCCccc-----cCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccc
Q 048205          552 ILCLNLSLNFFT-----GPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKS  626 (1027)
Q Consensus       552 L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~  626 (1027)
                      |+.|+|++|.++     +..|..+..+++|+.|+|++|++++.+|..|+++++|+.|+|++|+|++..|..+.  ++|+.
T Consensus       453 L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~  530 (844)
T 3j0a_A          453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEI  530 (844)
T ss_dssp             CCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCE
T ss_pred             cccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccE
Confidence            777777777776     44556788899999999999999988888899999999999999999965555554  88999


Q ss_pred             cccccccccCCchhhhhcccCCcceeccCCCCCCCCCC
Q 048205          627 LNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       627 L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~  664 (1027)
                      |||++|+|+|.+|..+   .+|+.+++++|++....+.
T Consensus       531 L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          531 LDISRNQLLAPNPDVF---VSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             EEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred             EECCCCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence            9999999999998765   4788999999999876653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=535.94  Aligned_cols=542  Identities=23%  Similarity=0.260  Sum_probs=398.4

Q ss_pred             EEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCc
Q 048205           55 LHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENN  134 (1027)
Q Consensus        55 L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~  134 (1027)
                      .+.++++++ .+|.   -.++|++|+|++|.|++..|..|.++++|++|+|++|...+.+++..+.++++|++|+|++|.
T Consensus         9 ~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~   84 (844)
T 3j0a_A            9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK   84 (844)
T ss_dssp             EEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred             EEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence            344444444 3443   224455555555555544455555555555555555544444444555555566666666666


Q ss_pred             CCccCcccccCCCCCcEEEccCCccccccCcc--ccCCCCCcEEEccCccCCCCCC-hhccCCCCCCeeeccccccCCCC
Q 048205          135 FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE--IGNLTKLKYLHLDQNRLQGEIP-EELGNLAELEKLQLQNNFLTGTI  211 (1027)
Q Consensus       135 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~  211 (1027)
                      +.+..|..|.++++|++|+|++|.+++..|..  |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..
T Consensus        85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~  164 (844)
T 3j0a_A           85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC  164 (844)
T ss_dssp             CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred             CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence            66677888889999999999999998755554  8899999999999999987655 57889999999999999998888


Q ss_pred             CccccCC--CCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccC
Q 048205          212 PPSIFNL--SSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGN  289 (1027)
Q Consensus       212 p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~  289 (1027)
                      +..+..+  ++|+.|++++|.+++..|..+..       .+. .+.. ..|+.|++++|.+++.+|..+..     .+ .
T Consensus       165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~-------~~~-~~~~-~~L~~L~Ls~n~l~~~~~~~~~~-----~l-~  229 (844)
T 3j0a_A          165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGK-------CMN-PFRN-MVLEILDVSGNGWTVDITGNFSN-----AI-S  229 (844)
T ss_dssp             SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCS-------SSC-TTTT-CCBSEEBCSSCCSSTTTTSGGGG-----TS-C
T ss_pred             HHHcccccCCccceEECCCCccccccccchhh-------cCC-cccc-CceeEEecCCCcCchhHHHHHHh-----hc-C
Confidence            8888877  88899999999888655543210       000 1111 24777888888777655543321     11 1


Q ss_pred             cCCccceeccCccccccCCccccCcCcccceeccCcccccccCcccccc--CCcceEEccCccccccCCCCccCCCCCcc
Q 048205          290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNV--STLKFLYLGSNSFFGRLPSSADVRLPNLE  367 (1027)
Q Consensus       290 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  367 (1027)
                      ..+++.|.++.+.+..               .++.|.+.+..+..|.++  ++|+.|++++|.+.+. +...+..+++|+
T Consensus       230 ~~~l~~L~l~~~~~~~---------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~  293 (844)
T 3j0a_A          230 KSQAFSLILAHHIMGA---------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL-NSRVFETLKDLK  293 (844)
T ss_dssp             SCCBSEEECCSSCCBC---------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEE-CSCCSSSCCCCC
T ss_pred             cccccceecccccccc---------------cccccccCCCChhhhhccccCCccEEECCCCccccc-ChhhhhcCCCCC
Confidence            2456666666443321               223455555556666665  6788899988888644 444456788889


Q ss_pred             EEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeec
Q 048205          368 ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSI  447 (1027)
Q Consensus       368 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~L  447 (1027)
                      +|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++.++..    .+..+++|++|+|
T Consensus       294 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~L  369 (844)
T 3j0a_A          294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ----TFKFLEKLQTLDL  369 (844)
T ss_dssp             EEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSS----CSCSCCCCCEEEE
T ss_pred             EEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChh----hhcCCCCCCEEEC
Confidence            999998888888888888888889999999888888888888888888888888888776654    2356788888888


Q ss_pred             cCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeec
Q 048205          448 SNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEG  527 (1027)
Q Consensus       448 s~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g  527 (1027)
                      ++|.++++                              ..+++|+.|++++|+++. +|..   ..+++.|++++|++++
T Consensus       370 s~N~l~~i------------------------------~~~~~L~~L~l~~N~l~~-l~~~---~~~l~~L~ls~N~l~~  415 (844)
T 3j0a_A          370 RDNALTTI------------------------------HFIPSIPDIFLSGNKLVT-LPKI---NLTANLIHLSENRLEN  415 (844)
T ss_dssp             ETCCSCCC------------------------------SSCCSCSEEEEESCCCCC-CCCC---CTTCCEEECCSCCCCS
T ss_pred             CCCCCCcc------------------------------cCCCCcchhccCCCCccc-cccc---ccccceeecccCcccc
Confidence            88887632                              125678899999999983 4433   5689999999999964


Q ss_pred             ccCCCCCccccccccCccccccCcccEEecCCCccccCccc-cccCcccccEEcccccccc-----cccchhhccCcccc
Q 048205          528 SIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPL-EIGNLKVLVQIDLSINNFS-----DVIPTTIGGLKDLQ  601 (1027)
Q Consensus       528 ~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~n~l~-----~~~p~~~~~l~~L~  601 (1027)
                      .            ..+..++++++|+.|+|++|.+++..+. .+..+++|+.|++++|.++     +..|..|+++++|+
T Consensus       416 l------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~  483 (844)
T 3j0a_A          416 L------------DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ  483 (844)
T ss_dssp             S------------TTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEE
T ss_pred             C------------chhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccccc
Confidence            2            1233456889999999999999975443 4567899999999999997     44567799999999


Q ss_pred             EEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCCCCCCCCcccccccCCcc
Q 048205          602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNEL  681 (1027)
Q Consensus       602 ~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~  681 (1027)
                      .|+|++|+|++.+|..++.+++|+.|+|++|+|++..|..+.  ++|+.|++++|+++|.+|.  .|.++....+.||+.
T Consensus       484 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~  559 (844)
T 3j0a_A          484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKF  559 (844)
T ss_dssp             CCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECC
T ss_pred             EEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCc
Confidence            999999999988888899999999999999999988777766  8999999999999999996  466777778889988


Q ss_pred             ccCC
Q 048205          682 LCGM  685 (1027)
Q Consensus       682 l~g~  685 (1027)
                      .|.-
T Consensus       560 ~C~c  563 (844)
T 3j0a_A          560 ICEC  563 (844)
T ss_dssp             CCSS
T ss_pred             cccc
Confidence            8843

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-51  Score=494.73  Aligned_cols=519  Identities=21%  Similarity=0.216  Sum_probs=308.7

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      +.++.++..++ .+|..+.  +++++|+|++|++++..+.+|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n   86 (570)
T 2z63_A           10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (570)
T ss_dssp             TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence            34555555555 4554443  34555555555555555555555555555555555555544555555555555555555


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccc-ccCccccCCCCCcEEEccCccCCCCC
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG-DIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      +++ .++...+.++++|++|++++|++++..+..|.++++|++|++++|.+++ .+|..|+++++|++|++++|++++..
T Consensus        87 ~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~  165 (570)
T 2z63_A           87 PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (570)
T ss_dssp             CCC-EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred             cCC-ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence            554 2333444555555555555555554444455666666666666666654 24556666666666666666666555


Q ss_pred             ChhccCCCCC----CeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEE
Q 048205          188 PEELGNLAEL----EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEI  263 (1027)
Q Consensus       188 p~~~~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L  263 (1027)
                      +..++.+.+|    +.|++++|.+++..|..|..+ +|+.|++++|.....             .+ ...+..++.++.+
T Consensus       166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~-------------~~-~~~~~~l~~l~~~  230 (570)
T 2z63_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLN-------------VM-KTCIQGLAGLEVH  230 (570)
T ss_dssp             GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTT-------------HH-HHHHHTTTTCEEE
T ss_pred             HHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEeccccccccc-------------ch-hhhhcCcccccee
Confidence            5555555555    556666666665444444443 566666665543210             00 0111223333333


Q ss_pred             EeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcC--cccceeccCc-ccccccCccccccCC
Q 048205          264 YLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH--NLEWMIFSFN-KLVGVVPTTIFNVST  340 (1027)
Q Consensus       264 ~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N-~l~~~~~~~~~~l~~  340 (1027)
                      .+..+.+..                 ...          +..+....+..+.  .++.+++++| .+.+..|..+..+++
T Consensus       231 ~l~~~~~~~-----------------~~~----------l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~  283 (570)
T 2z63_A          231 RLVLGEFRN-----------------EGN----------LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN  283 (570)
T ss_dssp             EEEEEECCC-----------------CSS----------CEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTT
T ss_pred             eeccccccC-----------------chh----------hhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCc
Confidence            332222210                 000          0111111122221  1333444444 444444444444445


Q ss_pred             cceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecC
Q 048205          341 LKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG  420 (1027)
Q Consensus       341 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  420 (1027)
                      |++|++++|.+. .+|.... .+ +|++|++++|.+. .+|.  ..+++|+.|++++|.+.+..+.  ..+         
T Consensus       284 L~~L~l~~~~l~-~l~~~~~-~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~---------  346 (570)
T 2z63_A          284 VSSFSLVSVTIE-RVKDFSY-NF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDL---------  346 (570)
T ss_dssp             CSEEEEESCEEC-SCCBCCS-CC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBC---------
T ss_pred             ccEEEecCccch-hhhhhhc-cC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccC---------
Confidence            555555444443 2333322 22 4444444444444 2332  2344444444444444433222  333         


Q ss_pred             CCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCcc
Q 048205          421 DNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNK  500 (1027)
Q Consensus       421 ~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~  500 (1027)
                                         ++|++|++++|++++.                       +..|..+..+++|++|++++|+
T Consensus       347 -------------------~~L~~L~l~~n~l~~~-----------------------~~~~~~~~~~~~L~~L~l~~n~  384 (570)
T 2z63_A          347 -------------------PSLEFLDLSRNGLSFK-----------------------GCCSQSDFGTTSLKYLDLSFNG  384 (570)
T ss_dssp             -------------------TTCCEEECCSSCCBEE-----------------------EEEEHHHHTCSCCCEEECCSCS
T ss_pred             -------------------CCCCEEeCcCCccCcc-----------------------ccccccccccCccCEEECCCCc
Confidence                               4444444444444311                       1124556667777888888887


Q ss_pred             ccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEc
Q 048205          501 LNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQID  580 (1027)
Q Consensus       501 l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  580 (1027)
                      +++..+. +.++++|++|++++|++.+..|            +..+.++++|++|++++|.+++..|..++.+++|+.|+
T Consensus       385 l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  451 (570)
T 2z63_A          385 VITMSSN-FLGLEQLEHLDFQHSNLKQMSE------------FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK  451 (570)
T ss_dssp             EEEEEEE-EETCTTCCEEECTTSEEESCTT------------SCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred             ccccccc-ccccCCCCEEEccCCccccccc------------hhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence            7765444 8888888888888888865432            13466788899999999999988899999999999999


Q ss_pred             ccccccc-cccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCC
Q 048205          581 LSINNFS-DVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE  659 (1027)
Q Consensus       581 ls~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  659 (1027)
                      +++|+++ +.+|..++.+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|+.|++++|+++
T Consensus       452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  531 (570)
T 2z63_A          452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD  531 (570)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCccc
Confidence            9999998 679999999999999999999999888999999999999999999999998888999999999999999999


Q ss_pred             CCCCCC
Q 048205          660 GEIPRE  665 (1027)
Q Consensus       660 g~~p~~  665 (1027)
                      |.+|..
T Consensus       532 ~~~~~~  537 (570)
T 2z63_A          532 CSCPRI  537 (570)
T ss_dssp             CCTTTT
T ss_pred             CCCcch
Confidence            998864

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=489.78  Aligned_cols=518  Identities=21%  Similarity=0.198  Sum_probs=372.5

Q ss_pred             CcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccC
Q 048205            4 LEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQN   83 (1027)
Q Consensus         4 l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~   83 (1027)
                      .+.++-++.+++ .+|..+.  +++++|+|++|.+++..+..|..+++|++|+|++|++++..|+.|+++++|++|+|++
T Consensus         9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~   85 (570)
T 2z63_A            9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG   85 (570)
T ss_dssp             TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence            356777888888 5676554  6899999999999988888999999999999999999988889999999999999999


Q ss_pred             cccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCcc-CcccccCCCCCcEEEccCCccccc
Q 048205           84 NFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK-IPSTLLRCKHLQTLSLSINDFSGD  162 (1027)
Q Consensus        84 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~  162 (1027)
                      |++++..|..|..+++|++|++++|+++ .++...+..+++|++|++++|.+++. +|..|.++++|++|++++|.+++.
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~  164 (570)
T 2z63_A           86 NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI  164 (570)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred             CcCCccCHhhhcCccccccccccccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence            9999888899999999999999999998 45555588999999999999999874 689999999999999999999988


Q ss_pred             cCccccCCCCC----cEEEccCccCCCCCChhccCCCCCCeeeccccccCC-CCCccccCCCCCCEEEccCccCCCCCCc
Q 048205          163 IPKEIGNLTKL----KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG-TIPPSIFNLSSLSDLELSFNSLTGNFPK  237 (1027)
Q Consensus       163 ~p~~~~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  237 (1027)
                      .+..|+.+++|    +.|++++|.+++..|..|... +|++|++++|.... .++..+.++++++.+.+..+.+...-. 
T Consensus       165 ~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~-  242 (570)
T 2z63_A          165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN-  242 (570)
T ss_dssp             CGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS-
T ss_pred             cHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchh-
Confidence            88899999998    899999999998888888776 89999999986542 345677888888888776655431100 


Q ss_pred             chhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCc-cccccCCccccCcCc
Q 048205          238 DMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFN-RLQCVIPHEIDNLHN  316 (1027)
Q Consensus       238 ~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~  316 (1027)
                              ...++...+..++.                              + .++.+++++| .+.+..|..|..+++
T Consensus       243 --------l~~~~~~~~~~l~~------------------------------l-~l~~l~l~~~~~~~~~~~~~~~~l~~  283 (570)
T 2z63_A          243 --------LEKFDKSALEGLCN------------------------------L-TIEEFRLAYLDYYLDDIIDLFNCLTN  283 (570)
T ss_dssp             --------CEECCTTTTGGGGG------------------------------S-EEEEEEEEETTEEESCSTTTTGGGTT
T ss_pred             --------hhhcchhhhccccc------------------------------c-chhhhhhhcchhhhhhchhhhcCcCc
Confidence                    00112111211111                              1 2445555555 555555666666666


Q ss_pred             ccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecC
Q 048205          317 LEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQ  396 (1027)
Q Consensus       317 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  396 (1027)
                      |+.|++++|.+.+ .|..+..+ +|++|++++|.+. .+|..   .+++|++|++++|.+.+..+.  ..+++|++|+++
T Consensus       284 L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~-~l~~~---~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~  355 (570)
T 2z63_A          284 VSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFG-QFPTL---KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLS  355 (570)
T ss_dssp             CSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCS-SCCBC---BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECC
T ss_pred             ccEEEecCccchh-hhhhhccC-CccEEeeccCccc-ccCcc---cccccCEEeCcCCcccccccc--ccCCCCCEEeCc
Confidence            6666666666663 45555556 6777777777664 45542   456777777777777655444  567777777777


Q ss_pred             CCcccCCC--CcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCC
Q 048205          397 RNSFSGFI--PNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPN  474 (1027)
Q Consensus       397 ~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~  474 (1027)
                      +|++++..  |..+..+++|++|++++|.++.++..     +..+++|++|++++|++++.++                 
T Consensus       356 ~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-----~~~l~~L~~L~l~~n~l~~~~~-----------------  413 (570)
T 2z63_A          356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-----FLGLEQLEHLDFQHSNLKQMSE-----------------  413 (570)
T ss_dssp             SSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-----EETCTTCCEEECTTSEEESCTT-----------------
T ss_pred             CCccCccccccccccccCccCEEECCCCcccccccc-----ccccCCCCEEEccCCccccccc-----------------
Confidence            77776543  56666777777777777765543322     1233444444444443332211                 


Q ss_pred             CccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccE
Q 048205          475 SNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILC  554 (1027)
Q Consensus       475 n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~  554 (1027)
                             +..+.++++|++|++++|++++..|..|.+                                     +++|++
T Consensus       414 -------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-------------------------------------l~~L~~  449 (570)
T 2z63_A          414 -------FSVFLSLRNLIYLDISHTHTRVAFNGIFNG-------------------------------------LSSLEV  449 (570)
T ss_dssp             -------SCTTTTCTTCCEEECTTSCCEECCTTTTTT-------------------------------------CTTCCE
T ss_pred             -------hhhhhcCCCCCEEeCcCCcccccchhhhhc-------------------------------------CCcCcE
Confidence                   022334444555555555544444444444                                     445555


Q ss_pred             EecCCCccc-cCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccccccccccc
Q 048205          555 LNLSLNFFT-GPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNN  633 (1027)
Q Consensus       555 L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~  633 (1027)
                      |++++|.++ +.+|..++.+++|+.|++++|++++..|..|+.+++|++|+|++|++++..|..++.+++|+.|++++|+
T Consensus       450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~  529 (570)
T 2z63_A          450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP  529 (570)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCc
Confidence            555555554 4567777788888888888888887778888888888888888888887666778888888888888888


Q ss_pred             ccCCchh
Q 048205          634 LFGIIPI  640 (1027)
Q Consensus       634 l~~~~p~  640 (1027)
                      +++..|.
T Consensus       530 ~~~~~~~  536 (570)
T 2z63_A          530 WDCSCPR  536 (570)
T ss_dssp             BCCCTTT
T ss_pred             ccCCCcc
Confidence            8887764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-51  Score=448.76  Aligned_cols=254  Identities=30%  Similarity=0.449  Sum_probs=213.3

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++++|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45778899999999999999864      478899999987666667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          824 VLEYMPYGSLEKCLYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                      |||||++|+|.++++..+            ..++|.++..|+.|||+||+|||   +++||||||||+|||++.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642            46899999999999999999999   899999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||......  .+...+    
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i----  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECI----  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHH----
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH----
Confidence            99999987654443334445579999999999999999999999999999999999 89999764321  111111    


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                             ....       ....+..++.++.+|+.+||+.||++|||++||.+.|+
T Consensus       244 -------~~~~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          244 -------TQGR-------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             -------HHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HcCC-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                   1111       11223467888999999999999999999999998876

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.5e-51  Score=450.95  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=206.2

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ++|...+.||+|+||+||+|+++      +++.||||+++.......+.|.+|++++++++|||||+++++|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999864      478899999987666667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC--------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          824 VLEYMPYGSLEKCLYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      |||||++|+|.++++...              ..++|.++..|+.|||+||+|||   +++||||||||+|||++.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999987542              35899999999999999999999   8999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||+|+.+...+........+||+.|||||++.+..++.++|||||||++|||+| |+.||......+  ....   
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~---  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDC---  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHH---
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHH---
Confidence            9999999997654444444455679999999999999999999999999999999999 899997643211  1111   


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                               +...      .+...+..+++++.+|+.+||+.||++||||+||++.|+
T Consensus       273 ---------i~~g------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          273 ---------ITQG------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             ---------HHHT------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred             ---------HHcC------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence                     1010      112234567888999999999999999999999999886

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=441.07  Aligned_cols=257  Identities=28%  Similarity=0.416  Sum_probs=204.8

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||+||+|++++  .||||+++..  ..+..+.|.+|++++++++|||||+++++|.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4568888999999999999998763  5999998643  23456789999999999999999999999865 56899999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      ||+||+|.++++..+..+++.++..|+.|||+||+|||   +++||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999887777999999999999999999999   899999999999999999999999999999876543333


Q ss_pred             ceecccccCccccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          907 LTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      ......+||+.|||||++.+   ++|+.++|||||||++|||+||+.||........ +...            +.....
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~------------~~~~~~  255 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFM------------VGRGYA  255 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH------------HHTTCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHH------------HhcCCC
Confidence            34455689999999999863   4689999999999999999999999976432211 1111            111110


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .  ......+..++.++.+|+.+||+.||++||||+||++.|+
T Consensus       256 ~--p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          256 S--PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             C--CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             C--CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            0  0011223467888999999999999999999999998875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7e-51  Score=445.09  Aligned_cols=254  Identities=24%  Similarity=0.415  Sum_probs=212.3

Q ss_pred             CCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      +++..+.||+|+||+||+|++.      +++.||||+++... ....+.|.+|++++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3566789999999999999863      46789999986443 3345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 048205          824 VLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV  888 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  888 (1027)
                      |||||++|+|.+++....               ..++|.++..|+.|||+||+|||   +++||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996532               35899999999999999999999   999999999999999999999


Q ss_pred             EEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHH
Q 048205          889 AHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVN  967 (1027)
Q Consensus       889 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  967 (1027)
                      +||+|||+|+.+...+........+||+.|||||++.++.++.++|||||||++|||+| |+.||.+....  .+...  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~--  259 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEM--  259 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHH--
Confidence            99999999997655444444455689999999999999999999999999999999999 89999764321  11111  


Q ss_pred             HHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          968 DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       968 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                                +...      ...+.+..++.++.+|+.+||+.||++||||+||++.|++
T Consensus       260 ----------i~~~------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          260 ----------IRNR------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             ----------HHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ----------HHcC------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                      1111      1112345688889999999999999999999999999975

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.3e-49  Score=479.10  Aligned_cols=473  Identities=18%  Similarity=0.182  Sum_probs=319.5

Q ss_pred             CCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeec
Q 048205          123 PLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQL  202 (1027)
Q Consensus       123 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  202 (1027)
                      ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus        26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  105 (549)
T 2z81_A           26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL  105 (549)
T ss_dssp             TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred             CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence            34555555555555566667777777777777777777666677777777777777777777666666777777777777


Q ss_pred             cccccCCC-CCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCC
Q 048205          203 QNNFLTGT-IPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNC  281 (1027)
Q Consensus       203 ~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  281 (1027)
                      ++|.+++. .|..+.++++|++|++++|++.+              .+|...+..+++|++|++++|.+++.        
T Consensus       106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~--------------~~~~~~~~~l~~L~~L~L~~n~l~~~--------  163 (549)
T 2z81_A          106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS--------------EIRRIDFAGLTSLNELEIKALSLRNY--------  163 (549)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC--------------EECTTTTTTCCEEEEEEEEETTCCEE--------
T ss_pred             CCCcccccchhhhhhccCCccEEECCCCcccc--------------ccCHhhhhcccccCeeeccCCccccc--------
Confidence            77777753 45667777777777777776432              23333444555555555555555542        


Q ss_pred             CCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccC
Q 048205          282 TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADV  361 (1027)
Q Consensus       282 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  361 (1027)
                       +|..++.+++|++|++++|.+.......+..+++|++|++++|++++...                      .|.....
T Consensus       164 -~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----------------------~~~~~~~  220 (549)
T 2z81_A          164 -QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF----------------------SPLPVDE  220 (549)
T ss_dssp             -CTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCC----------------------CCCSSCC
T ss_pred             -ChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccc----------------------cccchhh
Confidence             22334444555555555555543222222334444444444444443210                      0122222


Q ss_pred             CCCCccEEEccccccCCcCc----ccccCCCCCCeeecCCCcccCCC------CcccCCcccccEEecCCCCCCCCCCcc
Q 048205          362 RLPNLEELSLSGNNFSGTIP----SFIFNTSKLSTLELQRNSFSGFI------PNTFGNLRNLKWLDLGDNYLTSSTSEL  431 (1027)
Q Consensus       362 ~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~~~~l  431 (1027)
                      .+++|+.|++++|.+++..+    ..+..+++|+.|++++|.+.+..      ...+..+++|+.|++++|.+.......
T Consensus       221 ~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~  300 (549)
T 2z81_A          221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY  300 (549)
T ss_dssp             CCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSC
T ss_pred             hhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcc
Confidence            34556666666665554322    22344556666666666665431      123455666777777777655432110


Q ss_pred             ccc-cccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccC---cccccccccceEEecCccccCchh-
Q 048205          432 SFL-SSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIP---KEINNLTNLIAIYLGVNKLNGSIL-  506 (1027)
Q Consensus       432 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~-  506 (1027)
                      ..- .....+.|++|++++|.++.++...+..+ ..++.|++++|.+.+.+|   ..++.+++|++|++++|++++..+ 
T Consensus       301 ~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  379 (549)
T 2z81_A          301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHL-KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT  379 (549)
T ss_dssp             CCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHC-TTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHH
T ss_pred             cchhhhhhcccceEEEeccCccccCCHHHHhcC-ccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccc
Confidence            000 01224567777777777765544433333 357777777787877664   447889999999999999997654 


Q ss_pred             -HhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccc
Q 048205          507 -IALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINN  585 (1027)
Q Consensus       507 -~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~  585 (1027)
                       ..+..+++|++|+|++|+++              .+|..++.+++|++|++++|.+++ +|..+  .++|+.||+++|+
T Consensus       380 ~~~~~~l~~L~~L~Ls~N~l~--------------~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~  442 (549)
T 2z81_A          380 GEILLTLKNLTSLDISRNTFH--------------PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNN  442 (549)
T ss_dssp             HHHGGGCTTCCEEECTTCCCC--------------CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSC
T ss_pred             hhhhhcCCCCCEEECCCCCCc--------------cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCC
Confidence             67999999999999999984              567788889999999999999985 66554  3689999999999


Q ss_pred             cccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCC
Q 048205          586 FSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       586 l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~  664 (1027)
                      +++.+    +.+++|++|+|++|+|+ .||+ .+.+++|++|+|++|++++.+|..+..+++|+.|++++|++.+..|.
T Consensus       443 l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          443 LDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             CSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             hhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            99743    67899999999999999 7987 57899999999999999999999999999999999999999998874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.2e-50  Score=483.48  Aligned_cols=495  Identities=18%  Similarity=0.155  Sum_probs=262.4

Q ss_pred             EecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCccc
Q 048205            7 LFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFL   86 (1027)
Q Consensus         7 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l   86 (1027)
                      .|.++++++ .+|..+.  ++|++|+|++|++++..|..++.+++|++|+|++|++++..|+.|+++++|++|+|++|++
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            444444444 3333332  4455555555555444444455555555555555555444444445555555555555555


Q ss_pred             CCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCc-cccccCc
Q 048205           87 TGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIND-FSGDIPK  165 (1027)
Q Consensus        87 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~  165 (1027)
                      ++..|..|+++++|++|++++|++++.                        ..|..|.++++|++|++++|. +....+.
T Consensus        87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~------------------------~~~~~~~~l~~L~~L~L~~n~~~~~~~~~  142 (549)
T 2z81_A           87 SSLSSSWFGPLSSLKYLNLMGNPYQTL------------------------GVTSLFPNLTNLQTLRIGNVETFSEIRRI  142 (549)
T ss_dssp             CSCCHHHHTTCTTCCEEECTTCCCSSS------------------------CSSCSCTTCTTCCEEEEEESSSCCEECTT
T ss_pred             CccCHHHhccCCCCcEEECCCCccccc------------------------chhhhhhccCCccEEECCCCccccccCHh
Confidence            444444444444444444444444421                        123445555555555555554 2222223


Q ss_pred             cccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccc-cCCCCCCEEEccCccCCCCCCcchhhhhh
Q 048205          166 EIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSI-FNLSSLSDLELSFNSLTGNFPKDMHIVNR  244 (1027)
Q Consensus       166 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  244 (1027)
                      .|.++++|++|++++|++++..|..++.+++|++|++++|.+. .+|..+ ..+++|++|++++|++++..         
T Consensus       143 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~---------  212 (549)
T 2z81_A          143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQ---------  212 (549)
T ss_dssp             TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCC---------
T ss_pred             hhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCcccccc---------
Confidence            4555555555555555555545555555555555555555554 223222 33555555555555554211         


Q ss_pred             ccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccC
Q 048205          245 LSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSF  324 (1027)
Q Consensus       245 ~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  324 (1027)
                         ..+......++.|+.|++++|.+++..+.     .++..+..+++|+.+++++|.+.+...-..             
T Consensus       213 ---~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-----~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~-------------  271 (549)
T 2z81_A          213 ---FSPLPVDEVSSPMKKLAFRGSVLTDESFN-----ELLKLLRYILELSEVEFDDCTLNGLGDFNP-------------  271 (549)
T ss_dssp             ---CCCCSSCCCCCCCCEEEEESCEEEHHHHH-----HHHGGGGGCTTCCEEEEESCEEECCSCCCC-------------
T ss_pred             ---ccccchhhhhhcccceeccccccchhHHH-----HHHHHhhhhccccccccccccccccccccc-------------
Confidence               00111222334455555555554432221     112223344455555555555443211000             


Q ss_pred             cccccccCccccccCCcceEEccCccccccCC----CCccCCCCCccEEEccccccCCcCcccc-cCCCCCCeeecCCCc
Q 048205          325 NKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLP----SSADVRLPNLEELSLSGNNFSGTIPSFI-FNTSKLSTLELQRNS  399 (1027)
Q Consensus       325 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~  399 (1027)
                           .....+..+.+|+.|++.++.+.....    ...+...++|++|++++|++. .+|..+ .++++|++|+|++|+
T Consensus       272 -----~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~  345 (549)
T 2z81_A          272 -----SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENL  345 (549)
T ss_dssp             -----CTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSC
T ss_pred             -----cchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCc
Confidence                 000112233344444444443321100    000112356788888888876 566555 467888888888888


Q ss_pred             ccCCCC---cccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCc
Q 048205          400 FSGFIP---NTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSN  476 (1027)
Q Consensus       400 l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~  476 (1027)
                      +++..|   ..++.+++|++|+|++|++++++..-.  .+..+++|++|++++|+++                       
T Consensus       346 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~~~l~~L~~L~Ls~N~l~-----------------------  400 (549)
T 2z81_A          346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE--ILLTLKNLTSLDISRNTFH-----------------------  400 (549)
T ss_dssp             CCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHH--HGGGCTTCCEEECTTCCCC-----------------------
T ss_pred             cccccccchhhhhccccCcEEEccCCcccccccchh--hhhcCCCCCEEECCCCCCc-----------------------
Confidence            876553   347778888888888888765432100  1233445555555555443                       


Q ss_pred             cccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEe
Q 048205          477 ISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLN  556 (1027)
Q Consensus       477 ~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~  556 (1027)
                                                 .+|..+..+++|++|+|++|++++              +|..+  .++|++|+
T Consensus       401 ---------------------------~lp~~~~~~~~L~~L~Ls~N~l~~--------------l~~~~--~~~L~~L~  437 (549)
T 2z81_A          401 ---------------------------PMPDSCQWPEKMRFLNLSSTGIRV--------------VKTCI--PQTLEVLD  437 (549)
T ss_dssp             ---------------------------CCCSCCCCCTTCCEEECTTSCCSC--------------CCTTS--CTTCSEEE
T ss_pred             ---------------------------cCChhhcccccccEEECCCCCccc--------------ccchh--cCCceEEE
Confidence                                       223333334445555555555421              11111  13567777


Q ss_pred             cCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccC
Q 048205          557 LSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFG  636 (1027)
Q Consensus       557 Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~  636 (1027)
                      +++|++++.+    +.+++|++|||++|+++ .+|. .+.+++|++|+|++|++++.+|..++.+++|+.|+|++|++++
T Consensus       438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  511 (549)
T 2z81_A          438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  511 (549)
T ss_dssp             CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred             CCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence            7777777632    46788999999999998 6787 5778999999999999998778889999999999999999998


Q ss_pred             Cch
Q 048205          637 IIP  639 (1027)
Q Consensus       637 ~~p  639 (1027)
                      ..|
T Consensus       512 ~~~  514 (549)
T 2z81_A          512 SCP  514 (549)
T ss_dssp             CHH
T ss_pred             CCc
Confidence            887

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-50  Score=443.68  Aligned_cols=249  Identities=24%  Similarity=0.308  Sum_probs=212.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ..|+..+.||+|+||+||+|+++ +|+.||||+++.......+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45899999999999999999976 79999999998766666677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +||+|.+++...  .+++.++..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence            999999998764  4899999999999999999999   9999999999999999999999999999998764332  23


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|++||......+  ....           +.+ .    ...
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~-----------i~~-~----~~~  288 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKM-----------IRD-N----LPP  288 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH-----------HHH-S----SCC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHH-----------HHc-C----CCC
Confidence            445789999999999999999999999999999999999999997642211  1110           000 0    011


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....+..++.++.+|+.+||.+||++|||++|+++
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12223456778999999999999999999999986

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9.9e-51  Score=494.45  Aligned_cols=382  Identities=19%  Similarity=0.231  Sum_probs=231.3

Q ss_pred             CCccccccCccccCCCCCcEEEccCccCCCC-----------------CChhcc--CCCCCCeeeccccccCCCCCcccc
Q 048205          156 INDFSGDIPKEIGNLTKLKYLHLDQNRLQGE-----------------IPEELG--NLAELEKLQLQNNFLTGTIPPSIF  216 (1027)
Q Consensus       156 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~  216 (1027)
                      .|.+++ +|..|+++++|++|+|++|++++.                 +|..++  ++++|++|+|++|.+.+.+|..|+
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            567776 777777778888888888877764                 788877  888888888888888888888888


Q ss_pred             CCCCCCEEEccCcc-CCC-CCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCc--cccCcCC
Q 048205          217 NLSSLSDLELSFNS-LTG-NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPK--EIGNLAK  292 (1027)
Q Consensus       217 ~l~~L~~L~Ls~N~-l~~-~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~--~l~~l~~  292 (1027)
                      ++++|++|++++|+ ++| .+|..+..+.         .+..+++|++|++++|+++          .+|.  .++.+++
T Consensus       271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~---------~~~~l~~L~~L~L~~n~l~----------~ip~~~~l~~l~~  331 (636)
T 4eco_A          271 ALPEMQLINVACNRGISGEQLKDDWQALA---------DAPVGEKIQIIYIGYNNLK----------TFPVETSLQKMKK  331 (636)
T ss_dssp             TCSSCCEEECTTCTTSCHHHHHHHHHHHH---------HSGGGGTCCEEECCSSCCS----------SCCCHHHHTTCTT
T ss_pred             cCCCCCEEECcCCCCCccccchHHHHhhh---------ccccCCCCCEEECCCCcCC----------ccCchhhhccCCC
Confidence            88888888888887 775 4554433211         1122355666666666665          3444  5566666


Q ss_pred             ccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCC-cceEEccCccccccCCCCccC-CCCCccEEE
Q 048205          293 LEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST-LKFLYLGSNSFFGRLPSSADV-RLPNLEELS  370 (1027)
Q Consensus       293 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~-~l~~L~~L~  370 (1027)
                      |++|++++|++++.+| .|+.+++|+.|++++|+++ .+|..+.++++ |++|++++|++. .+|..+.. .+++|++|+
T Consensus       332 L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~  408 (636)
T 4eco_A          332 LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAID  408 (636)
T ss_dssp             CCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEE
T ss_pred             CCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEE
Confidence            6666666666665555 6666666666666666666 34445555555 555555555554 44433211 122455555


Q ss_pred             ccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCC
Q 048205          371 LSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNN  450 (1027)
Q Consensus       371 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N  450 (1027)
                      |++|++++.+|..+....                 .....+++|++|+|++|+++.+|..+.    ..+++|++|+|++|
T Consensus       409 Ls~N~l~~~~p~~l~~~~-----------------~~~~~~~~L~~L~Ls~N~l~~lp~~~~----~~l~~L~~L~Ls~N  467 (636)
T 4eco_A          409 FSYNEIGSVDGKNFDPLD-----------------PTPFKGINVSSINLSNNQISKFPKELF----STGSPLSSINLMGN  467 (636)
T ss_dssp             CCSSCTTTTTTCSSCTTC-----------------SSCCCCCCEEEEECCSSCCCSCCTHHH----HTTCCCSEEECCSS
T ss_pred             CcCCcCCCcchhhhcccc-----------------cccccCCCCCEEECcCCccCcCCHHHH----ccCCCCCEEECCCC
Confidence            555555544444444000                 000044455555555555554444322    23455555555555


Q ss_pred             CCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhh--cccccceeeccCceeecc
Q 048205          451 PLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALG--KLKKLQLLSLKDNQLEGS  528 (1027)
Q Consensus       451 ~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~g~  528 (1027)
                      +++.+++..+...                  +..+.++++|++|+|++|+++ .+|..+.  .+++|++|+|++|+++  
T Consensus       468 ~l~~i~~~~~~~~------------------~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~--  526 (636)
T 4eco_A          468 MLTEIPKNSLKDE------------------NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS--  526 (636)
T ss_dssp             CCSBCCSSSSEET------------------TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCS--
T ss_pred             CCCCcCHHHhccc------------------cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCC--
Confidence            5554333322211                  112334456666666666666 4555554  6666666666666663  


Q ss_pred             cCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCC
Q 048205          529 IPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYN  608 (1027)
Q Consensus       529 ~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N  608 (1027)
                                  .+|..++++++|+.|+|++|+                  ++++|++.+.+|..++.+++|++|+|++|
T Consensus       527 ------------~ip~~~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  576 (636)
T 4eco_A          527 ------------KFPTQPLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSN  576 (636)
T ss_dssp             ------------SCCCGGGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSS
T ss_pred             ------------CcChhhhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCC
Confidence                        244455555566666665554                  44677788888888888888888888888


Q ss_pred             ccccCcccccccccccccccccccccc
Q 048205          609 RLQGSIPDSIGDMINLKSLNLSNNNLF  635 (1027)
Q Consensus       609 ~l~g~ip~~~~~l~~L~~L~l~~N~l~  635 (1027)
                      ++ +.||..+.  ++|+.|||++|++.
T Consensus       577 ~l-~~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          577 DI-RKVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             CC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred             cC-CccCHhHh--CcCCEEECcCCCCc
Confidence            88 47887766  68888888888664

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-50  Score=438.92  Aligned_cols=248  Identities=24%  Similarity=0.359  Sum_probs=210.9

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|++. +|+.||||++++..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999975 79999999997542   334577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||++||+|.+++.+.+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999997654 4899999999999999999999   99999999999999999999999999999997765444


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|++||......     ....        .+.....   
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----~~~~--------~i~~~~~---  251 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-----LIFA--------KIIKLEY---  251 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHTCC---
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--------HHHcCCC---
Confidence            44556678999999999999999999999999999999999999999764221     1111        1111110   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                           ..+..++.++.+|+.+||.+||++|||++|++
T Consensus       252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                 11234567789999999999999999998863

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.6e-50  Score=443.99  Aligned_cols=250  Identities=20%  Similarity=0.322  Sum_probs=204.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++++..  ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            468999999999999999999975 79999999997653  334577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          826 EYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+||+|.+++...+ ..+++.++..|+.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999997654 45799999999999999999999   999999999999999999999999999999865321 


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       .......+||+.|||||++.+..|+.++||||+||++|||+||++||......     +.+..        +...... 
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~--------i~~~~~~-  243 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-----NLVLK--------IISGSFP-  243 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHH--------HHHTCCC-
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHH--------HHcCCCC-
Confidence             12234567999999999999999999999999999999999999999764221     11111        1111110 


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            ..+..++.++.+|+.+||.+||++|||++|+++
T Consensus       244 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 ------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  112346778999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-49  Score=435.83  Aligned_cols=250  Identities=23%  Similarity=0.271  Sum_probs=205.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +.|+..+.||+|+||+||+|+++ +|+.||||+++.+..     ..+|++++++++|||||++++++.+++..|+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45778889999999999999976 699999999985432     246999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCcccccCCCc-
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKEDQS-  906 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~-  906 (1027)
                      +||+|.+++...+ .+++.++..++.||+.||+|||   +++||||||||+|||++.+| ++||+|||+|+.+...... 
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999999997654 4899999999999999999999   99999999999999999988 6999999999876543221 


Q ss_pred             --ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          907 --LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       907 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                        ......+||+.|||||++.+..|+.++||||+||++|||+||++||........ .....            ..    
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~------------~~----  271 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIA------------SE----  271 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHH------------HS----
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHH------------cC----
Confidence              122345799999999999999999999999999999999999999986543322 11110            00    


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       .......+..+++++.+++.+||++||++|||+.|+++.|.
T Consensus       272 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          272 -PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             -CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence             00111223467788999999999999999999999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=445.44  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=211.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +.|+..+.||+|+||+||+|+++ +|+.||||+++.......+.+.+|++++++++|||||+++++|.+.+..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999976 69999999998766666677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +||+|.+++...  .+++.++..|+.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            999999998764  3899999999999999999999   9999999999999999999999999999998764332  23


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|++||......+  ....+        ....        ..
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i--------~~~~--------~~  365 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMI--------RDNL--------PP  365 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH--------HHSC--------CC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHH--------HcCC--------CC
Confidence            455789999999999999999999999999999999999999997642211  11100        0000        01


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....+..++.++.+|+.+||..||++|||+.|+++
T Consensus       366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11222356778999999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-48  Score=421.69  Aligned_cols=244  Identities=26%  Similarity=0.370  Sum_probs=197.9

Q ss_pred             CccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec----CCeeEEEE
Q 048205          753 SENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS----DDFKALVL  825 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  825 (1027)
                      +..+.||+|+||+||+|++. +++.||||++....  ....+.+.+|++++++++|||||+++++|.+    ++..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45568999999999999976 68999999997542  3345678999999999999999999999865    34689999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEcC-CCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~  902 (1027)
                      |||+||+|.+++.+.. .+++..+..++.||+.||+|||   +++  ||||||||+|||++. +|.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997654 5899999999999999999999   877  999999999999984 79999999999985322


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                          ......+||+.|||||++.+ +|+.++||||+||++|||+||++||........ +...            +....
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~------------i~~~~  246 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRR------------VTSGV  246 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHH------------HTTTC
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHH------------HHcCC
Confidence                12345689999999998865 699999999999999999999999975422111 1110            00100


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         .  ....+..+++++.+|+.+||.+||++|||++|+++
T Consensus       247 ---~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 ---K--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---C--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---C--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0  11122345667899999999999999999999986

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.4e-49  Score=482.32  Aligned_cols=466  Identities=18%  Similarity=0.247  Sum_probs=340.2

Q ss_pred             CCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccc------c------ccCccccCCCCCcEEEccCccCCCCCChh
Q 048205          123 PLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS------G------DIPKEIGNLTKLKYLHLDQNRLQGEIPEE  190 (1027)
Q Consensus       123 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~------~------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  190 (1027)
                      .+++.|+|++|.+.|.+|.+|+.+++|++|+|++|.+.      +      .+|...  +..|+ +++++|.+.+.+|..
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            46778888888888888888888888888888888662      1      222222  34555 677777777666655


Q ss_pred             ccCC-CCCCeeecc--------------------ccccCCCCCccccCCCCCCEEEccCccCCCC-CCcchhhhhhcccc
Q 048205          191 LGNL-AELEKLQLQ--------------------NNFLTGTIPPSIFNLSSLSDLELSFNSLTGN-FPKDMHIVNRLSAE  248 (1027)
Q Consensus       191 ~~~l-~~L~~L~L~--------------------~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~~~  248 (1027)
                      +..+ ..+..+++.                    +|++++ +|..|+++++|++|+|++|+++|. ++..+         
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~---------  227 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW---------  227 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC---------
T ss_pred             HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccc---------
Confidence            5421 112222222                    345554 555555555555555555555431 00000         


Q ss_pred             CCccccCCCccccEEEeccccccccCCCCCCCCCCCcccc--CcCCccceeccCccccccCCccccCcCcccceeccCcc
Q 048205          249 LPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG--NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNK  326 (1027)
Q Consensus       249 l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  326 (1027)
                      +|.              +.+...+         .+|..++  ++++|++|+|++|++.+.+|..|+++++|++|++++|+
T Consensus       228 ~~~--------------~~~~~~~---------~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~  284 (636)
T 4eco_A          228 ENE--------------NSEYAQQ---------YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR  284 (636)
T ss_dssp             SCT--------------TSHHHHH---------HTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred             ccc--------------ccchhcc---------cCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence            000              0000000         1566777  88889999999999888888889999999999999998


Q ss_pred             -ccc-ccCcccccc------CCcceEEccCccccccCCC-CccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCC
Q 048205          327 -LVG-VVPTTIFNV------STLKFLYLGSNSFFGRLPS-SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR  397 (1027)
Q Consensus       327 -l~~-~~~~~~~~l------~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  397 (1027)
                       +++ .+|..+.++      ++|++|++++|++. .+|. ..+..+++|++|+|++|+++|.+| .+.++++|++|+|++
T Consensus       285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~  362 (636)
T 4eco_A          285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY  362 (636)
T ss_dssp             TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred             CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence             887 778777776      88888888888886 6776 234578888888888888887888 888888888888888


Q ss_pred             CcccCCCCcccCCccc-ccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCc
Q 048205          398 NSFSGFIPNTFGNLRN-LKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSN  476 (1027)
Q Consensus       398 N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~  476 (1027)
                      |+++ .+|..|..+++ |++|++++|+++.+|..+..   ..+++|++|++++|++++..|..+....            
T Consensus       363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~---~~l~~L~~L~Ls~N~l~~~~p~~l~~~~------------  426 (636)
T 4eco_A          363 NQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDA---KSVSVMSAIDFSYNEIGSVDGKNFDPLD------------  426 (636)
T ss_dssp             SEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCT---TCSSCEEEEECCSSCTTTTTTCSSCTTC------------
T ss_pred             Cccc-cccHhhhhhcccCcEEEccCCcCcccchhhhh---cccCccCEEECcCCcCCCcchhhhcccc------------
Confidence            8888 67778888888 88888888888877764432   2344677777777777766555443110            


Q ss_pred             cccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEe
Q 048205          477 ISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLN  556 (1027)
Q Consensus       477 ~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~  556 (1027)
                            .....+.+|++|+|++|++++..+..+..+++|++|+|++|+++ .+|....     ...+..+.++++|+.|+
T Consensus       427 ------~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~-----~~~~~~~~~l~~L~~L~  494 (636)
T 4eco_A          427 ------PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSL-----KDENENFKNTYLLTSID  494 (636)
T ss_dssp             ------SSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSS-----EETTEECTTGGGCCEEE
T ss_pred             ------cccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHh-----ccccccccccCCccEEE
Confidence                  11115678999999999999655566778999999999999996 4443221     11112233455999999


Q ss_pred             cCCCccccCcccccc--CcccccEEcccccccccccchhhccCccccEEEc------cCCccccCccccccccccccccc
Q 048205          557 LSLNFFTGPLPLEIG--NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFL------KYNRLQGSIPDSIGDMINLKSLN  628 (1027)
Q Consensus       557 Ls~N~l~~~~p~~~~--~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L------~~N~l~g~ip~~~~~l~~L~~L~  628 (1027)
                      |++|.++ .+|..+.  .+++|+.|+|++|++++ +|..++.+++|++|+|      ++|++.+.+|..++.+++|+.|+
T Consensus       495 Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~  572 (636)
T 4eco_A          495 LRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ  572 (636)
T ss_dssp             CCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEE
T ss_pred             CcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEE
Confidence            9999999 6999887  99999999999999997 9999999999999999      56889999999999999999999


Q ss_pred             cccccccCCchhhhhcccCCcceeccCCCCC
Q 048205          629 LSNNNLFGIIPISLEKLLDLKDINVSFNKLE  659 (1027)
Q Consensus       629 l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  659 (1027)
                      |++|++ +.+|..+.  ++|+.|++++|++.
T Consensus       573 Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          573 IGSNDI-RKVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             CCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred             CCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence            999999 78998866  79999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-48  Score=418.40  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=193.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|++. +|+.||||++++..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999865 79999999997542   233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+ +|+|.+++.... .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence            999 679999987654 4899999999999999999999   999999999999999999999999999999865332  


Q ss_pred             cceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.....     .......        ....   
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~~~i--------~~~~---  228 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLFKNI--------SNGV---  228 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH--------HHTC---
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH--------HcCC---
Confidence             22345689999999999998876 5799999999999999999999976421     1111111        1111   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ...+..++.++.+++.+||++||++|||++|+++
T Consensus       229 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 -----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 0112345677899999999999999999999986

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=467.11  Aligned_cols=458  Identities=21%  Similarity=0.239  Sum_probs=295.9

Q ss_pred             cEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeecccc
Q 048205          126 QTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN  205 (1027)
Q Consensus       126 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  205 (1027)
                      ++|++++|+++. +|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            468888888884 555554  78888888888888777778888888888888888888777888888888888888888


Q ss_pred             ccCCCCCccccCCCCCCEEEccCccCCC-CCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCC
Q 048205          206 FLTGTIPPSIFNLSSLSDLELSFNSLTG-NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIP  284 (1027)
Q Consensus       206 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p  284 (1027)
                      +|+ .+|..  .+++|++|+|++|++++ .+|               ..+..+++|++|++++|.+++            
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p---------------~~~~~l~~L~~L~L~~n~l~~------------  129 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPIC---------------KEFGNMSQLKFLGLSTTHLEK------------  129 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCC---------------GGGGGCTTCCEEEEEESSCCG------------
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccch---------------hhhccCCcceEEEecCcccch------------
Confidence            888 45555  78888888888888864 122               234466777777777777763            


Q ss_pred             ccccCcCCc--cceeccCccc--cccCCccccCcC-cccceeccCcccccccC-ccccccCCcceEEccCcc-------c
Q 048205          285 KEIGNLAKL--EKLDLQFNRL--QCVIPHEIDNLH-NLEWMIFSFNKLVGVVP-TTIFNVSTLKFLYLGSNS-------F  351 (1027)
Q Consensus       285 ~~l~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~-------l  351 (1027)
                      ..+..+++|  +.|++++|++  .+..|..+..+. +...+++++|++.+..+ ..+.++++|+.|++++|.       +
T Consensus       130 ~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~  209 (520)
T 2z7x_B          130 SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF  209 (520)
T ss_dssp             GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHH
T ss_pred             hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccccccee
Confidence            234555666  7777777777  666666666655 33455666776655433 345667777777777775       4


Q ss_pred             cccCCCCccCCCCCccEEEccccccCCcCccccc---CCCCCCeeecCCCcccCCCCccc-----CCcccccEEecCCCC
Q 048205          352 FGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIF---NTSKLSTLELQRNSFSGFIPNTF-----GNLRNLKWLDLGDNY  423 (1027)
Q Consensus       352 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~  423 (1027)
                      .+.+|  .+..+++|+.|++++|.+++..+..+.   ..++|++|++++|++++.+|..+     +.+++|+.+++++|.
T Consensus       210 ~~~~~--~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~  287 (520)
T 2z7x_B          210 LSILA--KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV  287 (520)
T ss_dssp             HHHHH--GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECC
T ss_pred             ecchh--hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccc
Confidence            44444  234567777777777766543222221   13467777777777776677766     677777777777777


Q ss_pred             CCCCCCc-cccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCcccc
Q 048205          424 LTSSTSE-LSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLN  502 (1027)
Q Consensus       424 l~~~~~~-l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~  502 (1027)
                      + .+|.+ +..+  ....+|+.|++++|.+.....                           .+.+++|++|++++|+++
T Consensus       288 ~-~~p~~~~~~~--~~~~~L~~L~l~~n~l~~~~~---------------------------~~~l~~L~~L~Ls~n~l~  337 (520)
T 2z7x_B          288 F-GFPQSYIYEI--FSNMNIKNFTVSGTRMVHMLC---------------------------PSKISPFLHLDFSNNLLT  337 (520)
T ss_dssp             C-CSCTHHHHHH--HHTCCCSEEEEESSCCCCCCC---------------------------CSSCCCCCEEECCSSCCC
T ss_pred             e-ecchhhhhcc--cccCceeEEEcCCCccccccc---------------------------hhhCCcccEEEeECCccC
Confidence            6 44421 1100  011346677777766643321                           134555666666666666


Q ss_pred             CchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCcccc-ccCcccccEEcc
Q 048205          503 GSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLE-IGNLKVLVQIDL  581 (1027)
Q Consensus       503 ~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l  581 (1027)
                      +.+|..++++++|++|+|++|++++           +..+|..+..+++|++|++++|.+++.+|.. +..+++|++|++
T Consensus       338 ~~~~~~~~~l~~L~~L~L~~N~l~~-----------l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L  406 (520)
T 2z7x_B          338 DTVFENCGHLTELETLILQMNQLKE-----------LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM  406 (520)
T ss_dssp             TTTTTTCCCCSSCCEEECCSSCCCB-----------HHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEEC
T ss_pred             hhhhhhhccCCCCCEEEccCCccCc-----------cccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEEC
Confidence            5555566666666666666666532           1133445555666666666666666545543 556666777777


Q ss_pred             cccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhh-hhcccCCcceeccCCCCCC
Q 048205          582 SINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPIS-LEKLLDLKDINVSFNKLEG  660 (1027)
Q Consensus       582 s~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~-l~~l~~L~~l~l~~N~l~g  660 (1027)
                      ++|++++.+|..+.  ++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|.. +..+++|+.|++++|++++
T Consensus       407 s~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          407 SSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             CSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcc
Confidence            77776666666554  56677777777776 56766667777777777777776 34444 6667777777777777766


Q ss_pred             CCC
Q 048205          661 EIP  663 (1027)
Q Consensus       661 ~~p  663 (1027)
                      ..+
T Consensus       483 ~c~  485 (520)
T 2z7x_B          483 SCP  485 (520)
T ss_dssp             CHH
T ss_pred             cCC
Confidence            544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3e-48  Score=479.00  Aligned_cols=489  Identities=20%  Similarity=0.220  Sum_probs=306.8

Q ss_pred             CCCcEEEccccccceeCcccccCCCCCCEEEc-cCcccCCccCccccCCCCCCeEeCCcc--------------------
Q 048205           50 TTLIGLHLRGNKLQGEIPEELGNLAELEELWL-QNNFLTGTIPSSIFNLSSLSNLDLSVN--------------------  108 (1027)
Q Consensus        50 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L-~~N~l~~~~p~~l~~l~~L~~L~Ls~N--------------------  108 (1027)
                      ..++.|+|++|.+.+.+|..|+++++|+.|+| ++|.+.|..|-.....    .++++..                    
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~----~~~l~~~~l~~lr~~~~~~~l~~~~~~  398 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL----TPDMSEERKHRIRMHYKKMFLDYDQRL  398 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCC----CSSCCHHHHHHHHTHHHHHHTCCCGGG
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeeccccccccccccccccc----ccccchhHHHHHHHhhhhhhhccCcch
Confidence            46777888888888788888888888888888 7777765533221111    0111111                    


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccC--CccccccCccccCCCCCcEEEccCccCCC-
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSI--NDFSGDIPKEIGNLTKLKYLHLDQNRLQG-  185 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-  185 (1027)
                      .+.+... ..+...+.             ..+........++.+.+..  |.+++ +|..|+++++|++|+|++|++++ 
T Consensus       399 ~~s~l~~-~~l~~~~~-------------~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~  463 (876)
T 4ecn_A          399 NLSDLLQ-DAINRNPE-------------MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYD  463 (876)
T ss_dssp             GSCHHHH-HHHHTCTT-------------SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGG
T ss_pred             hhhHHHH-HHhhhCcc-------------ccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCC
Confidence            0110000 00000000             0000111222333333333  67776 67777777777777777777776 


Q ss_pred             ----------------CCChhcc--CCCCCCeeeccccccCCCCCccccCCCCCCEEEccCcc-CCC-CCCcchhhhhhc
Q 048205          186 ----------------EIPEELG--NLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNS-LTG-NFPKDMHIVNRL  245 (1027)
Q Consensus       186 ----------------~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~~~~~  245 (1027)
                                      .+|..++  ++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ ++| .+|..+....  
T Consensus       464 ~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~--  541 (876)
T 4ecn_A          464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA--  541 (876)
T ss_dssp             GBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHH--
T ss_pred             cccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhh--
Confidence                            3788877  99999999999999988999999999999999999998 876 5665443221  


Q ss_pred             cccCCccccCCCccccEEEeccccccccCCCCCCCCCCCc--cccCcCCccceeccCccccccCCccccCcCcccceecc
Q 048205          246 SAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPK--EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFS  323 (1027)
Q Consensus       246 ~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  323 (1027)
                            ..+..+++|+.|+|++|+++          .+|.  .++++++|+.|+|++|+++ .+| .|+.+++|+.|+|+
T Consensus       542 ------~~~~~l~~L~~L~Ls~N~L~----------~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls  603 (876)
T 4ecn_A          542 ------DDEDTGPKIQIFYMGYNNLE----------EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLD  603 (876)
T ss_dssp             ------HCTTTTTTCCEEECCSSCCC----------BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECC
T ss_pred             ------hcccccCCccEEEeeCCcCC----------ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECc
Confidence                  12345567777777777776          4555  5667777777777777777 445 66777777777777


Q ss_pred             CcccccccCccccccCC-cceEEccCccccccCCCCccCCC--CCccEEEccccccCCcCcccccCCCCCCeeecCCCcc
Q 048205          324 FNKLVGVVPTTIFNVST-LKFLYLGSNSFFGRLPSSADVRL--PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSF  400 (1027)
Q Consensus       324 ~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  400 (1027)
                      +|++. .+|..+.++++ |++|+|++|++. .+|..+. .+  ++|+.|+|++|++.+.+|....               
T Consensus       604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~-~~~~~~L~~L~Ls~N~l~g~ip~l~~---------------  665 (876)
T 4ecn_A          604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN-AKSVYVMGSVDFSYNKIGSEGRNISC---------------  665 (876)
T ss_dssp             SSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCC-TTCSSCEEEEECCSSCTTTTSSSCSS---------------
T ss_pred             CCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhh-ccccCCCCEEECcCCcCCCccccchh---------------
Confidence            77766 45555666666 666666666664 4553321 22  2366666666666554432211               


Q ss_pred             cCCCCcccC--CcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccc
Q 048205          401 SGFIPNTFG--NLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNIS  478 (1027)
Q Consensus       401 ~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~  478 (1027)
                            .++  .+++|+.|+|++|+|+.+|..+.    ..+++|+.|+|++|+|+.+++..+..                
T Consensus       666 ------~l~~~~~~~L~~L~Ls~N~L~~lp~~~~----~~l~~L~~L~Ls~N~L~~ip~~~~~~----------------  719 (876)
T 4ecn_A          666 ------SMDDYKGINASTVTLSYNEIQKFPTELF----ATGSPISTIILSNNLMTSIPENSLKP----------------  719 (876)
T ss_dssp             ------CTTTCCCCCEEEEECCSSCCCSCCHHHH----HTTCCCSEEECCSCCCSCCCTTSSSC----------------
T ss_pred             ------hhccccCCCcCEEEccCCcCCccCHHHH----ccCCCCCEEECCCCcCCccChHHhcc----------------
Confidence                  111  22345555555555554444322    23455555555555555433332221                


Q ss_pred             cccCcccccccccceEEecCccccCchhHhhh--cccccceeeccCceeecccCCCCCccccccccCccccccCcccEEe
Q 048205          479 GSIPKEINNLTNLIAIYLGVNKLNGSILIALG--KLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLN  556 (1027)
Q Consensus       479 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~  556 (1027)
                        .+...+++++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|+              .+|..++++++|+.|+
T Consensus       720 --~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~--------------~lp~~l~~L~~L~~L~  782 (876)
T 4ecn_A          720 --KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS--------------SFPTQPLNSSQLKAFG  782 (876)
T ss_dssp             --TTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCS--------------SCCCGGGGCTTCCEEE
T ss_pred             --ccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCC--------------ccchhhhcCCCCCEEE
Confidence              1122345567777777777777 5666665  6777777777777763              2455666777777777


Q ss_pred             cCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccC
Q 048205          557 LSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFG  636 (1027)
Q Consensus       557 Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~  636 (1027)
                      |++|.                  ++++|++.+.+|..|+.+++|+.|+|++|++ +.||..+.  ++|+.|||++|++..
T Consensus       783 Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          783 IRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNIS  841 (876)
T ss_dssp             CCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCE
T ss_pred             CCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCc
Confidence            77765                  5667888888898899999999999999999 58888876  589999999998887


Q ss_pred             CchhhhhcccCCcceeccCCCCC
Q 048205          637 IIPISLEKLLDLKDINVSFNKLE  659 (1027)
Q Consensus       637 ~~p~~l~~l~~L~~l~l~~N~l~  659 (1027)
                      .-+..+.....+..+.+++|.+.
T Consensus       842 i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          842 IDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             EECGGGHHHHHTTCCEEECCTTS
T ss_pred             cChHHccccccchheeecCCCcc
Confidence            66677776667777777777653

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=458.60  Aligned_cols=466  Identities=19%  Similarity=0.186  Sum_probs=264.2

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      ++||+++|.++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            45666666666 4555554  56666666666666555556666666666666666666555566666666666666666


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCCc-cCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFDG-KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      +++ .++..   .+++|++|+|++|++++ ..|..|+++++|++|++++|.+++   ..|..+++|              
T Consensus        80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L--------------  138 (520)
T 2z7x_B           80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHL--------------  138 (520)
T ss_dssp             CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTS--------------
T ss_pred             cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccc--------------
Confidence            665 23222   33444444444444443 234445555555555555554442   223333333              


Q ss_pred             ChhccCCCCCCeeecccccc--CCCCCccccCCC-CCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEE
Q 048205          188 PEELGNLAELEKLQLQNNFL--TGTIPPSIFNLS-SLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY  264 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~  264 (1027)
                              +|++|++++|.+  .+..|..+..+. +...+++++|.+.+              .++...+..++.|+.++
T Consensus       139 --------~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~--------------~~~~~~~~~l~~L~~L~  196 (520)
T 2z7x_B          139 --------NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH--------------FILDVSVKTVANLELSN  196 (520)
T ss_dssp             --------CEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCC--------------CCCCCCCTTCSEEEECC
T ss_pred             --------eeeEEEeecccccccccccccccccccceEEEEeccCcchh--------------hhhhhhhhcccceeecc
Confidence                    004444444444  334444443332 12233444444432              11222223333334444


Q ss_pred             eccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCcccc---ccCCc
Q 048205          265 LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF---NVSTL  341 (1027)
Q Consensus       265 Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L  341 (1027)
                      +++|.-...+                          ..+.+.+| .++.+++|+.|++++|.+.+..+..+.   ..++|
T Consensus       197 l~~n~~~~~~--------------------------~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L  249 (520)
T 2z7x_B          197 IKCVLEDNKC--------------------------SYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTV  249 (520)
T ss_dssp             EEECCSTTTT--------------------------HHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSC
T ss_pred             cccccccccc--------------------------ceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcc
Confidence            4333300000                          00222222 333444444444444443322111110   12345


Q ss_pred             ceEEccCccccccCCCCcc----CCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCc---ccc
Q 048205          342 KFLYLGSNSFFGRLPSSAD----VRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL---RNL  414 (1027)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L  414 (1027)
                      ++|++++|++.+.+|...+    ..+++|+.+++++|.+  .+|                       +..+..+   .+|
T Consensus       250 ~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p-----------------------~~~~~~~~~~~~L  304 (520)
T 2z7x_B          250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFP-----------------------QSYIYEIFSNMNI  304 (520)
T ss_dssp             SEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSC-----------------------THHHHHHHHTCCC
T ss_pred             cEEEeecccccCccccchhhcccccCceeEeccccccce--ecc-----------------------hhhhhcccccCce
Confidence            5555555555444444432    2344444444444444  222                       1222222   334


Q ss_pred             cEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceE
Q 048205          415 KWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAI  494 (1027)
Q Consensus       415 ~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L  494 (1027)
                      +.|++++|.++..+.      ...+++|++|++++|++++                         .+|..++.+++|++|
T Consensus       305 ~~L~l~~n~l~~~~~------~~~l~~L~~L~Ls~n~l~~-------------------------~~~~~~~~l~~L~~L  353 (520)
T 2z7x_B          305 KNFTVSGTRMVHMLC------PSKISPFLHLDFSNNLLTD-------------------------TVFENCGHLTELETL  353 (520)
T ss_dssp             SEEEEESSCCCCCCC------CSSCCCCCEEECCSSCCCT-------------------------TTTTTCCCCSSCCEE
T ss_pred             eEEEcCCCccccccc------hhhCCcccEEEeECCccCh-------------------------hhhhhhccCCCCCEE
Confidence            455555554443221      0234455555555555443                         345566777888888


Q ss_pred             EecCccccC--chhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccC
Q 048205          495 YLGVNKLNG--SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGN  572 (1027)
Q Consensus       495 ~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  572 (1027)
                      ++++|++++  .+|..++++++|++|+|++|++++.+|.            ..+..+++|+.|++++|.+++.+|..+. 
T Consensus       354 ~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~------------~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-  420 (520)
T 2z7x_B          354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK------------GDCSWTKSLLSLNMSSNILTDTIFRCLP-  420 (520)
T ss_dssp             ECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG------------CSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred             EccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc------------chhccCccCCEEECcCCCCCcchhhhhc-
Confidence            888888887  6678899999999999999998653332            1256678999999999999988888775 


Q ss_pred             cccccEEcccccccccccchhhccCccccEEEccCCccccCcccc-ccccccccccccccccccCCch
Q 048205          573 LKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDS-IGDMINLKSLNLSNNNLFGIIP  639 (1027)
Q Consensus       573 l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~L~~L~l~~N~l~~~~p  639 (1027)
                       ++|+.||+++|+++ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|++|+|++|++++..+
T Consensus       421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence             78999999999998 79999999999999999999999 68876 8999999999999999998766

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-48  Score=434.40  Aligned_cols=264  Identities=23%  Similarity=0.373  Sum_probs=216.8

Q ss_pred             cHHHHHHHhCCCCccceeeccccceEEEEEecC------CceEEEEEEecccc-hhHHHHHHHHHHHhhccC-CccceEE
Q 048205          741 TYLELFQATNGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRH-RNIIKFI  812 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~  812 (1027)
                      ...+++...++|++.+.||+|+||+||+|++..      ++.||||+++.... ...+.+.+|++++++++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            334444556789999999999999999998652      36799999975433 345678999999999965 8999999


Q ss_pred             eEEecC-CeeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 048205          813 SSCSSD-DFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL  876 (1027)
Q Consensus       813 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  876 (1027)
                      ++|.+. +..++|||||++|+|.++++...               ..+++.++..++.|||+||+|||   +++||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence            999764 56899999999999999997532               34899999999999999999999   999999999


Q ss_pred             CCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 048205          877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDES  955 (1027)
Q Consensus       877 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~  955 (1027)
                      ||+|||+++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997765554445566789999999999999999999999999999999998 89999765


Q ss_pred             cccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          956 FTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       956 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..... +...+            ...      .+...+..+++++.+++.+||+.||++|||++||+++|+
T Consensus       292 ~~~~~-~~~~i------------~~g------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          292 KIDEE-FCRRL------------KEG------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             CCSHH-HHHHH------------HHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHH-HHHHH------------HcC------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            32221 11111            111      111223457788999999999999999999999999875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=6.3e-47  Score=464.47  Aligned_cols=548  Identities=22%  Similarity=0.187  Sum_probs=340.0

Q ss_pred             cCCccCcCCC---CCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCcc
Q 048205           17 KIPSTLSNCK---RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSS   93 (1027)
Q Consensus        17 ~~~~~~~~~~---~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~   93 (1027)
                      .+|.+...|.   .-+..+.++.+++ .+|..+.  +++++|||++|+|++..+.+|.++++|++|+|++|+|+++.|.+
T Consensus        19 ~~p~~~~~c~~~~~~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~   95 (635)
T 4g8a_A           19 SIPESWEPCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA   95 (635)
T ss_dssp             ------CCSEEEETTTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred             CCCCCCCCccccCCCCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhH
Confidence            4555554442   2357788888898 7888775  68999999999999777888999999999999999999877888


Q ss_pred             ccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccc-ccCccccCCCC
Q 048205           94 IFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG-DIPKEIGNLTK  172 (1027)
Q Consensus        94 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~  172 (1027)
                      |.++++|++|+|++|+|+ .++...|.++++|++|+|++|+++++.+..|+++++|++|+|++|.+++ ..|..++.+++
T Consensus        96 f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~  174 (635)
T 4g8a_A           96 YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN  174 (635)
T ss_dssp             TTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTT
T ss_pred             hcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchh
Confidence            999999999999999998 6778889999999999999999998888889999999999999999975 35788899999


Q ss_pred             CcEEEccCccCCCCCChhccCCCCC----CeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhcccc
Q 048205          173 LKYLHLDQNRLQGEIPEELGNLAEL----EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAE  248 (1027)
Q Consensus       173 L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~  248 (1027)
                      |++|+|++|++++..+..|..+.++    ..++++.|.++...+ .......++.+++++|..+.              .
T Consensus       175 L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~-~~~~~~~~~~l~l~~n~~~~--------------~  239 (635)
T 4g8a_A          175 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRLHKLTLRNNFDSL--------------N  239 (635)
T ss_dssp             CCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECT-TTTTTCEEEEEEEESCCSSH--------------H
T ss_pred             hhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCc-ccccchhhhhhhhhcccccc--------------c
Confidence            9999999999998888877766554    368889999985444 44455567888888887641              1


Q ss_pred             CCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccc---cCCccccCcCcccceeccCc
Q 048205          249 LPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC---VIPHEIDNLHNLEWMIFSFN  325 (1027)
Q Consensus       249 l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~Ls~N  325 (1027)
                      +....+..++.++...+..+..........   .....+..+..+...++..+....   ..+..+..+.+++.+.+.+|
T Consensus       240 ~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~---~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~  316 (635)
T 4g8a_A          240 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEK---FDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSV  316 (635)
T ss_dssp             HHHHHHHTTTTCEEEEEEEECCTTSCCCSC---CCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESC
T ss_pred             ccchhhcCCccccccccccccccccccccc---ccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccc
Confidence            223334455666666665444332111000   112233344445555444433321   12334555666667777776


Q ss_pred             ccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccC--C
Q 048205          326 KLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSG--F  403 (1027)
Q Consensus       326 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~  403 (1027)
                      .+..+.+  +....+|+.|++.+|.+.+ ++..   .+..|+.+++++|.+...  .....+++|+.|++++|.+..  .
T Consensus       317 ~~~~~~~--~~~~~~L~~L~l~~~~~~~-~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~  388 (635)
T 4g8a_A          317 TIERVKD--FSYNFGWQHLELVNCKFGQ-FPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGC  388 (635)
T ss_dssp             EEEECGG--GGSCCCCSEEEEESCEESS-CCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEE
T ss_pred             ccccccc--cccchhhhhhhcccccccC-cCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccc
Confidence            6665432  3445566677777666642 2222   345666666666665432  233456666666666666642  2


Q ss_pred             CCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCc
Q 048205          404 IPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPK  483 (1027)
Q Consensus       404 ~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~  483 (1027)
                      .+..+..+.+|++|+++.|.+...+...     ..++.|+.++++.|......                        .+.
T Consensus       389 ~~~~~~~~~~L~~L~~~~~~~~~~~~~~-----~~l~~L~~l~l~~~~~~~~~------------------------~~~  439 (635)
T 4g8a_A          389 CSQSDFGTISLKYLDLSFNGVITMSSNF-----LGLEQLEHLDFQHSNLKQMS------------------------EFS  439 (635)
T ss_dssp             CCHHHHSCSCCCEEECCSCSEEEECSCC-----TTCTTCCEEECTTSEEESTT------------------------SSC
T ss_pred             cccchhhhhhhhhhhccccccccccccc-----cccccccchhhhhccccccc------------------------ccc
Confidence            3444555566666666666544333221     23344444444444332211                        112


Q ss_pred             ccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccc
Q 048205          484 EINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT  563 (1027)
Q Consensus       484 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~  563 (1027)
                      .+..+.+++.++++.|++.+..+..+..+++|++|+|++|++.                                    .
T Consensus       440 ~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~------------------------------------~  483 (635)
T 4g8a_A          440 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ------------------------------------E  483 (635)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEG------------------------------------G
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhhhcccc------------------------------------c
Confidence            3344455555555555555555555555555555555555432                                    2


Q ss_pred             cCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhh
Q 048205          564 GPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLE  643 (1027)
Q Consensus       564 ~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~  643 (1027)
                      +.+|..++.+++|+.|||++|++++.+|..|+++++|++|+|++|+|++..|..|+.+++|+.|||++|+|++.+|..+.
T Consensus       484 ~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  563 (635)
T 4g8a_A          484 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ  563 (635)
T ss_dssp             GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTT
T ss_pred             ccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHH
Confidence            23444455555555555555555555555555555555555555555544444555555555555555555555555555


Q ss_pred             cc-cCCcceeccCCCCC
Q 048205          644 KL-LDLKDINVSFNKLE  659 (1027)
Q Consensus       644 ~l-~~L~~l~l~~N~l~  659 (1027)
                      .+ ++|+.|++++|++.
T Consensus       564 ~l~~~L~~L~L~~Np~~  580 (635)
T 4g8a_A          564 HFPSSLAFLNLTQNDFA  580 (635)
T ss_dssp             CCCTTCCEEECTTCCBC
T ss_pred             hhhCcCCEEEeeCCCCc
Confidence            55 34555555555554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.8e-48  Score=426.01  Aligned_cols=272  Identities=24%  Similarity=0.300  Sum_probs=199.6

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC----eeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD----FKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  825 (1027)
                      ++|...+.||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||+++++|.+++    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3567788999999999999998 5899999999754322 223445677778899999999999997654    579999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      |||++|+|.++++...  ++|..+.+++.|+++||+|||..     +..+||||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999998654  89999999999999999999932     1239999999999999999999999999999876


Q ss_pred             ccCCCc--ceecccccCccccCcccccCC------CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh-
Q 048205          901 LKEDQS--LTQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL-  971 (1027)
Q Consensus       901 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-  971 (1027)
                      ......  ......+||+.|||||++.+.      .++.++|||||||++|||+||++||.........+..+...... 
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            443322  122345799999999998754      46789999999999999999988875432222111111000000 


Q ss_pred             hhHH-HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          972 ISIM-EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       972 ~~~~-~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .... .+.+........ .......++..+.+|+.+||+.||++||||+||++.|+
T Consensus       239 ~~~~~~~~~~~~rp~~p-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  293 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             HHHHHHHTTSCCCCCCC-GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCC-ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            0001 111121111111 11122346678999999999999999999999999886

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-48  Score=424.50  Aligned_cols=247  Identities=24%  Similarity=0.324  Sum_probs=198.7

Q ss_pred             CCCCccceeeccccceEEEEEec----CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ++|++.+.||+|+||+||+|+..    +++.||||++++..  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999853    47889999997542  2233467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||++||+|.+++.+.. .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997654 4899999999999999999999   999999999999999999999999999999865332


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .  ......+||+.|||||++.+..|+.++||||+||++|||+||++||.+....     +...        .+....  
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~--------~i~~~~--  242 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-----ETMT--------MILKAK--  242 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHCC--
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-----HHHH--------HHHcCC--
Confidence            2  2334568999999999999999999999999999999999999999764221     1111        111111  


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA-----KEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~-----~evl~ 1023 (1027)
                            ...+..+++++.+|+.+||++||++|||+     +|+++
T Consensus       243 ------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 ------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                  11123467789999999999999999984     67764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1e-46  Score=465.42  Aligned_cols=489  Identities=19%  Similarity=0.204  Sum_probs=273.9

Q ss_pred             CCCcEEEccCCcccccCCccccccCCCcEEEc-cccccceeCcccccCC-CCCCEE-----E----------ccCcccCC
Q 048205           26 KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHL-RGNKLQGEIPEELGNL-AELEEL-----W----------LQNNFLTG   88 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L-~~n~i~~~~p~~l~~l-~~L~~L-----~----------L~~N~l~~   88 (1027)
                      .+++.|+|++|.+.|.+|..+++++.|++|+| ++|.+++..|-..... ..+...     .          .....+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57999999999999999999999999999999 9999886644321111 000000     0          00000110


Q ss_pred             ccCc-----------cccCCCCCCeEeCCc--ccccccchhhhhcCCCCCcEEEccCCcCCcc-CcccccCCCCCcEEEc
Q 048205           89 TIPS-----------SIFNLSSLSNLDLSV--NNLTGELLANICSNLPLLQTLFLDENNFDGK-IPSTLLRCKHLQTLSL  154 (1027)
Q Consensus        89 ~~p~-----------~l~~l~~L~~L~Ls~--N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L  154 (1027)
                      ..+.           .......++.+.++.  |++++ +|. .+..+++|++|+|++|++++. ++..+.        ..
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~-~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~--------~~  472 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISK-AIQRLTKLQIIYFANSPFTYDNIAVDWE--------DA  472 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCS--------CT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhH-HHhcCCCCCEEECcCCcCCCCccccccc--------cc
Confidence            1101           111122223333322  44443 222 233444444444444444431 000000        00


Q ss_pred             cCCccccccCcccc--CCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccc-cCC-CCCccccCCC-------CCCE
Q 048205          155 SINDFSGDIPKEIG--NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNF-LTG-TIPPSIFNLS-------SLSD  223 (1027)
Q Consensus       155 s~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~  223 (1027)
                      +.|.+++.+|..++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++       +|+.
T Consensus       473 s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~  552 (876)
T 4ecn_A          473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI  552 (876)
T ss_dssp             TSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCE
T ss_pred             ccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccE
Confidence            00001112444444  55555555555555555555555555555555555554 444 3444333332       5555


Q ss_pred             EEccCccCCCCCCcchhhhhhccccCCc-cccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCcc
Q 048205          224 LELSFNSLTGNFPKDMHIVNRLSAELPA-KFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNR  302 (1027)
Q Consensus       224 L~Ls~N~l~~~~p~~~~~~~~~~~~l~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~  302 (1027)
                      |+|++|+++               .+|. ..+..+++|+.|+|++|+++          .+| .++.+++|+.|+|++|+
T Consensus       553 L~Ls~N~L~---------------~ip~~~~l~~L~~L~~L~Ls~N~l~----------~lp-~~~~L~~L~~L~Ls~N~  606 (876)
T 4ecn_A          553 FYMGYNNLE---------------EFPASASLQKMVKLGLLDCVHNKVR----------HLE-AFGTNVKLTDLKLDYNQ  606 (876)
T ss_dssp             EECCSSCCC---------------BCCCHHHHTTCTTCCEEECTTSCCC----------BCC-CCCTTSEESEEECCSSC
T ss_pred             EEeeCCcCC---------------ccCChhhhhcCCCCCEEECCCCCcc----------cch-hhcCCCcceEEECcCCc
Confidence            555555554               2222 12334555555555555554          233 45556666666666666


Q ss_pred             ccccCCccccCcCc-ccceeccCcccccccCccccccCC--cceEEccCccccccCCCCc----cCCCCCccEEEccccc
Q 048205          303 LQCVIPHEIDNLHN-LEWMIFSFNKLVGVVPTTIFNVST--LKFLYLGSNSFFGRLPSSA----DVRLPNLEELSLSGNN  375 (1027)
Q Consensus       303 l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~----~~~l~~L~~L~Ls~N~  375 (1027)
                      ++ .+|..+..+++ |+.|+|++|+++ .+|..+..+..  |+.|+|++|++.+.+|...    ...+++|++|+|++|+
T Consensus       607 l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~  684 (876)
T 4ecn_A          607 IE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE  684 (876)
T ss_dssp             CS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSC
T ss_pred             cc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCc
Confidence            66 55566666666 777777777766 44555655543  7777777777766554321    1134577888888888


Q ss_pred             cCCcCcccc-cCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCC
Q 048205          376 FSGTIPSFI-FNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGG  454 (1027)
Q Consensus       376 l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~  454 (1027)
                      ++ .+|..+ ..+++|+.|+|++|+|+.+.+..+.....                     ...+|++|++|+|++|+|+ 
T Consensus       685 L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~---------------------~l~nl~~L~~L~Ls~N~L~-  741 (876)
T 4ecn_A          685 IQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG---------------------NYKNTYLLTTIDLRFNKLT-  741 (876)
T ss_dssp             CC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTS---------------------CCTTGGGCCEEECCSSCCC-
T ss_pred             CC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccc---------------------cccccCCccEEECCCCCCc-
Confidence            87 445444 36777777777777777433333322210                     0012334444444444443 


Q ss_pred             CCCccccCcccccceeecCCCccccccCcccc--cccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCC
Q 048205          455 ILPRVIGNLSQSMEDFHMPNSNISGSIPKEIN--NLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDN  532 (1027)
Q Consensus       455 ~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~  532 (1027)
                                               .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+        
T Consensus       742 -------------------------~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~--------  787 (876)
T 4ecn_A          742 -------------------------SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR--------  787 (876)
T ss_dssp             -------------------------CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB--------
T ss_pred             -------------------------cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC--------
Confidence                                     2333343  56667777777777776 56677777788888887765        


Q ss_pred             CCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCcccc
Q 048205          533 LSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQG  612 (1027)
Q Consensus       533 ~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g  612 (1027)
                                             ++++|.+.+.+|..++.+++|+.|+|++|++ +.+|..+.  ++|+.|+|++|++..
T Consensus       788 -----------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          788 -----------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNIS  841 (876)
T ss_dssp             -----------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCE
T ss_pred             -----------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCc
Confidence                                   3456777777788888888888888888888 57887765  588888888888875


Q ss_pred             Ccccccccccccccccccccccc
Q 048205          613 SIPDSIGDMINLKSLNLSNNNLF  635 (1027)
Q Consensus       613 ~ip~~~~~l~~L~~L~l~~N~l~  635 (1027)
                      .-+..+.....+..+.|++|++.
T Consensus       842 i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          842 IDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             EECGGGHHHHHTTCCEEECCTTS
T ss_pred             cChHHccccccchheeecCCCcc
Confidence            45566666667777778777765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.4e-47  Score=411.47  Aligned_cols=249  Identities=23%  Similarity=0.380  Sum_probs=189.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCC--------
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD--------  819 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  819 (1027)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35889999999999999999976 799999999975443 34567889999999999999999999986544        


Q ss_pred             ----eeEEEEEecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 048205          820 ----FKALVLEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  893 (1027)
Q Consensus       820 ----~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  893 (1027)
                          ..|+||||+++|+|.+++....  ...++..+..++.||++||+|||   +++|+||||||+|||++.+|.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                3689999999999999998654  23566778899999999999999   99999999999999999999999999


Q ss_pred             ecCCcccccCCCc----------ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHH
Q 048205          894 FGMAKPFLKEDQS----------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK  963 (1027)
Q Consensus       894 fgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~  963 (1027)
                      ||+|+.+......          ...+..+||+.|||||++.+..|+.++||||+||++|||++   ||....+   ...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HHH
Confidence            9999876533211          12234579999999999999999999999999999999996   7653211   000


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .+         ..+.+.    ...   +.....++...+++.+||++||++|||+.|+++
T Consensus       236 ~~---------~~~~~~----~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 TL---------TDVRNL----KFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH---------HHHHTT----CCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH---------HHHhcC----CCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00         011000    001   122234455778999999999999999999986

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.1e-45  Score=449.42  Aligned_cols=537  Identities=22%  Similarity=0.194  Sum_probs=407.0

Q ss_pred             EEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcc
Q 048205            6 YLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNF   85 (1027)
Q Consensus         6 ~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~   85 (1027)
                      ..+=++.+++ .+|..+.  +++++|||++|+|++..|..|..+++|++|+|++|+|++..|++|.++++|++|+|++|+
T Consensus        35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~  111 (635)
T 4g8a_A           35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP  111 (635)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence            3455556777 6776664  579999999999997777889999999999999999998888899999999999999999


Q ss_pred             cCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCcc-CcccccCCCCCcEEEccCCccccccC
Q 048205           86 LTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK-IPSTLLRCKHLQTLSLSINDFSGDIP  164 (1027)
Q Consensus        86 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p  164 (1027)
                      |++..+..|.++++|++|+|++|+++ .++...|.++++|++|+|++|++++. .|..+..+++|++|+|++|.+++..+
T Consensus       112 l~~l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  190 (635)
T 4g8a_A          112 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  190 (635)
T ss_dssp             CCEECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             CCCCCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence            99777788999999999999999998 57777789999999999999999864 57888999999999999999998888


Q ss_pred             ccccCCCCCc----EEEccCccCCCCCChhccCCCCCCeeeccccccCCC-CCccccCCCCCCEEEccCccCCCCCCcch
Q 048205          165 KEIGNLTKLK----YLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGT-IPPSIFNLSSLSDLELSFNSLTGNFPKDM  239 (1027)
Q Consensus       165 ~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  239 (1027)
                      ..|..+.+++    .++++.|.++.+.+..+ ....++.+++++|..... .+..+.++..++...+..+...+...   
T Consensus       191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~---  266 (635)
T 4g8a_A          191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN---  266 (635)
T ss_dssp             GGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCC---
T ss_pred             ccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccc---
Confidence            8887766544    78999999996555444 445678899999876532 34567788888888876665432111   


Q ss_pred             hhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccc
Q 048205          240 HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEW  319 (1027)
Q Consensus       240 ~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  319 (1027)
                            ........+..+..+...++..+.......      .++..+..+.+++.+++.+|.+..+  ..+.....|+.
T Consensus       267 ------l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~------~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~  332 (635)
T 4g8a_A          267 ------LEKFDKSALEGLCNLTIEEFRLAYLDYYLD------GIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQH  332 (635)
T ss_dssp             ------CSCCCTTTTGGGGGSEEEEEEEECCCSCEE------ECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSE
T ss_pred             ------cccccccccccccchhhhhhhhhhhccccc------chhhhhhhhcccccccccccccccc--cccccchhhhh
Confidence                  012223334455566666666555432111      2334566678899999999988765  34667789999


Q ss_pred             eeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCC--cCcccccCCCCCCeeecCC
Q 048205          320 MIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSG--TIPSFIFNTSKLSTLELQR  397 (1027)
Q Consensus       320 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~  397 (1027)
                      |++++|.+.+..+.   .+..|+.+++.+|.+... +..  ..+++|+.|++++|.+..  ..+..+..+.+|+.|+++.
T Consensus       333 L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~-~~~--~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~  406 (635)
T 4g8a_A          333 LELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA-FSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSF  406 (635)
T ss_dssp             EEEESCEESSCCCC---BCTTCCEEEEESCCSCCB-CCC--CBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCS
T ss_pred             hhcccccccCcCcc---cchhhhhcccccccCCCC-ccc--ccccccccchhhccccccccccccchhhhhhhhhhhccc
Confidence            99999999876554   467889999999987533 222  358999999999999853  4566778899999999999


Q ss_pred             CcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCcc
Q 048205          398 NSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNI  477 (1027)
Q Consensus       398 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~  477 (1027)
                      |.+.. .+..|..+++|+.+++++|++.......   .+..++.++.++++.|.+...                      
T Consensus       407 ~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~---~~~~l~~l~~l~ls~n~l~~~----------------------  460 (635)
T 4g8a_A          407 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS---VFLSLRNLIYLDISHTHTRVA----------------------  460 (635)
T ss_dssp             CSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSC---TTTTCTTCCEEECTTSCCEEC----------------------
T ss_pred             ccccc-ccccccccccccchhhhhcccccccccc---ccccccccccccccccccccc----------------------
Confidence            99985 5677899999999999999876554432   235677788888887776644                      


Q ss_pred             ccccCcccccccccceEEecCcccc-CchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEe
Q 048205          478 SGSIPKEINNLTNLIAIYLGVNKLN-GSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLN  556 (1027)
Q Consensus       478 ~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~  556 (1027)
                         .|..+..+++|+.|++++|++. +..|..|..+++|++|+|++|+|++                             
T Consensus       461 ---~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~-----------------------------  508 (635)
T 4g8a_A          461 ---FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-----------------------------  508 (635)
T ss_dssp             ---CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE-----------------------------
T ss_pred             ---cccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCC-----------------------------
Confidence               4455666778888999988754 4566677777777777777777643                             


Q ss_pred             cCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccc-cccccccccccccc
Q 048205          557 LSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDM-INLKSLNLSNNNLF  635 (1027)
Q Consensus       557 Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l-~~L~~L~l~~N~l~  635 (1027)
                              ..|..|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|++.+|..+..+ ++|+.|+|++|+++
T Consensus       509 --------l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~  580 (635)
T 4g8a_A          509 --------LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  580 (635)
T ss_dssp             --------ECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred             --------cChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence                    345556666677777777777776666667777777777777777777667777666 56777777777776


Q ss_pred             C
Q 048205          636 G  636 (1027)
Q Consensus       636 ~  636 (1027)
                      -
T Consensus       581 C  581 (635)
T 4g8a_A          581 C  581 (635)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.4e-45  Score=438.07  Aligned_cols=467  Identities=22%  Similarity=0.235  Sum_probs=229.4

Q ss_pred             CCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCC
Q 048205           27 RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        27 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  106 (1027)
                      ..+++++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus        32 ~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  108 (562)
T 3a79_B           32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS  108 (562)
T ss_dssp             -CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence            3456666666666 3555443  566666666666665555556666666666666666665555556666666666666


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccc-cCccccCCCCCcEEEccCccCCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD-IPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      +|+++ .++..                           .+++|++|+|++|.+++. .|..|+++++|++|+|++|++++
T Consensus       109 ~N~l~-~lp~~---------------------------~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~  160 (562)
T 3a79_B          109 HNRLQ-NISCC---------------------------PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ  160 (562)
T ss_dssp             TSCCC-EECSC---------------------------CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred             CCcCC-ccCcc---------------------------ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence            66555 23222                           344455555555554431 23445555555555555555543


Q ss_pred             CCChhccCCCCC--Ceeecccccc--CCCCCccccCCC--CCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCcc
Q 048205          186 EIPEELGNLAEL--EKLQLQNNFL--TGTIPPSIFNLS--SLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPF  259 (1027)
Q Consensus       186 ~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~  259 (1027)
                      .   .+..+++|  ++|++++|.+  ++..|..+..+.  .+ .++++.|.+.+              .++...+..++.
T Consensus       161 ~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~--------------~~~~~~~~~l~~  222 (562)
T 3a79_B          161 L---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFS--------------VQVNMSVNALGH  222 (562)
T ss_dssp             T---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCC--------------CCCEEEESSEEE
T ss_pred             C---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchh--------------hhhhhcccccce
Confidence            2   22333333  5555555555  445555554433  22 34555555542              122233334445


Q ss_pred             ccEEEecccccccc-CCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCcccccc
Q 048205          260 LEEIYLSKNMFYGE-IPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNV  338 (1027)
Q Consensus       260 L~~L~Ls~N~l~~~-~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  338 (1027)
                      |+.+++++|..... ++      ..+..+..+++|+.|+++++.+.+                   |.+.+..+.  ...
T Consensus       223 L~~L~l~~n~~~~~~l~------~~~~~l~~l~~L~~L~L~~~~l~~-------------------~~~~~~~~~--~~~  275 (562)
T 3a79_B          223 LQLSNIKLNDENCQRLM------TFLSELTRGPTLLNVTLQHIETTW-------------------KCSVKLFQF--FWP  275 (562)
T ss_dssp             EEEEEEECCSTTHHHHH------HHHHHHHSCSSCEEEEEEEEEECH-------------------HHHHHHHHH--HTT
T ss_pred             EEEecccccccccchHH------HHHHHHhccCcceEEEecCCcCcH-------------------HHHHHHHHh--hhc
Confidence            55555555431000 00      001122233333333333332221                   111111111  112


Q ss_pred             CCcceEEccCccccccCCCCcc----CCCCCccEEEccccccCCcCc-ccccCCCCCCeeecCCCcccCCCCcccCCccc
Q 048205          339 STLKFLYLGSNSFFGRLPSSAD----VRLPNLEELSLSGNNFSGTIP-SFIFNTSKLSTLELQRNSFSGFIPNTFGNLRN  413 (1027)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  413 (1027)
                      .+|++|++++|.+.+.+|...+    ..++.|+.++++.|.+  .+| ..+..+                     ..-.+
T Consensus       276 ~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~---------------------~~~~~  332 (562)
T 3a79_B          276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV---------------------FAEMN  332 (562)
T ss_dssp             SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH---------------------HHTCC
T ss_pred             ccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhh---------------------hccCc
Confidence            2445555555555444444332    2233333333333333  122 111111                     00123


Q ss_pred             ccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccce
Q 048205          414 LKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIA  493 (1027)
Q Consensus       414 L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~  493 (1027)
                      |++|++++|.+...+.      ...+++|++|++++|+++                         +.+|..++++++|++
T Consensus       333 L~~L~l~~n~~~~~~~------~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~  381 (562)
T 3a79_B          333 IKMLSISDTPFIHMVC------PPSPSSFTFLNFTQNVFT-------------------------DSVFQGCSTLKRLQT  381 (562)
T ss_dssp             CSEEEEESSCCCCCCC------CSSCCCCCEEECCSSCCC-------------------------TTTTTTCCSCSSCCE
T ss_pred             ceEEEccCCCcccccC------ccCCCCceEEECCCCccc-------------------------cchhhhhcccCCCCE
Confidence            4445555544432211      012334444444444433                         234455566667777


Q ss_pred             EEecCccccC--chhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCcccccc
Q 048205          494 IYLGVNKLNG--SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIG  571 (1027)
Q Consensus       494 L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  571 (1027)
                      |++++|++++  .+|..|+++++|++|+|++|++++.+|.            ..+..+++|++|++++|.+++.+|..+.
T Consensus       382 L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~------------~~~~~l~~L~~L~l~~n~l~~~~~~~l~  449 (562)
T 3a79_B          382 LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD------------RTCAWAESILVLNLSSNMLTGSVFRCLP  449 (562)
T ss_dssp             EECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS------------CCCCCCTTCCEEECCSSCCCGGGGSSCC
T ss_pred             EECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh------------hhhcCcccCCEEECCCCCCCcchhhhhc
Confidence            7777777775  4456677777777777777777543332            1244556666666666666665555443


Q ss_pred             CcccccEEcccccccccccchhhccCccccEEEccCCccccCcccc-ccccccccccccccccccCCch
Q 048205          572 NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDS-IGDMINLKSLNLSNNNLFGIIP  639 (1027)
Q Consensus       572 ~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~L~~L~l~~N~l~~~~p  639 (1027)
                        ++|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|.. ++.+++|+.|+|++|++++..|
T Consensus       450 --~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             --TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             --CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence              46666666666665 46666666666666666666666 45554 6666666666666666665544

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.7e-45  Score=443.68  Aligned_cols=462  Identities=22%  Similarity=0.238  Sum_probs=333.4

Q ss_pred             CCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeee
Q 048205          122 LPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQ  201 (1027)
Q Consensus       122 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  201 (1027)
                      ....+++++++|++++ +|..+.  ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus        30 ~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  106 (562)
T 3a79_B           30 NELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLD  106 (562)
T ss_dssp             ---CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEE
Confidence            3345788888888885 554443  7888888888888877777888888888888888888877788888888888888


Q ss_pred             ccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCc-cccCCCccccEEEeccccccccCCCCCCC
Q 048205          202 LQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPA-KFCNNIPFLEEIYLSKNMFYGEIPSDLGN  280 (1027)
Q Consensus       202 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  280 (1027)
                      |++|+|+ .+|..  .+++|++|+|++|++++               ++. ..+..+++|++|++++|++++        
T Consensus       107 Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~---------------l~~p~~~~~l~~L~~L~L~~n~l~~--------  160 (562)
T 3a79_B          107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFDV---------------LPVCKEFGNLTKLTFLGLSAAKFRQ--------  160 (562)
T ss_dssp             CTTSCCC-EECSC--CCTTCSEEECCSSCCSB---------------CCCCGGGGGCTTCCEEEEECSBCCT--------
T ss_pred             CCCCcCC-ccCcc--ccccCCEEECCCCCccc---------------cCchHhhcccCcccEEecCCCcccc--------
Confidence            8888888 45555  78888888888888862               221 345567777777777777763        


Q ss_pred             CCCCccccCcCCc--cceeccCccc--cccCCccccCcC--cccceeccCcccccccCc-cccccCCcceEEccCcc---
Q 048205          281 CTIPKEIGNLAKL--EKLDLQFNRL--QCVIPHEIDNLH--NLEWMIFSFNKLVGVVPT-TIFNVSTLKFLYLGSNS---  350 (1027)
Q Consensus       281 ~~~p~~l~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~---  350 (1027)
                          ..+..+++|  +.|++++|++  ++..|..|..+.  .+ .+++++|.+.+..+. .+.++++|+.|++++|+   
T Consensus       161 ----~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  235 (562)
T 3a79_B          161 ----LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC  235 (562)
T ss_dssp             ----TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTH
T ss_pred             ----CchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEeccccccccc
Confidence                123344444  7777777777  666676666654  23 456677776654433 34556677777777764   


Q ss_pred             --ccccCCCCccCCCCCccEEEccccccCCc----CcccccCCCCCCeeecCCCcccCCCCccc-----CCcccccEEec
Q 048205          351 --FFGRLPSSADVRLPNLEELSLSGNNFSGT----IPSFIFNTSKLSTLELQRNSFSGFIPNTF-----GNLRNLKWLDL  419 (1027)
Q Consensus       351 --l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L  419 (1027)
                        +.+.++  .+..+++|+.|+|+++.+++.    ++..+ ..++|++|++++|.+++.+|..+     ..++.|+.+++
T Consensus       236 ~~l~~~~~--~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~  312 (562)
T 3a79_B          236 QRLMTFLS--ELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV  312 (562)
T ss_dssp             HHHHHHHH--HHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEE
T ss_pred             chHHHHHH--HHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhc
Confidence              111111  123456666666666655432    11111 23467777777777776666665     56666666666


Q ss_pred             CCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCc
Q 048205          420 GDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVN  499 (1027)
Q Consensus       420 ~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N  499 (1027)
                      +.|.+ .+|.+..+ ......+|++|++++|++..                         ..  ..+.+++|++|++++|
T Consensus       313 ~~~~~-~~p~~~~~-~~~~~~~L~~L~l~~n~~~~-------------------------~~--~~~~l~~L~~L~l~~n  363 (562)
T 3a79_B          313 KNQVF-LFSKEALY-SVFAEMNIKMLSISDTPFIH-------------------------MV--CPPSPSSFTFLNFTQN  363 (562)
T ss_dssp             EECCC-SSCHHHHH-HHHHTCCCSEEEEESSCCCC-------------------------CC--CCSSCCCCCEEECCSS
T ss_pred             cccee-ecChhhhh-hhhccCcceEEEccCCCccc-------------------------cc--CccCCCCceEEECCCC
Confidence            66665 33322110 00011346666666665532                         11  1257889999999999


Q ss_pred             cccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccc-cccCcccccE
Q 048205          500 KLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPL-EIGNLKVLVQ  578 (1027)
Q Consensus       500 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~  578 (1027)
                      ++++.+|..++++++|++|+|++|++++           +..+|..+.++++|++|++++|.+++.+|. .+..+++|+.
T Consensus       364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~  432 (562)
T 3a79_B          364 VFTDSVFQGCSTLKRLQTLILQRNGLKN-----------FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV  432 (562)
T ss_dssp             CCCTTTTTTCCSCSSCCEEECCSSCCCB-----------TTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred             ccccchhhhhcccCCCCEEECCCCCcCC-----------cccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence            9999999999999999999999999963           124556788999999999999999986776 4888999999


Q ss_pred             EcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhh-hhcccCCcceeccCCC
Q 048205          579 IDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPIS-LEKLLDLKDINVSFNK  657 (1027)
Q Consensus       579 L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~-l~~l~~L~~l~l~~N~  657 (1027)
                      |++++|++++.+|..+.  ++|++|+|++|+++ .||..++.+++|+.|+|++|+++ .+|.. +..+++|+.|++++|+
T Consensus       433 L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~  508 (562)
T 3a79_B          433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP  508 (562)
T ss_dssp             EECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCC
T ss_pred             EECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCC
Confidence            99999999988888765  78999999999999 79999999999999999999999 56666 9999999999999999


Q ss_pred             CCCCCCC
Q 048205          658 LEGEIPR  664 (1027)
Q Consensus       658 l~g~~p~  664 (1027)
                      +.+..|.
T Consensus       509 ~~c~c~~  515 (562)
T 3a79_B          509 WDCTCPG  515 (562)
T ss_dssp             BCCCHHH
T ss_pred             cCCCcch
Confidence            9987764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.8e-45  Score=408.48  Aligned_cols=268  Identities=21%  Similarity=0.250  Sum_probs=204.9

Q ss_pred             HHhCCCCccceeeccccceEEEEEec----CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      ...++|++.+.||+|+||+||+|+.+    +++.||||++....  ....+.+|+++++.+ +|||||++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45678999999999999999999854    46789999986543  235678899999998 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCCccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPF  900 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~  900 (1027)
                      |+||||++||+|.+++..    +++.++..++.|++.||+|||   ++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            999999999999999853    899999999999999999999   9999999999999999876 89999999999855


Q ss_pred             ccCCC--------------------------cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCC
Q 048205          901 LKEDQ--------------------------SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTD  953 (1027)
Q Consensus       901 ~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~  953 (1027)
                      .....                          .......+||++|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            32211                          1122345799999999998875 58999999999999999999999997


Q ss_pred             CCcccchhHHHHHHHHHhhh---HHHhhhccccC-------------------------------ccchhhhHHhhhHHH
Q 048205          954 ESFTGEMTLKRWVNDLLLIS---IMEVVDANLLS-------------------------------HEDKHFVAKEQCMSF  999 (1027)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~~~---~~~~~d~~~~~-------------------------------~~~~~~~~~~~~~~~  999 (1027)
                      ...+....+...........   ...........                               ........+...+++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            65444333333332221111   11110000000                               000011122345677


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 048205         1000 VFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus      1000 l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +.+|+.+||..||++|||++|+++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhc
Confidence            899999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=410.77  Aligned_cols=269  Identities=23%  Similarity=0.257  Sum_probs=205.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec------CC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS------DD  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  819 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|++++++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            467999999999999999999975 79999999997543  2345678899999999999999999998754      36


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999996 58999987654 5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cccCC--CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH--
Q 048205          900 FLKED--QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI--  974 (1027)
Q Consensus       900 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  974 (1027)
                      +....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+.... ..+............  
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence            64322  12234557899999999998775 5699999999999999999999999864321 112221111110000  


Q ss_pred             ---------HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 ---------MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ---------~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                               ...+..................+.++.+|+.+||.+||++|||++|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     0000000000000011112345677899999999999999999999986

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.2e-44  Score=423.66  Aligned_cols=252  Identities=19%  Similarity=0.262  Sum_probs=213.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+++++.++|||||+++++|.+.+..++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            367999999999999999999976 7999999999876666667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC--CcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN--MVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+||+|.+++......+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+...  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            9999999999876667999999999999999999999   9999999999999999854  89999999999976432  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       ......+||+.|||||++.+..|+.++||||+||++|||++|++||.+....+. +..            +....    
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~------------i~~~~----  372 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRN------------VKSCD----  372 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH------------HHTTC----
T ss_pred             -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHH------------HHhCC----
Confidence             233456899999999999999999999999999999999999999976432111 111            11000    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .......+..++.++.+|+.+||+.||++||++.|+++
T Consensus       373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00111223456778899999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7e-44  Score=418.90  Aligned_cols=249  Identities=24%  Similarity=0.313  Sum_probs=202.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHH---HHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKS---FDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++++..   ......   ...++++++.++|||||+++++|.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999976 69999999997542   111222   23446677888999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |+||||++||+|.+++.... .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999997654 4899999999999999999999   9999999999999999999999999999998664


Q ss_pred             cCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..    .....+||+.|||||++.. ..|+.++||||+||++|||++|++||........  ......        +...
T Consensus       344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~--------i~~~  409 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRM--------TLTM  409 (689)
T ss_dssp             SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHH--------HHHC
T ss_pred             CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHh--------hcCC
Confidence            32    2345689999999999975 5799999999999999999999999976432221  111110        0111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                      .        ...+..++.++.+|+.+||.+||++|++     ++||++
T Consensus       410 ~--------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 A--------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             C--------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             C--------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1        1112346677899999999999999998     677764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.1e-42  Score=404.79  Aligned_cols=398  Identities=23%  Similarity=0.288  Sum_probs=190.2

Q ss_pred             CCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeec
Q 048205          123 PLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQL  202 (1027)
Q Consensus       123 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  202 (1027)
                      +.|++|++++|.+ +.+|.+++++++|++|++++|.+.+.+|..++++.+|+.+++++|..           .++++|++
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l   78 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL   78 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence            3455555555555 34455555555555555555555555555555555444444433321           23466666


Q ss_pred             cccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCC
Q 048205          203 QNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT  282 (1027)
Q Consensus       203 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  282 (1027)
                      ++|.+++ +|..   .++|++|++++|.+++ +|              .    .+++|++|++++|++++          
T Consensus        79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp--------------~----~~~~L~~L~l~~n~l~~----------  125 (454)
T 1jl5_A           79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LP--------------E----LPQSLKSLLVDNNNLKA----------  125 (454)
T ss_dssp             TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CC--------------C----CCTTCCEEECCSSCCSC----------
T ss_pred             cCCcccc-CCCC---cCCCCEEEccCCcCCc-cc--------------c----ccCCCcEEECCCCccCc----------
Confidence            6666663 3331   2566666666666653 22              1    12456666666666652          


Q ss_pred             CCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCC
Q 048205          283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVR  362 (1027)
Q Consensus       283 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  362 (1027)
                      +|..   .++|++|++++|++++ +| .|+++++|++|++++|+++++ |..   ..+|++|++++|++.+ +|.  +..
T Consensus       126 l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~-l~~--~~~  193 (454)
T 1jl5_A          126 LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE-LPE--LQN  193 (454)
T ss_dssp             CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS-CCC--CTT
T ss_pred             ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCc-Ccc--ccC
Confidence            1111   1466677777777665 34 466666666666666666652 322   2366666666666653 442  345


Q ss_pred             CCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccc
Q 048205          363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYL  442 (1027)
Q Consensus       363 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L  442 (1027)
                      +++|++|++++|++++ +|...   ++|++|++++|+++ .+| .|+.+++|++|++++|+++++|..        .+.|
T Consensus       194 l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~~--------~~~L  259 (454)
T 1jl5_A          194 LPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDL--------PPSL  259 (454)
T ss_dssp             CTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSC--------CTTC
T ss_pred             CCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCccccc--------cccc
Confidence            6666666666666653 33322   45666666666666 344 366666666666666666655431        2456


Q ss_pred             cEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccC
Q 048205          443 EYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD  522 (1027)
Q Consensus       443 ~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  522 (1027)
                      ++|++++|+++++                          |..   +++|++|++++|++++. |.   -.++|+.|++++
T Consensus       260 ~~L~l~~N~l~~l--------------------------~~~---~~~L~~L~ls~N~l~~l-~~---~~~~L~~L~l~~  306 (454)
T 1jl5_A          260 EALNVRDNYLTDL--------------------------PEL---PQSLTFLDVSENIFSGL-SE---LPPNLYYLNASS  306 (454)
T ss_dssp             CEEECCSSCCSCC--------------------------CCC---CTTCCEEECCSSCCSEE-SC---CCTTCCEEECCS
T ss_pred             CEEECCCCccccc--------------------------Ccc---cCcCCEEECcCCccCcc-cC---cCCcCCEEECcC
Confidence            6666666666543                          222   14455555555555541 10   014566666666


Q ss_pred             ceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccE
Q 048205          523 NQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY  602 (1027)
Q Consensus       523 N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~  602 (1027)
                      |++++. +          .+      .++|++|++++|++++ +|..   +++|+.|++++|+++ .+|.   .+++|++
T Consensus       307 N~l~~i-~----------~~------~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~  361 (454)
T 1jl5_A          307 NEIRSL-C----------DL------PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQ  361 (454)
T ss_dssp             SCCSEE-C----------CC------CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCE
T ss_pred             CcCCcc-c----------CC------cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccE
Confidence            665321 0          01      1356666666666664 4543   355666666666666 3555   3566666


Q ss_pred             EEccCCcccc--CccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCC
Q 048205          603 LFLKYNRLQG--SIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEG  660 (1027)
Q Consensus       603 L~L~~N~l~g--~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g  660 (1027)
                      |+|++|+++|  .+|.+++.+        +.|++.|.+|..   +++|+.|++++|+++|
T Consensus       362 L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          362 LHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLRE  410 (454)
T ss_dssp             EECCSSCCSSCCCCCTTCCEE--------ECCC---------------------------
T ss_pred             EECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCCc
Confidence            6666666666  555555433        234444555542   3445555555555555

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.1e-41  Score=396.36  Aligned_cols=425  Identities=24%  Similarity=0.321  Sum_probs=249.4

Q ss_pred             CccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCC
Q 048205           91 PSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNL  170 (1027)
Q Consensus        91 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  170 (1027)
                      |..+ ..++|++|++++|.+ +.+|.. +..+++|++|++++|++.+..|..++.+++|+.+++++|..           
T Consensus         5 p~~~-~~~~L~~L~l~~n~l-~~iP~~-i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------   70 (454)
T 1jl5_A            5 PRNV-SNTFLQEPLRHSSNL-TEMPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------   70 (454)
T ss_dssp             --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------
T ss_pred             cccc-ccccchhhhcccCch-hhCChh-HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------
Confidence            4444 468999999999999 577765 58899999999999999999999999999886666655532           


Q ss_pred             CCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCC
Q 048205          171 TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELP  250 (1027)
Q Consensus       171 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~  250 (1027)
                      .++++|++++|.+++ +|..   .++|++|++++|.+++ +|..   +++|++|++++|++++               ++
T Consensus        71 ~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~---------------l~  127 (454)
T 1jl5_A           71 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA---------------LS  127 (454)
T ss_dssp             HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC---------------CC
T ss_pred             cCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc---------------cc
Confidence            456677777777764 3331   3567777777777775 4533   3677777777777762               11


Q ss_pred             ccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccc
Q 048205          251 AKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGV  330 (1027)
Q Consensus       251 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  330 (1027)
                      .    ..++|++|++++|+++          .+| +++.+++|++|++++|++++ +|..+   .+|++|++++|+++++
T Consensus       128 ~----~~~~L~~L~L~~n~l~----------~lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l  188 (454)
T 1jl5_A          128 D----LPPLLEYLGVSNNQLE----------KLP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL  188 (454)
T ss_dssp             S----CCTTCCEEECCSSCCS----------SCC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC
T ss_pred             C----CCCCCCEEECcCCCCC----------CCc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC
Confidence            1    0146777777777776          344 36677788888888888876 34332   4788888888888874


Q ss_pred             cCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCC
Q 048205          331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGN  410 (1027)
Q Consensus       331 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  410 (1027)
                       | .+.++++|++|++++|++.+ +|..    .++|++|++++|+++ .+|. +..+++|++|++++|++++ +|..   
T Consensus       189 -~-~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---  255 (454)
T 1jl5_A          189 -P-ELQNLPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---  255 (454)
T ss_dssp             -C-CCTTCTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---
T ss_pred             -c-cccCCCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---
Confidence             4 57888888888888888864 5543    257899999999887 6674 8888999999999999986 4443   


Q ss_pred             cccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccc
Q 048205          411 LRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTN  490 (1027)
Q Consensus       411 l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~  490 (1027)
                      +++|++|++++|+++++|..        .++|++|++++|++++++.     ++                        .+
T Consensus       256 ~~~L~~L~l~~N~l~~l~~~--------~~~L~~L~ls~N~l~~l~~-----~~------------------------~~  298 (454)
T 1jl5_A          256 PPSLEALNVRDNYLTDLPEL--------PQSLTFLDVSENIFSGLSE-----LP------------------------PN  298 (454)
T ss_dssp             CTTCCEEECCSSCCSCCCCC--------CTTCCEEECCSSCCSEESC-----CC------------------------TT
T ss_pred             ccccCEEECCCCcccccCcc--------cCcCCEEECcCCccCcccC-----cC------------------------Cc
Confidence            47889999999998887653        2678888888888875321     11                        35


Q ss_pred             cceEEecCccccCchhHhhhcc-cccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCcccc
Q 048205          491 LIAIYLGVNKLNGSILIALGKL-KKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLE  569 (1027)
Q Consensus       491 L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  569 (1027)
                      |++|++++|++++     +..+ ++|++|++++|++++              +|..   +++|++|++++|.+++ +|. 
T Consensus       299 L~~L~l~~N~l~~-----i~~~~~~L~~L~Ls~N~l~~--------------lp~~---~~~L~~L~L~~N~l~~-lp~-  354 (454)
T 1jl5_A          299 LYYLNASSNEIRS-----LCDLPPSLEELNVSNNKLIE--------------LPAL---PPRLERLIASFNHLAE-VPE-  354 (454)
T ss_dssp             CCEEECCSSCCSE-----ECCCCTTCCEEECCSSCCSC--------------CCCC---CTTCCEEECCSSCCSC-CCC-
T ss_pred             CCEEECcCCcCCc-----ccCCcCcCCEEECCCCcccc--------------cccc---CCcCCEEECCCCcccc-ccc-
Confidence            5666666666664     1223 477888888888753              2322   4678888888888884 676 


Q ss_pred             ccCcccccEEccccccccc--ccchhhccCccccEEEccCCccccCccccccccccccccccccccccC--Cchhhhhcc
Q 048205          570 IGNLKVLVQIDLSINNFSD--VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFG--IIPISLEKL  645 (1027)
Q Consensus       570 ~~~l~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~--~~p~~l~~l  645 (1027)
                        .+++|++|++++|++++  .+|.+++.+        +.|++.|.+|..   +++|+.||+++|+++|  .+|.+    
T Consensus       355 --~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s----  417 (454)
T 1jl5_A          355 --LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES----  417 (454)
T ss_dssp             --CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC--------------------------------------
T ss_pred             --hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCCccccchhh----
Confidence              47888999999999987  677766543        457788888874   5789999999999988  77865    


Q ss_pred             cCCcceeccCCCCCCCCCC
Q 048205          646 LDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       646 ~~L~~l~l~~N~l~g~~p~  664 (1027)
                        ++.|.+.+|.+.+.+|.
T Consensus       418 --l~~L~~~~~~~~~~~~~  434 (454)
T 1jl5_A          418 --VEDLRMNSERVVDPYEF  434 (454)
T ss_dssp             -------------------
T ss_pred             --HhheeCcCcccCCcccc
Confidence              44556788888888775

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.7e-42  Score=383.08  Aligned_cols=278  Identities=33%  Similarity=0.543  Sum_probs=227.9

Q ss_pred             ccHHHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          740 FTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       740 ~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      +++.++...+++|+..+.||+|+||.||+|++++|+.||||++........+.+.+|++++++++||||+++++++...+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            33444556778999999999999999999998889999999987666666788999999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                      ..++||||+++|+|.+++....   ..+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999987654   35899999999999999999999   89999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc-chhHHHHHHHHHhh-hH
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG-EMTLKRWVNDLLLI-SI  974 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~-~~  974 (1027)
                      ++...............||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......|....... ..
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            98654333333334456899999999999889999999999999999999999999765433 23344444322211 12


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...+++...      ......++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       266 ~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          266 EQIVDPNLA------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CSSSSSSCT------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcChhhc------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            222222221      1123457788999999999999999999999999886

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-41  Score=370.15  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=210.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            467999999999999999999864 7899999999876665667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++|+|.+++...  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            9999999999765  3899999999999999999999   99999999999999999999999999999986643322  


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...            +....     .
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~------------~~~~~-----~  233 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYL------------IATNG-----T  233 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH------------HHHHC-----S
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH------------HHhCC-----C
Confidence            33456799999999999999999999999999999999999999976422111 000            00000     0


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....+..++..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111223456777999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.4e-41  Score=380.15  Aligned_cols=285  Identities=36%  Similarity=0.550  Sum_probs=230.0

Q ss_pred             ccccccHHHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeE
Q 048205          736 NQRRFTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISS  814 (1027)
Q Consensus       736 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~  814 (1027)
                      ..+.|++.++....++|+..+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            4467889999999999999999999999999999988899999999875432 223468899999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhcCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 048205          815 CSSDDFKALVLEYMPYGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  891 (1027)
Q Consensus       815 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  891 (1027)
                      +...+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||..+..+|+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997653   34899999999999999999999322239999999999999999999999


Q ss_pred             eeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCC---cccchhHHHHHHH
Q 048205          892 SDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDES---FTGEMTLKRWVND  968 (1027)
Q Consensus       892 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~---~~~~~~~~~~~~~  968 (1027)
                      +|||+++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...   .........|+..
T Consensus       176 ~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999998664332 23344456999999999999889999999999999999999999999632   1223344555443


Q ss_pred             HHhhh-HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          969 LLLIS-IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       969 ~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ..... .....+....      ......++..+.+++.+||+.||++|||++|++++|++
T Consensus       255 ~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQ------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSSCCSTTSSCTTCT------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HhhchhhhhhcChhhc------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            32211 2222222211      11234567789999999999999999999999999974

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=372.20  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=213.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|+..+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            356888999999999999999976 6899999998766666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++|+|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.......
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999887777999999999999999999999   9999999999999999999999999999998664322211


Q ss_pred             ------------eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          908 ------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       908 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                                  ......||+.|+|||++.+..++.++||||+||++|||++|..|+..............        .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~--------~  237 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV--------R  237 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--------H
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--------h
Confidence                        11145799999999999999999999999999999999999999876433221111000        0


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...+.          ..+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       238 ~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          238 GFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             HHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            00111          112345667899999999999999999999999886

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.5e-40  Score=387.14  Aligned_cols=380  Identities=20%  Similarity=0.221  Sum_probs=232.0

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEcccccccee-CcccccCCCCCCEEEccC
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGE-IPEELGNLAELEELWLQN   83 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~-~p~~l~~l~~L~~L~L~~   83 (1027)
                      +.++.++++++ .+|. +.  ++|++|+|++|.+++..|..++.+++|++|+|++|.+.+. .+..|.++++|++|+|++
T Consensus        13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            45677777777 4554 32  6788888888888877777888888888888888887633 356678888888888888


Q ss_pred             cccCCccCccccCCCCCCeEeCCcccccccch-hhhhcCCCCCcEEEccCCcCCccCccc-ccCCCCCcEEEccCCcccc
Q 048205           84 NFLTGTIPSSIFNLSSLSNLDLSVNNLTGELL-ANICSNLPLLQTLFLDENNFDGKIPST-LLRCKHLQTLSLSINDFSG  161 (1027)
Q Consensus        84 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~  161 (1027)
                      |++++..|..|.++++|++|+|++|++++.++ ...+..+++|++|+|++|++++..|.. |..+++|++|++++|.+++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            88887777788888888888888888875332 234666777777777777777666655 6777777777777777776


Q ss_pred             ccCccccCC--CCCcEEEccCccCCCCCChhc--------cCCCCCCeeeccccccCCCCCccccCC---CCCCEEEccC
Q 048205          162 DIPKEIGNL--TKLKYLHLDQNRLQGEIPEEL--------GNLAELEKLQLQNNFLTGTIPPSIFNL---SSLSDLELSF  228 (1027)
Q Consensus       162 ~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~  228 (1027)
                      ..|..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|.+++..|..+...   ++|+.|++++
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~  248 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN  248 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred             cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence            666666655  566777777777765433322        234455555555555555444444332   4555555555


Q ss_pred             ccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCcccc--CcCCccceeccCcccccc
Q 048205          229 NSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG--NLAKLEKLDLQFNRLQCV  306 (1027)
Q Consensus       229 N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~--~l~~L~~L~L~~N~l~~~  306 (1027)
                      |.+.+...                             ..+.+.+..         +..+.  ..++|+.|++++|++++.
T Consensus       249 ~~~~~~~~-----------------------------~~~~~~~~~---------~~~~~~~~~~~L~~L~l~~n~l~~~  290 (455)
T 3v47_A          249 SYNMGSSF-----------------------------GHTNFKDPD---------NFTFKGLEASGVKTCDLSKSKIFAL  290 (455)
T ss_dssp             CTTTSCCT-----------------------------TCCSSCCCC---------TTTTGGGTTSCCCEEECCSSCCCEE
T ss_pred             cccccccc-----------------------------chhhhccCc---------ccccccccccCceEEEecCcccccc
Confidence            54432100                             001111000         01111  124566666666666666


Q ss_pred             CCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccC
Q 048205          307 IPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFN  386 (1027)
Q Consensus       307 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  386 (1027)
                      .|..|+.+++|++|++++|++.++.|..|.++++|++|+|++|++.+ ++...+..+++|++|+|++|++++..|..|.+
T Consensus       291 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  369 (455)
T 3v47_A          291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLG  369 (455)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECGGGGTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred             chhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCC-cChhHhcCcccCCEEECCCCcccccChhhccc
Confidence            66666666666666666666666666666666666666666665532 22233344555555555555555555555555


Q ss_pred             CCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCC
Q 048205          387 TSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS  427 (1027)
Q Consensus       387 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  427 (1027)
                      +++|++|+|++|+++++.+..|..+++|++|++++|++++.
T Consensus       370 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  410 (455)
T 3v47_A          370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  410 (455)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence            55555555555555555555555555555555555555543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.8e-40  Score=386.84  Aligned_cols=385  Identities=22%  Similarity=0.199  Sum_probs=250.4

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCcc-CccccCCCCCCeEeCC
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTI-PSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls  106 (1027)
                      -+.++++++.++ .+|. +.  ++|++|+|++|+|++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|+
T Consensus        12 ~~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           12 GYNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TTEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             ccccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            345777777776 5665 32  66777777777777666777777777777777777765333 4566667777777777


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCccc--ccCCCCCcEEEccCCccccccCcc-ccCCCCCcEEEccCccC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPST--LLRCKHLQTLSLSINDFSGDIPKE-IGNLTKLKYLHLDQNRL  183 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l  183 (1027)
                      +|+++ .+.+..+.++++|++|+|++|++++..+..  |..+++|++|+|++|.+++..|.. |.++++|++|++++|++
T Consensus        88 ~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l  166 (455)
T 3v47_A           88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV  166 (455)
T ss_dssp             TCTTC-EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred             CCccC-ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence            77765 333444555666666666666665533333  555666666666666665544544 55566666666666666


Q ss_pred             CCCCChhccCC--CCCCeeeccccccCCCCCcc--------ccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccc
Q 048205          184 QGEIPEELGNL--AELEKLQLQNNFLTGTIPPS--------IFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF  253 (1027)
Q Consensus       184 ~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~--------~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~  253 (1027)
                      ++..+..+..+  .+|+.|++++|.+.+..+..        +..+++|++|++++|++++..|..+          .  .
T Consensus       167 ~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~----------~--~  234 (455)
T 3v47_A          167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF----------F--D  234 (455)
T ss_dssp             SCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHH----------H--H
T ss_pred             cccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhh----------h--c
Confidence            55555555444  45555566666555433222        2234455555555555542211110          0  0


Q ss_pred             cCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCc--CcccceeccCccccccc
Q 048205          254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL--HNLEWMIFSFNKLVGVV  331 (1027)
Q Consensus       254 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~  331 (1027)
                      ....+.|+.|++++|.+.+..                       +..+.+....+..+..+  ++|+.|++++|++.+..
T Consensus       235 ~~~~~~L~~L~l~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  291 (455)
T 3v47_A          235 AIAGTKIQSLILSNSYNMGSS-----------------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL  291 (455)
T ss_dssp             HTTTCCEEEEECTTCTTTSCC-----------------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEEC
T ss_pred             cccccceeeEeeccccccccc-----------------------cchhhhccCcccccccccccCceEEEecCccccccc
Confidence            011244555555555443210                       01112222233333333  68999999999999998


Q ss_pred             CccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCc
Q 048205          332 PTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNL  411 (1027)
Q Consensus       332 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  411 (1027)
                      |..|.++++|++|++++|++.+..|. .+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+
T Consensus       292 ~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  370 (455)
T 3v47_A          292 KSVFSHFTDLEQLTLAQNEINKIDDN-AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL  370 (455)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             hhhcccCCCCCEEECCCCcccccChh-HhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccc
Confidence            99999999999999999998754444 45578899999999999988888888999999999999999998888999999


Q ss_pred             ccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCC
Q 048205          412 RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILP  457 (1027)
Q Consensus       412 ~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~  457 (1027)
                      ++|++|+|++|+|++++.+.    +..+++|++|++++|++++..|
T Consensus       371 ~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          371 PNLKELALDTNQLKSVPDGI----FDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTCCEEECCSSCCSCCCTTT----TTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccccEEECCCCccccCCHhH----hccCCcccEEEccCCCcccCCC
Confidence            99999999999998877653    2577889999999998887655

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.6e-41  Score=374.85  Aligned_cols=271  Identities=25%  Similarity=0.319  Sum_probs=209.3

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC----eeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD----FKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV  824 (1027)
                      .++|++.+.||+|+||+||+|++. ++.||||++..... .......|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            356888999999999999999876 79999999975432 3345566899999999999999999998754    46999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC----------CeEeccCCCCcEEEcCCCcEEEeee
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV----------PIIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                      |||+++|+|.+++....  +++..+..++.|+++||+|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999997654  899999999999999999999   88          9999999999999999999999999


Q ss_pred             cCCcccccCCCcceecccccCccccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccch-hHHHHHHH
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEM-TLKRWVND  968 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~  968 (1027)
                      |+++.+.............||+.|+|||++.+     ..++.++||||+||++|||+||+.||........ .+......
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987654443333445679999999999886     3566789999999999999999999976533221 11111100


Q ss_pred             HHh-hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          969 LLL-ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ... ....+...................++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  314 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT  314 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            000 0111111111111111122223456777999999999999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-40  Score=371.28  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=207.4

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ...+|++.+.||+|+||.||+|++. +|+.||||++....  ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            3467999999999999999999974 79999999997543  33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||......     .....        +....  
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~--------i~~~~--  230 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-----ELRER--------VLRGK--  230 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH--------HHHCC--
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-----HHHHH--------HHhCC--
Confidence               23456799999999999888765 7999999999999999999999764221     11111        11110  


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            ...+..++.++.+++.+||..||++|||++|+++
T Consensus       231 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 ------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  0112235667899999999999999999999975

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.3e-41  Score=379.18  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=210.9

Q ss_pred             hCCCCccceeeccccceEEEEEec--------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD  818 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  818 (1027)
                      .++|++.+.||+|+||.||+|++.        ++..||||+++... ....+.+.+|+++++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367889999999999999999853        35579999987543 33456789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      +..++||||+++|+|.+++....               ..+++.++..++.||++||+|||   +.+|+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997643               34789999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTL  962 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  962 (1027)
                      +.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence            9999999999999986654333333344567889999999999999999999999999999999 999987643221  1


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...            +....      ....+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       315 ~~~------------~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~  360 (370)
T 2psq_A          315 FKL------------LKEGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  360 (370)
T ss_dssp             HHH------------HHTTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH------------HhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111            11110      11122356778999999999999999999999999886

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.5e-40  Score=366.44  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=216.1

Q ss_pred             ccccHHHHHHHhCC----------CCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCC
Q 048205          738 RRFTYLELFQATNG----------FSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR  806 (1027)
Q Consensus       738 ~~~~~~~~~~~~~~----------f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  806 (1027)
                      ..++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45777777776654          677789999999999999976 7999999999876666667889999999999999


Q ss_pred             ccceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 048205          807 NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN  886 (1027)
Q Consensus       807 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  886 (1027)
                      ||+++++++...+..++||||+++++|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999988753  4899999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHH
Q 048205          887 MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV  966 (1027)
Q Consensus       887 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  966 (1027)
                      +.+||+|||+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~  253 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRL  253 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH
T ss_pred             CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence            9999999999986543221  234457999999999999999999999999999999999999999764221  111100


Q ss_pred             HHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          967 NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       967 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                              .....        ........++..+.+++.+||+.||++|||+.|+++.
T Consensus       254 --------~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          254 --------RDSPP--------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             --------HHSSC--------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --------hcCCC--------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    00000        1111223456778999999999999999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-40  Score=367.06  Aligned_cols=252  Identities=19%  Similarity=0.292  Sum_probs=210.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467999999999999999999976 68899999987443 3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--CCcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      +++|+|.+++......+++.++..++.|+++|++|||   +.+|+||||||+||+++.  ++.+||+|||+++.+.... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999877667999999999999999999999   999999999999999987  7899999999998764322 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......     ....        .+.....   
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~--------~i~~~~~---  220 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIE--------NIMNAEY---  220 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH--------HHHHTCC---
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHH--------HHHcCCC---
Confidence              234457999999999999988999999999999999999999999764221     1111        1111111   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       .........++.++.+++.+|+..||++|||+.|+++.
T Consensus       221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             11112234567789999999999999999999999873

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.7e-40  Score=370.72  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=208.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch------hHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .+.|++.+.||+|+||+||+|+.. +|+.||+|++......      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467899999999999999999976 6899999999764322      346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMA  897 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla  897 (1027)
                      ++||||++||+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999999998764 35899999999999999999999   99999999999999998877    7999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      +.+....   .....+||+.|+|||++.+..++.++||||+||++|+|++|++||......+     ...        .+
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-----~~~--------~i  230 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLA--------NI  230 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHH--------HH
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH--------HH
Confidence            8654322   2344679999999999999999999999999999999999999997642211     111        11


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....    .......+..++..+.+++.+||.+||++|||+.|+++
T Consensus       231 ~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 TAVS----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HTTC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcC----CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1110    11111233456778999999999999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.9e-40  Score=369.56  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=208.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999876 789999999875432 234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++|+|.+++.... .+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999887543 4899999999999999999999   999999999999999999999999999999866443333


Q ss_pred             ceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|...            .    
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------~----  225 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------K----  225 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT------------C----
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc------------c----
Confidence            33445679999999999987765 778999999999999999999998754443333333210            0    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ........++.++.+++.+||..||++|||+.|+++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              011112346677899999999999999999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-40  Score=368.46  Aligned_cols=254  Identities=30%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             HhCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ...+|++.+.||+|+||+||+|++ +|+.||||++....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            456788999999999999999987 58899999987543  334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          826 EYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ||+++|+|.+++....  ..+++..+..++.|+++||+|||   +.+  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999998654  24899999999999999999999   889  9999999999999999999999999998543


Q ss_pred             cCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ..  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....+           ....
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~-----------~~~~  255 (309)
T 3p86_A          191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAV-----------GFKC  255 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHH-----------HHSC
T ss_pred             cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-----------HhcC
Confidence            22  222344579999999999999999999999999999999999999997642211  11100           0000


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            .....+..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       256 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          256 ------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                  011122456778999999999999999999999999886

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-39  Score=359.09  Aligned_cols=276  Identities=31%  Similarity=0.481  Sum_probs=225.7

Q ss_pred             ccccHHHHHHHhCCCCcc------ceeeccccceEEEEEecCCceEEEEEEeccc----chhHHHHHHHHHHHhhccCCc
Q 048205          738 RRFTYLELFQATNGFSEN------NLIGRGGFGFVYKARIQDGMEVAVKVFDLQY----GRAIKSFDIECGMIKRIRHRN  807 (1027)
Q Consensus       738 ~~~~~~~~~~~~~~f~~~------~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~n  807 (1027)
                      ..|++.++..++++|...      +.||+|+||.||+|+. +++.||||++....    ....+.+.+|++++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            568899999999999887      8999999999999987 58899999986432    234577889999999999999


Q ss_pred             cceEEeEEecCCeeEEEEEecCCCCHHHHHhcC--CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC
Q 048205          808 IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD  885 (1027)
Q Consensus       808 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  885 (1027)
                      |+++++++...+..++||||+++|+|.+++...  ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence            999999999999999999999999999998743  345899999999999999999999   999999999999999999


Q ss_pred             CCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHH
Q 048205          886 NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRW  965 (1027)
Q Consensus       886 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  965 (1027)
                      ++.+||+|||+++...............||+.|+|||++.+ .++.++||||+|+++|+|++|+.||...... .....+
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~  246 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDI  246 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHH
Confidence            99999999999986654433334445679999999998765 5889999999999999999999999865332 222333


Q ss_pred             HHHHHhh--hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          966 VNDLLLI--SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       966 ~~~~~~~--~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .......  ...+.+++....       .+..++..+.+++.+||+.||++||++.++++.|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~  302 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ  302 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSCSC-------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             HHHhhhhhhhhhhhccccccc-------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            3222211  123333332211       12356778999999999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=370.65  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=208.7

Q ss_pred             hCCCCccceeeccccceEEEEEec----CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..+|++.+.||+|+||+||+|++.    .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888999999999999999975    34569999997543 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877667999999999999999999999   999999999999999999999999999999876433


Q ss_pred             CC-cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          904 DQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       904 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      .. ........+|+.|+|||++.+..++.++||||+||++|||++ |+.||.......  ...            .+...
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~------------~~~~~  270 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VIS------------SVEEG  270 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHH------------HHHTT
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHH------------HHHcC
Confidence            22 122233456788999999998899999999999999999999 999997642211  111            01111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .      ....+..++.++.+++.+||..||++||++.|+++.|+
T Consensus       271 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          271 Y------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             C------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            0      11122356778999999999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.7e-40  Score=367.33  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=207.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|+..+.||+|+||+||+|+.+ +|+.||+|++++..   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357899999999999999999976 68999999997542   23456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999887643 4899999999999999999999   9999999999999999999999999999998543222


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+.....  
T Consensus       160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~--------~i~~~~~--  222 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFE--------LILMEEI--  222 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHCCC--
T ss_pred             --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-----HHHH--------HHHcCCC--
Confidence              2334567999999999999999999999999999999999999999764211     1111        0111111  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                            ..+..++.++.+++.+||+.||++||     +++|+++
T Consensus       223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                  11234567789999999999999999     8999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-39  Score=361.61  Aligned_cols=269  Identities=23%  Similarity=0.284  Sum_probs=209.1

Q ss_pred             HhCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ..++|++.+.||+|+||+||+|++.+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            346799999999999999999999889999999986442  223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++ ++.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  173 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-  173 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence            99985 888888877777999999999999999999999   9999999999999999999999999999998654322 


Q ss_pred             cceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---HHH-----
Q 048205          906 SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---IME-----  976 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-----  976 (1027)
                       .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .............   ...     
T Consensus       174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccc
Confidence             22344578999999999876 568999999999999999999999998654332 2222222111100   000     


Q ss_pred             -hhhccccC-ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 -VVDANLLS-HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 -~~d~~~~~-~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ..+..... ...........++.++.+++.+|+++||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             00000000 011111223346678899999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4e-40  Score=357.40  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=211.6

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|++.+.||+|+||.||+|+++++..||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            457889999999999999999998888999999975433 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++......+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.++...... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999877667999999999999999999999   9999999999999999999999999999998654322 223


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||........ ...            +....      
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~------------~~~~~------  222 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLK------------VSQGH------  222 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHH------------HHTTC------
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHH------------HHcCC------
Confidence            334456788999999998899999999999999999999 9999876432211 000            00000      


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                       ....+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus       223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (268)
T 3sxs_A          223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP  261 (268)
T ss_dssp             -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred             -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             011122345678999999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-40  Score=375.60  Aligned_cols=266  Identities=23%  Similarity=0.377  Sum_probs=215.5

Q ss_pred             cccHHHHHHHhCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccce
Q 048205          739 RFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIK  810 (1027)
Q Consensus       739 ~~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~  810 (1027)
                      .+.........++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3445555566788999999999999999999742      46889999997543 33456789999999999 7999999


Q ss_pred             EEeEEecCC-eeEEEEEecCCCCHHHHHhcCCc-----------------------------------------------
Q 048205          811 FISSCSSDD-FKALVLEYMPYGSLEKCLYSSNY-----------------------------------------------  842 (1027)
Q Consensus       811 l~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------  842 (1027)
                      +++++.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998755 48999999999999999876532                                               


Q ss_pred             ------------------cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          843 ------------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       843 ------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                                        .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                              1889999999999999999999   9999999999999999999999999999998765444


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .........||+.|+|||++.+..++.++||||+||++|||++ |+.||........ ....+            .... 
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~------------~~~~-  313 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRL------------KEGT-  313 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHH------------HHTC-
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHH------------HcCC-
Confidence            4444555678999999999999999999999999999999998 9999976533221 11110            0000 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           ....+..++.++.+++.+||+.||++|||+.|++++|+
T Consensus       314 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          314 -----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence                 01112345677899999999999999999999999986

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4.2e-39  Score=375.02  Aligned_cols=362  Identities=19%  Similarity=0.179  Sum_probs=199.6

Q ss_pred             CccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccc
Q 048205          136 DGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSI  215 (1027)
Q Consensus       136 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  215 (1027)
                      .+..+..+..+++|++|++++|.+++. | .|..+++|++|+|++|++++. |  ++.+++|++|++++|++++. +  +
T Consensus        31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~  102 (457)
T 3bz5_A           31 QATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--V  102 (457)
T ss_dssp             CTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--C
T ss_pred             CcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--c
Confidence            334455666677777777777777643 4 566777777777777777653 3  66667777777777777653 2  6


Q ss_pred             cCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccc
Q 048205          216 FNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEK  295 (1027)
Q Consensus       216 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~  295 (1027)
                      +++++|++|++++|++++               ++   +..+++|++|++++|++++          +  .++.+++|++
T Consensus       103 ~~l~~L~~L~L~~N~l~~---------------l~---~~~l~~L~~L~l~~N~l~~----------l--~l~~l~~L~~  152 (457)
T 3bz5_A          103 TPLTKLTYLNCDTNKLTK---------------LD---VSQNPLLTYLNCARNTLTE----------I--DVSHNTQLTE  152 (457)
T ss_dssp             TTCTTCCEEECCSSCCSC---------------CC---CTTCTTCCEEECTTSCCSC----------C--CCTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCCe---------------ec---CCCCCcCCEEECCCCccce----------e--ccccCCcCCE
Confidence            666777777777776652               11   2334444555555554442          1  1334445555


Q ss_pred             eeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccc
Q 048205          296 LDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN  375 (1027)
Q Consensus       296 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~  375 (1027)
                      |++++|+..+..  .                        +..+++|++|++++|++.+ +|   +..+++|++|++++|+
T Consensus       153 L~l~~n~~~~~~--~------------------------~~~l~~L~~L~ls~n~l~~-l~---l~~l~~L~~L~l~~N~  202 (457)
T 3bz5_A          153 LDCHLNKKITKL--D------------------------VTPQTQLTTLDCSFNKITE-LD---VSQNKLLNRLNCDTNN  202 (457)
T ss_dssp             EECTTCSCCCCC--C------------------------CTTCTTCCEEECCSSCCCC-CC---CTTCTTCCEEECCSSC
T ss_pred             EECCCCCccccc--c------------------------cccCCcCCEEECCCCccce-ec---cccCCCCCEEECcCCc
Confidence            555555322221  2                        3344444444444444432 22   2234555555555555


Q ss_pred             cCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCC
Q 048205          376 FSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGI  455 (1027)
Q Consensus       376 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~  455 (1027)
                      +++.   .+..+++|++|++++|++++ +|  ++.+++|++|++++|+++.++.       ..++.|+.|++++|.++  
T Consensus       203 l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~-------~~l~~L~~L~l~~n~L~--  267 (457)
T 3bz5_A          203 ITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV-------STLSKLTTLHCIQTDLL--  267 (457)
T ss_dssp             CSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC-------TTCTTCCEEECTTCCCS--
T ss_pred             CCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH-------HHCCCCCEEeccCCCCC--
Confidence            5532   24555555555555555554 23  5555556666666665555431       23455555555554332  


Q ss_pred             CCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCc
Q 048205          456 LPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSF  535 (1027)
Q Consensus       456 ~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~  535 (1027)
                                   .+++++|.+.+.+|                          ++.+++|+.|+|++|++.|.+|.    
T Consensus       268 -------------~L~l~~n~~~~~~~--------------------------~~~l~~L~~L~Ls~n~~l~~l~~----  304 (457)
T 3bz5_A          268 -------------EIDLTHNTQLIYFQ--------------------------AEGCRKIKELDVTHNTQLYLLDC----  304 (457)
T ss_dssp             -------------CCCCTTCTTCCEEE--------------------------CTTCTTCCCCCCTTCTTCCEEEC----
T ss_pred             -------------EEECCCCccCCccc--------------------------ccccccCCEEECCCCcccceecc----
Confidence                         33444444444443                          23445555555555554333321    


Q ss_pred             cccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcc
Q 048205          536 SCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP  615 (1027)
Q Consensus       536 ~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip  615 (1027)
                                  ...+|+.|++++|             ++|+.|++++|++++ +|  ++.+++|+.|++++|+|+| + 
T Consensus       305 ------------~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~-l-  354 (457)
T 3bz5_A          305 ------------QAAGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-F-  354 (457)
T ss_dssp             ------------TTCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB-C-
T ss_pred             ------------CCCcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC-c-
Confidence                        1123333333333             456777777777775 33  6777777777777777775 2 


Q ss_pred             ccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCC
Q 048205          616 DSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       616 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~  664 (1027)
                            +.|+.|++++|+++|.     ..+..|..+++++|+++|.||.
T Consensus       355 ------~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          355 ------SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             ------TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred             ------cccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence                  3566677777777766     3556677777777777777776

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-40  Score=380.27  Aligned_cols=255  Identities=29%  Similarity=0.412  Sum_probs=210.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|...+.||+|+||+||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            356888899999999999999986 78999999987543 2334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++|+|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999876667899999999999999999999   999999999999999999999999999999854322111


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......+++.|+|||++..+.++.++|||||||++|||++ |+.||......  ....            .+....   
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~------------~~~~~~---  332 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTRE------------FVEKGG---  332 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHH------------HHHTTC---
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH------------HHHcCC---
Confidence            11122235778999999998899999999999999999998 99998764221  1111            111111   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         ....+..++.++.+++.+||+.||++|||++++++.|+
T Consensus       333 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence               11223457778999999999999999999999999886

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-39  Score=358.90  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=206.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357899999999999999999865 68999999986432   33457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       ........||+.|+|||.+.+..++.++||||+||++|||++|+.||............             ....   
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-------------~~~~---  228 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-------------IQDS---  228 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-------------HSSC---
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------hhcc---
Confidence             22234457999999999999999999999999999999999999999764321111000             0010   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-CHHHHHHHhh
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-NAKEIVTKLA 1026 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-s~~evl~~L~ 1026 (1027)
                      ........+..++..+.+++.+|+.+||++|| +++++.+.|+
T Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            01111122345677899999999999999999 8999988875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-40  Score=357.91  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=210.9

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||+||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            356888999999999999999998899999999975433 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            999999999877777999999999999999999999   9999999999999999999999999999998653221 122


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.......     ...        .+... .     
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-----~~~--------~~~~~-~-----  224 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVE--------DISTG-F-----  224 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHH--------HHHTT-C-----
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-----HHH--------HHhcC-c-----
Confidence            233456788999999998999999999999999999999 999987642211     110        00010 0     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ....+..++.++.+++.+||+.||++||+++|+++.|+
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  262 (269)
T 4hcu_A          225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  262 (269)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence             01112335667899999999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9e-40  Score=368.67  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=205.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-----chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...     ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            45889999999999999999875 68999999997432     1135678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeecCC
Q 048205          824 VLEYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGMA  897 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla  897 (1027)
                      ||||+++|+|.+++...   ...+++..+..++.||++||+|||   +.+|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998877543   245899999999999999999999   999999999999999987654   999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      +......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ....            .+
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~------------~i  244 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFE------------GI  244 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHH------------HH
T ss_pred             eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHH------------HH
Confidence            8664322  223456799999999999999999999999999999999999999976311  1000            11


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....    ......+..++.++.+++.+||..||++||++.|+++
T Consensus       245 ~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKY----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCC----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCC----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111    1111223456778999999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.7e-40  Score=363.07  Aligned_cols=266  Identities=24%  Similarity=0.439  Sum_probs=209.2

Q ss_pred             hCCCCccceeeccccceEEEEEe-----cCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec--CCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  821 (1027)
                      .++|++.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35688999999999999999984     2688999999987666667889999999999999999999999855  3568


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887767999999999999999999999   9999999999999999999999999999998764


Q ss_pred             cCCCc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH-----hhhHH
Q 048205          902 KEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL-----LISIM  975 (1027)
Q Consensus       902 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~  975 (1027)
                      ..... .......+++.|+|||++.+..++.++||||+|+++|||++|..|+......   ...+.....     .....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence            33221 2223345778899999999999999999999999999999999998653211   111110000     00111


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +.+...      .....+..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       243 ~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          243 ELLKNN------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HHHHTT------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhcc------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            111111      111223467788999999999999999999999999886

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=370.35  Aligned_cols=253  Identities=18%  Similarity=0.282  Sum_probs=210.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999876 6899999999876555566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--CCcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      +++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.  ++.+||+|||+++.+.... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999877667999999999999999999999   999999999999999974  5789999999998764322 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ...   .        +..... ..
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~---~--------i~~~~~-~~  269 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQ---N--------VKRCDW-EF  269 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH---H--------HHHCCC-CC
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHH---H--------HHhCCC-CC
Confidence              2234579999999999999999999999999999999999999997642211  111   0        000000 00


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                         .......++.++.+++.+||..||++|||+.|+++.
T Consensus       270 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               011123456778999999999999999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=375.61  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=206.9

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..++|++.+.||+|+||+||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3467999999999999999999865 78999999997653  23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecCCcccc
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~  901 (1027)
                      |||++||+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++   .++.+||+|||+++...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999887654 4899999999999999999999   99999999999999998   46889999999998654


Q ss_pred             cCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ...  .......||+.|+|||++.+..++.++||||+||++|+|++|++||......+  ...           .+....
T Consensus       165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~-----------~i~~~~  229 (444)
T 3soa_A          165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQ-----------QIKAGA  229 (444)
T ss_dssp             TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-----------HHHHTC
T ss_pred             CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHH-----------HHHhCC
Confidence            322  22344679999999999999999999999999999999999999997642211  111           000111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      . ...   ...+..++.++.+++.+|++.||++|||+.|+++.
T Consensus       230 ~-~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          230 Y-DFP---SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             C-CCC---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             C-CCC---ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0 001   11123467789999999999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=369.92  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=201.3

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  822 (1027)
                      ..++|++.+.||+|+||+||+|+.+ +|+.||||++++..   ....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999976 68999999997542   23456677899999988 6999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999987654 4899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .  .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ...        .+.....
T Consensus       177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~--------~i~~~~~  241 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFE--------AILNDEV  241 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHH--------HHHHCCC
T ss_pred             C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----HHH--------HHHcCCC
Confidence            2  223445679999999999999899999999999999999999999997643211     111        1111111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA------KEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~------~evl~ 1023 (1027)
                              ..+..++.++.+++.+|+++||++||++      .|+++
T Consensus       242 --------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 --------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                    1122356678999999999999999998      77764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=360.94  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=207.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccch------hHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++......      ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45888999999999999999976 6899999999754321      3567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecCCc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAK  898 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~  898 (1027)
                      +||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            999999999999998764 35899999999999999999999   99999999999999999887    89999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      .+....   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+     ...        .+.
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~--------~~~  230 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLA--------NVS  230 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHH--------HHH
T ss_pred             ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHH--------HHH
Confidence            664322   2234579999999999998999999999999999999999999997642211     100        000


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...    ..........++..+.+++.+||..||++|||+.|+++.
T Consensus       231 ~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          231 AVN----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HTC----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hcC----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000    001112234567778999999999999999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-39  Score=357.03  Aligned_cols=268  Identities=24%  Similarity=0.271  Sum_probs=208.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999976 68999999997543  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--C
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--c
Confidence            9986 677767666667999999999999999999999   999999999999999999999999999999865432  2


Q ss_pred             ceecccccCccccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH------Hhhh
Q 048205          907 LTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM------EVVD  979 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~d  979 (1027)
                      .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.......................      ...+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2334457899999999988765 79999999999999999999988755433333333322222111000      0000


Q ss_pred             ccc---cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANL---LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~---~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...   .............++.++.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000   00000011112346677899999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.1e-40  Score=372.65  Aligned_cols=255  Identities=25%  Similarity=0.455  Sum_probs=199.3

Q ss_pred             hCCCCccceeeccccceEEEEEec----CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..+|++.+.||+|+||.||+|++.    ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999865    57789999987543 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++.++..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999887777999999999999999999999   899999999999999999999999999999866432


Q ss_pred             CCc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          904 DQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       904 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  ..            +.+...
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~------------~~i~~~  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VI------------KAVDEG  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HH------------HHHHTT
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH------------HHHHcC
Confidence            211 11222235778999999999999999999999999999998 999987542211  11            111111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..      ...+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       267 ~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          267 YR------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             EE------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence            11      1112356778999999999999999999999999885

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-39  Score=371.09  Aligned_cols=255  Identities=22%  Similarity=0.292  Sum_probs=204.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  822 (1027)
                      ..++|+..+.||+|+||+||+|+.+ +++.||||++++..   ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3467999999999999999999976 68899999998653   23345678899999887 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+....
T Consensus       130 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999987654 4899999999999999999999   99999999999999999999999999999985332


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchh---HHHHHHHHHhhhHHHhhh
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT---LKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~d  979 (1027)
                      .  .......+||+.|+|||++.+..++.++||||+||++|||++|++||......+..   ...+..       ..+..
T Consensus       206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~-------~~i~~  276 (396)
T 4dc2_A          206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-------QVILE  276 (396)
T ss_dssp             T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH-------HHHHH
T ss_pred             C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH-------HHHhc
Confidence            2  22345568999999999999999999999999999999999999999754221110   011100       01111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA------KEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~------~evl~ 1023 (1027)
                      ...        ..+..++.++.+++.+||+.||++||++      .|+++
T Consensus       277 ~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          277 KQI--------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             CCC--------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ccc--------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            111        1123456778999999999999999985      56654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-39  Score=367.54  Aligned_cols=252  Identities=20%  Similarity=0.346  Sum_probs=206.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .++|+..+.||+|+||.||+|+.+ +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456999999999999999999876 68999999997543  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.+   +.+||+|||+++....
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999887654 5899999999999999999999   9999999999999999865   4599999999986543


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..   ......||+.|+|||++.+..++.++||||+||++|+|++|++||......     .....        +.....
T Consensus       184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~--------i~~~~~  247 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQ--------IKAGAY  247 (362)
T ss_dssp             CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH--------HHHTCC
T ss_pred             Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH--------HHhCCC
Confidence            22   233467999999999999989999999999999999999999999764221     11110        001100


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       ..   ....+..++.++.+++.+||..||++||++.|+++.
T Consensus       248 -~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          248 -DY---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CC---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00   111223567789999999999999999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-39  Score=353.73  Aligned_cols=252  Identities=27%  Similarity=0.454  Sum_probs=206.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch-------hHHHHHHHHHHHhhccCCccceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR-------AIKSFDIECGMIKRIRHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  820 (1027)
                      .++|+..+.||+|+||+||+|++. +++.||||++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999975 7899999998643221       1267889999999999999999999997765 


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEcCCCc-----EEEee
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMV-----AHLSD  893 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl~D  893 (1027)
                       ++||||+++|+|.+++......+++..+..++.|++.|++|||   +.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999998877777999999999999999999999   888  999999999999988776     99999


Q ss_pred             ecCCcccccCCCcceecccccCccccCccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          894 FGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR--EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      ||+++....     ......||+.|+|||++.  ...++.++||||+||++|||++|+.||...............    
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR----  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH----
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh----
Confidence            999984322     234467999999999984  456789999999999999999999999765433221111111    


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                             ....      ....+..++.++.+++.+||+.||++||++.|+++.|++
T Consensus       244 -------~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 -------EEGL------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -------HSCC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -------ccCC------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                   1111      111223567789999999999999999999999999874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.5e-40  Score=378.35  Aligned_cols=262  Identities=19%  Similarity=0.244  Sum_probs=211.1

Q ss_pred             HHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEec
Q 048205          742 YLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSS  817 (1027)
Q Consensus       742 ~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  817 (1027)
                      +.++....++|+..+.||+|+||+||+|+++ +++.||||++++..   ....+.+.+|+.++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3444456788999999999999999999977 58899999997532   1223447889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       818 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                      .+..++||||++||+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999999876667999999999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      +...... .......+||++|+|||++.     ...++.++||||+||++|||++|++||......+ .....       
T Consensus       223 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i-------  293 (437)
T 4aw2_A          223 LKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKI-------  293 (437)
T ss_dssp             EECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHH-------
T ss_pred             hhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhh-------
Confidence            8654332 23334468999999999987     5678999999999999999999999998642211 11111       


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVT 1023 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~ 1023 (1027)
                           ..........   .....++.++.+++.+|+..+|++  ||+++|+++
T Consensus       294 -----~~~~~~~~~p---~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          294 -----MNHKERFQFP---TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             -----HTHHHHCCCC---SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             -----hhccccccCC---cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                 1000000000   001235667899999999998888  999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5e-40  Score=375.82  Aligned_cols=258  Identities=22%  Similarity=0.267  Sum_probs=208.8

Q ss_pred             HHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       744 ~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      ++....++|+..+.||+|+||+||+|+++ +++.||+|++.+..   ....+.+.+|+++++.++||||++++++|.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445688999999999999999999976 68999999997532   122345788999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++||||++||+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            999999999999999998764  3899999999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      +.... .......+||+.|+|||++.+..    ++.++||||+||++|||++|++||...... ......          
T Consensus       218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i----------  285 (410)
T 3v8s_A          218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKI----------  285 (410)
T ss_dssp             CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHH----------
T ss_pred             eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHH----------
Confidence            54322 22334568999999999988665    789999999999999999999999764221 111111          


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE--RINAKEIVTK 1024 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~evl~~ 1024 (1027)
                        .....    ...++....++.++.+++.+|+..+|++  ||+++||+++
T Consensus       286 --~~~~~----~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          286 --MNHKN----SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             --HTHHH----HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             --Hhccc----cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence              11000    0011112245677899999999999998  9999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-39  Score=358.55  Aligned_cols=245  Identities=26%  Similarity=0.311  Sum_probs=205.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357899999999999999999976 78999999997542   23456778899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++....  
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            99999999999997654 4899999999999999999999   99999999999999999999999999999986532  


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                         .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......     ...        ..+.....  
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~--------~~i~~~~~--  220 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KTY--------EKILNAEL--  220 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHH--------HHHHHCCC--
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHH--------HHHHhCCC--
Confidence               223457999999999999999999999999999999999999999764221     110        11111111  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                            ..+..++.++.+++.+|+..||++||     +++|+++
T Consensus       221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                  11224566789999999999999999     8888875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-39  Score=356.34  Aligned_cols=267  Identities=24%  Similarity=0.291  Sum_probs=204.8

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||+|+||+||+|+..+|+.||||++.....  ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57889999999999999999998899999999875432  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++ +|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            986 999998877667899999999999999999999   9999999999999999999999999999998653221  1


Q ss_pred             eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------HHH--hh
Q 048205          908 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------IME--VV  978 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~--~~  978 (1027)
                      ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .............      ..+  .+
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccccc
Confidence            23345689999999998764 58999999999999999999999997643221 1122111111000      000  00


Q ss_pred             hccccC-ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANLLS-HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~-~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ++.... ...........++.++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            110000 000011112346778899999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=371.29  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=211.3

Q ss_pred             hCCCCccceeeccccceEEEEEec--------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD  818 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  818 (1027)
                      .++|++.+.||+|+||+||+|++.        +++.||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357888999999999999999853        23579999997553 33457788999999999 999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      +..++||||+++|+|.+++....               ..+++.++..++.||++||+|||   +.+|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997653               35899999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTL  962 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  962 (1027)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||......    
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----  300 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  300 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999987654433334445567899999999999999999999999999999999 99998764211    


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ++..         .+....      ....+..++.++.+++.+||+.||++||+++|+++.|+
T Consensus       301 -~~~~---------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  348 (382)
T 3tt0_A          301 -ELFK---------LLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  348 (382)
T ss_dssp             -HHHH---------HHHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHH---------HHHcCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             1111         111110      01112346778999999999999999999999999886

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-39  Score=355.28  Aligned_cols=263  Identities=27%  Similarity=0.388  Sum_probs=203.4

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhh--ccCCccceEEeEEec----CCeeE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR--IRHRNIIKFISSCSS----DDFKA  822 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~  822 (1027)
                      .++|++.+.||+|+||+||+|++ +++.||||++...   ..+.+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999987 6899999998743   23445556666665  799999999998654    34689


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                      +||||+++|+|.+++...  .+++..+..++.|+++|++|||..     ++.+|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  489999999999999999999932     2678999999999999999999999999999


Q ss_pred             cccccCCCcc--eecccccCccccCcccccCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCCCcccc
Q 048205          898 KPFLKEDQSL--TQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTR----------KKPTDESFTGE  959 (1027)
Q Consensus       898 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg----------~~p~~~~~~~~  959 (1027)
                      +.........  ......||+.|+|||++.+.      .++.++||||+||++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8654332221  12334799999999999876      456799999999999999999          88887654333


Q ss_pred             hhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          960 MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       960 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .....+.....       .+..  ............++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       241 ~~~~~~~~~~~-------~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          241 PSFEDMRKVVC-------VDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             CCHHHHHHHHT-------TSCC--CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cchhhhhHHHh-------ccCC--CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            32222211110       0111  1111111223457788999999999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-39  Score=363.79  Aligned_cols=246  Identities=25%  Similarity=0.354  Sum_probs=204.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..+|.+.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999974 78999999997542   22345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+ +|+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 679999887654 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         .....+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........                 ....  
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~i--  220 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKKV--  220 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCCC--
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHHH--
Confidence               2234579999999999988776 7899999999999999999999976422110                 0000  


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .......+..++.++.+++.+|+..||++|||++|+++
T Consensus       221 --~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          221 --NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              01111223346677899999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=367.20  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=201.7

Q ss_pred             CccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCC
Q 048205          753 SENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      ...+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33568999999999999865 68999999998765566678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE--cCCCcEEEeeecCCcccccCCCccee
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL--DDNMVAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      +|.+++......+++..+..++.||++||+|||   +.+|+||||||+||++  +.++.+||+|||+++.+....   ..
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            999998877667999999999999999999999   9999999999999999  567899999999998764332   22


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchh
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH  989 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  989 (1027)
                      ....||+.|+|||++....++.++||||+||++|||++|+.||......+ .+..            +...... .   .
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~------------i~~~~~~-~---~  308 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNN------------ILACRWD-L---E  308 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH------------HHHTCCC-S---C
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH------------HHhccCC-C---C
Confidence            34569999999999999999999999999999999999999997643211 1111            1111110 0   0


Q ss_pred             hhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          990 FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       990 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ......++.++.+++.+||..||++||++.|+++
T Consensus       309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1122346778999999999999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=373.42  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=207.8

Q ss_pred             CCCCccceeeccccceEEEEEec------CCceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ++|+..+.||+|+||+||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888999999999999999843      4678999998644 2344567888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCC------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEee
Q 048205          823 LVLEYMPYGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSD  893 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~D  893 (1027)
                      +||||+++|+|.+++....      ..+++.+++.++.||++||+|||   +.+|+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999987643      45899999999999999999999   99999999999999999555   599999


Q ss_pred             ecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhh
Q 048205          894 FGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      ||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....       
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~-------  298 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEF-------  298 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH-------
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH-------
Confidence            999986543333333444568999999999999999999999999999999998 99998764221  11111       


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           +....      ....+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       299 -----i~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          299 -----VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             -----HHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----HHcCC------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                 11110      01112356677899999999999999999999999885

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.7e-40  Score=365.00  Aligned_cols=253  Identities=23%  Similarity=0.389  Sum_probs=201.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCce----EEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGME----VAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ++|+..+.||+|+||+||+|++. +++.    ||+|.+.... ....+.+.+|++++++++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56888999999999999999865 4544    5777765332 234577899999999999999999999998765 789


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+||+.+|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999887777999999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..........+|+.|+|||++.+..++.++||||+||++|||++ |+.||.......  ...            .+....
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~------------~~~~~~  236 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS------------ILEKGE  236 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH------------HHHTTC
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHH------------HHHcCC
Confidence            44334444567889999999999999999999999999999999 999997653221  111            111111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++.++.+++.+||+.||++||+++|+++.|+
T Consensus       237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence                  11122346677899999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-39  Score=357.65  Aligned_cols=270  Identities=19%  Similarity=0.277  Sum_probs=209.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCC--eeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD--FKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999976 58999999997543 234567789999999999999999999998755  789999


Q ss_pred             EecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeecCCcc
Q 048205          826 EYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~~  899 (1027)
                      ||+++++|.+++....  ..+++.++..++.|+++||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999997654  23899999999999999999999   9999999999999999    7888999999999986


Q ss_pred             cccCCCcceecccccCccccCccccc--------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGR--------EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      +....   ......||+.|+|||++.        +..++.++||||+||++|||++|+.||............. .....
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~  241 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM-YKIIT  241 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH-HHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH-HHHhc
Confidence            64332   223456999999999876        5678999999999999999999999997543332222211 11111


Q ss_pred             hhHHHhhh-------ccc--cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          972 ISIMEVVD-------ANL--LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       972 ~~~~~~~d-------~~~--~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....+...       ...  .............++..+.+++.+||++||++|||++|+++...
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            10000000       000  00001111223567778999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=367.75  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=211.3

Q ss_pred             HHhCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      ...++|+..+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            44678999999999999999999875      34789999987543 334567899999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL  876 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  876 (1027)
                      ..++||||+++|+|.+++....                       ..+++.+++.++.||++||+|||   +.+|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            9999999999999999987642                       45899999999999999999999   999999999


Q ss_pred             CCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 048205          877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDES  955 (1027)
Q Consensus       877 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~  955 (1027)
                      ||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999986543332233344568899999999998899999999999999999999 99999764


Q ss_pred             cccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          956 FTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       956 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...     ....        .+.+...       ...+..++.++.+++.+||+.||++||++.++++.|+
T Consensus       281 ~~~-----~~~~--------~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          281 AHE-----EVIY--------YVRDGNI-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             CHH-----HHHH--------HHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ChH-----HHHH--------HHhCCCc-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence            221     1111        0111111       0112356778999999999999999999999999886

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-39  Score=356.09  Aligned_cols=253  Identities=22%  Similarity=0.379  Sum_probs=207.5

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||+||+|++.++..||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            457888999999999999999999888999999975433 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++......+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence            999999999876667999999999999999999999   9999999999999999999999999999998653221 122


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||........  ..            .+.....    
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~------------~~~~~~~----  239 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE------------HIAQGLR----  239 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH------------HHHTTCC----
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HH------------HHhcccC----
Confidence            233456788999999998899999999999999999998 9999976432110  00            0111110    


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        ...+..++..+.+++.+||+.||++|||++|+++.|+
T Consensus       240 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          240 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence              1112334567899999999999999999999999886

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.5e-39  Score=360.32  Aligned_cols=258  Identities=20%  Similarity=0.199  Sum_probs=208.7

Q ss_pred             hCCCCccceeeccccceEEEEEe-cCCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++.....  .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36789999999999999999996 4789999999875432  34678899999999 99999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-----EEEeeecCCcccc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-----AHLSDFGMAKPFL  901 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~~~  901 (1027)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 89999999876667999999999999999999999   999999999999999998887     9999999998764


Q ss_pred             cCCCcc-----eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          902 KEDQSL-----TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       902 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ............   
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~~---  236 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIGDTK---  236 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHHHHH---
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHHhhh---
Confidence            332211     1245679999999999999999999999999999999999999998753221  111111110000   


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           ...   ........++ ++.+++.+|+..||++||++.++.+.|+
T Consensus       237 -----~~~---~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          237 -----RAT---PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             -----HHS---CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             -----ccC---CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence                 000   0001112345 7999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=364.74  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=210.5

Q ss_pred             HhCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCC
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  819 (1027)
                      ..++|+..+.||+|+||.||+|++.      +++.||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3467899999999999999999862      45689999997542 33457788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCc----------------------cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNY----------------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  877 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  877 (1027)
                      ..++||||+++|+|.+++.....                      .+++..+..++.||++||+|||   +.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976542                      3789999999999999999999   9999999999


Q ss_pred             CCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCc
Q 048205          878 PNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESF  956 (1027)
Q Consensus       878 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~  956 (1027)
                      |+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987655444444455667889999999998999999999999999999998 999997653


Q ss_pred             ccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          957 TGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ... .....            +.....      ...+..++.++.+++.+||..||++||++.|+++.|+
T Consensus       280 ~~~-~~~~~------------~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          280 VDA-NFYKL------------IQNGFK------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CSH-HHHHH------------HHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cHH-HHHHH------------HhcCCC------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            321 11111            111110      1112345677999999999999999999999999886

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=364.77  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=204.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||++++++|.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56889999999999999999876 68899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+.||+|.+++.... .+++..+..++.||+.||+|||   +.||+||||||+||+++.+|.+||+|||+++.+...  
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence            9999999999987653 4899999999999999999999   999999999999999999999999999999865432  


Q ss_pred             cceecccccCccccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          906 SLTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                       ......+||+.|+|||++..   ..++.++||||+||++|||++|+.||.......  ........         ....
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~---------~~~~  236 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTF---------ETTV  236 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHH---------HHCC
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHH---------hhcc
Confidence             23345679999999999874   458999999999999999999999997543221  11111110         0110


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-AKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~evl~ 1023 (1027)
                             ...+..++.++.+++.+||..||++||+ ++++++
T Consensus       237 -------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 -------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   0112345677899999999999999998 777654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-38  Score=349.94  Aligned_cols=259  Identities=14%  Similarity=0.124  Sum_probs=210.3

Q ss_pred             hCCCCccceeeccccceEEEEEe-cCCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....  ..+.+.+|+++++.+ +|++++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999996 478999999986443  235678899999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-----EEEeeecCCcccc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-----AHLSDFGMAKPFL  901 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~~~  901 (1027)
                      |+ +++|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 88999999877667999999999999999999999   999999999999999987776     9999999998765


Q ss_pred             cCCCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          902 KEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       902 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      .....     .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+ ....      
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~-~~~~------  234 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKY-ERIG------  234 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHH-HHHH------
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHH-HHHH------
Confidence            43221     123455799999999999999999999999999999999999999987432211 1111 0000      


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        ....   ..........++.++.+++.+||+.||++||+++++++.|+
T Consensus       235 --~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          235 --EKKQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             --HHHH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             --hhcc---CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence              0000   00011112356778999999999999999999999999886

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-39  Score=365.05  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCe
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  820 (1027)
                      ....++|+..+.||+|+||.||+|+++ +|+.||||++++..   ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999976 68999999997542   23456677899998877 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999987643 4899999999999999999999   999999999999999999999999999999854


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ....  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ..   ..        +...
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~---~~--------i~~~  233 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LF---HS--------IRMD  233 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH---HH--------HHHC
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HH---HH--------HHhC
Confidence            3222  22345679999999999999999999999999999999999999997642211  11   10        0001


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAK-EIV 1022 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-evl 1022 (1027)
                      ..        ..+..++.++.+++.+|+..||++||++. |++
T Consensus       234 ~~--------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 NP--------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CC--------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CC--------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            00        11123567789999999999999999987 654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.2e-39  Score=360.39  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=211.2

Q ss_pred             hCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|.+.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            456888999999999999999852      45789999987543 34457788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP  878 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  878 (1027)
                      ++||||+++|+|.+++....                       ..+++.++..++.|+++||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            99999999999999997643                       24889999999999999999999   99999999999


Q ss_pred             CcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcc
Q 048205          879 NNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFT  957 (1027)
Q Consensus       879 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~  957 (1027)
                      +||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333444567889999999998899999999999999999999 9999976432


Q ss_pred             cchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          958 GEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..  ....            +....      ....+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       259 ~~--~~~~------------~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          259 ER--LFNL------------LKTGH------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE  307 (314)
T ss_dssp             GG--HHHH------------HHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--HHHH------------hhcCC------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            21  1111            11110      01112356778999999999999999999999999886

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=373.00  Aligned_cols=261  Identities=23%  Similarity=0.299  Sum_probs=209.5

Q ss_pred             HHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEec
Q 048205          742 YLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSS  817 (1027)
Q Consensus       742 ~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  817 (1027)
                      +.+.....++|+..+.||+|+||+||+|+.+ +|+.||||++++..   ....+.+.+|.+++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444456788999999999999999999976 79999999997532   2234557889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       818 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                      .+..++||||++||+|.+++.+.+..+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999876556899999999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcceecccccCccccCccccc-------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGR-------EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +.+.... .......+||+.|+|||++.       ...++.++||||+||++|||++|+.||......+ .....+... 
T Consensus       210 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~-  286 (412)
T 2vd5_A          210 LKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYK-  286 (412)
T ss_dssp             EECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHH-
T ss_pred             eeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcc-
Confidence            8664332 22334467999999999987       4578999999999999999999999997643211 111111000 


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER---INAKEIVT 1023 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R---ps~~evl~ 1023 (1027)
                           +    .. ..    ...+..++.++.+++.+|+. +|++|   |+++|+++
T Consensus       287 -----~----~~-~~----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          287 -----E----HL-SL----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -----H----HC-CC----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             -----c----Cc-CC----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                 0    00 00    01123467788999999999 99998   58999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-39  Score=358.49  Aligned_cols=256  Identities=24%  Similarity=0.384  Sum_probs=212.1

Q ss_pred             hCCCCccceeeccccceEEEEEe------cCCceEEEEEEecccc-hhHHHHHHHHHHHhhc-cCCccceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI------QDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  820 (1027)
                      .++|+..+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35788999999999999999985      2467899999975533 3457788999999999 99999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCc-----------------cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          821 KALVLEYMPYGSLEKCLYSSNY-----------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      .++||||+++|+|.+++.....                 .+++..+..++.|+++||+|||   +.+|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999876542                 4899999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTL  962 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  962 (1027)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||........ .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence            9999999999999987655443333445567889999999998999999999999999999999 9999876533221 1


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...            +......      ..+..++.++.+++.+|++.||++||++.|+++.|+
T Consensus       258 ~~~------------~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  303 (313)
T 1t46_A          258 YKM------------IKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (313)
T ss_dssp             HHH------------HHHTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH------------hccCCCC------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            111            1111100      112345677899999999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.3e-39  Score=361.37  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=204.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|+..+.||+|+||.||+|+.+ +++.||||++.+..   ....+.+.+|.++++++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56889999999999999999976 68999999998643   23456678899999988 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999987644 4899999999999999999999   9999999999999999999999999999998543222


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchh---HHHHHHHHHhhhHHHhhhcc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT---LKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~d~~  981 (1027)
                        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.........   .....       ...+....
T Consensus       165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------~~~i~~~~  235 (345)
T 3a8x_A          165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-------FQVILEKQ  235 (345)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH-------HHHHHHCC
T ss_pred             --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH-------HHHHHcCC
Confidence              2334567999999999999999999999999999999999999999753221110   00000       00111111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA------KEIVT 1023 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~------~evl~ 1023 (1027)
                      .        ..+..++.++.+++.+||+.||++||++      .|+++
T Consensus       236 ~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 I--------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             C--------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             C--------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            1        1123456778999999999999999995      56654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.7e-39  Score=367.04  Aligned_cols=272  Identities=18%  Similarity=0.266  Sum_probs=206.3

Q ss_pred             hCCCCccceeecc--ccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRG--GFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..+|++.+.||+|  +||.||+|+.. +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3568889999999  99999999976 79999999998653  3345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          824 VLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999987652 45899999999999999999999   99999999999999999999999999999875432


Q ss_pred             CCC-----cceecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh---
Q 048205          903 EDQ-----SLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI---  972 (1027)
Q Consensus       903 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  972 (1027)
                      ...     ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||............+.......   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            211     111233478999999999987  5789999999999999999999999976533322211111100000   


Q ss_pred             ---hH----------------HHh---hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 ---SI----------------MEV---VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 ---~~----------------~~~---~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         ..                .+.   ..+............+..++.++.+|+.+||++||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence               00                000   0000000001111234456778999999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-39  Score=361.09  Aligned_cols=256  Identities=24%  Similarity=0.451  Sum_probs=193.6

Q ss_pred             HhCCCCccceeeccccceEEEEEecC-C---ceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQD-G---MEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      ..++|+..+.||+|+||+||+|++.. +   ..||||+++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45679999999999999999998763 3   27999998754  344567889999999999999999999999877655


Q ss_pred             ------EEEEEecCCCCHHHHHhcCC-----ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 048205          822 ------ALVLEYMPYGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  890 (1027)
Q Consensus       822 ------~lV~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  890 (1027)
                            ++||||+++|+|.+++....     ..+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999886432     25899999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDL  969 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  969 (1027)
                      |+|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |+.||......+.  ...    
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~----  251 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNY----  251 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HHH----
Confidence            999999987654433333344557889999999999999999999999999999999 8999876533211  110    


Q ss_pred             HhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          970 LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       970 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                             +....       ....+..++.++.+++.+||+.||++|||+.++++.|+
T Consensus       252 -------~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          252 -------LIGGN-------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             -------HHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HhcCC-------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                   01111       01112346677999999999999999999999999886

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.7e-40  Score=364.80  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=203.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCce----EEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGME----VAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ++|+..+.||+|+||+||+|++. +++.    ||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence            56888999999999999999865 4554    7777765332 2334567789999999999999999999864 56889


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999977554


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..........+|+.|+|||++.+..++.++||||+||++|||++ |+.||.......  ....            +....
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~------------~~~~~  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDL------------LEKGE  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHH------------HHTTC
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHH------------HHcCC
Confidence            44444455678889999999998999999999999999999999 999998643221  1111            11110


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++.++.+++.+||..||++||+++|+++.|+
T Consensus       235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          235 ------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT  272 (325)
T ss_dssp             ------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred             ------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                  01112235556789999999999999999999999885

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=8.6e-38  Score=363.96  Aligned_cols=317  Identities=21%  Similarity=0.199  Sum_probs=145.5

Q ss_pred             cccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCC
Q 048205           45 EIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPL  124 (1027)
Q Consensus        45 ~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~  124 (1027)
                      .++.+++|++|++++|.+++ +| .++.+++|++|+|++|++++. |  ++.+++|++|++++|++++ ++   +..+++
T Consensus        37 ~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~---~~~l~~  107 (457)
T 3bz5_A           37 SEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD---VTPLTK  107 (457)
T ss_dssp             EHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC---CTTCTT
T ss_pred             ChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee---cCCCCc
Confidence            34444444444444444442 22 344444444444444444432 2  4444444444444444442 11   334444


Q ss_pred             CcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccc
Q 048205          125 LQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN  204 (1027)
Q Consensus       125 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  204 (1027)
                      |++|++++|++++. +  +..+++|++|++++|.+++.   .++.+++|++|++++|+..+.+  .++.+++|++|++++
T Consensus       108 L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~  179 (457)
T 3bz5_A          108 LTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSF  179 (457)
T ss_dssp             CCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCC
Confidence            44444444444432 1  44444455555555544432   1444445555555555332222  244445555555555


Q ss_pred             cccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCC
Q 048205          205 NFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIP  284 (1027)
Q Consensus       205 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p  284 (1027)
                      |++++ +|  +..+++|+.|++++|++++               ++   +..+++|++|++++|++++          +|
T Consensus       180 n~l~~-l~--l~~l~~L~~L~l~~N~l~~---------------~~---l~~l~~L~~L~Ls~N~l~~----------ip  228 (457)
T 3bz5_A          180 NKITE-LD--VSQNKLLNRLNCDTNNITK---------------LD---LNQNIQLTFLDCSSNKLTE----------ID  228 (457)
T ss_dssp             SCCCC-CC--CTTCTTCCEEECCSSCCSC---------------CC---CTTCTTCSEEECCSSCCSC----------CC
T ss_pred             Cccce-ec--cccCCCCCEEECcCCcCCe---------------ec---cccCCCCCEEECcCCcccc----------cC
Confidence            55543 22  4444555555555555442               10   2234444555555554442          22


Q ss_pred             ccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCC
Q 048205          285 KEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLP  364 (1027)
Q Consensus       285 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~  364 (1027)
                        ++.+++|+.|++++|+++++.   ++.+++|+.|++++|              +|+.|++++|.+.+.+|.   ..++
T Consensus       229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~~---~~l~  286 (457)
T 3bz5_A          229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQA---EGCR  286 (457)
T ss_dssp             --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEEC---TTCT
T ss_pred             --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCcccc---cccc
Confidence              334455555555555555432   233444444444443              233445555555444442   2345


Q ss_pred             CccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccE
Q 048205          365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEY  444 (1027)
Q Consensus       365 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~  444 (1027)
                      +|++|+|++|...+.+|.   ...+|+.|++++|             ++|++|++++|+|++++       +..|+.|+.
T Consensus       287 ~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l~-------l~~l~~L~~  343 (457)
T 3bz5_A          287 KIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTELD-------VSHNTKLKS  343 (457)
T ss_dssp             TCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCCC-------CTTCTTCSE
T ss_pred             cCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCcccccc-------cccCCcCcE
Confidence            556666666655555443   2334444444433             45666666666665542       235566666


Q ss_pred             eeccCCCCCC
Q 048205          445 FSISNNPLGG  454 (1027)
Q Consensus       445 L~Ls~N~l~~  454 (1027)
                      |++++|++++
T Consensus       344 L~l~~N~l~~  353 (457)
T 3bz5_A          344 LSCVNAHIQD  353 (457)
T ss_dssp             EECCSSCCCB
T ss_pred             EECCCCCCCC
Confidence            6666666554

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.6e-39  Score=362.65  Aligned_cols=265  Identities=18%  Similarity=0.229  Sum_probs=207.3

Q ss_pred             HhCCCCccceeeccccceEEEEEecC------CceEEEEEEecccchhH-----------HHHHHHHHHHhhccCCccce
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQD------GMEVAVKVFDLQYGRAI-----------KSFDIECGMIKRIRHRNIIK  810 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~  810 (1027)
                      ..++|++.+.||+|+||+||+|++..      ++.||||++........           ..+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34579999999999999999998764      47899999875532111           12334566677888999999


Q ss_pred             EEeEEecC----CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--
Q 048205          811 FISSCSSD----DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--  884 (1027)
Q Consensus       811 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--  884 (1027)
                      +++++...    ...++||||+ +++|.+++......+++.++..++.||+.||+|||   +.+|+||||||+||+++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            99998764    4589999999 89999999887677999999999999999999999   99999999999999999  


Q ss_pred             CCCcEEEeeecCCcccccCCCcc-----eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSL-----TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE  959 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  959 (1027)
                      .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            88999999999998764332211     1133459999999999999999999999999999999999999998643322


Q ss_pred             hhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          960 MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       960 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       ....+..........+..++...         ...++.++.+++.+||..+|++||++.++++.|+
T Consensus       269 -~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          269 -KYVRDSKIRYRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             -HHHHHHHHHHHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             -HHHHHHHHHhhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence             22222222222223333333221         1245678999999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-39  Score=356.16  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=204.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CC-------ceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DG-------MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  820 (1027)
                      .++|+..+.||+|+||+||+|++. ++       +.||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            356888999999999999999865 33       4699999987666667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--------EEEe
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--------AHLS  892 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~  892 (1027)
                      .++||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999887766999999999999999999999   999999999999999998887        9999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |||.+.....      .....+|+.|+|||++.+ ..++.++||||+||++|||++|..|+............+      
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~------  231 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY------  231 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh------
Confidence            9999975422      123458899999999987 678999999999999999999665544332211111100      


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                            .+...         .+..++.++.+++.+||+.||++|||++|+++.|++
T Consensus       232 ------~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  272 (289)
T 4fvq_A          232 ------EDRHQ---------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS  272 (289)
T ss_dssp             ------HTTCC---------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred             ------hccCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                  00000         011234457899999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=354.38  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=198.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------------------------hhHHHHHHHHHHHh
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------------------------RAIKSFDIECGMIK  801 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  801 (1027)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467899999999999999999865 689999999875421                          12356889999999


Q ss_pred             hccCCccceEEeEEec--CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 048205          802 RIRHRNIIKFISSCSS--DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN  879 (1027)
Q Consensus       802 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~  879 (1027)
                      +++||||+++++++.+  .+..++||||+++++|.+++..  ..+++.++..++.|+++||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  5688999999999999886543  35899999999999999999999   999999999999


Q ss_pred             cEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCc
Q 048205          880 NVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTRKKPTDESF  956 (1027)
Q Consensus       880 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~  956 (1027)
                      ||+++.++.+||+|||+++.+....  .......||+.|+|||++.+..   ++.++||||+||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999998664332  2234567999999999988665   4788999999999999999999997542


Q ss_pred             ccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          957 TGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .     ..+...        +......      +.....++.++.+++.+||+.||++||++.|+++
T Consensus       245 ~-----~~~~~~--------~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 I-----MCLHSK--------IKSQALE------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H-----HHHHHH--------HHHCCCC------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H-----HHHHHH--------HhcccCC------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            1     111110        0011110      0111245677899999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-39  Score=361.79  Aligned_cols=249  Identities=20%  Similarity=0.274  Sum_probs=205.2

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  822 (1027)
                      ..++|+..+.||+|+||.||+|+.+ +|+.||||++++..   ....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999976 58899999997542   23456678899999888 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999987644 4899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+.....
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~--------~i~~~~~  238 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQ--------SIMEHNV  238 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHCCC
T ss_pred             CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-----HHHH--------HHHhCCC
Confidence            22  2334567999999999999999999999999999999999999999764221     1111        1111111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                              ..+..++.++.+++.+|+..||++||+     ++|+++
T Consensus       239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                    112346677899999999999999995     577764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.3e-39  Score=361.10  Aligned_cols=245  Identities=21%  Similarity=0.246  Sum_probs=205.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.+..   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357899999999999999999976 68999999997542   23456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999987654 4899999999999999999999   999999999999999999999999999999865322 


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                          ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+.....  
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~--------~i~~~~~--  255 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-----QIYE--------KIVSGKV--  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHCCC--
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-----HHHH--------HHHcCCC--
Confidence                23457999999999999999999999999999999999999999764211     1111        1111111  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                            ..+..++.++.+++.+||+.||++||+     ++|+++
T Consensus       256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                  112346677899999999999999998     888875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.3e-39  Score=349.92  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=196.2

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccc----hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG----RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..+|+..+.||+|+||.||+|++. ++.||||++.....    ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357889999999999999999975 88999999864422    2356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC---eEeccCCCCcEEEcC--------CCcEEEee
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP---IIHCDLKPNNVLLDD--------NMVAHLSD  893 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~kl~D  893 (1027)
                      |||+++++|.+++...  .+++..+..++.|+++|++|||   +.+   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999998643  5899999999999999999999   777   999999999999986        77899999


Q ss_pred             ecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          894 FGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       894 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      ||.++.+....    .....||+.|+|||++.+..++.++||||+|+++|||++|+.||........  ..         
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~---------  224 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--AY---------  224 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HH---------
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---------
Confidence            99998654322    2245689999999999998999999999999999999999999976432111  00         


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        .......      ....+..++..+.+++.+||+.||++|||+.|++++|++
T Consensus       225 --~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          225 --GVAMNKL------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             --HHHTSCC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             --hhhcCCC------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence              0001110      111223566789999999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-38  Score=354.23  Aligned_cols=265  Identities=27%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             HHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhh--ccCCccceEEeEEecC---
Q 048205          744 ELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR--IRHRNIIKFISSCSSD---  818 (1027)
Q Consensus       744 ~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~---  818 (1027)
                      ......++|++.+.||+|+||.||+|++. ++.||||++....   ...+..|.+++..  ++||||+++++++...   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            33445578999999999999999999876 8999999986432   2334445555554  4899999999999877   


Q ss_pred             -CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC--------CeEeccCCCCcEEEcCCCcE
Q 048205          819 -DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV--------PIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       819 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~Dlkp~NIll~~~~~~  889 (1027)
                       ...++||||+++|+|.+++...  .+++..+..++.|++.||+|||   +.        +|+||||||+||+++.++.+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence             7889999999999999999765  4899999999999999999999   77        99999999999999999999


Q ss_pred             EEeeecCCcccccCCCc--ceecccccCccccCcccccCCCCCcc------hhHHHHHHHHHHHHcC----------CCC
Q 048205          890 HLSDFGMAKPFLKEDQS--LTQTQTLATIGYMAPEYGREGRVSTN------GDVYSFGIMLMETFTR----------KKP  951 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslGvil~elltg----------~~p  951 (1027)
                      ||+|||+++.+......  .......||+.|+|||++.+.....+      +||||+||++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999999866433221  11234579999999999987766554      9999999999999999          566


Q ss_pred             CCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          952 TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      |............+..         ...................++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       262 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMRE---------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             TTTTSCSSCCHHHHHH---------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HhhhcCCCCchhhhHH---------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence            6544333222222211         11111111111122223468888999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.4e-39  Score=351.96  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=195.8

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..+|+..+.||+|+||+||+|++.  ..||||+++...  ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999865  359999987543  33457789999999999999999999965 4556899999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++++|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877777999999999999999999999   999999999999999999999999999999865433333


Q ss_pred             ceecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          907 LTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .......||+.|+|||++.   ...++.++||||+|+++|||++|+.||....... .....+            .....
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~------------~~~~~  243 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMV------------GRGSL  243 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHH------------HHTSC
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHh------------ccccc
Confidence            3344567999999999986   5678899999999999999999999997643221 111111            11110


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...  .......++.++.+++.+||+.||++||++.|+++.|+
T Consensus       244 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  284 (289)
T 3og7_A          244 SPD--LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE  284 (289)
T ss_dssp             CCC--TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             Ccc--hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            000  00112356778999999999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-38  Score=347.05  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=209.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356889999999999999999976 78999999997543 3345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++++|.+++... ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.+..+......
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999999988654 35899999999999999999999   999999999999999999999999999999865433322


Q ss_pred             ceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||............|..            ..    
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------~~----  225 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------KK----  225 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT------------TC----
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh------------cc----
Confidence            23345678999999999987765 77899999999999999999999875443333333321            00    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ........++..+.+++.+|++.||++|||+.|+++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              011112345677899999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=361.92  Aligned_cols=252  Identities=22%  Similarity=0.357  Sum_probs=198.5

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccC--CccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRH--RNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||.||+|+..+++.||||++....  ....+.+.+|++++++++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45688999999999999999998889999999997543  3345778899999999987  9999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||+ .+++|.+++.... .+++.++..++.|+++||+|||   +.+|+||||||+||+++ ++.+||+|||+++.+....
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5779999998754 4899999999999999999999   99999999999999997 6889999999998765443


Q ss_pred             CcceecccccCccccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          905 QSLTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      .........||+.|+|||++.+           ..++.++||||+||++|||++|+.||.........            
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------  229 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------  229 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH------------
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH------------
Confidence            3333445679999999999864           67899999999999999999999999754321111            


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .....++....      ..+...+.++.+++.+||+.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          230 LHAIIDPNHEI------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHHCTTSCC------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhcCCccc------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            11122221111      1112334568899999999999999999999863

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.2e-39  Score=360.32  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=192.4

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..++|++.+.||+|+||.||+|++. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3467899999999999999999976 58899999997543  34567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCCcccccC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+++|+|.+++.... .+++.++..++.|+++||+|||   +.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999987654 4899999999999999999999   999999999999999975   899999999999865322


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         .......||+.|+|||++.+..++.++||||+||++|||++|+.||............            +......
T Consensus       205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------i~~~~~~  269 (349)
T 2w4o_A          205 ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR------------ILNCEYY  269 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH------------HHTTCCC
T ss_pred             ---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH------------HHhCCCc
Confidence               1233457999999999999999999999999999999999999999764322111111            1111110


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .    .......++.++.+++.+|+..||++||++.|+++.
T Consensus       270 ~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 F----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             C----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0    011123466778999999999999999999999863

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-39  Score=359.07  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCe----
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF----  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  820 (1027)
                      .++|++.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            467999999999999999999964 78999999997543   2335678899999999999999999999876543    


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||+++++|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999987654 4899999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCCCc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          901 LKEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       901 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      ...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...            ...
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~------------~~~  233 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQ------------HVR  233 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH------------HHH
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHH------------Hhc
Confidence            433221 223345689999999999999999999999999999999999999976432111 000            000


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .    ...........++.++.+++.+||+.||++||++.++++
T Consensus       234 ~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          234 E----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             C----CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             C----CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            1    111111223456778999999999999999997777664

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=353.27  Aligned_cols=244  Identities=22%  Similarity=0.247  Sum_probs=196.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||+||+|++. +|+.||||++.....  ........|+..+.++ +||||++++++|.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            56999999999999999999976 799999999865432  2333445555555555 8999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence            999 66999988877777999999999999999999999   899999999999999999999999999999865432  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       .......||+.|+|||++.+ .++.++||||+||++|||++|..|+....       .|.         .+....    
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-------~~~---------~~~~~~----  268 (311)
T 3p1a_A          211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-------GWQ---------QLRQGY----  268 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------HHH---------HHTTTC----
T ss_pred             -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHH---------HHhccC----
Confidence             22344569999999998875 78999999999999999999987765421       110         011100    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .....+..++.++.+++.+||++||++|||++|+++
T Consensus       269 --~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 --LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              011233456788999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.1e-39  Score=351.26  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             hCCCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|++.+.||+|+||.||+|++..    +..||+|++.... ....+.+.+|++++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4578889999999999999998642    4579999986533 334567889999999999999999999985 456899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877767999999999999999999999   999999999999999999999999999999865432


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      . ........+++.|+|||++....++.++||||+||++|||++ |+.||......+  ....           +.... 
T Consensus       170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~-----------i~~~~-  234 (281)
T 1mp8_A          170 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR-----------IENGE-  234 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH-----------HHTTC-
T ss_pred             c-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH-----------HHcCC-
Confidence            2 122233456789999999998899999999999999999997 999997653221  1111           00100 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                  01122356778999999999999999999999999886

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.9e-39  Score=361.22  Aligned_cols=253  Identities=23%  Similarity=0.297  Sum_probs=195.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|+..+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999976 789999999975432 336688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--EEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--AHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~~~~  905 (1027)
                      +++|+|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.  +||+|||+++.....  
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--  171 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  171 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence            99999999987644 4899999999999999999999   999999999999999987765  999999999743221  


Q ss_pred             cceecccccCccccCcccccCCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ ....+..        +.....  
T Consensus       172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~--------~~~~~~--  239 (361)
T 3uc3_A          172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQR--------ILSVKY--  239 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHH--------HHTTCC--
T ss_pred             -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHH--------HhcCCC--
Confidence             22344579999999999988877655 8999999999999999999986533221 1221111        111111  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          .......++.++.+++.+||..||++|||+.|+++.
T Consensus       240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                111112356678999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-38  Score=355.27  Aligned_cols=248  Identities=20%  Similarity=0.243  Sum_probs=182.6

Q ss_pred             cceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          755 NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      .+.||+|+||+||+|++. +++.||||++...   ....+.+|+++++.++ ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999976 6899999999743   3456778999999997 9999999999999999999999999999


Q ss_pred             HHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeeecCCcccccCCCccee
Q 048205          833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFGMAKPFLKEDQSLTQ  909 (1027)
Q Consensus       833 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~~  909 (1027)
                      |.+++.... .+++.++..++.|+++||+|||   +.+|+||||||+||+++.++   .+||+|||+++......  ...
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            999998754 5899999999999999999999   99999999999999998766   89999999998654322  223


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc--hhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE--MTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....+.            ..........
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------~~~i~~~~~~  234 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI------------MKKIKKGDFS  234 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH------------HHHHTTTCCC
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH------------HHHHHcCCCC
Confidence            44568999999999999999999999999999999999999997643211  011111            1111111111


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....+..++.++.+++.+||++||++|||++|+++
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            122233457788999999999999999999998874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4e-39  Score=360.36  Aligned_cols=268  Identities=25%  Similarity=0.354  Sum_probs=212.7

Q ss_pred             CCCCccceeeccccceEEEEEe-----cCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEe--cCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS--SDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~  822 (1027)
                      ++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688899999999999999984     368899999998766666778999999999999999999999886  456789


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999876666999999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh-hhHHHhhhc
Q 048205          903 EDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL-ISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~  980 (1027)
                      .... .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||............+...... ....+.+..
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            3221 12234468888999999998889999999999999999999999986532111000000000000 011111111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..      ....+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       260 ~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          260 GQ------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             TC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cc------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11      11123457788999999999999999999999999886

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-38  Score=354.11  Aligned_cols=268  Identities=24%  Similarity=0.305  Sum_probs=192.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..+|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999875 689999999975432 234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-----ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          827 YMPYGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |++ |+|.+++....     ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 49999886432     35899999999999999999999   9999999999999999999999999999998654


Q ss_pred             cCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---HHHh
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---IMEV  977 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  977 (1027)
                      ...  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..............   ....
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhh
Confidence            322  12334578999999999876 46899999999999999999999999865322 11222211111000   0000


Q ss_pred             -----hhccccCccch------hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 -----VDANLLSHEDK------HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 -----~d~~~~~~~~~------~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           +.+........      .......++.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                 00000000000      00111245678999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-38  Score=359.04  Aligned_cols=259  Identities=23%  Similarity=0.318  Sum_probs=204.1

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc-----cchhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ-----YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      ....++|++.+.||+|+||+||+|+.. +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            455677999999999999999999875 6889999998754     2344578889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcC---------------------------------------CccCCHHHHHHHHHHHHHHH
Q 048205          820 FKALVLEYMPYGSLEKCLYSS---------------------------------------NYILDIFQRLNIMIDVASAL  860 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~l  860 (1027)
                      ..++||||+++|+|.+++...                                       ...+++..+..++.|+++||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999988521                                       12246778889999999999


Q ss_pred             HHhhcCCCCCeEeccCCCCcEEEcCCC--cEEEeeecCCcccccCCC--cceecccccCccccCcccccC--CCCCcchh
Q 048205          861 EYLHFGYSVPIIHCDLKPNNVLLDDNM--VAHLSDFGMAKPFLKEDQ--SLTQTQTLATIGYMAPEYGRE--GRVSTNGD  934 (1027)
Q Consensus       861 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  934 (1027)
                      +|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999   99999999999999998776  899999999986543222  122345679999999999875  67899999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCC
Q 048205          935 VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEE 1014 (1027)
Q Consensus       935 vwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~ 1014 (1027)
                      |||+||++|||++|+.||......+. .            ..+.......    .......++.++.+++.+||..||++
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~-~------------~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADT-I------------SQVLNKKLCF----ENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHCCCCT----TSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHH-H------------HHHHhccccc----CCcccccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999976432211 1            1111111111    11122346778999999999999999


Q ss_pred             CCCHHHHHHH
Q 048205         1015 RINAKEIVTK 1024 (1027)
Q Consensus      1015 Rps~~evl~~ 1024 (1027)
                      ||++.|+++.
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.1e-39  Score=349.21  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=210.2

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            356888999999999999999998889999999975543 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            999999999887677899999999999999999999   999999999999999999999999999999865321 1112


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......     ....        .+.. ...    
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~--------~i~~-~~~----  223 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVE--------DIST-GFR----  223 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH--------HHHT-TCC----
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHHH--------HHhc-CCc----
Confidence            233457788999999998899999999999999999999 89998764221     1111        0000 000    


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        ...+..++..+.+++.+||+.||++||+++|+++.|+
T Consensus       224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          224 --LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              0112235667899999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=358.14  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceE----EEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEV----AVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      .++|+..+.||+|+||+||+|++. +++.|    |+|.+... .....+.+.+|++++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367899999999999999999865 55554    66666432 2345678889999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +|+||+.+|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ...........+|+.|+|||++.+..++.++||||+||++|||++ |+.||.......  ...            .+...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~------------~~~~~  235 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS------------ILEKG  235 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH------------HHHTT
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH------------HHHcC
Confidence            443334444567889999999999999999999999999999999 999997653322  111            11111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .      ....+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       236 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  274 (327)
T 3lzb_A          236 E------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             C------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1      11122346677999999999999999999999999886

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.5e-39  Score=347.49  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=204.5

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV  824 (1027)
                      .++|+..+.||+|+||+||+|++. ++.||||++....  ....+.+.+|++++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            356889999999999999999985 8899999997543  33456789999999999999999999999887  788999


Q ss_pred             EEecCCCCHHHHHhcCCc-cCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          825 LEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |||+++|+|.+++..... .+++..+..++.|+++|++|||   +.+  |+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987653 5899999999999999999999   888  9999999999999999999999999876422


Q ss_pred             cCCCcceecccccCccccCcccccCCCCCc---chhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGRVST---NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                             .....||+.|+|||++.+..++.   ++||||+||++|||++|+.||.........             ....
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------~~~~  224 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-------------MKVA  224 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-------------HHHH
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-------------HHHH
Confidence                   22346899999999998765544   799999999999999999999764321110             0011


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....      ....+..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       225 ~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~  266 (271)
T 3kmu_A          225 LEGL------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE  266 (271)
T ss_dssp             HSCC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111      01122356778999999999999999999999999886

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-38  Score=355.46  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCC-------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-------  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  819 (1027)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356889999999999999999976 79999999997543 335577899999999999999999999986543       


Q ss_pred             --------------------------------------------------eeEEEEEecCCCCHHHHHhcCC--ccCCHH
Q 048205          820 --------------------------------------------------FKALVLEYMPYGSLEKCLYSSN--YILDIF  847 (1027)
Q Consensus       820 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~--~~~~~~  847 (1027)
                                                                        ..++||||+++|+|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3799999999999999998654  335677


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc----------ceecccccCcc
Q 048205          848 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS----------LTQTQTLATIG  917 (1027)
Q Consensus       848 ~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~  917 (1027)
                      .+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   999999999999999999999999999999876543211          12234579999


Q ss_pred             ccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhH
Q 048205          918 YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCM  997 (1027)
Q Consensus       918 y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  997 (1027)
                      |+|||++.+..++.++||||+||++|||++|..|+...       .....        .....    .   ........+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~--------~~~~~----~---~~~~~~~~~  299 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIIT--------DVRNL----K---FPLLFTQKY  299 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHH--------HHHTT----C---CCHHHHHHC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHH--------Hhhcc----C---CCcccccCC
Confidence            99999999999999999999999999999987663210       00000        00000    0   111223455


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          998 SFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       998 ~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      +++.+++.+||+.||++||++.|+++.
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            667899999999999999999999873

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.1e-39  Score=359.37  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=208.7

Q ss_pred             hCCCCccceeeccccceEEEEEec--------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD  818 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  818 (1027)
                      .++|++.+.||+|+||.||+|++.        +++.||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367889999999999999999863        46789999987543 33456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      +..++||||+++|+|.+++....               ..+++..+..++.||++||+|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999997653               24889999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTL  962 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  962 (1027)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||......    
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence            9999999999999987654333333344567889999999998889999999999999999999 99998764221    


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       .....         +.....      ...+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       267 -~~~~~---------~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  314 (334)
T 2pvf_A          267 -ELFKL---------LKEGHR------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  314 (334)
T ss_dssp             -HHHHH---------HHHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHH---------HhcCCC------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             11110         000000      0112346677999999999999999999999999886

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-38  Score=364.53  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhcc--CCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIR--HRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .+|++.+.||+|+||.||+|+..+++.||||++....  ....+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4589999999999999999998889999999997543  334577899999999997  599999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      | +.+++|.+++.... .+++.++..++.||++||+|||   +.+|+||||||+||+++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 55779999998754 5788899999999999999999   99999999999999995 58999999999987654333


Q ss_pred             cceecccccCccccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          906 SLTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      .......+||+.|+|||++.+           ..++.++||||+||++|||++|+.||.........            .
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~------------~  277 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------L  277 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------------H
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH------------H
Confidence            333445679999999999865           46889999999999999999999999754221111            1


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ..++++.....      .+...+.++.+++.+||..||++||++.|+++.
T Consensus       278 ~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 HAIIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhCccccCC------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            12222221111      112235568899999999999999999999853

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-39  Score=355.82  Aligned_cols=265  Identities=23%  Similarity=0.412  Sum_probs=207.6

Q ss_pred             CCCCccceeeccccceEEEEEe-----cCCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecC--Cee
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  821 (1027)
                      +.|+..+.||+|+||.||+|++     .+++.||||++.... ....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4478889999999999999983     368899999987543 23457788999999999999999999999876  668


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999776667999999999999999999999   9999999999999999999999999999998765


Q ss_pred             cCCCc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH----hhhHHH
Q 048205          902 KEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL----LISIME  976 (1027)
Q Consensus       902 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~  976 (1027)
                      ..... .......+|..|+|||++.+..++.++||||+|+++|||++|+.|+......   .........    ......
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHHH
Confidence            43322 2233456888899999999999999999999999999999999986532110   000000000    000111


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ......      ....+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       255 ~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          255 TLKEGK------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             HHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhccC------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            111111      11223456778999999999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-38  Score=345.65  Aligned_cols=250  Identities=23%  Similarity=0.307  Sum_probs=207.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            456899999999999999999876 5789999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecCCcccccCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||++..+....
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999887654 4899999999999999999999   9999999999999999   788999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                         ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||......+. ...            +.....  
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~------------~~~~~~--  224 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLK------------IREGTF--  224 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHHCCC--
T ss_pred             ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHH------------HHhCCC--
Confidence               2334569999999998865 489999999999999999999999976432111 010            111110  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .........++.++.+++.+|++.||++||++.|+++
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 --TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0011122356778999999999999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.7e-39  Score=357.00  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=196.0

Q ss_pred             hCCCCccceeeccccceEEEEEe----cCCceEEEEEEeccc----chhHHHHHHHHHHHhhccCCccceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI----QDGMEVAVKVFDLQY----GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  820 (1027)
                      .++|+..+.||+|+||.||+|+.    .+|+.||+|++++..    ......+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46789999999999999999986    478999999997542    2334567789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987644 4789999999999999999999   999999999999999999999999999999854


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ....  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......     ...        .+...
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~--------~i~~~  236 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----TID--------KILKC  236 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHH--------HHHHT
T ss_pred             ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----HHH--------HHHhC
Confidence            3221  22344579999999999999999999999999999999999999997642211     111        11111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      ..        ..+..++.++.+++.+||..||++||     ++.|+++
T Consensus       237 ~~--------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KL--------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CC--------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CC--------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            11        11224567789999999999999999     7888875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7e-39  Score=356.69  Aligned_cols=265  Identities=23%  Similarity=0.380  Sum_probs=214.2

Q ss_pred             ccHHHHHHHhCCCCccceeeccccceEEEEEe------cCCceEEEEEEecccc-hhHHHHHHHHHHHhhc-cCCccceE
Q 048205          740 FTYLELFQATNGFSENNLIGRGGFGFVYKARI------QDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRI-RHRNIIKF  811 (1027)
Q Consensus       740 ~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l  811 (1027)
                      +.........++|++.+.||+|+||+||+|++      .+++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            33444445567899999999999999999974      2568899999975433 3456788999999999 79999999


Q ss_pred             EeEEecCC-eeEEEEEecCCCCHHHHHhcCCc---------------cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 048205          812 ISSCSSDD-FKALVLEYMPYGSLEKCLYSSNY---------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD  875 (1027)
Q Consensus       812 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  875 (1027)
                      ++++...+ ..++||||+++|+|.+++.....               .+++..+..++.|+++||+|||   +.+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99987754 58999999999999999976543               2789999999999999999999   99999999


Q ss_pred             CCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 048205          876 LKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDE  954 (1027)
Q Consensus       876 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~  954 (1027)
                      |||+||+++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||+||++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654444444455668899999999999999999999999999999998 9999976


Q ss_pred             CcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          955 SFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...... ....+            .....      ...+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       254 ~~~~~~-~~~~~------------~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          254 VKIDEE-FCRRL------------KEGTR------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             CCCSHH-HHHHH------------HHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cchhHH-HHHHh------------ccCcc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            533221 11110            00000      0112235667899999999999999999999999886

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-38  Score=363.80  Aligned_cols=271  Identities=24%  Similarity=0.358  Sum_probs=196.3

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhcc-CCccceEEeEEecCC--e
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDD--F  820 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  820 (1027)
                      ...++|++.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999865 7899999998643  2344567788999999997 999999999997544  7


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||++ |+|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999998 5999988764  4899999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCC-------------------CcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccch
Q 048205          901 LKED-------------------QSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEM  960 (1027)
Q Consensus       901 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  960 (1027)
                      ....                   ........+||++|+|||++.+ ..++.++||||+||++|||++|++||.+.... .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            3211                   1122344679999999999876 67899999999999999999999999865322 1


Q ss_pred             hHHHHHHHHHhhhHHHhh-----------h---ccc---cCccchhhh----------HHhhhHHHHHHHHHHhcccCCC
Q 048205          961 TLKRWVNDLLLISIMEVV-----------D---ANL---LSHEDKHFV----------AKEQCMSFVFNLAMKCTIESPE 1013 (1027)
Q Consensus       961 ~~~~~~~~~~~~~~~~~~-----------d---~~~---~~~~~~~~~----------~~~~~~~~l~~Li~~cl~~dP~ 1013 (1027)
                      .+..............+.           +   ...   .......+.          .+..++.++.+|+.+||..||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            222222111111000000           0   000   000000000          0114567899999999999999


Q ss_pred             CCCCHHHHHHH
Q 048205         1014 ERINAKEIVTK 1024 (1027)
Q Consensus      1014 ~Rps~~evl~~ 1024 (1027)
                      +|||++|+++.
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-38  Score=371.30  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             HhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC-eeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-FKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e  826 (1027)
                      ..++|+..+.||+|+||.||+|++. |+.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999876 7899999997543  4578899999999999999999999987665 7899999


Q ss_pred             ecCCCCHHHHHhcCCc-cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++|+|.+++..... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999986543 4699999999999999999999   999999999999999999999999999999854221  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                         .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....            +...   
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~------------i~~~---  402 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR------------VEKG---  402 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHH------------HHTT---
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HHcC---
Confidence               122357889999999999999999999999999999998 999997653221  1111            1111   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         .+...+..++.++.+++.+||+.||++|||+.++++.|+
T Consensus       403 ---~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          403 ---YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence               111233467888999999999999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.4e-39  Score=376.85  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=208.7

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||+||+|++++++.||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            45688889999999999999999888999999997543 34678999999999999999999999987 56789999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+++.... ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~  340 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  340 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HH
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-ee
Confidence            9999999997543 35789999999999999999999   9999999999999999999999999999998653211 11


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......+++.|+|||++....++.++|||||||++|||+| |+.||......+  ....            +....    
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~------------i~~~~----  402 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRA------------LERGY----  402 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH------------HHHTC----
T ss_pred             ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HHcCC----
Confidence            1223346788999999998999999999999999999999 999997642211  1111            11110    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        +...+..++.++.+++.+||+.||++|||+++|++.|++
T Consensus       403 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~  441 (454)
T 1qcf_A          403 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  441 (454)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence              112234577889999999999999999999999999863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-38  Score=368.61  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=206.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..+|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            356889999999999999999976 79999999997542   22356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999987643 5899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......     ....        .+.+... 
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~--------~i~~~~~-  233 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFK--------KICDGIF-  233 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHH--------HHHTTCC-
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHH--------HHhcCCc-
Confidence               2334579999999999988765 68999999999999999999999764221     1111        1111111 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                             ..+..++.++.+++.+||..||++|||+.|+++
T Consensus       234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                   112235667899999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.1e-38  Score=352.03  Aligned_cols=252  Identities=20%  Similarity=0.302  Sum_probs=207.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch------hHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++......      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            346889999999999999999976 6899999999754321      356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMA  897 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla  897 (1027)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999999998764 35899999999999999999999   99999999999999999888    7999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      +......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......     .....        +
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~--------i  230 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLAN--------I  230 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHH--------H
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH--------H
Confidence            8654322   223456999999999999999999999999999999999999999764221     11110        0


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ....    ..........++..+.+++.+|+..||++|||+.|+++.
T Consensus       231 ~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 TSVS----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HTTC----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             Hhcc----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000    011112234567779999999999999999999999863

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.4e-37  Score=363.30  Aligned_cols=352  Identities=26%  Similarity=0.351  Sum_probs=278.6

Q ss_pred             cCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCe
Q 048205           23 SNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSN  102 (1027)
Q Consensus        23 ~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  102 (1027)
                      ..+++++.|+++++.+. .+|. +..+++|++|+|++|.+++. +. ++++++|++|++++|.+++..+  +.++++|++
T Consensus        43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            34678888999888887 4663 78888899999999988844 44 8888899999999998885544  888899999


Q ss_pred             EeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCcc
Q 048205          103 LDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNR  182 (1027)
Q Consensus       103 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  182 (1027)
                      |++++|++++ ++.  +..+++|++|++++|.+.+.  ..+..+++|++|+++ |.+.+..  .+.++++|++|++++|+
T Consensus       117 L~L~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~  188 (466)
T 1o6v_A          117 LTLFNNQITD-IDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNK  188 (466)
T ss_dssp             EECCSSCCCC-CGG--GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             EECCCCCCCC-ChH--HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCc
Confidence            9999998874 332  77888999999999988854  358888999999986 4555332  38888999999999999


Q ss_pred             CCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccE
Q 048205          183 LQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEE  262 (1027)
Q Consensus       183 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~  262 (1027)
                      +++.  ..+..+++|++|++++|.+++..|  +..+++|+.|++++|++++               +  ..+..+++|+.
T Consensus       189 l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~---------------~--~~l~~l~~L~~  247 (466)
T 1o6v_A          189 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD---------------I--GTLASLTNLTD  247 (466)
T ss_dssp             CCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC---------------C--GGGGGCTTCSE
T ss_pred             CCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc---------------c--hhhhcCCCCCE
Confidence            8854  358888999999999999986554  7778899999999998873               2  13456788888


Q ss_pred             EEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcc
Q 048205          263 IYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLK  342 (1027)
Q Consensus       263 L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  342 (1027)
                      |++++|.+++.          +. +..+++|+.|++++|++++..+  +..+++|+.|++++|++.+..+  +..+++|+
T Consensus       248 L~l~~n~l~~~----------~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~  312 (466)
T 1o6v_A          248 LDLANNQISNL----------AP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLT  312 (466)
T ss_dssp             EECCSSCCCCC----------GG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCS
T ss_pred             EECCCCccccc----------hh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCC
Confidence            88888888742          22 6677888999999998887654  7888888899999988887655  77888888


Q ss_pred             eEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCC
Q 048205          343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN  422 (1027)
Q Consensus       343 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  422 (1027)
                      .|++++|++.+..|   +..+++|++|++++|++++.  ..+.++++|+.|++++|++++..|  +..+++|+.|++++|
T Consensus       313 ~L~L~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n  385 (466)
T 1o6v_A          313 YLTLYFNNISDISP---VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  385 (466)
T ss_dssp             EEECCSSCCSCCGG---GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCE
T ss_pred             EEECcCCcCCCchh---hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCC
Confidence            88888888876554   34678888888888888764  467888888888888888887766  788888888888888


Q ss_pred             CCCCCCCcc
Q 048205          423 YLTSSTSEL  431 (1027)
Q Consensus       423 ~l~~~~~~l  431 (1027)
                      +++..|...
T Consensus       386 ~~~~~p~~~  394 (466)
T 1o6v_A          386 AWTNAPVNY  394 (466)
T ss_dssp             EEECCCBCC
T ss_pred             cccCCchhh
Confidence            888776543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.1e-38  Score=345.66  Aligned_cols=251  Identities=20%  Similarity=0.346  Sum_probs=205.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999876 68999999997543  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~  902 (1027)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999998887654 4899999999999999999999   999999999999999986655   99999999986543


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..   ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......  ...   .        +.....
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~---~--------~~~~~~  224 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYA---Q--------IKAGAY  224 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---H--------HHHTCC
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHH---H--------HHhccc
Confidence            22   2234579999999999999999999999999999999999999997642211  111   0        000000


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ..   .......++.++.+++.+|+++||++|||+.|+++
T Consensus       225 -~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 -DY---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -CC---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cC---CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00   01112345677899999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=349.29  Aligned_cols=269  Identities=25%  Similarity=0.309  Sum_probs=203.1

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-----hhHHHHHHHHHHHhhcc---CCccceEEeEEecC
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-----RAIKSFDIECGMIKRIR---HRNIIKFISSCSSD  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  818 (1027)
                      ..++|++.+.||+|+||+||+|++. +++.||||++.....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999964 789999999874321     12345667777777665   99999999999876


Q ss_pred             C-----eeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 048205          819 D-----FKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  892 (1027)
Q Consensus       819 ~-----~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  892 (1027)
                      .     ..++||||+++ +|.+++.... ..+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     57999999974 9999987654 34899999999999999999999   9999999999999999999999999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      |||+++.+...   .......||+.|+|||++.+..++.++||||+||++|||++|++||...... .............
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            99999865322   2234567899999999999999999999999999999999999999764322 1222222111100


Q ss_pred             hHHHhhh-----cccc--CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 SIMEVVD-----ANLL--SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ~~~~~~d-----~~~~--~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .......     ....  ............++.++.+++.+|+++||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0000000     0000  00011112223567789999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.2e-39  Score=362.97  Aligned_cols=245  Identities=27%  Similarity=0.315  Sum_probs=194.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHH-HhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGM-IKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|+..+.||+|+||.||+|+.+ +++.||||++++...   ...+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            356899999999999999999976 688999999976532   233455566666 577899999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999987644 4789999999999999999999   999999999999999999999999999999854322


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                        .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ..        ..+......
T Consensus       193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~--------~~i~~~~~~  257 (373)
T 2r5t_A          193 --NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MY--------DNILNKPLQ  257 (373)
T ss_dssp             --CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----HH--------HHHHHSCCC
T ss_pred             --CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HH--------HHHHhcccC
Confidence              223445679999999999999999999999999999999999999997642211     11        111111111


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~e 1020 (1027)
                              .+..++.++.+++.+|++.||++||++.+
T Consensus       258 --------~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 --------LKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --------CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --------CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                    11245667899999999999999999853

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.1e-38  Score=366.26  Aligned_cols=271  Identities=22%  Similarity=0.265  Sum_probs=199.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC-----C
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----D  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  819 (1027)
                      ..++|++.+.||+|+||+||+|++. +++.||||++....  ....+.+.+|++++++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3568999999999999999999876 68899999997542  33456788999999999999999999999766     5


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++||||+++ +|.+++... ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCc-CHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            78999999974 999988764 45899999999999999999999   99999999999999999999999999999987


Q ss_pred             cccCCCc--------------------ceecccccCccccCcccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc
Q 048205          900 FLKEDQS--------------------LTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG  958 (1027)
Q Consensus       900 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~  958 (1027)
                      .......                    ......+||++|+|||++ ....++.++||||+||++|||++|..||.....+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            6432211                    123566899999999986 5667999999999999999999865554322110


Q ss_pred             c---------------------------hhHHHHHHHHHhhh-----------HHHhhhccccCccchhhhHHhhhHHHH
Q 048205          959 E---------------------------MTLKRWVNDLLLIS-----------IMEVVDANLLSHEDKHFVAKEQCMSFV 1000 (1027)
Q Consensus       959 ~---------------------------~~~~~~~~~~~~~~-----------~~~~~d~~~~~~~~~~~~~~~~~~~~l 1000 (1027)
                      .                           ..+...........           ....+.................++.++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence            0                           00011111000000           000000000000011111123467889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 048205         1001 FNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus      1001 ~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .+|+.+||..||++|||++|+++
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.4e-39  Score=376.64  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=211.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ..+|+..+.||+|+||.||+|+++ +++.||||+++.... ..+.+.+|++++++++||||++++++|...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            356888899999999999999987 488999999875432 457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++|+|.+++.... ..+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++.+... ..
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC-ce
Confidence            99999999998643 45899999999999999999999   999999999999999999999999999999865432 12


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......+++.|+|||++....++.++|||||||++|||++ |+.||.......  ...            .+....   
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~------------~~~~~~---  436 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE------------LLEKDY---  436 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH------------HHHTTC---
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH------------HHHcCC---
Confidence            22233456788999999998999999999999999999999 999987643221  111            111111   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                         +...+..++.++.+++.+||+.||++||++.++++.|++
T Consensus       437 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~  475 (495)
T 1opk_A          437 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  475 (495)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence               112234577889999999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=357.22  Aligned_cols=264  Identities=20%  Similarity=0.231  Sum_probs=200.9

Q ss_pred             hCCCCccceeeccccceEEEEEec----CCceEEEEEEecccch-----------hHHHHHHHHHHHhhccCCccceEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQYGR-----------AIKSFDIECGMIKRIRHRNIIKFIS  813 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  813 (1027)
                      .++|++.+.||+|+||.||+|++.    +++.||||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            356889999999999999999975    5788999998754321           1234567888899999999999999


Q ss_pred             EEec----CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC--
Q 048205          814 SCSS----DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM--  887 (1027)
Q Consensus       814 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  887 (1027)
                      ++..    ....++||||+ +++|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9987    77899999999 899999987655 6899999999999999999999   89999999999999999887  


Q ss_pred             cEEEeeecCCcccccCCCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhH
Q 048205          888 VAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL  962 (1027)
Q Consensus       888 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~  962 (1027)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432211     11244579999999999999999999999999999999999999996533222222


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ........ .........         ......++.++.+++.+||..||++||+++++++.|+.
T Consensus       271 ~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          271 QTAKTNLL-DELPQSVLK---------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             HHHHHHHH-HTTTHHHHH---------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             HHHHHhhc-ccccHHHHh---------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            22111110 000000000         00011466789999999999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=348.95  Aligned_cols=267  Identities=21%  Similarity=0.232  Sum_probs=202.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|+||+||+|++. +|+.||||++.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999976 589999999865432  235667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++++|.+++... ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.++......  
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--  156 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence            99999998877654 34899999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--hhHHHhhhc---
Q 048205          907 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--ISIMEVVDA---  980 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~---  980 (1027)
                      .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. ..........  ......+..   
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccccccccccccccc
Confidence            22334578999999999876 6689999999999999999999999976533221 1111111100  000000000   


Q ss_pred             ---cccCc---cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 ---NLLSH---EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ---~~~~~---~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         .....   ..........++.++.+++.+||++||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               00000   00111112356777999999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=346.58  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=187.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            457899999999999999999874 78999999997542   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999877667899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      .  ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ..            .+...    
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~------------~~~~~----  227 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LN------------KVVLA----  227 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSS----
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HH------------HHhhc----
Confidence            1  22345689999999999988899999999999999999999999976432211 00            00000    


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          ....+..++.++.+++.+||+.||++||+++++++
T Consensus       228 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 ----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                01112345677899999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.5e-38  Score=352.25  Aligned_cols=268  Identities=21%  Similarity=0.268  Sum_probs=201.5

Q ss_pred             CCCCcc-ceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSEN-NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      +.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            457774 78999999999999865 7899999999876555567888999999985 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeecCCcccccC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGMAKPFLKE  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~~  903 (1027)
                      |+++|+|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.   +||+|||+++.....
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999987654 4899999999999999999999   899999999999999998776   999999999865322


Q ss_pred             CC-----cceecccccCccccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHH-HHHhh
Q 048205          904 DQ-----SLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVN-DLLLI  972 (1027)
Q Consensus       904 ~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~  972 (1027)
                      ..     .......+||+.|+|||++..     ..++.++||||+||++|||++|+.||......+........ .....
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            11     111223469999999999875     56889999999999999999999999765332211000000 00000


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...+.+.......+   ......++.++.+++.+||+.||++|||+.|+++.
T Consensus       248 ~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          248 MLFESIQEGKYEFP---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHCCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhccCcccC---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            01111111111111   11223467789999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4e-39  Score=359.62  Aligned_cols=258  Identities=23%  Similarity=0.417  Sum_probs=210.5

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec------CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecC
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSD  818 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  818 (1027)
                      ....++|++.+.||+|+||.||+|++.      +++.||||++..... .....+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            345577999999999999999999864      367899999875432 3455788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      +..++||||+++|+|.+++....         ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeE
Confidence            99999999999999999987532         34689999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||......  .....   
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~---  252 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRF---  252 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHH---
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHH---
Confidence            9999999986544332223334457889999999998899999999999999999999 88898764221  11111   


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                              +.....       ...+..++..+.+++.+||..||++||++.|+++.|+
T Consensus       253 --------~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~  295 (322)
T 1p4o_A          253 --------VMEGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  295 (322)
T ss_dssp             --------HHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             --------HHcCCc-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                    111111       0112356677999999999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-38  Score=357.51  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=201.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||.||+|+.+ +|+.||||+++....    ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            456999999999999999999976 689999999975533    234688888888 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC----CcEEEeeecCCccccc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~~~  902 (1027)
                      |++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||++..+    +.+||+|||+++.+..
T Consensus        97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999987654 4899999999999999999999   9999999999999998543    3599999999986543


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ...  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..........        ....
T Consensus       173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~--------~~~~  240 (342)
T 2qr7_A          173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIG--------SGKF  240 (342)
T ss_dssp             TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHH--------HCCC
T ss_pred             CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHc--------cCCc
Confidence            322  233457899999999998888999999999999999999999999764221  1111111111        0110


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ...   ...+..++.++.+++.+||..||++||++.|+++
T Consensus       241 -~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 -SLS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -CCC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -ccC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             000   0112346778899999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-38  Score=346.06  Aligned_cols=248  Identities=24%  Similarity=0.354  Sum_probs=202.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      +.++|++.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467999999999999999999876 57899999987542   2234678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999999887653 4899999999999999999999   999999999999999999999999999998644321


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                          ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.......     ....        +...   
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~--------~~~~---  222 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKR--------ISRV---  222 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHH--------HHHT---
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----HHHH--------HHhC---
Confidence                2234578999999999999999999999999999999999999997642111     1000        0000   


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           ....+..++..+.+++.+||+.||++||++.|+++.
T Consensus       223 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 -----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 001123356678999999999999999999999863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=349.77  Aligned_cols=249  Identities=29%  Similarity=0.443  Sum_probs=196.5

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      ++|++.+.||+|+||+||+|++. ++.||||++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            46888899999999999999875 788999998643  345778899999999999999999999874  4789999999


Q ss_pred             CCCHHHHHhcCCc--cCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-EEEeeecCCcccccCCCc
Q 048205          830 YGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-AHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       830 ~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~  906 (1027)
                      +|+|.+++.....  .+++..+..++.|+++|++|||..+..+|+||||||+||+++.++. +||+|||+++.....   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999986542  4788999999999999999999332289999999999999998886 799999999754321   


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .|.          .....     
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~----------~~~~~-----  221 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-MWA----------VHNGT-----  221 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-HHH----------HHTTC-----
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-HHH----------HhcCC-----
Confidence              223468999999999999999999999999999999999999997643221111 110          00000     


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        .......++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       222 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          222 --RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             --CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence              00112345677899999999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.6e-38  Score=367.03  Aligned_cols=266  Identities=22%  Similarity=0.223  Sum_probs=199.3

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecC------
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD------  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  818 (1027)
                      ..++|++.+.||+|+||+||+|++. +|+.||||++...  .....+.+.+|+++++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999865 6899999999754  234456788999999999999999999999654      


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ...++||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            457999999986 56666643   3889999999999999999999   9999999999999999999999999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh------
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI------  972 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  972 (1027)
                      ....   .......+||++|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+...+......      
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred             ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            6532   22344568999999999999999999999999999999999999999764321 1122222111100      


Q ss_pred             ----hHHHhhhccccCcc------------chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 ----SIMEVVDANLLSHE------------DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ----~~~~~~d~~~~~~~------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          .....++.......            ..........+.++.+|+.+||..||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00011110000000            00011122336779999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.5e-38  Score=350.66  Aligned_cols=262  Identities=22%  Similarity=0.289  Sum_probs=208.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEec--CCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSS--DDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV  824 (1027)
                      .++|++.+.||+|+||+||+|+.. +++.||||+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            366889999999999999999864 7899999998743   3467889999999997 9999999999987  6678999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCcccccC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~  903 (1027)
                      |||+++++|.+++..    +++..+..++.|+++||+|||   +.+|+||||||+||+++.++ .+||+|||+++.+...
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998854    789999999999999999999   99999999999999999777 8999999999865432


Q ss_pred             CCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .   ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+.............+.++...
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            2   2344578999999999877 67899999999999999999999999765444343443333332222222222111


Q ss_pred             cCccc-----------------hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHED-----------------KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~-----------------~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....                 ........++.++.+++.+||++||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            10000                 001112336788999999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-38  Score=369.90  Aligned_cols=271  Identities=21%  Similarity=0.246  Sum_probs=188.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec-----CCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS-----DDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~  820 (1027)
                      .++|++.+.||+|+||+||+|++. +++.||||++....  ....+.+.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            467999999999999999999866 78999999986532  3345778899999999999999999999943     357


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .|+||||+. |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            899999985 6999988764 45899999999999999999999   999999999999999999999999999999876


Q ss_pred             ccCCCc-------------------------ceecccccCccccCcccc-cCCCCCcchhHHHHHHHHHHHHc-------
Q 048205          901 LKEDQS-------------------------LTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFT-------  947 (1027)
Q Consensus       901 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~ellt-------  947 (1027)
                      ......                         ......+||++|+|||++ ....++.++||||+||++|||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            432111                         123456789999999976 45679999999999999999999       


Q ss_pred             ----CCCCCCCCcccc-------------------hhHHHHHHHHHhhhHH-----------HhhhccccCccchhhhHH
Q 048205          948 ----RKKPTDESFTGE-------------------MTLKRWVNDLLLISIM-----------EVVDANLLSHEDKHFVAK  993 (1027)
Q Consensus       948 ----g~~p~~~~~~~~-------------------~~~~~~~~~~~~~~~~-----------~~~d~~~~~~~~~~~~~~  993 (1027)
                          |+++|.+...-.                   ..+.............           ..................
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                555554421100                   0000000000000000           000000000000111112


Q ss_pred             hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          994 EQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       994 ~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...+.++.+|+.+||..||++|||++|+++.
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            3457788999999999999999999999873

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-38  Score=372.38  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++...   .......+.+|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999865 6899999999754   223345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |||+++|+|.+++.... .+++..+..++.||++||+|||   + .+|+||||||+||+++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999887654 4899999999999999999999   7 89999999999999999999999999999854322


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+..... 
T Consensus       303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~--------~i~~~~~-  366 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFE--------LILMEEI-  366 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHCCC-
T ss_pred             C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHH--------HHHhCCC-
Confidence            2  2334567999999999999999999999999999999999999999764221     1111        0111110 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                             ..+..++.++.+++.+||+.||++||     +++|+++
T Consensus       367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                   11234567789999999999999999     9999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-38  Score=372.88  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=208.2

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++.+..   ......+.+|++++++++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3466999999999999999999976 79999999997542   2234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          824 VLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||||++||+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++.+..
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999987654 34899999999999999999999   99999999999999999999999999999986543


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......         +....
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~---------i~~~~  405 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERL---------VKEVP  405 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHH---------HHHCC
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHH---------hhccc
Confidence            22   23345899999999999999999999999999999999999999986532211 1111110         00000


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      .       ..+..++.++.+++.+||+.||++||     +++|+++
T Consensus       406 ~-------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 E-------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             C-------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             c-------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            0       01134567789999999999999999     7888875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=347.00  Aligned_cols=253  Identities=22%  Similarity=0.371  Sum_probs=206.8

Q ss_pred             CCCCccc-eeeccccceEEEEEec---CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENN-LIGRGGFGFVYKARIQ---DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|.+.. .||+|+||.||+|++.   +++.||||+++... ....+.+.+|++++++++||||+++++++. .+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence            4455555 8999999999999854   57889999997643 345677889999999999999999999994 5568999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999877677999999999999999999999   9999999999999999999999999999998764332


Q ss_pred             Cc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          905 QS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       905 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .. .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+  ....+            ....
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i------------~~~~  230 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFI------------EQGK  230 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHH------------HTTC
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH------------hcCC
Confidence            21 11223346889999999998889999999999999999998 999997643211  11111            1110


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++.++.+++.+||..||++||++.|+++.|+
T Consensus       231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                  01122356778999999999999999999999999886

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2e-38  Score=347.89  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=212.1

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567888999999999999999977 58899999997543 345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++++|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.++...... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999997643 45899999999999999999999   9999999999999999999999999999998664332 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      ........+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.......  ....            +....  
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~------------~~~~~--  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL------------LEKDY--  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH------------HHTTC--
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HhccC--
Confidence            233344567889999999998999999999999999999999 999987643221  1111            11111  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                          ....+..++.++.+++.+|+..||++||++.|+++.|+
T Consensus       230 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          230 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence                11122356678999999999999999999999999876

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-38  Score=349.28  Aligned_cols=254  Identities=25%  Similarity=0.421  Sum_probs=201.9

Q ss_pred             CCCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEe-cCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCS-SDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l  823 (1027)
                      .+|+..+.||+|+||+||+|++.+    +..||+|.+.... ....+.+.+|++++++++||||+++++++. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457888999999999999998642    2358999887533 334577889999999999999999999864 5567899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999877777899999999999999999999   999999999999999999999999999999865432


Q ss_pred             CC--cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          904 DQ--SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       904 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..  ........+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||........ ....            ...
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~------------~~~  248 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYL------------LQG  248 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHH------------HTT
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHH------------hcC
Confidence            21  122334567889999999999999999999999999999999 4555554322211 1111            000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .       ....+..++..+.+++.+||+.||++||+++|+++.|+
T Consensus       249 ~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          249 R-------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C-------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            0       01112345677999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-38  Score=355.88  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=210.1

Q ss_pred             HhCCCCccceeeccccceEEEEEecC-C-----ceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCC
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQD-G-----MEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDD  819 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  819 (1027)
                      ..++|+..+.||+|+||.||+|++.. +     +.||+|++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35679999999999999999998652 3     479999997543 23456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcC-------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 048205          820 FKALVLEYMPYGSLEKCLYSS-------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN  886 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  886 (1027)
                      ..++||||+++|+|.+++...             ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            999999999999999998753             234789999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHH
Q 048205          887 MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRW  965 (1027)
Q Consensus       887 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~  965 (1027)
                      +.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |..||........ ....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHH
Confidence            9999999999987654443333444567889999999998899999999999999999999 9999876432211 1111


Q ss_pred             HHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          966 VNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       966 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +            .....      ...+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       280 ~------------~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          280 V------------KDGYQ------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             H------------HHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H------------hcCCC------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence            1            11110      0112234667899999999999999999999999886

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-37  Score=342.99  Aligned_cols=259  Identities=21%  Similarity=0.235  Sum_probs=203.5

Q ss_pred             HHhCCCCccceeeccccceEEEEEe-cCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEE-ecCCeeEEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC-SSDDFKALV  824 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV  824 (1027)
                      ...++|+..+.||+|+||.||+|++ .+++.||||++.....  .+.+.+|+++++.++|++++..++++ ...+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999996 4789999998764432  24577899999999988877766655 667788999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecCCcccc
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  901 (1027)
                      |||+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 88999999876667999999999999999999999   9999999999999999   789999999999998765


Q ss_pred             cCCCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc--hhHHHHHHHHHhhhH
Q 048205          902 KEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE--MTLKRWVNDLLLISI  974 (1027)
Q Consensus       902 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~  974 (1027)
                      .....     .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ............   
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  236 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---  236 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH---
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc---
Confidence            43221     12234578999999999999999999999999999999999999998643221  111111110000   


Q ss_pred             HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          975 MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       975 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                  .........++.++.+++.+||+.||++||+++++++.|+
T Consensus       237 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          237 ------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             ------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             ------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence                        0001112345678999999999999999999999999886

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-38  Score=350.36  Aligned_cols=257  Identities=24%  Similarity=0.355  Sum_probs=197.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ...+|++.+.||+|+||.||+|+.. +|+.||||++...   .....+.+.+|++++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3457999999999999999999864 7899999999753   23445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          824 VLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ||||+++++|.+++..   ....+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999998864   3456899999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ....  .......|++.|+|||++.+..++.++||||||+++|||++|+.||.......   ..+.....        ..
T Consensus       187 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~--------~~  253 (310)
T 2wqm_A          187 SSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIE--------QC  253 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH---HHHHHHHH--------TT
T ss_pred             cCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH---HHHHHHhh--------cc
Confidence            4322  22234568999999999999999999999999999999999999997542221   11111110        00


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....      .....++.++.+++.+||..||++||++.++++.|+
T Consensus       254 ~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~  293 (310)
T 2wqm_A          254 DYPP------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK  293 (310)
T ss_dssp             CSCC------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCC------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            0000      011345677999999999999999999999999886

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-38  Score=351.48  Aligned_cols=264  Identities=25%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             CCccceeeccccceEEEEEec-----CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecC--CeeEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQ-----DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSD--DFKAL  823 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  823 (1027)
                      |+..+.||+|+||+||+|++.     +++.||||++..... ...+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999988643     688999999986533 3456789999999999999999999999874  67899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++....  +++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997654  899999999999999999999   999999999999999999999999999999876543


Q ss_pred             CCc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH-HhhhHHHhhhcc
Q 048205          904 DQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL-LLISIMEVVDAN  981 (1027)
Q Consensus       904 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~  981 (1027)
                      ... .......+|+.|+|||++.+..++.++||||+|+++|||++|+.||............+.... ......+.++..
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            221 123344578889999999998999999999999999999999999875322111111110000 001122222222


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..      ...+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       268 ~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          268 ER------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cC------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11      1223456778999999999999999999999999886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=357.78  Aligned_cols=269  Identities=25%  Similarity=0.334  Sum_probs=196.7

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHH--HHHHHhhccCCccceEEeEEec-----CCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDI--ECGMIKRIRHRNIIKFISSCSS-----DDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~-----~~~~  821 (1027)
                      .++|++.+.||+|+||+||+|+. +++.||||++.....   ..+..  |+..+..++||||+++++++..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46789999999999999999976 589999999975432   33333  4444556899999999985532     3367


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC---------CeEeccCCCCcEEEcCCCcEEEe
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV---------PIIHCDLKPNNVLLDDNMVAHLS  892 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~Dlkp~NIll~~~~~~kl~  892 (1027)
                      ++||||+++|+|.+++....  .++..+..++.||++||+|||   +.         +|+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997654  588999999999999999999   77         99999999999999999999999


Q ss_pred             eecCCcccccCCC------cceecccccCccccCcccccC-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc
Q 048205          893 DFGMAKPFLKEDQ------SLTQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE  959 (1027)
Q Consensus       893 Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  959 (1027)
                      |||+++.+.....      ........||+.|+|||++.+       ..++.++||||+||++|||++|+.||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999986643211      122334569999999999886       456788999999999999999987765432211


Q ss_pred             hhHHHHHHHHHhh----hHHHhh-hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          960 MTLKRWVNDLLLI----SIMEVV-DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       960 ~~~~~~~~~~~~~----~~~~~~-d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .....+.......    ...... .................++.++.+++.+||+.||++|||++|+++.|+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            1111111100000    000111 111111111122222346778999999999999999999999999886

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=355.34  Aligned_cols=267  Identities=21%  Similarity=0.263  Sum_probs=200.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccch-hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999976 7899999998654322 122345699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~  155 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  155 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence            985 999999887777999999999999999999999   999999999999999999999999999999854322  22


Q ss_pred             eecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---HHHhh-----
Q 048205          908 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---IMEVV-----  978 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----  978 (1027)
                      ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..............   .....     
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchhh
Confidence            2334568999999999876 56899999999999999999999999865322 11222111111000   00000     


Q ss_pred             -hccc-cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 -DANL-LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 -d~~~-~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       .... .............++.++.+++.+|+++||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence             0000 00011112233456778899999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-38  Score=350.13  Aligned_cols=257  Identities=24%  Similarity=0.427  Sum_probs=197.1

Q ss_pred             HHhCCCCccceeeccccceEEEEEec----CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC-
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD-  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  819 (1027)
                      ...++|...+.||+|+||.||+|++.    +++.||||+++...  ....+.+.+|++++++++||||+++++++.+.+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34567888999999999999999864    34589999987542  334567889999999999999999999997754 


Q ss_pred             ----eeEEEEEecCCCCHHHHHhc-----CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 048205          820 ----FKALVLEYMPYGSLEKCLYS-----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  890 (1027)
Q Consensus       820 ----~~~lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  890 (1027)
                          ..++||||+++|+|.+++..     ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence                35999999999999999843     2356899999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDL  969 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  969 (1027)
                      |+|||+++.+.............+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......  ....    
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~----  261 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDY----  261 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH----
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHH----
Confidence            999999986644333233344567889999999999999999999999999999999 888987643221  1111    


Q ss_pred             HhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          970 LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       970 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                             +....       ....+..++.++.+++.+||..||++||++.++++.|+
T Consensus       262 -------~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          262 -------LLHGH-------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             -------HHTTC-------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHcCC-------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                   00110       01112356678999999999999999999999999886

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.9e-38  Score=355.22  Aligned_cols=245  Identities=26%  Similarity=0.352  Sum_probs=201.6

Q ss_pred             CCCCccceeeccccceEEEEEe-cCCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      +.|+..+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4488899999999999999986 478999999997542   234467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+. |++.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....   
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence            9997 5888888766667899999999999999999999   89999999999999999999999999999986532   


Q ss_pred             cceecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          906 SLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                         .....||+.|+|||++.   ...++.++||||+||++|||++|+.||.......     ...        .+.....
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~--------~~~~~~~  270 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALY--------HIAQNES  270 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHH--------HHHHSCC
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHH--------HHHhcCC
Confidence               12357999999999884   5678999999999999999999999987642211     100        0000000


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..      .....++..+.+++.+||+.||++|||+.++++
T Consensus       271 ~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          271 PA------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            00      011245667899999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-38  Score=352.62  Aligned_cols=254  Identities=27%  Similarity=0.472  Sum_probs=201.6

Q ss_pred             CCCCccceeeccccceEEEEEecC-----CceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD-----GMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..+.||+|+||+||+|++..     +..||||+++.... .....+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567778999999999999998653     23599999975432 345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999877677999999999999999999999   899999999999999999999999999999866432


Q ss_pred             CC-cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          904 DQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       904 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      .. ........+|+.|+|||++.+..++.++||||+||++|||++ |+.||......+  ...           .+.+. 
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~-----------~~~~~-  266 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK-----------AINDG-  266 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH-----------HHHTT-
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHH-----------HHHCC-
Confidence            21 112223346788999999998999999999999999999999 999997542211  111           01111 


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .      ....+..++.++.+++.+||+.||++||++.++++.|+
T Consensus       267 ~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          267 F------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             C------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             C------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            0      01112346678999999999999999999999999885

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=7.3e-37  Score=359.21  Aligned_cols=102  Identities=32%  Similarity=0.440  Sum_probs=52.9

Q ss_pred             CCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeec
Q 048205          123 PLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQL  202 (1027)
Q Consensus       123 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  202 (1027)
                      +++++|+++++.+.. +| .+..+++|++|+|++|.+++..+  +.++++|++|++++|++++..+  ++.+++|++|++
T Consensus        46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L  119 (466)
T 1o6v_A           46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL  119 (466)
T ss_dssp             HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence            455555666555553 22 25555555555555555553322  5555555555555555554332  555555555555


Q ss_pred             cccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          203 QNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       203 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      ++|.+++. +. +.++++|++|++++|.++
T Consensus       120 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~  147 (466)
T 1o6v_A          120 FNNQITDI-DP-LKNLTNLNRLELSSNTIS  147 (466)
T ss_dssp             CSSCCCCC-GG-GTTCTTCSEEEEEEEEEC
T ss_pred             CCCCCCCC-hH-HcCCCCCCEEECCCCccC
Confidence            55555533 21 455555555555555543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-38  Score=371.95  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=203.6

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||+||+|++.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            356788899999999999999998888899999875432 34678999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+++.... ..+++.++..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence            9999999997532 45899999999999999999999   9999999999999999999999999999998654321 12


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......+++.|+|||++....++.++|||||||++|||++ |+.||......+  ...            .+....    
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~------------~i~~~~----  398 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD------------QVERGY----  398 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH------------HHHTTC----
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH------------HHHcCC----
Confidence            2233456789999999998999999999999999999999 999987642211  111            111110    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        +...+..++..+.+++.+||+.||++|||++++++.|++
T Consensus       399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~  437 (452)
T 1fmk_A          399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  437 (452)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              112234577889999999999999999999999998863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=355.77  Aligned_cols=243  Identities=26%  Similarity=0.331  Sum_probs=203.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------hhHHHHHHHHHHHhhccCCccceEEeEEecC
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRIRHRNIIKFISSCSSD  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  818 (1027)
                      ..++|+..+.||+|+||+||+|++. +++.||||++.....        ...+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3467999999999999999999865 789999999975421        1334567899999999999999999999999


Q ss_pred             CeeEEEEEecCCC-CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          819 DFKALVLEYMPYG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       819 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887654 4899999999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      +......   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....                   
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------  235 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------  235 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------
T ss_pred             eECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------
Confidence            8654322   2234579999999999988776 8899999999999999999999975211                   


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ......        ..+..++.++.+++.+||.+||++|||+.|+++.
T Consensus       236 ~~~~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 TVEAAI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             GTTTCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHhhcc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011111        1112356678999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.5e-38  Score=356.69  Aligned_cols=248  Identities=17%  Similarity=0.186  Sum_probs=201.4

Q ss_pred             HhCCCCccceeeccccceEEEEE------ecCCceEEEEEEecccchhHHHHHHHHHHHhhcc---CCccceEEeEEecC
Q 048205          748 ATNGFSENNLIGRGGFGFVYKAR------IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR---HRNIIKFISSCSSD  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  818 (1027)
                      ..++|++.+.||+|+||+||+|+      ..+++.||||+++...   ...+..|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34678999999999999999994      3468999999987543   345667777777776   99999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhc----CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---------
Q 048205          819 DFKALVLEYMPYGSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---------  885 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---------  885 (1027)
                      +..++||||+++|+|.+++..    ....+++..+..++.||++||+|||   +.+|+||||||+||+++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999974    3456999999999999999999999   999999999999999998         


Q ss_pred             --CCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHH
Q 048205          886 --NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK  963 (1027)
Q Consensus       886 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~  963 (1027)
                        ++.+||+|||+|+.+............+||++|+|||++.+..++.++||||+||++|||+||+.||.....+...  
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--  294 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--  294 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence              8999999999998654334444556678999999999999999999999999999999999999998653222110  


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCC-CCHHHHHHHhh
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER-INAKEIVTKLA 1026 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R-ps~~evl~~L~ 1026 (1027)
                                    ....     ....    .....+.+++.+|+..+|.+| |+++++.+.|+
T Consensus       295 --------------~~~~-----~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          295 --------------PEGL-----FRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             --------------ECSC-----CTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             --------------echh-----cccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence                          0000     0000    124457789999999999998 57777776654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=360.83  Aligned_cols=253  Identities=25%  Similarity=0.437  Sum_probs=195.0

Q ss_pred             CCCccceeeccccceEEEEEec--CC--ceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEec-CCeeEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ--DG--MEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSS-DDFKALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV  824 (1027)
                      .|+..+.||+|+||+||+|++.  ++  ..||||.++... ....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3666789999999999999864  22  368999886432 3456788999999999999999999998754 5678999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877777899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             Cc--ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          905 QS--LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       905 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ..  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+  ....+.           ...
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~-----------~~~  313 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL-----------QGR  313 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHH-----------TTC
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHH-----------cCC
Confidence            11  12233457889999999999999999999999999999999 677776543222  111110           000


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                             ....+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                   11112356778999999999999999999999999886

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.8e-38  Score=345.38  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=204.1

Q ss_pred             hCCCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|...+.||+|+||.||+|++..    +..||+|++.... ....+.+.+|++++++++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4578889999999999999998653    3469999987553 33457788999999999999999999998754 5689


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999865432


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      . ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||.......  ....+            ....
T Consensus       167 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~------------~~~~  231 (281)
T 3cc6_A          167 D-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVL------------EKGD  231 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHH------------HHTC
T ss_pred             c-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHH------------hcCC
Confidence            2 122334457889999999998899999999999999999998 999997543221  11111            0000


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++..+.+++.+||..||++||++.|+++.|+
T Consensus       232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence                  01112345677899999999999999999999999886

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.1e-38  Score=361.94  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=192.7

Q ss_pred             CCCCcc-ceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHH-hhccCCccceEEeEEec----CCeeE
Q 048205          750 NGFSEN-NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMI-KRIRHRNIIKFISSCSS----DDFKA  822 (1027)
Q Consensus       750 ~~f~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~  822 (1027)
                      ++|... +.||+|+||+||+|++. +|+.||||+++..     ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999876 6899999998632     4566788876 44589999999999865    56789


Q ss_pred             EEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCCc
Q 048205          823 LVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAK  898 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~  898 (1027)
                      +||||++||+|.+++.... ..+++.++..++.||+.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998654 45899999999999999999999   899999999999999987   7899999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchh--HHHHHHHHHhhhHHH
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT--LKRWVNDLLLISIME  976 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~  976 (1027)
                      .....   ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.........  ....+.         
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---------  280 (400)
T 1nxk_A          213 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---------  280 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---------
T ss_pred             ccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---------
Confidence            65322   2234567899999999999999999999999999999999999999765322110  111100         


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        .... ...   ...+..++.++.+++.+||+.||++|||+.|+++.
T Consensus       281 --~~~~-~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          281 --MGQY-EFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --HTCC-CCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --cCcc-cCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0000 000   01123467789999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-38  Score=346.19  Aligned_cols=254  Identities=23%  Similarity=0.390  Sum_probs=203.7

Q ss_pred             CCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCee-EEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK-ALV  824 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lV  824 (1027)
                      .|...+.||+|+||+||+|++.+    +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35566899999999999998642    2369999987543 34457788999999999999999999999876554 999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+.+|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999887777899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             --CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          905 --QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       905 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                        .........+++.|+|||.+.+..++.++||||+|+++|||++|+.|+....... .....+.            ...
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~------------~~~  245 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLA------------QGR  245 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHH------------TTC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhh------------cCC
Confidence              1122334567899999999999999999999999999999999666654432221 1111111            110


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++.++.+++.+||+.||++|||++++++.|+
T Consensus       246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  283 (298)
T 3pls_A          246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE  283 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                  01112345677899999999999999999999999886

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.8e-38  Score=357.53  Aligned_cols=273  Identities=24%  Similarity=0.276  Sum_probs=209.1

Q ss_pred             cccHHHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-----CCccceEE
Q 048205          739 RFTYLELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-----HRNIIKFI  812 (1027)
Q Consensus       739 ~~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~  812 (1027)
                      .+++.+.....++|++.+.||+|+||+||+|++. +++.||||++... ....+.+..|+++++.++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            4444455556788999999999999999999975 6899999998743 334466778999999987     99999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC------
Q 048205          813 SSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD------  885 (1027)
Q Consensus       813 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------  885 (1027)
                      +++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 889999987654 45899999999999999999999   999999999999999975      


Q ss_pred             -------------------CCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 048205          886 -------------------NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF  946 (1027)
Q Consensus       886 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  946 (1027)
                                         ++.+||+|||+|+....     ......||+.|+|||++.+..++.++||||+||++|||+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                               88999999999985432     123457899999999999999999999999999999999


Q ss_pred             cCCCCCCCCcccchhHHHHHHHHHhh-h---HHHhhh--------ccc-c---Cccch-----------hhhHHhhhHHH
Q 048205          947 TRKKPTDESFTGEMTLKRWVNDLLLI-S---IMEVVD--------ANL-L---SHEDK-----------HFVAKEQCMSF  999 (1027)
Q Consensus       947 tg~~p~~~~~~~~~~~~~~~~~~~~~-~---~~~~~d--------~~~-~---~~~~~-----------~~~~~~~~~~~  999 (1027)
                      +|+.||......+ .... +...... .   ..+...        ... .   .....           ...........
T Consensus       254 ~g~~pf~~~~~~~-~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          254 TGSLLFRTHEHME-HLAM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HSSCSCCCSSHHH-HHHH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HCCCCCCCCcHHH-HHHH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999997643221 1111 1111000 0   000000        000 0   00000           00011122366


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 048205         1000 VFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus      1000 l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +.+++.+||+.||++|||++|+++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            889999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-37  Score=341.08  Aligned_cols=257  Identities=21%  Similarity=0.234  Sum_probs=206.7

Q ss_pred             hCCCCccceeeccccceEEEEEe-cCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEE-ecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC-SSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||.||+|++ .+|+.||||++.....  .+.+.+|+++++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999996 4799999999875432  35688899999999998876666555 56778899999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecCCcccccC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 88999999866667999999999999999999999   9999999999999999   48899999999999876543


Q ss_pred             CCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccc--hhHHHHHHHHHhhhHHH
Q 048205          904 DQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE--MTLKRWVNDLLLISIME  976 (1027)
Q Consensus       904 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  976 (1027)
                      ...     .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ............     
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  236 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-----  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-----
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-----
Confidence            221     11244579999999999999999999999999999999999999998643221  111111110000     


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                .........++.++.+++.+||+.||++||++.++++.|+
T Consensus       237 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          237 ----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             ----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             ----------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence                      0001112346678999999999999999999999999886

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-38  Score=344.08  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=198.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888999999999999999875 68999999987653 23457888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecCCcccc
Q 048205          828 MPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       828 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  901 (1027)
                      +++|+|.+++...   ...+++..+..++.|+++||+|||   +.+|+||||||+||++   +.++.+||+|||+++.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988543   356899999999999999999999   9999999999999999   456889999999998654


Q ss_pred             cCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ...   ......||+.|+|||++. ..++.++||||+||++|||++|+.||........  ....         ....+.
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~---------~~~~~~  243 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKA---------TYKEPN  243 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH---------HHCCCC
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--Hhhh---------ccCCcc
Confidence            322   234456899999999876 5689999999999999999999999976432111  1100         000010


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..       .....++.++.+++.+|++.||++|||+.|+++
T Consensus       244 ~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YA-------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC-------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc-------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00       011224567889999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.4e-38  Score=361.38  Aligned_cols=254  Identities=23%  Similarity=0.266  Sum_probs=196.2

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------hhHHHHHHHHHHHhhccCCccceEEeEEec
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRIRHRNIIKFISSCSS  817 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  817 (1027)
                      ...++|...+.||+|+||+||+|+.. +++.||||++.....        .....+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34578999999999999999999865 689999999975421        122357889999999999999999999865


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeee
Q 048205          818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDF  894 (1027)
Q Consensus       818 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Df  894 (1027)
                       +..++||||+++|+|.+++.... .+++.++..++.|+++||+|||   +.+|+||||||+||+++.++   .+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             45799999999999999887654 5899999999999999999999   89999999999999997544   5999999


Q ss_pred             cCCcccccCCCcceecccccCccccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |+|+.....   ......+||+.|+|||++..   ..++.++||||+||++|||++|+.||........ ....+     
T Consensus       287 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i-----  357 (419)
T 3i6u_A          287 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQI-----  357 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHH-----
T ss_pred             ccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHH-----
Confidence            999865422   22344679999999999863   5678899999999999999999999976433221 11111     


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             ....   .......+..++.++.+++.+||+.||++||++.|+++.
T Consensus       358 -------~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 -------TSGK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -------HTTC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -------hcCC---CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                   0110   011112234567789999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.1e-38  Score=347.56  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=203.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            456889999999999999999976 7899999999865544556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecCCcccccCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||+++..... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999886544 4899999999999999999999   9999999999999999   78899999999999754221 


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                         ......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....        .+..... .
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~--------~i~~~~~-~  225 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-----KLFE--------KIKEGYY-E  225 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHH--------HHHHCCC-C
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH--------HHHcCCC-C
Confidence               223456899999999999999999999999999999999999999764221     1111        0111100 0


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .   ....+..++.++.+++.+|+..||++||++.|+++
T Consensus       226 ~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 F---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             C---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             C---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0   01122346678999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=351.85  Aligned_cols=256  Identities=23%  Similarity=0.290  Sum_probs=203.3

Q ss_pred             CCCCccceeeccccceEEEEEe-cCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEe----cCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARI-QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS----SDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lV  824 (1027)
                      ++|+..+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++.    .....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            5688899999999999999997 478999999987666666778899999999999999999999986    33478999


Q ss_pred             EEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          825 LEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |||+++|+|.+++..   ....+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.++...
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999998875   3456899999999999999999999   8999999999999999999999999999987543


Q ss_pred             cCCCc-------ceecccccCccccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          902 KEDQS-------LTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       902 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      .....       .......||+.|+|||++....   ++.++||||+||++|||++|+.||.............      
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------  259 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA------  259 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH------
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH------
Confidence            21110       0112335799999999987553   6889999999999999999999986422111111110      


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            .....      .......++.++.+++.+||+.||++||++.|+++.|+
T Consensus       260 ------~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          260 ------VQNQL------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             ------HHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------hhccC------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence                  00100      01112345677999999999999999999999999886

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-37  Score=352.36  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=207.0

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------hhHHHHHHHHHHHhhc-cCCccceEEeEE
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRI-RHRNIIKFISSC  815 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~  815 (1027)
                      ....++|++.+.||+|+||.||+|++. +|+.||||+++....        ...+.+.+|+++++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344567999999999999999999976 799999999975431        2245678899999999 799999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          816 SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       816 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                      ...+..++||||+++++|.+++.... .+++..+..++.||+.||+|||   +.||+||||||+||+++.++.+||+|||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence            99999999999999999999987543 4899999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccccCCCcceecccccCccccCcccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGRE------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL  969 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  969 (1027)
                      ++..+....   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||......  .....    
T Consensus       246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~----  316 (365)
T 2y7j_A          246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRM----  316 (365)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----
T ss_pred             cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHH----
Confidence            998664322   2344679999999998863      35889999999999999999999999764211  11110    


Q ss_pred             HhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          970 LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       970 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                             +....    .......+..++..+.+++.+|+..||++||++.|+++
T Consensus       317 -------i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          317 -------IMEGQ----YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -------HHHTC----CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------HHhCC----CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   00110    01111223456677999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.2e-38  Score=346.95  Aligned_cols=255  Identities=21%  Similarity=0.271  Sum_probs=199.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|++++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            477999999999999999999976 689999999875422   2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999987653 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       ........|++.|+|||++.+..++.++||||+|+++|||++|+.||......  ....            .+....  
T Consensus       189 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~------------~~~~~~--  251 (309)
T 2h34_A          189 -LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGA------------HINQAI--  251 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHH------------HHHSCC--
T ss_pred             -cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHH------------HhccCC--
Confidence             12233456899999999999999999999999999999999999999764211  0000            011110  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-CHHHHHHHhh
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-NAKEIVTKLA 1026 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-s~~evl~~L~ 1026 (1027)
                        ......+..++.++.+++.+||..||++|| +++++++.|+
T Consensus       252 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          252 --PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             --CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             --CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence              001122345667789999999999999999 9999999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.8e-38  Score=368.34  Aligned_cols=253  Identities=23%  Similarity=0.319  Sum_probs=207.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|...+.||+|+||.||+|+.+ +|+.||||++.+..   ....+.+..|++++++++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999976 69999999997542   22346788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          825 LEYMPYGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |||++||+|.+++....   ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987643   45899999999999999999999   9999999999999999999999999999998654


Q ss_pred             cCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      ...  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+...        +....
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~--------i~~~~  409 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQR--------VLEQA  409 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHH--------HHHCC
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHH--------Hhhcc
Confidence            322  12334579999999999999999999999999999999999999998653221 11111111        11111


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA-----KEIVT 1023 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~-----~evl~ 1023 (1027)
                      .        ..+..++.++.+++.+||..||++||++     .++++
T Consensus       410 ~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 V--------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             C--------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             c--------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1        1123456778999999999999999964     66653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-37  Score=341.02  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=204.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc------hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++.....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46889999999999999999976 689999999875422      13577899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecCCc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAK  898 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~  898 (1027)
                      +||||+++++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++    .+||+|||.+.
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999987643 4899999999999999999999   99999999999999998877    89999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      ......   ......+++.|+|||++.+..++.++||||+|+++|+|++|+.||......+ ....            +.
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~------------~~  224 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTN------------IS  224 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH------------HH
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHH------------hH
Confidence            654322   2234568999999999998999999999999999999999999997642211 0111            00


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..    ...........++..+.+++.+|+..||++||++.|+++
T Consensus       225 ~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          225 AV----NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             TT----CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hc----ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00    001112223456778999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.9e-38  Score=354.41  Aligned_cols=277  Identities=21%  Similarity=0.228  Sum_probs=208.1

Q ss_pred             ccHHHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccc-----------hhHHHHHHHHHHHhhccCCcc
Q 048205          740 FTYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG-----------RAIKSFDIECGMIKRIRHRNI  808 (1027)
Q Consensus       740 ~~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni  808 (1027)
                      ..+.++....++|+..+.||+|+||.||+|+..+|+.||||++.....           ...+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345677888999999999999999999999988899999999854321           123678899999999999999


Q ss_pred             ceEEeEEec-----CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          809 IKFISSCSS-----DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       809 v~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      +++++++..     ....++||||++ |++.+++......+++..+..++.||+.||+|||   +.+|+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            999999843     346899999998 5899988877777999999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL  962 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~  962 (1027)
                      +.++.+||+|||+++.....   .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~  243 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQL  243 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence            99999999999999754322   22344578999999999876 67899999999999999999999999864321 112


Q ss_pred             HHHHHHHHhhh-----------HHHhhhccccCc-cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          963 KRWVNDLLLIS-----------IMEVVDANLLSH-EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       963 ~~~~~~~~~~~-----------~~~~~d~~~~~~-~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...+.......           ..+......... ..........++..+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            22221111110           111111111111 111222334567789999999999999999999999863

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=362.33  Aligned_cols=272  Identities=19%  Similarity=0.265  Sum_probs=209.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCC--eeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD--FKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV  824 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            356889999999999999999976 58999999997543 234567789999999999999999999998755  77999


Q ss_pred             EEecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeecCCc
Q 048205          825 LEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAK  898 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~  898 (1027)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999987643  23899999999999999999999   9999999999999999    778889999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccC--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      ......   ......||+.|+|||++.+        ..++.++||||+||++|||++|+.||..................
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            654322   2234579999999998865        56788999999999999999999999754332222222111111


Q ss_pred             hhhH---HHh---hhccc--cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          971 LISI---MEV---VDANL--LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       971 ~~~~---~~~---~d~~~--~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....   ...   .....  .............++..+.+++.+||.+||++||++.|+++.++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence            0000   000   00000  00001111223567788999999999999999999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.5e-38  Score=368.43  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=204.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .++|++.+.||+|+||+||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356999999999999999999976 78999999997432  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++   .++.+||+|||+++.+..
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999886654 4899999999999999999999   99999999999999995   566899999999986543


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .   ......+||+.|+|||++.+ .++.++||||+||++|+|++|++||......+  ...           .+.... 
T Consensus       177 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~-----------~i~~~~-  238 (486)
T 3mwu_A          177 N---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK-----------RVETGK-  238 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-----------HHHHTC-
T ss_pred             C---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-----------HHHhCC-
Confidence            2   22344579999999999875 58999999999999999999999997642211  111           001111 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                         .....+.+..++.++.+++.+||.+||++|||+.|+++.
T Consensus       239 ---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          239 ---YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ---CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ---CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               111122334567789999999999999999999999873

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-38  Score=354.96  Aligned_cols=263  Identities=24%  Similarity=0.280  Sum_probs=198.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  819 (1027)
                      .++|+..+.||+|+||.||+|++. +|+.||||++....  ....+.+.+|++++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467889999999999999999975 79999999986432  234567889999999999999999999997653      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++||||+ +++|.+++...  .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 77999998763  4899999999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--H--
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--I--  974 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~--  974 (1027)
                      ...     .....++|++|+|||++.+ ..++.++||||+||++|||++|++||...... ..+...........  .  
T Consensus       178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          178 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             ccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            432     2334578999999999887 67999999999999999999999999864321 11222211111100  0  


Q ss_pred             -------HHhhhccccCcc-chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          975 -------MEVVDANLLSHE-DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       975 -------~~~~d~~~~~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             ..... ...... .........++.++.+++.+|+..||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          252 RLQSDEAKNYMK-GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             TCSCHHHHHHHH-HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhhHHHHHHHH-hCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                   00000 000000 00111123457789999999999999999999999873

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=357.13  Aligned_cols=258  Identities=14%  Similarity=0.153  Sum_probs=204.0

Q ss_pred             CCCCccceeeccccceEEEEEecC---------CceEEEEEEecccchhHHHHHHHHHHHhhccCCccce----------
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD---------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK----------  810 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----------  810 (1027)
                      ++|++.+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578899999999999999998763         789999998743     46778999999999999987          


Q ss_pred             -----EEeEEec-CCeeEEEEEecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          811 -----FISSCSS-DDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       811 -----l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                           +++++.. ....++||||+ +++|.+++... ...+++.++..++.||+.||+|||   +.+|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5677765 67889999999 89999999875 356899999999999999999999   9999999999999999


Q ss_pred             cCCC--cEEEeeecCCcccccCCCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCc
Q 048205          884 DDNM--VAHLSDFGMAKPFLKEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESF  956 (1027)
Q Consensus       884 ~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  956 (1027)
                      +.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999866433221     11234479999999999999999999999999999999999999998654


Q ss_pred             ccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          957 TGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ........+.....        .. .. ...........++.++.+++.+||..||++||+++++++.|+
T Consensus       273 ~~~~~~~~~~~~~~--------~~-~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          273 PNTEDIMKQKQKFV--------DK-PG-PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             TCHHHHHHHHHHHH--------HS-CC-CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cCHHHHHHHHHhcc--------CC-hh-hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence            33222222211110        00 00 000000111234677999999999999999999999999886

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-38  Score=345.85  Aligned_cols=252  Identities=24%  Similarity=0.409  Sum_probs=206.5

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            46788999999999999999998888899999987543 235678899999999999999999999874 4589999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++++|.+++.... ..+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.++...... ..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence            9999999987543 25899999999999999999999   9999999999999999999999999999998654322 12


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+     ....         +....    
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~---------~~~~~----  227 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQN---------LERGY----  227 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHH---------HHTTC----
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----HHHH---------Hhccc----
Confidence            2233456788999999998889999999999999999999 899987642211     1110         00100    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        ....+..++.++.+++.+|++.||++|||+.++++.|+
T Consensus       228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence              01112346678999999999999999999999999886

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=352.09  Aligned_cols=266  Identities=24%  Similarity=0.454  Sum_probs=211.3

Q ss_pred             hCCCCccceeeccccceEEEEEe-----cCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC--ee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI-----QDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD--FK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  821 (1027)
                      .++|++.+.||+|+||.||+|++     .+|+.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35588899999999999999983     368899999998766666788999999999999999999999987654  78


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ++||||+++++|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887767999999999999999999999   9999999999999999999999999999998765


Q ss_pred             cCCCcc-eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHH-----HHhhhHH
Q 048205          902 KEDQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVND-----LLLISIM  975 (1027)
Q Consensus       902 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~  975 (1027)
                      ...... ......++..|+|||++.+..++.++||||+|+++|||++|+.|+......   .......     .......
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence            433221 122345778899999999888999999999999999999999987642110   1110000     0000111


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +.+....      ....+..++.++.+++.+||..||++||++.|+++.|+
T Consensus       274 ~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~  318 (326)
T 2w1i_A          274 ELLKNNG------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  318 (326)
T ss_dssp             HHHHTTC------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHhhcCC------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111111      11123457788999999999999999999999999886

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-38  Score=354.18  Aligned_cols=271  Identities=25%  Similarity=0.289  Sum_probs=202.7

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-----hhHHHHHHHHHHHhhccCCccceEEeEEecCCe
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-----RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  820 (1027)
                      ...++|+..+.||+|+||.||+|++. +|+.||||++.....     ...+.+.+|++++++++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            44578999999999999999999976 689999999864322     123467889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||+++ +|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999986 899988877767899999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh-
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV-  978 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  978 (1027)
                      ....  .......+|+.|+|||++.+. .++.++||||+||++|||++|.+||...... ..+................ 
T Consensus       163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSS
T ss_pred             cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhh
Confidence            4322  223445789999999998754 5899999999999999999999998764322 1222221111100000000 


Q ss_pred             -----hccccC--ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          979 -----DANLLS--HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       979 -----d~~~~~--~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                           +.....  ...........++.++.+++.+|+..||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                 000000  0000011123456789999999999999999999999863

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.4e-38  Score=350.16  Aligned_cols=269  Identities=24%  Similarity=0.326  Sum_probs=203.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3467899999999999999999976 589999999865432  2345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||++++++.++..... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus       103 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99999988888765443 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--hhHHHhhhcc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--ISIMEVVDAN  981 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~  981 (1027)
                        .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .....+.....  ....+.+...
T Consensus       179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhc
Confidence              223345789999999998875 68999999999999999999999997653221 22222111110  0000111000


Q ss_pred             ------c---cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 ------L---LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ------~---~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            .   .............++.++.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  0   00011111222356788999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.4e-37  Score=346.28  Aligned_cols=271  Identities=24%  Similarity=0.365  Sum_probs=210.8

Q ss_pred             cHHHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhh--ccCCccceEEeEEecC
Q 048205          741 TYLELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKR--IRHRNIIKFISSCSSD  818 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~  818 (1027)
                      ++.......++|++.+.||+|+||.||+|++ +|+.||||++...   ..+.+.+|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3334445567899999999999999999987 4899999998643   34567778888887  7899999999999887


Q ss_pred             C----eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCcEEEcCCCcE
Q 048205          819 D----FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       819 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      .    ..++||||+++|+|.+++...  .+++.++..++.|++.|++|||..     ++.+|+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            6    789999999999999999764  489999999999999999999932     14689999999999999999999


Q ss_pred             EEeeecCCcccccCCCcc--eecccccCccccCcccccCC------CCCcchhHHHHHHHHHHHHcC----------CCC
Q 048205          890 HLSDFGMAKPFLKEDQSL--TQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTR----------KKP  951 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg----------~~p  951 (1027)
                      ||+|||+++.........  ......||+.|+|||++.+.      .++.++||||+||++|||++|          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998664433221  23445799999999998765      334789999999999999999          678


Q ss_pred             CCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          952 TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      |............+....        ............+ ....++..+.+++.+||+.||++||++.|+++.|+
T Consensus       267 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVV--------CEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHH--------TTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             ccccCcCcccHHHHHHHH--------HHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            766543333333332211        1111111111111 22356778999999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-37  Score=367.34  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=204.0

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-------------hhHHHHHHHHHHHhhccCCccceEEe
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-------------RAIKSFDIECGMIKRIRHRNIIKFIS  813 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~  813 (1027)
                      ..++|++.+.||+|+||+||+|+.. +++.||||++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3567999999999999999999976 688999999875421             23467889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEE
Q 048205          814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAH  890 (1027)
Q Consensus       814 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k  890 (1027)
                      ++.+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999887653 4899999999999999999999   99999999999999998776   699


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      |+|||+++.+....   .....+||+.|+|||++. +.++.++||||+||++|+|++|++||......     .....  
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~--  258 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-----DIIKK--  258 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH--
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH--
Confidence            99999998664322   234457999999999987 46899999999999999999999999764321     11111  


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            +...    ........+..++.++.+++.+|+.+||++|||++|+++
T Consensus       259 ------i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          259 ------VEKG----KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ------HHHC----CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HHcC----CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  1111    111122334567788999999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-37  Score=340.80  Aligned_cols=246  Identities=24%  Similarity=0.321  Sum_probs=205.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            356889999999999999999876 67899999987542   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999987654 4899999999999999999999   999999999999999999999999999998754321 


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                         ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+     ...        .+.....  
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~--------~~~~~~~--  229 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----THR--------RIVNVDL--  229 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHH--------HHHTTCC--
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-----HHH--------HHhcccc--
Confidence               2234568999999999999999999999999999999999999997642211     000        1111110  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            ..+..++.++.+++.+|++.||++||++.|+++
T Consensus       230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                  112345667899999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-37  Score=343.46  Aligned_cols=248  Identities=20%  Similarity=0.313  Sum_probs=206.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888999999999999999976 58899999987542   23456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++.... .+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.++......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999886543 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      .  ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+    .+ .        .+....   
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~-~--------~~~~~~---  231 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY-L--------RIKKNE---  231 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH-H--------HHHTTC---
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH-H--------HHhhcc---
Confidence            2  2334568999999999999899999999999999999999999997643211    01 0        000110   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ...+..++..+.+++.+|++.||++||++.|+++
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                 0112245567899999999999999999999876

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.5e-38  Score=377.54  Aligned_cols=246  Identities=22%  Similarity=0.379  Sum_probs=200.0

Q ss_pred             eeeccccceEEEEEec---CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCCCC
Q 048205          757 LIGRGGFGFVYKARIQ---DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      .||+|+||.||+|.++   ++..||||+++... ....+.+.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   46679999987543 3356789999999999999999999999976 56899999999999


Q ss_pred             HHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc-eecc
Q 048205          833 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL-TQTQ  911 (1027)
Q Consensus       833 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~  911 (1027)
                      |.+++......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+....... ....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999877777999999999999999999999   9999999999999999999999999999998764332211 1122


Q ss_pred             cccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhh
Q 048205          912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF  990 (1027)
Q Consensus       912 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  990 (1027)
                      ..+++.|+|||++....++.++|||||||++|||++ |+.||......+  ....            +....      +.
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~------------i~~~~------~~  558 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAF------------IEQGK------RM  558 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHH------------HHTTC------CC
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH------------HHcCC------CC
Confidence            345688999999999999999999999999999998 999997653221  1111            11111      11


Q ss_pred             hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          991 VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       991 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..+..++.++.+++.+||..||++||++.++++.|+
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            223457788999999999999999999999999886

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-37  Score=367.96  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=199.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|+..+.||+|+||+||+|+.. +++.||||++....  ......+.+|+++++.++||||++++++|.+....++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45889999999999999999976 68999999997543  2335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCCcccccC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+++|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.   ++.+||+|||+++.+...
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999886653 4899999999999999999999   999999999999999976   455999999999866432


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .   .....+||+.|+|||++. ..++.++||||+||++|+|++|++||......+     ....        +..... 
T Consensus       193 ~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~--------i~~~~~-  254 (494)
T 3lij_A          193 K---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-----ILRK--------VEKGKY-  254 (494)
T ss_dssp             B---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH--------HHHTCC-
T ss_pred             c---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH--------HHhCCC-
Confidence            2   234467999999999876 568999999999999999999999997643211     1110        001110 


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .   .....+..++.++.+++.+||++||++|||+.|+++
T Consensus       255 ~---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          255 T---FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             C---CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C---CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            0   011122356778899999999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=344.94  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=203.4

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..++|++.+.||+|+||.||+|++. +|+.||||++....  ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999876 58999999997543  34678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++++|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+..+....  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999998765666899999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........    . .        . ....    .
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~-~--------~-~~~~----~  241 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA----I-F--------M-IPTN----P  241 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----H-H--------H-HHHS----C
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----H-H--------H-HhcC----C
Confidence            223345689999999999999999999999999999999999999976422110    0 0        0 0000    0


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...+..+..++..+.+++.+||..||++||++.++++
T Consensus       242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0111223446678999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-38  Score=363.54  Aligned_cols=240  Identities=16%  Similarity=0.149  Sum_probs=190.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc---cchhHHHHHHHH---HHHhhccCCccceEE-------eE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ---YGRAIKSFDIEC---GMIKRIRHRNIIKFI-------SS  814 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  814 (1027)
                      .++|+..+.||+|+||+||+|++. +|+.||||++...   .....+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            356888999999999999999964 6999999999743   334567888999   556666899999998       66


Q ss_pred             EecCC-----------------eeEEEEEecCCCCHHHHHhcCCc------cCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 048205          815 CSSDD-----------------FKALVLEYMPYGSLEKCLYSSNY------ILDIFQRLNIMIDVASALEYLHFGYSVPI  871 (1027)
Q Consensus       815 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  871 (1027)
                      +.+.+                 ..++||||+ +|+|.+++.....      .+++..+..++.||++||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            66553                 278999999 5799999876432      2335888899999999999999   9999


Q ss_pred             EeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCC-----------CCCcchhHHHHHH
Q 048205          872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGI  940 (1027)
Q Consensus       872 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGv  940 (1027)
                      +||||||+||+++.++.+||+|||+|+...     ......+| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            999999999999999999999999998532     13344567 999999999887           8999999999999


Q ss_pred             HHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 048205          941 MLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020 (1027)
Q Consensus       941 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~e 1020 (1027)
                      ++|||++|+.||........                 .....        .....++.++.+++.+||..||++||++.|
T Consensus       302 il~elltg~~Pf~~~~~~~~-----------------~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG-----------------SEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------CC-----------------SGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCcccccccc-----------------hhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            99999999999975422110                 00000        011245677899999999999999999999


Q ss_pred             HHH
Q 048205         1021 IVT 1023 (1027)
Q Consensus      1021 vl~ 1023 (1027)
                      +++
T Consensus       357 ~l~  359 (377)
T 3byv_A          357 AME  359 (377)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-38  Score=352.07  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=203.0

Q ss_pred             hCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|++.+.||+|+||.||+|++.      +++.||||++.... ......+.+|++++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            357889999999999999999842      57789999986442 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEe
Q 048205          822 ALVLEYMPYGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLS  892 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  892 (1027)
                      ++||||+++|+|.+++....      ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      34889999999999999999999   999999999999999984   4469999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......  ....++     
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~-----  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFV-----  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHH-----
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHH-----
Confidence            9999986543333333344568899999999998899999999999999999998 99998764211  111111     


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                             ....      ....+..++..+.+++.+||..||++||++.|+++.|+
T Consensus       259 -------~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          259 -------TSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             -------HTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------hcCC------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence                   0100      01112346677899999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.2e-38  Score=347.99  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467899999999999999999976 589999999976655567788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999998876666999999999999999999999   899999999999999999999999999987643211  1


Q ss_pred             ceecccccCccccCcccc-----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcc
Q 048205          907 LTQTQTLATIGYMAPEYG-----REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN  981 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  981 (1027)
                      .......||+.|+|||++     ....++.++||||+|+++|||++|+.||....... ....            +....
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~------------~~~~~  238 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLK------------IAKSD  238 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH------------HHHSC
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHH------------HhccC
Confidence            122335689999999988     46678999999999999999999999997643211 0111            00000


Q ss_pred             ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          982 LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ......+..++.++.+++.+||+.||++|||+.|+++
T Consensus       239 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          239 -----PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 0011123456677999999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.1e-38  Score=345.19  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=203.1

Q ss_pred             hCCCCccc-eeeccccceEEEEEec---CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          749 TNGFSENN-LIGRGGFGFVYKARIQ---DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       749 ~~~f~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ..+|++.+ .||+|+||+||+|++.   +++.||||+++...  ....+.+.+|++++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 9999999999999643   46889999987543  23357788999999999999999999999 556789


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999998754 4899999999999999999999   99999999999999999999999999999987644


Q ss_pred             CCCcc-eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          903 EDQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......  .....            +..
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~------------~~~  235 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM------------LEK  235 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH------------HHT
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HHc
Confidence            33221 1222346788999999998889999999999999999999 99999764221  11111            111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..      ....+..++.++.+++.+||+.||++||++.++++.|+
T Consensus       236 ~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          236 GE------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             TC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            10      01112356778999999999999999999999999886

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.5e-38  Score=355.56  Aligned_cols=263  Identities=23%  Similarity=0.342  Sum_probs=206.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999976 78999999998653 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++++|.+++.... .+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||+++.....  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999987654 4899999999999999999999   75 8999999999999999999999999999754321  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH---------------
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL---------------  970 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------------  970 (1027)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||..........  ......               
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL--MFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH--HHC------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HhcccccccCCCCCCCcccCC
Confidence              2234578999999999999999999999999999999999999997643222110  000000               


Q ss_pred             ------------hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 ------------LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ------------~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                                  .....+..+........  ......++.++.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                        00000111111000000  0011235677999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.2e-38  Score=352.08  Aligned_cols=269  Identities=23%  Similarity=0.264  Sum_probs=197.7

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ...++|++.+.||+|+||+||+|+.. +++.||||+++....  ...+.+.+|++++++++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44567999999999999999999865 789999999865432  234567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-----CCCcEEEeeecCCc
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-----DNMVAHLSDFGMAK  898 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfgla~  898 (1027)
                      ||||+++ +|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++     .++.+||+|||+++
T Consensus       111 v~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9999985 9999987654 4899999999999999999999   99999999999999994     55569999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---H
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---I  974 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  974 (1027)
                      .+....  .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..............   .
T Consensus       186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred             ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhh
Confidence            654221  223445689999999998875 4899999999999999999999999764322 12222221111000   0


Q ss_pred             HHhh---h--cccc--CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 MEVV---D--ANLL--SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ~~~~---d--~~~~--~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....   +  ....  ............++.++.+++.+||++||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000   0  0000  0000111122336678899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=340.65  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=200.2

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      +|.....||+|+||.||+|++. +++.||||++........+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555679999999999999965 688999999987666667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecCCcccccCCCc
Q 048205          830 YGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       830 ~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++|.+++....  ...++..+..++.|+++|++|||   +.+|+||||||+||+++. ++.+||+|||.++......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            999999987653  34678889999999999999999   899999999999999987 8999999999998654322  


Q ss_pred             ceecccccCccccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          907 LTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      .......|++.|+|||++.+..  ++.++||||+|+++|||++|+.||............  .        ... . .  
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~--------~~~-~-~--  243 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK--V--------GMF-K-V--  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH--H--------HHH-C-C--
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh--h--------ccc-c-c--
Confidence            1233456899999999987654  789999999999999999999999653221110000  0        000 0 0  


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          ....+..++.++.+++.+||+.||++||++.|+++
T Consensus       244 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 ----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                00112346677899999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.1e-37  Score=337.83  Aligned_cols=246  Identities=26%  Similarity=0.363  Sum_probs=198.6

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec----CCeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS----DDFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  823 (1027)
                      .|...+.||+|+||.||+|++. ++..||+|++....  ....+.+.+|++++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3677789999999999999875 68899999987542  3345678899999999999999999998865    456899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEc-CCCcEEEeeecCCccc
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLD-DNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~  900 (1027)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+  |+||||||+||+++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999997643 4899999999999999999999   888  99999999999998 7899999999999754


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ...    ......||+.|+|||++. +.++.++||||+||++|+|++|+.||............    .         ..
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~---------~~  244 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----V---------TS  244 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH----H---------TT
T ss_pred             ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH----H---------hc
Confidence            322    223456999999999876 45899999999999999999999999764322111111    0         00


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..     .....+..++.++.+++.+||+.||++|||++|+++
T Consensus       245 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          245 GV-----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TC-----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cC-----CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            00     011122344567899999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.8e-38  Score=370.49  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=206.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46889999999999999999976 78999999997542   334577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+.+|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||++   +.++.+||+|||+++.+..
T Consensus       106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999887654 4899999999999999999999   9999999999999999   5678999999999986543


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..   .....+||+.|+|||++.+ .++.++||||+||++|+|++|++||......+  ....           +.... 
T Consensus       182 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~-----------i~~~~-  243 (484)
T 3nyv_A          182 SK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKK-----------VEKGK-  243 (484)
T ss_dssp             CC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----------HHHCC-
T ss_pred             cc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-----------HHcCC-
Confidence            22   2344579999999999875 68999999999999999999999997642211  1111           11111 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         .....+.+..++.++.+++.+||.+||++|||+.|+++
T Consensus       244 ---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          244 ---YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               11112233456778999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.7e-38  Score=349.09  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=202.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceE--EEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEV--AVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|+..+.||+|+||.||+|++. +++.+  |+|++.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888999999999999999865 56654  999887432 33456788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          825 LEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      |||+++|+|.+++....               ..+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997654               36899999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||+++.....   .......+++.|+|||++.+..++.++||||+||++|||++ |+.||......     ...  
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~--  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELY--  251 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH--
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHH--
Confidence            99999998743211   12233456889999999998889999999999999999998 99999764221     111  


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                             +.+....      ....+..++.++.+++.+||..||++||++.|+++.|+
T Consensus       252 -------~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  296 (327)
T 1fvr_A          252 -------EKLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  296 (327)
T ss_dssp             -------HHGGGTC------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHhhcCC------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                   0111110      01112346678999999999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-37  Score=342.46  Aligned_cols=249  Identities=26%  Similarity=0.357  Sum_probs=206.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888999999999999999865 68999999997553 3446788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++++|.+++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++..+....  
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999998753  4899999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.......  ....+            ......  
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~------------~~~~~~--  237 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLI------------PKNNPP--  237 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH------------HHSCCC--
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHh------------hcCCCC--
Confidence            22344578999999999999999999999999999999999999987542211  11100            000000  


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          ..+..++..+.+++.+||+.||++||++.|+++.
T Consensus       238 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          238 ----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                1112456678999999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-37  Score=349.75  Aligned_cols=248  Identities=20%  Similarity=0.312  Sum_probs=205.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..+|...+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            356888999999999999999976 58899999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++.... .+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999887643 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                      .  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+    .+ ..        +....   
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~-~~--------~~~~~---  257 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY-LR--------IKKNE---  257 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH-HH--------HHHTC---
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HH-HH--------HhcCC---
Confidence            2  2334578999999999999899999999999999999999999997642211    11 00        00000   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ...+..++..+.+++.+||+.||++||++.|+++
T Consensus       258 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0112245567889999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-37  Score=353.47  Aligned_cols=266  Identities=23%  Similarity=0.300  Sum_probs=200.8

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec-------
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS-------  817 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  817 (1027)
                      ....++|+..+.||+|+||+||+|+.. +|+.||||++.....    ...+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999864 799999999864422    22369999999999999999999844       


Q ss_pred             -------------------------------CCeeEEEEEecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHh
Q 048205          818 -------------------------------DDFKALVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYL  863 (1027)
Q Consensus       818 -------------------------------~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L  863 (1027)
                                                     ....++||||+++ +|.+.+..   ....+++..+..++.||++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348899999985 88777653   345689999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEEc-CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHH
Q 048205          864 HFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIM  941 (1027)
Q Consensus       864 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvi  941 (1027)
                      |   +.+|+||||||+||+++ .++.+||+|||+|+.+....   ......+|+.|+|||++.+. .++.++||||+||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   99999999999999998 68999999999998664332   23345689999999998765 48999999999999


Q ss_pred             HHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh--hcccc-------CccchhhhHHhhhHHHHHHHHHHhcccCC
Q 048205          942 LMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV--DANLL-------SHEDKHFVAKEQCMSFVFNLAMKCTIESP 1012 (1027)
Q Consensus       942 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~~~-------~~~~~~~~~~~~~~~~l~~Li~~cl~~dP 1012 (1027)
                      +|||++|+.||..... ...+...+.........++.  ++...       ....-....+..++.++.+++.+||++||
T Consensus       232 l~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999986432 22333333322211111111  11000       00111112234567789999999999999


Q ss_pred             CCCCCHHHHHH
Q 048205         1013 EERINAKEIVT 1023 (1027)
Q Consensus      1013 ~~Rps~~evl~ 1023 (1027)
                      ++|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-37  Score=349.77  Aligned_cols=269  Identities=22%  Similarity=0.303  Sum_probs=203.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEec--------C
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSS--------D  818 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  818 (1027)
                      .+|++.+.||+|+||+||+|+.. +|+.||||++.....  .....+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            56899999999999999999975 789999999864432  234567889999999999999999999977        3


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      +..++||||+++ ++.+.+......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999986 888888776667999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccccCC--CcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--
Q 048205          899 PFLKED--QSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--  973 (1027)
Q Consensus       899 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  973 (1027)
                      .+....  .........||+.|+|||++.+ ..++.++||||+||++|||++|++||....... .............  
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITPE  251 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChh
Confidence            664322  1223345678999999998876 458999999999999999999999998643221 1111111110000  


Q ss_pred             -HH-----Hhhhcccc-Cccch---hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 -IM-----EVVDANLL-SHEDK---HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 -~~-----~~~d~~~~-~~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                       ..     +..+.... .....   ........+.++.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence             00     00000000 00000   00111123566899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.9e-38  Score=341.74  Aligned_cols=247  Identities=28%  Similarity=0.413  Sum_probs=197.4

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecC-CeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-DFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~  827 (1027)
                      .++|+..+.||+|+||.||+|++. |+.||||+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            457889999999999999999875 8899999986443  456788999999999999999999997554 578999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++++|.+++.... ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++.....   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            99999999987653 23789999999999999999999   999999999999999999999999999999854322   


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.......  ....            +....   
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~------------~~~~~---  231 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR------------VEKGY---  231 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHH------------HTTTC---
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HhcCC---
Confidence              123357889999999998899999999999999999998 999987643221  1110            11110   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         ....+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  269 (278)
T 1byg_A          232 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  269 (278)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence               11122356778999999999999999999999999886

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.6e-37  Score=355.57  Aligned_cols=259  Identities=19%  Similarity=0.201  Sum_probs=207.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccC-CccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH-RNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....  ...+..|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            467999999999999999999964 789999999875433  2457789999999987 456666677778888999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecCCcccccC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+ +++|.+++......+++.+++.|+.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 88999999876667999999999999999999999   9999999999999999   68899999999999876543


Q ss_pred             CCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          904 DQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       904 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...+.........   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~i~~~~~~---  234 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEKISEKKVA---  234 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHHHHHHHHH---
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHHHhhcccc---
Confidence            321     122356799999999999999999999999999999999999999987533221  1111111000000   


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                              .........++.++.+++.+||..+|++||++.+|++.|+
T Consensus       235 --------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          235 --------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             --------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             --------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence                    0011122456778999999999999999999999999875

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=365.85  Aligned_cols=320  Identities=23%  Similarity=0.221  Sum_probs=217.5

Q ss_pred             cEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCC
Q 048205          261 EEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST  340 (1027)
Q Consensus       261 ~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  340 (1027)
                      +.++.+++.++          .+|..+.  ++++.|+|++|+|+++.+..|.++++|++|+|++|.++++.|..|.++++
T Consensus        14 ~~v~c~~~~l~----------~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~   81 (477)
T 2id5_A           14 RAVLCHRKRFV----------AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN   81 (477)
T ss_dssp             TEEECCSCCCS----------SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             CEEEeCCCCcC----------cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCcc
Confidence            45666666666          4454442  57889999999999888889999999999999999999888888999999


Q ss_pred             cceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecC
Q 048205          341 LKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG  420 (1027)
Q Consensus       341 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  420 (1027)
                      |++|+|++|++. .+|...+..+++|++|+|++|++++..|..|.++++|++|+|++|.++++.+..|.++++|++|+|+
T Consensus        82 L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  160 (477)
T 2id5_A           82 LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE  160 (477)
T ss_dssp             CCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEE
T ss_pred             CCEEECCCCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECC
Confidence            999999999885 6677667788899999999999988888888889999999999999988888888888888888888


Q ss_pred             CCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCcc
Q 048205          421 DNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNK  500 (1027)
Q Consensus       421 ~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~  500 (1027)
                      +|+++.++...    +..+++|+.|++++|.+.+++                         +..+..+++|+.|++++|.
T Consensus       161 ~n~l~~~~~~~----l~~l~~L~~L~l~~n~i~~~~-------------------------~~~~~~l~~L~~L~l~~~~  211 (477)
T 2id5_A          161 KCNLTSIPTEA----LSHLHGLIVLRLRHLNINAIR-------------------------DYSFKRLYRLKVLEISHWP  211 (477)
T ss_dssp             SCCCSSCCHHH----HTTCTTCCEEEEESCCCCEEC-------------------------TTCSCSCTTCCEEEEECCT
T ss_pred             CCcCcccChhH----hcccCCCcEEeCCCCcCcEeC-------------------------hhhcccCcccceeeCCCCc
Confidence            88887665432    245566666666666655332                         2344555666667776666


Q ss_pred             ccCchhHhhhcccccceeeccCceeecccCCCCCccccccccC-ccccccCcccEEecCCCccccCccccccCcccccEE
Q 048205          501 LNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIP-STLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQI  579 (1027)
Q Consensus       501 l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  579 (1027)
                      +.+.+|..+....+|++|+|++|+++              .+| ..+.++++|+.|+|++|.+++..+..+..+.+|+.|
T Consensus       212 ~~~~~~~~~~~~~~L~~L~l~~n~l~--------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  277 (477)
T 2id5_A          212 YLDTMTPNCLYGLNLTSLSITHCNLT--------------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEI  277 (477)
T ss_dssp             TCCEECTTTTTTCCCSEEEEESSCCC--------------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEE
T ss_pred             cccccCcccccCccccEEECcCCccc--------------ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEE
Confidence            66665555555556666666666552              223 234445555555555555554444445555555555


Q ss_pred             cccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccC
Q 048205          580 DLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFG  636 (1027)
Q Consensus       580 ~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~  636 (1027)
                      +|++|++++..|..|+++++|++|+|++|++++..+..|..+++|+.|+|++|+++.
T Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          278 QLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             ECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             ECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence            555555555445555555555555555555554333344455555555555555543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.4e-38  Score=343.15  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=198.1

Q ss_pred             CCCCccceeeccccceEEEEEec--CCc--eEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ--DGM--EVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ++|+..+.||+|+||+||+|++.  +++  .||||+++..   .....+.+.+|++++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56888999999999999999864  333  6899988754   2345678889999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999999876666899999999999999999999   99999999999999999999999999999987644


Q ss_pred             CCCcc-eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          903 EDQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......     ....        .+...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~--------~~~~~  240 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILH--------KIDKE  240 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH--------HHHTS
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHH--------HHHcc
Confidence            33221 2233457889999999998889999999999999999999 99999764221     1111        01000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .      .....+..++.++.+++.+||..||++||++.++++.|+
T Consensus       241 ~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          241 G------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             C------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            0      011122356778999999999999999999999999886

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-37  Score=346.18  Aligned_cols=252  Identities=20%  Similarity=0.281  Sum_probs=201.8

Q ss_pred             hCCCCcc-ceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEE
Q 048205          749 TNGFSEN-NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|.+. +.||+|+||.||+|+.. +|+.||||++....  ......+.+|+++++.++ ||||+++++++...+..++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4456666 88999999999999876 68999999987543  233567889999999995 6999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCCcc
Q 048205          824 VLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKP  899 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~  899 (1027)
                      ||||+++|+|.+++... ...+++.++..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++.
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            99999999999988654 356899999999999999999999   999999999999999987   78999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      .....   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...            +..
T Consensus       184 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~------------i~~  247 (327)
T 3lm5_A          184 IGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLN------------ISQ  247 (327)
T ss_dssp             C------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHH
T ss_pred             cCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHH------------HHh
Confidence            54322   22345799999999999999999999999999999999999999976432111 000            000


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...    .........++..+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          248 VNV----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TCC----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccc----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            000    0011122346677899999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.7e-38  Score=374.04  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=207.9

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|++.+.||+|+||+||+|++.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            356788899999999999999998888999999975432 34678999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+++.... ..+++.++..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++.+.... ..
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  419 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  419 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence            9999999997532 45899999999999999999999   9999999999999999999999999999998653211 11


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      ......++..|+|||++....++.++|||||||++|||++ |+.||......+  ...            .+....    
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~------------~i~~~~----  481 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD------------QVERGY----  481 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHH------------HHHTTC----
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------------HHHcCC----
Confidence            1223446788999999998999999999999999999999 899987642211  111            111111    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        +...+..++.++.++|.+||+.||++||++.++++.|+.
T Consensus       482 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  520 (535)
T 2h8h_A          482 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  520 (535)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              112234577889999999999999999999999999863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.8e-37  Score=348.00  Aligned_cols=269  Identities=22%  Similarity=0.222  Sum_probs=205.7

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecC-----Ce
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----DF  820 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  820 (1027)
                      ...+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3467999999999999999999866 68899999997533 33457788999999999999999999999654     46


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||+++ +|.+++...  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            8999999975 999988764  3899999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCCCc-ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH---
Q 048205          901 LKEDQS-LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM---  975 (1027)
Q Consensus       901 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  975 (1027)
                      ...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ...............   
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence            433221 11244579999999998654 458999999999999999999999997653222 222222211111000   


Q ss_pred             --------HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          976 --------EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       976 --------~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                              ....................++.++.+++.+||.+||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    000000000011111122345678999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.5e-38  Score=356.80  Aligned_cols=253  Identities=12%  Similarity=0.107  Sum_probs=185.4

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhc--cCCccceEE-------eEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRI--RHRNIIKFI-------SSCS  816 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~  816 (1027)
                      ..|+..+.||+|+||+||+|++. +|+.||||++.....   ...+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            34888999999999999999976 789999999986532   3455677785555544  699988755       4443


Q ss_pred             cC-----------------CeeEEEEEecCCCCHHHHHhcCCccCCHHHH------HHHHHHHHHHHHHhhcCCCCCeEe
Q 048205          817 SD-----------------DFKALVLEYMPYGSLEKCLYSSNYILDIFQR------LNIMIDVASALEYLHFGYSVPIIH  873 (1027)
Q Consensus       817 ~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~ivH  873 (1027)
                      ..                 ...++||||++ |+|.+++...+..+++..+      ..++.||++||+|||   +++|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence            33                 23799999999 7999999875544566666      788899999999999   999999


Q ss_pred             ccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCC
Q 048205          874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKP  951 (1027)
Q Consensus       874 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p  951 (1027)
                      |||||+||+++.++.+||+|||+|+....     ......+|+.|+|||++.+  ..++.++||||+||++|||++|+.|
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999985431     1224457799999999987  6799999999999999999999999


Q ss_pred             CCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          952 TDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      |.........  .|.          .............+.....++.++.+++.+||+.||++||++.|+++
T Consensus       293 f~~~~~~~~~--~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          293 FGLVTPGIKG--SWK----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TTBCCTTCTT--CCC----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCcCccccc--chh----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9875332110  000          00000000111112222356788999999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-37  Score=341.09  Aligned_cols=250  Identities=23%  Similarity=0.277  Sum_probs=188.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.....  ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467899999999999999999975 789999999875422  22334445556688899999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          826 EYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       826 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      ||+++ +|.+++..   ....+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99985 88777654   4456899999999999999999999   87 99999999999999999999999999998654


Q ss_pred             cCCCcceecccccCccccCcccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      ...   ......||+.|+|||++    ....++.++||||+||++|||++|+.||............            .
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~  226 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ------------V  226 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH------------H
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH------------H
Confidence            322   22334699999999996    5667899999999999999999999999754322211111            1


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ........      ....++.++.+++.+|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          227 VEEPSPQL------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHSCCCCC------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hccCCCCc------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11111111      11245677899999999999999999999976

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-37  Score=376.58  Aligned_cols=249  Identities=21%  Similarity=0.277  Sum_probs=206.5

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  822 (1027)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++++..   ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999976 68899999997542   23456677899999887 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998654 4899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ..        ..+.....
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-----~~--------~~i~~~~~  559 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LF--------QSIMEHNV  559 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH--------HHHHSSCC
T ss_pred             CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-----HH--------HHHHhCCC
Confidence            22  23445689999999999999999999999999999999999999998642211     11        11111111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINA-----KEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~-----~evl~ 1023 (1027)
                              ..+..++.++.+|+.+||..||++||++     +||++
T Consensus       560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    1123466788999999999999999997     67654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.9e-38  Score=347.16  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=198.0

Q ss_pred             HHhCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhcc--CCccceEEeEEecCCeeE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIR--HRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~  822 (1027)
                      ...++|++.+.||+|+||.||+|+..+++.||||++....  ....+.+.+|++++++++  ||||+++++++...+..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            4456799999999999999999998889999999997543  334577889999999997  499999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||| +.+++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++ ++.+||+|||+++.+..
T Consensus       105 lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             EEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            9999 55779999988654 5899999999999999999999   99999999999999996 48999999999987654


Q ss_pred             CCCcceecccccCccccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      ...........||+.|+|||++.+           ..++.++||||+||++|||++|+.||..........         
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---------  249 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---------  249 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---------
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH---------
Confidence            333333345578999999999875           468889999999999999999999997643221111         


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         ....++....      ..+..++.++.+++.+||+.||++||++.|+++
T Consensus       250 ---~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          250 ---HAIIDPNHEI------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ---HHHHCTTSCC------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHHHhccccc------CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence               1112221111      111233567899999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-37  Score=352.45  Aligned_cols=262  Identities=22%  Similarity=0.253  Sum_probs=186.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC------C
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD------D  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  819 (1027)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            467899999999999999999865 78999999986532  23456788999999999999999999998654      5


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++|+||+ +++|.+++..  ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 6799998865  34899999999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh-----
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS-----  973 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  973 (1027)
                      ...     ......||++|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+...........     
T Consensus       182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          182 TAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred             ccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            432     2334579999999999887 67899999999999999999999999764321 12222222111100     


Q ss_pred             ------HHHhhhccccCccch-hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 ------IMEVVDANLLSHEDK-HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ------~~~~~d~~~~~~~~~-~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                            ....+.. ....... .......++..+.+|+.+||..||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          256 KISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TCCCHHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhHHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                  0001110 0000111 11112345677899999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.7e-38  Score=342.62  Aligned_cols=252  Identities=22%  Similarity=0.295  Sum_probs=203.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEe--cCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCS--SDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  823 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            457889999999999999999976 68999999997543  334567889999999999999999999874  4678999


Q ss_pred             EEEecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEeccCCCCcEEEcCCCcEEEeeec
Q 048205          824 VLEYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVP-----IIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                      ||||+++++|.+++...   ...+++..+..++.|++.|++|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   244899999999999999999999   777     9999999999999999999999999


Q ss_pred             CCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      .++......  .......|++.|+|||++.+..++.++||||+|+++|||++|+.||......  .....          
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----------  227 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGK----------  227 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----------
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHH----------
Confidence            998653221  1223456899999999999989999999999999999999999999764221  11110          


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L 1025 (1027)
                       +......       ..+..++.++.+++.+||+.||++||++.|+++.+
T Consensus       228 -i~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          228 -IREGKFR-------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             -HHHTCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             -Hhhcccc-------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence             0011100       11224667799999999999999999999999865

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=351.97  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             CCCCccceeeccccceEEEEEe----cCCceEEEEEEeccc----chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCe
Q 048205          750 NGFSENNLIGRGGFGFVYKARI----QDGMEVAVKVFDLQY----GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  820 (1027)
                      ++|++.+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5689999999999999999987    368999999986432    23345677799999999 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||+++|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999999999999987654 4899999999999999999999   999999999999999999999999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      .... .......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... ....+....        .
T Consensus       210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~--------~  279 (355)
T 1vzo_A          210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRI--------L  279 (355)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHH--------H
T ss_pred             ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHH--------h
Confidence            4322 222334579999999999885  347899999999999999999999997543221 111211111        0


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVTK 1024 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~~ 1024 (1027)
                      ...        ...+..++..+.+++.+||..||++||     ++.|+++.
T Consensus       280 ~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          280 KSE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ccC--------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            000        011234566789999999999999999     99999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.9e-37  Score=336.40  Aligned_cols=248  Identities=25%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367899999999999999999976 79999999997542   23356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999987654 4899999999999999999999   8999999999999999999999999999998654321


Q ss_pred             CcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         ......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||......     .....         +.....
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~---------~~~~~~  228 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-----TLFKK---------IRGGVF  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH---------HHHCCC
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHH---------hhcCcc
Confidence               2234568999999999987765 68999999999999999999999764211     11110         001110


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             ..+..++..+.+++.+|++.||++||++.|+++.
T Consensus       229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   1122356678999999999999999999999873

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.6e-37  Score=338.86  Aligned_cols=251  Identities=21%  Similarity=0.313  Sum_probs=200.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc----chhHHHHHHHHHHHhhccCCccceEEeEE--ecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY----GRAIKSFDIECGMIKRIRHRNIIKFISSC--SSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~  821 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....    ....+.+.+|++++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 68999999997542    23456788999999999999999999998  445688


Q ss_pred             EEEEEecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          822 ALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ++||||++++ +.+++... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999886 77766543 356899999999999999999999   999999999999999999999999999999876


Q ss_pred             ccCCCcceecccccCccccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      .............||+.|+|||++.+..  ++.++||||+|+++|||++|+.||.....     .......         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i---------  225 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFENI---------  225 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHH---------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHHH---------
Confidence            5433333444567999999999987643  47899999999999999999999976421     1111110         


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ....       ...+..++..+.+++.+||..||++||+++|+++.
T Consensus       226 ~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 GKGS-------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHCC-------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hcCC-------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000       01123456778999999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5e-37  Score=349.17  Aligned_cols=265  Identities=21%  Similarity=0.218  Sum_probs=194.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  819 (1027)
                      .++|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367889999999999999999865 68999999997542  334567889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++||||+++ +|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78887753   3789999999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--------
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--------  971 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------  971 (1027)
                      ....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+...+.....        
T Consensus       177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTT
T ss_pred             cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHH
Confidence            5321   22344679999999999999999999999999999999999999997643211 11111110000        


Q ss_pred             --hhHHHhhhccccCc------------cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          972 --ISIMEVVDANLLSH------------EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       972 --~~~~~~~d~~~~~~------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                        ..............            ...........+.++.+|+.+||..||++|||++|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence              00000000000000            000111223457789999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.3e-37  Score=337.32  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=205.2

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---------chhHHHHHHHHHHHhhcc-CCccceEEeEEe
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---------GRAIKSFDIECGMIKRIR-HRNIIKFISSCS  816 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  816 (1027)
                      ..++|+..+.||+|+||.||+|++. +|+.||||+++...         ....+.+.+|++++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3467999999999999999999976 68999999997543         123456788999999996 999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          817 SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       817 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                      ..+..++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999998764 34899999999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      +..+....   ......+++.|+|||++.      ...++.++||||+|+++|||++|+.||.......  ...      
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~------  239 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLR------  239 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHH------
Confidence            98654322   223456899999999875      4568899999999999999999999997542111  110      


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           .+...... .   .......++.++.+++.+||..||++||++.|+++
T Consensus       240 -----~~~~~~~~-~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 -----MIMSGNYQ-F---GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -----HHHHTCCC-C---CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----HHhcCCcc-c---CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                 01111110 0   11122356778999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.4e-38  Score=346.17  Aligned_cols=263  Identities=23%  Similarity=0.298  Sum_probs=188.0

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999865 68999999886442 33456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhc-------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          825 LEYMPYGSLEKCLYS-------SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                      |||+++++|.+++..       ....+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999864       2345899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccCCC---cceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          898 KPFLKEDQ---SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       898 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      +.......   ........||+.|+|||++.. ..++.++||||+||++|||++|+.||............    ...  
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~--  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----LQN--  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----HTS--
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH----hcc--
Confidence            76543221   112234568999999999876 56899999999999999999999999765332211100    000  


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ++...............++.++.+++.+||+.||++||++.|+++
T Consensus       243 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 -----DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -----SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                 000000000011112345667899999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=348.39  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=186.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEe--------cC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCS--------SD  818 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~  818 (1027)
                      ..+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            346888999999999999999975 78999999987666666678899999999996 999999999984        34


Q ss_pred             CeeEEEEEecCCCCHHHHHhc--CCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEcCCCcEEEeee
Q 048205          819 DFKALVLEYMPYGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                      ...++||||+. |+|.+++..  ....+++.++..++.||+.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            45899999996 699988864  3456899999999999999999999   888  999999999999999999999999


Q ss_pred             cCCcccccCCCcc----------eecccccCccccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchh
Q 048205          895 GMAKPFLKEDQSL----------TQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT  961 (1027)
Q Consensus       895 gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  961 (1027)
                      |+++.........          ......||+.|+|||++   .+..++.++||||+||++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998664322111          11234689999999998   56678999999999999999999999996532110  


Q ss_pred             HHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          962 LKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       962 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                                     +.......      .....++..+.+++.+||+.||++||++.|+++.|+
T Consensus       261 ---------------~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 ---------------IVNGKYSI------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------------------CCC------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ---------------hhcCcccC------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                           01111100      111223344788999999999999999999999885

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.2e-37  Score=341.78  Aligned_cols=251  Identities=24%  Similarity=0.286  Sum_probs=198.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--------hhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....        .....+.+|++++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            456999999999999999999876 689999999864321        22345788999999999999999999997765


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeecC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGM  896 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl  896 (1027)
                       .++||||+++++|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             899999999999999887543 5899999999999999999999   999999999999999987664   99999999


Q ss_pred             CcccccCCCcceecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS  973 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  973 (1027)
                      ++.....   .......||+.|+|||++.   ...++.++||||+||++|+|++|+.||........ ....+.      
T Consensus       164 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~------  233 (322)
T 2ycf_A          164 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQIT------  233 (322)
T ss_dssp             CEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHH------
T ss_pred             ceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHH------
Confidence            9865321   1223456899999999864   56788999999999999999999999976433221 111111      


Q ss_pred             HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           ....    ......+..++.++.+++.+||..||++||++.|+++
T Consensus       234 -----~~~~----~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 -----SGKY----NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -----HTCC----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----hCcc----ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                 0000    0011223456778999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.5e-37  Score=352.99  Aligned_cols=264  Identities=21%  Similarity=0.250  Sum_probs=203.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc------cCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI------RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~  821 (1027)
                      ..+|++.+.||+|+||+||+|+.. +++.||||++... ......+.+|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457899999999999999999866 6899999999754 23345677788888877      467999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--EEEeeecCCc
Q 048205          822 ALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--AHLSDFGMAK  898 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~  898 (1027)
                      ++||||+. ++|.+++.... ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 59999887654 45899999999999999999999   899999999999999999987  9999999997


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--H--
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--I--  974 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~--  974 (1027)
                      ....     .....+||+.|+|||++.+..++.++||||+||++|||++|++||...... ..+..++.......  .  
T Consensus       251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHH
Confidence            5422     223457899999999999999999999999999999999999999865322 22333322221110  0  


Q ss_pred             -----HHhhhccccC----------------------------ccchh--hhHHhhhHHHHHHHHHHhcccCCCCCCCHH
Q 048205          975 -----MEVVDANLLS----------------------------HEDKH--FVAKEQCMSFVFNLAMKCTIESPEERINAK 1019 (1027)
Q Consensus       975 -----~~~~d~~~~~----------------------------~~~~~--~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~ 1019 (1027)
                           ...++.....                            .....  ...+...+.++.+|+.+||++||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                 0111100000                            00000  001112356789999999999999999999


Q ss_pred             HHHH
Q 048205         1020 EIVT 1023 (1027)
Q Consensus      1020 evl~ 1023 (1027)
                      |+++
T Consensus       405 e~L~  408 (429)
T 3kvw_A          405 QALR  408 (429)
T ss_dssp             HHHT
T ss_pred             HHhC
Confidence            9986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.7e-37  Score=348.85  Aligned_cols=263  Identities=22%  Similarity=0.281  Sum_probs=205.5

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccch-----------------hHHHHHHHHHHHhhccCCccceE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR-----------------AIKSFDIECGMIKRIRHRNIIKF  811 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~l  811 (1027)
                      .++|++.+.||+|+||.||+|+. +|+.||||++......                 ..+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46799999999999999999998 8999999999754221                 11788999999999999999999


Q ss_pred             EeEEecCCeeEEEEEecCCCCHHHH------HhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEE
Q 048205          812 ISSCSSDDFKALVLEYMPYGSLEKC------LYSS-NYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLL  883 (1027)
Q Consensus       812 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll  883 (1027)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..+..++.|++.|++|||   + .+|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5543 456899999999999999999999   8 999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCC-CCCc-chhHHHHHHHHHHHHcCCCCCCCCcccchh
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RVST-NGDVYSFGIMLMETFTRKKPTDESFTGEMT  961 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslGvil~elltg~~p~~~~~~~~~~  961 (1027)
                      +.++.+||+|||.+......    ......|++.|+|||++.+. .++. ++||||+||++|||++|+.||........ 
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence            99999999999999865332    33456799999999999877 5666 99999999999999999999986533211 


Q ss_pred             HHHHHHHHHhhhHHHhhhcc--ccC-ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          962 LKRWVNDLLLISIMEVVDAN--LLS-HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       962 ~~~~~~~~~~~~~~~~~d~~--~~~-~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....+.   ........+..  ... ...........++.++.+++.+||+.||++||++.|+++
T Consensus       261 ~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111110   00000000000  000 000001112456778999999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.6e-37  Score=334.95  Aligned_cols=244  Identities=19%  Similarity=0.286  Sum_probs=199.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||+||+|++. +++.||||++....  ......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456899999999999999999976 79999999997542  33456778899999999 999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---------------
Q 048205          825 LEYMPYGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---------------  886 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---------------  886 (1027)
                      |||+++++|.+++....   ..+++..+..++.||++||+|||   +.+|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999987642   45899999999999999999999   9999999999999999844               


Q ss_pred             ----CcEEEeeecCCcccccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchh
Q 048205          887 ----MVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT  961 (1027)
Q Consensus       887 ----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  961 (1027)
                          ..+||+|||.+......      ....||+.|+|||++.+. .++.++||||+||++|||++|.+|+....    .
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----H
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----H
Confidence                47999999999865432      223589999999998866 56689999999999999999998764321    1


Q ss_pred             HHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          962 LKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       962 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ...            +......       ..+..++.++.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~------------~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 WHE------------IRQGRLP-------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHH------------HHTTCCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHH------------HHcCCCC-------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            111            1111110       1123456778999999999999999999999863

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.8e-37  Score=373.32  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=197.9

Q ss_pred             ceeeccccceEEEEEec---CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|.+.   .++.||||+++....  ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   467899999975432  335789999999999999999999999975 457899999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc-cee
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS-LTQ  909 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~  909 (1027)
                      |+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...... ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 4899999999999999999999   999999999999999999999999999999876433221 222


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....+|+.|+|||++....++.++|||||||++|||++ |+.||......+  ..            +.+....      
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~------------~~i~~~~------  589 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT------------AMLEKGE------  589 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH------------HHHHTTC------
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH------------HHHHcCC------
Confidence            33456789999999999999999999999999999998 999997643211  11            1111111      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ....+..++.++.+++.+||+.||++||++.++++.|+
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            11223457788999999999999999999999999886

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-37  Score=339.36  Aligned_cols=243  Identities=26%  Similarity=0.438  Sum_probs=201.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec----------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS----------  817 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------  817 (1027)
                      ..+|+..+.||+|+||.||+|++. +++.||+|++....    +.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            356889999999999999999976 79999999997543    346689999999999999999998854          


Q ss_pred             ------CCeeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 048205          818 ------DDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  890 (1027)
Q Consensus       818 ------~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  890 (1027)
                            ....++||||+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence                  345799999999999999997542 46899999999999999999999   89999999999999999999999


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||+|+++|||++|..|+...       ..+..   
T Consensus       163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~---  229 (284)
T 2a19_B          163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFT---  229 (284)
T ss_dssp             ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHH---
T ss_pred             ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHH---
Confidence            99999998664332   223456899999999999999999999999999999999999886421       11111   


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           ...+...          +..++..+.+++.+||+.||++||++.|+++.|.
T Consensus       230 -----~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          230 -----DLRDGII----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             -----HHHTTCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----Hhhcccc----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                 1111110          1234566889999999999999999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.3e-37  Score=340.12  Aligned_cols=268  Identities=21%  Similarity=0.278  Sum_probs=198.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEe-----------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS-----------  816 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  816 (1027)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467899999999999999999976 58999999998766666788899999999999999999999874           


Q ss_pred             ---cCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEe
Q 048205          817 ---SDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLS  892 (1027)
Q Consensus       817 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~  892 (1027)
                         +....++||||++ |+|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++ .++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999998 5999998653  4889999999999999999999   99999999999999997 56799999


Q ss_pred             eecCCcccccCCC-cceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          893 DFGMAKPFLKEDQ-SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       893 Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      |||+++....... ........+|+.|+|||.+.. ..++.++||||+||++|||++|+.||....... ..........
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence            9999986543211 122234467899999998765 678999999999999999999999998653211 1111111100


Q ss_pred             h---hhHHHh-------hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 L---ISIMEV-------VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ~---~~~~~~-------~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .   ....+.       ..................++.++.+++.+||+.||++||+++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0   000000       0000111111111223456788999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8e-37  Score=347.47  Aligned_cols=263  Identities=20%  Similarity=0.234  Sum_probs=200.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCee----
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK----  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  821 (1027)
                      .++|...+.||+|+||.||+|++. +|+.||||++....  ....+.+.+|++++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999866 68999999997543  23356788999999999999999999999877654    


Q ss_pred             --EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          822 --ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       822 --~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                        ++||||+. ++|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 588887743   3899999999999999999999   99999999999999999999999999999985


Q ss_pred             cccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--H--
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--I--  974 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~--  974 (1027)
                      ...     ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+...........  .  
T Consensus       194 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          194 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHT
T ss_pred             ccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHHH
Confidence            432     2334578999999999887 67899999999999999999999999764321 11222211111000  0  


Q ss_pred             -------HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          975 -------MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       975 -------~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             .....................++.++.+++.+||+.||++|||++|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                   00000000111111122233567889999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.3e-37  Score=353.14  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=197.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecC------CeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD------DFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~  822 (1027)
                      .+|+..+.||+|+||+||+|++. +|+.||||++.....    ...+|++++++++||||++++++|...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999976 689999999864322    234699999999999999999988532      2367


Q ss_pred             EEEEecCCCCHHHHHh---cCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecCCc
Q 048205          823 LVLEYMPYGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAK  898 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~  898 (1027)
                      +||||+++ ++.+.+.   .....+++..+..++.||++||+|||   +.+|+||||||+||+++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 6666554   33456899999999999999999999   9999999999999999965 678999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      .+....   .....+||+.|+|||++.+. .++.++||||+||++|||++|++||.... ....+.+++..........+
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHH
Confidence            654322   22345789999999998764 78999999999999999999999998643 22333343333221111111


Q ss_pred             --hhccccCc-----cchhh--hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 --VDANLLSH-----EDKHF--VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 --~d~~~~~~-----~~~~~--~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .++.....     ....+  ..+...+.++.+|+.+||.+||++||++.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              11111000     00000  112345678999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.4e-37  Score=352.55  Aligned_cols=265  Identities=20%  Similarity=0.191  Sum_probs=201.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc--------CCccceEEeEEe---
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR--------HRNIIKFISSCS---  816 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~---  816 (1027)
                      .++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            367999999999999999999865 6889999999743 334567888999999996        788999999987   


Q ss_pred             -cCCeeEEEEEecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCC------
Q 048205          817 -SDDFKALVLEYMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNM------  887 (1027)
Q Consensus       817 -~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~------  887 (1027)
                       .....++||||+. +++.+++... ...+++..+..++.||+.||+|||   ++ +|+||||||+||+++.++      
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             5568899999995 5666665544 356899999999999999999999   87 999999999999999775      


Q ss_pred             -------------------------------------------cEEEeeecCCcccccCCCcceecccccCccccCcccc
Q 048205          888 -------------------------------------------VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG  924 (1027)
Q Consensus       888 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~  924 (1027)
                                                                 .+||+|||.++.....     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999865322     2345789999999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccch-----hHHHHHHHHHhhhHHHh---------hhccc--cCcc--
Q 048205          925 REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEM-----TLKRWVNDLLLISIMEV---------VDANL--LSHE--  986 (1027)
Q Consensus       925 ~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~---------~d~~~--~~~~--  986 (1027)
                      .+..++.++||||+||++|||++|+.||........     ................+         +....  ....  
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            999999999999999999999999999976433221     11111111110000000         00000  0000  


Q ss_pred             ---------chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          987 ---------DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       987 ---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                               ......+...+.++.+|+.+||++||++|||++|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     0011123456778999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=345.59  Aligned_cols=254  Identities=24%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             HHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEec-----
Q 048205          745 LFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSS-----  817 (1027)
Q Consensus       745 ~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----  817 (1027)
                      +....++|++.+.||+|+||.||+|++. +|+.||||++..... ..+.+.+|+++++++ +||||+++++++..     
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3345678999999999999999999975 789999999975433 346788999999999 79999999999976     


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          818 -DDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       818 -~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                       .+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence             467899999999999999997653 46899999999999999999999   9999999999999999999999999999


Q ss_pred             CCcccccCCCcceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHH
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL  970 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  970 (1027)
                      ++..+....  .......||+.|+|||++.     +..++.++||||+||++|+|++|+.||........  ..      
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~------  244 (326)
T 2x7f_A          175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LF------  244 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH------
T ss_pred             CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HH------
Confidence            998653221  1233456899999999987     56789999999999999999999999975422111  00      


Q ss_pred             hhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          971 LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       971 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           .+.......      .....++..+.+++.+||..||++||++.|+++
T Consensus       245 -----~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          245 -----LIPRNPAPR------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -----HHHHSCCCC------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----HhhcCcccc------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 000000000      011235667899999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9e-37  Score=349.51  Aligned_cols=264  Identities=24%  Similarity=0.320  Sum_probs=197.2

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC------eeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------FKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l  823 (1027)
                      .+|+..+.||+|+||+||+|++.++..||+|++.....    ...+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            45888999999999999999988777799998764322    2236999999999999999999995533      3789


Q ss_pred             EEEecCCCCHHHHH--hcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeecCCccc
Q 048205          824 VLEYMPYGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       824 V~e~~~~gsL~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~  900 (1027)
                      ||||++++.+....  ......+++..+..++.||++||+|||   +.+|+||||||+||+++ .++.+||+|||+|+.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            99999875433322  123456899999999999999999999   99999999999999999 7999999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH--Hh
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM--EV  977 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  977 (1027)
                      ....   ......+|+.|+|||++.+. .++.++||||+||++|||++|++||..... ...+...+.........  ..
T Consensus       193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence            4332   22345789999999998765 589999999999999999999999986532 22233333322211111  11


Q ss_pred             hhccccCc-----cc--hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          978 VDANLLSH-----ED--KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       978 ~d~~~~~~-----~~--~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .++.....     ..  .....+..++.++.+++.+||.+||++|||+.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            11111000     00  0111123466789999999999999999999999863

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-36  Score=353.29  Aligned_cols=319  Identities=23%  Similarity=0.246  Sum_probs=204.9

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      -+.++++++.++ .+|..+.  +.+++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus        13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            356777777777 6776654  5778888888888777777788888888888888888777777788888888888888


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |+++ .++...|.++++|++|+|++|++.+..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..
T Consensus        90 n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  168 (477)
T 2id5_A           90 NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP  168 (477)
T ss_dssp             SCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred             CcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence            8876 456666677777777777777777777777778888888888888887777777888888888888888887665


Q ss_pred             ChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEecc
Q 048205          188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSK  267 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~  267 (1027)
                      +..|..+++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|              ...+. ..+|++|++++
T Consensus       169 ~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~--------------~~~~~-~~~L~~L~l~~  233 (477)
T 2id5_A          169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT--------------PNCLY-GLNLTSLSITH  233 (477)
T ss_dssp             HHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEEC--------------TTTTT-TCCCSEEEEES
T ss_pred             hhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccC--------------ccccc-CccccEEECcC
Confidence            6667777888888888888776666677777777777777776653222              22221 12455555555


Q ss_pred             ccccccCCCCCCCCCCC-ccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEc
Q 048205          268 NMFYGEIPSDLGNCTIP-KEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYL  346 (1027)
Q Consensus       268 N~l~~~~p~~~~~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  346 (1027)
                      |+++          .+| ..+..+++|+.|+|++|+++++.+..|..+++|+.|+|++|++.++.|..|.++++|++|+|
T Consensus       234 n~l~----------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  303 (477)
T 2id5_A          234 CNLT----------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV  303 (477)
T ss_dssp             SCCC----------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEEC
T ss_pred             Cccc----------ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEEC
Confidence            5554          222 23444455555555555555444444555555555555555554444444444444444444


Q ss_pred             cCccccccCCCCccCCCCCccEEEcccccc
Q 048205          347 GSNSFFGRLPSSADVRLPNLEELSLSGNNF  376 (1027)
Q Consensus       347 ~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l  376 (1027)
                      ++|++. .++...+..+++|++|+|++|.+
T Consensus       304 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l  332 (477)
T 2id5_A          304 SGNQLT-TLEESVFHSVGNLETLILDSNPL  332 (477)
T ss_dssp             CSSCCS-CCCGGGBSCGGGCCEEECCSSCE
T ss_pred             CCCcCc-eeCHhHcCCCcccCEEEccCCCc
Confidence            444442 23333333333444444444443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-36  Score=342.29  Aligned_cols=269  Identities=23%  Similarity=0.253  Sum_probs=203.3

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecC-----Ce
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----DF  820 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  820 (1027)
                      ..++|+..+.||+|+||.||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3467999999999999999999976 68999999996433 23456778999999999999999999988654     67


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||++ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            899999997 5999988764  4899999999999999999999   999999999999999999999999999999866


Q ss_pred             ccCCCc--------ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          901 LKEDQS--------LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       901 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      ......        .......||+.|+|||++.. ..++.++||||+||++|||++|++||....... ...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  241 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGT  241 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence            432211        11223568999999998764 678999999999999999999999998653211 11111111100


Q ss_pred             h------------hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          972 I------------SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       972 ~------------~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .            ...+...................++.++.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0            000111000000011111222356788999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-36  Score=335.68  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=195.0

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec----------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS----------  817 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------  817 (1027)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            456899999999999999999975 7899999998643 3445778899999999999999999998865          


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 048205          818 ---DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       818 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                         ....++||||+++|+|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               35679999999999999999877777889999999999999999999   999999999999999999999999999


Q ss_pred             cCCcccccCCC------------cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchh
Q 048205          895 GMAKPFLKEDQ------------SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT  961 (1027)
Q Consensus       895 gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  961 (1027)
                      |+++.......            ........||+.|+|||++.+. .++.++||||+||++|||++   ||.....    
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~----  233 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME----  233 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh----
Confidence            99986542210            1122345689999999998764 68999999999999999998   5443211    


Q ss_pred             HHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          962 LKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       962 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .......        +..... . ...  .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~--------~~~~~~-~-~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 RVNILKK--------LRSVSI-E-FPP--DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHH--------HHSTTC-C-CCT--TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHh--------cccccc-c-cCc--cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1111110        000000 0 000  1123455678899999999999999999999873

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.1e-37  Score=352.98  Aligned_cols=266  Identities=21%  Similarity=0.272  Sum_probs=182.8

Q ss_pred             CCc-cceeeccccceEEEEEec---CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEe--cCCeeEEEE
Q 048205          752 FSE-NNLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCS--SDDFKALVL  825 (1027)
Q Consensus       752 f~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lV~  825 (1027)
                      |.+ .++||+|+||+||+|+++   +++.||||++....  ....+.+|++++++++||||+++++++.  .....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            554 568999999999999965   57899999986442  2356788999999999999999999994  467899999


Q ss_pred             EecCCCCHHHHHhcC--------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEee
Q 048205          826 EYMPYGSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSD  893 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~D  893 (1027)
                      ||+.+ +|.+++...        ...+++..+..++.||+.||+|||   +.+|+||||||+||++    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99975 888776532        124899999999999999999999   9999999999999999    6789999999


Q ss_pred             ecCCcccccCCC-cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccc--------hhHH
Q 048205          894 FGMAKPFLKEDQ-SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGE--------MTLK  963 (1027)
Q Consensus       894 fgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~--------~~~~  963 (1027)
                      ||+|+.+..... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.......        ..+.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            999986643221 1233456799999999998874 58999999999999999999999997643211        1112


Q ss_pred             HHHHHHHhhh---HHHh------------hhccccCccc-hhh--hHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          964 RWVNDLLLIS---IMEV------------VDANLLSHED-KHF--VAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       964 ~~~~~~~~~~---~~~~------------~d~~~~~~~~-~~~--~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..+.......   +.++            +......... ...  ......+.++.+|+.+||++||++|||++|+++
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            2211111000   0000            0000000000 000  000011456889999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-36  Score=331.29  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=204.3

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34467999999999999999999976 78999999997543  2345778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeecCCccc
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPF  900 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~  900 (1027)
                      ||||+++++|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.+   +.+||+|||+++..
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999999999886544 4899999999999999999999   9999999999999999754   47999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ....   ......+++.|+|||++.+ .++.++||||+|+++|+|++|+.||......     .....        +...
T Consensus       175 ~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~--------~~~~  237 (287)
T 2wei_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DILKR--------VETG  237 (287)
T ss_dssp             CCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH--------HHHC
T ss_pred             cCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----HHHHH--------HHcC
Confidence            4322   2233458899999998875 4899999999999999999999999764221     11110        0011


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..    .........++.++.+++.+|+..||++|||+.|+++
T Consensus       238 ~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 KY----AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CC----CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC----CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00    0111222456778999999999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.5e-36  Score=336.75  Aligned_cols=264  Identities=20%  Similarity=0.246  Sum_probs=203.8

Q ss_pred             hCCCCccceeeccccceEEEEEe-c-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCc------cceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARI-Q-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN------IIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  820 (1027)
                      .++|++.+.||+|+||.||+|+. . +++.||||+++.. ....+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46799999999999999999986 3 6889999998743 334567888999999998765      9999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--------------
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--------------  885 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------------  885 (1027)
                      .++||||+ +++|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 789999987654 45889999999999999999999   999999999999999987              


Q ss_pred             -----CCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccch
Q 048205          886 -----NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEM  960 (1027)
Q Consensus       886 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  960 (1027)
                           ++.+||+|||+++....     ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ 
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             cccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                 67899999999985432     1234578999999999999999999999999999999999999997643221 


Q ss_pred             hHHHHHHHHHhhh--HHHhhhcc-c---------------------cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC
Q 048205          961 TLKRWVNDLLLIS--IMEVVDAN-L---------------------LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI 1016 (1027)
Q Consensus       961 ~~~~~~~~~~~~~--~~~~~d~~-~---------------------~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp 1016 (1027)
                      .............  ........ .                     .............++.++.+++.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            1111111111000  00000000 0                     0000000111234567899999999999999999


Q ss_pred             CHHHHHH
Q 048205         1017 NAKEIVT 1023 (1027)
Q Consensus      1017 s~~evl~ 1023 (1027)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=346.52  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             HHhCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ...++|++.+.||+|+||.||+|++.+  .||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345779999999999999999998753  59999986542  22345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++ ++.+||+|||+++......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999999887767899999999999999999999   99999999999999998 6899999999987543211


Q ss_pred             ---CcceecccccCccccCcccccC---------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          905 ---QSLTQTQTLATIGYMAPEYGRE---------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       905 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                         .........|++.|+|||++..         ..++.++||||+||++|||++|+.||........     ....   
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~---  255 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-----IWQM---  255 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-----HHHH---
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHh---
Confidence               1122233458999999999874         3578899999999999999999999976432111     0000   


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                        .....+..         ....++.++.+++.+||..||++||++.+++++|++
T Consensus       256 --~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  299 (319)
T 2y4i_B          256 --GTGMKPNL---------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK  299 (319)
T ss_dssp             --HTTCCCCC---------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred             --ccCCCCCC---------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence              00001100         011345568899999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.4e-36  Score=335.67  Aligned_cols=268  Identities=25%  Similarity=0.329  Sum_probs=202.9

Q ss_pred             HhCCCCccceeeccccceEEEEEe--cCCceEEEEEEecccch--hHHHHHHHHHHHhhc---cCCccceEEeEEe----
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARI--QDGMEVAVKVFDLQYGR--AIKSFDIECGMIKRI---RHRNIIKFISSCS----  816 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  816 (1027)
                      ..++|++.+.||+|+||.||+|++  .+|+.||||++......  ....+.+|+++++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  36889999998754321  223556677777666   8999999999987    


Q ss_pred             -cCCeeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 048205          817 -SDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       817 -~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                       .....++||||++ |+|.+++.... ..+++..+..++.|+++||+|||   +.||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999998 59999987654 44899999999999999999999   999999999999999999999999999


Q ss_pred             cCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI  974 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  974 (1027)
                      |+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+........
T Consensus       165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCG
T ss_pred             cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCc
Confidence            999865322   1233457899999999999999999999999999999999999999865321 111121111110000


Q ss_pred             HHhhh----cc--ccC-ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 MEVVD----AN--LLS-HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 ~~~~d----~~--~~~-~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....    +.  ... ...........++..+.+++.+||..||++||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000    00  000 000011122346778899999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-36  Score=367.95  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             hCCCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .++|+..+.||+|+||.||+|++..    +..||||++.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            4568889999999999999998642    4579999886543 3345678899999999999999999999854 56899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999877767899999999999999999999   899999999999999999999999999999866432


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      . ........+|+.|+|||++.+..++.++||||+||++|||++ |..||......+  ....+           .... 
T Consensus       545 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i-----------~~~~-  609 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI-----------ENGE-  609 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH-----------HHTC-
T ss_pred             c-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH-----------HcCC-
Confidence            2 222233457789999999998899999999999999999997 999987643211  11111           0100 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ....+..++..+.+++.+||..||++||++.|+++.|+
T Consensus       610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                  01122356778999999999999999999999999886

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.4e-36  Score=338.34  Aligned_cols=274  Identities=21%  Similarity=0.232  Sum_probs=193.9

Q ss_pred             HHHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCe-
Q 048205          743 LELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF-  820 (1027)
Q Consensus       743 ~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  820 (1027)
                      .+.....++|++.+.||+|+||+||+|++. +|+.||||++.... .....+.+|++.++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345566789999999999999999999975 68999999986442 233456678888999999999999999965433 


Q ss_pred             ------eEEEEEecCCCCHHHHHh---cCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEE
Q 048205          821 ------KALVLEYMPYGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAH  890 (1027)
Q Consensus       821 ------~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k  890 (1027)
                            .++||||+++ ++.+.+.   .....+++..+..++.|++.|++||| .++.+|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999987 5554443   23456889999999999999999999 33789999999999999996 89999


Q ss_pred             EeeecCCcccccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH
Q 048205          891 LSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL  969 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  969 (1027)
                      |+|||+++.+....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+..++...
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHc
Confidence            99999998664322   23345689999999998665 489999999999999999999999987432 22233332222


Q ss_pred             Hhh--hHHHhhhccccCcc-----ch-----hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          970 LLI--SIMEVVDANLLSHE-----DK-----HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       970 ~~~--~~~~~~d~~~~~~~-----~~-----~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...  ......++......     ..     .......++.++.+++.+||++||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111  11111111110000     00     00011225678999999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=340.48  Aligned_cols=262  Identities=20%  Similarity=0.233  Sum_probs=198.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCe-----
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF-----  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  820 (1027)
                      .++|...+.||+|+||.||+|++. +|+.||||++....  ....+.+.+|++++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467888999999999999999875 68999999997543  2335678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          821 -KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       821 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                       .++||||++ ++|.+++..   .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887643   3899999999999999999999   99999999999999999999999999999985


Q ss_pred             cccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--H--
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--I--  974 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~--  974 (1027)
                      ...     ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+...........  .  
T Consensus       176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHHT
T ss_pred             CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            432     1234578999999999876 67899999999999999999999999764321 11111111111000  0  


Q ss_pred             -------HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          975 -------MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       975 -------~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                             ...+.................++.++.+++.+|+..||++||+++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   0000000000000011112356778999999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-35  Score=338.06  Aligned_cols=201  Identities=25%  Similarity=0.342  Sum_probs=172.1

Q ss_pred             HHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CC-----ccceEEeEEecCC
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HR-----NIIKFISSCSSDD  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~  819 (1027)
                      ...++|++.+.||+|+||+||+|+.. +++.||||+++.. ......+..|+++++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999876 6889999999743 233566778888888885 44     4999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--CCCcEEEeeecC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNMVAHLSDFGM  896 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgl  896 (1027)
                      ..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||. ++.+|+||||||+||+++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            99999999965 9999987654 458999999999999999999992 147899999999999995  578899999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDES  955 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  955 (1027)
                      ++....     ......||+.|+|||++.+..++.++||||+||++|||++|++||...
T Consensus       208 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          208 SCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            986532     123457899999999999999999999999999999999999999865

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6e-36  Score=347.07  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=187.2

Q ss_pred             CCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEecC
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            35556889999999998776678999999998753   235677899999886 89999999999999999999999996


Q ss_pred             CCCHHHHHhcCCcc------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-------------CcEE
Q 048205          830 YGSLEKCLYSSNYI------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-------------MVAH  890 (1027)
Q Consensus       830 ~gsL~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k  890 (1027)
                       |+|.+++......      .++..+..++.||+.||+|||   +.+|+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             5999999765421      123345779999999999999   9999999999999999754             4899


Q ss_pred             EeeecCCcccccCCCcc--eecccccCccccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccch
Q 048205          891 LSDFGMAKPFLKEDQSL--TQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEM  960 (1027)
Q Consensus       891 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  960 (1027)
                      |+|||+++.+.......  ......||+.|+|||++.+       ..++.++||||+||++|||++ |+.||........
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            99999998765432211  1234579999999999875       568999999999999999999 9999975432211


Q ss_pred             hHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          961 TLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       961 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                         .+..        ...+.     ..........++.++.+++.+||+.||++||++.|+++
T Consensus       249 ---~i~~--------~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 ---NIIR--------GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---HHHH--------TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHhc--------CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               1100        00000     00011112346678999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-36  Score=337.94  Aligned_cols=252  Identities=19%  Similarity=0.223  Sum_probs=174.8

Q ss_pred             HhCCCCccc-eeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec----CCee
Q 048205          748 ATNGFSENN-LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS----DDFK  821 (1027)
Q Consensus       748 ~~~~f~~~~-~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  821 (1027)
                      ..++|++.+ .||+|+||+||+|++. +|+.||||++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788854 6999999999999976 68999999986432    112223334667799999999999876    4558


Q ss_pred             EEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMA  897 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla  897 (1027)
                      ++||||+++|+|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998654 46899999999999999999999   999999999999999976   456999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      +.....    ......+|+.|+|||++....++.++||||+||++|+|++|+.||......... .....         .
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~---------~  244 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKR---------R  244 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHH---------h
Confidence            855322    223456899999999998889999999999999999999999999764322110 00000         0


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +.....   .........++.++.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          245 IRLGQY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhcccc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000   0011112346778999999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.2e-36  Score=335.14  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=179.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc-hhHHHHHHHHH-HHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-RAIKSFDIECG-MIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888999999999999999975 789999999976532 23344555555 778889999999999999999999999


Q ss_pred             EecCCCCHHHHHhc----CCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          826 EYMPYGSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       826 e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ||+++ +|.+++..    ....+++..+..++.|+++|++|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 88777653    2456899999999999999999999   87 9999999999999999999999999999865


Q ss_pred             ccCCCcceecccccCccccCcccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      ....   ......||+.|+|||++    .+..++.++||||+||++|||++|+.||.........            ...
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------------~~~  241 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------------LTQ  241 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------------HHH
Confidence            4321   22334689999999998    4567899999999999999999999999753211100            000


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +.....   ..........++.++.+++.+||..||++||++.|+++
T Consensus       242 ~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          242 VVKGDP---PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCSCC---CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HhcCCC---CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            110000   00000111246677999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-35  Score=334.57  Aligned_cols=263  Identities=21%  Similarity=0.254  Sum_probs=200.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CC-ceEEEEEEecccchhHHHHHHHHHHHhhccCCc------cceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DG-MEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN------IIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  820 (1027)
                      .++|++.+.||+|+||+||+|+.. ++ +.||||+++.. ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            467999999999999999999875 44 68999999743 334567888999999998776      8999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----------------
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----------------  883 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----------------  883 (1027)
                      .++||||+ ++++.+++.... ..+++.++..++.||++||+|||   +.+|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 557777666543 56899999999999999999999   9999999999999999                


Q ss_pred             ---cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccch
Q 048205          884 ---DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEM  960 (1027)
Q Consensus       884 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~  960 (1027)
                         +.++.+||+|||+++....     ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... 
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence               6788999999999985432     1234579999999999999999999999999999999999999998643221 


Q ss_pred             hHHHHHHHHHhhhHHHhhhcc----------c---------------cCccchhhhHHhhhHHHHHHHHHHhcccCCCCC
Q 048205          961 TLKRWVNDLLLISIMEVVDAN----------L---------------LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEER 1015 (1027)
Q Consensus       961 ~~~~~~~~~~~~~~~~~~d~~----------~---------------~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R 1015 (1027)
                      ............. .++....          .               ..............+.++.+++.+||+.||++|
T Consensus       247 ~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          247 HLVMMEKILGPIP-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHCCCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHcCCCc-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            1111111111000 0000000          0               000000011112345678999999999999999


Q ss_pred             CCHHHHHH
Q 048205         1016 INAKEIVT 1023 (1027)
Q Consensus      1016 ps~~evl~ 1023 (1027)
                      ||+.|+++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.4e-36  Score=333.65  Aligned_cols=251  Identities=21%  Similarity=0.265  Sum_probs=182.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch--hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR--AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      .++|+..+.||+|+||.||+|++. +|+.||||++......  ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356888999999999999999976 7899999999755322  2233445556788889999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      ||+ ++.+..+.......+++..+..++.|+++||+|||   +. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666666554566899999999999999999999   75 99999999999999999999999999997653322


Q ss_pred             CcceecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          905 QSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                         ......+|+.|+|||++.     ...++.++||||+||++|||++|+.||............            +..
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------~~~  244 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK------------VLQ  244 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH------------HHH
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH------------Hhc
Confidence               223456899999999984     456889999999999999999999999764222111111            111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...     ........++.++.+++.+||..||++||++.|+++
T Consensus       245 ~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          245 EEP-----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             SCC-----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCC-----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            100     011111235677899999999999999999999975

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=9.9e-36  Score=360.33  Aligned_cols=335  Identities=21%  Similarity=0.228  Sum_probs=240.6

Q ss_pred             cCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEE
Q 048205          290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEEL  369 (1027)
Q Consensus       290 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  369 (1027)
                      +.+++.|++++|.+..+++..|..+++|+.|+|++|.+.++.|..|.++++|++|+|++|.+.+ +|...+..+++|++|
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEE
Confidence            4566667777777766666666677777777777777777666677777777777777777653 444444567777777


Q ss_pred             EccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccC
Q 048205          370 SLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISN  449 (1027)
Q Consensus       370 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~  449 (1027)
                      +|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.++.++.       ..++.|+.|++++
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------~~l~~L~~L~l~~  201 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL-------SLIPSLFHANVSY  201 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG-------GGCTTCSEEECCS
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh-------hhhhhhhhhhccc
Confidence            777777775555556777777777777777777777777777777777777777765532       3456677777777


Q ss_pred             CCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeeccc
Q 048205          450 NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSI  529 (1027)
Q Consensus       450 N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~  529 (1027)
                      |.++++.                              ...+|+.|++++|.++...+..   .++|+.|+|++|++++  
T Consensus       202 n~l~~l~------------------------------~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--  246 (597)
T 3oja_B          202 NLLSTLA------------------------------IPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--  246 (597)
T ss_dssp             SCCSEEE------------------------------CCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--
T ss_pred             Ccccccc------------------------------CCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--
Confidence            7665321                              1224555555555555322211   2467777777777743  


Q ss_pred             CCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCc
Q 048205          530 PDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNR  609 (1027)
Q Consensus       530 p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~  609 (1027)
                                   +..++.+++|+.|+|++|.+++..|..++.+++|+.|+|++|++++ +|..++.+++|+.|+|++|.
T Consensus       247 -------------~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~  312 (597)
T 3oja_B          247 -------------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH  312 (597)
T ss_dssp             -------------CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSC
T ss_pred             -------------ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCC
Confidence                         2456677788888888888888788888888999999999999985 68888888999999999999


Q ss_pred             cccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCCCCCCCCcccccccCCccccCCC
Q 048205          610 LQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP  686 (1027)
Q Consensus       610 l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g~~  686 (1027)
                      ++ .+|..++.+++|+.|+|++|++++. |  +..+++|+.|++++|++++..+. +.+..+...++.++...|+.+
T Consensus       313 l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          313 LL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            98 6888888899999999999998855 3  66788899999999998876432 356677777889999999965

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=347.84  Aligned_cols=249  Identities=22%  Similarity=0.348  Sum_probs=188.7

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .+|+..+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+....++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            45888899999999997765566799999999865432   2356799999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-----CCcEEEeeecCCcccccC
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-----NMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~~~  903 (1027)
                      + |+|.+++........+.++..++.||++||+|||   +.+|+||||||+||+++.     ...+||+|||+|+.+...
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            7 5999999877655666677889999999999999   999999999999999953     336889999999866433


Q ss_pred             CCc-ceecccccCccccCccccc---CCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          904 DQS-LTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       904 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      ... .......||++|+|||++.   ...++.++||||+||++|||++ |..||........   .           ...
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---~-----------~~~  242 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---N-----------ILL  242 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---H-----------HHT
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---H-----------HHh
Confidence            211 2334567999999999987   4567889999999999999999 8989854321110   0           000


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....    .........+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          243 GACSL----DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TCCCC----TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCc----cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00000    001111234556789999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.1e-36  Score=340.75  Aligned_cols=265  Identities=17%  Similarity=0.223  Sum_probs=199.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-----------CCccceEEeEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-----------HRNIIKFISSCS  816 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  816 (1027)
                      ..+|++.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357899999999999999999964 78999999997432 33466788999988886           899999999997


Q ss_pred             cCC----eeEEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEc------
Q 048205          817 SDD----FKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLD------  884 (1027)
Q Consensus       817 ~~~----~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~------  884 (1027)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   ++ +|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 889999987643 45899999999999999999999   87 999999999999995      


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc-----c
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG-----E  959 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-----~  959 (1027)
                      ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||......     .
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4448999999999865322     23457899999999999999999999999999999999999999764321     1


Q ss_pred             hhHHHHHHHHHhhhH---------HHhhhccc-cC------------ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC
Q 048205          960 MTLKRWVNDLLLISI---------MEVVDANL-LS------------HEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN 1017 (1027)
Q Consensus       960 ~~~~~~~~~~~~~~~---------~~~~d~~~-~~------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps 1017 (1027)
                      ..+............         ...++... ..            ........+..++.++.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            111111111110000         00000000 00            000011123467788999999999999999999


Q ss_pred             HHHHHH
Q 048205         1018 AKEIVT 1023 (1027)
Q Consensus      1018 ~~evl~ 1023 (1027)
                      ++|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-36  Score=337.71  Aligned_cols=245  Identities=22%  Similarity=0.303  Sum_probs=200.4

Q ss_pred             HHHHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccch------hHHHHHHHHHHHhhcc--CCccceEEeE
Q 048205          744 ELFQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR------AIKSFDIECGMIKRIR--HRNIIKFISS  814 (1027)
Q Consensus       744 ~~~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~  814 (1027)
                      +.....++|++.+.||+|+||.||+|+.. +++.||||++......      ..+.+.+|++++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            33445678999999999999999999865 7899999999754321      2245667999999996  5999999999


Q ss_pred             EecCCeeEEEEEecCC-CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEe
Q 048205          815 CSSDDFKALVLEYMPY-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLS  892 (1027)
Q Consensus       815 ~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~  892 (1027)
                      +...+..++||||+.+ ++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++ .++.+||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999999976 89999987643 4899999999999999999999   99999999999999999 78999999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |||+++.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....       .       
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~-------  254 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E-------  254 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H-------
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------h-------
Confidence            99999865432    2234569999999999887665 688999999999999999999986521       0       


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                           .......        .+..++.++.+++.+||..||++||++.|+++
T Consensus       255 -----~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 -----IIRGQVF--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -----HHHCCCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----hhccccc--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0011110        11235667899999999999999999999986

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.4e-35  Score=338.25  Aligned_cols=335  Identities=21%  Similarity=0.223  Sum_probs=219.5

Q ss_pred             cCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEE
Q 048205          290 LAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEEL  369 (1027)
Q Consensus       290 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  369 (1027)
                      +.+++.|++++|.++.+.+..|..+++|++|++++|.+.++.+..|.++++|++|++++|++.+ ++...+..+++|++|
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCCEE
Confidence            4566666666666666555556666666666666666666666666666667777777666643 333444566677777


Q ss_pred             EccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccC
Q 048205          370 SLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISN  449 (1027)
Q Consensus       370 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~  449 (1027)
                      +|++|+++...+..|.++++|++|++++|++++..|..|+.+++|++|++++|+++.++       ...++.|+.|++++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-------~~~l~~L~~L~l~~  195 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-------LSLIPSLFHANVSY  195 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC-------GGGCTTCSEEECCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc-------cccccccceeeccc
Confidence            77777776443444566777777777777777666666777777777777777766543       23456677777777


Q ss_pred             CCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeeccc
Q 048205          450 NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSI  529 (1027)
Q Consensus       450 N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~  529 (1027)
                      |.++++.                              ...+|++|++++|+++.. |.  ...++|+.|+|++|++++  
T Consensus       196 n~l~~~~------------------------------~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~--  240 (390)
T 3o6n_A          196 NLLSTLA------------------------------IPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTD--  240 (390)
T ss_dssp             SCCSEEE------------------------------CCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCC--
T ss_pred             ccccccC------------------------------CCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCcc--
Confidence            7665321                              112344555555555432 21  113566666666666632  


Q ss_pred             CCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCc
Q 048205          530 PDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNR  609 (1027)
Q Consensus       530 p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~  609 (1027)
                                   +..+..+++|+.|++++|.+++..|..++.+++|+.|++++|++++ +|..++.+++|++|+|++|+
T Consensus       241 -------------~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~  306 (390)
T 3o6n_A          241 -------------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH  306 (390)
T ss_dssp             -------------CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSC
T ss_pred             -------------cHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCc
Confidence                         1345566677777777777777667777788888888888888874 67777778888888888888


Q ss_pred             cccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCCCCCCCCcccccccCCccccCCC
Q 048205          610 LQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP  686 (1027)
Q Consensus       610 l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g~~  686 (1027)
                      ++ .+|..++.+++|+.|+|++|++++. |  +..+++|+.|++++|++.+.-. ...+..+....+.++...|+.|
T Consensus       307 l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          307 LL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             CC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCCTT
T ss_pred             ce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceeccc
Confidence            87 5777778888888888888888744 3  5677788888888888776422 1234555566677888888865

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-36  Score=333.77  Aligned_cols=243  Identities=24%  Similarity=0.338  Sum_probs=191.9

Q ss_pred             HHHhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc------hhHHHHHHHHHHHhhc----cCCccceEEeE
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG------RAIKSFDIECGMIKRI----RHRNIIKFISS  814 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~~  814 (1027)
                      ....++|++.+.||+|+||.||+|+.. +++.||||+++....      .....+.+|+++++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            345678999999999999999999865 689999999865432      1223455689999998    89999999999


Q ss_pred             EecCCeeEEEEEe-cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEe
Q 048205          815 CSSDDFKALVLEY-MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLS  892 (1027)
Q Consensus       815 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~  892 (1027)
                      +...+..++|||| +.+++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++ .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEE
Confidence            9999999999999 78999999987644 4899999999999999999999   89999999999999999 89999999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |||+++.....    ......|++.|+|||++.+..+. .++||||+||++|||++|+.||....               
T Consensus       183 dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------------  243 (312)
T 2iwi_A          183 DFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------------  243 (312)
T ss_dssp             CCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------------
T ss_pred             EcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------------
Confidence            99999865432    22345689999999998876664 58999999999999999999986421               


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          ++.+...        ..+..++.++.+++.+||+.||++||++.|+++
T Consensus       244 ----~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 ----EILEAEL--------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHHHTCC--------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----HHhhhcc--------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0011111        111345667899999999999999999999987

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.3e-35  Score=328.85  Aligned_cols=260  Identities=30%  Similarity=0.515  Sum_probs=218.7

Q ss_pred             CCccEEEccccccCC--cCcccccCCCCCCeeecCC-CcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccc
Q 048205          364 PNLEELSLSGNNFSG--TIPSFIFNTSKLSTLELQR-NSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCK  440 (1027)
Q Consensus       364 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~  440 (1027)
                      .+++.|+|++|++++  .+|..+.++++|++|+|++ |.+.+.+|..|+.+++|++|+|++|+++               
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~---------------  114 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS---------------  114 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE---------------
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeC---------------
Confidence            468888888888887  7888888888888888884 8888888888888888888888877743               


Q ss_pred             cccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeec
Q 048205          441 YLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSL  520 (1027)
Q Consensus       441 ~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  520 (1027)
                                                            +.+|..++++++|++|++++|++++.+|..|+++++|++|+|
T Consensus       115 --------------------------------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  156 (313)
T 1ogq_A          115 --------------------------------------GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF  156 (313)
T ss_dssp             --------------------------------------EECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred             --------------------------------------CcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEEC
Confidence                                                  345666677777777777777777777778888888888888


Q ss_pred             cCceeecccCCCCCccccccccCccccccC-cccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCcc
Q 048205          521 KDNQLEGSIPDNLSFSCTLTSIPSTLWNLK-DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD  599 (1027)
Q Consensus       521 s~N~l~g~~p~~~~~~~~~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~  599 (1027)
                      ++|+++|.             +|..++.++ .|++|++++|.+++.+|..++.+. |+.|++++|++++.+|..|+.+++
T Consensus       157 ~~N~l~~~-------------~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~  222 (313)
T 1ogq_A          157 DGNRISGA-------------IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKN  222 (313)
T ss_dssp             CSSCCEEE-------------CCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSC
T ss_pred             cCCcccCc-------------CCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCC
Confidence            88887643             455666776 788888888888888888888887 999999999999889999999999


Q ss_pred             ccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCCCCCCCCcccccccCC
Q 048205          600 LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGN  679 (1027)
Q Consensus       600 L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n  679 (1027)
                      |+.|+|++|++++.+|. ++.+++|++|+|++|+++|.+|..+..+++|+.|++++|+++|.+|..+.+.++....+.||
T Consensus       223 L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N  301 (313)
T 1ogq_A          223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN  301 (313)
T ss_dssp             CSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSS
T ss_pred             CCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCC
Confidence            99999999999976665 88899999999999999999999999999999999999999999999888999999999999


Q ss_pred             ccccCCCcccccccc
Q 048205          680 ELLCGMPNLQVRSCR  694 (1027)
Q Consensus       680 ~~l~g~~~~~~~~c~  694 (1027)
                      +.+||.|.   ++|.
T Consensus       302 ~~lc~~p~---~~C~  313 (313)
T 1ogq_A          302 KCLCGSPL---PACT  313 (313)
T ss_dssp             SEEESTTS---SCCC
T ss_pred             CCccCCCC---CCCC
Confidence            99999884   3673

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.2e-36  Score=354.46  Aligned_cols=264  Identities=24%  Similarity=0.309  Sum_probs=199.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEec------CCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSS------DDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  820 (1027)
                      .++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            367999999999999999999875 6899999998754 23445678899999999999999999999765      667


Q ss_pred             eEEEEEecCCCCHHHHHhcCC--ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeec
Q 048205          821 KALVLEYMPYGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFG  895 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  895 (1027)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999997644  35888899999999999999999   899999999999999997765   9999999


Q ss_pred             CCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH
Q 048205          896 MAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM  975 (1027)
Q Consensus       896 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  975 (1027)
                      .++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......    ..|..........
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC-----
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccch
Confidence            998654322   234467999999999999999999999999999999999999999764221    2222111110000


Q ss_pred             H-hhhccccC------ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          976 E-VVDANLLS------HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       976 ~-~~d~~~~~------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                      . ........      ...........++..+.+++.+|+.+||++|||++|++
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0 00000000      00001112335778899999999999999999997743

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-34  Score=316.49  Aligned_cols=227  Identities=13%  Similarity=0.060  Sum_probs=184.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56899999999999999999976 58999999987543   233477889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||++|++|.+++...   ....++.+++.|++.||+|||   +.||+||||||+||+++.+|.+||+++|          
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            999999999998643   355678899999999999999   9999999999999999999999998543          


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                                  |++       .++.++||||+||++|||++|+.||..........              .........
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~~~~~  221 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERDTAGQ  221 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBCTTSC
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHHhccC
Confidence                        333       36889999999999999999999998653321100              000000111


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..........++.++.+++.+||++||++| |+.|+++.|+
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~  261 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ  261 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence            111112234567789999999999999999 9999999986

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-33  Score=323.33  Aligned_cols=310  Identities=22%  Similarity=0.242  Sum_probs=166.0

Q ss_pred             cCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEE
Q 048205           49 VTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTL  128 (1027)
Q Consensus        49 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L  128 (1027)
                      +.++++|++++|.++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+++ .+++..+..+++|++|
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEE
Confidence            345555555555555333333455555555555555555444445555555555555555544 2223333334444444


Q ss_pred             EccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccC
Q 048205          129 FLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT  208 (1027)
Q Consensus       129 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  208 (1027)
                      +|++|+++...+..|..+++|++|++++|.+++..|..|..+++|++|++++|++++.   .+..+++|+.|++++|.++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence            4444444433333334444444444444444443344444444444444444444422   1233334444444444443


Q ss_pred             CCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCcccc
Q 048205          209 GTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG  288 (1027)
Q Consensus       209 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~  288 (1027)
                      +     +...++                                       |++|++++|.++.          +|..  
T Consensus       200 ~-----~~~~~~---------------------------------------L~~L~l~~n~l~~----------~~~~--  223 (390)
T 3o6n_A          200 T-----LAIPIA---------------------------------------VEELDASHNSINV----------VRGP--  223 (390)
T ss_dssp             E-----EECCSS---------------------------------------CSEEECCSSCCCE----------EECC--
T ss_pred             c-----cCCCCc---------------------------------------ceEEECCCCeeee----------cccc--
Confidence            1     112233                                       4444444444431          1111  


Q ss_pred             CcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccE
Q 048205          289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEE  368 (1027)
Q Consensus       289 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~  368 (1027)
                      ..++|+.|++++|++++.  ..+..+++|+.|++++|++.++.|..|.++++|++|+|++|++.+ +|... ..+++|++
T Consensus       224 ~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~-~~l~~L~~  299 (390)
T 3o6n_A          224 VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYG-QPIPTLKV  299 (390)
T ss_dssp             CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSS-SCCTTCCE
T ss_pred             ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCccc-CCCCCCCE
Confidence            124566666666666643  456666777777777777777667777777777777777777643 33332 35677888


Q ss_pred             EEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCC
Q 048205          369 LSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS  426 (1027)
Q Consensus       369 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  426 (1027)
                      |+|++|+++ .+|..+..+++|++|+|++|+++.. +  +..+++|++|++++|++++
T Consensus       300 L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             EECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             EECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence            888888877 5666677778888888888887754 2  5667777777777777654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.6e-33  Score=314.87  Aligned_cols=305  Identities=27%  Similarity=0.445  Sum_probs=141.0

Q ss_pred             ccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcE
Q 048205           48 NVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQT  127 (1027)
Q Consensus        48 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~  127 (1027)
                      .+++|++|++++|.++ .++. +..+++|++|++++|.+++..+  +..+++|++|++++|++++ ++  .+..+++|++
T Consensus        42 ~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~--~~~~l~~L~~  114 (347)
T 4fmz_A           42 ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS--ALQNLTNLRE  114 (347)
T ss_dssp             HHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG--GGTTCTTCSE
T ss_pred             hcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch--HHcCCCcCCE
Confidence            4444555555555544 2222 4444555555555555442222  4444555555555554442 11  2333444444


Q ss_pred             EEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeecccccc
Q 048205          128 LFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFL  207 (1027)
Q Consensus       128 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  207 (1027)
                      |++++|++.+..+  +..+++|++|++++|.....+ ..+..+++|++|++++|.+.+..+  +..+++|++|++++|.+
T Consensus       115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l  189 (347)
T 4fmz_A          115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI  189 (347)
T ss_dssp             EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred             EECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence            4444444442211  444444444444444333222 224444444444444444443221  44444444444444444


Q ss_pred             CCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccc
Q 048205          208 TGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEI  287 (1027)
Q Consensus       208 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l  287 (1027)
                      ++. +. +..+++|+.|++++|.+++                                                 ++. +
T Consensus       190 ~~~-~~-~~~l~~L~~L~l~~n~l~~-------------------------------------------------~~~-~  217 (347)
T 4fmz_A          190 EDI-SP-LASLTSLHYFTAYVNQITD-------------------------------------------------ITP-V  217 (347)
T ss_dssp             CCC-GG-GGGCTTCCEEECCSSCCCC-------------------------------------------------CGG-G
T ss_pred             ccc-cc-ccCCCccceeecccCCCCC-------------------------------------------------Cch-h
Confidence            422 11 4444444444444444431                                                 111 3


Q ss_pred             cCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCcc
Q 048205          288 GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLE  367 (1027)
Q Consensus       288 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  367 (1027)
                      ..+++|++|++++|++++..+  +..+++|++|++++|.++++  ..+..+++|++|++++|++.+ ++  .+..+++|+
T Consensus       218 ~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~--~~~~l~~L~  290 (347)
T 4fmz_A          218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-IS--VLNNLSQLN  290 (347)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG--GGGGCTTCS
T ss_pred             hcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Ch--hhcCCCCCC
Confidence            334455555555555543322  44555555555555555443  234445555555555555532 21  233455666


Q ss_pred             EEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCC
Q 048205          368 ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLT  425 (1027)
Q Consensus       368 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  425 (1027)
                      +|+|++|++++..|..+.++++|++|++++|++++..|  +..+++|++|++++|+|+
T Consensus       291 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            66666666655555556666666666666666665444  555666666666666543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.9e-34  Score=313.97  Aligned_cols=229  Identities=18%  Similarity=0.247  Sum_probs=180.5

Q ss_pred             CCCCcc-ceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHH-hhccCCccceEEeEEec----CCeeE
Q 048205          750 NGFSEN-NLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMI-KRIRHRNIIKFISSCSS----DDFKA  822 (1027)
Q Consensus       750 ~~f~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~  822 (1027)
                      ++|... +.||+|+||.||+|+.. +++.||||+++.     ...+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 78999999999999875 789999999863     24566788887 66689999999999876    67789


Q ss_pred             EEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCCc
Q 048205          823 LVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAK  898 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~  898 (1027)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999998754 46899999999999999999999   999999999999999998   7899999999987


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      ...                        +..++.++||||+||++|||++|+.||........             .....
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------------~~~~~  211 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------------SPGMK  211 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSC
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------------hHHHH
Confidence            432                        13467899999999999999999999975422110             00000


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .................++.++.+++.+||+.||++|||+.|+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000111111223457788999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-34  Score=332.67  Aligned_cols=239  Identities=17%  Similarity=0.141  Sum_probs=181.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHHHHHHHHHhhccC-CccceE-------------
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRH-RNIIKF-------------  811 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~l-------------  811 (1027)
                      ..|...+.||+|+||+||+|++. +|+.||||++.....   ...+.+.+|+.+++.++| ++...+             
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34677889999999999999965 799999999874322   235778999999999987 221111             


Q ss_pred             --------EeEEec-----CCeeEEEEEecCCCCHHHHHh------cCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 048205          812 --------ISSCSS-----DDFKALVLEYMPYGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPII  872 (1027)
Q Consensus       812 --------~~~~~~-----~~~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  872 (1027)
                              +.++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+|||   +++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                    111111     12356777766 569999884      23455788899999999999999999   99999


Q ss_pred             eccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccc----------cCCCCCcchhHHHHHHHH
Q 048205          873 HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYG----------REGRVSTNGDVYSFGIML  942 (1027)
Q Consensus       873 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslGvil  942 (1027)
                      ||||||+||+++.++.+||+|||+++....     .....+| +.|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            999999999999999999999999885432     1344567 999999998          556688999999999999


Q ss_pred             HHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          943 METFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       943 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                      |||++|+.||........                 .+...        .....++.++.+++.+||..||++||++.|++
T Consensus       308 ~elltg~~Pf~~~~~~~~-----------------~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-----------------SEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-----------------SGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh-----------------HHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999976432111                 01110        11123456789999999999999999988876


Q ss_pred             H
Q 048205         1023 T 1023 (1027)
Q Consensus      1023 ~ 1023 (1027)
                      +
T Consensus       363 ~  363 (413)
T 3dzo_A          363 E  363 (413)
T ss_dssp             T
T ss_pred             h
Confidence            4

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.3e-32  Score=310.29  Aligned_cols=307  Identities=24%  Similarity=0.353  Sum_probs=247.3

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS  101 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  101 (1027)
                      +..+++|++|++++|.+. .+| .+..+++|++|++++|++++ ++. +..+++|++|++++|.+++ ++ .+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence            567788899999988887 455 48888899999999998874 444 8888999999999998884 33 688889999


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCc
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQN  181 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  181 (1027)
                      +|++++|++++ ++.  +..+++|++|++++|......+ .+..+++|++|++++|.+.+..+  +..+++|++|++++|
T Consensus       114 ~L~l~~n~i~~-~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n  187 (347)
T 4fmz_A          114 ELYLNEDNISD-ISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN  187 (347)
T ss_dssp             EEECTTSCCCC-CGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred             EEECcCCcccC-chh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence            99999998874 333  7788889999999886654443 48888999999999998875433  888899999999999


Q ss_pred             cCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCcccc
Q 048205          182 RLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLE  261 (1027)
Q Consensus       182 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~  261 (1027)
                      .+++..+  +..+++|++|++++|.+++..+  +..+++|++|++++|++++               ++.  +..+++|+
T Consensus       188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~---------------~~~--~~~l~~L~  246 (347)
T 4fmz_A          188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD---------------LSP--LANLSQLT  246 (347)
T ss_dssp             CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC---------------CGG--GTTCTTCC
T ss_pred             ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC---------------Ccc--hhcCCCCC
Confidence            9885433  7888899999999999885543  7888899999999998872               333  56788899


Q ss_pred             EEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCc
Q 048205          262 EIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTL  341 (1027)
Q Consensus       262 ~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  341 (1027)
                      +|++++|.+++          + ..+..+++|++|++++|+++++  ..+..+++|+.|++++|++.+..+..+.++++|
T Consensus       247 ~L~l~~n~l~~----------~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  313 (347)
T 4fmz_A          247 WLEIGTNQISD----------I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL  313 (347)
T ss_dssp             EEECCSSCCCC----------C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred             EEECCCCccCC----------C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence            99999998873          2 3577888999999999999875  468889999999999999998888889999999


Q ss_pred             ceEEccCccccccCCCCccCCCCCccEEEccccccC
Q 048205          342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFS  377 (1027)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  377 (1027)
                      ++|++++|++++..|   ...+++|++|++++|.++
T Consensus       314 ~~L~L~~n~l~~~~~---~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          314 TTLFLSQNHITDIRP---LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             SEEECCSSSCCCCGG---GGGCTTCSEESSSCC---
T ss_pred             CEEEccCCccccccC---hhhhhccceeehhhhccc
Confidence            999999999976555   456889999999999885

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.7e-34  Score=351.25  Aligned_cols=236  Identities=22%  Similarity=0.326  Sum_probs=190.7

Q ss_pred             hCCCCccceeeccccceEEEEEec--CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCe-----
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ--DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDF-----  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  820 (1027)
                      .++|++.+.||+|+||+||+|++.  +|+.||||++.... ....+.+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            367999999999999999999975  68999999886432 3445678899999999999999999999987665     


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||++|++|.+++..   .+++.++..++.||++||+|||   +.+|+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            7999999999999987754   5899999999999999999999   9999999999999999885 9999999999865


Q ss_pred             ccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ...      ....||++|+|||++.+.. +.++|||||||++|+|++|.+||........                    
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------------  284 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------------  284 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------------
Confidence            322      3457999999999987654 8899999999999999999988765321110                    


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-AKEIVTKL 1025 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~evl~~L 1025 (1027)
                           .  ........+..+.+++.+||++||++||+ ++++.+.+
T Consensus       285 -----~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          285 -----P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             -----C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             -----c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence                 0  00011123456889999999999999995 55555443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.2e-33  Score=336.49  Aligned_cols=308  Identities=20%  Similarity=0.209  Sum_probs=134.4

Q ss_pred             CCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEE
Q 048205           98 SSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLH  177 (1027)
Q Consensus        98 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  177 (1027)
                      ++++.|++++|.++ .++..++..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            34444444444443 33444444444444444444444444444444444444444444444444444444444444444


Q ss_pred             ccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCC
Q 048205          178 LDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNI  257 (1027)
Q Consensus       178 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l  257 (1027)
                      |++|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|++++|.+++.               +   +..+
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---------------~---~~~l  191 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---------------D---LSLI  191 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---------------C---GGGC
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---------------C---hhhh
Confidence            444444433333344444444444444444444444444444455555544444311               1   1123


Q ss_pred             ccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccc
Q 048205          258 PFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFN  337 (1027)
Q Consensus       258 ~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  337 (1027)
                      +.|+.|++++|.+++              +....+|+.|++++|.+..+.+..+   ++|+.|+|++|.+++.  ..+..
T Consensus       192 ~~L~~L~l~~n~l~~--------------l~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~~--~~l~~  252 (597)
T 3oja_B          192 PSLFHANVSYNLLST--------------LAIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT--AWLLN  252 (597)
T ss_dssp             TTCSEEECCSSCCSE--------------EECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCCC--GGGGG
T ss_pred             hhhhhhhcccCcccc--------------ccCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCCC--hhhcc
Confidence            334444444444431              1112344444444444443322111   2344444444444431  33444


Q ss_pred             cCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEE
Q 048205          338 VSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWL  417 (1027)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  417 (1027)
                      +++|+.|+|++|.+.+..|.. +..+++|++|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L  329 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHP-FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL  329 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGG-GTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred             CCCCCEEECCCCccCCCCHHH-hcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence            444444444444443332222 2234444444444444442 3334444445555555555554 234444455555555


Q ss_pred             ecCCCCCCCCCCccccccccccccccEeeccCCCCC
Q 048205          418 DLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLG  453 (1027)
Q Consensus       418 ~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~  453 (1027)
                      +|++|+|+.++       ...++.|++|++++|++.
T Consensus       330 ~L~~N~l~~~~-------~~~~~~L~~L~l~~N~~~  358 (597)
T 3oja_B          330 YLDHNSIVTLK-------LSTHHTLKNLTLSHNDWD  358 (597)
T ss_dssp             ECCSSCCCCCC-------CCTTCCCSEEECCSSCEE
T ss_pred             ECCCCCCCCcC-------hhhcCCCCEEEeeCCCCC
Confidence            55555554432       123445555555555543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.4e-32  Score=307.73  Aligned_cols=288  Identities=23%  Similarity=0.299  Sum_probs=234.1

Q ss_pred             CCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCC
Q 048205           27 RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        27 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  106 (1027)
                      +++.++++++.++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            6999999999998 7888775  789999999999998888899999999999999999998888999999999999999


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccc--cccCccccCCCCCcEEEccCccCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS--GDIPKEIGNLTKLKYLHLDQNRLQ  184 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~  184 (1027)
                      +|+++ .++...+   ++|++|++++|++++..+..|.++++|++|++++|.++  +..+..|..+ +|++|++++|+++
T Consensus       111 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~  185 (332)
T 2ft3_A          111 KNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT  185 (332)
T ss_dssp             SSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred             CCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence            99998 5665544   78999999999999888888999999999999999996  3677888888 9999999999998


Q ss_pred             CCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEE
Q 048205          185 GEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY  264 (1027)
Q Consensus       185 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~  264 (1027)
                      + +|..+.  ++|++|++++|.+++..+..|..+++|+.|++++|++++               ++...+..+++|++|+
T Consensus       186 ~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~---------------~~~~~~~~l~~L~~L~  247 (332)
T 2ft3_A          186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM---------------IENGSLSFLPTLRELH  247 (332)
T ss_dssp             S-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC---------------CCTTGGGGCTTCCEEE
T ss_pred             c-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc---------------CChhHhhCCCCCCEEE
Confidence            5 555544  789999999999998877889999999999999999873               3444455677888888


Q ss_pred             eccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCc------CcccceeccCcccc--cccCcccc
Q 048205          265 LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL------HNLEWMIFSFNKLV--GVVPTTIF  336 (1027)
Q Consensus       265 Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~--~~~~~~~~  336 (1027)
                      +++|+++          .+|.++..+++|+.|++++|+|+++.+..|...      ..|+.|++++|.+.  ++.|.+|.
T Consensus       248 L~~N~l~----------~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~  317 (332)
T 2ft3_A          248 LDNNKLS----------RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR  317 (332)
T ss_dssp             CCSSCCC----------BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred             CCCCcCe----------ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence            8888887          566667778888888888888887777766653      45666677776665  55566666


Q ss_pred             ccCCcceEEccCcc
Q 048205          337 NVSTLKFLYLGSNS  350 (1027)
Q Consensus       337 ~l~~L~~L~L~~N~  350 (1027)
                      .+++|+.+++++|+
T Consensus       318 ~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          318 CVTDRLAIQFGNYK  331 (332)
T ss_dssp             TBCCSTTEEC----
T ss_pred             ccchhhhhhccccc
Confidence            66666666666553

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.5e-33  Score=312.20  Aligned_cols=232  Identities=32%  Similarity=0.484  Sum_probs=145.5

Q ss_pred             CCCCccEEEccc-cccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccc
Q 048205          362 RLPNLEELSLSG-NNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCK  440 (1027)
Q Consensus       362 ~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~  440 (1027)
                      .+++|++|+|++ |++.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|.++               
T Consensus        74 ~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~---------------  138 (313)
T 1ogq_A           74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS---------------  138 (313)
T ss_dssp             GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE---------------
T ss_pred             CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccC---------------
Confidence            344455555552 5555555555555555555555555555555555555555555555555422               


Q ss_pred             cccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhccc-ccceee
Q 048205          441 YLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLK-KLQLLS  519 (1027)
Q Consensus       441 ~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~  519 (1027)
                                                            +.+|..++.+++|++|++++|++++.+|..++.++ +|++|+
T Consensus       139 --------------------------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~  180 (313)
T 1ogq_A          139 --------------------------------------GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT  180 (313)
T ss_dssp             --------------------------------------SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEE
T ss_pred             --------------------------------------CcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEE
Confidence                                                  22333444444444444444444445555555555 556666


Q ss_pred             ccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCcc
Q 048205          520 LKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD  599 (1027)
Q Consensus       520 Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~  599 (1027)
                      |++|+++|.+             |..+..++ |++|++++|.+++.+|..++.+++|+.|++++|++++.+|. ++.+++
T Consensus       181 L~~N~l~~~~-------------~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~  245 (313)
T 1ogq_A          181 ISRNRLTGKI-------------PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKN  245 (313)
T ss_dssp             CCSSEEEEEC-------------CGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTT
T ss_pred             CcCCeeeccC-------------ChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCC
Confidence            6666654332             33444444 66666666666666777777777888888888888765555 777788


Q ss_pred             ccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCC-CCCCC
Q 048205          600 LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNK-LEGEI  662 (1027)
Q Consensus       600 L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~-l~g~~  662 (1027)
                      |++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|.. +.+++|+.+++++|+ ++|.+
T Consensus       246 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             CCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTT
T ss_pred             CCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCCC
Confidence            888888888888778888888888888888888888888776 777888888888887 77753

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=3.5e-32  Score=304.34  Aligned_cols=289  Identities=24%  Similarity=0.296  Sum_probs=222.6

Q ss_pred             CCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeC
Q 048205           26 KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDL  105 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  105 (1027)
                      .+++.++++++.++ .+|..+.  +.|++|+|++|+|++..+..|+++++|++|+|++|.+++..|..|..+++|++|++
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            37899999999988 6787665  68899999999998777778999999999999999999877889999999999999


Q ss_pred             CcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccc--ccCccccCCCCCcEEEccCccC
Q 048205          106 SVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG--DIPKEIGNLTKLKYLHLDQNRL  183 (1027)
Q Consensus       106 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l  183 (1027)
                      ++|+++ .++...+   ++|++|++++|++++..+..|.++++|++|++++|.+..  ..+..|.++++|++|++++|++
T Consensus       108 s~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l  183 (330)
T 1xku_A          108 SKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI  183 (330)
T ss_dssp             CSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred             CCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence            999987 5555443   689999999999998888889999999999999998863  6778888899999999999998


Q ss_pred             CCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEE
Q 048205          184 QGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEI  263 (1027)
Q Consensus       184 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L  263 (1027)
                      +. +|..+.  ++|++|++++|++++..|..|..+++|+.|++++|++++               ++...+..+++|++|
T Consensus       184 ~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~---------------~~~~~~~~l~~L~~L  245 (330)
T 1xku_A          184 TT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA---------------VDNGSLANTPHLREL  245 (330)
T ss_dssp             CS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE---------------ECTTTGGGSTTCCEE
T ss_pred             cc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce---------------eChhhccCCCCCCEE
Confidence            84 555443  789999999999988778888899999999999998873               333445567778888


Q ss_pred             EeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCc------CcccceeccCccccc--ccCccc
Q 048205          264 YLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL------HNLEWMIFSFNKLVG--VVPTTI  335 (1027)
Q Consensus       264 ~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~~--~~~~~~  335 (1027)
                      ++++|+++          .+|.++..+++|++|++++|+|+++.+..|...      ..|+.|++++|.+..  +.|..|
T Consensus       246 ~L~~N~l~----------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f  315 (330)
T 1xku_A          246 HLNNNKLV----------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF  315 (330)
T ss_dssp             ECCSSCCS----------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGG
T ss_pred             ECCCCcCc----------cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccc
Confidence            88888877          556667777788888888888877766666533      445555555555532  334444


Q ss_pred             cccCCcceEEccCc
Q 048205          336 FNVSTLKFLYLGSN  349 (1027)
Q Consensus       336 ~~l~~L~~L~L~~N  349 (1027)
                      ..+.+++.++|++|
T Consensus       316 ~~~~~l~~l~L~~N  329 (330)
T 1xku_A          316 RCVYVRAAVQLGNY  329 (330)
T ss_dssp             TTCCCGGGEEC---
T ss_pred             ccccceeEEEeccc
Confidence            44444454544444

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.3e-33  Score=316.89  Aligned_cols=243  Identities=18%  Similarity=0.162  Sum_probs=185.8

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEeccc--------chhHHHHHHHHHHHhhcc---------CCccceE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--------GRAIKSFDIECGMIKRIR---------HRNIIKF  811 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  811 (1027)
                      .++|+..+.||+|+||+||+|++ +|+.||||++....        ....+.+.+|+++++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 68999999997542        223477889999999886         6666655


Q ss_pred             EeE-----------------Eec-------------CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHH
Q 048205          812 ISS-----------------CSS-------------DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALE  861 (1027)
Q Consensus       812 ~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~  861 (1027)
                      .++                 +.+             .+..++||||+++|++.+.+.+  ..+++..+..++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999977666644  34799999999999999999


Q ss_pred             HhhcCCCCCeEeccCCCCcEEEcCCC--------------------cEEEeeecCCcccccCCCcceecccccCccccCc
Q 048205          862 YLHFGYSVPIIHCDLKPNNVLLDDNM--------------------VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP  921 (1027)
Q Consensus       862 ~LH~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP  921 (1027)
                      |||+  +.+|+||||||+|||++.++                    .+||+|||+|+....       ...+||+.|+||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9992  36899999999999999887                    999999999986532       234799999999


Q ss_pred             ccccCCCCCcchhHHHHHHH-HHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHH
Q 048205          922 EYGREGRVSTNGDVYSFGIM-LMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFV 1000 (1027)
Q Consensus       922 E~~~~~~~~~~~DvwslGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l 1000 (1027)
                      |++.+.. +.++||||+|++ .+++++|..||..        ..|.....    ..+.... ..........+..++.++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLT----DKMLKQM-TFKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHH----HHHHHTC-CCSSCCCSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHH----Hhhhhhh-ccCcccchhhhhhcCHHH
Confidence            9998766 899999998776 7788889988742        12322111    1111111 111112223455688899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHH
Q 048205         1001 FNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus      1001 ~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                      .+|+.+||+.|     |++|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            99999999976     999998

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=6.4e-32  Score=302.37  Aligned_cols=294  Identities=21%  Similarity=0.265  Sum_probs=200.0

Q ss_pred             cccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCcccccc
Q 048205          259 FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNV  338 (1027)
Q Consensus       259 ~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  338 (1027)
                      .++.+++++|.++          .+|..+.  ++|+.|++++|+++++.+..|.++++|++|++++|+++++.|..|.++
T Consensus        34 ~l~~l~~~~~~l~----------~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  101 (332)
T 2ft3_A           34 HLRVVQCSDLGLK----------AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL  101 (332)
T ss_dssp             ETTEEECCSSCCS----------SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTC
T ss_pred             cCCEEECCCCCcc----------ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCc
Confidence            5788888888877          4454443  588999999999998888889999999999999999998888889999


Q ss_pred             CCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCccc--CCCCcccCCcccccE
Q 048205          339 STLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFS--GFIPNTFGNLRNLKW  416 (1027)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~  416 (1027)
                      ++|++|++++|++. .+|...+   ++|++|++++|++++..+..|.++++|++|++++|.++  +..|..|..+ +|++
T Consensus       102 ~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~  176 (332)
T 2ft3_A          102 RKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNY  176 (332)
T ss_dssp             TTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSC
T ss_pred             CCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCE
Confidence            99999999999885 6676654   68889999988888766667888888888888888885  3677778877 8888


Q ss_pred             EecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEe
Q 048205          417 LDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYL  496 (1027)
Q Consensus       417 L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L  496 (1027)
                      |++++|+++.+|..+.       ++|++|++++|+++++                         .|..+..+++|++|++
T Consensus       177 L~l~~n~l~~l~~~~~-------~~L~~L~l~~n~i~~~-------------------------~~~~l~~l~~L~~L~L  224 (332)
T 2ft3_A          177 LRISEAKLTGIPKDLP-------ETLNELHLDHNKIQAI-------------------------ELEDLLRYSKLYRLGL  224 (332)
T ss_dssp             CBCCSSBCSSCCSSSC-------SSCSCCBCCSSCCCCC-------------------------CTTSSTTCTTCSCCBC
T ss_pred             EECcCCCCCccCcccc-------CCCCEEECCCCcCCcc-------------------------CHHHhcCCCCCCEEEC
Confidence            8888888877665432       4556666666655433                         3344555666666677


Q ss_pred             cCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccc
Q 048205          497 GVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVL  576 (1027)
Q Consensus       497 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  576 (1027)
                      ++|++++..+..|..+++|++|+|++|+++              .+|..+..+++|++|++++|.+++..+..++...  
T Consensus       225 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~--  288 (332)
T 2ft3_A          225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS--------------RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG--  288 (332)
T ss_dssp             CSSCCCCCCTTGGGGCTTCCEEECCSSCCC--------------BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSS--
T ss_pred             CCCcCCcCChhHhhCCCCCCEEECCCCcCe--------------ecChhhhcCccCCEEECCCCCCCccChhHccccc--
Confidence            777666666666666666666666666652              3444444455555555555555443333332210  


Q ss_pred             cEEcccccccccccchhhccCccccEEEccCCccc--cCcccccccccccccccccccc
Q 048205          577 VQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQ--GSIPDSIGDMINLKSLNLSNNN  633 (1027)
Q Consensus       577 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--g~ip~~~~~l~~L~~L~l~~N~  633 (1027)
                                    +  -.....|+.|++++|.+.  +..|..+..+++|+.++|++|+
T Consensus       289 --------------~--~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          289 --------------F--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             --------------C--CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             --------------c--ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence                          0  001245666666666665  4455566666666666666664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=4.1e-31  Score=295.64  Aligned_cols=288  Identities=23%  Similarity=0.287  Sum_probs=146.6

Q ss_pred             CCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEcc
Q 048205           76 LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLS  155 (1027)
Q Consensus        76 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  155 (1027)
                      ++.++++++.++ .+|..+.  ++|++|++++|+++ .++...+..+++|++|+|++|++++..|..|..+++|++|+++
T Consensus        33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            444444444443 2333222  33444444444443 2222233333444444444444444445555555555555555


Q ss_pred             CCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCC--CCCccccCCCCCCEEEccCccCCC
Q 048205          156 INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG--TIPPSIFNLSSLSDLELSFNSLTG  233 (1027)
Q Consensus       156 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~  233 (1027)
                      +|.++ .+|..+.  ++|++|++++|++++..+..|..+++|++|++++|.++.  ..+..+.++++|++|++++|.++ 
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-  184 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-  184 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-
Confidence            55555 2333332  455555555555554444445555555555555555532  33444555555555555555543 


Q ss_pred             CCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccC
Q 048205          234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDN  313 (1027)
Q Consensus       234 ~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  313 (1027)
                                                                      .+|..+.  ++|++|++++|+++++.+..|..
T Consensus       185 ------------------------------------------------~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~  214 (330)
T 1xku_A          185 ------------------------------------------------TIPQGLP--PSLTELHLDGNKITKVDAASLKG  214 (330)
T ss_dssp             ------------------------------------------------SCCSSCC--TTCSEEECTTSCCCEECTGGGTT
T ss_pred             ------------------------------------------------cCCcccc--ccCCEEECCCCcCCccCHHHhcC
Confidence                                                            1222221  45666666666666666666666


Q ss_pred             cCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccC------C
Q 048205          314 LHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFN------T  387 (1027)
Q Consensus       314 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l  387 (1027)
                      +++|+.|++++|+++++.+..+..+++|++|++++|++. .+|..+ ..+++|++|+|++|++++..+..|..      .
T Consensus       215 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l-~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~  292 (330)
T 1xku_A          215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL-ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK  292 (330)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT-TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTS
T ss_pred             CCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh-ccCCCcCEEECCCCcCCccChhhcCCccccccc
Confidence            666666666666666666656666666666666666664 444432 34556666666666665444444432      2


Q ss_pred             CCCCeeecCCCcccC--CCCcccCCcccccEEecCCCC
Q 048205          388 SKLSTLELQRNSFSG--FIPNTFGNLRNLKWLDLGDNY  423 (1027)
Q Consensus       388 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~  423 (1027)
                      ..|+.|++++|.+..  +.|..|..+.+++.++|++|+
T Consensus       293 ~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            455666666666542  445566666666666666653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.4e-34  Score=339.96  Aligned_cols=357  Identities=19%  Similarity=0.156  Sum_probs=198.9

Q ss_pred             CCCcEEecCCCcCcccCCcc-CcCCCCCcEEEccCCcccc----cCCccccccCCCcEEEccccccceeCcccc-cCCC-
Q 048205            2 SNLEYLFLKSNMFHGKIPST-LSNCKRLRNISLSLNDFSG----TIPKEIGNVTTLIGLHLRGNKLQGEIPEEL-GNLA-   74 (1027)
Q Consensus         2 ~~l~~L~l~~n~l~~~~~~~-~~~~~~L~~L~L~~n~l~~----~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l-~~l~-   74 (1027)
                      ++|++|++++|++++..... +..+++|++|+|++|.+++    .++..+..+++|++|+|++|.+++..+..+ ..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            56778888888876544333 6777888888888888774    345666777888888888888765444333 3344 


Q ss_pred             ---CCCEEEccCcccCC----ccCccccCCCCCCeEeCCcccccccchhhh----hcCCCCCcEEEccCCcCCccC----
Q 048205           75 ---ELEELWLQNNFLTG----TIPSSIFNLSSLSNLDLSVNNLTGELLANI----CSNLPLLQTLFLDENNFDGKI----  139 (1027)
Q Consensus        75 ---~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~----~~~l~~L~~L~L~~N~l~~~~----  139 (1027)
                         +|++|+|++|.++.    .++..+..+++|++|++++|.+++.....+    ....++|++|++++|++++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               58888888888773    346777777888888888887764333322    223445777777777666532    


Q ss_pred             cccccCCCCCcEEEccCCccccccCcccc-----CCCCCcEEEccCccCCCC----CChhccCCCCCCeeeccccccCCC
Q 048205          140 PSTLLRCKHLQTLSLSINDFSGDIPKEIG-----NLTKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQNNFLTGT  210 (1027)
Q Consensus       140 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~  210 (1027)
                      +..+..+++|++|++++|.+....+..+.     ..++|++|+|++|.++..    ++..+..+++|++|++++|.+++.
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            44455566666666666666543333222     244566666666665542    244444555555555555555432


Q ss_pred             C-----CccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCc
Q 048205          211 I-----PPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPK  285 (1027)
Q Consensus       211 ~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~  285 (1027)
                      .     +..+..+++|++|++++|.++                                       +.-.     ..++.
T Consensus       243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~---------------------------------------~~~~-----~~l~~  278 (461)
T 1z7x_W          243 GMAELCPGLLHPSSRLRTLWIWECGIT---------------------------------------AKGC-----GDLCR  278 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCC---------------------------------------HHHH-----HHHHH
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCC---------------------------------------HHHH-----HHHHH
Confidence            1     111223445555555555443                                       1100     01233


Q ss_pred             cccCcCCccceeccCccccccCCccccC-----cCcccceeccCcccccc----cCccccccCCcceEEccCccccccCC
Q 048205          286 EIGNLAKLEKLDLQFNRLQCVIPHEIDN-----LHNLEWMIFSFNKLVGV----VPTTIFNVSTLKFLYLGSNSFFGRLP  356 (1027)
Q Consensus       286 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~  356 (1027)
                      .+..+++|++|++++|+++...+..+..     .++|+.|++++|.+++.    ++..+..+++|++|++++|.+.+..+
T Consensus       279 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~  358 (461)
T 1z7x_W          279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV  358 (461)
T ss_dssp             HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred             HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence            3444556666666666655433333322     14566666666665543    23444455556666666665532211


Q ss_pred             CCc----cCCCCCccEEEccccccCC----cCcccccCCCCCCeeecCCCcccC
Q 048205          357 SSA----DVRLPNLEELSLSGNNFSG----TIPSFIFNTSKLSTLELQRNSFSG  402 (1027)
Q Consensus       357 ~~~----~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~  402 (1027)
                      ...    ....++|++|+|++|++++    .+|..+..+++|++|++++|++++
T Consensus       359 ~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             HHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            111    0113456666666666654    455555556666666666666553

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=2e-34  Score=338.71  Aligned_cols=365  Identities=17%  Similarity=0.123  Sum_probs=224.4

Q ss_pred             ccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCcccccc----CCccccCcCcccceeccCcccccccCc
Q 048205          258 PFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCV----IPHEIDNLHNLEWMIFSFNKLVGVVPT  333 (1027)
Q Consensus       258 ~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~  333 (1027)
                      +.|++|++++|+++..        .....+..+++|++|+|++|+++..    ++..+..+++|++|++++|.+.+..+.
T Consensus         3 ~~l~~L~Ls~~~l~~~--------~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~   74 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDA--------RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH   74 (461)
T ss_dssp             EEEEEEEEESCCCCHH--------HHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH
T ss_pred             ccceehhhhhcccCch--------hHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHH
Confidence            5677788887777631        1112255667777777777777642    344555667777777777776654333


Q ss_pred             ccc-ccC----CcceEEccCccccc----cCCCCccCCCCCccEEEccccccCCcCcccccC-----CCCCCeeecCCCc
Q 048205          334 TIF-NVS----TLKFLYLGSNSFFG----RLPSSADVRLPNLEELSLSGNNFSGTIPSFIFN-----TSKLSTLELQRNS  399 (1027)
Q Consensus       334 ~~~-~l~----~L~~L~L~~N~l~~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~  399 (1027)
                      .+. .+.    +|++|+|++|++..    .++. .+..+++|++|+|++|.+.+..+..+..     .++|++|+|++|+
T Consensus        75 ~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~-~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  153 (461)
T 1z7x_W           75 CVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS-TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCS  153 (461)
T ss_dssp             HHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH-HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             HHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH-HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCC
Confidence            322 233    46666666665542    1222 1234555566666655554322222221     3345555555555


Q ss_pred             ccCCC----CcccCCcccccEEecCCCCCCCCCCc-cccccccccccccEeeccCCCCCCCCCccccCcccccceeecCC
Q 048205          400 FSGFI----PNTFGNLRNLKWLDLGDNYLTSSTSE-LSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPN  474 (1027)
Q Consensus       400 l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~  474 (1027)
                      +++..    +..+..+++|++|++++|.++..... +...-....++|++|++++|.+++....                
T Consensus       154 l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~----------------  217 (461)
T 1z7x_W          154 LSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR----------------  217 (461)
T ss_dssp             CBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH----------------
T ss_pred             CCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH----------------
Confidence            55422    33344455555555555554422111 0000000123445555555544321000                


Q ss_pred             CccccccCcccccccccceEEecCccccCchh-----HhhhcccccceeeccCceeecccCCCCCccccccccCcccccc
Q 048205          475 SNISGSIPKEINNLTNLIAIYLGVNKLNGSIL-----IALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNL  549 (1027)
Q Consensus       475 n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l  549 (1027)
                           .++..+..+++|++|++++|++++...     ..+..+++|++|+|++|++++.         ....++..+.++
T Consensus       218 -----~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~---------~~~~l~~~l~~~  283 (461)
T 1z7x_W          218 -----DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK---------GCGDLCRVLRAK  283 (461)
T ss_dssp             -----HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH---------HHHHHHHHHHHC
T ss_pred             -----HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHH---------HHHHHHHHHhhC
Confidence                 256677788888899999888875432     2233578899999998888532         112366677778


Q ss_pred             CcccEEecCCCccccCccccccCc-----ccccEEcccccccccc----cchhhccCccccEEEccCCccccCccccccc
Q 048205          550 KDILCLNLSLNFFTGPLPLEIGNL-----KVLVQIDLSINNFSDV----IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGD  620 (1027)
Q Consensus       550 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~  620 (1027)
                      ++|+.|++++|.+++..+..+...     ++|+.|++++|.+++.    +|..+..+++|++|+|++|++++..+..++.
T Consensus       284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  363 (461)
T 1z7x_W          284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ  363 (461)
T ss_dssp             TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred             CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence            889999999998876544444432     6889999999998865    6777888899999999999888655555553


Q ss_pred             -----cccccccccccccccC----CchhhhhcccCCcceeccCCCCCCC
Q 048205          621 -----MINLKSLNLSNNNLFG----IIPISLEKLLDLKDINVSFNKLEGE  661 (1027)
Q Consensus       621 -----l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~~l~l~~N~l~g~  661 (1027)
                           .++|++|+|++|++++    .+|..+..+++|+.|++++|++++.
T Consensus       364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence                 5689999999999886    7888888899999999999988753

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=6.4e-29  Score=274.71  Aligned_cols=284  Identities=19%  Similarity=0.213  Sum_probs=212.4

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEcccccccee--CcccccCCCCCCEEEcc
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGE--IPEELGNLAELEELWLQ   82 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~--~p~~l~~l~~L~~L~L~   82 (1027)
                      +.++.++++++ .+|..+.  ++|++|+|++|+++...+..+..+++|++|+|++|+++..  .+..+..+++|++|+|+
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            56788888888 5665543  6889999999998844444578889999999999988733  36777788899999999


Q ss_pred             CcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccc-
Q 048205           83 NNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG-  161 (1027)
Q Consensus        83 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-  161 (1027)
                      +|.++ .+|..+..+++|++|++++|++++......+..+++|++|++++|.+.+..+..|..+++|++|++++|.+++ 
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            99888 5677788889999999999988754444677788888888888888888888888888888888888888875 


Q ss_pred             ccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhh
Q 048205          162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHI  241 (1027)
Q Consensus       162 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  241 (1027)
                      ..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|     
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----  240 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK-----  240 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS-----
T ss_pred             cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH-----
Confidence            578888888888888888888887778888888888888888888887766678888888888888888874333     


Q ss_pred             hhhccccCCccccCCC-ccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCc
Q 048205          242 VNRLSAELPAKFCNNI-PFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL  314 (1027)
Q Consensus       242 ~~~~~~~l~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  314 (1027)
                                ..+..+ +.|++|+|++|.+++..       .+.....-+...+.+....+.+.+..|..+.+.
T Consensus       241 ----------~~~~~~~~~L~~L~L~~N~~~~~c-------~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~  297 (306)
T 2z66_A          241 ----------QELQHFPSSLAFLNLTQNDFACTC-------EHQSFLQWIKDQRQLLVEVERMECATPSDKQGM  297 (306)
T ss_dssp             ----------SSCCCCCTTCCEEECTTCCEECSG-------GGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTC
T ss_pred             ----------HHHHhhhccCCEEEccCCCeeccc-------ChHHHHHHHHhhhhhhccccccccCCchhhCCc
Confidence                      223344 36778888888777421       111111223344455556666666666655543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=4e-31  Score=321.03  Aligned_cols=132  Identities=17%  Similarity=0.175  Sum_probs=61.6

Q ss_pred             CCCCCCeEeCCcccccccchhhhhcCCCC-CcEEEccCCc-CCc-cCcccccCCCCCcEEEccCCccccc----cCcccc
Q 048205           96 NLSSLSNLDLSVNNLTGELLANICSNLPL-LQTLFLDENN-FDG-KIPSTLLRCKHLQTLSLSINDFSGD----IPKEIG  168 (1027)
Q Consensus        96 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~-L~~L~L~~N~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~  168 (1027)
                      .+++|++|+|++|.+++.....+...++. |++|+|++|. +.. .++.....+++|++|+|++|.+++.    ++..+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            34455555555554443222222222223 5555555443 110 0111223455555555555555433    222334


Q ss_pred             CCCCCcEEEccCccCCCC----CChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccC
Q 048205          169 NLTKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSF  228 (1027)
Q Consensus       169 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  228 (1027)
                      .+++|++|++++|.+++.    ++..+..+++|++|++++|.+.+ +|..+.++++|+.|+++.
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            455556666665555421    22233455666666666666653 445555666666666654

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=7.7e-29  Score=275.98  Aligned_cols=234  Identities=22%  Similarity=0.266  Sum_probs=143.8

Q ss_pred             CCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCcccccccccccccc
Q 048205          364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLE  443 (1027)
Q Consensus       364 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~  443 (1027)
                      +++++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..|+.+++|++|+|++|+++.+|..+     ..+++|+
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l-----~~l~~L~  153 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASI-----ASLNRLR  153 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGG-----GGCTTCC
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHH-----hcCcCCC
Confidence            56777777777776 56666777777777777777777 56777777777777777777777665543     3556677


Q ss_pred             EeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCc
Q 048205          444 YFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDN  523 (1027)
Q Consensus       444 ~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  523 (1027)
                      +|++++|++.+..|..++..                .++..++.+++|++|+|++|+++ .+|..++++++|++|+|++|
T Consensus       154 ~L~L~~n~~~~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N  216 (328)
T 4fcg_A          154 ELSIRACPELTELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS  216 (328)
T ss_dssp             EEEEEEETTCCCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESS
T ss_pred             EEECCCCCCccccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCC
Confidence            77777666555544433221                12233444555555555555555 44444555555555555555


Q ss_pred             eeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEE
Q 048205          524 QLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYL  603 (1027)
Q Consensus       524 ~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L  603 (1027)
                      +                                     +++ +|..++.+++|+.|++++|++.+.+|..++++++|++|
T Consensus       217 ~-------------------------------------l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L  258 (328)
T 4fcg_A          217 P-------------------------------------LSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL  258 (328)
T ss_dssp             C-------------------------------------CCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEE
T ss_pred             C-------------------------------------CCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEE
Confidence            4                                     443 44455556666666666666666666666666666666


Q ss_pred             EccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCC
Q 048205          604 FLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLE  659 (1027)
Q Consensus       604 ~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  659 (1027)
                      +|++|++.+.+|..++.+++|++|+|++|++.|.+|..++++++|+.+++..|.+.
T Consensus       259 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             ECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             ECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            66666666666666666666666666666666666666666666666666655443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=2.4e-29  Score=283.98  Aligned_cols=286  Identities=22%  Similarity=0.202  Sum_probs=211.7

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS  101 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  101 (1027)
                      -..++.....+++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|++++|.+++..|..|.++++|+
T Consensus        27 ~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  103 (353)
T 2z80_A           27 SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE  103 (353)
T ss_dssp             CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence            345677778999999998 7888776  5899999999999977777899999999999999999988788899999999


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCc-ccccCCCCCcEEEccCC-ccccccCccccCCCCCcEEEcc
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIP-STLLRCKHLQTLSLSIN-DFSGDIPKEIGNLTKLKYLHLD  179 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~  179 (1027)
                      +|++++|+++ .++...+..+++|++|++++|++++..+ ..|..+++|++|++++| .+....+..|.++++|++|+++
T Consensus       104 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~  182 (353)
T 2z80_A          104 HLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID  182 (353)
T ss_dssp             EEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred             EEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence            9999999998 5777778899999999999999996655 58899999999999999 5776677889999999999999


Q ss_pred             CccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCcc
Q 048205          180 QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPF  259 (1027)
Q Consensus       180 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~  259 (1027)
                      +|++++..|..+..+++|++|++++|.++...+..+..+++|+.|++++|++++..+..+.            .....+.
T Consensus       183 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~------------~~~~~~~  250 (353)
T 2z80_A          183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS------------TGETNSL  250 (353)
T ss_dssp             ETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------------------CCCC
T ss_pred             CCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc------------cccccch
Confidence            9999988899999999999999999999743333445689999999999999854333221            0112344


Q ss_pred             ccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccc
Q 048205          260 LEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLV  328 (1027)
Q Consensus       260 L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  328 (1027)
                      ++.+++++|.+++.-     ...+|..+..+++|+.|++++|+++.+.+..|..+++|++|++++|++.
T Consensus       251 l~~l~L~~~~l~~~~-----l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~  314 (353)
T 2z80_A          251 IKKFTFRNVKITDES-----LFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD  314 (353)
T ss_dssp             CCEEEEESCBCCHHH-----HHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             hhccccccccccCcc-----hhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCcc
Confidence            555555555554210     0023334444555555555555555333333344444444444444444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=7.6e-29  Score=276.02  Aligned_cols=216  Identities=20%  Similarity=0.280  Sum_probs=173.4

Q ss_pred             CCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccc
Q 048205          387 TSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQS  466 (1027)
Q Consensus       387 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~  466 (1027)
                      ..+++.|+|++|.++ .+|..+..+++|++|+|++|.++.+                                       
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~l---------------------------------------  119 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL---------------------------------------  119 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCC---------------------------------------
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccch---------------------------------------
Confidence            466777788887777 4566677777777777777775543                                       


Q ss_pred             cceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccc
Q 048205          467 MEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTL  546 (1027)
Q Consensus       467 l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l  546 (1027)
                                     |..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..    ..++..+
T Consensus       120 ---------------p~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~----~~~~~~~  179 (328)
T 4fcg_A          120 ---------------PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS----TDASGEH  179 (328)
T ss_dssp             ---------------CSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE----EC-CCCE
T ss_pred             ---------------hHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh----ccchhhh
Confidence                           444555556666666666666 55666666677777777776665555544321    1233456


Q ss_pred             cccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccc
Q 048205          547 WNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKS  626 (1027)
Q Consensus       547 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~  626 (1027)
                      .++++|++|+|++|.++ .+|..++.+++|++|++++|++++ +|..++.+++|++|+|++|++.+.+|..++.+++|+.
T Consensus       180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~  257 (328)
T 4fcg_A          180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR  257 (328)
T ss_dssp             EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred             ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence            67899999999999999 799999999999999999999995 7888999999999999999999999999999999999


Q ss_pred             cccccccccCCchhhhhcccCCcceeccCCCCCCCCCC
Q 048205          627 LNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       627 L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~  664 (1027)
                      |+|++|++.+.+|..+..+++|+.|++++|++.|.+|.
T Consensus       258 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~  295 (328)
T 4fcg_A          258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS  295 (328)
T ss_dssp             EECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCG
T ss_pred             EECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccH
Confidence            99999999999999999999999999999999999997

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=1.1e-30  Score=317.05  Aligned_cols=379  Identities=13%  Similarity=0.088  Sum_probs=161.9

Q ss_pred             ccCCCcEEEccccccceeCcccccCC--CCCCEEEccCcc-cCC-ccCccccCCCCCCeEeCCcccccccc---hhhhhc
Q 048205           48 NVTTLIGLHLRGNKLQGEIPEELGNL--AELEELWLQNNF-LTG-TIPSSIFNLSSLSNLDLSVNNLTGEL---LANICS  120 (1027)
Q Consensus        48 ~l~~L~~L~L~~n~i~~~~p~~l~~l--~~L~~L~L~~N~-l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~  120 (1027)
                      .+++|++|+|++|.+++..+..+...  .+|++|+|++|. ++. .++.....+++|++|+|++|.+++..   ....+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            34555555555555544444444332  225555555544 110 01111224455555555555543221   222334


Q ss_pred             CCCCCcEEEccCCcCCc----cCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCC---CCCChhccC
Q 048205          121 NLPLLQTLFLDENNFDG----KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQ---GEIPEELGN  193 (1027)
Q Consensus       121 ~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~  193 (1027)
                      .+++|++|++++|.+++    .++..+..+++|++|++++|.+.+ +|..+..+++|++|+++.+...   ...+..+..
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~  268 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF  268 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence            45555555555555542    222233445555555555555543 3444555555555555432211   112233444


Q ss_pred             CCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEecccccccc
Q 048205          194 LAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGE  273 (1027)
Q Consensus       194 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~  273 (1027)
                      +++|+.|+++++... .+|..+..+++|++|+|++|.+++.              .....+..+++|++|+++ |.+...
T Consensus       269 ~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~--------------~~~~~~~~~~~L~~L~L~-~~~~~~  332 (592)
T 3ogk_B          269 PRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETE--------------DHCTLIQKCPNLEVLETR-NVIGDR  332 (592)
T ss_dssp             CTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHH--------------HHHHHHTTCTTCCEEEEE-GGGHHH
T ss_pred             cccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHH--------------HHHHHHHhCcCCCEEecc-CccCHH
Confidence            455555555544322 3444444555555555555554310              001122344555555555 222211


Q ss_pred             CCCCCCCCCCCccccCcCCccceecc-----------CccccccCCc-cccCcCcccceeccCcccccccCccccc-cCC
Q 048205          274 IPSDLGNCTIPKEIGNLAKLEKLDLQ-----------FNRLQCVIPH-EIDNLHNLEWMIFSFNKLVGVVPTTIFN-VST  340 (1027)
Q Consensus       274 ~p~~~~~~~~p~~l~~l~~L~~L~L~-----------~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~  340 (1027)
                              .++..+..+++|++|+++           .|.++..... .+..+++|++|+++.|++++..+..+.. +++
T Consensus       333 --------~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~  404 (592)
T 3ogk_B          333 --------GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKN  404 (592)
T ss_dssp             --------HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCS
T ss_pred             --------HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCC
Confidence                    111122334455555555           2344322111 1233455555555555555444444433 555


Q ss_pred             cceEEcc----CccccccCCCC-----ccCCCCCccEEEcccc--ccCCcCccccc-CCCCCCeeecCCCcccC-CCCcc
Q 048205          341 LKFLYLG----SNSFFGRLPSS-----ADVRLPNLEELSLSGN--NFSGTIPSFIF-NTSKLSTLELQRNSFSG-FIPNT  407 (1027)
Q Consensus       341 L~~L~L~----~N~l~~~~~~~-----~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~L~~N~l~~-~~p~~  407 (1027)
                      |+.|+++    .|.+++. |..     ....+++|++|+|++|  .+++..+..+. .+++|++|++++|++++ .++..
T Consensus       405 L~~L~l~~~~~~n~l~~~-p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~  483 (592)
T 3ogk_B          405 LCDFRLVLLDREERITDL-PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF  483 (592)
T ss_dssp             CCEEEEEECSCCSCCSSC-CCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHH
T ss_pred             CcEEEEeecCCCccccCc-hHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHH
Confidence            5555553    3333221 100     0123455555555432  23333333332 24555555555555543 12333


Q ss_pred             cCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCC
Q 048205          408 FGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGI  455 (1027)
Q Consensus       408 ~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~  455 (1027)
                      +.++++|++|+|++|.++...  +. .....+++|++|+|++|++++.
T Consensus       484 ~~~~~~L~~L~l~~n~l~~~~--~~-~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          484 SRGCPNLQKLEMRGCCFSERA--IA-AAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HTCCTTCCEEEEESCCCBHHH--HH-HHHHHCSSCCEEEEESCBCCTT
T ss_pred             HhcCcccCeeeccCCCCcHHH--HH-HHHHhcCccCeeECcCCcCCHH
Confidence            445555555555555543210  00 0012345555555555555543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.1e-28  Score=278.60  Aligned_cols=281  Identities=20%  Similarity=0.205  Sum_probs=170.4

Q ss_pred             CCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEE
Q 048205           97 LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYL  176 (1027)
Q Consensus        97 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  176 (1027)
                      ++.....++++|.++ .+|..++   ++|++|++++|++++..+..|.++++|++|++++|.+++..|..|.++++|++|
T Consensus        30 C~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           30 CDRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             ECTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            344455677777766 4444332   356666666666665555566666666666666666665555566666666666


Q ss_pred             EccCccCCCCCChhccCCCCCCeeeccccccCCCCC-ccccCCCCCCEEEccCcc-CCCCCCcchhhhhhccccCCcccc
Q 048205          177 HLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIP-PSIFNLSSLSDLELSFNS-LTGNFPKDMHIVNRLSAELPAKFC  254 (1027)
Q Consensus       177 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~~~~~~l~~~~~  254 (1027)
                      +|++|++++..+..|+.+++|++|++++|++++..+ ..|..+++|++|++++|. ++               .++.   
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~---------------~~~~---  167 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT---------------KIQR---  167 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC---------------EECT---
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc---------------ccCH---
Confidence            666666664433446666666666666666663222 245556666666666653 32               1222   


Q ss_pred             CCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCcc
Q 048205          255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTT  334 (1027)
Q Consensus       255 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  334 (1027)
                                                    ..+..+++|++|++++|++++..|..|..+++|++|++++|++..+.+..
T Consensus       168 ------------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~  217 (353)
T 2z80_A          168 ------------------------------KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF  217 (353)
T ss_dssp             ------------------------------TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHH
T ss_pred             ------------------------------HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhh
Confidence                                          23444555555555555555555556666666666666666665444444


Q ss_pred             ccccCCcceEEccCccccccCCCCc--cCCCCCccEEEccccccCC----cCcccccCCCCCCeeecCCCcccCCCCccc
Q 048205          335 IFNVSTLKFLYLGSNSFFGRLPSSA--DVRLPNLEELSLSGNNFSG----TIPSFIFNTSKLSTLELQRNSFSGFIPNTF  408 (1027)
Q Consensus       335 ~~~l~~L~~L~L~~N~l~~~~~~~~--~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  408 (1027)
                      +..+++|++|++++|++.+..+...  ....+.++.++|+++.+++    .+|..+.++++|++|+|++|+++.+.+..|
T Consensus       218 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~  297 (353)
T 2z80_A          218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIF  297 (353)
T ss_dssp             HHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             hhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHH
Confidence            4456666666666666643322211  1134567777777777765    467778888888888888888886555556


Q ss_pred             CCcccccEEecCCCCCCCCCC
Q 048205          409 GNLRNLKWLDLGDNYLTSSTS  429 (1027)
Q Consensus       409 ~~l~~L~~L~L~~N~l~~~~~  429 (1027)
                      +.+++|++|+|++|++++.+.
T Consensus       298 ~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          298 DRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             TTCTTCCEEECCSSCBCCCHH
T ss_pred             hcCCCCCEEEeeCCCccCcCC
Confidence            888888888888888775443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=3.8e-28  Score=268.51  Aligned_cols=249  Identities=25%  Similarity=0.294  Sum_probs=182.0

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCc--cCccccCCCCCCeEeCC
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGT--IPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~Ls  106 (1027)
                      +.++++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.++..  .+..+..+++|++|+++
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            57888888888 6777654  6888888888888854445578888888888888888733  25667778888888888


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCc-ccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIP-STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      +|.++ .++.. +..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..|..+++|++|++++|++++
T Consensus        87 ~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  164 (306)
T 2z66_A           87 FNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE  164 (306)
T ss_dssp             SCSEE-EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCccc-cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence            88887 34333 5677888888888888876655 577788888888888888877777778888888888888888775


Q ss_pred             -CCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEE
Q 048205          186 -EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY  264 (1027)
Q Consensus       186 -~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~  264 (1027)
                       ..|..+..+++|++|++++|++++..|..|..+++|++|++++|+++               .++...+..+++|+.|+
T Consensus       165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---------------~~~~~~~~~l~~L~~L~  229 (306)
T 2z66_A          165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF---------------SLDTFPYKCLNSLQVLD  229 (306)
T ss_dssp             GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS---------------BCCSGGGTTCTTCCEEE
T ss_pred             ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC---------------ccChhhccCcccCCEeE
Confidence             46777788888888888888887766777778888888888888776               33333455666677777


Q ss_pred             eccccccccCCCCCCCCCCCccccCc-CCccceeccCcccccc
Q 048205          265 LSKNMFYGEIPSDLGNCTIPKEIGNL-AKLEKLDLQFNRLQCV  306 (1027)
Q Consensus       265 Ls~N~l~~~~p~~~~~~~~p~~l~~l-~~L~~L~L~~N~l~~~  306 (1027)
                      +++|++++..|         ..+..+ ++|++|+|++|++++.
T Consensus       230 L~~N~l~~~~~---------~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          230 YSLNHIMTSKK---------QELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             CTTSCCCBCSS---------SSCCCCCTTCCEEECTTCCEECS
T ss_pred             CCCCCCcccCH---------HHHHhhhccCCEEEccCCCeecc
Confidence            77777765333         233444 3666666666666543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=6.7e-28  Score=263.49  Aligned_cols=255  Identities=24%  Similarity=0.284  Sum_probs=126.1

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      ++++++++.++ .+|..+  .++|++|+|++|++++..+..|..+++|++|++++|.+++..|..|..+++|++|++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            34444444444 334332  234455555555554444444445555555555555554444444555555555555555


Q ss_pred             c-ccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          109 N-LTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       109 ~-l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      + ++ .+....+..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..|+.+++|++|+|++|++++..
T Consensus        91 ~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             TTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            4 33 333334444455555555555555444555555555555555555555444444555555555555555555444


Q ss_pred             ChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEecc
Q 048205          188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSK  267 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~  267 (1027)
                      +..|..+++|++|++++|.+++..|..|..+++|+.|++++|+++               .++...+..+++|+.|++++
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---------------~~~~~~~~~l~~L~~L~l~~  234 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS---------------ALPTEALAPLRALQYLRLND  234 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS---------------CCCHHHHTTCTTCCEEECCS
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC---------------cCCHHHcccCcccCEEeccC
Confidence            444555555555555555555555555555555555555555554               22333344455555555555


Q ss_pred             ccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCcccc
Q 048205          268 NMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEID  312 (1027)
Q Consensus       268 N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  312 (1027)
                      |.+.+..+       ..   .-...++.+..+.+.+.+..|..+.
T Consensus       235 N~~~c~~~-------~~---~~~~~l~~~~~~~~~~~c~~p~~l~  269 (285)
T 1ozn_A          235 NPWVCDCR-------AR---PLWAWLQKFRGSSSEVPCSLPQRLA  269 (285)
T ss_dssp             SCEECSGG-------GH---HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred             CCccCCCC-------cH---HHHHHHHhcccccCccccCCchHhC
Confidence            55543211       00   0112344445556666665555544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1.6e-27  Score=285.22  Aligned_cols=268  Identities=24%  Similarity=0.240  Sum_probs=176.0

Q ss_pred             CccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEc
Q 048205          292 KLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSL  371 (1027)
Q Consensus       292 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  371 (1027)
                      +++.|++++|.++. +|..+.  ++|+.|++++|+|+.+.+    .+++|++|+|++|++. .+|.    .+++|++|+|
T Consensus        41 ~l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~L  108 (622)
T 3g06_A           41 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLT-SLPV----LPPGLLELSI  108 (622)
T ss_dssp             CCCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCS-CCCC----CCTTCCEEEE
T ss_pred             CCcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCC-cCCC----CCCCCCEEEC
Confidence            57777777777773 344443  567777777777665433    3566666666666664 3444    3456666666


Q ss_pred             cccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCC
Q 048205          372 SGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNP  451 (1027)
Q Consensus       372 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~  451 (1027)
                      ++|++++ +|.   .+++|+.|++++|++++ +|..   +++|++|+|++|+|+.+|..        +++|+.|++++|.
T Consensus       109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~~--------~~~L~~L~L~~N~  172 (622)
T 3g06_A          109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPAL--------PSELCKLWAYNNQ  172 (622)
T ss_dssp             CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCCC--------CTTCCEEECCSSC
T ss_pred             cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcCCc--------cCCCCEEECCCCC
Confidence            6666653 333   34556666666666654 2332   35566666666665554431        2345555555555


Q ss_pred             CCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCC
Q 048205          452 LGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPD  531 (1027)
Q Consensus       452 l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~  531 (1027)
                      |++                          +|   ..+++|+.|++++|++++ +|.   .+++|+.|++++|+++     
T Consensus       173 l~~--------------------------l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-----  214 (622)
T 3g06_A          173 LTS--------------------------LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLT-----  214 (622)
T ss_dssp             CSC--------------------------CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-----
T ss_pred             CCC--------------------------Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCccc-----
Confidence            543                          33   334667777777777775 332   2467888888888774     


Q ss_pred             CCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccc
Q 048205          532 NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQ  611 (1027)
Q Consensus       532 ~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1027)
                               .+|..   +++|+.|+|++|.+++ +|   ..+++|+.|++++|+|+ .+|.   .+++|+.|+|++|+|+
T Consensus       215 ---------~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          215 ---------SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             ---------SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC
T ss_pred             ---------ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC
Confidence                     23322   3678888888888886 66   45678888888888887 4676   5678888888888888


Q ss_pred             cCccccccccccccccccccccccCCchhhhhccc
Q 048205          612 GSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLL  646 (1027)
Q Consensus       612 g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~  646 (1027)
                       .||..++.+++|+.|+|++|+++|.+|..+..++
T Consensus       275 -~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          275 -RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             -SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             -cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence             7888888888888889998888888888888776

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=2.2e-29  Score=295.83  Aligned_cols=236  Identities=23%  Similarity=0.242  Sum_probs=160.5

Q ss_pred             CCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccc
Q 048205          363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYL  442 (1027)
Q Consensus       363 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L  442 (1027)
                      +++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|  |+.+++|++|+|++|.|++++.         .++|
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~---------~~~L  101 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV---------GPSI  101 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE---------CTTC
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC---------CCCc
Confidence            3467777777777776666677777777777777777776554  7777777777777777665432         2567


Q ss_pred             cEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccC
Q 048205          443 EYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD  522 (1027)
Q Consensus       443 ~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  522 (1027)
                      ++|++++|.|+++++..                            +++|++|+|++|++++..|..|+++++|++|+|++
T Consensus       102 ~~L~L~~N~l~~~~~~~----------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (487)
T 3oja_A          102 ETLHAANNNISRVSCSR----------------------------GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (487)
T ss_dssp             CEEECCSSCCCCEEECC----------------------------CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTT
T ss_pred             CEEECcCCcCCCCCccc----------------------------cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCC
Confidence            77777777766544322                            23455555555555555555566666666666666


Q ss_pred             ceeecccCCCCCccccccccCcccc-ccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCcccc
Q 048205          523 NQLEGSIPDNLSFSCTLTSIPSTLW-NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ  601 (1027)
Q Consensus       523 N~l~g~~p~~~~~~~~~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~  601 (1027)
                      |++++.+             |..+. .+++|+.|+|++|.+++. |. +..+++|+.|+|++|++++ +|..++.+++|+
T Consensus       154 N~l~~~~-------------~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~  217 (487)
T 3oja_A          154 NEIDTVN-------------FAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT  217 (487)
T ss_dssp             SCCCEEE-------------GGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCS
T ss_pred             CCCCCcC-------------hHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCcc
Confidence            6654332             22333 455666666666666653 22 3357788888888888885 555688888888


Q ss_pred             EEEccCCccccCcccccccccccccccccccccc-CCchhhhhcccCCcceecc
Q 048205          602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLF-GIIPISLEKLLDLKDINVS  654 (1027)
Q Consensus       602 ~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~l~l~  654 (1027)
                      .|+|++|.|++ +|..++.+++|+.|+|++|+++ +.+|..+..++.|+.++++
T Consensus       218 ~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          218 WISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             EEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             EEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            88888888884 7888888888888888888887 7788888888888887775

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=3.3e-27  Score=274.80  Aligned_cols=249  Identities=25%  Similarity=0.303  Sum_probs=161.9

Q ss_pred             CCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCC
Q 048205           27 RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        27 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  106 (1027)
                      +.+.++++++.++ .+|..+.  ++++.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            3456666666666 5666554  566667777777766666666677777777777777666555666667777777777


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccC-CccccccCccccCCCCCcEEEccCccCCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSI-NDFSGDIPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      +|+++ .++...+..+++|++|+|++|+++...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|+++.
T Consensus       121 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  199 (440)
T 3zyj_A          121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE  199 (440)
T ss_dssp             SSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred             CCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence            77666 45555666666777777777777666666667777777777776 34443344456667777777777777763


Q ss_pred             CCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEe
Q 048205          186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYL  265 (1027)
Q Consensus       186 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~L  265 (1027)
                       +| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+++               .++...|..+++|+.|+|
T Consensus       200 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~---------------~~~~~~~~~l~~L~~L~L  262 (440)
T 3zyj_A          200 -IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ---------------VIERNAFDNLQSLVEINL  262 (440)
T ss_dssp             -CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC---------------EECTTSSTTCTTCCEEEC
T ss_pred             -cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCcee---------------EEChhhhcCCCCCCEEEC
Confidence             33 3666677777777777777666666777777777777777765               334445566667777777


Q ss_pred             ccccccccCCCCCCCCCCCccccCcCCccceeccCccccc
Q 048205          266 SKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC  305 (1027)
Q Consensus       266 s~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~  305 (1027)
                      ++|++++..         +..+..+++|+.|+|++|.+.+
T Consensus       263 ~~N~l~~~~---------~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          263 AHNNLTLLP---------HDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             TTSCCCCCC---------TTTTSSCTTCCEEECCSSCEEC
T ss_pred             CCCCCCccC---------hhHhccccCCCEEEcCCCCccC
Confidence            777776311         2234556777777777777765

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=3.3e-27  Score=275.91  Aligned_cols=248  Identities=24%  Similarity=0.278  Sum_probs=156.0

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      .+.++++++.++ .+|..+.  +++++|+|++|+|++..|+.|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            456666666666 5565554  5666666666666666666666666666666666666665566666666666666666


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccC-CccccccCccccCCCCCcEEEccCccCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSI-NDFSGDIPKEIGNLTKLKYLHLDQNRLQGE  186 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  186 (1027)
                      |+++ .++...+..+++|++|+|++|+++...+..|..+++|++|++++ |.+....+..|.++++|++|+|++|++++.
T Consensus       133 n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          133 NWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             SCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            6665 45555566666666666666666666666666666666666666 344433344566666666666666666643


Q ss_pred             CChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEec
Q 048205          187 IPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLS  266 (1027)
Q Consensus       187 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls  266 (1027)
                       | .+..+++|++|+|++|.|++..|..|.++++|+.|+|++|+++               .++...+..+++|+.|+|+
T Consensus       212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~---------------~~~~~~~~~l~~L~~L~L~  274 (452)
T 3zyi_A          212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS---------------LIERNAFDGLASLVELNLA  274 (452)
T ss_dssp             -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCC---------------EECTTTTTTCTTCCEEECC
T ss_pred             -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCc---------------eECHHHhcCCCCCCEEECC
Confidence             3 3566666666666666666666666666666667777666665               2333445566666677777


Q ss_pred             cccccccCCCCCCCCCCCccccCcCCccceeccCccccc
Q 048205          267 KNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC  305 (1027)
Q Consensus       267 ~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~  305 (1027)
                      +|+|++..         +..+..+++|+.|+|++|.+.+
T Consensus       275 ~N~l~~~~---------~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          275 HNNLSSLP---------HDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             SSCCSCCC---------TTSSTTCTTCCEEECCSSCEEC
T ss_pred             CCcCCccC---------hHHhccccCCCEEEccCCCcCC
Confidence            77666311         1234556677777777777664

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.9e-27  Score=259.95  Aligned_cols=225  Identities=25%  Similarity=0.234  Sum_probs=207.3

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      ++++.+++.++ .+|..+  .++|++|+|++|.+++..+..++.+++|++|+|++|++++..|..|.++++|++|++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            67899999998 566544  479999999999999877788999999999999999999888999999999999999999


Q ss_pred             c-cCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccccc
Q 048205           85 F-LTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDI  163 (1027)
Q Consensus        85 ~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  163 (1027)
                      . ++...|..|..+++|++|++++|+++ .++...+..+++|++|++++|++++..+..|..+++|++|+|++|.+++..
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCC-EECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            7 88777899999999999999999998 456677889999999999999999888888999999999999999999777


Q ss_pred             CccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCC
Q 048205          164 PKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTG  233 (1027)
Q Consensus       164 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  233 (1027)
                      +..|..+++|++|+|++|++++..|..|..+++|++|++++|.+++..+..+..+++|+.|++++|.+..
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence            7789999999999999999998889999999999999999999998777789999999999999999974

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.9e-29  Score=278.54  Aligned_cols=246  Identities=24%  Similarity=0.252  Sum_probs=158.7

Q ss_pred             CCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccc
Q 048205          363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYL  442 (1027)
Q Consensus       363 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L  442 (1027)
                      +++|++|+|++|++++..|..|.++++|++|+|++|++++..+  |..+++|++|+|++|+|++++         .++.|
T Consensus        33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~---------~~~~L  101 (317)
T 3o53_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL---------VGPSI  101 (317)
T ss_dssp             GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE---------ECTTC
T ss_pred             CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc---------CCCCc
Confidence            4456666666666665555566666666666666666665433  666666666666666655433         12456


Q ss_pred             cEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccC
Q 048205          443 EYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKD  522 (1027)
Q Consensus       443 ~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  522 (1027)
                      ++|++++|+++++++..                            +++|++|++++|++++..+..++.+++|++|+|++
T Consensus       102 ~~L~l~~n~l~~~~~~~----------------------------~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (317)
T 3o53_A          102 ETLHAANNNISRVSCSR----------------------------GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (317)
T ss_dssp             CEEECCSSCCSEEEECC----------------------------CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred             CEEECCCCccCCcCccc----------------------------cCCCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence            66666666665433221                            23455555555555555555556666666666666


Q ss_pred             ceeecccCCCCCccccccccCccc-cccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCcccc
Q 048205          523 NQLEGSIPDNLSFSCTLTSIPSTL-WNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ  601 (1027)
Q Consensus       523 N~l~g~~p~~~~~~~~~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~  601 (1027)
                      |++++..             |..+ ..+++|++|+|++|.+++. |. ...+++|++|+|++|++++ +|..++.+++|+
T Consensus       154 N~l~~~~-------------~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~  217 (317)
T 3o53_A          154 NEIDTVN-------------FAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT  217 (317)
T ss_dssp             SCCCEEE-------------GGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCS
T ss_pred             CCCCccc-------------HHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCccc
Confidence            6654321             1222 2455666666666666643 32 2347788888888888874 566688888888


Q ss_pred             EEEccCCccccCcccccccccccccccccccccc-CCchhhhhcccCCcceecc-CCCCCCCCCC
Q 048205          602 YLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLF-GIIPISLEKLLDLKDINVS-FNKLEGEIPR  664 (1027)
Q Consensus       602 ~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~l~l~-~N~l~g~~p~  664 (1027)
                      +|+|++|+++ .+|..++.+++|+.|+|++|+++ +.+|..+..++.|+.++++ .+.++|..|.
T Consensus       218 ~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             EEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             EEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            8888888888 57888888888888888888888 7788888888888888888 5567777665

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=3e-28  Score=269.73  Aligned_cols=133  Identities=19%  Similarity=0.208  Sum_probs=80.2

Q ss_pred             ccCcCCccceeccCccccccCCccccCcCcccceeccCccccc-ccCcccc-------ccCCcceEEccCccccccCCCC
Q 048205          287 IGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVG-VVPTTIF-------NVSTLKFLYLGSNSFFGRLPSS  358 (1027)
Q Consensus       287 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~  358 (1027)
                      ++..++|+.|++++|.+  .+|..+...  |+.|++++|++.. ..|..+.       ++++|++|+|++|++.+.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            34456677777777777  455555443  7777777777743 3343333       4666666666666666566655


Q ss_pred             cc-CCCCCccEEEccccccCCcCcccccCC-----CCCCeeecCCCcccCCCCcccCCcccccEEecCCCCC
Q 048205          359 AD-VRLPNLEELSLSGNNFSGTIPSFIFNT-----SKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYL  424 (1027)
Q Consensus       359 ~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  424 (1027)
                      ++ ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..|..|+.+++|++|+|++|++
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  185 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE  185 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTT
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCc
Confidence            42 4566666666666666654 5555555     5666666666666655556666666666666665553

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=9.5e-27  Score=271.98  Aligned_cols=249  Identities=22%  Similarity=0.273  Sum_probs=227.9

Q ss_pred             CCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc
Q 048205            3 NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ   82 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~   82 (1027)
                      +.+.++.++++++ .+|..+.  +++++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            3467888999998 5776654  789999999999998889999999999999999999998888999999999999999


Q ss_pred             CcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccC-CcCCccCcccccCCCCCcEEEccCCcccc
Q 048205           83 NNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE-NNFDGKIPSTLLRCKHLQTLSLSINDFSG  161 (1027)
Q Consensus        83 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  161 (1027)
                      +|++++..+..|..+++|++|+|++|+++ .++...|..+++|++|++++ |.+....+..|.++++|++|+|++|.+++
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence            99999777778999999999999999998 67888899999999999999 66776667789999999999999999985


Q ss_pred             ccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhh
Q 048205          162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHI  241 (1027)
Q Consensus       162 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  241 (1027)
                       +| .+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|+|+         
T Consensus       211 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---------  279 (452)
T 3zyi_A          211 -MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS---------  279 (452)
T ss_dssp             -CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS---------
T ss_pred             -cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC---------
Confidence             44 5889999999999999999988999999999999999999999888999999999999999999998         


Q ss_pred             hhhccccCCccccCCCccccEEEeccccccc
Q 048205          242 VNRLSAELPAKFCNNIPFLEEIYLSKNMFYG  272 (1027)
Q Consensus       242 ~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~  272 (1027)
                            .++...+..+++|+.|+|++|.+..
T Consensus       280 ------~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          280 ------SLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             ------CCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             ------ccChHHhccccCCCEEEccCCCcCC
Confidence                  5667778889999999999999995

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2e-28  Score=271.85  Aligned_cols=257  Identities=23%  Similarity=0.242  Sum_probs=143.5

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      ++.++++.+.+....+..+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+  +..+++|++|++++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            4445555555553333444445566666666666665555566666666666666666654333  66666666666666


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |++++ ++     ..++|++|++++|++++..+..   +++|++|++++|.+++..+..|..+++|++|+|++|++++..
T Consensus        90 n~l~~-l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (317)
T 3o53_A           90 NYVQE-LL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (317)
T ss_dssp             SEEEE-EE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred             Ccccc-cc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence            66652 11     2255666666666665444332   455666666666666555556666666666666666666554


Q ss_pred             Chhc-cCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEec
Q 048205          188 PEEL-GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLS  266 (1027)
Q Consensus       188 p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls  266 (1027)
                      +..+ ..+++|++|+|++|.|++. + ....+++|++|+|++|+++               .+|.. +..+++|++|+++
T Consensus       161 ~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~---------------~l~~~-~~~l~~L~~L~L~  222 (317)
T 3o53_A          161 FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA---------------FMGPE-FQSAAGVTWISLR  222 (317)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC---------------EECGG-GGGGTTCSEEECT
T ss_pred             HHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC---------------cchhh-hcccCcccEEECc
Confidence            5444 3556666666666666533 2 2223566666666666665               22222 2344555555555


Q ss_pred             cccccccCCCCCCCCCCCccccCcCCccceeccCcccc-ccCCccccCcCcccceecc
Q 048205          267 KNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQ-CVIPHEIDNLHNLEWMIFS  323 (1027)
Q Consensus       267 ~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls  323 (1027)
                      +|+++          .+|..+..+++|+.|++++|++. +..+..+..+++|+.|+++
T Consensus       223 ~N~l~----------~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          223 NNKLV----------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             TSCCC----------EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             CCccc----------chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            55554          33444455556666666666665 3444555555555555555

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.1e-28  Score=293.52  Aligned_cols=185  Identities=19%  Similarity=0.093  Sum_probs=131.9

Q ss_pred             eeeccccceEEEEE-ecCCceEEEEEEeccc----------chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEE
Q 048205          757 LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY----------GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       757 ~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ..+.|+.|.+..++ ...|+.||||++.+..          ....+.+.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35677777777665 3368999999997542          12346789999999999 699999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||++|++|.+++.+.. .++..   +|+.||++||+|+|   ++|||||||||+|||++.+|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999998754 35543   58999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP  951 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p  951 (1027)
                        ......+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence              23345689999999999875 467789999999998887766544

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=2.6e-28  Score=270.16  Aligned_cols=205  Identities=22%  Similarity=0.229  Sum_probs=125.3

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccc-eeCccccc-------CCCCCCEEEccCcccCCccCcc
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQ-GEIPEELG-------NLAELEELWLQNNFLTGTIPSS   93 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~-~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~   93 (1027)
                      +...++|++|++++|.+  .+|..+...  |++|+|++|+++ ..+|..+.       ++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            34456677777777777  567666644  777777777773 45565554       6777777777777777767766


Q ss_pred             c--cCCCCCCeEeCCcccccccchhhhhcCC-----CCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccc--cC
Q 048205           94 I--FNLSSLSNLDLSVNNLTGELLANICSNL-----PLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD--IP  164 (1027)
Q Consensus        94 l--~~l~~L~~L~Ls~N~l~~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p  164 (1027)
                      +  ..+++|++|+|++|++++. + ..+..+     ++|++|+|++|++++..+..|..+++|++|+|++|++.+.  .|
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-D-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI  192 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-S-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-h-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence            5  6777777777777777643 2 333333     6666666666666666666666666666666666665543  22


Q ss_pred             ccc--cCCCCCcEEEccCccCCCC---CChhccCCCCCCeeeccccccCCCCC-ccccCCCCCCEEEccCccCC
Q 048205          165 KEI--GNLTKLKYLHLDQNRLQGE---IPEELGNLAELEKLQLQNNFLTGTIP-PSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       165 ~~~--~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      ..+  ..+++|++|+|++|++++.   ....+..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+
T Consensus       193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (312)
T 1wwl_A          193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK  266 (312)
T ss_dssp             HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred             HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence            233  5566666666666666521   11233455566666666666655443 23444555555555555554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=1.6e-26  Score=269.08  Aligned_cols=249  Identities=24%  Similarity=0.285  Sum_probs=228.0

Q ss_pred             CCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc
Q 048205            3 NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ   82 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~   82 (1027)
                      ..+.++.++++++ .+|..+.  ++++.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            3568899999998 6777665  789999999999998888999999999999999999998888999999999999999


Q ss_pred             CcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccC-CcCCccCcccccCCCCCcEEEccCCcccc
Q 048205           83 NNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE-NNFDGKIPSTLLRCKHLQTLSLSINDFSG  161 (1027)
Q Consensus        83 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  161 (1027)
                      +|++++..+..|..+++|++|+|++|+++ .++...|..+++|++|+|++ |.+....+..|.++++|++|+|++|.++ 
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-  198 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-  198 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-
Confidence            99999777778999999999999999998 67788899999999999999 5666666778999999999999999998 


Q ss_pred             ccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhh
Q 048205          162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHI  241 (1027)
Q Consensus       162 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  241 (1027)
                      .+| .+..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|+         
T Consensus       199 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---------  268 (440)
T 3zyj_A          199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT---------  268 (440)
T ss_dssp             SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC---------
T ss_pred             ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC---------
Confidence            455 5889999999999999999888999999999999999999999988999999999999999999998         


Q ss_pred             hhhccccCCccccCCCccccEEEeccccccc
Q 048205          242 VNRLSAELPAKFCNNIPFLEEIYLSKNMFYG  272 (1027)
Q Consensus       242 ~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~  272 (1027)
                            .++...+..+++|+.|+|++|.+..
T Consensus       269 ------~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          269 ------LLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             ------CCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             ------ccChhHhccccCCCEEEcCCCCccC
Confidence                  5667778889999999999999994

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=5.6e-26  Score=271.88  Aligned_cols=261  Identities=26%  Similarity=0.273  Sum_probs=129.1

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      ++.|++++|.++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+|+ .+|.   .+++|++|++++
T Consensus        42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~  110 (622)
T 3g06_A           42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS  110 (622)
T ss_dssp             CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred             CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence            444444444444 3444333  44444444444444 2333   2344444444444444 2232   334444555555


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |++++ ++.    .+++|++|++++|+++++ |..   +++|++|+|++|.+++ +|.   .+.+|+.|++++|++++ +
T Consensus       111 N~l~~-l~~----~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l  176 (622)
T 3g06_A          111 NPLTH-LPA----LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-L  176 (622)
T ss_dssp             CCCCC-CCC----CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred             CcCCC-CCC----CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-C
Confidence            54442 211    334455555555555432 221   2555555555555552 232   23455555555555553 3


Q ss_pred             ChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEecc
Q 048205          188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSK  267 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~  267 (1027)
                      |   ..+++|+.|++++|.|++ +|..   +++|+.|++++|.++               .+|.    .+++|+.|++++
T Consensus       177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~---------------~l~~----~~~~L~~L~Ls~  230 (622)
T 3g06_A          177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT---------------SLPA----LPSGLKELIVSG  230 (622)
T ss_dssp             C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS---------------SCCC----CCTTCCEEECCS
T ss_pred             c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc---------------ccCC----CCCCCCEEEccC
Confidence            3   334555555555555553 3322   245556666666554               1221    124556666666


Q ss_pred             ccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEcc
Q 048205          268 NMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG  347 (1027)
Q Consensus       268 N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  347 (1027)
                      |+|++          +|   ..+++|+.|+|++|+|+.+.+    .+++|+.|+|++|+|+. +|..+.++++|+.|+|+
T Consensus       231 N~L~~----------lp---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~~-lp~~l~~l~~L~~L~L~  292 (622)
T 3g06_A          231 NRLTS----------LP---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLE  292 (622)
T ss_dssp             SCCSC----------CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCCS-CCGGGGGSCTTCEEECC
T ss_pred             CccCc----------CC---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCCc-CCHHHhhccccCEEEec
Confidence            66552          22   223556666666666664332    45566666666666663 35556666777777777


Q ss_pred             CccccccCCC
Q 048205          348 SNSFFGRLPS  357 (1027)
Q Consensus       348 ~N~l~~~~~~  357 (1027)
                      +|.+.+..|.
T Consensus       293 ~N~l~~~~~~  302 (622)
T 3g06_A          293 GNPLSERTLQ  302 (622)
T ss_dssp             SCCCCHHHHH
T ss_pred             CCCCCCcCHH
Confidence            7766554443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=3.4e-26  Score=268.63  Aligned_cols=169  Identities=30%  Similarity=0.348  Sum_probs=94.8

Q ss_pred             CCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEc
Q 048205           51 TLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFL  130 (1027)
Q Consensus        51 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L  130 (1027)
                      +|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|  +..+++|++|+|++|.+++ ++     ..++|++|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-----~~~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL-----VGPSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EE-----ECTTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CC-----CCCCcCEEEC
Confidence            56666666666665555556666666666666666654433  5566666666666666552 11     1255555555


Q ss_pred             cCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhcc-CCCCCCeeeccccccCC
Q 048205          131 DENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELG-NLAELEKLQLQNNFLTG  209 (1027)
Q Consensus       131 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~  209 (1027)
                      ++|.+++..+.   .+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..+. .+++|++|+|++|.|++
T Consensus       107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            55555544333   235566666666666655555566666666666666666655555544 45566666666666654


Q ss_pred             CCCccccCCCCCCEEEccCccCC
Q 048205          210 TIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       210 ~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      . | .+..+++|+.|+|++|.|+
T Consensus       184 ~-~-~~~~l~~L~~L~Ls~N~l~  204 (487)
T 3oja_A          184 V-K-GQVVFAKLKTLDLSSNKLA  204 (487)
T ss_dssp             E-E-CCCCCTTCCEEECCSSCCC
T ss_pred             c-c-ccccCCCCCEEECCCCCCC
Confidence            3 1 2233556666666666554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=1e-27  Score=291.25  Aligned_cols=34  Identities=18%  Similarity=0.123  Sum_probs=22.0

Q ss_pred             CCCCCeeecCCCcccCCCCcccC-CcccccEEecC
Q 048205          387 TSKLSTLELQRNSFSGFIPNTFG-NLRNLKWLDLG  420 (1027)
Q Consensus       387 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~  420 (1027)
                      +++|+.|.++.|.+++..+..+. .+++|+.|+|+
T Consensus       371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~  405 (594)
T 2p1m_B          371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC  405 (594)
T ss_dssp             CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred             chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence            56677776666666654444443 46777777777

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=6e-28  Score=293.22  Aligned_cols=161  Identities=16%  Similarity=0.121  Sum_probs=104.9

Q ss_pred             ccccceEEecCccccCchhHhhh-cccccceeecc--C----ceeecccCCCCCccccccccCccccccCcccEEecCCC
Q 048205          488 LTNLIAIYLGVNKLNGSILIALG-KLKKLQLLSLK--D----NQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLN  560 (1027)
Q Consensus       488 l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N  560 (1027)
                      +++|+.|.++.|.+++..+..+. .+++|+.|+|+  +    |++++. |       ....++..+..+++|+.|++++ 
T Consensus       371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~-~-------~~~~~~~l~~~~~~L~~L~L~~-  441 (594)
T 2p1m_B          371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLE-P-------LDIGFGAIVEHCKDLRRLSLSG-  441 (594)
T ss_dssp             CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCC-C-------THHHHHHHHHHCTTCCEEECCS-
T ss_pred             chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCC-c-------hhhHHHHHHhhCCCccEEeecC-
Confidence            45666666666666665555554 47777777777  3    333210 0       0012223355677788888876 


Q ss_pred             ccccCccccccC-cccccEEcccccccccccchhh-ccCccccEEEccCCccccCccc-cccccccccccccccccccCC
Q 048205          561 FFTGPLPLEIGN-LKVLVQIDLSINNFSDVIPTTI-GGLKDLQYLFLKYNRLQGSIPD-SIGDMINLKSLNLSNNNLFGI  637 (1027)
Q Consensus       561 ~l~~~~p~~~~~-l~~L~~L~ls~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~g~ip~-~~~~l~~L~~L~l~~N~l~~~  637 (1027)
                      .+++..+..++. +++|+.|+|++|.+++..+..+ .++++|++|+|++|.+++..+. .+..+++|+.|+|++|+++..
T Consensus       442 ~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~  521 (594)
T 2p1m_B          442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFG  521 (594)
T ss_dssp             SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHH
T ss_pred             cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHH
Confidence            566555555555 7889999999999876655555 7789999999999998654443 345688999999999988544


Q ss_pred             chhhh-hcccCCcceeccCCC
Q 048205          638 IPISL-EKLLDLKDINVSFNK  657 (1027)
Q Consensus       638 ~p~~l-~~l~~L~~l~l~~N~  657 (1027)
                      -...+ ..++.|+...+..+.
T Consensus       522 ~~~~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          522 ACKLLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             HHHHHHHHCTTEEEEEECSSS
T ss_pred             HHHHHHHhCCCCEEEEecCCC
Confidence            44444 456666665555443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=1.6e-24  Score=235.38  Aligned_cols=197  Identities=26%  Similarity=0.231  Sum_probs=98.0

Q ss_pred             EEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccc
Q 048205           31 ISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNL  110 (1027)
Q Consensus        31 L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  110 (1027)
                      ++..+..+. .+|..+.  ++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l   88 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (276)
T ss_dssp             EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence            444444444 3444443  3455555555555544444555555555555555555544444555555555555555555


Q ss_pred             cccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccc-cCccccCCCCCcEEEccCccCCCCCCh
Q 048205          111 TGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD-IPKEIGNLTKLKYLHLDQNRLQGEIPE  189 (1027)
Q Consensus       111 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~  189 (1027)
                      + .++...+.++++|++|++++|++.+..+..+..+++|++|++++|.+++. +|..|.++++|++|+|++|++++..+.
T Consensus        89 ~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  167 (276)
T 2z62_A           89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (276)
T ss_dssp             C-EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             C-ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence            4 23333444444555555555555444444455555555555555555532 355555555555555555555544444


Q ss_pred             hccCCCCCC----eeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          190 ELGNLAELE----KLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       190 ~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      .+..+.+|+    .|++++|.+++..+. .....+|+.|++++|+++
T Consensus       168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~-~~~~~~L~~L~L~~n~l~  213 (276)
T 2z62_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLKELALDTNQLK  213 (276)
T ss_dssp             GGHHHHTCTTCCEEEECCSSCCCEECTT-SSCSCCEEEEECCSSCCS
T ss_pred             HhhhhhhccccceeeecCCCcccccCcc-ccCCCcccEEECCCCcee
Confidence            444444444    455555555533222 222235555555555554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=3e-24  Score=233.31  Aligned_cols=226  Identities=23%  Similarity=0.198  Sum_probs=197.5

Q ss_pred             EEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcc
Q 048205            6 YLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNF   85 (1027)
Q Consensus         6 ~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~   85 (1027)
                      .++-.+.+++ .+|..+.  ++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..|.++++|++|+|++|.
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            4566666777 5676664  689999999999997777799999999999999999998888899999999999999999


Q ss_pred             cCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCcc-CcccccCCCCCcEEEccCCccccccC
Q 048205           86 LTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK-IPSTLLRCKHLQTLSLSINDFSGDIP  164 (1027)
Q Consensus        86 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p  164 (1027)
                      +++..+..|..+++|++|++++|++++ ++...+..+++|++|++++|++++. +|..|..+++|++|++++|.+++..+
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             cCccChhhhcCCccccEEECCCCCccc-cCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            998888899999999999999999984 5555688899999999999999875 58999999999999999999998777


Q ss_pred             ccccCCCCCc----EEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCC
Q 048205          165 KEIGNLTKLK----YLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP  236 (1027)
Q Consensus       165 ~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  236 (1027)
                      ..|..+.+|+    .|++++|++++..+..+. ..+|++|+|++|++++..+..|..+++|+.|++++|.+++..|
T Consensus       167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             GGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             HHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            8888887777    899999999966555554 4589999999999997766778899999999999999986544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=1.3e-23  Score=227.28  Aligned_cols=202  Identities=27%  Similarity=0.293  Sum_probs=145.1

Q ss_pred             CCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCC
Q 048205           27 RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        27 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  106 (1027)
                      +.+.++++++.++ .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|.++...+..|..+++|++|+++
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            4677788877777 5676554  567777887777776555677777777777777777775555556777777777777


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGE  186 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  186 (1027)
                      +|+++ .++...+..+++|++|++++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++.
T Consensus        94 ~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             SSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            77776 45556666777777777777777766666777777777777777777765555677777777777777777766


Q ss_pred             CChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          187 IPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       187 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      .+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            5566777777777777777777555555667777777777777765

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=7.1e-24  Score=229.54  Aligned_cols=223  Identities=21%  Similarity=0.199  Sum_probs=137.6

Q ss_pred             CCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCC
Q 048205           27 RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        27 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  106 (1027)
                      ++..+++..+.+.+.  .....+++|+.|++++|.++ .++ .++.+++|++|++++|.+++.  ..+..+++|++|+++
T Consensus        20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~   93 (272)
T 3rfs_A           20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT   93 (272)
T ss_dssp             HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred             HHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence            344455555555432  23445666666666666665 222 356666666666666666632  356666666666666


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGE  186 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  186 (1027)
                      +|+++ .++...+..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++.
T Consensus        94 ~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  172 (272)
T 3rfs_A           94 GNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL  172 (272)
T ss_dssp             TSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence            66665 34444555666666666666666666666666677777777777777655555666677777777777777765


Q ss_pred             CChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEec
Q 048205          187 IPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLS  266 (1027)
Q Consensus       187 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls  266 (1027)
                      .+..|+.+++|++|++++|++++..+..+..+++|+.|++++|.+.+                      .++.|+.++++
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----------------------~~~~l~~l~~~  230 (272)
T 3rfs_A          173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----------------------TCPGIRYLSEW  230 (272)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC----------------------CTTTTHHHHHH
T ss_pred             CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc----------------------cCcHHHHHHHH
Confidence            55566667777777777777776655566667777777777776652                      23345556666


Q ss_pred             cccccccCCCCC
Q 048205          267 KNMFYGEIPSDL  278 (1027)
Q Consensus       267 ~N~l~~~~p~~~  278 (1027)
                      .|.++|.+|.++
T Consensus       231 ~n~~~g~ip~~~  242 (272)
T 3rfs_A          231 INKHSGVVRNSA  242 (272)
T ss_dssp             HHHTGGGBBCTT
T ss_pred             HHhCCCcccCcc
Confidence            666666555443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=4e-23  Score=223.45  Aligned_cols=204  Identities=28%  Similarity=0.298  Sum_probs=185.6

Q ss_pred             CCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc
Q 048205            3 NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ   82 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~   82 (1027)
                      +.+.+++++++++ .+|..+.  +++++|+|++|++++..+..++.+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            5689999999999 5776664  789999999999997777789999999999999999996666678999999999999


Q ss_pred             CcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccc
Q 048205           83 NNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD  162 (1027)
Q Consensus        83 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  162 (1027)
                      +|++++..+..|..+++|++|++++|+++ .++...+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++.
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            99999877788899999999999999998 56777789999999999999999988888899999999999999999987


Q ss_pred             cCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCC
Q 048205          163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGT  210 (1027)
Q Consensus       163 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  210 (1027)
                      .+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+...
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            777899999999999999999987777899999999999999998743

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=2.9e-23  Score=226.54  Aligned_cols=203  Identities=27%  Similarity=0.224  Sum_probs=160.5

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS  101 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  101 (1027)
                      +.++++++++++++|.++ .+|..+.  +.+++|+|++|+|++..+..|..+++|++|+|++|.+++..+  ...+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence            677788888888888888 6777665  688888888888887778888888888888888888885433  26788888


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCc
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQN  181 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  181 (1027)
                      +|++++|+++ .++. .+..+++|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus        81 ~L~Ls~N~l~-~l~~-~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             EEECCSSCCS-SCCC-CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCC-cCch-hhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            8888888887 3433 4567778888888888888777778888888888888888888766777788888888888888


Q ss_pred             cCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          182 RLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       182 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      +++...+..|..+++|++|+|++|+|+ .+|..++.+.+|+.|+|++|.+.
T Consensus       159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            888666666777888888888888887 66777777778888888888775

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=7.1e-25  Score=259.40  Aligned_cols=186  Identities=17%  Similarity=0.142  Sum_probs=145.5

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccc--------hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG--------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ...+.||+|+||+||+|+. .++.+|+|+......        ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 478899998643211        1234578999999999999999666666677778999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++++|.+++..         +..++.|+++||+|||   +++|+||||||+||+++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999875         5679999999999999   999999999999999998  99999999999764322


Q ss_pred             Ccc-----eecccccCccccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 048205          905 QSL-----TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTRKKPTD  953 (1027)
Q Consensus       905 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~  953 (1027)
                      ...     ......||+.|+|||++..  ..|+..+|+|+.++-..+-+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            111     1235679999999999987  567888999999999999888877764

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=5.4e-23  Score=224.36  Aligned_cols=204  Identities=29%  Similarity=0.377  Sum_probs=111.8

Q ss_pred             ccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCC
Q 048205           46 IGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLL  125 (1027)
Q Consensus        46 i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L  125 (1027)
                      ++.+++++++++++|+++ .+|..+.  ++++.|+|++|.+++..+..|..+++|++|+|++|++++ ++..  ..+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~--~~l~~L   79 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD--GTLPVL   79 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC--SCCTTC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC--CCCCcC
Confidence            556667777777777776 4555443  566777777777766666666667777777777766653 2211  344444


Q ss_pred             cEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeecccc
Q 048205          126 QTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN  205 (1027)
Q Consensus       126 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  205 (1027)
                      ++|++++|+++                         .+|..+..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        80 ~~L~Ls~N~l~-------------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N  134 (290)
T 1p9a_G           80 GTLDLSHNQLQ-------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (290)
T ss_dssp             CEEECCSSCCS-------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCC-------------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence            44444444444                         34444444555555555555555444444555555555555555


Q ss_pred             ccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCc
Q 048205          206 FLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPK  285 (1027)
Q Consensus       206 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~  285 (1027)
                      +|++..+..|..+++|+.|+|++|+|+               .+|...|..+++|+.|+|++|+|+          .+|.
T Consensus       135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~---------------~l~~~~~~~l~~L~~L~L~~N~l~----------~ip~  189 (290)
T 1p9a_G          135 ELKTLPPGLLTPTPKLEKLSLANNNLT---------------ELPAGLLNGLENLDTLLLQENSLY----------TIPK  189 (290)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCS---------------CCCTTTTTTCTTCCEEECCSSCCC----------CCCT
T ss_pred             CCCccChhhcccccCCCEEECCCCcCC---------------ccCHHHhcCcCCCCEEECCCCcCC----------ccCh
Confidence            555444444445555555555555554               333444444555555555555554          3444


Q ss_pred             cccCcCCccceeccCccccc
Q 048205          286 EIGNLAKLEKLDLQFNRLQC  305 (1027)
Q Consensus       286 ~l~~l~~L~~L~L~~N~l~~  305 (1027)
                      .+..+.+|+.|+|++|.+.+
T Consensus       190 ~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          190 GFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             TTTTTCCCSEEECCSCCBCC
T ss_pred             hhcccccCCeEEeCCCCccC
Confidence            45555566666666666653

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.90  E-value=3.1e-23  Score=224.50  Aligned_cols=222  Identities=24%  Similarity=0.237  Sum_probs=186.1

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      ..+++.++.+.+..  .+..+++|+.|++++|.++ .++ .++.+++|++|+|++|++++ + ..+..+++|++|+|++|
T Consensus        22 ~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n   95 (272)
T 3rfs_A           22 IKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGN   95 (272)
T ss_dssp             HHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTS
T ss_pred             HHHHhcCccccccc--ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCC
Confidence            34456666666543  3567889999999999987 333 58889999999999999974 3 47889999999999999


Q ss_pred             ccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccC
Q 048205           85 FLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIP  164 (1027)
Q Consensus        85 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  164 (1027)
                      .+++..+..|..+++|++|++++|+++ .++...+..+++|++|++++|++++..+..|..+++|++|++++|.+++..+
T Consensus        96 ~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  174 (272)
T 3rfs_A           96 QLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE  174 (272)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             ccCccChhHhcCCcCCCEEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence            999777777889999999999999998 5666778889999999999999998888888999999999999999997777


Q ss_pred             ccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchh
Q 048205          165 KEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH  240 (1027)
Q Consensus       165 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  240 (1027)
                      ..|+.+++|++|+|++|++++..+..|..+++|++|++++|.+.+.       +++|+.|+++.|.++|.+|..+.
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~  243 (272)
T 3rfs_A          175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAG  243 (272)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred             HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccc
Confidence            7789999999999999999988787889999999999999988753       45788999999999988877654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=5.2e-25  Score=249.12  Aligned_cols=264  Identities=19%  Similarity=0.216  Sum_probs=124.4

Q ss_pred             eeccCccccccCCccccCcCcccceeccCcccccccC----ccccccCCcceEEccCccccccCCCCccCCCCCccEEEc
Q 048205          296 LDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVP----TTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSL  371 (1027)
Q Consensus       296 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  371 (1027)
                      +++++|++++.+|..+...++|++|+|++|.+.+..+    ..|.+++                        .+|++|+|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~------------------------~~L~~L~L   58 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTP------------------------ASVTSLNL   58 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCC------------------------TTCCEEEC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCC------------------------CceeEEEC
Confidence            3455555555555444444445555555555554443    3333333                        04555555


Q ss_pred             cccccCCcCcccccCC-----CCCCeeecCCCcccCCCCcccCC----c-ccccEEecCCCCCCCCCCccccccccc-cc
Q 048205          372 SGNNFSGTIPSFIFNT-----SKLSTLELQRNSFSGFIPNTFGN----L-RNLKWLDLGDNYLTSSTSELSFLSSSN-CK  440 (1027)
Q Consensus       372 s~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~~~l~~~~~~~-l~  440 (1027)
                      ++|++++..+..+..+     ++|++|+|++|++++..+..+..    + ++|++|+|++|+|+..+.....-.+.. ++
T Consensus        59 s~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~  138 (362)
T 3goz_A           59 SGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA  138 (362)
T ss_dssp             CSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCT
T ss_pred             cCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCC
Confidence            5555544444444443     55555555555555444443222    2 455555555555544333211111112 23


Q ss_pred             cccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCccccccc-ccceEEecCccccCchhHhhhc----c-cc
Q 048205          441 YLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLT-NLIAIYLGVNKLNGSILIALGK----L-KK  514 (1027)
Q Consensus       441 ~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~  514 (1027)
                      +|++|+|++|++++..+.                     .++..+..+. +|++|+|++|++++..+..+..    + ++
T Consensus       139 ~L~~L~Ls~N~l~~~~~~---------------------~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~  197 (362)
T 3goz_A          139 SITSLNLRGNDLGIKSSD---------------------ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS  197 (362)
T ss_dssp             TCCEEECTTSCGGGSCHH---------------------HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ceeEEEccCCcCCHHHHH---------------------HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCC
Confidence            455555555554432111                     1223333333 6666666666666555544433    3 46


Q ss_pred             cceeeccCceeecccCCCCCccccccccCcccccc-CcccEEecCCCccccCcc----ccccCcccccEEcccccccccc
Q 048205          515 LQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNL-KDILCLNLSLNFFTGPLP----LEIGNLKVLVQIDLSINNFSDV  589 (1027)
Q Consensus       515 L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~ls~n~l~~~  589 (1027)
                      |++|+|++|++++.         ....++..+..+ ++|++|+|++|.+++.-+    ..+..+++|+.|+|++|.+.+.
T Consensus       198 L~~L~Ls~N~i~~~---------~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i  268 (362)
T 3goz_A          198 VTSLDLSANLLGLK---------SYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM  268 (362)
T ss_dssp             CCEEECTTSCGGGS---------CHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTC
T ss_pred             CCEEECCCCCCChh---------HHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCcccc
Confidence            77777777766431         112244444442 356666666666554322    2234455566666666653322


Q ss_pred             -------cchhhccCccccEEEccCCccccC
Q 048205          590 -------IPTTIGGLKDLQYLFLKYNRLQGS  613 (1027)
Q Consensus       590 -------~p~~~~~l~~L~~L~L~~N~l~g~  613 (1027)
                             ++..+..+++|+.|||++|++.+.
T Consensus       269 ~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          269 SKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             CHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             CHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence                   223344555555555555555544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=1e-24  Score=249.30  Aligned_cols=255  Identities=18%  Similarity=0.232  Sum_probs=168.7

Q ss_pred             cCcccccCCCCCCeeecCCCcccCCCC----cccCCcccccEEecCCCCCCCCCCccccc------cccccccccEeecc
Q 048205          379 TIPSFIFNTSKLSTLELQRNSFSGFIP----NTFGNLRNLKWLDLGDNYLTSSTSELSFL------SSSNCKYLEYFSIS  448 (1027)
Q Consensus       379 ~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~l~~~------~~~~l~~L~~L~Ls  448 (1027)
                      .++..+..+++|++|+|++|.++...+    ..|..+++|++|+|++|.+..+...++..      .+..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            344555556666666666666654422    33556666666666666554433222110      12345666666666


Q ss_pred             CCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhh----cc---------ccc
Q 048205          449 NNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALG----KL---------KKL  515 (1027)
Q Consensus       449 ~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l---------~~L  515 (1027)
                      +|+++....                     ..+|..+..+++|++|+|++|++++..+..+.    .+         ++|
T Consensus       103 ~n~l~~~~~---------------------~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L  161 (386)
T 2ca6_A          103 DNAFGPTAQ---------------------EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL  161 (386)
T ss_dssp             SCCCCTTTH---------------------HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             CCcCCHHHH---------------------HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCC
Confidence            666543100                     02455666777777777777777654443333    33         788


Q ss_pred             ceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccc--c---CccccccCcccccEEcccccccc---
Q 048205          516 QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT--G---PLPLEIGNLKVLVQIDLSINNFS---  587 (1027)
Q Consensus       516 ~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~ls~n~l~---  587 (1027)
                      ++|+|++|+++..         ....+...+..+++|+.|++++|.++  |   .+|..+..+++|+.|+|++|.++   
T Consensus       162 ~~L~L~~n~l~~~---------~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g  232 (386)
T 2ca6_A          162 RSIICGRNRLENG---------SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG  232 (386)
T ss_dssp             CEEECCSSCCTGG---------GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH
T ss_pred             cEEECCCCCCCcH---------HHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH
Confidence            8888888887411         11122245667778888888888877  3   34447778888888888888885   


Q ss_pred             -cccchhhccCccccEEEccCCccccC----ccccc--cccccccccccccccccC----Cchhhh-hcccCCcceeccC
Q 048205          588 -DVIPTTIGGLKDLQYLFLKYNRLQGS----IPDSI--GDMINLKSLNLSNNNLFG----IIPISL-EKLLDLKDINVSF  655 (1027)
Q Consensus       588 -~~~p~~~~~l~~L~~L~L~~N~l~g~----ip~~~--~~l~~L~~L~l~~N~l~~----~~p~~l-~~l~~L~~l~l~~  655 (1027)
                       +.+|..+..+++|++|+|++|++++.    +|..+  +.+++|++|+|++|++++    .+|..+ .++++|+.|++++
T Consensus       233 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~  312 (386)
T 2ca6_A          233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG  312 (386)
T ss_dssp             HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred             HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccC
Confidence             56888888888889999998888865    66766  448888999999998887    488887 6688899999999


Q ss_pred             CCCCCCCC
Q 048205          656 NKLEGEIP  663 (1027)
Q Consensus       656 N~l~g~~p  663 (1027)
                      |++++..|
T Consensus       313 N~l~~~~~  320 (386)
T 2ca6_A          313 NRFSEEDD  320 (386)
T ss_dssp             SBSCTTSH
T ss_pred             CcCCcchh
Confidence            88887654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=4.6e-24  Score=241.38  Aligned_cols=265  Identities=20%  Similarity=0.253  Sum_probs=126.8

Q ss_pred             EecCCCcCcccCCccCcCCCCCcEEEccCCcccccCC----ccccccC-CCcEEEccccccceeCcccccCC-----CCC
Q 048205            7 LFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIP----KEIGNVT-TLIGLHLRGNKLQGEIPEELGNL-----AEL   76 (1027)
Q Consensus         7 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p----~~i~~l~-~L~~L~L~~n~i~~~~p~~l~~l-----~~L   76 (1027)
                      .++++|.+++.+|..+...++|++|+|++|.+++..+    ..+..++ +|++|+|++|+|++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4555566665555544444456666666666654433    4455555 55566666665554444444443     555


Q ss_pred             CEEEccCcccCCccCcccc----CC-CCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCccccc----C-C
Q 048205           77 EELWLQNNFLTGTIPSSIF----NL-SSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLL----R-C  146 (1027)
Q Consensus        77 ~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~-l  146 (1027)
                      ++|+|++|.+++..+..+.    .+ ++|++|+|++|+++                         +..+..+.    . .
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-------------------------~~~~~~l~~~l~~~~  137 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS-------------------------SKSSSEFKQAFSNLP  137 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG-------------------------GSCHHHHHHHHTTSC
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC-------------------------cHHHHHHHHHHHhCC
Confidence            5555555555544333222    22 45555555555554                         33332222    1 1


Q ss_pred             CCCcEEEccCCccccc----cCccccCCC-CCcEEEccCccCCCCCChhcc----CC-CCCCeeeccccccCCC----CC
Q 048205          147 KHLQTLSLSINDFSGD----IPKEIGNLT-KLKYLHLDQNRLQGEIPEELG----NL-AELEKLQLQNNFLTGT----IP  212 (1027)
Q Consensus       147 ~~L~~L~Ls~N~l~~~----~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~----~p  212 (1027)
                      ++|++|+|++|.++..    ++..+..++ +|++|+|++|++++..+..+.    .. ++|++|+|++|.|++.    ++
T Consensus       138 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~  217 (362)
T 3goz_A          138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA  217 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             CceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHH
Confidence            3455555555555421    222233333 555555555555544333222    22 3555555555555532    22


Q ss_pred             ccccC-CCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcC
Q 048205          213 PSIFN-LSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLA  291 (1027)
Q Consensus       213 ~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~  291 (1027)
                      ..+.. .++|++|+|++|.+++..+..+           ...+..++.|+.|+|++|.+.+..+..+  ..++..+..++
T Consensus       218 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l-----------~~~~~~l~~L~~L~L~~n~l~~i~~~~~--~~l~~~~~~l~  284 (362)
T 3goz_A          218 YIFSSIPNHVVSLNLCLNCLHGPSLENL-----------KLLKDSLKHLQTVYLDYDIVKNMSKEQC--KALGAAFPNIQ  284 (362)
T ss_dssp             HHHHHSCTTCCEEECCSSCCCCCCHHHH-----------HHTTTTTTTCSEEEEEHHHHTTCCHHHH--HHHHTTSTTCC
T ss_pred             HHHhcCCCCceEEECcCCCCCcHHHHHH-----------HHHHhcCCCccEEEeccCCccccCHHHH--HHHHHHhccCC
Confidence            33333 2356666666665553211111           1223445556666666665432111100  02334455667


Q ss_pred             CccceeccCccccccCCc
Q 048205          292 KLEKLDLQFNRLQCVIPH  309 (1027)
Q Consensus       292 ~L~~L~L~~N~l~~~~~~  309 (1027)
                      +|+.|++++|++....+.
T Consensus       285 ~L~~LdL~~N~l~~~~~~  302 (362)
T 3goz_A          285 KIILVDKNGKEIHPSHSI  302 (362)
T ss_dssp             EEEEECTTSCBCCGGGCH
T ss_pred             ceEEEecCCCcCCCcchH
Confidence            777777777777655433

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=2.9e-23  Score=229.43  Aligned_cols=225  Identities=19%  Similarity=0.216  Sum_probs=168.1

Q ss_pred             CCCcEEEccCCcccccCCc---cccccCCCcEEEccccccceeCcccc--cCCCCCCEEEccCcccCCccC----ccccC
Q 048205           26 KRLRNISLSLNDFSGTIPK---EIGNVTTLIGLHLRGNKLQGEIPEEL--GNLAELEELWLQNNFLTGTIP----SSIFN   96 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~~~~p~---~i~~l~~L~~L~L~~n~i~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~l~~   96 (1027)
                      ..++.|.+.++.++...-.   .+..+++|++|+|++|++++..|..+  ..+++|++|+|++|.+++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            4477888888777532111   12234668888888888888888887  888888888888888886544    34557


Q ss_pred             CCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCcc---C-cccccCCCCCcEEEccCCccccccCc----ccc
Q 048205           97 LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK---I-PSTLLRCKHLQTLSLSINDFSGDIPK----EIG  168 (1027)
Q Consensus        97 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~  168 (1027)
                      +++|++|+|++|+++ .++...+..+++|++|+|++|++.+.   . +..+..+++|++|+|++|.++. ++.    .++
T Consensus       144 ~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~  221 (310)
T 4glp_A          144 KPGLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAA  221 (310)
T ss_dssp             CSCCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHh
Confidence            888888888888886 45666777888888888888887642   1 2334678888899999988863 333    356


Q ss_pred             CCCCCcEEEccCccCCCCCChhccCC---CCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhc
Q 048205          169 NLTKLKYLHLDQNRLQGEIPEELGNL---AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRL  245 (1027)
Q Consensus       169 ~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  245 (1027)
                      .+++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++            
T Consensus       222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~------------  286 (310)
T 4glp_A          222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR------------  286 (310)
T ss_dssp             HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS------------
T ss_pred             cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC------------
Confidence            78889999999999887777777666   68899999999988 6677664  788999999998873            


Q ss_pred             cccCCccccCCCccccEEEeccccccc
Q 048205          246 SAELPAKFCNNIPFLEEIYLSKNMFYG  272 (1027)
Q Consensus       246 ~~~l~~~~~~~l~~L~~L~Ls~N~l~~  272 (1027)
                         +|.  +..++.|+.|+|++|.|+.
T Consensus       287 ---~~~--~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          287 ---APQ--PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             ---CCC--TTSCCCCSCEECSSTTTSC
T ss_pred             ---Cch--hhhCCCccEEECcCCCCCC
Confidence               222  3567888999999998875

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=2.6e-24  Score=245.92  Aligned_cols=216  Identities=21%  Similarity=0.305  Sum_probs=128.9

Q ss_pred             cCCccCcCCCCCcEEEccCCcccccCCc----cccccCCCcEEEcccc---ccceeCcccc-------cCCCCCCEEEcc
Q 048205           17 KIPSTLSNCKRLRNISLSLNDFSGTIPK----EIGNVTTLIGLHLRGN---KLQGEIPEEL-------GNLAELEELWLQ   82 (1027)
Q Consensus        17 ~~~~~~~~~~~L~~L~L~~n~l~~~~p~----~i~~l~~L~~L~L~~n---~i~~~~p~~l-------~~l~~L~~L~L~   82 (1027)
                      .++..+..+++|++|+|++|.+++..+.    .+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            4555666677777777777777655333    3556777777777775   3334445444       566777777777


Q ss_pred             CcccCC----ccCccccCCCCCCeEeCCcccccccchhhh---hcCC---------CCCcEEEccCCcCC-ccCc---cc
Q 048205           83 NNFLTG----TIPSSIFNLSSLSNLDLSVNNLTGELLANI---CSNL---------PLLQTLFLDENNFD-GKIP---ST  142 (1027)
Q Consensus        83 ~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~---~~~l---------~~L~~L~L~~N~l~-~~~~---~~  142 (1027)
                      +|.+++    .+|..+..+++|++|+|++|.+++..+..+   +..+         ++|++|+|++|+++ ...+   ..
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  182 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  182 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence            777765    355666677777777777777753222221   2222         66667777666665 2223   34


Q ss_pred             ccCCCCCcEEEccCCccc--c---ccCccccCCCCCcEEEccCccCC----CCCChhccCCCCCCeeeccccccCCC---
Q 048205          143 LLRCKHLQTLSLSINDFS--G---DIPKEIGNLTKLKYLHLDQNRLQ----GEIPEELGNLAELEKLQLQNNFLTGT---  210 (1027)
Q Consensus       143 ~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~---  210 (1027)
                      +..+++|++|+|++|.++  +   ..|..+..+++|++|+|++|+++    ..+|..+..+++|++|+|++|.|++.   
T Consensus       183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  262 (386)
T 2ca6_A          183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  262 (386)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence            556666666666666665  1   23335666666666666666664    34555566666666666666666543   


Q ss_pred             -CCcccc--CCCCCCEEEccCccCC
Q 048205          211 -IPPSIF--NLSSLSDLELSFNSLT  232 (1027)
Q Consensus       211 -~p~~~~--~l~~L~~L~Ls~N~l~  232 (1027)
                       ++..+.  .+++|+.|+|++|.++
T Consensus       263 ~l~~~l~~~~~~~L~~L~L~~n~i~  287 (386)
T 2ca6_A          263 AVVDAFSKLENIGLQTLRLQYNEIE  287 (386)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred             HHHHHHhhccCCCeEEEECcCCcCC
Confidence             334442  2566666666666654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=1.4e-23  Score=235.21  Aligned_cols=222  Identities=17%  Similarity=0.183  Sum_probs=104.6

Q ss_pred             CcEEecCCCcCcccCCccCcCC--CCCcEEEccCCcccccCCccccccCCCcEEEcccccccee-CcccccCCCCCCEEE
Q 048205            4 LEYLFLKSNMFHGKIPSTLSNC--KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGE-IPEELGNLAELEELW   80 (1027)
Q Consensus         4 l~~L~l~~n~l~~~~~~~~~~~--~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~-~p~~l~~l~~L~~L~   80 (1027)
                      ++.+++++|.+.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            345555555444   2233344  4555555555555533332 33455555555555555433 444555555555555


Q ss_pred             ccCcccCCccCccccCCCCCCeEeCCcc-cccccchhhhhcCCCCCcEEEccCC-cCCcc-CcccccCCC-CCcEEEccC
Q 048205           81 LQNNFLTGTIPSSIFNLSSLSNLDLSVN-NLTGELLANICSNLPLLQTLFLDEN-NFDGK-IPSTLLRCK-HLQTLSLSI  156 (1027)
Q Consensus        81 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~  156 (1027)
                      |++|.+++..+..+..+++|++|++++| .+++......+..+++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            5555555444455555555555555555 3443223333444555555555555 44432 334444455 555555555


Q ss_pred             C--ccc-cccCccccCCCCCcEEEccCcc-CCCCCChhccCCCCCCeeeccccc-cCCCCCccccCCCCCCEEEccCc
Q 048205          157 N--DFS-GDIPKEIGNLTKLKYLHLDQNR-LQGEIPEELGNLAELEKLQLQNNF-LTGTIPPSIFNLSSLSDLELSFN  229 (1027)
Q Consensus       157 N--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N  229 (1027)
                      |  .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+.++++|+.|++++|
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence            5  232 2233444445555555555555 343444444445555555555543 11111113444445555555544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=1.9e-22  Score=213.96  Aligned_cols=178  Identities=21%  Similarity=0.233  Sum_probs=81.8

Q ss_pred             CCcEEEccccccceeCcccccCCCCCCEEEccCcc-cCCccCccccCCCCCCeEeCCc-ccccccchhhhhcCCCCCcEE
Q 048205           51 TLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNF-LTGTIPSSIFNLSSLSNLDLSV-NNLTGELLANICSNLPLLQTL  128 (1027)
Q Consensus        51 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~L~~L  128 (1027)
                      +|++|+|++|+|++..+..|+++++|++|++++|. +++..+..|.++++|++|++++ |+++ .++...|.++++|++|
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFL  110 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTSEECCTTCCEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHHhCCCCCCCEE
Confidence            44444444444443333344444444444444443 4433333444444444444444 4443 3333344444444444


Q ss_pred             EccCCcCCccCcccccCCCCCc---EEEccCC-ccccccCccccCCCCCc-EEEccCccCCCCCChhccCCCCCCeeecc
Q 048205          129 FLDENNFDGKIPSTLLRCKHLQ---TLSLSIN-DFSGDIPKEIGNLTKLK-YLHLDQNRLQGEIPEELGNLAELEKLQLQ  203 (1027)
Q Consensus       129 ~L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  203 (1027)
                      ++++|++++ +|. |..+++|+   +|++++| .+++..+..|.++++|+ +|++++|+++.+.+..|.. ++|++|+++
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~  187 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN  187 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence            444444443 222 44444444   5555555 55544444455555555 5555555555222222322 455555555


Q ss_pred             ccc-cCCCCCccccCC-CCCCEEEccCccCC
Q 048205          204 NNF-LTGTIPPSIFNL-SSLSDLELSFNSLT  232 (1027)
Q Consensus       204 ~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~  232 (1027)
                      +|+ +++..+..|.++ ++|+.|++++|+++
T Consensus       188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             TCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            553 554334445555 55555555555554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=1.7e-22  Score=223.19  Aligned_cols=225  Identities=21%  Similarity=0.231  Sum_probs=184.8

Q ss_pred             CCcEEecCCCcCcccCCc---cCcCCCCCcEEEccCCcccccCCccc--cccCCCcEEEccccccceeCc----ccccCC
Q 048205            3 NLEYLFLKSNMFHGKIPS---TLSNCKRLRNISLSLNDFSGTIPKEI--GNVTTLIGLHLRGNKLQGEIP----EELGNL   73 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~~~~---~~~~~~~L~~L~L~~n~l~~~~p~~i--~~l~~L~~L~L~~n~i~~~~p----~~l~~l   73 (1027)
                      .++.+.+.++.+....-.   .+..+++|++|++++|.+++..|..+  +.+++|++|+|++|++++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            467888888877532111   12345779999999999999999888  899999999999999986555    445679


Q ss_pred             CCCCEEEccCcccCCccCccccCCCCCCeEeCCccccccc--ch-hhhhcCCCCCcEEEccCCcCCccCcc---cccCCC
Q 048205           74 AELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGE--LL-ANICSNLPLLQTLFLDENNFDGKIPS---TLLRCK  147 (1027)
Q Consensus        74 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~-~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~  147 (1027)
                      ++|++|+|++|++.+..+..|..+++|++|+|++|++.+.  ++ ...+..+++|++|+|++|+++...+.   .+..++
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~  224 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV  224 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence            9999999999999988889999999999999999998642  22 23346889999999999999733221   367889


Q ss_pred             CCcEEEccCCccccccCccccCC---CCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEE
Q 048205          148 HLQTLSLSINDFSGDIPKEIGNL---TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDL  224 (1027)
Q Consensus       148 ~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  224 (1027)
                      +|++|+|++|.+++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|++|+|++|+|++. |. +..+++|+.|
T Consensus       225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L  299 (310)
T 4glp_A          225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL  299 (310)
T ss_dssp             CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred             CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence            99999999999998778888777   69999999999999 5677664  7999999999999964 43 7888999999


Q ss_pred             EccCccCC
Q 048205          225 ELSFNSLT  232 (1027)
Q Consensus       225 ~Ls~N~l~  232 (1027)
                      +|++|+++
T Consensus       300 ~L~~N~l~  307 (310)
T 4glp_A          300 TLDGNPFL  307 (310)
T ss_dssp             ECSSTTTS
T ss_pred             ECcCCCCC
Confidence            99999997

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.87  E-value=7.2e-22  Score=209.46  Aligned_cols=209  Identities=18%  Similarity=0.186  Sum_probs=179.0

Q ss_pred             CCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccc-cceeCcccccCCCCCCEEEccC-cccCC
Q 048205           11 SNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK-LQGEIPEELGNLAELEELWLQN-NFLTG   88 (1027)
Q Consensus        11 ~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~-i~~~~p~~l~~l~~L~~L~L~~-N~l~~   88 (1027)
                      .++++ .+|. +.  ++|++|++++|++++..+..++.+++|++|+|++|+ +++..+..|.++++|++|++++ |++++
T Consensus        20 c~~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~   95 (239)
T 2xwt_C           20 CKDIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY   95 (239)
T ss_dssp             ECSCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE
T ss_pred             ccCcc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE
Confidence            33455 5666 44  489999999999997777789999999999999997 9877777899999999999999 99997


Q ss_pred             ccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCc---EEEccCC-cCCccCcccccCCCCCc-EEEccCCcccccc
Q 048205           89 TIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQ---TLFLDEN-NFDGKIPSTLLRCKHLQ-TLSLSINDFSGDI  163 (1027)
Q Consensus        89 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~  163 (1027)
                      ..+..|..+++|++|++++|++++ ++.  +..+++|+   +|++++| ++++..+..|.++++|+ +|++++|.++...
T Consensus        96 i~~~~f~~l~~L~~L~l~~n~l~~-lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~  172 (239)
T 2xwt_C           96 IDPDALKELPLLKFLGIFNTGLKM-FPD--LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQ  172 (239)
T ss_dssp             ECTTSEECCTTCCEEEEEEECCCS-CCC--CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEEC
T ss_pred             cCHHHhCCCCCCCEEeCCCCCCcc-ccc--cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccC
Confidence            777889999999999999999985 554  77888888   9999999 99988888999999999 9999999999544


Q ss_pred             CccccCCCCCcEEEccCcc-CCCCCChhccCC-CCCCeeeccccccCCCCCccccCCCCCCEEEccCcc
Q 048205          164 PKEIGNLTKLKYLHLDQNR-LQGEIPEELGNL-AELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNS  230 (1027)
Q Consensus       164 p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  230 (1027)
                      +..|.. ++|++|+|++|+ ++++.+..|..+ ++|++|++++|++++ +|..  .+++|+.|+++++.
T Consensus       173 ~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          173 GYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNTW  237 (239)
T ss_dssp             TTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC-
T ss_pred             HhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCcc
Confidence            445555 899999999995 997777889999 999999999999995 4544  67899999998764

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=9.6e-22  Score=216.67  Aligned_cols=206  Identities=28%  Similarity=0.381  Sum_probs=142.8

Q ss_pred             ecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccC
Q 048205            8 FLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLT   87 (1027)
Q Consensus         8 ~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~   87 (1027)
                      .+..+.+++.++  +..+++|++|++++|.++ .+| .+..+++|++|+|++|++++ ++. +..+++|++|+|++|+++
T Consensus        25 ~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~   98 (308)
T 1h6u_A           25 AAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLK   98 (308)
T ss_dssp             HTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCS
T ss_pred             HhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCC
Confidence            344455554332  456677888888888777 455 57777888888888888774 343 777888888888888877


Q ss_pred             CccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccc
Q 048205           88 GTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI  167 (1027)
Q Consensus        88 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  167 (1027)
                      +. + .+..+++|++|++++|++++ ++.  +..+++|++|++++|++++..+  +..+++|++|++++|.+++. +. +
T Consensus        99 ~~-~-~~~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l  169 (308)
T 1h6u_A           99 NV-S-AIAGLQSIKTLDLTSTQITD-VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-L  169 (308)
T ss_dssp             CC-G-GGTTCTTCCEEECTTSCCCC-CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-G
T ss_pred             Cc-h-hhcCCCCCCEEECCCCCCCC-chh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-h
Confidence            43 3 57777888888888887764 322  6677777777777777775433  77777777777777777743 32 7


Q ss_pred             cCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          168 GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       168 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      ..+++|+.|++++|++++..+  +..+++|++|+|++|++++..  .+..+++|+.|++++|.++
T Consensus       170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            777777777777777775433  677777777777777777443  3677777777777777775

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=4.4e-23  Score=231.08  Aligned_cols=250  Identities=17%  Similarity=0.162  Sum_probs=136.4

Q ss_pred             ccceeccCcccccccCcccccc--CCcceEEccCccccccCCCCccCCCCCccEEEccccccCCc-CcccccCCCCCCee
Q 048205          317 LEWMIFSFNKLVGVVPTTIFNV--STLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGT-IPSFIFNTSKLSTL  393 (1027)
Q Consensus       317 L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L  393 (1027)
                      ++.+++++|.+.   +..+..+  .+++.|++++|.+.+..+. . ..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~-~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-H-FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-C-CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-h-ccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            444555555443   2333444  4555666666655444333 1 2455666666666665543 55555556666666


Q ss_pred             ecCCCcccCCCCcccCCcccccEEecCCC-CCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeec
Q 048205          394 ELQRNSFSGFIPNTFGNLRNLKWLDLGDN-YLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHM  472 (1027)
Q Consensus       394 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l  472 (1027)
                      +|++|.+++..+..|+.+++|++|+|++| .++.                                              
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~----------------------------------------------  157 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE----------------------------------------------  157 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH----------------------------------------------
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCH----------------------------------------------
Confidence            66666655555555555555555555555 2221                                              


Q ss_pred             CCCccccccCcccccccccceEEecCc-cccCc-hhHhhhccc-ccceeeccCceeecccCCCCCccccccccCcccccc
Q 048205          473 PNSNISGSIPKEINNLTNLIAIYLGVN-KLNGS-ILIALGKLK-KLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNL  549 (1027)
Q Consensus       473 ~~n~~~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l  549 (1027)
                            ..+|..++++++|++|++++| ++++. ++..+..++ +|++|+|++|.+                        
T Consensus       158 ------~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~------------------------  207 (336)
T 2ast_B          158 ------FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK------------------------  207 (336)
T ss_dssp             ------HHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG------------------------
T ss_pred             ------HHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcc------------------------
Confidence                  012233344445555555555 44432 344455555 555555555521                        


Q ss_pred             CcccEEecCCCccc-cCccccccCcccccEEcccccc-cccccchhhccCccccEEEccCCccccCccc---cccccccc
Q 048205          550 KDILCLNLSLNFFT-GPLPLEIGNLKVLVQIDLSINN-FSDVIPTTIGGLKDLQYLFLKYNRLQGSIPD---SIGDMINL  624 (1027)
Q Consensus       550 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~n~-l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~---~~~~l~~L  624 (1027)
                                 .++ +.+|..++.+++|+.|++++|. +++..+..++.+++|++|+|++|.  +..|.   .++.+++|
T Consensus       208 -----------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L  274 (336)
T 2ast_B          208 -----------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTL  274 (336)
T ss_dssp             -----------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTC
T ss_pred             -----------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCC
Confidence                       222 2345555566666777777766 555666667777777777777774  12233   46667777


Q ss_pred             cccccccccccCCchhhhhccc-CCcceeccCCCCCCCCCC
Q 048205          625 KSLNLSNNNLFGIIPISLEKLL-DLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       625 ~~L~l~~N~l~~~~p~~l~~l~-~L~~l~l~~N~l~g~~p~  664 (1027)
                      +.|+|++| ++.   ..+..+. .+..|++++|+++|.+|.
T Consensus       275 ~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~  311 (336)
T 2ast_B          275 KTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARP  311 (336)
T ss_dssp             CEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred             CEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCC
Confidence            77777777 322   2344442 366777888888887775

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=2.2e-21  Score=207.34  Aligned_cols=179  Identities=22%  Similarity=0.220  Sum_probs=105.9

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      .++++++++.++ .+|..+.  +.++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            344555555554 4444443  3455555555555544444455555555555555555444444444444444444444


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |                         ++++..+..|..+++|++|+|++|.|++..+..|..+++|++|+|++|++++..
T Consensus        93 n-------------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  147 (251)
T 3m19_A           93 N-------------------------QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP  147 (251)
T ss_dssp             S-------------------------CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             C-------------------------cccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence            4                         444455555666666666666666666555555666777777777777777555


Q ss_pred             ChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCC
Q 048205          188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN  234 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  234 (1027)
                      +..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++.
T Consensus       148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            55677777777777777777766666677777777777777777654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=6.6e-22  Score=222.45  Aligned_cols=170  Identities=21%  Similarity=0.163  Sum_probs=80.1

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccC-ccccCCCCCCe-EeCC
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIP-SSIFNLSSLSN-LDLS  106 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~-L~Ls  106 (1027)
                      +++++++++++ .+|..+.  +++++|+|++|+|+...+++|+++++|++|+|++|++.+.+| ..|.+++++++ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            45666666666 5555542  455666666666654333455555555555555555543333 23444544443 3333


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccC-ccCCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ-NRLQG  185 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~  185 (1027)
                      +|++                         +.+.|..|..+++|++|++++|.++...+..+....++..|++.+ |++..
T Consensus        89 ~N~l-------------------------~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~  143 (350)
T 4ay9_X           89 ANNL-------------------------LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT  143 (350)
T ss_dssp             ETTC-------------------------CEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCE
T ss_pred             CCcc-------------------------cccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccc
Confidence            4444                         434444444444555555555544433333344444444444433 33443


Q ss_pred             CCChhccCCC-CCCeeeccccccCCCCCccccCCCCCCEEEcc
Q 048205          186 EIPEELGNLA-ELEKLQLQNNFLTGTIPPSIFNLSSLSDLELS  227 (1027)
Q Consensus       186 ~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  227 (1027)
                      +.+..|..+. .++.|+|++|+|+ .+|...+...+|+.|+++
T Consensus       144 l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~  185 (350)
T 4ay9_X          144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS  185 (350)
T ss_dssp             ECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECT
T ss_pred             ccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhc
Confidence            3333343332 3444555555554 233333333444455544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=4.2e-21  Score=205.06  Aligned_cols=179  Identities=24%  Similarity=0.251  Sum_probs=140.0

Q ss_pred             CCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc
Q 048205            3 NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ   82 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~   82 (1027)
                      ..++++++++.++ .+|..+.  +++++|+|++|.+++..+..++.+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            4688999999999 5776665  789999999999998888899999999999999999998888889999999999999


Q ss_pred             CcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccc
Q 048205           83 NNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD  162 (1027)
Q Consensus        83 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  162 (1027)
                      +|++++..+..|..+++|++|+|++|+++ .++...+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++.
T Consensus        92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           92 NNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            99999877788889999999999999887 45555556666666666666666655555566666666666666666555


Q ss_pred             cCccccCCCCCcEEEccCccCCC
Q 048205          163 IPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       163 ~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      .+..|..+++|++|+|++|.+++
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeC
Confidence            45555555556666666555553

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.2e-22  Score=218.03  Aligned_cols=152  Identities=16%  Similarity=0.113  Sum_probs=121.8

Q ss_pred             HHHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccc------------------hhHHHHHHHHHHHhhcc
Q 048205          743 LELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG------------------RAIKSFDIECGMIKRIR  804 (1027)
Q Consensus       743 ~~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~  804 (1027)
                      .........|+..+.||+|+||.||+|++.+|+.||||+++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344455566778899999999999999997799999999864321                  13456889999999999


Q ss_pred             CCccceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 048205          805 HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  884 (1027)
Q Consensus       805 h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  884 (1027)
                        | +++++++.. +..++||||++||+|.+ +..       .....++.|+++|++|||   +.||+||||||+||+++
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence              4 566665544 45699999999999988 422       124469999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCcccccCCCcceecccccCccccCccccc
Q 048205          885 DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR  925 (1027)
Q Consensus       885 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  925 (1027)
                       ++.+||+|||+|+.               +..|+|||++.
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence             99999999999872               23478899765

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=3.4e-21  Score=212.32  Aligned_cols=197  Identities=24%  Similarity=0.304  Sum_probs=171.6

Q ss_pred             CCCCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEE
Q 048205            1 LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELW   80 (1027)
Q Consensus         1 l~~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~   80 (1027)
                      +++|++|++++|.++. ++ .+..+++|++|+|++|.+++ ++. +..+++|++|+|++|++++ ++ .+..+++|++|+
T Consensus        40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~  113 (308)
T 1h6u_A           40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLD  113 (308)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEE
T ss_pred             cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEE
Confidence            3579999999999985 45 68999999999999999995 454 9999999999999999984 44 699999999999


Q ss_pred             ccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccc
Q 048205           81 LQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS  160 (1027)
Q Consensus        81 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  160 (1027)
                      +++|++++. + .+..+++|++|++++|++++. +.  +..+++|++|++++|++++..+  +..+++|+.|++++|.++
T Consensus       114 l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~-~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~  186 (308)
T 1h6u_A          114 LTSTQITDV-T-PLAGLSNLQVLYLDLNQITNI-SP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS  186 (308)
T ss_dssp             CTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-GG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCc-h-hhcCCCCCCEEECCCCccCcC-cc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence            999999964 4 399999999999999999853 33  7889999999999999996544  999999999999999998


Q ss_pred             cccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccc
Q 048205          161 GDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSI  215 (1027)
Q Consensus       161 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  215 (1027)
                      +..+  +..+++|++|+|++|++++..  .+..+++|+.|++++|.+++ .|..+
T Consensus       187 ~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~-~~~~~  236 (308)
T 1h6u_A          187 DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN-QPVFY  236 (308)
T ss_dssp             CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC-CCEEC
T ss_pred             cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec-CCeee
Confidence            6543  899999999999999999655  38999999999999999984 44433

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=2.8e-21  Score=217.34  Aligned_cols=206  Identities=20%  Similarity=0.235  Sum_probs=129.5

Q ss_pred             cEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccc
Q 048205          174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKF  253 (1027)
Q Consensus       174 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~  253 (1027)
                      +.++.++++++ .+|..+  .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+              .+|.. 
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~--------------~i~~~-   73 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE--------------VIEAD-   73 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC--------------EECTT-
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC--------------ccChh-
Confidence            34555666665 344433  2355555666665553333445555555555555555531              12222 


Q ss_pred             cCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccc-eeccCccccccCCccccCcCcccceeccCcccccccC
Q 048205          254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEK-LDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVP  332 (1027)
Q Consensus       254 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  332 (1027)
                                                      .|.++++++. +.+++|+|+.+.|..|..+++|++|++++|++..+.+
T Consensus        74 --------------------------------~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~  121 (350)
T 4ay9_X           74 --------------------------------VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD  121 (350)
T ss_dssp             --------------------------------SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC
T ss_pred             --------------------------------HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCc
Confidence                                            2344555443 4555667776777777777777777777777777766


Q ss_pred             ccccccCCcceEEccCccccccCCCCccCCCC-CccEEEccccccCCcCcccccCCCCCCeeecCC-CcccCCCCcccCC
Q 048205          333 TTIFNVSTLKFLYLGSNSFFGRLPSSADVRLP-NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR-NSFSGFIPNTFGN  410 (1027)
Q Consensus       333 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~  410 (1027)
                      ..+....++..|++.++.-...++...+..+. .+++|+|++|+|+ .+|...+...+|++|++++ |.++.+.++.|.+
T Consensus       122 ~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~  200 (350)
T 4ay9_X          122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG  200 (350)
T ss_dssp             CTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTT
T ss_pred             hhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhcc
Confidence            66666777777777654333456655554443 5778888888887 4555555667788888864 6676666667888


Q ss_pred             cccccEEecCCCCCCCCCCc
Q 048205          411 LRNLKWLDLGDNYLTSSTSE  430 (1027)
Q Consensus       411 l~~L~~L~L~~N~l~~~~~~  430 (1027)
                      +++|++|||++|+|+++|..
T Consensus       201 l~~L~~LdLs~N~l~~lp~~  220 (350)
T 4ay9_X          201 ASGPVILDISRTRIHSLPSY  220 (350)
T ss_dssp             EECCSEEECTTSCCCCCCSS
T ss_pred             CcccchhhcCCCCcCccChh
Confidence            88888888888888877764

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=1e-21  Score=231.90  Aligned_cols=189  Identities=24%  Similarity=0.298  Sum_probs=140.9

Q ss_pred             CCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccc
Q 048205          389 KLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSME  468 (1027)
Q Consensus       389 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~  468 (1027)
                      +|+.|+|++|++++ +|..+  .++|++|+|++|+|+.+| .       .+++|++|+|++|+|++++            
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~ip-~-------~l~~L~~L~Ls~N~l~~ip------------  116 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALISLP-E-------LPASLEYLDACDNRLSTLP------------  116 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSCCC-C-------CCTTCCEEECCSSCCSCCC------------
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcccc-c-------ccCCCCEEEccCCCCCCcc------------
Confidence            88888998888886 55544  377888888888888776 2       2467888888888777533            


Q ss_pred             eeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccc
Q 048205          469 DFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWN  548 (1027)
Q Consensus       469 ~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~  548 (1027)
                                    . +.+  +|++|+|++|++++ +|.   .+++|+.|+|++|+|++              +|.   .
T Consensus       117 --------------~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~--------------lp~---~  158 (571)
T 3cvr_A          117 --------------E-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM--------------LPE---L  158 (571)
T ss_dssp             --------------C-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC--------------CCC---C
T ss_pred             --------------h-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc--------------CCC---c
Confidence                          2 222  56666666666665 443   56777777777777742              333   3


Q ss_pred             cCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccc-------cEEEccCCccccCcccccccc
Q 048205          549 LKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDL-------QYLFLKYNRLQGSIPDSIGDM  621 (1027)
Q Consensus       549 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L-------~~L~L~~N~l~g~ip~~~~~l  621 (1027)
                      +++|++|+|++|.+++ +|. ++  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .||..++.+
T Consensus       159 l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l  229 (571)
T 3cvr_A          159 PTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSL  229 (571)
T ss_dssp             CTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGS
T ss_pred             CCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcC
Confidence            5677888888888876 676 65  78888888888887 6777 655  67       99999999999 699999999


Q ss_pred             ccccccccccccccCCchhhhhcccC
Q 048205          622 INLKSLNLSNNNLFGIIPISLEKLLD  647 (1027)
Q Consensus       622 ~~L~~L~l~~N~l~~~~p~~l~~l~~  647 (1027)
                      ++|+.|+|++|+|++.+|..+..++.
T Consensus       230 ~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          230 DPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             CCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            99999999999999999999888765

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=4.9e-21  Score=226.17  Aligned_cols=189  Identities=25%  Similarity=0.327  Sum_probs=148.2

Q ss_pred             CccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccE
Q 048205          365 NLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEY  444 (1027)
Q Consensus       365 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~  444 (1027)
                      +|+.|+|++|++++ +|..+.  ++|++|+|++|+|+. +|   ..+++|++|+|++|+|+.+|. +.       .+|++
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~ip~-l~-------~~L~~  124 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLSTLPE-LP-------ASLKH  124 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC-CC-------TTCCE
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCCcch-hh-------cCCCE
Confidence            89999999999986 777663  789999999999994 56   458999999999999999887 33       18999


Q ss_pred             eeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeeccCce
Q 048205          445 FSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQ  524 (1027)
Q Consensus       445 L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  524 (1027)
                      |+|++|+|+++++                             .+++|+.|+|++|++++ +|.   .+++|++|+|++|+
T Consensus       125 L~Ls~N~l~~lp~-----------------------------~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~  171 (571)
T 3cvr_A          125 LDVDNNQLTMLPE-----------------------------LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ  171 (571)
T ss_dssp             EECCSSCCSCCCC-----------------------------CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred             EECCCCcCCCCCC-----------------------------cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence            9999998875332                             34566777777777765 443   46677788888877


Q ss_pred             eecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccc-------cEEcccccccccccchhhccC
Q 048205          525 LEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVL-------VQIDLSINNFSDVIPTTIGGL  597 (1027)
Q Consensus       525 l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~ls~n~l~~~~p~~~~~l  597 (1027)
                      |++              +|. +.  ++|+.|+|++|.++ .+|. +..  +|       +.|+|++|+|+ .+|..++.+
T Consensus       172 L~~--------------lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l  229 (571)
T 3cvr_A          172 LTF--------------LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSL  229 (571)
T ss_dssp             CSC--------------CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGS
T ss_pred             CCC--------------cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcC
Confidence            743              333 33  67888888888888 5676 554  66       99999999998 689999999


Q ss_pred             ccccEEEccCCccccCcccccccccc
Q 048205          598 KDLQYLFLKYNRLQGSIPDSIGDMIN  623 (1027)
Q Consensus       598 ~~L~~L~L~~N~l~g~ip~~~~~l~~  623 (1027)
                      ++|+.|+|++|.|+|.+|..++.++.
T Consensus       230 ~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          230 DPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             CCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            99999999999999999998887765

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=4.1e-20  Score=191.34  Aligned_cols=181  Identities=22%  Similarity=0.252  Sum_probs=128.8

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      +.++++++.++ .+|..+.  ++|++|+|++|++++..+..|+.+++|++|++++|++++..+..|..+++|++|++++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCCC--CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            45666666666 4555443  56777777777777555555677777777777777777555556667777777777777


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCC
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIP  188 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  188 (1027)
                      +++ .++...+..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|.+.+   
T Consensus        87 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---  162 (208)
T 2o6s_A           87 QLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---  162 (208)
T ss_dssp             CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred             cCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec---
Confidence            776 4555566677777777777777776666677778888888888888876666667778888888888887663   


Q ss_pred             hhccCCCCCCeeeccccccCCCCCccccCCCC
Q 048205          189 EELGNLAELEKLQLQNNFLTGTIPPSIFNLSS  220 (1027)
Q Consensus       189 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  220 (1027)
                          .+++|++|+++.|+++|.+|..++.++.
T Consensus       163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence                3457788888888888888877776654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=4.5e-20  Score=191.05  Aligned_cols=181  Identities=23%  Similarity=0.321  Sum_probs=143.7

Q ss_pred             cEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCC
Q 048205          261 EEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST  340 (1027)
Q Consensus       261 ~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  340 (1027)
                      +.++.+++.++          .+|..+  .++|++|++++|+++++.+..|..+++|++|++++|+++++.+..|.++++
T Consensus        10 ~~v~c~~~~l~----------~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~   77 (208)
T 2o6s_A           10 TTVECYSQGRT----------SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS   77 (208)
T ss_dssp             TEEECCSSCCS----------SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred             CEEEecCCCcc----------CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCC
Confidence            45666666665          344433  357888999999988877778888899999999999988887777888888


Q ss_pred             cceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecC
Q 048205          341 LKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG  420 (1027)
Q Consensus       341 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  420 (1027)
                      |++|++++|++. .++...+..+++|++|+|++|++++..+..|.++++|++|++++|+++++.+..|..+++|++|+++
T Consensus        78 L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  156 (208)
T 2o6s_A           78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH  156 (208)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             cCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEec
Confidence            999999988886 5566666678889999999999887767678888899999999999988777778888999999999


Q ss_pred             CCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCccc
Q 048205          421 DNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQ  465 (1027)
Q Consensus       421 ~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  465 (1027)
                      +|.++.           .++.|++|+++.|++++.+|..++.++.
T Consensus       157 ~N~~~~-----------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          157 DNPWDC-----------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             SCCBCC-----------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CCCeec-----------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            987653           4567788888888888777777666544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=1.1e-21  Score=233.17  Aligned_cols=204  Identities=20%  Similarity=0.198  Sum_probs=112.6

Q ss_pred             cCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcc
Q 048205          385 FNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLS  464 (1027)
Q Consensus       385 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  464 (1027)
                      ..+++|+.|+|++|+++ .+|..++.+++|+.|++++|..      +.        .+.                     
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~------l~--------~l~---------------------  389 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWC------LL--------TII---------------------  389 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHH------HH--------HHH---------------------
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchh------hh--------hHH---------------------
Confidence            45667777777777776 5677777777787777766541      00        000                     


Q ss_pred             cccceeecCCCccccccCcccccccccceEE-ecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccC
Q 048205          465 QSMEDFHMPNSNISGSIPKEINNLTNLIAIY-LGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIP  543 (1027)
Q Consensus       465 ~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~-L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p  543 (1027)
                      ..     +..+++.+.+|..++++++|+.|+ ++.|.+.           +|+.+.+++|.+++              +|
T Consensus       390 ~l-----l~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-----------~L~~l~l~~n~i~~--------------l~  439 (567)
T 1dce_A          390 LL-----MRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-----------DLRSKFLLENSVLK--------------ME  439 (567)
T ss_dssp             HH-----HHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-----------HHHHHHHHHHHHHH--------------HH
T ss_pred             HH-----HHhcccccCCHHHHHHHHhcccCcchhhcccc-----------hhhhhhhhcccccc--------------cC
Confidence            00     001113345566666666666666 5554432           33344444444421              11


Q ss_pred             ccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccc
Q 048205          544 STLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIN  623 (1027)
Q Consensus       544 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~  623 (1027)
                      .     ..|+.|+|++|.+++ +|. ++.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++
T Consensus       440 ~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~  509 (567)
T 1dce_A          440 Y-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPR  509 (567)
T ss_dssp             H-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSS
T ss_pred             c-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCC
Confidence            1     125555555555554 454 555566666666666665 455556666666666666666653 55 5556666


Q ss_pred             ccccccccccccCCc-hhhhhcccCCcceeccCCCCCCCCCC
Q 048205          624 LKSLNLSNNNLFGII-PISLEKLLDLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       624 L~~L~l~~N~l~~~~-p~~l~~l~~L~~l~l~~N~l~g~~p~  664 (1027)
                      |+.|+|++|+|++.+ |..++.+++|+.|++++|++++.+|.
T Consensus       510 L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            666666666665554 55566666666666666666555543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=1.8e-19  Score=215.39  Aligned_cols=170  Identities=25%  Similarity=0.372  Sum_probs=81.5

Q ss_pred             ccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcE
Q 048205           48 NVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQT  127 (1027)
Q Consensus        48 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~  127 (1027)
                      .+++|+.|++++|.|+ .++ .+..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++ ++  .+..+++|++
T Consensus        41 ~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~  113 (605)
T 1m9s_A           41 ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS--SLKDLKKLKS  113 (605)
T ss_dssp             HHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT--TSTTCTTCCE
T ss_pred             cCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch--hhccCCCCCE
Confidence            3444444444444443 222 24444444444444444443222  4444444444444444442 11  2334444444


Q ss_pred             EEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeecccccc
Q 048205          128 LFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFL  207 (1027)
Q Consensus       128 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  207 (1027)
                      |+|++|++.+.  +.+..+++|+.|+|++|.+++.  ..|..+++|+.|+|++|++++..|  +..+++|+.|+|++|+|
T Consensus       114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i  187 (605)
T 1m9s_A          114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  187 (605)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence            44444444432  2355555555555555555532  345555555555555555554433  55555555555555555


Q ss_pred             CCCCCccccCCCCCCEEEccCccCC
Q 048205          208 TGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       208 ~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      ++.  +.+..+++|+.|+|++|.++
T Consensus       188 ~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          188 SDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             CBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             CCC--hHHccCCCCCEEEccCCcCc
Confidence            532  24555555555555555554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.79  E-value=8.6e-19  Score=191.23  Aligned_cols=186  Identities=24%  Similarity=0.355  Sum_probs=108.9

Q ss_pred             EEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCccc
Q 048205           30 NISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNN  109 (1027)
Q Consensus        30 ~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  109 (1027)
                      .+.+..+.+++..  .+..+++|+.|++++|.++ .++ .+..+++|++|+|++|++++..+  +..+++|++|++++|+
T Consensus        28 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~  101 (291)
T 1h6t_A           28 KDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK  101 (291)
T ss_dssp             HHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhcCCCccccc--chhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence            3344444444321  2345566666666666665 233 25566666666666666664333  6666666666666666


Q ss_pred             ccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCCh
Q 048205          110 LTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPE  189 (1027)
Q Consensus       110 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  189 (1027)
                      +++ ++  .+..+++|++|++++|++++.  +.+..+++|++|++++|.+++.  ..+..+++|++|+|++|++++..+ 
T Consensus       102 l~~-~~--~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-  173 (291)
T 1h6t_A          102 VKD-LS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-  173 (291)
T ss_dssp             CCC-GG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred             CCC-Ch--hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence            653 22  245556666666666666543  3466666666666666666643  456666666666666666665433 


Q ss_pred             hccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          190 ELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       190 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                       +..+++|++|++++|.|++ ++ .+..+++|+.|++++|+++
T Consensus       174 -l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          174 -LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             -GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             -hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence             6666666666666666664 23 3666666666666666665

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=3.9e-19  Score=193.99  Aligned_cols=186  Identities=28%  Similarity=0.390  Sum_probs=159.8

Q ss_pred             EecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCccc
Q 048205            7 LFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFL   86 (1027)
Q Consensus         7 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l   86 (1027)
                      +.+..+.+++..+  +..+++|++|++++|.++ .++ .+..+++|++|+|++|++++. +. +..+++|++|++++|.+
T Consensus        29 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l  102 (291)
T 1h6t_A           29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKV  102 (291)
T ss_dssp             HHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCC
T ss_pred             HHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcC
Confidence            3456666665433  567899999999999998 455 489999999999999999854 44 99999999999999999


Q ss_pred             CCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCcc
Q 048205           87 TGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE  166 (1027)
Q Consensus        87 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  166 (1027)
                      ++ ++ .+..+++|++|++++|++++ +  ..+..+++|++|++++|++++.  ..+..+++|++|++++|.+++..+  
T Consensus       103 ~~-~~-~l~~l~~L~~L~L~~n~i~~-~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--  173 (291)
T 1h6t_A          103 KD-LS-SLKDLKKLKSLSLEHNGISD-I--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--  173 (291)
T ss_dssp             CC-GG-GGTTCTTCCEEECTTSCCCC-C--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred             CC-Ch-hhccCCCCCEEECCCCcCCC-C--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--
Confidence            85 33 49999999999999999985 3  3577899999999999999976  689999999999999999996554  


Q ss_pred             ccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCC
Q 048205          167 IGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG  209 (1027)
Q Consensus       167 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  209 (1027)
                      +..+++|++|+|++|++++. + .+..+++|+.|++++|.++.
T Consensus       174 l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          174 LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            99999999999999999964 4 48999999999999999985

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=6.4e-19  Score=198.86  Aligned_cols=176  Identities=24%  Similarity=0.208  Sum_probs=101.1

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCccccc-CCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELG-NLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      +.++++++.++ .+|..+.  ..++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            56677777766 4665554  3466667777766655555565 666666666666666655555666666666666666


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |+|+                         ...+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..
T Consensus        98 N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~  152 (361)
T 2xot_A           98 NHLH-------------------------TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP  152 (361)
T ss_dssp             SCCC-------------------------EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred             CcCC-------------------------cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence            6665                         333444455555555555555555444555555555555555555555433


Q ss_pred             Chhc---cCCCCCCeeeccccccCCCCCccccCCCC--CCEEEccCccCC
Q 048205          188 PEEL---GNLAELEKLQLQNNFLTGTIPPSIFNLSS--LSDLELSFNSLT  232 (1027)
Q Consensus       188 p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~  232 (1027)
                      +..|   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|.+.
T Consensus       153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            3333   34556666666666666444445555554  366777777664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=8.9e-19  Score=209.41  Aligned_cols=185  Identities=29%  Similarity=0.413  Sum_probs=99.0

Q ss_pred             ecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccC
Q 048205            8 FLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLT   87 (1027)
Q Consensus         8 ~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~   87 (1027)
                      .+..+.+.+.++  +..+++|+.|+|++|.+. .+| .+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|.++
T Consensus        27 ~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~  100 (605)
T 1m9s_A           27 NLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK  100 (605)
T ss_dssp             HTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             hccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC
Confidence            344444443322  345555555666655555 233 35555566666666665553322  555555666666666555


Q ss_pred             CccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccc
Q 048205           88 GTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI  167 (1027)
Q Consensus        88 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  167 (1027)
                      + +| .+..+++|++|+|++|++++ +  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|.|++..|  +
T Consensus       101 ~-l~-~l~~l~~L~~L~Ls~N~l~~-l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l  171 (605)
T 1m9s_A          101 D-LS-SLKDLKKLKSLSLEHNGISD-I--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L  171 (605)
T ss_dssp             C-CT-TSTTCTTCCEEECTTSCCCC-C--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G
T ss_pred             C-Ch-hhccCCCCCEEEecCCCCCC-C--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--h
Confidence            3 22 45555556666666665553 2  2244555566666666655543  455555566666666665554433  5


Q ss_pred             cCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCC
Q 048205          168 GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG  209 (1027)
Q Consensus       168 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  209 (1027)
                      ..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+.+
T Consensus       172 ~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          172 AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             TTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             ccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence            5555666666666655542  245555556666666665553

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=1.6e-18  Score=180.67  Aligned_cols=152  Identities=24%  Similarity=0.290  Sum_probs=92.5

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      +.++++++.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            56777777777 5666554  56777777777777666667777777777777777777666777777777777777777


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCC
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQ  184 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  184 (1027)
                      +|+ .++...|.++++|++|+|++|+|++..+..|..+++|++|+|++|.|++..+..|..+++|++|+|++|.+.
T Consensus        91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            776 444444555555555555555555444445555555555555555554444444444444444444444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.77  E-value=1.7e-18  Score=180.42  Aligned_cols=153  Identities=24%  Similarity=0.244  Sum_probs=104.3

Q ss_pred             EEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCC
Q 048205           78 ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN  157 (1027)
Q Consensus        78 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  157 (1027)
                      .+++++|.++ .+|..+.  ..+++|+|++|++++..+...+..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            4555555554 3343332  234556666666553333444555666666666666666666667777777777777777


Q ss_pred             ccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCC
Q 048205          158 DFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTG  233 (1027)
Q Consensus       158 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  233 (1027)
                      .+++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+++
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            7776666677777777788888887777777777777888888888888877767777788888888888887764

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=1.6e-18  Score=180.68  Aligned_cols=154  Identities=20%  Similarity=0.262  Sum_probs=133.7

Q ss_pred             cEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCC
Q 048205          261 EEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVST  340 (1027)
Q Consensus       261 ~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  340 (1027)
                      +.++.++|.++          .+|..+.  ++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|+++.|..|.++++
T Consensus        14 ~~v~c~~~~l~----------~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~   81 (220)
T 2v9t_B           14 NIVDCRGKGLT----------EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS   81 (220)
T ss_dssp             TEEECTTSCCS----------SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSS
T ss_pred             CEEEcCCCCcC----------cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcC
Confidence            56777777776          4555443  68899999999999888889999999999999999999998999999999


Q ss_pred             cceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecC
Q 048205          341 LKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG  420 (1027)
Q Consensus       341 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  420 (1027)
                      |++|+|++|++. .+|...+..+++|++|+|++|++++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus        82 L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  160 (220)
T 2v9t_B           82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA  160 (220)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeC
Confidence            999999999996 6777777788999999999999998888889999999999999999998888889999999999999


Q ss_pred             CCCCCCC
Q 048205          421 DNYLTSS  427 (1027)
Q Consensus       421 ~N~l~~~  427 (1027)
                      +|+++..
T Consensus       161 ~N~~~c~  167 (220)
T 2v9t_B          161 QNPFICD  167 (220)
T ss_dssp             SSCEECS
T ss_pred             CCCcCCC
Confidence            9987653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.76  E-value=3.9e-18  Score=177.71  Aligned_cols=153  Identities=20%  Similarity=0.222  Sum_probs=84.9

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCc-ccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIP-EELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            35566666655 3554443  334555555555554433 2345555555555555555544444555555555555555


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |+++                         +..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|++++..
T Consensus        91 N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  145 (220)
T 2v70_A           91 NRLE-------------------------NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA  145 (220)
T ss_dssp             SCCC-------------------------CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred             CccC-------------------------ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence            5554                         444455555556666666666665555555666666666666666666555


Q ss_pred             ChhccCCCCCCeeeccccccCC
Q 048205          188 PEELGNLAELEKLQLQNNFLTG  209 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~  209 (1027)
                      |..|..+++|++|+|++|.+..
T Consensus       146 ~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A          146 PGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             TTTTTTCTTCCEEECCSCCEEC
T ss_pred             HHHhcCCCCCCEEEecCcCCcC
Confidence            5666666666666666666654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.8e-20  Score=222.75  Aligned_cols=171  Identities=18%  Similarity=0.188  Sum_probs=136.8

Q ss_pred             ccCcccccccccceEEecCcc-------------ccCchhHhhhcccccceee-ccCceeecccCCCCCccccccccCcc
Q 048205          480 SIPKEINNLTNLIAIYLGVNK-------------LNGSILIALGKLKKLQLLS-LKDNQLEGSIPDNLSFSCTLTSIPST  545 (1027)
Q Consensus       480 ~~p~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~g~~p~~~~~~~~~~~~p~~  545 (1027)
                      .+|..++++++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|++                    
T Consensus       363 ~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--------------------  422 (567)
T 1dce_A          363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--------------------  422 (567)
T ss_dssp             HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--------------------
T ss_pred             hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--------------------
Confidence            566777777777777776664             5667777888888888887 666654                    


Q ss_pred             ccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccc
Q 048205          546 LWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLK  625 (1027)
Q Consensus       546 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~  625 (1027)
                          .+|..+.+++|.+++ +|.     ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+.+++|+
T Consensus       423 ----~~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~  489 (567)
T 1dce_A          423 ----DDLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLE  489 (567)
T ss_dssp             ----HHHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCC
T ss_pred             ----chhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCC
Confidence                234555667777775 332     248999999999996 787 999999999999999999 8999999999999


Q ss_pred             ccccccccccCCchhhhhcccCCcceeccCCCCCCCC-CC-CCCCCCcccccccCCccccCCC
Q 048205          626 SLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEI-PR-EGPFRNFSLESFKGNELLCGMP  686 (1027)
Q Consensus       626 ~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~-p~-~~~~~~~~~~~~~~n~~l~g~~  686 (1027)
                      .|+|++|+|++ +| .++.+++|+.|+|++|++++.+ |. -+.+.++......+|+ +++.|
T Consensus       490 ~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~-l~~~~  549 (567)
T 1dce_A          490 VLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS-LCQEE  549 (567)
T ss_dssp             EEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG-GGGSS
T ss_pred             EEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc-CCCCc
Confidence            99999999997 77 8999999999999999999996 64 3456666666777884 55544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.76  E-value=1.7e-18  Score=195.43  Aligned_cols=177  Identities=28%  Similarity=0.285  Sum_probs=139.3

Q ss_pred             CEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhc-CCCCCcEEEccCCcCCccCcccccCCCCCcEEEcc
Q 048205           77 EELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS-NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLS  155 (1027)
Q Consensus        77 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  155 (1027)
                      +.+++++|.++ .+|..+.  ..++.|+|++|+|+ .++...+. .+++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            45666666665 3454443  34666777777666 34444554 67777777777777777788889999999999999


Q ss_pred             CCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccc---cCCCCCCEEEccCccCC
Q 048205          156 INDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSI---FNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       156 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~  232 (1027)
                      +|.|++..+..|.++++|++|+|++|+|+++.|..|..+++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            999998888889999999999999999998889999999999999999999996544455   57999999999999998


Q ss_pred             CCCCcchhhhhhccccCCccccCCCcc--ccEEEeccccccc
Q 048205          233 GNFPKDMHIVNRLSAELPAKFCNNIPF--LEEIYLSKNMFYG  272 (1027)
Q Consensus       233 ~~~p~~~~~~~~~~~~l~~~~~~~l~~--L~~L~Ls~N~l~~  272 (1027)
                                     .+|...+..++.  ++.|+|++|.+..
T Consensus       177 ---------------~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          177 ---------------KLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             ---------------CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             ---------------ccCHHHhhhccHhhcceEEecCCCccC
Confidence                           444445555665  5899999999994

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=2.2e-19  Score=220.26  Aligned_cols=155  Identities=21%  Similarity=0.250  Sum_probs=75.8

Q ss_pred             ccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccC
Q 048205          486 NNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP  565 (1027)
Q Consensus       486 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~  565 (1027)
                      .++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+              .+|..++++++|++|+|++|.++ .
T Consensus       244 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~--------------~lp~~~~~l~~L~~L~L~~N~l~-~  307 (727)
T 4b8c_D          244 FKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT--------------SLPAELGSCFQLKYFYFFDNMVT-T  307 (727)
T ss_dssp             GGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS--------------SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred             cCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC--------------ccChhhcCCCCCCEEECCCCCCC-c
Confidence            34445555555555555 45555666666666666666652              44555666666666666666665 4


Q ss_pred             ccccccCcccccEEcccccccccccchhhccCcc-ccEEEccCCccccCccccccccccccccccccc--------cccC
Q 048205          566 LPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKD-LQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNN--------NLFG  636 (1027)
Q Consensus       566 ~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N--------~l~~  636 (1027)
                      +|..|+.+++|+.|+|++|.|++.+|..++.+.. +..|+|++|.++|.+|.+      |+.|++++|        .|.+
T Consensus       308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~  381 (727)
T 4b8c_D          308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQ  381 (727)
T ss_dssp             CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred             cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccc
Confidence            6666777777777777777777777776655422 234677777777777654      345556655        4444


Q ss_pred             CchhhhhcccCCcceeccCCCCCCCC
Q 048205          637 IIPISLEKLLDLKDINVSFNKLEGEI  662 (1027)
Q Consensus       637 ~~p~~l~~l~~L~~l~l~~N~l~g~~  662 (1027)
                      .++..+.++..+....+++|.+.+..
T Consensus       382 ~~~~~~~~l~~~~~~~ls~Nil~~~~  407 (727)
T 4b8c_D          382 STEHLATDLAKRTFTVLSYNTLCQHY  407 (727)
T ss_dssp             --------------------CCCGGG
T ss_pred             cccchhhcccccceeeeecccccccc
Confidence            44445556666666677777766443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.75  E-value=9.7e-18  Score=175.97  Aligned_cols=156  Identities=24%  Similarity=0.267  Sum_probs=131.0

Q ss_pred             ccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccC
Q 048205          260 LEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS  339 (1027)
Q Consensus       260 L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  339 (1027)
                      .+.++.+++.++          .+|..+.  ++|++|+|++|+|+++.|..|..+++|+.|+|++|+|..+.+..|.+++
T Consensus        21 ~~~v~c~~~~l~----------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~   88 (229)
T 3e6j_A           21 GTTVDCRSKRHA----------SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT   88 (229)
T ss_dssp             TTEEECTTSCCS----------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCEeEccCCCcC----------ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCC
Confidence            456777777776          4554443  7889999999999988888899999999999999999888888888899


Q ss_pred             CcceEEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEec
Q 048205          340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL  419 (1027)
Q Consensus       340 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  419 (1027)
                      +|++|+|++|++. .++...+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|+++.+..|..+++|+.|+|
T Consensus        89 ~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  166 (229)
T 3e6j_A           89 QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL  166 (229)
T ss_dssp             TCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEe
Confidence            9999999999886 566666678899999999999998 77888889999999999999999887788899999999999


Q ss_pred             CCCCCCCCCC
Q 048205          420 GDNYLTSSTS  429 (1027)
Q Consensus       420 ~~N~l~~~~~  429 (1027)
                      ++|+++....
T Consensus       167 ~~N~~~c~c~  176 (229)
T 3e6j_A          167 FGNPWDCECR  176 (229)
T ss_dssp             TTSCBCTTBG
T ss_pred             eCCCccCCcc
Confidence            9998876554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=3.5e-18  Score=174.96  Aligned_cols=157  Identities=18%  Similarity=0.215  Sum_probs=135.7

Q ss_pred             ccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccc
Q 048205          484 EINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFT  563 (1027)
Q Consensus       484 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~  563 (1027)
                      ..+.+.+|+.|++++|.++ .+| .+..+++|++|++++|+++               .+..+..+++|++|++++|.++
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~---------------~~~~l~~l~~L~~L~l~~n~l~  101 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT---------------NYNPISGLSNLERLRIMGKDVT  101 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS---------------CCGGGTTCTTCCEEEEECTTCB
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC---------------cchhhhcCCCCCEEEeECCccC
Confidence            3477889999999999998 455 6899999999999999763               2346788999999999999999


Q ss_pred             cCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhh
Q 048205          564 GPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLE  643 (1027)
Q Consensus       564 ~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~  643 (1027)
                      +..|..++.+++|+.|++++|++++..|..++.+++|++|+|++|++.+.+| .++.+++|++|++++|++++ +| .+.
T Consensus       102 ~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~  178 (197)
T 4ezg_A          102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIE  178 (197)
T ss_dssp             GGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGG
T ss_pred             cccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-Hhc
Confidence            8889999999999999999999998889999999999999999998334787 69999999999999999986 44 789


Q ss_pred             cccCCcceeccCCCCCC
Q 048205          644 KLLDLKDINVSFNKLEG  660 (1027)
Q Consensus       644 ~l~~L~~l~l~~N~l~g  660 (1027)
                      .+++|+.|++++|++.+
T Consensus       179 ~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          179 DFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             GCSSCCEEEECBC----
T ss_pred             cCCCCCEEEeeCcccCC
Confidence            99999999999999865

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.74  E-value=1.9e-17  Score=173.82  Aligned_cols=151  Identities=25%  Similarity=0.269  Sum_probs=70.0

Q ss_pred             EEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCC
Q 048205           54 GLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDEN  133 (1027)
Q Consensus        54 ~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N  133 (1027)
                      .++.++++++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|+++                      
T Consensus        23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~----------------------   77 (229)
T 3e6j_A           23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG----------------------   77 (229)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC----------------------
T ss_pred             EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC----------------------
Confidence            3444444443 3333332  44444555555444444444444444444444444443                      


Q ss_pred             cCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCc
Q 048205          134 NFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPP  213 (1027)
Q Consensus       134 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  213 (1027)
                         .+.+..|..+++|++|+|++|.|++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+.
T Consensus        78 ---~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~  153 (229)
T 3e6j_A           78 ---ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG  153 (229)
T ss_dssp             ---CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred             ---CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence               222333344444444444444444333333444444444444444444 3444444555555555555555544334


Q ss_pred             cccCCCCCCEEEccCccCCC
Q 048205          214 SIFNLSSLSDLELSFNSLTG  233 (1027)
Q Consensus       214 ~~~~l~~L~~L~Ls~N~l~~  233 (1027)
                      .|..+++|+.|++++|.+..
T Consensus       154 ~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          154 AFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             TTTTCTTCCEEECTTSCBCT
T ss_pred             HHhCCCCCCEEEeeCCCccC
Confidence            45555555555555555543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=8.1e-19  Score=215.31  Aligned_cols=154  Identities=23%  Similarity=0.195  Sum_probs=115.1

Q ss_pred             ccCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCC
Q 048205          480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSL  559 (1027)
Q Consensus       480 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~  559 (1027)
                      ..|..+..+.+|+.|+|++|++. .+|..+.++++|++|+|++|+|+              .+|..++++++|++|+|++
T Consensus       215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~--------------~lp~~~~~l~~L~~L~Ls~  279 (727)
T 4b8c_D          215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT--------------ELPAEIKNLSNLRVLDLSH  279 (727)
T ss_dssp             -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS--------------CCCGGGGGGTTCCEEECTT
T ss_pred             cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc--------------ccChhhhCCCCCCEEeCcC
Confidence            45677788888999999999888 67777778899999999998883              5677788888899999999


Q ss_pred             CccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccc-ccccccccccccCCc
Q 048205          560 NFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMIN-LKSLNLSNNNLFGII  638 (1027)
Q Consensus       560 N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~-L~~L~l~~N~l~~~~  638 (1027)
                      |.|+ .+|..|+.+++|+.|+|++|.|+ .+|.+|+.|++|++|+|++|.|+|.+|..++.+.. +..|+|++|.++|.+
T Consensus       280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~  357 (727)
T 4b8c_D          280 NRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL  357 (727)
T ss_dssp             SCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred             CcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence            9888 67888888888999999988886 68888888888999999999998888888766533 345788889888888


Q ss_pred             hhhhhcccCCcceeccCC
Q 048205          639 PISLEKLLDLKDINVSFN  656 (1027)
Q Consensus       639 p~~l~~l~~L~~l~l~~N  656 (1027)
                      |.++.      .|+++.|
T Consensus       358 p~~l~------~l~l~~n  369 (727)
T 4b8c_D          358 PHERR------FIEINTD  369 (727)
T ss_dssp             CCC---------------
T ss_pred             ccccc------eeEeecc
Confidence            86543      4455555

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=1.8e-18  Score=176.22  Aligned_cols=136  Identities=24%  Similarity=0.288  Sum_probs=78.6

Q ss_pred             cccEEecCCCccccCccc-cccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccccccc
Q 048205          551 DILCLNLSLNFFTGPLPL-EIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNL  629 (1027)
Q Consensus       551 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l  629 (1027)
                      +++.|++++|.+++..|. .++.+++|+.|+|++|++++..|..|+++++|++|+|++|+|++..|..|+.+++|++|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            555666666666553332 2566666666666666666655666666666666666666666555555666666666666


Q ss_pred             ccccccCCchhhhhcccCCcceeccCCCCCCCCCCCCCCCCcccccccCCccccCCC
Q 048205          630 SNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP  686 (1027)
Q Consensus       630 ~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g~~  686 (1027)
                      ++|++++.+|..+..+++|+.|++++|++.+..+.......+....+.++...|+.|
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            666666666666666666666666666666655431111111222344555556655

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=3.1e-18  Score=183.74  Aligned_cols=167  Identities=20%  Similarity=0.287  Sum_probs=85.9

Q ss_pred             CCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeC
Q 048205           26 KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDL  105 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  105 (1027)
                      .++..+++++|.+++ ++ .+..+++|++|++++|+|+ .++ .+..+++|++|+|++|++++..+  +..+++|++|++
T Consensus        19 ~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L   92 (263)
T 1xeu_A           19 ANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV   92 (263)
T ss_dssp             HHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred             HHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence            334444455555542 22 3444555555555555554 233 34444455555555555443222  444444444444


Q ss_pred             CcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCC
Q 048205          106 SVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       106 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      ++|++                         ++..+  +.. ++|++|+|++|.+++.  ..+..+++|++|+|++|++++
T Consensus        93 ~~N~l-------------------------~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A           93 NRNRL-------------------------KNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             CSSCC-------------------------SCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB
T ss_pred             CCCcc-------------------------CCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC
Confidence            44444                         43211  111 5566666666666532  245566666666666666654


Q ss_pred             CCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       186 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      . + .++.+++|++|+|++|++++.  ..+..+++|+.|++++|.++
T Consensus       143 ~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          143 I-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             C-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred             C-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence            3 2 455666666666666666644  45666666666666666665

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=1.9e-18  Score=185.46  Aligned_cols=168  Identities=21%  Similarity=0.231  Sum_probs=132.9

Q ss_pred             CCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc
Q 048205            3 NLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ   82 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~   82 (1027)
                      +++.+++++|.+++..  .+..+++|++|++++|.++ .+| .+..+++|++|+|++|+|++. +. +..+++|++|+|+
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~   93 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECC
Confidence            3566788999998654  5889999999999999998 566 799999999999999999954 44 9999999999999


Q ss_pred             CcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccc
Q 048205           83 NNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGD  162 (1027)
Q Consensus        83 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  162 (1027)
                      +|++++ +|.. .. ++|++|++++|++++ ++  .+..+++|++|++++|++++. + .+..+++|++|+|++|.+++.
T Consensus        94 ~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~--~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A           94 RNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD--SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             SSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG--GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCccCC-cCcc-cc-CcccEEEccCCccCC-Ch--hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            999995 4433 33 889999999999984 32  366777788888888887754 2 577777777777777777754


Q ss_pred             cCccccCCCCCcEEEccCccCCCC
Q 048205          163 IPKEIGNLTKLKYLHLDQNRLQGE  186 (1027)
Q Consensus       163 ~p~~~~~l~~L~~L~L~~N~l~~~  186 (1027)
                        ..+..+++|+.|++++|.++..
T Consensus       166 --~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          166 --GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             --TTSTTCCCCCEEEEEEEEEECC
T ss_pred             --HHhccCCCCCEEeCCCCcccCC
Confidence              5677777777777777777643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=7.5e-18  Score=180.19  Aligned_cols=137  Identities=20%  Similarity=0.235  Sum_probs=106.6

Q ss_pred             CCccceeeccccceEEEEEe-cCCce--EEEEEEecccch------------------------hHHHHHHHHHHHhhcc
Q 048205          752 FSENNLIGRGGFGFVYKARI-QDGME--VAVKVFDLQYGR------------------------AIKSFDIECGMIKRIR  804 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  804 (1027)
                      |++.+.||+|+||.||+|++ .+|+.  ||||+++.....                        ....+.+|++++++++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            66788999999999999998 68999  999997543111                        1136788999999999


Q ss_pred             CCcc--ceEEeEEecCCeeEEEEEecCC-C----CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 048205          805 HRNI--IKFISSCSSDDFKALVLEYMPY-G----SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  877 (1027)
Q Consensus       805 h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  877 (1027)
                      |+++  ..++++    ...++||||+.+ |    +|.++...    .++..+..++.|++.|++|||.  +.||+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8864  344432    356899999942 3    67765432    2344567899999999999993  4689999999


Q ss_pred             CCcEEEcCCCcEEEeeecCCccc
Q 048205          878 PNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       878 p~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999988  9999999999743

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.70  E-value=8.7e-18  Score=187.06  Aligned_cols=81  Identities=11%  Similarity=0.079  Sum_probs=47.5

Q ss_pred             ccCcCCccceeccCccccccCCccccCcCccc-ceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCC
Q 048205          287 IGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLE-WMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPN  365 (1027)
Q Consensus       287 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~  365 (1027)
                      |.++++|+.++|.+| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.+++++|++. .++..+|..+++
T Consensus       246 F~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~aF~~~~~  322 (329)
T 3sb4_A          246 FAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT-TLGDELFGNGVP  322 (329)
T ss_dssp             TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC-EECTTTTCTTCC
T ss_pred             hhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC-ccchhhhcCCcc
Confidence            444555555555555 5555555666666666 666655 555555666666666666666666553 555555666666


Q ss_pred             ccEEE
Q 048205          366 LEELS  370 (1027)
Q Consensus       366 L~~L~  370 (1027)
                      |+.++
T Consensus       323 L~~ly  327 (329)
T 3sb4_A          323 SKLIY  327 (329)
T ss_dssp             CCEEE
T ss_pred             hhhhc
Confidence            66654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.70  E-value=3.9e-17  Score=167.12  Aligned_cols=155  Identities=19%  Similarity=0.238  Sum_probs=132.6

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS  101 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  101 (1027)
                      ...+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|.+++..+..+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            467789999999999998 677 6999999999999999886  345789999999999999999987889999999999


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCc-CCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccC
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENN-FDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ  180 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  180 (1027)
                      +|++++|++++.. ...+..+++|++|++++|. ++. ++ .+..+++|++|++++|.+++ ++ .+..+++|++|++++
T Consensus       116 ~L~Ls~n~i~~~~-~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~  190 (197)
T 4ezg_A          116 LLDISHSAHDDSI-LTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS  190 (197)
T ss_dssp             EEECCSSBCBGGG-HHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred             EEEecCCccCcHh-HHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence            9999999998533 4566789999999999998 664 44 79999999999999999985 44 789999999999999


Q ss_pred             ccCCC
Q 048205          181 NRLQG  185 (1027)
Q Consensus       181 N~l~~  185 (1027)
                      |++.+
T Consensus       191 N~i~~  195 (197)
T 4ezg_A          191 QTIGG  195 (197)
T ss_dssp             C----
T ss_pred             cccCC
Confidence            99864

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.69  E-value=5.4e-17  Score=165.20  Aligned_cols=175  Identities=21%  Similarity=0.235  Sum_probs=115.8

Q ss_pred             ceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCc--cccccCcccEEecCCCccccCcccc
Q 048205          492 IAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPS--TLWNLKDILCLNLSLNFFTGPLPLE  569 (1027)
Q Consensus       492 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~  569 (1027)
                      +++++++|.++ .+|..+..  +|++|+|++|++++              ++.  .+..+++|++|+|++|.+++..|..
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~--------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~   73 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGR--------------ISSDGLFGRLPHLVKLELKRNQLTGIEPNA   73 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCS--------------BCCSCSGGGCTTCCEEECCSSCCCCBCTTT
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCc--------------cCCccccccCCCCCEEECCCCCCCCcCHhH
Confidence            44555555554 34443322  66777777777642              222  2566777777777777778777888


Q ss_pred             ccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCc
Q 048205          570 IGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLK  649 (1027)
Q Consensus       570 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~  649 (1027)
                      |+.+++|+.|+|++|++++..|..|+++++|++|+|++|+|++.+|..++.+++|++|+|++|++++..+...- ...++
T Consensus        74 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~-~~~l~  152 (192)
T 1w8a_A           74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLR  152 (192)
T ss_dssp             TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHH
T ss_pred             cCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHH-HHHHH
Confidence            88888888999999998887777788889999999999999888888888889999999999999887663210 11122


Q ss_pred             ceeccCCCCCCCCCCCCCCCCcccccccCCccccCCC
Q 048205          650 DINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMP  686 (1027)
Q Consensus       650 ~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g~~  686 (1027)
                      ...+..+.....-|.  .++.........+..-|..+
T Consensus       153 ~~~~~~~~~~C~~P~--~l~~~~l~~l~~~~~~C~~~  187 (192)
T 1w8a_A          153 KKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             HHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC
T ss_pred             HcCCCCCCCCCCCCh--HHcCCChhhCcHhhcCcCCC
Confidence            223333433333333  24444444555555556544

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.66  E-value=1.5e-16  Score=176.99  Aligned_cols=260  Identities=14%  Similarity=0.075  Sum_probs=152.1

Q ss_pred             CCCCcEEecCCCcCc--ccCCccCcCCCCCcEEEccCCcccccCCccccc--------cCCCcEEEccccccceeCcccc
Q 048205            1 LSNLEYLFLKSNMFH--GKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGN--------VTTLIGLHLRGNKLQGEIPEEL   70 (1027)
Q Consensus         1 l~~l~~L~l~~n~l~--~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~--------l~~L~~L~L~~n~i~~~~p~~l   70 (1027)
                      +++|++|||++|++.  ...+..+   +.++.+.+..|.|.   +.+|..        +++|+.|+|.+ +++...+.+|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred             hccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence            578999999999988  3333223   33566666666444   456666        89999999988 8887777889


Q ss_pred             cCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCccccc---ccchhhhhcCCCCCc-EEEccCCcCCccCcccc---
Q 048205           71 GNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLT---GELLANICSNLPLLQ-TLFLDENNFDGKIPSTL---  143 (1027)
Q Consensus        71 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~---~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~---  143 (1027)
                      .++++|++|++++|.+..+.+.+|..+.++..+.++.+...   ..+....|.++..|+ .+.+....   .++..+   
T Consensus       121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~  197 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKA  197 (329)
T ss_dssp             TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHT
T ss_pred             hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhc
Confidence            99999999999999888777788888888887777663320   123334455555665 44443221   111111   


Q ss_pred             -cCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCC
Q 048205          144 -LRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS  222 (1027)
Q Consensus       144 -~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  222 (1027)
                       ....+++.+.+.++-...........+++|+.|+|++|+++.+.+..|.++.+|+.|+|.+| ++.+.+.+|.++++|+
T Consensus       198 ~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~  276 (329)
T 3sb4_A          198 GLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA  276 (329)
T ss_dssp             TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             ccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence             12344445544443221111111112456666666666665444455666666666666655 5544445566666666


Q ss_pred             -EEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCC-ccccCcCCcccee
Q 048205          223 -DLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIP-KEIGNLAKLEKLD  297 (1027)
Q Consensus       223 -~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p-~~l~~l~~L~~L~  297 (1027)
                       .+++.+ .++               .++...|.++++|+.++++.|+++          .++ .+|.++++|+.++
T Consensus       277 ~~l~l~~-~l~---------------~I~~~aF~~c~~L~~l~l~~n~i~----------~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          277 GTLELPA-SVT---------------AIEFGAFMGCDNLRYVLATGDKIT----------TLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EEEEECT-TCC---------------EECTTTTTTCTTEEEEEECSSCCC----------EECTTTTCTTCCCCEEE
T ss_pred             EEEEEcc-cce---------------EEchhhhhCCccCCEEEeCCCccC----------ccchhhhcCCcchhhhc
Confidence             666655 443               455555666666666666666665          222 2455566666654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.62  E-value=9.5e-15  Score=165.91  Aligned_cols=263  Identities=16%  Similarity=0.159  Sum_probs=140.7

Q ss_pred             CCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEE
Q 048205          146 CKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLE  225 (1027)
Q Consensus       146 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  225 (1027)
                      +..++.+.+.++ ++.+...+|.+. +|+.+.+..| ++.+...+|.+ .+|+.+.+.+ .++.+.+.+|.++++|+.++
T Consensus       112 ~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          112 LKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             CSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             cCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            345555555532 333444555553 5666666554 44344445555 3466666654 44444445566666666666


Q ss_pred             ccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCccccc
Q 048205          226 LSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC  305 (1027)
Q Consensus       226 Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~  305 (1027)
                      ++.|+++               .++...|. ...|                                 +.+.|.. .++.
T Consensus       187 l~~n~l~---------------~I~~~aF~-~~~L---------------------------------~~l~lp~-~l~~  216 (401)
T 4fdw_A          187 LSKTKIT---------------KLPASTFV-YAGI---------------------------------EEVLLPV-TLKE  216 (401)
T ss_dssp             CTTSCCS---------------EECTTTTT-TCCC---------------------------------SEEECCT-TCCE
T ss_pred             cCCCcce---------------EechhhEe-eccc---------------------------------CEEEeCC-chhe
Confidence            6666554               33333333 2334                                 4444432 2443


Q ss_pred             cCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccC-----CcC
Q 048205          306 VIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFS-----GTI  380 (1027)
Q Consensus       306 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~  380 (1027)
                      +...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+.+ .+ ..++..+|..+++|+.+++.+|.+.     ...
T Consensus       217 I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~-~i-~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~  292 (401)
T 4fdw_A          217 IGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPN-GV-TNIASRAFYYCPELAEVTTYGSTFNDDPEAMIH  292 (401)
T ss_dssp             ECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEET-TC-CEECTTTTTTCTTCCEEEEESSCCCCCTTCEEC
T ss_pred             ehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCC-Cc-cEEChhHhhCCCCCCEEEeCCccccCCcccEEC
Confidence            44445555555555555443 44444445544 4555555532 23 2455555555556666666555443     244


Q ss_pred             cccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccc
Q 048205          381 PSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVI  460 (1027)
Q Consensus       381 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  460 (1027)
                      +..|.++++|+.++|. |.++.+...+|.++++|+.++|..| ++.+..    ..|.+| .|+.+++++|.+..+.+.+|
T Consensus       293 ~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~----~aF~~~-~L~~l~l~~n~~~~l~~~~F  365 (401)
T 4fdw_A          293 PYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF----SAFNNT-GIKEVKVEGTTPPQVFEKVW  365 (401)
T ss_dssp             TTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT----TSSSSS-CCCEEEECCSSCCBCCCSSC
T ss_pred             HHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH----HhCCCC-CCCEEEEcCCCCcccccccc
Confidence            4566666677777776 3466566667777777777777544 443332    334566 77777777777766666666


Q ss_pred             cCcccccceeecCC
Q 048205          461 GNLSQSMEDFHMPN  474 (1027)
Q Consensus       461 ~~l~~~l~~l~l~~  474 (1027)
                      .+++..+..+++..
T Consensus       366 ~~~~~~l~~l~vp~  379 (401)
T 4fdw_A          366 YGFPDDITVIRVPA  379 (401)
T ss_dssp             CCSCTTCCEEEECG
T ss_pred             cCCCCCccEEEeCH
Confidence            66554444444433

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=1.2e-15  Score=151.81  Aligned_cols=133  Identities=23%  Similarity=0.195  Sum_probs=76.3

Q ss_pred             CCCcEEEccCCccc-ccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEe
Q 048205           26 KRLRNISLSLNDFS-GTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLD  104 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~-~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  104 (1027)
                      ++|++|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            55666666666665 45666666666666666666666533  5566666666666666666654555555556666666


Q ss_pred             CCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccC---ccccCCCCCcEEEccCc
Q 048205          105 LSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIP---KEIGNLTKLKYLHLDQN  181 (1027)
Q Consensus       105 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N  181 (1027)
                      +++|++++....                        ..+..+++|++|++++|.+++..+   ..|..+++|++|++++|
T Consensus       102 Ls~N~l~~~~~~------------------------~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n  157 (168)
T 2ell_A          102 LSGNKLKDISTL------------------------EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR  157 (168)
T ss_dssp             CBSSSCCSSGGG------------------------GGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred             ccCCccCcchhH------------------------HHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence            666655531111                        445555555555555555553322   25555556666666665


Q ss_pred             cCC
Q 048205          182 RLQ  184 (1027)
Q Consensus       182 ~l~  184 (1027)
                      .+.
T Consensus       158 ~~~  160 (168)
T 2ell_A          158 EDQ  160 (168)
T ss_dssp             TSC
T ss_pred             Chh
Confidence            555

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=8.2e-16  Score=152.90  Aligned_cols=133  Identities=20%  Similarity=0.170  Sum_probs=97.4

Q ss_pred             cccceeeccCceee-cccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccc
Q 048205          513 KKLQLLSLKDNQLE-GSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIP  591 (1027)
Q Consensus       513 ~~L~~L~Ls~N~l~-g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p  591 (1027)
                      ++|++|+|++|+++ |             .+|..+..+++|++|++++|.+++.  ..++.+++|+.|++++|++++.+|
T Consensus        24 ~~L~~L~l~~n~l~~~-------------~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~   88 (168)
T 2ell_A           24 AAVRELVLDNCKSNDG-------------KIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLD   88 (168)
T ss_dssp             TSCSEEECCSCBCBTT-------------BCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCC
T ss_pred             ccCCEEECCCCCCChh-------------hHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHH
Confidence            55666666666663 2             3344455666667777777776654  667778888888888888887677


Q ss_pred             hhhccCccccEEEccCCccccCcc--ccccccccccccccccccccCCch---hhhhcccCCcceeccCCCCCCC
Q 048205          592 TTIGGLKDLQYLFLKYNRLQGSIP--DSIGDMINLKSLNLSNNNLFGIIP---ISLEKLLDLKDINVSFNKLEGE  661 (1027)
Q Consensus       592 ~~~~~l~~L~~L~L~~N~l~g~ip--~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~l~~L~~l~l~~N~l~g~  661 (1027)
                      ..++.+++|++|+|++|++++ +|  ..++.+++|++|+|++|++++..+   ..+..+++|+.|++++|.+...
T Consensus        89 ~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A           89 MLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             HHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             HHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            777778888888888888884 44  677888888888888888886655   4778888888888888887643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=1.5e-16  Score=175.84  Aligned_cols=137  Identities=14%  Similarity=0.098  Sum_probs=100.9

Q ss_pred             CCCccceeeccccceEEEEEecCCceEEEEEEecccch------------------h----HHHHHHHHHHHhhccCCcc
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGR------------------A----IKSFDIECGMIKRIRHRNI  808 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~----~~~~~~e~~~l~~l~h~ni  808 (1027)
                      =|++.+.||+|++|.||+|+..+|+.||||+++.....                  .    ......|...+.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38999999999999999999999999999997532100                  0    0112346677777765544


Q ss_pred             ceEEeEEecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-
Q 048205          809 IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-  887 (1027)
Q Consensus       809 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-  887 (1027)
                      ....-+...  ..++||||++|+++.++...       .....++.|++.++.|||   +.|||||||||.|||++++| 
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            322111111  23799999999888764321       123568899999999999   89999999999999998776 


Q ss_pred             ---------cEEEeeecCCcc
Q 048205          888 ---------VAHLSDFGMAKP  899 (1027)
Q Consensus       888 ---------~~kl~Dfgla~~  899 (1027)
                               .+.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     389999998764

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.61  E-value=2e-14  Score=163.20  Aligned_cols=269  Identities=12%  Similarity=0.154  Sum_probs=196.2

Q ss_pred             cCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEE
Q 048205           49 VTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTL  128 (1027)
Q Consensus        49 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L  128 (1027)
                      ...++.+.+.++ ++.....+|.++ +|+.+.+..| ++.+...+|.+ .+|+.+.+.. .++ .+....|.++++|+.+
T Consensus       112 ~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l  185 (401)
T 4fdw_A          112 LKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLE-QLKEDIFYYCYNLKKA  185 (401)
T ss_dssp             CSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCC-EECSSTTTTCTTCCEE
T ss_pred             cCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-Ccc-EehHHHhhCcccCCee
Confidence            456666666543 454556667764 6888887766 66555666666 4688888775 554 5666777788888888


Q ss_pred             EccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccC
Q 048205          129 FLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT  208 (1027)
Q Consensus       129 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  208 (1027)
                      ++.+|+++.+...+|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++
T Consensus       186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~  260 (401)
T 4fdw_A          186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT  260 (401)
T ss_dssp             ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred             ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence            8888888766667776 478888888744 66566777888888888888765 55455567777 77888888 45566


Q ss_pred             CCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCC-Cccc
Q 048205          209 GTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTI-PKEI  287 (1027)
Q Consensus       209 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~-p~~l  287 (1027)
                      .+...+|.++++|+.+++.+|.+...          ....++...|..+++|+.+++.+ .++          .+ ..+|
T Consensus       261 ~I~~~aF~~c~~L~~l~l~~~~~~~~----------~~~~I~~~aF~~c~~L~~l~l~~-~i~----------~I~~~aF  319 (401)
T 4fdw_A          261 NIASRAFYYCPELAEVTTYGSTFNDD----------PEAMIHPYCLEGCPKLARFEIPE-SIR----------ILGQGLL  319 (401)
T ss_dssp             EECTTTTTTCTTCCEEEEESSCCCCC----------TTCEECTTTTTTCTTCCEECCCT-TCC----------EECTTTT
T ss_pred             EEChhHhhCCCCCCEEEeCCccccCC----------cccEECHHHhhCCccCCeEEeCC-ceE----------EEhhhhh
Confidence            56667888888888888888776410          01246777888888888888884 354          22 2357


Q ss_pred             cCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccC-CcceEEccCccc
Q 048205          288 GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS-TLKFLYLGSNSF  351 (1027)
Q Consensus       288 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l  351 (1027)
                      .++++|+.++|..| ++.+...+|.++ +|+.+++++|.+..+.+..|.+++ +++.|++..+.+
T Consensus       320 ~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          320 GGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             TTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             cCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            77889999999554 777888899999 999999999999988888898884 788999988765

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.61  E-value=1.9e-14  Score=164.25  Aligned_cols=335  Identities=12%  Similarity=0.056  Sum_probs=217.8

Q ss_pred             ccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhh
Q 048205           38 FSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLAN  117 (1027)
Q Consensus        38 l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~  117 (1027)
                      ++.....+|..+.+|+.+.|..+ ++.....+|.++++|+.+++.++ ++.+...+|.++.+|+.+.+..+ +. .+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecce
Confidence            44344556667777777777643 55555666777777777777654 44455566777777777666544 32 34455


Q ss_pred             hhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCC
Q 048205          118 ICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAEL  197 (1027)
Q Consensus       118 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  197 (1027)
                      .|.+...+.......  +......+|.++++|+.+.+..+... ....+|.++.+|+.+.+..| ++.+....|.++..|
T Consensus       135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L  210 (394)
T 4fs7_A          135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL  210 (394)
T ss_dssp             TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred             eeecccccccccCcc--ccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence            565554443333222  22244567777788888887765433 55667777788888887766 443555677777788


Q ss_pred             CeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCC
Q 048205          198 EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSD  277 (1027)
Q Consensus       198 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  277 (1027)
                      +.+.+..+...  +.+.+....+|+.+.+..+. +               .+....|.....|+.+.+..+..+      
T Consensus       211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~---------------~i~~~~f~~~~~l~~~~~~~~~~~------  266 (394)
T 4fs7_A          211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-T---------------ELGKSVFYGCTDLESISIQNNKLR------  266 (394)
T ss_dssp             CBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-C---------------EECSSTTTTCSSCCEEEECCTTCE------
T ss_pred             ceeecCCCceE--eehhhcccCCCceEEECCCc-e---------------ecccccccccccceeEEcCCCcce------
Confidence            87777766543  23344555677777765332 2               445566677777777777766543      


Q ss_pred             CCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCC
Q 048205          278 LGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS  357 (1027)
Q Consensus       278 ~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  357 (1027)
                          .-...+..+..++.+....+.+   ....|..+.+|+.+.+..+ ++.+...+|.++.+|+.+++.++ + ..++.
T Consensus       267 ----i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v-~~I~~  336 (394)
T 4fs7_A          267 ----IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V-EEIGK  336 (394)
T ss_dssp             ----ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C-CEECT
T ss_pred             ----eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c-cEEhH
Confidence                1123455666777777666543   3456777888888888654 66677778888888888888654 3 46777


Q ss_pred             CccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEE
Q 048205          358 SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWL  417 (1027)
Q Consensus       358 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  417 (1027)
                      .+|..+.+|+.+++..| ++.+-..+|.++++|+.+++..+ ++ .+..+|.++++|+.+
T Consensus       337 ~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          337 RSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             HhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            88888888888888766 65455667888888888888755 33 235678888888765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=8.4e-16  Score=149.46  Aligned_cols=129  Identities=19%  Similarity=0.163  Sum_probs=97.8

Q ss_pred             ccccceeeccCceee-cccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEccccccccccc
Q 048205          512 LKKLQLLSLKDNQLE-GSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVI  590 (1027)
Q Consensus       512 l~~L~~L~Ls~N~l~-g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~  590 (1027)
                      .++|++|++++|+++ +             .+|..+..+++|++|++++|.+++.  ..++.+++|+.|++++|++++.+
T Consensus        16 ~~~l~~L~l~~n~l~~~-------------~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~   80 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEG-------------KLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGL   80 (149)
T ss_dssp             GGGCSEEECTTCBCBTT-------------BCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCT
T ss_pred             CccCeEEEccCCcCChh-------------HHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchH
Confidence            356666777776664 2             3444555667777777777777764  66778888888888888888778


Q ss_pred             chhhccCccccEEEccCCccccC-ccccccccccccccccccccccCCch---hhhhcccCCcceeccC
Q 048205          591 PTTIGGLKDLQYLFLKYNRLQGS-IPDSIGDMINLKSLNLSNNNLFGIIP---ISLEKLLDLKDINVSF  655 (1027)
Q Consensus       591 p~~~~~l~~L~~L~L~~N~l~g~-ip~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~l~~L~~l~l~~  655 (1027)
                      |..++.+++|++|++++|++++. .|..++.+++|++|++++|++++..+   ..+..+++|+.||+++
T Consensus        81 ~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             HHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             HHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            88888888888888888888852 34788888888889999888887766   5788888888888763

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.60  E-value=2e-15  Score=153.57  Aligned_cols=110  Identities=30%  Similarity=0.394  Sum_probs=76.1

Q ss_pred             CcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccccccc
Q 048205          550 KDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNL  629 (1027)
Q Consensus       550 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l  629 (1027)
                      ++++.|++++|.++ .+|..+..+++|+.|+|++|++++..|..|+++++|++|+|++|+|++..|..|+.+++|+.|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            35666666666666 46666777777777777777777655566777777777777777777655556777777777777


Q ss_pred             ccccccCCchhhhhcccCCcceeccCCCCCC
Q 048205          630 SNNNLFGIIPISLEKLLDLKDINVSFNKLEG  660 (1027)
Q Consensus       630 ~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g  660 (1027)
                      ++|+|++..+..+..+++|+.|++++|++..
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            7777775555566777777777777777654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.59  E-value=2e-15  Score=151.44  Aligned_cols=114  Identities=23%  Similarity=0.257  Sum_probs=82.6

Q ss_pred             CcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccccccc
Q 048205          550 KDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNL  629 (1027)
Q Consensus       550 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l  629 (1027)
                      ++|+.|++++|.+++..+..++.+++|+.|++++|++++..+..|+.+++|++|+|++|++++..|..++.+++|++|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            46677777777777655556677777777777777777555555677777888888888877555555677777888888


Q ss_pred             ccccccCCchhhhhcccCCcceeccCCCCCCCCC
Q 048205          630 SNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIP  663 (1027)
Q Consensus       630 ~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p  663 (1027)
                      ++|++++..+..+..+++|+.|++++|++.+.+|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            8887776555556777778888888887777665

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.59  E-value=2.2e-15  Score=146.49  Aligned_cols=127  Identities=20%  Similarity=0.194  Sum_probs=61.9

Q ss_pred             CCCcEEEccCCccc-ccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEe
Q 048205           26 KRLRNISLSLNDFS-GTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLD  104 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~-~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  104 (1027)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|++++.  ..++.+++|++|++++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            44555555555554 44444445555555555555555422  3444444555555555554443444444444444444


Q ss_pred             CCcccccccchhhhhcCCCCCcEEEccCCcCCcc-CcccccCCCCCcEEEccCCccccccC---ccccCCCCCcEEEcc
Q 048205          105 LSVNNLTGELLANICSNLPLLQTLFLDENNFDGK-IPSTLLRCKHLQTLSLSINDFSGDIP---KEIGNLTKLKYLHLD  179 (1027)
Q Consensus       105 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~  179 (1027)
                      +++|+++                         +. .+..+..+++|++|++++|.+++..+   ..+..+++|++|+++
T Consensus        95 ls~N~i~-------------------------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIK-------------------------DLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCC-------------------------SHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCC-------------------------ChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            4444444                         32 12445555555555555555554333   345555555555554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.58  E-value=6.5e-14  Score=159.84  Aligned_cols=336  Identities=13%  Similarity=0.063  Sum_probs=256.0

Q ss_pred             ccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCc
Q 048205           61 KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIP  140 (1027)
Q Consensus        61 ~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  140 (1027)
                      .++.....+|.++.+|+.+.+..+ ++.+...+|.++++|+.+++..+ ++ .+....|.++.+|+.+.+..+ +..+..
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~  133 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGV  133 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecc
Confidence            466677788999999999999854 77677789999999999999865 55 677889999999999887755 555677


Q ss_pred             ccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCC
Q 048205          141 STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSS  220 (1027)
Q Consensus       141 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  220 (1027)
                      .+|.++..+........  ......+|.++++|+.+.+.++..+ +....|.++.+|+.+++..| ++.+...+|.++..
T Consensus       134 ~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~  209 (394)
T 4fs7_A          134 EAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL  209 (394)
T ss_dssp             TTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred             eeeecccccccccCccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence            78888765554443333  2245678999999999999876543 66678999999999999887 55466678899999


Q ss_pred             CCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccC
Q 048205          221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQF  300 (1027)
Q Consensus       221 L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~  300 (1027)
                      |+.+.+..+...                +...++ ....|+.+.+..+.-.  +        -...+..+..|+.+.+..
T Consensus       210 L~~i~~~~~~~~----------------i~~~~~-~~~~l~~i~ip~~~~~--i--------~~~~f~~~~~l~~~~~~~  262 (394)
T 4fs7_A          210 LENMEFPNSLYY----------------LGDFAL-SKTGVKNIIIPDSFTE--L--------GKSVFYGCTDLESISIQN  262 (394)
T ss_dssp             CCBCCCCTTCCE----------------ECTTTT-TTCCCCEEEECTTCCE--E--------CSSTTTTCSSCCEEEECC
T ss_pred             cceeecCCCceE----------------eehhhc-ccCCCceEEECCCcee--c--------ccccccccccceeEEcCC
Confidence            999888766532                122222 2356788877644321  1        123466788999999987


Q ss_pred             ccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccCCcC
Q 048205          301 NRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTI  380 (1027)
Q Consensus       301 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  380 (1027)
                      +... +....|.....++.+.+..+.+   ....|.++.+|+.+.+..+ + ..++..+|..+.+|+.++|.++ ++.+-
T Consensus       263 ~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i-~~I~~~aF~~c~~L~~i~lp~~-v~~I~  335 (394)
T 4fs7_A          263 NKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-V-KFIGEEAFESCTSLVSIDLPYL-VEEIG  335 (394)
T ss_dssp             TTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-C-CEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred             Ccce-eeccccccccccceeccCceee---ccccccccccccccccccc-c-ceechhhhcCCCCCCEEEeCCc-ccEEh
Confidence            7544 7788899999999998887654   4467889999999999876 4 4788889999999999999754 66555


Q ss_pred             cccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEe
Q 048205          381 PSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYF  445 (1027)
Q Consensus       381 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L  445 (1027)
                      ..+|.++++|+.+++..| ++.+...+|.++.+|+.+++..+ ++.+     ...+.+|+.|+.+
T Consensus       336 ~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~~~-----~~~F~~c~~L~~I  393 (394)
T 4fs7_A          336 KRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LEQY-----RYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GGGG-----GGGBCTTCEEEEE
T ss_pred             HHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CEEh-----hheecCCCCCcEE
Confidence            778999999999999877 77788899999999999999765 3322     1246788888764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.58  E-value=8.4e-15  Score=148.89  Aligned_cols=128  Identities=30%  Similarity=0.309  Sum_probs=69.1

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            34555555555 4444332  34555555555554 44444555555555555555555444444444444444444444


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCC
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG  185 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  185 (1027)
                      +                         |+++.+..|.++++|++|+|++|.|+...+..|..+++|+.|+|++|.+..
T Consensus        89 ~-------------------------l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           89 R-------------------------LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             C-------------------------CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             c-------------------------cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            4                         444555556666666666666666665545556666666666666666653

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.58  E-value=7e-17  Score=165.41  Aligned_cols=151  Identities=22%  Similarity=0.313  Sum_probs=92.9

Q ss_pred             ccccceEEecCccccCchhH------hhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCc
Q 048205          488 LTNLIAIYLGVNKLNGSILI------ALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNF  561 (1027)
Q Consensus       488 l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~  561 (1027)
                      ...++.++++.|.++|.+|.      .+..+++|++|+|++|+++              .+| .+.++++|++|++++|.
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~--------------~l~-~~~~l~~L~~L~l~~n~   81 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE--------------KIS-SLSGMENLRILSLGRNL   81 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES--------------CCC-CHHHHTTCCEEEEEEEE
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc--------------ccc-ccccCCCCCEEECCCCC
Confidence            34445555555555555444      6666666666666666663              234 55566666666666666


Q ss_pred             cccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcc--ccccccccccccccccccccCCch
Q 048205          562 FTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP--DSIGDMINLKSLNLSNNNLFGIIP  639 (1027)
Q Consensus       562 l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip--~~~~~l~~L~~L~l~~N~l~~~~p  639 (1027)
                      ++ .+|..++.+++|+.|++++|++++ +| .++.+++|++|+|++|++++ +|  +.++.+++|++|++++|++++.+|
T Consensus        82 l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           82 IK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             EC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             cc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCccccccc
Confidence            66 356666666667777777777764 44 46666777777777777663 33  256666777777777777766655


Q ss_pred             hh----------hhcccCCcceeccCCCCC
Q 048205          640 IS----------LEKLLDLKDINVSFNKLE  659 (1027)
Q Consensus       640 ~~----------l~~l~~L~~l~l~~N~l~  659 (1027)
                      ..          +..+++|+.||  +|.++
T Consensus       158 ~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          158 ENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             TTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             cccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            42          66666676665  44443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.55  E-value=2.5e-14  Score=143.49  Aligned_cols=114  Identities=26%  Similarity=0.257  Sum_probs=81.3

Q ss_pred             CCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeec
Q 048205          123 PLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQL  202 (1027)
Q Consensus       123 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  202 (1027)
                      ++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            34555555555555555566677777777777777777655666777777888888888777666666777788888888


Q ss_pred             cccccCCCCCccccCCCCCCEEEccCccCCCCCC
Q 048205          203 QNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFP  236 (1027)
Q Consensus       203 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  236 (1027)
                      ++|++++..+..|..+++|++|++++|.+++..|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            8888875555556778888888888888775433

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=2.7e-16  Score=161.04  Aligned_cols=136  Identities=22%  Similarity=0.242  Sum_probs=118.6

Q ss_pred             cCcccccccccceEEecCccccCchhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCC
Q 048205          481 IPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLN  560 (1027)
Q Consensus       481 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N  560 (1027)
                      +|..++.+++|++|++++|++++ +| .+.++++|++|+|++|+++              .+|..+..+++|++|++++|
T Consensus        40 l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~--------------~l~~~~~~~~~L~~L~L~~N  103 (198)
T 1ds9_A           40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK--------------KIENLDAVADTLEELWISYN  103 (198)
T ss_dssp             CHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC--------------SCSSHHHHHHHCSEEEEEEE
T ss_pred             hhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc--------------cccchhhcCCcCCEEECcCC
Confidence            44489999999999999999997 66 9999999999999999984              56777778899999999999


Q ss_pred             ccccCccccccCcccccEEcccccccccccc-hhhccCccccEEEccCCccccCcccc----------cccccccccccc
Q 048205          561 FFTGPLPLEIGNLKVLVQIDLSINNFSDVIP-TTIGGLKDLQYLFLKYNRLQGSIPDS----------IGDMINLKSLNL  629 (1027)
Q Consensus       561 ~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~----------~~~l~~L~~L~l  629 (1027)
                      .+++ +| .++.+++|+.|++++|++++..+ ..++.+++|++|++++|.+++.+|..          +..+++|+.|| 
T Consensus       104 ~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld-  180 (198)
T 1ds9_A          104 QIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD-  180 (198)
T ss_dssp             ECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC-
T ss_pred             cCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC-
Confidence            9997 66 68899999999999999985322 47999999999999999999877764          88999999987 


Q ss_pred             ccccccC
Q 048205          630 SNNNLFG  636 (1027)
Q Consensus       630 ~~N~l~~  636 (1027)
                       +|.++.
T Consensus       181 -~~~i~~  186 (198)
T 1ds9_A          181 -GMPVDV  186 (198)
T ss_dssp             -CGGGTT
T ss_pred             -CcccCH
Confidence             777763

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.52  E-value=1.3e-14  Score=145.25  Aligned_cols=105  Identities=18%  Similarity=0.133  Sum_probs=67.5

Q ss_pred             cccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccc--cccccccccccc
Q 048205          551 DILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPD--SIGDMINLKSLN  628 (1027)
Q Consensus       551 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~--~~~~l~~L~~L~  628 (1027)
                      +|++|++++|.+++.  ..++.+++|+.|++++|++++..|..++.+++|++|+|++|+++ .+|.  .++.+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            555555555555542  45666667777777777776433344467777777777777775 5665  666777777777


Q ss_pred             cccccccCCchhh----hhcccCCcceeccCCCCC
Q 048205          629 LSNNNLFGIIPIS----LEKLLDLKDINVSFNKLE  659 (1027)
Q Consensus       629 l~~N~l~~~~p~~----l~~l~~L~~l~l~~N~l~  659 (1027)
                      |++|+++ .+|..    +..+++|+.||+++|..+
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            7777776 44543    667777777777776653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.49  E-value=4.9e-14  Score=141.13  Aligned_cols=134  Identities=20%  Similarity=0.236  Sum_probs=71.5

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccC-CCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVT-TLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSL  100 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~-~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  100 (1027)
                      +..+.+|++|++++|+++ .+|. +..+. +|++|+|++|+|++.  ..|+.+++|++|+|++|++++..+..+..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            455666666666666666 3443 33333 666666666666533  445555666666666666554333333555555


Q ss_pred             CeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCcc----ccCCCCCcEE
Q 048205          101 SNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE----IGNLTKLKYL  176 (1027)
Q Consensus       101 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L  176 (1027)
                      ++|++++|+++. ++.                       ...+..+++|++|++++|.+. .+|..    +..+++|++|
T Consensus        91 ~~L~L~~N~i~~-~~~-----------------------~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L  145 (176)
T 1a9n_A           91 TELILTNNSLVE-LGD-----------------------LDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL  145 (176)
T ss_dssp             CEEECCSCCCCC-GGG-----------------------GGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred             CEEECCCCcCCc-chh-----------------------hHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence            555555555542 221                       014555555555555555555 33432    5556666666


Q ss_pred             EccCccCC
Q 048205          177 HLDQNRLQ  184 (1027)
Q Consensus       177 ~L~~N~l~  184 (1027)
                      ++++|.+.
T Consensus       146 d~~~n~~~  153 (176)
T 1a9n_A          146 DFQKVKLK  153 (176)
T ss_dssp             TTEECCHH
T ss_pred             CCCcCCHH
Confidence            66665544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.44  E-value=1.5e-13  Score=136.45  Aligned_cols=108  Identities=20%  Similarity=0.195  Sum_probs=66.6

Q ss_pred             cEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccc
Q 048205          553 LCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNN  632 (1027)
Q Consensus       553 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N  632 (1027)
                      +.+++++|.++. +|..+.  ++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            455666666653 555442  55666666666666655666666666666666666666433344566666666666666


Q ss_pred             cccCCchhhhhcccCCcceeccCCCCCCCCC
Q 048205          633 NLFGIIPISLEKLLDLKDINVSFNKLEGEIP  663 (1027)
Q Consensus       633 ~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p  663 (1027)
                      +|++..|..+..+++|+.|++++|++.+..+
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            6665555556666666666666666665543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=3.1e-13  Score=134.23  Aligned_cols=109  Identities=21%  Similarity=0.178  Sum_probs=92.4

Q ss_pred             cceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhh
Q 048205          515 LQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI  594 (1027)
Q Consensus       515 L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~  594 (1027)
                      .+++++++|+|+              ++|..+.  ++|++|+|++|.+++..|..|+.+++|+.|+|++|+|++..|..|
T Consensus        11 ~~~l~~s~n~l~--------------~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f   74 (170)
T 3g39_A           11 GTTVDCSGKSLA--------------SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVF   74 (170)
T ss_dssp             TTEEECTTSCCS--------------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred             CCEEEeCCCCcC--------------ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhc
Confidence            467888888773              4555553  788999999999998888899999999999999999997666678


Q ss_pred             ccCccccEEEccCCccccCccccccccccccccccccccccCCch
Q 048205          595 GGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIP  639 (1027)
Q Consensus       595 ~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p  639 (1027)
                      +++++|++|+|++|+|++..|..|+.+++|+.|+|++|+++...+
T Consensus        75 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           75 DKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             cCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            999999999999999996555679999999999999999986644

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.41  E-value=3.1e-13  Score=134.71  Aligned_cols=107  Identities=21%  Similarity=0.254  Sum_probs=64.2

Q ss_pred             cEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccc
Q 048205          553 LCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNN  632 (1027)
Q Consensus       553 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N  632 (1027)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|+.+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45556666554 3555443  56666666666666555666666666666666666666432333456666666666666


Q ss_pred             cccCCchhhhhcccCCcceeccCCCCCCCC
Q 048205          633 NLFGIIPISLEKLLDLKDINVSFNKLEGEI  662 (1027)
Q Consensus       633 ~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~  662 (1027)
                      +|++..|..+..+++|+.|++++|++....
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence            666554445666666666666666665443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.39  E-value=5.6e-13  Score=132.77  Aligned_cols=112  Identities=21%  Similarity=0.174  Sum_probs=90.3

Q ss_pred             ceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhc
Q 048205          516 QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIG  595 (1027)
Q Consensus       516 ~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~  595 (1027)
                      +.+++++|++              +++|..+.  ++|++|+|++|.+++..|..|+.+++|+.|+|++|+|++..+..|+
T Consensus        15 ~~l~~~~n~l--------------~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~   78 (174)
T 2r9u_A           15 TLVNCQNIRL--------------ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFD   78 (174)
T ss_dssp             SEEECCSSCC--------------SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cEEEeCCCCC--------------CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhC
Confidence            5678888877              34555553  7888999999999988888999999999999999999975555679


Q ss_pred             cCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhc
Q 048205          596 GLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEK  644 (1027)
Q Consensus       596 ~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~  644 (1027)
                      .+++|++|+|++|+|++..|..|+.+++|++|+|++|++... |..+..
T Consensus        79 ~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~-~~~~~~  126 (174)
T 2r9u_A           79 KLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE-CRDIMY  126 (174)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTT-BGGGHH
T ss_pred             CcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccc-cccHHH
Confidence            999999999999999964444589999999999999999844 443333

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=3.3e-11  Score=137.35  Aligned_cols=336  Identities=10%  Similarity=0.120  Sum_probs=196.3

Q ss_pred             cceeCcccccCCC-CCCEEEccCcccCCccCccccCCCCCCeEeCCccc---ccccchhhhhcCCCCCcEEEccCCcCCc
Q 048205           62 LQGEIPEELGNLA-ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNN---LTGELLANICSNLPLLQTLFLDENNFDG  137 (1027)
Q Consensus        62 i~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~---l~~~~~~~~~~~l~~L~~L~L~~N~l~~  137 (1027)
                      ++.....+|.++. .|+.+.+..+ ++.+...+|.++++|+.+.++.|.   ++ .+....|.++.+|+.+.+.++ ++.
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~~  127 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VTE  127 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cce
Confidence            4444555677664 4788777654 555666777788888888877664   44 556667777777777766554 444


Q ss_pred             cCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccC
Q 048205          138 KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFN  217 (1027)
Q Consensus       138 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  217 (1027)
                      +...+|..+.+|+.+.+..+. .......|..+.+|+.+.+..+ ++.+...+|.+ ..|+.+.+..+-.. ....+|.+
T Consensus       128 I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~  203 (394)
T 4gt6_A          128 IDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSE  203 (394)
T ss_dssp             ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTT
T ss_pred             ehhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhh
Confidence            666677778888888876543 3355567777788888877655 33344445544 56777777665443 45566777


Q ss_pred             CCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCcccee
Q 048205          218 LSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLD  297 (1027)
Q Consensus       218 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~  297 (1027)
                      +.+++......+...               .+...++...........                    .+.....+..+.
T Consensus       204 c~~l~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~  248 (394)
T 4gt6_A          204 CFALSTITSDSESYP---------------AIDNVLYEKSANGDYALI--------------------RYPSQREDPAFK  248 (394)
T ss_dssp             CTTCCEEEECCSSSC---------------BSSSCEEEECTTSCEEEE--------------------ECCTTCCCSEEE
T ss_pred             ccccceecccccccc---------------cccceeeccccccccccc--------------------ccccccccceEE
Confidence            777777766655443               011111100000000000                    000111222232


Q ss_pred             ccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccEEEccccccC
Q 048205          298 LQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFS  377 (1027)
Q Consensus       298 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  377 (1027)
                      +. +.++.+...+|.++..|+.+.+..+. ..+...+|.++.+|+.+.+..+ + ..++..+|..+.+|+.++|..+ ++
T Consensus       249 ip-~~v~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~~~-i-~~I~~~aF~~c~~L~~i~lp~~-v~  323 (394)
T 4gt6_A          249 IP-NGVARIETHAFDSCAYLASVKMPDSV-VSIGTGAFMNCPALQDIEFSSR-I-TELPESVFAGCISLKSIDIPEG-IT  323 (394)
T ss_dssp             CC-TTEEEECTTTTTTCSSCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-C-CEECTTTTTTCTTCCEEECCTT-CC
T ss_pred             cC-CcceEcccceeeecccccEEeccccc-ceecCcccccccccccccCCCc-c-cccCceeecCCCCcCEEEeCCc-cc
Confidence            22 23444555667777777777776543 3456667777777877777533 3 3677777777778888888654 55


Q ss_pred             CcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCCccccccccccccccEeeccCCCC
Q 048205          378 GTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL  452 (1027)
Q Consensus       378 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l  452 (1027)
                      .+-..+|.++++|+.+.+..+ ++.+...+|.++++|+.+++.+|...       ...+..+..|+.+.+..|.+
T Consensus       324 ~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~-------~~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          324 QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ-------WNAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH-------HHTCBCCCCC----------
T ss_pred             EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee-------hhhhhccCCCCEEEeCCCCE
Confidence            444567777888888888644 66666777888888888888776521       11234566666666655543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.33  E-value=1.4e-10  Score=132.25  Aligned_cols=329  Identities=12%  Similarity=0.118  Sum_probs=181.3

Q ss_pred             CccccccC-CCcEEEccccccceeCcccccCCCCCCEEEccCcc---cCCccCccccCCCCCCeEeCCcccccccchhhh
Q 048205           43 PKEIGNVT-TLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNF---LTGTIPSSIFNLSSLSNLDLSVNNLTGELLANI  118 (1027)
Q Consensus        43 p~~i~~l~-~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~---l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~  118 (1027)
                      ..+|.+.. .|+.+.+..+ ++.....+|.++.+|+.+.++.|.   ++.+...+|..+.+|+.+.+..+ ++ .+....
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~a  132 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSEA  132 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTTT
T ss_pred             HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhhh
Confidence            34454443 4666666543 555566667777777777776653   54444566777777777666544 33 455666


Q ss_pred             hcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCC
Q 048205          119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELE  198 (1027)
Q Consensus       119 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  198 (1027)
                      |.++.+|+.+.+..+ +..+...+|..+.+|+.+.+..+ ++.....+|.. .+|+.+.+..+-.. +....|..+.++.
T Consensus       133 F~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~  208 (394)
T 4gt6_A          133 FHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALS  208 (394)
T ss_dssp             TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCC
T ss_pred             hhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccc
Confidence            777777777777644 34456667777777877777655 33344455654 56777777655433 4556677777777


Q ss_pred             eeeccccccCCCCCccccC-CCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCC
Q 048205          199 KLQLQNNFLTGTIPPSIFN-LSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSD  277 (1027)
Q Consensus       199 ~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  277 (1027)
                      ......+.... ....+.. ......-......                          ...+..+.+..+ ++.     
T Consensus       209 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~ip~~-v~~-----  255 (394)
T 4gt6_A          209 TITSDSESYPA-IDNVLYEKSANGDYALIRYPS--------------------------QREDPAFKIPNG-VAR-----  255 (394)
T ss_dssp             EEEECCSSSCB-SSSCEEEECTTSCEEEEECCT--------------------------TCCCSEEECCTT-EEE-----
T ss_pred             eeccccccccc-ccceeeccccccccccccccc--------------------------ccccceEEcCCc-ceE-----
Confidence            77666655542 2222211 1111111100000                          001111111100 000     


Q ss_pred             CCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCC
Q 048205          278 LGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPS  357 (1027)
Q Consensus       278 ~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  357 (1027)
                          .-..+|.++..|+.+.+..+.. .+...+|.++..|+.+.+. +.++.+...+|.++.+|+.+++..+ + ..+..
T Consensus       256 ----i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v-~~I~~  327 (394)
T 4gt6_A          256 ----IETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-I-TQILD  327 (394)
T ss_dssp             ----ECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-C-CEECT
T ss_pred             ----cccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-c-cEehH
Confidence                0012344455555555544332 2455566666777766664 4456666667777777777777654 3 35667


Q ss_pred             CccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCC
Q 048205          358 SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY  423 (1027)
Q Consensus       358 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  423 (1027)
                      .+|..+.+|+.+.|..+ ++.+-..+|.++++|+.+++.+|....   ..|....+|+.+.+..|.
T Consensus       328 ~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~  389 (394)
T 4gt6_A          328 DAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS  389 (394)
T ss_dssp             TTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred             hHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence            77777777777777544 554445677777888888887776542   456667777777776664

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.28  E-value=4.8e-13  Score=150.40  Aligned_cols=161  Identities=17%  Similarity=0.172  Sum_probs=112.9

Q ss_pred             ccccceEEecCccccCchhHhhhcc-----cccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCcc
Q 048205          488 LTNLIAIYLGVNKLNGSILIALGKL-----KKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFF  562 (1027)
Q Consensus       488 l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l  562 (1027)
                      +..|+.|+|++|.++......+..+     ++|++|+|++|++++..            +..-...+++|+.|+|++|.+
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~------------~~~l~~~L~~L~~L~Ls~n~l  138 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAG------------LRTLLPVFLRARKLGLQLNSL  138 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHH------------HHHTHHHHHTEEEEECCSSCC
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHH------------HHHHHHHHHhccHhhcCCCCC
Confidence            3567778888888776555555544     67888888888874321            111122355778888888888


Q ss_pred             ccCccccc-----cCcccccEEccccccccc----ccchhhccCccccEEEccCCcccc----Ccccccccccccccccc
Q 048205          563 TGPLPLEI-----GNLKVLVQIDLSINNFSD----VIPTTIGGLKDLQYLFLKYNRLQG----SIPDSIGDMINLKSLNL  629 (1027)
Q Consensus       563 ~~~~p~~~-----~~l~~L~~L~ls~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~g----~ip~~~~~l~~L~~L~l  629 (1027)
                      +..-...+     .....|++|+|++|.++.    .++..+..+++|++|+|++|.|+.    .++..+...++|+.|+|
T Consensus       139 ~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~L  218 (372)
T 3un9_A          139 GPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV  218 (372)
T ss_dssp             CHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEEC
T ss_pred             CHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEEC
Confidence            75433333     235678889999998864    255556778889999999998874    24666777788999999


Q ss_pred             ccccccCC----chhhhhcccCCcceeccCCCCCC
Q 048205          630 SNNNLFGI----IPISLEKLLDLKDINVSFNKLEG  660 (1027)
Q Consensus       630 ~~N~l~~~----~p~~l~~l~~L~~l~l~~N~l~g  660 (1027)
                      ++|+++..    ++..+...++|+.|||++|.++.
T Consensus       219 s~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          219 AYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             CSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             CCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            99998753    44556667889999999998764

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.28  E-value=2e-13  Score=153.41  Aligned_cols=159  Identities=21%  Similarity=0.179  Sum_probs=97.3

Q ss_pred             CCCCEEEccCcccCCccCccccC-----CCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccc-----
Q 048205           74 AELEELWLQNNFLTGTIPSSIFN-----LSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTL-----  143 (1027)
Q Consensus        74 ~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----  143 (1027)
                      +.|++|+|++|.++......+..     .++|++|+|++|.++......++..+++|++|+|++|.++......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            45667777777766433333222     25677777777777644444455555667777777777764433333     


Q ss_pred             cCCCCCcEEEccCCcccc----ccCccccCCCCCcEEEccCccCCCCC----ChhccCCCCCCeeeccccccCCC----C
Q 048205          144 LRCKHLQTLSLSINDFSG----DIPKEIGNLTKLKYLHLDQNRLQGEI----PEELGNLAELEKLQLQNNFLTGT----I  211 (1027)
Q Consensus       144 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~----~  211 (1027)
                      ...++|++|+|++|.|+.    .++..+..+++|++|+|++|.|+...    +..+...++|++|+|++|.|++.    +
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence            235677777777777753    23444566777777777777776422    34455666777777777777642    2


Q ss_pred             CccccCCCCCCEEEccCccCC
Q 048205          212 PPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       212 p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      +..+...++|++|+|++|.|+
T Consensus       232 ~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          232 ARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHHHHCSSCCEEECTTSSCC
T ss_pred             HHHHHhCCCCCEEeccCCCCC
Confidence            233445677777777777775

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=2.6e-11  Score=129.95  Aligned_cols=146  Identities=15%  Similarity=0.094  Sum_probs=114.5

Q ss_pred             HHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEE
Q 048205          746 FQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       746 ~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .....+|+.....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888999999999999754 6899999987533233346888999999885 67788999999988899999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG--------------------------------------  866 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  866 (1027)
                      |||++|.++.+....      ......++.+++++++.||..                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999875321      122346788999999999951                                      


Q ss_pred             ------------------CCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          867 ------------------YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       867 ------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                                        ....++|+|++|.||++++++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              01458999999999999876666799999775

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.21  E-value=1.3e-11  Score=138.22  Aligned_cols=94  Identities=19%  Similarity=0.189  Sum_probs=63.2

Q ss_pred             cccCccccccCcccEEecCC-CccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccc-
Q 048205          540 TSIPSTLWNLKDILCLNLSL-NFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDS-  617 (1027)
Q Consensus       540 ~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~-  617 (1027)
                      +.+|. +..+++|+.|+|++ |.+++..|..|+.+++|+.|+|++|+|++..|..|++|++|++|+|++|+|++ +|+. 
T Consensus        22 ~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~   99 (347)
T 2ifg_A           22 DSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKT   99 (347)
T ss_dssp             TTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTT
T ss_pred             CccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHH
Confidence            35666 66677777777775 77776555667777777777777777776666667777777777777777774 4433 


Q ss_pred             ccccccccccccccccccC
Q 048205          618 IGDMINLKSLNLSNNNLFG  636 (1027)
Q Consensus       618 ~~~l~~L~~L~l~~N~l~~  636 (1027)
                      +..+. |+.|+|++|++..
T Consensus       100 ~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A          100 VQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             TCSCC-CCEEECCSSCCCC
T ss_pred             cccCC-ceEEEeeCCCccC
Confidence            33343 7777777777763

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.14  E-value=7.1e-11  Score=132.20  Aligned_cols=102  Identities=20%  Similarity=0.195  Sum_probs=47.4

Q ss_pred             EecCCC-cCcccCCccCcCCCCCcEEEccC-CcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205            7 LFLKSN-MFHGKIPSTLSNCKRLRNISLSL-NDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus         7 L~l~~n-~l~~~~~~~~~~~~~L~~L~L~~-n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      ++.+++ +++ .+|. |..+++|++|+|++ |.|++..|..|+.+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            344444 444 2343 44444555555543 4554433344445555555555555554444444455555555555555


Q ss_pred             ccCCccCccccCCCCCCeEeCCccccc
Q 048205           85 FLTGTIPSSIFNLSSLSNLDLSVNNLT  111 (1027)
Q Consensus        85 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~  111 (1027)
                      +|++..+..|..++ |+.|+|++|.+.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            55433333333333 445555444443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.08  E-value=2.4e-10  Score=122.29  Aligned_cols=136  Identities=15%  Similarity=0.100  Sum_probs=101.0

Q ss_pred             CCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCc--cceEEeEEecCCeeEEEEEec
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN--IIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +|....+.+.|..+.||++...+|+.+++|+....   ....+..|+++++.+++.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443333466679999998777889999997643   2345778999999986554  556888888888899999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----------------------------------------  867 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  867 (1027)
                      +|.++.  ...    .+   ...++.++++.++.||...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998874  211    11   2356778888888888321                                         


Q ss_pred             --------------CCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          868 --------------SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       868 --------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                                    ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          1129999999999999887667799999876

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.01  E-value=1.9e-08  Score=113.75  Aligned_cols=135  Identities=15%  Similarity=0.177  Sum_probs=89.7

Q ss_pred             ccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCc
Q 048205          287 IGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNL  366 (1027)
Q Consensus       287 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  366 (1027)
                      +....+|+.+.+..+ +..+...+|.+...|+.+.+..+ ++.+...+|.++.+|+.+.+..+ + ..++..+|..+++|
T Consensus       213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i-~~i~~~aF~~c~~L  288 (379)
T 4h09_A          213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-V-KTVPYLLCSGCSNL  288 (379)
T ss_dssp             TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-C-SEECTTTTTTCTTC
T ss_pred             cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-c-eecccccccccccc
Confidence            344455666665433 44455566777777777777655 55566667777777777777554 3 35666777777778


Q ss_pred             cEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCC
Q 048205          367 EELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS  427 (1027)
Q Consensus       367 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  427 (1027)
                      +.+.+.++.++.+-...|.++.+|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.+
T Consensus       289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I  347 (379)
T 4h09_A          289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLI  347 (379)
T ss_dssp             CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred             ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEE
Confidence            88887777776555667777788888887654 65566677888888888777654 4433

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.01  E-value=2.7e-08  Score=112.54  Aligned_cols=301  Identities=10%  Similarity=0.099  Sum_probs=209.2

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS  101 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  101 (1027)
                      +....+|+.+.+.. .++.....+|..+.+|+.++|..+ ++.....+|.++ +|+.+.+..+ ++.+...+|.. .+|+
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~  116 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD  116 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence            45556788888864 466455677888888888888754 665666778776 5777777654 44344445544 4788


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccc------------ccCccccC
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG------------DIPKEIGN  169 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------------~~p~~~~~  169 (1027)
                      .+.+..+- + .+....|.+. +++.+.+..+ ++.+...+|..+.+++...+..+....            .....+..
T Consensus       117 ~i~lp~~~-~-~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (379)
T 4h09_A          117 DFEFPGAT-T-EIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA  192 (379)
T ss_dssp             EEECCTTC-C-EECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred             cccCCCcc-c-cccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence            88887653 2 3445555544 5666665543 444666778888888888776554321            12234555


Q ss_pred             CCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccC
Q 048205          170 LTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAEL  249 (1027)
Q Consensus       170 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l  249 (1027)
                      ...+..+.+..+.-. .....+....+|+.+.+..+ ++.+...+|.++..|+.+.+..+ ++               .+
T Consensus       193 ~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~---------------~I  254 (379)
T 4h09_A          193 AKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT---------------SI  254 (379)
T ss_dssp             TCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC---------------EE
T ss_pred             cccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc---------------Ee
Confidence            666666666554433 45567777888888888765 44355667888899999888665 43               56


Q ss_pred             CccccCCCccccEEEeccccccccCCCCCCCCCCC-ccccCcCCccceeccCccccccCCccccCcCcccceeccCcccc
Q 048205          250 PAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIP-KEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLV  328 (1027)
Q Consensus       250 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  328 (1027)
                      ....|.....|+.+.+..+ ++          .++ ..|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++
T Consensus       255 ~~~aF~~~~~l~~i~l~~~-i~----------~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~  322 (379)
T 4h09_A          255 GSFLLQNCTALKTLNFYAK-VK----------TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK  322 (379)
T ss_dssp             CTTTTTTCTTCCEEEECCC-CS----------EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred             Cccccceeehhcccccccc-ce----------eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence            6777888888888888654 32          222 35677889999999999898888899999999999999755 77


Q ss_pred             cccCccccccCCcceEEccCccccccCCCCccCCC
Q 048205          329 GVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRL  363 (1027)
Q Consensus       329 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l  363 (1027)
                      .+...+|.++.+|+.+.+..+ + ..|...+|.+.
T Consensus       323 ~I~~~aF~~C~~L~~i~ip~~-v-~~I~~~aF~~c  355 (379)
T 4h09_A          323 TIQVYAFKNCKALSTISYPKS-I-TLIESGAFEGS  355 (379)
T ss_dssp             EECTTTTTTCTTCCCCCCCTT-C-CEECTTTTTTS
T ss_pred             EEHHHHhhCCCCCCEEEECCc-c-CEEchhHhhCC
Confidence            788889999999999998765 4 36777777554

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.87  E-value=4.3e-09  Score=118.20  Aligned_cols=144  Identities=10%  Similarity=0.097  Sum_probs=106.9

Q ss_pred             CCccceeeccccceEEEEEecCCceEEEEEEe--ccc-chhHHHHHHHHHHHhhcc--CCccceEEeEEecC---CeeEE
Q 048205          752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFD--LQY-GRAIKSFDIECGMIKRIR--HRNIIKFISSCSSD---DFKAL  823 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~l  823 (1027)
                      ....+.++.|.++.||+++..+ ..+++|+..  ... ......+.+|+++++.+.  +..+.++++++.+.   +..++
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            3446789999999999998764 678888765  221 122356788999999997  45678899988776   45899


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY------------------------------------  867 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  867 (1027)
                      ||||++|..+.+..   ...++..++..++.+++++|+.||...                                    
T Consensus       119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999998774421   122577888889999999999999420                                    


Q ss_pred             -------------------CCCeEeccCCCCcEEEcCCCc--EEEeeecCCcc
Q 048205          868 -------------------SVPIIHCDLKPNNVLLDDNMV--AHLSDFGMAKP  899 (1027)
Q Consensus       868 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~  899 (1027)
                                         ...++|||++|.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               256999999999999997753  68999998874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.83  E-value=1.2e-09  Score=121.46  Aligned_cols=179  Identities=17%  Similarity=0.260  Sum_probs=91.0

Q ss_pred             CCcEEEccCCcccc--------cCCccccccCCCcEEEccccccc---------eeCcccccCCCCCCEEEccCcccCCc
Q 048205           27 RLRNISLSLNDFSG--------TIPKEIGNVTTLIGLHLRGNKLQ---------GEIPEELGNLAELEELWLQNNFLTGT   89 (1027)
Q Consensus        27 ~L~~L~L~~n~l~~--------~~p~~i~~l~~L~~L~L~~n~i~---------~~~p~~l~~l~~L~~L~L~~N~l~~~   89 (1027)
                      +++.|.+......+        .+.+++..+++|+.|.+..+...         +.+...+..+++|++|+|++|.-. .
T Consensus       108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~  186 (362)
T 2ra8_A          108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-S  186 (362)
T ss_dssp             GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-B
T ss_pred             hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-e
Confidence            45566665443321        12334556777888877654321         124455667788888888877311 2


Q ss_pred             cCccccCCCCCCeEeCCcccccccchhhhh-cCCCCCcEEEccC--CcCCcc-----Ccccc--cCCCCCcEEEccCCcc
Q 048205           90 IPSSIFNLSSLSNLDLSVNNLTGELLANIC-SNLPLLQTLFLDE--NNFDGK-----IPSTL--LRCKHLQTLSLSINDF  159 (1027)
Q Consensus        90 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~~l~~L~~L~L~~--N~l~~~-----~~~~~--~~l~~L~~L~Ls~N~l  159 (1027)
                      ++. +. +++|++|+|..|.++......+. ..+|+|++|+|+.  |...+.     +...+  ..+++|++|+|++|.+
T Consensus       187 l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i  264 (362)
T 2ra8_A          187 IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE  264 (362)
T ss_dssp             CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTT
T ss_pred             ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCC
Confidence            222 33 77888888888887643333333 2577888887753  221111     01111  1345566666665555


Q ss_pred             ccccCccc---cCCCCCcEEEccCccCCCCC----ChhccCCCCCCeeeccccccC
Q 048205          160 SGDIPKEI---GNLTKLKYLHLDQNRLQGEI----PEELGNLAELEKLQLQNNFLT  208 (1027)
Q Consensus       160 ~~~~p~~~---~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~  208 (1027)
                      ....+..+   ..+++|++|+|+.|.+++..    +..+..+++|+.|+|++|.|+
T Consensus       265 ~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          265 QNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             HHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             chHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            43222222   13445555555555554321    112223345555555555444

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.80  E-value=2.9e-09  Score=116.55  Aligned_cols=187  Identities=18%  Similarity=0.166  Sum_probs=121.3

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCc--cceEEeEEecCC---eeEEEEEec
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRN--IIKFISSCSSDD---FKALVLEYM  828 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~  828 (1027)
                      .+.++.|.+..||++.    ..+++|+....  .....+.+|+++++.+. +..  +.+++.+....+   ..++||||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4678999999999874    57999986532  34567888999998884 333  445555543333   348899999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG------------------------------------------  866 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  866 (1027)
                      +|.++.+....   .++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888653321   256677778888888888888831                                          


Q ss_pred             -------------CCCCeEeccCCCCcEEEcC--CCcEEEeeecCCcccccCCCcceecc------------cccCcccc
Q 048205          867 -------------YSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKPFLKEDQSLTQTQ------------TLATIGYM  919 (1027)
Q Consensus       867 -------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~------------~~gt~~y~  919 (1027)
                                   ....++|+|++|.||+++.  ++.+.++||+.+..............            .....++.
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         0135799999999999998  45678999999864321100000000            00001111


Q ss_pred             C-cccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 048205          920 A-PEYGREGRVSTNGDVYSFGIMLMETFTRKKPT  952 (1027)
Q Consensus       920 a-PE~~~~~~~~~~~DvwslGvil~elltg~~p~  952 (1027)
                      . |+....  .....+.|++|.++|.+.+|..+|
T Consensus       256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1 222111  112258999999999999998765

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.78  E-value=2.6e-09  Score=118.80  Aligned_cols=183  Identities=17%  Similarity=0.267  Sum_probs=116.3

Q ss_pred             CccCcCCCCCcEEEccCCccc---------ccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCc
Q 048205           19 PSTLSNCKRLRNISLSLNDFS---------GTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGT   89 (1027)
Q Consensus        19 ~~~~~~~~~L~~L~L~~n~l~---------~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~   89 (1027)
                      ..++..+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.+...
T Consensus       132 ~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~  208 (362)
T 2ra8_A          132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDS  208 (362)
T ss_dssp             HTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHH
T ss_pred             HHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChH
Confidence            344566778888888654321         124455667788888888877311 2333 33 77888888888887643


Q ss_pred             cCcccc--CCCCCCeEeCCc--cccccc--c--hhhhh--cCCCCCcEEEccCCcCCccCccccc---CCCCCcEEEccC
Q 048205           90 IPSSIF--NLSSLSNLDLSV--NNLTGE--L--LANIC--SNLPLLQTLFLDENNFDGKIPSTLL---RCKHLQTLSLSI  156 (1027)
Q Consensus        90 ~p~~l~--~l~~L~~L~Ls~--N~l~~~--~--~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~Ls~  156 (1027)
                      ....+.  .+++|++|+|+.  |...+.  +  ....+  ..+|+|++|+|.+|.+....+..+.   .+++|++|+|+.
T Consensus       209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~  288 (362)
T 2ra8_A          209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA  288 (362)
T ss_dssp             HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCS
T ss_pred             HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCC
Confidence            333443  678888888753  221111  0  01122  2478899999988888643333333   478899999999


Q ss_pred             Cccccc----cCccccCCCCCcEEEccCccCCCCCChhccC-CCCCCeeeccccc
Q 048205          157 NDFSGD----IPKEIGNLTKLKYLHLDQNRLQGEIPEELGN-LAELEKLQLQNNF  206 (1027)
Q Consensus       157 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~  206 (1027)
                      |.+.+.    ++..+.++++|+.|+|++|.++...-..+.. +  ...+++++++
T Consensus       289 n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             SCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             CCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            998753    3444566789999999999887543333433 2  3568888887

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.48  E-value=1.9e-08  Score=105.89  Aligned_cols=80  Identities=21%  Similarity=0.297  Sum_probs=53.5

Q ss_pred             cCcccccEEccccccccc--ccchhhccCccccEEEccCCccccCccccccccc--cccccccccccccCCch-------
Q 048205          571 GNLKVLVQIDLSINNFSD--VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMI--NLKSLNLSNNNLFGIIP-------  639 (1027)
Q Consensus       571 ~~l~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~--~L~~L~l~~N~l~~~~p-------  639 (1027)
                      .++++|+.|+|++|+|++  .+|..++.+++|+.|+|++|+|++.  .++..+.  +|++|+|++|.+.+.+|       
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            345667777777777765  4556667777777777777777743  3455555  77777777777776665       


Q ss_pred             hhhhcccCCccee
Q 048205          640 ISLEKLLDLKDIN  652 (1027)
Q Consensus       640 ~~l~~l~~L~~l~  652 (1027)
                      ..+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence            2366777777765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.41  E-value=9.2e-08  Score=95.83  Aligned_cols=117  Identities=12%  Similarity=0.126  Sum_probs=61.7

Q ss_pred             ccccccCCCcEEEcccc-ccce----eCcccccCCCCCCEEEccCcccCCc----cCccccCCCCCCeEeCCcccccccc
Q 048205           44 KEIGNVTTLIGLHLRGN-KLQG----EIPEELGNLAELEELWLQNNFLTGT----IPSSIFNLSSLSNLDLSVNNLTGEL  114 (1027)
Q Consensus        44 ~~i~~l~~L~~L~L~~n-~i~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~  114 (1027)
                      ..+...++|++|+|++| .|..    .+...+...++|++|+|++|.|...    +...+...++|++|+|++|.|++..
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence            34444555555555555 5432    1233344455566666666655532    1223334455666666666665322


Q ss_pred             h---hhhhcCCCCCcEEEc--cCCcCCcc----CcccccCCCCCcEEEccCCccc
Q 048205          115 L---ANICSNLPLLQTLFL--DENNFDGK----IPSTLLRCKHLQTLSLSINDFS  160 (1027)
Q Consensus       115 ~---~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~  160 (1027)
                      .   ...+...+.|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            1   223334455666666  55666532    2344555677888888888775

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.40  E-value=8.8e-08  Score=95.96  Aligned_cols=121  Identities=13%  Similarity=0.071  Sum_probs=60.9

Q ss_pred             CcccccccccceEEecCc-cccCc----hhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEe
Q 048205          482 PKEINNLTNLIAIYLGVN-KLNGS----ILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLN  556 (1027)
Q Consensus       482 p~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~  556 (1027)
                      ...+...++|++|+|++| .+...    +...+...++|++|+|++|++...         ....+...+...       
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~---------g~~~l~~~L~~n-------   92 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDP---------VAFALAEMLKVN-------   92 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHH---------HHHHHHHHHHHC-------
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChH---------HHHHHHHHHHhC-------
Confidence            344555666777777776 66532    334455556666666666666321         111222233333       


Q ss_pred             cCCCccccCccccccCcccccEEcccccccccc----cchhhccCccccEEEc--cCCccccC----ccccccccccccc
Q 048205          557 LSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDV----IPTTIGGLKDLQYLFL--KYNRLQGS----IPDSIGDMINLKS  626 (1027)
Q Consensus       557 Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~L--~~N~l~g~----ip~~~~~l~~L~~  626 (1027)
                                       +.|++|+|++|.|.+.    +...+...+.|++|+|  ++|.|...    +...+...++|++
T Consensus        93 -----------------~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~  155 (185)
T 1io0_A           93 -----------------NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLK  155 (185)
T ss_dssp             -----------------SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCE
T ss_pred             -----------------CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCE
Confidence                             4445555555554422    3344444555566666  55555532    2233334455666


Q ss_pred             ccccccccc
Q 048205          627 LNLSNNNLF  635 (1027)
Q Consensus       627 L~l~~N~l~  635 (1027)
                      |+|++|.+.
T Consensus       156 L~L~~n~i~  164 (185)
T 1io0_A          156 FGYHFTQQG  164 (185)
T ss_dssp             EECCCSSHH
T ss_pred             EeccCCCCC
Confidence            666666553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.38  E-value=6.4e-08  Score=101.82  Aligned_cols=92  Identities=28%  Similarity=0.281  Sum_probs=72.4

Q ss_pred             cCcccccE--Ecccccccc---cccchhhccCccccEEEccCCcccc--CccccccccccccccccccccccCCchhhhh
Q 048205          571 GNLKVLVQ--IDLSINNFS---DVIPTTIGGLKDLQYLFLKYNRLQG--SIPDSIGDMINLKSLNLSNNNLFGIIPISLE  643 (1027)
Q Consensus       571 ~~l~~L~~--L~ls~n~l~---~~~p~~~~~l~~L~~L~L~~N~l~g--~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~  643 (1027)
                      .....|..  ++++.|+..   +.++....++++|+.|+|++|+|++  .+|..++.+++|+.|+|++|+|++.  .++.
T Consensus       138 ~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~  215 (267)
T 3rw6_A          138 RSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELD  215 (267)
T ss_dssp             GGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGG
T ss_pred             CCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhh
Confidence            33445554  778888543   3233333678999999999999998  5678888999999999999999976  4566


Q ss_pred             ccc--CCcceeccCCCCCCCCCC
Q 048205          644 KLL--DLKDINVSFNKLEGEIPR  664 (1027)
Q Consensus       644 ~l~--~L~~l~l~~N~l~g~~p~  664 (1027)
                      .+.  .|+.|+|++|++++.+|.
T Consensus       216 ~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          216 KIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             GGTTSCCSEEECTTSTTGGGCSS
T ss_pred             hcccCCcceEEccCCcCccccCc
Confidence            666  899999999999998774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.37  E-value=3.5e-06  Score=90.15  Aligned_cols=134  Identities=16%  Similarity=0.071  Sum_probs=96.7

Q ss_pred             eeeccccc-eEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          757 LIGRGGFG-FVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       757 ~lG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      .+..|..| .||+.... ++..+++|+-..   .....+.+|.+.++.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45566666 69998765 567899998653   24456788999988885 33477889999999999999999999888


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------------
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----------------------------------------------  867 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------  867 (1027)
                      .+.....     ......++.++++.++.||...                                              
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            7654321     1122345556666666666210                                              


Q ss_pred             ---------CCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          868 ---------SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       868 ---------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                               ...++|+|+++.||+++.++.+-|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     1127899999999999988777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.32  E-value=3.7e-06  Score=91.60  Aligned_cols=136  Identities=16%  Similarity=0.148  Sum_probs=95.0

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCC---ccceEEeEEe-cCCeeEEEEEecCC
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR---NIIKFISSCS-SDDFKALVLEYMPY  830 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~  830 (1027)
                      .+.++.|....||+.    |+.+++|+...  ......+..|+++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            467889999999988    67899998532  23456788999999999753   3567777764 45567899999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG--------------------------------------------  866 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  866 (1027)
                      ..+.+....   .++..++..++.++++.++.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            887653211   123444444555555555555421                                            


Q ss_pred             -------------CCCCeEeccCCCCcEEEcC---CCc-EEEeeecCCcc
Q 048205          867 -------------YSVPIIHCDLKPNNVLLDD---NMV-AHLSDFGMAKP  899 (1027)
Q Consensus       867 -------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfgla~~  899 (1027)
                                   ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1345799999999999987   455 48999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.08  E-value=4.6e-06  Score=93.22  Aligned_cols=80  Identities=6%  Similarity=-0.041  Sum_probs=56.6

Q ss_pred             ccee-eccccceEEEEEec-------CCceEEEEEEeccc---chhHHHHHHHHHHHhhccC---CccceEEeEEecC--
Q 048205          755 NNLI-GRGGFGFVYKARIQ-------DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRH---RNIIKFISSCSSD--  818 (1027)
Q Consensus       755 ~~~l-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--  818 (1027)
                      .+.| +.|....+|+++..       +++.+++|+.....   ......+.+|+++++.+..   ..+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88999999998754       26789999865322   1012457788888888853   3567788887665  


Q ss_pred             -CeeEEEEEecCCCCHH
Q 048205          819 -DFKALVLEYMPYGSLE  834 (1027)
Q Consensus       819 -~~~~lV~e~~~~gsL~  834 (1027)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.89  E-value=3.2e-05  Score=85.78  Aligned_cols=139  Identities=16%  Similarity=0.164  Sum_probs=80.6

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCC--ccceEEe------EEecCCeeEEEEE
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR--NIIKFIS------SCSSDDFKALVLE  826 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~------~~~~~~~~~lV~e  826 (1027)
                      .+.++.|..+.||++...+| .+++|+....    ...+..|+++++.+...  .+.+++.      +....+..++|||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566678899999987655 5999998742    12334455666655421  2344443      1234567899999


Q ss_pred             ecCCCCHH-----H---------HHhcC--Cc-----------cCCHHHH------------------------------
Q 048205          827 YMPYGSLE-----K---------CLYSS--NY-----------ILDIFQR------------------------------  849 (1027)
Q Consensus       827 ~~~~gsL~-----~---------~l~~~--~~-----------~~~~~~~------------------------------  849 (1027)
                      |++|..+.     +         .+|..  ..           ...|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542     0         12211  00           0122211                              


Q ss_pred             -HHHHHHHHHHHHHhhc----------CCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          850 -LNIMIDVASALEYLHF----------GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       850 -~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                       ..+...+.+++++++.          .....++|+|+++.||+++.++.+.++||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             0111223345666652          025789999999999999888899999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=4.7e-05  Score=86.28  Aligned_cols=75  Identities=17%  Similarity=0.163  Sum_probs=49.9

Q ss_pred             cceeeccccceEEEEEec-CCceEEEEEEecccc-------hhHHHHHHHHHHHhhccC--C-ccceEEeEEecCCeeEE
Q 048205          755 NNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG-------RAIKSFDIECGMIKRIRH--R-NIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l  823 (1027)
                      .+.+|.|.++.||+++.. +++.|+||.......       .....+..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            568999999999999765 468899998643211       123456778888888743  3 34455544  3345689


Q ss_pred             EEEecCCC
Q 048205          824 VLEYMPYG  831 (1027)
Q Consensus       824 V~e~~~~g  831 (1027)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.80  E-value=6.4e-06  Score=80.13  Aligned_cols=84  Identities=13%  Similarity=0.054  Sum_probs=44.8

Q ss_pred             CCCcEEEccCCcccccCCccccccCCCcEEEccccc-cceeCcccccCC----CCCCEEEccCcc-cCCccCccccCCCC
Q 048205           26 KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK-LQGEIPEELGNL----AELEELWLQNNF-LTGTIPSSIFNLSS   99 (1027)
Q Consensus        26 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~-i~~~~p~~l~~l----~~L~~L~L~~N~-l~~~~p~~l~~l~~   99 (1027)
                      ..|++|||+++.|+...-..+..+++|++|+|++|. |++..-..++.+    ++|++|+|++|. |++..-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            346666666666655545555556666666666653 544333344443    246666666553 55433344555555


Q ss_pred             CCeEeCCccc
Q 048205          100 LSNLDLSVNN  109 (1027)
Q Consensus       100 L~~L~Ls~N~  109 (1027)
                      |++|+++++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            6666665553

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.00022  Score=77.18  Aligned_cols=138  Identities=14%  Similarity=0.070  Sum_probs=93.2

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhcc---CCccceEEeEEecCCeeEEEEEecC
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR---HRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      ...+.|+.|....+|+.+. +++.+++|+....   ....+..|.+.++.+.   ...+.++++++...+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456799999999999986 4678899987633   3466888999988884   2568889999888888999999999


Q ss_pred             CCCHH--------H---HHhcCCc---------------------cCCHHHHH---HHHH----------------HHHH
Q 048205          830 YGSLE--------K---CLYSSNY---------------------ILDIFQRL---NIMI----------------DVAS  858 (1027)
Q Consensus       830 ~gsL~--------~---~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~  858 (1027)
                      |..+.        +   .+|....                     .-+|....   ++..                .+++
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87541        1   1232211                     11343321   1111                1111


Q ss_pred             H-HHHhh-cCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 048205          859 A-LEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  895 (1027)
Q Consensus       859 ~-l~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  895 (1027)
                      . ...|. ......++|+|+.+.|++++.++ +.|+|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 22342 12246799999999999999887 8899973

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.62  E-value=1.9e-05  Score=76.76  Aligned_cols=34  Identities=9%  Similarity=0.078  Sum_probs=16.0

Q ss_pred             CCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205           51 TLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus        51 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      .|+.|||++|.|+...-..+.++++|++|+|++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            4455555555544333334444444444444444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.51  E-value=0.00034  Score=75.19  Aligned_cols=79  Identities=13%  Similarity=0.078  Sum_probs=58.2

Q ss_pred             CCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCC---ccceEEeEEecCCeeEEEEEe
Q 048205          751 GFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR---NIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .....+.+|.|..+.||+++..+|+.|++|+...........+..|++.++.+...   .+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            34556789999999999999999999999986544333345688899999988532   345555542    23789999


Q ss_pred             cCCCCH
Q 048205          828 MPYGSL  833 (1027)
Q Consensus       828 ~~~gsL  833 (1027)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.32  E-value=9.8e-05  Score=73.21  Aligned_cols=67  Identities=21%  Similarity=0.183  Sum_probs=32.9

Q ss_pred             ccccCCCcEEEcccc-ccce----eCcccccCCCCCCEEEccCcccCCcc----CccccCCCCCCeEeCCcccccc
Q 048205           46 IGNVTTLIGLHLRGN-KLQG----EIPEELGNLAELEELWLQNNFLTGTI----PSSIFNLSSLSNLDLSVNNLTG  112 (1027)
Q Consensus        46 i~~l~~L~~L~L~~n-~i~~----~~p~~l~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~  112 (1027)
                      +.+-+.|++|+|++| +|..    .+.+.+..-+.|+.|+|++|+|.+..    ...+..-+.|++|+|++|.|.+
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            334455556666553 5432    23344445555666666666655322    1222234555666666665553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.31  E-value=0.00085  Score=72.58  Aligned_cols=138  Identities=13%  Similarity=0.133  Sum_probs=77.6

Q ss_pred             CCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCcc-ceEEeEEecCCeeEEEEEec-C
Q 048205          752 FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI-IKFISSCSSDDFKALVLEYM-P  829 (1027)
Q Consensus       752 f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~  829 (1027)
                      +.-.+.|+.|....+|++     +.+++|+....... ......|+++++.+...++ .++++++.  +.-++|+||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence            333678999999999998     67899987643221 1223568888877754333 45665433  3347899999 6


Q ss_pred             CCCHHHH------------------HhcCCcc----CCH-HHHHHHHH--------------HHHHHH----HHhh-cCC
Q 048205          830 YGSLEKC------------------LYSSNYI----LDI-FQRLNIMI--------------DVASAL----EYLH-FGY  867 (1027)
Q Consensus       830 ~gsL~~~------------------l~~~~~~----~~~-~~~~~i~~--------------~i~~~l----~~LH-~~~  867 (1027)
                      |.++...                  +|.....    .+. .....+..              .+.+.+    +.+. ...
T Consensus        92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            6444210                  1111100    011 11111100              011111    1111 012


Q ss_pred             CCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       868 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ...++|+|+.|.||+ ..++.+.++||..+.
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            345899999999999 667788999999876

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.28  E-value=0.00013  Score=72.31  Aligned_cols=114  Identities=13%  Similarity=0.128  Sum_probs=75.4

Q ss_pred             cCcCCCCCcEEEccCC-ccccc----CCccccccCCCcEEEcccccccee----CcccccCCCCCCEEEccCcccCCc--
Q 048205           21 TLSNCKRLRNISLSLN-DFSGT----IPKEIGNVTTLIGLHLRGNKLQGE----IPEELGNLAELEELWLQNNFLTGT--   89 (1027)
Q Consensus        21 ~~~~~~~L~~L~L~~n-~l~~~----~p~~i~~l~~L~~L~L~~n~i~~~----~p~~l~~l~~L~~L~L~~N~l~~~--   89 (1027)
                      .+.+-+.|++|+|++| +|...    +.+++..-+.|+.|+|++|+|...    +.+.+..-+.|++|+|+.|.|...  
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            3456678999999985 88643    455666778999999999999744    344455778899999999999843  


Q ss_pred             --cCccccCCCCCCeEeCCcc---cccccc---hhhhhcCCCCCcEEEccCCc
Q 048205           90 --IPSSIFNLSSLSNLDLSVN---NLTGEL---LANICSNLPLLQTLFLDENN  134 (1027)
Q Consensus        90 --~p~~l~~l~~L~~L~Ls~N---~l~~~~---~~~~~~~l~~L~~L~L~~N~  134 (1027)
                        +-.++..-+.|++|+|++|   .+....   .......-+.|++|+++.|.
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence              2334555677888888765   333211   12233334455555555443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.25  E-value=0.00098  Score=75.91  Aligned_cols=77  Identities=13%  Similarity=0.099  Sum_probs=47.6

Q ss_pred             CCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecccc--cCccccCcccccCC---CCCcchhHHHHHHHH
Q 048205          868 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTL--ATIGYMAPEYGREG---RVSTNGDVYSFGIML  942 (1027)
Q Consensus       868 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DvwslGvil  942 (1027)
                      ...++|+|++|.||+++.++ ++++||+.+..-...   .......  -...|++|+.....   ......++.+....+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            67899999999999998876 999999988742110   0000001  12346666655321   112234555777778


Q ss_pred             HHHHcC
Q 048205          943 METFTR  948 (1027)
Q Consensus       943 ~elltg  948 (1027)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.18  E-value=0.0013  Score=71.87  Aligned_cols=155  Identities=14%  Similarity=0.160  Sum_probs=87.0

Q ss_pred             cHHHHHHHhCCCCc-----cceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCc--cceEEe
Q 048205          741 TYLELFQATNGFSE-----NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN--IIKFIS  813 (1027)
Q Consensus       741 ~~~~~~~~~~~f~~-----~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~  813 (1027)
                      +.+++......|..     .+.|+.|....||++...+| .+++|+.....  ....+..|+++++.+...+  +.+++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            34455554455654     34567788899999987655 68899886421  2234566777777775323  333332


Q ss_pred             E------EecCCeeEEEEEecCCCCHHH-----H---------HhcC--C--cc-------CCHHHHHH-----------
Q 048205          814 S------CSSDDFKALVLEYMPYGSLEK-----C---------LYSS--N--YI-------LDIFQRLN-----------  851 (1027)
Q Consensus       814 ~------~~~~~~~~lV~e~~~~gsL~~-----~---------l~~~--~--~~-------~~~~~~~~-----------  851 (1027)
                      .      ....+..++||+|++|..+..     +         +|..  .  ..       ..|.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      122356789999999865311     0         2211  0  00       11221110           


Q ss_pred             -HHHHHHHHHHHhhcC----CCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          852 -IMIDVASALEYLHFG----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       852 -i~~~i~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                       +...+.+.+++++..    ...+++|+|+++.||+++.++.+.++||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             001133445555421    24579999999999999987666899999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.99  E-value=0.0029  Score=69.39  Aligned_cols=140  Identities=11%  Similarity=0.054  Sum_probs=74.6

Q ss_pred             cceeeccccce-EEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCC--ccceEEeEEecCCeeEEEEEecCCC
Q 048205          755 NNLIGRGGFGF-VYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR--NIIKFISSCSSDDFKALVLEYMPYG  831 (1027)
Q Consensus       755 ~~~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lV~e~~~~g  831 (1027)
                      .+.++.|+... +|+.+..+|+.+++|......   ...+..|+++++.+...  .+.+++.+..+.+  ++|||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            34566665554 667765446778777644321   13345577777777432  3556776644443  7899999776


Q ss_pred             CHHHHHhcCC-------------------------ccCCHHHHH-------H-H------------HHHHHHHHHHhh--
Q 048205          832 SLEKCLYSSN-------------------------YILDIFQRL-------N-I------------MIDVASALEYLH--  864 (1027)
Q Consensus       832 sL~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~LH--  864 (1027)
                      .+.+++....                         ..++.....       . +            ...+.+.++.+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6654332110                         011111100       0 0            011112222221  


Q ss_pred             -cCCCCCeEeccCCCCcEEEcCC----CcEEEeeecCCcc
Q 048205          865 -FGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKP  899 (1027)
Q Consensus       865 -~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~  899 (1027)
                       ......++|||+++.||+++.+    +.+.++||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1125679999999999999875    6899999998863

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.99  E-value=0.0045  Score=67.69  Aligned_cols=140  Identities=13%  Similarity=0.109  Sum_probs=82.4

Q ss_pred             cceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCc--cceEEeE-----EecCCeeEEEEEe
Q 048205          755 NNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN--IIKFISS-----CSSDDFKALVLEY  827 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~e~  827 (1027)
                      ...++ |....||++...+|+.+++|+...... ....+..|.++++.+....  +++++..     ....+..++||||
T Consensus        31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             EEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            34577 888899998877788899999863321 2345667888888775322  3444443     1224566889999


Q ss_pred             cCCCCHH-----HH---------Hhc----C----CccCCHHHH----------------------HHHHHHHHHHHHHh
Q 048205          828 MPYGSLE-----KC---------LYS----S----NYILDIFQR----------------------LNIMIDVASALEYL  863 (1027)
Q Consensus       828 ~~~gsL~-----~~---------l~~----~----~~~~~~~~~----------------------~~i~~~i~~~l~~L  863 (1027)
                      ++|..+.     .+         +|.    .    ....++...                      ...+..++..++-.
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875431     11         111    0    011222111                      01111122222222


Q ss_pred             hc-CCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          864 HF-GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       864 H~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      .. .....++|+|+++.||+++ + .+.++||+.+.
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            11 1245689999999999998 4 89999999876

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.96  E-value=0.0012  Score=75.06  Aligned_cols=73  Identities=18%  Similarity=0.231  Sum_probs=50.5

Q ss_pred             cceeeccccceEEEEEecC--------CceEEEEEEecccchhHHHHHHHHHHHhhccCCcc-ceEEeEEecCCeeEEEE
Q 048205          755 NNLIGRGGFGFVYKARIQD--------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI-IKFISSCSSDDFKALVL  825 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  825 (1027)
                      .+.|+.|....||++...+        ++.|++|+.....  ....+..|.++++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4578889999999998653        5789999985321  11445578888888854444 566766543    3899


Q ss_pred             EecCCCCH
Q 048205          826 EYMPYGSL  833 (1027)
Q Consensus       826 e~~~~gsL  833 (1027)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986433

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.79  E-value=0.0042  Score=68.93  Aligned_cols=139  Identities=14%  Similarity=0.185  Sum_probs=83.0

Q ss_pred             cceeeccccceEEEEEec--------CCceEEEEEEecccchhHHHHHHHHHHHhhccCCc-cceEEeEEecCCeeEEEE
Q 048205          755 NNLIGRGGFGFVYKARIQ--------DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN-IIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  825 (1027)
                      .+.+..|-...+|+++..        +++.|++|+.... ........+|.++++.+...+ ..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456778889999999864        2578999986432 123456678999998885333 3566666553    3999


Q ss_pred             EecCCCCHHHH-----------------HhcCC----ccCC--HHHHHHHHHHHHH-------------------HHHHh
Q 048205          826 EYMPYGSLEKC-----------------LYSSN----YILD--IFQRLNIMIDVAS-------------------ALEYL  863 (1027)
Q Consensus       826 e~~~~gsL~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~L  863 (1027)
                      ||++|.++..-                 +|..+    ....  +.++.++..++..                   .++.+
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99988654210                 12211    1122  3344444433321                   12222


Q ss_pred             ----hc-CCCCCeEeccCCCCcEEEcCC----CcEEEeeecCCc
Q 048205          864 ----HF-GYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAK  898 (1027)
Q Consensus       864 ----H~-~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~  898 (1027)
                          .. .....++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                21 123568999999999999876    789999999876

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.73  E-value=0.0032  Score=71.91  Aligned_cols=74  Identities=15%  Similarity=0.146  Sum_probs=49.0

Q ss_pred             cceeeccccceEEEEEecC-CceEEEEEEecccchhHHHHHHHHHHHhhccCCcc-ceEEeEEecCCeeEEEEEecCCCC
Q 048205          755 NNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI-IKFISSCSSDDFKALVLEYMPYGS  832 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gs  832 (1027)
                      .+.|+.|-...+|++...+ +..|++|+....... ......|.++++.+...++ .++++++. .   ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            4578889999999998765 578999987543221 1122578888888865554 46777663 2   35999998754


Q ss_pred             H
Q 048205          833 L  833 (1027)
Q Consensus       833 L  833 (1027)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.70  E-value=0.01  Score=58.95  Aligned_cols=101  Identities=14%  Similarity=0.060  Sum_probs=67.8

Q ss_pred             CHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcceecc
Q 048205          832 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQ  911 (1027)
Q Consensus       832 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  911 (1027)
                      +|.+.+...+.++.+.+++.++.|.+.+|.-.-.  .+.-..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            8999999999999999999999999999877621  11111233457899999999988764 1110             


Q ss_pred             cccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCC
Q 048205          912 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKK  950 (1027)
Q Consensus       912 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~  950 (1027)
                       .....+.|||... ...+.+.=|||+|+++|..+-=..
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence             0122366888764 345678899999999999885333

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.57  E-value=0.0034  Score=70.01  Aligned_cols=74  Identities=9%  Similarity=0.149  Sum_probs=45.4

Q ss_pred             cceeeccccceEEEEEecC---------CceEEEEEEecccchhHHHHHHHHHHHhhccCCc-cceEEeEEecCCeeEEE
Q 048205          755 NNLIGRGGFGFVYKARIQD---------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN-IIKFISSCSSDDFKALV  824 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV  824 (1027)
                      .+.++.|....||++...+         ++.+++|+....... ......|.++++.+...+ +.++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567888889999998653         268889987543221 123457888888885444 34666554  2  2689


Q ss_pred             EEecCCCCH
Q 048205          825 LEYMPYGSL  833 (1027)
Q Consensus       825 ~e~~~~gsL  833 (1027)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.45  E-value=0.011  Score=64.95  Aligned_cols=67  Identities=16%  Similarity=0.195  Sum_probs=43.5

Q ss_pred             ccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccC---CccceEEeE------EecCCeeEEEEEecCC
Q 048205          760 RGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH---RNIIKFISS------CSSDDFKALVLEYMPY  830 (1027)
Q Consensus       760 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~------~~~~~~~~lV~e~~~~  830 (1027)
                      .|....||++...+| .+++|+......      ..|+++++.+..   |.+++++..      ....+..++||+|++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            334679999987777 899998765431      345666666532   224444432      2334677999999998


Q ss_pred             CCH
Q 048205          831 GSL  833 (1027)
Q Consensus       831 gsL  833 (1027)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            755

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.33  E-value=0.005  Score=56.90  Aligned_cols=57  Identities=18%  Similarity=0.300  Sum_probs=38.9

Q ss_pred             EEEccccccC-CcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCC
Q 048205          368 ELSLSGNNFS-GTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTS  426 (1027)
Q Consensus       368 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  426 (1027)
                      .++.+++.++ ..+|..+  ..+|++|+|++|+|+.+.+..|..+++|+.|+|++|.+..
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            5666666664 2344332  2357777888888877777778888888888888887764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.25  E-value=0.0047  Score=57.07  Aligned_cols=56  Identities=23%  Similarity=0.257  Sum_probs=29.1

Q ss_pred             EEEccccccc-eeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCccccc
Q 048205           54 GLHLRGNKLQ-GEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLT  111 (1027)
Q Consensus        54 ~L~L~~n~i~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  111 (1027)
                      .++.++++++ ..+|..+.  .+|++|+|++|+|+.+.+..|..+++|++|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4444444443 13333322  24556666666665444455556666666666666554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.00  E-value=0.027  Score=63.41  Aligned_cols=74  Identities=11%  Similarity=0.155  Sum_probs=49.5

Q ss_pred             cceeeccccceEEEEEecC--------CceEEEEEEecccchhHHHHHHHHHHHhhccCCc-cceEEeEEecCCeeEEEE
Q 048205          755 NNLIGRGGFGFVYKARIQD--------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRN-IIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  825 (1027)
                      .+.+..|-...+|++...+        ++.|++|+..... .......+|.++++.+...+ ..++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567788899999998653        5789999865332 22223457888888885333 345665432    27899


Q ss_pred             EecCCCCH
Q 048205          826 EYMPYGSL  833 (1027)
Q Consensus       826 e~~~~gsL  833 (1027)
                      ||++|..+
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.15  E-value=0.24  Score=55.48  Aligned_cols=29  Identities=28%  Similarity=0.400  Sum_probs=24.8

Q ss_pred             CeEeccCCCCcEEE------cCCCcEEEeeecCCc
Q 048205          870 PIIHCDLKPNNVLL------DDNMVAHLSDFGMAK  898 (1027)
Q Consensus       870 ~ivH~Dlkp~NIll------~~~~~~kl~Dfgla~  898 (1027)
                      .++|+|+.+.||++      +++..++++||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            35799999999999      456789999999886

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1027
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-49
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-26
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-08
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-13
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-13
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.004
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.001
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 4e-61
 Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 26/275 (9%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFIS 813
              IG G FG VYK +     +VAVK+ ++     + +++F  E G++++ RH NI+ F+ 
Sbjct: 14   QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 814  SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
              ++    A+V ++    SL   L+      ++ + ++I    A  ++YLH      IIH
Sbjct: 72   YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY---GREGRVS 930
             DLK NN+ L +++   + DFG+A    +   S    Q   +I +MAPE      +   S
Sbjct: 128  RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 931  TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF 990
               DVY+FGI+L E  T + P       +  +       L   + +V             
Sbjct: 188  FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------------- 234

Query: 991  VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
              +  C   +  L  +C  +  +ER    +I+  +
Sbjct: 235  --RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 6e-58
 Identities = 64/303 (21%), Positives = 124/303 (40%), Gaps = 39/303 (12%)

Query: 740  FTYLELFQATNGFSEN---------NLIGRGGFGFVYKARI----QDGMEVAVKVFDLQY 786
            FT+ +  +A   F++           +IG G FG V    +    +  + VA+K     Y
Sbjct: 7    FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 787  G-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILD 845
              +  + F  E  ++ +  H N+I      +      ++ E+M  GSL+  L  ++    
Sbjct: 67   TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 846  IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ 905
            + Q + ++  +A+ ++YL     +  +H DL   N+L++ N+V  +SDFG+++    +  
Sbjct: 127  VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 906  SLTQTQTL---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL 962
              T T  L     I + APE  +  + ++  DV+S+GI++ E  +  +      T +  +
Sbjct: 184  DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243

Query: 963  KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
                 D  L   M+   A                   +  L + C  +    R    +IV
Sbjct: 244  NAIEQDYRLPPPMDCPSA-------------------LHQLMLDCWQKDRNHRPKFGQIV 284

Query: 1023 TKL 1025
              L
Sbjct: 285  NTL 287

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-56
 Identities = 60/275 (21%), Positives = 116/275 (42%), Gaps = 26/275 (9%)

Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
                  +G G FG V+        +VAVK        +  +F  E  ++K+++H+ +++ 
Sbjct: 15   LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRL 73

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVP 870
             +  + +    ++ EYM  GSL   L + + I L I + L++   +A  + ++       
Sbjct: 74   YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
             IH DL+  N+L+ D +   ++DFG+A+  +++++   +      I + APE    G  +
Sbjct: 130  YIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 931  TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF 990
               DV+SFGI+L E  T  +      T    ++       +                   
Sbjct: 189  IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------------------- 229

Query: 991  VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            V  + C   ++ L   C  E PE+R     + + L
Sbjct: 230  VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-55
 Identities = 59/274 (21%), Positives = 115/274 (41%), Gaps = 24/274 (8%)

Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
             +    +G G FG V   + +   +VA+K+       +   F  E  ++  + H  +++ 
Sbjct: 6    LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               C+      ++ EYM  G L   L    +     Q L +  DV  A+EYL        
Sbjct: 65   YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 121

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
            +H DL   N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     + S+
Sbjct: 122  LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 932  NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV 991
              D+++FG+++ E ++  K   E FT   T +     L L                 H  
Sbjct: 181  KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------------YRPHLA 226

Query: 992  AKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +++     V+ +   C  E  +ER   K +++ +
Sbjct: 227  SEK-----VYTIMYSCWHEKADERPTFKILLSNI 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 8e-55
 Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 24/274 (8%)

Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
             +    IG G FG V+     +  +VA+K        + + F  E  ++ ++ H  +++ 
Sbjct: 7    LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
               C       LV E+M +G L   L +   +      L + +DV   + YL       +
Sbjct: 66   YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
            IH DL   N L+ +N V  +SDFGM + F+ +DQ  + T T   + + +PE     R S+
Sbjct: 123  IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 932  NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV 991
              DV+SFG+++ E F+  K   E+ +    ++             +    L S       
Sbjct: 182  KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLASTH----- 230

Query: 992  AKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                    V+ +   C  E PE+R     ++ +L
Sbjct: 231  --------VYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-53
 Identities = 61/275 (22%), Positives = 115/275 (41%), Gaps = 26/275 (9%)

Query: 752  FSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKF 811
                  +G+G FG V+         VA+K        + ++F  E  ++K++RH  +++ 
Sbjct: 19   LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIF-QRLNIMIDVASALEYLHFGYSVP 870
             +  S +    +V EYM  GSL   L           Q +++   +AS + Y+     + 
Sbjct: 78   YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVS 930
             +H DL+  N+L+ +N+V  ++DFG+A+  +++++   +      I + APE    GR +
Sbjct: 134  YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 931  TNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHF 990
               DV+SFGI+L E  T+ +           L +                          
Sbjct: 193  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------------RM 233

Query: 991  VAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                +C   + +L  +C  + PEER   + +   L
Sbjct: 234  PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 8e-53
 Identities = 67/286 (23%), Positives = 115/286 (40%), Gaps = 22/286 (7%)

Query: 758  IGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS 817
            IG+G FG V++ +   G EVAVK+F  +  R+    + E      +RH NI+ FI++ + 
Sbjct: 11   IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 818  DDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FGYS 868
            D+       LV +Y  +GSL   L  + Y + +   + + +  AS L +LH         
Sbjct: 69   DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT--QTQTLATIGYMAPEY--- 923
              I H DLK  N+L+  N    ++D G+A        ++       + T  YMAPE    
Sbjct: 127  PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 924  ---GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM-EVVD 979
                +        D+Y+ G++  E   R          ++     V     +  M +VV 
Sbjct: 187  SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 980  ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
               L     +     + +  +  +  +C   +   R+ A  I   L
Sbjct: 247  EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 9e-53
 Identities = 58/288 (20%), Positives = 113/288 (39%), Gaps = 29/288 (10%)

Query: 744  ELFQATNGFS-ENNLIGRGGFGFVYKARIQ---DGMEVAVKVFDLQYGRA-IKSFDIECG 798
            +LF   +     +  +G G FG V +   +     ++VA+KV      +A  +    E  
Sbjct: 2    KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 799  MIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVAS 858
            ++ ++ +  I++ I  C ++    LV+E    G L K L      + +     ++  V+ 
Sbjct: 62   IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 859  ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIG 917
             ++YL        +H DL   NVLL +   A +SDFG++K    +D   T        + 
Sbjct: 121  GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 918  YMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV 977
            + APE     + S+  DV+S+G+ + E  +  +   +   G   +               
Sbjct: 178  WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------ 225

Query: 978  VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                    + K      +C   ++ L   C I   E+R +   +  ++
Sbjct: 226  -------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 2e-52
 Identities = 66/281 (23%), Positives = 124/281 (44%), Gaps = 29/281 (10%)

Query: 752  FSENNLIGRGGFGFVYKARIQDG-----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRH 805
             +   +IG G FG VYK  ++       + VA+K     Y  +    F  E G++ +  H
Sbjct: 9    VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 806  RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             NII+     S      ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL  
Sbjct: 69   HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 866  GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE-DQSLTQTQTLATIGYMAPEYG 924
              ++  +H DL   N+L++ N+V  +SDFG+++    + + + T +     I + APE  
Sbjct: 128  --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 925  REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
               + ++  DV+SFGI++ E  T  +      +    +K   +   L + M+   A    
Sbjct: 186  SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA---- 241

Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                           ++ L M+C  +    R    +IV+ L
Sbjct: 242  ---------------IYQLMMQCWQQERARRPKFADIVSIL 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-52
 Identities = 71/272 (26%), Positives = 113/272 (41%), Gaps = 32/272 (11%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
              IG+G FG V       G +VAVK          ++F  E  ++ ++RH N+++ +   
Sbjct: 13   QTIGKGEFGDVMLGD-YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 816  SSDDFK-ALVLEYMPYGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
              +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H
Sbjct: 70   VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
             DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 127  RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            DV+SFGI+L E ++  +        +  + R                     +     A 
Sbjct: 182  DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------------------KGYKMDAP 222

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            + C   V+ +   C       R +  ++  +L
Sbjct: 223  DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 3e-52
 Identities = 64/304 (21%), Positives = 119/304 (39%), Gaps = 34/304 (11%)

Query: 743  LELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKS-FDIECGMI 800
            +EL    + F + + +G G  G V+K      G+ +A K+  L+   AI++    E  ++
Sbjct: 1    MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 801  KRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
                   I+ F  +  SD   ++ +E+M  GSL++ L  +   +       + I V   L
Sbjct: 59   HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 861  EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMA 920
             YL   +   I+H D+KP+N+L++      L DFG++   L +  +      + T  YM+
Sbjct: 118  TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMA---NSFVGTRSYMS 171

Query: 921  PEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA 980
            PE  +    S   D++S G+ L+E    + P       E+ L          +       
Sbjct: 172  PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 981  NLLSHEDKHFVAKEQCMSF-----------------------VFNLAMKCTIESPEERIN 1017
                    + +     M+                          +   KC I++P ER +
Sbjct: 232  TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 1018 AKEI 1021
             K++
Sbjct: 292  LKQL 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (455), Expect = 4e-51
 Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 26/276 (9%)

Query: 752  FSENNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
             +  + +G G +G VY+   +   + VAVK         ++ F  E  ++K I+H N+++
Sbjct: 19   ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSV 869
             +  C+ +    ++ E+M YG+L   L   N   +     L +   ++SA+EYL      
Sbjct: 78   LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 134

Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
              IH DL   N L+ +N +  ++DFG+++  +  D           I + APE     + 
Sbjct: 135  NFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
            S   DV++FG++L E  T                          + E+++      +D  
Sbjct: 194  SIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------QVYELLE------KDYR 234

Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                E C   V+ L   C   +P +R +  EI    
Sbjct: 235  MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 9e-51
 Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 30/278 (10%)

Query: 754  ENNLIGRGGFGFVYKARIQD---GMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNI 808
            E+  +G G FG V K   Q       VAVK+   +            E  +++++ +  I
Sbjct: 11   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            ++ I  C ++ +  LV+E    G L K L  + + +     + ++  V+  ++YL     
Sbjct: 71   VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREG 927
               +H DL   NVLL     A +SDFG++K    ++            + + APE     
Sbjct: 127  -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
            + S+  DV+SFG+++ E F+  +       G                             
Sbjct: 186  KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------------G 226

Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +       C   +++L   C     E R     +  +L
Sbjct: 227  ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 29/277 (10%)

Query: 752  FSEN----NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR-AIKSFDIECGMIKRIRH 805
            F E+      +G G +G V  A        VAVK+ D++      ++   E  + K + H
Sbjct: 3    FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 806  RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             N++KF       + + L LEY   G L   +   +  +           + + + YLH 
Sbjct: 63   ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH- 120

Query: 866  GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
               + I H D+KP N+LLD+     +SDFG+A  F   ++     +   T+ Y+APE  +
Sbjct: 121  --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 926  EGRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
                     DV+S GI+L      + P D+          W      ++  + +D+  L 
Sbjct: 179  RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL- 237

Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                              L  K  +E+P  RI   +I
Sbjct: 238  -----------------ALLHKILVENPSARITIPDI 257

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-50
 Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 29/272 (10%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
              +G G FG VYKA+  +  +  A KV D +    ++ + +E  ++    H NI+K + +
Sbjct: 18   GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 815  CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
               ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH 
Sbjct: 78   FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 875  DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY-----GREGRV 929
            DLK  N+L   +    L+DFG++    +  Q         T  +MAPE       ++   
Sbjct: 135  DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 192

Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
                DV+S GI L+E    + P  E     + LK   ++   ++      +N        
Sbjct: 193  DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK------ 246

Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                        +   KC  ++ + R    ++
Sbjct: 247  ------------DFLKKCLEKNVDARWTTSQL 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 9e-50
 Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 51/300 (17%)

Query: 757  LIGRGGFGFVYKA------RIQDGMEVAVKVFDLQYGRA-IKSFDIECGMIKRI-RHRNI 808
            ++G G FG V  A      +    ++VAVK+   +   +  ++   E  M+ ++  H NI
Sbjct: 44   VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSN----------------------YILDI 846
            +  + +C+      L+ EY  YG L   L S                         +L  
Sbjct: 104  VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 847  FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
               L     VA  +E+L        +H DL   NVL+    V  + DFG+A+  + +   
Sbjct: 164  EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 907  LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV 966
            + +      + +MAPE   EG  +   DV+S+GI+L E F+           +    + +
Sbjct: 221  VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 967  NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026
                                             ++ +   C      +R +   + + L 
Sbjct: 281  Q------------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-49
 Identities = 63/279 (22%), Positives = 117/279 (41%), Gaps = 30/279 (10%)

Query: 755  NNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQYGRA-IKSFDIECGMIKRIRHRNII 809
            N +IGRG FG VY   + D     +  AVK  +       +  F  E  ++K   H N++
Sbjct: 32   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 810  KFISSCSSDDFKA-LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
              +  C   +    +VL YM +G L   + +  +   +   +   + VA  +++L     
Sbjct: 92   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 149

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED--QSLTQTQTLATIGYMAPEYGRE 926
               +H DL   N +LD+     ++DFG+A+    ++      +T     + +MA E  + 
Sbjct: 150  -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + +T  DV+SFG++L E  TR  P       ++        LL               +
Sbjct: 209  QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL---------------Q 249

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
             +  +  E C   ++ + +KC     E R +  E+V+++
Sbjct: 250  GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (440), Expect = 6e-49
 Identities = 73/306 (23%), Positives = 115/306 (37%), Gaps = 52/306 (16%)

Query: 750  NGFSENNLIGRGGFGFVYKAR------IQDGMEVAVKVFDLQY-GRAIKSFDIECGMIKR 802
            N       IG G FG V++AR       +    VAVK+   +        F  E  ++  
Sbjct: 13   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 803  IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNY-------------------- 842
              + NI+K +  C+      L+ EYM YG L + L S +                     
Sbjct: 73   FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 843  ---ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 899
                L   ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ 
Sbjct: 133  GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 900  FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGE 959
                D           I +M PE     R +T  DV+++G++L E F+           E
Sbjct: 190  IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 960  MTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAK 1019
              +              V D N+L+         E C   ++NL   C  + P +R +  
Sbjct: 250  EVIYY------------VRDGNILA-------CPENCPLELYNLMRLCWSKLPADRPSFC 290

Query: 1020 EIVTKL 1025
             I   L
Sbjct: 291  SIHRIL 296

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 8e-49
 Identities = 66/276 (23%), Positives = 113/276 (40%), Gaps = 33/276 (11%)

Query: 755  NNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKF 811
            +  IGRG F  VYK    +  +EVA      +       + F  E  M+K ++H NI++F
Sbjct: 14   DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 812  ISSCSS----DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
              S  S         LV E M  G+L+  L     ++ I    +    +   L++LH   
Sbjct: 74   YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 868  SVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            + PIIH DLK +N+ +        + D G+A        S  +   + T  +MAPE   E
Sbjct: 132  TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFMAPEM-YE 186

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             +   + DVY+FG+ ++E  T + P  E        +R  + +   S  +V    +    
Sbjct: 187  EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
                            +   C  ++ +ER + K+++
Sbjct: 244  ---------------EIIEGCIRQNKDERYSIKDLL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-48
 Identities = 61/299 (20%), Positives = 106/299 (35%), Gaps = 46/299 (15%)

Query: 752  FSENNLIGRGGFGFVYKARI------QDGMEVAVKVFDLQYGRA-IKSFDIECGMIKRI- 803
             S    +G G FG V +A           M VAVK+          ++   E  ++  + 
Sbjct: 25   LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 804  RHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSS-----------------NYILDI 846
             H NI+  + +C+      ++ EY  YG L   L                       LD+
Sbjct: 85   NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 847  FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS 906
               L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+    +   
Sbjct: 145  EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 907  LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWV 966
            + +      + +MAPE       +   DV+S+GI L E F+           +    + +
Sbjct: 202  VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 967  NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                               E    ++ E   + ++++   C    P +R   K+IV  +
Sbjct: 262  K------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-48
 Identities = 63/276 (22%), Positives = 98/276 (35%), Gaps = 30/276 (10%)

Query: 758  IGRGGFGFVYKARI----QDGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIK 810
            +G G FG V +          + VAVK           A+  F  E   +  + HRN+I+
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 811  FISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                  +   K +V E  P GSL   L        +       + VA  + YL    S  
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 871  IIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGYMAPEYGREGRV 929
             IH DL   N+LL    +  + DFG+ +   + +D  + Q        + APE  +    
Sbjct: 132  FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKH 989
            S   D + FG+ L E FT  +       G   L +                     E + 
Sbjct: 192  SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------------------EGER 233

Query: 990  FVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                E C   ++N+ ++C    PE+R     +   L
Sbjct: 234  LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (439), Expect = 1e-48
 Identities = 62/278 (22%), Positives = 102/278 (36%), Gaps = 36/278 (12%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDL---QYGRAIKSFDIECGMIKRIRHRN 807
            FS+   IG G FG VY AR +++   VA+K       Q     +    E   ++++RH N
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
             I++      +    LV+EY    + +         L   +   +       L YLH   
Sbjct: 77   TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY---G 924
            S  +IH D+K  N+LL +  +  L DFG A               + T  +MAPE     
Sbjct: 133  SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAM 186

Query: 925  REGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
             EG+     DV+S GI  +E   RK P                               ++
Sbjct: 187  DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------------------IA 227

Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
              +   +       +  N    C  + P++R  ++ ++
Sbjct: 228  QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-48
 Identities = 63/277 (22%), Positives = 100/277 (36%), Gaps = 32/277 (11%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFI 812
              IG G +G   K R   DG  +  K  D         +    E  +++ ++H NI+++ 
Sbjct: 10   YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 813  SSC--SSDDFKALVLEYMPYGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLH--F 865
                  ++    +V+EY   G L   +         LD    L +M  +  AL+  H   
Sbjct: 70   DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 866  GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
                 ++H DLKP NV LD      L DFG+A+  L  D S  +     T  YM+PE   
Sbjct: 130  DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFV-GTPYYMSPEQMN 187

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
                +   D++S G +L E      P    FT               S  E+        
Sbjct: 188  RMSYNEKSDIWSLGCLLYELCALMPP----FTAF-------------SQKELAGKIR--- 227

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
            E K      +    +  +  +        R + +EI+
Sbjct: 228  EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 7e-48
 Identities = 65/267 (24%), Positives = 106/267 (39%), Gaps = 26/267 (9%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISS 814
              IG+G  G VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ ++ S
Sbjct: 26   EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 815  CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 874
                D   +V+EY+  GSL   +  +    D  Q   +  +   ALE+LH   S  +IH 
Sbjct: 86   YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 875  DLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 934
            D+K +N+LL  +    L+DFG       E    +      T  +MAPE           D
Sbjct: 141  DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVD 198

Query: 935  VYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKE 994
            ++S GIM +E    + P               N    +   E + A              
Sbjct: 199  IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR----------- 247

Query: 995  QCMSFVFNLAMKCTIESPEERINAKEI 1021
                   +   +C     E+R +AKE+
Sbjct: 248  -------DFLNRCLDMDVEKRGSAKEL 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 9e-48
 Identities = 57/289 (19%), Positives = 114/289 (39%), Gaps = 30/289 (10%)

Query: 743  LELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKV-----FDLQYGRAIKSFDIE 796
            L + + T  F +  ++G G FG VYK   I +G +V + V      +    +A K    E
Sbjct: 3    LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 797  CGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV 856
              ++  + + ++ + +  C +   + L+ + MP+G L   +      +     LN  + +
Sbjct: 62   AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 857  ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
            A  + YL       ++H DL   NVL+       ++DFG+AK    E++          I
Sbjct: 121  AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 917  GYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME 976
             +MA E       +   DV+S+G+ + E  T      +                   I  
Sbjct: 178  KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------ISS 224

Query: 977  VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
            +++      + +       C   V+ + +KC +   + R   +E++ + 
Sbjct: 225  ILE------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-47
 Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 33/271 (12%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFD---LQYGRAIKSFDIECGMIKRIRHRNIIKF 811
              +G+G FG VY AR  Q    +A+KV     L+          E  +   +RH NI++ 
Sbjct: 12   RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                       L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +
Sbjct: 72   YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 127

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
            IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE         
Sbjct: 128  IHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 932  NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV 991
              D++S G++  E    K P    F        +      IS +E    + ++   +  +
Sbjct: 184  KVDLWSLGVLCYEFLVGKPP----FEANT----YQETYKRISRVEFTFPDFVTEGARDLI 235

Query: 992  AKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
                          +    +P +R   +E++
Sbjct: 236  -------------SRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 3e-47
 Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 29/274 (10%)

Query: 757  LIGRGGFGFVYKARI----QDGMEVAVKVFDLQYGRAIKS-FDIECGMIKRIRHRNIIKF 811
             IG G FG V++          + VA+K        +++  F  E   +++  H +I+K 
Sbjct: 14   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 812  ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
            I   + ++   +++E    G L   L    Y LD+   +     +++AL YL    S   
Sbjct: 74   IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 872  IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
            +H D+   NVL+  N    L DFG+++ ++++      ++    I +MAPE     R ++
Sbjct: 130  VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 932  NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV 991
              DV+ FG+ + E         +       + R  N                    +   
Sbjct: 189  ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------------------GERLP 229

Query: 992  AKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                C   +++L  KC    P  R    E+  +L
Sbjct: 230  MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-46
 Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 45/296 (15%)

Query: 750  NGFSENNLIGRGGFGFVYKARIQDG---MEVAVKVFDLQYGR-AIKSFDIECGMIKRI-R 804
            N     ++IG G FG V KARI+     M+ A+K       +   + F  E  ++ ++  
Sbjct: 10   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 805  HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------------LDIFQR 849
            H NII  + +C    +  L +EY P+G+L   L  S  +               L   Q 
Sbjct: 70   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 850  LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
            L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++     +  + +
Sbjct: 130  LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 910  TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDL 969
            T     + +MA E       +TN DV+S+G++L E  +         T     ++     
Sbjct: 184  TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 240

Query: 970  LLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                            +         C   V++L  +C  E P ER +  +I+  L
Sbjct: 241  ----------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  167 bits (425), Expect = 2e-46
 Identities = 52/268 (19%), Positives = 95/268 (35%), Gaps = 26/268 (9%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
             +G G FG V++      G   A K     +    ++   E   +  +RH  ++    + 
Sbjct: 33   ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
              D+   ++ E+M  G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93   EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 876  LKPNNVLL--DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            LKP N++     +    L DFG+      +      T T     + APE      V    
Sbjct: 150  LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            D++S G++     +   P    F GE       ND   +  ++  D N+           
Sbjct: 207  DMWSVGVLSYILLSGLSP----FGGE-------NDDETLRNVKSCDWNMDDSAFSGI--S 253

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEI 1021
            E    F+     K  +  P  R+   + 
Sbjct: 254  EDGKDFI----RKLLLADPNTRMTIHQA 277

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 9e-46
 Identities = 60/292 (20%), Positives = 120/292 (41%), Gaps = 38/292 (13%)

Query: 752  FSENNLIGRGGFGFVYKA------RIQDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIR 804
             + +  +G+G FG VY+       + +    VA+K  +     R    F  E  ++K   
Sbjct: 22   ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 805  HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYI---------LDIFQRLNIMID 855
              ++++ +   S      +++E M  G L+  L S               + + + +  +
Sbjct: 82   CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 856  VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLAT 915
            +A  + YL+   +   +H DL   N ++ ++    + DFGM +   + D      + L  
Sbjct: 142  IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 916  IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM 975
            + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+            
Sbjct: 199  VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----------- 247

Query: 976  EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027
             V++  LL   D        C   +F L   C   +P+ R +  EI++ +  
Sbjct: 248  -VMEGGLLDKPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 59/274 (21%), Positives = 105/274 (38%), Gaps = 29/274 (10%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG---RAIKSFDIECGMIKRIRHRN 807
            F    ++G G F  V  AR +    E A+K+ + ++      +     E  ++ R+ H  
Sbjct: 10   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
             +K   +   D+     L Y   G L K +       D         ++ SALEYLH   
Sbjct: 70   FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH--- 125

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
               IIH DLKP N+LL+++M   ++DFG AK    E +       + T  Y++PE   E 
Sbjct: 126  GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
                + D+++ G ++ +      P    F                +   +    +     
Sbjct: 186  SACKSSDLWALGCIIYQLVAGLPP----FRAG-------------NEYLIFQKII----K 224

Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
              +   E+      +L  K  +    +R+  +E+
Sbjct: 225  LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (420), Expect = 1e-45
 Identities = 51/268 (19%), Positives = 99/268 (36%), Gaps = 26/268 (9%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
             +G G FG V++      G     K  +  Y     +   E  ++ ++ H  +I    + 
Sbjct: 36   ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
                   L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D
Sbjct: 96   EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 876  LKPNNVLLD--DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            +KP N++ +        + DFG+A      +       T AT  + APE      V    
Sbjct: 153  IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            D+++ G++     +   P    F GE  L+         ++  V   +    ED      
Sbjct: 210  DMWAIGVLGYVLLSGLSP----FAGEDDLE---------TLQNVKRCDWEFDEDAFSSVS 256

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEI 1021
             +   F+         + P +R+   + 
Sbjct: 257  PEAKDFI----KNLLQKEPRKRLTVHDA 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-43
 Identities = 69/295 (23%), Positives = 111/295 (37%), Gaps = 47/295 (15%)

Query: 756  NLIGRGGFGFVYKAR--------IQDGMEVAVKVFDLQYG-RAIKSFDIECGMIKRI-RH 805
              +G G FG V  A              +VAVK+       + +     E  M+K I +H
Sbjct: 19   KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 806  RNIIKFISSCSSDDFKALVLEYMPYGSLEKCL---------------YSSNYILDIFQRL 850
            +NII  + +C+ D    +++EY   G+L + L               ++    L     +
Sbjct: 79   KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 851  NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQT 910
            +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+     D     T
Sbjct: 139  SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 911  QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL 970
                 + +MAPE   +   +   DV+SFG++L E FT           E   K       
Sbjct: 196  NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK---- 251

Query: 971  LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                           E         C + ++ +   C    P +R   K++V  L
Sbjct: 252  ---------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  155 bits (393), Expect = 6e-43
 Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 31/279 (11%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGR---AIKSFDIECGMIKRIRHRNIIKFI 812
            ++G GG   V+ AR ++   +VAVKV      R       F  E      + H  I+   
Sbjct: 14   ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 813  SSCSSDDFKA----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
             +  ++        +V+EY+   +L   +++    +   + + ++ D   AL + H    
Sbjct: 74   DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLA-TIGYMAPEYGREG 927
              IIH D+KP N+++       + DFG+A+       S+TQT  +  T  Y++PE  R  
Sbjct: 130  NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
             V    DVYS G +L E  T + P    FTG+             S + V   ++     
Sbjct: 190  SVDARSDVYSLGCVLYEVLTGEPP----FTGD-------------SPVSVAYQHVREDPI 232

Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEERI-NAKEIVTKL 1025
                  E   + +  + +K   ++PE R   A E+   L
Sbjct: 233  PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-40
 Identities = 59/298 (19%), Positives = 104/298 (34%), Gaps = 45/298 (15%)

Query: 752  FSENNLIGRGGFGFVYKAR------IQDGMEVAVKVFDLQYGRA-IKSFDIECGMIKRIR 804
                  +GRG FG V +A             VAVK+       +  ++   E  ++  I 
Sbjct: 15   LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 805  HRNIIKFI--SSCSSDDFKALVLEYMPYGSLEKCLYSSNY---------------ILDIF 847
            H   +  +  +         +++E+  +G+L   L S                   L + 
Sbjct: 75   HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 848  QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL 907
              +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+   K+   +
Sbjct: 135  HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 908  TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVN 967
             +      + +MAPE   +   +   DV+SFG++L E F+           +    R + 
Sbjct: 192  RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 968  DLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                              E     A +     ++   + C    P +R    E+V  L
Sbjct: 252  ------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 50/268 (18%), Positives = 104/268 (38%), Gaps = 27/268 (10%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
             +GRG FG V++            K   ++ G        E  ++   RHRNI+    S 
Sbjct: 12   DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             S +   ++ E++    + + + +S + L+  + ++ +  V  AL++LH   S  I H D
Sbjct: 71   ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 876  LKPNNVLLD--DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            ++P N++     +    + +FG A+                   Y APE  +   VST  
Sbjct: 128  IRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            D++S G ++    +   P    F  E             +  ++++  + +       A 
Sbjct: 185  DMWSLGTLVYVLLSGINP----FLAE-------------TNQQIIENIMNAEYTFDEEAF 227

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEI 1021
            ++      +   +  ++  + R+ A E 
Sbjct: 228  KEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 4e-40
 Identities = 50/268 (18%), Positives = 95/268 (35%), Gaps = 23/268 (8%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAI-KSFDIECGMIKRIRHRNIIKFIS 813
            +++G G F  V  A   +    VA+K    +       S + E  ++ +I+H NI+    
Sbjct: 15   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 814  SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
               S     L+++ +  G L   +    +         ++  V  A++YLH    V    
Sbjct: 75   IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
                     LD++    +SDFG++K    ED     +    T GY+APE   +   S   
Sbjct: 134  KPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190

Query: 934  DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAK 993
            D +S G++         P    F  E             +  ++ +  L +  +      
Sbjct: 191  DCWSIGVIAYILLCGYPP----FYDE-------------NDAKLFEQILKAEYEFDSPYW 233

Query: 994  EQCMSFVFNLAMKCTIESPEERINAKEI 1021
            +       +       + PE+R   ++ 
Sbjct: 234  DDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-39
 Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 22/281 (7%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY-----GRAIKSFDIECGMIKRIRHRNII 809
            + +G G F  VYKAR       VA+K   L +         ++   E  +++ + H NII
Sbjct: 4    DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
              + +       +LV ++M    LE  +  ++ +L        M+     LEYLH     
Sbjct: 64   GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 870  PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRV 929
             I+H DLKPNN+LLD+N V  L+DFG+AK F     +   T  + T  Y APE     R+
Sbjct: 120  WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 930  -STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK 988
                 D+++ G +L E   R          +  L R    L   +  +  D   L     
Sbjct: 178  YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 989  HFVAKEQCMSFVF--------NLAMKCTIESPEERINAKEI 1021
                    +  +F        +L     + +P  RI A + 
Sbjct: 237  FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (364), Expect = 5e-39
 Identities = 64/291 (21%), Positives = 112/291 (38%), Gaps = 45/291 (15%)

Query: 752  FSEN----NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDI---------EC 797
            F EN     ++GRG    V +        E AVK+ D+  G +  + ++         E 
Sbjct: 1    FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 798  GMIKRIR-HRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDV 856
             +++++  H NII+   +  ++ F  LV + M  G L   L +    L   +   IM  +
Sbjct: 61   DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRAL 119

Query: 857  ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATI 916
               +  LH    + I+H DLKP N+LLDD+M   L+DFG +      D      +   T 
Sbjct: 120  LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173

Query: 917  GYMAPEYGREGRVSTNG------DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLL 970
             Y+APE         +       D++S G+++        P    F              
Sbjct: 174  SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR----------- 218

Query: 971  LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                M ++   +  +        +     V +L  +  +  P++R  A+E 
Sbjct: 219  --KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  143 bits (362), Expect = 9e-39
 Identities = 65/278 (23%), Positives = 110/278 (39%), Gaps = 19/278 (6%)

Query: 756  NLIGRGGFGFVYKARIQDGMEVAVKVFDL--QYGRAIKSFDIECGMIKRIRHRNIIKFIS 813
              IG G +G VYKA+   G   A+K   L  +      +   E  ++K ++H NI+K   
Sbjct: 8    EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 814  SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
               +     LV E++    L+K L      L+     + ++ + + + Y H      ++H
Sbjct: 68   VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 874  CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGREGRVSTN 932
             DLKP N+L++      ++DFG+A+ F    +    T  + T+ Y AP+      + ST 
Sbjct: 124  RDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 933  GDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVA 992
             D++S G +  E              +  L R    L   +     +   L   D +F  
Sbjct: 182  IDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 993  KEQCMSFVF---------NLAMKCTIESPEERINAKEI 1021
             E      F         +L  K     P +RI AK+ 
Sbjct: 241  YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (359), Expect = 4e-38
 Identities = 53/278 (19%), Positives = 92/278 (33%), Gaps = 27/278 (9%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
             IG G FG +Y    I  G EVA+K+  ++         IE  + K ++    I  I  C
Sbjct: 14   KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
             ++    +++  +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 72   GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 876  LKPNNVL---LDDNMVAHLSDFGMAKPF-----LKEDQSLTQTQTLATIGYMAPEYGREG 927
            +KP+N L        + ++ DFG+AK +      +            T  Y +       
Sbjct: 129  VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              S   D+ S G +LM       P           K        +S    V       E 
Sbjct: 189  EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248

Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
              ++               C     +++ +   +    
Sbjct: 249  ATYL-------------NFCRSLRFDDKPDYSYLRQLF 273

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (359), Expect = 6e-38
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 13/200 (6%)

Query: 756 NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKF 811
             +G G FG V+  R   +G   A+KV   +     + ++  + E  M+  + H  II+ 
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 812 ISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
             +        ++++Y+  G     L   +             +V  ALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 872 IHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVST 931
           I+ DLKP N+LLD N    ++DFG AK       +L       T  Y+APE       + 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180

Query: 932 NGDVYSFGIMLMETFTRKKP 951
           + D +SFGI++ E      P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 9e-38
 Identities = 64/294 (21%), Positives = 113/294 (38%), Gaps = 19/294 (6%)

Query: 744  ELFQATNGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFD-LQYGRAIKSFDIECGMIK 801
            ++F     ++  + IG G +G V  A    + + VA+K     ++    +    E  ++ 
Sbjct: 2    QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 802  RIRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYS--SNYILDIFQRLNIMIDVASA 859
            R RH NII       +   + +   Y+    +   LY       L        +  +   
Sbjct: 62   RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 860  LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK-EDQSLTQTQTLATIGY 918
            L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +AT  Y
Sbjct: 122  LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 919  MAPEYGREGRVSTN-GDVYSFGIMLMETFTRKKPTDESFTGEM------TLKRWVNDLLL 971
             APE     +  T   D++S G +L E  + +         +        L     + L 
Sbjct: 179  RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 972  ISIMEVVDANLLSHEDKHFVAKEQCMSFV----FNLAMKCTIESPEERINAKEI 1021
              I       LLS   K+ V   +          +L  K    +P +RI  ++ 
Sbjct: 239  CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-37
 Identities = 58/276 (21%), Positives = 106/276 (38%), Gaps = 35/276 (12%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY------GRAIKSFDIECGMIKRIRHRNII 809
             +G G F  V K R    G++ A K    +       G + +  + E  ++K I+H N+I
Sbjct: 17   ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 810  KFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 869
                   +     L+LE +  G L     +    L   +    +  + + + YLH   S+
Sbjct: 77   TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SL 132

Query: 870  PIIHCDLKPNNVLLDDNMVA----HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             I H DLKP N++L D  V      + DFG+A      D          T  ++APE   
Sbjct: 133  QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVN 189

Query: 926  EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
               +    D++S G++     +   P    F G+   +           +  V A     
Sbjct: 190  YEPLGLEADMWSIGVITYILLSGASP----FLGDTKQE----------TLANVSAVNYEF 235

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            ED++F       +   +   +  ++ P++R+  ++ 
Sbjct: 236  EDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 65/282 (23%), Positives = 116/282 (41%), Gaps = 17/282 (6%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVF--DLQYGRAIKSFDIECGMIKRIRHRNI 808
            F +   IG G +G VYKAR    G  VA+K    D +      +   E  ++K + H NI
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 809  IKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 868
            +K +    +++   LV E++     +    S+   + +    + +  +   L + H   S
Sbjct: 64   VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120

Query: 869  VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGREG 927
              ++H DLKP N+L++      L+DFG+A+ F    +  T T  + T+ Y APE      
Sbjct: 121  HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
              ST  D++S G +  E  TR+         +   + +        ++     ++  ++ 
Sbjct: 179  YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 988  KHFVAKEQCMSFVF--------NLAMKCTIESPEERINAKEI 1021
                   Q  S V         +L  +     P +RI+AK  
Sbjct: 239  SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  142 bits (358), Expect = 3e-37
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 16/219 (7%)

Query: 750 NGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDL------QYGRAIKSFDIECGMIKR 802
           N FS + +IGRGGFG VY  R    G   A+K  D       Q      +  I   ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 803 IRHRNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 862
                I+    +  + D  + +L+ M  G L   L S + +           ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122

Query: 863 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE 922
           +H   +  +++ DLKP N+LLD++    +SD G+A  F K+        ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPE 175

Query: 923 YGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGEM 960
             ++G    ++ D +S G ML +      P  +  T + 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 3e-37
 Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 26/285 (9%)

Query: 756  NLIGRGGFGFVYKAR--IQDGMEVAVKVFDLQYGRAIKSFDI-----ECGMIKRIRHRNI 808
              IG G +G V+KAR     G  VA+K   +Q G                 ++   H N+
Sbjct: 13   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 809  IKFISSCSSDDFKA-----LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 863
            ++    C+           LV E++               +      ++M  +   L++L
Sbjct: 73   VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 864  HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEY 923
            H   S  ++H DLKP N+L+  +    L+DFG+A+ +      +  T  + T+ Y APE 
Sbjct: 133  H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 186

Query: 924  GREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL 983
              +   +T  D++S G +  E F RK     S +    L + ++ + L    +      L
Sbjct: 187  LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 984  SHEDKHFVAKEQCMSFV-------FNLAMKCTIESPEERINAKEI 1021
              +  H  + +    FV        +L +KC   +P +RI+A   
Sbjct: 246  PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 6e-37
 Identities = 58/276 (21%), Positives = 112/276 (40%), Gaps = 32/276 (11%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG---RAIKSFDIECGMIKR-IRHR 806
            F  + ++G+G FG V+ A   +     A+K            ++   +E  ++     H 
Sbjct: 4    FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 807  NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
             +     +  + +    V+EY+  G L   + S +   D+ +      ++   L++LH  
Sbjct: 64   FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH-- 120

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
             S  I++ DLK +N+LLD +    ++DFGM K  +  D          T  Y+APE    
Sbjct: 121  -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLG 177

Query: 927  GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE 986
             + + + D +SFG++L E    + P    F G+   + + +    I +        L  E
Sbjct: 178  QKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHS----IRMDNPFYPRWLEKE 229

Query: 987  DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022
             K  +             +K  +  PE+R+  +  +
Sbjct: 230  AKDLL-------------VKLFVREPEKRLGVRGDI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-36
 Identities = 49/274 (17%), Positives = 100/274 (36%), Gaps = 32/274 (11%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
            ++G G  G V +    +   + A+K+      +A +  ++     +  +  +I++ +   
Sbjct: 19   VLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVEL---HWRASQCPHIVRIVDVY 74

Query: 816  ----SSDDFKALVLEYMPYGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVP 870
                +      +V+E +  G L   +    +      +   IM  +  A++YLH   S+ 
Sbjct: 75   ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131

Query: 871  IIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
            I H D+KP N+L      N +  L+DFG AK     +   T      T  Y+APE     
Sbjct: 132  IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPE 188

Query: 928  RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED 987
            +   + D++S G+++        P   +    ++        +        + + +S E 
Sbjct: 189  KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 988  KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
            K  +                    P +R+   E 
Sbjct: 249  KMLI-------------RNLLKTEPTQRMTITEF 269

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 6e-36
 Identities = 59/279 (21%), Positives = 108/279 (38%), Gaps = 19/279 (6%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFI 812
              IG G +G V+KA+  +    VA+K   L         S   E  ++K ++H+NI++  
Sbjct: 8    EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 813  SSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 872
                SD    LV E+      +     +  + D     + +  +   L + H      ++
Sbjct: 68   DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123

Query: 873  HCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPE-YGREGRVST 931
            H DLKP N+L++ N    L++FG+A+ F    +    +  + T+ Y  P+        ST
Sbjct: 124  HRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 932  NGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFV 991
            + D++S G +  E     +P       +  LKR    L   +  +      L     + +
Sbjct: 182  SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 992  AKEQCMSFVF---------NLAMKCTIESPEERINAKEI 1021
                               +L       +P +RI+A+E 
Sbjct: 242  YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 8e-36
 Identities = 64/289 (22%), Positives = 110/289 (38%), Gaps = 29/289 (10%)

Query: 752  FSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIK 810
            +++  +IG G FG VY+A+    G  VA+K       +  +  + E  +++++ H NI++
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 811  FISSCSSDD------FKALVLEYMPYGSLEKCLY--SSNYILDIFQRLNIMIDVASALEY 862
                  S        +  LVL+Y+P        +   +   L +      M  +  +L Y
Sbjct: 78   LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 863  LHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAP 921
            +H   S  I H D+KP N+LLD D  V  L DFG AK           +   +       
Sbjct: 138  IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192

Query: 922  EYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDAN 981
                    +++ DV+S G +L E    +       +G   L   +  L   +  ++ + N
Sbjct: 193  LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD-SGVDQLVEIIKVLGTPTREQIREMN 251

Query: 982  LLSHEDKHFVAKEQCMSFVF---------NLAMKCTIESPEERINAKEI 1021
                E K    K    + VF          L  +    +P  R+   E 
Sbjct: 252  PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 7e-35
 Identities = 56/276 (20%), Positives = 93/276 (33%), Gaps = 45/276 (16%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVF------DLQYGRAIKSFDIECGMIKRIR--HRN 807
            L+G GGFG VY    + D + VA+K        D           +E  ++K++      
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 808  IIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
            +I+ +      D   L+LE            +    L      +    V  A+ + H   
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 868  SVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            +  ++H D+K  N+L+D +     L DFG         +    T    T  Y  PE+ R 
Sbjct: 128  NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183

Query: 927  GRVSTNG-DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH 985
             R       V+S GI+L +      P    F  +  + R                     
Sbjct: 184  HRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRG-------------------- 219

Query: 986  EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                   +++  S   +L   C    P +R   +EI
Sbjct: 220  ---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (326), Expect = 8e-34
 Identities = 39/282 (13%), Positives = 87/282 (30%), Gaps = 33/282 (11%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
             IG G FG +++   + +  +VA+K    +          E    K +     I  +   
Sbjct: 12   RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 816  SSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 875
              +    +++  +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 70   GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 876  LKPNNVLLDDNMVAH-----LSDFGMAK----PFLKEDQSLTQTQTLA-TIGYMAPEYGR 925
            +KP+N L+      +     + DFGM K    P  K+     + + L+ T  YM+     
Sbjct: 127  IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 926  EGRVSTNGDVYSFGIMLMETFTRK--KPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL 983
                S   D+ + G + M            ++ T +   +R         + E+      
Sbjct: 187  GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---- 242

Query: 984  SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKL 1025
                             +         + +   +   +    
Sbjct: 243  -----------GFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-33
 Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 29/291 (9%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFI 812
              IG+G FG V+KAR  + G +VA+K   ++        +   E  +++ ++H N++  I
Sbjct: 16   AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 813  SSCSSDDFKA--------LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 864
              C +             LV ++  +               + +   +M  + + L Y+H
Sbjct: 76   EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH 134

Query: 865  FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF--LKEDQSLTQTQTLATIGYMAPE 922
                  I+H D+K  NVL+  + V  L+DFG+A+ F   K  Q    T  + T+ Y  PE
Sbjct: 135  ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 923  YGREGR-VSTNGDVYSFGIMLMETFTRKKPTD-----------ESFTGEMTLKRWVNDLL 970
                 R      D++  G ++ E +TR                    G +T + W N   
Sbjct: 192  LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 971  LISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                 ++        + K  +       +  +L  K  +  P +RI++ + 
Sbjct: 252  YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-32
 Identities = 60/302 (19%), Positives = 107/302 (35%), Gaps = 27/302 (8%)

Query: 740  FTYLELFQATNGFSEN----NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKS 792
            F   E+ +              +G G +G V  A   + G +VA+K     +      K 
Sbjct: 4    FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 793  FDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY---MPYGSLEKCLYSSNYILDIFQR 849
               E  ++K +RH N+I  +   + D+      ++   MP+   +      +  L   + 
Sbjct: 64   AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 850  LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQ 909
              ++  +   L Y+H   +  IIH DLKP N+ ++++    + DFG+A    ++  S   
Sbjct: 124  QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMT 176

Query: 910  TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP---------TDESFTGEM 960
               +              R +   D++S G ++ E  T K             E      
Sbjct: 177  GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 961  TLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVF-NLAMKCTIESPEERINAK 1019
            T        L     +     L   E K F +     S +  NL  K  +   E+R+ A 
Sbjct: 237  TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

Query: 1020 EI 1021
            E 
Sbjct: 297  EA 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 9e-32
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 10/206 (4%)

Query: 750 NGFSENNLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRA---IKSFDIECGMIKRIRH 805
           N F    L+G+G FG V   R    G   A+K+   +   A   +     E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 806 RNIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 865
             +     +  + D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 866 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGR 925
             S  +++ D+K  N++LD +    ++DFG+ K  + +  ++       T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178

Query: 926 EGRVSTNGDVYSFGIMLMETFTRKKP 951
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 2e-31
 Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 13/198 (6%)

Query: 758 IGRGGFGFVYKAR-IQDGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFIS 813
           +G G FG V   +  + G   A+K+ D Q     + I+    E  +++ +    ++K   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 814 SCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 873
           S   +    +V+EY+  G +   L                  +    EYLH   S+ +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIY 164

Query: 874 CDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 933
            DLKP N+L+D      ++DFG AK       +L       T   +APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAV 219

Query: 934 DVYSFGIMLMETFTRKKP 951
           D ++ G+++ E      P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (299), Expect = 6e-30
 Identities = 59/289 (20%), Positives = 113/289 (39%), Gaps = 36/289 (12%)

Query: 756  NLIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFIS 813
              +GRG +  V++A  I +  +V VK+      + IK    E  +++ +R   NII    
Sbjct: 41   RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97

Query: 814  SCSSDDFK--ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 871
                   +  ALV E++     ++   +    L  +     M ++  AL+Y H   S+ I
Sbjct: 98   IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGI 150

Query: 872  IHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGR-V 929
            +H D+KP+NV++D ++    L D+G+A+ +            +A+  +  PE   + +  
Sbjct: 151  MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMY 207

Query: 930  STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK- 988
              + D++S G ML     RK+P          L R    L    + + +D   +  + + 
Sbjct: 208  DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 989  ----------------HFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
                            H   +        +   K      + R+ A+E 
Sbjct: 268  NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 2e-29
 Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 38/282 (13%)

Query: 756  NLIGRGGFGFVYKAR----IQDGMEVAVKVFD----LQYGRAIKSFDIECGMIKRIRHR- 806
             ++G G +G V+  R       G   A+KV      +Q  +  +    E  +++ IR   
Sbjct: 30   KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 807  NIIKFISSCSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 866
             ++    +  ++    L+L+Y+  G L   L         F    + I V   +  L   
Sbjct: 90   FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 867  YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGRE 926
            + + II+ D+K  N+LLD N    L+DFG++K F+ ++          TI YMAP+  R 
Sbjct: 146  HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRG 204

Query: 927  GRVSTNG--DVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS 984
            G    +   D +S G+++ E  T   P    FT +            I   E      +S
Sbjct: 205  GDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 985  HEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEI 1021
               K  +              +  ++ P++R+     +A EI
Sbjct: 261  ALAKDLI-------------QRLLMKDPKKRLGCGPRDADEI 289

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 1e-27
 Identities = 58/304 (19%), Positives = 112/304 (36%), Gaps = 31/304 (10%)

Query: 740  FTYLELFQATNGFSEN----NLIGRGGFGFVYKAR-IQDGMEVAVKVF--DLQYGRAIKS 792
            F   EL +      E     + +G G +G V  A   + G+ VAVK      Q     K 
Sbjct: 4    FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 793  FDIECGMIKRIRHRNIIKFISSCSSD----DFKALVLEYMPYGSLEKCLYSSNYILDIFQ 848
               E  ++K ++H N+I  +   +      +F  + L     G+    +      L    
Sbjct: 64   TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122

Query: 849  RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT 908
               ++  +   L+Y+H   S  IIH DLKP+N+ ++++    + DFG+A+    E     
Sbjct: 123  VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179

Query: 909  QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKP---TDESFTGEMTLKRW 965
             T                   +   D++S G ++ E  T +     TD     ++ L+  
Sbjct: 180  AT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 966  VNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVF--------NLAMKCTIESPEERIN 1017
                  + + ++   +  ++        +   + VF        +L  K  +   ++RI 
Sbjct: 236  GTPGAEL-LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

Query: 1018 AKEI 1021
            A + 
Sbjct: 295  AAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-27
 Identities = 58/295 (19%), Positives = 103/295 (34%), Gaps = 40/295 (13%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFIS 813
             IG G  G V  A        VA+K     +      K    E  ++K + H+NII  ++
Sbjct: 24   PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 814  SCSSDDFK------ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 867
              +            LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84   VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136

Query: 868  SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREG 927
            S  IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y APE     
Sbjct: 137  SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM 193

Query: 928  RVSTNGDVYSFGIMLMETFTRKKP---------------------TDESFTGEMTLKRWV 966
                N D++S G ++ E    K                        +     + T++ +V
Sbjct: 194  GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 967  NDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEI 1021
             +    + +        S         +   S   +L  K  +  P +RI+  + 
Sbjct: 254  ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (271), Expect = 4e-26
 Identities = 50/313 (15%), Positives = 102/313 (32%), Gaps = 55/313 (17%)

Query: 757  LIGRGGFGFVYKAR-IQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSC 815
             +G G F  V+ A+ + +   VA+K+         ++ + E  +++R+   +  K  S  
Sbjct: 20   KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 816  SSDDFK---------------ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASAL 860
            ++   K                +V E +    L       +  + +     I   +   L
Sbjct: 79   ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 861  EYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYM 919
            +Y+H      IIH D+KP NVL++  +   +L    +A            T ++ T  Y 
Sbjct: 139  DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 920  APEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV- 978
            +PE           D++S   ++ E  T        F  +       +D  +  I+E++ 
Sbjct: 197  SPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQIIELLG 252

Query: 979  -------------------DANLLSHEDKHFVAKEQCMSFVF-----------NLAMKCT 1008
                                  L +     F   E  ++  +           +      
Sbjct: 253  ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 1009 IESPEERINAKEI 1021
               P +R +A  +
Sbjct: 313  QLDPRKRADAGGL 325

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.9 bits (237), Expect = 5e-22
 Identities = 56/298 (18%), Positives = 94/298 (31%), Gaps = 33/298 (11%)

Query: 364 PNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY 423
           P+   L L  N  +        N   L TL L  N  S   P  F  L  L+ L L  N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 424 LTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSME-DFHMPNSNISGSIP 482
           L         L     K L+   +  N +  +   V   L+Q +  +        SG   
Sbjct: 91  LKE-------LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143

Query: 483 KEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSI 542
                +  L  I +    +     I  G    L  L L  N++                 
Sbjct: 144 GAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAA----------- 189

Query: 543 PSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQY 602
             +L  L ++  L LS N  +      + N   L ++ L+ N     +P  +   K +Q 
Sbjct: 190 --SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQV 246

Query: 603 LFLKYNRLQG------SIPDSIGDMINLKSLNLSNNNL--FGIIPISLEKLLDLKDIN 652
           ++L  N +          P       +   ++L +N +  + I P +   +     + 
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.2 bits (212), Expect = 8e-19
 Identities = 70/314 (22%), Positives = 116/314 (36%), Gaps = 39/314 (12%)

Query: 115 LANICSNLPL-LQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKL 173
           L  +  +LP     L L  N             K+L TL L  N  S   P     L KL
Sbjct: 22  LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTG 233
           + L+L +N+L+ E+PE++     L++L++  N +T         L+ +  +EL       
Sbjct: 82  ERLYLSKNQLK-ELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVEL------- 131

Query: 234 NFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKL 293
                     + S      F   +  L  I ++               TIP+  G    L
Sbjct: 132 -----GTNPLKSSGIENGAFQ-GMKKLSYIRIADTNI----------TTIPQ--GLPPSL 173

Query: 294 EKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFG 353
            +L L  N++  V    +  L+NL  +  SFN +  V   ++ N   L+ L+L +N    
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233

Query: 354 RLPSSADVRLPNLEELSLSGNNFSG------TIPSFIFNTSKLSTLELQRN--SFSGFIP 405
                AD     ++ + L  NN S         P +    +  S + L  N   +    P
Sbjct: 234 VPGGLAD--HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291

Query: 406 NTFGNLRNLKWLDL 419
           +TF  +     + L
Sbjct: 292 STFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.9 bits (211), Expect = 1e-18
 Identities = 58/289 (20%), Positives = 94/289 (32%), Gaps = 26/289 (8%)

Query: 17  KIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAEL 76
           K+P  L        + L  N  +     +  N+  L  L L  NK+    P     L +L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 77  EELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD 136
           E L+L  N L          L  L   +  +  +   +      N  ++  L  +     
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSS 139

Query: 137 GKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAE 196
           G         K L  + ++  + +  IP+  G    L  LHLD N++       L  L  
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 197 LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNN 256
           L KL L  N ++     S+ N   L +L L+ N L                        +
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG----------------GLAD 240

Query: 257 IPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC 305
             +++ +YL  N       +D      P      A    + L  N +Q 
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCP---PGYNTKKASYSGVSLFSNPVQY 286

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.8 bits (203), Expect = 1e-17
 Identities = 56/262 (21%), Positives = 97/262 (37%), Gaps = 38/262 (14%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK 61
            +   L L++N           N K L  + L  N  S   P     +  L  L+L  N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 62  LQGEIPEELG------------------------NLAELEELWLQNNFLTGTIPSSIFNL 97
           L+ E+PE++                         N   + EL       +G    +   +
Sbjct: 91  LK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 98  SSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN 157
             LS + ++  N+T  +   +  +   L  L LD N       ++L    +L  L LS N
Sbjct: 150 KKLSYIRIADTNIT-TIPQGLPPS---LTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 158 DFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF- 216
             S      + N   L+ LHL+ N+L  ++P  L +   ++ + L NN ++  I  + F 
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFC 263

Query: 217 ------NLSSLSDLELSFNSLT 232
                   +S S + L  N + 
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.5 bits (179), Expect = 1e-14
 Identities = 48/315 (15%), Positives = 91/315 (28%), Gaps = 80/315 (25%)

Query: 163 IPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS 222
           +PK++        L L  N++      +  NL  L  L L NN ++   P +   L  L 
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 223 DLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT 282
            L LS N L                ELP K    +  L             + + L    
Sbjct: 83  RLYLSKNQLK---------------ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 283 IPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLK 342
                     + +L     +   +       +  L ++  +   +  +            
Sbjct: 128 ----------VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL-------- 169

Query: 343 FLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSG 402
                                P+L EL L GN  +    + +   + L+ L L  NS S 
Sbjct: 170 --------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209

Query: 403 -----------------------FIPNTFGNLRNLKWLDLGDNYLTS--STSELSFLSSS 437
                                   +P    + + ++ + L +N +++  S        ++
Sbjct: 210 VDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 269

Query: 438 NCKYLEYFSISNNPL 452
                   S+ +NP+
Sbjct: 270 KKASYSGVSLFSNPV 284

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 69.3 bits (168), Expect = 3e-13
 Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 13/236 (5%)

Query: 456 LPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKL 515
           L +V  +L        + N+ I+     +  NL NL  + L  NK++     A   L KL
Sbjct: 22  LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 516 QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKD----------ILCLNLSLNFFTGP 565
           + L L  NQL+            L    + +  ++           ++ L  +    +G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 566 LPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLK 625
                  +K L  I ++  N + +     G    L  L L  N++      S+  + NL 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 626 SLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNEL 681
            L LS N++  +   SL     L++++++ NKL          +   +     N +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 68.9 bits (167), Expect = 4e-13
 Identities = 46/234 (19%), Positives = 85/234 (36%), Gaps = 14/234 (5%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L  LE L+L  N             + LR     +     ++   +  +  +  L     
Sbjct: 78  LVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPL 136

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           K  G        + +L  + + +  +T TIP  +    SL+ L L  N +T    A++  
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLK- 192

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            L  L  L L  N+       +L    HL+ L L+ N+    +P  + +   ++ ++L  
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN-NNKLVKVPGGLADHKYIQVVYLHN 251

Query: 181 NRLQG------EIPEELGNLAELEKLQLQNNFLT-GTIPPSIFN-LSSLSDLEL 226
           N +          P      A    + L +N +    I PS F  +   + ++L
Sbjct: 252 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 53.5 bits (127), Expect = 5e-08
 Identities = 27/157 (17%), Positives = 51/157 (32%), Gaps = 6/157 (3%)

Query: 548 NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKY 607
           +L+ + C +L L      LP +   L      DL  N  +++       LK+L  L L  
Sbjct: 11  HLRVVQCSDLGLEKVPKDLPPDTALL------DLQNNKITEIKDGDFKNLKNLHTLILIN 64

Query: 608 NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGP 667
           N++    P +   ++ L+ L LS N L  +     + L +L+       K+   +     
Sbjct: 65  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124

Query: 668 FRNFSLESFKGNELLCGMPNLQVRSCRTRIHHTSSKN 704
                       +             +      +  N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.9 bits (217), Expect = 2e-20
 Identities = 23/157 (14%), Positives = 48/157 (30%), Gaps = 26/157 (16%)

Query: 756 NLIGRGGFGFVYKARIQDGMEVAVKVFDL----------QYGRAIKSFDIECGMIKRIRH 805
            L+G G    V+    +   E  VK   +          +       F +      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 806 RNIIKFISSCSSDDF----KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALE 861
           R + K         +     A+++E +    L +          +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117

Query: 862 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 898
             +      I+H DL   NVL+ +  +  + DF  + 
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.5 bits (218), Expect = 4e-19
 Identities = 84/415 (20%), Positives = 143/415 (34%), Gaps = 65/415 (15%)

Query: 23  SNCKRLRNISLSLNDFSGTIPK-EIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWL 81
           +         L   + + T+ + ++  VTTL    L    + G     +  L  L ++  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73

Query: 82  QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPS 141
            NN LT   P  + NL+ L ++ ++ N +         +NL  L        + D     
Sbjct: 74  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 142 TLLRCKHLQTLSL--------------SINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI 187
           T L    L + ++                        K + NLT L+ L +  N++    
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSA 247
                 L  LE L   NN ++   P  I   ++L +L L+ N L                
Sbjct: 192 VL--AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-------------- 233

Query: 248 ELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVI 307
                   ++  L ++ L+ N      P           +  L KL +L L  N++  + 
Sbjct: 234 ---IGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNIS 279

Query: 308 PHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLE 367
           P  +  L  L  +  + N+      + I N+  L +L L  N+     P S    L  L+
Sbjct: 280 P--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISPVS---SLTKLQ 332

Query: 368 ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDN 422
            L  + N  S    S + N + ++ L    N  S   P    NL  +  L L D 
Sbjct: 333 RLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.5 bits (218), Expect = 4e-19
 Identities = 91/405 (22%), Positives = 151/405 (37%), Gaps = 41/405 (10%)

Query: 120 SNLPLLQTLFLDENNFDGKIP-STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
           + L       L + N    +  + L +   LQ   L I    G     +  L  L  ++ 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKD 238
             N+L    P  L NL +L  + + NN +    P +            +   LT    + 
Sbjct: 74  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLT---------NLTGLTLFNNQI 122

Query: 239 MHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDL 298
             I    +     +   +   + +I     +   +  S     T  K + NL  LE+LD+
Sbjct: 123 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182

Query: 299 QFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSS 358
             N  +      +  L NLE +I + N++  + P  I   + L  L L  N         
Sbjct: 183 SSN--KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD---IG 235

Query: 359 ADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLD 418
               L NL +L L+ N  S   P  +   +KL+ L+L  N  S   P     L  L  L+
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 291

Query: 419 LGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNIS 478
           L +N L            SN K L Y ++  N +  I P  + +L+  ++     N+ +S
Sbjct: 292 LNENQLE------DISPISNLKNLTYLTLYFNNISDISP--VSSLT-KLQRLFFANNKVS 342

Query: 479 GSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDN 523
                 + NLTN+  +  G N+++   L  L  L ++  L L D 
Sbjct: 343 D--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 86.2 bits (212), Expect = 2e-18
 Identities = 61/390 (15%), Positives = 116/390 (29%), Gaps = 37/390 (9%)

Query: 72  NLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLD 131
            LAE  +  L    +T T+  +  +L  ++ L      +    +  +   L  L  +   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGV-EYLNNLTQINFS 74

Query: 132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
            N      P  L     L  + ++ N  +   P           L  +Q      +    
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPA 251
                  +L          +             +++      N      +    +     
Sbjct: 133 NL--NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190

Query: 252 KFCNNIPFLEEIYLSKNMFYGEIPS---------DLGNCTI--PKEIGNLAKLEKLDLQF 300
                +  LE +  + N      P           L    +     + +L  L  LDL  
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLAN 250

Query: 301 NRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSAD 360
           N++  + P  +  L  L  +    N++  + P     ++ L  L     +       S  
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPI 303

Query: 361 VRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLG 420
             L NL  L+L  NN S   P  + + +KL  L    N  S    ++  NL N+ WL  G
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 421 DNYLTSSTSELSFLSSSNCKYLEYFSISNN 450
            N ++           +N   +    +++ 
Sbjct: 360 HNQIS------DLTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 83.5 bits (205), Expect = 2e-17
 Identities = 71/376 (18%), Positives = 138/376 (36%), Gaps = 42/376 (11%)

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
           +L ++  L      ++ +    ++ L+NL  + FS N+L  + P  + N++ L  + + +
Sbjct: 42  DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQR--------NSF 400
           N      P +    L  L   +    +          N  +LS+  +          +  
Sbjct: 98  NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157

Query: 401 SGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVI 460
                N   +L+ L  L   +    SS         +    LE    +NN +  I P  I
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217

Query: 461 GNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSL 520
                ++++  +  + +       + +LTNL  + L  N+++   L  L  L KL  L L
Sbjct: 218 LT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKL 270

Query: 521 KDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQID 580
             NQ+    P     + T   +          +                  NLK L  + 
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPIS-----------------NLKNLTYLT 313

Query: 581 LSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPI 640
           L  NN SD+ P  +  L  LQ LF   N++      S+ ++ N+  L+  +N +  + P+
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 369

Query: 641 SLEKLLDLKDINVSFN 656
           +   L  +  + ++  
Sbjct: 370 A--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 83.1 bits (204), Expect = 2e-17
 Identities = 54/205 (26%), Positives = 79/205 (38%), Gaps = 17/205 (8%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+NLE L   +N      P        L  +SL+ N         + ++T L  L L  N
Sbjct: 196 LTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           ++    P  L  L +L EL L  N ++   P     L+ L+ L     N       +  S
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPIS 304

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
           NL  L  L L  NN     P  +     LQ L  + N  S      + NLT + +L    
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 181 NRLQGEIPEELGNLAELEKLQLQNN 205
           N++    P  L NL  + +L L + 
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.3 bits (189), Expect = 2e-15
 Identities = 69/361 (19%), Positives = 132/361 (36%), Gaps = 54/361 (14%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L+NL  +   +N      P  L N  +L +I ++ N  +   P       T + L     
Sbjct: 65  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 122

Query: 61  KLQGEIPE------------ELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN 108
                +               + +++ L  L        G   + +  L++L+ L+    
Sbjct: 123 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182

Query: 109 NLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIG 168
           +       ++ + L  L++L    N      P  +    +L  LSL+ N         + 
Sbjct: 183 SSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLA 238

Query: 169 NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSF 228
           +LT L  L L  N++    P  L  L +L +L+L  N ++   P  +  L++L++LEL+ 
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294

Query: 229 NSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG 288
           N L                       +N+  L  + L  N      P           + 
Sbjct: 295 NQLEDIS-----------------PISNLKNLTYLTLYFNNISDISP-----------VS 326

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
           +L KL++L    N++       + NL N+ W+    N++  + P  + N++ +  L L  
Sbjct: 327 SLTKLQRLFFANNKVS--DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382

Query: 349 N 349
            
Sbjct: 383 Q 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 2e-04
 Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 5/78 (6%)

Query: 572 NLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
            L   ++  L   N +D +  +   L  +  L      ++ SI D +  + NL  +N SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75

Query: 632 NNLFGIIPIS-LEKLLDL 648
           N L  I P+  L KL+D+
Sbjct: 76  NQLTDITPLKNLTKLVDI 93

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (206), Expect = 3e-18
 Identities = 51/259 (19%), Positives = 88/259 (33%), Gaps = 8/259 (3%)

Query: 276 SDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTI 335
              G   +P  I      +++ L  NR+  V         NL  +    N L  +     
Sbjct: 19  PQQGLQAVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76

Query: 336 FNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
             ++ L+ L L  N+    +  +    L  L  L L         P      + L  L L
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136

Query: 396 QRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGI 455
           Q N+      +TF +L NL  L L  N ++S    +   +      L+   +  N +  +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISS----VPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 456 LPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKL 515
            P    +L + M  +   N N+S    + +  L  L  + L  N               L
Sbjct: 193 HPHAFRDLGRLMTLYLFAN-NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWL 250

Query: 516 QLLSLKDNQLEGSIPDNLS 534
           Q      +++  S+P  L+
Sbjct: 251 QKFRGSSSEVPCSLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (200), Expect = 2e-17
 Identities = 62/289 (21%), Positives = 96/289 (33%), Gaps = 30/289 (10%)

Query: 41  TIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSL 100
            +P  I   +    + L GN++             L  LWL +N L     ++   L+ L
Sbjct: 25  AVPVGIPAASQR--IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 101 SNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS 160
             LDLS N     +       L  L TL LD        P        LQ L L  N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 161 GDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSS 220
                   +L  L +L L  NR+          L  L++L L  N +    P +  +L  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 221 LSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGN 280
           L  L L  N+L+                LP +    +  L+ + L+ N +  +  +    
Sbjct: 203 LMTLYLFANNLS---------------ALPTEALAPLRALQYLRLNDNPWVCDCRA---- 243

Query: 281 CTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVG 329
                     A L+K     + + C +P     L   +    + N L G
Sbjct: 244 ------RPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.2 bits (170), Expect = 1e-13
 Identities = 44/185 (23%), Positives = 64/185 (34%), Gaps = 5/185 (2%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L  L  L L         P        L+ + L  N           ++  L  L L GN
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           ++          L  L+ L L  N +    P +  +L  L  L L  NNL+  L     +
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALA 222

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQ 180
            L  LQ L L++N +     +  L    LQ    S ++    +P+    L       L  
Sbjct: 223 PLRALQYLRLNDNPWVCDCRARPLW-AWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAA 278

Query: 181 NRLQG 185
           N LQG
Sbjct: 279 NDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (168), Expect = 3e-13
 Identities = 44/188 (23%), Positives = 68/188 (36%), Gaps = 4/188 (2%)

Query: 19  PSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEE 78
           P+T     RL  + L         P     +  L  L+L+ N LQ    +   +L  L  
Sbjct: 98  PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157

Query: 79  LWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK 138
           L+L  N ++     +   L SL  L L  N +   +  +   +L  L TL+L  NN    
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSAL 216

Query: 139 IPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGN--LAE 196
               L   + LQ L L+ N +  D          L+      + +   +P+ L    L  
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR 275

Query: 197 LEKLQLQN 204
           L    LQ 
Sbjct: 276 LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.5 bits (163), Expect = 1e-12
 Identities = 51/270 (18%), Positives = 91/270 (33%), Gaps = 20/270 (7%)

Query: 412 RNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFH 471
              + + L  N ++   +     S   C+ L    + +N L  I       L+   +   
Sbjct: 32  AASQRIFLHGNRISHVPAA----SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87

Query: 472 MPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPD 531
             N+ +    P   + L  L  ++L    L          L  LQ L L+DN L+    D
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 532 NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIP 591
                        T  +L ++  L L  N  +         L  L ++ L  N  + V P
Sbjct: 148 -------------TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 592 TTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDI 651
                L  L  L+L  N L     +++  +  L+ L L++N               L+  
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKF 253

Query: 652 NVSFNKLEGEIPREGPFRNFSLESFKGNEL 681
             S +++   +P+        L+    N+L
Sbjct: 254 RGSSSEVPCSLPQR--LAGRDLKRLAANDL 281

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.8 bits (130), Expect = 2e-08
 Identities = 41/245 (16%), Positives = 66/245 (26%), Gaps = 13/245 (5%)

Query: 442 LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKL 501
            +   +  N +  +              +   N                         +L
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 502 NGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNF 561
                     L +L  L L    L+   P        L               L L  N 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ-------------YLYLQDNA 140

Query: 562 FTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDM 621
                     +L  L  + L  N  S V      GL  L  L L  NR+    P +  D+
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 622 INLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNEL 681
             L +L L  NNL  +   +L  L  L+ + ++ N    +      +          +E+
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260

Query: 682 LCGMP 686
            C +P
Sbjct: 261 PCSLP 265

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.0 bits (193), Expect = 2e-16
 Identities = 54/297 (18%), Positives = 95/297 (31%), Gaps = 29/297 (9%)

Query: 87  TGTIPSSIFNLSSLSNLDLSVNNLTGEL-LANICSNLPLLQTLFLDEN-NFDGKIPSTLL 144
            G +  +      ++NLDLS  NL     + +  +NLP L  L++    N  G IP  + 
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 145 RCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN 204
           +   L  L ++  + SG IP  +  +  L  L    N L G +P  + +L  L  +    
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158

Query: 205 NFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY 264
           N ++G IP S  + S L                                 N +       
Sbjct: 159 NRISGAIPDSYGSFSKLFT-------------------------SMTISRNRLTGKIPPT 193

Query: 265 LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSF 324
            +         S          +    K  +              ++    NL  +    
Sbjct: 194 FANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRN 253

Query: 325 NKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP 381
           N++ G +P  +  +  L  L +  N+  G +P      L   +  + + N      P
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG--NLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 75.2 bits (183), Expect = 5e-15
 Identities = 57/284 (20%), Positives = 95/284 (33%), Gaps = 30/284 (10%)

Query: 47  GNVTTLIGLHLRGNKLQG--EIPEELGNLAELEELWLQNN-FLTGTIPSSIFNLSSLSNL 103
                +  L L G  L     IP  L NL  L  L++     L G IP +I  L+ L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 104 DLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDI 163
            ++  N++G +   +     L+   F   N   G +P ++    +L  ++   N  SG I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSY-NALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 164 PKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSD 223
           P   G+ +KL                         +L  +       +  +  +LS    
Sbjct: 166 PDSYGSFSKLFTSMTISR----------------NRLTGKIPPTFANLNLAFVDLSRNML 209

Query: 224 LELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTI 283
              +      +       + + S             L  + L  N  YG +P        
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ------- 262

Query: 284 PKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKL 327
              +  L  L  L++ FN L   IP +  NL   +   ++ NK 
Sbjct: 263 --GLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.4 bits (181), Expect = 7e-15
 Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 37/294 (12%)

Query: 358 SADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWL 417
             D +   +  L LSG N     P                      IP++  NL  L +L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFL 81

Query: 418 DLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNI 477
            +G      +       + +    L Y  I++  + G +P  +  +   +      N  +
Sbjct: 82  YIGGIN---NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN-AL 137

Query: 478 SGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQL-LSLKDNQLEGSIPDNLSFS 536
           SG++P  I++L NL+ I    N+++G+I  + G   KL   +++  N+L G IP   +  
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197

Query: 537 CTLTSIPST---------LWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFS 587
                  S          L+                     ++G  K L  +DL  N   
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257

Query: 588 DVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPIS 641
             +P  +  LK L  L + +N L G IP   G++        +NN      P+ 
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.0 bits (180), Expect = 1e-14
 Identities = 49/272 (18%), Positives = 90/272 (33%), Gaps = 14/272 (5%)

Query: 192 GNLAELEKLQLQNNFLTG--TIPPSIFNLSSLSDLELSFN-SLTGNFPKDMHIVNRLSAE 248
                +  L L    L     IP S+ NL  L+ L +    +L G  P  +  + +L   
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 249 LPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIP 308
                  +    + +   K +   +   +  + T+P  I +L  L  +    NR+   IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 309 HEIDNLHNLEWMIFSF-NKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLE 367
               +   L   +    N+L G +P T  N++        +             +     
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 368 ELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSS 427
                  N        +  +  L+ L+L+ N   G +P     L+ L  L++  N L   
Sbjct: 227 H---LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 428 TSELSFLSSSNCKYLEYFSISNNPL--GGILP 457
             +       N +  +  + +NN    G  LP
Sbjct: 284 IPQG-----GNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.5 bits (176), Expect = 3e-14
 Identities = 55/238 (23%), Positives = 88/238 (36%), Gaps = 25/238 (10%)

Query: 1   LSNLEYLFLKSNM-FHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRG 59
           L  L +L++       G IP  ++   +L  + ++  + SG IP  +  + TL+ L    
Sbjct: 75  LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNN---------- 109
           N L G +P  + +L  L  +    N ++G IP S  + S L        N          
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF 194

Query: 110 ------------LTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN 157
                          E  A++               N        +   K+L  L L  N
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254

Query: 158 DFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNN-FLTGTIPPS 214
              G +P+ +  L  L  L++  N L GEIP + GNL   +     NN  L G+  P+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 69.4 bits (168), Expect = 3e-13
 Identities = 63/283 (22%), Positives = 99/283 (34%), Gaps = 23/283 (8%)

Query: 3   NLEYLFLKSNMFHGK--IPSTLSNCKRLRNISLSLND-FSGTIPKEIGNVTTLIGLHLRG 59
            +  L L          IPS+L+N   L  + +   +   G IP  I  +T L  L++  
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 60  NKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANIC 119
             + G IP+ L  +  L  L    N L+GT+P SI +L +L  +    N ++G +  +  
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 120 SNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLD 179
           S   L  ++ +  N   GKIP T                          +    K     
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230

Query: 180 QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
            +         L          L+NN + GT+P  +  L  L  L +SFN+L G  P+  
Sbjct: 231 NSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-- 286

Query: 240 HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCT 282
                           N+   +    + N      P  L  CT
Sbjct: 287 --------------GGNLQRFDVSAYANNKCLCGSP--LPACT 313

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.1 bits (170), Expect = 1e-13
 Identities = 45/207 (21%), Positives = 64/207 (30%), Gaps = 24/207 (11%)

Query: 45  EIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLD 104
           E+  V + + ++     L   +P +L    +   L L  N L     +++   + L+ L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 105 LSVNNLTGELLANICSNLPLLQTLFLDE--------------------NNFDGKIPSTLL 144
           L    LT   +      L  L                           N         L 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 145 RCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN 204
               LQ L L  N+     P  +    KL+ L L  N L       L  L  L+ L LQ 
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 205 NFLTGTIPPSIFNLSSLSDLELSFNSL 231
           N L  TIP   F    L    L  N  
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.4 bits (137), Expect = 2e-09
 Identities = 35/207 (16%), Positives = 64/207 (30%), Gaps = 25/207 (12%)

Query: 166 EIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLE 225
           E+  +     ++ D+  L   +P +L    +   L L  N L      ++   + L+ L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 226 LSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLE---------------------EIY 264
           L    LT         V         +  +     +                      + 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 265 LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSF 324
               +    +  +      P  +    KLEKL L  N L  +    ++ L NL+ ++   
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 325 NKLVGVVPTTIFNVSTLKFLYLGSNSF 351
           N L   +P   F    L F +L  N +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 9e-09
 Identities = 40/183 (21%), Positives = 57/183 (31%), Gaps = 5/183 (2%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNK 61
            +   L L  N+ +    +TL    RL    L+L+    T  +  G +  L  L L  N+
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLT--QLNLDRAELTKLQVDGTLPVLGTLDLSHNQ 88

Query: 62  LQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSN 121
           LQ          A        N     ++P                 N    L   + + 
Sbjct: 89  LQSLPLLGQTLPALTVLDVSFNRLT--SLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146

Query: 122 LPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQN 181
            P L+ L L  NN        L   ++L TL L  N     IPK       L +  L  N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

Query: 182 RLQ 184
              
Sbjct: 206 PWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 2e-08
 Identities = 50/222 (22%), Positives = 71/222 (31%), Gaps = 26/222 (11%)

Query: 93  SIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTL 152
            +  ++S   ++    NLT  L  ++  +      L L EN       +TL+    L  L
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDT---TILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 153 SLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAE---------LEKLQLQ 203
           +L          +  G L  L  L L  N+LQ          A          L  L L 
Sbjct: 61  NLD--RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 204 NNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEI 263
                G +       + L  L     + T    K     N L+ ELPA   N +  L+ +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 264 YLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQC 305
            L +N  Y          TIPK       L    L  N   C
Sbjct: 178 LLQENSLY----------TIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 1e-07
 Identities = 34/198 (17%), Positives = 57/198 (28%), Gaps = 22/198 (11%)

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGD 421
           ++ +  E++    N +  +P  +      + L L  N    F   T      L  L+L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 422 NYLTSSTSELSFLSSSNCKYLEYFSISNNP-----------------LGGILPRVIGNLS 464
             LT    + +               S                    L  +    +  L 
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 465 QSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQ 524
           +  E +   N  +    P  +     L  + L  N L       L  L+ L  L L++N 
Sbjct: 125 ELQELYLKGN-ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 525 LEGSIPDNLSFSCTLTSI 542
           L  +IP     S  L   
Sbjct: 184 LY-TIPKGFFGSHLLPFA 200

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 5e-07
 Identities = 40/219 (18%), Positives = 56/219 (25%), Gaps = 37/219 (16%)

Query: 254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDN 313
            + +    E+   K      +P DL                 L L  N L       +  
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP-----------KDTTILHLSENLLYTFSLATLMP 53

Query: 314 LHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNS--------------------FFG 353
              L  +     +L  +       V     L                             
Sbjct: 54  YTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT 113

Query: 354 RLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRN 413
            LP  A   L  L+EL L GN      P  +  T KL  L L  N+ +         L N
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173

Query: 414 LKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPL 452
           L  L L +N L +               L +  +  NP 
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHL-----LPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (114), Expect = 1e-06
 Identities = 38/187 (20%), Positives = 65/187 (34%), Gaps = 11/187 (5%)

Query: 480 SIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEG--------SIPD 531
           ++P ++    +   ++L  N L    L  L    +L  L+L   +L           +  
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 532 NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIP 591
                  L S+P     L  +  L++S N  T      +  L  L ++ L  N    + P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 592 TTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDI 651
             +     L+ L L  N L       +  + NL +L L  N+L+  IP        L   
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200

Query: 652 NVSFNKL 658
            +  N  
Sbjct: 201 FLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 6e-05
 Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 3/65 (4%)

Query: 569 EIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLN 628
           E+  +   ++++    N +  +P  +   KD   L L  N L      ++     L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 629 LSNNN 633
           L    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 6e-05
 Identities = 41/217 (18%), Positives = 70/217 (32%), Gaps = 13/217 (5%)

Query: 286 EIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLY 345
           E+  +A   +++     L   +P ++    +   +  S N L      T+   + L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 346 LGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIP 405
           L             D  LP L  L LS N             +     ++  N  +    
Sbjct: 62  LDRAELTKLQV---DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPL 117

Query: 406 NTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQ 465
                L  L+ L L  N L +    L          LE  S++NN L  +   ++  L  
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLT----PTPKLEKLSLANNNLTELPAGLLNGLE- 172

Query: 466 SMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLN 502
           +++   +   N   +IPK       L   +L  N   
Sbjct: 173 NLDTLLL-QENSLYTIPKGFFGSHLLPFAFLHGNPWL 208

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.0 bits (149), Expect = 6e-11
 Identities = 45/293 (15%), Positives = 95/293 (32%), Gaps = 23/293 (7%)

Query: 124 LLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRL 183
           L QTL L   N    +   LL  + +       +     +  E  +  +++++ L  + +
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVI 58

Query: 184 QGE-IPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIV 242
           +   +   L   ++L+ L L+   L+  I  ++   S+L  L LS  S    F       
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA------ 112

Query: 243 NRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNR 302
                         +     +      +  +         +      + +L     + N 
Sbjct: 113 ----------LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162

Query: 303 LQCVIPHEIDNLHNLEWMIFSFNKLV-GVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADV 361
            +  +   +    NL  +  S + ++        F ++ L+ L L               
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNL 414
            +P L+ L + G    GT+         L  L++  + F+     T GN +N 
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLK---EALPHLQINCSHFTTIARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.4 bits (137), Expect = 2e-09
 Identities = 39/232 (16%), Positives = 72/232 (31%), Gaps = 13/232 (5%)

Query: 1   LSNLEYLFLKSNMFHGK-IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTL------- 52
              ++++ L +++     +   LS C +L+N+SL     S  I   +   + L       
Sbjct: 45  PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104

Query: 53  -IGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLT 111
             G      +        L  L            +   +      ++ L+      N   
Sbjct: 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 164

Query: 112 GELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLS-INDFSGDIPKEIGNL 170
            +L   +     L+     D             +  +LQ LSLS   D   +   E+G +
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224

Query: 171 TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLS 222
             LK L +      G +         L  LQ+  +  T    P+I N  +  
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEA---LPHLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 44/275 (16%), Positives = 78/275 (28%), Gaps = 20/275 (7%)

Query: 332 PTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSG-TIPSFIFNTSKL 390
           P     + +   +       F   P +       ++ + LS +     T+   +   SKL
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73

Query: 391 STLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSF----LSSSNCKYLEYFS 446
             L L+    S  I NT     NL  L+L      S  +  +                F 
Sbjct: 74  QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133

Query: 447 ISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSIL 506
            +   +   +  V   ++Q     +  N   S            +         L     
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193

Query: 507 IALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPL 566
               +L  LQ LSL                  +      L  +  +  L +      G L
Sbjct: 194 QEFFQLNYLQHLSLSRC------------YDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 567 PLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
            L    L  L    ++ ++F+ +   TIG  K+ +
Sbjct: 242 QLLKEALPHL---QINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 39/284 (13%), Positives = 86/284 (30%), Gaps = 39/284 (13%)

Query: 369 LSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSST 428
           L L+G N    +   + +   +      R+     +   F   R ++ +DL ++ +  ST
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 429 SELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSME-DFHMPNSNISGSIPKEINN 487
                   S C  L+  S+    L   +   +   S  +  +    +     ++   +++
Sbjct: 63  LHGIL---SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 488 LTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLW 547
            + L  +                                 S   + +      ++     
Sbjct: 120 CSRLDELN-------------------------------LSWCFDFTEKHVQVAVAHVSE 148

Query: 548 NLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSIN-NFSDVIPTTIGGLKDLQYLFLK 606
            +  +       N     L   +     LV +DLS +    +        L  LQ+L L 
Sbjct: 149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 208

Query: 607 Y-NRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLK 649
               +       +G++  LK+L +      G + +  E L  L+
Sbjct: 209 RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 60.6 bits (145), Expect = 3e-10
 Identities = 61/340 (17%), Positives = 108/340 (31%), Gaps = 29/340 (8%)

Query: 76  LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
             EL L N  L+ ++P    +L SL     S N+LT      +      L++L +D NN 
Sbjct: 40  AHELELNNLGLS-SLPELPPHLESL---VASCNSLT-----ELPELPQSLKSLLVDNNN- 89

Query: 136 DGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLA 195
                   L+        L     S +  +++  L    +L +                +
Sbjct: 90  --------LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPS 141

Query: 196 ELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
                   N         ++  L+++     S   L         IV   +         
Sbjct: 142 LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 201

Query: 256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH 315
           N+PFL  IY + N     +P    +        N         Q      V  +    L 
Sbjct: 202 NLPFLTTIY-ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
            L   ++  N     + +      +L+ L + +N     LP+      P LE L  S N+
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPAL----PPRLERLIASFNH 315

Query: 376 FSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLK 415
            +  +P    N   L  L ++ N      P+   ++ +L+
Sbjct: 316 LA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 56/336 (16%), Positives = 95/336 (28%), Gaps = 29/336 (8%)

Query: 55  LHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGEL 114
           L L    L   +PE   +L   E L    N LT  +P    +L S   L +  NNL    
Sbjct: 43  LELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKS---LLVDNNNLK--- 91

Query: 115 LANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLK 174
              +    PLL+ L +  N  +            +  +  +      D+P  +  +    
Sbjct: 92  --ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149

Query: 175 YLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN 234
               +   LQ                +L +  L+     +  N+        +   LT  
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209

Query: 235 FPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLE 294
           +  +  +              ++  L               S             L++L 
Sbjct: 210 YADNNLLKTLP------DLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263

Query: 295 KLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGR 354
                 N     I    D   +LE +  S NKL+  +P        L+ L    N     
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNH-LAE 318

Query: 355 LPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKL 390
           +P        NL++L +  N      P    +   L
Sbjct: 319 VPEL----PQNLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 50/331 (15%), Positives = 85/331 (25%), Gaps = 29/331 (8%)

Query: 145 RCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN 204
             +    L L+    S  +P+   +L     L    N L  E+PE   +L  L       
Sbjct: 36  LDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNL 90

Query: 205 NFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIP------ 258
             L+   P   +   S + LE        +F K + + N    +LP    +         
Sbjct: 91  KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150

Query: 259 ----FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL 314
                 E   L          + L                   L+       +P      
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210

Query: 315 HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGN 374
            +   +    +    +    + +        L  +  F  +  +    L  L       N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270

Query: 375 NFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFL 434
             S  I S       L  L +  N     +P     L     L    N+L          
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLAEVPELPQ-- 324

Query: 435 SSSNCKYLEYFSISNNPLGGI--LPRVIGNL 463
                  L+   +  NPL     +P  + +L
Sbjct: 325 ------NLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 52/331 (15%), Positives = 101/331 (30%), Gaps = 29/331 (8%)

Query: 171 TKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNS 230
            +   L L+   L   +PE   +L   E L    N LT  +P    +L SL     +  +
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 231 LTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIP---KEI 287
           L+   P   ++    +         N  FL+ I +  N              I     ++
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 288 GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG 347
             L +L+ L             +      L          +      + N+  L  +Y  
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKL-------STLELQRNSF 400
           +N           +   N+ +  L+         +F+  +  +              N+ 
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 401 SGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVI 460
           S  I +      +L+ L++ +N L    +            LE    S N L  + P + 
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIELPALPP--------RLERLIASFNHLAEV-PELP 323

Query: 461 GNLSQSMEDFHMPNSNISGSIPKEINNLTNL 491
            NL    +  H+  + +    P    ++ +L
Sbjct: 324 QNL----KQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 5e-07
 Identities = 51/317 (16%), Positives = 95/317 (29%), Gaps = 32/317 (10%)

Query: 348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNT 407
           +N     LP       P+LE L  S N+ +  +P    +   L        + S   P  
Sbjct: 46  NNLGLSSLPEL----PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL 100

Query: 408 FGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNP---------------- 451
                +   L+       SS  ++  + +++ K L     S                   
Sbjct: 101 EYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQN 160

Query: 452 -LGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALG 510
                      N  + + D  +   +I                 +L     + ++L  L 
Sbjct: 161 LPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLP 220

Query: 511 KLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI 570
            L          +     +P+       L    +    L ++      LN  +  +    
Sbjct: 221 DLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLC 280

Query: 571 GNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLS 630
                L ++++S N   + +P        L+ L   +N L   +P+      NLK L++ 
Sbjct: 281 DLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPELPQ---NLKQLHVE 332

Query: 631 NNNLFGI--IPISLEKL 645
            N L     IP S+E L
Sbjct: 333 YNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 5e-06
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 12/86 (13%)

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
           C   P L+ L +  N    ++P+       L+ L  S N  + ++P+   NL   K LH+
Sbjct: 280 CDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQNL---KQLHV 331

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQN 204
           + N L+ E P+   +   +E L++ +
Sbjct: 332 EYNPLR-EFPDIPES---VEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 3e-05
 Identities = 47/332 (14%), Positives = 90/332 (27%), Gaps = 33/332 (9%)

Query: 276 SDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTI 335
           ++LG  ++P+   +L   E L    N L   +P    +L +L     +   L  + P   
Sbjct: 46  NNLGLSSLPELPPHL---ESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLE 101

Query: 336 FNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
           +   +   L               DV   +L++L     +                   L
Sbjct: 102 YLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNL 161

Query: 396 QRNS------FSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISN 449
              +       S                             L FL++         ++ +
Sbjct: 162 PFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD 221

Query: 450 NPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIAL 509
            P       V  N    + +     + +  S                 +N  +  I    
Sbjct: 222 LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP-NLYYLNASSNEIRSLC 280

Query: 510 GKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLE 569
                L+ L++ +N+              L  +P+    L+    L  S N     +P  
Sbjct: 281 DLPPSLEELNVSNNK--------------LIELPALPPRLE---RLIASFNHLAE-VPEL 322

Query: 570 IGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQ 601
             NLK L    +  N   +  P     ++DL+
Sbjct: 323 PQNLKQL---HVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 1e-04
 Identities = 21/95 (22%), Positives = 32/95 (33%), Gaps = 10/95 (10%)

Query: 56  HLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELL 115
               N    EI         LEEL + NN L   +P+       L  L  S N+L     
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA---- 317

Query: 116 ANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQ 150
             +      L+ L ++ N    + P      + L+
Sbjct: 318 -EVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 21/100 (21%), Positives = 41/100 (41%), Gaps = 12/100 (12%)

Query: 532 NLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIP 591
               + +   I S       +  LN+S N     LP     L+ L     S N+ ++V  
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAEVPE 321

Query: 592 TTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSN 631
                 ++L+ L ++YN L+   PD      +++ L +++
Sbjct: 322 L----PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 7e-04
 Identities = 46/327 (14%), Positives = 93/327 (28%), Gaps = 21/327 (6%)

Query: 197 LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH--IVNRLSAELPAKFC 254
             +L+L N  L+ ++P    +L SL     S NSLT   P+         +         
Sbjct: 40  AHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94

Query: 255 NNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNL 314
           +  P LE + +S N           +     ++ N +  +  DL  +       +     
Sbjct: 95  DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154

Query: 315 HNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGN 374
                 +     +     +          L                  LP L  +    N
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214

Query: 375 NFSGTIPSFIFNTSKLSTLELQRNSFSG----FIPNTFGNLRNLKWLDLGDNYLTSSTSE 430
                        +         +           +   N+ +       + Y  +++S 
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274

Query: 431 LSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTN 490
                      LE  ++SNN L  + P +   L    E      ++++  +P+   NL  
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIEL-PALPPRL----ERLIASFNHLA-EVPELPQNLKQ 328

Query: 491 LIAIYLGVNKLNGSILIALGKLKKLQL 517
           L   ++  N L          ++ L++
Sbjct: 329 L---HVEYNPLR-EFPDIPESVEDLRM 351

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.2 bits (141), Expect = 1e-09
 Identities = 51/453 (11%), Positives = 108/453 (23%), Gaps = 27/453 (5%)

Query: 99  SLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK----IPSTLLRCKHLQTLSL 154
            + +LD+    L+    A +   L   Q + LD+          I S L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 155 SINDFSGDIPKEIG-----NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG 209
             N+        +         K++ L L    L G     L +         + +    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 210 TIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNM 269
            +  +   L     L+                                     +  +   
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182

Query: 270 FYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVG 329
             G      G    P ++  L          N                  +  +    VG
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242

Query: 330 VVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSK 389
           +       +     L        G                         ++       ++
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV--------LRAKESLKELSLAGNE 294

Query: 390 LSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISN 449
           L     +    +   P        +K         +  +S L+         +    + +
Sbjct: 295 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 354

Query: 450 NPLGGILPRVIGNLSQSMEDFHMPNSNISG----SIPKEINNLTNLIAIYLGVNKLNGSI 505
             +  +   +    S  +    + + ++S     S+   +    +L  + L  N L  + 
Sbjct: 355 AGVRELCQGLGQPGS-VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413

Query: 506 LIALGK-----LKKLQLLSLKDNQLEGSIPDNL 533
           ++ L +        L+ L L D      + D L
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.1 bits (125), Expect = 1e-07
 Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 9/87 (10%)

Query: 119 CSNLPLLQTLFLDENNFDGK----IPSTLLRCKHLQTLSLSINDFSGDIPKEIG-----N 169
                +L+ L+L + +        + +TLL    L+ L LS N        ++       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 170 LTKLKYLHLDQNRLQGEIPEELGNLAE 196
              L+ L L       E+ + L  L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 1e-07
 Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 12/90 (13%)

Query: 76  LEELWLQNNFLTGT----IPSSIFNLSSLSNLDLSVNNLTGE----LLANICSNLPLLQT 127
           L  LWL +  ++ +    + +++    SL  LDLS N L       L+ ++     LL+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 128 LFLDENNFDGKIPSTL----LRCKHLQTLS 153
           L L +  +  ++   L         L+ +S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 4e-06
 Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 9/90 (10%)

Query: 55  LHLRGNKLQGE-IPEELGNLAELEELWLQNNFLTG----TIPSSIFNLSSLSNLDLSVNN 109
           L ++  +L      E L  L + + + L +  LT      I S++    +L+ L+L  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 110 LTGELLANICSNLPL----LQTLFLDENNF 135
           L    +  +   L      +Q L L     
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 61/462 (13%), Positives = 129/462 (27%), Gaps = 27/462 (5%)

Query: 149 LQTLSLSINDFSGDIPKEI-GNLTKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQ 203
           +Q+L +   + S     E+   L + + + LD   L       I   L     L +L L+
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 204 NNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH--IVNRLSAELPAKFCNNIPFLE 261
           +N L       +         ++   SL           +++     LP     ++    
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123

Query: 262 EIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMI 321
                  +    +          +           +   + L+     +   + N +   
Sbjct: 124 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 183

Query: 322 FSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIP 381
                L   +  +   +  LK    G  S   R          +L EL+L  N       
Sbjct: 184 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 243

Query: 382 SFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKY 441
           + +       +  L+            G     + L   ++    S +            
Sbjct: 244 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 303

Query: 442 LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKL 501
            E        L  +  +     +     F    +     +  +I+N     A    + + 
Sbjct: 304 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 363

Query: 502 NGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNF 561
            G     L      ++L L D  +  S         + +S+ +TL     +  L+LS N 
Sbjct: 364 LGQPGSVL------RVLWLADCDVSDS---------SCSSLAATLLANHSLRELDLSNNC 408

Query: 562 FTGPLPLEIG-----NLKVLVQIDLSINNFSDVIPTTIGGLK 598
                 L++         +L Q+ L    +S+ +   +  L+
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 19/90 (21%), Positives = 31/90 (34%), Gaps = 9/90 (10%)

Query: 75  ELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTGELLANICS---NLPLLQTLFL 130
           +++ L +Q   L+    + +   L     + L    LT     +I S     P L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 131 DENNFDGKIPSTLLR-----CKHLQTLSLS 155
             N         +L+        +Q LSL 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 20/96 (20%), Positives = 31/96 (32%), Gaps = 15/96 (15%)

Query: 146 CKHLQTLSLSINDFSGD----IPKEIGNLTKLKYLHLDQNRLQGEIPEELG-----NLAE 196
              L+ L L+  D S      +   +     L+ L L  N L      +L          
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 197 LEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT 232
           LE+L L + + +  +         L  LE    SL 
Sbjct: 428 LEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 16/80 (20%), Positives = 29/80 (36%), Gaps = 8/80 (10%)

Query: 572 NLKVLVQIDLSINNFSDV-IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMI----NLKS 626
           +++ L   D+     SD      +  L+  Q + L    L  +    I   +     L  
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 627 LNLSNNNLFGIIPISLEKLL 646
           LNL +N L  +    + + L
Sbjct: 60  LNLRSNELGDVGVHCVLQGL 79

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 9/87 (10%)

Query: 572 NLKVLVQIDLSINNFSDV----IPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMI----- 622
              VL  + L+  + SD     +  T+     L+ L L  N L  +    + + +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 623 NLKSLNLSNNNLFGIIPISLEKLLDLK 649
            L+ L L +      +   L+ L   K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 18/93 (19%), Positives = 27/93 (29%), Gaps = 12/93 (12%)

Query: 48  NVTTLIGLHLRGNKLQGE----IPEELGNLAELEELWLQNNFLTGTIPSSIF-----NLS 98
             + L  L L    +       +   L     L EL L NN L       +         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 99  SLSNLDLSVNNLTGE---LLANICSNLPLLQTL 128
            L  L L     + E    L  +  + P L+ +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 17/83 (20%), Positives = 26/83 (31%), Gaps = 9/83 (10%)

Query: 2   SNLEYLFLKSNMFHGK----IPSTLSNCKRLRNISLSLNDFSGTIPKEIG-----NVTTL 52
           S L  L+L            + +TL     LR + LS N        ++          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 53  IGLHLRGNKLQGEIPEELGNLAE 75
             L L       E+ + L  L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 5e-04
 Identities = 17/87 (19%), Positives = 26/87 (29%), Gaps = 8/87 (9%)

Query: 337 NVSTLKFLYLGSNSFFGRLPS---SADVRLPNLEELSLSGNNFSGTIPSFIF-----NTS 388
             S L+ L+L          S   +  +   +L EL LS N         +         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 389 KLSTLELQRNSFSGFIPNTFGNLRNLK 415
            L  L L    +S  + +    L   K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)

Query: 3  NLEYLFLKSNMF-HGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNV----TTLIGLHL 57
          +++ L ++       +    L   ++ + + L     +    K+I +       L  L+L
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 58 RGNKLQGEIPEELGNLAELEELWLQNNFLTG 88
          R N+L       +    +     +Q   L  
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 9/75 (12%)

Query: 600 LQYLFLKYNRLQGSIPDSIGDMI----NLKSLNLSNNNLFGIIPISLEKLLD-----LKD 650
           L+ L+L    +  S   S+   +    +L+ L+LSNN L     + L + +      L+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 651 INVSFNKLEGEIPRE 665
           + +       E+   
Sbjct: 431 LVLYDIYWSEEMEDR 445

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 50.6 bits (119), Expect = 2e-07
 Identities = 38/163 (23%), Positives = 55/163 (33%), Gaps = 4/163 (2%)

Query: 78  ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDG 137
            +      L   IP  I      + L L+ N L       +   LP L  L L  N   G
Sbjct: 12  TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 138 KIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAEL 197
             P+      H+Q L L  N       K    L +LK L+L  N++   +P    +L  L
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 198 EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH 240
             L L +N        + F    L    L+  +     P  + 
Sbjct: 129 TSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPSKVR 170

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.9 bits (112), Expect = 1e-06
 Identities = 28/184 (15%), Positives = 61/184 (33%), Gaps = 9/184 (4%)

Query: 200 LQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNR-LSAELPAKFCNNIP 258
           +      L   IP  I      ++L L+ N L       +      L      +      
Sbjct: 13  VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69

Query: 259 FLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLE 318
                  + ++   ++  +       K    L +L+ L+L  N++ CV+P   ++L++L 
Sbjct: 70  EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129

Query: 319 WMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSG 378
            +  + N          F    L+   L   +     PS     + +++   L  + F  
Sbjct: 130 SLNLASNPFNCNCHLAWFA-EWLRKKSLNGGAARCGAPSK----VRDVQIKDLPHSEFKC 184

Query: 379 TIPS 382
           +  +
Sbjct: 185 SSEN 188

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.1 bits (110), Expect = 2e-06
 Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 6/168 (3%)

Query: 2   SNLEYLFLKSNMFHGKIPSTL-SNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
            +   L L  N         L      L  + L  N  +G  P      + +  L L  N
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 61  KLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICS 120
           K++    +    L +L+ L L +N ++  +P S  +L+SL++L+L+ N        ++  
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC--NCHLAW 146

Query: 121 NLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIG 168
               L+   L+        PS +   + +Q   L  ++F        G
Sbjct: 147 FAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 42.1 bits (97), Expect = 1e-04
 Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 3/149 (2%)

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEI-GNLKVLVQIDLSINNFSDVIPTTIGGL 597
           L  IP  +        L L+ N         + G L  LV+++L  N  + + P    G 
Sbjct: 20  LKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77

Query: 598 KDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNK 657
             +Q L L  N+++         +  LK+LNL +N +  ++P S E L  L  +N++ N 
Sbjct: 78  SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137

Query: 658 LEGEIPREGPFRNFSLESFKGNELLCGMP 686
                           +S  G    CG P
Sbjct: 138 FNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 41.3 bits (95), Expect = 2e-04
 Identities = 31/159 (19%), Positives = 56/159 (35%), Gaps = 8/159 (5%)

Query: 331 VPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKL 390
           +P  I        L L  N            RLP+L +L L  N  +G  P+     S +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 391 STLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNN 450
             L+L  N         F  L  LK L+L DN ++     +   S  +   L   ++++N
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC----VMPGSFEHLNSLTSLNLASN 136

Query: 451 PLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLT 489
           P        +   ++ +    +         P ++ ++ 
Sbjct: 137 PFNCNCH--LAWFAEWLRKKSLNGGAARCGAPSKVRDVQ 173

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.8 bits (91), Expect = 6e-04
 Identities = 22/174 (12%), Positives = 51/174 (29%), Gaps = 28/174 (16%)

Query: 282 TIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTL 341
            IP++I       +L L  N L  +    +         +      +  +    F  ++ 
Sbjct: 22  EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 342 KFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLST--------- 392
                   +    + +   + L  L+ L+L  N  S  +P    + + L++         
Sbjct: 80  IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

Query: 393 --------------LELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELS 432
                           L   +     P+    +R+++  DL  +    S+    
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENSE 190

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 38/227 (16%), Positives = 62/227 (27%), Gaps = 19/227 (8%)

Query: 169 NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSF 228
            L     +   ++ +   + +   +L  +  L      +T      +  L++L  LEL  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 229 NSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG 288
           N +T   P                  N         +          +D+        + 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGS 348
            L                I +             S         T + N+S L  L    
Sbjct: 133 VL----------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 349 NSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
           N      P +    LPNL E+ L  N  S   P  + NTS L  + L
Sbjct: 183 NKISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 1e-05
 Identities = 34/246 (13%), Positives = 74/246 (30%), Gaps = 36/246 (14%)

Query: 386 NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYF 445
             +    +   +++ +  +  T  +L  +  L      +T+    +  +       L   
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT----IEGVQ--YLNNLIGL 68

Query: 446 SISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSI 505
            + +N +       + NL++  E     N   + S    + ++  L      +       
Sbjct: 69  ELKDNQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT------ 120

Query: 506 LIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGP 565
                           D      + +       L  I +            LS+      
Sbjct: 121 ----------------DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS 164

Query: 566 LPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLK 625
               + NL  L  +    N  SD+ P  +  L +L  + LK N++    P  + +  NL 
Sbjct: 165 DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLF 220

Query: 626 SLNLSN 631
            + L+N
Sbjct: 221 IVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 37/217 (17%), Positives = 74/217 (34%), Gaps = 21/217 (9%)

Query: 24  NCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQN 83
                  I+   ++ + T+ +   ++  +  L   G  +     E +  L  L  L L++
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 84  NFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDE----------- 132
           N +T   P       +   L  +       +          L +  + +           
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 133 --NNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE 190
                  +I +            LSI +        + NL+KL  L  D N++    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 191 LGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELS 227
           L +L  L ++ L+NN ++   P  + N S+L  + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 6e-05
 Identities = 35/227 (15%), Positives = 66/227 (29%), Gaps = 19/227 (8%)

Query: 72  NLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLD 131
            LA   ++    + +T T+  +  +L  ++ L      +T   +  +   L  L  L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGV-QYLNNLIGLELK 71

Query: 132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
           +N      P   L       LS +       I       T         +         L
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 192 GNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPA 251
             L          + L G       ++ +    +L+  +            N++S   P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190

Query: 252 KFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDL 298
               ++P L E++L  N      P           + N + L  + L
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP-----------LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 42/258 (16%), Positives = 79/258 (30%), Gaps = 49/258 (18%)

Query: 193 NLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAK 252
            LA   K+    + +T T+  +  +L  ++ L      +T                   +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-----------------IE 57

Query: 253 FCNNIPFLEEIYLSKNMF-YGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEI 311
               +  L  + L  N         +L   T  +  GN  K          ++ +     
Sbjct: 58  GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117

Query: 312 DNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSL 371
                      S  +++ +    I N+S L  L                           
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSI------------------- 158

Query: 372 SGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSEL 431
              N   +  + + N SKL+TL+   N  S   P    +L NL  + L +N ++     +
Sbjct: 159 --GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD----V 210

Query: 432 SFLSSSNCKYLEYFSISN 449
           S L  +N   L   +++N
Sbjct: 211 SPL--ANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.002
 Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 4/65 (6%)

Query: 140 PSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEK 199
            + L     L TL    N  S   P  + +L  L  +HL  N++    P  L N + L  
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

Query: 200 LQLQN 204
           + L N
Sbjct: 222 VTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 17/72 (23%), Positives = 30/72 (41%), Gaps = 4/72 (5%)

Query: 12  NMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELG 71
                   + L+N  +L  +    N  S   P  + ++  LI +HL+ N++    P  L 
Sbjct: 159 GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LA 214

Query: 72  NLAELEELWLQN 83
           N + L  + L N
Sbjct: 215 NTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 41/246 (16%), Positives = 77/246 (31%), Gaps = 38/246 (15%)

Query: 410 NLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMED 469
            L N   +  G + +T + ++      ++   +   S     +                 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQ------ADLDGITTLSAFGTGV----------------- 53

Query: 470 FHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIA-LGKLKKLQLLSLKDNQLEGS 528
                + I G     +  L NLI + L  N++     +  L K+ +L+L       +   
Sbjct: 54  -----TTIEG-----VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAI 103

Query: 529 IPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSD 588
                  +  LTS   T       L     L      +        +     LSI N   
Sbjct: 104 AGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQV 163

Query: 589 VIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDL 648
              T +  L  L  L    N++    P  +  + NL  ++L NN +  + P  L    +L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219

Query: 649 KDINVS 654
             + ++
Sbjct: 220 FIVTLT 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.0 bits (120), Expect = 4e-07
 Identities = 44/323 (13%), Positives = 92/323 (28%), Gaps = 31/323 (9%)

Query: 144 LRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGE----IPEELGNLAELEK 199
           +  K L+  +++  D    +   +     +K + L  N +  E    + E + +  +LE 
Sbjct: 5   IEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 200 LQLQNNF---LTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNN 256
            +  + F   +   IP ++  L          +++  +             +  +K    
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 257 IPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHN 316
                           +I   L    + K+  N   L  +    NRL+     E      
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 317 LEWMIFSFNKLVGVVPTTIFNVSTLKFLY------------LGSNSFFGRLPSSADVRLP 364
              ++ +   +   +         L+ L                        + A    P
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 365 NLEELSLSGNNFSGTIPSFIFNT------SKLSTLELQRNSFSG-----FIPNTFGNLRN 413
           NL EL L+    S    + + +         L TL LQ N                 + +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 414 LKWLDLGDNYLTSSTSELSFLSS 436
           L +L+L  N  +     +  +  
Sbjct: 304 LLFLELNGNRFSEEDDVVDEIRE 326

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.8 bits (109), Expect = 9e-06
 Identities = 38/319 (11%), Positives = 87/319 (27%), Gaps = 25/319 (7%)

Query: 76  LEELWLQNNFLTG----TIPSSIFNLSSLSNLDLSVNNLTGE---LLANICSNLPLLQTL 128
           +E   L+ + +T     ++ + +    S+  + LS N +  E    L+   ++   L+  
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 129 FLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIP 188
              +              + L    L           +       +   +D       + 
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 189 EELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAE 248
                      L             +        + +        +     + +   S +
Sbjct: 125 H--------LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 176

Query: 249 LPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIP 308
             AK   +   L  + + +N    E    L    +           + +   +     + 
Sbjct: 177 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236

Query: 309 HEIDNLHNLEWMIFSFNKLVGVVPTTIFNV------STLKFLYLGSNSFFGR----LPSS 358
             + +  NL  +  +   L       + +         L+ L L  N         L + 
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296

Query: 359 ADVRLPNLEELSLSGNNFS 377
            D ++P+L  L L+GN FS
Sbjct: 297 IDEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 5e-05
 Identities = 37/318 (11%), Positives = 96/318 (30%), Gaps = 25/318 (7%)

Query: 365 NLEELSLSGNNFSG----TIPSFIFNTSKLSTLELQRNSFSG----FIPNTFGNLRNLKW 416
           ++E  SL  +  +     ++ + +     +  + L  N+       ++     + ++L+ 
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 417 LDLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHM--PN 474
            +  D +      E+        + L    +    L  +          + E        
Sbjct: 64  AEFSDIFTGRVKDEIP----EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119

Query: 475 SNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLS 534
                 +    N L       +       ++         L+ +    N+LE       +
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179

Query: 535 FSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTI 594
            +     +  T+  +++ +      +     L        + +Q +   +  S  +   +
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239

Query: 595 GGLKDLQYLFLKYNRLQGSIPDSIGDMI------NLKSLNLSNNNLFGIIPISL-----E 643
               +L+ L L    L      ++ D         L++L L  N +      +L     E
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299

Query: 644 KLLDLKDINVSFNKLEGE 661
           K+ DL  + ++ N+   E
Sbjct: 300 KMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 37/311 (11%), Positives = 88/311 (28%), Gaps = 13/311 (4%)

Query: 26  KRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGE----IPEELGNLAELEELWL 81
           K L+  +++  D   ++   +    ++  + L GN +  E    + E + +  +LE    
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 82  QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPS 141
            + F           L  L    L    L    L++        + L    +        
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 142 TLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQ 201
            L            I     ++              +   R + E           +  +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 202 LQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLE 261
           L +             +  L    L++           +    L +   A    + P L 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 262 EIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEI-----DNLHN 316
           E+ L+  +      + + +            L+ L LQ+N ++      +     + + +
Sbjct: 247 ELGLNDCLLSARGAAAVVDAF---SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 317 LEWMIFSFNKL 327
           L ++  + N+ 
Sbjct: 304 LLFLELNGNRF 314

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 2e-04
 Identities = 48/303 (15%), Positives = 95/303 (31%), Gaps = 18/303 (5%)

Query: 363 LPNLEELSLSGNNFSG----TIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLD 418
             +++E+ LSGN         +   I +   L   E                LR L    
Sbjct: 30  DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQAL 89

Query: 419 LGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNIS 478
           L    L +     +    +  + L  F   + PL  +     G   Q+          ++
Sbjct: 90  LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA 149

Query: 479 GSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCT 538
             + K+  N   L +I  G N+L    +    K  +   L      ++  I         
Sbjct: 150 --VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 207

Query: 539 LTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIG--- 595
           L  +          L  N   +  +  L + + +   L ++ L+    S      +    
Sbjct: 208 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 267

Query: 596 ---GLKDLQYLFLKYNRLQGSIPDSIGDMI-----NLKSLNLSNNNLFGIIPISLEKLLD 647
                  LQ L L+YN ++     ++  +I     +L  L L+ N  F      ++++ +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR-FSEEDDVVDEIRE 326

Query: 648 LKD 650
           +  
Sbjct: 327 VFS 329

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.002
 Identities = 15/89 (16%), Positives = 33/89 (37%), Gaps = 12/89 (13%)

Query: 129 FLDENNFDGKIPSTLLRC------KHLQTLSLSINDFSGDIPKEI-----GNLTKLKYLH 177
            L++     +  + ++          LQTL L  N+   D  + +       +  L +L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 178 LDQNRLQGEIPEELGNLAELEKLQLQNNF 206
           L+ NR   E  + +  + E+   + +   
Sbjct: 309 LNGNRF-SEEDDVVDEIREVFSTRGRGEL 336

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 3/115 (2%)

Query: 280 NCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVS 339
           + T+   +  L  +  LDL  NRL+ + P  +  L  LE +  S N L  V         
Sbjct: 9   DLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRL 67

Query: 340 TLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE 394
             + L L +N           V  P L  L+L GN+              L ++ 
Sbjct: 68  --QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 10/121 (8%)

Query: 79  LWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGK 138
           L L +  LT  +   +  L  +++LDLS N L       +   L  L+ L + + + +  
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-----LPPALAALRCLEVLQASDNAL 55

Query: 139 I-PSTLLRCKHLQTLSLSINDF-SGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAE 196
                +     LQ L L  N        + + +  +L  L+L  N L  +       LAE
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114

Query: 197 L 197
           +
Sbjct: 115 M 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 6/115 (5%)

Query: 18  IPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELE 77
           +   L     + ++ LS N      P  +  +  L  L    N    E  + + NL  L+
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALENVDGVANLPRLQ 68

Query: 78  ELWLQNNFLTGT-IPSSIFNLSSLSNLDLSVNNLTGE--LLANICSNLPLLQTLF 129
           EL L NN L  +     + +   L  L+L  N+L  E  +   +   LP + ++ 
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 9e-05
 Identities = 21/118 (17%), Positives = 42/118 (35%), Gaps = 5/118 (4%)

Query: 200 LQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPF 259
           L L +  LT  +   +  L  ++ L+LS N L    P    +      +       N+  
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 260 LEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNL 317
           +  +   + +      + L      + + +  +L  L+LQ N L C      + L  +
Sbjct: 61  VANLPRLQELLLCN--NRLQQSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 26/109 (23%), Positives = 40/109 (36%), Gaps = 6/109 (5%)

Query: 126 QTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQG 185
           + L L   +    +   L +   +  L LS N      P  +  L  L+ L    +    
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNAL 55

Query: 186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIF-NLSSLSDLELSFNSLTG 233
           E  + + NL  L++L L NN L  +       +   L  L L  NSL  
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 3e-04
 Identities = 27/108 (25%), Positives = 44/108 (40%), Gaps = 6/108 (5%)

Query: 555 LNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSI 614
           L+L+    T    L    L ++  +DLS N    + P  +  L+ L+ L  + +      
Sbjct: 3   LHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALEN 57

Query: 615 PDSIGDMINLKSLNLSNNNLFGIIPI-SLEKLLDLKDINVSFNKLEGE 661
            D + ++  L+ L L NN L     I  L     L  +N+  N L  E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 27/106 (25%), Positives = 39/106 (36%), Gaps = 4/106 (3%)

Query: 533 LSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPT 592
           L  +    ++   L  L  +  L+LS N      P  +  L+ L  +  S N   +V   
Sbjct: 3   LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGV 61

Query: 593 TIGGLKDLQYLFLKYNRLQG-SIPDSIGDMINLKSLNLSNNNLFGI 637
                  LQ L L  NRLQ  +    +     L  LNL  N+L   
Sbjct: 62  ANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 5e-04
 Identities = 24/141 (17%), Positives = 40/141 (28%), Gaps = 29/141 (20%)

Query: 296 LDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRL 355
           L L    L   +   ++ L  +  +  S N+L  + P     ++ L+ L +   S     
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56

Query: 356 PSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLK 415
                  LP L+EL L  N    +                              +   L 
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAA-----------------------IQPLVSCPRLV 93

Query: 416 WLDLGDNYLTSSTSELSFLSS 436
            L+L  N L         L+ 
Sbjct: 94  LLNLQGNSLCQEEGIQERLAE 114

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 25/107 (23%), Positives = 37/107 (34%), Gaps = 7/107 (6%)

Query: 1   LSNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGN 60
           L  + +L L  N      P+ L+  + L  +  S N                  L L  N
Sbjct: 19  LLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQE--LLLCNN 75

Query: 61  KLQG-EIPEELGNLAELEELWLQNNFLT---GTIPSSIFNLSSLSNL 103
           +LQ     + L +   L  L LQ N L    G        L S+S++
Sbjct: 76  RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 9e-06
 Identities = 30/247 (12%), Positives = 66/247 (26%), Gaps = 12/247 (4%)

Query: 140 PSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEK 199
              +  C   +      +  + +IP ++        L     +L+           +LEK
Sbjct: 2   HHRICHC-SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 200 LQLQNNFLTGTI----PPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCN 255
           +++  N +   I      ++  L  +   + +                +          +
Sbjct: 58  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117

Query: 256 NIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLH 315
                +   L K +   +   ++        +G   +   L L  N +Q +     +   
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177

Query: 316 NLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNN 375
             E  +   N L  +        S    L +        LPS     L  L   S     
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTR-IHSLPSYGLENLKKLRARSTYNL- 235

Query: 376 FSGTIPS 382
               +P+
Sbjct: 236 --KKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 2e-05
 Identities = 31/213 (14%), Positives = 63/213 (29%), Gaps = 5/213 (2%)

Query: 186 EIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRL 245
           EIP +L       +L+     L      +      L  +E+S N +      D+      
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 246 SAELPAKFCNNIPFLEEIYLSKNMFYGEIPSD---LGNCTIPKEIGNLAKLEKLDLQFNR 302
             E+  +  NN+ ++             +      + +     +I +L K+         
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 303 LQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVR 362
           +  +  +    L     +++     +  +    FN + L  L L  N+    LP+     
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 363 LPNLEELSLSGNNFSGTIPSFIFNTSKLSTLEL 395
                 L +S           + N  KL     
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 4e-05
 Identities = 33/223 (14%), Positives = 64/223 (28%), Gaps = 6/223 (2%)

Query: 200 LQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMH--IVNRLSAELPAKFCNNI 257
              Q + +T  IP  +    +  +L      L                           I
Sbjct: 13  FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69

Query: 258 PFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNL 317
                  L K        ++      P+   NL  L+ L +    ++ +      +    
Sbjct: 70  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129

Query: 318 EWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFS 377
             +    N  +  +    F   + + + L  N    +   +       L+EL+LS NN  
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189

Query: 378 GTIPSFIF-NTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL 419
             +P+ +F   S    L++ R            NL+ L+    
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 27/215 (12%), Positives = 48/215 (22%), Gaps = 6/215 (2%)

Query: 2   SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLR--- 58
            N   L               S    L  I +S ND    I  ++ +    +        
Sbjct: 29  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88

Query: 59  GNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANI 118
            N L                L              I +L  +        N+      + 
Sbjct: 89  NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148

Query: 119 CSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
                    L+L++N             +  +      N+            +    L +
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPP 213
            + R+       L NL +L      N      +P 
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 23/220 (10%), Positives = 57/220 (25%), Gaps = 14/220 (6%)

Query: 427 STSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQS--------------MEDFHM 472
             S+++ + S   +           L  I                           D   
Sbjct: 16  QESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75

Query: 473 PNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLKDNQLEGSIPDN 532
               +     ++ NNL  +             +LI+   +K L  +    +  +  +   
Sbjct: 76  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135

Query: 533 LSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPT 592
            + +       S +    + + L L+ N             ++        NN  ++   
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195

Query: 593 TIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNN 632
              G      L +   R+       + ++  L++ +  N 
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 26/233 (11%), Positives = 56/233 (24%), Gaps = 10/233 (4%)

Query: 99  SLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIND 158
           S        + +T E+ +++  N      L                    L+ + +S ND
Sbjct: 9   SNRVFLCQESKVT-EIPSDLPRNA---IELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64

Query: 159 FSGDI---PKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSI 215
               I               +    N L                L              I
Sbjct: 65  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124

Query: 216 FNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIP 275
            +L  +        ++          ++  S  L              +    +    + 
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184

Query: 276 SDLGNCTIPKEI-GNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKL 327
            +     +P ++    +    LD+   R+  +  + ++NL  L     S   L
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNL 235

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 36/217 (16%), Positives = 72/217 (33%), Gaps = 23/217 (10%)

Query: 163 IPKEIG------NLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIF 216
           +P  I          +    +L +  +   + +    L  ++++   N+ +       I 
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65

Query: 217 NLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPS 276
            L +++ L L+ N LT   P        L+      +        +   S          
Sbjct: 66  YLPNVTKLFLNGNKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117

Query: 277 DLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIF 336
            L +  I    G +   +   L     +      +  L  L+ +    N++  +VP  + 
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LA 175

Query: 337 NVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSLSG 373
            ++ L+ LYL  N     L + A   L NL+ L L  
Sbjct: 176 GLTKLQNLYLSKNHI-SDLRALA--GLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 9e-05
 Identities = 37/207 (17%), Positives = 75/207 (36%), Gaps = 17/207 (8%)

Query: 21  TLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELW 80
           +          +L     +  + +    + ++  +    + ++      +  L  + +L+
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 74

Query: 81  LQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIP 140
           L  N LT   P +         LD +          ++ S   L +   L   +      
Sbjct: 75  LNGNKLTDIKPLANLKNLGWLFLDENKVK-------DLSSLKDLKKLKSLSLEHNGISDI 127

Query: 141 STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKL 200
           + L+    L++L L  N  +         LTKL  L L+ N++   +P  L  L +L+ L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183

Query: 201 QLQNNFLTGTIPPSIFNLSSLSDLELS 227
            L  N ++     ++  L +L  LEL 
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 8e-04
 Identities = 31/200 (15%), Positives = 61/200 (30%), Gaps = 16/200 (8%)

Query: 120 SNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLD 179
                     L + +    +    L    +  +  + +D        I  L  +  L L+
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 180 QNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDM 239
            N+L    P             L+N          + +LSSL DL+   +    +     
Sbjct: 77  GNKLTDIKPLA----------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD 126

Query: 240 HIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQ 299
                   +L + +  N    +   LS+      +  +    +    +  L KL+ L L 
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186

Query: 300 FNRLQCVIPHEIDNLHNLEW 319
            N +  +    +  L NL+ 
Sbjct: 187 KNHISDL--RALAGLKNLDV 204

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 37/209 (17%), Positives = 69/209 (33%), Gaps = 22/209 (10%)

Query: 312 DNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEELSL 371
           D              +   V      ++++  +   ++             LPN+ +L L
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFL 75

Query: 372 SGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSEL 431
           +GN  +      I   + L  L       +     +             ++   S  + L
Sbjct: 76  NGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130

Query: 432 SFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNL 491
             L      YL    I++  +   L +        ++   + ++ IS  +P  +  LT L
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTK--------LDTLSLEDNQISDIVP--LAGLTKL 180

Query: 492 IAIYLGVNKLNGSILIALGKLKKLQLLSL 520
             +YL  N +  S L AL  LK L +L L
Sbjct: 181 QNLYLSKNHI--SDLRALAGLKNLDVLEL 207

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 28/151 (18%), Positives = 52/151 (34%), Gaps = 5/151 (3%)

Query: 538 TLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGL 597
            +  +   +    D     L L         ++    + V ++   ++ +  +      +
Sbjct: 8   QVEQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENI 64

Query: 598 KDLQYLFLKYNRLQG--SIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSF 655
            +L  L L  NRL     +   +    NLK LNLS N L     +   K L L+++ +  
Sbjct: 65  PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDG 124

Query: 656 NKLEGEIPREGPFRNFSLESFKGNELLCGMP 686
           N L      +  + +   E F     L G  
Sbjct: 125 NSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (100), Expect = 4e-05
 Identities = 30/163 (18%), Positives = 63/163 (38%), Gaps = 8/163 (4%)

Query: 56  HLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELL 115
            L+  +++ ++   +    +  +  L    L       +   +    L+   +      L
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA--TL 57

Query: 116 ANICSNLPLLQTLFLDENNFDGK--IPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKL 173
             I  N+P L +L L  N       + S + +  +L+ L+LS N+   +   +     KL
Sbjct: 58  RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117

Query: 174 KYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTG-TIPPSI 215
           + L LD N L     ++   ++ + +   +   L G  +PP I
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (84), Expect = 0.004
 Identities = 27/168 (16%), Positives = 49/168 (29%), Gaps = 35/168 (20%)

Query: 17  KIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAEL 76
           ++   +S        +L L                                 +L      
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLR--------------------------SDPDLVAQNID 44

Query: 77  EELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTG-ELLANICSNLPLLQTLFLDENNF 135
             L  +++    T+     N+  L +L+LS N L   + +++I    P L+ L L  N  
Sbjct: 45  VVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 103

Query: 136 DGKIPSTLLRCKHLQTLSLSINDFSGDIPKE-------IGNLTKLKYL 176
             +     ++   L+ L L  N  S     +            KL  L
Sbjct: 104 KSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (99), Expect = 3e-05
 Identities = 22/148 (14%), Positives = 40/148 (27%), Gaps = 3/148 (2%)

Query: 76  LEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF 135
              L    +         +    +L+ L +        L       L  L+ L + ++  
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 136 DGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQ-GEIPEELGNL 194
               P        L  L+LS N     +  +      L+ L L  N L        L   
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 195 AELEKLQLQNNFLTGTIPPSIFNLSSLS 222
            E     +    L       + ++ + S
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 5e-04
 Identities = 23/143 (16%), Positives = 43/143 (30%), Gaps = 5/143 (3%)

Query: 54  GLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIF-NLSSLSNLDLSVNNLTG 112
           GL    +    +    L     L EL+++N      +       L  L NL +  + L  
Sbjct: 12  GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70

Query: 113 ELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDI-PKEIGNLT 171
                      L +       N    +    ++   LQ L LS N        + +    
Sbjct: 71  VAPDAFHFTPRLSRLNL--SFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 172 KLKYLHLDQNRLQGEIPEELGNL 194
           +     + + +LQ      L ++
Sbjct: 129 EEGLGGVPEQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 20/132 (15%), Positives = 46/132 (34%), Gaps = 2/132 (1%)

Query: 576 LVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP-DSIGDMINLKSLNLSNNNL 634
              +  + +   D     + G ++L  L+++  +    +    +  +  L++L +  + L
Sbjct: 10  SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 635 FGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNELLCGMPNLQVRSCR 694
             + P +      L  +N+SFN LE    +     +       GN L C      ++   
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 695 TRIHHTSSKNDL 706
                   +  L
Sbjct: 129 EEGLGGVPEQKL 140

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 1e-04
 Identities = 24/131 (18%), Positives = 46/131 (35%), Gaps = 5/131 (3%)

Query: 72  NLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLD 131
           N     EL L+   +   I +    L     +D S N +      +    L  L+TL ++
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK---LDGFPLLRRLKTLLVN 71

Query: 132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSG-DIPKEIGNLTKLKYLHLDQNRLQGEIPEE 190
            N               L  L L+ N          + +L  L YL + +N +  +    
Sbjct: 72  NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131

Query: 191 LGNLAELEKLQ 201
           L  + ++ +++
Sbjct: 132 LYVIYKVPQVR 142

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 23/142 (16%), Positives = 47/142 (33%), Gaps = 11/142 (7%)

Query: 380 IPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNC 439
              +  N  +   L+L+       I N    L     +D  DN +               
Sbjct: 11  AAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR------KLDGFPLL 62

Query: 440 KYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLG-- 497
           + L+   ++NN +  I   +   L    E     NS +       + +L +L  + +   
Sbjct: 63  RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122

Query: 498 -VNKLNGSILIALGKLKKLQLL 518
            V       L  + K+ ++++L
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 24/153 (15%), Positives = 50/153 (32%), Gaps = 14/153 (9%)

Query: 244 RLSAELPAKF--CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFN 301
           +L+AEL  +     N     E+ L                 I      L + + +D   N
Sbjct: 2   KLTAELIEQAAQYTNAVRDRELDLRGYKI----------PVIENLGATLDQFDAIDFSDN 51

Query: 302 RLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADV 361
            ++ +       L  L+ ++ + N++  +       +  L  L L +NS           
Sbjct: 52  EIRKLDGFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 109

Query: 362 RLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLE 394
            L +L  L +  N  +      ++   K+  + 
Sbjct: 110 SLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVR 142

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.002
 Identities = 22/136 (16%), Positives = 45/136 (33%), Gaps = 6/136 (4%)

Query: 20  STLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEEL 79
           +  +N  R R + L        I      +     +    N+++    +    L  L+ L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68

Query: 80  WLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNF---D 136
            + NN +          L  L+ L L+ N+L      +  ++L  L  L +  N      
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 137 GKIPSTLLRCKHLQTL 152
                 + +   ++ L
Sbjct: 129 HYRLYVIYKVPQVRVL 144

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 27/165 (16%), Positives = 51/165 (30%), Gaps = 16/165 (9%)

Query: 147 KHLQTLSLSINDFSGDIPK------EIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKL 200
           K +        +  G IP        +  L   K+L L  N +  E    L  +  L  L
Sbjct: 18  KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRIL 75

Query: 201 QLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIV-------NRLSAELPAKF 253
            L  N +           +            + +  + +  +       N+++       
Sbjct: 76  SLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDK 135

Query: 254 CNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKE-IGNLAKLEKLD 297
              +  LE++ L+ N  Y +   +        E +  L  L+KLD
Sbjct: 136 LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 35/200 (17%), Positives = 63/200 (31%), Gaps = 18/200 (9%)

Query: 120 SNLPLLQTLFLDENNFDGKIP-STLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHL 178
           + L       L + N    +  + L +   LQ   L I    G     +  L  L  ++ 
Sbjct: 15  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 69

Query: 179 DQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKD 238
             N+L    P +           L            I +++ L++L         N    
Sbjct: 70  SNNQLTDITPLK----------NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119

Query: 239 MHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDL 298
                +    L     ++    +   LS      ++       T  K + NL  LE+LD+
Sbjct: 120 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDI 179

Query: 299 QFNRLQCVIPHEIDNLHNLE 318
             N++  +    +  L NLE
Sbjct: 180 SSNKVSDI--SVLAKLTNLE 197

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 24/176 (13%), Positives = 52/176 (29%), Gaps = 19/176 (10%)

Query: 72  NLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLD 131
            LAE  +  L    +T T+  +  +L  ++ L      +    +  +   L  L  +   
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGV-EYLNNLTQINFS 70

Query: 132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEEL 191
            N      P   L       ++ +       +           + +   +    +    L
Sbjct: 71  NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130

Query: 192 GNLAELEKLQLQNNFLTG--------------TIPPSIFNLSSLSDLELSFNSLTG 233
             L          + L+G              T    + NL++L  L++S N ++ 
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1027
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.77
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.76
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.75
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.74
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.71
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.58
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.49
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.48
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.35
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.32
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.24
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.22
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.42
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.39
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.35
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.96
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.7
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.58
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.39
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.12
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.95
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.94
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.58
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.44

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=424.42  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=208.6

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++... .+..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56899999999999999999976 68999999997653 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +++|+|.+++... ..+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus        85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999998754 45899999999999999999999   9999999999999999999999999999999765444334


Q ss_pred             eecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          908 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      .....+||+.|||||++.+..+ +.++||||+||++|||+||++||............+..            ...    
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~------------~~~----  224 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------KKT----  224 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT------------TCT----
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------CCC----
Confidence            4456789999999999988776 57899999999999999999999765433322222111            100    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ....+..++.++.+|+.+||+.||++|||++|+++
T Consensus       225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11112345677889999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=420.92  Aligned_cols=249  Identities=26%  Similarity=0.342  Sum_probs=211.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46999999999999999999865 79999999998766556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +||+|.+++...  .+++.++..++.||+.||+|||   ++||+||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999988764  4899999999999999999999   9999999999999999999999999999998764332  23


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ +...            ....     ..
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~------------~~~~-----~~  234 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLI------------ATNG-----TP  234 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHH------------HHHC-----SC
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHH------------HhCC-----CC
Confidence            3456799999999999999999999999999999999999999976422111 1110            0000     01


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....+..++.++.+++.+||++||++|||+.|+++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11223456778999999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=419.58  Aligned_cols=257  Identities=28%  Similarity=0.425  Sum_probs=204.9

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|+..+.||+|+||+||+|+++  ..||||+++..  .....+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999865  36999998644  34456789999999999999999999998765 56899999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++|+|.+++...+..+++..+..++.|||+||+|||   +++||||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877777999999999999999999999   899999999999999999999999999999876544433


Q ss_pred             ceecccccCccccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          907 LTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      .......||+.|||||++..   ..++.++|||||||++|||+||+.||........ ....            +.....
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~------------~~~~~~  227 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFM------------VGRGYL  227 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH------------HHHTSC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHH------------HhcCCC
Confidence            44455679999999999864   3589999999999999999999999976432211 1111            111110


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .  ......+..++.++.+++.+||+.||++||||+|+++.|+
T Consensus       228 ~--p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         228 S--PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             C--CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C--CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            0  0111223457788999999999999999999999999886

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=416.98  Aligned_cols=254  Identities=24%  Similarity=0.390  Sum_probs=201.9

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||+||+|++.+++.||||+++... ...+.+.+|++++++++|||||+++++|.+++..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            35688899999999999999999888999999987543 33567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++|+|.+++......+++..+..++.|||+||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+..... ..
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~  158 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  158 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence            999999999887777999999999999999999999   99999999999999999999999999999986643322 22


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      .....||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ..+...+            ....      
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i------------~~~~------  219 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDI------------STGF------  219 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHH------------HHTC------
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHH------------HhcC------
Confidence            33457899999999999999999999999999999999965554332211 1111111            0110      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +...+..++.++.+++.+||+.||++||||+||++.|+
T Consensus       220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~  257 (263)
T d1sm2a_         220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA  257 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            11122356778999999999999999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=413.48  Aligned_cols=245  Identities=24%  Similarity=0.351  Sum_probs=207.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56899999999999999999976 68999999997532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+++|+|.+++.... .+++..+..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999987654 4899999999999999999999   999999999999999999999999999999865322  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||......     +....        +....    
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~--------i~~~~----  220 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKR--------ISRVE----  220 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH--------HHTTC----
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----HHHHH--------HHcCC----
Confidence              234467999999999999999999999999999999999999999764211     11110        00110    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          ...+..++.++.+++.+||++||++|||++|+++
T Consensus       221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                1112346678899999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=420.19  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=211.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      +.|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45888999999999999999976 68999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++|+|.+++.+....+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999998776667999999999999999999999   999999999999999999999999999999754321  122


Q ss_pred             ecccccCccccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          909 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                      ....+||+.|+|||++.     ...++.++||||+||++|||+||+.||......+. +...            ...   
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i------------~~~---  230 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKI------------AKS---  230 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHH------------HHS---
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHH------------HcC---
Confidence            34567999999999874     45689999999999999999999999976533221 1111            000   


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .......+..++.++.+|+.+||++||++|||++|+++
T Consensus       231 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 --EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              01112223456778999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-48  Score=419.27  Aligned_cols=254  Identities=22%  Similarity=0.412  Sum_probs=199.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CC---ceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DG---MEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|+..+.||+|+||+||+|+++ ++   ..||||++.... ....+.|.+|++++++++|||||+++++|.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45667789999999999999875 33   258888876543 34557899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++......+++.++..++.|||+||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999998887777999999999999999999999   9999999999999999999999999999998765332


Q ss_pred             Ccc---eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          905 QSL---TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       905 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ...   ......||+.|+|||++.++.++.++|||||||++|||+| |++||......  .+...            +..
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~------------i~~  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINA------------IEQ  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH------------HHT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHc
Confidence            221   1223457899999999999999999999999999999998 89998764221  11111            111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..      +.+.+..++.++.+++.+||+.||++||||+||++.|+
T Consensus       249 ~~------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         249 DY------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD  288 (299)
T ss_dssp             TC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CC------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            11      11223457788999999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=404.92  Aligned_cols=253  Identities=22%  Similarity=0.386  Sum_probs=215.3

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|+..+.||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||++++++|.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            367999999999999999999998889999999986543 3467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      ++|++.+++......+++..+.+++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+...... ...
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence            999999998877777899999999999999999999   8999999999999999999999999999998664432 223


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+  ....           +.. ..     
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~-----------i~~-~~-----  218 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEH-----------IAQ-GL-----  218 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHH-----------HHT-TC-----
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHH-----------HHh-CC-----
Confidence            344678999999999999999999999999999999998 899987653221  1110           111 10     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       +...+..++.++.+++.+||+.||++|||++|+++.|.
T Consensus       219 -~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         219 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence             11223456778999999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=416.86  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=204.5

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++++..   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999975 78999999997542   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||++||+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 4899999999999999999999   99999999999999999999999999999997654444


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....            +....    
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~------------i~~~~----  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQK------------IIKLE----  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH------------HHTTC----
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHH------------HHcCC----
Confidence            444455689999999999999999999999999999999999999997642111 0110            11110    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIV 1022 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl 1022 (1027)
                          ...+..++.++.+|+.+||+.||++|||++|++
T Consensus       227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence                111234667789999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=411.18  Aligned_cols=253  Identities=23%  Similarity=0.393  Sum_probs=207.5

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      .++|++.+.||+|+||+||+|++++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35688899999999999999999888999999997543 335679999999999999999999998865 4579999999


Q ss_pred             CCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          829 PYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       829 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      ++|+|.+++.... ..+++..+..|+.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.+... ...
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-ccc
Confidence            9999999876543 35899999999999999999999   899999999999999999999999999999876432 223


Q ss_pred             eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccc
Q 048205          908 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHED  987 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  987 (1027)
                      ......||+.|+|||++.++.++.++|||||||++|||+||+.|+........ ....            +....     
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~------------i~~~~-----  227 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQN------------LERGY-----  227 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHH------------HHTTC-----
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHH------------HHhcC-----
Confidence            34456789999999999999999999999999999999997666544322111 1111            11110     


Q ss_pred             hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          988 KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       988 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       +...+..++.++.+++.+||+.||++||||+||++.|+
T Consensus       228 -~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         228 -RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence             11123456778999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-47  Score=414.28  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=212.4

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ..++|+..+.||+|+||+||+|+++ +|+.||||+++.... ..+.+.+|++++++++|||||+++++|.+.+..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3457888999999999999999976 588999999875433 45679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |+++|+|.+++... ...+++..+..++.|||+||+|||   +++|+||||||+|||++.++.+||+|||+|+..... .
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence            99999999998754 456899999999999999999999   899999999999999999999999999999865433 2


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                      ........|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...            +.+....   
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~------------~~i~~~~---  233 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVY------------ELLEKDY---  233 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH------------HHHHTTC---
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHH------------HHHhcCC---
Confidence            333444568999999999999999999999999999999999877765432211 111            1111111   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                         ....+..++.++.+|+.+||+.||++|||++||++.|+
T Consensus       234 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         234 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence               11223457788999999999999999999999998775

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=423.12  Aligned_cols=265  Identities=23%  Similarity=0.320  Sum_probs=207.2

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            567999999999999999999975 78999999998653 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      |++||+|.+++.+.. .+++..+..++.|+++||+|||   ++ +|+||||||+|||++.+|.+||+|||+|+.+...  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999997654 4899999999999999999999   74 8999999999999999999999999999865422  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh-------------
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI-------------  972 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------  972 (1027)
                        .....+||++|+|||++.+..|+.++||||+||++|||++|+.||....................             
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              22346899999999999999999999999999999999999999976533221111000000000             


Q ss_pred             ------------hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          973 ------------SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       973 ------------~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                                  ...+..+........ .. .....+.++.+++.+||..||++||||+|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPP-KL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCC-CC-CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhHHHHHhhhhccCCc-cC-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                        000000000000000 00 01124567899999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-48  Score=411.38  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=193.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec--CCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS--DDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV  824 (1027)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...  ....+.+.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999875 78999999997543  3345678899999999999999999999865  4568999


Q ss_pred             EEecCCCCHHHHHhcC---CccCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          825 LEYMPYGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGY--SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988642   356899999999999999999999211  13499999999999999999999999999987


Q ss_pred             cccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      +....  ......+||+.|+|||++.+..++.++||||+||++|||+||++||......  .+..           .+..
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~-----------~i~~  228 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAG-----------KIRE  228 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH-----------HHHH
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHH-----------HHHc
Confidence            64322  2234567999999999999999999999999999999999999999764221  1111           0111


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ....       ..+..++.++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~-------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         229 GKFR-------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             TCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC-------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1110       112346778999999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.8e-47  Score=420.16  Aligned_cols=253  Identities=18%  Similarity=0.256  Sum_probs=212.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999975 7999999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--CCCcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ++||+|.+++......+++..+..++.||+.||+|||   +++||||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999776667999999999999999999999   99999999999999996  46899999999998764322 


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                        ......||+.|||||++.+..++.++||||+||++|||++|+.||.+....     +...        .+.....   
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~--------~i~~~~~---  242 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLR--------NVKSCDW---  242 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHTCC---
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHH--------HHHhCCC---
Confidence              334467999999999999999999999999999999999999999764221     1111        1111110   


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       .........++.++.+|+.+||++||++|||++|+++.
T Consensus       243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00111223466788999999999999999999999873

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=408.29  Aligned_cols=253  Identities=22%  Similarity=0.382  Sum_probs=208.2

Q ss_pred             CCCCccce-eeccccceEEEEEec---CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNL-IGRGGFGFVYKARIQ---DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~-lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|..... ||+|+||+||+|+++   ++..||||+++... ....+.+.+|++++++++|||||+++++|.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34555664 999999999999764   35579999997543 3446789999999999999999999999975 457999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++...+..+++..+..++.|||+||+|||   +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877777999999999999999999999   9999999999999999999999999999999765433


Q ss_pred             Cc-ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          905 QS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       905 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .. .......||+.|+|||++..+.++.++|||||||++|||+| |+.||......  .+...            +... 
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~------------i~~~-  228 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF------------IEQG-  228 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH------------HHTT-
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHcC-
Confidence            22 22234568999999999999999999999999999999998 89999764322  11111            1111 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           .+...+..++.++.+|+.+||+.||++|||+.+|++.|+
T Consensus       229 -----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         229 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                 111223467888999999999999999999999998875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=401.05  Aligned_cols=244  Identities=26%  Similarity=0.367  Sum_probs=197.4

Q ss_pred             CccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec----CCeeEEEE
Q 048205          753 SENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS----DDFKALVL  825 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  825 (1027)
                      +..+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999976 68899999987542  3345678999999999999999999999865    34679999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCcEEEc-CCCcEEEeeecCCccccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLD-DNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~  902 (1027)
                      ||+++|+|.+++.+.. .+++..+..++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999987654 4899999999999999999999   877  99999999999996 578999999999985322


Q ss_pred             CCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          903 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       903 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                          ......+||+.|+|||++.+ +++.++||||+||++|||++|+.||............             +... 
T Consensus       168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~-------------i~~~-  228 (270)
T d1t4ha_         168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------------VTSG-  228 (270)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-------------HTTT-
T ss_pred             ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH-------------HHcC-
Confidence                12345679999999998865 6999999999999999999999999754322111111             0000 


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ..  ....+..+++++.+++.+||++||++|||++|+++
T Consensus       229 --~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 --VK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --CC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence              00  11122345667899999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=417.78  Aligned_cols=255  Identities=23%  Similarity=0.389  Sum_probs=210.1

Q ss_pred             CCCCccceeeccccceEEEEEecC-C-----ceEEEEEEecc-cchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCee
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD-G-----MEVAVKVFDLQ-YGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  821 (1027)
                      ++|++.+.||+|+||+||+|++.. +     ..||||++... .......+.+|+++++++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578899999999999999998653 2     36999988643 233456788999999998 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC----------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSN----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN  879 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~  879 (1027)
                      ++||||+++|+|.++++...                      ..+++..++.++.||++||+|||   +++||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            99999999999999997643                      24789999999999999999999   999999999999


Q ss_pred             cEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCccc
Q 048205          880 NVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTG  958 (1027)
Q Consensus       880 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~  958 (1027)
                      ||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |++||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987665554444556678999999999999999999999999999999998 89999764332


Q ss_pred             chhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          959 EMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       959 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      . .+...            +....      +...+..++.++.+|+.+||+.||++|||++||+++|.
T Consensus       274 ~-~~~~~------------~~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 A-NFYKL------------IQNGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             H-HHHHH------------HHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H-HHHHH------------HhcCC------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1 11211            11111      11223457788999999999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-47  Score=412.81  Aligned_cols=251  Identities=21%  Similarity=0.275  Sum_probs=193.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .+.|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            456999999999999999999976 68999999997543 2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecCCcccccC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |++||+|.+++... ..+++..+..++.||+.||+|||   +++|+||||||+||+++   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            99999999999764 45899999999999999999999   99999999999999995   5789999999999865322


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         ......+||+.|+|||++.+..++.++||||+||++|||++|++||.......  ...           .+....  
T Consensus       164 ---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~-----------~i~~~~--  225 (307)
T d1a06a_         164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFE-----------QILKAE--  225 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-----------HHHTTC--
T ss_pred             ---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHH-----------HHhccC--
Confidence               22344679999999999999999999999999999999999999997642211  111           011111  


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        .......+..+++++.+++.+||++||++|||++|+++
T Consensus       226 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         226 --YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              11111223456778999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=407.20  Aligned_cols=255  Identities=25%  Similarity=0.455  Sum_probs=202.7

Q ss_pred             CCCCccceeeccccceEEEEEecCC-----ceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDG-----MEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..++||+|+||+||+|+++++     ..||||+++.... .....+.+|++++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688899999999999999987632     3699999975433 345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      ||||+.+|++.+++......+++.++..++.||+.|++|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999988887777999999999999999999999   999999999999999999999999999999876433


Q ss_pred             CC-cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      .. ........||+.|+|||++.++.++.++|||||||++|||++|+.|+........ ...            .+....
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~------------~i~~~~  230 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMK------------AINDGF  230 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH------------HHHTTC
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHH------------HHhccC
Confidence            22 2233345689999999999999999999999999999999997666554322211 111            111111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            +.+.+..++.++.+|+.+||+.||++||||+||++.|+
T Consensus       231 ------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         231 ------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             ------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence                  11223456778999999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-46  Score=417.23  Aligned_cols=252  Identities=19%  Similarity=0.296  Sum_probs=212.2

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEec
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYM  828 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  828 (1027)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            56999999999999999999975 79999999998766556677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--CCCcEEEeeecCCcccccCCCc
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +||+|.+++......+++.++..|+.||+.||+|||   +.||+||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            999999988877777999999999999999999999   99999999999999998  67899999999998764332  


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                       ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... .+..            +.....    
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~------------i~~~~~----  245 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQN------------VKRCDW----  245 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHH------------HHHCCC----
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH------------HHhCCC----
Confidence             2344679999999999999999999999999999999999999997642211 1111            111000    


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      ......+..++.++.+|+.+||++||++|||++|+++.
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00111223467788999999999999999999999863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=403.64  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=199.7

Q ss_pred             ceeeccccceEEEEEecC---CceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecCC
Q 048205          756 NLIGRGGFGFVYKARIQD---GMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMPY  830 (1027)
Q Consensus       756 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  830 (1027)
                      +.||+|+||+||+|.+++   ++.||||+++...  ....+.+.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999998653   5689999986432  33456799999999999999999999999754 57899999999


Q ss_pred             CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc-ee
Q 048205          831 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL-TQ  909 (1027)
Q Consensus       831 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~  909 (1027)
                      |+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+....... ..
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999987654 4899999999999999999999   8999999999999999999999999999998765433222 23


Q ss_pred             cccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          910 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       910 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      ....||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .+..            .+...      .
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~------------~i~~~------~  227 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA------------MLEKG------E  227 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH------------HHHTT------C
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHH------------HHHcC------C
Confidence            34568999999999999999999999999999999998 89999764221  1111            11111      1


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +...+..++.++.+|+.+||+.||++|||+++|.+.|+
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            12223467788999999999999999999999988775

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-46  Score=408.85  Aligned_cols=244  Identities=25%  Similarity=0.321  Sum_probs=201.8

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .|+..+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999865 78999999997543   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+++|++..++... ..+++.++..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+....    
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            99999997766544 45899999999999999999999   99999999999999999999999999999986432    


Q ss_pred             ceecccccCccccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          907 LTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                        .....||+.|||||++.+   +.|+.++||||+||++|||++|+.||.......    .+.         .+......
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~~~---------~i~~~~~~  232 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALY---------HIAQNESP  232 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHH---------HHHHSCCC
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----HHH---------HHHhCCCC
Confidence              234579999999999863   468999999999999999999999997642211    110         01111100


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .      ..+..++.++.+|+.+||+.||++|||++|+++
T Consensus       233 ~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 A------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            0      011345677999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-46  Score=402.61  Aligned_cols=251  Identities=21%  Similarity=0.316  Sum_probs=209.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc------hhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG------RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++++...      ...+.+.+|++++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999975 799999999975422      2357789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMA  897 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla  897 (1027)
                      ++||||++||+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999987654 4899999999999999999999   99999999999999998776    5999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      +......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+..            +
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~------------i  228 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLAN------------V  228 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH------------H
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHH------------H
Confidence            8664322   2344579999999999999999999999999999999999999998642211 1111            0


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ...    ........+..++.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         229 SAV----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HTT----CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Hhc----CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000    111112233456778999999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-46  Score=408.09  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=208.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++++..   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            357999999999999999999975 79999999998542   23457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                        ......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+....+  +.   ..        +....   
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~---~~--------i~~~~---  221 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF---EL--------ILMEE---  221 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH---HH--------HHHCC---
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HH---HH--------HhcCC---
Confidence              23445689999999999999999999999999999999999999998643211  11   10        00000   


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                           ...+..++.++.+|+.+||++||++||+     ++|+++
T Consensus       222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                 1112346777899999999999999995     888875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-46  Score=400.18  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=202.5

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEYMP  829 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  829 (1027)
                      ++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++++|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5689999999999999999999888899999987543 335779999999999999999999999965 55789999999


Q ss_pred             CCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcce
Q 048205          830 YGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLT  908 (1027)
Q Consensus       830 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  908 (1027)
                      +|++.+++.... ..++|.++..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+.... ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  170 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence            999999887543 45899999999999999999999   8999999999999999999999999999998654322 233


Q ss_pred             ecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCccch
Q 048205          909 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHEDK  988 (1027)
Q Consensus       909 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  988 (1027)
                      .....||+.|+|||++..+.++.++|||||||++|||++|+.|+........ ...++            ....      
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i------------~~~~------  231 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQV------------ERGY------  231 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHH------------HTTC------
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHH------------HhcC------
Confidence            3445789999999999999999999999999999999997766654322211 11111            1111      


Q ss_pred             hhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          989 HFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       989 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +.+.+..++.++.+++.+||+.||++||++.+|+++|+
T Consensus       232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  269 (285)
T d1fmka3         232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  269 (285)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence            11223456778999999999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-46  Score=404.30  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=211.4

Q ss_pred             HHhCCCCccceeeccccceEEEEEec------CCceEEEEEEecccc-hhHHHHHHHHHHHhhccCCccceEEeEEecCC
Q 048205          747 QATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQYG-RAIKSFDIECGMIKRIRHRNIIKFISSCSSDD  819 (1027)
Q Consensus       747 ~~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  819 (1027)
                      ...++|+..+.||+|+||+||+|+++      +++.||||+++.... ...+.+.+|++++++++||||++++++|...+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34567999999999999999999864      357899999875433 34567999999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 048205          820 FKALVLEYMPYGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL  876 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  876 (1027)
                      ..++||||+++|+|.++++...                       ..+++..+..|+.|++.||+|||   +.+||||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEE
Confidence            9999999999999999986432                       24789999999999999999999   999999999


Q ss_pred             CCCcEEEcCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCCC
Q 048205          877 KPNNVLLDDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK-KPTDES  955 (1027)
Q Consensus       877 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~  955 (1027)
                      ||+||+++.++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||++|. +||...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999998765544444445567899999999999999999999999999999999996 566553


Q ss_pred             cccchhHHHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          956 FTGEMTLKRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       956 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                      ...+  ....+           .+..       ....+..++.++.+|+.+||+.||++||||.||+++|++
T Consensus       247 ~~~e--~~~~v-----------~~~~-------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~  298 (301)
T d1lufa_         247 AHEE--VIYYV-----------RDGN-------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  298 (301)
T ss_dssp             CHHH--HHHHH-----------HTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHH--HHHHH-----------HcCC-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2211  11111           1111       112234567789999999999999999999999999863

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-45  Score=400.55  Aligned_cols=244  Identities=26%  Similarity=0.310  Sum_probs=205.7

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++++..   ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56899999999999999999975 69999999997542   234577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||++||++.+++.... .+++..+..++.||+.|++|||   +++|+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999887655 4788889999999999999999   999999999999999999999999999999865422  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                         ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ...        .+....    
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~--------~i~~~~----  217 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----TYE--------KILNAE----  217 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHH--------HHHHCC----
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-----HHH--------HHHcCC----
Confidence               234679999999999999999999999999999999999999997642211     111        111111    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                          ...+..++.++.+++.+|+.+||++|+     +++|+++
T Consensus       218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                111234567789999999999999996     8999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=404.23  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=204.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCc----eEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGM----EVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  823 (1027)
                      .+|+..+.||+|+||+||+|++. +|+    .||+|+++.. ..+..+.+.+|++++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999865 454    5888887643 234567899999999999999999999999875 4678


Q ss_pred             EEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccC
Q 048205          824 VLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+||+.+|+|.+++......+++..+..++.|||+||+|||   +++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999998888778999999999999999999999   899999999999999999999999999999977654


Q ss_pred             CCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccc
Q 048205          904 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANL  982 (1027)
Q Consensus       904 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  982 (1027)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |++||......+  +...            +....
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~------------i~~~~  230 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI------------LEKGE  230 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHH------------HHHTC
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHH------------HHcCC
Confidence            44444455578999999999999999999999999999999999 788887643221  1111            11111


Q ss_pred             cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          983 LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       983 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            +...+..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence                  11223457788999999999999999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=399.85  Aligned_cols=251  Identities=19%  Similarity=0.275  Sum_probs=209.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++.... ....+.+|++++++++|||||++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367999999999999999999976 688999999976533 345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC--CcEEEeeecCCcccccCCC
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN--MVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ++||+|.+++...+..+++.++..++.||++||+|||   +.+|+||||||+||+++.+  +.+||+|||+++.....  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999999999877767999999999999999999999   9999999999999999854  58999999999865432  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       .......+|+.|+|||...+..++.++||||+||++|||++|+.||......+     ...        .+....    
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----~~~--------~i~~~~----  219 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIE--------NIMNAE----  219 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHH--------HHHHTC----
T ss_pred             -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----HHH--------HHHhCC----
Confidence             22344578999999999999999999999999999999999999997643211     111        111111    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .......+..++.++.+|+.+|+.+||++|||+.|+++
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11112223456778899999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.5e-45  Score=394.25  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCC----e
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD----F  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  820 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999865 79999999997543   234567899999999999999999999997654    4


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .|+||||++||+|.+++...+ .+++.++..++.||++||+|||   +++|+||||||+||+++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887654 4899999999999999999999   999999999999999999999999999998765


Q ss_pred             ccCC-CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhh
Q 048205          901 LKED-QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVD  979 (1027)
Q Consensus       901 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  979 (1027)
                      .... ........+||+.|+|||++.+..+++++||||+||++|||+||++||......+. ...            .+.
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~------------~~~  228 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQ------------HVR  228 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH------------HHH
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHH------------HHh
Confidence            4322 22234456799999999999999999999999999999999999999976422111 111            000


Q ss_pred             ccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-CHHHHHHHhh
Q 048205          980 ANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-NAKEIVTKLA 1026 (1027)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-s~~evl~~L~ 1026 (1027)
                      .    ...........++.++.+++.+|+++||++|| |++++++.|.
T Consensus       229 ~----~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         229 E----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             C----CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             c----CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            0    11111122235677899999999999999999 8999988774

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-44  Score=388.89  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=207.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---------hhHHHHHHHHHHHhhcc-CCccceEEeEEecC
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---------RAIKSFDIECGMIKRIR-HRNIIKFISSCSSD  818 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  818 (1027)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++...         ...+.+.+|++++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57899999999999999999975 789999999976431         12346788999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      +..++||||+++|+|.+++.... .+++.++..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997654 5899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGRE------GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLI  972 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  972 (1027)
                      ......   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||....... ....        
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~--------  226 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRM--------  226 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH--------
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHH--------
Confidence            764322   2345679999999998763      357889999999999999999999998643211 0111        


Q ss_pred             hHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          973 SIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       973 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                          +.....    .........+++++.+++.+||.+||++|||++|+++.
T Consensus       227 ----i~~~~~----~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         227 ----IMSGNY----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ----HHHTCC----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ----HHhCCC----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                111111    11112234577889999999999999999999999863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=393.72  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=197.8

Q ss_pred             CCCCccceeeccccceEEEEEecC----CceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQD----GMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|+..+.||+|+||+||+|++..    +..||||+++... ....+.+.+|++++++++|||||++++++.+ +..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence            578889999999999999998652    3568888876433 3345678999999999999999999999964 678999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|++.+++......+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999998877777999999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                       ........||+.|+|||++.+..++.++|||||||++|||+| |++||......+  +...+           ...   
T Consensus       163 -~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i-----------~~~---  225 (273)
T d1mp8a_         163 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI-----------ENG---  225 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH-----------HTT---
T ss_pred             -ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHH-----------HcC---
Confidence             223344568999999999999999999999999999999998 888987653322  11111           000   


Q ss_pred             CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          984 SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       984 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                          ...+.+..++.++.+|+.+||..||++|||++||++.|+
T Consensus       226 ----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         226 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                011223467788999999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-45  Score=399.05  Aligned_cols=257  Identities=24%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             HhCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecC-
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSD-  818 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  818 (1027)
                      ..++|++.+.||+|+||+||+|++.      +++.||||+++... ....+.+..|.+++.++ +|+||+.+++++.+. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3467999999999999999999854      34689999987543 33456677788887777 688999999998664 


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      ...++||||+++|+|.++++...               ..+++.++..++.||++||+|||   +++||||||||+|||+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeE
Confidence            46899999999999999987542               34889999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCcccchhH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK-KPTDESFTGEMTL  962 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~  962 (1027)
                      +.++.+||+|||+|+...............||+.|+|||++.+..++.++||||+||++|||+||. +||....... .+
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~  246 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF  246 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence            999999999999998765544444455667999999999999999999999999999999999975 5665432221 11


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ...+.            ...      ....+..+++++.+++.+||+.||++|||++|++++|+
T Consensus       247 ~~~~~------------~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         247 CRRLK------------EGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             HHHHH------------HTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHh------------cCC------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            11111            110      11223456778999999999999999999999999886

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=393.17  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=199.8

Q ss_pred             CCCCccceeeccccceEEEEEec--CC--ceEEEEEEecc---cchhHHHHHHHHHHHhhccCCccceEEeEEecCCeeE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ--DG--MEVAVKVFDLQ---YGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  822 (1027)
                      ++|+..+.||+|+||+||+|++.  ++  ..||||++.+.   ..+..+.|.+|++++++++||||++++++|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56888999999999999999864  22  36899988654   234567899999999999999999999999764 678


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccccc
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLK  902 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  902 (1027)
                      +||||+++|++.+++......+++..+..++.|||+||+|||   +++|+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988877677999999999999999999999   89999999999999999999999999999997654


Q ss_pred             CCCcc-eecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          903 EDQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       903 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..... ......|++.|+|||++.+..++.++|||||||++|||+| |+.||......+  ...++           ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i-----------~~~  230 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKI-----------DKE  230 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH-----------HTS
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHH-----------HhC
Confidence            43322 2334457889999999999999999999999999999998 899987542221  11111           111


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ..+.+.+..++.++.+++.+||++||++||||.||.+.|+
T Consensus       231 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         231 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                  1112233456788999999999999999999999999885

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=389.62  Aligned_cols=247  Identities=29%  Similarity=0.407  Sum_probs=198.0

Q ss_pred             hCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEec-CCeeEEEEEe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSS-DDFKALVLEY  827 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~  827 (1027)
                      .++|+..+.||+|+||.||+|+++ |+.||||+++..  ...+.+.+|++++++++||||++++++|.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            356788899999999999999985 789999998654  345778999999999999999999999855 4668999999


Q ss_pred             cCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          828 MPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      +++|+|.+++.... ..+++..++.++.||+.|++|||   +.+|+||||||+||+++.++.+|++|||+++....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999987543 45899999999999999999999   99999999999999999999999999999985432    


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                       ......+|+.|+|||++.++.++.++|||||||++|||+| |++||......  ....++.            ..    
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~------------~~----  216 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE------------KG----  216 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHT------------TT----
T ss_pred             -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH------------cC----
Confidence             2233467899999999999999999999999999999998 67777654222  2222211            00    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                        .+.+.+..+++++.+++.+||+.||++||||.|++++|+
T Consensus       217 --~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~  255 (262)
T d1byga_         217 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  255 (262)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence              112223456778999999999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-44  Score=402.37  Aligned_cols=249  Identities=24%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccc---hhHHHH---HHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG---RAIKSF---DIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+...   .....+   ..|+++++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            367999999999999999999976 699999999974321   112223   3457778888999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      |+||||++||+|.+++.... .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999987654 4789999999999999999999   9999999999999999999999999999998664


Q ss_pred             cCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc
Q 048205          902 KEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA  980 (1027)
Q Consensus       902 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  980 (1027)
                      ..    .....+||+.|+|||++.. ..++.++||||+||++|||+||+.||........  ...            ...
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~------------~~~  220 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEI------------DRM  220 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHH------------HHH
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHH------------HHh
Confidence            32    2344579999999999875 5689999999999999999999999986533221  110            000


Q ss_pred             cccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048205          981 NLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERIN-----AKEIVT 1023 (1027)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~evl~ 1023 (1027)
                      ...    .....+..+++++.+|+.+||++||++|||     ++|+++
T Consensus       221 ~~~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         221 TLT----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSS----CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ccc----CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            000    011122346778999999999999999999     688875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-44  Score=401.67  Aligned_cols=244  Identities=21%  Similarity=0.247  Sum_probs=206.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  825 (1027)
                      ++|++++.||+|+||+||+|+++ +|+.||||++++..   ....+.+.+|+++++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 79999999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQ  905 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  905 (1027)
                      ||+.+|+|.+++...+ .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987654 4899999999999999999999   999999999999999999999999999999876422  


Q ss_pred             cceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCc
Q 048205          906 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSH  985 (1027)
Q Consensus       906 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  985 (1027)
                         .....||+.|||||++.+..++.++||||+||++|||+||++||......     ....        .+....    
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~--------~i~~~~----  254 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-----QIYE--------KIVSGK----  254 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHCC----
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-----HHHH--------HHhcCC----
Confidence               23467999999999999999999999999999999999999999764211     1111        011111    


Q ss_pred             cchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          986 EDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       986 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                          ...+..+++++.+++.+||.+||++|+     +++|+++
T Consensus       255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                011234667889999999999999994     8999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=396.09  Aligned_cols=251  Identities=20%  Similarity=0.242  Sum_probs=199.9

Q ss_pred             hCCCCccc-eeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhc-cCCccceEEeEEec----CCee
Q 048205          749 TNGFSENN-LIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRI-RHRNIIKFISSCSS----DDFK  821 (1027)
Q Consensus       749 ~~~f~~~~-~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  821 (1027)
                      .++|.+.. .||+|+||+||+|++. +|+.||||+++.     .+.+.+|++++.++ +|||||+++++|.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35787764 6999999999999874 789999999863     24567899886654 89999999999865    4578


Q ss_pred             EEEEEecCCCCHHHHHhcCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecCC
Q 048205          822 ALVLEYMPYGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMA  897 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla  897 (1027)
                      |+|||||+||+|.+++.... ..+++.++..++.||+.||+|||   +.+|+||||||+||+++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997653 56899999999999999999999   999999999999999975   567999999999


Q ss_pred             cccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          898 KPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       898 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      +......   .....+||+.|+|||++.+..|+.++||||+||++|||+||++||.+...... ....            
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~------------  225 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGM------------  225 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHH------------
Confidence            8664332   23456799999999999999999999999999999999999999975422111 0000            


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..................++.++.+|+.+||++||++|||+.|+++
T Consensus       226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0000000111111223457788999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=394.99  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=211.7

Q ss_pred             hCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhc-cCCccceEEeEEecCCe
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  820 (1027)
                      .++|+..+.||+|+||+||+|++.      +++.||||+++... ......+.+|+.+++++ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            367888999999999999999852      46789999997543 33456788999999999 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-----------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          821 KALVLEYMPYGSLEKCLYSSN-----------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      .++||||+++|+|.++++...                 ..+++..+..++.||++|++|||   +++||||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999987543                 25889999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLK  963 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~  963 (1027)
                      +.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+.
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999999977655555555567899999999999999999999999999999999995555433322222222


Q ss_pred             HHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          964 RWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       964 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      +.+.            ....      ...+..++..+.+|+.+||++||++||||+||+++|+
T Consensus       259 ~~i~------------~~~~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         259 KMIK------------EGFR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             HHHH------------HTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHh------------cCCC------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2221            1111      1112345677999999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=395.72  Aligned_cols=246  Identities=22%  Similarity=0.329  Sum_probs=202.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc---chhHHHHHHHHHHHh-hccCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY---GRAIKSFDIECGMIK-RIRHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|.+.+.||+|+||+||+|+++ +|+.||||++++..   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999976 79999999997542   233455666776654 68999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCC
Q 048205          825 LEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  904 (1027)
                      |||+++|+|.+++.... .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence            99999999999997654 4889999999999999999999   999999999999999999999999999999865432 


Q ss_pred             CcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccC
Q 048205          905 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLS  984 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  984 (1027)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....  +..   .        +...    
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~---~--------i~~~----  218 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH---S--------IRMD----  218 (320)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---H--------HHHC----
T ss_pred             -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHH---H--------HHcC----
Confidence             223445679999999999999999999999999999999999999997642211  110   0        0000    


Q ss_pred             ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048205          985 HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAK-EIV 1022 (1027)
Q Consensus       985 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-evl 1022 (1027)
                          ....+..++.++.+|+.+||.+||++||++. |++
T Consensus       219 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         219 ----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                0111234667789999999999999999985 664

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=391.46  Aligned_cols=272  Identities=24%  Similarity=0.293  Sum_probs=199.8

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecCC----eeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD----FKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  825 (1027)
                      ++|...+.||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++||||++++++|.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            3567778999999999999986 5899999998744321 222344566667889999999999997654    579999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      ||+++|+|.+++++.  .++|..+..++.|+|.|++|+|..     ++++||||||||+|||++.++.+||+|||+++.+
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999875  389999999999999999999932     2369999999999999999999999999999876


Q ss_pred             ccCCCc--ceecccccCccccCcccccCC------CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh-
Q 048205          901 LKEDQS--LTQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL-  971 (1027)
Q Consensus       901 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-  971 (1027)
                      ......  .......||+.|+|||++.+.      .++.++|||||||++|||+||..||................... 
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            543322  223456799999999998754      26778999999999999999998875432221111110000000 


Q ss_pred             hh-HHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          972 IS-IMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       972 ~~-~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      .. .....+....... ........++..+.+++.+||+.||++|||+.||++.|+
T Consensus       239 ~~~~~~~~~~~~~p~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNI-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             HHHHHHHTTSCCCCCC-CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCC-CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            00 0111122211111 112223446677999999999999999999999999886

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-44  Score=388.92  Aligned_cols=250  Identities=25%  Similarity=0.459  Sum_probs=203.4

Q ss_pred             cceeeccccceEEEEEecC--C--ceEEEEEEecc-cchhHHHHHHHHHHHhhccCCccceEEeEEec-CCeeEEEEEec
Q 048205          755 NNLIGRGGFGFVYKARIQD--G--MEVAVKVFDLQ-YGRAIKSFDIECGMIKRIRHRNIIKFISSCSS-DDFKALVLEYM  828 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  828 (1027)
                      .++||+|+||+||+|++.+  +  ..||||+++.. .....+.+.+|++++++++||||+++++++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998653  2  35899998743 34456789999999999999999999999875 56889999999


Q ss_pred             CCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc--
Q 048205          829 PYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS--  906 (1027)
Q Consensus       829 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--  906 (1027)
                      ++|+|.+++.......++..+.+++.|+++|+.|+|   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999888777889999999999999999999   999999999999999999999999999999876433221  


Q ss_pred             ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhccccCcc
Q 048205          907 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLLSHE  986 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  986 (1027)
                      .......||+.|+|||++....++.++||||||+++|||+||+.||....... ....++.           ..      
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~-----------~g------  250 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL-----------QG------  250 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH-----------TT------
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHH-----------cC------
Confidence            22334568999999999999999999999999999999999888876532221 1111110           00      


Q ss_pred             chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          987 DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       987 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                       .+...+..++.++.+++.+||+.||++||++.||+++|+
T Consensus       251 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence             011123456778999999999999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=390.20  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=206.8

Q ss_pred             hCCCCccceeeccccceEEEEEecC--------CceEEEEEEecccc-hhHHHHHHHHHHHhhc-cCCccceEEeEEecC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQD--------GMEVAVKVFDLQYG-RAIKSFDIECGMIKRI-RHRNIIKFISSCSSD  818 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  818 (1027)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++.... .....+.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578889999999999999998532        34799999976543 3457788899999888 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 048205          819 DFKALVLEYMPYGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  883 (1027)
Q Consensus       819 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  883 (1027)
                      +..++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||   +.+||||||||+||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997543               34899999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCcccchhH
Q 048205          884 DDNMVAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-RKKPTDESFTGEMTL  962 (1027)
Q Consensus       884 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~  962 (1027)
                      +.++.+||+|||+++...............+|+.|+|||++.++.++.++|||||||++|||++ |++||......  ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence            9999999999999997765544444556678999999999999999999999999999999998 67787654221  11


Q ss_pred             HHHHHHHHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          963 KRWVNDLLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       963 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                      ..+            +....      ....+..++.++.+++.+||++||++||||.||++.|+
T Consensus       247 ~~~------------i~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~  292 (299)
T d1fgka_         247 FKL------------LKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  292 (299)
T ss_dssp             HHH------------HHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH------------HHcCC------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            111            11111      11223356778999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-44  Score=390.92  Aligned_cols=251  Identities=29%  Similarity=0.442  Sum_probs=201.8

Q ss_pred             CCCCccceeeccccceEEEEEec-CCc--eEEEEEEecc-cchhHHHHHHHHHHHhhc-cCCccceEEeEEecCCeeEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGM--EVAVKVFDLQ-YGRAIKSFDIECGMIKRI-RHRNIIKFISSCSSDDFKALV  824 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  824 (1027)
                      ++|++.+.||+|+||+||+|+++ +|.  .||||+++.. .....+.+.+|+++++++ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888999999999999999976 454  4778877543 334566899999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhcC---------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 048205          825 LEYMPYGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  889 (1027)
Q Consensus       825 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  889 (1027)
                      |||+++|+|.++++..               ...+++..+.+++.|||+|++|+|   +.+|+||||||+||+++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999998754               256899999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCC-CCCCCcccchhHHHHHHH
Q 048205          890 HLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKK-PTDESFTGEMTLKRWVND  968 (1027)
Q Consensus       890 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~  968 (1027)
                      ||+|||+|+.....   .......||+.|+|||.+..+.++.++|||||||++|||++|.. ||.....  ..+...   
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~~~~---  238 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEK---  238 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH---
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHHHHH---
Confidence            99999999854322   12234468999999999999999999999999999999999765 5554321  111111   


Q ss_pred             HHhhhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          969 LLLISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       969 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                               +...      .+...+..++.++.+|+.+||+.||++||||+||++.|+
T Consensus       239 ---------i~~~------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         239 ---------LPQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  281 (309)
T ss_dssp             ---------GGGT------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---------HHhc------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                     1111      112223457788999999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-44  Score=390.83  Aligned_cols=256  Identities=22%  Similarity=0.394  Sum_probs=211.1

Q ss_pred             hCCCCccceeeccccceEEEEEec------CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCCee
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ------DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFK  821 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  821 (1027)
                      .++|+..+.||+|+||+||+|++.      +++.||||+++... ......+.+|++++++++||||++++++|...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888999999999999999864      35789999987543 33445788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 048205          822 ALVLEYMPYGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  892 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  892 (1027)
                      ++||||+++|+|.+++....         ..+++..+.+++.|+|+||+|||   +.+|+||||||+||+++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886432         34688999999999999999999   8999999999999999999999999


Q ss_pred             eecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCcccchhHHHHHHHHHh
Q 048205          893 DFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRK-KPTDESFTGEMTLKRWVNDLLL  971 (1027)
Q Consensus       893 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~  971 (1027)
                      |||+|+.+.............||+.|+|||.+.++.++.++|||||||++|||+||+ +||.....     .++..    
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~~~----  246 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLR----  246 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHHH----
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHHHH----
Confidence            999998775554444455557899999999999999999999999999999999985 56654321     11111    


Q ss_pred             hhHHHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 048205          972 ISIMEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLAG 1027 (1027)
Q Consensus       972 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~~ 1027 (1027)
                          .+.+..       ....+..++..+.+++.+||+.+|++|||++||+++|++
T Consensus       247 ----~i~~~~-------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  291 (308)
T d1p4oa_         247 ----FVMEGG-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  291 (308)
T ss_dssp             ----HHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             ----HHHhCC-------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                111111       112234567789999999999999999999999998863

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=387.52  Aligned_cols=269  Identities=25%  Similarity=0.272  Sum_probs=204.3

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc--hhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG--RAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++....  ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999975 799999999965432  235678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      |+.++.+..........+++..+..++.|++.||+|||   +++||||||||+||+++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            99875444444444566999999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             ceecccccCccccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---HHHhhh-cc
Q 048205          907 LTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---IMEVVD-AN  981 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~d-~~  981 (1027)
                      .......||+.|+|||+..... ++.++||||+||++|+|++|+.||...... ..+...........   ...... +.
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhccccccccc
Confidence            2344557999999999877665 578999999999999999999999764322 11111111111000   000000 00


Q ss_pred             c-----cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          982 L-----LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       982 ~-----~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                      .     .............++.++.+|+.+|++.||++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0     000011111223456788999999999999999999999873

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-44  Score=388.61  Aligned_cols=263  Identities=25%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             ccceeeccccceEEEEEec-CCceEEEEEEecccch-----hHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          754 ENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGR-----AIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       754 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      .+++||+|+||+||+|+++ +|+.||||+++.....     ..+.+.+|++++++++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999975 6899999998644221     235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +.++++..+. .....+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+......  .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~  155 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R  155 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence            9987666554 44456888999999999999999999   9999999999999999999999999999998654332  2


Q ss_pred             eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhc------
Q 048205          908 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDA------  980 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------  980 (1027)
                      .....+||+.|+|||++... .++.++||||+||++|||++|++||...... ..+....+...........+.      
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhccchh
Confidence            33446799999999988754 5799999999999999999999999764322 112222111111000000000      


Q ss_pred             cccCc-c-chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          981 NLLSH-E-DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       981 ~~~~~-~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..... . ..........+.++.+|+.+||++||++||||+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000 0 0001112245677999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.3e-43  Score=380.98  Aligned_cols=267  Identities=22%  Similarity=0.267  Sum_probs=203.9

Q ss_pred             CCCCccceeeccccceEEEEEecCCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEEe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLEY  827 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  827 (1027)
                      ++|+..+.||+|+||+||+|++++|+.||||+++...  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999999999999999997543  23357889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCcc
Q 048205          828 MPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQSL  907 (1027)
Q Consensus       828 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  907 (1027)
                      +.++.+..+.. ....+++..+..++.||+.||+|||   +.+||||||||+||+++.++.+|++|||.|.......  .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            98866665544 4456999999999999999999999   8999999999999999999999999999998654322  2


Q ss_pred             eecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHH------Hh--h
Q 048205          908 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIM------EV--V  978 (1027)
Q Consensus       908 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~--~  978 (1027)
                      ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+ .+.+...........      +.  .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhhc
Confidence            33445689999999998754 56899999999999999999999997653221 122211111110000      00  0


Q ss_pred             hccc-cCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          979 DANL-LSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       979 d~~~-~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      +... ..............+.++.+++.+||++||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000 00011111223345678899999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-44  Score=382.47  Aligned_cols=239  Identities=23%  Similarity=0.308  Sum_probs=197.1

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccc------hhHHHHHHHHHHHhhcc--CCccceEEeEEecCCe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYG------RAIKSFDIECGMIKRIR--HRNIIKFISSCSSDDF  820 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  820 (1027)
                      ++|++.+.||+|+||+||+|++. +|+.||||++++...      ...+.+.+|++++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999975 789999999975421      12234668999999997  8999999999999999


Q ss_pred             eEEEEEecCC-CCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecCCc
Q 048205          821 KALVLEYMPY-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAK  898 (1027)
Q Consensus       821 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~  898 (1027)
                      .++||||+.+ +++.+++.... .+++.++..++.||++||+|||   +++|+||||||+||+++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 57777776543 4899999999999999999999   999999999999999985 5799999999998


Q ss_pred             ccccCCCcceecccccCccccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHh
Q 048205          899 PFLKEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEV  977 (1027)
Q Consensus       899 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  977 (1027)
                      .....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....                   ++
T Consensus       160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------------~i  216 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------------EI  216 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------------HH
T ss_pred             ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------------HH
Confidence            64322    2345679999999999987665 577899999999999999999997521                   00


Q ss_pred             hhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          978 VDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       978 ~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      .....        ..+..++.++.+++.+||+.||++|||++|+++
T Consensus       217 ~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 IRGQV--------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHCCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhccc--------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11111        111235677899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=380.80  Aligned_cols=268  Identities=24%  Similarity=0.298  Sum_probs=202.3

Q ss_pred             hCCCCccceeeccccceEEEEEec-C-CceEEEEEEecccc--hhHHHHHHHHHHHhhc---cCCccceEEeEEec----
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-D-GMEVAVKVFDLQYG--RAIKSFDIECGMIKRI---RHRNIIKFISSCSS----  817 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  817 (1027)
                      .++|++.+.||+|+||+||+|++. + ++.||||+++....  .....+.+|+++++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999874 4 56799999875432  2233456677776665   79999999999853    


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecC
Q 048205          818 -DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  896 (1027)
Q Consensus       818 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  896 (1027)
                       ....++||||++++.+..........+++..+..++.|++.||+|||   +++||||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             34689999999998777666666667899999999999999999999   99999999999999999999999999999


Q ss_pred             CcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHH
Q 048205          897 AKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIME  976 (1027)
Q Consensus       897 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  976 (1027)
                      ++....   ........||+.|+|||++.+..++.++||||+||++|||++|++||..... ...+..............
T Consensus       163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGG
T ss_pred             hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchhc
Confidence            985432   2234556799999999999999999999999999999999999999976432 122222222111100000


Q ss_pred             hh------hcccc-CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VV------DANLL-SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~------d~~~~-~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..      ..... .............+..+.+|+.+||++||++||||+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00      00000 0001111122345677899999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-41  Score=374.43  Aligned_cols=271  Identities=21%  Similarity=0.213  Sum_probs=200.6

Q ss_pred             HhCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc-chhHHHHHHHHHHHhhccCCccceEEeEEecCC----ee
Q 048205          748 ATNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY-GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD----FK  821 (1027)
Q Consensus       748 ~~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  821 (1027)
                      .+.+|++++.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3467999999999999999999864 79999999997543 334567889999999999999999999997643    23


Q ss_pred             EEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccc
Q 048205          822 ALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       822 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  901 (1027)
                      +++++|+.+|+|.+++...  .+++..+..++.|+++||+|||   +++||||||||+||+++.++.+||+|||+|+...
T Consensus        86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            4556667789999999764  4899999999999999999999   9999999999999999999999999999998664


Q ss_pred             cCCCc-ceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhH-----
Q 048205          902 KEDQS-LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISI-----  974 (1027)
Q Consensus       902 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  974 (1027)
                      ..... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. .............     
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhh
Confidence            33221 22344679999999999854 4678999999999999999999999976532211 1111111100000     


Q ss_pred             ------HHhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          975 ------MEVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       975 ------~~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                            ......................+.++.+|+.+|++.||++||||+|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00000000000011111223455678999999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=376.78  Aligned_cols=264  Identities=23%  Similarity=0.271  Sum_probs=197.6

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCC------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDD------  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  819 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999975 69999999997542  234567889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..++||||+ +.++.++.+..  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 55888877653  4899999999999999999999   99999999999999999999999999999986


Q ss_pred             cccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh--HH-
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS--IM-  975 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-  975 (1027)
                      ...     ..+...||+.|+|||++.+. .++.++||||+||++|||++|++||..... ...+...........  .. 
T Consensus       171 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred             cCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHHh
Confidence            532     23456799999999998764 578999999999999999999999976532 122222222111100  00 


Q ss_pred             -------HhhhccccCc-cchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          976 -------EVVDANLLSH-EDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       976 -------~~~d~~~~~~-~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                             .......... ...........++++.+|+.+||..||++||||+|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                   0000000000 011111123456778999999999999999999999873

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-40  Score=363.77  Aligned_cols=257  Identities=21%  Similarity=0.215  Sum_probs=200.8

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccc-eEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII-KFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  .+.+..|+++++.++|++++ .+.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            357999999999999999999875 689999999875432  34577899999999877655 55556677888999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecCCcccccC
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPFLKE  903 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~  903 (1027)
                      |+. +++.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++   .+..+|++|||+|+.+...
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            995 5777777766677999999999999999999999   99999999999999985   4567999999999976543


Q ss_pred             CCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhH--HHHHHHHHhhhHHH
Q 048205          904 DQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTL--KRWVNDLLLISIME  976 (1027)
Q Consensus       904 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~  976 (1027)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||+||+.||..........  ..+....       
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-------  232 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------  232 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-------
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-------
Confidence            221     22345579999999999999999999999999999999999999997653322111  1110000       


Q ss_pred             hhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          977 VVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       977 ~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                           .   ..........++.++.+++.+||+.+|++||+++++.+.|+
T Consensus       233 -----~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         233 -----M---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             -----H---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             -----C---CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence                 0   00011122356788999999999999999999998877664

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=375.16  Aligned_cols=262  Identities=24%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccCCccceEEeEEecC------CeeEE
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNIIKFISSCSSD------DFKAL  823 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  823 (1027)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|++++++++||||++++++|...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5778899999999999999976 699999999975432    234699999999999999999998543      35789


Q ss_pred             EEEecCCCCHHHHHh--cCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCccc
Q 048205          824 VLEYMPYGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPF  900 (1027)
Q Consensus       824 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~  900 (1027)
                      ||||++++.+..+.+  .....+++.++..++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764444332  34456899999999999999999999   99999999999999999775 8999999999866


Q ss_pred             ccCCCcceecccccCccccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh---HHH
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS---IME  976 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  976 (1027)
                      ....   .....+||+.|+|||.+.+ ..++.++||||+||++|||++|++||...... ..+...........   ..+
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhh
Confidence            4332   2334579999999998765 57899999999999999999999999764322 22222222211110   001


Q ss_pred             hh----hccccCcc--chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          977 VV----DANLLSHE--DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       977 ~~----d~~~~~~~--~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..    +.......  ..........++++.+|+.+||.+||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00    00000000  0000112245677899999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.5e-40  Score=359.30  Aligned_cols=258  Identities=14%  Similarity=0.112  Sum_probs=206.9

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhccC-CccceEEeEEecCCeeEEEEE
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRH-RNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ..+.+.+|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999966 68999999986543  23456778899999975 899999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-----CCcEEEeeecCCcccc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-----NMVAHLSDFGMAKPFL  901 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~  901 (1027)
                      |+ +++|.+++......+++.++..++.|++.|++|||   +.||+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 67999998887777999999999999999999999   999999999999999974     6789999999998765


Q ss_pred             cCCCc-----ceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchh-HHHHHHHHHhhhHH
Q 048205          902 KEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMT-LKRWVNDLLLISIM  975 (1027)
Q Consensus       902 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~  975 (1027)
                      .....     ......+||+.|||||++.+..++.++||||+||++|||+||+.||......... ....+....     
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-----  232 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-----  232 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-----
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-----
Confidence            33211     1233457999999999999999999999999999999999999999764332211 111111000     


Q ss_pred             HhhhccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 048205          976 EVVDANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTKLA 1026 (1027)
Q Consensus       976 ~~~d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~L~ 1026 (1027)
                            ..   .........+++++.+++..|+..+|++||+++.+.+.|+
T Consensus       233 ------~~---~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         233 ------QS---TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             ------HH---SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             ------CC---CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence                  00   0011112346778999999999999999999988877664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-41  Score=365.36  Aligned_cols=268  Identities=23%  Similarity=0.257  Sum_probs=208.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecCCeeEEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSDDFKALVLE  826 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  826 (1027)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+.++++++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 78999999997543  2346788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcccccCCCc
Q 048205          827 YMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPFLKEDQS  906 (1027)
Q Consensus       827 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  906 (1027)
                      ++.++++..++... ..+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+|++|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99998888876654 45789999999999999999999   99999999999999999999999999999987643322 


Q ss_pred             ceecccccCccccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------HHHhhh
Q 048205          907 LTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------IMEVVD  979 (1027)
Q Consensus       907 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d  979 (1027)
                       ......+++.|+|||++.... ++.++||||+||++|||++|+.||.........+...........      .....+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             233446788999999887665 689999999999999999999997654332222222111111100      000000


Q ss_pred             cc---ccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          980 AN---LLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       980 ~~---~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                      ..   ...............+.++.+|+.+|+++||++||||+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   000011112223345677899999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-41  Score=370.03  Aligned_cols=271  Identities=21%  Similarity=0.279  Sum_probs=198.5

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEecc--cchhHHHHHHHHHHHhhccCCccceEEeEEec--------
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQ--YGRAIKSFDIECGMIKRIRHRNIIKFISSCSS--------  817 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  817 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  .....+.+.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            367999999999999999999975 7999999998644  23345678899999999999999999999855        


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCC
Q 048205          818 DDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  897 (1027)
Q Consensus       818 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  897 (1027)
                      .+..++||||+.++.+... ......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            3468999999988665544 444456899999999999999999999   999999999999999999999999999999


Q ss_pred             cccccCCC--cceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh-
Q 048205          898 KPFLKEDQ--SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS-  973 (1027)
Q Consensus       898 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  973 (1027)
                      +.+.....  .......+||++|+|||++.+. .+++++||||+||++|||++|+.||....+.. ............. 
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  243 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP  243 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCCh
Confidence            86643222  1223345799999999998765 68999999999999999999999997643211 1111111110000 


Q ss_pred             -H---------HHhhhcccc-CccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048205          974 -I---------MEVVDANLL-SHEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVTK 1024 (1027)
Q Consensus       974 -~---------~~~~d~~~~-~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~~ 1024 (1027)
                       .         .+....... ................+.+|+.+||++||++||||+|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence             0         000000000 00000111122345567899999999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.3e-41  Score=370.12  Aligned_cols=261  Identities=22%  Similarity=0.285  Sum_probs=201.0

Q ss_pred             CCCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEec--CCeeEEEE
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSS--DDFKALVL  825 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~  825 (1027)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++..   ..+.+.+|++++++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999975 7899999998743   3467888999999995 9999999999974  45689999


Q ss_pred             EecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecCCcccccCC
Q 048205          826 EYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPFLKED  904 (1027)
Q Consensus       826 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~  904 (1027)
                      ||+++++|.++.    ..+++..+..++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999997754    24899999999999999999999   99999999999999998655 69999999998654332


Q ss_pred             CcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhhhcccc
Q 048205          905 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVVDANLL  983 (1027)
Q Consensus       905 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  983 (1027)
                         .....++|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......................+.......
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence               23456789999999998765 47999999999999999999999997654332222221111111111111110000


Q ss_pred             -----------Ccc------chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          984 -----------SHE------DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       984 -----------~~~------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                                 ...      .........++.++.+|+.+|+++||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       000      0011122346678899999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-41  Score=367.74  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=202.7

Q ss_pred             CCCCccceeeccccceEEEEEec----CCceEEEEEEeccc----chhHHHHHHHHHHHhhccC-CccceEEeEEecCCe
Q 048205          750 NGFSENNLIGRGGFGFVYKARIQ----DGMEVAVKVFDLQY----GRAIKSFDIECGMIKRIRH-RNIIKFISSCSSDDF  820 (1027)
Q Consensus       750 ~~f~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  820 (1027)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++++..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999752    58899999986432    2335667889999999977 799999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++||||+.+|+|.+++..... ..+..+..++.|++.|++|+|   +.+||||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999877654 678889999999999999999   999999999999999999999999999999866


Q ss_pred             ccCCCcceecccccCccccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhhHHHhh
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLISIMEVV  978 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  978 (1027)
                      .... ........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......... .......        .
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~--------~  249 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI--------L  249 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH--------H
T ss_pred             cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhc--------c
Confidence            4332 2223446799999999998754  4688999999999999999999999765433221 1111100        0


Q ss_pred             hccccCccchhhhHHhhhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048205          979 DANLLSHEDKHFVAKEQCMSFVFNLAMKCTIESPEERI-----NAKEIVT 1023 (1027)
Q Consensus       979 d~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~evl~ 1023 (1027)
                      ..        ....+..++.++.+++.+||.+||++||     +++|+++
T Consensus       250 ~~--------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         250 KS--------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cC--------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            00        0111235677899999999999999999     4889876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-40  Score=368.71  Aligned_cols=264  Identities=22%  Similarity=0.215  Sum_probs=193.7

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEec------CC
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSS------DD  819 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  819 (1027)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999976 69999999997543  3345678899999999999999999999964      36


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCcc
Q 048205          820 FKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  899 (1027)
Q Consensus       820 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  899 (1027)
                      ..|+||||+.++.+ +.+.   ..+++..++.++.||+.|++|||   ++||+||||||+||+++.++.+|++|||+++.
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eeEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            78999999977544 4443   24799999999999999999999   99999999999999999999999999999885


Q ss_pred             cccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHh--------
Q 048205          900 FLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLL--------  971 (1027)
Q Consensus       900 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------  971 (1027)
                      ...   .......++|+.|+|||++.+..+++++||||+||++|||++|++||...... ............        
T Consensus       169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTT
T ss_pred             ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHH
Confidence            432   23345567999999999999999999999999999999999999999764221 111111111100        


Q ss_pred             --hhHHHhhhccccC------------ccchhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          972 --ISIMEVVDANLLS------------HEDKHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       972 --~~~~~~~d~~~~~------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                        ....+..+.....            ............+.++.+|+.+|+.+||++||||+|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              0011111111000            001112234456778999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-40  Score=367.44  Aligned_cols=264  Identities=20%  Similarity=0.226  Sum_probs=198.1

Q ss_pred             hCCCCccceeeccccceEEEEEec-CCceEEEEEEeccc--chhHHHHHHHHHHHhhccCCccceEEeEEecC-----Ce
Q 048205          749 TNGFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQY--GRAIKSFDIECGMIKRIRHRNIIKFISSCSSD-----DF  820 (1027)
Q Consensus       749 ~~~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  820 (1027)
                      +++|++.+.||+|+||+||+|++. +|+.||||++++..  ....+.+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            567999999999999999999965 79999999997543  23456788999999999999999999998643     34


Q ss_pred             eEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCccc
Q 048205          821 KALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPF  900 (1027)
Q Consensus       821 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  900 (1027)
                      .++|++|+.+|+|.+++...  .+++.++..++.||+.||+|||   ++||+||||||+||+++.++.+|++|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46677888899999998654  4899999999999999999999   999999999999999999999999999999754


Q ss_pred             ccCCCcceecccccCccccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHHhhh------
Q 048205          901 LKEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTRKKPTDESFTGEMTLKRWVNDLLLIS------  973 (1027)
Q Consensus       901 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  973 (1027)
                      ..     ......||+.|+|||+..+. .++.++||||+||++|+|++|++||.+.... ..............      
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTT
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhh
Confidence            32     23445789999999987765 4689999999999999999999999764221 11111111111000      


Q ss_pred             ----HHHhhhccccCccc-hhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048205          974 ----IMEVVDANLLSHED-KHFVAKEQCMSFVFNLAMKCTIESPEERINAKEIVT 1023 (1027)
Q Consensus       974 ----~~~~~d~~~~~~~~-~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~evl~ 1023 (1027)
                          .............. .........+.++.+|+.+|++.||++||||+|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                00000000111111 111112345677899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-35  Score=330.97  Aligned_cols=265  Identities=17%  Similarity=0.204  Sum_probs=190.8

Q ss_pred             CCCccceeeccccceEEEEEec-CCceEEEEEEecccchhHHHHHHHHHHHhhcc-----------CCccceEEeEEec-
Q 048205          751 GFSENNLIGRGGFGFVYKARIQ-DGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-----------HRNIIKFISSCSS-  817 (1027)
Q Consensus       751 ~f~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~-  817 (1027)
                      +|++++.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5899999999999999999975 799999999975432 3456778898888875           5789999988754 


Q ss_pred             -CCeeEEEEEecCCCCHHHH--HhcCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCC------
Q 048205          818 -DDFKALVLEYMPYGSLEKC--LYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNM------  887 (1027)
Q Consensus       818 -~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~------  887 (1027)
                       ....++|++++..+.....  .......+++..+..++.||+.|++|||   + .||+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCcccccc
Confidence             4566677777655543222  2333456899999999999999999999   5 8999999999999998665      


Q ss_pred             cEEEeeecCCcccccCCCcceecccccCccccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCccc-----chhH
Q 048205          888 VAHLSDFGMAKPFLKEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTRKKPTDESFTG-----EMTL  962 (1027)
Q Consensus       888 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-----~~~~  962 (1027)
                      .++++|||.|.....     .....+||+.|+|||++....++.++||||+||+++||++|+.||......     ....
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            499999999985432     224467999999999999999999999999999999999999999754221     1112


Q ss_pred             HHHHHHHHhhh---------HHHhhhcc-----ccCcc--------chhhhHHhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 048205          963 KRWVNDLLLIS---------IMEVVDAN-----LLSHE--------DKHFVAKEQCMSFVFNLAMKCTIESPEERINAKE 1020 (1027)
Q Consensus       963 ~~~~~~~~~~~---------~~~~~d~~-----~~~~~--------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~e 1020 (1027)
                      ..++.......         .....+..     .....        ..........+.++.+|+.+|+++||++||||+|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            22222111100         00111100     00000        0011122456778999999999999999999999


Q ss_pred             HHHH
Q 048205         1021 IVTK 1024 (1027)
Q Consensus      1021 vl~~ 1024 (1027)
                      +++.
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9863

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.7e-33  Score=308.16  Aligned_cols=259  Identities=30%  Similarity=0.522  Sum_probs=202.4

Q ss_pred             CccEEEccccccCC--cCcccccCCCCCCeeecCC-CcccCCCCcccCCcccccEEecCCCCCCCCCCcccccccccccc
Q 048205          365 NLEELSLSGNNFSG--TIPSFIFNTSKLSTLELQR-NSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKY  441 (1027)
Q Consensus       365 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~  441 (1027)
                      +++.|+|++|.+++  .+|..++++++|++|+|++ |+++|.+|..|++|++|++|+|++|+++.               
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~---------------  115 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG---------------  115 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE---------------
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccc---------------
Confidence            57777888887776  4678888888888888886 78888888888888888888888887543               


Q ss_pred             ccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEecCccccCchhHhhhcccccceeecc
Q 048205          442 LEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLGVNKLNGSILIALGKLKKLQLLSLK  521 (1027)
Q Consensus       442 L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  521 (1027)
                                                            ..|..+..+..|+.+++++|++.+.+|..++++++|++++++
T Consensus       116 --------------------------------------~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~  157 (313)
T d1ogqa_         116 --------------------------------------AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD  157 (313)
T ss_dssp             --------------------------------------ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred             --------------------------------------cccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence                                                  223334455556666666666666666666666677777777


Q ss_pred             CceeecccCCCCCccccccccCccccccCcc-cEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccc
Q 048205          522 DNQLEGSIPDNLSFSCTLTSIPSTLWNLKDI-LCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDL  600 (1027)
Q Consensus       522 ~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L  600 (1027)
                      +|+++|.+             |..++.+..+ +.+++++|+++|..|..++++..+ .++++.|.+.|.+|..++.+++|
T Consensus       158 ~n~l~~~i-------------p~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l  223 (313)
T d1ogqa_         158 GNRISGAI-------------PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNT  223 (313)
T ss_dssp             SSCCEEEC-------------CGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCC
T ss_pred             cccccccc-------------ccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccc
Confidence            77665433             3444455544 567777777777777777777554 68999999999999999999999


Q ss_pred             cEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCCCCCCCCCCCCCCCCcccccccCCc
Q 048205          601 QYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNFSLESFKGNE  680 (1027)
Q Consensus       601 ~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~  680 (1027)
                      +.+++++|.++|.+| +++.+++|+.|+|++|+++|.+|.+|+++++|++|+|++|+|+|.||..+.+.++...++.||+
T Consensus       224 ~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         224 QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK  302 (313)
T ss_dssp             SEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred             ccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCc
Confidence            999999999997655 6888999999999999999999999999999999999999999999988888999999999999


Q ss_pred             cccCCCcccccccc
Q 048205          681 LLCGMPNLQVRSCR  694 (1027)
Q Consensus       681 ~l~g~~~~~~~~c~  694 (1027)
                      .+||.|   +|+|.
T Consensus       303 ~l~g~p---lp~c~  313 (313)
T d1ogqa_         303 CLCGSP---LPACT  313 (313)
T ss_dssp             EEESTT---SSCCC
T ss_pred             cccCCC---CCCCC
Confidence            999998   46784

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=2.9e-31  Score=291.72  Aligned_cols=251  Identities=33%  Similarity=0.467  Sum_probs=179.3

Q ss_pred             cceEEccCccccc--cCCCCccCCCCCccEEEccc-cccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEE
Q 048205          341 LKFLYLGSNSFFG--RLPSSADVRLPNLEELSLSG-NNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWL  417 (1027)
Q Consensus       341 L~~L~L~~N~l~~--~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  417 (1027)
                      ++.|+|++|.+.+  .+|..+ ..+++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l-~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSL-ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGG-GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEECCCCCCCCCCCCChHH-hcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            4444555544443  234333 3566666666665 56666667777777777777777777776666666666666666


Q ss_pred             ecCCCCCCCCCCccccccccccccccEeeccCCCCCCCCCccccCcccccceeecCCCccccccCcccccccccceEEec
Q 048205          418 DLGDNYLTSSTSELSFLSSSNCKYLEYFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEINNLTNLIAIYLG  497 (1027)
Q Consensus       418 ~L~~N~l~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~~~l~~L~~L~L~  497 (1027)
                      ++++|.+                                                     .+.+|..+++++.++.++++
T Consensus       131 ~l~~N~~-----------------------------------------------------~~~~p~~l~~l~~L~~l~l~  157 (313)
T d1ogqa_         131 DFSYNAL-----------------------------------------------------SGTLPPSISSLPNLVGITFD  157 (313)
T ss_dssp             ECCSSEE-----------------------------------------------------ESCCCGGGGGCTTCCEEECC
T ss_pred             ccccccc-----------------------------------------------------cccCchhhccCcccceeecc
Confidence            6666652                                                     23455556666666666666


Q ss_pred             CccccCchhHhhhccccc-ceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccc
Q 048205          498 VNKLNGSILIALGKLKKL-QLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVL  576 (1027)
Q Consensus       498 ~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  576 (1027)
                      +|+++|.+|..+..+.++ +.+++++|+++|..|             ..+.++.. ..+++++|.+.|.+|..++.+.++
T Consensus       158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~-------------~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l  223 (313)
T d1ogqa_         158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP-------------PTFANLNL-AFVDLSRNMLEGDASVLFGSDKNT  223 (313)
T ss_dssp             SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECC-------------GGGGGCCC-SEEECCSSEEEECCGGGCCTTSCC
T ss_pred             cccccccccccccccccccccccccccccccccc-------------cccccccc-cccccccccccccccccccccccc
Confidence            666666666666666664 677777777765433             33444433 367888888888888888888899


Q ss_pred             cEEcccccccccccchhhccCccccEEEccCCccccCccccccccccccccccccccccCCchhhhhcccCCcceeccCC
Q 048205          577 VQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLKSLNLSNNNLFGIIPISLEKLLDLKDINVSFN  656 (1027)
Q Consensus       577 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N  656 (1027)
                      +.+++++|.+.+.+| +++.+++|++|+|++|+|+|.+|++|+++++|++|||++|+|+|.|| +++++++|+.+++++|
T Consensus       224 ~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N  301 (313)
T d1ogqa_         224 QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN  301 (313)
T ss_dssp             SEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSS
T ss_pred             ccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCC
Confidence            999999999987654 68888999999999999999999999999999999999999999888 4678888999999999


Q ss_pred             C-CCCC
Q 048205          657 K-LEGE  661 (1027)
Q Consensus       657 ~-l~g~  661 (1027)
                      + ++|.
T Consensus       302 ~~l~g~  307 (313)
T d1ogqa_         302 KCLCGS  307 (313)
T ss_dssp             SEEEST
T ss_pred             ccccCC
Confidence            7 7775

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=6.9e-28  Score=272.94  Aligned_cols=103  Identities=27%  Similarity=0.451  Sum_probs=68.4

Q ss_pred             ccccCcccEEecCCCccccCccccccCcccccEEcccccccccccchhhccCccccEEEccCCccccCcccccccccccc
Q 048205          546 LWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSINNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIPDSIGDMINLK  625 (1027)
Q Consensus       546 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~l~~L~  625 (1027)
                      +..+..++.++++.|.+++ + ..+..+.+++.|++++|++++. + .+..+++|++|+|++|+|+ .+| .++++++|+
T Consensus       281 ~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~  354 (384)
T d2omza2         281 LAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNIN  354 (384)
T ss_dssp             GTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCC
T ss_pred             ccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCC
Confidence            3344555566666666554 2 2355666777777777777653 3 2677777777777777777 354 577777777


Q ss_pred             ccccccccccCCchhhhhcccCCcceeccCC
Q 048205          626 SLNLSNNNLFGIIPISLEKLLDLKDINVSFN  656 (1027)
Q Consensus       626 ~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N  656 (1027)
                      +|+|++|++++.+|  +.++++|+.|++++|
T Consensus       355 ~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             EEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             EEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            77777777776554  677777777777776

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=6.7e-28  Score=273.05  Aligned_cols=342  Identities=25%  Similarity=0.342  Sum_probs=162.7

Q ss_pred             CCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeE
Q 048205           24 NCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNL  103 (1027)
Q Consensus        24 ~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  103 (1027)
                      .+.+|++|+++++.|+. + +.+..+++|++|+|++|+|++ +| .++++++|++|++++|++.+..  .+..+++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred             HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc--ccccccccccc
Confidence            44556666666666552 2 345556666666666666653 23 2555666666666666655332  25555666666


Q ss_pred             eCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccC
Q 048205          104 DLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRL  183 (1027)
Q Consensus       104 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  183 (1027)
                      ++++|.+++..   .......+..+....|.+....+..................     ...+.............|..
T Consensus       116 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  187 (384)
T d2omza2         116 TLFNNQITDID---PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKV  187 (384)
T ss_dssp             ECCSSCCCCCG---GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc---cccccccccccccccccccccccccccccccccccccccch-----hhhhcccccccccccccccc
Confidence            66655555311   11223344445554444443322222221111111111111     11233333334444444433


Q ss_pred             CCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEE
Q 048205          184 QGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEI  263 (1027)
Q Consensus       184 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L  263 (1027)
                      .  ....+..+++++.+++++|.+++..|  +..+++|+.|++++|+++.                              
T Consensus       188 ~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~------------------------------  233 (384)
T d2omza2         188 S--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD------------------------------  233 (384)
T ss_dssp             C--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC------------------------------
T ss_pred             c--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC------------------------------
Confidence            2  22334444555555555555543322  2334445555555554431                              


Q ss_pred             EeccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcce
Q 048205          264 YLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKF  343 (1027)
Q Consensus       264 ~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  343 (1027)
                                         + ..+..+++|+.|++++|++++..  .+..+++|+.|++++|++++..+  +.++..++.
T Consensus       234 -------------------~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~  289 (384)
T d2omza2         234 -------------------I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTN  289 (384)
T ss_dssp             -------------------C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred             -------------------c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCc--ccccccccc
Confidence                               1 12334445555555555554332  24445555555555555544322  444555555


Q ss_pred             EEccCccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCC
Q 048205          344 LYLGSNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNY  423 (1027)
Q Consensus       344 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  423 (1027)
                      ++++.|.+.+ ++.  +..+++++.|++++|++++..  .+..+++|++|++++|+|+++ + .|+++++|++|++++|+
T Consensus       290 l~~~~n~l~~-~~~--~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~  362 (384)
T d2omza2         290 LELNENQLED-ISP--ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQ  362 (384)
T ss_dssp             EECCSSCCSC-CGG--GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSC
T ss_pred             cccccccccc-ccc--cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCc
Confidence            5555555532 111  234555666666666665432  255566666666666666532 2 45666666666666666


Q ss_pred             CCCCCCccccccccccccccEeeccCC
Q 048205          424 LTSSTSELSFLSSSNCKYLEYFSISNN  450 (1027)
Q Consensus       424 l~~~~~~l~~~~~~~l~~L~~L~Ls~N  450 (1027)
                      |++++.      +.++++|++|+|++|
T Consensus       363 l~~l~~------l~~l~~L~~L~L~~N  383 (384)
T d2omza2         363 ISDLTP------LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCBCGG------GTTCTTCSEEECCCE
T ss_pred             CCCChh------hccCCCCCEeeCCCC
Confidence            655432      235556666666655

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=5e-26  Score=248.63  Aligned_cols=266  Identities=24%  Similarity=0.321  Sum_probs=180.0

Q ss_pred             CCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCC
Q 048205           27 RLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        27 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  106 (1027)
                      ..+.+|.+++.++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4566777777777 6676664  567777777777774444567777777777777777776667777777777777777


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccc--cccCccccCCCCCcEEEccCccCC
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS--GDIPKEIGNLTKLKYLHLDQNRLQ  184 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~  184 (1027)
                      +|+++ .++...   .+.+..|++.+|.+.+..+..+.....+..++...|...  ...+..|..+++|+++++++|.++
T Consensus        88 ~n~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~  163 (305)
T d1xkua_          88 KNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  163 (305)
T ss_dssp             SSCCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCccC-cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence            77776 344322   346777777777777766667777777777777776543  234556777777888888887777


Q ss_pred             CCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEE
Q 048205          185 GEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIY  264 (1027)
Q Consensus       185 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~  264 (1027)
                      . +|..+  .++|+.|++++|.+++..+..|.+++.++.|++++|.++               .++...+..+++|++|+
T Consensus       164 ~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~---------------~~~~~~~~~l~~L~~L~  225 (305)
T d1xkua_         164 T-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS---------------AVDNGSLANTPHLRELH  225 (305)
T ss_dssp             S-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC---------------EECTTTGGGSTTCCEEE
T ss_pred             c-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccc---------------ccccccccccccceeee
Confidence            3 44332  467778888888777777777777778888888888776               34444555666777777


Q ss_pred             eccccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCcccc------CcCcccceeccCccc
Q 048205          265 LSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEID------NLHNLEWMIFSFNKL  327 (1027)
Q Consensus       265 Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~------~l~~L~~L~Ls~N~l  327 (1027)
                      |++|+|+          .+|.++..+++|++|+|++|+|+.+....|.      .+.+|+.|+|++|.+
T Consensus       226 L~~N~L~----------~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~  284 (305)
T d1xkua_         226 LNNNKLV----------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  284 (305)
T ss_dssp             CCSSCCS----------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             ccccccc----------ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence            7777776          4566667777777777777777765444443      233444444444443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.1e-24  Score=235.64  Aligned_cols=288  Identities=23%  Similarity=0.282  Sum_probs=236.5

Q ss_pred             CcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccC
Q 048205            4 LEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQN   83 (1027)
Q Consensus         4 l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~   83 (1027)
                      .+.+|=++++++ .+|..+.  +.+++|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|++++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            466777788888 6677764  7899999999999954445799999999999999999987888999999999999999


Q ss_pred             cccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCC--ccCcccccCCCCCcEEEccCCcccc
Q 048205           84 NFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFD--GKIPSTLLRCKHLQTLSLSINDFSG  161 (1027)
Q Consensus        84 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~  161 (1027)
                      |+++ .+|..+  ...++.|++++|.+. .++...+.....+..++...|...  ...+..|..+++|+.+++++|.+. 
T Consensus        89 n~l~-~l~~~~--~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-  163 (305)
T d1xkua_          89 NQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-  163 (305)
T ss_dssp             SCCS-BCCSSC--CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CccC-cCccch--hhhhhhhhccccchh-hhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence            9999 455543  368999999999998 577778888899999999988654  345678999999999999999998 


Q ss_pred             ccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhh
Q 048205          162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHI  241 (1027)
Q Consensus       162 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  241 (1027)
                      .+|..+  +++|+.|++++|..+...+..|..++.+++|++++|.+++..+..+.++++|++|+|++|+|+         
T Consensus       164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~---------  232 (305)
T d1xkua_         164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV---------  232 (305)
T ss_dssp             SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS---------
T ss_pred             ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc---------
Confidence            455543  689999999999999888999999999999999999999888889999999999999999997         


Q ss_pred             hhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCccccCcCCccceeccCcccc--ccCCccccCcCcccc
Q 048205          242 VNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQ--CVIPHEIDNLHNLEW  319 (1027)
Q Consensus       242 ~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~  319 (1027)
                            .+|. .+..+++|+.|+|++|+|+. ++....  ..+.....+.+|+.|+|++|+++  .+.|..|..+.....
T Consensus       233 ------~lp~-~l~~l~~L~~L~Ls~N~i~~-i~~~~f--~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~  302 (305)
T d1xkua_         233 ------KVPG-GLADHKYIQVVYLHNNNISA-IGSNDF--CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA  302 (305)
T ss_dssp             ------SCCT-TTTTCSSCCEEECCSSCCCC-CCTTSS--SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGG
T ss_pred             ------cccc-ccccccCCCEEECCCCccCc-cChhhc--cCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCcc
Confidence                  5554 45678999999999999983 333211  12334566789999999999986  355666665554443


Q ss_pred             e
Q 048205          320 M  320 (1027)
Q Consensus       320 L  320 (1027)
                      +
T Consensus       303 ~  303 (305)
T d1xkua_         303 V  303 (305)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.4e-25  Score=236.39  Aligned_cols=254  Identities=23%  Similarity=0.294  Sum_probs=127.1

Q ss_pred             EEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccc
Q 048205           31 ISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNL  110 (1027)
Q Consensus        31 L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  110 (1027)
                      +++++++++ .+|..+.  +.+++|+|++|+|++..+.+|.++++|++|++++|++..+.+..+..+..++.++.+.+.-
T Consensus        16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~   92 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ   92 (284)
T ss_dssp             EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred             EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence            344444444 4444443  3445555555555544444455555555555555555544444444455555554432222


Q ss_pred             cccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChh
Q 048205          111 TGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE  190 (1027)
Q Consensus       111 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  190 (1027)
                      ...++...|.++++|++|++++|.+....+..+...++|+.+++++|.|++..+..|..+++|+.|++++|+++++.+..
T Consensus        93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~  172 (284)
T d1ozna_          93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA  172 (284)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred             cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence            12344444455555555555555555444455555555555555555555444445555555555555555555544555


Q ss_pred             ccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccc
Q 048205          191 LGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMF  270 (1027)
Q Consensus       191 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l  270 (1027)
                      |.++++|+++++++|++++..|..|.++++|++|++++|+++               .++...|..+++|++|++++|.+
T Consensus       173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~---------------~~~~~~~~~~~~L~~L~l~~N~l  237 (284)
T d1ozna_         173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS---------------ALPTEALAPLRALQYLRLNDNPW  237 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS---------------CCCHHHHTTCTTCCEEECCSSCE
T ss_pred             hccccccchhhhhhccccccChhHhhhhhhcccccccccccc---------------cccccccccccccCEEEecCCCC
Confidence            555555555555555555555555555555555555555554               23333344455555555555555


Q ss_pred             cccCCCCCCCCCCCccccCcCCccceeccCccccccCCcccc
Q 048205          271 YGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEID  312 (1027)
Q Consensus       271 ~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  312 (1027)
                      .+..+.        .++  ...++.+....+++.+..|..+.
T Consensus       238 ~C~C~~--------~~l--~~~l~~~~~~~~~~~C~~p~~l~  269 (284)
T d1ozna_         238 VCDCRA--------RPL--WAWLQKFRGSSSEVPCSLPQRLA  269 (284)
T ss_dssp             ECSGGG--------HHH--HHHHHHCCSEECCCBEEESGGGT
T ss_pred             CCCccc--------hHH--HHHHHhCcCCCCceEeCCchHHc
Confidence            432110        000  12344555556666665555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2e-24  Score=233.04  Aligned_cols=226  Identities=25%  Similarity=0.237  Sum_probs=205.5

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc-C
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ-N   83 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~-~   83 (1027)
                      ..++.++++++ .+|..+.  +.+++|+|++|+|+...+.+|..++.|++|++++|++....+..+..+..++.++.. .
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            45678888888 6677664  679999999999996666789999999999999999998888889999999999865 6


Q ss_pred             cccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccccc
Q 048205           84 NFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDI  163 (1027)
Q Consensus        84 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  163 (1027)
                      |.++...+..|.++++|++|++++|.+. .+....+...++|+.+++++|+++++.+..|..+++|++|++++|.+++..
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~  169 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             cccccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence            7788777889999999999999999997 566777888999999999999999888899999999999999999999888


Q ss_pred             CccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCC
Q 048205          164 PKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGN  234 (1027)
Q Consensus       164 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  234 (1027)
                      +..|.++++|+++++++|+++++.|..|..+++|++|++++|.+.+..+..|.++++|++|++++|.+...
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            99999999999999999999998899999999999999999999988888999999999999999998743

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=9.1e-23  Score=217.29  Aligned_cols=202  Identities=27%  Similarity=0.234  Sum_probs=168.6

Q ss_pred             cCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCe
Q 048205           23 SNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSN  102 (1027)
Q Consensus        23 ~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  102 (1027)
                      .+...+.+++++++.++ .+|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence            45566777899999998 6787775  678899999999987667788999999999999999884 44 3577889999


Q ss_pred             EeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCcc
Q 048205          103 LDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNR  182 (1027)
Q Consensus       103 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  182 (1027)
                      |+|++|++++  ....+..+++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|+
T Consensus        82 L~Ls~N~l~~--~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          82 LDLSHNQLQS--LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             EECCSSCCSS--CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             cccccccccc--cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence            9999999874  23456778888888888888888888888888999999999999887777778888899999999999


Q ss_pred             CCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          183 LQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       183 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      +++..+..|..+++|++|+|++|+|+ .+|+.++.+++|+.|+|++|.+.
T Consensus       160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            98877788888899999999999988 77888888889999999988875

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=4.8e-22  Score=211.59  Aligned_cols=199  Identities=26%  Similarity=0.237  Sum_probs=180.2

Q ss_pred             CCCcEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEc
Q 048205            2 SNLEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWL   81 (1027)
Q Consensus         2 ~~l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L   81 (1027)
                      ..+.+++-++++++ .+|..+.  +++++|+|++|+|++..+..|..+++|++|+|++|+|+ .+| .++.+++|++|+|
T Consensus        10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~L   84 (266)
T d1p9ag_          10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL   84 (266)
T ss_dssp             TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEEC
T ss_pred             CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccc
Confidence            35677899999999 5787664  68999999999999766678999999999999999998 454 3688999999999


Q ss_pred             cCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCcccc
Q 048205           82 QNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSG  161 (1027)
Q Consensus        82 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  161 (1027)
                      ++|+++ ..+..+..+++|++|++++|.+. .++...+..+.++++|++++|.++...+..+..+++|+.|++++|++++
T Consensus        85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_          85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             CSSCCS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             cccccc-ccccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence            999998 56778999999999999999997 5777788899999999999999998889999999999999999999998


Q ss_pred             ccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccC
Q 048205          162 DIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT  208 (1027)
Q Consensus       162 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  208 (1027)
                      ..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+.
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            88889999999999999999999 78888889999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.7e-22  Score=203.34  Aligned_cols=163  Identities=18%  Similarity=0.167  Sum_probs=120.7

Q ss_pred             CccceeeccccceEEEEEecCCceEEEEEEecccc------------------hhHHHHHHHHHHHhhccCCccceEEeE
Q 048205          753 SENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYG------------------RAIKSFDIECGMIKRIRHRNIIKFISS  814 (1027)
Q Consensus       753 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~  814 (1027)
                      .+.+.||+|+||+||+|+..+|+.||||+++....                  ........|.+.+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988999999998753210                  112334568889999999999988866


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 048205          815 CSSDDFKALVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  894 (1027)
Q Consensus       815 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  894 (1027)
                      ..    .++||||+++..+.+        ++...+..++.|+++|++|||   +.+|+||||||+|||++++ .++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            32    379999998865543        334456679999999999999   9999999999999999865 5899999


Q ss_pred             cCCcccccCCCcceecccccCccccCc------ccccCCCCCcchhHHHHHHHH
Q 048205          895 GMAKPFLKEDQSLTQTQTLATIGYMAP------EYGREGRVSTNGDVYSFGIML  942 (1027)
Q Consensus       895 gla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslGvil  942 (1027)
                      |.|+....+..          ..|...      +. ....|+.++|+||..--+
T Consensus       147 G~a~~~~~~~~----------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGW----------REILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTH----------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCc----------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99975432111          011111      11 135678889999986543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=3.2e-19  Score=198.10  Aligned_cols=312  Identities=25%  Similarity=0.308  Sum_probs=152.9

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      +++|||++|.++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|++|++++|+++ .++..   .+.|++|++++
T Consensus        40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~  107 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN  107 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred             CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence            444444444444 34432   234444444444444 334322   24444444444444 22211   02345555555


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |.++ .++.  +..+++|++|++++|.+.....    ....+..+.+..+...  ....+..++.++.|++++|.+.. .
T Consensus       108 n~l~-~lp~--~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~-~  177 (353)
T d1jl5a_         108 NQLE-KLPE--LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-L  177 (353)
T ss_dssp             SCCS-SCCC--CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-C
T ss_pred             cccc-cccc--hhhhccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceecccccccccc-c
Confidence            5544 2221  2334455555555554442211    2234445555444443  22344555566666666665552 2


Q ss_pred             ChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEecc
Q 048205          188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSK  267 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~  267 (1027)
                      +.   .....+.+...++.+. .++ .+..++.|+.+++++|....               ++    .....+..+.+.+
T Consensus       178 ~~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~---------------~~----~~~~~l~~~~~~~  233 (353)
T d1jl5a_         178 PD---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT---------------LP----DLPPSLEALNVRD  233 (353)
T ss_dssp             CC---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS---------------CC----SCCTTCCEEECCS
T ss_pred             cc---cccccccccccccccc-ccc-cccccccccccccccccccc---------------cc----ccccccccccccc
Confidence            21   1122344444444444 222 34556666666666665531               11    1223455555665


Q ss_pred             ccccccCCCCCCCCCCCccccCcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEcc
Q 048205          268 NMFYGEIPSDLGNCTIPKEIGNLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLG  347 (1027)
Q Consensus       268 N~l~~~~p~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  347 (1027)
                      |.+..          .+.   ....++..++..|.+.++..    -.......++..|.+.+.    ...+++|++|+|+
T Consensus       234 ~~~~~----------~~~---~~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls  292 (353)
T d1jl5a_         234 NYLTD----------LPE---LPQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL----CDLPPSLEELNVS  292 (353)
T ss_dssp             SCCSC----------CCC---CCTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE----CCCCTTCCEEECC
T ss_pred             ccccc----------ccc---cccccccccccccccccccc----ccchhcccccccCccccc----cccCCCCCEEECC
Confidence            55542          111   12344445555444432210    012334455556655543    2235678888888


Q ss_pred             CccccccCCCCccCCCCCccEEEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEec
Q 048205          348 SNSFFGRLPSSADVRLPNLEELSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDL  419 (1027)
Q Consensus       348 ~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  419 (1027)
                      +|++. .+|..    +++|+.|+|++|+|+ .+|..   +.+|++|++++|+++. +|+...   .|+.|.+
T Consensus       293 ~N~l~-~lp~~----~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~~~~---~L~~L~~  351 (353)
T d1jl5a_         293 NNKLI-ELPAL----PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPDIPE---SVEDLRM  351 (353)
T ss_dssp             SSCCS-CCCCC----CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCCCCT---TCCEEEC
T ss_pred             CCccC-ccccc----cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCcccc---ccCeeEC
Confidence            88875 56643    578888888888887 56643   4678889999998874 565433   4555554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=6.1e-19  Score=195.87  Aligned_cols=303  Identities=30%  Similarity=0.385  Sum_probs=215.8

Q ss_pred             CCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCC-CCCcEE
Q 048205           50 TTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNL-PLLQTL  128 (1027)
Q Consensus        50 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l-~~L~~L  128 (1027)
                      .++++|||++|.++ .+|+.   .++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++     .+ +.|++|
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~-----~lp~~L~~L  103 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALS-----DLPPLLEYL  103 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCC-----SCCTTCCEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhh-----hhccccccc
Confidence            46889999999998 67864   468999999999998 667654   57899999999987 332     23 469999


Q ss_pred             EccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccC
Q 048205          129 FLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLT  208 (1027)
Q Consensus       129 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  208 (1027)
                      ++++|.+... | .+..+++|++|++++|.+.. .+.   ....+..+.+..+...  .+..+..++.++.|++++|.+.
T Consensus       104 ~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         104 GVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             ECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             cccccccccc-c-chhhhccceeeccccccccc-ccc---ccccccchhhcccccc--ccccccccccceeccccccccc
Confidence            9999999854 4 36789999999999998873 332   3466778888877765  3456788889999999999887


Q ss_pred             CCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCcccc
Q 048205          209 GTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG  288 (1027)
Q Consensus       209 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~  288 (1027)
                      . .+..   ....+.+..+++.+.               .++  .+..++.|+.+++++|...          .+|.   
T Consensus       176 ~-~~~~---~~~~~~l~~~~~~~~---------------~~~--~~~~l~~L~~l~l~~n~~~----------~~~~---  221 (353)
T d1jl5a_         176 K-LPDL---PLSLESIVAGNNILE---------------ELP--ELQNLPFLTTIYADNNLLK----------TLPD---  221 (353)
T ss_dssp             S-CCCC---CTTCCEEECCSSCCS---------------SCC--CCTTCTTCCEEECCSSCCS----------SCCS---
T ss_pred             c-cccc---ccccccccccccccc---------------ccc--ccccccccccccccccccc----------cccc---
Confidence            3 3322   234567777776664               222  2346788999999998876          2222   


Q ss_pred             CcCCccceeccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCccccccCCCCccCCCCCccE
Q 048205          289 NLAKLEKLDLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGRLPSSADVRLPNLEE  368 (1027)
Q Consensus       289 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~  368 (1027)
                      ...++..+.+.+|++... +.   ....+...++..|.+.++..    -.......++..|.+.+ ++    ..+++|++
T Consensus       222 ~~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~-~~----~~~~~L~~  288 (353)
T d1jl5a_         222 LPPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRS-LC----DLPPSLEE  288 (353)
T ss_dssp             CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSE-EC----CCCTTCCE
T ss_pred             cccccccccccccccccc-cc---cccccccccccccccccccc----ccchhcccccccCcccc-cc----ccCCCCCE
Confidence            234677888888887643 22   23455566666665554211    11344566777776643 22    23578999


Q ss_pred             EEccccccCCcCcccccCCCCCCeeecCCCcccCCCCcccCCcccccEEecCCCCCCCCCC
Q 048205          369 LSLSGNNFSGTIPSFIFNTSKLSTLELQRNSFSGFIPNTFGNLRNLKWLDLGDNYLTSSTS  429 (1027)
Q Consensus       369 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  429 (1027)
                      |+|++|+++ .+|..   +++|+.|+|++|+|+. +|..   +++|++|+|++|+|+++|.
T Consensus       289 L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~L~~N~L~~lp~  341 (353)
T d1jl5a_         289 LNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPD  341 (353)
T ss_dssp             EECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCC
T ss_pred             EECCCCccC-ccccc---cCCCCEEECCCCcCCc-cccc---cCCCCEEECcCCcCCCCCc
Confidence            999999998 56754   5789999999999984 5543   5689999999999998875

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.2e-21  Score=226.38  Aligned_cols=109  Identities=24%  Similarity=0.303  Sum_probs=58.6

Q ss_pred             CCcEEecCCCcCcccC-CccCcCCCCCcEEEccCCcccc----cCCccccccCCCcEEEcccccccee----CcccccC-
Q 048205            3 NLEYLFLKSNMFHGKI-PSTLSNCKRLRNISLSLNDFSG----TIPKEIGNVTTLIGLHLRGNKLQGE----IPEELGN-   72 (1027)
Q Consensus         3 ~l~~L~l~~n~l~~~~-~~~~~~~~~L~~L~L~~n~l~~----~~p~~i~~l~~L~~L~L~~n~i~~~----~p~~l~~-   72 (1027)
                      +|++||+++|++++.- ...+..++++++|+|++|.|+.    .++..+...++|++|||++|+|+..    +...+.. 
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            4666666666665321 2224445666666666666652    2334455566666666666666421    1222221 


Q ss_pred             CCCCCEEEccCcccCCc----cCccccCCCCCCeEeCCccccc
Q 048205           73 LAELEELWLQNNFLTGT----IPSSIFNLSSLSNLDLSVNNLT  111 (1027)
Q Consensus        73 l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~  111 (1027)
                      ..+|++|+|++|++++.    ++..+..+++|++|+|++|.++
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            23566666666666532    2344555666666666666654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=8.6e-19  Score=181.43  Aligned_cols=202  Identities=28%  Similarity=0.367  Sum_probs=101.1

Q ss_pred             EecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCccc
Q 048205            7 LFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFL   86 (1027)
Q Consensus         7 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l   86 (1027)
                      ++++.+.+++.+  .++.+.+|+.|++++|.|+ .++ .+..+++|++|++++|+|++..  .+..+++|+.+++++|.+
T Consensus        24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~   97 (227)
T d1h6ua2          24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPL   97 (227)
T ss_dssp             HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCC
T ss_pred             HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeeccc--cccccccccccccccccc
Confidence            344455555432  2345555666666666665 232 3556666666666666665322  255566666666666655


Q ss_pred             CCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCcc
Q 048205           87 TGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE  166 (1027)
Q Consensus        87 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  166 (1027)
                      +. + ..+.++++|+.+++++|...+.   ..+...+.++.+.++.+.+...  ..+..+++|++|++++|.+...  ..
T Consensus        98 ~~-i-~~l~~l~~L~~l~l~~~~~~~~---~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~  168 (227)
T d1h6ua2          98 KN-V-SAIAGLQSIKTLDLTSTQITDV---TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TP  168 (227)
T ss_dssp             SC-C-GGGTTCTTCCEEECTTSCCCCC---GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG
T ss_pred             cc-c-cccccccccccccccccccccc---chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hh
Confidence            52 2 2355556666666665555421   1233445555555555555422  2244455555555555555422  12


Q ss_pred             ccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEcc
Q 048205          167 IGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELS  227 (1027)
Q Consensus       167 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  227 (1027)
                      ++++++|++|+|++|++++. + .++.+++|++|+|++|+|++. + .+.++++|+.|+++
T Consensus       169 l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         169 LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT  225 (227)
T ss_dssp             GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred             hcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence            45555555555555555432 1 244555555555555555532 2 24455555555544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.3e-18  Score=180.24  Aligned_cols=221  Identities=18%  Similarity=0.132  Sum_probs=113.7

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCcc-CccccCCCCCCeEeCCc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTI-PSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~  107 (1027)
                      +.++++++.++ .+|..+.  +++++|+|++|+|+...+..|.++++|++|++++|.+...+ +.+|.++++++++++..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45555555555 4554442  35555555555555333344555555555555555554322 23455555555555543


Q ss_pred             -ccccccchhhhhcCCCCCcEEEccCCcCCccCcc-cccCCCCCcEEEccCCccccccCccccCCC-CCcEEEccCccCC
Q 048205          108 -NNLTGELLANICSNLPLLQTLFLDENNFDGKIPS-TLLRCKHLQTLSLSINDFSGDIPKEIGNLT-KLKYLHLDQNRLQ  184 (1027)
Q Consensus       108 -N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~  184 (1027)
                       |++. ..+...|.++++|++|++++|++....+. .+..++.+..+..+++.+....+..|..++ .++.|++++|+++
T Consensus        88 ~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          88 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence             3343 34444555555666666665555433221 223344444455555555544444555443 5666666666666


Q ss_pred             CCCChhccCCCCC-CeeeccccccCCCCCccccCCCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEE
Q 048205          185 GEIPEELGNLAEL-EKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEI  263 (1027)
Q Consensus       185 ~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L  263 (1027)
                      .+.+..|. ..++ +.+++++|+|+.+.+..|.++++|++|+|++|+|+               .+|...|.+++.|+.+
T Consensus       167 ~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~---------------~l~~~~~~~l~~L~~l  230 (242)
T d1xwdc1         167 EIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH---------------SLPSYGLENLKKLRAR  230 (242)
T ss_dssp             EECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC---------------CCCSSSCTTCCEEESS
T ss_pred             cccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC---------------ccCHHHHcCCcccccC
Confidence            43333332 2333 33345556666433344566666666666666665               4445555666666666


Q ss_pred             Eecccc
Q 048205          264 YLSKNM  269 (1027)
Q Consensus       264 ~Ls~N~  269 (1027)
                      ++.+.+
T Consensus       231 ~~~~l~  236 (242)
T d1xwdc1         231 STYNLK  236 (242)
T ss_dssp             SEESSS
T ss_pred             cCCCCC
Confidence            665543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=5.2e-18  Score=177.48  Aligned_cols=200  Identities=22%  Similarity=0.197  Sum_probs=112.1

Q ss_pred             cEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEcc-
Q 048205           53 IGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLD-  131 (1027)
Q Consensus        53 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~-  131 (1027)
                      +.++.+++.++ .+|+.+.  +++++|+|++|+|+...+..|.++++|++|++++|.+...++...|.+++.++++.+. 
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45566666665 5555442  3566666666666644444566666666666666666555555566666666666654 


Q ss_pred             CCcCCccCcccccCCCCCcEEEccCCccccccCc-cccCCCCCcEEEccCccCCCCCChhccCCC-CCCeeeccccccCC
Q 048205          132 ENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPK-EIGNLTKLKYLHLDQNRLQGEIPEELGNLA-ELEKLQLQNNFLTG  209 (1027)
Q Consensus       132 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~  209 (1027)
                      .|.+....+..|.++++|++|++++|.+....+. .+..+..+..+..+++++..+.+..|.+++ .++.|++++|+++.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~  167 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE  167 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred             cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence            3455555566666666666666666666532221 233344555555555566544445555443 56666666666663


Q ss_pred             CCCccccCCCCCCEE-EccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEecccccc
Q 048205          210 TIPPSIFNLSSLSDL-ELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFY  271 (1027)
Q Consensus       210 ~~p~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~  271 (1027)
                       ++...+...+++.+ ++++|+++               .+|...|..+++|++|++++|+|+
T Consensus       168 -i~~~~~~~~~l~~~~~l~~n~l~---------------~l~~~~f~~l~~L~~L~Ls~N~l~  214 (242)
T d1xwdc1         168 -IHNCAFNGTQLDELNLSDNNNLE---------------ELPNDVFHGASGPVILDISRTRIH  214 (242)
T ss_dssp             -ECTTTTTTCCEEEEECTTCTTCC---------------CCCTTTTTTSCCCSEEECTTSCCC
T ss_pred             -cccccccchhhhccccccccccc---------------cccHHHhcCCCCCCEEECCCCcCC
Confidence             33333333444333 44555554               455555666666666666666666

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=5.6e-21  Score=220.75  Aligned_cols=404  Identities=19%  Similarity=0.176  Sum_probs=211.3

Q ss_pred             CCcEEEccCCccccc-cCccccCCCCCcEEEccCccCCC----CCChhccCCCCCCeeeccccccCCC----CCcccc-C
Q 048205          148 HLQTLSLSINDFSGD-IPKEIGNLTKLKYLHLDQNRLQG----EIPEELGNLAELEKLQLQNNFLTGT----IPPSIF-N  217 (1027)
Q Consensus       148 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~  217 (1027)
                      +|+.||+++|++++. +...+..+++++.|+|++|.++.    .++..+...++|++|||++|.|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            578888888888742 23345567788888888887763    2234456777778888877777532    112222 2


Q ss_pred             CCCCCEEEccCccCCCCCCcchhhhhhccccCCccccCCCccccEEEeccccccccCCCCCCCCCCCcccc-CcCCccce
Q 048205          218 LSSLSDLELSFNSLTGNFPKDMHIVNRLSAELPAKFCNNIPFLEEIYLSKNMFYGEIPSDLGNCTIPKEIG-NLAKLEKL  296 (1027)
Q Consensus       218 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~p~~l~-~l~~L~~L  296 (1027)
                      ..+|+.|+|++|++++.   .+..       + +..+...++|++|++++|.++..-..     .+...+. ........
T Consensus        83 ~~~L~~L~L~~n~it~~---~~~~-------l-~~~l~~~~~L~~L~L~~N~i~~~~~~-----~l~~~l~~~~~~~~~~  146 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGA---GCGV-------L-SSTLRTLPTLQELHLSDNLLGDAGLQ-----LLCEGLLDPQCRLEKL  146 (460)
T ss_dssp             TCCCCEEECTTSCCBGG---GHHH-------H-HHHTTSCTTCCEEECCSSBCHHHHHH-----HHHHHHTSTTCCCCEE
T ss_pred             CCCCCEEECCCCCcccc---cccc-------c-cchhhccccccccccccccchhhhhh-----hhhhcccccccccccc
Confidence            24677777777777521   0000       0 12234455666666666655421000     0000000 00011111


Q ss_pred             eccCccccccCCccccCcCcccceeccCcccccccCccccccCCcceEEccCcccccc----CCCCccCCCCCccEEEcc
Q 048205          297 DLQFNRLQCVIPHEIDNLHNLEWMIFSFNKLVGVVPTTIFNVSTLKFLYLGSNSFFGR----LPSSADVRLPNLEELSLS  372 (1027)
Q Consensus       297 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~Ls  372 (1027)
                      ......+.....                    ......+.....++.++++.+.....    ........-.....+++.
T Consensus       147 ~~~~~~~~~~~~--------------------~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~  206 (460)
T d1z7xw1         147 QLEYCSLSAASC--------------------EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE  206 (460)
T ss_dssp             ECTTSCCBGGGH--------------------HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECT
T ss_pred             cccccccchhhh--------------------cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            111111110000                    00001122334455555555543210    000000111245566666


Q ss_pred             ccccCCc----CcccccCCCCCCeeecCCCcccC-----CCCcccCCcccccEEecCCCCCCCCCCcccccccccccccc
Q 048205          373 GNNFSGT----IPSFIFNTSKLSTLELQRNSFSG-----FIPNTFGNLRNLKWLDLGDNYLTSSTSELSFLSSSNCKYLE  443 (1027)
Q Consensus       373 ~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~~~l~~L~  443 (1027)
                      .+.+...    ....+.....++.+++++|++..     ..+..+.....++.+++++|.++.............++.++
T Consensus       207 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~  286 (460)
T d1z7xw1         207 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK  286 (460)
T ss_dssp             TSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCC
T ss_pred             cccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccc
Confidence            6655421    11233456677788888877532     22334455667888888888776443322222234566777


Q ss_pred             EeeccCCCCCCCCCccccCcccccceeecCCCccccccCccc-ccccccceEEecCccccCchh----Hhhhccccccee
Q 048205          444 YFSISNNPLGGILPRVIGNLSQSMEDFHMPNSNISGSIPKEI-NNLTNLIAIYLGVNKLNGSIL----IALGKLKKLQLL  518 (1027)
Q Consensus       444 ~L~Ls~N~l~~~~~~~~~~l~~~l~~l~l~~n~~~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L  518 (1027)
                      .+++++|+++......+.                     ..+ .....|+.+++++|.++....    ..+...++|++|
T Consensus       287 ~l~l~~n~i~~~~~~~l~---------------------~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L  345 (460)
T d1z7xw1         287 ELSLAGNELGDEGARLLC---------------------ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL  345 (460)
T ss_dssp             EEECTTCCCHHHHHHHHH---------------------HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEE
T ss_pred             ccccccccccccccchhh---------------------ccccccccccccccccccchhhhhhhhcccccccccchhhh
Confidence            888888776532111110                     011 122456677777777664432    334455678888


Q ss_pred             eccCceeecccCCCCCccccccccCcccc-ccCcccEEecCCCcccc----CccccccCcccccEEcccccccccccchh
Q 048205          519 SLKDNQLEGSIPDNLSFSCTLTSIPSTLW-NLKDILCLNLSLNFFTG----PLPLEIGNLKVLVQIDLSINNFSDVIPTT  593 (1027)
Q Consensus       519 ~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~-~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~n~l~~~~p~~  593 (1027)
                      +|++|++++.         +...++..+. ..+.|++|+|++|.++.    .+++.+..+++|++|||++|+|+......
T Consensus       346 ~Ls~N~i~~~---------g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~  416 (460)
T d1z7xw1         346 QISNNRLEDA---------GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ  416 (460)
T ss_dssp             ECCSSBCHHH---------HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHH
T ss_pred             heeeecccCc---------ccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHH
Confidence            8888887532         1223444443 34568888888888874    24555666788888999988887543333


Q ss_pred             h----c-cCccccEEEccCCccccCcccc
Q 048205          594 I----G-GLKDLQYLFLKYNRLQGSIPDS  617 (1027)
Q Consensus       594 ~----~-~l~~L~~L~L~~N~l~g~ip~~  617 (1027)
                      |    . .-..|+.|++++|.+....+..
T Consensus       417 l~~~l~~~~~~L~~l~l~~~~~~~~~~~~  445 (460)
T d1z7xw1         417 LVESVRQPGCLLEQLVLYDIYWSEEMEDR  445 (460)
T ss_dssp             HHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred             HHHHHHhCCCccCEEECCCCCCCHHHHHH
Confidence            3    2 3346899999999887544433

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=1.9e-17  Score=171.18  Aligned_cols=188  Identities=23%  Similarity=0.352  Sum_probs=115.9

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCc
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSV  107 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  107 (1027)
                      +..++++.+++++..  .++.+.+|+.|++.+|+|+ .++ .+..+++|++|++++|++++..|  +..+++|+++++++
T Consensus        21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG   94 (227)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred             HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence            344566666666433  4556677777777777776 343 47777777777777777764433  67777777777777


Q ss_pred             ccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCC
Q 048205          108 NNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEI  187 (1027)
Q Consensus       108 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  187 (1027)
                      |.++. +.  .+..+++|++++++++...+.  ..+...+.++.+.++++.+...  ..+..+++|++|++++|+++.. 
T Consensus        95 n~~~~-i~--~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-  166 (227)
T d1h6ua2          95 NPLKN-VS--AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-  166 (227)
T ss_dssp             CCCSC-CG--GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-
T ss_pred             ccccc-cc--ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc-
Confidence            77662 22  345666677777766665533  3355566666666666666532  2355566666666666666532 


Q ss_pred             ChhccCCCCCCeeeccccccCCCCCccccCCCCCCEEEccCccCC
Q 048205          188 PEELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       188 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                       ..++++++|++|+|++|++++. + .+.++++|++|+|++|+++
T Consensus       167 -~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         167 -TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             -GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             -hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCC
Confidence             2356666666666666666532 2 3556666666666666665

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=4.4e-17  Score=165.82  Aligned_cols=180  Identities=23%  Similarity=0.345  Sum_probs=106.6

Q ss_pred             EEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccc
Q 048205           31 ISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNL  110 (1027)
Q Consensus        31 L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  110 (1027)
                      ..+..+.+++.++.  ..+.+|++|++++|.|+. ++ .+..+++|++|+|++|++++..  .+..+++|++|++++|++
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i  102 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV  102 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence            34555555543332  245566677777776653 22 2566667777777777766432  255666777777777766


Q ss_pred             cccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCChh
Q 048205          111 TGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEE  190 (1027)
Q Consensus       111 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  190 (1027)
                      ++ ++  .+..+++|+.|++++|.+..  ...+..+++++.+++++|.+++  +..+..+++|+++++++|++++. + .
T Consensus       103 ~~-l~--~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~  173 (210)
T d1h6ta2         103 KD-LS--SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-P  173 (210)
T ss_dssp             CC-GG--GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-G
T ss_pred             cc-cc--cccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-c
Confidence            52 22  24556666666666666552  2346666666666666666653  23455566666666666666643 2 2


Q ss_pred             ccCCCCCCeeeccccccCCCCCccccCCCCCCEEEcc
Q 048205          191 LGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDLELS  227 (1027)
Q Consensus       191 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  227 (1027)
                      ++++++|++|+|++|+|+. ++ .+.++++|++|+|+
T Consensus       174 l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            5666666666666666663 33 46666666666665

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.71  E-value=5.5e-18  Score=170.04  Aligned_cols=129  Identities=26%  Similarity=0.356  Sum_probs=78.7

Q ss_pred             CcEEEccCCcccccCCccccccCCCcEEEccccccce-eCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCC
Q 048205           28 LRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQG-EIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLS  106 (1027)
Q Consensus        28 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  106 (1027)
                      .+.+++++++++ .+|..+.  +++++|+|++|+|++ ..+..|.++++|++|+|++|.+....+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            346677777776 5666554  566677777777754 334456666667777777766666666666666666666666


Q ss_pred             cccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccc
Q 048205          107 VNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFS  160 (1027)
Q Consensus       107 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  160 (1027)
                      +|+|+ .+++..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+.
T Consensus        87 ~N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          87 ENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             SCCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             ccccc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence            66665 444455555555555555555555555555555555555555555554

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.70  E-value=6.5e-18  Score=169.52  Aligned_cols=104  Identities=27%  Similarity=0.268  Sum_probs=41.6

Q ss_pred             EEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCC
Q 048205           78 ELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN  157 (1027)
Q Consensus        78 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  157 (1027)
                      .++.++++++ .+|..+.  +++++|+|++|+|++.++...|.++++|++|+|++|.+....+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            4444445444 3343332  344455555554443233333333333333333333333333333333444444444444


Q ss_pred             ccccccCccccCCCCCcEEEccCccCC
Q 048205          158 DFSGDIPKEIGNLTKLKYLHLDQNRLQ  184 (1027)
Q Consensus       158 ~l~~~~p~~~~~l~~L~~L~L~~N~l~  184 (1027)
                      +|+...|..|.++++|++|+|++|+|+
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~  115 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQIS  115 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred             cccccCHHHHhCCCcccccccCCcccc
Confidence            443333333333333333333333333

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=7.4e-17  Score=164.15  Aligned_cols=180  Identities=29%  Similarity=0.420  Sum_probs=149.9

Q ss_pred             ecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccC
Q 048205            8 FLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLT   87 (1027)
Q Consensus         8 ~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~   87 (1027)
                      .+.++.+++.++.  ..+.+|++|++++|.++. ++ .+..+++|++|+|++|+|++ ++ .++.+++|++|++++|+++
T Consensus        30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~  103 (210)
T d1h6ta2          30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK  103 (210)
T ss_dssp             HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred             HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence            4566666655543  356789999999999984 33 48899999999999999985 44 4789999999999999998


Q ss_pred             CccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccc
Q 048205           88 GTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEI  167 (1027)
Q Consensus        88 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  167 (1027)
                      + +| .+..+++|+.|++++|.+.. +  ..+..++.++.+++++|.+++  +..+..+++|+++++++|++++. + .+
T Consensus       104 ~-l~-~l~~l~~L~~L~l~~~~~~~-~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l  174 (210)
T d1h6ta2         104 D-LS-SLKDLKKLKSLSLEHNGISD-I--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PL  174 (210)
T ss_dssp             C-GG-GGTTCTTCCEEECTTSCCCC-C--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GG
T ss_pred             c-cc-cccccccccccccccccccc-c--ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cc
Confidence            4 44 58899999999999999873 3  346788999999999999984  34678899999999999999854 3 48


Q ss_pred             cCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccc
Q 048205          168 GNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN  204 (1027)
Q Consensus       168 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  204 (1027)
                      .++++|+.|+|++|+++. +| .+.++++|++|+|++
T Consensus       175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            899999999999999985 44 699999999999975

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=1.3e-16  Score=160.75  Aligned_cols=178  Identities=25%  Similarity=0.355  Sum_probs=100.4

Q ss_pred             EEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCccc
Q 048205           30 NISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNN  109 (1027)
Q Consensus        30 ~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  109 (1027)
                      .+.++.+.+++.++  ...+.++++|++++|.|+. ++ .++.+++|++|++++|++++..|  +.++++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            34455555554322  2345666666666666652 32 35566666666666666664322  6666666666666666


Q ss_pred             ccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCccccCCCCCcEEEccCccCCCCCCh
Q 048205          110 LTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPE  189 (1027)
Q Consensus       110 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  189 (1027)
                      +.. ++  .+.+++.|+.|++++|.+...  ..+..+++|+.|++++|.+.. + +.+..+++|++|++++|++++..  
T Consensus        96 ~~~-~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--  166 (199)
T d2omxa2          96 IAD-IT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--  166 (199)
T ss_dssp             CCC-CG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--
T ss_pred             ccc-cc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--
Confidence            652 22  244556666666666655532  235566666666666666652 2 24556666666666666666432  


Q ss_pred             hccCCCCCCeeeccccccCCCCCccccCCCCCCEE
Q 048205          190 ELGNLAELEKLQLQNNFLTGTIPPSIFNLSSLSDL  224 (1027)
Q Consensus       190 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  224 (1027)
                      .++++++|++|++++|+|++ ++ .++++++|+.|
T Consensus       167 ~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         167 PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            35666666666666666653 22 45556666554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=2.1e-16  Score=159.33  Aligned_cols=177  Identities=25%  Similarity=0.371  Sum_probs=147.5

Q ss_pred             EecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCccc
Q 048205            7 LFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFL   86 (1027)
Q Consensus         7 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l   86 (1027)
                      +.++.+.+++.++  ...++++++|++++|.|+. + +.+..+++|++|+|++|++++ ++. ++++++|++|++++|.+
T Consensus        23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~   96 (199)
T d2omxa2          23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQI   96 (199)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCC
T ss_pred             HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-ccc-ccCCccccccccccccc
Confidence            4567777776544  3567899999999999983 4 358899999999999999985 443 89999999999999999


Q ss_pred             CCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccCcccccCCCCCcEEEccCCccccccCcc
Q 048205           87 TGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIPSTLLRCKHLQTLSLSINDFSGDIPKE  166 (1027)
Q Consensus        87 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  166 (1027)
                      .. ++ .+.++++|+.|++++|.+.. +  ..+..+++|+.|++++|++...  +.+..+++|+.|++++|.+++. + .
T Consensus        97 ~~-~~-~l~~l~~L~~L~l~~~~~~~-~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l-~-~  167 (199)
T d2omxa2          97 AD-IT-PLANLTNLTGLTLFNNQITD-I--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL-K-P  167 (199)
T ss_dssp             CC-CG-GGTTCTTCSEEECCSSCCCC-C--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred             cc-cc-cccccccccccccccccccc-c--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC-c-c
Confidence            84 33 48899999999999999874 2  3467899999999999999843  4688999999999999999854 3 4


Q ss_pred             ccCCCCCcEEEccCccCCCCCChhccCCCCCCee
Q 048205          167 IGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKL  200 (1027)
Q Consensus       167 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  200 (1027)
                      ++++++|++|++++|++++ ++ .++.+++|++|
T Consensus       168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            8999999999999999985 33 58889998876

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=5.9e-16  Score=165.32  Aligned_cols=223  Identities=17%  Similarity=0.152  Sum_probs=161.0

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEcccccccee-CcccccCCCCCCEEEccC
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGE-IPEELGNLAELEELWLQN   83 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~-~p~~l~~l~~L~~L~L~~   83 (1027)
                      ++||++++.+.......+.. ..+..+.++...+.. .........+|++|||++|.++.. ++..+.++++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            57899988875322222211 246677777776663 333344567899999999988743 455678899999999999


Q ss_pred             cccCCccCccccCCCCCCeEeCCcc-cccccchhhhhcCCCCCcEEEccCC-cCCcc-CcccccC-CCCCcEEEccCC--
Q 048205           84 NFLTGTIPSSIFNLSSLSNLDLSVN-NLTGELLANICSNLPLLQTLFLDEN-NFDGK-IPSTLLR-CKHLQTLSLSIN--  157 (1027)
Q Consensus        84 N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~-l~~L~~L~Ls~N--  157 (1027)
                      |.+++..+..++.+++|++|++++| .+++.....++.++++|++|+++++ .++.. ....+.. .++|+.|+++++  
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~  160 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK  160 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence            9998777888889999999999995 6765445556778899999999986 44421 2223333 478999999875  


Q ss_pred             ccccc-cCccccCCCCCcEEEccCc-cCCCCCChhccCCCCCCeeecccc-ccCCCCCccccCCCCCCEEEccCc
Q 048205          158 DFSGD-IPKEIGNLTKLKYLHLDQN-RLQGEIPEELGNLAELEKLQLQNN-FLTGTIPPSIFNLSSLSDLELSFN  229 (1027)
Q Consensus       158 ~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N  229 (1027)
                      .++.. +...+.++++|++|++++| .+++.....+..+++|++|+|+++ .+++.....++++++|+.|+++++
T Consensus       161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            34321 2333456789999999886 467666777888889999999884 677666667788889999998877

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=1.7e-14  Score=139.08  Aligned_cols=111  Identities=19%  Similarity=0.151  Sum_probs=61.4

Q ss_pred             CcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCC
Q 048205           22 LSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLS  101 (1027)
Q Consensus        22 ~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  101 (1027)
                      |.++.++++|+|++|+|+ .++..+..+++|++|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            455666666777766666 445555556666666666666663 32 356666666666666666644444445566666


Q ss_pred             eEeCCcccccccchhhhhcCCCCCcEEEccCCcC
Q 048205          102 NLDLSVNNLTGELLANICSNLPLLQTLFLDENNF  135 (1027)
Q Consensus       102 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l  135 (1027)
                      +|++++|+++.......+..+++|++|++++|.+
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i  124 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPV  124 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred             cceeccccccccccccccccccccchhhcCCCcc
Confidence            6666666665211112333444444444444444

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=5e-14  Score=129.00  Aligned_cols=119  Identities=23%  Similarity=0.312  Sum_probs=78.5

Q ss_pred             cEEecCCCcCcccCCccCcCCCCCcEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205            5 EYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus         5 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      |+|++++|+++. ++ .+..+++|++|++++|+|+ .+|..++.+++|++|++++|+|+ .+| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            467777777773 33 3777777777777777777 56767777777777777777776 344 3777777777777777


Q ss_pred             ccCCcc-CccccCCCCCCeEeCCcccccc--cchhhhhcCCCCCcEE
Q 048205           85 FLTGTI-PSSIFNLSSLSNLDLSVNNLTG--ELLANICSNLPLLQTL  128 (1027)
Q Consensus        85 ~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~~l~~L~~L  128 (1027)
                      +|++.. ...+..+++|++|++++|+++.  .........+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            776432 2456677777777777777753  1233344444544443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.49  E-value=1.8e-15  Score=166.75  Aligned_cols=191  Identities=19%  Similarity=0.219  Sum_probs=94.5

Q ss_pred             CCccCcCCCCCcEEEccCCccccc----CCccccccCCCcEEEccccccce----------eCcccccCCCCCCEEEccC
Q 048205           18 IPSTLSNCKRLRNISLSLNDFSGT----IPKEIGNVTTLIGLHLRGNKLQG----------EIPEELGNLAELEELWLQN   83 (1027)
Q Consensus        18 ~~~~~~~~~~L~~L~L~~n~l~~~----~p~~i~~l~~L~~L~L~~n~i~~----------~~p~~l~~l~~L~~L~L~~   83 (1027)
                      +..++.....|++|+|++|.|+..    +...+...++|+.|+++++....          .+...+..+++|++|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            334455667777777777776533    22334455677777776654321          1223344566677777777


Q ss_pred             cccCCc----cCccccCCCCCCeEeCCcccccccchhh------------hhcCCCCCcEEEccCCcCCcc----Ccccc
Q 048205           84 NFLTGT----IPSSIFNLSSLSNLDLSVNNLTGELLAN------------ICSNLPLLQTLFLDENNFDGK----IPSTL  143 (1027)
Q Consensus        84 N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~------------~~~~l~~L~~L~L~~N~l~~~----~~~~~  143 (1027)
                      |.+...    +...+...++|++|++++|.+.......            .....+.|+.+++++|++...    +...+
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l  182 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  182 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence            766543    2223344566777777766654211111            112344555555555555421    12223


Q ss_pred             cCCCCCcEEEccCCccccc-----cCccccCCCCCcEEEccCccCCCC----CChhccCCCCCCeeeccccccC
Q 048205          144 LRCKHLQTLSLSINDFSGD-----IPKEIGNLTKLKYLHLDQNRLQGE----IPEELGNLAELEKLQLQNNFLT  208 (1027)
Q Consensus       144 ~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~  208 (1027)
                      ...+.|+.|+|++|.|...     +...+..+++|+.|+|++|.++..    +...+...++|++|+|++|.|+
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~  256 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS  256 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred             hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence            3445555555555555421     122344445555555555554321    1223344444555555555444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=2.8e-14  Score=137.62  Aligned_cols=111  Identities=22%  Similarity=0.216  Sum_probs=56.7

Q ss_pred             ccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCC
Q 048205           46 IGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLL  125 (1027)
Q Consensus        46 i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L  125 (1027)
                      +.+..++++|+|++|+|+ .++..+..+++|+.|+|++|+|+. + ..|..+++|++|++++|+++ .++..++..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhccccccc-CCCcccccccccc
Confidence            345555666666666665 345545555666666666666652 2 23555556666666666555 3333444445555


Q ss_pred             cEEEccCCcCCccCc-ccccCCCCCcEEEccCCccc
Q 048205          126 QTLFLDENNFDGKIP-STLLRCKHLQTLSLSINDFS  160 (1027)
Q Consensus       126 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  160 (1027)
                      ++|++++|+|+.... ..+..+++|++|++++|.++
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccc
Confidence            555555555442211 23444444444444444443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.48  E-value=7.3e-14  Score=127.86  Aligned_cols=103  Identities=26%  Similarity=0.322  Sum_probs=64.8

Q ss_pred             cEEEccCCcccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeEeCCcc
Q 048205           29 RNISLSLNDFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVN  108 (1027)
Q Consensus        29 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  108 (1027)
                      |+|+|++|+++ .++ .+..+++|++|++++|+|+ .+|+.++.+++|+.|++++|+|++ +| .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            56777777777 444 3677777777777777776 566667777777777777777763 33 4667777777777777


Q ss_pred             cccccchhhhhcCCCCCcEEEccCCcCC
Q 048205          109 NLTGELLANICSNLPLLQTLFLDENNFD  136 (1027)
Q Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~  136 (1027)
                      +|+.......+..+++|++|++++|.++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            7663222233344444555555544443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=7.5e-15  Score=161.80  Aligned_cols=231  Identities=20%  Similarity=0.206  Sum_probs=169.7

Q ss_pred             CCCcEEecCCCcCcc----cCCccCcCCCCCcEEEccCCcccc---c-------CCccccccCCCcEEEcccccccee--
Q 048205            2 SNLEYLFLKSNMFHG----KIPSTLSNCKRLRNISLSLNDFSG---T-------IPKEIGNVTTLIGLHLRGNKLQGE--   65 (1027)
Q Consensus         2 ~~l~~L~l~~n~l~~----~~~~~~~~~~~L~~L~L~~n~l~~---~-------~p~~i~~l~~L~~L~L~~n~i~~~--   65 (1027)
                      +.++.|+|++|.+..    .+...+...++|+.|+++++....   .       +...+...++|+.|+|++|.++..  
T Consensus        31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  110 (344)
T d2ca6a1          31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  110 (344)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence            578999999998853    344567888999999999876541   1       233456678999999999998743  


Q ss_pred             --CcccccCCCCCCEEEccCcccCCccCc-------------cccCCCCCCeEeCCcccccccc---hhhhhcCCCCCcE
Q 048205           66 --IPEELGNLAELEELWLQNNFLTGTIPS-------------SIFNLSSLSNLDLSVNNLTGEL---LANICSNLPLLQT  127 (1027)
Q Consensus        66 --~p~~l~~l~~L~~L~L~~N~l~~~~p~-------------~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~~l~~L~~  127 (1027)
                        +...+...++|++|++++|.+......             .....+.|+.+++++|+++...   ....+...+.|++
T Consensus       111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~  190 (344)
T d2ca6a1         111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT  190 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred             cchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcc
Confidence              444566789999999999987621111             1235678999999999987432   2334566789999


Q ss_pred             EEccCCcCCcc-----CcccccCCCCCcEEEccCCccccc----cCccccCCCCCcEEEccCccCCCCCChh----ccC-
Q 048205          128 LFLDENNFDGK-----IPSTLLRCKHLQTLSLSINDFSGD----IPKEIGNLTKLKYLHLDQNRLQGEIPEE----LGN-  193 (1027)
Q Consensus       128 L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~-  193 (1027)
                      |+|++|++...     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.....    +.. 
T Consensus       191 L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~  270 (344)
T d2ca6a1         191 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL  270 (344)
T ss_dssp             EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred             cccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhc
Confidence            99999998742     345677899999999999998632    4456788999999999999998543333    322 


Q ss_pred             -CCCCCeeeccccccCCC----CCcccc-CCCCCCEEEccCccCC
Q 048205          194 -LAELEKLQLQNNFLTGT----IPPSIF-NLSSLSDLELSFNSLT  232 (1027)
Q Consensus       194 -l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~  232 (1027)
                       ...|++|++++|+|+..    +...+. ++++|+.|+|++|++.
T Consensus       271 ~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             cCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence             35688888888888642    222332 4677888888888875

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=2.5e-14  Score=152.49  Aligned_cols=229  Identities=19%  Similarity=0.200  Sum_probs=164.0

Q ss_pred             CcEEecCCCcCcccCCccCcCCCCCcEEEccCCccccc-CCccccccCCCcEEEccccccceeCcccccCCCCCCEEEcc
Q 048205            4 LEYLFLKSNMFHGKIPSTLSNCKRLRNISLSLNDFSGT-IPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQ   82 (1027)
Q Consensus         4 l~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~-~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~   82 (1027)
                      +..+.+.+..+..... ......+|++|||+++.++.. ++..+..+++|++|+|++|.+++..+..++++++|++|+++
T Consensus        25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence            3455566555553332 344557899999999998744 44557789999999999999988888899999999999999


Q ss_pred             Cc-ccCCc-cCccccCCCCCCeEeCCcc-cccccchhh-hhcCCCCCcEEEccCC--cCCcc-CcccccCCCCCcEEEcc
Q 048205           83 NN-FLTGT-IPSSIFNLSSLSNLDLSVN-NLTGELLAN-ICSNLPLLQTLFLDEN--NFDGK-IPSTLLRCKHLQTLSLS  155 (1027)
Q Consensus        83 ~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~-~~~~l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~Ls  155 (1027)
                      +| .+++. +...+.++++|++|+++++ .+++..... +....++|+.|+++++  .++.. +...+.++++|++|+++
T Consensus       104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~  183 (284)
T d2astb2         104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS  183 (284)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred             ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence            95 56532 2223456899999999996 455433333 3344578999999975  34422 23344678999999999


Q ss_pred             CC-ccccccCccccCCCCCcEEEccCc-cCCCCCChhccCCCCCCeeeccccccCCC-CCccccCCCCCCEEEccCccCC
Q 048205          156 IN-DFSGDIPKEIGNLTKLKYLHLDQN-RLQGEIPEELGNLAELEKLQLQNNFLTGT-IPPSIFNLSSLSDLELSFNSLT  232 (1027)
Q Consensus       156 ~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~  232 (1027)
                      +| .+++.....+..+++|++|+|++| .+++.....++.+++|+.|+++++ ++.. ++.....+++|   .+..+.++
T Consensus       184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls  259 (284)
T d2astb2         184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFT  259 (284)
T ss_dssp             TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSC
T ss_pred             cccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCC
Confidence            86 477667778899999999999995 677666677889999999999988 4322 22222345555   45777887


Q ss_pred             CCCCc
Q 048205          233 GNFPK  237 (1027)
Q Consensus       233 ~~~p~  237 (1027)
                      +..+.
T Consensus       260 ~~~~~  264 (284)
T d2astb2         260 TIARP  264 (284)
T ss_dssp             CTTCS
T ss_pred             CCCCC
Confidence            55443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.35  E-value=3.6e-14  Score=141.86  Aligned_cols=130  Identities=22%  Similarity=0.347  Sum_probs=86.2

Q ss_pred             chhHhhhcccccceeeccCceeecccCCCCCccccccccCccccccCcccEEecCCCccccCccccccCcccccEEcccc
Q 048205          504 SILIALGKLKKLQLLSLKDNQLEGSIPDNLSFSCTLTSIPSTLWNLKDILCLNLSLNFFTGPLPLEIGNLKVLVQIDLSI  583 (1027)
Q Consensus       504 ~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  583 (1027)
                      .++..+..+++|++|+|++|+|+              .++ .+..+++|+.|+|++|.++. +|..+..+.+|+.|++++
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~--------------~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~  102 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE--------------KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISY  102 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES--------------CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSE
T ss_pred             hhhhHHhcccccceeECcccCCC--------------Ccc-cccCCccccChhhccccccc-cccccccccccccccccc
Confidence            34556777777777777777763              232 36667777777777777763 555555556777777777


Q ss_pred             cccccccchhhccCccccEEEccCCccccCcc--ccccccccccccccccccccCCchhh----------hhcccCCcce
Q 048205          584 NNFSDVIPTTIGGLKDLQYLFLKYNRLQGSIP--DSIGDMINLKSLNLSNNNLFGIIPIS----------LEKLLDLKDI  651 (1027)
Q Consensus       584 n~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip--~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~L~~l  651 (1027)
                      |+++. ++ .+..+++|+.|+|++|+++ .++  ..+..+++|+.|+|++|++....+..          +..+++|+.|
T Consensus       103 N~i~~-l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~L  179 (198)
T d1m9la_         103 NQIAS-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL  179 (198)
T ss_dssp             EECCC-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEE
T ss_pred             ccccc-cc-cccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEe
Confidence            77763 33 4677777777777777777 344  35677777777777777776443322          5667777777


Q ss_pred             e
Q 048205          652 N  652 (1027)
Q Consensus       652 ~  652 (1027)
                      |
T Consensus       180 D  180 (198)
T d1m9la_         180 D  180 (198)
T ss_dssp             S
T ss_pred             C
Confidence            6

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.32  E-value=4.7e-14  Score=141.06  Aligned_cols=128  Identities=20%  Similarity=0.232  Sum_probs=76.8

Q ss_pred             CCCcEEEccCC--cccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCcccCCccCccccCCCCCCeE
Q 048205           26 KRLRNISLSLN--DFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNNFLTGTIPSSIFNLSSLSNL  103 (1027)
Q Consensus        26 ~~L~~L~L~~n--~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  103 (1027)
                      ..++.++++++  .+. .+|..+..+++|++|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|..+..+++|++|
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L   98 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL   98 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred             cccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccc
Confidence            34555666554  344 45566777777777777777776 343 4667777777777777776 444444445567777


Q ss_pred             eCCcccccccchhhhhcCCCCCcEEEccCCcCCccCc-ccccCCCCCcEEEccCCccc
Q 048205          104 DLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKIP-STLLRCKHLQTLSLSINDFS  160 (1027)
Q Consensus       104 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  160 (1027)
                      ++++|+++. +  ..+..+++|++|++++|+|+.... ..+..+++|++|+|++|++.
T Consensus        99 ~l~~N~i~~-l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_          99 WISYNQIAS-L--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             ECSEEECCC-H--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccc-c--ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            777777662 2  224445566666666666653321 34555666666666666554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=8.3e-12  Score=119.08  Aligned_cols=104  Identities=20%  Similarity=0.170  Sum_probs=48.0

Q ss_pred             cEEEccCCcCCccCcccccCCCCCcEEEccCC-ccccccCccccCCCCCcEEEccCccCCCCCChhccCCCCCCeeeccc
Q 048205          126 QTLFLDENNFDGKIPSTLLRCKHLQTLSLSIN-DFSGDIPKEIGNLTKLKYLHLDQNRLQGEIPEELGNLAELEKLQLQN  204 (1027)
Q Consensus       126 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  204 (1027)
                      +.++.+++.+. ..|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            33455555544 23444444555555555433 24443344455555555555555555544444455555555555555


Q ss_pred             cccCCCCCccccCCCCCCEEEccCccC
Q 048205          205 NFLTGTIPPSIFNLSSLSDLELSFNSL  231 (1027)
Q Consensus       205 N~l~~~~p~~~~~l~~L~~L~Ls~N~l  231 (1027)
                      |+|+ .+|.......+|+.|+|++|.+
T Consensus        90 N~l~-~l~~~~~~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          90 NALE-SLSWKTVQGLSLQELVLSGNPL  115 (156)
T ss_dssp             SCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred             CCCc-ccChhhhccccccccccCCCcc
Confidence            5554 2222222222444444444444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=1.8e-11  Score=116.77  Aligned_cols=103  Identities=18%  Similarity=0.108  Sum_probs=46.1

Q ss_pred             EEecCCCcCcccCCccCcCCCCCcEEEccCC-cccccCCccccccCCCcEEEccccccceeCcccccCCCCCCEEEccCc
Q 048205            6 YLFLKSNMFHGKIPSTLSNCKRLRNISLSLN-DFSGTIPKEIGNVTTLIGLHLRGNKLQGEIPEELGNLAELEELWLQNN   84 (1027)
Q Consensus         6 ~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n-~l~~~~p~~i~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N   84 (1027)
                      .++.++++++ .+|..+..+++|++|++++| .|+..-+..|..+++|+.|+|++|+|+...+++|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3444444444 23444444455555555433 244333334444555555555555554444444455555555555555


Q ss_pred             ccCCccCccccCCCCCCeEeCCcccc
Q 048205           85 FLTGTIPSSIFNLSSLSNLDLSVNNL  110 (1027)
Q Consensus        85 ~l~~~~p~~l~~l~~L~~L~Ls~N~l  110 (1027)
                      +|+...+..| ...+|++|+|++|.+
T Consensus        91 ~l~~l~~~~~-~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          91 ALESLSWKTV-QGLSLQELVLSGNPL  115 (156)
T ss_dssp             CCSCCCSTTT-CSCCCCEEECCSSCC
T ss_pred             CCcccChhhh-ccccccccccCCCcc
Confidence            5542222222 222344455554444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.42  E-value=5.7e-07  Score=93.26  Aligned_cols=148  Identities=16%  Similarity=0.125  Sum_probs=103.7

Q ss_pred             HHHHHhCCCCccceeeccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhcc-CCccceEEeEEecCCeeE
Q 048205          744 ELFQATNGFSENNLIGRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIR-HRNIIKFISSCSSDDFKA  822 (1027)
Q Consensus       744 ~~~~~~~~f~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  822 (1027)
                      ++....+.|+..+..+.++.+.||+... +++.+++|+...........+.+|.++++.+. +--+.++++++..++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            5556667777766655566678998864 46677889876555444556778888888774 444678888888889999


Q ss_pred             EEEEecCCCCHHHHHhcCCccCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 048205          823 LVLEYMPYGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----------------------------------  867 (1027)
Q Consensus       823 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  867 (1027)
                      +||++++|.++.+......      ....++.++++.++.||...                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999988765432211      12234455555566665211                                   


Q ss_pred             ---------------------CCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          868 ---------------------SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       868 ---------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                                           ...++|+|+.|.||++++++.+-++||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 1127899999999999987777799999875

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.39  E-value=1.5e-08  Score=96.75  Aligned_cols=45  Identities=33%  Similarity=0.212  Sum_probs=21.0

Q ss_pred             cccccCCCCCCEEEccCcccCCcc--CccccCCCCCCeEeCCccccc
Q 048205           67 PEELGNLAELEELWLQNNFLTGTI--PSSIFNLSSLSNLDLSVNNLT  111 (1027)
Q Consensus        67 p~~l~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~  111 (1027)
                      +..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~  104 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  104 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence            333344555555555555555321  223344455555555555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.35  E-value=4e-08  Score=93.64  Aligned_cols=80  Identities=21%  Similarity=0.152  Sum_probs=36.3

Q ss_pred             CCCEEEccCcccCCccCccccCCCCCCeEeCCcccccccchhhhhcCCCCCcEEEccCCcCCccC--cccccCCCCCcEE
Q 048205           75 ELEELWLQNNFLTGTIPSSIFNLSSLSNLDLSVNNLTGELLANICSNLPLLQTLFLDENNFDGKI--PSTLLRCKHLQTL  152 (1027)
Q Consensus        75 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L  152 (1027)
                      +.+.|+++++...    ..+..+..+..++...+...  .....+..+++|++|+|++|+|+.+.  +..+..+++|+.|
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~--~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L   96 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA--TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL   96 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH--HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh--hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccc
Confidence            3445555544422    12333444444444444332  22333444555555555555555332  2334445555555


Q ss_pred             EccCCccc
Q 048205          153 SLSINDFS  160 (1027)
Q Consensus       153 ~Ls~N~l~  160 (1027)
                      +|++|.|+
T Consensus        97 ~Ls~N~i~  104 (162)
T d1koha1          97 NLSGNELK  104 (162)
T ss_dssp             CCTTSCCC
T ss_pred             ccccCccc
Confidence            55555554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.96  E-value=8.1e-06  Score=83.76  Aligned_cols=130  Identities=16%  Similarity=0.121  Sum_probs=85.4

Q ss_pred             eeecccc-ceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCC--ccceEEeEEecCCeeEEEEEecCCCCH
Q 048205          757 LIGRGGF-GFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHR--NIIKFISSCSSDDFKALVLEYMPYGSL  833 (1027)
Q Consensus       757 ~lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lV~e~~~~gsL  833 (1027)
                      .+..|.. +.||+....++..+++|......   ...+..|++.++.+...  .+.++++++.+.+..++||+|++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3455554 57899998888889999865332   33466788887777533  356788888888889999999988665


Q ss_pred             HHHHhcCCccCCHHHHHHHHHHHHHHHHHhh-------------------------------------------------
Q 048205          834 EKCLYSSNYILDIFQRLNIMIDVASALEYLH-------------------------------------------------  864 (1027)
Q Consensus       834 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH-------------------------------------------------  864 (1027)
                      .+..      ...   ...+.++++.++.||                                                 
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3310      010   111122223333333                                                 


Q ss_pred             --c----CCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          865 --F----GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       865 --~----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                        .    .....++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence              1    011237999999999999987777899999775

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.70  E-value=1e-05  Score=76.77  Aligned_cols=42  Identities=26%  Similarity=0.255  Sum_probs=18.2

Q ss_pred             ccCCCCCCEEEccCcccCCc----cCccccCCCCCCeEeCCccccc
Q 048205           70 LGNLAELEELWLQNNFLTGT----IPSSIFNLSSLSNLDLSVNNLT  111 (1027)
Q Consensus        70 l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~  111 (1027)
                      +...+.|++|+|++|.+...    +...+...+.|++|+|++|.++
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            33444444444444444421    1122233345555555555554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.58  E-value=2.6e-05  Score=73.98  Aligned_cols=89  Identities=15%  Similarity=0.189  Sum_probs=61.9

Q ss_pred             cCCCCCcEEEccCC-ccccc----CCccccccCCCcEEEcccccccee----CcccccCCCCCCEEEccCcccCCc----
Q 048205           23 SNCKRLRNISLSLN-DFSGT----IPKEIGNVTTLIGLHLRGNKLQGE----IPEELGNLAELEELWLQNNFLTGT----   89 (1027)
Q Consensus        23 ~~~~~L~~L~L~~n-~l~~~----~p~~i~~l~~L~~L~L~~n~i~~~----~p~~l~~l~~L~~L~L~~N~l~~~----   89 (1027)
                      .+.++|++|+|+++ .++..    +...+...++|++|+|++|.+...    +.+.+...+.|++|+|++|.++..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45578888888864 46532    344566677888888888888632    334455678899999999988843    


Q ss_pred             cCccccCCCCCCeEeCCccccc
Q 048205           90 IPSSIFNLSSLSNLDLSVNNLT  111 (1027)
Q Consensus        90 ~p~~l~~l~~L~~L~Ls~N~l~  111 (1027)
                      +-.++...++|++|++++|.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHHHhCCcCCEEECCCCcCC
Confidence            2235666677888888887654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.39  E-value=0.00028  Score=76.72  Aligned_cols=76  Identities=18%  Similarity=0.212  Sum_probs=48.9

Q ss_pred             cceeeccccceEEEEEecC-CceEEEEEEecc-------cchhHHHHHHHHHHHhhcc-C--CccceEEeEEecCCeeEE
Q 048205          755 NNLIGRGGFGFVYKARIQD-GMEVAVKVFDLQ-------YGRAIKSFDIECGMIKRIR-H--RNIIKFISSCSSDDFKAL  823 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  823 (1027)
                      .+.||.|....||+++..+ ++.|+||.-...       ......+...|.++++.+. +  ..+.+++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            4578999999999998764 678999965421       1112344556888887663 2  3455666543  345589


Q ss_pred             EEEecCCCC
Q 048205          824 VLEYMPYGS  832 (1027)
Q Consensus       824 V~e~~~~gs  832 (1027)
                      ||||+++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997754

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.12  E-value=4.5e-05  Score=72.19  Aligned_cols=15  Identities=20%  Similarity=0.370  Sum_probs=6.9

Q ss_pred             CCCCCeEeCCccccc
Q 048205           97 LSSLSNLDLSVNNLT  111 (1027)
Q Consensus        97 l~~L~~L~Ls~N~l~  111 (1027)
                      .++++.+++++|.++
T Consensus        73 ~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          73 NNTLKSLNVESNFIS   87 (166)
T ss_dssp             CSSCCEEECCSSCCC
T ss_pred             cccchhhhhcccccc
Confidence            344444444444443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.95  E-value=0.0011  Score=70.04  Aligned_cols=133  Identities=14%  Similarity=0.133  Sum_probs=78.2

Q ss_pred             cceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccc--eEE-----eEEecCCeeEEEEEecCCCCH--
Q 048205          763 FGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII--KFI-----SSCSSDDFKALVLEYMPYGSL--  833 (1027)
Q Consensus       763 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~-----~~~~~~~~~~lV~e~~~~gsL--  833 (1027)
                      --.||+++..+|+.|++|+.+.... ..+++..|.+.+..+....+.  ..+     ..+...+..+.|+++++|..+  
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            3589999999999999999875422 346677888888887533322  111     122345667889999976532  


Q ss_pred             ---HHH---------Hhc----C----CccCCHH----------------------HHHHHHHHHHHHHHHh-hcCCCCC
Q 048205          834 ---EKC---------LYS----S----NYILDIF----------------------QRLNIMIDVASALEYL-HFGYSVP  870 (1027)
Q Consensus       834 ---~~~---------l~~----~----~~~~~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~  870 (1027)
                         ..+         ++.    .    ....++.                      .....+.++...+.-. ......+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               111         110    0    0111111                      1112222233322222 1222467


Q ss_pred             eEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          871 IIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       871 ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ++|+|+.+.||+++++  ..++||+-+.
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcc
Confidence            8999999999999743  4589999886

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.94  E-value=0.00019  Score=67.75  Aligned_cols=91  Identities=18%  Similarity=0.254  Sum_probs=64.0

Q ss_pred             cCcCCCCCcEEEccC-Cccccc----CCccccccCCCcEEEcccccccee----CcccccCCCCCCEEEccCcccCCc--
Q 048205           21 TLSNCKRLRNISLSL-NDFSGT----IPKEIGNVTTLIGLHLRGNKLQGE----IPEELGNLAELEELWLQNNFLTGT--   89 (1027)
Q Consensus        21 ~~~~~~~L~~L~L~~-n~l~~~----~p~~i~~l~~L~~L~L~~n~i~~~----~p~~l~~l~~L~~L~L~~N~l~~~--   89 (1027)
                      ...+.+.|++|+|++ +.++..    +-.++...++|++|+|++|.++..    +...+...+.++.+++++|.+...  
T Consensus        12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~   91 (166)
T d1io0a_          12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI   91 (166)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence            345678899999987 557532    344556788899999999988633    334556778999999999998732  


Q ss_pred             --cCccccCCCCCCeEeC--Cccccc
Q 048205           90 --IPSSIFNLSSLSNLDL--SVNNLT  111 (1027)
Q Consensus        90 --~p~~l~~l~~L~~L~L--s~N~l~  111 (1027)
                        +...+...++|+.++|  ++|.+.
T Consensus        92 ~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          92 LALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHHhCccccEEeeccCCCcCc
Confidence              2345666788886544  566665

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.58  E-value=0.0047  Score=64.56  Aligned_cols=156  Identities=13%  Similarity=0.095  Sum_probs=86.2

Q ss_pred             ccHHHHHHHhCCCCcccee-----eccccceEEEEEecCCceEEEEEEecccchhHHHHHHHHHHHhhccCCccc--eEE
Q 048205          740 FTYLELFQATNGFSENNLI-----GRGGFGFVYKARIQDGMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNII--KFI  812 (1027)
Q Consensus       740 ~~~~~~~~~~~~f~~~~~l-----G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~  812 (1027)
                      .+.+++.....+|...++.     ..|---+.|+.+..+| .+++|++....  ..+.+..|++++..+...++.  ..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            3456777777888775543     3566678899987665 58999986432  234555677777777533321  111


Q ss_pred             e------EEecCCeeEEEEEecCCCCHHH-----H---------Hhc----CC----c------------------cCCH
Q 048205          813 S------SCSSDDFKALVLEYMPYGSLEK-----C---------LYS----SN----Y------------------ILDI  846 (1027)
Q Consensus       813 ~------~~~~~~~~~lV~e~~~~gsL~~-----~---------l~~----~~----~------------------~~~~  846 (1027)
                      .      +....+....++.++.+.....     .         ++.    ..    .                  ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1122345667777776643211     0         000    00    0                  0000


Q ss_pred             HHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCcEEEcCCCcEEEeeecCCc
Q 048205          847 FQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  898 (1027)
Q Consensus       847 ~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  898 (1027)
                      ......+..+...+...+ .....|+||+|+.+.||+++.+...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111122222333333333 2335789999999999999988877899999876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.44  E-value=0.0031  Score=68.28  Aligned_cols=73  Identities=18%  Similarity=0.226  Sum_probs=50.1

Q ss_pred             cceeeccccceEEEEEecC--------CceEEEEEEecccchhHHHHHHHHHHHhhccCCcc-ceEEeEEecCCeeEEEE
Q 048205          755 NNLIGRGGFGFVYKARIQD--------GMEVAVKVFDLQYGRAIKSFDIECGMIKRIRHRNI-IKFISSCSSDDFKALVL  825 (1027)
Q Consensus       755 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  825 (1027)
                      ++.|+.|-.-.+|+++..+        .+.|.+++... .. ......+|.++++.+.-.++ .++++++..    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4578889999999998653        34577777652 22 23455678888888853344 477777653    6899


Q ss_pred             EecCCCCH
Q 048205          826 EYMPYGSL  833 (1027)
Q Consensus       826 e~~~~gsL  833 (1027)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543